drug_id,category_name,source
DB00001,"Amino Acids, Peptides, and Proteins",DrugBank
DB00001,Anticoagulants,DrugBank
DB00001,Antithrombin Proteins,DrugBank
DB00001,Antithrombins,DrugBank
DB00001,Blood and Blood Forming Organs,DrugBank
DB00001,Cardiovascular Agents,DrugBank
DB00001,Enzyme Inhibitors,DrugBank
DB00001,Fibrin Modulating Agents,DrugBank
DB00001,Hematologic Agents,DrugBank
DB00001,Peptides,DrugBank
DB00001,Protease Inhibitors,DrugBank
DB00001,Proteins,DrugBank
DB00001,Serine Protease Inhibitors,DrugBank
DB00001,Serpins,DrugBank
DB00001,Thrombin Inhibitors,DrugBank
DB00002,"Amino Acids, Peptides, and Proteins",DrugBank
DB00002,Antibodies,DrugBank
DB00002,"Antibodies, Monoclonal",DrugBank
DB00002,"Antibodies, Monoclonal, Humanized",DrugBank
DB00002,Antineoplastic Agents,DrugBank
DB00002,"Antineoplastic Agents, Immunological",DrugBank
DB00002,Antineoplastic and Immunomodulating Agents,DrugBank
DB00002,Blood Proteins,DrugBank
DB00002,Cancer immunotherapy,DrugBank
DB00002,EGFR (Epidermal Growth Factor Receptor) inhibitors,DrugBank
DB00002,Epidermal Growth Factor Receptor Antagonist,DrugBank
DB00002,Globulins,DrugBank
DB00002,HER1 Antagonists,DrugBank
DB00002,Immunoglobulins,DrugBank
DB00002,Immunoproteins,DrugBank
DB00002,Immunotherapy,DrugBank
DB00002,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB00002,Narrow Therapeutic Index Drugs,DrugBank
DB00002,Proteins,DrugBank
DB00002,Serum Globulins,DrugBank
DB00004,ADP Ribose Transferases,DrugBank
DB00004,"Amino Acids, Peptides, and Proteins",DrugBank
DB00004,Antineoplastic Agents,DrugBank
DB00004,Antineoplastic and Immunomodulating Agents,DrugBank
DB00004,Bacterial Toxins,DrugBank
DB00004,Biological Factors,DrugBank
DB00004,Cancer immunotherapy,DrugBank
DB00004,CD25-directed Cytotoxin,DrugBank
DB00004,Cytotoxins,DrugBank
DB00004,Enzymes and Coenzymes,DrugBank
DB00004,Immunotherapy,DrugBank
DB00004,Intercellular Signaling Peptides and Proteins,DrugBank
DB00004,Interleukins,DrugBank
DB00004,Narrow Therapeutic Index Drugs,DrugBank
DB00004,Peptides,DrugBank
DB00004,Proteins,DrugBank
DB00004,Recombinant Fusion Proteins,DrugBank
DB00004,Recombinant Proteins,DrugBank
DB00004,"Toxins, Biological",DrugBank
DB00005,Agents reducing cytokine levels,DrugBank
DB00005,"Amino Acids, Peptides, and Proteins",DrugBank
DB00005,Anti-Inflammatory Agents,DrugBank
DB00005,Antibodies,DrugBank
DB00005,Antirheumatic Agents,DrugBank
DB00005,Biological Products,DrugBank
DB00005,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB00005,Dermatologicals,DrugBank
DB00005,Disease-modifying Antirheumatic Agents,DrugBank
DB00005,Immunoglobulin Constant Regions,DrugBank
DB00005,Immunoglobulin Fc Fragments,DrugBank
DB00005,Immunoglobulin Fragments,DrugBank
DB00005,Immunoglobulin Isotypes,DrugBank
DB00005,Immunologic Factors,DrugBank
DB00005,Immunoproteins,DrugBank
DB00005,Immunosuppressive Agents,DrugBank
DB00005,Membrane Proteins,DrugBank
DB00005,Peptides,DrugBank
DB00005,Proteins,DrugBank
DB00005,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB00005,Tumor Necrosis Factor Blockers,DrugBank
DB00006,"Amino Acids, Peptides, and Proteins",DrugBank
DB00006,Anticoagulants,DrugBank
DB00006,Antithrombins,DrugBank
DB00006,Blood and Blood Forming Organs,DrugBank
DB00006,Enzyme Inhibitors,DrugBank
DB00006,Hematologic Agents,DrugBank
DB00006,Peptides,DrugBank
DB00006,Protease Inhibitors,DrugBank
DB00006,Serine Protease Inhibitors,DrugBank
DB00006,Thrombin Inhibitors,DrugBank
DB00007,Adrenal Cortex Hormones,DrugBank
DB00007,Agents Causing Muscle Toxicity,DrugBank
DB00007,"Amino Acids, Peptides, and Proteins",DrugBank
DB00007,Antineoplastic Agents,DrugBank
DB00007,"Antineoplastic Agents, Hormonal",DrugBank
DB00007,Antineoplastic and Immunomodulating Agents,DrugBank
DB00007,Drugs causing inadvertant photosensitivity,DrugBank
DB00007,Drugs that are Mainly Renally Excreted,DrugBank
DB00007,Endocrine Therapy,DrugBank
DB00007,Fertility Agents,DrugBank
DB00007,"Fertility Agents, Female",DrugBank
DB00007,Gonadotropin Releasing Hormone Receptor Agonist,DrugBank
DB00007,Gonadotropin Releasing Hormone Receptor Agonists,DrugBank
DB00007,Gonadotropin-releasing hormone agonist,DrugBank
DB00007,Gonadotropins,DrugBank
DB00007,Hormones and Related Agents,DrugBank
DB00007,Hyperglycemia-Associated Agents,DrugBank
DB00007,Hypothalamic Hormones,DrugBank
DB00007,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00007,Nerve Tissue Proteins,DrugBank
DB00007,Neuropeptides,DrugBank
DB00007,Oligopeptides,DrugBank
DB00007,Peptides,DrugBank
DB00007,Photosensitizing Agents,DrugBank
DB00007,Pituitary Hormone-Releasing Hormones,DrugBank
DB00007,Proteins,DrugBank
DB00007,QTc Prolonging Agents,DrugBank
DB00007,Reproductive Control Agents,DrugBank
DB00008,"Adjuvants, Immunologic",DrugBank
DB00008,Alcohols,DrugBank
DB00008,Alfa Interferons,DrugBank
DB00008,"Amino Acids, Peptides, and Proteins",DrugBank
DB00008,Anti-Infective Agents,DrugBank
DB00008,Antineoplastic Agents,DrugBank
DB00008,Antineoplastic and Immunomodulating Agents,DrugBank
DB00008,Antiviral Agents,DrugBank
DB00008,Biological Factors,DrugBank
DB00008,Cardiotoxic antineoplastic agents,DrugBank
DB00008,"Compounds used in a research, industrial, or household setting",DrugBank
DB00008,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00008,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00008,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00008,Cytokines,DrugBank
DB00008,Drug Carriers,DrugBank
DB00008,Ethylene Glycols,DrugBank
DB00008,Glycols,DrugBank
DB00008,Hepatotoxic Agents,DrugBank
DB00008,Immunosuppressive Agents,DrugBank
DB00008,Intercellular Signaling Peptides and Proteins,DrugBank
DB00008,Interferon alpha,DrugBank
DB00008,Interferon Type I,DrugBank
DB00008,Interferons,DrugBank
DB00008,Macromolecular Substances,DrugBank
DB00008,Myelosuppressive Agents,DrugBank
DB00008,Narrow Therapeutic Index Drugs,DrugBank
DB00008,Pegylated agents,DrugBank
DB00008,Peptides,DrugBank
DB00008,Polymers,DrugBank
DB00008,Proteins,DrugBank
DB00008,Treatments for Hepatitis C,DrugBank
DB00009,Agents causing angioedema,DrugBank
DB00009,"Amino Acids, Peptides, and Proteins",DrugBank
DB00009,Anticoagulants,DrugBank
DB00009,Blood and Blood Forming Organs,DrugBank
DB00009,Blood Proteins,DrugBank
DB00009,Cardiovascular Agents,DrugBank
DB00009,Endopeptidases,DrugBank
DB00009,Enzymes,DrugBank
DB00009,Enzymes and Coenzymes,DrugBank
DB00009,Fibrin Modulating Agents,DrugBank
DB00009,Fibrinolytic Agents,DrugBank
DB00009,Hematologic Agents,DrugBank
DB00009,Hydrolases,DrugBank
DB00009,Ophthalmologicals,DrugBank
DB00009,Peptide Hydrolases,DrugBank
DB00009,Plasminogen Activators,DrugBank
DB00009,Proteins,DrugBank
DB00009,Sensory Organs,DrugBank
DB00009,Serine Endopeptidases,DrugBank
DB00009,Serine Proteases,DrugBank
DB00009,Tissue Plasminogen Activator,DrugBank
DB00009,"Tissue Plasminogen Activator, antagonists & inhibitors",DrugBank
DB00011,"Adjuvants, Immunologic",DrugBank
DB00011,"Amino Acids, Peptides, and Proteins",DrugBank
DB00011,Antineoplastic and Immunomodulating Agents,DrugBank
DB00011,Antiviral Agents,DrugBank
DB00011,Biological Factors,DrugBank
DB00011,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00011,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00011,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00011,Cytokines,DrugBank
DB00011,Immunosuppressive Agents,DrugBank
DB00011,Intercellular Signaling Peptides and Proteins,DrugBank
DB00011,Interferon Type I,DrugBank
DB00011,Interferons,DrugBank
DB00011,Myelosuppressive Agents,DrugBank
DB00011,Peptides,DrugBank
DB00011,Proteins,DrugBank
DB00012,"Amino Acids, Peptides, and Proteins",DrugBank
DB00012,Antianemic Preparations,DrugBank
DB00012,Blood and Blood Forming Organs,DrugBank
DB00012,Carbohydrates,DrugBank
DB00012,Colony-Stimulating Factors,DrugBank
DB00012,Erythropoiesis-Stimulating Agents,DrugBank
DB00012,Glycoconjugates,DrugBank
DB00012,Glycoproteins,DrugBank
DB00012,Hematinics,DrugBank
DB00012,Hematologic Agents,DrugBank
DB00012,Hematopoietic Cell Growth Factors,DrugBank
DB00012,Increased Erythroid Cell Production,DrugBank
DB00012,Proteins,DrugBank
DB00013,Agents causing angioedema,DrugBank
DB00013,"Amino Acids, Peptides, and Proteins",DrugBank
DB00013,Anticoagulants,DrugBank
DB00013,Biological Factors,DrugBank
DB00013,Blood and Blood Forming Organs,DrugBank
DB00013,Blood Proteins,DrugBank
DB00013,Endopeptidases,DrugBank
DB00013,Enzymes,DrugBank
DB00013,Enzymes and Coenzymes,DrugBank
DB00013,Fibrinolytic Agents,DrugBank
DB00013,Hydrolases,DrugBank
DB00013,Increased Thrombolysis,DrugBank
DB00013,Peptide Hydrolases,DrugBank
DB00013,Plasminogen Activators,DrugBank
DB00013,Proteins,DrugBank
DB00013,Serine Endopeptidases,DrugBank
DB00013,Serine Proteases,DrugBank
DB00013,"Urokinase-Type Plasminogen Activator, antagonists & inhibitors",DrugBank
DB00014,Adrenal Cortex Hormones,DrugBank
DB00014,"Amino Acids, Peptides, and Proteins",DrugBank
DB00014,Antineoplastic Agents,DrugBank
DB00014,"Antineoplastic Agents, Hormonal",DrugBank
DB00014,Antineoplastic and Immunomodulating Agents,DrugBank
DB00014,Drugs that are Mainly Renally Excreted,DrugBank
DB00014,Endocrine Therapy,DrugBank
DB00014,Gonadotropin Releasing Hormone Receptor Agonist,DrugBank
DB00014,Gonadotropin Releasing Hormone Receptor Agonists,DrugBank
DB00014,Gonadotropin-releasing hormone agonist,DrugBank
DB00014,Gonadotropins and Antigonadotropins,DrugBank
DB00014,Hormones,DrugBank
DB00014,Hormones and Related Agents,DrugBank
DB00014,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00014,Hyperglycemia-Associated Agents,DrugBank
DB00014,Hypothalamic Hormones,DrugBank
DB00014,Miscellaneous Therapeutic Agents,DrugBank
DB00014,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00014,Nerve Tissue Proteins,DrugBank
DB00014,Neuropeptides,DrugBank
DB00014,Oligopeptides,DrugBank
DB00014,Peptide Hormones,DrugBank
DB00014,Peptides,DrugBank
DB00014,Pituitary Hormone-Releasing Hormones,DrugBank
DB00014,QTc Prolonging Agents,DrugBank
DB00015,Agents causing angioedema,DrugBank
DB00015,"Amino Acids, Peptides, and Proteins",DrugBank
DB00015,Anticoagulants,DrugBank
DB00015,Biological Factors,DrugBank
DB00015,Blood and Blood Forming Organs,DrugBank
DB00015,Blood Proteins,DrugBank
DB00015,Cardiovascular Agents,DrugBank
DB00015,Endopeptidases,DrugBank
DB00015,Enzymes,DrugBank
DB00015,Enzymes and Coenzymes,DrugBank
DB00015,Fibrin Modulating Agents,DrugBank
DB00015,Fibrinolytic Agents,DrugBank
DB00015,Hematologic Agents,DrugBank
DB00015,Hydrolases,DrugBank
DB00015,Peptide Hydrolases,DrugBank
DB00015,Plasminogen Activators,DrugBank
DB00015,Proteins,DrugBank
DB00015,Serine Endopeptidases,DrugBank
DB00015,Serine Proteases,DrugBank
DB00015,Tissue Plasminogen Activator,DrugBank
DB00016,"Amino Acids, Peptides, and Proteins",DrugBank
DB00016,Antianemic Preparations,DrugBank
DB00016,Biological Factors,DrugBank
DB00016,Blood and Blood Forming Organs,DrugBank
DB00016,Carbohydrates,DrugBank
DB00016,Colony-Stimulating Factors,DrugBank
DB00016,Cytokines,DrugBank
DB00016,Erythropoiesis-Stimulating Agents,DrugBank
DB00016,"Erythropoietin, genetics",DrugBank
DB00016,Glycoconjugates,DrugBank
DB00016,Glycoproteins,DrugBank
DB00016,Hematinics,DrugBank
DB00016,Hematologic Agents,DrugBank
DB00016,Hematopoietic Cell Growth Factors,DrugBank
DB00016,Increased Erythroid Cell Production,DrugBank
DB00016,Intercellular Signaling Peptides and Proteins,DrugBank
DB00016,Peptides,DrugBank
DB00016,Proteins,DrugBank
DB00017,"Amino Acids, Peptides, and Proteins",DrugBank
DB00017,Bone Density Conservation Agents,DrugBank
DB00017,"Bone Density, drug effects",DrugBank
DB00017,Calcitonin Preparations,DrugBank
DB00017,Calcium Homeostasis,DrugBank
DB00017,Calcium-Regulating Hormones and Agents,DrugBank
DB00017,Drugs that are Mainly Renally Excreted,DrugBank
DB00017,Hormones,DrugBank
DB00017,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00017,Nerve Tissue Proteins,DrugBank
DB00017,Neuropeptides,DrugBank
DB00017,Parathyroid and Antiparathyroid Agents,DrugBank
DB00017,Parathyroid Hormones and Analogues,DrugBank
DB00017,Peptide Hormones,DrugBank
DB00017,Peptides,DrugBank
DB00017,Proteins,DrugBank
DB00017,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00017,Thyroid Products,DrugBank
DB00018,Alfa Interferons,DrugBank
DB00018,"Amino Acids, Peptides, and Proteins",DrugBank
DB00018,Biological Factors,DrugBank
DB00018,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00018,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00018,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00018,Cytokines,DrugBank
DB00018,Immunosuppressive Agents,DrugBank
DB00018,Intercellular Signaling Peptides and Proteins,DrugBank
DB00018,Interferon alpha,DrugBank
DB00018,Interferon Type I,DrugBank
DB00018,Interferon-alpha,DrugBank
DB00018,Interferons,DrugBank
DB00018,Myelosuppressive Agents,DrugBank
DB00018,Peptides,DrugBank
DB00018,Proteins,DrugBank
DB00019,"Adjuvants, Immunologic",DrugBank
DB00019,Alcohols,DrugBank
DB00019,"Amino Acids, Peptides, and Proteins",DrugBank
DB00019,Antineoplastic and Immunomodulating Agents,DrugBank
DB00019,Biological Factors,DrugBank
DB00019,Biological Products,DrugBank
DB00019,Carbohydrates,DrugBank
DB00019,Colony-Stimulating Factors,DrugBank
DB00019,Complex Mixtures,DrugBank
DB00019,"Compounds used in a research, industrial, or household setting",DrugBank
DB00019,Cytokines,DrugBank
DB00019,Ethylene Glycols,DrugBank
DB00019,Glycoconjugates,DrugBank
DB00019,Glycols,DrugBank
DB00019,Glycoproteins,DrugBank
DB00019,Granulocyte Colony-Stimulating Factors,DrugBank
DB00019,Hematinics,DrugBank
DB00019,Hematopoietic Cell Growth Factors,DrugBank
DB00019,Increased Myeloid Cell Production,DrugBank
DB00019,Intercellular Signaling Peptides and Proteins,DrugBank
DB00019,Leukocyte Growth Factor,DrugBank
DB00019,Macromolecular Substances,DrugBank
DB00019,Pegylated agents,DrugBank
DB00019,Peptides,DrugBank
DB00019,Polymers,DrugBank
DB00019,Proteins,DrugBank
DB00020,"Adjuvants, Immunologic",DrugBank
DB00020,"Amino Acids, Peptides, and Proteins",DrugBank
DB00020,Antineoplastic and Immunomodulating Agents,DrugBank
DB00020,Biological Factors,DrugBank
DB00020,Carbohydrates,DrugBank
DB00020,Colony-Stimulating Factors,DrugBank
DB00020,Cytokines,DrugBank
DB00020,Glycoconjugates,DrugBank
DB00020,Glycoproteins,DrugBank
DB00020,Granulocyte-Macrophage Colony-Stimulating Factor,DrugBank
DB00020,Hematopoietic Cell Growth Factors,DrugBank
DB00020,Immunologic Factors,DrugBank
DB00020,Increased Myeloid Cell Production,DrugBank
DB00020,Intercellular Signaling Peptides and Proteins,DrugBank
DB00020,Leukocyte Growth Factor,DrugBank
DB00020,Peptides,DrugBank
DB00020,Proteins,DrugBank
DB00022,"Adjuvants, Immunologic",DrugBank
DB00022,Alcohols,DrugBank
DB00022,Alfa Interferons,DrugBank
DB00022,"Amino Acids, Peptides, and Proteins",DrugBank
DB00022,Anti-Infective Agents,DrugBank
DB00022,Antineoplastic and Immunomodulating Agents,DrugBank
DB00022,Antiviral Agents,DrugBank
DB00022,Biological Factors,DrugBank
DB00022,Cancer immunotherapy,DrugBank
DB00022,"Compounds used in a research, industrial, or household setting",DrugBank
DB00022,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00022,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00022,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00022,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB00022,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00022,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00022,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00022,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00022,Cytokines,DrugBank
DB00022,Drug Carriers,DrugBank
DB00022,Ethylene Glycols,DrugBank
DB00022,Glycols,DrugBank
DB00022,Hepatitis C,DrugBank
DB00022,Immunosuppressive Agents,DrugBank
DB00022,Immunotherapy,DrugBank
DB00022,Intercellular Signaling Peptides and Proteins,DrugBank
DB00022,Interferon alpha,DrugBank
DB00022,Interferon Type I,DrugBank
DB00022,Interferon-alpha,DrugBank
DB00022,Interferons,DrugBank
DB00022,Macromolecular Substances,DrugBank
DB00022,Myelosuppressive Agents,DrugBank
DB00022,Pegylated agents,DrugBank
DB00022,Peptides,DrugBank
DB00022,Polymers,DrugBank
DB00022,Proteins,DrugBank
DB00022,Treatments for Hepatitis C,DrugBank
DB00023,Amidohydrolases,DrugBank
DB00023,Antineoplastic Agents,DrugBank
DB00023,Antineoplastic and Immunomodulating Agents,DrugBank
DB00023,Asparaginase,DrugBank
DB00023,Asparagine-specific Enzyme,DrugBank
DB00023,Enzymes,DrugBank
DB00023,Enzymes and Coenzymes,DrugBank
DB00023,Hydrolases,DrugBank
DB00023,Narrow Therapeutic Index Drugs,DrugBank
DB00023,Thyroxine-binding globulin inhibitors,DrugBank
DB00024,Agents used to treat hypothyroidism,DrugBank
DB00024,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB00024,Hormones,DrugBank
DB00024,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00024,Peptide Hormones,DrugBank
DB00024,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00024,Pituitary Hormones,DrugBank
DB00024,"Pituitary Hormones, Anterior",DrugBank
DB00024,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00024,Thyroid Products,DrugBank
DB00025,"Amino Acids, Peptides, and Proteins",DrugBank
DB00025,Biological Factors,DrugBank
DB00025,Blood and Blood Forming Organs,DrugBank
DB00025,Blood Coagulation Factors,DrugBank
DB00025,Blood Proteins,DrugBank
DB00025,Carbohydrates,DrugBank
DB00025,Disaccharides,DrugBank
DB00025,Hemophilia A,DrugBank
DB00025,Hemostatics,DrugBank
DB00025,Human Antihemophilic Factors,DrugBank
DB00025,Increased Coagulation Activity,DrugBank
DB00025,Oligosaccharides,DrugBank
DB00025,Polysaccharides,DrugBank
DB00025,Protein Precursors,DrugBank
DB00025,Proteins,DrugBank
DB00026,Agents reducing cytokine levels,DrugBank
DB00026,"Amino Acids, Peptides, and Proteins",DrugBank
DB00026,Antineoplastic and Immunomodulating Agents,DrugBank
DB00026,Antirheumatic Agents,DrugBank
DB00026,Biological Factors,DrugBank
DB00026,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB00026,Cytokines,DrugBank
DB00026,Disease-modifying Antirheumatic Agents,DrugBank
DB00026,Immunosuppressive Agents,DrugBank
DB00026,Immunotherapy,DrugBank
DB00026,Intercellular Signaling Peptides and Proteins,DrugBank
DB00026,Interleukin Inhibitors,DrugBank
DB00026,Interleukin-1 Receptor Antagonist,DrugBank
DB00026,Peptides,DrugBank
DB00026,Proteins,DrugBank
DB00027,"Amino Acids, Peptides, and Proteins",DrugBank
DB00027,Anti-Bacterial Agents,DrugBank
DB00027,Anti-Infective Agents,DrugBank
DB00027,"Anti-Infective Agents, Local",DrugBank
DB00027,Membrane Proteins,DrugBank
DB00027,P-glycoprotein inhibitors,DrugBank
DB00027,P-glycoprotein substrates,DrugBank
DB00027,Peptides,DrugBank
DB00027,"Peptides, Cyclic",DrugBank
DB00027,Pore Forming Cytotoxic Proteins,DrugBank
DB00027,Proteins,DrugBank
DB00027,Throat Preparations,DrugBank
DB00028,"Amino Acids, Peptides, and Proteins",DrugBank
DB00028,Antibodies,DrugBank
DB00028,Antigen Neutralization,DrugBank
DB00028,Blood Proteins,DrugBank
DB00028,Globulins,DrugBank
DB00028,Human Immunoglobulin G,DrugBank
DB00028,Immunoglobulin G,DrugBank
DB00028,Immunoglobulin Isotypes,DrugBank
DB00028,Immunoglobulins,DrugBank
DB00028,"Immunoglobulins, Intravenous",DrugBank
DB00028,Immunologic Factors,DrugBank
DB00028,Immunoproteins,DrugBank
DB00028,Passively Acquired Immunity,DrugBank
DB00028,Proteins,DrugBank
DB00028,Serum,DrugBank
DB00028,Serum Globulins,DrugBank
DB00029,Agents causing angioedema,DrugBank
DB00029,"Amino Acids, Peptides, and Proteins",DrugBank
DB00029,Anticoagulants,DrugBank
DB00029,Blood and Blood Forming Organs,DrugBank
DB00029,Blood Proteins,DrugBank
DB00029,Cardiovascular Agents,DrugBank
DB00029,Endopeptidases,DrugBank
DB00029,Enzymes,DrugBank
DB00029,Enzymes and Coenzymes,DrugBank
DB00029,Fibrin Modulating Agents,DrugBank
DB00029,Fibrinolytic Agents,DrugBank
DB00029,Hematologic Agents,DrugBank
DB00029,Hydrolases,DrugBank
DB00029,Peptide Hydrolases,DrugBank
DB00029,Plasminogen Activators,DrugBank
DB00029,Proteins,DrugBank
DB00029,Serine Endopeptidases,DrugBank
DB00029,Serine Proteases,DrugBank
DB00030,Alimentary Tract and Metabolism,DrugBank
DB00030,"Amino Acids, Peptides, and Proteins",DrugBank
DB00030,Blood Glucose Lowering Agents,DrugBank
DB00030,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00030,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00030,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00030,Drugs Used in Diabetes,DrugBank
DB00030,Hormones,DrugBank
DB00030,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00030,Hypoglycemia-Associated Agents,DrugBank
DB00030,Insulin,DrugBank
DB00030,"Insulin, metabolism",DrugBank
DB00030,"Insulin, Short-Acting",DrugBank
DB00030,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB00030,Pancreatic Hormones,DrugBank
DB00030,Peptide Hormones,DrugBank
DB00030,Peptides,DrugBank
DB00031,Agents causing angioedema,DrugBank
DB00031,"Amino Acids, Peptides, and Proteins",DrugBank
DB00031,Anticoagulants,DrugBank
DB00031,Biological Factors,DrugBank
DB00031,Blood and Blood Forming Organs,DrugBank
DB00031,Blood Proteins,DrugBank
DB00031,Cardiovascular Agents,DrugBank
DB00031,Endopeptidases,DrugBank
DB00031,Enzymes,DrugBank
DB00031,Enzymes and Coenzymes,DrugBank
DB00031,Fibrin Modulating Agents,DrugBank
DB00031,Fibrinolytic Agents,DrugBank
DB00031,Hematologic Agents,DrugBank
DB00031,Hydrolases,DrugBank
DB00031,Peptide Hydrolases,DrugBank
DB00031,Plasminogen Activators,DrugBank
DB00031,Proteins,DrugBank
DB00031,Serine Endopeptidases,DrugBank
DB00031,Serine Proteases,DrugBank
DB00031,Tissue Plasminogen Activator,DrugBank
DB00033,"Amino Acids, Peptides, and Proteins",DrugBank
DB00033,Biological Factors,DrugBank
DB00033,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00033,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00033,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00033,Cytokines,DrugBank
DB00033,Immunosuppressive Agents,DrugBank
DB00033,Intercellular Signaling Peptides and Proteins,DrugBank
DB00033,Interferon gamma,DrugBank
DB00033,Interferons,DrugBank
DB00033,Lymphokines,DrugBank
DB00033,Macrophage-Activating Factors,DrugBank
DB00033,Myelosuppressive Agents,DrugBank
DB00033,Peptides,DrugBank
DB00033,Proteins,DrugBank
DB00034,"Adjuvants, Immunologic",DrugBank
DB00034,Alfa Interferons,DrugBank
DB00034,"Amino Acids, Peptides, and Proteins",DrugBank
DB00034,Anti-Infective Agents,DrugBank
DB00034,Antineoplastic Agents,DrugBank
DB00034,Antineoplastic and Immunomodulating Agents,DrugBank
DB00034,Antiviral Agents,DrugBank
DB00034,Biological Factors,DrugBank
DB00034,Cancer immunotherapy,DrugBank
DB00034,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00034,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00034,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00034,Cytokines,DrugBank
DB00034,Immunosuppressive Agents,DrugBank
DB00034,Immunotherapy,DrugBank
DB00034,Intercellular Signaling Peptides and Proteins,DrugBank
DB00034,Interferon alpha,DrugBank
DB00034,Interferon Type I,DrugBank
DB00034,Interferon-alpha,DrugBank
DB00034,Interferons,DrugBank
DB00034,Myelosuppressive Agents,DrugBank
DB00034,Peptides,DrugBank
DB00034,Proteins,DrugBank
DB00035,Agents that produce hypertension,DrugBank
DB00035,"Amino Acids, Peptides, and Proteins",DrugBank
DB00035,Antidiuretic Agents,DrugBank
DB00035,Arginine Vasopressin,DrugBank
DB00035,Cardiovascular Agents,DrugBank
DB00035,Coagulants,DrugBank
DB00035,Drugs that are Mainly Renally Excreted,DrugBank
DB00035,Factor VIII Activator,DrugBank
DB00035,Hematologic Agents,DrugBank
DB00035,Hemostatics,DrugBank
DB00035,Hormones,DrugBank
DB00035,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00035,Increased Coagulation Factor VIII Activity,DrugBank
DB00035,Increased Coagulation Factor VIII Concentration,DrugBank
DB00035,Natriuretic Agents,DrugBank
DB00035,Nerve Tissue Proteins,DrugBank
DB00035,Neuropeptides,DrugBank
DB00035,Oligopeptides,DrugBank
DB00035,Peptide Hormones,DrugBank
DB00035,Peptides,DrugBank
DB00035,Pituitary,DrugBank
DB00035,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00035,Pituitary Hormones,DrugBank
DB00035,"Pituitary Hormones, Posterior",DrugBank
DB00035,Posterior Pituitary Lobe Hormones,DrugBank
DB00035,Proteins,DrugBank
DB00035,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00035,Vasopressin Analog,DrugBank
DB00035,Vasopressin and Analogues,DrugBank
DB00035,Vasopressins,DrugBank
DB00036,"Amino Acids, Peptides, and Proteins",DrugBank
DB00036,Biological Factors,DrugBank
DB00036,Blood and Blood Forming Organs,DrugBank
DB00036,Blood Coagulation Factors,DrugBank
DB00036,Blood Proteins,DrugBank
DB00036,Endopeptidases,DrugBank
DB00036,Enzymes,DrugBank
DB00036,Enzymes and Coenzymes,DrugBank
DB00036,Factor VII,DrugBank
DB00036,"Factor VIIa, antagonists & inhibitors",DrugBank
DB00036,Hemostatics,DrugBank
DB00036,Hydrolases,DrugBank
DB00036,Increased Coagulation Factor IX Activity,DrugBank
DB00036,Increased Coagulation Factor X Activity,DrugBank
DB00036,Peptide Hydrolases,DrugBank
DB00036,Proteins,DrugBank
DB00036,Serine Endopeptidases,DrugBank
DB00036,Serine Proteases,DrugBank
DB00039,"Amino Acids, Peptides, and Proteins",DrugBank
DB00039,Biological Factors,DrugBank
DB00039,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB00039,Fibroblast Growth Factors,DrugBank
DB00039,Increased Epithelial Proliferation,DrugBank
DB00039,Intercellular Signaling Peptides and Proteins,DrugBank
DB00039,Mucocutaneous Epithelial Cell Growth Factor,DrugBank
DB00039,Peptides,DrugBank
DB00039,Proteins,DrugBank
DB00040,"Amino Acids, Peptides, and Proteins",DrugBank
DB00040,Antihypoglycemic Agent,DrugBank
DB00040,Decreased GI Motility,DrugBank
DB00040,Decreased GI Smooth Muscle Tone,DrugBank
DB00040,Decreased Glycolysis,DrugBank
DB00040,Gastrointestinal Agents,DrugBank
DB00040,Gastrointestinal Hormones,DrugBank
DB00040,Gastrointestinal Motility Inhibitor,DrugBank
DB00040,"Glucagon, antagonists & inhibitors",DrugBank
DB00040,Glycogenolytic Agents,DrugBank
DB00040,Glycogenolytic Hormones,DrugBank
DB00040,Hormones,DrugBank
DB00040,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00040,Increased Gluconeogenesis,DrugBank
DB00040,Increased Glycogenolysis,DrugBank
DB00040,Pancreatic Hormones,DrugBank
DB00040,Peptide Hormones,DrugBank
DB00040,Peptides,DrugBank
DB00040,Proglucagon,DrugBank
DB00040,Protein Precursors,DrugBank
DB00040,Proteins,DrugBank
DB00040,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00041,"Adjuvants, Immunologic",DrugBank
DB00041,"Amino Acids, Peptides, and Proteins",DrugBank
DB00041,Anti-HIV Agents,DrugBank
DB00041,Anti-Infective Agents,DrugBank
DB00041,Antineoplastic Agents,DrugBank
DB00041,Antineoplastic and Immunomodulating Agents,DrugBank
DB00041,Biological Factors,DrugBank
DB00041,Cancer immunotherapy,DrugBank
DB00041,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00041,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00041,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00041,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00041,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00041,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00041,Cytokines,DrugBank
DB00041,Drugs that are Mainly Renally Excreted,DrugBank
DB00041,Hypotensive Agents,DrugBank
DB00041,Immunosuppressive Agents,DrugBank
DB00041,Immunotherapy,DrugBank
DB00041,Increased Lymphocyte Activation,DrugBank
DB00041,Increased Lymphocyte Cell Production,DrugBank
DB00041,Intercellular Signaling Peptides and Proteins,DrugBank
DB00041,Interleukins,DrugBank
DB00041,Lymphocyte Growth Factor,DrugBank
DB00041,Lymphokines,DrugBank
DB00041,Myelosuppressive Agents,DrugBank
DB00041,Narrow Therapeutic Index Drugs,DrugBank
DB00041,Peptides,DrugBank
DB00041,Proteins,DrugBank
DB00042,Acetylcholine Release Inhibitors,DrugBank
DB00042,Agents that produce neuromuscular block (indirect),DrugBank
DB00042,"Amino Acids, Peptides, and Proteins",DrugBank
DB00042,Amphibian Venoms,DrugBank
DB00042,Anti-Dyskinesia Agents,DrugBank
DB00042,Bacterial Proteins,DrugBank
DB00042,Bacterial Toxins,DrugBank
DB00042,Biological Factors,DrugBank
DB00042,Botulinum Toxins,DrugBank
DB00042,Central Nervous System Agents,DrugBank
DB00042,Central Nervous System Depressants,DrugBank
DB00042,Cholinergic Agents,DrugBank
DB00042,Complex Mixtures,DrugBank
DB00042,Endopeptidases,DrugBank
DB00042,Enzymes,DrugBank
DB00042,Enzymes and Coenzymes,DrugBank
DB00042,Ganglion Blockers,DrugBank
DB00042,Hydrolases,DrugBank
DB00042,Membrane Transport Modulators,DrugBank
DB00042,Metalloendopeptidases,DrugBank
DB00042,Metalloproteases,DrugBank
DB00042,Muscle Relaxants,DrugBank
DB00042,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00042,Musculo-Skeletal System,DrugBank
DB00042,Neurotoxins,DrugBank
DB00042,Neurotransmitter Agents,DrugBank
DB00042,Other Miscellaneous Therapeutic Agents,DrugBank
DB00042,Peptide Hydrolases,DrugBank
DB00042,Proteins,DrugBank
DB00042,"Toxins, Biological",DrugBank
DB00042,Venoms,DrugBank
DB00043,Agents to Treat Airway Disease,DrugBank
DB00043,"Amino Acids, Peptides, and Proteins",DrugBank
DB00043,Anti-Allergic Agents,DrugBank
DB00043,Anti-Asthmatic Agents,DrugBank
DB00043,Anti-IgE,DrugBank
DB00043,Antibodies,DrugBank
DB00043,"Antibodies, Monoclonal",DrugBank
DB00043,"Antibodies, Monoclonal, Humanized",DrugBank
DB00043,Antigens,DrugBank
DB00043,Biological Factors,DrugBank
DB00043,Blood Proteins,DrugBank
DB00043,Decreased IgE Activity,DrugBank
DB00043,Globulins,DrugBank
DB00043,IgE-directed Antibody Interactions,DrugBank
DB00043,Immunoglobulins,DrugBank
DB00043,Immunoproteins,DrugBank
DB00043,Proteins,DrugBank
DB00043,"Respiratory Agents, Miscellaneous",DrugBank
DB00043,Respiratory System Agents,DrugBank
DB00043,Serum Globulins,DrugBank
DB00046,Alimentary Tract and Metabolism,DrugBank
DB00046,"Amino Acids, Peptides, and Proteins",DrugBank
DB00046,Blood Glucose Lowering Agents,DrugBank
DB00046,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00046,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00046,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00046,Drugs Used in Diabetes,DrugBank
DB00046,Hormones,DrugBank
DB00046,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00046,Hypoglycemia-Associated Agents,DrugBank
DB00046,Insulin,DrugBank
DB00046,Insulin Analog,DrugBank
DB00046,"Insulin, Short-Acting",DrugBank
DB00046,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB00046,Pancreatic Hormones,DrugBank
DB00046,Peptide Hormones,DrugBank
DB00046,Peptides,DrugBank
DB00047,Alimentary Tract and Metabolism,DrugBank
DB00047,"Amino Acids, Peptides, and Proteins",DrugBank
DB00047,Antimetabolites,DrugBank
DB00047,Biological Products,DrugBank
DB00047,Blood Glucose Lowering Agents,DrugBank
DB00047,Complex Mixtures,DrugBank
DB00047,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00047,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00047,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00047,Drugs Used in Diabetes,DrugBank
DB00047,Hormones,DrugBank
DB00047,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00047,Hypoglycemia-Associated Agents,DrugBank
DB00047,Hypolipidemic Agents,DrugBank
DB00047,Insulin,DrugBank
DB00047,Insulin Analog,DrugBank
DB00047,"Insulin, Long-Acting",DrugBank
DB00047,Lipid Regulating Agents,DrugBank
DB00047,Pancreatic Hormones,DrugBank
DB00047,Peptide Hormones,DrugBank
DB00047,Peptides,DrugBank
DB00048,Collagen-specific Enzyme,DrugBank
DB00048,Collagenases,DrugBank
DB00048,Dermatologicals,DrugBank
DB00048,Endopeptidases,DrugBank
DB00048,Enzymes,DrugBank
DB00048,Enzymes and Coenzymes,DrugBank
DB00048,Hydrolases,DrugBank
DB00048,Metalloendopeptidases,DrugBank
DB00048,Metalloproteases,DrugBank
DB00048,"Microbial Collagenase, antagonists & inhibitors",DrugBank
DB00048,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00048,Musculo-Skeletal System,DrugBank
DB00048,Peptide Hydrolases,DrugBank
DB00048,Preparations for Treatment of Wounds and Ulcers,DrugBank
DB00049,Antigout Preparations,DrugBank
DB00049,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB00049,Enzymes,DrugBank
DB00049,Enzymes and Coenzymes,DrugBank
DB00049,Methemoglobinemia Associated Agents,DrugBank
DB00049,Musculo-Skeletal System,DrugBank
DB00049,Oxidoreductases,DrugBank
DB00049,Recombinant Proteins,DrugBank
DB00049,Urate Oxidase,DrugBank
DB00049,Uric Acid-specific Enzyme,DrugBank
DB00051,Agents reducing cytokine levels,DrugBank
DB00051,"Amino Acids, Peptides, and Proteins",DrugBank
DB00051,Anti-Inflammatory Agents,DrugBank
DB00051,Antibodies,DrugBank
DB00051,"Antibodies, Monoclonal",DrugBank
DB00051,"Antibodies, Monoclonal, Humanized",DrugBank
DB00051,Antineoplastic and Immunomodulating Agents,DrugBank
DB00051,Antirheumatic Agents,DrugBank
DB00051,Biological Products,DrugBank
DB00051,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB00051,Blood Proteins,DrugBank
DB00051,Disease-modifying Antirheumatic Agents,DrugBank
DB00051,Globulins,DrugBank
DB00051,Immunoglobulins,DrugBank
DB00051,Immunoproteins,DrugBank
DB00051,Immunosuppressive Agents,DrugBank
DB00051,Miscellaneous GI Drugs,DrugBank
DB00051,Proteins,DrugBank
DB00051,Serum Globulins,DrugBank
DB00051,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB00051,Tumor Necrosis Factor Blockers,DrugBank
DB00051,Tumor Necrosis Factor Receptor Blocking Activity,DrugBank
DB00052,Agents Causing Muscle Toxicity,DrugBank
DB00052,"Amino Acids, Peptides, and Proteins",DrugBank
DB00052,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB00052,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00052,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00052,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00052,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00052,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00052,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00052,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00052,Growth Hormone,DrugBank
DB00052,"Growth Hormone, antagonists & inhibitors",DrugBank
DB00052,Hormones,DrugBank
DB00052,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00052,"Human Growth Hormone, antagonists & inhibitors",DrugBank
DB00052,P-glycoprotein substrates,DrugBank
DB00052,Peptide Hormones,DrugBank
DB00052,Peptides,DrugBank
DB00052,Pituitary,DrugBank
DB00052,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00052,Pituitary Hormones,DrugBank
DB00052,"Pituitary Hormones, Anterior",DrugBank
DB00052,Recombinant Human Growth Hormone,DrugBank
DB00052,Somatotropin Agonists,DrugBank
DB00052,Somatropin and Somatropin Agonists,DrugBank
DB00052,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00054,"Amino Acids, Peptides, and Proteins",DrugBank
DB00054,Antibodies,DrugBank
DB00054,"Antibodies, Monoclonal",DrugBank
DB00054,"Antibodies, Monoclonal, Humanized",DrugBank
DB00054,Anticoagulants,DrugBank
DB00054,Antiplatelet agents,DrugBank
DB00054,Blood and Blood Forming Organs,DrugBank
DB00054,Blood Proteins,DrugBank
DB00054,Globulins,DrugBank
DB00054,Glycoprotein IIb/IIIa Receptor-directed Monoclonal Antibodies,DrugBank
DB00054,Hematologic Agents,DrugBank
DB00054,Immunoglobulin Fab Fragments,DrugBank
DB00054,Immunoglobulin Fragments,DrugBank
DB00054,Immunoglobulins,DrugBank
DB00054,Immunoproteins,DrugBank
DB00054,Miscellaneous Therapeutic Agents,DrugBank
DB00054,Peptide Fragments,DrugBank
DB00054,Peptides,DrugBank
DB00054,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00054,Proteins,DrugBank
DB00054,Serum Globulins,DrugBank
DB00055,"Amino Acids, Peptides, and Proteins",DrugBank
DB00055,Anti-Infective Agents,DrugBank
DB00055,Anticoagulants,DrugBank
DB00055,Biological Factors,DrugBank
DB00055,Blood and Blood Forming Organs,DrugBank
DB00055,Blood Coagulation Factor Inhibitors,DrugBank
DB00055,Blood Proteins,DrugBank
DB00055,Carbohydrates,DrugBank
DB00055,Enzyme Precursors,DrugBank
DB00055,Enzymes,DrugBank
DB00055,Enzymes and Coenzymes,DrugBank
DB00055,Fibrinolytic Agents,DrugBank
DB00055,Glycoconjugates,DrugBank
DB00055,Glycoproteins,DrugBank
DB00055,Protein Precursors,DrugBank
DB00055,Proteins,DrugBank
DB00055,Recombinant Activated Protein C,DrugBank
DB00056,"Amino Acids, Peptides, and Proteins",DrugBank
DB00056,Antibodies,DrugBank
DB00056,"Antibodies, Monoclonal",DrugBank
DB00056,"Antibodies, Monoclonal, Humanized",DrugBank
DB00056,Antibody-drug Conjugates,DrugBank
DB00056,Antineoplastic Agents,DrugBank
DB00056,"Antineoplastic Agents, Immunological",DrugBank
DB00056,Antineoplastic and Immunomodulating Agents,DrugBank
DB00056,Blood Proteins,DrugBank
DB00056,Calicheamicins,DrugBank
DB00056,Cancer immunotherapy,DrugBank
DB00056,Carbohydrates,DrugBank
DB00056,CD33-directed Antibody Interactions,DrugBank
DB00056,CD33-directed Cytotoxin,DrugBank
DB00056,Cytotoxins,DrugBank
DB00056,Globulins,DrugBank
DB00056,Glycosides,DrugBank
DB00056,Hepatotoxic Agents,DrugBank
DB00056,Immunoconjugates,DrugBank
DB00056,Immunoglobulins,DrugBank
DB00056,Immunologic Factors,DrugBank
DB00056,Immunoproteins,DrugBank
DB00056,Immunosuppressive Agents,DrugBank
DB00056,Immunotherapy,DrugBank
DB00056,Immunotoxins,DrugBank
DB00056,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB00056,Myelosuppressive Agents,DrugBank
DB00056,Narrow Therapeutic Index Drugs,DrugBank
DB00056,Noxae,DrugBank
DB00056,Proteins,DrugBank
DB00056,Serum Globulins,DrugBank
DB00056,Toxic Actions,DrugBank
DB00057,Acetates,DrugBank
DB00057,"Acids, Acyclic",DrugBank
DB00057,Amines,DrugBank
DB00057,"Amino Acids, Peptides, and Proteins",DrugBank
DB00057,Antibodies,DrugBank
DB00057,Blood Proteins,DrugBank
DB00057,Diagnostic Radiopharmaceuticals,DrugBank
DB00057,Globulins,DrugBank
DB00057,Immunoglobulins,DrugBank
DB00057,Immunoproteins,DrugBank
DB00057,Indium (111In) Compounds,DrugBank
DB00057,Indium Radioisotopes,DrugBank
DB00057,Peptides,DrugBank
DB00057,Polyamines,DrugBank
DB00057,Proteins,DrugBank
DB00057,Serum Globulins,DrugBank
DB00057,Tumour Detection,DrugBank
DB00058,Acute-Phase Proteins,DrugBank
DB00058,Alpha-Globulins,DrugBank
DB00058,"Amino Acids, Peptides, and Proteins",DrugBank
DB00058,Antifibrinolytic Agents,DrugBank
DB00058,Blood and Blood Forming Organs,DrugBank
DB00058,Blood Proteins,DrugBank
DB00058,Carbohydrates,DrugBank
DB00058,Enzyme Inhibitors,DrugBank
DB00058,Enzymes,DrugBank
DB00058,Enzymes and Coenzymes,DrugBank
DB00058,Globulins,DrugBank
DB00058,Glycoconjugates,DrugBank
DB00058,Glycoproteins,DrugBank
DB00058,Hemostatics,DrugBank
DB00058,Human alpha-1 Proteinase Inhibitor,DrugBank
DB00058,Peptides,DrugBank
DB00058,Protease Inhibitors,DrugBank
DB00058,Proteinase Inhibitors,DrugBank
DB00058,"Proteinase Inhibitory Proteins, Secretory",DrugBank
DB00058,Proteins,DrugBank
DB00058,Serine Protease Inhibitors,DrugBank
DB00058,Serpins,DrugBank
DB00058,Serum Globulins,DrugBank
DB00058,Trypsin Inhibitors,DrugBank
DB00059,Alcohols,DrugBank
DB00059,Amidohydrolases,DrugBank
DB00059,Antineoplastic Agents,DrugBank
DB00059,Antineoplastic and Immunomodulating Agents,DrugBank
DB00059,Asparaginase,DrugBank
DB00059,Asparagine-specific Enzyme,DrugBank
DB00059,"Compounds used in a research, industrial, or household setting",DrugBank
DB00059,Delayed-Action Preparations,DrugBank
DB00059,Enzymes,DrugBank
DB00059,Enzymes and Coenzymes,DrugBank
DB00059,Ethylene Glycols,DrugBank
DB00059,Glycols,DrugBank
DB00059,Hydrolases,DrugBank
DB00059,Immunosuppressive Agents,DrugBank
DB00059,Macromolecular Substances,DrugBank
DB00059,Pegylated agents,DrugBank
DB00059,Polymers,DrugBank
DB00059,Thyroxine-binding globulin inhibitors,DrugBank
DB00060,"Adjuvants, Immunologic",DrugBank
DB00060,"Amino Acids, Peptides, and Proteins",DrugBank
DB00060,Anti-Infective Agents,DrugBank
DB00060,Antineoplastic and Immunomodulating Agents,DrugBank
DB00060,Antiviral Agents,DrugBank
DB00060,Biological Factors,DrugBank
DB00060,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00060,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00060,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00060,Cytokines,DrugBank
DB00060,Immunologic Factors,DrugBank
DB00060,Immunomodulatory Agents,DrugBank
DB00060,Intercellular Signaling Peptides and Proteins,DrugBank
DB00060,Interferon Type I,DrugBank
DB00060,Interferon-beta,DrugBank
DB00060,Interferons,DrugBank
DB00060,Peptides,DrugBank
DB00060,Proteins,DrugBank
DB00060,Recombinant Human Interferon beta,DrugBank
DB00061,"Adjuvants, Immunologic",DrugBank
DB00061,Aminohydrolases,DrugBank
DB00061,Antineoplastic and Immunomodulating Agents,DrugBank
DB00061,Bovine Intestinal Adenosine Deaminase,DrugBank
DB00061,Enzymes,DrugBank
DB00061,Enzymes and Coenzymes,DrugBank
DB00061,Hydrolases,DrugBank
DB00061,Nucleoside Deaminases,DrugBank
DB00061,Pegylated agents,DrugBank
DB00061,Severe Combined Immunodeficiency,DrugBank
DB00063,"Amino Acids, Peptides, and Proteins",DrugBank
DB00063,Antiplatelet agents,DrugBank
DB00063,Blood and Blood Forming Organs,DrugBank
DB00063,Decreased Platelet Aggregation,DrugBank
DB00063,Hematologic Agents,DrugBank
DB00063,Peptides,DrugBank
DB00063,"Peptides, Cyclic",DrugBank
DB00063,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00065,Agents Causing Muscle Toxicity,DrugBank
DB00065,Agents reducing cytokine levels,DrugBank
DB00065,"Amino Acids, Peptides, and Proteins",DrugBank
DB00065,Anti-Inflammatory Agents,DrugBank
DB00065,Antibodies,DrugBank
DB00065,"Antibodies, Monoclonal",DrugBank
DB00065,Antineoplastic and Immunomodulating Agents,DrugBank
DB00065,Antirheumatic Agents,DrugBank
DB00065,Biological Products,DrugBank
DB00065,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB00065,Blood Proteins,DrugBank
DB00065,Complex Mixtures,DrugBank
DB00065,Dermatologicals,DrugBank
DB00065,Disease-modifying Antirheumatic Agents,DrugBank
DB00065,Gastrointestinal Agents,DrugBank
DB00065,Globulins,DrugBank
DB00065,Immunoglobulins,DrugBank
DB00065,Immunoproteins,DrugBank
DB00065,Immunosuppressive Agents,DrugBank
DB00065,Proteins,DrugBank
DB00065,Serum Globulins,DrugBank
DB00065,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB00065,Tumor Necrosis Factor Blockers,DrugBank
DB00065,Tumor Necrosis Factor Receptor Blocking Activity,DrugBank
DB00066,"Amino Acids, Peptides, and Proteins",DrugBank
DB00066,Follicle Stimulating Hormone,DrugBank
DB00066,Genito Urinary System and Sex Hormones,DrugBank
DB00066,Gonadotropins,DrugBank
DB00066,Gonadotropins and Antigonadotropins,DrugBank
DB00066,"Gonadotropins, Pituitary",DrugBank
DB00066,Hormones,DrugBank
DB00066,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00066,Peptide Hormones,DrugBank
DB00066,Peptides,DrugBank
DB00066,Pituitary Hormones,DrugBank
DB00066,"Pituitary Hormones, Anterior",DrugBank
DB00066,Proteins,DrugBank
DB00066,Sex Hormones and Modulators of the Genital System,DrugBank
DB00066,Thyroid Products,DrugBank
DB00067,"Amino Acids, Peptides, and Proteins",DrugBank
DB00067,Antidiuretic Agents,DrugBank
DB00067,Arginine Vasopressin,DrugBank
DB00067,"Arginine Vasopressin, analogs & derivatives",DrugBank
DB00067,Cardiovascular Agents,DrugBank
DB00067,Coagulants,DrugBank
DB00067,Decreased Diuresis,DrugBank
DB00067,Hematologic Agents,DrugBank
DB00067,Hemostatics,DrugBank
DB00067,Hormones,DrugBank
DB00067,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00067,Natriuretic Agents,DrugBank
DB00067,Nerve Tissue Proteins,DrugBank
DB00067,Neuropeptides,DrugBank
DB00067,Oligopeptides,DrugBank
DB00067,Peptide Hormones,DrugBank
DB00067,Peptides,DrugBank
DB00067,Pituitary,DrugBank
DB00067,Pituitary Hormones,DrugBank
DB00067,"Pituitary Hormones, Posterior",DrugBank
DB00067,Proteins,DrugBank
DB00067,Vasoconstriction,DrugBank
DB00067,Vasoconstrictor Agents,DrugBank
DB00067,Vasopressin and Analogues,DrugBank
DB00067,Vasopressins,DrugBank
DB00068,"Adjuvants, Immunologic",DrugBank
DB00068,"Amino Acids, Peptides, and Proteins",DrugBank
DB00068,Antineoplastic and Immunomodulating Agents,DrugBank
DB00068,Biological Factors,DrugBank
DB00068,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00068,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00068,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00068,Cytokines,DrugBank
DB00068,Immunologic Factors,DrugBank
DB00068,Immunosuppressive Agents,DrugBank
DB00068,Intercellular Signaling Peptides and Proteins,DrugBank
DB00068,Interferon Type I,DrugBank
DB00068,Interferon-beta,DrugBank
DB00068,Interferons,DrugBank
DB00068,Myelosuppressive Agents,DrugBank
DB00068,Peptides,DrugBank
DB00068,Proteins,DrugBank
DB00068,Recombinant Human Interferon beta,DrugBank
DB00069,"Adjuvants, Immunologic",DrugBank
DB00069,Alfa Interferons,DrugBank
DB00069,"Amino Acids, Peptides, and Proteins",DrugBank
DB00069,Anti-Infective Agents,DrugBank
DB00069,Antineoplastic and Immunomodulating Agents,DrugBank
DB00069,Antiviral Agents,DrugBank
DB00069,Biological Factors,DrugBank
DB00069,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00069,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00069,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00069,Cytokines,DrugBank
DB00069,Immunosuppressive Agents,DrugBank
DB00069,Intercellular Signaling Peptides and Proteins,DrugBank
DB00069,Interferon alpha,DrugBank
DB00069,Interferon Type I,DrugBank
DB00069,Interferons,DrugBank
DB00069,Myelosuppressive Agents,DrugBank
DB00069,Peptides,DrugBank
DB00069,Proteins,DrugBank
DB00070,Enzymes,DrugBank
DB00070,Enzymes and Coenzymes,DrugBank
DB00070,Glycoside Hydrolases,DrugBank
DB00071,Alimentary Tract and Metabolism,DrugBank
DB00071,"Amino Acids, Peptides, and Proteins",DrugBank
DB00071,Blood Glucose Lowering Agents,DrugBank
DB00071,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00071,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00071,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00071,Drugs Used in Diabetes,DrugBank
DB00071,Hormones,DrugBank
DB00071,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00071,Insulin,DrugBank
DB00071,"Insulin, Short-Acting",DrugBank
DB00071,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB00071,Pancreatic Hormones,DrugBank
DB00071,Peptide Hormones,DrugBank
DB00071,Peptides,DrugBank
DB00071,Proteins,DrugBank
DB00072,"Amino Acids, Peptides, and Proteins",DrugBank
DB00072,Antibodies,DrugBank
DB00072,"Antibodies, Monoclonal",DrugBank
DB00072,"Antibodies, Monoclonal, Humanized",DrugBank
DB00072,Antineoplastic Agents,DrugBank
DB00072,"Antineoplastic Agents, Immunological",DrugBank
DB00072,Antineoplastic and Immunomodulating Agents,DrugBank
DB00072,Biological Products,DrugBank
DB00072,Blood Proteins,DrugBank
DB00072,Cancer immunotherapy,DrugBank
DB00072,Cardiotoxic antineoplastic agents,DrugBank
DB00072,Complex Mixtures,DrugBank
DB00072,Globulins,DrugBank
DB00072,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB00072,HER2 Receptor Antagonists,DrugBank
DB00072,HER2/Neu/cerbB2 Antagonists,DrugBank
DB00072,Immunoglobulins,DrugBank
DB00072,Immunoproteins,DrugBank
DB00072,Immunosuppressive Agents,DrugBank
DB00072,Immunotherapy,DrugBank
DB00072,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB00072,Narrow Therapeutic Index Drugs,DrugBank
DB00072,Proteins,DrugBank
DB00072,Serum Globulins,DrugBank
DB00073,"Amino Acids, Peptides, and Proteins",DrugBank
DB00073,Antibodies,DrugBank
DB00073,"Antibodies, Monoclonal",DrugBank
DB00073,"Antibodies, Monoclonal, Murine-Derived",DrugBank
DB00073,Antineoplastic Agents,DrugBank
DB00073,"Antineoplastic Agents, Immunological",DrugBank
DB00073,Antirheumatic Agents,DrugBank
DB00073,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB00073,Blood Proteins,DrugBank
DB00073,Cancer immunotherapy,DrugBank
DB00073,CD20 (Clusters of Differentiation 20) inhibitors,DrugBank
DB00073,CD20-directed Antibody Interactions,DrugBank
DB00073,CD20-directed Cytolytic Antibody,DrugBank
DB00073,Globulins,DrugBank
DB00073,Immunoglobulins,DrugBank
DB00073,Immunologic Factors,DrugBank
DB00073,Immunoproteins,DrugBank
DB00073,Immunosuppressive Agents,DrugBank
DB00073,Immunotherapy,DrugBank
DB00073,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB00073,Myelosuppressive Agents,DrugBank
DB00073,Narrow Therapeutic Index Drugs,DrugBank
DB00073,Proteins,DrugBank
DB00073,Serum Globulins,DrugBank
DB00074,"Amino Acids, Peptides, and Proteins",DrugBank
DB00074,Antibodies,DrugBank
DB00074,"Antibodies, Monoclonal",DrugBank
DB00074,"Antibodies, Monoclonal, Humanized",DrugBank
DB00074,Antineoplastic and Immunomodulating Agents,DrugBank
DB00074,Blood Proteins,DrugBank
DB00074,Globulins,DrugBank
DB00074,Immunoglobulins,DrugBank
DB00074,Immunologic Factors,DrugBank
DB00074,Immunoproteins,DrugBank
DB00074,Immunosuppressive Agents,DrugBank
DB00074,Interleukin 2 Receptor-directed Antibody Interactions,DrugBank
DB00074,Interleukin Inhibitors,DrugBank
DB00074,Interleukin-2 Receptor Antagonist,DrugBank
DB00074,Interleukin-2 Receptor Blocking Antibody,DrugBank
DB00074,Proteins,DrugBank
DB00074,Serum Globulins,DrugBank
DB00075,"Amino Acids, Peptides, and Proteins",DrugBank
DB00075,Antibodies,DrugBank
DB00075,"Antibodies, Monoclonal",DrugBank
DB00075,"Antibodies, Monoclonal, Murine-Derived",DrugBank
DB00075,Antineoplastic and Immunomodulating Agents,DrugBank
DB00075,Blood Proteins,DrugBank
DB00075,CD3 Blocker Immunosuppressant,DrugBank
DB00075,CD3 Receptor Antagonists,DrugBank
DB00075,CD3-directed Antibody Interactions,DrugBank
DB00075,Decreased Immunologic Activity,DrugBank
DB00075,Globulins,DrugBank
DB00075,Immunoglobulin G,DrugBank
DB00075,Immunoglobulin Isotypes,DrugBank
DB00075,Immunoglobulins,DrugBank
DB00075,Immunologic Factors,DrugBank
DB00075,Immunoproteins,DrugBank
DB00075,Immunosuppressive Agents,DrugBank
DB00075,Proteins,DrugBank
DB00075,Selective Immunosuppressants,DrugBank
DB00075,Serum Globulins,DrugBank
DB00076,"Amino Acids, Peptides, and Proteins",DrugBank
DB00076,Antidotes,DrugBank
DB00076,Blood Proteins,DrugBank
DB00076,Digoxin Binding Activity,DrugBank
DB00076,Immunoglobulin G,DrugBank
DB00076,Immunoglobulins,DrugBank
DB00076,Proteins,DrugBank
DB00076,Serum,DrugBank
DB00076,Serum Globulins,DrugBank
DB00078,"Amino Acids, Peptides, and Proteins",DrugBank
DB00078,Antibodies,DrugBank
DB00078,"Antibodies, Monoclonal",DrugBank
DB00078,"Antigens, CD20",DrugBank
DB00078,Blood Proteins,DrugBank
DB00078,Cancer immunotherapy,DrugBank
DB00078,CD20-directed Antibody Interactions,DrugBank
DB00078,CD20-directed Radiotherapeutic Antibody,DrugBank
DB00078,Globulins,DrugBank
DB00078,Immunoglobulins,DrugBank
DB00078,Immunoproteins,DrugBank
DB00078,Immunosuppressive Agents,DrugBank
DB00078,Immunotherapy,DrugBank
DB00078,"Lymphoma, B-Cell",DrugBank
DB00078,Myelosuppressive Agents,DrugBank
DB00078,Proteins,DrugBank
DB00078,Radiopharmaceutical Activity,DrugBank
DB00078,Serum Globulins,DrugBank
DB00078,Therapeutic Radiopharmaceuticals,DrugBank
DB00078,Various Therapeutic Radiopharmaceuticals,DrugBank
DB00078,Yttrium Radioisotopes,DrugBank
DB00080,Agents Causing Muscle Toxicity,DrugBank
DB00080,"Amino Acids, Peptides, and Proteins",DrugBank
DB00080,Anti-Bacterial Agents,DrugBank
DB00080,Anti-Infective Agents,DrugBank
DB00080,Antibacterials for Systemic Use,DrugBank
DB00080,Antiinfectives for Systemic Use,DrugBank
DB00080,Cyclic Lipopeptides,DrugBank
DB00080,Drugs that are Mainly Renally Excreted,DrugBank
DB00080,Lipids,DrugBank
DB00080,Lipopeptide Antibacterial,DrugBank
DB00080,Lipopeptides,DrugBank
DB00080,P-glycoprotein substrates,DrugBank
DB00080,Peptides,DrugBank
DB00080,"Peptides, Cyclic",DrugBank
DB00081,"Amino Acids, Peptides, and Proteins",DrugBank
DB00081,Antibodies,DrugBank
DB00081,"Antigens, CD20",DrugBank
DB00081,Antineoplastic Agents,DrugBank
DB00081,Blood Proteins,DrugBank
DB00081,CD20-directed Antibody Interactions,DrugBank
DB00081,CD20-directed Radiotherapeutic Antibody,DrugBank
DB00081,Drugs that are Mainly Renally Excreted,DrugBank
DB00081,Globulins,DrugBank
DB00081,Immunoglobulins,DrugBank
DB00081,Immunoproteins,DrugBank
DB00081,Immunosuppressive Agents,DrugBank
DB00081,Iodine (131I) Compounds,DrugBank
DB00081,Myelosuppressive Agents,DrugBank
DB00081,Proteins,DrugBank
DB00081,Radioimmunotherapy,DrugBank
DB00081,Radiopharmaceutical Activity,DrugBank
DB00081,Serum Globulins,DrugBank
DB00081,Therapeutic Radiopharmaceuticals,DrugBank
DB00082,Acromegaly,DrugBank
DB00082,"Amino Acids, Peptides, and Proteins",DrugBank
DB00082,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB00082,Cholinesterase Inhibitors,DrugBank
DB00082,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00082,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00082,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00082,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00082,Growth Hormone Receptor Antagonist,DrugBank
DB00082,Growth Hormone Receptor Antagonists,DrugBank
DB00082,Hormones,DrugBank
DB00082,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00082,Hypoglycemia-Associated Agents,DrugBank
DB00082,Pegylated agents,DrugBank
DB00082,Peptide Hormones,DrugBank
DB00082,Peptides,DrugBank
DB00082,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00082,Pituitary Hormones,DrugBank
DB00082,"Pituitary Hormones, Anterior",DrugBank
DB00082,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00083,Acetylcholine Release Inhibitors,DrugBank
DB00083,Agents that produce neuromuscular block (indirect),DrugBank
DB00083,"Amino Acids, Peptides, and Proteins",DrugBank
DB00083,Bacterial Proteins,DrugBank
DB00083,Bacterial Toxins,DrugBank
DB00083,Biological Factors,DrugBank
DB00083,Botulinum Toxins,DrugBank
DB00083,"Botulinum Toxins, Type A",DrugBank
DB00083,Central Nervous System Depressants,DrugBank
DB00083,Cholinergic Agents,DrugBank
DB00083,Endopeptidases,DrugBank
DB00083,Enzymes,DrugBank
DB00083,Enzymes and Coenzymes,DrugBank
DB00083,Ganglion Blockers,DrugBank
DB00083,Hydrolases,DrugBank
DB00083,Membrane Transport Modulators,DrugBank
DB00083,Metalloendopeptidases,DrugBank
DB00083,Metalloproteases,DrugBank
DB00083,Muscle Relaxants,DrugBank
DB00083,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00083,Musculo-Skeletal System,DrugBank
DB00083,Neuromuscular Agents,DrugBank
DB00083,Neuromuscular Blocking Agents,DrugBank
DB00083,Neurotoxins,DrugBank
DB00083,Neurotransmitter Agents,DrugBank
DB00083,Noxae,DrugBank
DB00083,Other Miscellaneous Therapeutic Agents,DrugBank
DB00083,Peptide Hydrolases,DrugBank
DB00083,Peripheral Nervous System Agents,DrugBank
DB00083,Proteins,DrugBank
DB00083,Toxic Actions,DrugBank
DB00083,"Toxins, Biological",DrugBank
DB00085,Alimentary Tract and Metabolism,DrugBank
DB00085,Carboxylic Ester Hydrolases,DrugBank
DB00085,Complex Mixtures,DrugBank
DB00085,"Digestives, Incl. Enzymes",DrugBank
DB00085,Enzyme Preparations,DrugBank
DB00085,Enzymes,DrugBank
DB00085,Enzymes and Coenzymes,DrugBank
DB00085,Esterases,DrugBank
DB00085,Gastrointestinal Agents,DrugBank
DB00085,Hydrolases,DrugBank
DB00085,Lipase,DrugBank
DB00085,Pancreatic Extracts,DrugBank
DB00085,Tissue Extracts,DrugBank
DB00086,Agents causing angioedema,DrugBank
DB00086,"Amino Acids, Peptides, and Proteins",DrugBank
DB00086,Anticoagulants,DrugBank
DB00086,Blood and Blood Forming Organs,DrugBank
DB00086,Blood Proteins,DrugBank
DB00086,Cardiovascular Agents,DrugBank
DB00086,Endopeptidases,DrugBank
DB00086,Enzymes,DrugBank
DB00086,Enzymes and Coenzymes,DrugBank
DB00086,Fibrin Modulating Agents,DrugBank
DB00086,Fibrinolytic Agents,DrugBank
DB00086,Hematologic Agents,DrugBank
DB00086,Hydrolases,DrugBank
DB00086,Hypotensive Agents,DrugBank
DB00086,Peptide Hydrolases,DrugBank
DB00086,Plasminogen Activators,DrugBank
DB00086,Proteins,DrugBank
DB00086,"Streptokinase, antagonists & inhibitors",DrugBank
DB00087,"Amino Acids, Peptides, and Proteins",DrugBank
DB00087,Antibodies,DrugBank
DB00087,"Antibodies, Monoclonal",DrugBank
DB00087,"Antibodies, Monoclonal, Humanized",DrugBank
DB00087,Antineoplastic Agents,DrugBank
DB00087,"Antineoplastic Agents, Immunological",DrugBank
DB00087,Antineoplastic and Immunomodulating Agents,DrugBank
DB00087,Blood Proteins,DrugBank
DB00087,Cancer immunotherapy,DrugBank
DB00087,CD52-directed Antibody Interactions,DrugBank
DB00087,CD52-directed Cytolytic Antibody,DrugBank
DB00087,Globulins,DrugBank
DB00087,Immunoglobulins,DrugBank
DB00087,Immunoproteins,DrugBank
DB00087,Immunosuppressive Agents,DrugBank
DB00087,Immunotherapy,DrugBank
DB00087,Myelosuppressive Agents,DrugBank
DB00087,Narrow Therapeutic Index Drugs,DrugBank
DB00087,Proteins,DrugBank
DB00087,Selective Immunosuppressants,DrugBank
DB00087,Serum Globulins,DrugBank
DB00089,"Amino Acids, Peptides, and Proteins",DrugBank
DB00089,Antibodies,DrugBank
DB00089,Blood Proteins,DrugBank
DB00089,"Compounds used in a research, industrial, or household setting",DrugBank
DB00089,Diagnostic Radiopharmaceuticals,DrugBank
DB00089,Globulins,DrugBank
DB00089,Immunoglobulins,DrugBank
DB00089,Immunoproteins,DrugBank
DB00089,Indicators and Reagents,DrugBank
DB00089,Indium (111In) Compounds,DrugBank
DB00089,Indium Radioisotopes,DrugBank
DB00089,Laboratory Chemicals,DrugBank
DB00089,Prostatic Neoplasms,DrugBank
DB00089,Proteins,DrugBank
DB00089,Serum Globulins,DrugBank
DB00089,Tumour Detection,DrugBank
DB00091,Agents causing hyperkalemia,DrugBank
DB00091,Agents Causing Muscle Toxicity,DrugBank
DB00091,Agents that produce hypertension,DrugBank
DB00091,Agents that produce neuromuscular block (indirect),DrugBank
DB00091,Agents that reduce seizure threshold,DrugBank
DB00091,"Amino Acids, Peptides, and Proteins",DrugBank
DB00091,Anti-Inflammatory Agents,DrugBank
DB00091,Antirheumatic Agents,DrugBank
DB00091,BCRP/ABCG2 Inhibitors,DrugBank
DB00091,BSEP/ABCB11 Inhibitors,DrugBank
DB00091,BSEP/ABCB11 Substrates,DrugBank
DB00091,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00091,Calcineurin Inhibitor Immunosuppressant,DrugBank
DB00091,Calcineurin Inhibitors,DrugBank
DB00091,Cyclosporins,DrugBank
DB00091,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00091,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00091,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00091,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00091,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00091,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00091,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00091,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00091,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00091,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00091,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00091,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00091,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00091,Cytochrome P-450 Substrates,DrugBank
DB00091,Dermatologicals,DrugBank
DB00091,Enzyme Inhibitors,DrugBank
DB00091,Immunologic Factors,DrugBank
DB00091,Immunosuppressive Agents,DrugBank
DB00091,Narrow Therapeutic Index Drugs,DrugBank
DB00091,Nephrotoxic agents,DrugBank
DB00091,Neurotoxic agents,DrugBank
DB00091,NTCP Inhibitors,DrugBank
DB00091,OAT1/SLC22A6 inhibitors,DrugBank
DB00091,OAT1/SLC22A6 Substrates,DrugBank
DB00091,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00091,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00091,OATP1B3 inhibitors,DrugBank
DB00091,Ophthalmologicals,DrugBank
DB00091,P-glycoprotein inhibitors,DrugBank
DB00091,P-glycoprotein substrates,DrugBank
DB00091,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00091,Peptides,DrugBank
DB00091,"Peptides, Cyclic",DrugBank
DB00092,"Amino Acids, Peptides, and Proteins",DrugBank
DB00092,Antibodies,DrugBank
DB00092,Antineoplastic and Immunomodulating Agents,DrugBank
DB00092,Blood Proteins,DrugBank
DB00092,Carbohydrates,DrugBank
DB00092,CD2-directed Antibody Interactions,DrugBank
DB00092,CD2-directed LFA-3/Fc Fusion Protein,DrugBank
DB00092,CD58 Antigens,DrugBank
DB00092,Dermatologicals,DrugBank
DB00092,Globulins,DrugBank
DB00092,Glycoconjugates,DrugBank
DB00092,Glycoproteins,DrugBank
DB00092,Immunoglobulin Isotypes,DrugBank
DB00092,Immunologic Factors,DrugBank
DB00092,Immunoproteins,DrugBank
DB00092,Immunosuppressive Agents,DrugBank
DB00092,Membrane Glycoproteins,DrugBank
DB00092,Membrane Proteins,DrugBank
DB00092,Proteins,DrugBank
DB00092,Recombinant Fusion Proteins,DrugBank
DB00092,Recombinant Proteins,DrugBank
DB00092,Selective Immunosuppressants,DrugBank
DB00092,Serum Globulins,DrugBank
DB00093,"Amino Acids, Peptides, and Proteins",DrugBank
DB00093,Cardiovascular Agents,DrugBank
DB00093,Hormones,DrugBank
DB00093,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00093,Nerve Tissue Proteins,DrugBank
DB00093,Neuropeptides,DrugBank
DB00093,Oligopeptides,DrugBank
DB00093,Peptide Hormones,DrugBank
DB00093,Peptides,DrugBank
DB00093,Pituitary Hormones,DrugBank
DB00093,"Pituitary Hormones, Posterior",DrugBank
DB00093,Proteins,DrugBank
DB00093,Vasoconstrictor Agents,DrugBank
DB00093,Vasopressin and Analogues,DrugBank
DB00093,Vasopressins,DrugBank
DB00095,"Amino Acids, Peptides, and Proteins",DrugBank
DB00095,Antibodies,DrugBank
DB00095,"Antibodies, Monoclonal",DrugBank
DB00095,"Antibodies, Monoclonal, Humanized",DrugBank
DB00095,"Antigens, CD11",DrugBank
DB00095,Antineoplastic and Immunomodulating Agents,DrugBank
DB00095,Blood Proteins,DrugBank
DB00095,Cancer immunotherapy,DrugBank
DB00095,CD11a-directed Antibody Interactions,DrugBank
DB00095,CD11a-directed Humanized IgG1 Antibody,DrugBank
DB00095,Globulins,DrugBank
DB00095,Immunoglobulins,DrugBank
DB00095,Immunoproteins,DrugBank
DB00095,Immunosuppressive Agents,DrugBank
DB00095,Immunotherapy,DrugBank
DB00095,Proteins,DrugBank
DB00095,Selective Immunosuppressants,DrugBank
DB00095,Serum Globulins,DrugBank
DB00098,"Amino Acids, Peptides, and Proteins",DrugBank
DB00098,Antibodies,DrugBank
DB00098,Antibody-Surface Protein Interactions,DrugBank
DB00098,Antineoplastic and Immunomodulating Agents,DrugBank
DB00098,Biological Products,DrugBank
DB00098,Blood,DrugBank
DB00098,Blood Proteins,DrugBank
DB00098,Body Fluids,DrugBank
DB00098,Complex Mixtures,DrugBank
DB00098,Fluids and Secretions,DrugBank
DB00098,Globulins,DrugBank
DB00098,Immune Sera,DrugBank
DB00098,Immunoglobulin G,DrugBank
DB00098,Immunoglobulins,DrugBank
DB00098,Immunologic Factors,DrugBank
DB00098,Immunoproteins,DrugBank
DB00098,Immunosuppressive Agents,DrugBank
DB00098,Immunotherapy,DrugBank
DB00098,Increased T Lymphocyte Destruction,DrugBank
DB00098,Lymphocyte Function Alteration,DrugBank
DB00098,Miscellaneous Therapeutic Agents,DrugBank
DB00098,Proteins,DrugBank
DB00098,Selective Immunosuppressants,DrugBank
DB00098,Serum,DrugBank
DB00098,Serum Globulins,DrugBank
DB00099,"Amino Acids, Peptides, and Proteins",DrugBank
DB00099,Antineoplastic and Immunomodulating Agents,DrugBank
DB00099,Biological Factors,DrugBank
DB00099,Colony-Stimulating Factors,DrugBank
DB00099,Glycoconjugates,DrugBank
DB00099,Glycoproteins,DrugBank
DB00099,Granulocyte Colony-Stimulating Factors,DrugBank
DB00099,Hematologic Agents,DrugBank
DB00099,Hematopoietic Cell Growth Factors,DrugBank
DB00099,Increased Myeloid Cell Production,DrugBank
DB00099,Leukocyte Growth Factor,DrugBank
DB00099,Peptides,DrugBank
DB00099,Proteins,DrugBank
DB00100,Blood Coagulation Factors,DrugBank
DB00100,Hemostatics,DrugBank
DB00100,Increased Coagulation Activity,DrugBank
DB00103,Alimentary Tract and Metabolism,DrugBank
DB00103,"Amino Acids, Peptides, and Proteins",DrugBank
DB00103,Enzymes,DrugBank
DB00103,Enzymes and Coenzymes,DrugBank
DB00103,Galactosidases,DrugBank
DB00103,Glycoside Hydrolases,DrugBank
DB00103,Hydrolases,DrugBank
DB00103,Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme,DrugBank
DB00103,Protein Isoforms,DrugBank
DB00103,Proteins,DrugBank
DB00104,"Amino Acids, Peptides, and Proteins",DrugBank
DB00104,Antineoplastic Agents,DrugBank
DB00104,"Antineoplastic Agents, Hormonal",DrugBank
DB00104,Bradycardia-Causing Agents,DrugBank
DB00104,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00104,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00104,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00104,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00104,Gastrointestinal Agents,DrugBank
DB00104,Hyperglycemia-Associated Agents,DrugBank
DB00104,Hypoglycemia-Associated Agents,DrugBank
DB00104,Hypothalamic Hormones,DrugBank
DB00104,Miscellaneous Therapeutic Agents,DrugBank
DB00104,P-glycoprotein substrates,DrugBank
DB00104,Peptides,DrugBank
DB00104,"Peptides, Cyclic",DrugBank
DB00104,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00104,Potential QTc-Prolonging Agents,DrugBank
DB00104,QTc Prolonging Agents,DrugBank
DB00104,Somatostatin and Analogues,DrugBank
DB00104,Somatostatin Receptor Agonists,DrugBank
DB00104,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00105,"Adjuvants, Immunologic",DrugBank
DB00105,Alfa Interferons,DrugBank
DB00105,"Amino Acids, Peptides, and Proteins",DrugBank
DB00105,Anti-Infective Agents,DrugBank
DB00105,Antineoplastic Agents,DrugBank
DB00105,Antineoplastic and Immunomodulating Agents,DrugBank
DB00105,Antiviral Agents,DrugBank
DB00105,Biological Factors,DrugBank
DB00105,Cancer immunotherapy,DrugBank
DB00105,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00105,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00105,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00105,Cytokines,DrugBank
DB00105,Drugs causing inadvertant photosensitivity,DrugBank
DB00105,Hepatotoxic Agents,DrugBank
DB00105,Immunosuppressive Agents,DrugBank
DB00105,Immunotherapy,DrugBank
DB00105,Intercellular Signaling Peptides and Proteins,DrugBank
DB00105,Interferon alpha,DrugBank
DB00105,Interferon Type I,DrugBank
DB00105,Interferon-alpha,DrugBank
DB00105,Interferons,DrugBank
DB00105,Myelosuppressive Agents,DrugBank
DB00105,Narrow Therapeutic Index Drugs,DrugBank
DB00105,Peptides,DrugBank
DB00105,Photosensitizing Agents,DrugBank
DB00105,Proteins,DrugBank
DB00107,"Amino Acids, Peptides, and Proteins",DrugBank
DB00107,Genito Urinary System and Sex Hormones,DrugBank
DB00107,Hormones,DrugBank
DB00107,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00107,Increased Uterine Smooth Muscle Contraction or Tone,DrugBank
DB00107,Oxytocin and Analogues,DrugBank
DB00107,"Oxytocin, analogs & derivatives",DrugBank
DB00107,Peptide Hormones,DrugBank
DB00107,Peptides,DrugBank
DB00107,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00107,Pituitary Hormones,DrugBank
DB00107,"Pituitary Hormones, Posterior",DrugBank
DB00107,Posterior Pituitary Lobe Hormones,DrugBank
DB00107,Potential QTc-Prolonging Agents,DrugBank
DB00107,QTc Prolonging Agents,DrugBank
DB00107,Reproductive Control Agents,DrugBank
DB00107,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00107,Uterotonic agents,DrugBank
DB00108,"Amino Acids, Peptides, and Proteins",DrugBank
DB00108,Antibodies,DrugBank
DB00108,"Antibodies, Monoclonal",DrugBank
DB00108,"Antibodies, Monoclonal, Humanized",DrugBank
DB00108,Antineoplastic and Immunomodulating Agents,DrugBank
DB00108,Blood Proteins,DrugBank
DB00108,Globulins,DrugBank
DB00108,Immunoglobulins,DrugBank
DB00108,Immunologic Factors,DrugBank
DB00108,Immunomodulatory Agents,DrugBank
DB00108,Immunoproteins,DrugBank
DB00108,Immunosuppressive Agents,DrugBank
DB00108,Integrin Receptor Antagonist,DrugBank
DB00108,Multiple Sclerosis,DrugBank
DB00108,Proteins,DrugBank
DB00108,Selective Immunosuppressants,DrugBank
DB00108,Serum Globulins,DrugBank
DB00110,"Amino Acids, Peptides, and Proteins",DrugBank
DB00110,Anti-Infective Agents,DrugBank
DB00110,Antibodies,DrugBank
DB00110,"Antibodies, Monoclonal",DrugBank
DB00110,"Antibodies, Monoclonal, Humanized",DrugBank
DB00110,Antiinfectives for Systemic Use,DrugBank
DB00110,Antiviral Agents,DrugBank
DB00110,Antiviral monoclonal antibodies,DrugBank
DB00110,Blood Proteins,DrugBank
DB00110,Fusion Protein Inhibitors,DrugBank
DB00110,Globulins,DrugBank
DB00110,Immune Sera and Immunoglobulins,DrugBank
DB00110,Immunoglobulins,DrugBank
DB00110,Immunoproteins,DrugBank
DB00110,Proteins,DrugBank
DB00110,Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody,DrugBank
DB00110,Serum Globulins,DrugBank
DB00110,Specific Immunoglobulins,DrugBank
DB00111,"Amino Acids, Peptides, and Proteins",DrugBank
DB00111,Antibodies,DrugBank
DB00111,"Antibodies, Monoclonal",DrugBank
DB00111,"Antibodies, Monoclonal, Humanized",DrugBank
DB00111,Antineoplastic and Immunomodulating Agents,DrugBank
DB00111,Blood Proteins,DrugBank
DB00111,Cancer immunotherapy,DrugBank
DB00111,Globulins,DrugBank
DB00111,Immunoglobulins,DrugBank
DB00111,Immunologic Factors,DrugBank
DB00111,Immunomodulatory Agents,DrugBank
DB00111,Immunoproteins,DrugBank
DB00111,Immunosuppressive Agents,DrugBank
DB00111,Immunotherapy,DrugBank
DB00111,Interleukin 2 Receptor-directed Antibody Interactions,DrugBank
DB00111,Interleukin Inhibitors,DrugBank
DB00111,Interleukin-2 Receptor Antagonist,DrugBank
DB00111,Interleukin-2 Receptor Blocking Antibody,DrugBank
DB00111,Proteins,DrugBank
DB00111,Serum Globulins,DrugBank
DB00112,"Amino Acids, Peptides, and Proteins",DrugBank
DB00112,Angiogenesis Inhibitors,DrugBank
DB00112,Angiogenesis Modulating Agents,DrugBank
DB00112,Antibodies,DrugBank
DB00112,"Antibodies, Monoclonal",DrugBank
DB00112,"Antibodies, Monoclonal, Humanized",DrugBank
DB00112,Antineoplastic Agents,DrugBank
DB00112,"Antineoplastic Agents, Immunological",DrugBank
DB00112,Antineoplastic and Immunomodulating Agents,DrugBank
DB00112,Antineovascularisation Agents,DrugBank
DB00112,Biological Products,DrugBank
DB00112,Blood Proteins,DrugBank
DB00112,Cancer immunotherapy,DrugBank
DB00112,Cardiotoxic antineoplastic agents,DrugBank
DB00112,Complex Mixtures,DrugBank
DB00112,Experimental Unapproved Treatments for COVID-19,DrugBank
DB00112,Globulins,DrugBank
DB00112,Growth Inhibitors,DrugBank
DB00112,Immunoglobulins,DrugBank
DB00112,Immunoproteins,DrugBank
DB00112,Immunotherapy,DrugBank
DB00112,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB00112,Narrow Therapeutic Index Drugs,DrugBank
DB00112,Ocular Vascular Disorder Agents,DrugBank
DB00112,Ophthalmologicals,DrugBank
DB00112,Proteins,DrugBank
DB00112,Sensory Organs,DrugBank
DB00112,Serum Globulins,DrugBank
DB00112,Vascular Endothelial Growth Factor Inhibitor,DrugBank
DB00112,Vascular Endothelial Growth Factor Inhibitors,DrugBank
DB00112,Vascular Endothelial Growth Factor-directed Antibody Interactions,DrugBank
DB00112,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,DrugBank
DB00112,VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors,DrugBank
DB00113,"Amino Acids, Peptides, and Proteins",DrugBank
DB00113,Antibodies,DrugBank
DB00113,Blood Proteins,DrugBank
DB00113,Diagnostic Radiopharmaceuticals,DrugBank
DB00113,Globulins,DrugBank
DB00113,Immunoglobulins,DrugBank
DB00113,Immunoproteins,DrugBank
DB00113,Organometallic Compounds,DrugBank
DB00113,Proteins,DrugBank
DB00113,Serum Globulins,DrugBank
DB00113,Technetium (99Mtc) Compounds,DrugBank
DB00113,Tumour Detection,DrugBank
DB00115,Antianemic Preparations,DrugBank
DB00115,Blood and Blood Forming Organs,DrugBank
DB00115,Corrinoids,DrugBank
DB00115,"Diet, Food, and Nutrition",DrugBank
DB00115,Drugs that are Mainly Renally Excreted,DrugBank
DB00115,Food,DrugBank
DB00115,Growth Substances,DrugBank
DB00115,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00115,Micronutrients,DrugBank
DB00115,"Vitamin B 12, biosynthesis",DrugBank
DB00115,Vitamin B Complex,DrugBank
DB00115,Vitamin B12 and Folic Acid,DrugBank
DB00115,Vitamins,DrugBank
DB00116,Coenzymes,DrugBank
DB00116,Dietary Supplements,DrugBank
DB00116,Enzymes and Coenzymes,DrugBank
DB00116,Folic Acid and Derivatives,DrugBank
DB00116,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00116,Pteridines,DrugBank
DB00116,Pterins,DrugBank
DB00116,Supplements,DrugBank
DB00116,Vitamin B Complex,DrugBank
DB00116,Vitamins,DrugBank
DB00118,Alimentary Tract and Metabolism,DrugBank
DB00118,Amino Acids,DrugBank
DB00118,Amino Acids and Derivatives,DrugBank
DB00118,"Amino Acids, Peptides, and Proteins",DrugBank
DB00118,"Amino Acids, Sulfur",DrugBank
DB00118,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00118,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00118,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00118,Dietary Supplements,DrugBank
DB00118,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00118,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00118,Nucleosides,DrugBank
DB00118,Purine Nucleosides,DrugBank
DB00118,Purines,DrugBank
DB00118,Ribonucleosides,DrugBank
DB00118,Sulfur Compounds,DrugBank
DB00118,Supplements,DrugBank
DB00120,Amino Acids,DrugBank
DB00120,"Amino Acids, Aromatic",DrugBank
DB00120,"Amino Acids, Cyclic",DrugBank
DB00120,"Amino Acids, Essential",DrugBank
DB00120,"Amino Acids, Peptides, and Proteins",DrugBank
DB00120,Dietary Supplements,DrugBank
DB00120,Immunosuppressive Agents,DrugBank
DB00120,Myelosuppressive Agents,DrugBank
DB00120,Proteinogenic Amino Acids,DrugBank
DB00120,Supplements,DrugBank
DB00122,Alcohols,DrugBank
DB00122,Amines,DrugBank
DB00122,Amino Alcohols,DrugBank
DB00122,Analgesics,DrugBank
DB00122,Antimetabolites,DrugBank
DB00122,Central Nervous System Agents,DrugBank
DB00122,Dietary Supplements,DrugBank
DB00122,Ethanolamines,DrugBank
DB00122,Gastrointestinal Agents,DrugBank
DB00122,Hypolipidemic Agents,DrugBank
DB00122,Lipid Regulating Agents,DrugBank
DB00122,Lipotropic Agents,DrugBank
DB00122,Nervous System,DrugBank
DB00122,Nootropic Agents,DrugBank
DB00122,OCT1 inhibitors,DrugBank
DB00122,OCT1 substrates,DrugBank
DB00122,OCT2 Inhibitors,DrugBank
DB00122,OCT2 Substrates,DrugBank
DB00122,Onium Compounds,DrugBank
DB00122,Other Nutritional Agents,DrugBank
DB00122,Quaternary Ammonium Compounds,DrugBank
DB00122,Salicylic Acid and Derivatives,DrugBank
DB00122,Supplements,DrugBank
DB00122,Trimethyl Ammonium Compounds,DrugBank
DB00122,Vitamin B Complex,DrugBank
DB00122,Vitamins,DrugBank
DB00126,"Acids, Acyclic",DrugBank
DB00126,Alimentary Tract and Metabolism,DrugBank
DB00126,Antioxidants,DrugBank
DB00126,Biological Factors,DrugBank
DB00126,Carbohydrates,DrugBank
DB00126,"Compounds used in a research, industrial, or household setting",DrugBank
DB00126,"Diet, Food, and Nutrition",DrugBank
DB00126,Food,DrugBank
DB00126,Gastrointestinal Acidifying Agents,DrugBank
DB00126,Genito Urinary System and Sex Hormones,DrugBank
DB00126,Growth Substances,DrugBank
DB00126,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00126,Hydroxy Acids,DrugBank
DB00126,Micronutrients,DrugBank
DB00126,Ophthalmologicals,DrugBank
DB00126,Organic Acids,DrugBank
DB00126,Physiological Phenomena,DrugBank
DB00126,Protective Agents,DrugBank
DB00126,Sensory Organs,DrugBank
DB00126,Sugar Acids,DrugBank
DB00126,Urinary Acidifying Agents,DrugBank
DB00126,Vitamin C and analogues,DrugBank
DB00126,Vitamins,DrugBank
DB00127,Amines,DrugBank
DB00127,Biogenic Amines,DrugBank
DB00127,Biogenic Polyamines,DrugBank
DB00127,Dietary Supplements,DrugBank
DB00127,OCT1 substrates,DrugBank
DB00127,Polyamines,DrugBank
DB00127,Supplements,DrugBank
DB00136,Alimentary Tract and Metabolism,DrugBank
DB00136,Antipsoriatics,DrugBank
DB00136,Antipsoriatics for Topical Use,DrugBank
DB00136,Bone Density Conservation Agents,DrugBank
DB00136,Calcium-Regulating Hormones and Agents,DrugBank
DB00136,Cholestanes,DrugBank
DB00136,Cholestenes,DrugBank
DB00136,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00136,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00136,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00136,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00136,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00136,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00136,Cytochrome P-450 Substrates,DrugBank
DB00136,"Diet, Food, and Nutrition",DrugBank
DB00136,Food,DrugBank
DB00136,Fused-Ring Compounds,DrugBank
DB00136,Growth Substances,DrugBank
DB00136,Lipids,DrugBank
DB00136,Membrane Lipids,DrugBank
DB00136,Membrane Transport Modulators,DrugBank
DB00136,Micronutrients,DrugBank
DB00136,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00136,Physiological Phenomena,DrugBank
DB00136,Secosteroids,DrugBank
DB00136,Steroids,DrugBank
DB00136,Sterols,DrugBank
DB00136,Vitamin D and Analogues,DrugBank
DB00136,Vitamins,DrugBank
DB00136,Vitamins (Fat Soluble),DrugBank
DB00139,"Acids, Acyclic",DrugBank
DB00139,Dicarboxylic Acids,DrugBank
DB00139,Dietary Supplements,DrugBank
DB00139,OAT3/SLC22A8 Substrates,DrugBank
DB00139,Succinates,DrugBank
DB00139,Supplements,DrugBank
DB00140,Alimentary Tract and Metabolism,DrugBank
DB00140,Biological Factors,DrugBank
DB00140,Coenzymes,DrugBank
DB00140,Dermatologicals,DrugBank
DB00140,Enzymes and Coenzymes,DrugBank
DB00140,Flavins,DrugBank
DB00140,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00140,Micronutrients,DrugBank
DB00140,OAT1/SLC22A6 inhibitors,DrugBank
DB00140,Ophthalmologicals,DrugBank
DB00140,Photosensitizing Agents,DrugBank
DB00140,"Pigments, Biological",DrugBank
DB00140,Pteridines,DrugBank
DB00140,Radiation-Sensitizing Agents,DrugBank
DB00140,Sensory Organs,DrugBank
DB00140,Vitamin B Complex,DrugBank
DB00140,Vitamins,DrugBank
DB00142,Acid Preparations,DrugBank
DB00142,Alimentary Tract and Metabolism,DrugBank
DB00142,Amino Acids,DrugBank
DB00142,"Amino Acids, Acidic",DrugBank
DB00142,"Amino Acids, Dicarboxylic",DrugBank
DB00142,"Amino Acids, Peptides, and Proteins",DrugBank
DB00142,Dietary Supplements,DrugBank
DB00142,"Digestives, Incl. Enzymes",DrugBank
DB00142,Excitatory Amino Acids,DrugBank
DB00142,Gastrointestinal Acidifying Agents,DrugBank
DB00142,Gastrointestinal Agents,DrugBank
DB00142,Glutamates,DrugBank
DB00142,Proteinogenic Amino Acids,DrugBank
DB00142,Supplements,DrugBank
DB00145,Amino Acids,DrugBank
DB00145,"Amino Acids, Peptides, and Proteins",DrugBank
DB00145,Blood and Blood Forming Organs,DrugBank
DB00145,Blood Substitutes and Perfusion Solutions,DrugBank
DB00145,Dietary Supplements,DrugBank
DB00145,Glycine Agents,DrugBank
DB00145,Irrigating Solutions,DrugBank
DB00145,Neurotransmitter Agents,DrugBank
DB00145,Proteinogenic Amino Acids,DrugBank
DB00145,Supplements,DrugBank
DB00146,Alimentary Tract and Metabolism,DrugBank
DB00146,Anti-Parathyroid Agents,DrugBank
DB00146,Bone Density Conservation Agents,DrugBank
DB00146,Calcium Homeostasis,DrugBank
DB00146,Cholestanes,DrugBank
DB00146,Cholestenes,DrugBank
DB00146,"Diet, Food, and Nutrition",DrugBank
DB00146,Food,DrugBank
DB00146,Fused-Ring Compounds,DrugBank
DB00146,Lipids,DrugBank
DB00146,Membrane Lipids,DrugBank
DB00146,Micronutrients,DrugBank
DB00146,Physiological Phenomena,DrugBank
DB00146,Secosteroids,DrugBank
DB00146,Steroids,DrugBank
DB00146,Sterols,DrugBank
DB00146,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00146,Vitamin D and Analogues,DrugBank
DB00146,Vitamins,DrugBank
DB00146,Vitamins (Fat Soluble),DrugBank
DB00150,Amino Acids,DrugBank
DB00150,"Amino Acids, Aromatic",DrugBank
DB00150,"Amino Acids, Cyclic",DrugBank
DB00150,"Amino Acids, Essential",DrugBank
DB00150,"Amino Acids, Peptides, and Proteins",DrugBank
DB00150,Antidepressive Agents,DrugBank
DB00150,"Antidepressive Agents, Second-Generation",DrugBank
DB00150,Central Nervous System Agents,DrugBank
DB00150,Central Nervous System Depressants,DrugBank
DB00150,Dietary Supplements,DrugBank
DB00150,Miscellaneous Antidepressants,DrugBank
DB00150,Nervous System,DrugBank
DB00150,Proteinogenic Amino Acids,DrugBank
DB00150,Psychoanaleptics,DrugBank
DB00150,Psychotropic Drugs,DrugBank
DB00150,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00150,Supplements,DrugBank
DB00152,Alimentary Tract and Metabolism,DrugBank
DB00152,"Diet, Food, and Nutrition",DrugBank
DB00152,Food,DrugBank
DB00152,Growth Substances,DrugBank
DB00152,Micronutrients,DrugBank
DB00152,OCT1 substrates,DrugBank
DB00152,OCT2 Inhibitors,DrugBank
DB00152,Physiological Phenomena,DrugBank
DB00152,Pyrimidines,DrugBank
DB00152,Sulfur Compounds,DrugBank
DB00152,Thiazoles,DrugBank
DB00152,Vitamin B Complex,DrugBank
DB00152,Vitamins,DrugBank
DB00153,Alimentary Tract and Metabolism,DrugBank
DB00153,Bone Density Conservation Agents,DrugBank
DB00153,Calcium-Regulating Hormones and Agents,DrugBank
DB00153,"Diet, Food, and Nutrition",DrugBank
DB00153,Food,DrugBank
DB00153,Fused-Ring Compounds,DrugBank
DB00153,Growth Substances,DrugBank
DB00153,Lipids,DrugBank
DB00153,Micronutrients,DrugBank
DB00153,Physiological Phenomena,DrugBank
DB00153,Secosteroids,DrugBank
DB00153,Vitamin D and Analogues,DrugBank
DB00153,Vitamins,DrugBank
DB00153,Vitamins (Fat Soluble),DrugBank
DB00155,"Acids, Acyclic",DrugBank
DB00155,Amino Acids,DrugBank
DB00155,"Amino Acids, Diamino",DrugBank
DB00155,"Amino Acids, Peptides, and Proteins",DrugBank
DB00155,Dicarboxylic Acids,DrugBank
DB00155,Dietary Supplements,DrugBank
DB00155,Hydroxy Acids,DrugBank
DB00155,OAT1/SLC22A6 Substrates,DrugBank
DB00155,OAT3/SLC22A8 Substrates,DrugBank
DB00155,Proteins,DrugBank
DB00155,Supplements,DrugBank
DB00158,Antianemic Preparations,DrugBank
DB00158,Autacoids,DrugBank
DB00158,BCRP/ABCG2 Substrates,DrugBank
DB00158,Biological Factors,DrugBank
DB00158,Diagnostic Agents,DrugBank
DB00158,"Diet, Food, and Nutrition",DrugBank
DB00158,Dietary Supplements,DrugBank
DB00158,Drugs that are Mainly Renally Excreted,DrugBank
DB00158,Folic Acid and Derivatives,DrugBank
DB00158,Food,DrugBank
DB00158,Growth Substances,DrugBank
DB00158,Hematinics,DrugBank
DB00158,Hematologic Agents,DrugBank
DB00158,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00158,Micronutrients,DrugBank
DB00158,OAT1/SLC22A6 inhibitors,DrugBank
DB00158,Pteridines,DrugBank
DB00158,Pterins,DrugBank
DB00158,Supplements,DrugBank
DB00158,Vitamin B Complex,DrugBank
DB00158,Vitamin B12 and Folic Acid,DrugBank
DB00158,Vitamins,DrugBank
DB00159,Agents causing hyperkalemia,DrugBank
DB00159,Agents that produce hypertension,DrugBank
DB00159,Anti-Inflammatory Agents,DrugBank
DB00159,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00159,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00159,Dietary Fats,DrugBank
DB00159,"Dietary Fats, Unsaturated",DrugBank
DB00159,Dietary Supplements,DrugBank
DB00159,Eicosanoids,DrugBank
DB00159,Fats,DrugBank
DB00159,Fatty Acids,DrugBank
DB00159,"Fatty Acids, Omega-3",DrugBank
DB00159,"Fatty Acids, Unsaturated",DrugBank
DB00159,Fish Oils,DrugBank
DB00159,Hypolipidemic Agents,DrugBank
DB00159,Lipids,DrugBank
DB00159,Nephrotoxic agents,DrugBank
DB00159,Non COX-2 selective NSAIDS,DrugBank
DB00159,Oils,DrugBank
DB00159,Supplements,DrugBank
DB00163,Antioxidants,DrugBank
DB00163,Basic Ointments and Protectants,DrugBank
DB00163,Benzopyrans,DrugBank
DB00163,Biological Factors,DrugBank
DB00163,"Compounds used in a research, industrial, or household setting",DrugBank
DB00163,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00163,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00163,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00163,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00163,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00163,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00163,Cytochrome P-450 Substrates,DrugBank
DB00163,"Diet, Food, and Nutrition",DrugBank
DB00163,Dietary Supplements,DrugBank
DB00163,Food,DrugBank
DB00163,Growth Substances,DrugBank
DB00163,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00163,Micronutrients,DrugBank
DB00163,Physiological Phenomena,DrugBank
DB00163,Protective Agents,DrugBank
DB00163,Pyrans,DrugBank
DB00163,Supplements,DrugBank
DB00163,Vitamin E,DrugBank
DB00163,"Vitamin E, analogs & derivatives",DrugBank
DB00163,Vitamins,DrugBank
DB00163,Vitamins (Fat Soluble),DrugBank
DB00165,Alimentary Tract and Metabolism,DrugBank
DB00165,Analogs/Derivatives,DrugBank
DB00165,Antiinfectives for Systemic Use,DrugBank
DB00165,Antimycobacterials,DrugBank
DB00165,"Diet, Food, and Nutrition",DrugBank
DB00165,Drugs for Treatment of Tuberculosis,DrugBank
DB00165,Drugs that are Mainly Renally Excreted,DrugBank
DB00165,Food,DrugBank
DB00165,Micronutrients,DrugBank
DB00165,Picolines,DrugBank
DB00165,Pyridines,DrugBank
DB00165,Vitamin B Complex,DrugBank
DB00165,Vitamins,DrugBank
DB00166,Alimentary Tract and Metabolism,DrugBank
DB00166,Antioxidants,DrugBank
DB00166,Biological Factors,DrugBank
DB00166,Coenzymes,DrugBank
DB00166,"Compounds used in a research, industrial, or household setting",DrugBank
DB00166,Dietary Supplements,DrugBank
DB00166,Enzymes and Coenzymes,DrugBank
DB00166,Fatty Acids,DrugBank
DB00166,Hypoglycemia-Associated Agents,DrugBank
DB00166,Lipids,DrugBank
DB00166,Micronutrients,DrugBank
DB00166,Protective Agents,DrugBank
DB00166,Sulfur Compounds,DrugBank
DB00166,Supplements,DrugBank
DB00166,Thiophenes,DrugBank
DB00166,Various Alimentary Tract and Metabolism Products,DrugBank
DB00166,Vitamin B Complex,DrugBank
DB00166,Vitamins,DrugBank
DB00168,"Amino Acids, Peptides, and Proteins",DrugBank
DB00168,"Compounds used in a research, industrial, or household setting",DrugBank
DB00168,"Diet, Food, and Nutrition",DrugBank
DB00168,Dietary Supplements,DrugBank
DB00168,Dipeptides,DrugBank
DB00168,Flavoring Agents,DrugBank
DB00168,Food,DrugBank
DB00168,Food Additives,DrugBank
DB00168,Food Ingredients,DrugBank
DB00168,OAT1/SLC22A6 inhibitors,DrugBank
DB00168,OAT3/SLC22A8 Inhibitors,DrugBank
DB00168,Oligopeptides,DrugBank
DB00168,Peptides,DrugBank
DB00168,Physiological Phenomena,DrugBank
DB00168,Supplements,DrugBank
DB00168,Sweetening Agents,DrugBank
DB00169,Alimentary Tract and Metabolism,DrugBank
DB00169,Bone Density Conservation Agents,DrugBank
DB00169,Calcium-Regulating Hormones and Agents,DrugBank
DB00169,"Cholecalciferol, antagonists & inhibitors",DrugBank
DB00169,Cholestanes,DrugBank
DB00169,Cholestenes,DrugBank
DB00169,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00169,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00169,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00169,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00169,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00169,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00169,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00169,Cytochrome P-450 Substrates,DrugBank
DB00169,"Diet, Food, and Nutrition",DrugBank
DB00169,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00169,Drugs for Treatment of Bone Diseases,DrugBank
DB00169,Food,DrugBank
DB00169,Fused-Ring Compounds,DrugBank
DB00169,Growth Substances,DrugBank
DB00169,Lipids,DrugBank
DB00169,Membrane Lipids,DrugBank
DB00169,Micronutrients,DrugBank
DB00169,Musculo-Skeletal System,DrugBank
DB00169,Physiological Phenomena,DrugBank
DB00169,Secosteroids,DrugBank
DB00169,Steroids,DrugBank
DB00169,Sterols,DrugBank
DB00169,Vitamin D and Analogues,DrugBank
DB00169,Vitamins,DrugBank
DB00169,Vitamins (Fat Soluble),DrugBank
DB00170,Antifibrinolytic Agents,DrugBank
DB00170,Blood and Blood Forming Organs,DrugBank
DB00170,Coagulants,DrugBank
DB00170,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00170,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00170,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00170,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00170,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00170,"Diet, Food, and Nutrition",DrugBank
DB00170,Dietary Supplements,DrugBank
DB00170,Diterpenes,DrugBank
DB00170,Fibrin Modulating Agents,DrugBank
DB00170,Food,DrugBank
DB00170,Hematologic Agents,DrugBank
DB00170,Hemostatics,DrugBank
DB00170,Micronutrients,DrugBank
DB00170,Naphthalenes,DrugBank
DB00170,Naphthoquinones,DrugBank
DB00170,Physiological Phenomena,DrugBank
DB00170,Phytol,DrugBank
DB00170,Quinones,DrugBank
DB00170,Supplements,DrugBank
DB00170,Terpenes,DrugBank
DB00170,Vitamin K,DrugBank
DB00170,Vitamins,DrugBank
DB00170,Vitamins (Fat Soluble),DrugBank
DB00173,Dietary Supplements,DrugBank
DB00173,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00173,Purines,DrugBank
DB00173,Supplements,DrugBank
DB00173,UGT1A1 Inhibitors,DrugBank
DB00175,Agents Causing Muscle Toxicity,DrugBank
DB00175,Anticholesteremic Agents,DrugBank
DB00175,BCRP/ABCG2 Inhibitors,DrugBank
DB00175,BCRP/ABCG2 Substrates,DrugBank
DB00175,BSEP/ABCB11 Substrates,DrugBank
DB00175,Drugs causing inadvertant photosensitivity,DrugBank
DB00175,Enzyme Inhibitors,DrugBank
DB00175,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB00175,Hypolipidemic Agents,DrugBank
DB00175,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00175,Lipid Modifying Agents,DrugBank
DB00175,"Lipid Modifying Agents, Plain",DrugBank
DB00175,Lipid Regulating Agents,DrugBank
DB00175,Noxae,DrugBank
DB00175,OAT1/SLC22A6 inhibitors,DrugBank
DB00175,OAT3/SLC22A8 Inhibitors,DrugBank
DB00175,OAT3/SLC22A8 Substrates,DrugBank
DB00175,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00175,OATP1B3 substrates,DrugBank
DB00175,OATP2B1/SLCO2B1 substrates,DrugBank
DB00175,P-glycoprotein substrates,DrugBank
DB00175,Photosensitizing Agents,DrugBank
DB00175,Toxic Actions,DrugBank
DB00176,Amines,DrugBank
DB00176,Anti-Anxiety Agents,DrugBank
DB00176,Antidepressive Agents,DrugBank
DB00176,Antidepressive Agents Indicated for Depression,DrugBank
DB00176,"Antidepressive Agents, Second-Generation",DrugBank
DB00176,BSEP/ABCB11 Substrates,DrugBank
DB00176,Central Nervous System Agents,DrugBank
DB00176,Central Nervous System Depressants,DrugBank
DB00176,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00176,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00176,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00176,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00176,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00176,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00176,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00176,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00176,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00176,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00176,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00176,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00176,Cytochrome P-450 CYP3A7 Inhibitors (moderate),DrugBank
DB00176,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00176,Cytochrome P-450 Substrates,DrugBank
DB00176,Drugs that are Mainly Renally Excreted,DrugBank
DB00176,Enzyme Inhibitors,DrugBank
DB00176,Hydroxylamines,DrugBank
DB00176,Hypoglycemia-Associated Agents,DrugBank
DB00176,Membrane Transport Modulators,DrugBank
DB00176,Nervous System,DrugBank
DB00176,Neurotransmitter Agents,DrugBank
DB00176,Neurotransmitter Uptake Inhibitors,DrugBank
DB00176,Oximes,DrugBank
DB00176,P-glycoprotein inhibitors,DrugBank
DB00176,Psychoanaleptics,DrugBank
DB00176,Psychotropic Drugs,DrugBank
DB00176,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00176,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00176,Serotonin Agents,DrugBank
DB00176,Serotonin Modulators,DrugBank
DB00176,Tranquilizing Agents,DrugBank
DB00177,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00177,Agents causing angioedema,DrugBank
DB00177,Agents causing hyperkalemia,DrugBank
DB00177,Angiotensin 2 Receptor Blocker,DrugBank
DB00177,Angiotensin II Antagonists and Calcium Channel Blockers,DrugBank
DB00177,Angiotensin II Antagonists and Diuretics,DrugBank
DB00177,Angiotensin II receptor antagonists,DrugBank
DB00177,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00177,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB00177,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB00177,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB00177,Angiotensin II Type 2 Receptor Blockers,DrugBank
DB00177,Angiotensin Receptor Antagonists,DrugBank
DB00177,Antihypertensive Agents,DrugBank
DB00177,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00177,Cardiovascular Agents,DrugBank
DB00177,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00177,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00177,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00177,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00177,Cytochrome P-450 Substrates,DrugBank
DB00177,Hypotensive Agents,DrugBank
DB00177,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00177,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00177,OATP1B3 substrates,DrugBank
DB00178,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00178,ACE Inhibitors and Diuretics,DrugBank
DB00178,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00178,Agents causing angioedema,DrugBank
DB00178,Agents causing hyperkalemia,DrugBank
DB00178,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00178,Antihypertensive Agents,DrugBank
DB00178,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00178,Cardiovascular Agents,DrugBank
DB00178,Cholinesterase Inhibitors,DrugBank
DB00178,Drugs causing inadvertant photosensitivity,DrugBank
DB00178,Enzyme Inhibitors,DrugBank
DB00178,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00178,Hypotensive Agents,DrugBank
DB00178,Lipid Modifying Agents,DrugBank
DB00178,Photosensitizing Agents,DrugBank
DB00178,Protease Inhibitors,DrugBank
DB00179,Analgesics,DrugBank
DB00179,"Analgesics, Non-Narcotic",DrugBank
DB00179,Anti-Inflammatory Agents,DrugBank
DB00179,Antineoplastic Agents,DrugBank
DB00179,Antineoplastic and Immunomodulating Agents,DrugBank
DB00179,Antioxidants,DrugBank
DB00179,Benzene Derivatives,DrugBank
DB00179,Benzyl Compounds,DrugBank
DB00179,Biological Factors,DrugBank
DB00179,Catechols,DrugBank
DB00179,"Compounds used in a research, industrial, or household setting",DrugBank
DB00179,Cyclooxygenase Inhibitors,DrugBank
DB00179,Enzyme Inhibitors,DrugBank
DB00179,Lignans,DrugBank
DB00179,Lipoxygenase Inhibitors,DrugBank
DB00179,Peripheral Nervous System Agents,DrugBank
DB00179,Phenols,DrugBank
DB00179,Protective Agents,DrugBank
DB00179,Sensory System Agents,DrugBank
DB00180,Adrenal Cortex Hormones,DrugBank
DB00180,Adrenals,DrugBank
DB00180,Agents to Treat Airway Disease,DrugBank
DB00180,Anti-Asthmatic Agents,DrugBank
DB00180,Anti-Inflammatory Agents,DrugBank
DB00180,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00180,Corticosteroids,DrugBank
DB00180,Corticosteroids for Systemic Use,DrugBank
DB00180,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00180,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00180,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00180,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00180,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00180,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00180,Cytochrome P-450 Substrates,DrugBank
DB00180,Drugs for Obstructive Airway Diseases,DrugBank
DB00180,Fused-Ring Compounds,DrugBank
DB00180,Immunosuppressive Agents,DrugBank
DB00180,Nasal Preparations,DrugBank
DB00180,Pregnadienes,DrugBank
DB00180,Pregnanes,DrugBank
DB00180,Respiratory System Agents,DrugBank
DB00180,Steroids,DrugBank
DB00180,"Steroids, Fluorinated",DrugBank
DB00181,Agents Causing Muscle Toxicity,DrugBank
DB00181,Amino Acids,DrugBank
DB00181,"Amino Acids, Peptides, and Proteins",DrugBank
DB00181,Aminobutyrates,DrugBank
DB00181,Butyrates,DrugBank
DB00181,Central Nervous System Agents,DrugBank
DB00181,Central Nervous System Depressants,DrugBank
DB00181,Drugs that are Mainly Renally Excreted,DrugBank
DB00181,GABA Agents,DrugBank
DB00181,GABA Agonists,DrugBank
DB00181,GABA-B Receptor Agonists,DrugBank
DB00181,Gaba-derivative Skeletal Muscle Relaxants,DrugBank
DB00181,gamma-Aminobutyric Acid-ergic Agonist,DrugBank
DB00181,Muscle Relaxants,DrugBank
DB00181,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00181,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00181,Musculo-Skeletal System,DrugBank
DB00181,Neurotransmitter Agents,DrugBank
DB00182,Adrenergic Agents,DrugBank
DB00182,Agents producing tachycardia,DrugBank
DB00182,Agents that produce hypertension,DrugBank
DB00182,Agents that reduce seizure threshold,DrugBank
DB00182,Amines,DrugBank
DB00182,Amphetamines,DrugBank
DB00182,Autonomic Agents,DrugBank
DB00182,Benzene Derivatives,DrugBank
DB00182,Biogenic Amines,DrugBank
DB00182,Biogenic Monoamines,DrugBank
DB00182,Catechols,DrugBank
DB00182,Central Nervous System Agents,DrugBank
DB00182,Central Nervous System Stimulants,DrugBank
DB00182,Central Nervous System Stimulation,DrugBank
DB00182,Centrally Acting Sympathomimetics,DrugBank
DB00182,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00182,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB00182,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00182,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00182,Cytochrome P-450 Substrates,DrugBank
DB00182,Dopamine Agents,DrugBank
DB00182,Dopamine Uptake Inhibitors,DrugBank
DB00182,Drugs that are Mainly Renally Excreted,DrugBank
DB00182,Membrane Transport Modulators,DrugBank
DB00182,Nervous System,DrugBank
DB00182,Neurotransmitter Agents,DrugBank
DB00182,Neurotransmitter Uptake Inhibitors,DrugBank
DB00182,Peripheral Nervous System Agents,DrugBank
DB00182,Phenethylamines,DrugBank
DB00182,Phenols,DrugBank
DB00182,Psychoanaleptics,DrugBank
DB00182,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB00182,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00182,Sympathomimetics,DrugBank
DB00184,Agents producing tachycardia,DrugBank
DB00184,Alkaloids,DrugBank
DB00184,Autonomic Agents,DrugBank
DB00184,Cholinergic Agents,DrugBank
DB00184,Cholinergic Agonists,DrugBank
DB00184,Cholinergic Nicotinic Agonist,DrugBank
DB00184,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00184,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00184,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00184,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00184,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00184,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00184,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00184,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00184,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00184,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00184,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00184,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00184,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00184,Cytochrome P-450 Substrates,DrugBank
DB00184,Drugs Used in Addictive Disorders,DrugBank
DB00184,Drugs Used in Nicotine Dependence,DrugBank
DB00184,Ganglion Blockers,DrugBank
DB00184,Ganglionic Stimulants,DrugBank
DB00184,Miscellaneous Autonomic Drugs,DrugBank
DB00184,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00184,Nervous System,DrugBank
DB00184,Neurotransmitter Agents,DrugBank
DB00184,"Nicotine, antagonists & inhibitors",DrugBank
DB00184,Nicotinic Agonists,DrugBank
DB00184,OCT1 inhibitors,DrugBank
DB00184,OCT2 Inhibitors,DrugBank
DB00184,Peripheral Nervous System Agents,DrugBank
DB00184,Pyridines,DrugBank
DB00184,Smoking Cessation Agents,DrugBank
DB00184,Solanaceous Alkaloids,DrugBank
DB00185,Autonomic Agents,DrugBank
DB00185,Cholinergic Agents,DrugBank
DB00185,Cholinergic Agonists,DrugBank
DB00185,Cholinergic Receptor Agonist,DrugBank
DB00185,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00185,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00185,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00185,Cytochrome P-450 Substrates,DrugBank
DB00185,Drugs that are Mainly Renally Excreted,DrugBank
DB00185,Muscarinic Agonists,DrugBank
DB00185,Nervous System,DrugBank
DB00185,Neurotransmitter Agents,DrugBank
DB00185,Parasympathomimetics,DrugBank
DB00185,Peripheral Nervous System Agents,DrugBank
DB00185,Sulfur Compounds,DrugBank
DB00186,Anti-Anxiety Agents,DrugBank
DB00186,Anticonvulsants,DrugBank
DB00186,Antiemetics,DrugBank
DB00186,Autonomic Agents,DrugBank
DB00186,Benzazepines,DrugBank
DB00186,Benzodiazepine hypnotics and sedatives,DrugBank
DB00186,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00186,Benzodiazepinones,DrugBank
DB00186,Central Nervous System Agents,DrugBank
DB00186,Central Nervous System Depressants,DrugBank
DB00186,Drugs that are Mainly Renally Excreted,DrugBank
DB00186,GABA Agents,DrugBank
DB00186,GABA Modulators,DrugBank
DB00186,Gastrointestinal Agents,DrugBank
DB00186,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00186,Hypnotics and Sedatives,DrugBank
DB00186,Muscle Relaxants,DrugBank
DB00186,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00186,Nervous System,DrugBank
DB00186,Neurotransmitter Agents,DrugBank
DB00186,Peripheral Nervous System Agents,DrugBank
DB00186,Psycholeptics,DrugBank
DB00186,Psychotropic Drugs,DrugBank
DB00186,Tranquilizing Agents,DrugBank
DB00187,Adrenergic Agents,DrugBank
DB00187,Adrenergic Antagonists,DrugBank
DB00187,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB00187,Adrenergic beta-Antagonists,DrugBank
DB00187,Agents causing hyperkalemia,DrugBank
DB00187,Alcohols,DrugBank
DB00187,Amines,DrugBank
DB00187,Amino Alcohols,DrugBank
DB00187,Antiarrhythmic agents,DrugBank
DB00187,Antihypertensive Agents,DrugBank
DB00187,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00187,"Beta Blocking Agents, Selective",DrugBank
DB00187,Beta-Blockers (Beta1 Selective),DrugBank
DB00187,Bradycardia-Causing Agents,DrugBank
DB00187,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00187,Cytochrome P-450 Substrates,DrugBank
DB00187,Hypotensive Agents,DrugBank
DB00187,Neurotransmitter Agents,DrugBank
DB00187,Potential QTc-Prolonging Agents,DrugBank
DB00187,Propanols,DrugBank
DB00187,QTc Prolonging Agents,DrugBank
DB00188,Acids,DrugBank
DB00188,"Acids, Noncarboxylic",DrugBank
DB00188,Antineoplastic Agents,DrugBank
DB00188,Antineoplastic and Immunomodulating Agents,DrugBank
DB00188,Boron Compounds,DrugBank
DB00188,Boronic Acids,DrugBank
DB00188,Cardiotoxic antineoplastic agents,DrugBank
DB00188,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00188,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00188,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00188,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00188,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00188,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00188,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00188,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00188,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00188,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00188,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00188,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00188,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00188,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00188,Cytochrome P-450 Substrates,DrugBank
DB00188,Hepatotoxic Agents,DrugBank
DB00188,Hypotensive Agents,DrugBank
DB00188,Immunosuppressive Agents,DrugBank
DB00188,Myelosuppressive Agents,DrugBank
DB00188,Narrow Therapeutic Index Drugs,DrugBank
DB00188,OATP1B3 inhibitors,DrugBank
DB00188,P-glycoprotein substrates,DrugBank
DB00188,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00188,Potential QTc-Prolonging Agents,DrugBank
DB00188,Proteasome Inhibitors,DrugBank
DB00188,Pyrazines,DrugBank
DB00188,QTc Prolonging Agents,DrugBank
DB00189,Alcohols,DrugBank
DB00189,Central Nervous System Agents,DrugBank
DB00189,Central Nervous System Depressants,DrugBank
DB00189,Chlorohydrins,DrugBank
DB00189,Hypnotics and Sedatives,DrugBank
DB00189,Nervous System,DrugBank
DB00189,Psycholeptics,DrugBank
DB00190,Amines,DrugBank
DB00190,Anti-Dyskinesia Agents,DrugBank
DB00190,Anti-Parkinson Drugs,DrugBank
DB00190,Aromatic Amino Acid Decarboxylase Inhibitors,DrugBank
DB00190,Aromatic L-amino Acid Decarboxylase Inhibitors,DrugBank
DB00190,Benzene Derivatives,DrugBank
DB00190,Biogenic Amines,DrugBank
DB00190,Biogenic Monoamines,DrugBank
DB00190,Catecholamines,DrugBank
DB00190,Catechols,DrugBank
DB00190,Central Nervous System Agents,DrugBank
DB00190,Drugs that are Mainly Renally Excreted,DrugBank
DB00190,Enzyme Inhibitors,DrugBank
DB00190,Hydrazines,DrugBank
DB00190,Phenols,DrugBank
DB00191,Adrenergic Agents,DrugBank
DB00191,Agents producing tachycardia,DrugBank
DB00191,Agents that produce hypertension,DrugBank
DB00191,Alimentary Tract and Metabolism,DrugBank
DB00191,Amines,DrugBank
DB00191,Amphetamines,DrugBank
DB00191,Anti-Obesity Agents,DrugBank
DB00191,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00191,Appetite Depressants,DrugBank
DB00191,Appetite Suppression,DrugBank
DB00191,Autonomic Agents,DrugBank
DB00191,Central Nervous System Agents,DrugBank
DB00191,Centrally Acting Antiobesity Products,DrugBank
DB00191,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00191,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00191,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00191,Cytochrome P-450 Substrates,DrugBank
DB00191,Increased Sympathetic Activity,DrugBank
DB00191,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00191,Neurotransmitter Agents,DrugBank
DB00191,Peripheral Nervous System Agents,DrugBank
DB00191,Phenethylamines,DrugBank
DB00191,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00191,Sympathomimetic Amine Anorectic,DrugBank
DB00191,Sympathomimetics,DrugBank
DB00193,Agents producing tachycardia,DrugBank
DB00193,Agents that reduce seizure threshold,DrugBank
DB00193,Alcohols,DrugBank
DB00193,Amines,DrugBank
DB00193,Analgesics,DrugBank
DB00193,Anticholinergic Agents,DrugBank
DB00193,Antidepressive Agents,DrugBank
DB00193,Central Nervous System Agents,DrugBank
DB00193,Central Nervous System Depressants,DrugBank
DB00193,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00193,Cyclohexanes,DrugBank
DB00193,Cyclohexanols,DrugBank
DB00193,Cycloparaffins,DrugBank
DB00193,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00193,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00193,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00193,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00193,Cytochrome P-450 Substrates,DrugBank
DB00193,Dimethylamines,DrugBank
DB00193,Drugs that are Mainly Renally Excreted,DrugBank
DB00193,Muscarinic Antagonists,DrugBank
DB00193,Narcotics,DrugBank
DB00193,Nervous System,DrugBank
DB00193,NMDA Receptor Antagonists,DrugBank
DB00193,Opiate Agonists,DrugBank
DB00193,Opioid Agonist,DrugBank
DB00193,Opioids,DrugBank
DB00193,Peripheral Nervous System Agents,DrugBank
DB00193,Sensory System Agents,DrugBank
DB00193,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00193,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00193,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00193,Serotonin Agents,DrugBank
DB00193,Serotonin Modulators,DrugBank
DB00193,Serotonin Receptor Antagonists,DrugBank
DB00193,UGT1A1 Substrates,DrugBank
DB00195,Adrenergic Agents,DrugBank
DB00195,Adrenergic Antagonists,DrugBank
DB00195,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB00195,Adrenergic beta-Antagonists,DrugBank
DB00195,Agents causing hyperkalemia,DrugBank
DB00195,Alcohols,DrugBank
DB00195,Amines,DrugBank
DB00195,Amino Alcohols,DrugBank
DB00195,Antiarrhythmic agents,DrugBank
DB00195,Antiglaucoma Preparations and Miotics,DrugBank
DB00195,Antihypertensive Agents,DrugBank
DB00195,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00195,Autonomic Agents,DrugBank
DB00195,"Beta Blocking Agents, Selective",DrugBank
DB00195,Beta-adrenergic Agents,DrugBank
DB00195,Beta-Blockers (Beta1 Selective),DrugBank
DB00195,Bradycardia-Causing Agents,DrugBank
DB00195,Cardiovascular Agents,DrugBank
DB00195,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00195,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00195,Cytochrome P-450 Substrates,DrugBank
DB00195,Hypotensive Agents,DrugBank
DB00195,Neurotransmitter Agents,DrugBank
DB00195,Ophthalmologicals,DrugBank
DB00195,Peripheral Nervous System Agents,DrugBank
DB00195,Phenoxypropanolamines,DrugBank
DB00195,Propanolamines,DrugBank
DB00195,Propanols,DrugBank
DB00195,QTc Prolonging Agents,DrugBank
DB00195,Sensory Organs,DrugBank
DB00195,Sympatholytics,DrugBank
DB00196,14-alpha Demethylase Inhibitors,DrugBank
DB00196,Agents causing hyperkalemia,DrugBank
DB00196,Anti-Infective Agents,DrugBank
DB00196,Antifungal Agents,DrugBank
DB00196,Antifungals for Dermatological Use,DrugBank
DB00196,Antifungals for Topical Use,DrugBank
DB00196,Antiinfectives for Systemic Use,DrugBank
DB00196,Antimycotics for Systemic Use,DrugBank
DB00196,Azole Antifungals,DrugBank
DB00196,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00196,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00196,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00196,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00196,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00196,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00196,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00196,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00196,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB00196,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00196,Dermatologicals,DrugBank
DB00196,Drugs that are Mainly Renally Excreted,DrugBank
DB00196,Enzyme Inhibitors,DrugBank
DB00196,Hormone Antagonists,DrugBank
DB00196,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00196,Imidazole and Triazole Derivatives,DrugBank
DB00196,P-glycoprotein inhibitors,DrugBank
DB00196,Potential QTc-Prolonging Agents,DrugBank
DB00196,QTc Prolonging Agents,DrugBank
DB00196,Steroid Synthesis Inhibitors,DrugBank
DB00196,Triazole and tetrazole derivatives,DrugBank
DB00196,Triazole Derivatives,DrugBank
DB00196,Triazoles,DrugBank
DB00197,Alimentary Tract and Metabolism,DrugBank
DB00197,Benzopyrans,DrugBank
DB00197,Blood Glucose Lowering Agents,DrugBank
DB00197,BSEP/ABCB11 Inhibitors,DrugBank
DB00197,Chromans,DrugBank
DB00197,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00197,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00197,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00197,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00197,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00197,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00197,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00197,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00197,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00197,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00197,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00197,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00197,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00197,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00197,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00197,Cytochrome P-450 Substrates,DrugBank
DB00197,Drugs Used in Diabetes,DrugBank
DB00197,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00197,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00197,Oral Hypoglycemics,DrugBank
DB00197,Pyrans,DrugBank
DB00197,Sulfur Compounds,DrugBank
DB00197,Thiazoles,DrugBank
DB00197,Thiazolidinediones,DrugBank
DB00197,UGT1A1 Substrates,DrugBank
DB00197,UGT1A3 substrates,DrugBank
DB00197,UGT1A4 substrates,DrugBank
DB00197,UGT1A6 Inhibitors,DrugBank
DB00197,UGT1A6 substrate,DrugBank
DB00197,UGT1A9 Substrates,DrugBank
DB00197,UGT2B7 substrates,DrugBank
DB00198,Acetamides,DrugBank
DB00198,Acetates,DrugBank
DB00198,Amides,DrugBank
DB00198,Anti-Infective Agents,DrugBank
DB00198,Antiinfectives for Systemic Use,DrugBank
DB00198,Antiviral Agents,DrugBank
DB00198,Antivirals for Systemic Use,DrugBank
DB00198,Direct Acting Antivirals,DrugBank
DB00198,Drugs that are Mainly Renally Excreted,DrugBank
DB00198,Neuraminidase Inhibitors,DrugBank
DB00198,OAT3/SLC22A8 Substrates,DrugBank
DB00199,Anti-Acne Preparations,DrugBank
DB00199,Anti-Acne Preparations for Topical Use,DrugBank
DB00199,Anti-Bacterial Agents,DrugBank
DB00199,Anti-Infective Agents,DrugBank
DB00199,Antibacterials for Systemic Use,DrugBank
DB00199,Antiinfectives for Systemic Use,DrugBank
DB00199,Antiinfectives for Treatment of Acne,DrugBank
DB00199,BSEP/ABCB11 Inhibitors,DrugBank
DB00199,BSEP/ABCB11 Substrates,DrugBank
DB00199,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00199,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00199,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00199,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00199,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00199,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00199,Cytochrome P-450 CYP3A5 Inhibitors (moderate),DrugBank
DB00199,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00199,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00199,Cytochrome P-450 CYP3A7 Inhibitors (moderate),DrugBank
DB00199,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00199,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00199,Cytochrome P-450 Substrates,DrugBank
DB00199,Dermatologicals,DrugBank
DB00199,Enzyme Inhibitors,DrugBank
DB00199,Erythromycin and similars,DrugBank
DB00199,Erythromycins,DrugBank
DB00199,Gastrointestinal Agents,DrugBank
DB00199,Lactones,DrugBank
DB00199,Macrolide Antimicrobial,DrugBank
DB00199,Macrolides,DrugBank
DB00199,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB00199,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00199,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00199,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00199,OATP1B3 inhibitors,DrugBank
DB00199,OATP1B3 substrates,DrugBank
DB00199,Ophthalmologicals,DrugBank
DB00199,P-glycoprotein inhibitors,DrugBank
DB00199,P-glycoprotein substrates,DrugBank
DB00199,Protein Synthesis Inhibitors,DrugBank
DB00199,QTc Prolonging Agents,DrugBank
DB00200,Antianemic Preparations,DrugBank
DB00200,Antidotes,DrugBank
DB00200,Blood and Blood Forming Organs,DrugBank
DB00200,Corrinoids,DrugBank
DB00200,Drugs that are Mainly Renally Excreted,DrugBank
DB00200,Hematinics,DrugBank
DB00200,Hematologic Agents,DrugBank
DB00200,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00200,Micronutrients,DrugBank
DB00200,Nutritional Support,DrugBank
DB00200,Vitamin B Complex,DrugBank
DB00200,Vitamin B12 and Folic Acid,DrugBank
DB00200,Vitamins,DrugBank
DB00201,Alkaloids,DrugBank
DB00201,Anorexigenic Agents & Respiratory and CNS Stimulants,DrugBank
DB00201,BCRP/ABCG2 Inhibitors,DrugBank
DB00201,Caffeine and Caffeine Containing Products,DrugBank
DB00201,Central Nervous System Agents,DrugBank
DB00201,Central Nervous System Stimulants,DrugBank
DB00201,Central Nervous System Stimulation,DrugBank
DB00201,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00201,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00201,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00201,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00201,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00201,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00201,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00201,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00201,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00201,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00201,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00201,Cytochrome P-450 Substrates,DrugBank
DB00201,Dermatologicals,DrugBank
DB00201,Diagnostic Agents,DrugBank
DB00201,Drugs for Obstructive Airway Diseases,DrugBank
DB00201,Enzyme Inhibitors,DrugBank
DB00201,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00201,Nervous System,DrugBank
DB00201,Neurotransmitter Agents,DrugBank
DB00201,Phosphodiesterase Inhibitors,DrugBank
DB00201,Psychoanaleptics,DrugBank
DB00201,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB00201,Purinergic Agents,DrugBank
DB00201,Purinergic Antagonists,DrugBank
DB00201,Purines,DrugBank
DB00201,Purinones,DrugBank
DB00201,Respiratory and CNS Stimulants,DrugBank
DB00201,Tests for Gastric Secretion,DrugBank
DB00201,Tricarboxylic Acids,DrugBank
DB00201,Xanthine derivatives,DrugBank
DB00202,"Acids, Acyclic",DrugBank
DB00202,Agents causing hyperkalemia,DrugBank
DB00202,Amines,DrugBank
DB00202,Ammonium Compounds,DrugBank
DB00202,Central Nervous System Depressants,DrugBank
DB00202,Choline Derivatives,DrugBank
DB00202,Cholinesterase substrates,DrugBank
DB00202,Dicarboxylic Acids,DrugBank
DB00202,Ethanolamines,DrugBank
DB00202,Muscle Relaxants,DrugBank
DB00202,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00202,Musculo-Skeletal System,DrugBank
DB00202,Neuromuscular Agents,DrugBank
DB00202,Neuromuscular Blocking Agents,DrugBank
DB00202,Neuromuscular Depolarizing Agents,DrugBank
DB00202,Neuromuscular Depolarizing Blockade,DrugBank
DB00202,Neurotoxic agents,DrugBank
DB00202,Nitrogen Compounds,DrugBank
DB00202,Onium Compounds,DrugBank
DB00202,Peripheral Nervous System Agents,DrugBank
DB00202,Quaternary Ammonium Compounds,DrugBank
DB00202,Succinates,DrugBank
DB00202,Trimethyl Ammonium Compounds,DrugBank
DB00203,Agents Causing Muscle Toxicity,DrugBank
DB00203,Amides,DrugBank
DB00203,Cardiovascular Agents,DrugBank
DB00203,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00203,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00203,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00203,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00203,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00203,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00203,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00203,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00203,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00203,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00203,Cytochrome P-450 Substrates,DrugBank
DB00203,Drugs Used in Erectile Dysfunction,DrugBank
DB00203,Enzyme Inhibitors,DrugBank
DB00203,Genitourinary Agents,DrugBank
DB00203,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00203,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00203,P-glycoprotein inhibitors,DrugBank
DB00203,P-glycoprotein substrates,DrugBank
DB00203,Phosphodiesterase 5 Inhibitors,DrugBank
DB00203,Phosphodiesterase Inhibitors,DrugBank
DB00203,Piperazines,DrugBank
DB00203,Purines,DrugBank
DB00203,Sulfonamides,DrugBank
DB00203,Sulfones,DrugBank
DB00203,Sulfur Compounds,DrugBank
DB00203,Urological Agents,DrugBank
DB00203,Urologicals,DrugBank
DB00203,Vasodilating Agents,DrugBank
DB00204,Amides,DrugBank
DB00204,Amines,DrugBank
DB00204,Antiarrhythmic agents,DrugBank
DB00204,"Antiarrhythmics, Class III",DrugBank
DB00204,Cardiac Therapy,DrugBank
DB00204,Cardiovascular Agents,DrugBank
DB00204,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00204,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00204,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00204,Cytochrome P-450 Substrates,DrugBank
DB00204,Ethylamines,DrugBank
DB00204,Highest Risk QTc-Prolonging Agents,DrugBank
DB00204,Membrane Transport Modulators,DrugBank
DB00204,Narrow Therapeutic Index Drugs,DrugBank
DB00204,OCT2 Substrates,DrugBank
DB00204,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00204,Potassium Channel Blockers,DrugBank
DB00204,QTc Prolonging Agents,DrugBank
DB00204,Sulfones,DrugBank
DB00204,Sulfur Compounds,DrugBank
DB00205,Anti-Infective Agents,DrugBank
DB00205,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB00205,Antimalarial diaminopyrimidines,DrugBank
DB00205,Antimalarials,DrugBank
DB00205,Antiparasitic Agents,DrugBank
DB00205,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00205,Antiprotozoals,DrugBank
DB00205,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00205,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00205,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00205,Enzyme Inhibitors,DrugBank
DB00205,Folic Acid Antagonists,DrugBank
DB00205,MATE 1 Inhibitors,DrugBank
DB00205,MATE 2 Inhibitors,DrugBank
DB00205,MATE inhibitors,DrugBank
DB00205,Pyrimidines,DrugBank
DB00206,Adrenergic Agents,DrugBank
DB00206,Adrenergic Uptake Inhibitors,DrugBank
DB00206,Alkaloids,DrugBank
DB00206,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB00206,Antidepressive Agents,DrugBank
DB00206,Antihypertensive Agents,DrugBank
DB00206,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00206,Antipsychotic Agents,DrugBank
DB00206,BSEP/ABCB11 Inhibitors,DrugBank
DB00206,Cardiovascular Agents,DrugBank
DB00206,Catecholamine-depleting Sympatholytic,DrugBank
DB00206,Central Nervous System Agents,DrugBank
DB00206,Central Nervous System Depressants,DrugBank
DB00206,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00206,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00206,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00206,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00206,Decreased Sympathetic Activity,DrugBank
DB00206,Drugs that are Mainly Renally Excreted,DrugBank
DB00206,Gastrointestinal Acidifying Agents,DrugBank
DB00206,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00206,Hypotensive Agents,DrugBank
DB00206,Indole Alkaloids,DrugBank
DB00206,Indoles,DrugBank
DB00206,Indolizidines,DrugBank
DB00206,Indolizines,DrugBank
DB00206,Membrane Transport Modulators,DrugBank
DB00206,Neurotoxic agents,DrugBank
DB00206,Neurotransmitter Agents,DrugBank
DB00206,Neurotransmitter Uptake Inhibitors,DrugBank
DB00206,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00206,OCT1 inhibitors,DrugBank
DB00206,OCT2 Substrates,DrugBank
DB00206,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00206,P-glycoprotein inducers,DrugBank
DB00206,P-glycoprotein inhibitors,DrugBank
DB00206,P-glycoprotein substrates,DrugBank
DB00206,Psychotropic Drugs,DrugBank
DB00206,Secologanin Tryptamine Alkaloids,DrugBank
DB00206,Tranquilizing Agents,DrugBank
DB00207,Anti-Bacterial Agents,DrugBank
DB00207,Anti-Infective Agents,DrugBank
DB00207,Antibacterials for Systemic Use,DrugBank
DB00207,Antiinfectives for Systemic Use,DrugBank
DB00207,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00207,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00207,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00207,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00207,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00207,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00207,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00207,Cytochrome P-450 Substrates,DrugBank
DB00207,Drugs causing inadvertant photosensitivity,DrugBank
DB00207,Experimental Unapproved Treatments for COVID-19,DrugBank
DB00207,Lactones,DrugBank
DB00207,Macrolide Antimicrobial,DrugBank
DB00207,Macrolides,DrugBank
DB00207,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB00207,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00207,Ophthalmologicals,DrugBank
DB00207,P-glycoprotein inhibitors,DrugBank
DB00207,P-glycoprotein substrates,DrugBank
DB00207,Photosensitizing Agents,DrugBank
DB00207,Polyketides,DrugBank
DB00207,QTc Prolonging Agents,DrugBank
DB00208,Antiplatelet agents,DrugBank
DB00208,Blood and Blood Forming Organs,DrugBank
DB00208,Cardiovascular Agents,DrugBank
DB00208,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00208,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB00208,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB00208,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB00208,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00208,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00208,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00208,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00208,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00208,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00208,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00208,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00208,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00208,Cytochrome P-450 Substrates,DrugBank
DB00208,Decreased Platelet Aggregation,DrugBank
DB00208,Drugs that are Mainly Renally Excreted,DrugBank
DB00208,Enzyme Inhibitors,DrugBank
DB00208,Fibrin Modulating Agents,DrugBank
DB00208,Hematologic Agents,DrugBank
DB00208,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00208,Neurotransmitter Agents,DrugBank
DB00208,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00208,Purinergic Agents,DrugBank
DB00208,Purinergic Antagonists,DrugBank
DB00208,Purinergic P2 Receptor Antagonists,DrugBank
DB00208,Purinergic P2Y Receptor Antagonists,DrugBank
DB00208,Pyridines,DrugBank
DB00208,Sulfur Compounds,DrugBank
DB00208,Thienopyridines,DrugBank
DB00208,Thiophenes,DrugBank
DB00209,"Acids, Carbocyclic",DrugBank
DB00209,Agents producing tachycardia,DrugBank
DB00209,Alimentary Tract and Metabolism,DrugBank
DB00209,Anticholinergic Agents,DrugBank
DB00209,Autonomic Agents,DrugBank
DB00209,Aza Compounds,DrugBank
DB00209,Azabicyclo Compounds,DrugBank
DB00209,Cholinergic Agents,DrugBank
DB00209,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00209,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00209,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00209,Diphenylacetic Acids,DrugBank
DB00209,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00209,Drugs for Urinary Frequency and Incontinence,DrugBank
DB00209,Genito Urinary System and Sex Hormones,DrugBank
DB00209,Genitourinary Agents,DrugBank
DB00209,Hydroxy Acids,DrugBank
DB00209,Muscarinic Antagonists,DrugBank
DB00209,Neurotransmitter Agents,DrugBank
DB00209,Parasympatholytics,DrugBank
DB00209,Peripheral Nervous System Agents,DrugBank
DB00209,Phenylacetates,DrugBank
DB00209,Tropanes,DrugBank
DB00209,Urological Agents,DrugBank
DB00209,Urologicals,DrugBank
DB00211,Adrenergic Agents,DrugBank
DB00211,Adrenergic Agonists,DrugBank
DB00211,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00211,Adrenergic alpha-Agonists,DrugBank
DB00211,Adrenergic and Dopaminergic Agents,DrugBank
DB00211,Agents producing tachycardia,DrugBank
DB00211,Agents that produce hypertension,DrugBank
DB00211,Alcohols,DrugBank
DB00211,Amines,DrugBank
DB00211,Amino Alcohols,DrugBank
DB00211,Autonomic Agents,DrugBank
DB00211,Bradycardia-Causing Agents,DrugBank
DB00211,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00211,Cardiac Therapy,DrugBank
DB00211,Cardiovascular Agents,DrugBank
DB00211,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00211,Cytochrome P-450 Substrates,DrugBank
DB00211,Ethanolamines,DrugBank
DB00211,Neurotransmitter Agents,DrugBank
DB00211,Peripheral Nervous System Agents,DrugBank
DB00211,Sympathomimetics,DrugBank
DB00211,Vasoconstrictor Agents,DrugBank
DB00212,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00212,Antihypertensive Agents,DrugBank
DB00212,Cardiovascular Agents,DrugBank
DB00212,Enzyme Inhibitors,DrugBank
DB00212,Protease Inhibitors,DrugBank
DB00212,Renin Inhibitors,DrugBank
DB00213,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB00213,Acid Reducers,DrugBank
DB00213,Alimentary Tract and Metabolism,DrugBank
DB00213,Anti-Ulcer Agents,DrugBank
DB00213,BCRP/ABCG2 Inhibitors,DrugBank
DB00213,BCRP/ABCG2 Substrates,DrugBank
DB00213,Benzimidazoles,DrugBank
DB00213,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00213,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00213,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00213,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00213,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00213,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00213,Cytochrome P-450 Substrates,DrugBank
DB00213,Drugs for Acid Related Disorders,DrugBank
DB00213,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00213,Drugs that are Mainly Renally Excreted,DrugBank
DB00213,Enzyme Inhibitors,DrugBank
DB00213,Gastric Acid Lowering Agents,DrugBank
DB00213,Gastrointestinal Agents,DrugBank
DB00213,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00213,OAT3/SLC22A8 Inhibitors,DrugBank
DB00213,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00213,P-glycoprotein inhibitors,DrugBank
DB00213,P-glycoprotein substrates,DrugBank
DB00213,Proton Pump Inhibitors,DrugBank
DB00213,Proton-pump Inhibitors,DrugBank
DB00213,Pyridines,DrugBank
DB00213,Sulfoxides,DrugBank
DB00213,Sulfur Compounds,DrugBank
DB00214,Antihypertensive Agents,DrugBank
DB00214,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00214,Cardiovascular Agents,DrugBank
DB00214,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00214,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00214,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00214,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00214,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00214,Cytochrome P-450 Substrates,DrugBank
DB00214,Diuretics,DrugBank
DB00214,High-Ceiling Diuretics,DrugBank
DB00214,Hyperglycemia-Associated Agents,DrugBank
DB00214,Hypotensive Agents,DrugBank
DB00214,Increased Diuresis at Loop of Henle,DrugBank
DB00214,Membrane Transport Modulators,DrugBank
DB00214,Natriuretic Agents,DrugBank
DB00214,Non Potassium Sparing Diuretics,DrugBank
DB00214,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00214,Ototoxic agents,DrugBank
DB00214,Pyridines,DrugBank
DB00214,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB00214,Sulfonamides,DrugBank
DB00214,Sulfones,DrugBank
DB00214,Sulfur Compounds,DrugBank
DB00215,Amines,DrugBank
DB00215,Antidepressive Agents,DrugBank
DB00215,Antidepressive Agents Indicated for Depression,DrugBank
DB00215,"Antidepressive Agents, Second-Generation",DrugBank
DB00215,Benzofurans,DrugBank
DB00215,Central Nervous System Agents,DrugBank
DB00215,Central Nervous System Depressants,DrugBank
DB00215,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00215,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00215,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00215,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00215,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00215,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00215,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00215,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00215,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00215,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00215,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00215,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00215,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00215,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00215,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00215,Cytochrome P-450 Substrates,DrugBank
DB00215,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00215,Highest Risk QTc-Prolonging Agents,DrugBank
DB00215,Hypoglycemia-Associated Agents,DrugBank
DB00215,Monoamine Oxidase A Substrates,DrugBank
DB00215,Nervous System,DrugBank
DB00215,Neurotransmitter Agents,DrugBank
DB00215,Neurotransmitter Uptake Inhibitors,DrugBank
DB00215,Nitriles,DrugBank
DB00215,P-glycoprotein inhibitors,DrugBank
DB00215,P-glycoprotein substrates,DrugBank
DB00215,Propylamines,DrugBank
DB00215,Psychoanaleptics,DrugBank
DB00215,Psychotropic Drugs,DrugBank
DB00215,QTc Prolonging Agents,DrugBank
DB00215,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00215,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00215,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00215,Serotonin Agents,DrugBank
DB00215,Serotonin Modulators,DrugBank
DB00215,Serotonin Receptor Antagonists,DrugBank
DB00215,Vasodilating Agents,DrugBank
DB00216,Agents that produce hypertension,DrugBank
DB00216,Amines,DrugBank
DB00216,Analgesics,DrugBank
DB00216,Antidepressive Agents,DrugBank
DB00216,Antimigraine Preparations,DrugBank
DB00216,Biogenic Amines,DrugBank
DB00216,Biogenic Monoamines,DrugBank
DB00216,Central Nervous System Depressants,DrugBank
DB00216,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00216,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00216,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00216,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00216,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00216,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00216,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00216,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00216,Cytochrome P-450 Substrates,DrugBank
DB00216,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00216,Indoles,DrugBank
DB00216,Nervous System,DrugBank
DB00216,Neurotransmitter Agents,DrugBank
DB00216,P-glycoprotein substrates,DrugBank
DB00216,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00216,Selective Serotonin Agonists,DrugBank
DB00216,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00216,Serotonin 1b Receptor Agonists,DrugBank
DB00216,Serotonin 1d Receptor Agonists,DrugBank
DB00216,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00216,Serotonin Agents,DrugBank
DB00216,Serotonin Modulators,DrugBank
DB00216,Serotonin Receptor Agonists,DrugBank
DB00216,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00216,Triptans,DrugBank
DB00217,Adrenergic Agents,DrugBank
DB00217,Adrenergic Agonists,DrugBank
DB00217,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00217,Adrenergic alpha-Agonists,DrugBank
DB00217,Agents producing tachycardia,DrugBank
DB00217,Agents that produce hypertension,DrugBank
DB00217,Amidines,DrugBank
DB00217,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB00217,Antihypertensive Agents,DrugBank
DB00217,Autonomic Agents,DrugBank
DB00217,Cardiovascular Agents,DrugBank
DB00217,Guanidine Derivatives,DrugBank
DB00217,Guanidines,DrugBank
DB00217,Neurotransmitter Agents,DrugBank
DB00217,Peripheral Nervous System Agents,DrugBank
DB00217,Sympatholytics,DrugBank
DB00218,4-Quinolones,DrugBank
DB00218,Anti-Bacterial Agents,DrugBank
DB00218,Anti-Infective Agents,DrugBank
DB00218,Antibacterials for Systemic Use,DrugBank
DB00218,Antiinfectives for Systemic Use,DrugBank
DB00218,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00218,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00218,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00218,Enzyme Inhibitors,DrugBank
DB00218,Fluoroquinolone Antibacterial,DrugBank
DB00218,Fluoroquinolones,DrugBank
DB00218,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00218,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00218,Ophthalmologicals,DrugBank
DB00218,QTc Prolonging Agents,DrugBank
DB00218,Quinolines,DrugBank
DB00218,Quinolone Antimicrobial,DrugBank
DB00218,Quinolones,DrugBank
DB00218,Sensory Organs,DrugBank
DB00218,Topoisomerase II Inhibitors,DrugBank
DB00218,Topoisomerase Inhibitors,DrugBank
DB00219,Agents producing tachycardia,DrugBank
DB00219,Alimentary Tract and Metabolism,DrugBank
DB00219,Amines,DrugBank
DB00219,Anticholinergic Agents,DrugBank
DB00219,Autonomic Agents,DrugBank
DB00219,Cholinergic Agents,DrugBank
DB00219,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00219,Muscarinic Antagonists,DrugBank
DB00219,Mydriatics,DrugBank
DB00219,Neurotransmitter Agents,DrugBank
DB00219,Onium Compounds,DrugBank
DB00219,Parasympatholytics,DrugBank
DB00219,Peripheral Nervous System Agents,DrugBank
DB00219,Quaternary Ammonium Compounds,DrugBank
DB00219,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB00220,Anti-HIV Agents,DrugBank
DB00220,Anti-Infective Agents,DrugBank
DB00220,Anti-Retroviral Agents,DrugBank
DB00220,Antiinfectives for Systemic Use,DrugBank
DB00220,Antiviral Agents,DrugBank
DB00220,Antivirals for Systemic Use,DrugBank
DB00220,BCRP/ABCG2 Inhibitors,DrugBank
DB00220,BSEP/ABCB11 Substrates,DrugBank
DB00220,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00220,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00220,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00220,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00220,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00220,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00220,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00220,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00220,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00220,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00220,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB00220,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00220,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00220,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB00220,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00220,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00220,Cytochrome P-450 Substrates,DrugBank
DB00220,Direct Acting Antivirals,DrugBank
DB00220,Enzyme Inhibitors,DrugBank
DB00220,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00220,HIV Protease Inhibitors,DrugBank
DB00220,Hyperglycemia-Associated Agents,DrugBank
DB00220,Isoquinolines,DrugBank
DB00220,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00220,OATP1B3 inhibitors,DrugBank
DB00220,OCT1 inhibitors,DrugBank
DB00220,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00220,P-glycoprotein inducers,DrugBank
DB00220,P-glycoprotein inhibitors,DrugBank
DB00220,P-glycoprotein substrates,DrugBank
DB00220,Potential QTc-Prolonging Agents,DrugBank
DB00220,Protease Inhibitors,DrugBank
DB00220,QTc Prolonging Agents,DrugBank
DB00220,UGT1A1 Inducers,DrugBank
DB00220,Viral Protease Inhibitors,DrugBank
DB00221,Adrenergic Agents,DrugBank
DB00221,Adrenergic Agonists,DrugBank
DB00221,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00221,Adrenergic beta-Agonists,DrugBank
DB00221,Adrenergics for Systemic Use,DrugBank
DB00221,"Adrenergics, Inhalants",DrugBank
DB00221,Agents producing tachycardia,DrugBank
DB00221,Agents that produce hypertension,DrugBank
DB00221,Alcohols,DrugBank
DB00221,Amines,DrugBank
DB00221,Amino Alcohols,DrugBank
DB00221,Anti-Asthmatic Agents,DrugBank
DB00221,Autonomic Agents,DrugBank
DB00221,Bronchodilator Agents,DrugBank
DB00221,Drugs for Obstructive Airway Diseases,DrugBank
DB00221,Neurotransmitter Agents,DrugBank
DB00221,Peripheral Nervous System Agents,DrugBank
DB00221,Respiratory System Agents,DrugBank
DB00221,Selective Beta 2-adrenergic Agonists,DrugBank
DB00222,Alimentary Tract and Metabolism,DrugBank
DB00222,Amides,DrugBank
DB00222,Blood Glucose Lowering Agents,DrugBank
DB00222,BSEP/ABCB11 Substrates,DrugBank
DB00222,Cardiovascular Agents,DrugBank
DB00222,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00222,Cytochrome P-450 Substrates,DrugBank
DB00222,Drugs Used in Diabetes,DrugBank
DB00222,Hypoglycemia-Associated Agents,DrugBank
DB00222,Immunosuppressive Agents,DrugBank
DB00222,Insulin Secretagogues,DrugBank
DB00222,Oral Hypoglycemics,DrugBank
DB00222,Sulfones,DrugBank
DB00222,Sulfonylureas,DrugBank
DB00222,Sulfur Compounds,DrugBank
DB00223,Adrenal Cortex Hormones,DrugBank
DB00223,Anti-Inflammatory Agents,DrugBank
DB00223,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00223,Corticosteroids,DrugBank
DB00223,"Corticosteroids, Dermatological Preparations",DrugBank
DB00223,"Corticosteroids, Potent (Group III)",DrugBank
DB00223,Dermatologicals,DrugBank
DB00223,Fused-Ring Compounds,DrugBank
DB00223,Hormones,DrugBank
DB00223,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00223,Immunosuppressive Agents,DrugBank
DB00223,Pregnadienes,DrugBank
DB00223,Pregnadienetriols,DrugBank
DB00223,Pregnanes,DrugBank
DB00223,Steroids,DrugBank
DB00223,"Steroids, Fluorinated",DrugBank
DB00224,Agents Causing Muscle Toxicity,DrugBank
DB00224,Anti-HIV Agents,DrugBank
DB00224,Anti-Infective Agents,DrugBank
DB00224,Anti-Retroviral Agents,DrugBank
DB00224,Antiinfectives for Systemic Use,DrugBank
DB00224,Antiviral Agents,DrugBank
DB00224,Antivirals for Systemic Use,DrugBank
DB00224,BSEP/ABCB11 Substrates,DrugBank
DB00224,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00224,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00224,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00224,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00224,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00224,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00224,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00224,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00224,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB00224,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00224,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00224,Cytochrome P-450 CYP3A7 Inhibitors (weak),DrugBank
DB00224,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00224,Cytochrome P-450 Substrates,DrugBank
DB00224,Direct Acting Antivirals,DrugBank
DB00224,Enzyme Inhibitors,DrugBank
DB00224,HIV Protease Inhibitors,DrugBank
DB00224,Hyperglycemia-Associated Agents,DrugBank
DB00224,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00224,OCT1 inhibitors,DrugBank
DB00224,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00224,P-glycoprotein inducers,DrugBank
DB00224,P-glycoprotein inhibitors,DrugBank
DB00224,P-glycoprotein substrates,DrugBank
DB00224,Protease Inhibitors,DrugBank
DB00224,Pyridines,DrugBank
DB00224,UGT1A1 Inhibitors,DrugBank
DB00224,Viral Protease Inhibitors,DrugBank
DB00225,Acetates,DrugBank
DB00225,"Acids, Acyclic",DrugBank
DB00225,Amines,DrugBank
DB00225,"Compounds used in a research, industrial, or household setting",DrugBank
DB00225,Contrast Media,DrugBank
DB00225,Coordination Complexes,DrugBank
DB00225,Diagnostic Uses of Chemicals,DrugBank
DB00225,Drugs that are Mainly Renally Excreted,DrugBank
DB00225,"Injections, Intravenous",DrugBank
DB00225,Magnetic Resonance Contrast Activity,DrugBank
DB00225,Magnetic Resonance Imaging Contrast Media,DrugBank
DB00225,Miscellaneous Therapeutic Agents,DrugBank
DB00225,Other Diagnostics,DrugBank
DB00225,Paramagnetic Contrast Agent,DrugBank
DB00225,Paramagnetic Contrast Media,DrugBank
DB00225,Polyamines,DrugBank
DB00226,Adrenergic Antagonists,DrugBank
DB00226,Amidines,DrugBank
DB00226,Antihypertensive Agents,DrugBank
DB00226,Cardiovascular Agents,DrugBank
DB00227,Agents Causing Muscle Toxicity,DrugBank
DB00227,Anticholesteremic Agents,DrugBank
DB00227,BSEP/ABCB11 Substrates,DrugBank
DB00227,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00227,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00227,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00227,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00227,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00227,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00227,Cytochrome P-450 Substrates,DrugBank
DB00227,Drugs causing inadvertant photosensitivity,DrugBank
DB00227,Enzyme Inhibitors,DrugBank
DB00227,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB00227,Hypolipidemic Agents,DrugBank
DB00227,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00227,Lipid Modifying Agents,DrugBank
DB00227,Lipid Regulating Agents,DrugBank
DB00227,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00227,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00227,P-glycoprotein inhibitors,DrugBank
DB00227,Photosensitizing Agents,DrugBank
DB00227,UGT1A1 Substrates,DrugBank
DB00227,UGT1A3 substrates,DrugBank
DB00227,UGT2B7 substrates,DrugBank
DB00228,Agents that reduce seizure threshold,DrugBank
DB00228,Anesthetics,DrugBank
DB00228,"Anesthetics, General",DrugBank
DB00228,"Anesthetics, Inhalation",DrugBank
DB00228,Central Nervous System Agents,DrugBank
DB00228,Central Nervous System Depressants,DrugBank
DB00228,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00228,Cytochrome P-450 Substrates,DrugBank
DB00228,Ethers,DrugBank
DB00228,Methyl Ethers,DrugBank
DB00228,Nervous System,DrugBank
DB00229,Amides,DrugBank
DB00229,Anti-Bacterial Agents,DrugBank
DB00229,Anti-Infective Agents,DrugBank
DB00229,Antibacterials for Systemic Use,DrugBank
DB00229,Antiinfectives for Systemic Use,DrugBank
DB00229,beta-Lactams,DrugBank
DB00229,Cephalosporins,DrugBank
DB00229,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00229,Lactams,DrugBank
DB00229,Nephrotoxic agents,DrugBank
DB00229,OAT1/SLC22A6 inhibitors,DrugBank
DB00229,OAT1/SLC22A6 Substrates,DrugBank
DB00229,OAT3/SLC22A8 Inhibitors,DrugBank
DB00229,OAT3/SLC22A8 Substrates,DrugBank
DB00229,Second-Generation Cephalosporins,DrugBank
DB00229,Sulfur Compounds,DrugBank
DB00229,Thiazines,DrugBank
DB00230,"Acids, Acyclic",DrugBank
DB00230,Agents causing angioedema,DrugBank
DB00230,Amino Acids,DrugBank
DB00230,"Amino Acids, Peptides, and Proteins",DrugBank
DB00230,Aminobutyrates,DrugBank
DB00230,Analgesics,DrugBank
DB00230,Anti-Anxiety Agents,DrugBank
DB00230,Anticonvulsants,DrugBank
DB00230,Bradycardia-Causing Agents,DrugBank
DB00230,Butyrates,DrugBank
DB00230,Central Nervous System Agents,DrugBank
DB00230,Central Nervous System Depressants,DrugBank
DB00230,Drugs that are Mainly Renally Excreted,DrugBank
DB00230,Gabapentinoids,DrugBank
DB00230,Hypoglycemia-Associated Agents,DrugBank
DB00230,Membrane Transport Modulators,DrugBank
DB00230,Miscellaneous Anticonvulsants,DrugBank
DB00230,Muscle Relaxants,DrugBank
DB00230,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00230,Nervous System,DrugBank
DB00230,Peripheral Nervous System Agents,DrugBank
DB00230,Potential QTc-Prolonging Agents,DrugBank
DB00230,Psychotropic Drugs,DrugBank
DB00230,QTc Prolonging Agents,DrugBank
DB00230,Sensory System Agents,DrugBank
DB00230,Tranquilizing Agents,DrugBank
DB00230,Vasodilating Agents,DrugBank
DB00231,Anti-Anxiety Agents,DrugBank
DB00231,Benzazepines,DrugBank
DB00231,Benzodiazepine hypnotics and sedatives,DrugBank
DB00231,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00231,Central Nervous System Agents,DrugBank
DB00231,Central Nervous System Depressants,DrugBank
DB00231,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00231,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00231,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00231,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00231,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00231,Cytochrome P-450 Substrates,DrugBank
DB00231,Drugs that are Mainly Renally Excreted,DrugBank
DB00231,GABA Agents,DrugBank
DB00231,GABA Modulators,DrugBank
DB00231,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00231,Hypnotics and Sedatives,DrugBank
DB00231,Muscle Relaxants,DrugBank
DB00231,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00231,Psychotropic Drugs,DrugBank
DB00231,Tranquilizing Agents,DrugBank
DB00232,Benzothiadiazines,DrugBank
DB00232,Diuretics,DrugBank
DB00232,Drugs causing inadvertant photosensitivity,DrugBank
DB00232,Genito Urinary System and Sex Hormones,DrugBank
DB00232,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00232,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00232,Hyperglycemia-Associated Agents,DrugBank
DB00232,Hypotensive Agents,DrugBank
DB00232,Increased Diuresis,DrugBank
DB00232,Membrane Transport Modulators,DrugBank
DB00232,Natriuretic Agents,DrugBank
DB00232,Photosensitizing Agents,DrugBank
DB00232,Sodium Chloride Symporter Inhibitors,DrugBank
DB00232,Sulfonamides,DrugBank
DB00232,Sulfones,DrugBank
DB00232,Sulfur Compounds,DrugBank
DB00232,Thiazides,DrugBank
DB00233,"Acids, Carbocyclic",DrugBank
DB00233,Aminobenzoates,DrugBank
DB00233,Aminosalicylic Acid and Derivatives,DrugBank
DB00233,Aminosalicylic Acids,DrugBank
DB00233,Anti-Bacterial Agents,DrugBank
DB00233,Anti-Infective Agents,DrugBank
DB00233,Antiinfectives for Systemic Use,DrugBank
DB00233,Antimycobacterials,DrugBank
DB00233,Benzene Derivatives,DrugBank
DB00233,Benzoates,DrugBank
DB00233,Drugs for Treatment of Tuberculosis,DrugBank
DB00233,Hydroxy Acids,DrugBank
DB00233,Hydroxybenzoates,DrugBank
DB00233,Methemoglobinemia Associated Agents,DrugBank
DB00233,para-Aminobenzoates,DrugBank
DB00233,Phenols,DrugBank
DB00233,Salicylates,DrugBank
DB00234,Adrenergic Agents,DrugBank
DB00234,Adrenergic Uptake Inhibitors,DrugBank
DB00234,Antidepressive Agents,DrugBank
DB00234,Central Nervous System Agents,DrugBank
DB00234,Central Nervous System Depressants,DrugBank
DB00234,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00234,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00234,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00234,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00234,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00234,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00234,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00234,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00234,Cytochrome P-450 Substrates,DrugBank
DB00234,Membrane Transport Modulators,DrugBank
DB00234,Morpholines,DrugBank
DB00234,Nervous System,DrugBank
DB00234,Neurotransmitter Agents,DrugBank
DB00234,Neurotransmitter Uptake Inhibitors,DrugBank
DB00234,Oxazines,DrugBank
DB00234,P-glycoprotein inhibitors,DrugBank
DB00234,Psychoanaleptics,DrugBank
DB00234,Psychotropic Drugs,DrugBank
DB00235,Amines,DrugBank
DB00235,Aminopyridines,DrugBank
DB00235,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00235,Cardiac Therapy,DrugBank
DB00235,Cardiotonic Agents,DrugBank
DB00235,Cardiovascular Agents,DrugBank
DB00235,"Compounds used in a research, industrial, or household setting",DrugBank
DB00235,Drugs that are Mainly Renally Excreted,DrugBank
DB00235,Enzyme Inhibitors,DrugBank
DB00235,Hematologic Agents,DrugBank
DB00235,Phosphodiesterase 3 Inhibitors,DrugBank
DB00235,Phosphodiesterase Inhibitors,DrugBank
DB00235,Protective Agents,DrugBank
DB00235,Pyridines,DrugBank
DB00235,Vasodilating Agents,DrugBank
DB00236,Alkylating Drugs,DrugBank
DB00236,Antineoplastic Agents,DrugBank
DB00236,"Antineoplastic Agents, Alkylating",DrugBank
DB00236,Antineoplastic and Immunomodulating Agents,DrugBank
DB00236,Noxae,DrugBank
DB00236,Piperazines,DrugBank
DB00236,Toxic Actions,DrugBank
DB00237,Anticholinergic Agents,DrugBank
DB00237,Anticonvulsants,DrugBank
DB00237,Barbiturates,DrugBank
DB00237,Central Nervous System Agents,DrugBank
DB00237,Central Nervous System Depressants,DrugBank
DB00237,Drugs that are Mainly Renally Excreted,DrugBank
DB00237,Hypnotics and Sedatives,DrugBank
DB00237,Nervous System,DrugBank
DB00237,Nicotinic Antagonists,DrugBank
DB00237,Psycholeptics,DrugBank
DB00237,Pyrimidines,DrugBank
DB00237,Pyrimidinones,DrugBank
DB00238,Anti-HIV Agents,DrugBank
DB00238,Anti-Infective Agents,DrugBank
DB00238,Anti-Retroviral Agents,DrugBank
DB00238,Antiinfectives for Systemic Use,DrugBank
DB00238,Antiviral Agents,DrugBank
DB00238,Antivirals for Systemic Use,DrugBank
DB00238,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00238,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00238,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00238,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00238,Cytochrome P-450 CYP2B6 Inducers (strong),DrugBank
DB00238,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00238,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00238,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00238,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00238,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00238,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00238,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00238,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00238,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00238,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00238,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00238,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00238,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00238,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00238,Cytochrome P-450 Substrates,DrugBank
DB00238,Direct Acting Antivirals,DrugBank
DB00238,Enzyme Inhibitors,DrugBank
DB00238,Hepatotoxic Agents,DrugBank
DB00238,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00238,Inducers of Drug Clearance,DrugBank
DB00238,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00238,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00238,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00238,OCT1 inhibitors,DrugBank
DB00238,Pyridines,DrugBank
DB00238,Reverse Transcriptase Inhibitors,DrugBank
DB00239,Anti-Infective Agents,DrugBank
DB00239,Antifungal Agents,DrugBank
DB00239,Antifungals for Dermatological Use,DrugBank
DB00239,Antifungals for Topical Use,DrugBank
DB00239,Azole Antifungals,DrugBank
DB00239,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00239,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00239,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00239,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00239,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00239,Cytochrome P-450 Substrates,DrugBank
DB00239,Dermatologicals,DrugBank
DB00239,Genito Urinary System and Sex Hormones,DrugBank
DB00239,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00239,Imidazole and Triazole Derivatives,DrugBank
DB00239,Imidazole Derivatives,DrugBank
DB00240,Adrenal Cortex Hormones,DrugBank
DB00240,Anti-Inflammatory Agents,DrugBank
DB00240,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00240,Corticosteroids,DrugBank
DB00240,"Corticosteroids, Dermatological Preparations",DrugBank
DB00240,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB00240,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00240,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00240,Cytochrome P-450 Substrates,DrugBank
DB00240,Dermatologicals,DrugBank
DB00240,Fused-Ring Compounds,DrugBank
DB00240,Hormones,DrugBank
DB00240,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00240,Immunosuppressive Agents,DrugBank
DB00240,Ophthalmologicals,DrugBank
DB00240,Pregnadienes,DrugBank
DB00240,Pregnadienetriols,DrugBank
DB00240,Pregnanes,DrugBank
DB00240,Sensory Organs,DrugBank
DB00240,Steroids,DrugBank
DB00241,Anticholinergic Agents,DrugBank
DB00241,Anticonvulsants,DrugBank
DB00241,Barbiturates,DrugBank
DB00241,Central Nervous System Depressants,DrugBank
DB00241,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00241,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00241,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00241,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00241,Hypnotics and Sedatives,DrugBank
DB00241,Methemoglobinemia Associated Agents,DrugBank
DB00241,Nervous System,DrugBank
DB00241,Nicotinic Antagonists,DrugBank
DB00241,Psycholeptics,DrugBank
DB00241,Pyrimidines,DrugBank
DB00241,Pyrimidinones,DrugBank
DB00242,2-Chloroadenosine,DrugBank
DB00242,Agents Causing Muscle Toxicity,DrugBank
DB00242,Antimetabolites,DrugBank
DB00242,Antineoplastic Agents,DrugBank
DB00242,Antineoplastic and Immunomodulating Agents,DrugBank
DB00242,BCRP/ABCG2 Substrates,DrugBank
DB00242,Cardiotoxic antineoplastic agents,DrugBank
DB00242,Deoxyadenosines,DrugBank
DB00242,Deoxyribonucleosides,DrugBank
DB00242,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00242,Immunologic Factors,DrugBank
DB00242,Immunosuppressive Agents,DrugBank
DB00242,Myelosuppressive Agents,DrugBank
DB00242,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00242,Nucleosides,DrugBank
DB00242,P-glycoprotein substrates,DrugBank
DB00242,Purine Analogues,DrugBank
DB00242,Purine Antimetabolite,DrugBank
DB00242,Purine Nucleosides,DrugBank
DB00242,Purines,DrugBank
DB00242,Ribonucleosides,DrugBank
DB00242,Selective Immunosuppressants,DrugBank
DB00243,Acetamides,DrugBank
DB00243,Antianginal Agents,DrugBank
DB00243,BSEP/ABCB11 Substrates,DrugBank
DB00243,Cardiac Therapy,DrugBank
DB00243,Cardiovascular Agents,DrugBank
DB00243,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00243,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00243,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00243,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00243,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00243,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00243,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00243,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00243,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00243,Cytochrome P-450 Substrates,DrugBank
DB00243,Drugs that are Mainly Renally Excreted,DrugBank
DB00243,MATE 1 Inhibitors,DrugBank
DB00243,MATE 2 Inhibitors,DrugBank
DB00243,MATE inhibitors,DrugBank
DB00243,Membrane Transport Modulators,DrugBank
DB00243,Miscellaneous Cardiac Drugs,DrugBank
DB00243,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00243,OCT2 Inhibitors,DrugBank
DB00243,P-glycoprotein inhibitors,DrugBank
DB00243,P-glycoprotein substrates,DrugBank
DB00243,Piperazines,DrugBank
DB00243,QTc Prolonging Agents,DrugBank
DB00243,Sodium Channel Blockers,DrugBank
DB00243,Vasodilating Agents,DrugBank
DB00244,Agents causing hyperkalemia,DrugBank
DB00244,Agents that produce hypertension,DrugBank
DB00244,Aminosalicylate,DrugBank
DB00244,Aminosalicylic Acids,DrugBank
DB00244,Analgesics,DrugBank
DB00244,"Analgesics, Non-Narcotic",DrugBank
DB00244,Anti-Inflammatory Agents,DrugBank
DB00244,Benzene Derivatives,DrugBank
DB00244,Hydroxybenzoates,DrugBank
DB00244,Intestinal Antiinflammatory Agents,DrugBank
DB00244,Nephrotoxic agents,DrugBank
DB00244,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00244,OATP1B3 substrates,DrugBank
DB00244,OATP2B1/SLCO2B1 substrates,DrugBank
DB00244,Phenols,DrugBank
DB00244,Salicylates,DrugBank
DB00245,Agents producing tachycardia,DrugBank
DB00245,Alkaloids,DrugBank
DB00245,Anti-Dyskinesia Agents,DrugBank
DB00245,Anti-Parkinson Drugs,DrugBank
DB00245,Anticholinergic Agents,DrugBank
DB00245,Aza Compounds,DrugBank
DB00245,Central Nervous System Agents,DrugBank
DB00245,Cholinergic Agents,DrugBank
DB00245,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00245,Cytochrome P-450 Substrates,DrugBank
DB00245,Dopamine Agents,DrugBank
DB00245,Dopamine Uptake Inhibitors,DrugBank
DB00245,Drugs that are Mainly Renally Excreted,DrugBank
DB00245,Ethers of Tropine or Tropine Derivatives,DrugBank
DB00245,Histamine Antagonists,DrugBank
DB00245,Histamine H1 Antagonists,DrugBank
DB00245,Histamine Receptor Antagonists,DrugBank
DB00245,Membrane Transport Modulators,DrugBank
DB00245,Muscarinic Antagonists,DrugBank
DB00245,Nervous System,DrugBank
DB00245,Neurotransmitter Agents,DrugBank
DB00245,Neurotransmitter Uptake Inhibitors,DrugBank
DB00245,Peripheral Nervous System Agents,DrugBank
DB00245,Potential QTc-Prolonging Agents,DrugBank
DB00245,QTc Prolonging Agents,DrugBank
DB00245,Tropanes,DrugBank
DB00246,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00246,Adrenergic alpha-Antagonists,DrugBank
DB00246,Adrenergic Antagonists,DrugBank
DB00246,Agents that produce hypertension,DrugBank
DB00246,Anticholinergic Agents,DrugBank
DB00246,Antidepressive Agents,DrugBank
DB00246,Antipsychotic Agents,DrugBank
DB00246,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB00246,Central Nervous System Agents,DrugBank
DB00246,Central Nervous System Depressants,DrugBank
DB00246,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00246,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00246,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00246,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00246,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00246,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00246,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00246,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00246,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00246,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00246,Cytochrome P-450 Substrates,DrugBank
DB00246,Dopamine Agents,DrugBank
DB00246,Dopamine Antagonists,DrugBank
DB00246,Dopamine D2 Receptor Antagonists,DrugBank
DB00246,Highest Risk QTc-Prolonging Agents,DrugBank
DB00246,Histamine Antagonists,DrugBank
DB00246,Histamine H1 Antagonists,DrugBank
DB00246,Hyperglycemia-Associated Agents,DrugBank
DB00246,Indole Derivatives,DrugBank
DB00246,Muscarinic Antagonists,DrugBank
DB00246,Nervous System,DrugBank
DB00246,Neurotoxic agents,DrugBank
DB00246,Neurotransmitter Agents,DrugBank
DB00246,Psycholeptics,DrugBank
DB00246,Psychotropic Drugs,DrugBank
DB00246,QTc Prolonging Agents,DrugBank
DB00246,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00246,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00246,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00246,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB00246,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00246,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00246,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00246,Serotonin Agents,DrugBank
DB00246,Serotonin Receptor Agonists,DrugBank
DB00246,Serotonin Receptor Antagonists,DrugBank
DB00246,Sulfur Compounds,DrugBank
DB00246,Tranquilizing Agents,DrugBank
DB00247,Agents that produce hypertension,DrugBank
DB00247,Alkaloids,DrugBank
DB00247,Analgesics,DrugBank
DB00247,Antidepressive Agents,DrugBank
DB00247,Antimigraine Preparations,DrugBank
DB00247,Cardiovascular Agents,DrugBank
DB00247,Central Nervous System Depressants,DrugBank
DB00247,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00247,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00247,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00247,Cytochrome P-450 Substrates,DrugBank
DB00247,Ergolines,DrugBank
DB00247,Ergot Alkaloids and Derivatives,DrugBank
DB00247,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00247,Lysergic Acid,DrugBank
DB00247,Nervous System,DrugBank
DB00247,Neurotransmitter Agents,DrugBank
DB00247,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00247,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00247,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00247,Serotonin Agents,DrugBank
DB00247,Serotonin Receptor Antagonists,DrugBank
DB00247,Vasoconstrictor Agents,DrugBank
DB00248,Agents that produce hypertension,DrugBank
DB00248,Alkaloids,DrugBank
DB00248,Anti-Dyskinesia Agents,DrugBank
DB00248,Anti-Parkinson Drugs,DrugBank
DB00248,Antidepressive Agents,DrugBank
DB00248,Antineoplastic Agents,DrugBank
DB00248,Central Nervous System Agents,DrugBank
DB00248,Central Nervous System Depressants,DrugBank
DB00248,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00248,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00248,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00248,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00248,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00248,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00248,Cytochrome P-450 Substrates,DrugBank
DB00248,Dopamine Agents,DrugBank
DB00248,Dopamine Agonists,DrugBank
DB00248,Ergolines,DrugBank
DB00248,Ergot Alkaloids and Derivatives,DrugBank
DB00248,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB00248,Genito Urinary System and Sex Hormones,DrugBank
DB00248,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00248,Narrow Therapeutic Index Drugs,DrugBank
DB00248,Nervous System,DrugBank
DB00248,Neurotransmitter Agents,DrugBank
DB00248,P-glycoprotein substrates,DrugBank
DB00248,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00248,Prolactine Inhibitors,DrugBank
DB00248,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00248,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00248,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB00248,Serotonin Agents,DrugBank
DB00248,Serotonin Modulators,DrugBank
DB00248,Serotonin Receptor Agonists,DrugBank
DB00250,Anti-Acne Preparations,DrugBank
DB00250,Anti-Acne Preparations for Topical Use,DrugBank
DB00250,Anti-Bacterial Agents,DrugBank
DB00250,Anti-Infective Agents,DrugBank
DB00250,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB00250,Antiinfectives for Systemic Use,DrugBank
DB00250,Antimalarials,DrugBank
DB00250,Antimycobacterials,DrugBank
DB00250,Antiparasitic Agents,DrugBank
DB00250,Antiprotozoals,DrugBank
DB00250,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00250,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00250,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00250,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00250,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00250,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00250,Cytochrome P-450 Substrates,DrugBank
DB00250,Dermatologicals,DrugBank
DB00250,Drugs causing inadvertant photosensitivity,DrugBank
DB00250,Drugs for Treatment of Lepra,DrugBank
DB00250,Enzyme Inhibitors,DrugBank
DB00250,Folic Acid Antagonists,DrugBank
DB00250,Leprostatic Agents,DrugBank
DB00250,Methemoglobinemia Associated Agents,DrugBank
DB00250,Miscellaneous Antimycobacterials,DrugBank
DB00250,Miscellaneous Local Anti-infectives,DrugBank
DB00250,Photosensitizing Agents,DrugBank
DB00250,Sulfones,DrugBank
DB00250,Sulfur Compounds,DrugBank
DB00252,Agents Causing Muscle Toxicity,DrugBank
DB00252,Anti-epileptic Agent,DrugBank
DB00252,Anticonvulsants,DrugBank
DB00252,Central Nervous System Agents,DrugBank
DB00252,Central Nervous System Depressants,DrugBank
DB00252,COMT Substrates,DrugBank
DB00252,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00252,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00252,Cytochrome P-450 CYP2B6 Inducers (strong),DrugBank
DB00252,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB00252,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP2C8 Inducers (strong),DrugBank
DB00252,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00252,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00252,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00252,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00252,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00252,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00252,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00252,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00252,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB00252,Cytochrome P-450 CYP3A7 Inducers (weak),DrugBank
DB00252,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00252,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00252,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00252,Cytochrome P-450 Substrates,DrugBank
DB00252,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00252,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB00252,Hydantoins,DrugBank
DB00252,Hyperglycemia-Associated Agents,DrugBank
DB00252,Imidazoles,DrugBank
DB00252,Imidazolidines,DrugBank
DB00252,Inducers of Drug Clearance,DrugBank
DB00252,Membrane Transport Modulators,DrugBank
DB00252,Methemoglobinemia Associated Agents,DrugBank
DB00252,Narrow Therapeutic Index Drugs,DrugBank
DB00252,Nervous System,DrugBank
DB00252,P-glycoprotein substrates,DrugBank
DB00252,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Phenytoin and Prodrugs,DrugBank
DB00252,Sodium Channel Blockers,DrugBank
DB00252,Thyroxine-binding globulin substrates,DrugBank
DB00252,UGT1A1 Inducers,DrugBank
DB00252,UGT1A1 Substrates,DrugBank
DB00252,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,UGT1A4 substrates,DrugBank
DB00252,UGT1A6 Inhibitors,DrugBank
DB00252,UGT1A6 substrate,DrugBank
DB00252,UGT1A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,UGT1A9 Inhibitors,DrugBank
DB00252,UGT1A9 Substrates,DrugBank
DB00252,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00252,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00253,Adrenal Cortex Hormones,DrugBank
DB00253,Anti-Inflammatory Agents,DrugBank
DB00253,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00253,Corticosteroids,DrugBank
DB00253,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00253,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00253,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00253,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00253,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00253,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00253,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00253,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00253,Cytochrome P-450 Substrates,DrugBank
DB00253,Fused-Ring Compounds,DrugBank
DB00253,Glucocorticoids,DrugBank
DB00253,Hormones,DrugBank
DB00253,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00253,Hyperglycemia-Associated Agents,DrugBank
DB00253,Immunosuppressive Agents,DrugBank
DB00253,OAT3/SLC22A8 Substrates,DrugBank
DB00253,Ophthalmologicals,DrugBank
DB00253,P-glycoprotein substrates,DrugBank
DB00253,Pregnanes,DrugBank
DB00253,Pregnenes,DrugBank
DB00253,Sensory Organs,DrugBank
DB00253,Steroids,DrugBank
DB00253,Thyroxine-binding globulin inhibitors,DrugBank
DB00254,Agents that produce neuromuscular block (indirect),DrugBank
DB00254,Alimentary Tract and Metabolism,DrugBank
DB00254,Anti-Bacterial Agents,DrugBank
DB00254,Anti-Infective Agents,DrugBank
DB00254,Antibacterials for Systemic Use,DrugBank
DB00254,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00254,Antiinfectives for Systemic Use,DrugBank
DB00254,Antiparasitic Agents,DrugBank
DB00254,Antiprotozoals,DrugBank
DB00254,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00254,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00254,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00254,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00254,Drugs causing inadvertant photosensitivity,DrugBank
DB00254,Drugs that are Mainly Renally Excreted,DrugBank
DB00254,Naphthacenes,DrugBank
DB00254,OAT1/SLC22A6 inhibitors,DrugBank
DB00254,Photosensitizing Agents,DrugBank
DB00254,Stomatological Preparations,DrugBank
DB00254,Tetracyclines,DrugBank
DB00255,Adrenal Cortex Hormones,DrugBank
DB00255,"Antineoplastic Agents, Hormonal",DrugBank
DB00255,Antineoplastic and Immunomodulating Agents,DrugBank
DB00255,BCRP/ABCG2 Inhibitors,DrugBank
DB00255,Benzene Derivatives,DrugBank
DB00255,Benzylidene Compounds,DrugBank
DB00255,BSEP/ABCB11 Substrates,DrugBank
DB00255,Carcinogens,DrugBank
DB00255,COMT Substrates,DrugBank
DB00255,"Contraceptive Agents, Female",DrugBank
DB00255,"Contraceptive Agents, Male",DrugBank
DB00255,"Contraceptives, Postcoital",DrugBank
DB00255,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00255,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00255,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00255,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00255,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00255,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00255,Cytochrome P-450 CYP2E1 Inhibitors (strong),DrugBank
DB00255,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00255,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00255,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00255,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00255,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00255,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00255,Cytochrome P-450 Substrates,DrugBank
DB00255,Endocrine Therapy,DrugBank
DB00255,Estrogen Contraceptives,DrugBank
DB00255,Estrogens,DrugBank
DB00255,"Estrogens, Non-Steroidal",DrugBank
DB00255,Genito Urinary System and Sex Hormones,DrugBank
DB00255,Hormonal Contraceptives for Systemic Use,DrugBank
DB00255,Hormones,DrugBank
DB00255,Hormones and Related Agents,DrugBank
DB00255,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00255,Noxae,DrugBank
DB00255,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00255,OATP2B1/SLCO2B1 substrates,DrugBank
DB00255,P-glycoprotein substrates,DrugBank
DB00255,Sex Hormones and Modulators of the Genital System,DrugBank
DB00255,Stilbenes,DrugBank
DB00255,Stilbestrols,DrugBank
DB00255,"Synthetic Estrogens, Plain",DrugBank
DB00255,Thyroxine-binding globulin inducers,DrugBank
DB00255,Toxic Actions,DrugBank
DB00256,Agents that produce neuromuscular block (indirect),DrugBank
DB00256,Anti-Bacterial Agents,DrugBank
DB00256,Anti-Infective Agents,DrugBank
DB00256,Antibacterials for Systemic Use,DrugBank
DB00256,Antiinfectives for Systemic Use,DrugBank
DB00256,Naphthacenes,DrugBank
DB00256,Tetracyclines,DrugBank
DB00257,Anti-Infective Agents,DrugBank
DB00257,"Anti-Infective Agents, Local",DrugBank
DB00257,Antifungal Agents,DrugBank
DB00257,Antifungal Agents (Vaginal),DrugBank
DB00257,Antifungals for Dermatological Use,DrugBank
DB00257,Antifungals for Topical Use,DrugBank
DB00257,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00257,Azole Antifungals,DrugBank
DB00257,BSEP/ABCB11 Inhibitors,DrugBank
DB00257,BSEP/ABCB11 Substrates,DrugBank
DB00257,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2A6 Inhibitors (strong),DrugBank
DB00257,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00257,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00257,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB00257,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00257,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00257,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00257,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00257,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00257,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP2E1 Inhibitors (moderate),DrugBank
DB00257,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00257,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00257,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00257,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00257,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00257,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00257,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00257,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00257,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB00257,Cytochrome P-450 CYP3A7 Inducers (strong),DrugBank
DB00257,Cytochrome P-450 CYP3A7 Inducers (weak),DrugBank
DB00257,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00257,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00257,Cytochrome P-450 Substrates,DrugBank
DB00257,Dermatologicals,DrugBank
DB00257,Enzyme Inhibitors,DrugBank
DB00257,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00257,Hormone Antagonists,DrugBank
DB00257,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00257,Imidazole and Triazole Derivatives,DrugBank
DB00257,Imidazole Derivatives,DrugBank
DB00257,Imidazoles,DrugBank
DB00257,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00257,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00257,OATP1B3 inducers,DrugBank
DB00257,P-glycoprotein inducers,DrugBank
DB00257,P-glycoprotein inhibitors,DrugBank
DB00257,P-glycoprotein substrates,DrugBank
DB00257,Steroid Synthesis Inhibitors,DrugBank
DB00257,Stomatological Preparations,DrugBank
DB00258,"Acids, Acyclic",DrugBank
DB00258,Alimentary Tract and Metabolism,DrugBank
DB00258,Arylsulfonates,DrugBank
DB00258,Arylsulfonic Acids,DrugBank
DB00258,Benzene Derivatives,DrugBank
DB00258,Calcium Salts,DrugBank
DB00258,Chelating Agents,DrugBank
DB00258,"Compounds used in a research, industrial, or household setting",DrugBank
DB00258,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB00258,Fatty Acids,DrugBank
DB00258,"Fatty Acids, Volatile",DrugBank
DB00258,Lipids,DrugBank
DB00258,Minerals,DrugBank
DB00258,Phosphate Binder,DrugBank
DB00258,Phosphate-removing Agents,DrugBank
DB00258,Sequestering Agents,DrugBank
DB00258,Sulfonic Acids,DrugBank
DB00258,Sulfur Acids,DrugBank
DB00258,Sulfur Compounds,DrugBank
DB00259,Amides,DrugBank
DB00259,Amines,DrugBank
DB00259,Aniline Compounds,DrugBank
DB00259,Anti-Bacterial Agents,DrugBank
DB00259,Anti-Infective Agents,DrugBank
DB00259,Antibacterials for Systemic Use,DrugBank
DB00259,Antiinfectives for Systemic Use,DrugBank
DB00259,Benzene Derivatives,DrugBank
DB00259,Benzenesulfonamides,DrugBank
DB00259,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00259,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00259,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00259,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00259,Dermatologicals,DrugBank
DB00259,Genito Urinary System and Sex Hormones,DrugBank
DB00259,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00259,Methemoglobinemia Associated Agents,DrugBank
DB00259,Short-Acting Antibacterial Sulfonamides,DrugBank
DB00259,Sulfanilamides,DrugBank
DB00259,Sulfonamide Antibacterial,DrugBank
DB00259,Sulfonamides,DrugBank
DB00259,Sulfonamides and trimethoprim,DrugBank
DB00259,Sulfones,DrugBank
DB00259,Sulfur Compounds,DrugBank
DB00260,Amino Acids,DrugBank
DB00260,"Amino Acids, Neutral",DrugBank
DB00260,"Amino Acids, Peptides, and Proteins",DrugBank
DB00260,Anti-Bacterial Agents,DrugBank
DB00260,Anti-Infective Agents,DrugBank
DB00260,"Anti-Infective Agents, Urinary",DrugBank
DB00260,"Antibiotics, Antitubercular",DrugBank
DB00260,Antiinfectives for Systemic Use,DrugBank
DB00260,Antimetabolites,DrugBank
DB00260,Antimycobacterials,DrugBank
DB00260,Drugs for Treatment of Tuberculosis,DrugBank
DB00260,Isoxazoles,DrugBank
DB00260,Neurotoxic agents,DrugBank
DB00260,Noxae,DrugBank
DB00260,Oxazoles,DrugBank
DB00260,Oxazolidinones,DrugBank
DB00260,Toxic Actions,DrugBank
DB00261,Agents producing tachycardia,DrugBank
DB00261,Antineoplastic Agents,DrugBank
DB00261,Antineoplastic and Immunomodulating Agents,DrugBank
DB00261,Antiplatelet agents,DrugBank
DB00261,Cardiovascular Agents,DrugBank
DB00261,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00261,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00261,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00261,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00261,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00261,Cytochrome P-450 Substrates,DrugBank
DB00261,Decreased Platelet Production,DrugBank
DB00261,Hematologic Agents,DrugBank
DB00261,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00261,Highest Risk QTc-Prolonging Agents,DrugBank
DB00261,Narrow Therapeutic Index Drugs,DrugBank
DB00261,Phosphodiesterase 3 Inhibitors,DrugBank
DB00261,Phosphodiesterase Inhibitors,DrugBank
DB00261,Platelet-reducing Agents,DrugBank
DB00261,QTc Prolonging Agents,DrugBank
DB00261,Thrombocytosis,DrugBank
DB00262,Alkylating Activity,DrugBank
DB00262,Alkylating Drugs,DrugBank
DB00262,Amides,DrugBank
DB00262,Antineoplastic Agents,DrugBank
DB00262,"Antineoplastic Agents, Alkylating",DrugBank
DB00262,Antineoplastic and Immunomodulating Agents,DrugBank
DB00262,Cardiotoxic antineoplastic agents,DrugBank
DB00262,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00262,Cytochrome P-450 Substrates,DrugBank
DB00262,Drugs that are Mainly Renally Excreted,DrugBank
DB00262,Immunosuppressive Agents,DrugBank
DB00262,Myelosuppressive Agents,DrugBank
DB00262,Narrow Therapeutic Index Drugs,DrugBank
DB00262,Nitroso Compounds,DrugBank
DB00262,Nitrosourea Compounds,DrugBank
DB00262,Nitrosoureas,DrugBank
DB00262,Noxae,DrugBank
DB00262,Toxic Actions,DrugBank
DB00263,Amides,DrugBank
DB00263,Amines,DrugBank
DB00263,Aniline Compounds,DrugBank
DB00263,Anti-Bacterial Agents,DrugBank
DB00263,Anti-Infective Agents,DrugBank
DB00263,Antibacterials for Systemic Use,DrugBank
DB00263,Antiinfectives for Systemic Use,DrugBank
DB00263,Benzene Derivatives,DrugBank
DB00263,Benzenesulfonamides,DrugBank
DB00263,Blood Glucose Lowering Agents,DrugBank
DB00263,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00263,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00263,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00263,Drugs causing inadvertant photosensitivity,DrugBank
DB00263,Genito Urinary System and Sex Hormones,DrugBank
DB00263,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00263,Hypoglycemia-Associated Agents,DrugBank
DB00263,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00263,Ophthalmologicals,DrugBank
DB00263,Photosensitizing Agents,DrugBank
DB00263,QTc Prolonging Agents,DrugBank
DB00263,Sensory Organs,DrugBank
DB00263,Short-Acting Antibacterial Sulfonamides,DrugBank
DB00263,Sulfanilamides,DrugBank
DB00263,Sulfonamide Antibacterial,DrugBank
DB00263,Sulfonamides,DrugBank
DB00263,Sulfonamides and trimethoprim,DrugBank
DB00263,Sulfones,DrugBank
DB00263,Sulfur Compounds,DrugBank
DB00264,Adrenergic Agents,DrugBank
DB00264,Adrenergic Antagonists,DrugBank
DB00264,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB00264,Adrenergic beta-Antagonists,DrugBank
DB00264,Agents causing hyperkalemia,DrugBank
DB00264,Alcohols,DrugBank
DB00264,Amines,DrugBank
DB00264,Amino Alcohols,DrugBank
DB00264,Antiarrhythmic agents,DrugBank
DB00264,Antihypertensive Agents,DrugBank
DB00264,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00264,Beta blocking agents and calcium channel blockers,DrugBank
DB00264,Beta Blocking Agents and Thiazides,DrugBank
DB00264,"Beta Blocking Agents, Selective",DrugBank
DB00264,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB00264,Beta-Blockers (Beta1 Selective),DrugBank
DB00264,Bradycardia-Causing Agents,DrugBank
DB00264,Cardiovascular Agents,DrugBank
DB00264,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00264,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00264,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00264,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00264,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00264,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00264,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00264,Cytochrome P-450 Substrates,DrugBank
DB00264,Drugs causing inadvertant photosensitivity,DrugBank
DB00264,Drugs that are Mainly Renally Excreted,DrugBank
DB00264,Hypotensive Agents,DrugBank
DB00264,OCT2 Inhibitors,DrugBank
DB00264,Photosensitizing Agents,DrugBank
DB00264,Propanolamines,DrugBank
DB00266,4-Hydroxycoumarins,DrugBank
DB00266,Anticoagulants,DrugBank
DB00266,Benzopyrans,DrugBank
DB00266,Blood and Blood Forming Organs,DrugBank
DB00266,Coumarins,DrugBank
DB00266,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00266,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00266,Cytochrome P-450 Substrates,DrugBank
DB00266,Enzyme Inhibitors,DrugBank
DB00266,Fibrinolytic Agents,DrugBank
DB00266,Hematologic Agents,DrugBank
DB00266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00266,Narrow Therapeutic Index Drugs,DrugBank
DB00266,Pyrans,DrugBank
DB00266,Uncoupling Agents,DrugBank
DB00266,Vitamin K Antagonists,DrugBank
DB00267,Amides,DrugBank
DB00267,Anti-Bacterial Agents,DrugBank
DB00267,Anti-Infective Agents,DrugBank
DB00267,Antibacterials for Systemic Use,DrugBank
DB00267,Antiinfectives for Systemic Use,DrugBank
DB00267,beta-Lactams,DrugBank
DB00267,Cephalosporins,DrugBank
DB00267,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00267,Lactams,DrugBank
DB00267,Nephrotoxic agents,DrugBank
DB00267,Ophthalmologicals,DrugBank
DB00267,Otologicals,DrugBank
DB00267,Sensory Organs,DrugBank
DB00267,Sulfur Compounds,DrugBank
DB00267,Thiazines,DrugBank
DB00267,Third-Generation Cephalosporins,DrugBank
DB00268,Anti-Dyskinesia Agents,DrugBank
DB00268,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB00268,Anti-Parkinson Drugs,DrugBank
DB00268,Central Nervous System Agents,DrugBank
DB00268,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00268,Cytochrome P-450 Substrates,DrugBank
DB00268,Dopamine Agents,DrugBank
DB00268,Dopamine Agonists,DrugBank
DB00268,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00268,Hypotensive Agents,DrugBank
DB00268,Nervous System,DrugBank
DB00268,Neurotransmitter Agents,DrugBank
DB00268,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB00269,Antineoplastic Agents,DrugBank
DB00269,"Antineoplastic Agents, Hormonal",DrugBank
DB00269,Benzene Derivatives,DrugBank
DB00269,Benzylidene Compounds,DrugBank
DB00269,Estrogens,DrugBank
DB00269,"Estrogens, Non-Steroidal",DrugBank
DB00269,Genito Urinary System and Sex Hormones,DrugBank
DB00269,Hormones,DrugBank
DB00269,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00269,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB00269,Sex Hormones and Modulators of the Genital System,DrugBank
DB00269,Stilbenes,DrugBank
DB00270,Agents causing hyperkalemia,DrugBank
DB00270,Antiarrhythmic agents,DrugBank
DB00270,Antihypertensive Agents,DrugBank
DB00270,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00270,Bradycardia-Causing Agents,DrugBank
DB00270,BSEP/ABCB11 Substrates,DrugBank
DB00270,Calcium Channel Blockers,DrugBank
DB00270,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB00270,Calcium-Regulating Hormones and Agents,DrugBank
DB00270,Cardiovascular Agents,DrugBank
DB00270,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00270,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00270,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00270,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00270,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00270,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00270,Cytochrome P-450 Substrates,DrugBank
DB00270,Dihydropyridine Derivatives,DrugBank
DB00270,Dihydropyridines,DrugBank
DB00270,Drugs that are Mainly Renally Excreted,DrugBank
DB00270,Hypotensive Agents,DrugBank
DB00270,Membrane Transport Modulators,DrugBank
DB00270,P-glycoprotein inhibitors,DrugBank
DB00270,Potential QTc-Prolonging Agents,DrugBank
DB00270,Pyridines,DrugBank
DB00270,QTc Prolonging Agents,DrugBank
DB00270,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00270,Vasodilating Agents,DrugBank
DB00271,"Acids, Carbocyclic",DrugBank
DB00271,Alcohols,DrugBank
DB00271,Amino Sugars,DrugBank
DB00271,Benzene Derivatives,DrugBank
DB00271,Benzoates,DrugBank
DB00271,Carbohydrates,DrugBank
DB00271,"Compounds used in a research, industrial, or household setting",DrugBank
DB00271,Contrast Media,DrugBank
DB00271,Diagnostic Uses of Chemicals,DrugBank
DB00271,Drugs that are Mainly Renally Excreted,DrugBank
DB00271,Hexosamines,DrugBank
DB00271,Iodinated Contrast Agents,DrugBank
DB00271,Iodobenzoates,DrugBank
DB00271,Radiographic Contrast Agent,DrugBank
DB00271,Roentgenography,DrugBank
DB00271,Sugar Alcohols,DrugBank
DB00271,Triiodobenzoic Acids,DrugBank
DB00271,"Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media",DrugBank
DB00271,X-Ray Contrast Activity,DrugBank
DB00271,"X-Ray Contrast Media, Iodinated",DrugBank
DB00273,Alimentary Tract and Metabolism,DrugBank
DB00273,Anti-Obesity Agents,DrugBank
DB00273,Anticonvulsants,DrugBank
DB00273,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00273,Carbohydrates,DrugBank
DB00273,Central Nervous System Agents,DrugBank
DB00273,Central Nervous System Depressants,DrugBank
DB00273,Centrally Acting Antiobesity Products,DrugBank
DB00273,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00273,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00273,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00273,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00273,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00273,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00273,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00273,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00273,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00273,Drugs that are Mainly Renally Excreted,DrugBank
DB00273,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB00273,Hexoses,DrugBank
DB00273,Ketoses,DrugBank
DB00273,Miscellaneous Anticonvulsants,DrugBank
DB00273,Monosaccharides,DrugBank
DB00273,Nervous System,DrugBank
DB00273,Neuroprotective Agents,DrugBank
DB00273,P-glycoprotein substrates,DrugBank
DB00274,Amides,DrugBank
DB00274,Anti-Bacterial Agents,DrugBank
DB00274,Anti-Infective Agents,DrugBank
DB00274,Antibacterials for Systemic Use,DrugBank
DB00274,Antiinfectives for Systemic Use,DrugBank
DB00274,beta-Lactams,DrugBank
DB00274,Cephalosporins,DrugBank
DB00274,Cephamycins,DrugBank
DB00274,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00274,Lactams,DrugBank
DB00274,Nephrotoxic agents,DrugBank
DB00274,Second-Generation Cephalosporins,DrugBank
DB00274,Sulfur Compounds,DrugBank
DB00274,Thiazines,DrugBank
DB00275,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00275,Agents causing hyperkalemia,DrugBank
DB00275,Angiotensin 2 Receptor Blocker,DrugBank
DB00275,Angiotensin II Antagonists and Calcium Channel Blockers,DrugBank
DB00275,Angiotensin II receptor antagonists,DrugBank
DB00275,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00275,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB00275,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB00275,Angiotensin Receptor Antagonists,DrugBank
DB00275,Antihypertensive Agents,DrugBank
DB00275,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00275,BSEP/ABCB11 Inhibitors,DrugBank
DB00275,Cardiovascular Agents,DrugBank
DB00275,Hypotensive Agents,DrugBank
DB00275,Imidazoles,DrugBank
DB00275,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00275,OATP1B3 substrates,DrugBank
DB00275,Tetrazoles,DrugBank
DB00276,Acridines,DrugBank
DB00276,Aminoacridines,DrugBank
DB00276,Antineoplastic Agents,DrugBank
DB00276,Antineoplastic and Immunomodulating Agents,DrugBank
DB00276,Cardiotoxic antineoplastic agents,DrugBank
DB00276,"Compounds used in a research, industrial, or household setting",DrugBank
DB00276,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00276,Immunosuppressive Agents,DrugBank
DB00276,Indicators and Reagents,DrugBank
DB00276,Intercalating Agents,DrugBank
DB00276,Laboratory Chemicals,DrugBank
DB00276,Myelosuppressive Agents,DrugBank
DB00276,Narrow Therapeutic Index Drugs,DrugBank
DB00276,P-glycoprotein inhibitors,DrugBank
DB00277,Agents that reduce seizure threshold,DrugBank
DB00277,Alkaloids,DrugBank
DB00277,Anti-Asthmatic Agents,DrugBank
DB00277,Autonomic Agents,DrugBank
DB00277,Bronchodilator Agents,DrugBank
DB00277,Cardiovascular Agents,DrugBank
DB00277,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00277,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00277,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00277,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00277,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00277,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00277,Cytochrome P-450 Substrates,DrugBank
DB00277,Drugs for Obstructive Airway Diseases,DrugBank
DB00277,Enzyme Inhibitors,DrugBank
DB00277,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00277,Narrow Therapeutic Index Drugs,DrugBank
DB00277,Neurotransmitter Agents,DrugBank
DB00277,Peripheral Nervous System Agents,DrugBank
DB00277,Phosphodiesterase 5 Inhibitors,DrugBank
DB00277,Phosphodiesterase Inhibitors,DrugBank
DB00277,Purinergic Agents,DrugBank
DB00277,Purinergic Antagonists,DrugBank
DB00277,Purinergic P1 Receptor Antagonists,DrugBank
DB00277,Purines,DrugBank
DB00277,Purinones,DrugBank
DB00277,Respiratory Smooth Muscle Relaxants,DrugBank
DB00277,Respiratory System Agents,DrugBank
DB00277,Vasodilating Agents,DrugBank
DB00277,Xanthine derivatives,DrugBank
DB00277,Xanthines and Adrenergics,DrugBank
DB00278,Amides,DrugBank
DB00278,Amino Acids,DrugBank
DB00278,"Amino Acids, Basic",DrugBank
DB00278,"Amino Acids, Diamino",DrugBank
DB00278,"Amino Acids, Essential",DrugBank
DB00278,"Amino Acids, Peptides, and Proteins",DrugBank
DB00278,Anticoagulants,DrugBank
DB00278,Antithrombins,DrugBank
DB00278,Blood and Blood Forming Organs,DrugBank
DB00278,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00278,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00278,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00278,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00278,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00278,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00278,Cytochrome P-450 Substrates,DrugBank
DB00278,Enzyme Inhibitors,DrugBank
DB00278,Hematologic Agents,DrugBank
DB00278,Narrow Therapeutic Index Drugs,DrugBank
DB00278,Piperidines,DrugBank
DB00278,Protease Inhibitors,DrugBank
DB00278,Serine Protease Inhibitors,DrugBank
DB00278,Sulfones,DrugBank
DB00278,Sulfur Compounds,DrugBank
DB00278,Thrombin Inhibitors,DrugBank
DB00279,Agents used to treat hypothyroidism,DrugBank
DB00279,Drugs that are Mainly Renally Excreted,DrugBank
DB00279,Hormones,DrugBank
DB00279,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00279,l-Triiodothyronine,DrugBank
DB00279,OAT3/SLC22A8 Inhibitors,DrugBank
DB00279,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00279,OATP1B3 substrates,DrugBank
DB00279,P-glycoprotein inducers,DrugBank
DB00279,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00279,Thyroid Products,DrugBank
DB00279,Thyronines,DrugBank
DB00279,Thyroxine-binding globulin substrates,DrugBank
DB00279,Triiodothyronine,DrugBank
DB00279,UGT1A1 Substrates,DrugBank
DB00280,Agents producing tachycardia,DrugBank
DB00280,Antiarrhythmic agents,DrugBank
DB00280,"Antiarrhythmics, Class I",DrugBank
DB00280,"Antiarrhythmics, Class Ia",DrugBank
DB00280,Anticholinergic Agents,DrugBank
DB00280,Blood Glucose Lowering Agents,DrugBank
DB00280,Cardiac Therapy,DrugBank
DB00280,Cardiovascular Agents,DrugBank
DB00280,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00280,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00280,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00280,Cytochrome P-450 Substrates,DrugBank
DB00280,Drugs that are Mainly Renally Excreted,DrugBank
DB00280,Highest Risk QTc-Prolonging Agents,DrugBank
DB00280,Hypoglycemia-Associated Agents,DrugBank
DB00280,Membrane Transport Modulators,DrugBank
DB00280,Muscarinic Antagonists,DrugBank
DB00280,Negative Inotrope,DrugBank
DB00280,OCT1 inhibitors,DrugBank
DB00280,OCT2 Inhibitors,DrugBank
DB00280,Pyridines,DrugBank
DB00280,QTc Prolonging Agents,DrugBank
DB00280,Sodium Channel Blockers,DrugBank
DB00280,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00281,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00281,Agents that reduce seizure threshold,DrugBank
DB00281,Amides,DrugBank
DB00281,Amines,DrugBank
DB00281,Analgesics and Anesthetics,DrugBank
DB00281,Anesthetics,DrugBank
DB00281,Anesthetics for Topical Use,DrugBank
DB00281,"Anesthetics, Local",DrugBank
DB00281,Anilides,DrugBank
DB00281,Aniline Compounds,DrugBank
DB00281,Antiarrhythmic agents,DrugBank
DB00281,"Antiarrhythmics, Class I",DrugBank
DB00281,"Antiarrhythmics, Class Ib",DrugBank
DB00281,Antipruritics and Local Anesthetics,DrugBank
DB00281,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB00281,Cardiac Therapy,DrugBank
DB00281,Cardiovascular Agents,DrugBank
DB00281,Central Nervous System Agents,DrugBank
DB00281,Central Nervous System Depressants,DrugBank
DB00281,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00281,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00281,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00281,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00281,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00281,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00281,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00281,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00281,Cytochrome P-450 Substrates,DrugBank
DB00281,Dermatologicals,DrugBank
DB00281,Local Anesthesia,DrugBank
DB00281,Local Anesthetics (Amide),DrugBank
DB00281,Membrane Transport Modulators,DrugBank
DB00281,Methemoglobinemia Associated Agents,DrugBank
DB00281,Nervous System,DrugBank
DB00281,Neuraxial Anesthetics,DrugBank
DB00281,Ophthalmologicals,DrugBank
DB00281,Otologicals,DrugBank
DB00281,P-glycoprotein inhibitors,DrugBank
DB00281,Peripheral Nervous System Agents,DrugBank
DB00281,Sensory System Agents,DrugBank
DB00281,Sodium Channel Blockers,DrugBank
DB00281,Throat Preparations,DrugBank
DB00281,Vasoprotectives,DrugBank
DB00281,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00282,Agents Causing Muscle Toxicity,DrugBank
DB00282,Antineoplastic Agents,DrugBank
DB00282,Bisphosphonates,DrugBank
DB00282,Bone Density Conservation Agents,DrugBank
DB00282,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00282,Drugs for Treatment of Bone Diseases,DrugBank
DB00282,Musculo-Skeletal System,DrugBank
DB00282,Nephrotoxic agents,DrugBank
DB00282,Organophosphonates,DrugBank
DB00282,Organophosphorus Compounds,DrugBank
DB00283,Aminoalkyl Ethers,DrugBank
DB00283,Anti-Allergic Agents,DrugBank
DB00283,Antihistamines for Systemic Use,DrugBank
DB00283,Antihistamines for Topical Use,DrugBank
DB00283,Antipruritics,DrugBank
DB00283,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB00283,Central Nervous System Depressants,DrugBank
DB00283,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00283,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00283,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00283,Dermatologicals,DrugBank
DB00283,Highest Risk QTc-Prolonging Agents,DrugBank
DB00283,Histamine Agents,DrugBank
DB00283,Histamine Antagonists,DrugBank
DB00283,Histamine H1 Antagonists,DrugBank
DB00283,Neurotransmitter Agents,DrugBank
DB00283,Pyrrolidines,DrugBank
DB00283,QTc Prolonging Agents,DrugBank
DB00284,Alimentary Tract and Metabolism,DrugBank
DB00284,Blood Glucose Lowering Agents,DrugBank
DB00284,Carbohydrates,DrugBank
DB00284,Drugs that are Mainly Renally Excreted,DrugBank
DB00284,Drugs Used in Diabetes,DrugBank
DB00284,Enzyme Inhibitors,DrugBank
DB00284,Glycoside Hydrolase Inhibitors,DrugBank
DB00284,Hypoglycemia-Associated Agents,DrugBank
DB00284,Oligosaccharides,DrugBank
DB00284,Oral Hypoglycemics,DrugBank
DB00284,Polysaccharides,DrugBank
DB00284,Trisaccharides,DrugBank
DB00285,Agents producing tachycardia,DrugBank
DB00285,Agents that reduce seizure threshold,DrugBank
DB00285,Amines,DrugBank
DB00285,Antidepressive Agents,DrugBank
DB00285,Antidepressive Agents Indicated for Depression,DrugBank
DB00285,"Antidepressive Agents, Second-Generation",DrugBank
DB00285,BCRP/ABCG2 Inducers,DrugBank
DB00285,Central Nervous System Agents,DrugBank
DB00285,Central Nervous System Depressants,DrugBank
DB00285,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00285,Cyclohexanes,DrugBank
DB00285,Cyclohexanols,DrugBank
DB00285,Cycloparaffins,DrugBank
DB00285,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00285,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00285,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00285,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00285,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00285,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00285,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00285,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00285,Cytochrome P-450 Substrates,DrugBank
DB00285,Drugs that are Mainly Renally Excreted,DrugBank
DB00285,Ethylamines,DrugBank
DB00285,Hexanols,DrugBank
DB00285,Hypoglycemia-Associated Agents,DrugBank
DB00285,Membrane Transport Modulators,DrugBank
DB00285,Nervous System,DrugBank
DB00285,Neurotransmitter Agents,DrugBank
DB00285,Neurotransmitter Uptake Inhibitors,DrugBank
DB00285,Norepinephrine Uptake Inhibitors,DrugBank
DB00285,P-glycoprotein inhibitors,DrugBank
DB00285,P-glycoprotein substrates,DrugBank
DB00285,Phenethylamines,DrugBank
DB00285,Potential QTc-Prolonging Agents,DrugBank
DB00285,Psychoanaleptics,DrugBank
DB00285,Psychotropic Drugs,DrugBank
DB00285,QTc Prolonging Agents,DrugBank
DB00285,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00285,Serotonin Agents,DrugBank
DB00285,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB00285,Serotonin Modulators,DrugBank
DB00286,Agents causing angioedema,DrugBank
DB00286,BCRP/ABCG2 Substrates,DrugBank
DB00286,COMT Substrates,DrugBank
DB00286,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00286,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00286,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00286,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00286,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00286,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00286,Cytochrome P-450 Substrates,DrugBank
DB00286,Drugs that are Mainly Renally Excreted,DrugBank
DB00286,Estradiol Congeners,DrugBank
DB00286,Estrogens,DrugBank
DB00286,"Estrogens, Conjugated (USP)",DrugBank
DB00286,Genito Urinary System and Sex Hormones,DrugBank
DB00286,Gonadal Hormones,DrugBank
DB00286,Gonadal Steroid Hormones,DrugBank
DB00286,Hormones,DrugBank
DB00286,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00286,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB00286,OAT3/SLC22A8 Inhibitors,DrugBank
DB00286,OAT3/SLC22A8 Substrates,DrugBank
DB00286,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00286,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00286,OATP1B3 substrates,DrugBank
DB00286,OATP2B1/SLCO2B1 substrates,DrugBank
DB00286,P-glycoprotein substrates,DrugBank
DB00286,Sex Hormones and Modulators of the Genital System,DrugBank
DB00286,Thyroxine-binding globulin inducers,DrugBank
DB00287,Antiglaucoma Preparations and Miotics,DrugBank
DB00287,Antihypertensive Agents,DrugBank
DB00287,Eicosanoids,DrugBank
DB00287,Fatty Acids,DrugBank
DB00287,"Fatty Acids, Unsaturated",DrugBank
DB00287,Inflammation Mediators,DrugBank
DB00287,Lipids,DrugBank
DB00287,Ophthalmics,DrugBank
DB00287,Ophthalmologicals,DrugBank
DB00287,Prostaglandin analogs reducing intraocular pressure (IOP),DrugBank
DB00287,Prostaglandins,DrugBank
DB00287,"Prostaglandins F, Synthetic",DrugBank
DB00287,"Prostaglandins, Synthetic",DrugBank
DB00288,Adrenal Cortex Hormones,DrugBank
DB00288,Anti-Inflammatory Agents,DrugBank
DB00288,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00288,Corticosteroids,DrugBank
DB00288,"Corticosteroids, Dermatological Preparations",DrugBank
DB00288,"Corticosteroids, Potent (Group III)",DrugBank
DB00288,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00288,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00288,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00288,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00288,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00288,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00288,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00288,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00288,Cytochrome P-450 Substrates,DrugBank
DB00288,Dermatologicals,DrugBank
DB00288,Fused-Ring Compounds,DrugBank
DB00288,Glucocorticoids,DrugBank
DB00288,Hormones,DrugBank
DB00288,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00288,Hyperglycemia-Associated Agents,DrugBank
DB00288,Immunosuppressive Agents,DrugBank
DB00288,Pregnadienes,DrugBank
DB00288,Pregnanes,DrugBank
DB00288,Steroids,DrugBank
DB00288,"Steroids, Fluorinated",DrugBank
DB00288,Thyroxine-binding globulin inhibitors,DrugBank
DB00289,Adrenergic Agents,DrugBank
DB00289,Agents producing tachycardia,DrugBank
DB00289,Agents that produce hypertension,DrugBank
DB00289,Amines,DrugBank
DB00289,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00289,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00289,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00289,Cytochrome P-450 Substrates,DrugBank
DB00289,Drugs that are Mainly Renally Excreted,DrugBank
DB00289,Membrane Transport Modulators,DrugBank
DB00289,Miscellaneous Central Nervous System Agents,DrugBank
DB00289,Nervous System,DrugBank
DB00289,Neurotransmitter Agents,DrugBank
DB00289,Neurotransmitter Uptake Inhibitors,DrugBank
DB00289,Norepinephrine Reuptake Inhibitor,DrugBank
DB00289,Norepinephrine Uptake Inhibitors,DrugBank
DB00289,Potential QTc-Prolonging Agents,DrugBank
DB00289,Propylamines,DrugBank
DB00289,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB00289,QTc Prolonging Agents,DrugBank
DB00290,"Amino Acids, Peptides, and Proteins",DrugBank
DB00290,"Antibiotics, Antineoplastic",DrugBank
DB00290,Antineoplastic Agents,DrugBank
DB00290,Antineoplastic and Immunomodulating Agents,DrugBank
DB00290,Carbohydrates,DrugBank
DB00290,Cardiotoxic antineoplastic agents,DrugBank
DB00290,Cytoprotective Agent,DrugBank
DB00290,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00290,Cytotoxins,DrugBank
DB00290,Drugs that are Mainly Renally Excreted,DrugBank
DB00290,Glycoconjugates,DrugBank
DB00290,Glycopeptides,DrugBank
DB00290,Immunosuppressive Agents,DrugBank
DB00290,Narrow Therapeutic Index Drugs,DrugBank
DB00290,Peptides,DrugBank
DB00291,Agents that reduce seizure threshold,DrugBank
DB00291,Alkylating Activity,DrugBank
DB00291,Alkylating Drugs,DrugBank
DB00291,Antineoplastic Agents,DrugBank
DB00291,"Antineoplastic Agents, Alkylating",DrugBank
DB00291,Antineoplastic and Immunomodulating Agents,DrugBank
DB00291,"Hydrocarbons, Halogenated",DrugBank
DB00291,Immunosuppressive Agents,DrugBank
DB00291,Mustard Compounds,DrugBank
DB00291,Myelosuppressive Agents,DrugBank
DB00291,Narrow Therapeutic Index Drugs,DrugBank
DB00291,Nitrogen Mustard Analogues,DrugBank
DB00291,Nitrogen Mustard Compounds,DrugBank
DB00291,Noxae,DrugBank
DB00291,Toxic Actions,DrugBank
DB00292,Adrenergic Agonists,DrugBank
DB00292,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00292,Adrenergic alpha-Agonists,DrugBank
DB00292,Agents producing tachycardia,DrugBank
DB00292,Agents that produce hypertension,DrugBank
DB00292,Anesthetics,DrugBank
DB00292,"Anesthetics, General",DrugBank
DB00292,"Anesthetics, Intravenous",DrugBank
DB00292,Central Nervous System Agents,DrugBank
DB00292,Central Nervous System Depressants,DrugBank
DB00292,Drugs that are Mainly Renally Excreted,DrugBank
DB00292,Hypnotics and Sedatives,DrugBank
DB00292,Imidazoles,DrugBank
DB00292,Nervous System,DrugBank
DB00293,Antimetabolites,DrugBank
DB00293,Antineoplastic Agents,DrugBank
DB00293,Antineoplastic and Immunomodulating Agents,DrugBank
DB00293,Enzyme Inhibitors,DrugBank
DB00293,Folic Acid Analogues,DrugBank
DB00293,Folic Acid Antagonists,DrugBank
DB00293,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00293,Immunosuppressive Agents,DrugBank
DB00293,Myelosuppressive Agents,DrugBank
DB00293,Narrow Therapeutic Index Drugs,DrugBank
DB00293,Noxae,DrugBank
DB00293,Sulfur Compounds,DrugBank
DB00293,"Thymidylate Synthase, antagonists & inhibitors",DrugBank
DB00293,Toxic Actions,DrugBank
DB00294,Adrenal Cortex Hormones,DrugBank
DB00294,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00294,"Contraceptive Agents, Female",DrugBank
DB00294,"Contraceptive Agents, Hormonal",DrugBank
DB00294,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00294,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00294,Cytochrome P-450 Substrates,DrugBank
DB00294,Drugs that are Mainly Renally Excreted,DrugBank
DB00294,Fused-Ring Compounds,DrugBank
DB00294,Genito Urinary System and Sex Hormones,DrugBank
DB00294,Hormonal Contraceptives for Systemic Use,DrugBank
DB00294,Hyperglycemia-Associated Agents,DrugBank
DB00294,Intravaginal Contraceptives,DrugBank
DB00294,Norpregnanes,DrugBank
DB00294,Norpregnenes,DrugBank
DB00294,Norsteroids,DrugBank
DB00294,Progesterone Congeners,DrugBank
DB00294,Progestins,DrugBank
DB00294,Reproductive Control Agents,DrugBank
DB00294,Sex Hormones and Modulators of the Genital System,DrugBank
DB00294,Steroids,DrugBank
DB00295,Alkaloids,DrugBank
DB00295,Analgesics,DrugBank
DB00295,Anesthetics,DrugBank
DB00295,Central Nervous System Agents,DrugBank
DB00295,Central Nervous System Depressants,DrugBank
DB00295,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00295,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00295,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00295,Cytochrome P-450 Substrates,DrugBank
DB00295,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00295,High-risk opioids,DrugBank
DB00295,Hypotensive Agents,DrugBank
DB00295,Narcotics,DrugBank
DB00295,Natural Opium Alkaloids,DrugBank
DB00295,Nervous System,DrugBank
DB00295,Neuraxial Anesthetics,DrugBank
DB00295,Opiate Agonists,DrugBank
DB00295,Opiate Alkaloids,DrugBank
DB00295,Opioid Agonist,DrugBank
DB00295,Opioids,DrugBank
DB00295,P-glycoprotein substrates,DrugBank
DB00295,Peripheral Nervous System Agents,DrugBank
DB00295,Phenanthrenes,DrugBank
DB00295,Sensory System Agents,DrugBank
DB00295,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00295,UGT1A1 Substrates,DrugBank
DB00295,UGT1A3 substrates,DrugBank
DB00295,UGT2B7 substrates,DrugBank
DB00296,Amides,DrugBank
DB00296,Amines,DrugBank
DB00296,Anesthetics,DrugBank
DB00296,"Anesthetics, Local",DrugBank
DB00296,Anilides,DrugBank
DB00296,Aniline Compounds,DrugBank
DB00296,Central Nervous System Agents,DrugBank
DB00296,Central Nervous System Depressants,DrugBank
DB00296,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00296,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00296,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00296,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00296,Cytochrome P-450 Substrates,DrugBank
DB00296,Drugs that are Mainly Renally Excreted,DrugBank
DB00296,Hypotensive Agents,DrugBank
DB00296,Local Anesthesia,DrugBank
DB00296,Local Anesthetics (Amide),DrugBank
DB00296,Methemoglobinemia Associated Agents,DrugBank
DB00296,Nervous System,DrugBank
DB00296,Neuraxial Anesthetics,DrugBank
DB00296,Peripheral Nervous System Agents,DrugBank
DB00296,Sensory System Agents,DrugBank
DB00297,Agents that reduce seizure threshold,DrugBank
DB00297,Amides,DrugBank
DB00297,Amines,DrugBank
DB00297,Anesthetics,DrugBank
DB00297,"Anesthetics, Local",DrugBank
DB00297,Anilides,DrugBank
DB00297,Aniline Compounds,DrugBank
DB00297,Central Nervous System Agents,DrugBank
DB00297,Central Nervous System Depressants,DrugBank
DB00297,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00297,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00297,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00297,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00297,Cytochrome P-450 Substrates,DrugBank
DB00297,Hypotensive Agents,DrugBank
DB00297,Local Anesthesia,DrugBank
DB00297,Local Anesthetics (Amide),DrugBank
DB00297,Methemoglobinemia Associated Agents,DrugBank
DB00297,Nervous System,DrugBank
DB00297,Neuraxial Anesthetics,DrugBank
DB00297,Peripheral Nervous System Agents,DrugBank
DB00297,Sensory System Agents,DrugBank
DB00299,Anti-Infective Agents,DrugBank
DB00299,Antiinfectives for Systemic Use,DrugBank
DB00299,Antiviral Agents,DrugBank
DB00299,Antivirals for Systemic Use,DrugBank
DB00299,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00299,Cytochrome P-450 Substrates,DrugBank
DB00299,Dermatologicals,DrugBank
DB00299,Direct Acting Antivirals,DrugBank
DB00299,Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00299,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00299,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00299,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB00299,Purines,DrugBank
DB00299,Purinones,DrugBank
DB00299,Reverse Transcriptase Inhibitors,DrugBank
DB00300,Anti-HIV Agents,DrugBank
DB00300,Anti-Infective Agents,DrugBank
DB00300,Anti-Retroviral Agents,DrugBank
DB00300,Antiinfectives for Systemic Use,DrugBank
DB00300,Antiviral Agents,DrugBank
DB00300,Antivirals for Systemic Use,DrugBank
DB00300,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00300,Direct Acting Antivirals,DrugBank
DB00300,Drugs that are Mainly Renally Excreted,DrugBank
DB00300,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00300,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00300,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00300,Nephrotoxic agents,DrugBank
DB00300,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00300,OAT1/SLC22A6 Substrates,DrugBank
DB00300,OAT3/SLC22A8 Substrates,DrugBank
DB00300,Organophosphorus Compounds,DrugBank
DB00300,P-glycoprotein inhibitors,DrugBank
DB00300,P-glycoprotein substrates,DrugBank
DB00300,Purines,DrugBank
DB00300,Reverse Transcriptase Inhibitors,DrugBank
DB00300,Tenofovir and prodrugs,DrugBank
DB00301,Amides,DrugBank
DB00301,Anti-Bacterial Agents,DrugBank
DB00301,Anti-Infective Agents,DrugBank
DB00301,Antibacterials for Systemic Use,DrugBank
DB00301,Antiinfectives for Systemic Use,DrugBank
DB00301,Beta-Lactam Antibacterials,DrugBank
DB00301,Beta-Lactamase Resistant Penicillins,DrugBank
DB00301,beta-Lactams,DrugBank
DB00301,BSEP/ABCB11 Substrates,DrugBank
DB00301,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00301,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00301,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00301,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00301,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00301,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00301,Cytochrome P-450 Substrates,DrugBank
DB00301,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00301,Lactams,DrugBank
DB00301,Penicillins,DrugBank
DB00301,Sulfur Compounds,DrugBank
DB00302,"Acids, Carbocyclic",DrugBank
DB00302,Amino Acids,DrugBank
DB00302,"Amino Acids, Peptides, and Proteins",DrugBank
DB00302,Antifibrinolytic Agents,DrugBank
DB00302,Blood and Blood Forming Organs,DrugBank
DB00302,Coagulants,DrugBank
DB00302,Cyclohexanecarboxylic Acids,DrugBank
DB00302,Cyclohexanes,DrugBank
DB00302,Cycloparaffins,DrugBank
DB00302,Decreased Fibrinolysis,DrugBank
DB00302,Fibrin Modulating Agents,DrugBank
DB00302,Hematologic Agents,DrugBank
DB00302,Hemostatics,DrugBank
DB00303,Amides,DrugBank
DB00303,Anti-Bacterial Agents,DrugBank
DB00303,Anti-Infective Agents,DrugBank
DB00303,Antibacterials for Systemic Use,DrugBank
DB00303,Antiinfectives for Systemic Use,DrugBank
DB00303,beta-Lactams,DrugBank
DB00303,Carbapenems,DrugBank
DB00303,Drugs that are Mainly Renally Excreted,DrugBank
DB00303,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00303,Lactams,DrugBank
DB00303,Penem Antibacterial,DrugBank
DB00303,Sulfur Compounds,DrugBank
DB00304,Adrenal Cortex Hormones,DrugBank
DB00304,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00304,"Contraceptive Agents, Female",DrugBank
DB00304,"Contraceptive Agents, Hormonal",DrugBank
DB00304,"Contraceptives, Oral",DrugBank
DB00304,"Contraceptives, Oral, Hormonal",DrugBank
DB00304,"Contraceptives, Oral, Synthetic",DrugBank
DB00304,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00304,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00304,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00304,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00304,Cytochrome P-450 Substrates,DrugBank
DB00304,Fused-Ring Compounds,DrugBank
DB00304,Genito Urinary System and Sex Hormones,DrugBank
DB00304,Hormonal Contraceptives for Systemic Use,DrugBank
DB00304,Hormones,DrugBank
DB00304,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00304,Hyperglycemia-Associated Agents,DrugBank
DB00304,Norpregnanes,DrugBank
DB00304,Norpregnenes,DrugBank
DB00304,Norsteroids,DrugBank
DB00304,Progestin Contraceptives,DrugBank
DB00304,Progestins,DrugBank
DB00304,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00304,Reproductive Control Agents,DrugBank
DB00304,Sex Hormones and Modulators of the Genital System,DrugBank
DB00304,Steroids,DrugBank
DB00304,UGT1A1 Inducers,DrugBank
DB00305,Alkylating Activity,DrugBank
DB00305,Alkylating Drugs,DrugBank
DB00305,"Antibiotics, Antineoplastic",DrugBank
DB00305,Antineoplastic Agents,DrugBank
DB00305,Antineoplastic and Immunomodulating Agents,DrugBank
DB00305,Azirines,DrugBank
DB00305,Cardiotoxic antineoplastic agents,DrugBank
DB00305,"Compounds used in a research, industrial, or household setting",DrugBank
DB00305,Cross-Linking Reagents,DrugBank
DB00305,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00305,Cytotoxins,DrugBank
DB00305,Enzyme Inhibitors,DrugBank
DB00305,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00305,Immunosuppressive Agents,DrugBank
DB00305,Indicators and Reagents,DrugBank
DB00305,Indolequinones,DrugBank
DB00305,Indoles,DrugBank
DB00305,Mitomycins,DrugBank
DB00305,Myelosuppressive Agents,DrugBank
DB00305,Narrow Therapeutic Index Drugs,DrugBank
DB00305,Noxae,DrugBank
DB00305,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00305,Toxic Actions,DrugBank
DB00306,Anticholinergic Agents,DrugBank
DB00306,"Barbiturates, Plain",DrugBank
DB00306,Central Nervous System Depressants,DrugBank
DB00306,Hypnotics and Sedatives,DrugBank
DB00306,Nervous System,DrugBank
DB00306,Nicotinic Antagonists,DrugBank
DB00306,Psycholeptics,DrugBank
DB00306,Pyrimidines,DrugBank
DB00306,Pyrimidinones,DrugBank
DB00307,Antineoplastic Agents,DrugBank
DB00307,Antineoplastic and Immunomodulating Agents,DrugBank
DB00307,"Compounds used in a research, industrial, or household setting",DrugBank
DB00307,Cyclohexanes,DrugBank
DB00307,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00307,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00307,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00307,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00307,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00307,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00307,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB00307,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00307,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00307,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00307,Cytochrome P-450 Substrates,DrugBank
DB00307,Immunosuppressive Agents,DrugBank
DB00307,Myelosuppressive Agents,DrugBank
DB00307,Naphthalenes,DrugBank
DB00307,Retinoids,DrugBank
DB00307,Retinoids for cancer treatment,DrugBank
DB00307,Tetrahydronaphthalenes,DrugBank
DB00308,Amides,DrugBank
DB00308,Antiarrhythmic agents,DrugBank
DB00308,"Antiarrhythmics, Class III",DrugBank
DB00308,Cardiac Therapy,DrugBank
DB00308,Cardiovascular Agents,DrugBank
DB00308,Drugs that are Mainly Renally Excreted,DrugBank
DB00308,Highest Risk QTc-Prolonging Agents,DrugBank
DB00308,QTc Prolonging Agents,DrugBank
DB00308,Sulfones,DrugBank
DB00308,Sulfur Compounds,DrugBank
DB00309,Alkaloids,DrugBank
DB00309,Antimitotic Agents,DrugBank
DB00309,Antineoplastic Agents,DrugBank
DB00309,"Antineoplastic Agents, Phytogenic",DrugBank
DB00309,Antineoplastic and Immunomodulating Agents,DrugBank
DB00309,Cardiotoxic antineoplastic agents,DrugBank
DB00309,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00309,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00309,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00309,Cytochrome P-450 Substrates,DrugBank
DB00309,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00309,Immunosuppressive Agents,DrugBank
DB00309,Indole Alkaloids,DrugBank
DB00309,Indoles,DrugBank
DB00309,Indolizidines,DrugBank
DB00309,Indolizines,DrugBank
DB00309,Mitosis Modulators,DrugBank
DB00309,Myelosuppressive Agents,DrugBank
DB00309,Narrow Therapeutic Index Drugs,DrugBank
DB00309,Secologanin Tryptamine Alkaloids,DrugBank
DB00309,Tubulin Modulators,DrugBank
DB00309,Vinca Alkaloids,DrugBank
DB00310,Amides,DrugBank
DB00310,Antihypertensive Agents,DrugBank
DB00310,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00310,Benzene Derivatives,DrugBank
DB00310,Benzenesulfonamides,DrugBank
DB00310,Benzophenones,DrugBank
DB00310,Cardiovascular Agents,DrugBank
DB00310,Diuretics,DrugBank
DB00310,Drugs causing inadvertant photosensitivity,DrugBank
DB00310,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00310,Hyperglycemia-Associated Agents,DrugBank
DB00310,Hypotensive Agents,DrugBank
DB00310,Imides,DrugBank
DB00310,Increased Diuresis,DrugBank
DB00310,Isoindoles,DrugBank
DB00310,Ketones,DrugBank
DB00310,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00310,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB00310,Membrane Transport Modulators,DrugBank
DB00310,Natriuretic Agents,DrugBank
DB00310,Non Potassium Sparing Diuretics,DrugBank
DB00310,Photosensitizing Agents,DrugBank
DB00310,Phthalimides,DrugBank
DB00310,Sodium Chloride Symporter Inhibitors,DrugBank
DB00310,Sulfonamides,DrugBank
DB00310,Sulfones,DrugBank
DB00310,Sulfur Compounds,DrugBank
DB00310,Thiazide-like Diuretic,DrugBank
DB00311,Amides,DrugBank
DB00311,Benzothiazoles,DrugBank
DB00311,Carbonic Anhydrase Inhibitors,DrugBank
DB00311,Diuretics,DrugBank
DB00311,Enzyme Inhibitors,DrugBank
DB00311,Genito Urinary System and Sex Hormones,DrugBank
DB00311,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00311,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00311,Natriuretic Agents,DrugBank
DB00311,OAT1/SLC22A6 inhibitors,DrugBank
DB00311,Sulfonamides,DrugBank
DB00311,Sulfones,DrugBank
DB00311,Sulfur Compounds,DrugBank
DB00311,Thiazoles,DrugBank
DB00312,"Adjuvants, Anesthesia",DrugBank
DB00312,Anticholinergic Agents,DrugBank
DB00312,Anticonvulsants,DrugBank
DB00312,Barbiturates,DrugBank
DB00312,"Barbiturates, Plain",DrugBank
DB00312,Central Nervous System Agents,DrugBank
DB00312,Central Nervous System Depressants,DrugBank
DB00312,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00312,Cytochrome P-450 CYP2A6 Inducers (strong),DrugBank
DB00312,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00312,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00312,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00312,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00312,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00312,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00312,Cytochrome P-450 Substrates,DrugBank
DB00312,Drugs that are Mainly Renally Excreted,DrugBank
DB00312,GABA Agents,DrugBank
DB00312,GABA Modulators,DrugBank
DB00312,Hypnotics and Sedatives,DrugBank
DB00312,Nervous System,DrugBank
DB00312,Neurotransmitter Agents,DrugBank
DB00312,Nicotinic Antagonists,DrugBank
DB00312,Psycholeptics,DrugBank
DB00312,Pyrimidines,DrugBank
DB00312,Pyrimidinones,DrugBank
DB00313,"Acids, Acyclic",DrugBank
DB00313,Anti-epileptic Agent,DrugBank
DB00313,Anticonvulsants,DrugBank
DB00313,Antimanic Agents,DrugBank
DB00313,Antineoplastic Agents,DrugBank
DB00313,Central Nervous System Agents,DrugBank
DB00313,Central Nervous System Depressants,DrugBank
DB00313,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00313,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00313,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00313,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00313,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00313,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00313,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00313,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00313,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00313,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00313,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00313,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00313,Cytochrome P-450 Substrates,DrugBank
DB00313,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00313,Drugs causing inadvertant photosensitivity,DrugBank
DB00313,Enzyme Inhibitors,DrugBank
DB00313,Fatty Acid Derivatives,DrugBank
DB00313,Fatty Acids,DrugBank
DB00313,"Fatty Acids, Volatile",DrugBank
DB00313,GABA Agents,DrugBank
DB00313,Hepatotoxic Agents,DrugBank
DB00313,Highest Risk QTc-Prolonging Agents,DrugBank
DB00313,Histone Deacetylase Inhibitors,DrugBank
DB00313,Lipids,DrugBank
DB00313,Methemoglobinemia Associated Agents,DrugBank
DB00313,Miscellaneous Anticonvulsants,DrugBank
DB00313,Mood Stabilizer,DrugBank
DB00313,Narrow Therapeutic Index Drugs,DrugBank
DB00313,Nervous System,DrugBank
DB00313,Neurotransmitter Agents,DrugBank
DB00313,OAT1/SLC22A6 inhibitors,DrugBank
DB00313,OAT3/SLC22A8 Inhibitors,DrugBank
DB00313,OAT3/SLC22A8 Substrates,DrugBank
DB00313,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00313,Pentanoic Acids,DrugBank
DB00313,Photosensitizing Agents,DrugBank
DB00313,Psychotropic Drugs,DrugBank
DB00313,QTc Prolonging Agents,DrugBank
DB00313,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00313,Tranquilizing Agents,DrugBank
DB00313,UGT1A1 Inhibitors,DrugBank
DB00313,UGT1A1 Substrates,DrugBank
DB00313,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,UGT1A3 substrates,DrugBank
DB00313,UGT1A3 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,UGT1A4 substrates,DrugBank
DB00313,UGT1A6 substrate,DrugBank
DB00313,UGT1A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,UGT1A9 Substrates,DrugBank
DB00313,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,UGT2B7 substrates,DrugBank
DB00313,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00313,Valerates,DrugBank
DB00314,Agents that produce neuromuscular block (indirect),DrugBank
DB00314,"Amino Acids, Peptides, and Proteins",DrugBank
DB00314,Aminoglycoside Antibacterials,DrugBank
DB00314,Anti-Bacterial Agents,DrugBank
DB00314,Anti-Infective Agents,DrugBank
DB00314,"Antibiotics, Antitubercular",DrugBank
DB00314,Antiinfectives for Systemic Use,DrugBank
DB00314,Antimycobacterials,DrugBank
DB00314,Drugs for Treatment of Tuberculosis,DrugBank
DB00314,Drugs that are Mainly Renally Excreted,DrugBank
DB00314,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00314,Enzyme Inhibitors,DrugBank
DB00314,Narrow Therapeutic Index Drugs,DrugBank
DB00314,Nephrotoxic agents,DrugBank
DB00314,Peptides,DrugBank
DB00314,"Peptides, Cyclic",DrugBank
DB00314,Protein Synthesis Inhibitors,DrugBank
DB00315,Agents that produce hypertension,DrugBank
DB00315,Amines,DrugBank
DB00315,Analgesics,DrugBank
DB00315,Antidepressive Agents,DrugBank
DB00315,Antimigraine Preparations,DrugBank
DB00315,Biogenic Amines,DrugBank
DB00315,Biogenic Monoamines,DrugBank
DB00315,Central Nervous System Depressants,DrugBank
DB00315,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00315,Cytochrome P-450 Substrates,DrugBank
DB00315,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00315,Indoles,DrugBank
DB00315,Monoamine Oxidase A Substrates,DrugBank
DB00315,Nervous System,DrugBank
DB00315,Neurotransmitter Agents,DrugBank
DB00315,Oxazoles,DrugBank
DB00315,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00315,Selective Serotonin Agonists,DrugBank
DB00315,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00315,Serotonin 1b Receptor Agonists,DrugBank
DB00315,Serotonin 1d Receptor Agonists,DrugBank
DB00315,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00315,Serotonin Agents,DrugBank
DB00315,Serotonin Modulators,DrugBank
DB00315,Serotonin Receptor Agonists,DrugBank
DB00315,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00315,Triptans,DrugBank
DB00316,Acetaminophen and Prodrugs,DrugBank
DB00316,Amides,DrugBank
DB00316,Amines,DrugBank
DB00316,Analgesics,DrugBank
DB00316,"Analgesics, Non-Narcotic",DrugBank
DB00316,Anilides,DrugBank
DB00316,Aniline Compounds,DrugBank
DB00316,Antipyretics,DrugBank
DB00316,Central Nervous System Agents,DrugBank
DB00316,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00316,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00316,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00316,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00316,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00316,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00316,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00316,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00316,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00316,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00316,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00316,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00316,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00316,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00316,Cytochrome P-450 Substrates,DrugBank
DB00316,Drugs that are Mainly Renally Excreted,DrugBank
DB00316,Methemoglobinemia Associated Agents,DrugBank
DB00316,Miscellaneous Analgesics and Antipyretics,DrugBank
DB00316,Nervous System,DrugBank
DB00316,P-glycoprotein inhibitors,DrugBank
DB00316,P-glycoprotein substrates,DrugBank
DB00316,Sensory System Agents,DrugBank
DB00316,UGT1A1 Substrates,DrugBank
DB00316,UGT1A6 substrate,DrugBank
DB00316,UGT1A9 Substrates,DrugBank
DB00317,Antineoplastic Agents,DrugBank
DB00317,Antineoplastic and Immunomodulating Agents,DrugBank
DB00317,BCRP/ABCG2 Inhibitors,DrugBank
DB00317,BCRP/ABCG2 Substrates,DrugBank
DB00317,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00317,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00317,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00317,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00317,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00317,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00317,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00317,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00317,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00317,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00317,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00317,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00317,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00317,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00317,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00317,Cytochrome P-450 Substrates,DrugBank
DB00317,Enzyme Inhibitors,DrugBank
DB00317,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB00317,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00317,Kinase Inhibitor,DrugBank
DB00317,P-glycoprotein inhibitors,DrugBank
DB00317,P-glycoprotein substrates,DrugBank
DB00317,Protein Kinase Inhibitors,DrugBank
DB00317,Quinazolines,DrugBank
DB00317,Tyrosine Kinase Inhibitors,DrugBank
DB00318,Alkaloids,DrugBank
DB00318,Analgesics,DrugBank
DB00318,Antitussive Agents,DrugBank
DB00318,Central Nervous System Agents,DrugBank
DB00318,Central Nervous System Depressants,DrugBank
DB00318,Cough and Cold Preparations,DrugBank
DB00318,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00318,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00318,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00318,Cytochrome P-450 Substrates,DrugBank
DB00318,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00318,Morphinans,DrugBank
DB00318,Morphine Derivatives,DrugBank
DB00318,Narcotics,DrugBank
DB00318,Natural Opium Alkaloids,DrugBank
DB00318,Nervous System,DrugBank
DB00318,OAT1/SLC22A6 inhibitors,DrugBank
DB00318,OCT1 inhibitors,DrugBank
DB00318,OCT1 substrates,DrugBank
DB00318,Opiate Agonists,DrugBank
DB00318,Opiate Alkaloids,DrugBank
DB00318,Opioid Agonist,DrugBank
DB00318,Opioids,DrugBank
DB00318,Opium Alkaloids and Derivatives,DrugBank
DB00318,Phenanthrenes,DrugBank
DB00318,Respiratory System Agents,DrugBank
DB00318,Sensory System Agents,DrugBank
DB00318,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00318,UGT2B7 substrates,DrugBank
DB00319,Agents that produce neuromuscular block (indirect),DrugBank
DB00319,Amides,DrugBank
DB00319,Anti-Bacterial Agents,DrugBank
DB00319,Anti-Infective Agents,DrugBank
DB00319,Antibacterials for Systemic Use,DrugBank
DB00319,Antiinfectives for Systemic Use,DrugBank
DB00319,Beta-Lactam Antibacterials,DrugBank
DB00319,beta-Lactams,DrugBank
DB00319,Drugs that are Mainly Renally Excreted,DrugBank
DB00319,Extended-spectrum Penicillins,DrugBank
DB00319,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00319,Lactams,DrugBank
DB00319,OAT1/SLC22A6 inhibitors,DrugBank
DB00319,OAT3/SLC22A8 Substrates,DrugBank
DB00319,Penicillin G,DrugBank
DB00319,Penicillins,DrugBank
DB00319,Penicillins With Extended Spectrum,DrugBank
DB00319,Sulfur Compounds,DrugBank
DB00320,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00320,Adrenergic alpha-Antagonists,DrugBank
DB00320,Adrenergic Antagonists,DrugBank
DB00320,Agents that produce hypertension,DrugBank
DB00320,Alkaloids,DrugBank
DB00320,Analgesics,DrugBank
DB00320,Antidepressive Agents,DrugBank
DB00320,Antimigraine Preparations,DrugBank
DB00320,Cardiovascular Agents,DrugBank
DB00320,Central Nervous System Agents,DrugBank
DB00320,Central Nervous System Depressants,DrugBank
DB00320,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00320,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00320,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00320,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00320,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00320,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00320,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00320,Cytochrome P-450 Substrates,DrugBank
DB00320,Dopamine Agents,DrugBank
DB00320,Dopamine Agonists,DrugBank
DB00320,Ergot Alkaloids and Derivatives,DrugBank
DB00320,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB00320,Ergotamine Derivative,DrugBank
DB00320,Ergotamines,DrugBank
DB00320,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00320,Narrow Therapeutic Index Drugs,DrugBank
DB00320,Nervous System,DrugBank
DB00320,Neurotransmitter Agents,DrugBank
DB00320,P-glycoprotein inhibitors,DrugBank
DB00320,Peripheral Nervous System Agents,DrugBank
DB00320,Sensory System Agents,DrugBank
DB00320,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00320,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00320,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB00320,Serotonin Agents,DrugBank
DB00320,Serotonin Modulators,DrugBank
DB00320,Serotonin Receptor Agonists,DrugBank
DB00320,Sympatholytic (Adrenergic Blocking) Agents,DrugBank
DB00320,Vasoconstrictor Agents,DrugBank
DB00321,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00321,Adrenergic alpha-Antagonists,DrugBank
DB00321,Adrenergic Antagonists,DrugBank
DB00321,Adrenergic Uptake Inhibitors,DrugBank
DB00321,Agents producing tachycardia,DrugBank
DB00321,Agents that produce hypertension,DrugBank
DB00321,Agents that reduce seizure threshold,DrugBank
DB00321,Analgesics,DrugBank
DB00321,"Analgesics, Non-Narcotic",DrugBank
DB00321,Anticholinergic Agents,DrugBank
DB00321,Antidepressive Agents,DrugBank
DB00321,Antidepressive Agents Indicated for Depression,DrugBank
DB00321,"Antidepressive Agents, Tricyclic",DrugBank
DB00321,Central Nervous System Agents,DrugBank
DB00321,Central Nervous System Depressants,DrugBank
DB00321,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00321,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00321,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00321,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00321,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00321,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00321,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00321,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00321,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00321,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00321,Cytochrome P-450 Substrates,DrugBank
DB00321,Drugs that are Mainly Renally Excreted,DrugBank
DB00321,Histamine Antagonists,DrugBank
DB00321,Histamine H1 Antagonists,DrugBank
DB00321,Membrane Transport Modulators,DrugBank
DB00321,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00321,Muscarinic Antagonists,DrugBank
DB00321,Narrow Therapeutic Index Drugs,DrugBank
DB00321,Neurotoxic agents,DrugBank
DB00321,Neurotransmitter Agents,DrugBank
DB00321,Neurotransmitter Uptake Inhibitors,DrugBank
DB00321,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00321,P-glycoprotein substrates,DrugBank
DB00321,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00321,Psychotropic Drugs,DrugBank
DB00321,QTc Prolonging Agents,DrugBank
DB00321,Sensory System Agents,DrugBank
DB00321,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00321,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00321,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00321,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00321,Serotonin Agents,DrugBank
DB00321,Serotonin Modulators,DrugBank
DB00321,Serotonin Receptor Antagonists,DrugBank
DB00321,Tertiary amine tricyclic antidepressants,DrugBank
DB00321,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB00321,UGT1A1 Inhibitors,DrugBank
DB00321,UGT1A4 substrates,DrugBank
DB00322,Antimetabolites,DrugBank
DB00322,Antineoplastic Agents,DrugBank
DB00322,Antineoplastic and Immunomodulating Agents,DrugBank
DB00322,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00322,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00322,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00322,Deoxyribonucleosides,DrugBank
DB00322,Deoxyuridine,DrugBank
DB00322,Drugs that are Mainly Renally Excreted,DrugBank
DB00322,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00322,Immunosuppressive Agents,DrugBank
DB00322,Myelosuppressive Agents,DrugBank
DB00322,Narrow Therapeutic Index Drugs,DrugBank
DB00322,Noxae,DrugBank
DB00322,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00322,Nucleosides,DrugBank
DB00322,Pyrimidine Analogues,DrugBank
DB00322,Pyrimidine Nucleosides,DrugBank
DB00322,Pyrimidines,DrugBank
DB00322,Thyroxine-binding globulin inducers,DrugBank
DB00322,Toxic Actions,DrugBank
DB00323,Anti-Dyskinesia Agents,DrugBank
DB00323,Anti-Parkinson Drugs,DrugBank
DB00323,Benzene Derivatives,DrugBank
DB00323,Benzophenones,DrugBank
DB00323,Central Nervous System Agents,DrugBank
DB00323,Central Nervous System Depressants,DrugBank
DB00323,COMT Inhibitors,DrugBank
DB00323,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00323,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00323,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00323,Dopamine Agents,DrugBank
DB00323,Drugs that are Mainly Renally Excreted,DrugBank
DB00323,Enzyme Inhibitors,DrugBank
DB00323,Hypotensive Agents,DrugBank
DB00323,Ketones,DrugBank
DB00323,Nervous System,DrugBank
DB00323,Nitro Compounds,DrugBank
DB00323,Nitrophenols,DrugBank
DB00323,Phenols,DrugBank
DB00324,Adrenal Cortex Hormones,DrugBank
DB00324,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00324,Anti-Acne Preparations,DrugBank
DB00324,Anti-Acne Preparations for Topical Use,DrugBank
DB00324,Anti-Allergic Agents,DrugBank
DB00324,Anti-Inflammatory Agents,DrugBank
DB00324,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00324,Corticosteroids,DrugBank
DB00324,"Corticosteroids, Dermatological Preparations",DrugBank
DB00324,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB00324,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00324,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00324,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00324,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00324,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00324,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00324,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00324,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00324,Cytochrome P-450 Substrates,DrugBank
DB00324,Dermatologicals,DrugBank
DB00324,Fused-Ring Compounds,DrugBank
DB00324,Glucocorticoids,DrugBank
DB00324,Hormones,DrugBank
DB00324,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00324,Hyperglycemia-Associated Agents,DrugBank
DB00324,Immunosuppressive Agents,DrugBank
DB00324,Ophthalmologicals,DrugBank
DB00324,Pregnadienediols,DrugBank
DB00324,Pregnadienes,DrugBank
DB00324,Pregnanes,DrugBank
DB00324,Sensory Organs,DrugBank
DB00324,Steroids,DrugBank
DB00324,"Steroids, Fluorinated",DrugBank
DB00324,Thyroxine-binding globulin inhibitors,DrugBank
DB00324,Vasoprotectives,DrugBank
DB00325,Anions,DrugBank
DB00325,Antihypertensive Agents,DrugBank
DB00325,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB00325,Cardiovascular Agents,DrugBank
DB00325,"Compounds used in a research, industrial, or household setting",DrugBank
DB00325,Cyanides,DrugBank
DB00325,Direct Vasodilators,DrugBank
DB00325,Drugs that are Mainly Renally Excreted,DrugBank
DB00325,Electrolytes,DrugBank
DB00325,Ferric Compounds,DrugBank
DB00325,Ferricyanides,DrugBank
DB00325,Hypotensive Agents,DrugBank
DB00325,Indicators and Reagents,DrugBank
DB00325,Ions,DrugBank
DB00325,Iron Compounds,DrugBank
DB00325,Laboratory Chemicals,DrugBank
DB00325,Methemoglobinemia Associated Agents,DrugBank
DB00325,Nitrates and Nitrites,DrugBank
DB00325,Nitric Oxide Donors,DrugBank
DB00325,Nitroferricyanide Derivatives,DrugBank
DB00325,Nitrogen Compounds,DrugBank
DB00325,Vasodilating Agents,DrugBank
DB00325,Vasodilation,DrugBank
DB00326,"Acids, Acyclic",DrugBank
DB00326,Alimentary Tract and Metabolism,DrugBank
DB00326,Calcium Salts,DrugBank
DB00326,Carbohydrates,DrugBank
DB00326,Hydroxy Acids,DrugBank
DB00326,Mineral Supplements,DrugBank
DB00326,Supplements,DrugBank
DB00327,Alkaloids,DrugBank
DB00327,Analgesics,DrugBank
DB00327,Central Nervous System Agents,DrugBank
DB00327,Central Nervous System Depressants,DrugBank
DB00327,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00327,Cytochrome P-450 Substrates,DrugBank
DB00327,Drugs that are Mainly Renally Excreted,DrugBank
DB00327,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00327,High-risk opioids,DrugBank
DB00327,Morphinans,DrugBank
DB00327,Morphine Derivatives,DrugBank
DB00327,Narcotics,DrugBank
DB00327,Natural Opium Alkaloids,DrugBank
DB00327,Nervous System,DrugBank
DB00327,Opiate Agonists,DrugBank
DB00327,Opiate Alkaloids,DrugBank
DB00327,Opioid Agonist,DrugBank
DB00327,Opioids,DrugBank
DB00327,Peripheral Nervous System Agents,DrugBank
DB00327,Phenanthrenes,DrugBank
DB00327,Semi-synthetic Opioids,DrugBank
DB00327,Sensory System Agents,DrugBank
DB00327,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00327,UGT1A3 substrates,DrugBank
DB00327,UGT2B7 substrates,DrugBank
DB00328,Acetic Acid Derivatives and Related Substances,DrugBank
DB00328,Agents causing hyperkalemia,DrugBank
DB00328,Agents that produce hypertension,DrugBank
DB00328,Analgesics,DrugBank
DB00328,"Analgesics, Non-Narcotic",DrugBank
DB00328,Anti-Inflammatory Agents,DrugBank
DB00328,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00328,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00328,Antigout Preparations,DrugBank
DB00328,Antiinflammatory and Antirheumatic Products,DrugBank
DB00328,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00328,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00328,Antirheumatic Agents,DrugBank
DB00328,BSEP/ABCB11 Substrates,DrugBank
DB00328,Cardiac Therapy,DrugBank
DB00328,Cardiovascular Agents,DrugBank
DB00328,Central Nervous System Agents,DrugBank
DB00328,Cyclooxygenase Inhibitors,DrugBank
DB00328,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00328,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00328,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00328,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00328,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00328,Cytochrome P-450 Substrates,DrugBank
DB00328,Enzyme Inhibitors,DrugBank
DB00328,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00328,Hypoglycemia-Associated Agents,DrugBank
DB00328,Immunosuppressive Agents,DrugBank
DB00328,Indoles,DrugBank
DB00328,Musculo-Skeletal System,DrugBank
DB00328,Myelosuppressive Agents,DrugBank
DB00328,Nephrotoxic agents,DrugBank
DB00328,Non COX-2 selective NSAIDS,DrugBank
DB00328,OAT1/SLC22A6 inhibitors,DrugBank
DB00328,OAT1/SLC22A6 Substrates,DrugBank
DB00328,OAT3/SLC22A8 Inhibitors,DrugBank
DB00328,OAT3/SLC22A8 Substrates,DrugBank
DB00328,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00328,Ophthalmologicals,DrugBank
DB00328,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00328,P-glycoprotein inhibitors,DrugBank
DB00328,P-glycoprotein substrates,DrugBank
DB00328,Peripheral Nervous System Agents,DrugBank
DB00328,Sensory Organs,DrugBank
DB00328,Sensory System Agents,DrugBank
DB00328,Tocolytic Agents,DrugBank
DB00328,Topical Products for Joint and Muscular Pain,DrugBank
DB00328,UGT1A1 Inhibitors,DrugBank
DB00328,UGT1A1 Substrates,DrugBank
DB00328,UGT1A9 Substrates,DrugBank
DB00328,UGT2B7 Inhibitors,DrugBank
DB00328,UGT2B7 substrates,DrugBank
DB00330,Amines,DrugBank
DB00330,Anti-Bacterial Agents,DrugBank
DB00330,Anti-Infective Agents,DrugBank
DB00330,Antiinfectives for Systemic Use,DrugBank
DB00330,Antimycobacterials,DrugBank
DB00330,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00330,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00330,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00330,Diamines,DrugBank
DB00330,Drugs for Treatment of Tuberculosis,DrugBank
DB00330,Drugs that are Mainly Renally Excreted,DrugBank
DB00330,Ethylenediamines,DrugBank
DB00330,Polyamines,DrugBank
DB00331,Alimentary Tract and Metabolism,DrugBank
DB00331,Amidines,DrugBank
DB00331,Biguanides,DrugBank
DB00331,Blood Glucose Lowering Agents,DrugBank
DB00331,Drugs that are Mainly Renally Excreted,DrugBank
DB00331,Drugs Used in Diabetes,DrugBank
DB00331,Guanidines,DrugBank
DB00331,MATE 1 Substrates,DrugBank
DB00331,MATE 2 Substrates,DrugBank
DB00331,MATE substrates,DrugBank
DB00331,OCT1 substrates,DrugBank
DB00331,OCT2 Inhibitors,DrugBank
DB00331,OCT2 Substrates,DrugBank
DB00331,Oral Hypoglycemics,DrugBank
DB00332,"Adrenergics, Inhalants",DrugBank
DB00332,Agents producing tachycardia,DrugBank
DB00332,Agents to Treat Airway Disease,DrugBank
DB00332,Alkaloids,DrugBank
DB00332,Anti-Asthmatic Agents,DrugBank
DB00332,Anticholinergic Agents,DrugBank
DB00332,Antimuscarinics Antispasmodics,DrugBank
DB00332,Atropine Derivatives,DrugBank
DB00332,Autonomic Agents,DrugBank
DB00332,Aza Compounds,DrugBank
DB00332,Azabicyclo Compounds,DrugBank
DB00332,Belladonna Alkaloids,DrugBank
DB00332,Bronchodilator Agents,DrugBank
DB00332,Cholinergic Agents,DrugBank
DB00332,Drugs for Obstructive Airway Diseases,DrugBank
DB00332,Muscarinic Antagonists,DrugBank
DB00332,Nasal Preparations,DrugBank
DB00332,Neurotransmitter Agents,DrugBank
DB00332,Peripheral Nervous System Agents,DrugBank
DB00332,Respiratory System Agents,DrugBank
DB00332,Solanaceous Alkaloids,DrugBank
DB00332,Tropanes,DrugBank
DB00333,Analgesics,DrugBank
DB00333,Anticholinergic Agents,DrugBank
DB00333,Antidepressive Agents,DrugBank
DB00333,Antitussive Agents,DrugBank
DB00333,Central Nervous System Agents,DrugBank
DB00333,Central Nervous System Depressants,DrugBank
DB00333,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00333,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00333,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00333,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00333,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00333,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00333,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00333,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00333,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00333,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00333,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00333,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00333,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00333,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00333,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00333,Cytochrome P-450 Substrates,DrugBank
DB00333,Diphenylpropylamine Derivatives,DrugBank
DB00333,Drugs that are Mainly Renally Excreted,DrugBank
DB00333,Drugs Used in Addictive Disorders,DrugBank
DB00333,Drugs Used in Opioid Dependence,DrugBank
DB00333,High-risk opioids,DrugBank
DB00333,Ketones,DrugBank
DB00333,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00333,Narcotics,DrugBank
DB00333,Nervous System,DrugBank
DB00333,Nicotinic Antagonists,DrugBank
DB00333,NMDA Receptor Antagonists,DrugBank
DB00333,Opiate Agonists,DrugBank
DB00333,Opioid Agonist,DrugBank
DB00333,Opioids,DrugBank
DB00333,P-glycoprotein inhibitors,DrugBank
DB00333,Peripheral Nervous System Agents,DrugBank
DB00333,QTc Prolonging Agents,DrugBank
DB00333,Respiratory System Agents,DrugBank
DB00333,Sensory System Agents,DrugBank
DB00333,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00333,Serotonin Agents,DrugBank
DB00333,Serotonin Modulators,DrugBank
DB00333,Thyroxine-binding globulin inducers,DrugBank
DB00334,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00334,Adrenergic alpha-Antagonists,DrugBank
DB00334,Adrenergic Antagonists,DrugBank
DB00334,Agents producing tachycardia,DrugBank
DB00334,Anticholinergic Agents,DrugBank
DB00334,Antidepressive Agents,DrugBank
DB00334,Antiemetics,DrugBank
DB00334,Antipsychotic Agents,DrugBank
DB00334,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB00334,Autonomic Agents,DrugBank
DB00334,Benzazepines,DrugBank
DB00334,Central Nervous System Agents,DrugBank
DB00334,Central Nervous System Depressants,DrugBank
DB00334,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00334,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00334,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00334,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00334,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00334,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00334,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00334,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00334,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00334,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00334,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00334,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00334,Cytochrome P-450 Substrates,DrugBank
DB00334,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB00334,Dopamine Antagonists,DrugBank
DB00334,Dopamine D2 Receptor Antagonists,DrugBank
DB00334,Gastrointestinal Agents,DrugBank
DB00334,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00334,Histamine Antagonists,DrugBank
DB00334,Histamine H1 Antagonists,DrugBank
DB00334,Histamine H2 Antagonists,DrugBank
DB00334,Hyperglycemia-Associated Agents,DrugBank
DB00334,Hypotensive Agents,DrugBank
DB00334,Muscarinic Antagonists,DrugBank
DB00334,Nervous System,DrugBank
DB00334,Neurotransmitter Agents,DrugBank
DB00334,P-glycoprotein substrates,DrugBank
DB00334,Peripheral Nervous System Agents,DrugBank
DB00334,Potential QTc-Prolonging Agents,DrugBank
DB00334,Psycholeptics,DrugBank
DB00334,Psychotropic Drugs,DrugBank
DB00334,QTc Prolonging Agents,DrugBank
DB00334,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00334,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00334,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00334,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00334,Serotonin Agents,DrugBank
DB00334,Serotonin Receptor Antagonists,DrugBank
DB00334,Tranquilizing Agents,DrugBank
DB00334,UGT1A4 substrates,DrugBank
DB00335,Adrenergic Agents,DrugBank
DB00335,Adrenergic Antagonists,DrugBank
DB00335,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB00335,Adrenergic beta-Antagonists,DrugBank
DB00335,Agents causing hyperkalemia,DrugBank
DB00335,Alcohols,DrugBank
DB00335,Amines,DrugBank
DB00335,Amino Alcohols,DrugBank
DB00335,Antiarrhythmic agents,DrugBank
DB00335,Antihypertensive Agents,DrugBank
DB00335,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00335,Autonomic Agents,DrugBank
DB00335,Beta blocking agents and calcium channel blockers,DrugBank
DB00335,Beta Blocking Agents and Thiazides,DrugBank
DB00335,"Beta Blocking Agents, Selective",DrugBank
DB00335,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB00335,Beta-Blockers (Beta1 Selective),DrugBank
DB00335,Bradycardia-Causing Agents,DrugBank
DB00335,BSEP/ABCB11 Substrates,DrugBank
DB00335,Cardiovascular Agents,DrugBank
DB00335,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00335,Cytochrome P-450 Substrates,DrugBank
DB00335,Hypotensive Agents,DrugBank
DB00335,Peripheral Nervous System Agents,DrugBank
DB00335,QTc shortening agents,DrugBank
DB00335,Sympatholytics,DrugBank
DB00337,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB00337,Analgesics,DrugBank
DB00337,"Analgesics, Non-Narcotic",DrugBank
DB00337,Anti-Inflammatory Agents,DrugBank
DB00337,Calcineurin Inhibitor Immunosuppressant,DrugBank
DB00337,Calcineurin Inhibitors,DrugBank
DB00337,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00337,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00337,Cytochrome P-450 Substrates,DrugBank
DB00337,Dermatologicals,DrugBank
DB00337,Enzyme Inhibitors,DrugBank
DB00337,Immunologic Factors,DrugBank
DB00337,Immunosuppressive Agents,DrugBank
DB00337,Lactones,DrugBank
DB00337,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00337,mTOR Inhibitors,DrugBank
DB00337,"Peptidylprolyl Isomerase, antagonists & inhibitors",DrugBank
DB00337,Peripheral Nervous System Agents,DrugBank
DB00337,Sensory System Agents,DrugBank
DB00338,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB00338,Acid Reducers,DrugBank
DB00338,Alimentary Tract and Metabolism,DrugBank
DB00338,Anti-Ulcer Agents,DrugBank
DB00338,BCRP/ABCG2 Inhibitors,DrugBank
DB00338,Benzimidazoles,DrugBank
DB00338,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00338,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00338,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00338,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00338,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00338,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00338,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00338,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00338,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00338,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00338,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00338,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00338,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00338,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00338,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00338,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00338,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00338,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00338,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00338,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00338,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00338,Cytochrome P-450 Substrates,DrugBank
DB00338,Drugs for Acid Related Disorders,DrugBank
DB00338,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00338,Enzyme Inhibitors,DrugBank
DB00338,Gastric Acid Lowering Agents,DrugBank
DB00338,Gastrointestinal Agents,DrugBank
DB00338,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00338,P-glycoprotein inhibitors,DrugBank
DB00338,P-glycoprotein substrates,DrugBank
DB00338,Proton Pump Inhibitors,DrugBank
DB00338,Proton-pump Inhibitors,DrugBank
DB00338,Pyridines,DrugBank
DB00338,Sulfoxides,DrugBank
DB00338,Sulfur Compounds,DrugBank
DB00339,Anti-Bacterial Agents,DrugBank
DB00339,Anti-Infective Agents,DrugBank
DB00339,Antiinfectives for Systemic Use,DrugBank
DB00339,Antimycobacterials,DrugBank
DB00339,Drugs causing inadvertant photosensitivity,DrugBank
DB00339,Drugs for Treatment of Tuberculosis,DrugBank
DB00339,Drugs that are Mainly Renally Excreted,DrugBank
DB00339,Hepatotoxic Agents,DrugBank
DB00339,Photosensitizing Agents,DrugBank
DB00339,Pyrazines,DrugBank
DB00340,Agents producing tachycardia,DrugBank
DB00340,Anti-Parkinson Drugs,DrugBank
DB00340,Anticholinergic Agents,DrugBank
DB00340,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00340,Muscarinic Antagonists,DrugBank
DB00340,Nervous System,DrugBank
DB00340,Sulfur Compounds,DrugBank
DB00340,Tertiary Amines,DrugBank
DB00340,Xanthenes,DrugBank
DB00341,Anti-Allergic Agents,DrugBank
DB00341,Antihistamines for Systemic Use,DrugBank
DB00341,Central Nervous System Depressants,DrugBank
DB00341,Decongestants and Antiallergics,DrugBank
DB00341,Drugs that are Mainly Renally Excreted,DrugBank
DB00341,Histamine Agents,DrugBank
DB00341,Histamine Antagonists,DrugBank
DB00341,Histamine H1 Antagonists,DrugBank
DB00341,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00341,Ophthalmologicals,DrugBank
DB00341,P-glycoprotein inhibitors,DrugBank
DB00341,P-glycoprotein substrates,DrugBank
DB00341,Piperazine Derivatives,DrugBank
DB00341,Piperazines,DrugBank
DB00341,Potential QTc-Prolonging Agents,DrugBank
DB00341,QTc Prolonging Agents,DrugBank
DB00341,Sensory Organs,DrugBank
DB00342,Anticholinergic Agents,DrugBank
DB00342,Antihistamines for Systemic Use,DrugBank
DB00342,Benzene Derivatives,DrugBank
DB00342,Benzhydryl Compounds,DrugBank
DB00342,BSEP/ABCB11 Substrates,DrugBank
DB00342,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00342,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00342,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00342,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00342,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00342,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00342,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00342,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00342,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00342,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00342,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00342,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00342,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00342,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00342,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00342,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00342,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00342,Cytochrome P-450 Substrates,DrugBank
DB00342,Highest Risk QTc-Prolonging Agents,DrugBank
DB00342,Histamine Agents,DrugBank
DB00342,Histamine Antagonists,DrugBank
DB00342,Histamine H1 Antagonists,DrugBank
DB00342,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00342,Muscarinic Antagonists,DrugBank
DB00342,Neurotransmitter Agents,DrugBank
DB00342,P-glycoprotein inhibitors,DrugBank
DB00342,P-glycoprotein substrates,DrugBank
DB00342,Piperidines,DrugBank
DB00342,QTc Prolonging Agents,DrugBank
DB00343,Agents causing hyperkalemia,DrugBank
DB00343,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00343,Antiarrhythmic agents,DrugBank
DB00343,Antihypertensive Agents,DrugBank
DB00343,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00343,Benzazepines,DrugBank
DB00343,Benzothiazepine Derivatives,DrugBank
DB00343,Bradycardia-Causing Agents,DrugBank
DB00343,Calcium Channel Blockers,DrugBank
DB00343,Calcium Channel Blockers (Nondihydropyridine),DrugBank
DB00343,Calcium-Regulating Hormones and Agents,DrugBank
DB00343,Cardiovascular Agents,DrugBank
DB00343,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00343,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00343,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00343,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00343,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00343,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00343,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00343,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00343,Cytochrome P-450 CYP3A5 Inhibitors (moderate),DrugBank
DB00343,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00343,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00343,Cytochrome P-450 CYP3A7 Inhibitors (moderate),DrugBank
DB00343,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB00343,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00343,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00343,Cytochrome P-450 Substrates,DrugBank
DB00343,Drugs causing inadvertant photosensitivity,DrugBank
DB00343,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00343,Hypotensive Agents,DrugBank
DB00343,Membrane Transport Modulators,DrugBank
DB00343,Miscellaneous Calcium-channel Blocking Agents,DrugBank
DB00343,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00343,Negative Inotrope,DrugBank
DB00343,P-glycoprotein inhibitors,DrugBank
DB00343,P-glycoprotein substrates,DrugBank
DB00343,Photosensitizing Agents,DrugBank
DB00343,QTc Prolonging Agents,DrugBank
DB00343,Selective Calcium Channel Blockers With Direct Cardiac Effects,DrugBank
DB00343,Vasodilating Agents,DrugBank
DB00343,Vasoprotectives,DrugBank
DB00344,Adrenergic Agents,DrugBank
DB00344,Adrenergic Uptake Inhibitors,DrugBank
DB00344,Agents that produce hypertension,DrugBank
DB00344,Agents that reduce seizure threshold,DrugBank
DB00344,Antidepressive Agents,DrugBank
DB00344,Antidepressive Agents Indicated for Depression,DrugBank
DB00344,"Antidepressive Agents, Tricyclic",DrugBank
DB00344,Benzocycloheptenes,DrugBank
DB00344,Central Nervous System Agents,DrugBank
DB00344,Central Nervous System Depressants,DrugBank
DB00344,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00344,Dibenzocycloheptenes,DrugBank
DB00344,Membrane Transport Modulators,DrugBank
DB00344,Narrow Therapeutic Index Drugs,DrugBank
DB00344,Nervous System,DrugBank
DB00344,Neurotoxic agents,DrugBank
DB00344,Neurotransmitter Agents,DrugBank
DB00344,Neurotransmitter Uptake Inhibitors,DrugBank
DB00344,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00344,P-glycoprotein inhibitors,DrugBank
DB00344,Potential QTc-Prolonging Agents,DrugBank
DB00344,Psychoanaleptics,DrugBank
DB00344,Psychotropic Drugs,DrugBank
DB00344,QTc Prolonging Agents,DrugBank
DB00344,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00344,Serotonin Agents,DrugBank
DB00344,Serotonin Modulators,DrugBank
DB00345,"Acids, Carbocyclic",DrugBank
DB00345,Amides,DrugBank
DB00345,Aminobenzoates,DrugBank
DB00345,Aminohippuric Acids,DrugBank
DB00345,Benzamides and benzamide derivatives,DrugBank
DB00345,Benzene Derivatives,DrugBank
DB00345,Benzoates,DrugBank
DB00345,"Compounds used in a research, industrial, or household setting",DrugBank
DB00345,Diagnostic Agents,DrugBank
DB00345,Hippurates,DrugBank
DB00345,Indicators and Reagents,DrugBank
DB00345,Keto Acids,DrugBank
DB00345,Laboratory Chemicals,DrugBank
DB00345,OAT1/SLC22A6 inhibitors,DrugBank
DB00345,OAT1/SLC22A6 Substrates,DrugBank
DB00345,OAT3/SLC22A8 Inhibitors,DrugBank
DB00345,OAT3/SLC22A8 Substrates,DrugBank
DB00345,OCT2 Inhibitors,DrugBank
DB00345,para-Aminobenzoates,DrugBank
DB00345,Tests for Renal Function and Ureteral Injuries,DrugBank
DB00346,Adrenergic Agents,DrugBank
DB00346,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00346,Adrenergic alpha-Antagonists,DrugBank
DB00346,Adrenergic Antagonists,DrugBank
DB00346,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00346,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00346,Cytochrome P-450 Substrates,DrugBank
DB00346,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB00346,Genito Urinary System and Sex Hormones,DrugBank
DB00346,Genitourinary Agents,DrugBank
DB00346,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00346,Neurotransmitter Agents,DrugBank
DB00346,P-glycoprotein substrates,DrugBank
DB00346,Peripheral alpha-1 blockers,DrugBank
DB00346,Potential QTc-Prolonging Agents,DrugBank
DB00346,Prostatic Hyperplasia,DrugBank
DB00346,QTc Prolonging Agents,DrugBank
DB00346,Selective Alfa-1-adrenergic Blocking Agents,DrugBank
DB00346,Urological Agents,DrugBank
DB00346,Urologicals,DrugBank
DB00347,Agents causing hyperkalemia,DrugBank
DB00347,Anti-epileptic Agent,DrugBank
DB00347,Antiarrhythmic agents,DrugBank
DB00347,Anticonvulsants,DrugBank
DB00347,Bradycardia-Causing Agents,DrugBank
DB00347,Calcium Channel Blockers,DrugBank
DB00347,Central Nervous System Agents,DrugBank
DB00347,Central Nervous System Depressants,DrugBank
DB00347,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00347,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00347,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00347,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00347,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00347,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00347,Cytochrome P-450 Substrates,DrugBank
DB00347,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00347,Nervous System,DrugBank
DB00347,Oxazoles,DrugBank
DB00347,Oxazolidine Derivatives,DrugBank
DB00347,Potential QTc-Prolonging Agents,DrugBank
DB00347,QTc Prolonging Agents,DrugBank
DB00349,Anti-Anxiety Agents,DrugBank
DB00349,Anticonvulsants,DrugBank
DB00349,Benzazepines,DrugBank
DB00349,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00349,Central Nervous System Agents,DrugBank
DB00349,Central Nervous System Depressants,DrugBank
DB00349,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00349,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00349,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00349,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00349,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00349,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00349,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00349,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00349,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00349,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00349,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00349,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00349,Cytochrome P-450 Substrates,DrugBank
DB00349,Drugs that are Mainly Renally Excreted,DrugBank
DB00349,GABA Agents,DrugBank
DB00349,GABA Agonists,DrugBank
DB00349,GABA-A Receptor Agonists,DrugBank
DB00349,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00349,Nervous System,DrugBank
DB00349,Neurotransmitter Agents,DrugBank
DB00349,P-glycoprotein substrates,DrugBank
DB00349,Psycholeptics,DrugBank
DB00349,Psychotropic Drugs,DrugBank
DB00349,Tranquilizing Agents,DrugBank
DB00349,UGT1A4 Inhibitors,DrugBank
DB00349,UGT1A6 Inhibitors,DrugBank
DB00350,Antihypertensive Agents,DrugBank
DB00350,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00350,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB00350,Arteriolar Vasodilation,DrugBank
DB00350,Arteriolar Vasodilator,DrugBank
DB00350,Cardiovascular Agents,DrugBank
DB00350,Dermatologicals,DrugBank
DB00350,Direct Vasodilators,DrugBank
DB00350,Hypotensive Agents,DrugBank
DB00350,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00350,Piperidines,DrugBank
DB00350,Potassium Channel Opener,DrugBank
DB00350,Pyrimidine Derivatives,DrugBank
DB00350,Pyrimidines,DrugBank
DB00350,UGT1A1 Substrates,DrugBank
DB00350,Vasodilating Agents,DrugBank
DB00351,Adrenal Cortex Hormones,DrugBank
DB00351,Antineoplastic Agents,DrugBank
DB00351,"Antineoplastic Agents, Hormonal",DrugBank
DB00351,Antineoplastic and Immunomodulating Agents,DrugBank
DB00351,Appetite Stimulants,DrugBank
DB00351,Central Nervous System Agents,DrugBank
DB00351,Central Nervous System Stimulants,DrugBank
DB00351,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00351,"Contraceptive Agents, Female",DrugBank
DB00351,"Contraceptive Agents, Hormonal",DrugBank
DB00351,"Contraceptives, Oral",DrugBank
DB00351,"Contraceptives, Oral, Hormonal",DrugBank
DB00351,"Contraceptives, Oral, Synthetic",DrugBank
DB00351,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00351,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00351,Cytochrome P-450 Substrates,DrugBank
DB00351,Drugs that are Mainly Renally Excreted,DrugBank
DB00351,Endocrine Therapy,DrugBank
DB00351,Fused-Ring Compounds,DrugBank
DB00351,Genito Urinary System and Sex Hormones,DrugBank
DB00351,Hormonal Contraceptives for Systemic Use,DrugBank
DB00351,Hormones and Related Agents,DrugBank
DB00351,Hyperglycemia-Associated Agents,DrugBank
DB00351,Megestrol,DrugBank
DB00351,P-glycoprotein inhibitors,DrugBank
DB00351,Pregnadien Derivatives,DrugBank
DB00351,Pregnadienes,DrugBank
DB00351,Pregnanes,DrugBank
DB00351,Progestin Contraceptives,DrugBank
DB00351,Progestins,DrugBank
DB00351,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00351,Reproductive Control Agents,DrugBank
DB00351,Sex Hormones and Modulators of the Genital System,DrugBank
DB00351,Steroids,DrugBank
DB00352,Antimetabolites,DrugBank
DB00352,Antineoplastic Agents,DrugBank
DB00352,Antineoplastic and Immunomodulating Agents,DrugBank
DB00352,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00352,Immunosuppressive Agents,DrugBank
DB00352,Myelosuppressive Agents,DrugBank
DB00352,Narrow Therapeutic Index Drugs,DrugBank
DB00352,Noxae,DrugBank
DB00352,Purine Analogues,DrugBank
DB00352,Purines,DrugBank
DB00352,Thiopurine Analogs,DrugBank
DB00352,Toxic Actions,DrugBank
DB00353,Agents that produce hypertension,DrugBank
DB00353,Alkaloids,DrugBank
DB00353,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00353,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00353,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00353,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00353,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00353,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00353,Cytochrome P-450 Substrates,DrugBank
DB00353,Dopamine Antagonists,DrugBank
DB00353,Ergolines,DrugBank
DB00353,Ergonovine,DrugBank
DB00353,Ergot Alkaloids and Derivatives,DrugBank
DB00353,Genito Urinary System and Sex Hormones,DrugBank
DB00353,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00353,Reproductive Control Agents,DrugBank
DB00353,Uterotonic agents,DrugBank
DB00354,Agents producing tachycardia,DrugBank
DB00354,Anticholinergic Agents,DrugBank
DB00354,Antihistamines for Systemic Use,DrugBank
DB00354,Histamine Agents,DrugBank
DB00354,Histamine Antagonists,DrugBank
DB00354,Histamine H1 Antagonists,DrugBank
DB00354,Muscarinic Antagonists,DrugBank
DB00354,Neurotransmitter Agents,DrugBank
DB00354,Piperazine Derivatives,DrugBank
DB00354,Potential QTc-Prolonging Agents,DrugBank
DB00354,QTc Prolonging Agents,DrugBank
DB00355,Amides,DrugBank
DB00355,Anti-Bacterial Agents,DrugBank
DB00355,Anti-Infective Agents,DrugBank
DB00355,Antibacterials for Systemic Use,DrugBank
DB00355,Antiinfectives for Systemic Use,DrugBank
DB00355,beta-Lactams,DrugBank
DB00355,Drugs that are Mainly Renally Excreted,DrugBank
DB00355,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00355,Lactams,DrugBank
DB00355,Monobactam Antibacterial,DrugBank
DB00355,Monobactams,DrugBank
DB00355,Sulfur Compounds,DrugBank
DB00356,Benzoxazoles and derivatives,DrugBank
DB00356,Central Nervous System Agents,DrugBank
DB00356,Central Nervous System Depressants,DrugBank
DB00356,Centrally-mediated Muscle Relaxation,DrugBank
DB00356,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00356,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00356,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00356,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00356,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00356,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00356,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00356,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00356,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00356,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00356,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00356,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00356,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00356,Cytochrome P-450 Substrates,DrugBank
DB00356,Drugs that are Mainly Renally Excreted,DrugBank
DB00356,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00356,Muscle Relaxants,DrugBank
DB00356,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00356,Musculo-Skeletal System,DrugBank
DB00356,"Oxazol, Thiazine, and Triazine Derivatives",DrugBank
DB00356,Peripheral Nervous System Agents,DrugBank
DB00357,Antineoplastic Agents,DrugBank
DB00357,"Antineoplastic Agents, Hormonal",DrugBank
DB00357,Antineoplastic and Immunomodulating Agents,DrugBank
DB00357,Aromatase Inhibitors,DrugBank
DB00357,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00357,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00357,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00357,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00357,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00357,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00357,Endocrine Therapy,DrugBank
DB00357,Enzyme Inhibitors,DrugBank
DB00357,Estrogen Antagonists,DrugBank
DB00357,Hormone Antagonists,DrugBank
DB00357,Hormone Antagonists and Related Agents,DrugBank
DB00357,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00357,Narrow Therapeutic Index Drugs,DrugBank
DB00357,Piperidines,DrugBank
DB00357,Piperidones,DrugBank
DB00357,Steroid Synthesis Inhibitors,DrugBank
DB00358,Agents Causing Muscle Toxicity,DrugBank
DB00358,Agents that reduce seizure threshold,DrugBank
DB00358,Aminoquinolines,DrugBank
DB00358,Anti-Infective Agents,DrugBank
DB00358,Antimalarial methanolquinolines,DrugBank
DB00358,Antimalarials,DrugBank
DB00358,Antiparasitic Agents,DrugBank
DB00358,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00358,Antiprotozoals,DrugBank
DB00358,Cholinesterase Inhibitors,DrugBank
DB00358,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00358,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00358,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00358,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00358,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00358,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00358,Cytochrome P-450 Substrates,DrugBank
DB00358,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00358,P-glycoprotein inhibitors,DrugBank
DB00358,P-glycoprotein substrates,DrugBank
DB00358,Potential QTc-Prolonging Agents,DrugBank
DB00358,QTc Prolonging Agents,DrugBank
DB00358,Quinolines,DrugBank
DB00359,Amides,DrugBank
DB00359,Amines,DrugBank
DB00359,Aniline Compounds,DrugBank
DB00359,Anti-Bacterial Agents,DrugBank
DB00359,Anti-Infective Agents,DrugBank
DB00359,Antibacterials for Systemic Use,DrugBank
DB00359,Antiinfectives for Systemic Use,DrugBank
DB00359,Antiparasitic Agents,DrugBank
DB00359,Antiprotozoals,DrugBank
DB00359,Benzene Derivatives,DrugBank
DB00359,Benzenesulfonamides,DrugBank
DB00359,Blood Glucose Lowering Agents,DrugBank
DB00359,Coccidiostats,DrugBank
DB00359,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00359,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00359,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00359,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00359,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00359,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00359,Cytochrome P-450 Substrates,DrugBank
DB00359,Drugs that are Mainly Renally Excreted,DrugBank
DB00359,Genito Urinary System and Sex Hormones,DrugBank
DB00359,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00359,Hypoglycemia-Associated Agents,DrugBank
DB00359,Intermediate-Acting Antibacterial Sulfonamides,DrugBank
DB00359,Methemoglobinemia Associated Agents,DrugBank
DB00359,Sulfanilamides,DrugBank
DB00359,Sulfonamide Antibacterial,DrugBank
DB00359,Sulfonamides,DrugBank
DB00359,Sulfonamides and trimethoprim,DrugBank
DB00359,Sulfones,DrugBank
DB00359,Sulfur Compounds,DrugBank
DB00360,Alimentary Tract and Metabolism,DrugBank
DB00360,Amines,DrugBank
DB00360,BCRP/ABCG2 Inhibitors,DrugBank
DB00360,Coenzymes,DrugBank
DB00360,Dietary Supplements,DrugBank
DB00360,Enzymes and Coenzymes,DrugBank
DB00360,Ethylamines,DrugBank
DB00360,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00360,Nitric Oxide Synthase,DrugBank
DB00360,Other Miscellaneous Therapeutic Agents,DrugBank
DB00360,P-glycoprotein inhibitors,DrugBank
DB00360,Phenethylamines,DrugBank
DB00360,Phenylalanine Hydroxylase Activator,DrugBank
DB00360,Phenylalanine Hydroxylase Activators,DrugBank
DB00360,Pteridines,DrugBank
DB00360,Pterins,DrugBank
DB00360,Supplements,DrugBank
DB00360,Various Alimentary Tract and Metabolism Products,DrugBank
DB00361,Alkaloids,DrugBank
DB00361,Antimitotic Agents,DrugBank
DB00361,Antineoplastic Agents,DrugBank
DB00361,"Antineoplastic Agents, Phytogenic",DrugBank
DB00361,Antineoplastic and Immunomodulating Agents,DrugBank
DB00361,Cardiotoxic antineoplastic agents,DrugBank
DB00361,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00361,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00361,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00361,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00361,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00361,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00361,Cytochrome P-450 Substrates,DrugBank
DB00361,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00361,Immunosuppressive Agents,DrugBank
DB00361,Indole Alkaloids,DrugBank
DB00361,Indoles,DrugBank
DB00361,Indolizidines,DrugBank
DB00361,Indolizines,DrugBank
DB00361,Mitosis Modulators,DrugBank
DB00361,Myelosuppressive Agents,DrugBank
DB00361,Narrow Therapeutic Index Drugs,DrugBank
DB00361,Neurotoxic agents,DrugBank
DB00361,Secologanin Tryptamine Alkaloids,DrugBank
DB00361,Tubulin Modulators,DrugBank
DB00361,Vinca Alkaloids,DrugBank
DB00362,"Amino Acids, Peptides, and Proteins",DrugBank
DB00362,Anti-Infective Agents,DrugBank
DB00362,Antifungal Agents,DrugBank
DB00362,Antiinfectives for Systemic Use,DrugBank
DB00362,Antimycotics for Systemic Use,DrugBank
DB00362,Echinocandin Antifungal,DrugBank
DB00362,Echinocandins,DrugBank
DB00362,Peptides,DrugBank
DB00362,"Peptides, Cyclic",DrugBank
DB00363,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00363,Adrenergic alpha-Antagonists,DrugBank
DB00363,Adrenergic Antagonists,DrugBank
DB00363,Agents producing tachycardia,DrugBank
DB00363,Agents that produce hypertension,DrugBank
DB00363,Agents that reduce seizure threshold,DrugBank
DB00363,Anticholinergic Agents,DrugBank
DB00363,Antidepressive Agents,DrugBank
DB00363,Antipsychotic Agents,DrugBank
DB00363,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB00363,Central Nervous System Agents,DrugBank
DB00363,Central Nervous System Depressants,DrugBank
DB00363,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00363,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00363,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00363,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00363,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00363,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00363,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00363,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00363,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00363,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00363,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00363,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00363,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00363,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00363,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00363,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00363,Cytochrome P-450 Substrates,DrugBank
DB00363,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB00363,Dibenzazepines,DrugBank
DB00363,Dopamine Antagonists,DrugBank
DB00363,Dopamine D2 Receptor Antagonists,DrugBank
DB00363,Drugs causing inadvertant photosensitivity,DrugBank
DB00363,Drugs that are Mainly Renally Excreted,DrugBank
DB00363,GABA Agents,DrugBank
DB00363,GABA Antagonists,DrugBank
DB00363,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00363,Histamine Antagonists,DrugBank
DB00363,Histamine H1 Antagonists,DrugBank
DB00363,Hyperglycemia-Associated Agents,DrugBank
DB00363,Hypotensive Agents,DrugBank
DB00363,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00363,Muscarinic Antagonists,DrugBank
DB00363,Nervous System,DrugBank
DB00363,Neurotoxic agents,DrugBank
DB00363,Neurotransmitter Agents,DrugBank
DB00363,OCT1 substrates,DrugBank
DB00363,P-glycoprotein substrates,DrugBank
DB00363,Photosensitizing Agents,DrugBank
DB00363,Psycholeptics,DrugBank
DB00363,Psychotropic Drugs,DrugBank
DB00363,QTc Prolonging Agents,DrugBank
DB00363,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00363,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00363,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB00363,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00363,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00363,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00363,Serotonin Agents,DrugBank
DB00363,Serotonin Receptor Antagonists,DrugBank
DB00363,Tranquilizing Agents,DrugBank
DB00363,UGT1A4 substrates,DrugBank
DB00364,Alimentary Tract and Metabolism,DrugBank
DB00364,Aluminium Compounds,DrugBank
DB00364,Aluminum Complex,DrugBank
DB00364,Anti-Ulcer Agents,DrugBank
DB00364,Carbohydrates,DrugBank
DB00364,Drugs for Acid Related Disorders,DrugBank
DB00364,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00364,Drugs that are Mainly Renally Excreted,DrugBank
DB00364,Gastric Cytoprotectants,DrugBank
DB00364,Gastrointestinal Agents,DrugBank
DB00364,Glycosides,DrugBank
DB00364,Metal cations,DrugBank
DB00364,Metal divalent cations,DrugBank
DB00364,Organometallic Compounds,DrugBank
DB00364,Protectants,DrugBank
DB00364,Sulfur Compounds,DrugBank
DB00364,Thioglycosides,DrugBank
DB00365,4-Quinolones,DrugBank
DB00365,Anti-Bacterial Agents,DrugBank
DB00365,Anti-Infective Agents,DrugBank
DB00365,Antibacterials for Systemic Use,DrugBank
DB00365,Antiinfectives for Systemic Use,DrugBank
DB00365,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00365,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00365,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00365,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00365,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00365,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00365,Cytochrome P-450 Substrates,DrugBank
DB00365,Enzyme Inhibitors,DrugBank
DB00365,Fluoroquinolones,DrugBank
DB00365,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00365,Highest Risk QTc-Prolonging Agents,DrugBank
DB00365,OAT1/SLC22A6 Substrates,DrugBank
DB00365,OCT2 Inhibitors,DrugBank
DB00365,P-glycoprotein inhibitors,DrugBank
DB00365,P-glycoprotein substrates,DrugBank
DB00365,QTc Prolonging Agents,DrugBank
DB00365,Quinolines,DrugBank
DB00365,Quinolones,DrugBank
DB00365,Topoisomerase II Inhibitors,DrugBank
DB00365,Topoisomerase Inhibitors,DrugBank
DB00366,Agents producing tachycardia,DrugBank
DB00366,Aminoalkyl Ethers,DrugBank
DB00366,Anticholinergic Agents,DrugBank
DB00366,Antiemetics,DrugBank
DB00366,Antihistamines for Systemic Use,DrugBank
DB00366,Autonomic Agents,DrugBank
DB00366,Central Nervous System Agents,DrugBank
DB00366,Central Nervous System Depressants,DrugBank
DB00366,Ethanolamine Derivatives,DrugBank
DB00366,Gastrointestinal Agents,DrugBank
DB00366,Histamine Agents,DrugBank
DB00366,Histamine Antagonists,DrugBank
DB00366,Histamine H1 Antagonists,DrugBank
DB00366,Histamine Receptor Antagonists,DrugBank
DB00366,Muscarinic Antagonists,DrugBank
DB00366,Neurotransmitter Agents,DrugBank
DB00366,Peripheral Nervous System Agents,DrugBank
DB00366,Potential QTc-Prolonging Agents,DrugBank
DB00366,Pyridines,DrugBank
DB00366,QTc Prolonging Agents,DrugBank
DB00367,Adrenal Cortex Hormones,DrugBank
DB00367,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00367,"Contraceptive Agents, Female",DrugBank
DB00367,"Contraceptive Agents, Hormonal",DrugBank
DB00367,"Contraceptives, Oral",DrugBank
DB00367,"Contraceptives, Oral, Synthetic",DrugBank
DB00367,"Contraceptives, Postcoital",DrugBank
DB00367,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00367,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00367,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00367,Cytochrome P-450 Substrates,DrugBank
DB00367,Fused-Ring Compounds,DrugBank
DB00367,Genito Urinary System and Sex Hormones,DrugBank
DB00367,Hormonal Contraceptives for Systemic Use,DrugBank
DB00367,Hyperglycemia-Associated Agents,DrugBank
DB00367,Inhibit Ovum Fertilization,DrugBank
DB00367,Norpregnanes,DrugBank
DB00367,Norpregnenes,DrugBank
DB00367,Norsteroids,DrugBank
DB00367,Progestin Contraceptives,DrugBank
DB00367,Progestin-containing Intrauterine Device,DrugBank
DB00367,Progestins,DrugBank
DB00367,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00367,Reproductive Control Agents,DrugBank
DB00367,Sex Hormones and Modulators of the Genital System,DrugBank
DB00367,Steroids,DrugBank
DB00368,Adrenergic Agents,DrugBank
DB00368,Adrenergic Agonists,DrugBank
DB00368,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00368,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00368,Adrenergic alpha-Agonists,DrugBank
DB00368,Adrenergic and Dopaminergic Agents,DrugBank
DB00368,Adrenergic beta-1 Receptor Agonists,DrugBank
DB00368,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00368,Adrenergic beta-3 Receptor Agonists,DrugBank
DB00368,Adrenergic beta-Agonists,DrugBank
DB00368,Agents producing tachycardia,DrugBank
DB00368,Agents that produce hypertension,DrugBank
DB00368,Alcohols,DrugBank
DB00368,Alpha-and Beta-adrenergic Agonists,DrugBank
DB00368,Amines,DrugBank
DB00368,Amino Alcohols,DrugBank
DB00368,Autonomic Agents,DrugBank
DB00368,Benzene Derivatives,DrugBank
DB00368,Biogenic Amines,DrugBank
DB00368,Biogenic Monoamines,DrugBank
DB00368,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00368,Cardiac Therapy,DrugBank
DB00368,Cardiovascular Agents,DrugBank
DB00368,Catecholamines,DrugBank
DB00368,Catechols,DrugBank
DB00368,COMT Substrates,DrugBank
DB00368,Epinephrine and similars,DrugBank
DB00368,Ethanolamines,DrugBank
DB00368,Neurotransmitter Agents,DrugBank
DB00368,"Norepinephrine, antagonists & inhibitors",DrugBank
DB00368,OCT1 substrates,DrugBank
DB00368,OCT2 Inhibitors,DrugBank
DB00368,OCT2 Substrates,DrugBank
DB00368,Peripheral Nervous System Agents,DrugBank
DB00368,Phenols,DrugBank
DB00368,Sympathomimetics,DrugBank
DB00368,Vasoconstrictor Agents,DrugBank
DB00369,Anti-Infective Agents,DrugBank
DB00369,Antiinfectives for Systemic Use,DrugBank
DB00369,Antiviral Agents,DrugBank
DB00369,Antivirals for Systemic Use,DrugBank
DB00369,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00369,Cytosine,DrugBank
DB00369,Direct Acting Antivirals,DrugBank
DB00369,Drugs that are Mainly Renally Excreted,DrugBank
DB00369,Enzyme Inhibitors,DrugBank
DB00369,Nephrotoxic agents,DrugBank
DB00369,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00369,Nucleosides and Nucleotides,DrugBank
DB00369,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB00369,OAT1/SLC22A6 inhibitors,DrugBank
DB00369,OAT1/SLC22A6 Substrates,DrugBank
DB00369,Organophosphonates,DrugBank
DB00369,Organophosphorus Compounds,DrugBank
DB00369,Pyrimidines,DrugBank
DB00369,Pyrimidinones,DrugBank
DB00370,Adrenergic Agents,DrugBank
DB00370,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB00370,Adrenergic alpha-Antagonists,DrugBank
DB00370,Adrenergic Antagonists,DrugBank
DB00370,Agents that produce hypertension,DrugBank
DB00370,Anti-Anxiety Agents,DrugBank
DB00370,Antidepressive Agents,DrugBank
DB00370,Antidepressive Agents Indicated for Depression,DrugBank
DB00370,"Antidepressive Agents, Second-Generation",DrugBank
DB00370,"Antidepressive Agents, Tetracyclic",DrugBank
DB00370,Central Nervous System Agents,DrugBank
DB00370,Central Nervous System Depressants,DrugBank
DB00370,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00370,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00370,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00370,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00370,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00370,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00370,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00370,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00370,Cytochrome P-450 Substrates,DrugBank
DB00370,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00370,Histamine Agents,DrugBank
DB00370,Histamine Antagonists,DrugBank
DB00370,Histamine H1 Antagonists,DrugBank
DB00370,Miscellaneous Antidepressants,DrugBank
DB00370,Nervous System,DrugBank
DB00370,Neurotransmitter Agents,DrugBank
DB00370,Potential QTc-Prolonging Agents,DrugBank
DB00370,Psychoanaleptics,DrugBank
DB00370,Psychotropic Drugs,DrugBank
DB00370,QTc Prolonging Agents,DrugBank
DB00370,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00370,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00370,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00370,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00370,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00370,Serotonin Agents,DrugBank
DB00370,Serotonin Modulators,DrugBank
DB00370,Serotonin Receptor Antagonists,DrugBank
DB00370,Tranquilizing Agents,DrugBank
DB00371,"Acids, Acyclic",DrugBank
DB00371,Anti-Anxiety Agents,DrugBank
DB00371,Carbamates,DrugBank
DB00371,Central Nervous System Agents,DrugBank
DB00371,Central Nervous System Depressants,DrugBank
DB00371,Hypnotics and Sedatives,DrugBank
DB00371,Muscle Relaxants,DrugBank
DB00371,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00371,Nervous System,DrugBank
DB00371,Peripheral Nervous System Agents,DrugBank
DB00371,Psycholeptics,DrugBank
DB00371,Psychotropic Drugs,DrugBank
DB00371,Tranquilizing Agents,DrugBank
DB00372,Antiemetics,DrugBank
DB00372,Antihistamines for Systemic Use,DrugBank
DB00372,Antipsychotic Agents,DrugBank
DB00372,Autonomic Agents,DrugBank
DB00372,Central Nervous System Agents,DrugBank
DB00372,Central Nervous System Depressants,DrugBank
DB00372,Dopamine Agents,DrugBank
DB00372,Dopamine Antagonists,DrugBank
DB00372,Dopamine D2 Receptor Antagonists,DrugBank
DB00372,Drugs that are Mainly Renally Excreted,DrugBank
DB00372,Gastrointestinal Agents,DrugBank
DB00372,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00372,Neurotoxic agents,DrugBank
DB00372,Neurotransmitter Agents,DrugBank
DB00372,Peripheral Nervous System Agents,DrugBank
DB00372,Phenothiazine Derivatives,DrugBank
DB00372,Phenothiazines,DrugBank
DB00372,Piperazines,DrugBank
DB00372,Sulfur Compounds,DrugBank
DB00373,Adrenergic Antagonists,DrugBank
DB00373,Adrenergic beta-Antagonists,DrugBank
DB00373,Agents causing hyperkalemia,DrugBank
DB00373,Alcohols,DrugBank
DB00373,Amines,DrugBank
DB00373,Amino Alcohols,DrugBank
DB00373,Antiarrhythmic agents,DrugBank
DB00373,Antiglaucoma Preparations and Miotics,DrugBank
DB00373,Antihypertensive Agents,DrugBank
DB00373,Beta Blocking Agents and Thiazides,DrugBank
DB00373,"Beta Blocking Agents, Non-Selective",DrugBank
DB00373,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB00373,Bradycardia-Causing Agents,DrugBank
DB00373,Cardiovascular Agents,DrugBank
DB00373,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00373,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00373,Cytochrome P-450 Substrates,DrugBank
DB00373,Drugs that are Mainly Renally Excreted,DrugBank
DB00373,"EENT Drugs, Miscellaneous",DrugBank
DB00373,Hypotensive Agents,DrugBank
DB00373,Morpholines,DrugBank
DB00373,Ophthalmologicals,DrugBank
DB00373,Oxazines,DrugBank
DB00373,P-glycoprotein substrates,DrugBank
DB00373,Potential QTc-Prolonging Agents,DrugBank
DB00373,Propanolamines,DrugBank
DB00373,Propanols,DrugBank
DB00373,QTc Prolonging Agents,DrugBank
DB00373,Sulfur Compounds,DrugBank
DB00373,Thiadiazoles,DrugBank
DB00373,Thiazoles,DrugBank
DB00374,Antihypertensive Agents,DrugBank
DB00374,Autacoids,DrugBank
DB00374,Biological Factors,DrugBank
DB00374,Blood and Blood Forming Organs,DrugBank
DB00374,Cardiovascular Agents,DrugBank
DB00374,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00374,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00374,Cytochrome P-450 Substrates,DrugBank
DB00374,Eicosanoids,DrugBank
DB00374,Fatty Acids,DrugBank
DB00374,"Fatty Acids, Unsaturated",DrugBank
DB00374,Inflammation Mediators,DrugBank
DB00374,Lipids,DrugBank
DB00374,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00374,Potential QTc-Prolonging Agents,DrugBank
DB00374,Prostacyclin Analogues,DrugBank
DB00374,Prostacycline Vasodilator,DrugBank
DB00374,Prostaglandins,DrugBank
DB00374,Prostaglandins I,DrugBank
DB00374,QTc Prolonging Agents,DrugBank
DB00374,Vasodilating Agents,DrugBank
DB00374,Vasodilation,DrugBank
DB00375,Amines,DrugBank
DB00375,Anion Exchange Resins,DrugBank
DB00375,Bile Acid Sequestrants,DrugBank
DB00375,Bile-acid Binding Activity,DrugBank
DB00375,"Compounds used in a research, industrial, or household setting",DrugBank
DB00375,Hypolipidemic Agents,DrugBank
DB00375,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00375,Lipid Modifying Agents,DrugBank
DB00375,"Lipid Modifying Agents, Plain",DrugBank
DB00375,Lipid Regulating Agents,DrugBank
DB00375,Macromolecular Substances,DrugBank
DB00375,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00375,Polyamines,DrugBank
DB00375,Polymers,DrugBank
DB00375,Sequestering Agents,DrugBank
DB00376,Agents producing tachycardia,DrugBank
DB00376,Anti-Dyskinesia Agents,DrugBank
DB00376,Anti-Parkinson Drugs,DrugBank
DB00376,Anticholinergic Agents,DrugBank
DB00376,Central Nervous System Agents,DrugBank
DB00376,Cholinergic Agents,DrugBank
DB00376,Muscarinic Antagonists,DrugBank
DB00376,Nervous System,DrugBank
DB00376,Neurotransmitter Agents,DrugBank
DB00376,Piperidines,DrugBank
DB00376,Tertiary Amines,DrugBank
DB00377,Alimentary Tract and Metabolism,DrugBank
DB00377,Antidepressive Agents,DrugBank
DB00377,Antiemetic Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00377,Antiemetics,DrugBank
DB00377,Antiemetics and Antinauseants,DrugBank
DB00377,Autonomic Agents,DrugBank
DB00377,Central Nervous System Agents,DrugBank
DB00377,Central Nervous System Depressants,DrugBank
DB00377,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00377,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00377,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00377,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00377,Cytochrome P-450 Substrates,DrugBank
DB00377,Drugs that are Mainly Renally Excreted,DrugBank
DB00377,Gastrointestinal Agents,DrugBank
DB00377,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00377,Isoquinolines,DrugBank
DB00377,Neurotransmitter Agents,DrugBank
DB00377,Peripheral Nervous System Agents,DrugBank
DB00377,Quinuclidines,DrugBank
DB00377,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00377,Serotonin 3 Receptor Antagonists,DrugBank
DB00377,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00377,Serotonin Agents,DrugBank
DB00377,Serotonin Receptor Antagonists,DrugBank
DB00378,Adrenal Cortex Hormones,DrugBank
DB00378,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00378,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00378,Cytochrome P-450 Substrates,DrugBank
DB00378,Fused-Ring Compounds,DrugBank
DB00378,Genito Urinary System and Sex Hormones,DrugBank
DB00378,Hormones,DrugBank
DB00378,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00378,Pregnadien Derivatives,DrugBank
DB00378,Pregnadienes,DrugBank
DB00378,Pregnanes,DrugBank
DB00378,Progestins,DrugBank
DB00378,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00378,Sex Hormones and Modulators of the Genital System,DrugBank
DB00378,Steroids,DrugBank
DB00379,Amines,DrugBank
DB00379,Antiarrhythmic agents,DrugBank
DB00379,"Antiarrhythmics, Class I",DrugBank
DB00379,"Antiarrhythmics, Class Ib",DrugBank
DB00379,Benzene Derivatives,DrugBank
DB00379,Cardiac Therapy,DrugBank
DB00379,Cardiovascular Agents,DrugBank
DB00379,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00379,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00379,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00379,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00379,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00379,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00379,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00379,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00379,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00379,Cytochrome P-450 Substrates,DrugBank
DB00379,Membrane Transport Modulators,DrugBank
DB00379,Phenols,DrugBank
DB00379,Phenyl Ethers,DrugBank
DB00379,Propylamines,DrugBank
DB00379,Sodium Channel Blockers,DrugBank
DB00379,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00380,Cardiotonic Agents,DrugBank
DB00380,Cardiovascular Agents,DrugBank
DB00380,"Compounds used in a research, industrial, or household setting",DrugBank
DB00380,Cytoprotective Agent,DrugBank
DB00380,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB00380,Diketopiperazines,DrugBank
DB00380,Drugs that are Mainly Renally Excreted,DrugBank
DB00380,Enzyme Inhibitors,DrugBank
DB00380,Immunosuppressive Agents,DrugBank
DB00380,Miscellaneous Therapeutic Agents,DrugBank
DB00380,Myelosuppressive Agents,DrugBank
DB00380,Piperazines,DrugBank
DB00380,Protective Agents,DrugBank
DB00380,Topoisomerase II Inhibitors,DrugBank
DB00380,Topoisomerase Inhibitors,DrugBank
DB00381,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00381,Agents causing hyperkalemia,DrugBank
DB00381,Angiotensin II Antagonists and Calcium Channel Blockers,DrugBank
DB00381,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00381,Antianginal Agents,DrugBank
DB00381,Antiarrhythmic agents,DrugBank
DB00381,Antihypertensive Agents,DrugBank
DB00381,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00381,Bradycardia-Causing Agents,DrugBank
DB00381,Calcium Channel Blockers,DrugBank
DB00381,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB00381,Calcium Channel Blockers and Diuretics,DrugBank
DB00381,Calcium-Regulating Hormones and Agents,DrugBank
DB00381,Cardiovascular Agents,DrugBank
DB00381,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00381,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00381,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00381,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00381,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00381,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00381,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00381,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00381,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00381,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00381,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00381,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00381,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB00381,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00381,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00381,Cytochrome P-450 Substrates,DrugBank
DB00381,Dihydropyridine Derivatives,DrugBank
DB00381,Dihydropyridines,DrugBank
DB00381,Hypotensive Agents,DrugBank
DB00381,Membrane Transport Modulators,DrugBank
DB00381,P-glycoprotein inhibitors,DrugBank
DB00381,P-glycoprotein substrates,DrugBank
DB00381,Pyridines,DrugBank
DB00381,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00381,Vasodilating Agents,DrugBank
DB00382,Acridines,DrugBank
DB00382,Agents Causing Muscle Toxicity,DrugBank
DB00382,Aminoacridines,DrugBank
DB00382,Anti-Dementia Drugs,DrugBank
DB00382,Autonomic Agents,DrugBank
DB00382,Central Nervous System Agents,DrugBank
DB00382,Cholinergic Agents,DrugBank
DB00382,Cholinesterase Inhibitors,DrugBank
DB00382,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00382,Cytochrome P-450 Substrates,DrugBank
DB00382,Enzyme Inhibitors,DrugBank
DB00382,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00382,Nervous System,DrugBank
DB00382,Neurotransmitter Agents,DrugBank
DB00382,Nootropic Agents,DrugBank
DB00382,P-glycoprotein substrates,DrugBank
DB00382,Parasympathomimetics,DrugBank
DB00382,Peripheral Nervous System Agents,DrugBank
DB00382,Psychoanaleptics,DrugBank
DB00383,Agents producing tachycardia,DrugBank
DB00383,Alimentary Tract and Metabolism,DrugBank
DB00383,Anticholinergic Agents,DrugBank
DB00383,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00383,Muscarinic Antagonists,DrugBank
DB00383,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB00384,Agents causing hyperkalemia,DrugBank
DB00384,Cardiovascular Agents,DrugBank
DB00384,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00384,Cytochrome P-450 Substrates,DrugBank
DB00384,Decreased Renal K+ Excretion,DrugBank
DB00384,Diuretics,DrugBank
DB00384,Drugs causing inadvertant photosensitivity,DrugBank
DB00384,Epithelial Sodium Channel Blockers,DrugBank
DB00384,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00384,Hypotensive Agents,DrugBank
DB00384,Increased Diuresis,DrugBank
DB00384,Membrane Transport Modulators,DrugBank
DB00384,Natriuretic Agents,DrugBank
DB00384,Nephrotoxic agents,DrugBank
DB00384,Photosensitizing Agents,DrugBank
DB00384,Potassium-Sparing Diuretics,DrugBank
DB00384,Pteridines,DrugBank
DB00384,Sodium Channel Blockers,DrugBank
DB00385,Anthracycline Topoisomerase Inhibitor,DrugBank
DB00385,Anthracyclines,DrugBank
DB00385,Anthracyclines and Related Substances,DrugBank
DB00385,Antineoplastic Agents,DrugBank
DB00385,Antineoplastic and Immunomodulating Agents,DrugBank
DB00385,Carbohydrates,DrugBank
DB00385,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00385,Cytotoxins,DrugBank
DB00385,Enzyme Inhibitors,DrugBank
DB00385,Glycosides,DrugBank
DB00385,Naphthacenes,DrugBank
DB00385,Topoisomerase II Inhibitors,DrugBank
DB00385,Topoisomerase Inhibitors,DrugBank
DB00387,Agents producing tachycardia,DrugBank
DB00387,Anti-Dyskinesia Agents,DrugBank
DB00387,Anti-Parkinson Drugs,DrugBank
DB00387,Anticholinergic Agents,DrugBank
DB00387,Central Nervous System Agents,DrugBank
DB00387,Cholinergic Agents,DrugBank
DB00387,Muscarinic Antagonists,DrugBank
DB00387,Nervous System,DrugBank
DB00387,Neurotransmitter Agents,DrugBank
DB00387,Pyrrolidines,DrugBank
DB00387,Tertiary Amines,DrugBank
DB00388,Adrenergic Agents,DrugBank
DB00388,Adrenergic Agonists,DrugBank
DB00388,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00388,Adrenergic alpha-Agonists,DrugBank
DB00388,Adrenergic and Dopaminergic Agents,DrugBank
DB00388,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00388,Agents producing tachycardia,DrugBank
DB00388,Agents that produce hypertension,DrugBank
DB00388,Alcohols,DrugBank
DB00388,Amines,DrugBank
DB00388,Amino Alcohols,DrugBank
DB00388,Autonomic Agents,DrugBank
DB00388,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00388,Cardiac Therapy,DrugBank
DB00388,Cardiotonic Agents,DrugBank
DB00388,Cardiovascular Agents,DrugBank
DB00388,"Compounds used in a research, industrial, or household setting",DrugBank
DB00388,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00388,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00388,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00388,Decongestants and Antiallergics,DrugBank
DB00388,Ethanolamines,DrugBank
DB00388,Monoamine Oxidase A Substrates,DrugBank
DB00388,Mydriatics,DrugBank
DB00388,Mydriatics and Cycloplegics,DrugBank
DB00388,Nasal Decongestants,DrugBank
DB00388,Nasal Decongestants for Systemic Use,DrugBank
DB00388,Nasal Preparations,DrugBank
DB00388,Neurotransmitter Agents,DrugBank
DB00388,Ophthalmologicals,DrugBank
DB00388,Peripheral Nervous System Agents,DrugBank
DB00388,Protective Agents,DrugBank
DB00388,Respiratory System Agents,DrugBank
DB00388,Sensory Organs,DrugBank
DB00388,Sympathomimetic (Adrenergic) Agents,DrugBank
DB00388,Sympathomimetics,DrugBank
DB00388,Sympathomimetics Excl. Antiglaucoma Preparations,DrugBank
DB00388,Sympathomimetics Used as Decongestants,DrugBank
DB00388,"Sympathomimetics, Plain",DrugBank
DB00388,Vasoconstrictor Agents,DrugBank
DB00388,Vasoprotectives,DrugBank
DB00389,Agents Causing Muscle Toxicity,DrugBank
DB00389,Antithyroid agents,DrugBank
DB00389,Hormone Antagonists,DrugBank
DB00389,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00389,Imidazoles,DrugBank
DB00389,Sulfur-Containing Imidazole Derivatives,DrugBank
DB00389,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00389,Thyroid Products,DrugBank
DB00390,Agents causing hyperkalemia,DrugBank
DB00390,Antiarrhythmic agents,DrugBank
DB00390,Bradycardia-Causing Agents,DrugBank
DB00390,BSEP/ABCB11 Substrates,DrugBank
DB00390,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00390,Carbohydrates,DrugBank
DB00390,Cardanolides,DrugBank
DB00390,Cardenolides,DrugBank
DB00390,Cardiac Glycosides,DrugBank
DB00390,Cardiac Therapy,DrugBank
DB00390,Cardiotonic Agents,DrugBank
DB00390,Cardiovascular Agents,DrugBank
DB00390,"Compounds used in a research, industrial, or household setting",DrugBank
DB00390,Digitalis Glycosides,DrugBank
DB00390,Digoxin and derivatives,DrugBank
DB00390,"Digoxin, antagonists & inhibitors",DrugBank
DB00390,"Digoxin, immunology",DrugBank
DB00390,Drugs that are Mainly Renally Excreted,DrugBank
DB00390,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00390,Fused-Ring Compounds,DrugBank
DB00390,Glycosides,DrugBank
DB00390,Narrow Therapeutic Index Drugs,DrugBank
DB00390,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00390,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00390,P-glycoprotein inducers,DrugBank
DB00390,P-glycoprotein inhibitors,DrugBank
DB00390,P-glycoprotein substrates,DrugBank
DB00390,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00390,Potential QTc-Prolonging Agents,DrugBank
DB00390,Protective Agents,DrugBank
DB00390,QTc Prolonging Agents,DrugBank
DB00391,"Acids, Carbocyclic",DrugBank
DB00391,Amides,DrugBank
DB00391,Antidepressive Agents,DrugBank
DB00391,"Antidepressive Agents, Second-Generation",DrugBank
DB00391,Antipsychotic Agents,DrugBank
DB00391,BCRP/ABCG2 Substrates,DrugBank
DB00391,Benzamides and benzamide derivatives,DrugBank
DB00391,Benzene Derivatives,DrugBank
DB00391,Benzoates,DrugBank
DB00391,Central Nervous System Agents,DrugBank
DB00391,Central Nervous System Depressants,DrugBank
DB00391,Cholinesterase Inhibitors,DrugBank
DB00391,Dopamine Agents,DrugBank
DB00391,Dopamine Antagonists,DrugBank
DB00391,Dopamine D2 Receptor Antagonists,DrugBank
DB00391,MATE 1 Substrates,DrugBank
DB00391,MATE 2 Substrates,DrugBank
DB00391,MATE substrates,DrugBank
DB00391,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00391,Nervous System,DrugBank
DB00391,Neurotoxic agents,DrugBank
DB00391,Neurotransmitter Agents,DrugBank
DB00391,OCT1 substrates,DrugBank
DB00391,OCT2 Substrates,DrugBank
DB00391,P-glycoprotein substrates,DrugBank
DB00391,Psycholeptics,DrugBank
DB00391,Psychotropic Drugs,DrugBank
DB00391,QTc Prolonging Agents,DrugBank
DB00391,Tranquilizing Agents,DrugBank
DB00392,Adrenergic Agents,DrugBank
DB00392,Adrenergic Antagonists,DrugBank
DB00392,Agents producing tachycardia,DrugBank
DB00392,Anti-Parkinson Drugs,DrugBank
DB00392,Anticholinergic Agents,DrugBank
DB00392,Cholinergic Agents,DrugBank
DB00392,Cholinesterase Inhibitors,DrugBank
DB00392,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00392,Histamine Agents,DrugBank
DB00392,Muscarinic Antagonists,DrugBank
DB00392,Nervous System,DrugBank
DB00392,Neurotransmitter Agents,DrugBank
DB00392,NMDA Receptor Antagonists,DrugBank
DB00392,Sulfur Compounds,DrugBank
DB00392,Tertiary Amines,DrugBank
DB00393,Agents causing hyperkalemia,DrugBank
DB00393,Antiarrhythmic agents,DrugBank
DB00393,Antihypertensive Agents,DrugBank
DB00393,Bradycardia-Causing Agents,DrugBank
DB00393,Calcium Channel Blockers,DrugBank
DB00393,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB00393,Calcium-Regulating Hormones and Agents,DrugBank
DB00393,Cardiovascular Agents,DrugBank
DB00393,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00393,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00393,Cytochrome P-450 Substrates,DrugBank
DB00393,Dihydropyridine Derivatives,DrugBank
DB00393,Dihydropyridines,DrugBank
DB00393,Hypotensive Agents,DrugBank
DB00393,Membrane Transport Modulators,DrugBank
DB00393,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00393,Nicotinic Acids,DrugBank
DB00393,P-glycoprotein inhibitors,DrugBank
DB00393,Pyridines,DrugBank
DB00393,QTc Prolonging Agents,DrugBank
DB00393,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00393,Vasodilating Agents,DrugBank
DB00394,Adrenal Cortex Hormones,DrugBank
DB00394,Adrenals,DrugBank
DB00394,Agents to Treat Airway Disease,DrugBank
DB00394,Alimentary Tract and Metabolism,DrugBank
DB00394,Anti-Asthmatic Agents,DrugBank
DB00394,Anti-Inflammatory Agents,DrugBank
DB00394,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00394,BCRP/ABCG2 Inhibitors,DrugBank
DB00394,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00394,Corticosteroids,DrugBank
DB00394,Corticosteroids Acting Locally,DrugBank
DB00394,"Corticosteroids, Dermatological Preparations",DrugBank
DB00394,"Corticosteroids, Potent (Group III)",DrugBank
DB00394,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00394,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00394,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00394,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00394,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00394,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00394,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00394,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00394,Cytochrome P-450 Substrates,DrugBank
DB00394,Dermatologicals,DrugBank
DB00394,Drugs for Obstructive Airway Diseases,DrugBank
DB00394,Fused-Ring Compounds,DrugBank
DB00394,Glucocorticoids,DrugBank
DB00394,Hormones,DrugBank
DB00394,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00394,Hyperglycemia-Associated Agents,DrugBank
DB00394,Immunosuppressive Agents,DrugBank
DB00394,Intestinal Antiinflammatory Agents,DrugBank
DB00394,Nasal Preparations,DrugBank
DB00394,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00394,OATP1B3 inhibitors,DrugBank
DB00394,P-glycoprotein inducers,DrugBank
DB00394,P-glycoprotein substrates,DrugBank
DB00394,Pregnadienes,DrugBank
DB00394,Pregnadienetriols,DrugBank
DB00394,Pregnanes,DrugBank
DB00394,Respiratory System Agents,DrugBank
DB00394,Steroids,DrugBank
DB00394,"Steroids, Chlorinated",DrugBank
DB00394,Thyroxine-binding globulin inhibitors,DrugBank
DB00395,Carbamates,DrugBank
DB00395,Carbamic Acid Esters,DrugBank
DB00395,Central Nervous System Agents,DrugBank
DB00395,Central Nervous System Depressants,DrugBank
DB00395,Centrally-mediated Muscle Relaxation,DrugBank
DB00395,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00395,Cytochrome P-450 Substrates,DrugBank
DB00395,Muscle Relaxants,DrugBank
DB00395,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00395,Musculo-Skeletal System,DrugBank
DB00396,Adrenal Cortex Hormones,DrugBank
DB00396,BCRP/ABCG2 Inducers,DrugBank
DB00396,BCRP/ABCG2 Inhibitors,DrugBank
DB00396,BSEP/ABCB11 Inhibitors,DrugBank
DB00396,Corpus Luteum Hormones,DrugBank
DB00396,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00396,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00396,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00396,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00396,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00396,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00396,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00396,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00396,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00396,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00396,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00396,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00396,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00396,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00396,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00396,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00396,Cytochrome P-450 Substrates,DrugBank
DB00396,Fused-Ring Compounds,DrugBank
DB00396,Genito Urinary System and Sex Hormones,DrugBank
DB00396,Gonadal Hormones,DrugBank
DB00396,Gonadal Steroid Hormones,DrugBank
DB00396,Hormonal Contraceptives for Systemic Use,DrugBank
DB00396,Hormones,DrugBank
DB00396,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00396,Hyperglycemia-Associated Agents,DrugBank
DB00396,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00396,OATP1B3 inducers,DrugBank
DB00396,OCT1 inhibitors,DrugBank
DB00396,OCT2 Inhibitors,DrugBank
DB00396,P-glycoprotein inducers,DrugBank
DB00396,P-glycoprotein inhibitors,DrugBank
DB00396,P-glycoprotein substrates,DrugBank
DB00396,Pregnanes,DrugBank
DB00396,Pregnenediones,DrugBank
DB00396,Pregnenes,DrugBank
DB00396,Progesterone and Derivatives,DrugBank
DB00396,"Progesterone, antagonists & inhibitors",DrugBank
DB00396,Progestin-containing Intrauterine Device,DrugBank
DB00396,Progestins,DrugBank
DB00396,Sex Hormones and Modulators of the Genital System,DrugBank
DB00396,Steroids,DrugBank
DB00397,Adrenergic Agents,DrugBank
DB00397,Adrenergic Agonists,DrugBank
DB00397,Adrenergic alpha-Agonists,DrugBank
DB00397,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00397,Adrenergic beta-Agonists,DrugBank
DB00397,Agents producing tachycardia,DrugBank
DB00397,Agents that produce hypertension,DrugBank
DB00397,Agents that reduce seizure threshold,DrugBank
DB00397,Alcohols,DrugBank
DB00397,Amines,DrugBank
DB00397,Amino Alcohols,DrugBank
DB00397,Anti-Obesity Agents,DrugBank
DB00397,Appetite Depressants,DrugBank
DB00397,Autonomic Agents,DrugBank
DB00397,Cardiovascular Agents,DrugBank
DB00397,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00397,Nasal Decongestants,DrugBank
DB00397,Nasal Decongestants for Systemic Use,DrugBank
DB00397,Nasal Preparations,DrugBank
DB00397,Neurotransmitter Agents,DrugBank
DB00397,Peripheral Nervous System Agents,DrugBank
DB00397,Propanolamines,DrugBank
DB00397,Propanols,DrugBank
DB00397,Respiratory System Agents,DrugBank
DB00397,Sympathomimetics,DrugBank
DB00397,Vasoconstrictor Agents,DrugBank
DB00398,Amides,DrugBank
DB00398,Antineoplastic Agents,DrugBank
DB00398,Antineoplastic and Immunomodulating Agents,DrugBank
DB00398,BCRP/ABCG2 Inhibitors,DrugBank
DB00398,BCRP/ABCG2 Substrates,DrugBank
DB00398,Benzene Derivatives,DrugBank
DB00398,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00398,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB00398,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00398,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00398,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00398,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00398,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00398,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00398,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00398,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00398,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00398,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00398,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00398,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00398,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00398,Cytochrome P-450 Substrates,DrugBank
DB00398,Drugs that are Mainly Renally Excreted,DrugBank
DB00398,Enzyme Inhibitors,DrugBank
DB00398,Immunosuppressive Agents,DrugBank
DB00398,Kinase Inhibitor,DrugBank
DB00398,Myelosuppressive Agents,DrugBank
DB00398,Narrow Therapeutic Index Drugs,DrugBank
DB00398,Nicotinic Acids,DrugBank
DB00398,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00398,P-glycoprotein inhibitors,DrugBank
DB00398,P-glycoprotein substrates,DrugBank
DB00398,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00398,Phenylurea Compounds,DrugBank
DB00398,Potential QTc-Prolonging Agents,DrugBank
DB00398,Protein Kinase Inhibitors,DrugBank
DB00398,Pyridines,DrugBank
DB00398,QTc Prolonging Agents,DrugBank
DB00398,Tyrosine Kinase Inhibitors,DrugBank
DB00398,UGT1A1 Inhibitors,DrugBank
DB00398,UGT1A9 Inhibitors,DrugBank
DB00398,UGT1A9 Substrates,DrugBank
DB00398,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00399,Bisphosphonates,DrugBank
DB00399,Bone Density Conservation Agents,DrugBank
DB00399,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00399,Drugs for Treatment of Bone Diseases,DrugBank
DB00399,Imidazoles,DrugBank
DB00399,Musculo-Skeletal System,DrugBank
DB00399,Organophosphonates,DrugBank
DB00399,Organophosphorus Compounds,DrugBank
DB00400,Anti-Infective Agents,DrugBank
DB00400,Antifungal Agents,DrugBank
DB00400,Antifungals for Dermatological Use,DrugBank
DB00400,Antifungals for Systemic Use,DrugBank
DB00400,Antifungals for Topical Use,DrugBank
DB00400,Benzofurans,DrugBank
DB00400,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00400,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00400,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00400,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00400,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00400,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00400,Decreased Mitosis,DrugBank
DB00400,Dermatologicals,DrugBank
DB00400,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00400,Microtubule Inhibition,DrugBank
DB00400,Tubulin Inhibiting Agent,DrugBank
DB00401,Agents causing hyperkalemia,DrugBank
DB00401,Antiarrhythmic agents,DrugBank
DB00401,Antihypertensive Agents,DrugBank
DB00401,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00401,Bradycardia-Causing Agents,DrugBank
DB00401,Calcium Channel Blockers,DrugBank
DB00401,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB00401,Calcium-Regulating Hormones and Agents,DrugBank
DB00401,Cardiovascular Agents,DrugBank
DB00401,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00401,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00401,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00401,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00401,Cytochrome P-450 Substrates,DrugBank
DB00401,Decreased Blood Pressure,DrugBank
DB00401,Dihydropyridine Derivatives,DrugBank
DB00401,Dihydropyridines,DrugBank
DB00401,Drugs causing inadvertant photosensitivity,DrugBank
DB00401,Drugs that are Mainly Renally Excreted,DrugBank
DB00401,Hypotensive Agents,DrugBank
DB00401,Membrane Transport Modulators,DrugBank
DB00401,P-glycoprotein inhibitors,DrugBank
DB00401,Photosensitizing Agents,DrugBank
DB00401,Pyridines,DrugBank
DB00401,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00401,Vasodilating Agents,DrugBank
DB00402,Benzodiazepine hypnotics and sedatives,DrugBank
DB00402,Central Nervous System Agents,DrugBank
DB00402,Central Nervous System Depressants,DrugBank
DB00402,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00402,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00402,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00402,Cytochrome P-450 Substrates,DrugBank
DB00402,Drugs causing inadvertant photosensitivity,DrugBank
DB00402,Drugs that are Mainly Renally Excreted,DrugBank
DB00402,Hypnotics (Nonbenzodiazepine),DrugBank
DB00402,Hypnotics and Sedatives,DrugBank
DB00402,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00402,Muscle Relaxants,DrugBank
DB00402,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00402,Nervous System,DrugBank
DB00402,Photosensitizing Agents,DrugBank
DB00402,Piperazines,DrugBank
DB00402,Psycholeptics,DrugBank
DB00402,Pyrazines,DrugBank
DB00402,Pyridines,DrugBank
DB00402,Zopiclone and prodrugs,DrugBank
DB00404,Amines,DrugBank
DB00404,Anti-Anxiety Agents,DrugBank
DB00404,Benzazepines,DrugBank
DB00404,Benzene Derivatives,DrugBank
DB00404,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00404,Biogenic Amines,DrugBank
DB00404,Biogenic Monoamines,DrugBank
DB00404,Catechols,DrugBank
DB00404,Central Nervous System Agents,DrugBank
DB00404,Central Nervous System Depressants,DrugBank
DB00404,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00404,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00404,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00404,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00404,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00404,Cytochrome P-450 Substrates,DrugBank
DB00404,Drugs that are Mainly Renally Excreted,DrugBank
DB00404,Ethanolamines,DrugBank
DB00404,GABA Agents,DrugBank
DB00404,GABA Modulators,DrugBank
DB00404,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00404,Hypnotics and Sedatives,DrugBank
DB00404,Nervous System,DrugBank
DB00404,Neurotransmitter Agents,DrugBank
DB00404,Psycholeptics,DrugBank
DB00404,Psychotropic Drugs,DrugBank
DB00404,Tranquilizing Agents,DrugBank
DB00404,Triazolobenzodiazepines,DrugBank
DB00405,Antihistamines for Systemic Use,DrugBank
DB00405,Central Nervous System Depressants,DrugBank
DB00405,Histamine Agents,DrugBank
DB00405,Histamine Antagonists,DrugBank
DB00405,Histamine H1 Antagonists,DrugBank
DB00405,Neurotransmitter Agents,DrugBank
DB00405,Potential QTc-Prolonging Agents,DrugBank
DB00405,Pyridines,DrugBank
DB00405,QTc Prolonging Agents,DrugBank
DB00405,Substituted Alkylamines,DrugBank
DB00407,Agents causing hyperkalemia,DrugBank
DB00407,Anticoagulants,DrugBank
DB00407,Carbohydrates,DrugBank
DB00407,Cardiovascular Agents,DrugBank
DB00407,Fibrin Modulating Agents,DrugBank
DB00407,Glycosaminoglycans,DrugBank
DB00407,Hematologic Agents,DrugBank
DB00407,Heparin (Low Molecular Weight),DrugBank
DB00407,Heparin and similars,DrugBank
DB00407,Polysaccharides,DrugBank
DB00408,Antidepressive Agents,DrugBank
DB00408,Antipsychotic Agents,DrugBank
DB00408,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00408,Central Nervous System Agents,DrugBank
DB00408,Central Nervous System Depressants,DrugBank
DB00408,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB00408,Dibenzoxazepines,DrugBank
DB00408,Dopamine Agents,DrugBank
DB00408,Dopamine Antagonists,DrugBank
DB00408,Dopamine D2 Receptor Antagonists,DrugBank
DB00408,Drugs causing inadvertant photosensitivity,DrugBank
DB00408,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00408,Miscellaneous Antipsychotics,DrugBank
DB00408,Nervous System,DrugBank
DB00408,Neurotoxic agents,DrugBank
DB00408,Neurotransmitter Agents,DrugBank
DB00408,P-glycoprotein inhibitors,DrugBank
DB00408,Photosensitizing Agents,DrugBank
DB00408,Psycholeptics,DrugBank
DB00408,Psychotropic Drugs,DrugBank
DB00408,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00408,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00408,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00408,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00408,Serotonin Agents,DrugBank
DB00408,Serotonin Receptor Antagonists,DrugBank
DB00408,Tranquilizing Agents,DrugBank
DB00409,"Acids, Carbocyclic",DrugBank
DB00409,Amides,DrugBank
DB00409,Antipsychotic Agents,DrugBank
DB00409,Benzamides and benzamide derivatives,DrugBank
DB00409,Benzene Derivatives,DrugBank
DB00409,Benzoates,DrugBank
DB00409,Bromobenzoates,DrugBank
DB00409,Central Nervous System Agents,DrugBank
DB00409,Central Nervous System Depressants,DrugBank
DB00409,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00409,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00409,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00409,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00409,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00409,Cytochrome P-450 Substrates,DrugBank
DB00409,Dopamine Agents,DrugBank
DB00409,Dopamine Antagonists,DrugBank
DB00409,Dopamine D2 Receptor Antagonists,DrugBank
DB00409,Nervous System,DrugBank
DB00409,Neurotoxic agents,DrugBank
DB00409,Neurotransmitter Agents,DrugBank
DB00409,Psycholeptics,DrugBank
DB00409,Psychotropic Drugs,DrugBank
DB00409,Tranquilizing Agents,DrugBank
DB00410,Anti-Bacterial Agents,DrugBank
DB00410,Anti-Infective Agents,DrugBank
DB00410,Antibiotics for Topical Use,DrugBank
DB00410,Dermatologicals,DrugBank
DB00410,Enzyme Inhibitors,DrugBank
DB00410,Epoxy Compounds,DrugBank
DB00410,Ethers,DrugBank
DB00410,"Ethers, Cyclic",DrugBank
DB00410,Fatty Acids,DrugBank
DB00410,Lipids,DrugBank
DB00410,Nasal Preparations,DrugBank
DB00410,Protein Synthesis Inhibitors,DrugBank
DB00410,Pyrans,DrugBank
DB00410,RNA Synthetase Inhibitor Antibacterial,DrugBank
DB00410,RNA Synthetase Inhibitors,DrugBank
DB00411,Alcohols,DrugBank
DB00411,Amines,DrugBank
DB00411,Amino Alcohols,DrugBank
DB00411,Ammonium Compounds,DrugBank
DB00411,Analgesics,DrugBank
DB00411,"Analgesics, Non-Narcotic",DrugBank
DB00411,Antiglaucoma Preparations and Miotics,DrugBank
DB00411,Autonomic Agents,DrugBank
DB00411,Cardiotonic Agents,DrugBank
DB00411,Cardiovascular Agents,DrugBank
DB00411,Central Nervous System Agents,DrugBank
DB00411,Choline Esters,DrugBank
DB00411,Cholinergic Agents,DrugBank
DB00411,Cholinergic Agonists,DrugBank
DB00411,Cholinergic Receptor Agonist,DrugBank
DB00411,"Compounds used in a research, industrial, or household setting",DrugBank
DB00411,Ethanolamines,DrugBank
DB00411,Miotics,DrugBank
DB00411,Nervous System,DrugBank
DB00411,Neurotransmitter Agents,DrugBank
DB00411,Nitrogen Compounds,DrugBank
DB00411,Onium Compounds,DrugBank
DB00411,Ophthalmologicals,DrugBank
DB00411,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB00411,Parasympathomimetics,DrugBank
DB00411,Peripheral Nervous System Agents,DrugBank
DB00411,Protective Agents,DrugBank
DB00411,Quaternary Ammonium Compounds,DrugBank
DB00411,Sensory Organs,DrugBank
DB00411,Sensory System Agents,DrugBank
DB00411,Trimethyl Ammonium Compounds,DrugBank
DB00412,Alimentary Tract and Metabolism,DrugBank
DB00412,Blood Glucose Lowering Agents,DrugBank
DB00412,BSEP/ABCB11 Substrates,DrugBank
DB00412,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00412,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00412,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00412,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00412,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00412,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00412,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00412,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00412,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00412,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00412,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00412,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00412,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00412,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00412,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00412,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00412,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00412,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00412,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00412,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00412,Cytochrome P-450 Substrates,DrugBank
DB00412,Drugs that are Mainly Renally Excreted,DrugBank
DB00412,Drugs Used in Diabetes,DrugBank
DB00412,Hypoglycemia-Associated Agents,DrugBank
DB00412,NTCP Inhibitors,DrugBank
DB00412,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00412,Oral Hypoglycemics,DrugBank
DB00412,Peroxisome Proliferator Receptor gamma Agonist,DrugBank
DB00412,Peroxisome Proliferator-activated Receptor Activity,DrugBank
DB00412,Sulfur Compounds,DrugBank
DB00412,Thiazoles,DrugBank
DB00412,Thiazolidinediones,DrugBank
DB00412,Vasodilating Agents,DrugBank
DB00413,Anti-Dyskinesia Agents,DrugBank
DB00413,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB00413,Anti-Parkinson Drugs,DrugBank
DB00413,Antioxidants,DrugBank
DB00413,Benzothiazoles,DrugBank
DB00413,Biological Factors,DrugBank
DB00413,Central Nervous System Agents,DrugBank
DB00413,Dopamine Agents,DrugBank
DB00413,Dopamine Agonists,DrugBank
DB00413,Drugs that are Mainly Renally Excreted,DrugBank
DB00413,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00413,Hypotensive Agents,DrugBank
DB00413,Nervous System,DrugBank
DB00413,Neurotransmitter Agents,DrugBank
DB00413,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB00413,OCT1 substrates,DrugBank
DB00413,OCT2 Substrates,DrugBank
DB00413,Restless Legs Syndrome,DrugBank
DB00413,Sulfur Compounds,DrugBank
DB00413,Thiazoles,DrugBank
DB00414,Alimentary Tract and Metabolism,DrugBank
DB00414,Amides,DrugBank
DB00414,Benzene Derivatives,DrugBank
DB00414,Benzenesulfonamides,DrugBank
DB00414,Blood Glucose Lowering Agents,DrugBank
DB00414,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00414,Cytochrome P-450 Substrates,DrugBank
DB00414,Drugs Used in Diabetes,DrugBank
DB00414,Genito Urinary System and Sex Hormones,DrugBank
DB00414,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00414,Insulin Secretagogues,DrugBank
DB00414,Oral Hypoglycemics,DrugBank
DB00414,Sulfonamides,DrugBank
DB00414,Sulfones,DrugBank
DB00414,Sulfonylureas,DrugBank
DB00414,Sulfur Compounds,DrugBank
DB00415,Amides,DrugBank
DB00415,Aminopenicillins,DrugBank
DB00415,Anti-Bacterial Agents,DrugBank
DB00415,Anti-Infective Agents,DrugBank
DB00415,Antibacterials for Systemic Use,DrugBank
DB00415,Antiinfectives for Systemic Use,DrugBank
DB00415,Beta-Lactam Antibacterials,DrugBank
DB00415,beta-Lactams,DrugBank
DB00415,Drugs that are Mainly Renally Excreted,DrugBank
DB00415,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00415,Lactams,DrugBank
DB00415,Ophthalmologicals,DrugBank
DB00415,Penicillin G,DrugBank
DB00415,Penicillins,DrugBank
DB00415,Penicillins With Extended Spectrum,DrugBank
DB00415,Sensory Organs,DrugBank
DB00415,Sulfur Compounds,DrugBank
DB00416,Alkaloids,DrugBank
DB00416,Amines,DrugBank
DB00416,Anticholinergic Agents,DrugBank
DB00416,Benzylisoquinolines,DrugBank
DB00416,Central Nervous System Depressants,DrugBank
DB00416,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00416,Isoquinolines,DrugBank
DB00416,Neuromuscular Agents,DrugBank
DB00416,Neuromuscular Blocking Agents,DrugBank
DB00416,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB00416,Nicotinic Antagonists,DrugBank
DB00416,Onium Compounds,DrugBank
DB00416,Peripheral Nervous System Agents,DrugBank
DB00416,Quaternary Ammonium Compounds,DrugBank
DB00416,Tetrahydroisoquinolines,DrugBank
DB00417,Amides,DrugBank
DB00417,Anti-Bacterial Agents,DrugBank
DB00417,Anti-Infective Agents,DrugBank
DB00417,Antibacterials for Systemic Use,DrugBank
DB00417,Antiinfectives for Systemic Use,DrugBank
DB00417,Aza Compounds,DrugBank
DB00417,Azabicyclo Compounds,DrugBank
DB00417,Beta-Lactam Antibacterials,DrugBank
DB00417,Beta-Lactamase Sensitive Penicillins,DrugBank
DB00417,beta-Lactams,DrugBank
DB00417,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00417,Lactams,DrugBank
DB00417,Natural Penicillins,DrugBank
DB00417,Penicillin G,DrugBank
DB00417,Penicillins,DrugBank
DB00417,Sulfur Compounds,DrugBank
DB00418,Adjuvants,DrugBank
DB00418,"Adjuvants, Anesthesia",DrugBank
DB00418,Anticholinergic Agents,DrugBank
DB00418,Anticonvulsants,DrugBank
DB00418,Barbiturates,DrugBank
DB00418,"Barbiturates, Plain",DrugBank
DB00418,Central Nervous System Agents,DrugBank
DB00418,Central Nervous System Depressants,DrugBank
DB00418,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00418,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00418,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00418,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00418,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00418,Cytochrome P-450 CYP2C8 Inducers (strong),DrugBank
DB00418,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00418,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00418,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00418,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00418,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00418,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00418,Drugs that are Mainly Renally Excreted,DrugBank
DB00418,GABA Agents,DrugBank
DB00418,GABA Modulators,DrugBank
DB00418,Hypnotics and Sedatives,DrugBank
DB00418,Nervous System,DrugBank
DB00418,Neurotransmitter Agents,DrugBank
DB00418,Nicotinic Antagonists,DrugBank
DB00418,Psycholeptics,DrugBank
DB00418,Pyrimidines,DrugBank
DB00418,Pyrimidinones,DrugBank
DB00420,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00420,Adrenergic alpha-Antagonists,DrugBank
DB00420,Adrenergic Antagonists,DrugBank
DB00420,Agents producing tachycardia,DrugBank
DB00420,Agents that produce hypertension,DrugBank
DB00420,Amino Acids,DrugBank
DB00420,"Amino Acids, Branched-Chain",DrugBank
DB00420,"Amino Acids, Peptides, and Proteins",DrugBank
DB00420,Anticholinergic Agents,DrugBank
DB00420,Antidepressive Agents,DrugBank
DB00420,Antiemetics,DrugBank
DB00420,Antipsychotic Agents,DrugBank
DB00420,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00420,Autonomic Agents,DrugBank
DB00420,Central Nervous System Agents,DrugBank
DB00420,Central Nervous System Depressants,DrugBank
DB00420,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00420,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00420,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00420,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00420,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00420,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00420,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00420,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00420,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00420,Cytochrome P-450 Substrates,DrugBank
DB00420,Dopamine Agents,DrugBank
DB00420,Dopamine Antagonists,DrugBank
DB00420,Dopamine D2 Receptor Antagonists,DrugBank
DB00420,Gastrointestinal Agents,DrugBank
DB00420,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00420,Histamine Antagonists,DrugBank
DB00420,Histamine H1 Antagonists,DrugBank
DB00420,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00420,Muscarinic Antagonists,DrugBank
DB00420,Nervous System,DrugBank
DB00420,Neurotoxic agents,DrugBank
DB00420,Neurotransmitter Agents,DrugBank
DB00420,Peripheral Nervous System Agents,DrugBank
DB00420,Phenothiazines,DrugBank
DB00420,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB00420,Psycholeptics,DrugBank
DB00420,Psychotropic Drugs,DrugBank
DB00420,QTc Prolonging Agents,DrugBank
DB00420,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00420,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00420,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00420,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00420,Serotonin Agents,DrugBank
DB00420,Serotonin Receptor Antagonists,DrugBank
DB00420,Sulfur Compounds,DrugBank
DB00420,Tranquilizing Agents,DrugBank
DB00421,Agents causing hyperkalemia,DrugBank
DB00421,Antihypertensive Agents,DrugBank
DB00421,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00421,BSEP/ABCB11 Substrates,DrugBank
DB00421,Cardiovascular Agents,DrugBank
DB00421,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00421,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00421,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00421,Diuretics,DrugBank
DB00421,Fused-Ring Compounds,DrugBank
DB00421,Hormone Antagonists,DrugBank
DB00421,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00421,Hypotensive Agents,DrugBank
DB00421,Lactones,DrugBank
DB00421,Mineralocorticoid (Aldosterone) Receptor Antagonists,DrugBank
DB00421,Mineralocorticoid Receptor Antagonists,DrugBank
DB00421,Natriuretic Agents,DrugBank
DB00421,P-glycoprotein inducers,DrugBank
DB00421,Potassium-Sparing Diuretics,DrugBank
DB00421,Pregnanes,DrugBank
DB00421,Pregnenes,DrugBank
DB00421,Steroids,DrugBank
DB00422,"Acids, Carbocyclic",DrugBank
DB00422,Agents that produce hypertension,DrugBank
DB00422,Agents that reduce seizure threshold,DrugBank
DB00422,Central Nervous System Agents,DrugBank
DB00422,Central Nervous System Stimulants,DrugBank
DB00422,Central Nervous System Stimulation,DrugBank
DB00422,Centrally Acting Sympathomimetics,DrugBank
DB00422,Dopamine Agents,DrugBank
DB00422,Dopamine Uptake Inhibitors,DrugBank
DB00422,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00422,Membrane Transport Modulators,DrugBank
DB00422,Methylphenidate and isomer,DrugBank
DB00422,Nervous System,DrugBank
DB00422,Neurotransmitter Agents,DrugBank
DB00422,Neurotransmitter Uptake Inhibitors,DrugBank
DB00422,Phenylacetates,DrugBank
DB00422,Piperidines,DrugBank
DB00422,Psychoanaleptics,DrugBank
DB00422,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB00422,Respiratory and CNS Stimulants,DrugBank
DB00423,"Acids, Acyclic",DrugBank
DB00423,Benzene Derivatives,DrugBank
DB00423,Carbamates,DrugBank
DB00423,Carbamic Acid Esters,DrugBank
DB00423,Catechols,DrugBank
DB00423,Central Nervous System Agents,DrugBank
DB00423,Central Nervous System Depressants,DrugBank
DB00423,Centrally-mediated Muscle Relaxation,DrugBank
DB00423,Ethers,DrugBank
DB00423,Methyl Ethers,DrugBank
DB00423,Muscle Relaxants,DrugBank
DB00423,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00423,Musculo-Skeletal System,DrugBank
DB00423,Peripheral Nervous System Agents,DrugBank
DB00423,Phenols,DrugBank
DB00423,Phenyl Ethers,DrugBank
DB00423,Phenylcarbamates,DrugBank
DB00424,"Adjuvants, Anesthesia",DrugBank
DB00424,Agents producing tachycardia,DrugBank
DB00424,Alimentary Tract and Metabolism,DrugBank
DB00424,Alkaloids,DrugBank
DB00424,Anti-Asthmatic Agents,DrugBank
DB00424,Antiarrhythmic agents,DrugBank
DB00424,Anticholinergic Agents,DrugBank
DB00424,Atropine Derivatives,DrugBank
DB00424,Autonomic Agents,DrugBank
DB00424,Aza Compounds,DrugBank
DB00424,Azabicyclo Compounds,DrugBank
DB00424,Belladonna Alkaloids,DrugBank
DB00424,"Belladonna Alkaloids, Tertiary Amines",DrugBank
DB00424,"Belladonna and Derivatives, Plain",DrugBank
DB00424,Bronchodilator Agents,DrugBank
DB00424,Cardiovascular Agents,DrugBank
DB00424,Central Nervous System Agents,DrugBank
DB00424,Cholinergic Agents,DrugBank
DB00424,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00424,Muscarinic Antagonists,DrugBank
DB00424,Mydriatics,DrugBank
DB00424,Neurotransmitter Agents,DrugBank
DB00424,Parasympatholytics,DrugBank
DB00424,Peripheral Nervous System Agents,DrugBank
DB00424,Potential QTc-Prolonging Agents,DrugBank
DB00424,QTc Prolonging Agents,DrugBank
DB00424,Respiratory System Agents,DrugBank
DB00424,Solanaceous Alkaloids,DrugBank
DB00424,Tropanes,DrugBank
DB00425,Benzodiazepine hypnotics and sedatives,DrugBank
DB00425,Central Nervous System Agents,DrugBank
DB00425,Central Nervous System Depressants,DrugBank
DB00425,Central Nervous System Depression,DrugBank
DB00425,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00425,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00425,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00425,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00425,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00425,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00425,Cytochrome P-450 Substrates,DrugBank
DB00425,GABA Agents,DrugBank
DB00425,GABA Agonists,DrugBank
DB00425,GABA-A Receptor Agonists,DrugBank
DB00425,gamma-Aminobutyric Acid A Receptor Positive Modulator,DrugBank
DB00425,gamma-Aminobutyric Acid-ergic Agonist,DrugBank
DB00425,Hypnotics (Nonbenzodiazepine),DrugBank
DB00425,Hypnotics and Sedatives,DrugBank
DB00425,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00425,Nervous System,DrugBank
DB00425,Neurotransmitter Agents,DrugBank
DB00425,Psycholeptics,DrugBank
DB00425,Pyridines,DrugBank
DB00425,"Sleep Aids, Pharmaceutical",DrugBank
DB00427,Anti-Allergic Agents,DrugBank
DB00427,Antihistamines for Systemic Use,DrugBank
DB00427,Central Nervous System Depressants,DrugBank
DB00427,Histamine Agents,DrugBank
DB00427,Histamine Antagonists,DrugBank
DB00427,Histamine H1 Antagonists,DrugBank
DB00427,Neurotransmitter Agents,DrugBank
DB00427,Potential QTc-Prolonging Agents,DrugBank
DB00427,Pyridines,DrugBank
DB00427,QTc Prolonging Agents,DrugBank
DB00428,Alkylating Activity,DrugBank
DB00428,Alkylating Drugs,DrugBank
DB00428,Amides,DrugBank
DB00428,"Antibiotics, Antineoplastic",DrugBank
DB00428,Antineoplastic Agents,DrugBank
DB00428,"Antineoplastic Agents, Alkylating",DrugBank
DB00428,Antineoplastic and Immunomodulating Agents,DrugBank
DB00428,Carbohydrates,DrugBank
DB00428,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00428,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00428,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00428,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00428,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00428,Glycosides,DrugBank
DB00428,Immunosuppressive Agents,DrugBank
DB00428,Myelosuppressive Agents,DrugBank
DB00428,Narrow Therapeutic Index Drugs,DrugBank
DB00428,Nitroso Compounds,DrugBank
DB00428,Nitrosourea Compounds,DrugBank
DB00428,Nitrosoureas,DrugBank
DB00428,P-glycoprotein inducers,DrugBank
DB00430,Amides,DrugBank
DB00430,Anti-Bacterial Agents,DrugBank
DB00430,Anti-Infective Agents,DrugBank
DB00430,Antibacterials for Systemic Use,DrugBank
DB00430,Antiinfectives for Systemic Use,DrugBank
DB00430,beta-Lactams,DrugBank
DB00430,Cephalosporins,DrugBank
DB00430,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00430,Lactams,DrugBank
DB00430,Nephrotoxic agents,DrugBank
DB00430,Sulfur Compounds,DrugBank
DB00430,Thiazines,DrugBank
DB00430,Third-Generation Cephalosporins,DrugBank
DB00432,Anti-Infective Agents,DrugBank
DB00432,Antimetabolites,DrugBank
DB00432,Antineoplastic Agents,DrugBank
DB00432,Antineoplastic and Immunomodulating Agents,DrugBank
DB00432,Antiviral Agents,DrugBank
DB00432,Deoxyribonucleosides,DrugBank
DB00432,Drugs that are Mainly Renally Excreted,DrugBank
DB00432,Immunosuppressive Agents,DrugBank
DB00432,Noxae,DrugBank
DB00432,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00432,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00432,Nucleoside Analog Antiviral,DrugBank
DB00432,Nucleoside Metabolic Inhibitor,DrugBank
DB00432,Nucleosides,DrugBank
DB00432,OAT1/SLC22A6 inhibitors,DrugBank
DB00432,OAT1/SLC22A6 Substrates,DrugBank
DB00432,OAT3/SLC22A8 Substrates,DrugBank
DB00432,Ophthalmologicals,DrugBank
DB00432,Pyrimidine Analogues,DrugBank
DB00432,Pyrimidine Nucleosides,DrugBank
DB00432,Pyrimidines,DrugBank
DB00432,Sensory Organs,DrugBank
DB00432,Toxic Actions,DrugBank
DB00433,Antiemetics,DrugBank
DB00433,Antipsychotic Agents,DrugBank
DB00433,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00433,Autonomic Agents,DrugBank
DB00433,Central Nervous System Agents,DrugBank
DB00433,Central Nervous System Depressants,DrugBank
DB00433,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00433,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00433,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00433,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00433,Cytochrome P-450 Substrates,DrugBank
DB00433,Dopamine Agents,DrugBank
DB00433,Dopamine Antagonists,DrugBank
DB00433,Dopamine D2 Receptor Antagonists,DrugBank
DB00433,Drugs causing inadvertant photosensitivity,DrugBank
DB00433,Gastrointestinal Agents,DrugBank
DB00433,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00433,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00433,Nervous System,DrugBank
DB00433,Neurotoxic agents,DrugBank
DB00433,Neurotransmitter Agents,DrugBank
DB00433,Peripheral Nervous System Agents,DrugBank
DB00433,Phenothiazines,DrugBank
DB00433,Phenothiazines With Piperazine Structure,DrugBank
DB00433,Photosensitizing Agents,DrugBank
DB00433,Psycholeptics,DrugBank
DB00433,Psychotropic Drugs,DrugBank
DB00433,QTc Prolonging Agents,DrugBank
DB00433,Schizophrenia,DrugBank
DB00433,Sulfur Compounds,DrugBank
DB00433,Tranquilizing Agents,DrugBank
DB00434,Agents producing tachycardia,DrugBank
DB00434,Agents that reduce seizure threshold,DrugBank
DB00434,Anti-Allergic Agents,DrugBank
DB00434,Anticholinergic Agents,DrugBank
DB00434,Antidepressive Agents,DrugBank
DB00434,Antihistamines for Systemic Use,DrugBank
DB00434,Antipruritics,DrugBank
DB00434,Benzocycloheptenes,DrugBank
DB00434,Central Nervous System Depressants,DrugBank
DB00434,Dermatologicals,DrugBank
DB00434,Dibenzocycloheptenes,DrugBank
DB00434,Drugs causing inadvertant photosensitivity,DrugBank
DB00434,Gastrointestinal Agents,DrugBank
DB00434,Histamine Agents,DrugBank
DB00434,Histamine Antagonists,DrugBank
DB00434,Histamine H1 Antagonists,DrugBank
DB00434,Miscellaneous Derivatives,DrugBank
DB00434,Muscarinic Antagonists,DrugBank
DB00434,Neurotransmitter Agents,DrugBank
DB00434,OCT1 inhibitors,DrugBank
DB00434,Photosensitizing Agents,DrugBank
DB00434,Piperidines,DrugBank
DB00434,Potential QTc-Prolonging Agents,DrugBank
DB00434,QTc Prolonging Agents,DrugBank
DB00434,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00434,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00434,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00434,Serotonin Agents,DrugBank
DB00434,Serotonin Receptor Antagonists,DrugBank
DB00434,UGT1A3 substrates,DrugBank
DB00434,UGT1A4 substrates,DrugBank
DB00435,Anti-Asthmatic Agents,DrugBank
DB00435,Antioxidants,DrugBank
DB00435,Autonomic Agents,DrugBank
DB00435,Bronchodilator Agents,DrugBank
DB00435,Cardiovascular Agents,DrugBank
DB00435,"Compounds used in a research, industrial, or household setting",DrugBank
DB00435,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00435,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00435,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00435,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00435,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00435,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00435,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00435,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00435,Drugs that are Mainly Renally Excreted,DrugBank
DB00435,Endothelium-Dependent Relaxing Factors,DrugBank
DB00435,Free Radical Scavengers,DrugBank
DB00435,Free Radicals,DrugBank
DB00435,Gases,DrugBank
DB00435,Gasotransmitters,DrugBank
DB00435,Hypotensive Agents,DrugBank
DB00435,Methemoglobinemia Associated Agents,DrugBank
DB00435,Neurotransmitter Agents,DrugBank
DB00435,Nitrates and Nitrites,DrugBank
DB00435,Nitrogen Compounds,DrugBank
DB00435,Nitrogen Oxides,DrugBank
DB00435,Oxides,DrugBank
DB00435,Oxygen Compounds,DrugBank
DB00435,Peripheral Nervous System Agents,DrugBank
DB00435,Reactive Nitrogen Species,DrugBank
DB00435,Respiratory System Agents,DrugBank
DB00435,Vasodilating Agents,DrugBank
DB00435,Vasodilation,DrugBank
DB00436,Antihypertensive Agents,DrugBank
DB00436,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00436,Benzothiadiazines,DrugBank
DB00436,Bradycardia-Causing Agents,DrugBank
DB00436,Cardiovascular Agents,DrugBank
DB00436,Diuretics,DrugBank
DB00436,Genito Urinary System and Sex Hormones,DrugBank
DB00436,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00436,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00436,Hyperglycemia-Associated Agents,DrugBank
DB00436,Hypotensive Agents,DrugBank
DB00436,Increased Diuresis,DrugBank
DB00436,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00436,Membrane Transport Modulators,DrugBank
DB00436,Natriuretic Agents,DrugBank
DB00436,Sodium Chloride Symporter Inhibitors,DrugBank
DB00436,Sulfonamides,DrugBank
DB00436,Sulfones,DrugBank
DB00436,Sulfur Compounds,DrugBank
DB00436,Thiazides,DrugBank
DB00437,Antigout Preparations,DrugBank
DB00437,Antimetabolites,DrugBank
DB00437,Antioxidants,DrugBank
DB00437,BCRP/ABCG2 Substrates,DrugBank
DB00437,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00437,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00437,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00437,Drugs that are Mainly Renally Excreted,DrugBank
DB00437,Enzyme Inhibitors,DrugBank
DB00437,Free Radical Scavengers,DrugBank
DB00437,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00437,Musculo-Skeletal System,DrugBank
DB00437,OAT3/SLC22A8 Substrates,DrugBank
DB00437,Preparations Inhibiting Uric Acid Production,DrugBank
DB00437,Protective Agents,DrugBank
DB00437,Purines,DrugBank
DB00437,Uricosuric Agents,DrugBank
DB00437,Xanthine Oxidase Inhibitors,DrugBank
DB00438,Amides,DrugBank
DB00438,Anti-Bacterial Agents,DrugBank
DB00438,Anti-Infective Agents,DrugBank
DB00438,Antibacterials for Systemic Use,DrugBank
DB00438,Antiinfectives for Systemic Use,DrugBank
DB00438,beta Lactam Antibiotics,DrugBank
DB00438,beta-Lactams,DrugBank
DB00438,Cephalosporins,DrugBank
DB00438,Drugs that are Mainly Renally Excreted,DrugBank
DB00438,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00438,Lactams,DrugBank
DB00438,Nephrotoxic agents,DrugBank
DB00438,OAT1/SLC22A6 inhibitors,DrugBank
DB00438,Sulfur Compounds,DrugBank
DB00438,Thiazines,DrugBank
DB00438,Third-Generation Cephalosporins,DrugBank
DB00439,Agents Causing Muscle Toxicity,DrugBank
DB00439,Anticholesteremic Agents,DrugBank
DB00439,BCRP/ABCG2 Substrates,DrugBank
DB00439,BSEP/ABCB11 Substrates,DrugBank
DB00439,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00439,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00439,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00439,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00439,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00439,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00439,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00439,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00439,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00439,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00439,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00439,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00439,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00439,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00439,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00439,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00439,Cytochrome P-450 Substrates,DrugBank
DB00439,Enzyme Inhibitors,DrugBank
DB00439,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB00439,Hypolipidemic Agents,DrugBank
DB00439,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00439,Lipid Modifying Agents,DrugBank
DB00439,"Lipid Modifying Agents, Plain",DrugBank
DB00439,Lipid Regulating Agents,DrugBank
DB00439,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00439,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00439,P-glycoprotein substrates,DrugBank
DB00439,UGT1A1 Substrates,DrugBank
DB00440,Agents causing hyperkalemia,DrugBank
DB00440,Agents Causing Muscle Toxicity,DrugBank
DB00440,Anti-Infective Agents,DrugBank
DB00440,"Anti-Infective Agents, Urinary",DrugBank
DB00440,Antibacterials for Systemic Use,DrugBank
DB00440,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB00440,Antiinfectives for Systemic Use,DrugBank
DB00440,Antimycobacterials,DrugBank
DB00440,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00440,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00440,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00440,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00440,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00440,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00440,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00440,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00440,Cytochrome P-450 Substrates,DrugBank
DB00440,Drugs causing inadvertant photosensitivity,DrugBank
DB00440,Drugs that are Mainly Renally Excreted,DrugBank
DB00440,Enzyme Inhibitors,DrugBank
DB00440,Folic Acid Antagonists,DrugBank
DB00440,MATE 1 Inhibitors,DrugBank
DB00440,MATE 1 Substrates,DrugBank
DB00440,MATE 2 Inhibitors,DrugBank
DB00440,MATE 2 Substrates,DrugBank
DB00440,MATE inhibitors,DrugBank
DB00440,MATE substrates,DrugBank
DB00440,P-glycoprotein inducers,DrugBank
DB00440,P-glycoprotein inhibitors,DrugBank
DB00440,P-glycoprotein substrates,DrugBank
DB00440,Photosensitizing Agents,DrugBank
DB00440,Pyrimidines,DrugBank
DB00440,Renal Agents,DrugBank
DB00440,Sulfonamides and trimethoprim,DrugBank
DB00440,Trimethoprim and Derivatives,DrugBank
DB00441,Antimetabolites,DrugBank
DB00441,Antineoplastic Agents,DrugBank
DB00441,Antineoplastic and Immunomodulating Agents,DrugBank
DB00441,Carbohydrates,DrugBank
DB00441,Cytidine Deaminase Substrates,DrugBank
DB00441,Cytotoxins,DrugBank
DB00441,Deoxycytidine,DrugBank
DB00441,Deoxyribonucleosides,DrugBank
DB00441,Drugs that are Mainly Renally Excreted,DrugBank
DB00441,Enzyme Inhibitors,DrugBank
DB00441,Glycosides,DrugBank
DB00441,Immunosuppressive Agents,DrugBank
DB00441,Myelosuppressive Agents,DrugBank
DB00441,Narrow Therapeutic Index Drugs,DrugBank
DB00441,Noxae,DrugBank
DB00441,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00441,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00441,Nucleoside Metabolic Inhibitor,DrugBank
DB00441,Nucleosides,DrugBank
DB00441,P-glycoprotein substrates,DrugBank
DB00441,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00441,Pyrimidine Analogues,DrugBank
DB00441,Pyrimidine Nucleosides,DrugBank
DB00441,Pyrimidines,DrugBank
DB00441,Ribonucleosides,DrugBank
DB00441,"Ribonucleotide Reductases, antagonists & inhibitors",DrugBank
DB00441,Toxic Actions,DrugBank
DB00442,Anti-Infective Agents,DrugBank
DB00442,Antiinfectives for Systemic Use,DrugBank
DB00442,Antiviral Agents,DrugBank
DB00442,Antivirals for Systemic Use,DrugBank
DB00442,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00442,Cytochrome P-450 Substrates,DrugBank
DB00442,Direct Acting Antivirals,DrugBank
DB00442,Hepatitis B virus,DrugBank
DB00442,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00442,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00442,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00442,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00442,Nucleosides and Nucleotides,DrugBank
DB00442,Purines,DrugBank
DB00442,Purinones,DrugBank
DB00443,Adrenal Cortex Hormones,DrugBank
DB00443,Adrenals,DrugBank
DB00443,Agents Causing Muscle Toxicity,DrugBank
DB00443,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00443,Alimentary Tract and Metabolism,DrugBank
DB00443,Anti-Inflammatory Agents,DrugBank
DB00443,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00443,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00443,Corticosteroids,DrugBank
DB00443,Corticosteroids Acting Locally,DrugBank
DB00443,Corticosteroids for Systemic Use,DrugBank
DB00443,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00443,"Corticosteroids, Dermatological Preparations",DrugBank
DB00443,"Corticosteroids, Potent (Group III)",DrugBank
DB00443,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00443,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00443,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00443,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00443,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00443,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00443,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00443,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00443,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00443,Cytochrome P-450 CYP3A5 Inducers (weak),DrugBank
DB00443,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00443,Cytochrome P-450 Substrates,DrugBank
DB00443,Dermatologicals,DrugBank
DB00443,Drugs for Obstructive Airway Diseases,DrugBank
DB00443,Fused-Ring Compounds,DrugBank
DB00443,Glucocorticoids,DrugBank
DB00443,Hormones,DrugBank
DB00443,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00443,Hyperglycemia-Associated Agents,DrugBank
DB00443,Immunosuppressive Agents,DrugBank
DB00443,Intestinal Antiinflammatory Agents,DrugBank
DB00443,Nasal Preparations,DrugBank
DB00443,Ophthalmological and Otological Preparations,DrugBank
DB00443,Ophthalmologicals,DrugBank
DB00443,Otologicals,DrugBank
DB00443,P-glycoprotein substrates,DrugBank
DB00443,Pregnadienes,DrugBank
DB00443,Pregnadienetriols,DrugBank
DB00443,Pregnanes,DrugBank
DB00443,Respiratory System Agents,DrugBank
DB00443,Steroids,DrugBank
DB00443,"Steroids, Fluorinated",DrugBank
DB00443,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00443,Thyroxine-binding globulin inhibitors,DrugBank
DB00443,Vasoprotectives,DrugBank
DB00444,Antineoplastic Agents,DrugBank
DB00444,Antineoplastic and Immunomodulating Agents,DrugBank
DB00444,BCRP/ABCG2 Substrates,DrugBank
DB00444,Carbohydrates,DrugBank
DB00444,Cardiotoxic antineoplastic agents,DrugBank
DB00444,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00444,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00444,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00444,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00444,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00444,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00444,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00444,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00444,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00444,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00444,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00444,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00444,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00444,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00444,Cytochrome P-450 Substrates,DrugBank
DB00444,Enzyme Inhibitors,DrugBank
DB00444,Glucosides,DrugBank
DB00444,Glycosides,DrugBank
DB00444,Immunosuppressive Agents,DrugBank
DB00444,Myelosuppressive Agents,DrugBank
DB00444,Narrow Therapeutic Index Drugs,DrugBank
DB00444,Neurotoxic agents,DrugBank
DB00444,Podophyllotoxin Derivatives,DrugBank
DB00444,Topoisomerase II Inhibitors,DrugBank
DB00444,Topoisomerase Inhibitors,DrugBank
DB00445,Anthracycline Topoisomerase Inhibitor,DrugBank
DB00445,Anthracyclines,DrugBank
DB00445,Anthracyclines and Related Substances,DrugBank
DB00445,"Antibiotics, Antineoplastic",DrugBank
DB00445,Antineoplastic Agents,DrugBank
DB00445,Antineoplastic and Immunomodulating Agents,DrugBank
DB00445,Carbohydrates,DrugBank
DB00445,Cardiotoxic antineoplastic agents,DrugBank
DB00445,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00445,Cytotoxins,DrugBank
DB00445,Enzyme Inhibitors,DrugBank
DB00445,Glycosides,DrugBank
DB00445,Hepatotoxic Agents,DrugBank
DB00445,Immunosuppressive Agents,DrugBank
DB00445,Myelosuppressive Agents,DrugBank
DB00445,Naphthacenes,DrugBank
DB00445,Narrow Therapeutic Index Drugs,DrugBank
DB00445,Topoisomerase II Inhibitors,DrugBank
DB00445,Topoisomerase Inhibitors,DrugBank
DB00445,UGT2B7 substrates,DrugBank
DB00445,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00446,Alcohols,DrugBank
DB00446,Amphenicols,DrugBank
DB00446,Anti-Acne Preparations,DrugBank
DB00446,Anti-Acne Preparations for Topical Use,DrugBank
DB00446,Anti-Bacterial Agents,DrugBank
DB00446,Anti-Infective Agents,DrugBank
DB00446,Antibacterials for Systemic Use,DrugBank
DB00446,Antibiotics for Topical Use,DrugBank
DB00446,Antiinfectives for Systemic Use,DrugBank
DB00446,Antiinfectives for Treatment of Acne,DrugBank
DB00446,Benzene Derivatives,DrugBank
DB00446,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00446,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00446,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00446,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00446,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00446,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00446,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00446,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00446,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00446,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00446,Dermatologicals,DrugBank
DB00446,Enzyme Inhibitors,DrugBank
DB00446,Genito Urinary System and Sex Hormones,DrugBank
DB00446,Glycols,DrugBank
DB00446,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00446,Immunosuppressive Agents,DrugBank
DB00446,Myelosuppressive Agents,DrugBank
DB00446,Nitro Compounds,DrugBank
DB00446,Nitrobenzenes,DrugBank
DB00446,OAT1/SLC22A6 inhibitors,DrugBank
DB00446,Ophthalmological and Otological Preparations,DrugBank
DB00446,Ophthalmologicals,DrugBank
DB00446,Otologicals,DrugBank
DB00446,Propylene Glycols,DrugBank
DB00446,Protein Synthesis Inhibitors,DrugBank
DB00446,Sensory Organs,DrugBank
DB00447,Amides,DrugBank
DB00447,Anti-Bacterial Agents,DrugBank
DB00447,Anti-Infective Agents,DrugBank
DB00447,Antibacterials for Systemic Use,DrugBank
DB00447,Antiinfectives for Systemic Use,DrugBank
DB00447,beta-Lactams,DrugBank
DB00447,Cephalosporins,DrugBank
DB00447,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00447,Lactams,DrugBank
DB00447,Nephrotoxic agents,DrugBank
DB00447,Second-Generation Cephalosporins,DrugBank
DB00447,Sulfur Compounds,DrugBank
DB00447,Thiazines,DrugBank
DB00448,Acid Reducers,DrugBank
DB00448,Alimentary Tract and Metabolism,DrugBank
DB00448,Anti-Ulcer Agents,DrugBank
DB00448,BCRP/ABCG2 Inhibitors,DrugBank
DB00448,Benzimidazoles,DrugBank
DB00448,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00448,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00448,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00448,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00448,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00448,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00448,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00448,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00448,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00448,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00448,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00448,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00448,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00448,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00448,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00448,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00448,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00448,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00448,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00448,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00448,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00448,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00448,Cytochrome P-450 Substrates,DrugBank
DB00448,Drugs for Acid Related Disorders,DrugBank
DB00448,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00448,Gastric Acid Lowering Agents,DrugBank
DB00448,Gastrointestinal Agents,DrugBank
DB00448,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00448,Inhibition Gastric Acid Secretion,DrugBank
DB00448,OAT3/SLC22A8 Inhibitors,DrugBank
DB00448,P-glycoprotein inhibitors,DrugBank
DB00448,P-glycoprotein substrates,DrugBank
DB00448,Proton Pump Inhibitors,DrugBank
DB00448,Proton-pump Inhibitors,DrugBank
DB00448,Pyridines,DrugBank
DB00448,Sulfoxides,DrugBank
DB00448,Sulfur Compounds,DrugBank
DB00449,Adrenergic Agents,DrugBank
DB00449,Adrenergic Agonists,DrugBank
DB00449,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00449,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00449,Adrenergic alpha-Agonists,DrugBank
DB00449,Adrenergic beta-1 Receptor Agonists,DrugBank
DB00449,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00449,Adrenergic beta-3 Receptor Agonists,DrugBank
DB00449,Adrenergic beta-Agonists,DrugBank
DB00449,Alcohols,DrugBank
DB00449,Amines,DrugBank
DB00449,Amino Alcohols,DrugBank
DB00449,Antiglaucoma Preparations and Miotics,DrugBank
DB00449,Benzene Derivatives,DrugBank
DB00449,Biogenic Amines,DrugBank
DB00449,Biogenic Monoamines,DrugBank
DB00449,Catecholamines,DrugBank
DB00449,Catechols,DrugBank
DB00449,Cholinesterase substrates,DrugBank
DB00449,Ethanolamines,DrugBank
DB00449,Mydriatics,DrugBank
DB00449,Neurotransmitter Agents,DrugBank
DB00449,Ophthalmics,DrugBank
DB00449,Ophthalmologicals,DrugBank
DB00449,Phenols,DrugBank
DB00449,Sensory Organs,DrugBank
DB00449,Sympathomimetics in Glaucoma Therapy,DrugBank
DB00450,"Adjuvants, Anesthesia",DrugBank
DB00450,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00450,Adrenergic alpha-Antagonists,DrugBank
DB00450,Adrenergic Antagonists,DrugBank
DB00450,Agents that produce hypertension,DrugBank
DB00450,Antiemetics,DrugBank
DB00450,Antipsychotic Agents,DrugBank
DB00450,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00450,Autonomic Agents,DrugBank
DB00450,Benzimidazoles,DrugBank
DB00450,Butyrophenone Derivatives,DrugBank
DB00450,Butyrophenones,DrugBank
DB00450,Central Nervous System Agents,DrugBank
DB00450,Central Nervous System Depressants,DrugBank
DB00450,Dopamine Agents,DrugBank
DB00450,Dopamine Antagonists,DrugBank
DB00450,Dopamine D2 Receptor Antagonists,DrugBank
DB00450,Gastrointestinal Agents,DrugBank
DB00450,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00450,Ketones,DrugBank
DB00450,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00450,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00450,Nervous System,DrugBank
DB00450,Neurotoxic agents,DrugBank
DB00450,Neurotransmitter Agents,DrugBank
DB00450,Peripheral Nervous System Agents,DrugBank
DB00450,Psycholeptics,DrugBank
DB00450,Psychotropic Drugs,DrugBank
DB00450,QTc Prolonging Agents,DrugBank
DB00450,Tranquilizing Agents,DrugBank
DB00451,Agents used to treat hypothyroidism,DrugBank
DB00451,Amino Acids,DrugBank
DB00451,"Amino Acids, Aromatic",DrugBank
DB00451,"Amino Acids, Cyclic",DrugBank
DB00451,"Amino Acids, Peptides, and Proteins",DrugBank
DB00451,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00451,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00451,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00451,Hormones,DrugBank
DB00451,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00451,Narrow Therapeutic Index Drugs,DrugBank
DB00451,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00451,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00451,P-glycoprotein inducers,DrugBank
DB00451,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00451,Thyroid Products,DrugBank
DB00451,Thyroxine-binding globulin substrates,DrugBank
DB00451,UGT1A1 Substrates,DrugBank
DB00451,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00452,Agents that produce neuromuscular block (indirect),DrugBank
DB00452,Aminoglycoside Antibacterials,DrugBank
DB00452,Anti-Bacterial Agents,DrugBank
DB00452,Anti-Infective Agents,DrugBank
DB00452,Carbohydrates,DrugBank
DB00452,Dermatologicals,DrugBank
DB00452,Glycosides,DrugBank
DB00452,Medicated Dressings,DrugBank
DB00452,Medicated Dressings With Antiinfectives,DrugBank
DB00452,Nasal Preparations,DrugBank
DB00452,Nephrotoxic agents,DrugBank
DB00452,Ophthalmologicals,DrugBank
DB00452,Sensory Organs,DrugBank
DB00453,Agents that produce neuromuscular block (indirect),DrugBank
DB00453,Anti-Bacterial Agents,DrugBank
DB00453,Antibacterials for Systemic Use,DrugBank
DB00453,Antiinfectives for Systemic Use,DrugBank
DB00453,Naphthacenes,DrugBank
DB00453,Tetracyclines,DrugBank
DB00454,Adjuvants,DrugBank
DB00454,"Adjuvants, Anesthesia",DrugBank
DB00454,Agents that reduce seizure threshold,DrugBank
DB00454,Analgesics,DrugBank
DB00454,Antidepressive Agents,DrugBank
DB00454,Central Nervous System Agents,DrugBank
DB00454,Central Nervous System Depressants,DrugBank
DB00454,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00454,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00454,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00454,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00454,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00454,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00454,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00454,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00454,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00454,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00454,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00454,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00454,Cytochrome P-450 Substrates,DrugBank
DB00454,Drugs that are Mainly Renally Excreted,DrugBank
DB00454,High-risk opioids,DrugBank
DB00454,Isonipecotic Acids,DrugBank
DB00454,Narcotics,DrugBank
DB00454,Nervous System,DrugBank
DB00454,NMDA Receptor Antagonists,DrugBank
DB00454,Opiate Agonists,DrugBank
DB00454,Opioid Agonist,DrugBank
DB00454,Opioids,DrugBank
DB00454,P-glycoprotein substrates,DrugBank
DB00454,Peripheral Nervous System Agents,DrugBank
DB00454,Phenylpiperidine opioids,DrugBank
DB00454,Piperidines,DrugBank
DB00454,Sensory System Agents,DrugBank
DB00454,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00454,Serotonin Agents,DrugBank
DB00454,Serotonin Modulators,DrugBank
DB00455,Anti-Allergic Agents,DrugBank
DB00455,Antihistamines for Systemic Use,DrugBank
DB00455,Antipruritics,DrugBank
DB00455,Benzocycloheptenes,DrugBank
DB00455,BSEP/ABCB11 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00455,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00455,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00455,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00455,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00455,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00455,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00455,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00455,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00455,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00455,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00455,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00455,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00455,Cytochrome P-450 Substrates,DrugBank
DB00455,Dermatologicals,DrugBank
DB00455,Dibenzocycloheptenes,DrugBank
DB00455,Histamine Antagonists,DrugBank
DB00455,Histamine H1 Antagonists,DrugBank
DB00455,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00455,Loratadine and derivatives,DrugBank
DB00455,Neurotransmitter Agents,DrugBank
DB00455,P-glycoprotein inhibitors,DrugBank
DB00455,P-glycoprotein substrates,DrugBank
DB00455,Piperidines,DrugBank
DB00455,Potential QTc-Prolonging Agents,DrugBank
DB00455,QTc Prolonging Agents,DrugBank
DB00456,Agents that reduce seizure threshold,DrugBank
DB00456,Amides,DrugBank
DB00456,Anti-Bacterial Agents,DrugBank
DB00456,Anti-Infective Agents,DrugBank
DB00456,Antibacterials for Systemic Use,DrugBank
DB00456,Antiinfectives for Systemic Use,DrugBank
DB00456,beta-Lactams,DrugBank
DB00456,Cephalosporins,DrugBank
DB00456,First-Generation Cephalosporins,DrugBank
DB00456,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00456,Lactams,DrugBank
DB00456,Nephrotoxic agents,DrugBank
DB00456,OAT1/SLC22A6 inhibitors,DrugBank
DB00456,OAT3/SLC22A8 Inhibitors,DrugBank
DB00456,Sulfur Compounds,DrugBank
DB00456,Thiazines,DrugBank
DB00457,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00457,Adrenergic alpha-Antagonists,DrugBank
DB00457,Adrenergic Antagonists,DrugBank
DB00457,Alpha-Adrenoreceptor Antagonists and Diuretics,DrugBank
DB00457,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB00457,Antihypertensive Agents,DrugBank
DB00457,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00457,BCRP/ABCG2 Substrates,DrugBank
DB00457,Cardiovascular Agents,DrugBank
DB00457,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00457,Hypotensive Agents,DrugBank
DB00457,OCT1 inhibitors,DrugBank
DB00457,OCT1 substrates,DrugBank
DB00457,OCT2 Substrates,DrugBank
DB00457,P-glycoprotein inhibitors,DrugBank
DB00457,P-glycoprotein substrates,DrugBank
DB00457,Peripheral alpha-1 blockers,DrugBank
DB00457,Quinazolines,DrugBank
DB00457,Vasodilating Agents,DrugBank
DB00458,Adrenergic Agents,DrugBank
DB00458,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00458,Adrenergic alpha-Antagonists,DrugBank
DB00458,Adrenergic Antagonists,DrugBank
DB00458,Adrenergic Uptake Inhibitors,DrugBank
DB00458,Agents producing tachycardia,DrugBank
DB00458,Agents that produce hypertension,DrugBank
DB00458,Agents that reduce seizure threshold,DrugBank
DB00458,Anticholinergic Agents,DrugBank
DB00458,Antidepressive Agents,DrugBank
DB00458,Antidepressive Agents Indicated for Depression,DrugBank
DB00458,"Antidepressive Agents, Tricyclic",DrugBank
DB00458,Central Nervous System Agents,DrugBank
DB00458,Central Nervous System Depressants,DrugBank
DB00458,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00458,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00458,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00458,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00458,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00458,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00458,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00458,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00458,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00458,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00458,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00458,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00458,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00458,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00458,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00458,Cytochrome P-450 Substrates,DrugBank
DB00458,Dibenzazepines,DrugBank
DB00458,Drugs that are Mainly Renally Excreted,DrugBank
DB00458,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00458,Histamine Antagonists,DrugBank
DB00458,Histamine H1 Antagonists,DrugBank
DB00458,Hypotensive Agents,DrugBank
DB00458,Membrane Transport Modulators,DrugBank
DB00458,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00458,Muscarinic Antagonists,DrugBank
DB00458,Narrow Therapeutic Index Drugs,DrugBank
DB00458,Nervous System,DrugBank
DB00458,Neurotoxic agents,DrugBank
DB00458,Neurotransmitter Agents,DrugBank
DB00458,Neurotransmitter Uptake Inhibitors,DrugBank
DB00458,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00458,OCT2 Inhibitors,DrugBank
DB00458,P-glycoprotein substrates,DrugBank
DB00458,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00458,Psychoanaleptics,DrugBank
DB00458,Psychotropic Drugs,DrugBank
DB00458,QTc Prolonging Agents,DrugBank
DB00458,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00458,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00458,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00458,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00458,Serotonin Agents,DrugBank
DB00458,Serotonin Modulators,DrugBank
DB00458,Serotonin Receptor Antagonists,DrugBank
DB00458,Tertiary amine tricyclic antidepressants,DrugBank
DB00458,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB00460,Antineovascularisation Agents,DrugBank
DB00460,Dermatologicals,DrugBank
DB00460,"EENT Drugs, Miscellaneous",DrugBank
DB00460,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00460,Ocular Vascular Disorder Agents,DrugBank
DB00460,Ophthalmologicals,DrugBank
DB00460,Photoabsorption,DrugBank
DB00460,Photoenhancer,DrugBank
DB00460,Photosensitizing Activity,DrugBank
DB00460,Photosensitizing Agents,DrugBank
DB00460,Porphyrins,DrugBank
DB00460,Radiation-Sensitizing Agents,DrugBank
DB00460,Sensory Organs,DrugBank
DB00461,Agents causing hyperkalemia,DrugBank
DB00461,Agents that produce hypertension,DrugBank
DB00461,Analgesics,DrugBank
DB00461,"Analgesics, Non-Narcotic",DrugBank
DB00461,Anti-Inflammatory Agents,DrugBank
DB00461,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00461,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00461,Antiinflammatory and Antirheumatic Products,DrugBank
DB00461,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00461,Antirheumatic Agents,DrugBank
DB00461,Butanones,DrugBank
DB00461,COX-2 Inhibitors,DrugBank
DB00461,Cyclooxygenase Inhibitors,DrugBank
DB00461,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00461,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00461,Cytochrome P-450 Substrates,DrugBank
DB00461,Drugs causing inadvertant photosensitivity,DrugBank
DB00461,Enzyme Inhibitors,DrugBank
DB00461,Ketones,DrugBank
DB00461,Musculo-Skeletal System,DrugBank
DB00461,Nephrotoxic agents,DrugBank
DB00461,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00461,Photosensitizing Agents,DrugBank
DB00461,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00462,Agents producing tachycardia,DrugBank
DB00462,Alkaloids,DrugBank
DB00462,Anticholinergic Agents,DrugBank
DB00462,Autonomic Agents,DrugBank
DB00462,Aza Compounds,DrugBank
DB00462,Azabicyclo Compounds,DrugBank
DB00462,Muscarinic Antagonists,DrugBank
DB00462,Parasympatholytics,DrugBank
DB00462,Peripheral Nervous System Agents,DrugBank
DB00462,Scopolamine Derivatives,DrugBank
DB00462,Tropanes,DrugBank
DB00463,Anticholinergic Agents,DrugBank
DB00463,Anticonvulsants,DrugBank
DB00463,Barbiturates and Derivatives,DrugBank
DB00463,Central Nervous System Depressants,DrugBank
DB00463,Nervous System,DrugBank
DB00463,Nicotinic Antagonists,DrugBank
DB00463,Pyrimidines,DrugBank
DB00463,Pyrimidinones,DrugBank
DB00465,Acetic Acid Derivatives and Related Substances,DrugBank
DB00465,Agents causing hyperkalemia,DrugBank
DB00465,Agents that produce hypertension,DrugBank
DB00465,Analgesics,DrugBank
DB00465,"Analgesics, Non-Narcotic",DrugBank
DB00465,Anti-Inflammatory Agents,DrugBank
DB00465,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00465,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00465,Antiinflammatory and Antirheumatic Products,DrugBank
DB00465,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00465,Antirheumatic Agents,DrugBank
DB00465,Cyclooxygenase Inhibitors,DrugBank
DB00465,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00465,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00465,Cytochrome P-450 Substrates,DrugBank
DB00465,Drugs causing inadvertant photosensitivity,DrugBank
DB00465,Enzyme Inhibitors,DrugBank
DB00465,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00465,Musculo-Skeletal System,DrugBank
DB00465,Mydriatics,DrugBank
DB00465,Mydriatics and Cycloplegics,DrugBank
DB00465,Nephrotoxic agents,DrugBank
DB00465,Non COX-2 selective NSAIDS,DrugBank
DB00465,Ophthalmologicals,DrugBank
DB00465,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00465,Photosensitizing Agents,DrugBank
DB00465,Sensory Organs,DrugBank
DB00465,Sympathomimetics Excl. Antiglaucoma Preparations,DrugBank
DB00465,UGT2B7 substrates,DrugBank
DB00467,4-Quinolones,DrugBank
DB00467,Anti-Bacterial Agents,DrugBank
DB00467,Anti-Infective Agents,DrugBank
DB00467,Antibacterials for Systemic Use,DrugBank
DB00467,Antiinfectives for Systemic Use,DrugBank
DB00467,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00467,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00467,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00467,Enzyme Inhibitors,DrugBank
DB00467,Fluoroquinolones,DrugBank
DB00467,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00467,Potential QTc-Prolonging Agents,DrugBank
DB00467,QTc Prolonging Agents,DrugBank
DB00467,Quinolines,DrugBank
DB00467,Quinolones,DrugBank
DB00467,Topoisomerase II Inhibitors,DrugBank
DB00467,Topoisomerase Inhibitors,DrugBank
DB00468,Agents that produce neuromuscular block (indirect),DrugBank
DB00468,Agents that reduce seizure threshold,DrugBank
DB00468,Alkaloids,DrugBank
DB00468,Analgesics,DrugBank
DB00468,"Analgesics, Non-Narcotic",DrugBank
DB00468,Anti-Infective Agents,DrugBank
DB00468,Antimalarial methanolquinolines,DrugBank
DB00468,Antimalarials,DrugBank
DB00468,Antiparasitic Agents,DrugBank
DB00468,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00468,Antiprotozoals,DrugBank
DB00468,Blood Glucose Lowering Agents,DrugBank
DB00468,Central Nervous System Agents,DrugBank
DB00468,Central Nervous System Depressants,DrugBank
DB00468,Cinchona Alkaloids,DrugBank
DB00468,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00468,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00468,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00468,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00468,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00468,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00468,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00468,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00468,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00468,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00468,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00468,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00468,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00468,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00468,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00468,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00468,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00468,Cytochrome P-450 Substrates,DrugBank
DB00468,Herbs (Hypotensive Properties),DrugBank
DB00468,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00468,Highest Risk QTc-Prolonging Agents,DrugBank
DB00468,Hypoglycemia-Associated Agents,DrugBank
DB00468,Methemoglobinemia Associated Agents,DrugBank
DB00468,Muscle Relaxants,DrugBank
DB00468,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00468,Musculo-Skeletal System,DrugBank
DB00468,Neuromuscular Agents,DrugBank
DB00468,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00468,OCT1 inhibitors,DrugBank
DB00468,OCT1 substrates,DrugBank
DB00468,OCT2 Inhibitors,DrugBank
DB00468,P-glycoprotein inhibitors,DrugBank
DB00468,P-glycoprotein substrates,DrugBank
DB00468,Peripheral Nervous System Agents,DrugBank
DB00468,QTc Prolonging Agents,DrugBank
DB00468,Quinolines,DrugBank
DB00468,Quinuclidines,DrugBank
DB00468,Sensory System Agents,DrugBank
DB00469,Agents causing hyperkalemia,DrugBank
DB00469,Agents that produce hypertension,DrugBank
DB00469,Analgesics,DrugBank
DB00469,"Analgesics, Non-Narcotic",DrugBank
DB00469,Anti-Inflammatory Agents,DrugBank
DB00469,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00469,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00469,Antiinflammatory and Antirheumatic Products,DrugBank
DB00469,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00469,Antirheumatic Agents,DrugBank
DB00469,Cyclooxygenase Inhibitors,DrugBank
DB00469,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00469,Cytochrome P-450 Substrates,DrugBank
DB00469,Enzyme Inhibitors,DrugBank
DB00469,Musculo-Skeletal System,DrugBank
DB00469,Nephrotoxic agents,DrugBank
DB00469,Non COX-2 selective NSAIDS,DrugBank
DB00469,OAT3/SLC22A8 Inhibitors,DrugBank
DB00469,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00469,Oxicams,DrugBank
DB00469,Peripheral Nervous System Agents,DrugBank
DB00469,Sensory System Agents,DrugBank
DB00469,Sulfur Compounds,DrugBank
DB00469,Thiazines,DrugBank
DB00470,Agents producing tachycardia,DrugBank
DB00470,Alimentary Tract and Metabolism,DrugBank
DB00470,Analgesics,DrugBank
DB00470,"Analgesics, Non-Narcotic",DrugBank
DB00470,Antiemetics and Antinauseants,DrugBank
DB00470,BCRP/ABCG2 Inhibitors,DrugBank
DB00470,Cannabinoid Receptor Agonists,DrugBank
DB00470,Cannabinoids and similars,DrugBank
DB00470,Central Nervous System Agents,DrugBank
DB00470,Central Nervous System Depressants,DrugBank
DB00470,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00470,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00470,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00470,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00470,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00470,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00470,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB00470,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00470,Cytochrome P-450 CYP3A7 Inhibitors (weak),DrugBank
DB00470,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00470,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00470,Cytochrome P-450 Substrates,DrugBank
DB00470,Hallucinogens,DrugBank
DB00470,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00470,Miscellaneous Antiemetics,DrugBank
DB00470,Neurotransmitter Agents,DrugBank
DB00470,P-glycoprotein inhibitors,DrugBank
DB00470,Peripheral Nervous System Agents,DrugBank
DB00470,Psychotropic Drugs,DrugBank
DB00470,Sensory System Agents,DrugBank
DB00470,Terpenes,DrugBank
DB00470,UGT1A1 Substrates,DrugBank
DB00470,UGT1A3 substrates,DrugBank
DB00470,UGT1A9 Substrates,DrugBank
DB00471,"Acids, Acyclic",DrugBank
DB00471,Agents Causing Muscle Toxicity,DrugBank
DB00471,Agents to Treat Airway Disease,DrugBank
DB00471,Anions,DrugBank
DB00471,Anti-Asthmatic Agents,DrugBank
DB00471,Cycloparaffins,DrugBank
DB00471,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00471,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00471,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00471,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00471,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00471,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00471,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00471,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00471,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00471,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00471,Cytochrome P-450 Substrates,DrugBank
DB00471,Drugs for Obstructive Airway Diseases,DrugBank
DB00471,Electrolytes,DrugBank
DB00471,Fatty Acids,DrugBank
DB00471,"Fatty Acids, Volatile",DrugBank
DB00471,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00471,Hormone Antagonists,DrugBank
DB00471,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00471,Hydrogen Sulfide,DrugBank
DB00471,Ions,DrugBank
DB00471,Leukotriene Antagonists,DrugBank
DB00471,Leukotriene Modifiers,DrugBank
DB00471,Lipids,DrugBank
DB00471,OATP2B1/SLCO2B1 substrates,DrugBank
DB00471,Respiratory System Agents,DrugBank
DB00471,Sulfur Compounds,DrugBank
DB00472,Agents that reduce seizure threshold,DrugBank
DB00472,Amines,DrugBank
DB00472,Anticholinergic Agents,DrugBank
DB00472,Antidepressive Agents,DrugBank
DB00472,Antidepressive Agents Indicated for Depression,DrugBank
DB00472,"Antidepressive Agents, Second-Generation",DrugBank
DB00472,Central Nervous System Agents,DrugBank
DB00472,Central Nervous System Depressants,DrugBank
DB00472,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00472,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00472,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00472,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB00472,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00472,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00472,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00472,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00472,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00472,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00472,Cytochrome P-450 Substrates,DrugBank
DB00472,Enzyme Inhibitors,DrugBank
DB00472,Highest Risk QTc-Prolonging Agents,DrugBank
DB00472,Hypoglycemia-Associated Agents,DrugBank
DB00472,Membrane Transport Modulators,DrugBank
DB00472,Nervous System,DrugBank
DB00472,Neurotransmitter Agents,DrugBank
DB00472,Neurotransmitter Uptake Inhibitors,DrugBank
DB00472,Nicotinic Antagonists,DrugBank
DB00472,P-glycoprotein inhibitors,DrugBank
DB00472,Propylamines,DrugBank
DB00472,Psychoanaleptics,DrugBank
DB00472,Psychotropic Drugs,DrugBank
DB00472,QTc Prolonging Agents,DrugBank
DB00472,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00472,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00472,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00472,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00472,Serotonin Agents,DrugBank
DB00472,Serotonin Modulators,DrugBank
DB00472,Serotonin Receptor Antagonists,DrugBank
DB00472,Vasodilating Agents,DrugBank
DB00474,Anesthetics,DrugBank
DB00474,"Anesthetics, General",DrugBank
DB00474,"Anesthetics, Intravenous",DrugBank
DB00474,Anticonvulsants,DrugBank
DB00474,Barbiturates,DrugBank
DB00474,"Barbiturates, Plain",DrugBank
DB00474,Central Nervous System Agents,DrugBank
DB00474,Central Nervous System Depressants,DrugBank
DB00474,Hypnotics and Sedatives,DrugBank
DB00474,Nervous System,DrugBank
DB00474,Psycholeptics,DrugBank
DB00474,Pyrimidines,DrugBank
DB00474,Pyrimidinones,DrugBank
DB00475,"Adjuvants, Anesthesia",DrugBank
DB00475,Anti-Anxiety Agents,DrugBank
DB00475,Benzazepines,DrugBank
DB00475,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00475,Central Nervous System Agents,DrugBank
DB00475,Central Nervous System Depressants,DrugBank
DB00475,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00475,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00475,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00475,Cytochrome P-450 Substrates,DrugBank
DB00475,Cytosine Nucleotides,DrugBank
DB00475,GABA Agents,DrugBank
DB00475,GABA Modulators,DrugBank
DB00475,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00475,Hypnotics and Sedatives,DrugBank
DB00475,Nervous System,DrugBank
DB00475,Neurotransmitter Agents,DrugBank
DB00475,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00475,Nucleotides,DrugBank
DB00475,Psycholeptics,DrugBank
DB00475,Psychotropic Drugs,DrugBank
DB00475,Pyrimidine Nucleotides,DrugBank
DB00475,Pyrimidines,DrugBank
DB00475,Ribonucleotides,DrugBank
DB00475,Tranquilizing Agents,DrugBank
DB00476,Agents producing tachycardia,DrugBank
DB00476,Analgesics,DrugBank
DB00476,Antidepressive Agents,DrugBank
DB00476,Antidepressive Agents Indicated for Depression,DrugBank
DB00476,Central Nervous System Agents,DrugBank
DB00476,Central Nervous System Depressants,DrugBank
DB00476,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00476,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00476,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00476,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00476,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00476,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00476,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00476,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00476,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00476,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00476,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00476,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00476,Cytochrome P-450 Substrates,DrugBank
DB00476,Drugs that are Mainly Renally Excreted,DrugBank
DB00476,Hypoglycemia-Associated Agents,DrugBank
DB00476,Membrane Transport Modulators,DrugBank
DB00476,Nervous System,DrugBank
DB00476,Neurotransmitter Uptake Inhibitors,DrugBank
DB00476,Norepinephrine Uptake Inhibitors,DrugBank
DB00476,P-glycoprotein inhibitors,DrugBank
DB00476,Peripheral Nervous System Agents,DrugBank
DB00476,Psychoanaleptics,DrugBank
DB00476,Psychotropic Drugs,DrugBank
DB00476,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00476,Sensory System Agents,DrugBank
DB00476,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00476,Serotonin Agents,DrugBank
DB00476,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB00476,Serotonin Modulators,DrugBank
DB00476,Sulfur Compounds,DrugBank
DB00476,Thiophenes,DrugBank
DB00477,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00477,Adrenergic alpha-Antagonists,DrugBank
DB00477,Adrenergic Antagonists,DrugBank
DB00477,Agents producing tachycardia,DrugBank
DB00477,Agents that produce hypertension,DrugBank
DB00477,Agents that reduce seizure threshold,DrugBank
DB00477,Anticholinergic Agents,DrugBank
DB00477,Antidepressive Agents,DrugBank
DB00477,Antiemetics,DrugBank
DB00477,Antipsychotic Agents,DrugBank
DB00477,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00477,Autonomic Agents,DrugBank
DB00477,BSEP/ABCB11 Inhibitors,DrugBank
DB00477,Central Nervous System Agents,DrugBank
DB00477,Central Nervous System Depressants,DrugBank
DB00477,Cholinesterase Inhibitors,DrugBank
DB00477,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00477,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00477,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00477,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00477,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00477,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00477,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00477,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00477,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00477,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00477,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00477,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00477,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00477,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00477,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00477,Cytochrome P-450 Substrates,DrugBank
DB00477,Dopamine Agents,DrugBank
DB00477,Dopamine Antagonists,DrugBank
DB00477,Dopamine D2 Receptor Antagonists,DrugBank
DB00477,Drugs causing inadvertant photosensitivity,DrugBank
DB00477,Drugs that are Mainly Renally Excreted,DrugBank
DB00477,Gastrointestinal Agents,DrugBank
DB00477,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00477,Histamine Antagonists,DrugBank
DB00477,Histamine H1 Antagonists,DrugBank
DB00477,Hyperglycemia-Associated Agents,DrugBank
DB00477,Hypotensive Agents,DrugBank
DB00477,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00477,Muscarinic Antagonists,DrugBank
DB00477,Nervous System,DrugBank
DB00477,Neurotoxic agents,DrugBank
DB00477,Neurotransmitter Agents,DrugBank
DB00477,P-glycoprotein inhibitors,DrugBank
DB00477,P-glycoprotein substrates,DrugBank
DB00477,Peripheral Nervous System Agents,DrugBank
DB00477,Phenothiazines,DrugBank
DB00477,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB00477,Photosensitizing Agents,DrugBank
DB00477,Psycholeptics,DrugBank
DB00477,Psychotropic Drugs,DrugBank
DB00477,QTc Prolonging Agents,DrugBank
DB00477,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00477,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00477,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00477,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00477,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00477,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00477,Serotonin Agents,DrugBank
DB00477,Serotonin Receptor Antagonists,DrugBank
DB00477,Sulfur Compounds,DrugBank
DB00477,Tranquilizing Agents,DrugBank
DB00479,Aminoglycoside Antibacterials,DrugBank
DB00479,Anti-Bacterial Agents,DrugBank
DB00479,Anti-Infective Agents,DrugBank
DB00479,Antibacterials for Systemic Use,DrugBank
DB00479,Antiinfectives for Systemic Use,DrugBank
DB00479,Drugs that are Mainly Renally Excreted,DrugBank
DB00479,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00479,Glycosides,DrugBank
DB00479,Narrow Therapeutic Index Drugs,DrugBank
DB00479,Nephrotoxic agents,DrugBank
DB00480,"Acids, Carbocyclic",DrugBank
DB00480,Angiogenesis Inhibitors,DrugBank
DB00480,Angiogenesis Modulating Agents,DrugBank
DB00480,Antineoplastic Agents,DrugBank
DB00480,Antineoplastic and Immunomodulating Agents,DrugBank
DB00480,Drugs that are Mainly Renally Excreted,DrugBank
DB00480,Growth Inhibitors,DrugBank
DB00480,Growth Substances,DrugBank
DB00480,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00480,Imides,DrugBank
DB00480,Immunologic Factors,DrugBank
DB00480,Immunosuppressive Agents,DrugBank
DB00480,Isoindoles,DrugBank
DB00480,Myelosuppressive Agents,DrugBank
DB00480,P-glycoprotein substrates,DrugBank
DB00480,Phthalic Acids,DrugBank
DB00480,Phthalimides,DrugBank
DB00480,Piperidines,DrugBank
DB00480,Piperidones,DrugBank
DB00480,Thalidomide Analog,DrugBank
DB00480,Tumor Necrosis Factor Blockers,DrugBank
DB00481,BCRP/ABCG2 Substrates,DrugBank
DB00481,Benzene Derivatives,DrugBank
DB00481,Benzylidene Compounds,DrugBank
DB00481,Bone Density Conservation Agents,DrugBank
DB00481,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00481,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB00481,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00481,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00481,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00481,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00481,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00481,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00481,Estrogen Agonist-antagonists,DrugBank
DB00481,Estrogen Agonist/Antagonist,DrugBank
DB00481,Estrogen Antagonists,DrugBank
DB00481,Estrogen Receptor Modulators,DrugBank
DB00481,Genito Urinary System and Sex Hormones,DrugBank
DB00481,Hormone Antagonists,DrugBank
DB00481,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00481,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00481,OATP1B3 substrates,DrugBank
DB00481,P-glycoprotein substrates,DrugBank
DB00481,Selective Estrogen Receptor Modulators,DrugBank
DB00481,Sex Hormones and Modulators of the Genital System,DrugBank
DB00481,Stilbenes,DrugBank
DB00481,UGT1A1 Substrates,DrugBank
DB00482,Agents causing hyperkalemia,DrugBank
DB00482,Agents that produce hypertension,DrugBank
DB00482,Amides,DrugBank
DB00482,Analgesics,DrugBank
DB00482,"Analgesics, Non-Narcotic",DrugBank
DB00482,Anti-Inflammatory Agents,DrugBank
DB00482,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00482,Antiinflammatory and Antirheumatic Products,DrugBank
DB00482,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00482,Antineoplastic and Immunomodulating Agents,DrugBank
DB00482,Antirheumatic Agents,DrugBank
DB00482,BCRP/ABCG2 Substrates,DrugBank
DB00482,Benzene Derivatives,DrugBank
DB00482,Benzenesulfonamides,DrugBank
DB00482,BSEP/ABCB11 Inhibitors,DrugBank
DB00482,Central Nervous System Agents,DrugBank
DB00482,COX-2 Inhibitors,DrugBank
DB00482,Cyclooxygenase Inhibitors,DrugBank
DB00482,Cyclooxygenase-2 (COX-2) Inhibitors,DrugBank
DB00482,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00482,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00482,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00482,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00482,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00482,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00482,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00482,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00482,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00482,Cytochrome P-450 Substrates,DrugBank
DB00482,Drugs causing inadvertant photosensitivity,DrugBank
DB00482,Enzyme Inhibitors,DrugBank
DB00482,Genito Urinary System and Sex Hormones,DrugBank
DB00482,Methemoglobinemia Associated Agents,DrugBank
DB00482,Musculo-Skeletal System,DrugBank
DB00482,Nephrotoxic agents,DrugBank
DB00482,P-glycoprotein substrates,DrugBank
DB00482,Peripheral Nervous System Agents,DrugBank
DB00482,Photosensitizing Agents,DrugBank
DB00482,Pyrazoles,DrugBank
DB00482,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00482,Sensory System Agents,DrugBank
DB00482,Sulfonamides,DrugBank
DB00482,Sulfones,DrugBank
DB00482,Sulfur Compounds,DrugBank
DB00483,Agents producing tachycardia,DrugBank
DB00483,Amines,DrugBank
DB00483,Anticholinergic Agents,DrugBank
DB00483,Central Nervous System Depressants,DrugBank
DB00483,Cholinergic Agents,DrugBank
DB00483,Cholinesterase Inhibitors,DrugBank
DB00483,Muscarinic Antagonists,DrugBank
DB00483,Neuromuscular Agents,DrugBank
DB00483,Neuromuscular Blocking Agents,DrugBank
DB00483,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB00483,Neurotransmitter Agents,DrugBank
DB00483,Nicotinic Antagonists,DrugBank
DB00483,Onium Compounds,DrugBank
DB00483,Peripheral Nervous System Agents,DrugBank
DB00483,Quaternary Ammonium Compounds,DrugBank
DB00484,Adrenergic Agents,DrugBank
DB00484,Adrenergic Agonists,DrugBank
DB00484,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00484,Adrenergic alpha-Agonists,DrugBank
DB00484,Antiglaucoma Preparations and Miotics,DrugBank
DB00484,Cardiovascular Agents,DrugBank
DB00484,Central Nervous System Depressants,DrugBank
DB00484,Decongestants and Antiallergics,DrugBank
DB00484,Dermatologicals,DrugBank
DB00484,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00484,Hypotensive Agents,DrugBank
DB00484,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00484,Ophthalmologicals,DrugBank
DB00484,Quinoxalines,DrugBank
DB00484,Sensory Organs,DrugBank
DB00484,Sympathomimetics in Glaucoma Therapy,DrugBank
DB00484,Sympathomimetics Used as Decongestants,DrugBank
DB00485,Amides,DrugBank
DB00485,Anti-Bacterial Agents,DrugBank
DB00485,Anti-Infective Agents,DrugBank
DB00485,Antibacterials for Systemic Use,DrugBank
DB00485,Antiinfectives for Systemic Use,DrugBank
DB00485,Beta-Lactam Antibacterials,DrugBank
DB00485,Beta-Lactamase Resistant Penicillins,DrugBank
DB00485,beta-Lactams,DrugBank
DB00485,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00485,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00485,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00485,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00485,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00485,Lactams,DrugBank
DB00485,Penicillins,DrugBank
DB00485,Sulfur Compounds,DrugBank
DB00486,Agents producing tachycardia,DrugBank
DB00486,Alimentary Tract and Metabolism,DrugBank
DB00486,Antiemetics,DrugBank
DB00486,Antiemetics and Antinauseants,DrugBank
DB00486,Autonomic Agents,DrugBank
DB00486,Cannabinoids and similars,DrugBank
DB00486,Central Nervous System Agents,DrugBank
DB00486,Central Nervous System Depressants,DrugBank
DB00486,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00486,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00486,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00486,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00486,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00486,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00486,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00486,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00486,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00486,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00486,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00486,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00486,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00486,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00486,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00486,Cytochrome P-450 Substrates,DrugBank
DB00486,Drugs causing inadvertant photosensitivity,DrugBank
DB00486,Gastrointestinal Agents,DrugBank
DB00486,Hypotensive Agents,DrugBank
DB00486,Miscellaneous Antiemetics,DrugBank
DB00486,Peripheral Nervous System Agents,DrugBank
DB00486,Photosensitizing Agents,DrugBank
DB00486,Psychotropic Drugs,DrugBank
DB00486,Terpenes,DrugBank
DB00486,Tranquilizing Agents,DrugBank
DB00487,4-Quinolones,DrugBank
DB00487,Anti-Bacterial Agents,DrugBank
DB00487,Anti-Infective Agents,DrugBank
DB00487,Antibacterials for Systemic Use,DrugBank
DB00487,Antiinfectives for Systemic Use,DrugBank
DB00487,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00487,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00487,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00487,Enzyme Inhibitors,DrugBank
DB00487,Fluoroquinolones,DrugBank
DB00487,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00487,Potential QTc-Prolonging Agents,DrugBank
DB00487,QTc Prolonging Agents,DrugBank
DB00487,Quinolines,DrugBank
DB00487,Quinolones,DrugBank
DB00487,Topoisomerase II Inhibitors,DrugBank
DB00487,Topoisomerase Inhibitors,DrugBank
DB00488,Alkylating Activity,DrugBank
DB00488,Alkylating Drugs,DrugBank
DB00488,Antineoplastic Agents,DrugBank
DB00488,"Antineoplastic Agents, Alkylating",DrugBank
DB00488,Antineoplastic and Immunomodulating Agents,DrugBank
DB00488,Immunosuppressive Agents,DrugBank
DB00488,Myelosuppressive Agents,DrugBank
DB00488,Narrow Therapeutic Index Drugs,DrugBank
DB00488,Noxae,DrugBank
DB00488,Toxic Actions,DrugBank
DB00488,Triazines,DrugBank
DB00489,Adrenergic Agents,DrugBank
DB00489,Adrenergic Antagonists,DrugBank
DB00489,Adrenergic beta-Antagonists,DrugBank
DB00489,Agents causing hyperkalemia,DrugBank
DB00489,Alcohols,DrugBank
DB00489,Amines,DrugBank
DB00489,Amino Alcohols,DrugBank
DB00489,Antiarrhythmic agents,DrugBank
DB00489,Autonomic Agents,DrugBank
DB00489,Beta Blocking Agents and Thiazides,DrugBank
DB00489,"Beta Blocking Agents, Non-Selective",DrugBank
DB00489,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB00489,Bradycardia-Causing Agents,DrugBank
DB00489,Cardiac Rhythm Alteration,DrugBank
DB00489,Cardiovascular Agents,DrugBank
DB00489,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00489,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00489,Cytochrome P-450 Substrates,DrugBank
DB00489,Ethanolamines,DrugBank
DB00489,Highest Risk QTc-Prolonging Agents,DrugBank
DB00489,Hypotensive Agents,DrugBank
DB00489,Narrow Therapeutic Index Drugs,DrugBank
DB00489,Neurotransmitter Agents,DrugBank
DB00489,Peripheral Nervous System Agents,DrugBank
DB00489,QTc Prolonging Agents,DrugBank
DB00489,Sympatholytics,DrugBank
DB00490,Agents that produce hypertension,DrugBank
DB00490,Antidepressive Agents,DrugBank
DB00490,Azaspirodecanedione Derivatives,DrugBank
DB00490,Central Nervous System Agents,DrugBank
DB00490,Central Nervous System Depressants,DrugBank
DB00490,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00490,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00490,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00490,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00490,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00490,Cytochrome P-450 Substrates,DrugBank
DB00490,Dopamine Antagonists,DrugBank
DB00490,Dopamine D2 Receptor Antagonists,DrugBank
DB00490,Drugs that are Mainly Renally Excreted,DrugBank
DB00490,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00490,Nervous System,DrugBank
DB00490,Neurotransmitter Agents,DrugBank
DB00490,P-glycoprotein inhibitors,DrugBank
DB00490,Piperazines,DrugBank
DB00490,Psycholeptics,DrugBank
DB00490,Pyrimidines,DrugBank
DB00490,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00490,Serotonin Agents,DrugBank
DB00490,Spiro Compounds,DrugBank
DB00490,Tranquilizing Agents,DrugBank
DB00491,Alimentary Tract and Metabolism,DrugBank
DB00491,Alkaloids,DrugBank
DB00491,Blood Glucose Lowering Agents,DrugBank
DB00491,Carbohydrates,DrugBank
DB00491,Drugs Used in Diabetes,DrugBank
DB00491,Enzyme Inhibitors,DrugBank
DB00491,Glycoside Hydrolase Inhibitors,DrugBank
DB00491,Hypoglycemia-Associated Agents,DrugBank
DB00491,Imines,DrugBank
DB00491,Imino Pyranoses,DrugBank
DB00491,Imino Sugars,DrugBank
DB00491,Oral Hypoglycemics,DrugBank
DB00491,Piperidines,DrugBank
DB00492,ACE Inhibitors and Diuretics,DrugBank
DB00492,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00492,Agents causing angioedema,DrugBank
DB00492,Agents causing hyperkalemia,DrugBank
DB00492,Amino Acids,DrugBank
DB00492,"Amino Acids, Cyclic",DrugBank
DB00492,"Amino Acids, Peptides, and Proteins",DrugBank
DB00492,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00492,Antihypertensive Agents,DrugBank
DB00492,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00492,Cardiovascular Agents,DrugBank
DB00492,Drugs causing inadvertant photosensitivity,DrugBank
DB00492,Drugs that are Mainly Renally Excreted,DrugBank
DB00492,Enzyme Inhibitors,DrugBank
DB00492,Hypotensive Agents,DrugBank
DB00492,Imino Acids,DrugBank
DB00492,Organophosphorus Compounds,DrugBank
DB00492,Phosphinic Acids,DrugBank
DB00492,Photosensitizing Agents,DrugBank
DB00492,Protease Inhibitors,DrugBank
DB00493,Agents that reduce seizure threshold,DrugBank
DB00493,Amides,DrugBank
DB00493,Anti-Bacterial Agents,DrugBank
DB00493,Anti-Infective Agents,DrugBank
DB00493,Antibacterials for Systemic Use,DrugBank
DB00493,Antiinfectives for Systemic Use,DrugBank
DB00493,beta-Lactams,DrugBank
DB00493,Cephalosporins,DrugBank
DB00493,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00493,Lactams,DrugBank
DB00493,Nephrotoxic agents,DrugBank
DB00493,OAT1/SLC22A6 inhibitors,DrugBank
DB00493,OAT3/SLC22A8 Inhibitors,DrugBank
DB00493,Sulfur Compounds,DrugBank
DB00493,Thiazines,DrugBank
DB00493,Third-Generation Cephalosporins,DrugBank
DB00494,Anti-Dyskinesia Agents,DrugBank
DB00494,Anti-Parkinson Drugs,DrugBank
DB00494,Benzene Derivatives,DrugBank
DB00494,Central Nervous System Agents,DrugBank
DB00494,Central Nervous System Depressants,DrugBank
DB00494,COMT Inhibitors,DrugBank
DB00494,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00494,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00494,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00494,Dopamine Agents,DrugBank
DB00494,Enzyme Inhibitors,DrugBank
DB00494,Nervous System,DrugBank
DB00494,Phenols,DrugBank
DB00494,UGT1A9 Substrates,DrugBank
DB00495,Agents Causing Muscle Toxicity,DrugBank
DB00495,Anti-HIV Agents,DrugBank
DB00495,Anti-Infective Agents,DrugBank
DB00495,Anti-Retroviral Agents,DrugBank
DB00495,Antiinfectives for Systemic Use,DrugBank
DB00495,Antimetabolites,DrugBank
DB00495,Antiviral Agents,DrugBank
DB00495,Antivirals for Systemic Use,DrugBank
DB00495,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00495,BCRP/ABCG2 Substrates,DrugBank
DB00495,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00495,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00495,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00495,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00495,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00495,Cytochrome P-450 Substrates,DrugBank
DB00495,Deoxyribonucleosides,DrugBank
DB00495,Dideoxynucleosides,DrugBank
DB00495,Direct Acting Antivirals,DrugBank
DB00495,Enzyme Inhibitors,DrugBank
DB00495,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00495,Immunosuppressive Agents,DrugBank
DB00495,Myelosuppressive Agents,DrugBank
DB00495,Noxae,DrugBank
DB00495,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00495,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00495,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00495,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00495,Nucleosides,DrugBank
DB00495,OAT1/SLC22A6 Substrates,DrugBank
DB00495,OAT3/SLC22A8 Inhibitors,DrugBank
DB00495,OAT3/SLC22A8 Substrates,DrugBank
DB00495,P-glycoprotein substrates,DrugBank
DB00495,Pyrimidine Nucleosides,DrugBank
DB00495,Pyrimidines,DrugBank
DB00495,Reverse Transcriptase Inhibitors,DrugBank
DB00495,Toxic Actions,DrugBank
DB00495,UGT1A1 Inducers,DrugBank
DB00495,UGT1A1 Substrates,DrugBank
DB00495,UGT2B7 substrates,DrugBank
DB00496,Agents producing tachycardia,DrugBank
DB00496,Anticholinergic Agents,DrugBank
DB00496,Cholinergic Agents,DrugBank
DB00496,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00496,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00496,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00496,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00496,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00496,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00496,Cytochrome P-450 Substrates,DrugBank
DB00496,Drugs for Urinary Frequency and Incontinence,DrugBank
DB00496,Genito Urinary System and Sex Hormones,DrugBank
DB00496,Genitourinary Agents,DrugBank
DB00496,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00496,Muscarinic Antagonists,DrugBank
DB00496,Neurotransmitter Agents,DrugBank
DB00496,Urological Agents,DrugBank
DB00496,Urologicals,DrugBank
DB00497,Alkaloids,DrugBank
DB00497,Analgesics,DrugBank
DB00497,Central Nervous System Agents,DrugBank
DB00497,Central Nervous System Depressants,DrugBank
DB00497,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00497,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00497,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00497,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00497,Cytochrome P-450 Substrates,DrugBank
DB00497,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00497,Morphinans,DrugBank
DB00497,Morphine Derivatives,DrugBank
DB00497,Narcotics,DrugBank
DB00497,Natural Opium Alkaloids,DrugBank
DB00497,Nervous System,DrugBank
DB00497,Opiate Agonists,DrugBank
DB00497,Opiate Alkaloids,DrugBank
DB00497,Opioid Agonist,DrugBank
DB00497,Opioids,DrugBank
DB00497,Peripheral Nervous System Agents,DrugBank
DB00497,Phenanthrenes,DrugBank
DB00497,Semi-synthetic Opioids,DrugBank
DB00497,Sensory System Agents,DrugBank
DB00497,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00498,Anticoagulants,DrugBank
DB00498,Blood and Blood Forming Organs,DrugBank
DB00498,Hematologic Agents,DrugBank
DB00498,Indans,DrugBank
DB00498,Indenes,DrugBank
DB00498,Narrow Therapeutic Index Drugs,DrugBank
DB00498,Vitamin K Antagonists,DrugBank
DB00499,Amides,DrugBank
DB00499,Amines,DrugBank
DB00499,Androgen Receptor Antagonists,DrugBank
DB00499,Androgen Receptor Inhibitors,DrugBank
DB00499,Anilides,DrugBank
DB00499,Aniline Compounds,DrugBank
DB00499,Antiandrogens,DrugBank
DB00499,"Antiandrogens, non-steroidal",DrugBank
DB00499,Antineoplastic Agents,DrugBank
DB00499,"Antineoplastic Agents, Hormonal",DrugBank
DB00499,Antineoplastic and Immunomodulating Agents,DrugBank
DB00499,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00499,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00499,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00499,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00499,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00499,Cytochrome P-450 Substrates,DrugBank
DB00499,Drugs that are Mainly Renally Excreted,DrugBank
DB00499,Endocrine Therapy,DrugBank
DB00499,Hormone Antagonists,DrugBank
DB00499,Hormone Antagonists and Related Agents,DrugBank
DB00499,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00499,Methemoglobinemia Associated Agents,DrugBank
DB00500,Acetic Acid Derivatives and Related Substances,DrugBank
DB00500,Agents causing hyperkalemia,DrugBank
DB00500,Agents that produce hypertension,DrugBank
DB00500,Analgesics,DrugBank
DB00500,"Analgesics, Non-Narcotic",DrugBank
DB00500,Anti-Inflammatory Agents,DrugBank
DB00500,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00500,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00500,Antiinflammatory and Antirheumatic Products,DrugBank
DB00500,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00500,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00500,Antirheumatic Agents,DrugBank
DB00500,Cyclooxygenase Inhibitors,DrugBank
DB00500,Enzyme Inhibitors,DrugBank
DB00500,Musculo-Skeletal System,DrugBank
DB00500,Nephrotoxic agents,DrugBank
DB00500,Non COX-2 selective NSAIDS,DrugBank
DB00500,OAT1/SLC22A6 inhibitors,DrugBank
DB00500,Peripheral Nervous System Agents,DrugBank
DB00500,Sensory System Agents,DrugBank
DB00500,Topical Products for Joint and Muscular Pain,DrugBank
DB00501,Acid Reducers,DrugBank
DB00501,Adjuvants,DrugBank
DB00501,Agents Causing Muscle Toxicity,DrugBank
DB00501,Alimentary Tract and Metabolism,DrugBank
DB00501,Amidines,DrugBank
DB00501,Anti-Ulcer Agents,DrugBank
DB00501,BSEP/ABCB11 Inhibitors,DrugBank
DB00501,Chemically-Induced Disorders,DrugBank
DB00501,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00501,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00501,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00501,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00501,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00501,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00501,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00501,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB00501,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00501,Cytochrome P-450 CYP3A7 Inhibitors (moderate),DrugBank
DB00501,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00501,Drugs for Acid Related Disorders,DrugBank
DB00501,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00501,Drugs that are Mainly Renally Excreted,DrugBank
DB00501,Enzyme Inhibitors,DrugBank
DB00501,Gastric Acid Lowering Agents,DrugBank
DB00501,Gastrointestinal Agents,DrugBank
DB00501,Guanidines,DrugBank
DB00501,Histamine Agents,DrugBank
DB00501,Histamine Antagonists,DrugBank
DB00501,Histamine H2 Antagonists,DrugBank
DB00501,Imidazoles,DrugBank
DB00501,MATE 1 Inhibitors,DrugBank
DB00501,MATE 1 Substrates,DrugBank
DB00501,MATE 2 Inhibitors,DrugBank
DB00501,MATE 2 Substrates,DrugBank
DB00501,MATE inhibitors,DrugBank
DB00501,MATE substrates,DrugBank
DB00501,Neurotransmitter Agents,DrugBank
DB00501,OAT1/SLC22A6 inhibitors,DrugBank
DB00501,OAT1/SLC22A6 Substrates,DrugBank
DB00501,OAT3/SLC22A8 Inhibitors,DrugBank
DB00501,OAT3/SLC22A8 Substrates,DrugBank
DB00501,OCT1 inhibitors,DrugBank
DB00501,OCT1 substrates,DrugBank
DB00501,OCT2 Inhibitors,DrugBank
DB00501,OCT2 Substrates,DrugBank
DB00501,P-glycoprotein inducers,DrugBank
DB00501,P-glycoprotein substrates,DrugBank
DB00502,Agents that reduce seizure threshold,DrugBank
DB00502,Anti-Dyskinesia Agents,DrugBank
DB00502,Antidepressive Agents,DrugBank
DB00502,Antiemetics,DrugBank
DB00502,Antipsychotic Agents,DrugBank
DB00502,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00502,Autonomic Agents,DrugBank
DB00502,Butyrophenone Derivatives,DrugBank
DB00502,Butyrophenones,DrugBank
DB00502,Central Nervous System Agents,DrugBank
DB00502,Central Nervous System Depressants,DrugBank
DB00502,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00502,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00502,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00502,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00502,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00502,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00502,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00502,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00502,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00502,Cytochrome P-450 Substrates,DrugBank
DB00502,Dopamine Agents,DrugBank
DB00502,Dopamine Antagonists,DrugBank
DB00502,Dopamine D2 Receptor Antagonists,DrugBank
DB00502,Drugs causing inadvertant photosensitivity,DrugBank
DB00502,Drugs that are Mainly Renally Excreted,DrugBank
DB00502,Gastrointestinal Agents,DrugBank
DB00502,Hyperglycemia-Associated Agents,DrugBank
DB00502,Ketones,DrugBank
DB00502,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00502,Nervous System,DrugBank
DB00502,Neurotoxic agents,DrugBank
DB00502,Neurotransmitter Agents,DrugBank
DB00502,NMDA Receptor Antagonists,DrugBank
DB00502,P-glycoprotein inhibitors,DrugBank
DB00502,P-glycoprotein substrates,DrugBank
DB00502,Peripheral Nervous System Agents,DrugBank
DB00502,Photosensitizing Agents,DrugBank
DB00502,Psycholeptics,DrugBank
DB00502,Psychotropic Drugs,DrugBank
DB00502,QTc Prolonging Agents,DrugBank
DB00502,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00502,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00502,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00502,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00502,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00502,Serotonin Agents,DrugBank
DB00502,Serotonin Receptor Antagonists,DrugBank
DB00502,Tranquilizing Agents,DrugBank
DB00502,UGT1A9 Substrates,DrugBank
DB00503,"Acids, Acyclic",DrugBank
DB00503,Agents Causing Muscle Toxicity,DrugBank
DB00503,Anti-HIV Agents,DrugBank
DB00503,Anti-Infective Agents,DrugBank
DB00503,Anti-Retroviral Agents,DrugBank
DB00503,Antiinfectives for Systemic Use,DrugBank
DB00503,Antiviral Agents,DrugBank
DB00503,Antivirals for Systemic Use,DrugBank
DB00503,Antivirals for treatment of HCV infections,DrugBank
DB00503,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00503,BCRP/ABCG2 Inhibitors,DrugBank
DB00503,BCRP/ABCG2 Substrates,DrugBank
DB00503,BSEP/ABCB11 Inhibitors,DrugBank
DB00503,BSEP/ABCB11 Substrates,DrugBank
DB00503,Chemically-Induced Disorders,DrugBank
DB00503,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00503,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00503,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00503,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00503,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB00503,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00503,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00503,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00503,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00503,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00503,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00503,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00503,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00503,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB00503,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00503,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00503,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00503,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00503,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00503,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00503,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00503,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB00503,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00503,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00503,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB00503,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00503,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00503,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00503,Cytochrome P-450 Substrates,DrugBank
DB00503,Direct Acting Antivirals,DrugBank
DB00503,Enzyme Inhibitors,DrugBank
DB00503,Experimental Unapproved Treatments for COVID-19,DrugBank
DB00503,HIV Protease Inhibitors,DrugBank
DB00503,Hyperglycemia-Associated Agents,DrugBank
DB00503,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00503,OATP1B3 inhibitors,DrugBank
DB00503,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00503,P-glycoprotein inducers,DrugBank
DB00503,P-glycoprotein inhibitors,DrugBank
DB00503,P-glycoprotein substrates,DrugBank
DB00503,Potential QTc-Prolonging Agents,DrugBank
DB00503,Protease Inhibitors,DrugBank
DB00503,QTc Prolonging Agents,DrugBank
DB00503,Sulfur Compounds,DrugBank
DB00503,Thiazoles,DrugBank
DB00503,Treatments for Hepatitis C,DrugBank
DB00503,UDP Glucuronosyltransferases Inducers,DrugBank
DB00503,UGT1A1 Inducers,DrugBank
DB00503,Viral Protease Inhibitors,DrugBank
DB00505,Agents producing tachycardia,DrugBank
DB00505,Alimentary Tract and Metabolism,DrugBank
DB00505,Amines,DrugBank
DB00505,Ammonium Compounds,DrugBank
DB00505,Anticholinergic Agents,DrugBank
DB00505,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00505,Muscarinic Antagonists,DrugBank
DB00505,Nitrogen Compounds,DrugBank
DB00505,Onium Compounds,DrugBank
DB00505,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB00508,Agents producing tachycardia,DrugBank
DB00508,Anticholinergic Agents,DrugBank
DB00508,Antidepressive Agents,DrugBank
DB00508,Antiemetics,DrugBank
DB00508,Antipsychotic Agents,DrugBank
DB00508,Autonomic Agents,DrugBank
DB00508,Central Nervous System Agents,DrugBank
DB00508,Central Nervous System Depressants,DrugBank
DB00508,Cholinesterase Inhibitors,DrugBank
DB00508,Dopamine Agents,DrugBank
DB00508,Dopamine Antagonists,DrugBank
DB00508,Dopamine D2 Receptor Antagonists,DrugBank
DB00508,Gastrointestinal Agents,DrugBank
DB00508,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00508,Muscarinic Antagonists,DrugBank
DB00508,Nervous System,DrugBank
DB00508,Neurotoxic agents,DrugBank
DB00508,Neurotransmitter Agents,DrugBank
DB00508,P-glycoprotein inhibitors,DrugBank
DB00508,Peripheral Nervous System Agents,DrugBank
DB00508,Phenothiazines,DrugBank
DB00508,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB00508,Psycholeptics,DrugBank
DB00508,Psychotropic Drugs,DrugBank
DB00508,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00508,Serotonin Agents,DrugBank
DB00508,Serotonin Receptor Antagonists,DrugBank
DB00508,Sulfur Compounds,DrugBank
DB00508,Tranquilizing Agents,DrugBank
DB00511,Antiarrhythmic agents,DrugBank
DB00511,Carbohydrates,DrugBank
DB00511,Cardanolides,DrugBank
DB00511,Cardenolides,DrugBank
DB00511,Cardiac Glycosides,DrugBank
DB00511,Cardiac Therapy,DrugBank
DB00511,Cardiotonic Agents,DrugBank
DB00511,Cardiovascular Agents,DrugBank
DB00511,"Compounds used in a research, industrial, or household setting",DrugBank
DB00511,Digitalis Glycosides,DrugBank
DB00511,Enzyme Inhibitors,DrugBank
DB00511,Fused-Ring Compounds,DrugBank
DB00511,Glycosides,DrugBank
DB00511,Protective Agents,DrugBank
DB00511,Steroids,DrugBank
DB00512,Agents that produce neuromuscular block (indirect),DrugBank
DB00512,Alimentary Tract and Metabolism,DrugBank
DB00512,"Amino Acids, Peptides, and Proteins",DrugBank
DB00512,Anti-Bacterial Agents,DrugBank
DB00512,Anti-Infective Agents,DrugBank
DB00512,Antibacterials for Systemic Use,DrugBank
DB00512,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00512,Antiinfectives for Systemic Use,DrugBank
DB00512,Carbohydrates,DrugBank
DB00512,Drugs that are Mainly Renally Excreted,DrugBank
DB00512,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00512,Glycoconjugates,DrugBank
DB00512,Glycopeptide Antibacterials,DrugBank
DB00512,Glycopeptides,DrugBank
DB00512,Intestinal Antiinfectives,DrugBank
DB00512,Narrow Therapeutic Index Drugs,DrugBank
DB00512,Nephrotoxic agents,DrugBank
DB00512,Ophthalmologicals,DrugBank
DB00512,Peptides,DrugBank
DB00512,Sensory Organs,DrugBank
DB00513,"Acids, Acyclic",DrugBank
DB00513,Amino Acids,DrugBank
DB00513,"Amino Acids, Peptides, and Proteins",DrugBank
DB00513,Aminocaproates,DrugBank
DB00513,Antifibrinolytic Agents,DrugBank
DB00513,Blood and Blood Forming Organs,DrugBank
DB00513,Caproates,DrugBank
DB00513,Coagulants,DrugBank
DB00513,Decreased Fibrinolysis,DrugBank
DB00513,Fibrin Modulating Agents,DrugBank
DB00513,Hematologic Agents,DrugBank
DB00513,Hemostatics,DrugBank
DB00514,Alkaloids,DrugBank
DB00514,Anticholinergic Agents,DrugBank
DB00514,Antidepressive Agents,DrugBank
DB00514,Antitussive Agents,DrugBank
DB00514,Central Nervous System Agents,DrugBank
DB00514,Central Nervous System Depressants,DrugBank
DB00514,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00514,Cough and Cold Preparations,DrugBank
DB00514,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00514,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00514,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00514,Cytochrome P-450 Substrates,DrugBank
DB00514,Excitatory Amino Acid Agents,DrugBank
DB00514,Excitatory Amino Acid Antagonists,DrugBank
DB00514,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00514,Morphinans,DrugBank
DB00514,Nervous System,DrugBank
DB00514,Neurotransmitter Agents,DrugBank
DB00514,Nicotinic Antagonists,DrugBank
DB00514,NMDA Receptor Antagonists,DrugBank
DB00514,Opiate Alkaloids,DrugBank
DB00514,Opioids,DrugBank
DB00514,Opium Alkaloids and Derivatives,DrugBank
DB00514,Phenanthrenes,DrugBank
DB00514,Psychoanaleptics,DrugBank
DB00514,Respiratory System Agents,DrugBank
DB00514,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00514,Serotonin Agents,DrugBank
DB00514,Serotonin Modulators,DrugBank
DB00514,Sigma-1 Agonist,DrugBank
DB00514,Sigma-1 Receptor Agonists,DrugBank
DB00514,UGT2B17 substrates,DrugBank
DB00514,UGT2B7 substrates,DrugBank
DB00514,Uncompetitive N-methyl-D-aspartate Receptor Antagonist,DrugBank
DB00514,Uncompetitive NMDA Receptor Antagonists,DrugBank
DB00515,Antineoplastic Agents,DrugBank
DB00515,Antineoplastic and Immunomodulating Agents,DrugBank
DB00515,BCRP/ABCG2 Substrates,DrugBank
DB00515,Cardiotoxic antineoplastic agents,DrugBank
DB00515,Chlorine Compounds,DrugBank
DB00515,Cholinesterase Inhibitors,DrugBank
DB00515,"Compounds used in a research, industrial, or household setting",DrugBank
DB00515,Cross-Linking Reagents,DrugBank
DB00515,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00515,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00515,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00515,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00515,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00515,Cytotoxins,DrugBank
DB00515,Drugs that are Mainly Renally Excreted,DrugBank
DB00515,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00515,Immunosuppressive Agents,DrugBank
DB00515,Indicators and Reagents,DrugBank
DB00515,Laboratory Chemicals,DrugBank
DB00515,Myelosuppressive Agents,DrugBank
DB00515,Narrow Therapeutic Index Drugs,DrugBank
DB00515,Nephrotoxic agents,DrugBank
DB00515,Nitrogen Compounds,DrugBank
DB00515,OCT2 Inhibitors,DrugBank
DB00515,OCT2 Substrates,DrugBank
DB00515,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00515,Platinum Compounds,DrugBank
DB00515,Radiation-Sensitizing Agents,DrugBank
DB00517,Agents producing tachycardia,DrugBank
DB00517,Alkaloids,DrugBank
DB00517,Anticholinergic Agents,DrugBank
DB00517,Aza Compounds,DrugBank
DB00517,Azabicyclo Compounds,DrugBank
DB00517,Cholinergic Agents,DrugBank
DB00517,Muscarinic Antagonists,DrugBank
DB00517,Neurotransmitter Agents,DrugBank
DB00518,"Acids, Acyclic",DrugBank
DB00518,Anthelmintics,DrugBank
DB00518,Anti-Infective Agents,DrugBank
DB00518,Anticestodal Agents,DrugBank
DB00518,Antihelminthic,DrugBank
DB00518,Antimitotic Agents,DrugBank
DB00518,Antinematodal Agents,DrugBank
DB00518,Antiparasitic Agents,DrugBank
DB00518,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00518,Antiplatyhelmintic Agents,DrugBank
DB00518,Benzimidazole Derivatives,DrugBank
DB00518,Benzimidazoles,DrugBank
DB00518,Carbamates,DrugBank
DB00518,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00518,Cytochrome P-450 CYP1A2 Inducers (strong),DrugBank
DB00518,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00518,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00518,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00518,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00518,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00518,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00518,Cytochrome P-450 Substrates,DrugBank
DB00518,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00518,Mitosis Modulators,DrugBank
DB00518,P-glycoprotein substrates,DrugBank
DB00518,Tubulin Modulators,DrugBank
DB00519,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00519,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00519,Agents causing angioedema,DrugBank
DB00519,Agents causing hyperkalemia,DrugBank
DB00519,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00519,Antihypertensive Agents,DrugBank
DB00519,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00519,Cardiovascular Agents,DrugBank
DB00519,Enzyme Inhibitors,DrugBank
DB00519,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00519,Hypotensive Agents,DrugBank
DB00519,Protease Inhibitors,DrugBank
DB00520,"Amino Acids, Peptides, and Proteins",DrugBank
DB00520,Anti-Infective Agents,DrugBank
DB00520,Antifungal Agents,DrugBank
DB00520,Antiinfectives for Systemic Use,DrugBank
DB00520,Antimycotics for Systemic Use,DrugBank
DB00520,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00520,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00520,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00520,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00520,Echinocandin Antifungal,DrugBank
DB00520,Echinocandins,DrugBank
DB00520,Enzyme Inhibitors,DrugBank
DB00520,Lipids,DrugBank
DB00520,Lipopeptides,DrugBank
DB00520,OAT1/SLC22A6 inhibitors,DrugBank
DB00520,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00520,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00520,OATP1B3 substrates,DrugBank
DB00520,P-glycoprotein inhibitors,DrugBank
DB00520,Peptides,DrugBank
DB00520,"Peptides, Cyclic",DrugBank
DB00521,Adrenergic Agents,DrugBank
DB00521,Adrenergic Antagonists,DrugBank
DB00521,Adrenergic beta-Antagonists,DrugBank
DB00521,Agents causing hyperkalemia,DrugBank
DB00521,Alcohols,DrugBank
DB00521,Amines,DrugBank
DB00521,Amino Alcohols,DrugBank
DB00521,Antiarrhythmic agents,DrugBank
DB00521,Antiglaucoma Preparations and Miotics,DrugBank
DB00521,Antihypertensive Agents,DrugBank
DB00521,Autonomic Agents,DrugBank
DB00521,"Beta Blocking Agents, Non-Selective",DrugBank
DB00521,Bradycardia-Causing Agents,DrugBank
DB00521,Cardiovascular Agents,DrugBank
DB00521,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00521,Cytochrome P-450 Substrates,DrugBank
DB00521,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00521,Hypotensive Agents,DrugBank
DB00521,Negative Inotrope,DrugBank
DB00521,Neurotransmitter Agents,DrugBank
DB00521,Ophthalmologicals,DrugBank
DB00521,Peripheral Nervous System Agents,DrugBank
DB00521,Phenoxypropanolamines,DrugBank
DB00521,Potential QTc-Prolonging Agents,DrugBank
DB00521,Propanolamines,DrugBank
DB00521,Propanols,DrugBank
DB00521,QTc Prolonging Agents,DrugBank
DB00521,Quinolines,DrugBank
DB00521,Quinolones,DrugBank
DB00521,Sensory Organs,DrugBank
DB00521,Sympatholytics,DrugBank
DB00523,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB00523,Alkenes,DrugBank
DB00523,Antineoplastic Agents,DrugBank
DB00523,Antineoplastic and Immunomodulating Agents,DrugBank
DB00523,Biological Factors,DrugBank
DB00523,Carotenoids,DrugBank
DB00523,Cyclohexanes,DrugBank
DB00523,Cyclohexenes,DrugBank
DB00523,Cycloparaffins,DrugBank
DB00523,Dermatologicals,DrugBank
DB00523,Diterpenes,DrugBank
DB00523,"Hydrocarbons, Acyclic",DrugBank
DB00523,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00523,P-glycoprotein substrates,DrugBank
DB00523,"Pigments, Biological",DrugBank
DB00523,Polyenes,DrugBank
DB00523,Retinoids,DrugBank
DB00523,Retinoids for cancer treatment,DrugBank
DB00523,Terpenes,DrugBank
DB00523,Vitamin A,DrugBank
DB00523,Vitamins,DrugBank
DB00523,Vitamins (Fat Soluble),DrugBank
DB00524,Amides,DrugBank
DB00524,Antihypertensive Agents,DrugBank
DB00524,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00524,Cardiovascular Agents,DrugBank
DB00524,Diuretics,DrugBank
DB00524,Drugs that are Mainly Renally Excreted,DrugBank
DB00524,Genito Urinary System and Sex Hormones,DrugBank
DB00524,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00524,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00524,Hyperglycemia-Associated Agents,DrugBank
DB00524,Hypotensive Agents,DrugBank
DB00524,Increased Diuresis,DrugBank
DB00524,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00524,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB00524,Membrane Transport Modulators,DrugBank
DB00524,Natriuretic Agents,DrugBank
DB00524,Non Potassium Sparing Diuretics,DrugBank
DB00524,Quinazolines,DrugBank
DB00524,Quinazolinones,DrugBank
DB00524,Sodium Chloride Symporter Inhibitors,DrugBank
DB00524,Sulfonamides,DrugBank
DB00524,Sulfones,DrugBank
DB00524,Sulfur Compounds,DrugBank
DB00524,Thiazide-like Diuretic,DrugBank
DB00526,Antineoplastic Agents,DrugBank
DB00526,Antineoplastic and Immunomodulating Agents,DrugBank
DB00526,BCRP/ABCG2 Substrates,DrugBank
DB00526,Coordination Complexes,DrugBank
DB00526,Immunosuppressive Agents,DrugBank
DB00526,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00526,Myelosuppressive Agents,DrugBank
DB00526,Narrow Therapeutic Index Drugs,DrugBank
DB00526,OCT2 Substrates,DrugBank
DB00526,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00526,Platinum Compounds,DrugBank
DB00526,QTc Prolonging Agents,DrugBank
DB00527,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00527,Amides,DrugBank
DB00527,Analgesics and Anesthetics,DrugBank
DB00527,Anesthetics,DrugBank
DB00527,Anesthetics for Topical Use,DrugBank
DB00527,"Anesthetics, Local",DrugBank
DB00527,Antipruritics and Local Anesthetics,DrugBank
DB00527,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB00527,Cell-mediated Immunity,DrugBank
DB00527,Central Nervous System Agents,DrugBank
DB00527,Central Nervous System Depressants,DrugBank
DB00527,Cholinesterase Inhibitors,DrugBank
DB00527,Dermatologicals,DrugBank
DB00527,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00527,Increased Histamine Release,DrugBank
DB00527,Local Anesthetics (Amide),DrugBank
DB00527,Nervous System,DrugBank
DB00527,Ophthalmologicals,DrugBank
DB00527,Otologicals,DrugBank
DB00527,Peripheral Nervous System Agents,DrugBank
DB00527,Quinolines,DrugBank
DB00527,Sensory Organs,DrugBank
DB00527,Sensory System Agents,DrugBank
DB00527,Standardized Chemical Allergen,DrugBank
DB00527,Vasoprotectives,DrugBank
DB00528,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00528,Agents causing hyperkalemia,DrugBank
DB00528,Agents Causing Muscle Toxicity,DrugBank
DB00528,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00528,Antiarrhythmic agents,DrugBank
DB00528,Antihypertensive Agents,DrugBank
DB00528,Bradycardia-Causing Agents,DrugBank
DB00528,Calcium Channel Blockers,DrugBank
DB00528,Calcium-Regulating Hormones and Agents,DrugBank
DB00528,Cardiovascular Agents,DrugBank
DB00528,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00528,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00528,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00528,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00528,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00528,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00528,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00528,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00528,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00528,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00528,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00528,Cytochrome P-450 Substrates,DrugBank
DB00528,Dihydropyridine Derivatives,DrugBank
DB00528,Hypotensive Agents,DrugBank
DB00528,Membrane Transport Modulators,DrugBank
DB00528,Pyridines,DrugBank
DB00528,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00528,Vasodilating Agents,DrugBank
DB00529,Acetates,DrugBank
DB00529,"Acids, Acyclic",DrugBank
DB00529,Anti-Infective Agents,DrugBank
DB00529,Anti-Retroviral Agents,DrugBank
DB00529,Antiinfectives for Systemic Use,DrugBank
DB00529,Antiviral Agents,DrugBank
DB00529,Antivirals for Systemic Use,DrugBank
DB00529,Chelating Activity,DrugBank
DB00529,Direct Acting Antivirals,DrugBank
DB00529,Enzyme Inhibitors,DrugBank
DB00529,Nephrotoxic agents,DrugBank
DB00529,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00529,OAT1/SLC22A6 inhibitors,DrugBank
DB00529,Organophosphonates,DrugBank
DB00529,Organophosphorus Compounds,DrugBank
DB00529,Phosphonic Acid Derivatives,DrugBank
DB00529,Potential QTc-Prolonging Agents,DrugBank
DB00529,Pyrophosphate Analog DNA Polymerase Inhibitor,DrugBank
DB00529,QTc Prolonging Agents,DrugBank
DB00529,Reverse Transcriptase Inhibitors,DrugBank
DB00530,Antineoplastic Agents,DrugBank
DB00530,Antineoplastic and Immunomodulating Agents,DrugBank
DB00530,BCRP/ABCG2 Inhibitors,DrugBank
DB00530,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00530,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00530,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00530,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00530,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00530,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00530,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00530,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00530,Cytochrome P-450 Substrates,DrugBank
DB00530,Enzyme Inhibitors,DrugBank
DB00530,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB00530,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00530,Highest Risk QTc-Prolonging Agents,DrugBank
DB00530,Kinase Inhibitor,DrugBank
DB00530,Narrow Therapeutic Index Drugs,DrugBank
DB00530,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00530,P-glycoprotein inhibitors,DrugBank
DB00530,P-glycoprotein substrates,DrugBank
DB00530,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00530,Protein Kinase Inhibitors,DrugBank
DB00530,QTc Prolonging Agents,DrugBank
DB00530,Quinazolines,DrugBank
DB00530,Tyrosine Kinase Inhibitors,DrugBank
DB00530,UGT1A1 Inhibitors,DrugBank
DB00531,Alkylating Activity,DrugBank
DB00531,Alkylating Drugs,DrugBank
DB00531,Antineoplastic Agents,DrugBank
DB00531,"Antineoplastic Agents, Alkylating",DrugBank
DB00531,Antineoplastic and Immunomodulating Agents,DrugBank
DB00531,Antirheumatic Agents,DrugBank
DB00531,Cardiotoxic antineoplastic agents,DrugBank
DB00531,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00531,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00531,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00531,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00531,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00531,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00531,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00531,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00531,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00531,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00531,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00531,Cytochrome P-450 Substrates,DrugBank
DB00531,Cytotoxins,DrugBank
DB00531,"Hydrocarbons, Halogenated",DrugBank
DB00531,Immunologic Factors,DrugBank
DB00531,Immunosuppressive Agents,DrugBank
DB00531,Methemoglobinemia Associated Agents,DrugBank
DB00531,Mustard Compounds,DrugBank
DB00531,Mutagens,DrugBank
DB00531,Myeloablative Agonists,DrugBank
DB00531,Myelosuppressive Agents,DrugBank
DB00531,Narrow Therapeutic Index Drugs,DrugBank
DB00531,Neurotoxic agents,DrugBank
DB00531,Nitrogen Mustard Analogues,DrugBank
DB00531,Nitrogen Mustard Compounds,DrugBank
DB00531,Noxae,DrugBank
DB00531,Organophosphorus Compounds,DrugBank
DB00531,Phosphoramide Mustards,DrugBank
DB00531,Phosphoramides,DrugBank
DB00531,Toxic Actions,DrugBank
DB00532,Anti-epileptic Agent,DrugBank
DB00532,Anticonvulsants,DrugBank
DB00532,Central Nervous System Agents,DrugBank
DB00532,Central Nervous System Depressants,DrugBank
DB00532,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00532,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00532,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00532,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00532,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00532,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00532,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00532,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00532,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00532,Cytochrome P-450 Substrates,DrugBank
DB00532,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00532,Hydantoins,DrugBank
DB00532,Imidazoles,DrugBank
DB00532,Imidazolidines,DrugBank
DB00532,Nervous System,DrugBank
DB00532,Thyroxine-binding globulin substrates,DrugBank
DB00533,Agents causing hyperkalemia,DrugBank
DB00533,Agents that produce hypertension,DrugBank
DB00533,Analgesics,DrugBank
DB00533,"Analgesics, Non-Narcotic",DrugBank
DB00533,Anti-Inflammatory Agents,DrugBank
DB00533,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00533,Antiinflammatory and Antirheumatic Products,DrugBank
DB00533,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00533,Antirheumatic Agents,DrugBank
DB00533,COX-2 Inhibitors,DrugBank
DB00533,Cyclooxygenase Inhibitors,DrugBank
DB00533,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00533,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00533,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00533,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00533,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00533,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00533,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00533,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00533,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00533,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00533,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00533,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00533,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00533,Cytochrome P-450 Substrates,DrugBank
DB00533,Enzyme Inhibitors,DrugBank
DB00533,Musculo-Skeletal System,DrugBank
DB00533,Nephrotoxic agents,DrugBank
DB00533,Peripheral Nervous System Agents,DrugBank
DB00533,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00533,Sensory System Agents,DrugBank
DB00533,Sulfur Compounds,DrugBank
DB00535,Anti-Bacterial Agents,DrugBank
DB00535,Anti-Infective Agents,DrugBank
DB00535,Antibacterials for Systemic Use,DrugBank
DB00535,Antiinfectives for Systemic Use,DrugBank
DB00535,Aza Compounds,DrugBank
DB00535,Azabicyclo Compounds,DrugBank
DB00535,beta Lactam Antibiotics,DrugBank
DB00535,beta-Lactams,DrugBank
DB00535,Cephalosporins,DrugBank
DB00535,Drugs that are Mainly Renally Excreted,DrugBank
DB00535,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00535,Lactams,DrugBank
DB00535,OAT1/SLC22A6 Substrates,DrugBank
DB00535,OAT3/SLC22A8 Substrates,DrugBank
DB00535,Sulfur Compounds,DrugBank
DB00535,Thiazines,DrugBank
DB00535,Third-Generation Cephalosporins,DrugBank
DB00536,Acetylcholine Releasing Agent,DrugBank
DB00536,Amidines,DrugBank
DB00536,Guanidines,DrugBank
DB00536,Increased Acetylcholine Activity,DrugBank
DB00536,MATE 1 Substrates,DrugBank
DB00536,MATE 2 Substrates,DrugBank
DB00536,MATE substrates,DrugBank
DB00536,OAT3/SLC22A8 Inhibitors,DrugBank
DB00536,OCT1 inhibitors,DrugBank
DB00536,OCT2 Inhibitors,DrugBank
DB00537,4-Quinolones,DrugBank
DB00537,Agents Causing Muscle Toxicity,DrugBank
DB00537,Anti-Bacterial Agents,DrugBank
DB00537,Anti-Infective Agents,DrugBank
DB00537,Antibacterials for Systemic Use,DrugBank
DB00537,Antiinfectives for Systemic Use,DrugBank
DB00537,Chemically-Induced Disorders,DrugBank
DB00537,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00537,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00537,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00537,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00537,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00537,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00537,Cytochrome P-450 CYP3A5 Inhibitors (moderate),DrugBank
DB00537,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00537,Cytochrome P-450 CYP3A7 Inhibitors (moderate),DrugBank
DB00537,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00537,Drugs causing inadvertant photosensitivity,DrugBank
DB00537,Drugs that are Mainly Renally Excreted,DrugBank
DB00537,Enzyme Inhibitors,DrugBank
DB00537,Fluoroquinolone Antibacterial,DrugBank
DB00537,Fluoroquinolones,DrugBank
DB00537,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00537,MATE 1 Inhibitors,DrugBank
DB00537,MATE 1 Substrates,DrugBank
DB00537,MATE 2 Inhibitors,DrugBank
DB00537,MATE inhibitors,DrugBank
DB00537,MATE substrates,DrugBank
DB00537,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00537,Ophthalmological and Otological Preparations,DrugBank
DB00537,Ophthalmologicals,DrugBank
DB00537,Otologicals,DrugBank
DB00537,P-glycoprotein substrates,DrugBank
DB00537,Photosensitizing Agents,DrugBank
DB00537,QTc Prolonging Agents,DrugBank
DB00537,Quinolines,DrugBank
DB00537,Quinolone Antimicrobial,DrugBank
DB00537,Quinolones,DrugBank
DB00537,Sensory Organs,DrugBank
DB00537,Topoisomerase II Inhibitors,DrugBank
DB00537,Topoisomerase Inhibitors,DrugBank
DB00539,Anti-Estrogens,DrugBank
DB00539,Antineoplastic Agents,DrugBank
DB00539,"Antineoplastic Agents, Hormonal",DrugBank
DB00539,Antineoplastic and Immunomodulating Agents,DrugBank
DB00539,Benzene Derivatives,DrugBank
DB00539,Benzylidene Compounds,DrugBank
DB00539,Bone Density Conservation Agents,DrugBank
DB00539,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00539,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00539,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00539,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00539,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00539,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00539,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00539,Cytochrome P-450 Substrates,DrugBank
DB00539,Endocrine Therapy,DrugBank
DB00539,Estrogen Agonist/Antagonist,DrugBank
DB00539,Estrogen Receptor Modulators,DrugBank
DB00539,Highest Risk QTc-Prolonging Agents,DrugBank
DB00539,Hormone Antagonists,DrugBank
DB00539,Hormone Antagonists and Related Agents,DrugBank
DB00539,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00539,P-glycoprotein inhibitors,DrugBank
DB00539,P-glycoprotein substrates,DrugBank
DB00539,QTc Prolonging Agents,DrugBank
DB00539,Selective Estrogen Receptor Modulators,DrugBank
DB00539,Stilbenes,DrugBank
DB00540,Adrenergic Agents,DrugBank
DB00540,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00540,Adrenergic alpha-Antagonists,DrugBank
DB00540,Adrenergic Antagonists,DrugBank
DB00540,Adrenergic Uptake Inhibitors,DrugBank
DB00540,Agents producing tachycardia,DrugBank
DB00540,Agents that produce hypertension,DrugBank
DB00540,Agents that reduce seizure threshold,DrugBank
DB00540,Anticholinergic Agents,DrugBank
DB00540,Antidepressive Agents,DrugBank
DB00540,Antidepressive Agents Indicated for Depression,DrugBank
DB00540,"Antidepressive Agents, Tricyclic",DrugBank
DB00540,Benzocycloheptenes,DrugBank
DB00540,Central Nervous System Agents,DrugBank
DB00540,Central Nervous System Depressants,DrugBank
DB00540,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00540,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00540,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00540,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00540,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00540,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00540,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00540,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00540,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00540,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00540,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00540,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00540,Cytochrome P-450 Substrates,DrugBank
DB00540,Dibenzocycloheptenes,DrugBank
DB00540,Dopamine Antagonists,DrugBank
DB00540,Dopamine D2 Receptor Antagonists,DrugBank
DB00540,Histamine Antagonists,DrugBank
DB00540,Histamine H1 Antagonists,DrugBank
DB00540,Membrane Transport Modulators,DrugBank
DB00540,Muscarinic Antagonists,DrugBank
DB00540,Narrow Therapeutic Index Drugs,DrugBank
DB00540,Nervous System,DrugBank
DB00540,Neurotoxic agents,DrugBank
DB00540,Neurotransmitter Agents,DrugBank
DB00540,Neurotransmitter Uptake Inhibitors,DrugBank
DB00540,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00540,P-glycoprotein substrates,DrugBank
DB00540,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00540,Potential QTc-Prolonging Agents,DrugBank
DB00540,Psychoanaleptics,DrugBank
DB00540,Psychotropic Drugs,DrugBank
DB00540,QTc Prolonging Agents,DrugBank
DB00540,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00540,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00540,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00540,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00540,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00540,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00540,Serotonin Agents,DrugBank
DB00540,Serotonin Modulators,DrugBank
DB00540,Serotonin Receptor Antagonists,DrugBank
DB00540,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB00541,Agents Causing Muscle Toxicity,DrugBank
DB00541,Alkaloids,DrugBank
DB00541,Antimitotic Agents,DrugBank
DB00541,Antineoplastic Agents,DrugBank
DB00541,"Antineoplastic Agents, Phytogenic",DrugBank
DB00541,Antineoplastic and Immunomodulating Agents,DrugBank
DB00541,BCRP/ABCG2 Substrates,DrugBank
DB00541,BSEP/ABCB11 Substrates,DrugBank
DB00541,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00541,Cardiotoxic antineoplastic agents,DrugBank
DB00541,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00541,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00541,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00541,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00541,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00541,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00541,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00541,Cytochrome P-450 Substrates,DrugBank
DB00541,Cytotoxins,DrugBank
DB00541,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00541,Immunosuppressive Agents,DrugBank
DB00541,Indole Alkaloids,DrugBank
DB00541,Indoles,DrugBank
DB00541,Indolizidines,DrugBank
DB00541,Indolizines,DrugBank
DB00541,Mitosis Modulators,DrugBank
DB00541,Narrow Therapeutic Index Drugs,DrugBank
DB00541,Neurotoxic agents,DrugBank
DB00541,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00541,OATP1B3 inhibitors,DrugBank
DB00541,P-glycoprotein inducers,DrugBank
DB00541,P-glycoprotein inhibitors,DrugBank
DB00541,P-glycoprotein substrates,DrugBank
DB00541,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00541,Secologanin Tryptamine Alkaloids,DrugBank
DB00541,Tubulin Modulators,DrugBank
DB00541,Vinca Alkaloids,DrugBank
DB00542,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00542,ACE Inhibitors and Diuretics,DrugBank
DB00542,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00542,Agents causing angioedema,DrugBank
DB00542,Agents causing hyperkalemia,DrugBank
DB00542,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00542,Antihypertensive Agents,DrugBank
DB00542,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00542,Cardiovascular Agents,DrugBank
DB00542,Decreased Blood Pressure,DrugBank
DB00542,Drugs causing inadvertant photosensitivity,DrugBank
DB00542,Enzyme Inhibitors,DrugBank
DB00542,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00542,Hypotensive Agents,DrugBank
DB00542,Photosensitizing Agents,DrugBank
DB00542,Protease Inhibitors,DrugBank
DB00543,Adrenergic Agents,DrugBank
DB00543,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00543,Adrenergic alpha-Antagonists,DrugBank
DB00543,Adrenergic Antagonists,DrugBank
DB00543,Adrenergic Uptake Inhibitors,DrugBank
DB00543,Agents producing tachycardia,DrugBank
DB00543,Agents that produce hypertension,DrugBank
DB00543,Agents that reduce seizure threshold,DrugBank
DB00543,Anticholinergic Agents,DrugBank
DB00543,Antidepressive Agents,DrugBank
DB00543,Antidepressive Agents Indicated for Depression,DrugBank
DB00543,"Antidepressive Agents, Tetracyclic",DrugBank
DB00543,"Antidepressive Agents, Tricyclic",DrugBank
DB00543,Antipsychotic Agents,DrugBank
DB00543,Central Nervous System Agents,DrugBank
DB00543,Central Nervous System Depressants,DrugBank
DB00543,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00543,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00543,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00543,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00543,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00543,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00543,Cytochrome P-450 Substrates,DrugBank
DB00543,Dibenzoxazepines,DrugBank
DB00543,Dopamine Agents,DrugBank
DB00543,Dopamine Antagonists,DrugBank
DB00543,Dopamine D2 Receptor Antagonists,DrugBank
DB00543,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00543,Histamine Antagonists,DrugBank
DB00543,Histamine H1 Antagonists,DrugBank
DB00543,Membrane Transport Modulators,DrugBank
DB00543,Muscarinic Antagonists,DrugBank
DB00543,Narrow Therapeutic Index Drugs,DrugBank
DB00543,Nervous System,DrugBank
DB00543,Neurotoxic agents,DrugBank
DB00543,Neurotransmitter Agents,DrugBank
DB00543,Neurotransmitter Uptake Inhibitors,DrugBank
DB00543,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00543,P-glycoprotein inhibitors,DrugBank
DB00543,Potential QTc-Prolonging Agents,DrugBank
DB00543,Psychoanaleptics,DrugBank
DB00543,Psychotropic Drugs,DrugBank
DB00543,QTc Prolonging Agents,DrugBank
DB00543,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00543,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00543,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00543,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00543,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00543,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00543,Serotonin Agents,DrugBank
DB00543,Serotonin Modulators,DrugBank
DB00543,Serotonin Receptor Antagonists,DrugBank
DB00544,Antimetabolites,DrugBank
DB00544,Antineoplastic Agents,DrugBank
DB00544,Antineoplastic and Immunomodulating Agents,DrugBank
DB00544,BCRP/ABCG2 Substrates,DrugBank
DB00544,Cardiotoxic antineoplastic agents,DrugBank
DB00544,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00544,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00544,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00544,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00544,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00544,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00544,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00544,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00544,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00544,Cytochrome P-450 Substrates,DrugBank
DB00544,Cytotoxins,DrugBank
DB00544,Drugs causing inadvertant photosensitivity,DrugBank
DB00544,Fluoropyrimidines,DrugBank
DB00544,Fluorouracil and prodrugs,DrugBank
DB00544,Immunologic Factors,DrugBank
DB00544,Immunosuppressive Agents,DrugBank
DB00544,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00544,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00544,Myelosuppressive Agents,DrugBank
DB00544,Narrow Therapeutic Index Drugs,DrugBank
DB00544,Noxae,DrugBank
DB00544,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00544,Nucleoside Metabolic Inhibitor,DrugBank
DB00544,Photosensitizing Agents,DrugBank
DB00544,Pyrimidine Analogues,DrugBank
DB00544,Pyrimidines,DrugBank
DB00544,Pyrimidinones,DrugBank
DB00544,QTc Prolonging Agents,DrugBank
DB00544,Thyroxine-binding globulin inducers,DrugBank
DB00544,Toxic Actions,DrugBank
DB00545,Cholinergic Agents,DrugBank
DB00545,Cholinesterase Inhibitors,DrugBank
DB00545,Cholinesterase substrates,DrugBank
DB00545,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00545,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00545,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00545,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00545,Enzyme Inhibitors,DrugBank
DB00545,Nervous System,DrugBank
DB00545,Neurotransmitter Agents,DrugBank
DB00545,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB00545,Parasympathomimetics,DrugBank
DB00545,Pyridines,DrugBank
DB00545,Pyridinium Compounds,DrugBank
DB00546,Anti-Anxiety Agents,DrugBank
DB00546,Antidepressive Agents,DrugBank
DB00546,Benzazepines,DrugBank
DB00546,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00546,Central Nervous System Agents,DrugBank
DB00546,Central Nervous System Depressants,DrugBank
DB00546,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00546,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00546,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00546,Cytochrome P-450 Substrates,DrugBank
DB00546,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00546,Nervous System,DrugBank
DB00546,Psycholeptics,DrugBank
DB00546,Psychotropic Drugs,DrugBank
DB00546,Triazolobenzodiazepines,DrugBank
DB00547,Adrenal Cortex Hormones,DrugBank
DB00547,Anti-Inflammatory Agents,DrugBank
DB00547,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00547,Corticosteroids,DrugBank
DB00547,"Corticosteroids, Dermatological Preparations",DrugBank
DB00547,"Corticosteroids, Potent (Group III)",DrugBank
DB00547,Dermatologicals,DrugBank
DB00547,Fused-Ring Compounds,DrugBank
DB00547,Hormones,DrugBank
DB00547,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00547,Immunosuppressive Agents,DrugBank
DB00547,Pregnadienediols,DrugBank
DB00547,Pregnadienes,DrugBank
DB00547,Pregnadienetriols,DrugBank
DB00547,Pregnanes,DrugBank
DB00547,Steroids,DrugBank
DB00547,"Steroids, Fluorinated",DrugBank
DB00548,"Acids, Acyclic",DrugBank
DB00548,Anti-Acne Preparations,DrugBank
DB00548,Anti-Acne Preparations for Topical Use,DrugBank
DB00548,Decreased Protein Synthesis,DrugBank
DB00548,Decreased Sebaceous Gland Activity,DrugBank
DB00548,Dermatologicals,DrugBank
DB00548,Drugs that are Mainly Renally Excreted,DrugBank
DB00548,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00549,"Acids, Acyclic",DrugBank
DB00549,Agents to Treat Airway Disease,DrugBank
DB00549,Amides,DrugBank
DB00549,Anti-Asthmatic Agents,DrugBank
DB00549,Carbamates,DrugBank
DB00549,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00549,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00549,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB00549,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00549,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00549,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00549,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00549,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00549,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00549,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00549,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00549,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00549,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00549,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00549,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00549,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00549,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00549,Cytochrome P-450 Substrates,DrugBank
DB00549,Drugs for Obstructive Airway Diseases,DrugBank
DB00549,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00549,Hormone Antagonists,DrugBank
DB00549,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00549,Leukotriene Antagonists,DrugBank
DB00549,Leukotriene Modifiers,DrugBank
DB00549,NTCP Inhibitors,DrugBank
DB00549,Respiratory System Agents,DrugBank
DB00549,Sulfones,DrugBank
DB00549,Sulfur Compounds,DrugBank
DB00550,Agents Causing Muscle Toxicity,DrugBank
DB00550,Antimetabolites,DrugBank
DB00550,Antithyroid agents,DrugBank
DB00550,Hormone Antagonists,DrugBank
DB00550,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00550,Immunosuppressive Agents,DrugBank
DB00550,Myelosuppressive Agents,DrugBank
DB00550,Noxae,DrugBank
DB00550,Pyrimidines,DrugBank
DB00550,Pyrimidinones,DrugBank
DB00550,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00550,Thiouracil,DrugBank
DB00550,Thiouracils,DrugBank
DB00550,Thyroid Hormone Synthesis Inhibitor,DrugBank
DB00550,Thyroid Hormone Synthesis Inhibitors,DrugBank
DB00550,Thyroid Products,DrugBank
DB00550,Toxic Actions,DrugBank
DB00552,Adenosine Deaminase Inhibitors,DrugBank
DB00552,Antineoplastic Agents,DrugBank
DB00552,Antineoplastic and Immunomodulating Agents,DrugBank
DB00552,Cancer immunotherapy,DrugBank
DB00552,Cardiotoxic antineoplastic agents,DrugBank
DB00552,Coformycin,DrugBank
DB00552,Deoxyribonucleosides,DrugBank
DB00552,Drugs that are Mainly Renally Excreted,DrugBank
DB00552,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00552,Enzyme Inhibitors,DrugBank
DB00552,Formycins,DrugBank
DB00552,Immunosuppressive Agents,DrugBank
DB00552,Immunotherapy,DrugBank
DB00552,Myelosuppressive Agents,DrugBank
DB00552,Narrow Therapeutic Index Drugs,DrugBank
DB00552,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00552,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00552,Nucleoside Metabolic Inhibitor,DrugBank
DB00552,Nucleosides,DrugBank
DB00552,Pyrimidine Nucleosides,DrugBank
DB00552,Pyrimidines,DrugBank
DB00553,Antipsoriatics,DrugBank
DB00553,Antipsoriatics for Systemic Use,DrugBank
DB00553,Antipsoriatics for Topical Use,DrugBank
DB00553,Benzopyrans,DrugBank
DB00553,Coloring Agents,DrugBank
DB00553,"Compounds used in a research, industrial, or household setting",DrugBank
DB00553,Cross-Linking Reagents,DrugBank
DB00553,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00553,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00553,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00553,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00553,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00553,Dermatologicals,DrugBank
DB00553,Drugs that are Mainly Renally Excreted,DrugBank
DB00553,Furocoumarins,DrugBank
DB00553,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00553,Indicators and Reagents,DrugBank
DB00553,Laboratory Chemicals,DrugBank
DB00553,Photoabsorption,DrugBank
DB00553,Photoactivated Radical Generator,DrugBank
DB00553,Photosensitizing Activity,DrugBank
DB00553,Photosensitizing Agents,DrugBank
DB00553,Photosensitizing Agents for Phototherapy,DrugBank
DB00553,Psoralens for Systemic Use,DrugBank
DB00553,Psoralens for Topical Use,DrugBank
DB00553,Pyrans,DrugBank
DB00553,Radiation-Sensitizing Agents,DrugBank
DB00554,Agents causing hyperkalemia,DrugBank
DB00554,Agents that produce hypertension,DrugBank
DB00554,Analgesics,DrugBank
DB00554,"Analgesics, Non-Narcotic",DrugBank
DB00554,Anti-Inflammatory Agents,DrugBank
DB00554,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00554,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00554,Antiinflammatory and Antirheumatic Products,DrugBank
DB00554,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00554,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00554,Antirheumatic Agents,DrugBank
DB00554,Cyclooxygenase Inhibitors,DrugBank
DB00554,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00554,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00554,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00554,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00554,Cytochrome P-450 Substrates,DrugBank
DB00554,Drugs causing inadvertant photosensitivity,DrugBank
DB00554,Drugs that are Mainly Renally Excreted,DrugBank
DB00554,Enzyme Inhibitors,DrugBank
DB00554,Musculo-Skeletal System,DrugBank
DB00554,Nephrotoxic agents,DrugBank
DB00554,Non COX-2 selective NSAIDS,DrugBank
DB00554,OAT1/SLC22A6 inhibitors,DrugBank
DB00554,OAT3/SLC22A8 Inhibitors,DrugBank
DB00554,Ophthalmologicals,DrugBank
DB00554,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00554,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00554,Oxicams,DrugBank
DB00554,Peripheral Nervous System Agents,DrugBank
DB00554,Photosensitizing Agents,DrugBank
DB00554,Sensory Organs,DrugBank
DB00554,Sensory System Agents,DrugBank
DB00554,Sulfur Compounds,DrugBank
DB00554,Thiazines,DrugBank
DB00554,Topical Products for Joint and Muscular Pain,DrugBank
DB00555,Agents causing hyperkalemia,DrugBank
DB00555,Agents producing tachycardia,DrugBank
DB00555,Anti-epileptic Agent,DrugBank
DB00555,Antiarrhythmic agents,DrugBank
DB00555,Anticholinergic Agents,DrugBank
DB00555,Anticonvulsants,DrugBank
DB00555,Bradycardia-Causing Agents,DrugBank
DB00555,Calcium Channel Blockers,DrugBank
DB00555,Calcium-Regulating Hormones and Agents,DrugBank
DB00555,Central Nervous System Agents,DrugBank
DB00555,Central Nervous System Depressants,DrugBank
DB00555,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00555,Drugs causing inadvertant photosensitivity,DrugBank
DB00555,Drugs that are Mainly Renally Excreted,DrugBank
DB00555,Membrane Transport Modulators,DrugBank
DB00555,Miscellaneous Anticonvulsants,DrugBank
DB00555,Mood Stabilizer,DrugBank
DB00555,Muscarinic Antagonists,DrugBank
DB00555,Nervous System,DrugBank
DB00555,OCT1 substrates,DrugBank
DB00555,OCT2 Inhibitors,DrugBank
DB00555,P-glycoprotein inhibitors,DrugBank
DB00555,P-glycoprotein substrates,DrugBank
DB00555,Photosensitizing Agents,DrugBank
DB00555,Potential QTc-Prolonging Agents,DrugBank
DB00555,Psychotropic Drugs,DrugBank
DB00555,QTc Prolonging Agents,DrugBank
DB00555,Sodium Channel Blockers,DrugBank
DB00555,Tranquilizing Agents,DrugBank
DB00555,Triazines,DrugBank
DB00555,UGT1A1 Inducers,DrugBank
DB00555,UGT1A1 Substrates,DrugBank
DB00555,UGT1A3 substrates,DrugBank
DB00555,UGT1A4 substrates,DrugBank
DB00556,"Amino Acids, Peptides, and Proteins",DrugBank
DB00556,"Compounds used in a research, industrial, or household setting",DrugBank
DB00556,Contrast Media,DrugBank
DB00556,Diagnostic Uses of Chemicals,DrugBank
DB00556,"Hydrocarbons, Fluorinated",DrugBank
DB00556,"Hydrocarbons, Halogenated",DrugBank
DB00556,Microspheres,DrugBank
DB00556,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00556,Other Diagnostics,DrugBank
DB00556,Proteins,DrugBank
DB00556,QTc Prolonging Agents,DrugBank
DB00556,Ultrasound Contrast Activity,DrugBank
DB00556,Ultrasound Contrast Media,DrugBank
DB00557,Anti-Anxiety Agents,DrugBank
DB00557,Antipruritics,DrugBank
DB00557,Central Nervous System Depressants,DrugBank
DB00557,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00557,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00557,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00557,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00557,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00557,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00557,Cytochrome P-450 Substrates,DrugBank
DB00557,Dermatologicals,DrugBank
DB00557,Diphenylmethane Derivatives,DrugBank
DB00557,Histamine Agents,DrugBank
DB00557,Histamine Antagonists,DrugBank
DB00557,Histamine H1 Antagonists,DrugBank
DB00557,Histamine Receptor Antagonists,DrugBank
DB00557,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00557,Nervous System,DrugBank
DB00557,Neurotransmitter Agents,DrugBank
DB00557,P-glycoprotein substrates,DrugBank
DB00557,Piperazines,DrugBank
DB00557,Potential QTc-Prolonging Agents,DrugBank
DB00557,Psycholeptics,DrugBank
DB00557,QTc Prolonging Agents,DrugBank
DB00558,"Acids, Acyclic",DrugBank
DB00558,Amidines,DrugBank
DB00558,Amino Sugars,DrugBank
DB00558,Anti-Infective Agents,DrugBank
DB00558,Antiinfectives for Systemic Use,DrugBank
DB00558,Antiviral Agents,DrugBank
DB00558,Antivirals for Systemic Use,DrugBank
DB00558,Carbohydrates,DrugBank
DB00558,Direct Acting Antivirals,DrugBank
DB00558,Drugs that are Mainly Renally Excreted,DrugBank
DB00558,Enzyme Inhibitors,DrugBank
DB00558,Guanidines,DrugBank
DB00558,Hydroxy Acids,DrugBank
DB00558,Neuraminic Acids,DrugBank
DB00558,Neuraminidase Inhibitors,DrugBank
DB00558,Pyrans,DrugBank
DB00558,Sialic Acids,DrugBank
DB00558,Sugar Acids,DrugBank
DB00559,Amides,DrugBank
DB00559,Antihypertensive Agents,DrugBank
DB00559,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB00559,Benzene Derivatives,DrugBank
DB00559,Benzenesulfonamides,DrugBank
DB00559,BSEP/ABCB11 Inhibitors,DrugBank
DB00559,Cardiovascular Agents,DrugBank
DB00559,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00559,Cytochrome P-450 CYP2C9 Inducers (moderate),DrugBank
DB00559,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00559,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00559,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00559,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00559,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB00559,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00559,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00559,Cytochrome P-450 Substrates,DrugBank
DB00559,Endothelin Receptor Antagonists,DrugBank
DB00559,Genito Urinary System and Sex Hormones,DrugBank
DB00559,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00559,Hepatotoxic Agents,DrugBank
DB00559,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00559,Pyrimidines,DrugBank
DB00559,Sulfonamides,DrugBank
DB00559,Sulfones,DrugBank
DB00559,Sulfur Compounds,DrugBank
DB00559,Vasodilating Agents,DrugBank
DB00560,Agents that produce neuromuscular block (indirect),DrugBank
DB00560,Anti-Bacterial Agents,DrugBank
DB00560,Anti-Infective Agents,DrugBank
DB00560,Antibacterials for Systemic Use,DrugBank
DB00560,Antiinfectives for Systemic Use,DrugBank
DB00560,Enzyme Inhibitors,DrugBank
DB00560,Glycylcyclines,DrugBank
DB00560,Naphthacenes,DrugBank
DB00560,Protein Synthesis Inhibitors,DrugBank
DB00560,Tetracyclines,DrugBank
DB00561,Agents that produce hypertension,DrugBank
DB00561,Central Nervous System Agents,DrugBank
DB00561,Central Nervous System Stimulants,DrugBank
DB00561,Increased Medullary Respiratory Drive,DrugBank
DB00561,Pyrrolidines,DrugBank
DB00561,Pyrrolidinones,DrugBank
DB00561,Respiratory System Agents,DrugBank
DB00562,Diuretics,DrugBank
DB00562,Genito Urinary System and Sex Hormones,DrugBank
DB00562,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00562,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00562,Hyperglycemia-Associated Agents,DrugBank
DB00562,Sodium Chloride Symporter Inhibitors,DrugBank
DB00562,Stimulants,DrugBank
DB00562,Sulfonamides,DrugBank
DB00562,Sulfones,DrugBank
DB00562,Sulfur Compounds,DrugBank
DB00562,Thiazides,DrugBank
DB00563,Abortifacient Agents,DrugBank
DB00563,"Abortifacient Agents, Nonsteroidal",DrugBank
DB00563,Agents Causing Muscle Toxicity,DrugBank
DB00563,Antimetabolites,DrugBank
DB00563,Antineoplastic Agents,DrugBank
DB00563,Antineoplastic and Immunomodulating Agents,DrugBank
DB00563,Antirheumatic Agents,DrugBank
DB00563,BCRP/ABCG2 Substrates,DrugBank
DB00563,Biological Factors,DrugBank
DB00563,Cancer immunotherapy,DrugBank
DB00563,Cardiotoxic antineoplastic agents,DrugBank
DB00563,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00563,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00563,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00563,Cytochrome P-450 Substrates,DrugBank
DB00563,Cytotoxins,DrugBank
DB00563,Dermatologicals,DrugBank
DB00563,Drugs causing inadvertant photosensitivity,DrugBank
DB00563,Drugs that are Mainly Renally Excreted,DrugBank
DB00563,Enzyme Inhibitors,DrugBank
DB00563,Folic Acid Analogues,DrugBank
DB00563,Folic Acid Antagonists,DrugBank
DB00563,Hepatotoxic Agents,DrugBank
DB00563,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00563,Immunologic Factors,DrugBank
DB00563,Immunosuppressive Agents,DrugBank
DB00563,Immunotherapy,DrugBank
DB00563,Myelosuppressive Agents,DrugBank
DB00563,Narrow Therapeutic Index Drugs,DrugBank
DB00563,Nephrotoxic agents,DrugBank
DB00563,Noxae,DrugBank
DB00563,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00563,OAT1/SLC22A6 inhibitors,DrugBank
DB00563,OAT3/SLC22A8 Inhibitors,DrugBank
DB00563,OAT3/SLC22A8 Substrates,DrugBank
DB00563,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00563,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00563,OATP1B3 substrates,DrugBank
DB00563,P-glycoprotein substrates,DrugBank
DB00563,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00563,Photosensitizing Agents,DrugBank
DB00563,"Pigments, Biological",DrugBank
DB00563,Pteridines,DrugBank
DB00563,Pterins,DrugBank
DB00563,Reproductive Control Agents,DrugBank
DB00563,Toxic Actions,DrugBank
DB00564,Analgesics,DrugBank
DB00564,"Analgesics, Non-Narcotic",DrugBank
DB00564,Anticonvulsants,DrugBank
DB00564,Antimanic Agents,DrugBank
DB00564,Carboxamide Derivatives,DrugBank
DB00564,Cardiovascular Agents,DrugBank
DB00564,Central Nervous System Agents,DrugBank
DB00564,Central Nervous System Depressants,DrugBank
DB00564,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP1A2 Inducers (strong),DrugBank
DB00564,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00564,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00564,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00564,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00564,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP2B6 Inducers (strong),DrugBank
DB00564,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00564,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00564,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB00564,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00564,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00564,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00564,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00564,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00564,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00564,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00564,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00564,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00564,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00564,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00564,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00564,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00564,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00564,Cytochrome P-450 CYP3A5 Inducers (strong),DrugBank
DB00564,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00564,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00564,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00564,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00564,Cytochrome P-450 Substrates,DrugBank
DB00564,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00564,Dibenzazepines,DrugBank
DB00564,Drugs that are Mainly Renally Excreted,DrugBank
DB00564,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00564,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB00564,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00564,Immunosuppressive Agents,DrugBank
DB00564,Inducers of Drug Clearance,DrugBank
DB00564,Membrane Transport Modulators,DrugBank
DB00564,Miscellaneous Anticonvulsants,DrugBank
DB00564,Mood Stabilizer,DrugBank
DB00564,Myelosuppressive Agents,DrugBank
DB00564,Narrow Therapeutic Index Drugs,DrugBank
DB00564,P-glycoprotein inducers,DrugBank
DB00564,P-glycoprotein substrates,DrugBank
DB00564,Peripheral Nervous System Agents,DrugBank
DB00564,Psychotropic Drugs,DrugBank
DB00564,Sensory System Agents,DrugBank
DB00564,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00564,Sodium Channel Blockers,DrugBank
DB00564,Thyroxine-binding globulin substrates,DrugBank
DB00564,UGT1A1 Inducers,DrugBank
DB00564,UGT1A6 inducer,DrugBank
DB00564,UGT2B7 substrates,DrugBank
DB00564,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00565,Anticholinergic Agents,DrugBank
DB00565,Benzylisoquinolines,DrugBank
DB00565,Central Nervous System Depressants,DrugBank
DB00565,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00565,Isoquinolines,DrugBank
DB00565,Muscle Relaxants,DrugBank
DB00565,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00565,Musculo-Skeletal System,DrugBank
DB00565,Neuromuscular Agents,DrugBank
DB00565,Neuromuscular Blocking Agents,DrugBank
DB00565,Neuromuscular Nondepolarizing Blockade,DrugBank
DB00565,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB00565,Nicotinic Antagonists,DrugBank
DB00565,Peripheral Nervous System Agents,DrugBank
DB00567,Amides,DrugBank
DB00567,Anti-Bacterial Agents,DrugBank
DB00567,Anti-Infective Agents,DrugBank
DB00567,Antibacterials for Systemic Use,DrugBank
DB00567,Antiinfectives for Systemic Use,DrugBank
DB00567,Aza Compounds,DrugBank
DB00567,Azabicyclo Compounds,DrugBank
DB00567,beta-Lactams,DrugBank
DB00567,Cephalosporins,DrugBank
DB00567,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00567,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00567,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00567,Cytochrome P-450 Substrates,DrugBank
DB00567,Drugs that are Mainly Renally Excreted,DrugBank
DB00567,First-Generation Cephalosporins,DrugBank
DB00567,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00567,Lactams,DrugBank
DB00567,MATE 1 Substrates,DrugBank
DB00567,MATE substrates,DrugBank
DB00567,Nephrotoxic agents,DrugBank
DB00567,OAT1/SLC22A6 inhibitors,DrugBank
DB00567,OAT1/SLC22A6 Substrates,DrugBank
DB00567,OAT3/SLC22A8 Inhibitors,DrugBank
DB00567,OAT3/SLC22A8 Substrates,DrugBank
DB00567,Sulfur Compounds,DrugBank
DB00567,Thiazines,DrugBank
DB00568,Agents causing hyperkalemia,DrugBank
DB00568,Antiarrhythmic agents,DrugBank
DB00568,Antivertigo Preparations,DrugBank
DB00568,Bradycardia-Causing Agents,DrugBank
DB00568,Calcium Channel Blockers,DrugBank
DB00568,Calcium-Regulating Hormones and Agents,DrugBank
DB00568,Cardiovascular Agents,DrugBank
DB00568,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00568,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00568,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00568,Cytochrome P-450 Substrates,DrugBank
DB00568,Histamine Agents,DrugBank
DB00568,Histamine Antagonists,DrugBank
DB00568,Histamine H1 Antagonists,DrugBank
DB00568,Membrane Transport Modulators,DrugBank
DB00568,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00568,Nervous System,DrugBank
DB00568,Neurotransmitter Agents,DrugBank
DB00568,Piperazines,DrugBank
DB00568,QTc Prolonging Agents,DrugBank
DB00568,Vasodilating Agents,DrugBank
DB00569,Anticoagulants,DrugBank
DB00569,Antithrombins,DrugBank
DB00569,Blood and Blood Forming Organs,DrugBank
DB00569,Carbohydrates,DrugBank
DB00569,Cardiovascular Agents,DrugBank
DB00569,Drugs that are Mainly Renally Excreted,DrugBank
DB00569,Enzyme Inhibitors,DrugBank
DB00569,Factor Xa Inhibitors,DrugBank
DB00569,Fibrin Modulating Agents,DrugBank
DB00569,Hematologic Agents,DrugBank
DB00569,Indirect factor Xa inhibitors,DrugBank
DB00569,Miscellaneous Anticoagulants,DrugBank
DB00569,Oligosaccharides,DrugBank
DB00569,Polysaccharides,DrugBank
DB00569,Protease Inhibitors,DrugBank
DB00569,Serine Protease Inhibitors,DrugBank
DB00570,Alkaloids,DrugBank
DB00570,Antimitotic Agents,DrugBank
DB00570,Antineoplastic Agents,DrugBank
DB00570,"Antineoplastic Agents, Phytogenic",DrugBank
DB00570,Antineoplastic and Immunomodulating Agents,DrugBank
DB00570,BSEP/ABCB11 Inhibitors,DrugBank
DB00570,BSEP/ABCB11 Substrates,DrugBank
DB00570,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00570,Cardiotoxic antineoplastic agents,DrugBank
DB00570,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00570,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00570,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00570,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00570,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00570,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00570,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00570,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00570,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00570,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00570,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00570,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00570,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00570,Cytochrome P-450 Substrates,DrugBank
DB00570,Cytotoxins,DrugBank
DB00570,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00570,Immunosuppressive Agents,DrugBank
DB00570,Indole Alkaloids,DrugBank
DB00570,Indoles,DrugBank
DB00570,Indolizidines,DrugBank
DB00570,Indolizines,DrugBank
DB00570,Mitosis Modulators,DrugBank
DB00570,Myelosuppressive Agents,DrugBank
DB00570,Narrow Therapeutic Index Drugs,DrugBank
DB00570,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00570,P-glycoprotein inducers,DrugBank
DB00570,P-glycoprotein inhibitors,DrugBank
DB00570,P-glycoprotein substrates,DrugBank
DB00570,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00570,Secologanin Tryptamine Alkaloids,DrugBank
DB00570,Tubulin Modulators,DrugBank
DB00570,Vinca Alkaloids,DrugBank
DB00571,Adrenergic Agents,DrugBank
DB00571,Adrenergic Antagonists,DrugBank
DB00571,Adrenergic beta-Antagonists,DrugBank
DB00571,Agents causing hyperkalemia,DrugBank
DB00571,Alcohols,DrugBank
DB00571,Amines,DrugBank
DB00571,Amino Alcohols,DrugBank
DB00571,Antiarrhythmic agents,DrugBank
DB00571,Antihypertensive Agents,DrugBank
DB00571,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00571,Beta Blocking Agents and Thiazides,DrugBank
DB00571,"Beta Blocking Agents, Non-Selective",DrugBank
DB00571,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB00571,Bradycardia-Causing Agents,DrugBank
DB00571,Cardiovascular Agents,DrugBank
DB00571,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00571,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00571,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00571,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00571,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00571,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00571,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00571,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00571,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00571,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00571,Cytochrome P-450 Substrates,DrugBank
DB00571,Drugs that are Mainly Renally Excreted,DrugBank
DB00571,Hypotensive Agents,DrugBank
DB00571,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00571,Naphthalenes,DrugBank
DB00571,Negative Inotrope,DrugBank
DB00571,Neurotransmitter Agents,DrugBank
DB00571,OCT2 Inhibitors,DrugBank
DB00571,P-glycoprotein inhibitors,DrugBank
DB00571,P-glycoprotein substrates,DrugBank
DB00571,Phenoxypropanolamines,DrugBank
DB00571,Propanolamines,DrugBank
DB00571,Propanols,DrugBank
DB00571,QTc Prolonging Agents,DrugBank
DB00571,Vasodilating Agents,DrugBank
DB00572,"Adjuvants, Anesthesia",DrugBank
DB00572,Agents producing tachycardia,DrugBank
DB00572,Agents that produce hypertension,DrugBank
DB00572,Alimentary Tract and Metabolism,DrugBank
DB00572,Alkaloids,DrugBank
DB00572,Anti-Asthmatic Agents,DrugBank
DB00572,Antiarrhythmic agents,DrugBank
DB00572,Anticholinergic Agents,DrugBank
DB00572,Antidotes,DrugBank
DB00572,Antimuscarinics Antispasmodics,DrugBank
DB00572,Autonomic Agents,DrugBank
DB00572,Aza Compounds,DrugBank
DB00572,Azabicyclo Compounds,DrugBank
DB00572,Belladonna Alkaloids,DrugBank
DB00572,"Belladonna Alkaloids, Tertiary Amines",DrugBank
DB00572,"Belladonna and Derivatives, Plain",DrugBank
DB00572,Bronchodilator Agents,DrugBank
DB00572,BSEP/ABCB11 Substrates,DrugBank
DB00572,Cardiovascular Agents,DrugBank
DB00572,Central Nervous System Agents,DrugBank
DB00572,Cholinergic Agents,DrugBank
DB00572,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00572,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00572,Muscarinic Antagonists,DrugBank
DB00572,Mydriatics,DrugBank
DB00572,Mydriatics and Cycloplegics,DrugBank
DB00572,Neurotransmitter Agents,DrugBank
DB00572,Ophthalmologicals,DrugBank
DB00572,Parasympatholytics,DrugBank
DB00572,Peripheral Nervous System Agents,DrugBank
DB00572,QTc Prolonging Agents,DrugBank
DB00572,Respiratory System Agents,DrugBank
DB00572,Sensory Organs,DrugBank
DB00572,Solanaceous Alkaloids,DrugBank
DB00572,Tropanes,DrugBank
DB00573,"Acids, Carbocyclic",DrugBank
DB00573,Agents causing hyperkalemia,DrugBank
DB00573,Agents that produce hypertension,DrugBank
DB00573,Analgesics,DrugBank
DB00573,"Analgesics, Non-Narcotic",DrugBank
DB00573,Anti-Inflammatory Agents,DrugBank
DB00573,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00573,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00573,Antiinflammatory and Antirheumatic Products,DrugBank
DB00573,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00573,Antirheumatic Agents,DrugBank
DB00573,Arylpropionic acid NSAIDS,DrugBank
DB00573,Cyclooxygenase Inhibitors,DrugBank
DB00573,Enzyme Inhibitors,DrugBank
DB00573,Musculo-Skeletal System,DrugBank
DB00573,Nephrotoxic agents,DrugBank
DB00573,Non COX-2 selective NSAIDS,DrugBank
DB00573,Peripheral Nervous System Agents,DrugBank
DB00573,Phenylpropionates,DrugBank
DB00573,Propionates,DrugBank
DB00573,Sensory System Agents,DrugBank
DB00574,Alimentary Tract and Metabolism,DrugBank
DB00574,Amines,DrugBank
DB00574,Anticonvulsants,DrugBank
DB00574,Antidepressive Agents,DrugBank
DB00574,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00574,Central Nervous System Depressants,DrugBank
DB00574,Centrally Acting Antiobesity Products,DrugBank
DB00574,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00574,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00574,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00574,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00574,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00574,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00574,Cytochrome P-450 Substrates,DrugBank
DB00574,Ethylamines,DrugBank
DB00574,Membrane Transport Modulators,DrugBank
DB00574,Nervous System,DrugBank
DB00574,Neurotransmitter Agents,DrugBank
DB00574,Neurotransmitter Uptake Inhibitors,DrugBank
DB00574,Phenethylamines,DrugBank
DB00574,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00574,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB00574,Serotonin Agents,DrugBank
DB00574,Serotonin Receptor Agonists,DrugBank
DB00574,Stimulants,DrugBank
DB00575,Adrenergic Agents,DrugBank
DB00575,Adrenergic Agonists,DrugBank
DB00575,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00575,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00575,Adrenergic alpha-Agonists,DrugBank
DB00575,Agents producing tachycardia,DrugBank
DB00575,Agents that produce hypertension,DrugBank
DB00575,Analgesics,DrugBank
DB00575,Anesthetics,DrugBank
DB00575,"Anesthetics, General",DrugBank
DB00575,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB00575,Antiglaucoma Preparations and Miotics,DrugBank
DB00575,Antihypertensive Agents,DrugBank
DB00575,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00575,Antimigraine Preparations,DrugBank
DB00575,Autonomic Agents,DrugBank
DB00575,Bradycardia-Causing Agents,DrugBank
DB00575,Cardiovascular Agents,DrugBank
DB00575,Central alpha-2 Adrenergic Agonist,DrugBank
DB00575,Central Alpha-agonists,DrugBank
DB00575,Central Nervous System Agents,DrugBank
DB00575,Central Nervous System Depressants,DrugBank
DB00575,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00575,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00575,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00575,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00575,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00575,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00575,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00575,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00575,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00575,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00575,Cytochrome P-450 Substrates,DrugBank
DB00575,Hypotensive Agents,DrugBank
DB00575,Imidazoles,DrugBank
DB00575,Imidazoline Receptor Agonists,DrugBank
DB00575,Imidazolines,DrugBank
DB00575,Narrow Therapeutic Index Drugs,DrugBank
DB00575,Nervous System,DrugBank
DB00575,Neurotransmitter Agents,DrugBank
DB00575,Ophthalmologicals,DrugBank
DB00575,Peripheral Nervous System Agents,DrugBank
DB00575,Sensory Organs,DrugBank
DB00575,Sensory System Agents,DrugBank
DB00575,Sympatholytics,DrugBank
DB00575,Sympathomimetics in Glaucoma Therapy,DrugBank
DB00576,Amides,DrugBank
DB00576,Amines,DrugBank
DB00576,Aniline Compounds,DrugBank
DB00576,Anti-Bacterial Agents,DrugBank
DB00576,Anti-Infective Agents,DrugBank
DB00576,Antibacterials for Systemic Use,DrugBank
DB00576,Antiinfectives for Systemic Use,DrugBank
DB00576,Benzene Derivatives,DrugBank
DB00576,Benzenesulfonamides,DrugBank
DB00576,Blood and Blood Forming Organs,DrugBank
DB00576,Blood Substitutes and Perfusion Solutions,DrugBank
DB00576,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00576,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00576,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00576,Dermatologicals,DrugBank
DB00576,Genito Urinary System and Sex Hormones,DrugBank
DB00576,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00576,Irrigating Solutions,DrugBank
DB00576,Ophthalmologicals,DrugBank
DB00576,Sensory Organs,DrugBank
DB00576,Short-Acting Antibacterial Sulfonamides,DrugBank
DB00576,Sulfanilamides,DrugBank
DB00576,Sulfathiazoles,DrugBank
DB00576,Sulfonamide Antibacterial,DrugBank
DB00576,Sulfonamides,DrugBank
DB00576,Sulfonamides and trimethoprim,DrugBank
DB00576,Sulfones,DrugBank
DB00576,Sulfur Compounds,DrugBank
DB00576,Thiazoles,DrugBank
DB00577,Acyclovir and prodrug,DrugBank
DB00577,Amino Acids,DrugBank
DB00577,"Amino Acids, Branched-Chain",DrugBank
DB00577,"Amino Acids, Peptides, and Proteins",DrugBank
DB00577,Anti-Infective Agents,DrugBank
DB00577,Antiinfectives for Systemic Use,DrugBank
DB00577,Antiviral Agents,DrugBank
DB00577,Antivirals for Systemic Use,DrugBank
DB00577,Direct Acting Antivirals,DrugBank
DB00577,Drugs that are Mainly Renally Excreted,DrugBank
DB00577,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00577,Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00577,Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00577,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00577,Nephrotoxic agents,DrugBank
DB00577,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00577,Nucleosides and Nucleotides,DrugBank
DB00577,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB00577,OAT3/SLC22A8 Substrates,DrugBank
DB00577,Prodrugs,DrugBank
DB00577,Purines,DrugBank
DB00577,Purinones,DrugBank
DB00578,Amides,DrugBank
DB00578,Anti-Bacterial Agents,DrugBank
DB00578,Anti-Infective Agents,DrugBank
DB00578,Antibacterials for Systemic Use,DrugBank
DB00578,Antiinfectives for Systemic Use,DrugBank
DB00578,Beta-Lactam Antibacterials,DrugBank
DB00578,beta-Lactams,DrugBank
DB00578,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00578,Lactams,DrugBank
DB00578,OAT1/SLC22A6 inhibitors,DrugBank
DB00578,Penicillin G,DrugBank
DB00578,Penicillins,DrugBank
DB00578,Penicillins With Extended Spectrum,DrugBank
DB00578,Sulfur Compounds,DrugBank
DB00579,Adrenergic Agents,DrugBank
DB00579,Adrenergic Uptake Inhibitors,DrugBank
DB00579,Alimentary Tract and Metabolism,DrugBank
DB00579,"Anorexigenic Agents & Respiratory and Cerebral Stimulants, Miscellaneous",DrugBank
DB00579,Anorexigenic Agents & Respiratory and CNS Stimulants,DrugBank
DB00579,Antidepressive Agents,DrugBank
DB00579,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00579,Central Nervous System Agents,DrugBank
DB00579,Central Nervous System Depressants,DrugBank
DB00579,Central Nervous System Stimulants,DrugBank
DB00579,Centrally Acting Antiobesity Products,DrugBank
DB00579,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00579,Dopamine Agents,DrugBank
DB00579,Dopamine Uptake Inhibitors,DrugBank
DB00579,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00579,Isoindoles,DrugBank
DB00579,Membrane Transport Modulators,DrugBank
DB00579,Neurotransmitter Agents,DrugBank
DB00579,Neurotransmitter Uptake Inhibitors,DrugBank
DB00579,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00579,Serotonin Agents,DrugBank
DB00579,Serotonin Modulators,DrugBank
DB00580,Agents causing hyperkalemia,DrugBank
DB00580,Agents that produce hypertension,DrugBank
DB00580,Amides,DrugBank
DB00580,Analgesics,DrugBank
DB00580,"Analgesics, Non-Narcotic",DrugBank
DB00580,Anti-Inflammatory Agents,DrugBank
DB00580,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00580,Antiinflammatory and Antirheumatic Products,DrugBank
DB00580,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00580,Antirheumatic Agents,DrugBank
DB00580,Benzene Derivatives,DrugBank
DB00580,COX-2 Inhibitors,DrugBank
DB00580,Cyclooxygenase Inhibitors,DrugBank
DB00580,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00580,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00580,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00580,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00580,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00580,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00580,Cytochrome P-450 Substrates,DrugBank
DB00580,Enzyme Inhibitors,DrugBank
DB00580,Genito Urinary System and Sex Hormones,DrugBank
DB00580,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00580,Musculo-Skeletal System,DrugBank
DB00580,Nephrotoxic agents,DrugBank
DB00580,Peripheral Nervous System Agents,DrugBank
DB00580,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00580,Sensory System Agents,DrugBank
DB00580,Sulfonamides,DrugBank
DB00580,Sulfones,DrugBank
DB00580,Sulfur Compounds,DrugBank
DB00580,UGT1A9 Substrates,DrugBank
DB00581,Acidifying Activity,DrugBank
DB00581,Alimentary Tract and Metabolism,DrugBank
DB00581,Ammonia Detoxicants,DrugBank
DB00581,Carbohydrates,DrugBank
DB00581,Disaccharides,DrugBank
DB00581,Drugs for Constipation,DrugBank
DB00581,Gastrointestinal Agents,DrugBank
DB00581,Laxatives,DrugBank
DB00581,Osmotic Activity,DrugBank
DB00581,Osmotic Laxatives,DrugBank
DB00581,Stimulation Large Intestine Fluid/Electrolyte Secretion,DrugBank
DB00582,14-alpha Demethylase Inhibitors,DrugBank
DB00582,Anti-Infective Agents,DrugBank
DB00582,Antifungal Agents,DrugBank
DB00582,Antiinfectives for Systemic Use,DrugBank
DB00582,Antimycotics for Systemic Use,DrugBank
DB00582,Azole Antifungals,DrugBank
DB00582,Chemically-Induced Disorders,DrugBank
DB00582,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB00582,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00582,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00582,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00582,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00582,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00582,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00582,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00582,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00582,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB00582,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00582,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00582,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB00582,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00582,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00582,Cytochrome P-450 Substrates,DrugBank
DB00582,Drugs causing inadvertant photosensitivity,DrugBank
DB00582,Enzyme Inhibitors,DrugBank
DB00582,Photosensitizing Agents,DrugBank
DB00582,Potential QTc-Prolonging Agents,DrugBank
DB00582,QTc Prolonging Agents,DrugBank
DB00582,Steroid Synthesis Inhibitors,DrugBank
DB00582,Triazole and tetrazole derivatives,DrugBank
DB00582,Triazole Derivatives,DrugBank
DB00582,Triazoles,DrugBank
DB00583,Alimentary Tract and Metabolism,DrugBank
DB00583,Amines,DrugBank
DB00583,Amino Acids and Derivatives,DrugBank
DB00583,Caloric Agents,DrugBank
DB00583,Carnitine Analog,DrugBank
DB00583,Dietary Supplements,DrugBank
DB00583,Drugs that are Mainly Renally Excreted,DrugBank
DB00583,OAT3/SLC22A8 Substrates,DrugBank
DB00583,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00583,Quaternary Ammonium Compounds,DrugBank
DB00583,Supplements,DrugBank
DB00583,Trimethyl Ammonium Compounds,DrugBank
DB00584,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00584,ACE Inhibitors and Diuretics,DrugBank
DB00584,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00584,Agents causing angioedema,DrugBank
DB00584,Agents causing hyperkalemia,DrugBank
DB00584,Agents Causing Muscle Toxicity,DrugBank
DB00584,"Amino Acids, Peptides, and Proteins",DrugBank
DB00584,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00584,Antihypertensive Agents,DrugBank
DB00584,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00584,Cardiovascular Agents,DrugBank
DB00584,Decreased Blood Pressure,DrugBank
DB00584,Dipeptides,DrugBank
DB00584,Drugs causing inadvertant photosensitivity,DrugBank
DB00584,Enzyme Inhibitors,DrugBank
DB00584,Hypotensive Agents,DrugBank
DB00584,OAT1/SLC22A6 inhibitors,DrugBank
DB00584,OAT3/SLC22A8 Inhibitors,DrugBank
DB00584,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00584,Oligopeptides,DrugBank
DB00584,P-glycoprotein inhibitors,DrugBank
DB00584,Peptides,DrugBank
DB00584,Photosensitizing Agents,DrugBank
DB00584,Protease Inhibitors,DrugBank
DB00585,Acid Reducers,DrugBank
DB00585,Agents Causing Muscle Toxicity,DrugBank
DB00585,Alimentary Tract and Metabolism,DrugBank
DB00585,Anti-Ulcer Agents,DrugBank
DB00585,Cholinesterase Inhibitors,DrugBank
DB00585,Drugs for Acid Related Disorders,DrugBank
DB00585,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00585,Gastric Acid Lowering Agents,DrugBank
DB00585,Gastrointestinal Agents,DrugBank
DB00585,Histamine Agents,DrugBank
DB00585,Histamine Antagonists,DrugBank
DB00585,Histamine H2 Antagonists,DrugBank
DB00585,Neurotransmitter Agents,DrugBank
DB00585,P-glycoprotein substrates,DrugBank
DB00585,Sulfur Compounds,DrugBank
DB00585,Thiazoles,DrugBank
DB00586,Acetic Acid Derivatives and Related Substances,DrugBank
DB00586,"Acids, Carbocyclic",DrugBank
DB00586,Agents causing angioedema,DrugBank
DB00586,Agents causing hyperkalemia,DrugBank
DB00586,Agents that produce hypertension,DrugBank
DB00586,Amines,DrugBank
DB00586,Analgesics,DrugBank
DB00586,"Analgesics, Non-Narcotic",DrugBank
DB00586,Anti-Inflammatory Agents,DrugBank
DB00586,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00586,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00586,Antiinflammatory and Antirheumatic Products,DrugBank
DB00586,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00586,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00586,"Antimigraine Agents, Miscellaneous",DrugBank
DB00586,Antirheumatic Agents,DrugBank
DB00586,BSEP/ABCB11 Substrates,DrugBank
DB00586,Central Nervous System Agents,DrugBank
DB00586,Cyclooxygenase Inhibitors,DrugBank
DB00586,Cyclooxygenase-2 (COX-2) Inhibitors,DrugBank
DB00586,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00586,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00586,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00586,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00586,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00586,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00586,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00586,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00586,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00586,Cytochrome P-450 Substrates,DrugBank
DB00586,Decreased Prostaglandin Production,DrugBank
DB00586,Dermatologicals,DrugBank
DB00586,Drugs causing inadvertant photosensitivity,DrugBank
DB00586,Enzyme Inhibitors,DrugBank
DB00586,Ethylamines,DrugBank
DB00586,Musculo-Skeletal System,DrugBank
DB00586,Nephrotoxic agents,DrugBank
DB00586,Non COX-2 selective NSAIDS,DrugBank
DB00586,OAT1/SLC22A6 inhibitors,DrugBank
DB00586,OAT3/SLC22A8 Inhibitors,DrugBank
DB00586,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00586,Ophthalmologicals,DrugBank
DB00586,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00586,P-glycoprotein inducers,DrugBank
DB00586,Peripheral Nervous System Agents,DrugBank
DB00586,Phenylacetates,DrugBank
DB00586,Photosensitizing Agents,DrugBank
DB00586,Sensory Organs,DrugBank
DB00586,Sensory System Agents,DrugBank
DB00586,Topical Products for Joint and Muscular Pain,DrugBank
DB00586,UDP Glucuronosyltransferases Inhibitors,DrugBank
DB00586,UGT1A1 Substrates,DrugBank
DB00586,UGT1A3 substrates,DrugBank
DB00586,UGT1A9 Substrates,DrugBank
DB00586,UGT2B17 Inhibitors,DrugBank
DB00586,UGT2B7 substrates,DrugBank
DB00588,Adrenal Cortex Hormones,DrugBank
DB00588,Adrenals,DrugBank
DB00588,Agents to Treat Airway Disease,DrugBank
DB00588,Androstadienes,DrugBank
DB00588,Androstanes,DrugBank
DB00588,Androstenes,DrugBank
DB00588,Anti-Allergic Agents,DrugBank
DB00588,Anti-Asthmatic Agents,DrugBank
DB00588,Anti-Inflammatory Agents,DrugBank
DB00588,Autonomic Agents,DrugBank
DB00588,Bronchodilator Agents,DrugBank
DB00588,Central Nervous System Depressants,DrugBank
DB00588,Corticosteroids,DrugBank
DB00588,"Corticosteroids, Dermatological Preparations",DrugBank
DB00588,"Corticosteroids, Potent (Group III)",DrugBank
DB00588,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00588,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00588,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00588,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00588,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00588,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00588,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00588,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00588,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00588,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00588,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00588,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00588,Cytochrome P-450 Substrates,DrugBank
DB00588,Dermatologicals,DrugBank
DB00588,Fused-Ring Compounds,DrugBank
DB00588,Glucocorticoids,DrugBank
DB00588,Immunosuppressive Agents,DrugBank
DB00588,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00588,P-glycoprotein substrates,DrugBank
DB00588,Peripheral Nervous System Agents,DrugBank
DB00588,Respiratory System Agents,DrugBank
DB00588,Steroids,DrugBank
DB00588,Thyroxine-binding globulin inhibitors,DrugBank
DB00589,Agents that produce hypertension,DrugBank
DB00589,Alkaloids,DrugBank
DB00589,Analgesics,DrugBank
DB00589,Anti-Dyskinesia Agents,DrugBank
DB00589,Anti-Parkinson Drugs,DrugBank
DB00589,Antidepressive Agents,DrugBank
DB00589,Antimigraine Preparations,DrugBank
DB00589,Central Nervous System Agents,DrugBank
DB00589,Central Nervous System Depressants,DrugBank
DB00589,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00589,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00589,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00589,Cytochrome P-450 Substrates,DrugBank
DB00589,Dopamine Agents,DrugBank
DB00589,Dopamine Agonists,DrugBank
DB00589,Dopamine Antagonists,DrugBank
DB00589,Ergolines,DrugBank
DB00589,Ergot Alkaloids and Derivatives,DrugBank
DB00589,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB00589,Genito Urinary System and Sex Hormones,DrugBank
DB00589,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00589,Nervous System,DrugBank
DB00589,Neurotransmitter Agents,DrugBank
DB00589,Prolactine Inhibitors,DrugBank
DB00589,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00589,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00589,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00589,Serotonin Agents,DrugBank
DB00589,Serotonin Receptor Agonists,DrugBank
DB00589,Serotonin Receptor Antagonists,DrugBank
DB00590,Adrenergic Agents,DrugBank
DB00590,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00590,Adrenergic alpha-Antagonists,DrugBank
DB00590,Adrenergic Antagonists,DrugBank
DB00590,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB00590,Antihypertensive Agents,DrugBank
DB00590,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00590,Cardiovascular Agents,DrugBank
DB00590,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00590,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00590,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00590,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00590,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00590,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00590,Cytochrome P-450 Substrates,DrugBank
DB00590,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB00590,Genito Urinary System and Sex Hormones,DrugBank
DB00590,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00590,Hypotensive Agents,DrugBank
DB00590,Neurotransmitter Agents,DrugBank
DB00590,OCT1 inhibitors,DrugBank
DB00590,P-glycoprotein inhibitors,DrugBank
DB00590,Peripheral alpha-1 blockers,DrugBank
DB00590,Quinazolines,DrugBank
DB00590,Urologicals,DrugBank
DB00591,Adrenal Cortex Hormones,DrugBank
DB00591,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00591,Anti-Inflammatory Agents,DrugBank
DB00591,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00591,Corticosteroids,DrugBank
DB00591,"Corticosteroids, Dermatological Preparations",DrugBank
DB00591,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00591,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00591,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00591,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00591,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00591,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00591,Cytochrome P-450 Substrates,DrugBank
DB00591,Dermatologicals,DrugBank
DB00591,Drugs that are Mainly Renally Excreted,DrugBank
DB00591,Fused-Ring Compounds,DrugBank
DB00591,Hormones,DrugBank
DB00591,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00591,Immunosuppressive Agents,DrugBank
DB00591,Ophthalmologicals,DrugBank
DB00591,Otologicals,DrugBank
DB00591,Pregnadienes,DrugBank
DB00591,Pregnanes,DrugBank
DB00591,Steroids,DrugBank
DB00591,"Steroids, Fluorinated",DrugBank
DB00591,Vasoprotectives,DrugBank
DB00592,Anthelmintics,DrugBank
DB00592,Anti-Infective Agents,DrugBank
DB00592,Antinematodal Agents,DrugBank
DB00592,Antiparasitic Agents,DrugBank
DB00592,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00592,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00592,Cytochrome P-450 Substrates,DrugBank
DB00592,Hyperglycemia-Associated Agents,DrugBank
DB00592,Piperazine and Derivatives,DrugBank
DB00592,Piperazines,DrugBank
DB00593,Agents causing hyperkalemia,DrugBank
DB00593,Anti-epileptic Agent,DrugBank
DB00593,Antiarrhythmic agents,DrugBank
DB00593,Anticonvulsants,DrugBank
DB00593,Bradycardia-Causing Agents,DrugBank
DB00593,Calcium Channel Blockers,DrugBank
DB00593,Central Nervous System Agents,DrugBank
DB00593,Central Nervous System Depressants,DrugBank
DB00593,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00593,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00593,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00593,Cytochrome P-450 Substrates,DrugBank
DB00593,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00593,Imides,DrugBank
DB00593,Nervous System,DrugBank
DB00593,Potential QTc-Prolonging Agents,DrugBank
DB00593,Pyrrolidines,DrugBank
DB00593,Pyrrolidinones,DrugBank
DB00593,QTc Prolonging Agents,DrugBank
DB00593,Succinimide Derivatives,DrugBank
DB00593,Succinimides,DrugBank
DB00594,Acid Sensing Ion Channel Blockers,DrugBank
DB00594,Agents causing hyperkalemia,DrugBank
DB00594,Cardiovascular Agents,DrugBank
DB00594,Decreased Renal K+ Excretion,DrugBank
DB00594,Diuretics,DrugBank
DB00594,Epithelial Sodium Channel Blockers,DrugBank
DB00594,Hypotensive Agents,DrugBank
DB00594,Increased Diuresis,DrugBank
DB00594,Membrane Transport Modulators,DrugBank
DB00594,Natriuretic Agents,DrugBank
DB00594,OCT2 Inhibitors,DrugBank
DB00594,Potassium-Sparing Diuretics,DrugBank
DB00594,Pyrazines,DrugBank
DB00594,Sodium Channel Blockers,DrugBank
DB00595,Agents that produce neuromuscular block (indirect),DrugBank
DB00595,Alimentary Tract and Metabolism,DrugBank
DB00595,Anti-Bacterial Agents,DrugBank
DB00595,Anti-Infective Agents,DrugBank
DB00595,Antibacterials for Systemic Use,DrugBank
DB00595,Antibiotics for Topical Use,DrugBank
DB00595,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00595,Antiinfectives for Systemic Use,DrugBank
DB00595,Dermatologicals,DrugBank
DB00595,Genito Urinary System and Sex Hormones,DrugBank
DB00595,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00595,Naphthacenes,DrugBank
DB00595,OAT1/SLC22A6 inhibitors,DrugBank
DB00595,OAT3/SLC22A8 Inhibitors,DrugBank
DB00595,OAT3/SLC22A8 Substrates,DrugBank
DB00595,Ophthalmologicals,DrugBank
DB00595,Sensory Organs,DrugBank
DB00595,Stomatological Preparations,DrugBank
DB00595,Tetracyclines,DrugBank
DB00596,Adrenal Cortex Hormones,DrugBank
DB00596,Anti-Inflammatory Agents,DrugBank
DB00596,Antipsoriatics,DrugBank
DB00596,Antipsoriatics for Topical Use,DrugBank
DB00596,Cardiovascular Agents,DrugBank
DB00596,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00596,Corticosteroids,DrugBank
DB00596,"Corticosteroids, Dermatological Preparations",DrugBank
DB00596,"Corticosteroids, Potent (Group III)",DrugBank
DB00596,Dermatologicals,DrugBank
DB00596,Fused-Ring Compounds,DrugBank
DB00596,Immunosuppressive Agents,DrugBank
DB00596,Pregnadienes,DrugBank
DB00596,Pregnadienetriols,DrugBank
DB00596,Pregnanes,DrugBank
DB00596,Steroids,DrugBank
DB00596,"Steroids, Fluorinated",DrugBank
DB00596,Vasoconstrictor Agents,DrugBank
DB00597,"Compounds used in a research, industrial, or household setting",DrugBank
DB00597,Contrast Media,DrugBank
DB00597,Diagnostic Uses of Chemicals,DrugBank
DB00597,Drugs that are Mainly Renally Excreted,DrugBank
DB00597,Elements,DrugBank
DB00597,Lanthanoid Series Elements,DrugBank
DB00597,Magnetic Resonance Contrast Activity,DrugBank
DB00597,Magnetic Resonance Imaging Contrast Media,DrugBank
DB00597,Metals,DrugBank
DB00597,"Metals, Rare Earth",DrugBank
DB00597,Other Diagnostics,DrugBank
DB00597,Paramagnetic Contrast Agent,DrugBank
DB00597,Paramagnetic Contrast Media,DrugBank
DB00598,Adrenergic Agents,DrugBank
DB00598,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00598,Adrenergic alpha-Antagonists,DrugBank
DB00598,Adrenergic Antagonists,DrugBank
DB00598,Adrenergic beta-Antagonists,DrugBank
DB00598,Agents causing hyperkalemia,DrugBank
DB00598,Agents producing tachycardia,DrugBank
DB00598,Alcohols,DrugBank
DB00598,Alpha and Beta Blocking Agents,DrugBank
DB00598,Alpha and Beta Blocking Agents and Thiazides,DrugBank
DB00598,Amides,DrugBank
DB00598,Amines,DrugBank
DB00598,Amino Alcohols,DrugBank
DB00598,Antihypertensive Agents,DrugBank
DB00598,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00598,Autonomic Agents,DrugBank
DB00598,Beta Blocking Agents and Thiazides,DrugBank
DB00598,Bradycardia-Causing Agents,DrugBank
DB00598,Cardiovascular Agents,DrugBank
DB00598,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00598,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00598,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00598,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00598,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00598,Cytochrome P-450 Substrates,DrugBank
DB00598,Drugs that are Mainly Renally Excreted,DrugBank
DB00598,Ethanolamines,DrugBank
DB00598,Hypotensive Agents,DrugBank
DB00598,Negative Inotrope,DrugBank
DB00598,Neurotransmitter Agents,DrugBank
DB00598,Peripheral alpha-1 blockers,DrugBank
DB00598,Peripheral Nervous System Agents,DrugBank
DB00598,Salicylamides,DrugBank
DB00598,Sympathomimetics,DrugBank
DB00598,UGT1A1 Substrates,DrugBank
DB00598,UGT1A9 Substrates,DrugBank
DB00598,UGT2B7 substrates,DrugBank
DB00598,Vasodilating Agents,DrugBank
DB00599,Anesthetics,DrugBank
DB00599,"Anesthetics, General",DrugBank
DB00599,"Anesthetics, Intravenous",DrugBank
DB00599,Anticholinergic Agents,DrugBank
DB00599,Anticonvulsants,DrugBank
DB00599,Barbiturates,DrugBank
DB00599,"Barbiturates, Plain",DrugBank
DB00599,Central Nervous System Agents,DrugBank
DB00599,Central Nervous System Depressants,DrugBank
DB00599,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00599,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00599,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00599,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00599,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00599,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00599,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00599,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00599,Cytochrome P-450 Substrates,DrugBank
DB00599,GABA Agents,DrugBank
DB00599,GABA Modulators,DrugBank
DB00599,Hypnotics and Sedatives,DrugBank
DB00599,Hypotensive Agents,DrugBank
DB00599,Narrow Therapeutic Index Drugs,DrugBank
DB00599,Nervous System,DrugBank
DB00599,Neurotransmitter Agents,DrugBank
DB00599,Nicotinic Antagonists,DrugBank
DB00599,Psycholeptics,DrugBank
DB00599,Pyrimidines,DrugBank
DB00599,Pyrimidinones,DrugBank
DB00599,Thiobarbiturates,DrugBank
DB00601,Acetamides,DrugBank
DB00601,Acetates,DrugBank
DB00601,"Acids, Acyclic",DrugBank
DB00601,Agents that produce hypertension,DrugBank
DB00601,Agents that reduce seizure threshold,DrugBank
DB00601,Amides,DrugBank
DB00601,Anti-Bacterial Agents,DrugBank
DB00601,Anti-Infective Agents,DrugBank
DB00601,Antibacterials for Systemic Use,DrugBank
DB00601,Antidepressive Agents,DrugBank
DB00601,Antiinfectives for Systemic Use,DrugBank
DB00601,Central Nervous System Depressants,DrugBank
DB00601,Enzyme Inhibitors,DrugBank
DB00601,Immunosuppressive Agents,DrugBank
DB00601,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00601,Monoamine Oxidase Inhibitors,DrugBank
DB00601,Myelosuppressive Agents,DrugBank
DB00601,OAT1/SLC22A6 inhibitors,DrugBank
DB00601,OAT3/SLC22A8 Inhibitors,DrugBank
DB00601,Oxazolidinone Antibacterial,DrugBank
DB00601,Oxazolidinones,DrugBank
DB00601,Protein Synthesis Inhibitors,DrugBank
DB00601,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00601,Serotonin Agents,DrugBank
DB00601,Serotonin Modulators,DrugBank
DB00602,Agents Causing Muscle Toxicity,DrugBank
DB00602,Agrochemicals,DrugBank
DB00602,Anthelmintics,DrugBank
DB00602,Anti-Infective Agents,DrugBank
DB00602,Antinematodal Agents,DrugBank
DB00602,Antiparasitic Agents,DrugBank
DB00602,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00602,Avermectines,DrugBank
DB00602,BCRP/ABCG2 Substrates,DrugBank
DB00602,"Compounds used in a research, industrial, or household setting",DrugBank
DB00602,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00602,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00602,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00602,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00602,Cytochrome P-450 Substrates,DrugBank
DB00602,Dermatologicals,DrugBank
DB00602,Insecticides,DrugBank
DB00602,Lactones,DrugBank
DB00602,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00602,OATP1B3 inhibitors,DrugBank
DB00602,P-glycoprotein inducers,DrugBank
DB00602,P-glycoprotein inhibitors,DrugBank
DB00602,P-glycoprotein substrates,DrugBank
DB00602,Pediculicides,DrugBank
DB00602,Pesticides,DrugBank
DB00602,Polyketides,DrugBank
DB00602,Scabicides and Pediculicides,DrugBank
DB00602,Toxic Actions,DrugBank
DB00603,Adrenal Cortex Hormones,DrugBank
DB00603,Antineoplastic Agents,DrugBank
DB00603,"Antineoplastic Agents, Hormonal",DrugBank
DB00603,Antineoplastic and Immunomodulating Agents,DrugBank
DB00603,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00603,"Contraceptive Agents, Female",DrugBank
DB00603,"Contraceptive Agents, Hormonal",DrugBank
DB00603,"Contraceptive Agents, Male",DrugBank
DB00603,"Contraceptives, Oral",DrugBank
DB00603,"Contraceptives, Oral, Hormonal",DrugBank
DB00603,"Contraceptives, Oral, Synthetic",DrugBank
DB00603,Corpus Luteum Hormones,DrugBank
DB00603,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00603,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00603,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00603,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00603,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00603,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00603,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00603,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00603,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00603,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00603,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00603,Cytochrome P-450 Substrates,DrugBank
DB00603,Drugs that are Mainly Renally Excreted,DrugBank
DB00603,Endocrine Therapy,DrugBank
DB00603,Fused-Ring Compounds,DrugBank
DB00603,Genito Urinary System and Sex Hormones,DrugBank
DB00603,Gonadal Hormones,DrugBank
DB00603,Gonadal Steroid Hormones,DrugBank
DB00603,Hormonal Contraceptives for Systemic Use,DrugBank
DB00603,Hormones,DrugBank
DB00603,Hormones and Related Agents,DrugBank
DB00603,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00603,Hydroxyprogesterones,DrugBank
DB00603,Hyperglycemia-Associated Agents,DrugBank
DB00603,P-glycoprotein inhibitors,DrugBank
DB00603,Pregnanes,DrugBank
DB00603,Pregnen (4) Derivatives,DrugBank
DB00603,Pregnenediones,DrugBank
DB00603,Pregnenes,DrugBank
DB00603,Progesterone and Derivatives,DrugBank
DB00603,Progesterone Congeners,DrugBank
DB00603,Progestin Contraceptives,DrugBank
DB00603,Progestins,DrugBank
DB00603,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00603,Reproductive Control Agents,DrugBank
DB00603,Sex Hormones and Modulators of the Genital System,DrugBank
DB00603,Steroids,DrugBank
DB00604,"Acids, Carbocyclic",DrugBank
DB00604,Alimentary Tract and Metabolism,DrugBank
DB00604,Amides,DrugBank
DB00604,Aminobenzoates,DrugBank
DB00604,Anti-Ulcer Agents,DrugBank
DB00604,Antidepressive Agents,DrugBank
DB00604,Benzamides and benzamide derivatives,DrugBank
DB00604,Benzene Derivatives,DrugBank
DB00604,Benzoates,DrugBank
DB00604,Central Nervous System Depressants,DrugBank
DB00604,Chlorobenzoates,DrugBank
DB00604,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00604,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB00604,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00604,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00604,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00604,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB00604,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00604,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00604,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00604,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00604,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00604,Cytochrome P-450 Substrates,DrugBank
DB00604,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00604,Gastrointestinal Agents,DrugBank
DB00604,Highest Risk QTc-Prolonging Agents,DrugBank
DB00604,Neurotransmitter Agents,DrugBank
DB00604,para-Aminobenzoates,DrugBank
DB00604,Piperidines,DrugBank
DB00604,Propulsives,DrugBank
DB00604,QTc Prolonging Agents,DrugBank
DB00604,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00604,Serotonin Agents,DrugBank
DB00604,Serotonin Receptor Agonists,DrugBank
DB00605,Acetic Acid Derivatives and Related Substances,DrugBank
DB00605,Agents causing hyperkalemia,DrugBank
DB00605,Agents that produce hypertension,DrugBank
DB00605,Analgesics,DrugBank
DB00605,"Analgesics, Non-Narcotic",DrugBank
DB00605,Anti-Inflammatory Agents,DrugBank
DB00605,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00605,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00605,Antiinflammatory and Antirheumatic Products,DrugBank
DB00605,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00605,Antirheumatic Agents,DrugBank
DB00605,Cyclooxygenase Inhibitors,DrugBank
DB00605,Drugs causing inadvertant photosensitivity,DrugBank
DB00605,Enzyme Inhibitors,DrugBank
DB00605,Indenes,DrugBank
DB00605,Musculo-Skeletal System,DrugBank
DB00605,Nephrotoxic agents,DrugBank
DB00605,Non COX-2 selective NSAIDS,DrugBank
DB00605,OAT1/SLC22A6 inhibitors,DrugBank
DB00605,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00605,Peripheral Nervous System Agents,DrugBank
DB00605,Photosensitizing Agents,DrugBank
DB00605,Sensory System Agents,DrugBank
DB00606,Antihypertensive Agents,DrugBank
DB00606,Cardiovascular Agents,DrugBank
DB00606,Diuretics,DrugBank
DB00606,Genito Urinary System and Sex Hormones,DrugBank
DB00606,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00606,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00606,Hyperglycemia-Associated Agents,DrugBank
DB00606,Natriuretic Agents,DrugBank
DB00606,OAT1/SLC22A6 inhibitors,DrugBank
DB00606,"Receptors, AMPA",DrugBank
DB00606,Sulfonamides,DrugBank
DB00606,Sulfones,DrugBank
DB00606,Sulfur Compounds,DrugBank
DB00606,Thiazides,DrugBank
DB00607,Amides,DrugBank
DB00607,Anti-Bacterial Agents,DrugBank
DB00607,Anti-Infective Agents,DrugBank
DB00607,Antibacterials for Systemic Use,DrugBank
DB00607,Antiinfectives for Systemic Use,DrugBank
DB00607,Beta-Lactam Antibacterials,DrugBank
DB00607,Beta-Lactamase Resistant Penicillins,DrugBank
DB00607,beta-Lactams,DrugBank
DB00607,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00607,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00607,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00607,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00607,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB00607,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00607,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00607,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00607,Lactams,DrugBank
DB00607,OAT1/SLC22A6 inhibitors,DrugBank
DB00607,Penicillins,DrugBank
DB00607,Sulfur Compounds,DrugBank
DB00608,Agents Causing Muscle Toxicity,DrugBank
DB00608,Agents that produce neuromuscular block (indirect),DrugBank
DB00608,Agents that reduce seizure threshold,DrugBank
DB00608,"alpha-Galactosidase, antagonists & inhibitors",DrugBank
DB00608,Amebicides,DrugBank
DB00608,Aminoquinolines,DrugBank
DB00608,Analgesics,DrugBank
DB00608,"Analgesics, Non-Narcotic",DrugBank
DB00608,Anti-Infective Agents,DrugBank
DB00608,Anti-Inflammatory Agents,DrugBank
DB00608,Antimalarials,DrugBank
DB00608,Antinematodal Agents,DrugBank
DB00608,Antiparasitic Agents,DrugBank
DB00608,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00608,Antiprotozoals,DrugBank
DB00608,Antirheumatic Agents,DrugBank
DB00608,Biguanides,DrugBank
DB00608,Central Nervous System Agents,DrugBank
DB00608,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00608,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00608,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00608,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00608,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00608,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00608,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00608,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00608,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00608,Cytochrome P-450 Substrates,DrugBank
DB00608,Drugs causing inadvertant photosensitivity,DrugBank
DB00608,Drugs that are Mainly Renally Excreted,DrugBank
DB00608,Experimental Unapproved Treatments for COVID-19,DrugBank
DB00608,Filaricides,DrugBank
DB00608,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00608,Methemoglobinemia Associated Agents,DrugBank
DB00608,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00608,P-glycoprotein inhibitors,DrugBank
DB00608,P-glycoprotein substrates,DrugBank
DB00608,Peripheral Nervous System Agents,DrugBank
DB00608,Photosensitizing Agents,DrugBank
DB00608,QTc Prolonging Agents,DrugBank
DB00608,Quinolines,DrugBank
DB00608,Sensory System Agents,DrugBank
DB00608,Tumor Necrosis Factor Blockers,DrugBank
DB00609,Anti-Bacterial Agents,DrugBank
DB00609,Anti-Infective Agents,DrugBank
DB00609,Antiinfectives for Systemic Use,DrugBank
DB00609,Antimycobacterials,DrugBank
DB00609,Drugs causing inadvertant photosensitivity,DrugBank
DB00609,Drugs for Treatment of Tuberculosis,DrugBank
DB00609,Fatty Acid Synthesis Inhibitors,DrugBank
DB00609,Hypolipidemic Agents,DrugBank
DB00609,Isonicotinic Acids,DrugBank
DB00609,Photosensitizing Agents,DrugBank
DB00609,Pyridines,DrugBank
DB00609,Thiocarbamide Derivatives,DrugBank
DB00610,Adrenergic Agents,DrugBank
DB00610,Adrenergic Agonists,DrugBank
DB00610,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00610,Adrenergic alpha-Agonists,DrugBank
DB00610,Adrenergic and Dopaminergic Agents,DrugBank
DB00610,Agents producing tachycardia,DrugBank
DB00610,Agents that produce hypertension,DrugBank
DB00610,Alcohols,DrugBank
DB00610,Amines,DrugBank
DB00610,Amino Alcohols,DrugBank
DB00610,Autonomic Agents,DrugBank
DB00610,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00610,Cardiac Therapy,DrugBank
DB00610,Cardiovascular Agents,DrugBank
DB00610,Neurotransmitter Agents,DrugBank
DB00610,Peripheral Nervous System Agents,DrugBank
DB00610,Propanolamines,DrugBank
DB00610,Propanols,DrugBank
DB00610,Sympathomimetics,DrugBank
DB00610,Vasoconstrictor Agents,DrugBank
DB00611,Alkaloids,DrugBank
DB00611,Analgesics,DrugBank
DB00611,Antitussive Agents,DrugBank
DB00611,Central Nervous System Agents,DrugBank
DB00611,Central Nervous System Depressants,DrugBank
DB00611,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00611,Mixed Agonist / Antagonist Opioids,DrugBank
DB00611,Morphinan Derivatives,DrugBank
DB00611,Morphinans,DrugBank
DB00611,Narcotics,DrugBank
DB00611,Nervous System,DrugBank
DB00611,Opiate Alkaloids,DrugBank
DB00611,Opiate Partial Agonists,DrugBank
DB00611,Opioid Agonist/Antagonist,DrugBank
DB00611,Opioid Antagonists,DrugBank
DB00611,Opioids,DrugBank
DB00611,Peripheral Nervous System Agents,DrugBank
DB00611,Phenanthrenes,DrugBank
DB00611,Respiratory System Agents,DrugBank
DB00611,Sensory System Agents,DrugBank
DB00611,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00612,Adrenergic Agents,DrugBank
DB00612,Adrenergic Antagonists,DrugBank
DB00612,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB00612,Adrenergic beta-Antagonists,DrugBank
DB00612,Agents causing hyperkalemia,DrugBank
DB00612,Alcohols,DrugBank
DB00612,Amines,DrugBank
DB00612,Amino Alcohols,DrugBank
DB00612,Antiarrhythmic agents,DrugBank
DB00612,Antihypertensive Agents,DrugBank
DB00612,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00612,Autonomic Agents,DrugBank
DB00612,Beta blocking agents and calcium channel blockers,DrugBank
DB00612,Beta Blocking Agents and Thiazides,DrugBank
DB00612,"Beta Blocking Agents, Selective",DrugBank
DB00612,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB00612,Beta-Blockers (Beta1 Selective),DrugBank
DB00612,Bradycardia-Causing Agents,DrugBank
DB00612,Cardiovascular Agents,DrugBank
DB00612,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00612,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00612,Cytochrome P-450 Substrates,DrugBank
DB00612,Drugs that are Mainly Renally Excreted,DrugBank
DB00612,Hypotensive Agents,DrugBank
DB00612,Neurotransmitter Agents,DrugBank
DB00612,P-glycoprotein inhibitors,DrugBank
DB00612,P-glycoprotein substrates,DrugBank
DB00612,Peripheral Nervous System Agents,DrugBank
DB00612,Phenoxypropanolamines,DrugBank
DB00612,Propanolamines,DrugBank
DB00612,Propanols,DrugBank
DB00612,Sympatholytics,DrugBank
DB00613,Aminoquinolines,DrugBank
DB00613,Anti-Infective Agents,DrugBank
DB00613,Antimalarials,DrugBank
DB00613,Antiparasitic Agents,DrugBank
DB00613,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00613,Antiprotozoals,DrugBank
DB00613,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00613,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00613,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00613,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00613,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00613,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00613,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00613,Cytochrome P-450 Substrates,DrugBank
DB00613,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00613,P-glycoprotein inhibitors,DrugBank
DB00613,Potential QTc-Prolonging Agents,DrugBank
DB00613,QTc Prolonging Agents,DrugBank
DB00613,Quinolines,DrugBank
DB00614,Agents that produce hypertension,DrugBank
DB00614,Agents that reduce seizure threshold,DrugBank
DB00614,Anti-Infective Agents,DrugBank
DB00614,"Anti-Infective Agents, Local",DrugBank
DB00614,"Anti-Infective Agents, Urinary",DrugBank
DB00614,Antidepressive Agents,DrugBank
DB00614,Antiparasitic Agents,DrugBank
DB00614,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00614,Antiprotozoals,DrugBank
DB00614,Antitrichomonal Agents,DrugBank
DB00614,Central Nervous System Depressants,DrugBank
DB00614,Enzyme Inhibitors,DrugBank
DB00614,Furans,DrugBank
DB00614,Genito Urinary System and Sex Hormones,DrugBank
DB00614,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00614,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00614,Monoamine Oxidase Inhibitors,DrugBank
DB00614,Nitro Compounds,DrugBank
DB00614,Nitrofurans,DrugBank
DB00614,Nitroimidazole Derivatives,DrugBank
DB00614,Oxazoles,DrugBank
DB00614,Oxazolidinones,DrugBank
DB00614,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00615,Alimentary Tract and Metabolism,DrugBank
DB00615,Anti-Bacterial Agents,DrugBank
DB00615,Anti-Infective Agents,DrugBank
DB00615,"Antibiotics, Antitubercular",DrugBank
DB00615,Antiinfectives for Systemic Use,DrugBank
DB00615,Antimycobacterials,DrugBank
DB00615,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00615,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB00615,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00615,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB00615,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00615,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB00615,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00615,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00615,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00615,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00615,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00615,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00615,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00615,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00615,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00615,Cytochrome P-450 Substrates,DrugBank
DB00615,Drugs for Acid Related Disorders,DrugBank
DB00615,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00615,Drugs for Treatment of Tuberculosis,DrugBank
DB00615,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00615,"Lactams, Macrocyclic",DrugBank
DB00615,P-glycoprotein inducers,DrugBank
DB00615,Rifamycin Antimycobacterial,DrugBank
DB00615,Rifamycins,DrugBank
DB00616,"Acids, Acyclic",DrugBank
DB00616,Antihypertensive Agents,DrugBank
DB00616,Cardiovascular Agents,DrugBank
DB00616,Enzyme Inhibitors,DrugBank
DB00616,Fatty Acids,DrugBank
DB00616,"Fatty Acids, Volatile",DrugBank
DB00616,Indenes,DrugBank
DB00616,Lipids,DrugBank
DB00616,"Neprilysin, antagonists & inhibitors",DrugBank
DB00616,Prodrugs,DrugBank
DB00616,Protease Inhibitors,DrugBank
DB00617,Anticonvulsants,DrugBank
DB00617,Central Nervous System Depressants,DrugBank
DB00617,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00617,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00617,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00617,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00617,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00617,Cytochrome P-450 Substrates,DrugBank
DB00617,Nervous System,DrugBank
DB00617,Oxazolidine Derivatives,DrugBank
DB00618,Agents that produce neuromuscular block (indirect),DrugBank
DB00618,Anti-Bacterial Agents,DrugBank
DB00618,Anti-Infective Agents,DrugBank
DB00618,Antibacterials for Systemic Use,DrugBank
DB00618,Antibiotics for Topical Use,DrugBank
DB00618,Antiinfectives for Systemic Use,DrugBank
DB00618,Dermatologicals,DrugBank
DB00618,Drugs causing inadvertant photosensitivity,DrugBank
DB00618,Naphthacenes,DrugBank
DB00618,Photosensitizing Agents,DrugBank
DB00618,Tetracyclines,DrugBank
DB00619,Amides,DrugBank
DB00619,Antineoplastic Agents,DrugBank
DB00619,Antineoplastic and Immunomodulating Agents,DrugBank
DB00619,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB00619,BCRP/ABCG2 Inhibitors,DrugBank
DB00619,BCRP/ABCG2 Substrates,DrugBank
DB00619,Benzamides and benzamide derivatives,DrugBank
DB00619,Benzene Derivatives,DrugBank
DB00619,BSEP/ABCB11 Substrates,DrugBank
DB00619,Cancer immunotherapy,DrugBank
DB00619,Cardiotoxic antineoplastic agents,DrugBank
DB00619,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00619,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00619,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00619,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00619,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00619,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00619,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00619,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00619,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00619,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00619,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00619,Cytochrome P-450 Substrates,DrugBank
DB00619,Drugs causing inadvertant photosensitivity,DrugBank
DB00619,Enzyme Inhibitors,DrugBank
DB00619,Highest Risk QTc-Prolonging Agents,DrugBank
DB00619,Immunosuppressive Agents,DrugBank
DB00619,Immunotherapy,DrugBank
DB00619,Kinase Inhibitor,DrugBank
DB00619,Myelosuppressive Agents,DrugBank
DB00619,OATP1B3 substrates,DrugBank
DB00619,OCT1 substrates,DrugBank
DB00619,OCT2 Inhibitors,DrugBank
DB00619,P-glycoprotein inhibitors,DrugBank
DB00619,P-glycoprotein substrates,DrugBank
DB00619,Photosensitizing Agents,DrugBank
DB00619,Piperazines,DrugBank
DB00619,Protein Kinase Inhibitors,DrugBank
DB00619,Pyrimidines,DrugBank
DB00619,QTc Prolonging Agents,DrugBank
DB00619,Tyrosine Kinase Inhibitors,DrugBank
DB00619,UDP Glucuronosyltransferases Inhibitors,DrugBank
DB00619,UGT2B17 Inhibitors,DrugBank
DB00620,Adrenal Cortex Hormones,DrugBank
DB00620,Adrenals,DrugBank
DB00620,Agents Causing Muscle Toxicity,DrugBank
DB00620,Agents to Treat Airway Disease,DrugBank
DB00620,Alimentary Tract and Metabolism,DrugBank
DB00620,Anti-Inflammatory Agents,DrugBank
DB00620,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00620,Corticosteroids,DrugBank
DB00620,Corticosteroids for Local Oral Treatment,DrugBank
DB00620,Corticosteroids for Systemic Use,DrugBank
DB00620,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00620,"Corticosteroids, Dermatological Preparations",DrugBank
DB00620,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB00620,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00620,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00620,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00620,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00620,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00620,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00620,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00620,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00620,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB00620,Cytochrome P-450 CYP3A7 Inducers (strength unknown),DrugBank
DB00620,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00620,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00620,Cytochrome P-450 Substrates,DrugBank
DB00620,Dermatologicals,DrugBank
DB00620,Drugs for Obstructive Airway Diseases,DrugBank
DB00620,Enzyme Inhibitors,DrugBank
DB00620,Fused-Ring Compounds,DrugBank
DB00620,Glucocorticoids,DrugBank
DB00620,Hormones,DrugBank
DB00620,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00620,Hyperglycemia-Associated Agents,DrugBank
DB00620,Immunologic Factors,DrugBank
DB00620,Immunosuppressive Agents,DrugBank
DB00620,Nasal Preparations,DrugBank
DB00620,Ophthalmologicals,DrugBank
DB00620,Pregnadienes,DrugBank
DB00620,Pregnanes,DrugBank
DB00620,"Protein-Lysine 6-Oxidase, antagonists & inhibitors",DrugBank
DB00620,Sensory Organs,DrugBank
DB00620,Steroids,DrugBank
DB00620,"Steroids, Fluorinated",DrugBank
DB00620,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00620,Thyroxine-binding globulin inhibitors,DrugBank
DB00620,Vasoprotectives,DrugBank
DB00621,Alimentary Tract and Metabolism,DrugBank
DB00621,Anabolic Agents,DrugBank
DB00621,Anabolic Agents for Systemic Use,DrugBank
DB00621,Anabolic Steroids,DrugBank
DB00621,Androgens,DrugBank
DB00621,Androstan Derivatives,DrugBank
DB00621,Androstanes,DrugBank
DB00621,Androstanols,DrugBank
DB00621,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00621,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00621,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00621,Fused-Ring Compounds,DrugBank
DB00621,Hormones,DrugBank
DB00621,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00621,Steroids,DrugBank
DB00621,Thyroxine-binding globulin inhibitors,DrugBank
DB00622,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00622,Adrenergic alpha-Antagonists,DrugBank
DB00622,Adrenergic Antagonists,DrugBank
DB00622,Agents causing hyperkalemia,DrugBank
DB00622,Agents producing tachycardia,DrugBank
DB00622,Antiarrhythmic agents,DrugBank
DB00622,Anticholinergic Agents,DrugBank
DB00622,Antihypertensive Agents,DrugBank
DB00622,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00622,Bradycardia-Causing Agents,DrugBank
DB00622,BSEP/ABCB11 Substrates,DrugBank
DB00622,Calcium Channel Blockers,DrugBank
DB00622,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB00622,Calcium-Regulating Hormones and Agents,DrugBank
DB00622,Cardiovascular Agents,DrugBank
DB00622,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00622,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00622,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00622,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00622,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00622,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00622,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00622,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00622,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00622,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00622,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00622,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00622,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00622,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00622,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00622,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00622,Cytochrome P-450 Substrates,DrugBank
DB00622,Dihydropyridine Derivatives,DrugBank
DB00622,Dihydropyridines,DrugBank
DB00622,Hypotensive Agents,DrugBank
DB00622,Membrane Transport Modulators,DrugBank
DB00622,Muscarinic Antagonists,DrugBank
DB00622,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00622,P-glycoprotein inhibitors,DrugBank
DB00622,P-glycoprotein substrates,DrugBank
DB00622,Potential QTc-Prolonging Agents,DrugBank
DB00622,Pyridines,DrugBank
DB00622,QTc Prolonging Agents,DrugBank
DB00622,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB00622,Vasodilating Agents,DrugBank
DB00623,Agents that reduce seizure threshold,DrugBank
DB00623,Antidepressive Agents,DrugBank
DB00623,Antipsychotic Agents,DrugBank
DB00623,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00623,Central Nervous System Agents,DrugBank
DB00623,Central Nervous System Depressants,DrugBank
DB00623,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00623,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00623,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00623,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00623,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00623,Delayed-Action Preparations,DrugBank
DB00623,Dopamine Agents,DrugBank
DB00623,Dopamine Antagonists,DrugBank
DB00623,Dopamine D2 Receptor Antagonists,DrugBank
DB00623,Drugs causing inadvertant photosensitivity,DrugBank
DB00623,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00623,Nervous System,DrugBank
DB00623,Neurotoxic agents,DrugBank
DB00623,Neurotransmitter Agents,DrugBank
DB00623,P-glycoprotein inhibitors,DrugBank
DB00623,Phenothiazines,DrugBank
DB00623,Phenothiazines With Piperazine Structure,DrugBank
DB00623,Photosensitizing Agents,DrugBank
DB00623,Psycholeptics,DrugBank
DB00623,Psychotropic Drugs,DrugBank
DB00623,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00623,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00623,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00623,Serotonin Agents,DrugBank
DB00623,Serotonin Receptor Antagonists,DrugBank
DB00623,Sulfur Compounds,DrugBank
DB00623,Tranquilizing Agents,DrugBank
DB00624,3-Oxoandrosten (4) Derivatives,DrugBank
DB00624,Anabolic Steroids,DrugBank
DB00624,Androgens,DrugBank
DB00624,Androgens and Estrogens,DrugBank
DB00624,Androstanes,DrugBank
DB00624,Androstenes,DrugBank
DB00624,Androstenols,DrugBank
DB00624,BCRP/ABCG2 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00624,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00624,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00624,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00624,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00624,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00624,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00624,Cytochrome P-450 Substrates,DrugBank
DB00624,Drugs that are Mainly Renally Excreted,DrugBank
DB00624,Fused-Ring Compounds,DrugBank
DB00624,Genito Urinary System and Sex Hormones,DrugBank
DB00624,Gonadal Hormones,DrugBank
DB00624,Gonadal Steroid Hormones,DrugBank
DB00624,Hormones,DrugBank
DB00624,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00624,OAT3/SLC22A8 Inducers,DrugBank
DB00624,OATP1B3 substrates,DrugBank
DB00624,P-glycoprotein inhibitors,DrugBank
DB00624,Sex Hormones and Modulators of the Genital System,DrugBank
DB00624,Steroids,DrugBank
DB00624,Testosterone and derivatives,DrugBank
DB00624,Testosterone Congeners,DrugBank
DB00624,Thyroxine-binding globulin inhibitors,DrugBank
DB00625,Anti-Infective Agents,DrugBank
DB00625,Anti-Retroviral Agents,DrugBank
DB00625,Antiinfectives for Systemic Use,DrugBank
DB00625,Antiviral Agents,DrugBank
DB00625,Antivirals for Systemic Use,DrugBank
DB00625,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00625,BSEP/ABCB11 Substrates,DrugBank
DB00625,Central Nervous System Depressants,DrugBank
DB00625,Cycloparaffins,DrugBank
DB00625,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00625,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00625,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00625,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00625,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00625,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00625,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00625,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB00625,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00625,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00625,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00625,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00625,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00625,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00625,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB00625,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00625,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00625,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00625,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00625,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB00625,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB00625,Cytochrome P-450 CYP3A7 Inducers (moderate),DrugBank
DB00625,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00625,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00625,Cytochrome P-450 Substrates,DrugBank
DB00625,Direct Acting Antivirals,DrugBank
DB00625,Enzyme Inhibitors,DrugBank
DB00625,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00625,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00625,"Hydrocarbons, Acyclic",DrugBank
DB00625,Inducers of Drug Clearance,DrugBank
DB00625,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00625,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00625,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00625,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00625,OCT1 inhibitors,DrugBank
DB00625,Oxazines,DrugBank
DB00625,QTc Prolonging Agents,DrugBank
DB00625,Reverse Transcriptase Inhibitors,DrugBank
DB00625,UGT1A1 Inducers,DrugBank
DB00626,"Acids, Carbocyclic",DrugBank
DB00626,"Amino Acids, Peptides, and Proteins",DrugBank
DB00626,Anti-Bacterial Agents,DrugBank
DB00626,Anti-Infective Agents,DrugBank
DB00626,"Anti-Infective Agents, Local",DrugBank
DB00626,Antibacterials for Systemic Use,DrugBank
DB00626,Antibiotics for Topical Use,DrugBank
DB00626,Antiinfectives for Systemic Use,DrugBank
DB00626,Bacitracins,DrugBank
DB00626,Benzene Derivatives,DrugBank
DB00626,Benzoates,DrugBank
DB00626,Decreased Cell Wall Synthesis & Repair,DrugBank
DB00626,Dermatologicals,DrugBank
DB00626,Hydroxy Acids,DrugBank
DB00626,Hydroxybenzoates,DrugBank
DB00626,Nephrotoxic agents,DrugBank
DB00626,Ophthalmologicals,DrugBank
DB00626,Peptides,DrugBank
DB00626,"Peptides, Cyclic",DrugBank
DB00626,Phenols,DrugBank
DB00626,Sensory Organs,DrugBank
DB00626,Throat Preparations,DrugBank
DB00627,Agents Causing Muscle Toxicity,DrugBank
DB00627,Cardiovascular Agents,DrugBank
DB00627,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00627,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00627,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00627,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00627,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00627,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00627,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00627,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00627,"Diet, Food, and Nutrition",DrugBank
DB00627,Food,DrugBank
DB00627,Growth Substances,DrugBank
DB00627,Hyperglycemia-Associated Agents,DrugBank
DB00627,Hypolipidemic Agents,DrugBank
DB00627,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00627,Lipid Modifying Agents,DrugBank
DB00627,"Lipid Modifying Agents, Plain",DrugBank
DB00627,Lipid Regulating Agents,DrugBank
DB00627,Micronutrients,DrugBank
DB00627,Miscellaneous Antilipemic Agents,DrugBank
DB00627,Nicotinic Acid and Derivatives,DrugBank
DB00627,Nicotinic Acids,DrugBank
DB00627,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00627,Noxae,DrugBank
DB00627,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00627,Peripheral Vasodilators,DrugBank
DB00627,Physiological Phenomena,DrugBank
DB00627,Pyridines,DrugBank
DB00627,Thyroxine-binding globulin inhibitors,DrugBank
DB00627,Toxic Actions,DrugBank
DB00627,Vasodilating Agents,DrugBank
DB00627,Vitamin B Complex,DrugBank
DB00627,Vitamins,DrugBank
DB00628,Anti-Anxiety Agents,DrugBank
DB00628,Anticonvulsants,DrugBank
DB00628,Benzazepines,DrugBank
DB00628,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00628,Central Nervous System Agents,DrugBank
DB00628,Central Nervous System Depressants,DrugBank
DB00628,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00628,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00628,Cytochrome P-450 Substrates,DrugBank
DB00628,Drugs that are Mainly Renally Excreted,DrugBank
DB00628,GABA Agents,DrugBank
DB00628,GABA Modulators,DrugBank
DB00628,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00628,Nervous System,DrugBank
DB00628,Neurotransmitter Agents,DrugBank
DB00628,Psycholeptics,DrugBank
DB00628,Psychotropic Drugs,DrugBank
DB00628,Tranquilizing Agents,DrugBank
DB00629,Adrenergic Agents,DrugBank
DB00629,Adrenergic Agonists,DrugBank
DB00629,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00629,Adrenergic alpha-Agonists,DrugBank
DB00629,Agents producing tachycardia,DrugBank
DB00629,Agents that produce hypertension,DrugBank
DB00629,Amidines,DrugBank
DB00629,Antihypertensive Agents,DrugBank
DB00629,Cardiovascular Agents,DrugBank
DB00629,Central alpha-2 Adrenergic Agonist,DrugBank
DB00629,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00629,Cytochrome P-450 Substrates,DrugBank
DB00629,Guanidines,DrugBank
DB00629,Neurotransmitter Agents,DrugBank
DB00630,Agents Causing Muscle Toxicity,DrugBank
DB00630,Bisphosphonates,DrugBank
DB00630,Bone Density Conservation Agents,DrugBank
DB00630,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00630,Drugs for Treatment of Bone Diseases,DrugBank
DB00630,Musculo-Skeletal System,DrugBank
DB00630,Organophosphonates,DrugBank
DB00630,Organophosphorus Compounds,DrugBank
DB00631,Adenine Nucleotides,DrugBank
DB00631,Antimetabolites,DrugBank
DB00631,Antineoplastic Agents,DrugBank
DB00631,Antineoplastic and Immunomodulating Agents,DrugBank
DB00631,Arabinonucleosides,DrugBank
DB00631,BCRP/ABCG2 Substrates,DrugBank
DB00631,Drugs that are Mainly Renally Excreted,DrugBank
DB00631,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00631,Hypotensive Agents,DrugBank
DB00631,Immunosuppressive Agents,DrugBank
DB00631,Myelosuppressive Agents,DrugBank
DB00631,Narrow Therapeutic Index Drugs,DrugBank
DB00631,Noxae,DrugBank
DB00631,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00631,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00631,Nucleoside Metabolic Inhibitor,DrugBank
DB00631,Nucleosides,DrugBank
DB00631,Nucleotides,DrugBank
DB00631,OAT3/SLC22A8 Substrates,DrugBank
DB00631,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00631,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00631,Purine Analogues,DrugBank
DB00631,Purine Nucleotides,DrugBank
DB00631,Purines,DrugBank
DB00631,Ribonucleotides,DrugBank
DB00631,Toxic Actions,DrugBank
DB00633,Adrenergic Agents,DrugBank
DB00633,Adrenergic Agonists,DrugBank
DB00633,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00633,Adrenergic alpha-Agonists,DrugBank
DB00633,Agents producing tachycardia,DrugBank
DB00633,Agents that produce hypertension,DrugBank
DB00633,Analgesics,DrugBank
DB00633,"Analgesics, Non-Narcotic",DrugBank
DB00633,Anesthetics,DrugBank
DB00633,"Anesthetics, General",DrugBank
DB00633,Bradycardia-Causing Agents,DrugBank
DB00633,Central alpha-2 Adrenergic Agonist,DrugBank
DB00633,Central Nervous System Agents,DrugBank
DB00633,Central Nervous System Depressants,DrugBank
DB00633,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00633,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00633,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00633,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00633,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00633,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00633,Cytochrome P-450 Substrates,DrugBank
DB00633,Drugs that are Mainly Renally Excreted,DrugBank
DB00633,Hypnotics and Sedatives,DrugBank
DB00633,Hypotensive Agents,DrugBank
DB00633,Imidazoles,DrugBank
DB00633,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00633,Nervous System,DrugBank
DB00633,Neurotransmitter Agents,DrugBank
DB00633,Peripheral Nervous System Agents,DrugBank
DB00633,Psycholeptics,DrugBank
DB00633,Sensory System Agents,DrugBank
DB00634,Amides,DrugBank
DB00634,Amines,DrugBank
DB00634,Aniline Compounds,DrugBank
DB00634,Anti-Acne Preparations,DrugBank
DB00634,Anti-Acne Preparations for Topical Use,DrugBank
DB00634,Anti-Bacterial Agents,DrugBank
DB00634,Anti-Infective Agents,DrugBank
DB00634,"Anti-Infective Agents, Local",DrugBank
DB00634,"Anti-Infective Agents, Urinary",DrugBank
DB00634,Antiinfectives for Treatment of Acne,DrugBank
DB00634,Dermatologicals,DrugBank
DB00634,Genito Urinary System and Sex Hormones,DrugBank
DB00634,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00634,Ophthalmologicals,DrugBank
DB00634,Sensory Organs,DrugBank
DB00634,Sulfanilamides,DrugBank
DB00634,Sulfonamide Antibacterial,DrugBank
DB00634,Sulfonamides,DrugBank
DB00634,Sulfones,DrugBank
DB00634,Sulfur Compounds,DrugBank
DB00635,Adrenal Cortex Hormones,DrugBank
DB00635,Adrenals,DrugBank
DB00635,Alimentary Tract and Metabolism,DrugBank
DB00635,Anti-Inflammatory Agents,DrugBank
DB00635,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00635,Antineoplastic Agents,DrugBank
DB00635,"Antineoplastic Agents, Hormonal",DrugBank
DB00635,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00635,Corticosteroids,DrugBank
DB00635,Corticosteroids Acting Locally,DrugBank
DB00635,Corticosteroids for Systemic Use,DrugBank
DB00635,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00635,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00635,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00635,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00635,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00635,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00635,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00635,Cytochrome P-450 Substrates,DrugBank
DB00635,Drugs that are Mainly Renally Excreted,DrugBank
DB00635,Fused-Ring Compounds,DrugBank
DB00635,Glucocorticoids,DrugBank
DB00635,Hormones,DrugBank
DB00635,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00635,Hyperglycemia-Associated Agents,DrugBank
DB00635,Immunosuppressive Agents,DrugBank
DB00635,Intestinal Antiinflammatory Agents,DrugBank
DB00635,P-glycoprotein inducers,DrugBank
DB00635,P-glycoprotein inhibitors,DrugBank
DB00635,P-glycoprotein substrates,DrugBank
DB00635,Prednisolone and Prodrugs,DrugBank
DB00635,Pregnadienediols,DrugBank
DB00635,Pregnadienes,DrugBank
DB00635,Pregnanes,DrugBank
DB00635,Steroids,DrugBank
DB00635,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00635,Thyroxine-binding globulin inhibitors,DrugBank
DB00636,"Acids, Acyclic",DrugBank
DB00636,Agents Causing Muscle Toxicity,DrugBank
DB00636,Anticholesteremic Agents,DrugBank
DB00636,Benzene Derivatives,DrugBank
DB00636,Butyrates,DrugBank
DB00636,Clofibric Acid,DrugBank
DB00636,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00636,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00636,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00636,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00636,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00636,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00636,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00636,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00636,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00636,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00636,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00636,Cytochrome P-450 Substrates,DrugBank
DB00636,Ethers,DrugBank
DB00636,Fibric Acids,DrugBank
DB00636,Hypolipidemic Agents,DrugBank
DB00636,Isobutyrates,DrugBank
DB00636,Lipid Modifying Agents,DrugBank
DB00636,"Lipid Modifying Agents, Plain",DrugBank
DB00636,Lipid Regulating Agents,DrugBank
DB00636,Phenols,DrugBank
DB00636,Phenyl Ethers,DrugBank
DB00636,Thyroxine-binding globulin inducers,DrugBank
DB00637,Anti-Allergic Agents,DrugBank
DB00637,Antihistamines for Systemic Use,DrugBank
DB00637,Benzimidazoles,DrugBank
DB00637,BSEP/ABCB11 Substrates,DrugBank
DB00637,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00637,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00637,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00637,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00637,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00637,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00637,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00637,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00637,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00637,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00637,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00637,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00637,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00637,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00637,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00637,Cytochrome P-450 Substrates,DrugBank
DB00637,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00637,Highest Risk QTc-Prolonging Agents,DrugBank
DB00637,Histamine Agents,DrugBank
DB00637,Histamine Antagonists,DrugBank
DB00637,Histamine H1 Antagonists,DrugBank
DB00637,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00637,Narrow Therapeutic Index Drugs,DrugBank
DB00637,Neurotransmitter Agents,DrugBank
DB00637,P-glycoprotein inhibitors,DrugBank
DB00637,QTc Prolonging Agents,DrugBank
DB00640,"Adenosine, antagonists & inhibitors",DrugBank
DB00640,Agents producing tachycardia,DrugBank
DB00640,Alkenes,DrugBank
DB00640,Analgesics,DrugBank
DB00640,Antiarrhythmic agents,DrugBank
DB00640,"Antiarrhythmics, Class V",DrugBank
DB00640,Biological Factors,DrugBank
DB00640,Carbohydrates,DrugBank
DB00640,Cardiac Therapy,DrugBank
DB00640,Cardiovascular Agents,DrugBank
DB00640,Central Nervous System Agents,DrugBank
DB00640,Cyclohexanes,DrugBank
DB00640,Cyclohexenes,DrugBank
DB00640,Cycloparaffins,DrugBank
DB00640,Glycosides,DrugBank
DB00640,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00640,"Hydrocarbons, Acyclic",DrugBank
DB00640,Miscellaneous Cardiac Drugs,DrugBank
DB00640,Miscellaneous Therapeutic Agents,DrugBank
DB00640,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00640,Neurotransmitter Agents,DrugBank
DB00640,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00640,Nucleosides,DrugBank
DB00640,Peripheral Nervous System Agents,DrugBank
DB00640,Polyenes,DrugBank
DB00640,Purine Nucleosides,DrugBank
DB00640,Purinergic Agents,DrugBank
DB00640,Purinergic Agonists,DrugBank
DB00640,Purinergic P1 Receptor Agonists,DrugBank
DB00640,Purines,DrugBank
DB00640,QTc Prolonging Agents,DrugBank
DB00640,Ribonucleosides,DrugBank
DB00640,Sensory System Agents,DrugBank
DB00640,Terpenes,DrugBank
DB00640,Vasodilating Agents,DrugBank
DB00641,Agents Causing Muscle Toxicity,DrugBank
DB00641,Anticholesteremic Agents,DrugBank
DB00641,BSEP/ABCB11 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00641,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00641,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00641,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB00641,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00641,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00641,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00641,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00641,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00641,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00641,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00641,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00641,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00641,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00641,Cytochrome P-450 Substrates,DrugBank
DB00641,Drugs causing inadvertant photosensitivity,DrugBank
DB00641,Enzyme Inhibitors,DrugBank
DB00641,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB00641,Hypolipidemic Agents,DrugBank
DB00641,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00641,Lipid Modifying Agents,DrugBank
DB00641,"Lipid Modifying Agents, Plain",DrugBank
DB00641,Lipid Regulating Agents,DrugBank
DB00641,Naphthalenes,DrugBank
DB00641,Noxae,DrugBank
DB00641,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00641,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00641,P-glycoprotein inhibitors,DrugBank
DB00641,P-glycoprotein substrates,DrugBank
DB00641,Photosensitizing Agents,DrugBank
DB00641,UGT1A1 Substrates,DrugBank
DB00641,UGT1A3 substrates,DrugBank
DB00641,UGT2B7 substrates,DrugBank
DB00642,Amino Acids,DrugBank
DB00642,"Amino Acids, Acidic",DrugBank
DB00642,"Amino Acids, Dicarboxylic",DrugBank
DB00642,"Amino Acids, Peptides, and Proteins",DrugBank
DB00642,Antimetabolites,DrugBank
DB00642,Antineoplastic Agents,DrugBank
DB00642,Antineoplastic and Immunomodulating Agents,DrugBank
DB00642,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00642,Cytochrome P-450 Substrates,DrugBank
DB00642,Drugs that are Mainly Renally Excreted,DrugBank
DB00642,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00642,Enzyme Inhibitors,DrugBank
DB00642,Folic Acid Analogues,DrugBank
DB00642,Folic Acid Antagonists,DrugBank
DB00642,Glutamates,DrugBank
DB00642,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00642,Immunosuppressive Agents,DrugBank
DB00642,Myelosuppressive Agents,DrugBank
DB00642,Narrow Therapeutic Index Drugs,DrugBank
DB00642,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00642,OAT3/SLC22A8 Substrates,DrugBank
DB00642,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00645,Anesthetics,DrugBank
DB00645,"Anesthetics, Local",DrugBank
DB00645,Central Nervous System Agents,DrugBank
DB00645,Central Nervous System Depressants,DrugBank
DB00645,Ketones,DrugBank
DB00645,Nervous System,DrugBank
DB00645,Peripheral Nervous System Agents,DrugBank
DB00645,Sensory System Agents,DrugBank
DB00645,Throat Preparations,DrugBank
DB00646,Alimentary Tract and Metabolism,DrugBank
DB00646,Anti-Infective Agents,DrugBank
DB00646,Antibacterials for Systemic Use,DrugBank
DB00646,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00646,Antifungal Agents,DrugBank
DB00646,Antifungal Agents (Vaginal),DrugBank
DB00646,Antifungals for Dermatological Use,DrugBank
DB00646,Antifungals for Topical Use,DrugBank
DB00646,Antiinfectives for Systemic Use,DrugBank
DB00646,"Compounds used in a research, industrial, or household setting",DrugBank
DB00646,Dermatologicals,DrugBank
DB00646,Genito Urinary System and Sex Hormones,DrugBank
DB00646,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00646,Intestinal Antiinfectives,DrugBank
DB00646,Ionophores,DrugBank
DB00646,Lactones,DrugBank
DB00646,Membrane Transport Modulators,DrugBank
DB00646,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00646,OATP1B3 inhibitors,DrugBank
DB00646,Polyene Antifungal,DrugBank
DB00646,Polyenes,DrugBank
DB00646,Polyketides,DrugBank
DB00647,"Acids, Acyclic",DrugBank
DB00647,Agents that reduce seizure threshold,DrugBank
DB00647,Analgesics,DrugBank
DB00647,Central Nervous System Agents,DrugBank
DB00647,Central Nervous System Depressants,DrugBank
DB00647,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00647,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00647,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00647,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00647,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00647,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00647,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00647,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00647,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00647,Cytochrome P-450 Substrates,DrugBank
DB00647,Diphenylpropylamine Derivatives,DrugBank
DB00647,High-risk opioids,DrugBank
DB00647,Narcotics,DrugBank
DB00647,Nervous System,DrugBank
DB00647,Opioid Agonist,DrugBank
DB00647,Opioids,DrugBank
DB00647,Peripheral Nervous System Agents,DrugBank
DB00647,Propionates,DrugBank
DB00647,Sensory System Agents,DrugBank
DB00647,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00648,Adrenal Cytotoxic Agents,DrugBank
DB00648,Antineoplastic Agents,DrugBank
DB00648,"Antineoplastic Agents, Hormonal",DrugBank
DB00648,Antineoplastic and Immunomodulating Agents,DrugBank
DB00648,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00648,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00648,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00648,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00648,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00648,Cytochrome P-450 CYP3A5 Inducers (strong),DrugBank
DB00648,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB00648,Cytochrome P-450 CYP3A7 Inducers (strong),DrugBank
DB00648,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00648,Cytotoxins,DrugBank
DB00648,"Hydrocarbons, Chlorinated",DrugBank
DB00648,"Hydrocarbons, Halogenated",DrugBank
DB00648,Narrow Therapeutic Index Drugs,DrugBank
DB00648,P-glycoprotein inhibitors,DrugBank
DB00648,Thyroxine-binding globulin inducers,DrugBank
DB00649,Agents Causing Muscle Toxicity,DrugBank
DB00649,Anti-HIV Agents,DrugBank
DB00649,Anti-Infective Agents,DrugBank
DB00649,Anti-Retroviral Agents,DrugBank
DB00649,Antiinfectives for Systemic Use,DrugBank
DB00649,Antimetabolites,DrugBank
DB00649,Antiviral Agents,DrugBank
DB00649,Antivirals for Systemic Use,DrugBank
DB00649,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00649,Deoxyribonucleosides,DrugBank
DB00649,Dideoxynucleosides,DrugBank
DB00649,Direct Acting Antivirals,DrugBank
DB00649,Enzyme Inhibitors,DrugBank
DB00649,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00649,Neurotoxic agents,DrugBank
DB00649,Noxae,DrugBank
DB00649,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00649,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00649,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00649,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00649,Nucleosides,DrugBank
DB00649,OAT1/SLC22A6 Substrates,DrugBank
DB00649,Pyrimidine Nucleosides,DrugBank
DB00649,Pyrimidines,DrugBank
DB00649,Reverse Transcriptase Inhibitors,DrugBank
DB00649,Toxic Actions,DrugBank
DB00650,Antidotes,DrugBank
DB00650,Coenzymes,DrugBank
DB00650,"Compounds used in a research, industrial, or household setting",DrugBank
DB00650,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB00650,Enzymes and Coenzymes,DrugBank
DB00650,Folate Analog,DrugBank
DB00650,Folic Acid and Derivatives,DrugBank
DB00650,Formyltetrahydrofolates,DrugBank
DB00650,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00650,Micronutrients,DrugBank
DB00650,OAT3/SLC22A8 Inhibitors,DrugBank
DB00650,OAT3/SLC22A8 Substrates,DrugBank
DB00650,Protective Agents,DrugBank
DB00650,Pteridines,DrugBank
DB00650,Pterins,DrugBank
DB00650,Tetrahydrofolates,DrugBank
DB00650,Vitamin B Complex,DrugBank
DB00650,Vitamins,DrugBank
DB00651,Anti-Asthmatic Agents,DrugBank
DB00651,Autonomic Agents,DrugBank
DB00651,Bronchodilator Agents,DrugBank
DB00651,Cardiovascular Agents,DrugBank
DB00651,Drugs for Obstructive Airway Diseases,DrugBank
DB00651,Drugs that are Mainly Renally Excreted,DrugBank
DB00651,Enzyme Inhibitors,DrugBank
DB00651,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00651,Peripheral Nervous System Agents,DrugBank
DB00651,Phosphodiesterase Inhibitors,DrugBank
DB00651,Purines,DrugBank
DB00651,Purinones,DrugBank
DB00651,Respiratory System Agents,DrugBank
DB00651,Vasodilating Agents,DrugBank
DB00651,Xanthine derivatives,DrugBank
DB00651,Xanthines and Adrenergics,DrugBank
DB00652,"Adjuvants, Anesthesia",DrugBank
DB00652,Agents that reduce seizure threshold,DrugBank
DB00652,Alkaloids,DrugBank
DB00652,Analgesics,DrugBank
DB00652,Benzomorphan Derivatives,DrugBank
DB00652,Benzomorphans,DrugBank
DB00652,Central Nervous System Agents,DrugBank
DB00652,Central Nervous System Depressants,DrugBank
DB00652,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00652,Mixed Agonist / Antagonist Opioids,DrugBank
DB00652,Morphinans,DrugBank
DB00652,Narcotics,DrugBank
DB00652,Nervous System,DrugBank
DB00652,Opiate Alkaloids,DrugBank
DB00652,Opiate Partial Agonists,DrugBank
DB00652,Opioid Antagonists,DrugBank
DB00652,Opioids,DrugBank
DB00652,P-glycoprotein substrates,DrugBank
DB00652,Partial Opioid Agonist/Antagonist,DrugBank
DB00652,Peripheral Nervous System Agents,DrugBank
DB00652,Phenanthrenes,DrugBank
DB00652,Sensory System Agents,DrugBank
DB00652,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00653,Agents causing hyperkalemia,DrugBank
DB00653,Agents that produce neuromuscular block (indirect),DrugBank
DB00653,Alimentary Tract and Metabolism,DrugBank
DB00653,Analgesics,DrugBank
DB00653,Anesthetics,DrugBank
DB00653,Antiarrhythmic agents,DrugBank
DB00653,Anticonvulsants,DrugBank
DB00653,Blood and Blood Forming Organs,DrugBank
DB00653,Blood Substitutes and Perfusion Solutions,DrugBank
DB00653,Bradycardia-Causing Agents,DrugBank
DB00653,Calcium Channel Blockers,DrugBank
DB00653,Calcium-Regulating Hormones and Agents,DrugBank
DB00653,Cardiovascular Agents,DrugBank
DB00653,Central Nervous System Agents,DrugBank
DB00653,Central Nervous System Depressants,DrugBank
DB00653,Dermatologicals,DrugBank
DB00653,Diagnostic Agents,DrugBank
DB00653,Drugs for Constipation,DrugBank
DB00653,Electrolyte Solutions,DrugBank
DB00653,I.V. Solution Additives,DrugBank
DB00653,Laxatives,DrugBank
DB00653,"Laxatives, magnesium containing",DrugBank
DB00653,Magnesium Compounds,DrugBank
DB00653,Magnesium Salts,DrugBank
DB00653,Membrane Transport Modulators,DrugBank
DB00653,Metal cations,DrugBank
DB00653,Metal divalent cations,DrugBank
DB00653,Mineral Supplements,DrugBank
DB00653,Miscellaneous Anticonvulsants,DrugBank
DB00653,Osmotic Laxatives,DrugBank
DB00653,Peripheral Nervous System Agents,DrugBank
DB00653,Replacement Preparations,DrugBank
DB00653,Reproductive Control Agents,DrugBank
DB00653,Sensory System Agents,DrugBank
DB00653,Sulfates,DrugBank
DB00653,Sulfur Acids,DrugBank
DB00653,Sulfur Compounds,DrugBank
DB00653,Sulfuric Acids,DrugBank
DB00653,Tests for Bile Duct Patency,DrugBank
DB00653,Tocolytic Agents,DrugBank
DB00653,Vasodilating Agents,DrugBank
DB00654,Antiglaucoma Preparations and Miotics,DrugBank
DB00654,Antihypertensive Agents,DrugBank
DB00654,Autacoids,DrugBank
DB00654,Biological Factors,DrugBank
DB00654,"Compounds used in a research, industrial, or household setting",DrugBank
DB00654,Eicosanoids,DrugBank
DB00654,Fatty Acids,DrugBank
DB00654,"Fatty Acids, Unsaturated",DrugBank
DB00654,Lipids,DrugBank
DB00654,OAT1/SLC22A6 inhibitors,DrugBank
DB00654,OAT3/SLC22A8 Inhibitors,DrugBank
DB00654,Ophthalmic Solutions,DrugBank
DB00654,Ophthalmologicals,DrugBank
DB00654,Pharmaceutical Preparations,DrugBank
DB00654,Pharmaceutical Solutions,DrugBank
DB00654,Prostaglandin analogs reducing intraocular pressure (IOP),DrugBank
DB00654,Prostaglandins,DrugBank
DB00654,"Prostaglandins F, Synthetic",DrugBank
DB00654,"Prostaglandins, Synthetic",DrugBank
DB00654,Sensory Organs,DrugBank
DB00654,Solutions,DrugBank
DB00655,17-Ketosteroids,DrugBank
DB00655,Adrenal Cortex Hormones,DrugBank
DB00655,BCRP/ABCG2 Inhibitors,DrugBank
DB00655,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00655,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00655,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00655,Cytochrome P-450 Substrates,DrugBank
DB00655,Estradiol Congeners,DrugBank
DB00655,Estranes,DrugBank
DB00655,Estrenes,DrugBank
DB00655,Estrogens,DrugBank
DB00655,Fused-Ring Compounds,DrugBank
DB00655,Genito Urinary System and Sex Hormones,DrugBank
DB00655,Gonadal Hormones,DrugBank
DB00655,Gonadal Steroid Hormones,DrugBank
DB00655,Hormones,DrugBank
DB00655,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00655,Ketosteroids,DrugBank
DB00655,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB00655,OAT3/SLC22A8 Substrates,DrugBank
DB00655,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00655,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00655,P-glycoprotein inducers,DrugBank
DB00655,P-glycoprotein substrates,DrugBank
DB00655,Sex Hormones and Modulators of the Genital System,DrugBank
DB00655,Steroids,DrugBank
DB00655,Thyroxine-binding globulin inducers,DrugBank
DB00656,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00656,Adrenergic alpha-Antagonists,DrugBank
DB00656,Adrenergic Antagonists,DrugBank
DB00656,Agents that produce hypertension,DrugBank
DB00656,Agents that reduce seizure threshold,DrugBank
DB00656,Anti-Anxiety Agents,DrugBank
DB00656,Antidepressive Agents,DrugBank
DB00656,Antidepressive Agents Indicated for Depression,DrugBank
DB00656,"Antidepressive Agents, Second-Generation",DrugBank
DB00656,"Antidepressive Agents, Triazolopyridine",DrugBank
DB00656,Central Nervous System Agents,DrugBank
DB00656,Central Nervous System Depressants,DrugBank
DB00656,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00656,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00656,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00656,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00656,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00656,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00656,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00656,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00656,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00656,Cytochrome P-450 Substrates,DrugBank
DB00656,Histamine Antagonists,DrugBank
DB00656,Histamine H1 Antagonists,DrugBank
DB00656,Membrane Transport Modulators,DrugBank
DB00656,Nervous System,DrugBank
DB00656,Neurotransmitter Agents,DrugBank
DB00656,Neurotransmitter Uptake Inhibitors,DrugBank
DB00656,P-glycoprotein inducers,DrugBank
DB00656,Peripheral alpha-1 blockers,DrugBank
DB00656,Piperazines,DrugBank
DB00656,Potential QTc-Prolonging Agents,DrugBank
DB00656,Psychoanaleptics,DrugBank
DB00656,Psychotropic Drugs,DrugBank
DB00656,Pyridines,DrugBank
DB00656,Pyridones,DrugBank
DB00656,QTc Prolonging Agents,DrugBank
DB00656,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00656,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00656,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00656,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00656,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00656,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00656,Serotonin Agents,DrugBank
DB00656,Serotonin antagonist and reuptake inhibitors (SARIs),DrugBank
DB00656,Serotonin Modulators,DrugBank
DB00656,Serotonin Receptor Antagonists,DrugBank
DB00656,Tranquilizing Agents,DrugBank
DB00657,Agents that produce neuromuscular block (indirect),DrugBank
DB00657,"Antiadrenergic Agents, Ganglion-Blocking",DrugBank
DB00657,Anticholinergic Agents,DrugBank
DB00657,Antihypertensive Agents,DrugBank
DB00657,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00657,Autonomic Agents,DrugBank
DB00657,Autonomic Ganglionic Blocker,DrugBank
DB00657,Bridged-Ring Compounds,DrugBank
DB00657,Cardiovascular Agents,DrugBank
DB00657,Cholinergic Agents,DrugBank
DB00657,Decreased Autonomic Ganglionic Activity,DrugBank
DB00657,Drugs that are Mainly Renally Excreted,DrugBank
DB00657,Ganglion Blockers,DrugBank
DB00657,Hypotensive Agents,DrugBank
DB00657,Neurotransmitter Agents,DrugBank
DB00657,Nicotinic Antagonists,DrugBank
DB00657,Norbornanes,DrugBank
DB00657,Peripheral Nervous System Agents,DrugBank
DB00657,Secondary and Tertiary Amines,DrugBank
DB00658,Amines,DrugBank
DB00658,Bile Acid Sequestrants,DrugBank
DB00658,Chelating Agents,DrugBank
DB00658,"Compounds used in a research, industrial, or household setting",DrugBank
DB00658,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB00658,Lipid Regulating Agents,DrugBank
DB00658,Phosphate Binder,DrugBank
DB00658,Phosphate Chelating Activity,DrugBank
DB00658,Phosphate-removing Agents,DrugBank
DB00658,Polyamines,DrugBank
DB00658,Polystyrene Sulfonates,DrugBank
DB00658,Sequestering Agents,DrugBank
DB00659,Alcohol Deterrents,DrugBank
DB00659,Central Nervous System Agents,DrugBank
DB00659,Drugs Used in Addictive Disorders,DrugBank
DB00659,Drugs Used in Alcohol Dependence,DrugBank
DB00659,"Hydrocarbons, Acyclic",DrugBank
DB00659,Miscellaneous Central Nervous System Agents,DrugBank
DB00659,Nervous System,DrugBank
DB00659,OAT1/SLC22A6 Substrates,DrugBank
DB00659,Sulfonic Acids,DrugBank
DB00659,Sulfur Acids,DrugBank
DB00659,Sulfur Compounds,DrugBank
DB00660,Central Nervous System Depressants,DrugBank
DB00660,Centrally-mediated Muscle Relaxation,DrugBank
DB00660,Drugs that are Mainly Renally Excreted,DrugBank
DB00660,Muscle Relaxants,DrugBank
DB00660,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00660,Oxazoles,DrugBank
DB00660,Peripheral Nervous System Agents,DrugBank
DB00660,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00661,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00661,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00661,Adrenergic alpha-Antagonists,DrugBank
DB00661,Adrenergic Antagonists,DrugBank
DB00661,Amines,DrugBank
DB00661,Antiarrhythmic agents,DrugBank
DB00661,Antihypertensive Agents,DrugBank
DB00661,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00661,Bradycardia-Causing Agents,DrugBank
DB00661,Calcium Channel Blockers,DrugBank
DB00661,Calcium Channel Blockers (Nondihydropyridine),DrugBank
DB00661,Cardiovascular Agents,DrugBank
DB00661,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00661,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00661,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00661,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00661,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00661,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00661,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00661,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00661,Cytochrome P-450 CYP3A5 Inhibitors (moderate),DrugBank
DB00661,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00661,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00661,Cytochrome P-450 Substrates,DrugBank
DB00661,Drugs that are Mainly Renally Excreted,DrugBank
DB00661,Hypotensive Agents,DrugBank
DB00661,MATE 1 Inhibitors,DrugBank
DB00661,MATE 2 Inhibitors,DrugBank
DB00661,MATE inhibitors,DrugBank
DB00661,Membrane Transport Modulators,DrugBank
DB00661,Miscellaneous Calcium-channel Blocking Agents,DrugBank
DB00661,Negative Inotrope,DrugBank
DB00661,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00661,OCT1 inhibitors,DrugBank
DB00661,OCT1 substrates,DrugBank
DB00661,P-glycoprotein inhibitors,DrugBank
DB00661,P-glycoprotein substrates,DrugBank
DB00661,Phenylalkylamine Derivatives,DrugBank
DB00661,Selective Calcium Channel Blockers With Direct Cardiac Effects,DrugBank
DB00661,Vasodilating Agents,DrugBank
DB00661,Verapamil and analogues,DrugBank
DB00662,"Acids, Carbocyclic",DrugBank
DB00662,Amides,DrugBank
DB00662,Aminoalkyl Ethers,DrugBank
DB00662,Antiemetics,DrugBank
DB00662,Antihistamines for Systemic Use,DrugBank
DB00662,Autonomic Agents,DrugBank
DB00662,Benzene Derivatives,DrugBank
DB00662,Benzoates,DrugBank
DB00662,Central Nervous System Agents,DrugBank
DB00662,Central Nervous System Depressants,DrugBank
DB00662,Emesis Suppression,DrugBank
DB00662,Gastrointestinal Agents,DrugBank
DB00662,Peripheral Nervous System Agents,DrugBank
DB00663,Adrenal Cortex Hormones,DrugBank
DB00663,Anti-Inflammatory Agents,DrugBank
DB00663,Corticosteroids,DrugBank
DB00663,"Corticosteroids, Dermatological Preparations",DrugBank
DB00663,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB00663,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00663,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00663,Cytochrome P-450 Substrates,DrugBank
DB00663,Dermatologicals,DrugBank
DB00663,Fused-Ring Compounds,DrugBank
DB00663,Hormones,DrugBank
DB00663,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00663,Immunosuppressive Agents,DrugBank
DB00663,Otologicals,DrugBank
DB00663,Pregnadienes,DrugBank
DB00663,Pregnadienetriols,DrugBank
DB00663,Pregnanes,DrugBank
DB00663,Sensory Organs,DrugBank
DB00663,Steroids,DrugBank
DB00663,"Steroids, Fluorinated",DrugBank
DB00664,Amides,DrugBank
DB00664,Amines,DrugBank
DB00664,Aniline Compounds,DrugBank
DB00664,Anti-Infective Agents,DrugBank
DB00664,"Anti-Infective Agents, Urinary",DrugBank
DB00664,Antibacterials for Systemic Use,DrugBank
DB00664,Antiinfectives for Systemic Use,DrugBank
DB00664,Antiparasitic Agents,DrugBank
DB00664,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00664,Antiprotozoals,DrugBank
DB00664,Benzene Derivatives,DrugBank
DB00664,Benzenesulfonamides,DrugBank
DB00664,Genito Urinary System and Sex Hormones,DrugBank
DB00664,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00664,Long-Acting Antibacterial Sulfonamides,DrugBank
DB00664,Sulfanilamides,DrugBank
DB00664,Sulfonamides,DrugBank
DB00664,Sulfonamides and trimethoprim,DrugBank
DB00664,Sulfones,DrugBank
DB00664,Sulfur Compounds,DrugBank
DB00665,Androgen Receptor Antagonists,DrugBank
DB00665,Androgen Receptor Inhibitors,DrugBank
DB00665,Antiandrogens,DrugBank
DB00665,"Antiandrogens, non-steroidal",DrugBank
DB00665,Antineoplastic Agents,DrugBank
DB00665,Antineoplastic and Immunomodulating Agents,DrugBank
DB00665,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00665,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00665,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00665,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00665,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00665,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00665,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00665,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00665,Cytochrome P-450 Substrates,DrugBank
DB00665,Drugs that are Mainly Renally Excreted,DrugBank
DB00665,Endocrine Therapy,DrugBank
DB00665,Hormone Antagonists,DrugBank
DB00665,Hormone Antagonists and Related Agents,DrugBank
DB00665,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00665,Imidazoles,DrugBank
DB00666,Adrenal Cortex Hormones,DrugBank
DB00666,Agents Causing Muscle Toxicity,DrugBank
DB00666,"Amino Acids, Peptides, and Proteins",DrugBank
DB00666,Fertility Agents,DrugBank
DB00666,"Fertility Agents, Female",DrugBank
DB00666,Gonadotropin Releasing Hormone Receptor Agonist,DrugBank
DB00666,Gonadotropin Releasing Hormone Receptor Agonists,DrugBank
DB00666,Gonadotropin-releasing hormone agonist,DrugBank
DB00666,Gonadotropins and Antigonadotropins,DrugBank
DB00666,Hormones,DrugBank
DB00666,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00666,Hypothalamic Hormones,DrugBank
DB00666,Nerve Tissue Proteins,DrugBank
DB00666,Neuropeptides,DrugBank
DB00666,Oligopeptides,DrugBank
DB00666,Peptide Hormones,DrugBank
DB00666,Peptides,DrugBank
DB00666,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00666,Pituitary Hormone-Releasing Hormones,DrugBank
DB00666,Proteins,DrugBank
DB00666,Reproductive Control Agents,DrugBank
DB00666,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00668,Adrenergic Agents,DrugBank
DB00668,Adrenergic Agonists,DrugBank
DB00668,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00668,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00668,Adrenergic alpha-Agonists,DrugBank
DB00668,Adrenergic and Dopaminergic Agents,DrugBank
DB00668,Adrenergic beta-1 Receptor Agonists,DrugBank
DB00668,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00668,Adrenergic beta-3 Receptor Agonists,DrugBank
DB00668,Adrenergic beta-Agonists,DrugBank
DB00668,"Adrenergics, Inhalants",DrugBank
DB00668,Agents producing tachycardia,DrugBank
DB00668,Agents that produce hypertension,DrugBank
DB00668,Alpha-and Beta-adrenergic Agonists,DrugBank
DB00668,Amines,DrugBank
DB00668,Anti-Asthmatic Agents,DrugBank
DB00668,Antiglaucoma Preparations and Miotics,DrugBank
DB00668,Autonomic Agents,DrugBank
DB00668,Benzene Derivatives,DrugBank
DB00668,Biogenic Amines,DrugBank
DB00668,Biogenic Monoamines,DrugBank
DB00668,Bronchodilator Agents,DrugBank
DB00668,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00668,Cardiac Therapy,DrugBank
DB00668,Cardiovascular Agents,DrugBank
DB00668,Catecholamines,DrugBank
DB00668,Catechols,DrugBank
DB00668,COMT Substrates,DrugBank
DB00668,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00668,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00668,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00668,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00668,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00668,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00668,Dental Agents,DrugBank
DB00668,Drugs for Obstructive Airway Diseases,DrugBank
DB00668,Epinephrine and similars,DrugBank
DB00668,Hemostatics,DrugBank
DB00668,Hyperglycemia-Associated Agents,DrugBank
DB00668,Local Hemostatics,DrugBank
DB00668,Mydriatics,DrugBank
DB00668,Nasal Preparations,DrugBank
DB00668,Neurotransmitter Agents,DrugBank
DB00668,OCT1 substrates,DrugBank
DB00668,OCT2 Substrates,DrugBank
DB00668,Ophthalmologicals,DrugBank
DB00668,Peripheral Nervous System Agents,DrugBank
DB00668,Phenols,DrugBank
DB00668,Respiratory System Agents,DrugBank
DB00668,Stomatological Preparations,DrugBank
DB00668,Sympathomimetic (Adrenergic) Agents,DrugBank
DB00668,Sympathomimetics,DrugBank
DB00668,Sympathomimetics in Glaucoma Therapy,DrugBank
DB00668,"Sympathomimetics, Plain",DrugBank
DB00668,Vasoconstrictor Agents,DrugBank
DB00669,Agents that produce hypertension,DrugBank
DB00669,Amides,DrugBank
DB00669,Amines,DrugBank
DB00669,Analgesics,DrugBank
DB00669,Antidepressive Agents,DrugBank
DB00669,Antimigraine Preparations,DrugBank
DB00669,BCRP/ABCG2 Substrates,DrugBank
DB00669,Biogenic Amines,DrugBank
DB00669,Biogenic Monoamines,DrugBank
DB00669,Cardiovascular Agents,DrugBank
DB00669,Central Nervous System Depressants,DrugBank
DB00669,Drugs that are Mainly Renally Excreted,DrugBank
DB00669,Genito Urinary System and Sex Hormones,DrugBank
DB00669,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00669,Indoles,DrugBank
DB00669,Monoamine Oxidase A Substrates,DrugBank
DB00669,Nervous System,DrugBank
DB00669,Neurotransmitter Agents,DrugBank
DB00669,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00669,P-glycoprotein substrates,DrugBank
DB00669,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00669,Selective Serotonin Agonists,DrugBank
DB00669,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00669,Serotonin 1b Receptor Agonists,DrugBank
DB00669,Serotonin 1d Receptor Agonists,DrugBank
DB00669,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00669,Serotonin Agents,DrugBank
DB00669,Serotonin Modulators,DrugBank
DB00669,Serotonin Receptor Agonists,DrugBank
DB00669,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00669,Sulfonamides,DrugBank
DB00669,Sulfones,DrugBank
DB00669,Sulfur Compounds,DrugBank
DB00669,Triptans,DrugBank
DB00669,Tryptamines,DrugBank
DB00669,Vasoconstrictor Agents,DrugBank
DB00670,Agents producing tachycardia,DrugBank
DB00670,Alimentary Tract and Metabolism,DrugBank
DB00670,Anti-Ulcer Agents,DrugBank
DB00670,Anticholinergic Agents,DrugBank
DB00670,Benzazepines,DrugBank
DB00670,Benzodiazepinones,DrugBank
DB00670,Cholinergic Agents,DrugBank
DB00670,Drugs for Acid Related Disorders,DrugBank
DB00670,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00670,Gastrointestinal Agents,DrugBank
DB00670,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00670,Muscarinic Antagonists,DrugBank
DB00670,Neurotransmitter Agents,DrugBank
DB00671,Amides,DrugBank
DB00671,Anti-Bacterial Agents,DrugBank
DB00671,Anti-Infective Agents,DrugBank
DB00671,Antibacterials for Systemic Use,DrugBank
DB00671,Antiinfectives for Systemic Use,DrugBank
DB00671,beta Lactam Antibiotics,DrugBank
DB00671,beta-Lactams,DrugBank
DB00671,Cephalosporins,DrugBank
DB00671,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00671,Lactams,DrugBank
DB00671,OAT3/SLC22A8 Substrates,DrugBank
DB00671,Sulfur Compounds,DrugBank
DB00671,Thiazines,DrugBank
DB00671,Third-Generation Cephalosporins,DrugBank
DB00672,Alimentary Tract and Metabolism,DrugBank
DB00672,Amides,DrugBank
DB00672,Benzene Derivatives,DrugBank
DB00672,Benzenesulfonamides,DrugBank
DB00672,Blood Glucose Lowering Agents,DrugBank
DB00672,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00672,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00672,Cytochrome P-450 Substrates,DrugBank
DB00672,Drugs that are Mainly Renally Excreted,DrugBank
DB00672,Drugs Used in Diabetes,DrugBank
DB00672,Genito Urinary System and Sex Hormones,DrugBank
DB00672,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00672,Hypoglycemia-Associated Agents,DrugBank
DB00672,Insulin Secretagogues,DrugBank
DB00672,OAT1/SLC22A6 inhibitors,DrugBank
DB00672,Oral Hypoglycemics,DrugBank
DB00672,Sulfonamides,DrugBank
DB00672,Sulfones,DrugBank
DB00672,Sulfonylureas,DrugBank
DB00672,Sulfur Compounds,DrugBank
DB00673,Alimentary Tract and Metabolism,DrugBank
DB00673,Antiemetics,DrugBank
DB00673,Antiemetics and Antinauseants,DrugBank
DB00673,Aprepitant and Prodrugs,DrugBank
DB00673,Autonomic Agents,DrugBank
DB00673,Central Nervous System Agents,DrugBank
DB00673,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00673,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00673,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00673,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00673,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00673,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00673,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00673,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00673,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00673,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00673,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00673,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00673,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00673,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00673,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00673,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00673,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00673,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00673,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00673,Cytochrome P-450 Substrates,DrugBank
DB00673,Gastrointestinal Agents,DrugBank
DB00673,Morpholines,DrugBank
DB00673,Neurokinin 1 Antagonists,DrugBank
DB00673,Neurokinin-1 Receptor Antagonists,DrugBank
DB00673,Neurotransmitter Agents,DrugBank
DB00673,Oxazines,DrugBank
DB00673,Peripheral Nervous System Agents,DrugBank
DB00673,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB00674,Alkaloids,DrugBank
DB00674,Amaryllidaceae Alkaloids,DrugBank
DB00674,Anti-Dementia Drugs,DrugBank
DB00674,Autonomic Agents,DrugBank
DB00674,Benzazepines,DrugBank
DB00674,Bradycardia-Causing Agents,DrugBank
DB00674,Central Nervous System Agents,DrugBank
DB00674,Cholinergic Agents,DrugBank
DB00674,Cholinesterase Inhibitors,DrugBank
DB00674,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00674,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00674,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00674,Cytochrome P-450 Substrates,DrugBank
DB00674,Enzyme Inhibitors,DrugBank
DB00674,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00674,Nervous System,DrugBank
DB00674,Neurotransmitter Agents,DrugBank
DB00674,Nootropic Agents,DrugBank
DB00674,P-glycoprotein inhibitors,DrugBank
DB00674,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB00674,Parasympathomimetics,DrugBank
DB00674,Peripheral Nervous System Agents,DrugBank
DB00674,Potential QTc-Prolonging Agents,DrugBank
DB00674,Psychoanaleptics,DrugBank
DB00674,QTc Prolonging Agents,DrugBank
DB00675,Anti-Estrogens,DrugBank
DB00675,Antineoplastic Agents,DrugBank
DB00675,"Antineoplastic Agents, Hormonal",DrugBank
DB00675,Antineoplastic and Immunomodulating Agents,DrugBank
DB00675,BCRP/ABCG2 Substrates,DrugBank
DB00675,Benzene Derivatives,DrugBank
DB00675,Benzylidene Compounds,DrugBank
DB00675,BSEP/ABCB11 Inhibitors,DrugBank
DB00675,Cardiotoxic antineoplastic agents,DrugBank
DB00675,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB00675,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB00675,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00675,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00675,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00675,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00675,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00675,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00675,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00675,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00675,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00675,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00675,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00675,Cytochrome P-450 Substrates,DrugBank
DB00675,Endocrine Therapy,DrugBank
DB00675,Estrogen Agonist/Antagonist,DrugBank
DB00675,Estrogen Antagonists,DrugBank
DB00675,Estrogen Receptor Modulators,DrugBank
DB00675,Hormone Antagonists,DrugBank
DB00675,Hormone Antagonists and Related Agents,DrugBank
DB00675,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00675,Narrow Therapeutic Index Drugs,DrugBank
DB00675,P-glycoprotein inducers,DrugBank
DB00675,P-glycoprotein inhibitors,DrugBank
DB00675,P-glycoprotein substrates,DrugBank
DB00675,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00675,Potential QTc-Prolonging Agents,DrugBank
DB00675,QTc Prolonging Agents,DrugBank
DB00675,Selective Estrogen Receptor Modulators,DrugBank
DB00675,Stilbenes,DrugBank
DB00675,Thyroxine-binding globulin inducers,DrugBank
DB00675,UGT2B17 substrates,DrugBank
DB00675,UGT2B7 substrates,DrugBank
DB00675,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00677,Cholinergic Agents,DrugBank
DB00677,Cholinesterase Inhibitors,DrugBank
DB00677,Enzyme Inhibitors,DrugBank
DB00677,Neurotransmitter Agents,DrugBank
DB00677,Ophthalmics,DrugBank
DB00677,Organofluorophosphonates,DrugBank
DB00677,Organophosphonates,DrugBank
DB00677,Organophosphorus Compounds,DrugBank
DB00677,Protease Inhibitors,DrugBank
DB00678,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00678,Agents causing angioedema,DrugBank
DB00678,Agents causing hyperkalemia,DrugBank
DB00678,Angiotensin 2 Receptor Blocker,DrugBank
DB00678,Angiotensin II receptor antagonists,DrugBank
DB00678,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00678,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB00678,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB00678,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB00678,Angiotensin II Type 2 Receptor Blockers,DrugBank
DB00678,Angiotensin Receptor Antagonists,DrugBank
DB00678,Antiarrhythmic agents,DrugBank
DB00678,Antihypertensive Agents,DrugBank
DB00678,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00678,Benzene Derivatives,DrugBank
DB00678,Biphenyl Compounds,DrugBank
DB00678,BSEP/ABCB11 Substrates,DrugBank
DB00678,Cardiovascular Agents,DrugBank
DB00678,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00678,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00678,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00678,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00678,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00678,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00678,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00678,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00678,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00678,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00678,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00678,Cytochrome P-450 Substrates,DrugBank
DB00678,Drugs causing inadvertant photosensitivity,DrugBank
DB00678,Hypotensive Agents,DrugBank
DB00678,Imidazoles,DrugBank
DB00678,OAT1/SLC22A6 inhibitors,DrugBank
DB00678,P-glycoprotein inhibitors,DrugBank
DB00678,P-glycoprotein substrates,DrugBank
DB00678,Photosensitizing Agents,DrugBank
DB00678,Tetrazoles,DrugBank
DB00678,UGT1A1 Substrates,DrugBank
DB00678,UGT1A3 substrates,DrugBank
DB00678,UGT2B17 substrates,DrugBank
DB00678,UGT2B7 substrates,DrugBank
DB00679,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00679,Adrenergic alpha-Antagonists,DrugBank
DB00679,Adrenergic Antagonists,DrugBank
DB00679,Agents that produce hypertension,DrugBank
DB00679,Antidepressive Agents,DrugBank
DB00679,Antipsychotic Agents,DrugBank
DB00679,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00679,Central Nervous System Agents,DrugBank
DB00679,Central Nervous System Depressants,DrugBank
DB00679,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00679,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00679,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB00679,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00679,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00679,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00679,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00679,Cytochrome P-450 Substrates,DrugBank
DB00679,Dopamine Agents,DrugBank
DB00679,Dopamine Antagonists,DrugBank
DB00679,Dopamine D2 Receptor Antagonists,DrugBank
DB00679,Drugs causing inadvertant photosensitivity,DrugBank
DB00679,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00679,Highest Risk QTc-Prolonging Agents,DrugBank
DB00679,Hypotensive Agents,DrugBank
DB00679,Nervous System,DrugBank
DB00679,Neurotoxic agents,DrugBank
DB00679,Neurotransmitter Agents,DrugBank
DB00679,Phenothiazines,DrugBank
DB00679,Phenothiazines With Piperidine Structure,DrugBank
DB00679,Photosensitizing Agents,DrugBank
DB00679,Psycholeptics,DrugBank
DB00679,Psychotropic Drugs,DrugBank
DB00679,QTc Prolonging Agents,DrugBank
DB00679,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00679,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00679,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00679,Serotonin Agents,DrugBank
DB00679,Serotonin Receptor Antagonists,DrugBank
DB00679,Sulfur Compounds,DrugBank
DB00679,Tranquilizing Agents,DrugBank
DB00680,Antiarrhythmic agents,DrugBank
DB00680,"Antiarrhythmics, Class I",DrugBank
DB00680,"Antiarrhythmics, Class Ic",DrugBank
DB00680,Antipsychotic Agents,DrugBank
DB00680,Cardiac Therapy,DrugBank
DB00680,Cardiovascular Agents,DrugBank
DB00680,Central Nervous System Depressants,DrugBank
DB00680,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00680,Membrane Transport Modulators,DrugBank
DB00680,Morpholines,DrugBank
DB00680,Neurotoxic agents,DrugBank
DB00680,Oxazines,DrugBank
DB00680,Phenothiazines,DrugBank
DB00680,Potential QTc-Prolonging Agents,DrugBank
DB00680,QTc Prolonging Agents,DrugBank
DB00680,Sodium Channel Blockers,DrugBank
DB00680,Sulfur Compounds,DrugBank
DB00680,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00681,Agents Causing Muscle Toxicity,DrugBank
DB00681,Agents that reduce seizure threshold,DrugBank
DB00681,Alimentary Tract and Metabolism,DrugBank
DB00681,Amebicides,DrugBank
DB00681,Anti-Bacterial Agents,DrugBank
DB00681,Anti-Infective Agents,DrugBank
DB00681,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00681,Antifungal Agents,DrugBank
DB00681,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00681,Antiinfectives for Systemic Use,DrugBank
DB00681,Antimycotics for Systemic Use,DrugBank
DB00681,Antiparasitic Agents,DrugBank
DB00681,Antiprotozoals,DrugBank
DB00681,Biomimetic Materials,DrugBank
DB00681,Carbohydrates,DrugBank
DB00681,"Compounds used in a research, industrial, or household setting",DrugBank
DB00681,Drug Carriers,DrugBank
DB00681,Genito Urinary System and Sex Hormones,DrugBank
DB00681,Glycosides,DrugBank
DB00681,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00681,Hypotensive Agents,DrugBank
DB00681,Intestinal Antiinfectives,DrugBank
DB00681,Lactones,DrugBank
DB00681,Lipid-based Polyene Antifungal,DrugBank
DB00681,Liposomes,DrugBank
DB00681,"Membranes, Artificial",DrugBank
DB00681,Narrow Therapeutic Index Drugs,DrugBank
DB00681,Nephrotoxic agents,DrugBank
DB00681,Pharmaceutical Preparations,DrugBank
DB00681,Polyene Antifungal,DrugBank
DB00681,Polyenes,DrugBank
DB00681,Polyketides,DrugBank
DB00681,Stomatological Preparations,DrugBank
DB00682,4-Hydroxycoumarins,DrugBank
DB00682,Agrochemicals,DrugBank
DB00682,Anticoagulants,DrugBank
DB00682,Blood and Blood Forming Organs,DrugBank
DB00682,"Compounds used in a research, industrial, or household setting",DrugBank
DB00682,Coumarins,DrugBank
DB00682,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00682,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00682,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00682,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00682,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB00682,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00682,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00682,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00682,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00682,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00682,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00682,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00682,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00682,Cytochrome P-450 Substrates,DrugBank
DB00682,Drugs that are Mainly Renally Excreted,DrugBank
DB00682,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00682,Hematologic Agents,DrugBank
DB00682,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00682,Narrow Therapeutic Index Drugs,DrugBank
DB00682,Pesticides,DrugBank
DB00682,Pyrans,DrugBank
DB00682,Rodenticides,DrugBank
DB00682,Toxic Actions,DrugBank
DB00682,Vitamin K Antagonists,DrugBank
DB00682,Vitamin K Inhibitors,DrugBank
DB00683,"Adjuvants, Anesthesia",DrugBank
DB00683,Anesthetics,DrugBank
DB00683,Anti-Anxiety Agents,DrugBank
DB00683,Benzodiazepine hypnotics and sedatives,DrugBank
DB00683,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00683,Central Nervous System Agents,DrugBank
DB00683,Central Nervous System Depressants,DrugBank
DB00683,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00683,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00683,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00683,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00683,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00683,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00683,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00683,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00683,Cytochrome P-450 Substrates,DrugBank
DB00683,Drugs that are Mainly Renally Excreted,DrugBank
DB00683,GABA Agents,DrugBank
DB00683,GABA Modulators,DrugBank
DB00683,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00683,Hypnotics and Sedatives,DrugBank
DB00683,Nervous System,DrugBank
DB00683,Neurotransmitter Agents,DrugBank
DB00683,P-glycoprotein substrates,DrugBank
DB00683,Psycholeptics,DrugBank
DB00683,Psychotropic Drugs,DrugBank
DB00683,Tranquilizing Agents,DrugBank
DB00683,Triazolobenzodiazepines,DrugBank
DB00683,UGT1A4 substrates,DrugBank
DB00683,UGT2B7 substrates,DrugBank
DB00684,Agents that produce neuromuscular block (indirect),DrugBank
DB00684,Aminoglycoside Antibacterials,DrugBank
DB00684,Anti-Bacterial Agents,DrugBank
DB00684,Anti-Infective Agents,DrugBank
DB00684,Antibacterials for Systemic Use,DrugBank
DB00684,Antiinfectives for Systemic Use,DrugBank
DB00684,Carbohydrates,DrugBank
DB00684,Drugs that are Mainly Renally Excreted,DrugBank
DB00684,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00684,Glycosides,DrugBank
DB00684,Narrow Therapeutic Index Drugs,DrugBank
DB00684,Nebramycin,DrugBank
DB00684,Nephrotoxic agents,DrugBank
DB00684,Ophthalmologicals,DrugBank
DB00684,Ototoxic agents,DrugBank
DB00684,Sensory Organs,DrugBank
DB00685,4-Quinolones,DrugBank
DB00685,Anti-Bacterial Agents,DrugBank
DB00685,Anti-Infective Agents,DrugBank
DB00685,Antibacterials for Systemic Use,DrugBank
DB00685,Antiinfectives for Systemic Use,DrugBank
DB00685,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00685,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00685,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00685,Drugs causing inadvertant photosensitivity,DrugBank
DB00685,Enzyme Inhibitors,DrugBank
DB00685,Fluoroquinolones,DrugBank
DB00685,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00685,Highest Risk QTc-Prolonging Agents,DrugBank
DB00685,Photosensitizing Agents,DrugBank
DB00685,QTc Prolonging Agents,DrugBank
DB00685,Quinolines,DrugBank
DB00685,Quinolones,DrugBank
DB00685,Topoisomerase II Inhibitors,DrugBank
DB00685,Topoisomerase Inhibitors,DrugBank
DB00686,Anti-Inflammatory Agents,DrugBank
DB00686,Anticoagulants,DrugBank
DB00686,Antivaricose Therapy,DrugBank
DB00686,Carbohydrates,DrugBank
DB00686,Drugs causing inadvertant photosensitivity,DrugBank
DB00686,Genito Urinary System and Sex Hormones,DrugBank
DB00686,Glycosaminoglycans,DrugBank
DB00686,Hematologic Agents,DrugBank
DB00686,Heparin and similars,DrugBank
DB00686,Heparinoids,DrugBank
DB00686,Miscellaneous Therapeutic Agents,DrugBank
DB00686,Photosensitizing Agents,DrugBank
DB00686,Polysaccharides,DrugBank
DB00686,Sulfur Acids,DrugBank
DB00686,Sulfur Compounds,DrugBank
DB00686,Sulfuric Acids,DrugBank
DB00686,Urologicals,DrugBank
DB00686,Vasoprotectives,DrugBank
DB00687,11-Hydroxycorticosteroids,DrugBank
DB00687,17-Hydroxycorticosteroids,DrugBank
DB00687,Adrenal Cortex Hormones,DrugBank
DB00687,Adrenals,DrugBank
DB00687,Anti-Inflammatory Agents,DrugBank
DB00687,Corticosteroids,DrugBank
DB00687,Corticosteroids for Systemic Use,DrugBank
DB00687,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00687,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00687,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00687,Cytochrome P-450 Substrates,DrugBank
DB00687,Fused-Ring Compounds,DrugBank
DB00687,Hormones,DrugBank
DB00687,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00687,Hydroxycorticosteroids,DrugBank
DB00687,Hyperglycemia-Associated Agents,DrugBank
DB00687,Immunosuppressive Agents,DrugBank
DB00687,Mineralocorticoids,DrugBank
DB00687,Pregnenes,DrugBank
DB00687,Steroids,DrugBank
DB00687,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00688,Agents Causing Muscle Toxicity,DrugBank
DB00688,Anti-Bacterial Agents,DrugBank
DB00688,Anti-Infective Agents,DrugBank
DB00688,"Antibiotics, Antineoplastic",DrugBank
DB00688,"Antibiotics, Antitubercular",DrugBank
DB00688,Antimetabolite Immunosuppressant,DrugBank
DB00688,BCRP/ABCG2 Substrates,DrugBank
DB00688,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00688,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00688,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00688,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00688,Cytochrome P-450 Substrates,DrugBank
DB00688,Drugs that are Mainly Renally Excreted,DrugBank
DB00688,Fatty Acids,DrugBank
DB00688,Immunologic Factors,DrugBank
DB00688,Immunosuppressive Agents,DrugBank
DB00688,"IMP Dehydrogenase, antagonists & inhibitors",DrugBank
DB00688,Lipids,DrugBank
DB00688,Mycophenolic Acid and Prodrugs,DrugBank
DB00688,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00688,OATP1B3 substrates,DrugBank
DB00688,P-glycoprotein substrates,DrugBank
DB00688,UGT1A1 Substrates,DrugBank
DB00688,UGT1A6 substrate,DrugBank
DB00688,UGT1A9 Substrates,DrugBank
DB00688,UGT2B7 substrates,DrugBank
DB00689,Amides,DrugBank
DB00689,Anti-Bacterial Agents,DrugBank
DB00689,Anti-Infective Agents,DrugBank
DB00689,beta-Lactams,DrugBank
DB00689,Cephalosporins,DrugBank
DB00689,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00689,Lactams,DrugBank
DB00689,Nephrotoxic agents,DrugBank
DB00689,Sulfur Compounds,DrugBank
DB00689,Thiazines,DrugBank
DB00690,Anti-Anxiety Agents,DrugBank
DB00690,Benzazepines,DrugBank
DB00690,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00690,Benzodiazepinones,DrugBank
DB00690,Central Nervous System Agents,DrugBank
DB00690,Central Nervous System Depressants,DrugBank
DB00690,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00690,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00690,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00690,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00690,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00690,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00690,Cytochrome P-450 Substrates,DrugBank
DB00690,Drugs that are Mainly Renally Excreted,DrugBank
DB00690,GABA Agents,DrugBank
DB00690,GABA Modulators,DrugBank
DB00690,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00690,Hypnotics and Sedatives,DrugBank
DB00690,Nervous System,DrugBank
DB00690,Neurotransmitter Agents,DrugBank
DB00690,OCT2 Inhibitors,DrugBank
DB00690,P-glycoprotein inhibitors,DrugBank
DB00690,Psycholeptics,DrugBank
DB00690,Psychotropic Drugs,DrugBank
DB00690,Tranquilizing Agents,DrugBank
DB00691,ACE Inhibitors and Diuretics,DrugBank
DB00691,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00691,Agents causing angioedema,DrugBank
DB00691,Agents causing hyperkalemia,DrugBank
DB00691,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00691,Antihypertensive Agents,DrugBank
DB00691,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00691,Cardiovascular Agents,DrugBank
DB00691,Drugs causing inadvertant photosensitivity,DrugBank
DB00691,Enzyme Inhibitors,DrugBank
DB00691,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00691,Hypotensive Agents,DrugBank
DB00691,Isoquinolines,DrugBank
DB00691,Photosensitizing Agents,DrugBank
DB00691,Potential QTc-Prolonging Agents,DrugBank
DB00691,Protease Inhibitors,DrugBank
DB00691,QTc Prolonging Agents,DrugBank
DB00692,Adrenergic Agents,DrugBank
DB00692,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00692,Adrenergic alpha-Antagonists,DrugBank
DB00692,Adrenergic Antagonists,DrugBank
DB00692,Agents that produce hypertension,DrugBank
DB00692,Antidotes,DrugBank
DB00692,Antihypertensive Agents,DrugBank
DB00692,Cardiovascular Agents,DrugBank
DB00692,Drugs that are Mainly Renally Excreted,DrugBank
DB00692,Hypotensive Agents,DrugBank
DB00692,Imidazoles,DrugBank
DB00692,Imidazoline Derivatives,DrugBank
DB00692,Neurotransmitter Agents,DrugBank
DB00692,Non-selective Alfa-adrenergic Blocking Agents,DrugBank
DB00692,Peripheral alpha-1 blockers,DrugBank
DB00692,Peripheral Vasodilators,DrugBank
DB00692,Sympatholytic (Adrenergic Blocking) Agents,DrugBank
DB00692,Vasodilating Agents,DrugBank
DB00693,BSEP/ABCB11 Substrates,DrugBank
DB00693,Coloring Agents,DrugBank
DB00693,Colouring Agents,DrugBank
DB00693,"Compounds used in a research, industrial, or household setting",DrugBank
DB00693,Contrast Media,DrugBank
DB00693,Diagnostic Agents,DrugBank
DB00693,Diagnostic Dye,DrugBank
DB00693,Diagnostic Uses of Chemicals,DrugBank
DB00693,Fluoresceins,DrugBank
DB00693,Fluorescent Dyes,DrugBank
DB00693,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00693,Indicators and Reagents,DrugBank
DB00693,Laboratory Chemicals,DrugBank
DB00693,Luminescent Agents,DrugBank
DB00693,OAT1/SLC22A6 inhibitors,DrugBank
DB00693,OAT1/SLC22A6 Substrates,DrugBank
DB00693,OAT3/SLC22A8 Inhibitors,DrugBank
DB00693,OAT3/SLC22A8 Substrates,DrugBank
DB00693,Ocular Disorders,DrugBank
DB00693,Ophthalmologicals,DrugBank
DB00693,Other Diagnostics,DrugBank
DB00693,Sensory Organs,DrugBank
DB00693,Spiro Compounds,DrugBank
DB00693,Xanthenes,DrugBank
DB00694,Anthracycline Topoisomerase Inhibitor,DrugBank
DB00694,Anthracyclines,DrugBank
DB00694,Anthracyclines and Related Substances,DrugBank
DB00694,"Antibiotics, Antineoplastic",DrugBank
DB00694,Antineoplastic Agents,DrugBank
DB00694,Antineoplastic and Immunomodulating Agents,DrugBank
DB00694,BCRP/ABCG2 Substrates,DrugBank
DB00694,Cardiotoxic antineoplastic agents,DrugBank
DB00694,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00694,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00694,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00694,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00694,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00694,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00694,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00694,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00694,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00694,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00694,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00694,Cytochrome P-450 Substrates,DrugBank
DB00694,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00694,Cytotoxins,DrugBank
DB00694,Enzyme Inhibitors,DrugBank
DB00694,Glycosides,DrugBank
DB00694,Immunosuppressive Agents,DrugBank
DB00694,Myelosuppressive Agents,DrugBank
DB00694,Naphthacenes,DrugBank
DB00694,Narrow Therapeutic Index Drugs,DrugBank
DB00694,P-glycoprotein inducers,DrugBank
DB00694,P-glycoprotein inhibitors,DrugBank
DB00694,P-glycoprotein substrates,DrugBank
DB00694,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00694,Topoisomerase II Inhibitors,DrugBank
DB00694,Topoisomerase Inhibitors,DrugBank
DB00695,"Acids, Carbocyclic",DrugBank
DB00695,Amides,DrugBank
DB00695,Amines,DrugBank
DB00695,Aminobenzoates,DrugBank
DB00695,Aniline Compounds,DrugBank
DB00695,Antihypertensive Agents,DrugBank
DB00695,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00695,Benzene Derivatives,DrugBank
DB00695,Benzoates,DrugBank
DB00695,Cardiovascular Agents,DrugBank
DB00695,Diuretics,DrugBank
DB00695,Drugs causing inadvertant photosensitivity,DrugBank
DB00695,Drugs that are Mainly Renally Excreted,DrugBank
DB00695,High-Ceiling Diuretics,DrugBank
DB00695,High-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00695,Hyperglycemia-Associated Agents,DrugBank
DB00695,Hypotensive Agents,DrugBank
DB00695,Increased Diuresis at Loop of Henle,DrugBank
DB00695,Membrane Transport Modulators,DrugBank
DB00695,Natriuretic Agents,DrugBank
DB00695,Nephrotoxic agents,DrugBank
DB00695,Non Potassium Sparing Diuretics,DrugBank
DB00695,OAT1/SLC22A6 inhibitors,DrugBank
DB00695,OAT3/SLC22A8 Inhibitors,DrugBank
DB00695,Ototoxic agents,DrugBank
DB00695,Photosensitizing Agents,DrugBank
DB00695,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB00695,Sulfanilamides,DrugBank
DB00695,Sulfonamides,DrugBank
DB00695,Sulfones,DrugBank
DB00695,Sulfur Compounds,DrugBank
DB00695,Thyroxine-binding globulin substrates,DrugBank
DB00695,UGT1A1 Substrates,DrugBank
DB00696,Adrenergic Agents,DrugBank
DB00696,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00696,Adrenergic alpha-Antagonists,DrugBank
DB00696,Adrenergic Antagonists,DrugBank
DB00696,Agents that produce hypertension,DrugBank
DB00696,Alkaloids,DrugBank
DB00696,Analgesics,DrugBank
DB00696,"Analgesics, Non-Narcotic",DrugBank
DB00696,Antidepressive Agents,DrugBank
DB00696,Antimigraine Preparations,DrugBank
DB00696,Cardiovascular Agents,DrugBank
DB00696,Central Nervous System Agents,DrugBank
DB00696,Central Nervous System Depressants,DrugBank
DB00696,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00696,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00696,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00696,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00696,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00696,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00696,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00696,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00696,Cytochrome P-450 Substrates,DrugBank
DB00696,Ergot Alkaloids and Derivatives,DrugBank
DB00696,Ergotamine Derivative,DrugBank
DB00696,Ergotamines,DrugBank
DB00696,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00696,Narrow Therapeutic Index Drugs,DrugBank
DB00696,Nervous System,DrugBank
DB00696,Neurotransmitter Agents,DrugBank
DB00696,P-glycoprotein inhibitors,DrugBank
DB00696,Peripheral Nervous System Agents,DrugBank
DB00696,Reproductive Control Agents,DrugBank
DB00696,Sensory System Agents,DrugBank
DB00696,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00696,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00696,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB00696,Serotonin Agents,DrugBank
DB00696,Serotonin Modulators,DrugBank
DB00696,Serotonin Receptor Agonists,DrugBank
DB00696,Sympatholytic (Adrenergic Blocking) Agents,DrugBank
DB00696,Uterotonic agents,DrugBank
DB00696,Vasoconstrictor Agents,DrugBank
DB00697,Adrenergic Agents,DrugBank
DB00697,Adrenergic Agonists,DrugBank
DB00697,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00697,Adrenergic alpha-Agonists,DrugBank
DB00697,Agents producing tachycardia,DrugBank
DB00697,Analgesics,DrugBank
DB00697,Anticonvulsants,DrugBank
DB00697,Autonomic Agents,DrugBank
DB00697,Bradycardia-Causing Agents,DrugBank
DB00697,Central alpha-2 Adrenergic Agonist,DrugBank
DB00697,Central Nervous System Agents,DrugBank
DB00697,Central Nervous System Depressants,DrugBank
DB00697,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00697,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00697,Cytochrome P-450 Substrates,DrugBank
DB00697,Hypotensive Agents,DrugBank
DB00697,Imidazoles,DrugBank
DB00697,Imidazolines,DrugBank
DB00697,Muscle Relaxants,DrugBank
DB00697,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00697,Musculo-Skeletal System,DrugBank
DB00697,Narrow Therapeutic Index Drugs,DrugBank
DB00697,Neuromuscular Agents,DrugBank
DB00697,Neurotransmitter Agents,DrugBank
DB00697,Potential QTc-Prolonging Agents,DrugBank
DB00697,QTc Prolonging Agents,DrugBank
DB00697,Sensory System Agents,DrugBank
DB00698,Agents causing hyperkalemia,DrugBank
DB00698,Anti-Bacterial Agents,DrugBank
DB00698,Anti-Infective Agents,DrugBank
DB00698,"Anti-Infective Agents, Urinary",DrugBank
DB00698,Antibacterials for Systemic Use,DrugBank
DB00698,Antiinfectives for Systemic Use,DrugBank
DB00698,BCRP/ABCG2 Substrates,DrugBank
DB00698,BSEP/ABCB11 Substrates,DrugBank
DB00698,Drugs that are Mainly Renally Excreted,DrugBank
DB00698,Furans,DrugBank
DB00698,Methemoglobinemia Associated Agents,DrugBank
DB00698,Nitro Compounds,DrugBank
DB00698,Nitrofuran Antibacterial,DrugBank
DB00698,Nitrofuran Derivatives,DrugBank
DB00698,Nitrofurans,DrugBank
DB00698,P-glycoprotein substrates,DrugBank
DB00698,Renal Agents,DrugBank
DB00698,Thyroxine-binding globulin substrates,DrugBank
DB00699,Adrenergic Agents,DrugBank
DB00699,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00699,Adrenergic alpha-Antagonists,DrugBank
DB00699,Adrenergic Antagonists,DrugBank
DB00699,Agents that produce hypertension,DrugBank
DB00699,Alkaloids,DrugBank
DB00699,Cardiovascular Agents,DrugBank
DB00699,Central Nervous System Agents,DrugBank
DB00699,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00699,Cytochrome P-450 Substrates,DrugBank
DB00699,Ergolines,DrugBank
DB00699,Ergot Alkaloids and Derivatives,DrugBank
DB00699,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00699,Neurotransmitter Agents,DrugBank
DB00699,Nootropic Agents,DrugBank
DB00699,Peripheral Vasodilators,DrugBank
DB00699,Vasodilating Agents,DrugBank
DB00700,Agents causing hyperkalemia,DrugBank
DB00700,Antihypertensive Agents,DrugBank
DB00700,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00700,Cardiovascular Agents,DrugBank
DB00700,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00700,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00700,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00700,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00700,Cytochrome P-450 Substrates,DrugBank
DB00700,Diuretics,DrugBank
DB00700,Fused-Ring Compounds,DrugBank
DB00700,Hormone Antagonists,DrugBank
DB00700,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00700,Hypotensive Agents,DrugBank
DB00700,Lactones,DrugBank
DB00700,Mineralocorticoid (Aldosterone) Receptor Antagonists,DrugBank
DB00700,Mineralocorticoid Receptor Antagonists,DrugBank
DB00700,Natriuretic Agents,DrugBank
DB00700,Potassium-Sparing Diuretics,DrugBank
DB00700,Pregnanes,DrugBank
DB00700,Pregnenes,DrugBank
DB00700,Steroids,DrugBank
DB00701,"Acids, Acyclic",DrugBank
DB00701,Amides,DrugBank
DB00701,Amprenavir and Prodrugs,DrugBank
DB00701,Anti-HIV Agents,DrugBank
DB00701,Anti-Infective Agents,DrugBank
DB00701,Anti-Retroviral Agents,DrugBank
DB00701,"Antibiotics, Antitubercular",DrugBank
DB00701,Antiinfectives for Systemic Use,DrugBank
DB00701,Antiviral Agents,DrugBank
DB00701,Antivirals for Systemic Use,DrugBank
DB00701,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00701,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB00701,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00701,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00701,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00701,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00701,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00701,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00701,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00701,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00701,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00701,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00701,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00701,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00701,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00701,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00701,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00701,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00701,Cytochrome P-450 Substrates,DrugBank
DB00701,Direct Acting Antivirals,DrugBank
DB00701,Drugs for Treatment of Tuberculosis,DrugBank
DB00701,Enzyme Inhibitors,DrugBank
DB00701,HIV Protease Inhibitors,DrugBank
DB00701,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00701,P-glycoprotein inducers,DrugBank
DB00701,P-glycoprotein substrates,DrugBank
DB00701,Protease Inhibitors,DrugBank
DB00701,Sulfones,DrugBank
DB00701,Sulfur Compounds,DrugBank
DB00701,Viral Protease Inhibitors,DrugBank
DB00703,Antiglaucoma Preparations and Miotics,DrugBank
DB00703,Carbonic Anhydrase Inhibitors,DrugBank
DB00703,Cardiovascular Agents,DrugBank
DB00703,Diuretics,DrugBank
DB00703,Drugs causing inadvertant photosensitivity,DrugBank
DB00703,Enzyme Inhibitors,DrugBank
DB00703,Genito Urinary System and Sex Hormones,DrugBank
DB00703,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00703,Hypotensive Agents,DrugBank
DB00703,Natriuretic Agents,DrugBank
DB00703,OAT1/SLC22A6 inhibitors,DrugBank
DB00703,Ophthalmologicals,DrugBank
DB00703,Photosensitizing Agents,DrugBank
DB00703,Sensory Organs,DrugBank
DB00703,Sulfonamides,DrugBank
DB00703,Sulfur Compounds,DrugBank
DB00703,Thiadiazoles,DrugBank
DB00703,Thiazoles,DrugBank
DB00704,Agents Causing Muscle Toxicity,DrugBank
DB00704,Alcohol Deterrents,DrugBank
DB00704,Alimentary Tract and Metabolism,DrugBank
DB00704,Alkaloids,DrugBank
DB00704,Analgesics,DrugBank
DB00704,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00704,Central Nervous System Agents,DrugBank
DB00704,Centrally Acting Antiobesity Products,DrugBank
DB00704,Drugs Used in Addictive Disorders,DrugBank
DB00704,Drugs Used in Alcohol Dependence,DrugBank
DB00704,Hepatotoxic Agents,DrugBank
DB00704,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00704,Morphinans,DrugBank
DB00704,Natural Opium Alkaloids,DrugBank
DB00704,Nervous System,DrugBank
DB00704,Opiate Alkaloids,DrugBank
DB00704,Opiate Antagonists,DrugBank
DB00704,Opioid Antagonists,DrugBank
DB00704,Opioids,DrugBank
DB00704,Peripheral Nervous System Agents,DrugBank
DB00704,Phenanthrenes,DrugBank
DB00704,Sensory System Agents,DrugBank
DB00704,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00704,UGT1A1 Substrates,DrugBank
DB00705,Anti-HIV Agents,DrugBank
DB00705,Anti-Infective Agents,DrugBank
DB00705,Anti-Retroviral Agents,DrugBank
DB00705,Antiinfectives for Systemic Use,DrugBank
DB00705,Antiviral Agents,DrugBank
DB00705,Antivirals for Systemic Use,DrugBank
DB00705,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00705,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB00705,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00705,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00705,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00705,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00705,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00705,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00705,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00705,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00705,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00705,Cytochrome P-450 Substrates,DrugBank
DB00705,Direct Acting Antivirals,DrugBank
DB00705,Enzyme Inhibitors,DrugBank
DB00705,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00705,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00705,Indoles,DrugBank
DB00705,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00705,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00705,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00705,Piperazines,DrugBank
DB00705,Reverse Transcriptase Inhibitors,DrugBank
DB00706,Adrenergic Agents,DrugBank
DB00706,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00706,Adrenergic alpha-Antagonists,DrugBank
DB00706,Adrenergic Antagonists,DrugBank
DB00706,Amides,DrugBank
DB00706,Benzene Derivatives,DrugBank
DB00706,Benzenesulfonamides,DrugBank
DB00706,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00706,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00706,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00706,Cytochrome P-450 Substrates,DrugBank
DB00706,Drugs that are Mainly Renally Excreted,DrugBank
DB00706,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB00706,Genito Urinary System and Sex Hormones,DrugBank
DB00706,Genitourinary Agents,DrugBank
DB00706,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00706,Hypotensive Agents,DrugBank
DB00706,Neurotransmitter Agents,DrugBank
DB00706,Peripheral alpha-1 blockers,DrugBank
DB00706,Selective Alfa-1-adrenergic Blocking Agents,DrugBank
DB00706,Sulfonamides,DrugBank
DB00706,Sulfones,DrugBank
DB00706,Sulfur Compounds,DrugBank
DB00706,Urological Agents,DrugBank
DB00706,Urologicals,DrugBank
DB00707,Antineoplastic Agents,DrugBank
DB00707,Antineoplastic and Immunomodulating Agents,DrugBank
DB00707,Biological Factors,DrugBank
DB00707,Dermatologicals,DrugBank
DB00707,Hematoporphyrin Derivative,DrugBank
DB00707,Hematoporphyrins,DrugBank
DB00707,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00707,Photoabsorption,DrugBank
DB00707,Photoactivated Radical Generator,DrugBank
DB00707,Photosensitizing Activity,DrugBank
DB00707,Photosensitizing Agents,DrugBank
DB00707,Photosensitizing Agents for Phototherapy,DrugBank
DB00707,"Pigments, Biological",DrugBank
DB00707,Porphyrins,DrugBank
DB00707,Radiation-Sensitizing Agents,DrugBank
DB00707,Sensitizers Used in Photodynamic/radiation Therapy,DrugBank
DB00708,"Adjuvants, Anesthesia",DrugBank
DB00708,Agents that produce hypertension,DrugBank
DB00708,Analgesics,DrugBank
DB00708,Anesthetics,DrugBank
DB00708,"Anesthetics, General",DrugBank
DB00708,"Anesthetics, Intravenous",DrugBank
DB00708,Bradycardia-Causing Agents,DrugBank
DB00708,Central Nervous System Agents,DrugBank
DB00708,Central Nervous System Depressants,DrugBank
DB00708,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00708,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00708,Cytochrome P-450 Substrates,DrugBank
DB00708,Fentanyl and fentanyl analogues,DrugBank
DB00708,High-risk opioids,DrugBank
DB00708,Hypotensive Agents,DrugBank
DB00708,Narcotics,DrugBank
DB00708,Nervous System,DrugBank
DB00708,Neuraxial Anesthetics,DrugBank
DB00708,Opiate Agonists,DrugBank
DB00708,Opioid Agonist,DrugBank
DB00708,Opioid Anesthetics,DrugBank
DB00708,Opioids,DrugBank
DB00708,"Opioids, Anilidopiperidine",DrugBank
DB00708,Peripheral Nervous System Agents,DrugBank
DB00708,Phenylpiperidine opioids,DrugBank
DB00708,Piperidines,DrugBank
DB00708,Sensory System Agents,DrugBank
DB00708,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00709,Agents Causing Muscle Toxicity,DrugBank
DB00709,Anti-HIV Agents,DrugBank
DB00709,Anti-Infective Agents,DrugBank
DB00709,Anti-Retroviral Agents,DrugBank
DB00709,Antiinfectives for Systemic Use,DrugBank
DB00709,Antiviral Agents,DrugBank
DB00709,Antivirals for Systemic Use,DrugBank
DB00709,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00709,BCRP/ABCG2 Substrates,DrugBank
DB00709,Deoxycytidine,DrugBank
DB00709,Deoxyribonucleosides,DrugBank
DB00709,Dideoxynucleosides,DrugBank
DB00709,Direct Acting Antivirals,DrugBank
DB00709,Drugs that are Mainly Renally Excreted,DrugBank
DB00709,Enzyme Inhibitors,DrugBank
DB00709,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00709,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00709,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00709,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00709,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00709,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00709,Nucleosides,DrugBank
DB00709,OAT1/SLC22A6 Substrates,DrugBank
DB00709,OCT1 substrates,DrugBank
DB00709,OCT2 Substrates,DrugBank
DB00709,P-glycoprotein substrates,DrugBank
DB00709,Pyrimidine Nucleosides,DrugBank
DB00709,Pyrimidines,DrugBank
DB00709,Reverse Transcriptase Inhibitors,DrugBank
DB00710,Agents Causing Muscle Toxicity,DrugBank
DB00710,Bisphosphonates,DrugBank
DB00710,Bone Density Conservation Agents,DrugBank
DB00710,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00710,Drugs for Treatment of Bone Diseases,DrugBank
DB00710,Musculo-Skeletal System,DrugBank
DB00710,Organophosphonates,DrugBank
DB00710,Organophosphorus Compounds,DrugBank
DB00710,Potential QTc-Prolonging Agents,DrugBank
DB00710,QTc Prolonging Agents,DrugBank
DB00711,"Acids, Acyclic",DrugBank
DB00711,Anthelmintics,DrugBank
DB00711,Anti-Infective Agents,DrugBank
DB00711,Antihelminthic,DrugBank
DB00711,Antinematodal Agents,DrugBank
DB00711,Antiparasitic Agents,DrugBank
DB00711,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00711,Carbamates,DrugBank
DB00711,Cholinesterase Inhibitors,DrugBank
DB00711,Enzyme Inhibitors,DrugBank
DB00711,Filaricides,DrugBank
DB00711,Lipoxygenase Inhibitors,DrugBank
DB00711,Piperazine and Derivatives,DrugBank
DB00711,Piperazines,DrugBank
DB00712,"Acids, Acyclic",DrugBank
DB00712,Agents causing hyperkalemia,DrugBank
DB00712,Agents that produce hypertension,DrugBank
DB00712,Analgesics,DrugBank
DB00712,"Analgesics, Non-Narcotic",DrugBank
DB00712,Anti-Inflammatory Agents,DrugBank
DB00712,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00712,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00712,Antiinflammatory and Antirheumatic Products,DrugBank
DB00712,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00712,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00712,Antirheumatic Agents,DrugBank
DB00712,Arylpropionic acid NSAIDS,DrugBank
DB00712,Benzene Derivatives,DrugBank
DB00712,Biphenyl Compounds,DrugBank
DB00712,Central Nervous System Agents,DrugBank
DB00712,Cyclooxygenase Inhibitors,DrugBank
DB00712,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00712,Cytochrome P-450 Substrates,DrugBank
DB00712,Drugs causing inadvertant photosensitivity,DrugBank
DB00712,Drugs that are Mainly Renally Excreted,DrugBank
DB00712,Enzyme Inhibitors,DrugBank
DB00712,Musculo-Skeletal System,DrugBank
DB00712,Nephrotoxic agents,DrugBank
DB00712,Non COX-2 selective NSAIDS,DrugBank
DB00712,OAT1/SLC22A6 inhibitors,DrugBank
DB00712,Ophthalmologicals,DrugBank
DB00712,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00712,Peripheral Nervous System Agents,DrugBank
DB00712,Photosensitizing Agents,DrugBank
DB00712,Propionates,DrugBank
DB00712,Sensory Organs,DrugBank
DB00712,Sensory System Agents,DrugBank
DB00712,Throat Preparations,DrugBank
DB00712,Topical Products for Joint and Muscular Pain,DrugBank
DB00712,UGT1A1 Inhibitors,DrugBank
DB00712,UGT1A1 Substrates,DrugBank
DB00712,UGT1A3 substrates,DrugBank
DB00712,UGT1A9 Substrates,DrugBank
DB00712,UGT2B7 substrates,DrugBank
DB00713,Amides,DrugBank
DB00713,Anti-Bacterial Agents,DrugBank
DB00713,Anti-Infective Agents,DrugBank
DB00713,Antibacterials for Systemic Use,DrugBank
DB00713,Antiinfectives for Systemic Use,DrugBank
DB00713,Beta-Lactam Antibacterials,DrugBank
DB00713,Beta-Lactamase Resistant Penicillins,DrugBank
DB00713,beta-Lactams,DrugBank
DB00713,Drugs that are Mainly Renally Excreted,DrugBank
DB00713,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00713,Lactams,DrugBank
DB00713,Penicillins,DrugBank
DB00713,Sulfur Compounds,DrugBank
DB00714,Alkaloids,DrugBank
DB00714,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB00714,Anti-Parkinson Drugs,DrugBank
DB00714,Antidepressive Agents,DrugBank
DB00714,Aporphines,DrugBank
DB00714,Autonomic Agents,DrugBank
DB00714,Benzylisoquinolines,DrugBank
DB00714,Central Nervous System Agents,DrugBank
DB00714,Central Nervous System Depressants,DrugBank
DB00714,COMT Substrates,DrugBank
DB00714,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00714,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00714,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00714,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00714,Cytochrome P-450 Substrates,DrugBank
DB00714,Dopamine Agents,DrugBank
DB00714,Dopamine Agonists,DrugBank
DB00714,Drugs Used in Erectile Dysfunction,DrugBank
DB00714,Emetics,DrugBank
DB00714,Gastrointestinal Agents,DrugBank
DB00714,Genito Urinary System and Sex Hormones,DrugBank
DB00714,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00714,Hypotensive Agents,DrugBank
DB00714,Isoquinolines,DrugBank
DB00714,Nervous System,DrugBank
DB00714,Neurotransmitter Agents,DrugBank
DB00714,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB00714,Opiate Agonists,DrugBank
DB00714,Peripheral Nervous System Agents,DrugBank
DB00714,Potential QTc-Prolonging Agents,DrugBank
DB00714,QTc Prolonging Agents,DrugBank
DB00714,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00714,Serotonin Agents,DrugBank
DB00714,Serotonin Receptor Antagonists,DrugBank
DB00714,Urologicals,DrugBank
DB00715,Agents producing tachycardia,DrugBank
DB00715,Anticholinergic Agents,DrugBank
DB00715,Antidepressive Agents,DrugBank
DB00715,Antidepressive Agents Indicated for Depression,DrugBank
DB00715,"Antidepressive Agents, Second-Generation",DrugBank
DB00715,Central Nervous System Agents,DrugBank
DB00715,Central Nervous System Depressants,DrugBank
DB00715,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00715,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00715,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00715,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00715,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00715,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB00715,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00715,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00715,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00715,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00715,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00715,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00715,Cytochrome P-450 Substrates,DrugBank
DB00715,Drugs causing inadvertant photosensitivity,DrugBank
DB00715,Enzyme Inhibitors,DrugBank
DB00715,Hypoglycemia-Associated Agents,DrugBank
DB00715,Membrane Transport Modulators,DrugBank
DB00715,Muscarinic Antagonists,DrugBank
DB00715,Nervous System,DrugBank
DB00715,Neurotransmitter Agents,DrugBank
DB00715,Neurotransmitter Uptake Inhibitors,DrugBank
DB00715,P-glycoprotein inhibitors,DrugBank
DB00715,Photosensitizing Agents,DrugBank
DB00715,Piperidines,DrugBank
DB00715,Psychoanaleptics,DrugBank
DB00715,Psychotropic Drugs,DrugBank
DB00715,Selective Serotonin Reuptake Inhibitors,DrugBank
DB00715,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00715,Serotonin Agents,DrugBank
DB00715,Serotonin Modulators,DrugBank
DB00716,4-Quinolones,DrugBank
DB00716,Anti-Allergic Agents,DrugBank
DB00716,Anti-Asthmatic Agents,DrugBank
DB00716,Anti-Inflammatory Agents,DrugBank
DB00716,"Antiallergic Agents, Excl. Corticosteroids",DrugBank
DB00716,Decongestants and Antiallergics,DrugBank
DB00716,Decreased Histamine Release,DrugBank
DB00716,Drugs for Obstructive Airway Diseases,DrugBank
DB00716,Drugs that are Mainly Renally Excreted,DrugBank
DB00716,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00716,Immunologic Factors,DrugBank
DB00716,Mast Cell Stabilizers,DrugBank
DB00716,Nasal Preparations,DrugBank
DB00716,Ophthalmologicals,DrugBank
DB00716,Quinolines,DrugBank
DB00716,Quinolones,DrugBank
DB00716,"Respiratory Agents, Miscellaneous",DrugBank
DB00716,Respiratory System Agents,DrugBank
DB00716,Sensory Organs,DrugBank
DB00717,Adrenal Cortex Hormones,DrugBank
DB00717,Anti-Gonadotropin-Releasing Hormones,DrugBank
DB00717,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00717,"Contraceptive Agents, Female",DrugBank
DB00717,"Contraceptive Agents, Hormonal",DrugBank
DB00717,"Contraceptives, Oral",DrugBank
DB00717,"Contraceptives, Oral, Hormonal",DrugBank
DB00717,"Contraceptives, Oral, Synthetic",DrugBank
DB00717,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00717,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00717,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00717,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00717,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00717,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00717,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00717,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB00717,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00717,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00717,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00717,Cytochrome P-450 Substrates,DrugBank
DB00717,Estren Derivatives,DrugBank
DB00717,Fused-Ring Compounds,DrugBank
DB00717,Genito Urinary System and Sex Hormones,DrugBank
DB00717,Hormonal Contraceptives for Systemic Use,DrugBank
DB00717,Hyperglycemia-Associated Agents,DrugBank
DB00717,Hypothalamic Hormones,DrugBank
DB00717,Norpregnenes,DrugBank
DB00717,Norsteroids,DrugBank
DB00717,P-glycoprotein inhibitors,DrugBank
DB00717,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00717,Progestin Contraceptives,DrugBank
DB00717,Progestins,DrugBank
DB00717,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00717,Reproductive Control Agents,DrugBank
DB00717,Sex Hormones and Modulators of the Genital System,DrugBank
DB00717,Steroids,DrugBank
DB00717,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00718,Anti-Infective Agents,DrugBank
DB00718,Antiinfectives for Systemic Use,DrugBank
DB00718,Antiviral Agents,DrugBank
DB00718,Antivirals for Systemic Use,DrugBank
DB00718,Direct Acting Antivirals,DrugBank
DB00718,Enzyme Inhibitors,DrugBank
DB00718,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00718,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00718,Nephrotoxic agents,DrugBank
DB00718,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00718,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00718,Nucleosides and Nucleotides,DrugBank
DB00718,OAT1/SLC22A6 inhibitors,DrugBank
DB00718,OAT1/SLC22A6 Substrates,DrugBank
DB00718,Organophosphorus Compounds,DrugBank
DB00718,Purines,DrugBank
DB00718,Reverse Transcriptase Inhibitors,DrugBank
DB00719,Agents that reduce seizure threshold,DrugBank
DB00719,Anticholinergic Agents,DrugBank
DB00719,Antihistamines for Systemic Use,DrugBank
DB00719,Benzocycloheptenes,DrugBank
DB00719,Cholinergic Agents,DrugBank
DB00719,Dibenzocycloheptenes,DrugBank
DB00719,Histamine Agents,DrugBank
DB00719,Histamine Antagonists,DrugBank
DB00719,Histamine H1 Antagonists,DrugBank
DB00719,Neurotransmitter Agents,DrugBank
DB00719,Piperidines,DrugBank
DB00719,Potential QTc-Prolonging Agents,DrugBank
DB00719,QTc Prolonging Agents,DrugBank
DB00720,Bisphosphonates,DrugBank
DB00720,Bone Density Conservation Agents,DrugBank
DB00720,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00720,Drugs for Treatment of Bone Diseases,DrugBank
DB00720,Musculo-Skeletal System,DrugBank
DB00720,Organophosphonates,DrugBank
DB00720,Organophosphorus Compounds,DrugBank
DB00721,"Acids, Carbocyclic",DrugBank
DB00721,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00721,Agents that reduce seizure threshold,DrugBank
DB00721,Aminobenzoates,DrugBank
DB00721,Anesthetics,DrugBank
DB00721,"Anesthetics, Local",DrugBank
DB00721,Anticholinergic Agents,DrugBank
DB00721,Antidepressive Agents,DrugBank
DB00721,Benzene Derivatives,DrugBank
DB00721,Benzoates,DrugBank
DB00721,Central Nervous System Agents,DrugBank
DB00721,Central Nervous System Depressants,DrugBank
DB00721,Cholinesterase Inhibitors,DrugBank
DB00721,Cholinesterase substrates,DrugBank
DB00721,Esters of Aminobenzoic Acid,DrugBank
DB00721,Local Anesthetics (Ester),DrugBank
DB00721,Methemoglobinemia Associated Agents,DrugBank
DB00721,Monoamine Oxidase Inhibitors,DrugBank
DB00721,Nervous System,DrugBank
DB00721,Nicotinic Antagonists,DrugBank
DB00721,NMDA Receptor Antagonists,DrugBank
DB00721,Ophthalmologicals,DrugBank
DB00721,para-Aminobenzoates,DrugBank
DB00721,Peripheral Nervous System Agents,DrugBank
DB00721,Sensory Organs,DrugBank
DB00721,Sensory System Agents,DrugBank
DB00721,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00721,Vasoprotectives,DrugBank
DB00722,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00722,ACE Inhibitors and Diuretics,DrugBank
DB00722,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00722,Agents causing angioedema,DrugBank
DB00722,Agents causing hyperkalemia,DrugBank
DB00722,"Amino Acids, Peptides, and Proteins",DrugBank
DB00722,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00722,Antihypertensive Agents,DrugBank
DB00722,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00722,Cardiotonic Agents,DrugBank
DB00722,Cardiovascular Agents,DrugBank
DB00722,"Compounds used in a research, industrial, or household setting",DrugBank
DB00722,Dipeptides,DrugBank
DB00722,Drugs causing inadvertant photosensitivity,DrugBank
DB00722,Drugs that are Mainly Renally Excreted,DrugBank
DB00722,Enzyme Inhibitors,DrugBank
DB00722,Hypotensive Agents,DrugBank
DB00722,Lipid Modifying Agents,DrugBank
DB00722,Oligopeptides,DrugBank
DB00722,Peptides,DrugBank
DB00722,Photosensitizing Agents,DrugBank
DB00722,Protease Inhibitors,DrugBank
DB00722,Protective Agents,DrugBank
DB00723,Adrenergic Agents,DrugBank
DB00723,Adrenergic Agonists,DrugBank
DB00723,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00723,Adrenergic alpha-Agonists,DrugBank
DB00723,Adrenergic and Dopaminergic Agents,DrugBank
DB00723,Agents producing tachycardia,DrugBank
DB00723,Agents that produce hypertension,DrugBank
DB00723,Alcohols,DrugBank
DB00723,Amines,DrugBank
DB00723,Amino Alcohols,DrugBank
DB00723,Autonomic Agents,DrugBank
DB00723,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00723,Cardiac Therapy,DrugBank
DB00723,Cardiovascular Agents,DrugBank
DB00723,Ethylamines,DrugBank
DB00723,Neurotransmitter Agents,DrugBank
DB00723,Peripheral Nervous System Agents,DrugBank
DB00723,Phenethylamines,DrugBank
DB00723,Propanolamines,DrugBank
DB00723,Propanols,DrugBank
DB00723,Sympathomimetics,DrugBank
DB00723,Vasoconstrictor Agents,DrugBank
DB00724,"Adjuvants, Immunologic",DrugBank
DB00724,Aminoquinolines,DrugBank
DB00724,Antineoplastic Agents,DrugBank
DB00724,Cancer immunotherapy,DrugBank
DB00724,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00724,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00724,Cytochrome P-450 Substrates,DrugBank
DB00724,Dermatologicals,DrugBank
DB00724,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00724,Immune Response Modifiers,DrugBank
DB00724,Immunologic Factors,DrugBank
DB00724,Immunomodulatory Agents,DrugBank
DB00724,Immunosuppressive Agents,DrugBank
DB00724,Immunotherapy,DrugBank
DB00724,Increased Cytokine Activity,DrugBank
DB00724,Increased Cytokine Production,DrugBank
DB00724,Interferon Inducers,DrugBank
DB00724,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00724,Quinolines,DrugBank
DB00724,Toll-Like Receptor Agonists,DrugBank
DB00725,Agents producing tachycardia,DrugBank
DB00725,Alimentary Tract and Metabolism,DrugBank
DB00725,Alkaloids,DrugBank
DB00725,Anticholinergic Agents,DrugBank
DB00725,Aza Compounds,DrugBank
DB00725,Azabicyclo Compounds,DrugBank
DB00725,"Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds",DrugBank
DB00725,"Belladonna and Derivatives, Plain",DrugBank
DB00725,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00725,Muscarinic Antagonists,DrugBank
DB00726,Adrenergic Agents,DrugBank
DB00726,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00726,Adrenergic alpha-Antagonists,DrugBank
DB00726,Adrenergic Antagonists,DrugBank
DB00726,Adrenergic Uptake Inhibitors,DrugBank
DB00726,Agents that produce hypertension,DrugBank
DB00726,Agents that reduce seizure threshold,DrugBank
DB00726,Antidepressive Agents,DrugBank
DB00726,Antidepressive Agents Indicated for Depression,DrugBank
DB00726,"Antidepressive Agents, Tricyclic",DrugBank
DB00726,Central Nervous System Agents,DrugBank
DB00726,Central Nervous System Depressants,DrugBank
DB00726,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB00726,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00726,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB00726,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00726,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00726,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00726,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00726,Cytochrome P-450 Substrates,DrugBank
DB00726,Dibenzazepines,DrugBank
DB00726,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00726,Histamine Antagonists,DrugBank
DB00726,Histamine H1 Antagonists,DrugBank
DB00726,Membrane Transport Modulators,DrugBank
DB00726,Narrow Therapeutic Index Drugs,DrugBank
DB00726,Nervous System,DrugBank
DB00726,Neurotoxic agents,DrugBank
DB00726,Neurotransmitter Agents,DrugBank
DB00726,Neurotransmitter Uptake Inhibitors,DrugBank
DB00726,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00726,P-glycoprotein substrates,DrugBank
DB00726,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00726,Potential QTc-Prolonging Agents,DrugBank
DB00726,Psychoanaleptics,DrugBank
DB00726,Psychotropic Drugs,DrugBank
DB00726,QTc Prolonging Agents,DrugBank
DB00726,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00726,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00726,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00726,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00726,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00726,Serotonin Agents,DrugBank
DB00726,Serotonin Modulators,DrugBank
DB00726,Serotonin Receptor Antagonists,DrugBank
DB00726,Tertiary amine tricyclic antidepressants,DrugBank
DB00726,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB00727,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00727,Antianginal Agents,DrugBank
DB00727,Antihypertensive Agents,DrugBank
DB00727,Cardiac Therapy,DrugBank
DB00727,Cardiovascular Agents,DrugBank
DB00727,"Compounds used in a research, industrial, or household setting",DrugBank
DB00727,Explosive Agents,DrugBank
DB00727,Hypotensive Agents,DrugBank
DB00727,Methemoglobinemia Associated Agents,DrugBank
DB00727,Nitrate Vasodilator,DrugBank
DB00727,Nitrates and Nitrites,DrugBank
DB00727,Nitro Compounds,DrugBank
DB00727,Organic Nitrates,DrugBank
DB00727,Vasodilating Agents,DrugBank
DB00727,Vasodilation,DrugBank
DB00727,Vasodilators Used in Cardiac Diseases,DrugBank
DB00727,Vasoprotectives,DrugBank
DB00728,Agents producing tachycardia,DrugBank
DB00728,Androstanes,DrugBank
DB00728,Androstanols,DrugBank
DB00728,Anticholinergic Agents,DrugBank
DB00728,Central Nervous System Depressants,DrugBank
DB00728,Fused-Ring Compounds,DrugBank
DB00728,Muscarinic Antagonists,DrugBank
DB00728,Muscle Relaxants,DrugBank
DB00728,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00728,Musculo-Skeletal System,DrugBank
DB00728,Neuromuscular Agents,DrugBank
DB00728,Neuromuscular Blocking Agents,DrugBank
DB00728,Neuromuscular Nondepolarizing Blockade,DrugBank
DB00728,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB00728,Nicotinic Antagonists,DrugBank
DB00728,OCT1 inhibitors,DrugBank
DB00728,OCT1 substrates,DrugBank
DB00728,Peripheral Nervous System Agents,DrugBank
DB00728,Steroids,DrugBank
DB00730,Anthelmintics,DrugBank
DB00730,Anti-Infective Agents,DrugBank
DB00730,Antifungals for Dermatological Use,DrugBank
DB00730,Antifungals for Topical Use,DrugBank
DB00730,Antihelminthic,DrugBank
DB00730,Antinematodal Agents,DrugBank
DB00730,Antiparasitic Agents,DrugBank
DB00730,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00730,Benzimidazole Derivatives,DrugBank
DB00730,Benzimidazoles,DrugBank
DB00730,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00730,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00730,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00730,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00730,Cytochrome P-450 Substrates,DrugBank
DB00730,Dermatologicals,DrugBank
DB00730,Drugs that are Mainly Renally Excreted,DrugBank
DB00730,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00730,Imidazole and Triazole Derivatives,DrugBank
DB00730,Sulfur Compounds,DrugBank
DB00730,Thiazoles,DrugBank
DB00731,Alimentary Tract and Metabolism,DrugBank
DB00731,Amino Acids,DrugBank
DB00731,"Amino Acids, Aromatic",DrugBank
DB00731,"Amino Acids, Cyclic",DrugBank
DB00731,"Amino Acids, Peptides, and Proteins",DrugBank
DB00731,Blood Glucose Lowering Agents,DrugBank
DB00731,Cyclohexanes,DrugBank
DB00731,Cycloparaffins,DrugBank
DB00731,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00731,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00731,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00731,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00731,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00731,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00731,Cytochrome P-450 Substrates,DrugBank
DB00731,Drugs that are Mainly Renally Excreted,DrugBank
DB00731,Drugs Used in Diabetes,DrugBank
DB00731,Glinide,DrugBank
DB00731,Hypoglycemia-Associated Agents,DrugBank
DB00731,Insulin Secretagogues,DrugBank
DB00731,OAT1/SLC22A6 inhibitors,DrugBank
DB00731,Oral Hypoglycemics,DrugBank
DB00731,Potassium Channel Blockers,DrugBank
DB00731,UGT1A9 Substrates,DrugBank
DB00732,Anticholinergic Agents,DrugBank
DB00732,Benzylisoquinolines,DrugBank
DB00732,Central Nervous System Depressants,DrugBank
DB00732,Cholinergic Agents,DrugBank
DB00732,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00732,Isoquinolines,DrugBank
DB00732,Miscellaneous Skeletal Muscle Relaxants,DrugBank
DB00732,Neuromuscular Agents,DrugBank
DB00732,Neuromuscular Blocking Agents,DrugBank
DB00732,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB00732,Neurotransmitter Agents,DrugBank
DB00732,Nicotinic Antagonists,DrugBank
DB00732,Peripheral Nervous System Agents,DrugBank
DB00733,Amines,DrugBank
DB00733,Antidotes,DrugBank
DB00733,Cholinergic Agents,DrugBank
DB00733,Cholinesterase Reactivators,DrugBank
DB00733,"Compounds used in a research, industrial, or household setting",DrugBank
DB00733,Drugs that are Mainly Renally Excreted,DrugBank
DB00733,Enzyme Reactivators,DrugBank
DB00733,Hydroxylamines,DrugBank
DB00733,Neurotransmitter Agents,DrugBank
DB00733,Oximes,DrugBank
DB00733,Protective Agents,DrugBank
DB00734,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00734,Adrenergic alpha-Antagonists,DrugBank
DB00734,Adrenergic Antagonists,DrugBank
DB00734,Agents that produce hypertension,DrugBank
DB00734,Agents that reduce seizure threshold,DrugBank
DB00734,Antidepressive Agents,DrugBank
DB00734,Antipsychotic Agents,DrugBank
DB00734,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB00734,Central Nervous System Agents,DrugBank
DB00734,Central Nervous System Depressants,DrugBank
DB00734,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00734,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00734,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00734,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00734,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00734,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00734,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00734,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00734,Cytochrome P-450 Substrates,DrugBank
DB00734,Dopamine Agents,DrugBank
DB00734,Dopamine Antagonists,DrugBank
DB00734,Dopamine D2 Receptor Antagonists,DrugBank
DB00734,Histamine Antagonists,DrugBank
DB00734,Histamine H1 Antagonists,DrugBank
DB00734,Hyperglycemia-Associated Agents,DrugBank
DB00734,Nervous System,DrugBank
DB00734,Neurotoxic agents,DrugBank
DB00734,Neurotransmitter Agents,DrugBank
DB00734,P-glycoprotein substrates,DrugBank
DB00734,Potential QTc-Prolonging Agents,DrugBank
DB00734,Psycholeptics,DrugBank
DB00734,Psychotropic Drugs,DrugBank
DB00734,Pyrimidines,DrugBank
DB00734,Pyrimidinones,DrugBank
DB00734,QTc Prolonging Agents,DrugBank
DB00734,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00734,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00734,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00734,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB00734,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00734,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00734,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00734,Serotonin Agents,DrugBank
DB00734,Serotonin Receptor Antagonists,DrugBank
DB00734,Tranquilizing Agents,DrugBank
DB00736,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB00736,Acid Reducers,DrugBank
DB00736,Alimentary Tract and Metabolism,DrugBank
DB00736,Anti-Ulcer Agents,DrugBank
DB00736,Antiinflammatory and Antirheumatic Products,DrugBank
DB00736,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00736,Benzimidazoles,DrugBank
DB00736,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00736,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00736,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00736,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00736,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00736,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00736,Cytochrome P-450 Substrates,DrugBank
DB00736,Drugs causing inadvertant photosensitivity,DrugBank
DB00736,Drugs for Acid Related Disorders,DrugBank
DB00736,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00736,Enzyme Inhibitors,DrugBank
DB00736,Gastric Acid Lowering Agents,DrugBank
DB00736,Gastrointestinal Agents,DrugBank
DB00736,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00736,Musculo-Skeletal System,DrugBank
DB00736,OAT3/SLC22A8 Inhibitors,DrugBank
DB00736,P-glycoprotein inhibitors,DrugBank
DB00736,P-glycoprotein substrates,DrugBank
DB00736,Photosensitizing Agents,DrugBank
DB00736,Propionates,DrugBank
DB00736,Proton Pump Inhibitors,DrugBank
DB00736,Proton-pump Inhibitors,DrugBank
DB00736,Pyridines,DrugBank
DB00736,Sulfoxides,DrugBank
DB00736,Sulfur Compounds,DrugBank
DB00737,Anti-Allergic Agents,DrugBank
DB00737,Anticholinergic Agents,DrugBank
DB00737,Antiemetics,DrugBank
DB00737,Antihistamines for Systemic Use,DrugBank
DB00737,Antivertigo Preparations,DrugBank
DB00737,Autonomic Agents,DrugBank
DB00737,Benzene Derivatives,DrugBank
DB00737,Benzhydryl Compounds,DrugBank
DB00737,Central Nervous System Agents,DrugBank
DB00737,Central Nervous System Depressants,DrugBank
DB00737,Cholinergic Agents,DrugBank
DB00737,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00737,Cytochrome P-450 Substrates,DrugBank
DB00737,Emesis Suppression,DrugBank
DB00737,Gastrointestinal Agents,DrugBank
DB00737,Histamine Agents,DrugBank
DB00737,Histamine Antagonists,DrugBank
DB00737,Histamine H1 Antagonists,DrugBank
DB00737,Neurotransmitter Agents,DrugBank
DB00737,Peripheral Nervous System Agents,DrugBank
DB00737,Piperazine Derivatives,DrugBank
DB00737,Piperazines,DrugBank
DB00738,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB00738,Agents causing hyperkalemia,DrugBank
DB00738,Amidines,DrugBank
DB00738,Anti-Infective Agents,DrugBank
DB00738,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB00738,Antifungal Agents,DrugBank
DB00738,Antiparasitic Agents,DrugBank
DB00738,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00738,Antiprotozoals,DrugBank
DB00738,Benzamidines,DrugBank
DB00738,Blood Glucose Lowering Agents,DrugBank
DB00738,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00738,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00738,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00738,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00738,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00738,Cytochrome P-450 Substrates,DrugBank
DB00738,Hyperglycemia-Associated Agents,DrugBank
DB00738,Hypoglycemia-Associated Agents,DrugBank
DB00738,Miscellaneous Antiprotozoals,DrugBank
DB00738,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00738,Nephrotoxic agents,DrugBank
DB00738,QTc Prolonging Agents,DrugBank
DB00738,Trypanocidal Agents,DrugBank
DB00739,Amides,DrugBank
DB00739,Anti-Bacterial Agents,DrugBank
DB00739,Antibacterials for Systemic Use,DrugBank
DB00739,Antiinfectives for Systemic Use,DrugBank
DB00739,Beta-Lactam Antibacterials,DrugBank
DB00739,beta-Lactams,DrugBank
DB00739,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00739,Lactams,DrugBank
DB00739,Penicillins,DrugBank
DB00739,Penicillins With Extended Spectrum,DrugBank
DB00739,Sulfur Compounds,DrugBank
DB00740,Anticonvulsants,DrugBank
DB00740,BCRP/ABCG2 Substrates,DrugBank
DB00740,Benzothiazoles,DrugBank
DB00740,Central Nervous System Agents,DrugBank
DB00740,Central Nervous System Depressants,DrugBank
DB00740,"Compounds used in a research, industrial, or household setting",DrugBank
DB00740,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00740,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00740,Cytochrome P-450 Substrates,DrugBank
DB00740,Excitatory Amino Acid Agents,DrugBank
DB00740,Excitatory Amino Acid Antagonists,DrugBank
DB00740,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00740,Miscellaneous Central Nervous System Agents,DrugBank
DB00740,Nervous System,DrugBank
DB00740,Neuroprotective Agents,DrugBank
DB00740,Neurotransmitter Agents,DrugBank
DB00740,Protective Agents,DrugBank
DB00740,Sulfur Compounds,DrugBank
DB00740,Thiazoles,DrugBank
DB00741,11-Hydroxycorticosteroids,DrugBank
DB00741,17-Hydroxycorticosteroids,DrugBank
DB00741,Adrenal Cortex Hormones,DrugBank
DB00741,Adrenals,DrugBank
DB00741,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00741,Alimentary Tract and Metabolism,DrugBank
DB00741,Anti-Inflammatory Agents,DrugBank
DB00741,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00741,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00741,Corticosteroids,DrugBank
DB00741,Corticosteroids Acting Locally,DrugBank
DB00741,Corticosteroids for Local Oral Treatment,DrugBank
DB00741,Corticosteroids for Systemic Use,DrugBank
DB00741,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00741,"Corticosteroids, Dermatological Preparations",DrugBank
DB00741,"Corticosteroids, Weak (Group I)",DrugBank
DB00741,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00741,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00741,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00741,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00741,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00741,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00741,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00741,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00741,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00741,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00741,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00741,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00741,Cytochrome P-450 Substrates,DrugBank
DB00741,Dermatologicals,DrugBank
DB00741,Fused-Ring Compounds,DrugBank
DB00741,Hormones,DrugBank
DB00741,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00741,Hydrocortisone and derivatives,DrugBank
DB00741,Hydroxycorticosteroids,DrugBank
DB00741,Hyperglycemia-Associated Agents,DrugBank
DB00741,Immunosuppressive Agents,DrugBank
DB00741,Intestinal Antiinflammatory Agents,DrugBank
DB00741,Nasal Preparations,DrugBank
DB00741,OAT3/SLC22A8 Substrates,DrugBank
DB00741,Ophthalmological and Otological Preparations,DrugBank
DB00741,Ophthalmologicals,DrugBank
DB00741,Otologicals,DrugBank
DB00741,P-glycoprotein inducers,DrugBank
DB00741,P-glycoprotein substrates,DrugBank
DB00741,Pregnanes,DrugBank
DB00741,Pregnenediones,DrugBank
DB00741,Pregnenes,DrugBank
DB00741,Sensory Organs,DrugBank
DB00741,Steroids,DrugBank
DB00741,Stomatological Preparations,DrugBank
DB00741,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00741,Vasoprotectives,DrugBank
DB00742,Agents causing hyperkalemia,DrugBank
DB00742,Alcohols,DrugBank
DB00742,Alimentary Tract and Metabolism,DrugBank
DB00742,Blood and Blood Forming Organs,DrugBank
DB00742,Blood Substitutes and Perfusion Solutions,DrugBank
DB00742,Carbohydrates,DrugBank
DB00742,"Compounds used in a research, industrial, or household setting",DrugBank
DB00742,Cough and Cold Preparations,DrugBank
DB00742,Diagnostic Agents,DrugBank
DB00742,"Diet, Food, and Nutrition",DrugBank
DB00742,Diuretics,DrugBank
DB00742,"Diuretics, Osmotic",DrugBank
DB00742,Drugs for Constipation,DrugBank
DB00742,Drugs that are Mainly Renally Excreted,DrugBank
DB00742,Expectorants,DrugBank
DB00742,Flavoring Agents,DrugBank
DB00742,Food,DrugBank
DB00742,Food Additives,DrugBank
DB00742,Food Ingredients,DrugBank
DB00742,Hypotensive Agents,DrugBank
DB00742,i.v. Solutions,DrugBank
DB00742,Increased Diuresis,DrugBank
DB00742,Irrigating Solutions,DrugBank
DB00742,Kidney Function,DrugBank
DB00742,Laxatives,DrugBank
DB00742,Natriuretic Agents,DrugBank
DB00742,Nephrotoxic agents,DrugBank
DB00742,Osmotic Activity,DrugBank
DB00742,Osmotic Laxatives,DrugBank
DB00742,P-glycoprotein substrates,DrugBank
DB00742,Physiological Phenomena,DrugBank
DB00742,Solutions Producing Osmotic Diuresis,DrugBank
DB00742,Sugar Alcohols,DrugBank
DB00742,Sweetening Agents,DrugBank
DB00743,Alcohols,DrugBank
DB00743,Amino Sugars,DrugBank
DB00743,Carbohydrates,DrugBank
DB00743,"Compounds used in a research, industrial, or household setting",DrugBank
DB00743,Contrast Media,DrugBank
DB00743,Diagnostic Uses of Chemicals,DrugBank
DB00743,Drugs that are Mainly Renally Excreted,DrugBank
DB00743,Gadolinium-based Contrast Agent,DrugBank
DB00743,Hexosamines,DrugBank
DB00743,Magnetic Resonance Contrast Activity,DrugBank
DB00743,Magnetic Resonance Imaging Contrast Media,DrugBank
DB00743,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00743,Other Diagnostics,DrugBank
DB00743,Paramagnetic Contrast Agent,DrugBank
DB00743,Paramagnetic Contrast Media,DrugBank
DB00743,QTc Prolonging Agents,DrugBank
DB00743,Sugar Alcohols,DrugBank
DB00744,Agents to Treat Airway Disease,DrugBank
DB00744,Amides,DrugBank
DB00744,Analgesics,DrugBank
DB00744,"Analgesics, Non-Narcotic",DrugBank
DB00744,Anti-Inflammatory Agents,DrugBank
DB00744,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00744,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00744,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00744,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00744,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00744,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00744,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00744,Cytochrome P-450 Substrates,DrugBank
DB00744,Decreased Leukotriene Production,DrugBank
DB00744,Enzyme Inhibitors,DrugBank
DB00744,Hormone Antagonists,DrugBank
DB00744,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00744,Leukotriene Antagonists,DrugBank
DB00744,Lipoxygenase Inhibitors,DrugBank
DB00744,Peripheral Nervous System Agents,DrugBank
DB00744,Sensory System Agents,DrugBank
DB00744,UGT1A9 Substrates,DrugBank
DB00745,Benzene Derivatives,DrugBank
DB00745,Benzhydryl Compounds,DrugBank
DB00745,Central Nervous System Agents,DrugBank
DB00745,Central Nervous System Stimulants,DrugBank
DB00745,Central Nervous System Stimulation,DrugBank
DB00745,Centrally Acting Sympathomimetics,DrugBank
DB00745,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00745,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00745,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00745,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00745,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00745,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00745,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00745,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00745,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00745,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00745,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB00745,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00745,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00745,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00745,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB00745,Cytochrome P-450 CYP3A5 Inducers (weak),DrugBank
DB00745,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00745,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00745,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00745,Cytochrome P-450 Substrates,DrugBank
DB00745,Increased Sympathetic Activity,DrugBank
DB00745,Nervous System,DrugBank
DB00745,Psychoanaleptics,DrugBank
DB00745,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB00745,Stimulants,DrugBank
DB00745,Sympathomimetic-like Agent,DrugBank
DB00745,Wakefulness-Promoting Agents,DrugBank
DB00746,Amines,DrugBank
DB00746,Chelating Agents,DrugBank
DB00746,"Compounds used in a research, industrial, or household setting",DrugBank
DB00746,Heavy Metal Antagonists,DrugBank
DB00746,Hydroxamic Acids,DrugBank
DB00746,Hydroxy Acids,DrugBank
DB00746,Hydroxylamines,DrugBank
DB00746,Iron Chelating Activity,DrugBank
DB00746,Iron Chelating Agents,DrugBank
DB00746,Sequestering Agents,DrugBank
DB00746,Siderophores,DrugBank
DB00747,Adjuvants,DrugBank
DB00747,"Adjuvants, Anesthesia",DrugBank
DB00747,Agents producing tachycardia,DrugBank
DB00747,Alimentary Tract and Metabolism,DrugBank
DB00747,Alkaloids,DrugBank
DB00747,Anticholinergic Agents,DrugBank
DB00747,Antiemetics,DrugBank
DB00747,Antiemetics and Antinauseants,DrugBank
DB00747,Antimuscarinics Antispasmodics,DrugBank
DB00747,Autonomic Agents,DrugBank
DB00747,Aza Compounds,DrugBank
DB00747,Azabicyclo Compounds,DrugBank
DB00747,Belladonna Alkaloids,DrugBank
DB00747,Central Nervous System Agents,DrugBank
DB00747,Central Nervous System Depressants,DrugBank
DB00747,Cholinergic Agents,DrugBank
DB00747,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00747,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00747,Cytochrome P-450 Substrates,DrugBank
DB00747,Gastrointestinal Agents,DrugBank
DB00747,Hypnotics and Sedatives,DrugBank
DB00747,Muscarinic Antagonists,DrugBank
DB00747,Mydriatics,DrugBank
DB00747,Mydriatics and Cycloplegics,DrugBank
DB00747,Nervous System,DrugBank
DB00747,Neurotransmitter Agents,DrugBank
DB00747,Ophthalmologicals,DrugBank
DB00747,Peripheral Nervous System Agents,DrugBank
DB00747,Psycholeptics,DrugBank
DB00747,Scopolamine Derivatives,DrugBank
DB00747,Sensory Organs,DrugBank
DB00747,Solanaceous Alkaloids,DrugBank
DB00747,Tropanes,DrugBank
DB00748,Aminoalkyl Ethers,DrugBank
DB00748,Antihistamines for Systemic Use,DrugBank
DB00748,Central Nervous System Depressants,DrugBank
DB00748,Drugs causing inadvertant photosensitivity,DrugBank
DB00748,Histamine Agents,DrugBank
DB00748,Histamine Antagonists,DrugBank
DB00748,Histamine H1 Antagonists,DrugBank
DB00748,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00748,Neurotransmitter Agents,DrugBank
DB00748,Photosensitizing Agents,DrugBank
DB00748,QTc Prolonging Agents,DrugBank
DB00749,Acetic Acid Derivatives and Related Substances,DrugBank
DB00749,Agents causing hyperkalemia,DrugBank
DB00749,Agents that produce hypertension,DrugBank
DB00749,Analgesics,DrugBank
DB00749,"Analgesics, Non-Narcotic",DrugBank
DB00749,Anti-Inflammatory Agents,DrugBank
DB00749,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00749,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00749,Antiinflammatory and Antirheumatic Products,DrugBank
DB00749,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00749,Antirheumatic Agents,DrugBank
DB00749,COX-2 Inhibitors,DrugBank
DB00749,Cyclooxygenase Inhibitors,DrugBank
DB00749,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00749,Cytochrome P-450 Substrates,DrugBank
DB00749,Drugs causing inadvertant photosensitivity,DrugBank
DB00749,Drugs that are Mainly Renally Excreted,DrugBank
DB00749,Enzyme Inhibitors,DrugBank
DB00749,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00749,Indoleacetic Acids,DrugBank
DB00749,Indoles,DrugBank
DB00749,Musculo-Skeletal System,DrugBank
DB00749,Nephrotoxic agents,DrugBank
DB00749,OAT1/SLC22A6 inhibitors,DrugBank
DB00749,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00749,Peripheral Nervous System Agents,DrugBank
DB00749,Photosensitizing Agents,DrugBank
DB00749,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00749,Sensory System Agents,DrugBank
DB00749,UGT1A3 substrates,DrugBank
DB00749,UGT1A9 Substrates,DrugBank
DB00749,UGT2B7 substrates,DrugBank
DB00750,Amides,DrugBank
DB00750,Amines,DrugBank
DB00750,Anesthetics,DrugBank
DB00750,"Anesthetics, Local",DrugBank
DB00750,Anilides,DrugBank
DB00750,Aniline Compounds,DrugBank
DB00750,Central Nervous System Agents,DrugBank
DB00750,Central Nervous System Depressants,DrugBank
DB00750,Local Anesthesia,DrugBank
DB00750,Local Anesthetics (Amide),DrugBank
DB00750,Methemoglobinemia Associated Agents,DrugBank
DB00750,Nervous System,DrugBank
DB00750,Peripheral Nervous System Agents,DrugBank
DB00750,Sensory System Agents,DrugBank
DB00751,Acid Reducers,DrugBank
DB00751,Antidepressive Agents,DrugBank
DB00751,Central Nervous System Depressants,DrugBank
DB00751,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00751,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00751,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00751,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00751,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00751,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00751,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00751,Cytochrome P-450 Substrates,DrugBank
DB00751,Decongestants and Antiallergics,DrugBank
DB00751,Decreased Histamine Release,DrugBank
DB00751,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00751,Histamine Agents,DrugBank
DB00751,Histamine Antagonists,DrugBank
DB00751,Histamine H1 Antagonists,DrugBank
DB00751,Histamine H1 Inhibitors,DrugBank
DB00751,Histamine H2 Antagonists,DrugBank
DB00751,Neurotransmitter Agents,DrugBank
DB00751,Ophthalmics,DrugBank
DB00751,Ophthalmologicals,DrugBank
DB00751,P-glycoprotein substrates,DrugBank
DB00751,Potential QTc-Prolonging Agents,DrugBank
DB00751,QTc Prolonging Agents,DrugBank
DB00751,Sensory Organs,DrugBank
DB00751,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00751,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00751,Serotonin Agents,DrugBank
DB00751,Serotonin Receptor Antagonists,DrugBank
DB00752,Agents that produce hypertension,DrugBank
DB00752,Agents that reduce seizure threshold,DrugBank
DB00752,Amines,DrugBank
DB00752,Anti-Anxiety Agents,DrugBank
DB00752,Antidepressive Agents,DrugBank
DB00752,Antidepressive Agents Indicated for Depression,DrugBank
DB00752,Central Nervous System Agents,DrugBank
DB00752,Central Nervous System Depressants,DrugBank
DB00752,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00752,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP2A6 Inhibitors (strong),DrugBank
DB00752,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00752,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00752,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00752,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00752,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00752,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00752,Enzyme Inhibitors,DrugBank
DB00752,Hypotensive Agents,DrugBank
DB00752,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00752,Monoamine Oxidase Inhibitors,DrugBank
DB00752,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB00752,Nervous System,DrugBank
DB00752,Propylamines,DrugBank
DB00752,Psychoanaleptics,DrugBank
DB00752,Psychotropic Drugs,DrugBank
DB00752,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00752,Serotonin Agents,DrugBank
DB00752,Serotonin Modulators,DrugBank
DB00752,Tranquilizing Agents,DrugBank
DB00753,Agents that produce hypertension,DrugBank
DB00753,Agents that reduce seizure threshold,DrugBank
DB00753,Anesthetics,DrugBank
DB00753,"Anesthetics, General",DrugBank
DB00753,"Anesthetics, Inhalation",DrugBank
DB00753,Anticholinergic Agents,DrugBank
DB00753,Central Nervous System Agents,DrugBank
DB00753,Central Nervous System Depressants,DrugBank
DB00753,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00753,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00753,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00753,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00753,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00753,Cytochrome P-450 Substrates,DrugBank
DB00753,Ethers,DrugBank
DB00753,"Hydrocarbons, Halogenated",DrugBank
DB00753,Hypotensive Agents,DrugBank
DB00753,Methyl Ethers,DrugBank
DB00753,Nervous System,DrugBank
DB00753,Nicotinic Antagonists,DrugBank
DB00753,Potential QTc-Prolonging Agents,DrugBank
DB00753,QTc Prolonging Agents,DrugBank
DB00754,Anti-epileptic Agent,DrugBank
DB00754,Anticonvulsants,DrugBank
DB00754,Cardiovascular Agents,DrugBank
DB00754,Central Nervous System Agents,DrugBank
DB00754,Central Nervous System Depressants,DrugBank
DB00754,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00754,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00754,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00754,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00754,Hydantoins,DrugBank
DB00754,Imidazoles,DrugBank
DB00754,Imidazolidines,DrugBank
DB00754,Membrane Transport Modulators,DrugBank
DB00754,Nervous System,DrugBank
DB00754,Sodium Channel Blockers,DrugBank
DB00754,Thyroxine-binding globulin substrates,DrugBank
DB00754,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00755,Agents that produce hypertension,DrugBank
DB00755,Alkenes,DrugBank
DB00755,Anti-Acne Preparations,DrugBank
DB00755,Anti-Acne Preparations for Topical Use,DrugBank
DB00755,Antineoplastic Agents,DrugBank
DB00755,Antineoplastic and Immunomodulating Agents,DrugBank
DB00755,Biological Factors,DrugBank
DB00755,Cardiotoxic antineoplastic agents,DrugBank
DB00755,Carotenoids,DrugBank
DB00755,Cell Stimulants and Proliferants,DrugBank
DB00755,Cyclohexanes,DrugBank
DB00755,Cyclohexenes,DrugBank
DB00755,Cycloparaffins,DrugBank
DB00755,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00755,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00755,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00755,Cytochrome P-450 Substrates,DrugBank
DB00755,Dermatologicals,DrugBank
DB00755,Diterpenes,DrugBank
DB00755,"Hydrocarbons, Acyclic",DrugBank
DB00755,Hypotensive Agents,DrugBank
DB00755,Immunosuppressive Agents,DrugBank
DB00755,Keratolytic Agents,DrugBank
DB00755,"Pigments, Biological",DrugBank
DB00755,Polyenes,DrugBank
DB00755,Retinoids,DrugBank
DB00755,Retinoids for cancer treatment,DrugBank
DB00755,Retinoids for Topical Use in Acne,DrugBank
DB00755,Terpenes,DrugBank
DB00755,UGT2B7 substrates,DrugBank
DB00755,Vitamin A,DrugBank
DB00755,Vitamins,DrugBank
DB00755,Vitamins (Fat Soluble),DrugBank
DB00757,Alimentary Tract and Metabolism,DrugBank
DB00757,Antidepressive Agents,DrugBank
DB00757,Antiemetic Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00757,Antiemetics,DrugBank
DB00757,Antiemetics and Antinauseants,DrugBank
DB00757,Autonomic Agents,DrugBank
DB00757,Central Nervous System Agents,DrugBank
DB00757,Central Nervous System Depressants,DrugBank
DB00757,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00757,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00757,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00757,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00757,Cytochrome P-450 Substrates,DrugBank
DB00757,Gastrointestinal Agents,DrugBank
DB00757,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00757,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00757,Neurotransmitter Agents,DrugBank
DB00757,Peripheral Nervous System Agents,DrugBank
DB00757,QTc Prolonging Agents,DrugBank
DB00757,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00757,Serotonin 3 Receptor Antagonists,DrugBank
DB00757,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00757,Serotonin Agents,DrugBank
DB00757,Serotonin Receptor Antagonists,DrugBank
DB00758,Antiplatelet agents,DrugBank
DB00758,Blood and Blood Forming Organs,DrugBank
DB00758,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00758,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00758,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB00758,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00758,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00758,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00758,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00758,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00758,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00758,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00758,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00758,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00758,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00758,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00758,Cytochrome P-450 Substrates,DrugBank
DB00758,Decreased Platelet Aggregation,DrugBank
DB00758,Hematologic Agents,DrugBank
DB00758,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00758,Neurotransmitter Agents,DrugBank
DB00758,OCT1 inhibitors,DrugBank
DB00758,OCT2 Inhibitors,DrugBank
DB00758,P-glycoprotein substrates,DrugBank
DB00758,P2Y12 Platelet Inhibitor,DrugBank
DB00758,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00758,Purinergic Agents,DrugBank
DB00758,Purinergic Antagonists,DrugBank
DB00758,Purinergic P2 Receptor Antagonists,DrugBank
DB00758,Purinergic P2Y Receptor Antagonists,DrugBank
DB00758,Pyridines,DrugBank
DB00758,Sulfur Compounds,DrugBank
DB00758,Thienopyridines,DrugBank
DB00758,Thiophenes,DrugBank
DB00759,Agents that produce neuromuscular block (indirect),DrugBank
DB00759,Alimentary Tract and Metabolism,DrugBank
DB00759,Anti-Bacterial Agents,DrugBank
DB00759,Anti-Infective Agents,DrugBank
DB00759,Antibacterials for Systemic Use,DrugBank
DB00759,Antibiotics for Topical Use,DrugBank
DB00759,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00759,Antiinfectives for Systemic Use,DrugBank
DB00759,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00759,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00759,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00759,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00759,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00759,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00759,Cytochrome P-450 Substrates,DrugBank
DB00759,Dermatologicals,DrugBank
DB00759,Drugs causing inadvertant photosensitivity,DrugBank
DB00759,Drugs for Acid Related Disorders,DrugBank
DB00759,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00759,Drugs that are Mainly Renally Excreted,DrugBank
DB00759,Enzyme Inhibitors,DrugBank
DB00759,Naphthacenes,DrugBank
DB00759,OAT1/SLC22A6 inhibitors,DrugBank
DB00759,OAT3/SLC22A8 Inhibitors,DrugBank
DB00759,OAT3/SLC22A8 Substrates,DrugBank
DB00759,Ophthalmological and Otological Preparations,DrugBank
DB00759,Ophthalmologicals,DrugBank
DB00759,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00759,Otologicals,DrugBank
DB00759,Photosensitizing Agents,DrugBank
DB00759,Protein Synthesis Inhibitors,DrugBank
DB00759,Sensory Organs,DrugBank
DB00759,Stomatological Preparations,DrugBank
DB00759,"Tetracycline, antagonists & inhibitors",DrugBank
DB00759,Tetracyclines,DrugBank
DB00760,Amides,DrugBank
DB00760,Anti-Bacterial Agents,DrugBank
DB00760,Anti-Infective Agents,DrugBank
DB00760,Antibacterials for Systemic Use,DrugBank
DB00760,Antiinfectives for Systemic Use,DrugBank
DB00760,beta-Lactams,DrugBank
DB00760,Carbapenems,DrugBank
DB00760,Drugs that are Mainly Renally Excreted,DrugBank
DB00760,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00760,Lactams,DrugBank
DB00760,Penem Antibacterial,DrugBank
DB00760,Sulfur Compounds,DrugBank
DB00760,Thienamycins,DrugBank
DB00761,Agents causing hyperkalemia,DrugBank
DB00761,Alimentary Tract and Metabolism,DrugBank
DB00761,Blood and Blood Forming Organs,DrugBank
DB00761,Blood Substitutes and Perfusion Solutions,DrugBank
DB00761,Chlorides,DrugBank
DB00761,Chlorine Compounds,DrugBank
DB00761,Drugs that are Mainly Renally Excreted,DrugBank
DB00761,Electrolyte Solutions,DrugBank
DB00761,Hemodialysis Solution,DrugBank
DB00761,I.V. Solution Additives,DrugBank
DB00761,Mineral Supplements,DrugBank
DB00761,Minerals,DrugBank
DB00761,Potassium Compounds,DrugBank
DB00761,Potassium Salt,DrugBank
DB00761,Replacement Preparations,DrugBank
DB00762,Alkaloids,DrugBank
DB00762,Antineoplastic Agents,DrugBank
DB00762,Antineoplastic and Immunomodulating Agents,DrugBank
DB00762,BCRP/ABCG2 Substrates,DrugBank
DB00762,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00762,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00762,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00762,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00762,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00762,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00762,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00762,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00762,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00762,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00762,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00762,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00762,Cytochrome P-450 Substrates,DrugBank
DB00762,Cytotoxins,DrugBank
DB00762,Enzyme Inhibitors,DrugBank
DB00762,Immunosuppressive Agents,DrugBank
DB00762,Myelosuppressive Agents,DrugBank
DB00762,Narrow Therapeutic Index Drugs,DrugBank
DB00762,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00762,P-glycoprotein substrates,DrugBank
DB00762,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00762,Pharmaceutical Preparations,DrugBank
DB00762,Topoisomerase 1 (TOP1) inhibitors,DrugBank
DB00762,Topoisomerase I Inhibitors,DrugBank
DB00762,Topoisomerase Inhibitors,DrugBank
DB00762,UGT1A1 Substrates,DrugBank
DB00762,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00762,UGT1A9 Substrates,DrugBank
DB00762,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00763,Antithyroid agents,DrugBank
DB00763,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00763,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB00763,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB00763,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00763,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00763,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00763,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00763,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB00763,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00763,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00763,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00763,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00763,Drugs that are Mainly Renally Excreted,DrugBank
DB00763,Hormone Antagonists,DrugBank
DB00763,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00763,Imidazoles,DrugBank
DB00763,Immunosuppressive Agents,DrugBank
DB00763,Myelosuppressive Agents,DrugBank
DB00763,Sulfur Compounds,DrugBank
DB00763,Sulfur-Containing Imidazole Derivatives,DrugBank
DB00763,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00763,Thyroid Hormone Synthesis Inhibitor,DrugBank
DB00763,Thyroid Hormone Synthesis Inhibitors,DrugBank
DB00763,Thyroid Products,DrugBank
DB00764,Adrenal Cortex Hormones,DrugBank
DB00764,Adrenals,DrugBank
DB00764,Anti-Allergic Agents,DrugBank
DB00764,Anti-Inflammatory Agents,DrugBank
DB00764,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00764,Corticosteroids,DrugBank
DB00764,"Corticosteroids, Dermatological Preparations",DrugBank
DB00764,"Corticosteroids, Potent (Group III)",DrugBank
DB00764,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00764,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00764,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00764,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00764,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00764,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00764,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00764,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00764,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00764,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00764,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00764,Cytochrome P-450 Substrates,DrugBank
DB00764,Dermatologicals,DrugBank
DB00764,Drugs for Obstructive Airway Diseases,DrugBank
DB00764,Fused-Ring Compounds,DrugBank
DB00764,Glucocorticoids,DrugBank
DB00764,Hyperglycemia-Associated Agents,DrugBank
DB00764,Immunosuppressive Agents,DrugBank
DB00764,Nasal Preparations,DrugBank
DB00764,Pregnadienediols,DrugBank
DB00764,Pregnadienes,DrugBank
DB00764,Pregnanes,DrugBank
DB00764,Steroids,DrugBank
DB00764,Thyroxine-binding globulin inhibitors,DrugBank
DB00765,Amino Acids,DrugBank
DB00765,"Amino Acids, Aromatic",DrugBank
DB00765,"Amino Acids, Cyclic",DrugBank
DB00765,"Amino Acids, Peptides, and Proteins",DrugBank
DB00765,Antihypertensive Agents,DrugBank
DB00765,Catecholamine Synthesis Inhibitor,DrugBank
DB00765,Enzyme Inhibitors,DrugBank
DB00765,Methyltyrosines,DrugBank
DB00765,Tyrosine Hydroxylase Inhibitors,DrugBank
DB00766,Anti-Bacterial Agents,DrugBank
DB00766,Anti-Infective Agents,DrugBank
DB00766,beta-Lactamase Inhibitors,DrugBank
DB00766,beta-Lactams,DrugBank
DB00766,Enzyme Inhibitors,DrugBank
DB00766,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00766,Lactams,DrugBank
DB00767,Agents producing tachycardia,DrugBank
DB00767,Anticholinergic Agents,DrugBank
DB00767,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00767,Histamine Antagonists,DrugBank
DB00767,Histamine H1 Antagonists,DrugBank
DB00767,Muscarinic Antagonists,DrugBank
DB00767,P-glycoprotein inhibitors,DrugBank
DB00769,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00769,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00769,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00769,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00770,Autacoids,DrugBank
DB00770,Biological Factors,DrugBank
DB00770,Cardiac Therapy,DrugBank
DB00770,Cardiovascular Agents,DrugBank
DB00770,Drugs Used in Erectile Dysfunction,DrugBank
DB00770,Eicosanoids,DrugBank
DB00770,Fatty Acids,DrugBank
DB00770,"Fatty Acids, Monounsaturated",DrugBank
DB00770,"Fatty Acids, Unsaturated",DrugBank
DB00770,Genito Urinary System and Sex Hormones,DrugBank
DB00770,Genitourinary Agents,DrugBank
DB00770,Genitourinary Arterial Vasodilation,DrugBank
DB00770,Hematologic Agents,DrugBank
DB00770,Inflammation Mediators,DrugBank
DB00770,Lipids,DrugBank
DB00770,Miscellaneous Vasodilatating Agents,DrugBank
DB00770,OAT1/SLC22A6 inhibitors,DrugBank
DB00770,OAT1/SLC22A6 Substrates,DrugBank
DB00770,OAT3/SLC22A8 Substrates,DrugBank
DB00770,OATP2B1/SLCO2B1 substrates,DrugBank
DB00770,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00770,Prostaglandin E1 Agonist,DrugBank
DB00770,Prostaglandin Receptor Agonists,DrugBank
DB00770,Prostaglandins,DrugBank
DB00770,Prostaglandins E,DrugBank
DB00770,"Prostaglandins, Synthetic",DrugBank
DB00770,Urological Agents,DrugBank
DB00770,Urologicals,DrugBank
DB00770,Vasodilating Agents,DrugBank
DB00770,Venous Vasodilation,DrugBank
DB00771,"Acids, Carbocyclic",DrugBank
DB00771,Agents producing tachycardia,DrugBank
DB00771,Alimentary Tract and Metabolism,DrugBank
DB00771,Anticholinergic Agents,DrugBank
DB00771,Autonomic Agents,DrugBank
DB00771,Benzilates,DrugBank
DB00771,Central Nervous System Depressants,DrugBank
DB00771,Decreased Parasympathetic Acetylcholine Activity,DrugBank
DB00771,Digestive/GI System Activity Alteration,DrugBank
DB00771,Diphenylacetic Acids,DrugBank
DB00771,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00771,GI Motility Alteration,DrugBank
DB00771,Hydroxy Acids,DrugBank
DB00771,Muscarinic Antagonists,DrugBank
DB00771,Parasympatholytics,DrugBank
DB00771,Peripheral Nervous System Agents,DrugBank
DB00771,Phenylacetates,DrugBank
DB00771,Quinuclidines,DrugBank
DB00772,Agrochemicals,DrugBank
DB00772,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00772,Cholinergic Agents,DrugBank
DB00772,Cholinesterase Inhibitors,DrugBank
DB00772,"Compounds used in a research, industrial, or household setting",DrugBank
DB00772,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00772,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00772,Cytochrome P-450 Substrates,DrugBank
DB00772,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB00772,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB00772,Enzyme Inhibitors,DrugBank
DB00772,Insecticides,DrugBank
DB00772,Neurotransmitter Agents,DrugBank
DB00772,Organophosphates,DrugBank
DB00772,Organophosphorus Compounds,DrugBank
DB00772,Organothiophosphates,DrugBank
DB00772,Organothiophosphorus Compounds,DrugBank
DB00772,Pesticides,DrugBank
DB00772,Potential QTc-Prolonging Agents,DrugBank
DB00772,QTc Prolonging Agents,DrugBank
DB00772,Sulfur Compounds,DrugBank
DB00772,Toxic Actions,DrugBank
DB00773,Antineoplastic Agents,DrugBank
DB00773,"Antineoplastic Agents, Phytogenic",DrugBank
DB00773,Antineoplastic and Immunomodulating Agents,DrugBank
DB00773,BCRP/ABCG2 Substrates,DrugBank
DB00773,Carbohydrates,DrugBank
DB00773,Cardiotoxic antineoplastic agents,DrugBank
DB00773,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00773,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00773,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00773,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00773,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00773,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00773,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00773,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00773,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00773,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00773,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00773,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00773,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00773,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00773,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00773,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00773,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00773,Cytochrome P-450 Substrates,DrugBank
DB00773,Cytotoxins,DrugBank
DB00773,Enzyme Inhibitors,DrugBank
DB00773,Glucosides,DrugBank
DB00773,Glycosides,DrugBank
DB00773,Immunosuppressive Agents,DrugBank
DB00773,Myelosuppressive Agents,DrugBank
DB00773,Naphthalenes,DrugBank
DB00773,Narrow Therapeutic Index Drugs,DrugBank
DB00773,P-glycoprotein inhibitors,DrugBank
DB00773,P-glycoprotein substrates,DrugBank
DB00773,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00773,Podophyllotoxin,DrugBank
DB00773,Podophyllotoxin Derivatives,DrugBank
DB00773,Tetrahydronaphthalenes,DrugBank
DB00773,Topoisomerase II Inhibitors,DrugBank
DB00773,Topoisomerase Inhibitors,DrugBank
DB00773,UGT1A1 Substrates,DrugBank
DB00773,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00774,Amides,DrugBank
DB00774,Antihypertensive Agents,DrugBank
DB00774,Benzothiadiazines,DrugBank
DB00774,Cardiovascular Agents,DrugBank
DB00774,Diuretics,DrugBank
DB00774,Drugs causing inadvertant photosensitivity,DrugBank
DB00774,Genito Urinary System and Sex Hormones,DrugBank
DB00774,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00774,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00774,Hypotensive Agents,DrugBank
DB00774,Increased Diuresis,DrugBank
DB00774,Membrane Transport Modulators,DrugBank
DB00774,Natriuretic Agents,DrugBank
DB00774,OAT1/SLC22A6 inhibitors,DrugBank
DB00774,OAT3/SLC22A8 Inhibitors,DrugBank
DB00774,OAT3/SLC22A8 Substrates,DrugBank
DB00774,Photosensitizing Agents,DrugBank
DB00774,Sodium Chloride Symporter Inhibitors,DrugBank
DB00774,Sulfonamides,DrugBank
DB00774,Sulfones,DrugBank
DB00774,Sulfur Compounds,DrugBank
DB00774,Thiazides,DrugBank
DB00775,Amino Acids,DrugBank
DB00775,"Amino Acids, Aromatic",DrugBank
DB00775,"Amino Acids, Cyclic",DrugBank
DB00775,"Amino Acids, Peptides, and Proteins",DrugBank
DB00775,Antiplatelet agents,DrugBank
DB00775,Blood and Blood Forming Organs,DrugBank
DB00775,Cardiovascular Agents,DrugBank
DB00775,Decreased Platelet Aggregation,DrugBank
DB00775,Drugs that are Mainly Renally Excreted,DrugBank
DB00775,Fibrin Modulating Agents,DrugBank
DB00775,Hematologic Agents,DrugBank
DB00775,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00776,Anti-epileptic Agent,DrugBank
DB00776,Anticonvulsants,DrugBank
DB00776,Carboxamide Derivatives,DrugBank
DB00776,Central Nervous System Agents,DrugBank
DB00776,Central Nervous System Depressants,DrugBank
DB00776,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00776,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00776,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00776,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00776,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00776,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00776,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00776,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00776,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00776,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00776,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00776,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00776,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00776,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00776,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00776,Dibenzazepines,DrugBank
DB00776,Drugs causing inadvertant photosensitivity,DrugBank
DB00776,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB00776,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00776,Membrane Transport Modulators,DrugBank
DB00776,Miscellaneous Anticonvulsants,DrugBank
DB00776,Nervous System,DrugBank
DB00776,P-glycoprotein inducers,DrugBank
DB00776,P-glycoprotein substrates,DrugBank
DB00776,Photosensitizing Agents,DrugBank
DB00776,Sodium Channel Blockers,DrugBank
DB00776,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00777,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00777,Adrenergic alpha-Antagonists,DrugBank
DB00777,Adrenergic Antagonists,DrugBank
DB00777,Agents producing tachycardia,DrugBank
DB00777,Agents that produce hypertension,DrugBank
DB00777,Anticholinergic Agents,DrugBank
DB00777,Antidepressive Agents,DrugBank
DB00777,Central Nervous System Depressants,DrugBank
DB00777,Dopamine Antagonists,DrugBank
DB00777,Dopamine D2 Receptor Antagonists,DrugBank
DB00777,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00777,Histamine Antagonists,DrugBank
DB00777,Histamine H1 Antagonists,DrugBank
DB00777,Hypnotics and Sedatives,DrugBank
DB00777,Muscarinic Antagonists,DrugBank
DB00777,Nervous System,DrugBank
DB00777,Psycholeptics,DrugBank
DB00777,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00777,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00777,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00777,Serotonin Agents,DrugBank
DB00777,Serotonin Receptor Antagonists,DrugBank
DB00777,Sulfur Compounds,DrugBank
DB00778,Anti-Bacterial Agents,DrugBank
DB00778,Anti-Infective Agents,DrugBank
DB00778,Antibacterials for Systemic Use,DrugBank
DB00778,Antiinfectives for Systemic Use,DrugBank
DB00778,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00778,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00778,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00778,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00778,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00778,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00778,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00778,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00778,Cytochrome P-450 Substrates,DrugBank
DB00778,Erythromycin and similars,DrugBank
DB00778,Lactones,DrugBank
DB00778,Macrolides,DrugBank
DB00778,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB00778,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00778,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00778,OATP1B3 inhibitors,DrugBank
DB00778,Polyketides,DrugBank
DB00778,QTc Prolonging Agents,DrugBank
DB00779,4-Quinolones,DrugBank
DB00779,Agents that reduce seizure threshold,DrugBank
DB00779,Anti-Bacterial Agents,DrugBank
DB00779,Anti-Infective Agents,DrugBank
DB00779,Antibacterials for Systemic Use,DrugBank
DB00779,Antiinfectives for Systemic Use,DrugBank
DB00779,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00779,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00779,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00779,Drugs causing inadvertant photosensitivity,DrugBank
DB00779,Enzyme Inhibitors,DrugBank
DB00779,Fluoroquinolones,DrugBank
DB00779,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00779,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00779,Naphthyridines,DrugBank
DB00779,OAT1/SLC22A6 inhibitors,DrugBank
DB00779,Photosensitizing Agents,DrugBank
DB00779,QTc Prolonging Agents,DrugBank
DB00779,Quinolines,DrugBank
DB00779,Quinolones,DrugBank
DB00779,Topoisomerase II Inhibitors,DrugBank
DB00779,Topoisomerase Inhibitors,DrugBank
DB00780,Agents that produce hypertension,DrugBank
DB00780,Agents that reduce seizure threshold,DrugBank
DB00780,Antidepressive Agents,DrugBank
DB00780,Antidepressive Agents Indicated for Depression,DrugBank
DB00780,Central Nervous System Agents,DrugBank
DB00780,Central Nervous System Depressants,DrugBank
DB00780,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00780,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00780,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00780,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00780,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00780,Drugs that are Mainly Renally Excreted,DrugBank
DB00780,Enzyme Inhibitors,DrugBank
DB00780,Hydrazines,DrugBank
DB00780,Hypotensive Agents,DrugBank
DB00780,Monoamine Oxidase A Substrates,DrugBank
DB00780,Monoamine Oxidase Inhibitors,DrugBank
DB00780,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB00780,Nervous System,DrugBank
DB00780,Psychoanaleptics,DrugBank
DB00780,Psychotropic Drugs,DrugBank
DB00780,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00780,Serotonin Agents,DrugBank
DB00780,Serotonin Modulators,DrugBank
DB00782,Agents producing tachycardia,DrugBank
DB00782,Alimentary Tract and Metabolism,DrugBank
DB00782,Amines,DrugBank
DB00782,Anti-Ulcer Agents,DrugBank
DB00782,Anticholinergic Agents,DrugBank
DB00782,Cholinergic Agents,DrugBank
DB00782,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00782,Drugs that are Mainly Renally Excreted,DrugBank
DB00782,Gastrointestinal Agents,DrugBank
DB00782,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00782,Muscarinic Antagonists,DrugBank
DB00782,Neurotransmitter Agents,DrugBank
DB00782,Onium Compounds,DrugBank
DB00782,Quaternary Ammonium Compounds,DrugBank
DB00782,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB00782,Xanthenes,DrugBank
DB00783,Adrenal Cortex Hormones,DrugBank
DB00783,Androgens and Estrogens,DrugBank
DB00783,Anti-Gonadotropin-Releasing Hormones,DrugBank
DB00783,Antiandrogens and Estrogens,DrugBank
DB00783,BCRP/ABCG2 Inhibitors,DrugBank
DB00783,COMT Substrates,DrugBank
DB00783,"Contraceptive Agents, Female",DrugBank
DB00783,"Contraceptives, Oral",DrugBank
DB00783,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00783,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00783,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00783,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00783,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00783,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00783,Cytochrome P-450 Substrates,DrugBank
DB00783,Drugs that are Mainly Renally Excreted,DrugBank
DB00783,Estradiol Congeners,DrugBank
DB00783,"Estradiol, agonists",DrugBank
DB00783,Estranes,DrugBank
DB00783,Estrenes,DrugBank
DB00783,Estrogen Contraceptives,DrugBank
DB00783,Estrogens,DrugBank
DB00783,"Estrogens, agonists",DrugBank
DB00783,Fused-Ring Compounds,DrugBank
DB00783,Genito Urinary System and Sex Hormones,DrugBank
DB00783,Gonadal Hormones,DrugBank
DB00783,Gonadal Steroid Hormones,DrugBank
DB00783,Hormonal Contraceptives for Systemic Use,DrugBank
DB00783,Hormones,DrugBank
DB00783,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00783,Hyperglycemia-Associated Agents,DrugBank
DB00783,Hypothalamic Hormones,DrugBank
DB00783,Intravaginal Contraceptives,DrugBank
DB00783,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB00783,OAT3/SLC22A8 Substrates,DrugBank
DB00783,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00783,OCT2 Inhibitors,DrugBank
DB00783,P-glycoprotein substrates,DrugBank
DB00783,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB00783,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00783,Sex Hormones and Modulators of the Genital System,DrugBank
DB00783,Steroids,DrugBank
DB00783,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00783,Thyroxine-binding globulin inducers,DrugBank
DB00783,UGT1A1 Substrates,DrugBank
DB00784,"Acids, Carbocyclic",DrugBank
DB00784,Agents causing hyperkalemia,DrugBank
DB00784,Agents that produce hypertension,DrugBank
DB00784,Amines,DrugBank
DB00784,Aminobenzoates,DrugBank
DB00784,Analgesics,DrugBank
DB00784,"Analgesics, Non-Narcotic",DrugBank
DB00784,Aniline Compounds,DrugBank
DB00784,Anti-Inflammatory Agents,DrugBank
DB00784,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00784,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00784,Antiinflammatory and Antirheumatic Products,DrugBank
DB00784,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00784,Antirheumatic Agents,DrugBank
DB00784,Benzene Derivatives,DrugBank
DB00784,Benzoates,DrugBank
DB00784,Central Nervous System Agents,DrugBank
DB00784,Cyclooxygenase Inhibitors,DrugBank
DB00784,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00784,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00784,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00784,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00784,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00784,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00784,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00784,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00784,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00784,Cytochrome P-450 Substrates,DrugBank
DB00784,Drugs causing inadvertant photosensitivity,DrugBank
DB00784,Enzyme Inhibitors,DrugBank
DB00784,Fenamates,DrugBank
DB00784,Musculo-Skeletal System,DrugBank
DB00784,Nephrotoxic agents,DrugBank
DB00784,ortho-Aminobenzoates,DrugBank
DB00784,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00784,Peripheral Nervous System Agents,DrugBank
DB00784,Photosensitizing Agents,DrugBank
DB00784,Sensory System Agents,DrugBank
DB00784,UGT1A9 Inhibitors,DrugBank
DB00784,UGT2B7 Inhibitors,DrugBank
DB00785,Alkaloids,DrugBank
DB00785,Antihypertensive Agents,DrugBank
DB00785,Cardiovascular Agents,DrugBank
DB00785,Cevanes,DrugBank
DB00785,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00785,Veratrum Alkaloids,DrugBank
DB00787,Acyclovir and prodrug,DrugBank
DB00787,Anti-Infective Agents,DrugBank
DB00787,Antiinfectives for Systemic Use,DrugBank
DB00787,Antiviral Agents,DrugBank
DB00787,Antivirals for Systemic Use,DrugBank
DB00787,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00787,Cytochrome P-450 Substrates,DrugBank
DB00787,Dermatologicals,DrugBank
DB00787,Direct Acting Antivirals,DrugBank
DB00787,Drugs that are Mainly Renally Excreted,DrugBank
DB00787,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00787,Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00787,Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB00787,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00787,MATE 1 Substrates,DrugBank
DB00787,MATE 2 Substrates,DrugBank
DB00787,MATE substrates,DrugBank
DB00787,Nephrotoxic agents,DrugBank
DB00787,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00787,Nucleosides and Nucleotides,DrugBank
DB00787,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB00787,OAT1/SLC22A6 inhibitors,DrugBank
DB00787,OAT1/SLC22A6 Substrates,DrugBank
DB00787,OAT3/SLC22A8 Inhibitors,DrugBank
DB00787,OAT3/SLC22A8 Substrates,DrugBank
DB00787,OCT1 inhibitors,DrugBank
DB00787,OCT1 substrates,DrugBank
DB00787,Ophthalmologicals,DrugBank
DB00787,Purines,DrugBank
DB00787,Purinones,DrugBank
DB00787,Sensory Organs,DrugBank
DB00788,Agents causing hyperkalemia,DrugBank
DB00788,Agents that produce hypertension,DrugBank
DB00788,Analgesics,DrugBank
DB00788,"Analgesics, Non-Narcotic",DrugBank
DB00788,Anti-Inflammatory Agents,DrugBank
DB00788,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00788,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00788,Antigout Preparations,DrugBank
DB00788,Antiinflammatory and Antirheumatic Products,DrugBank
DB00788,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00788,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00788,Antiinflammatory Products for Vaginal Administration,DrugBank
DB00788,Antimigraine Preparations,DrugBank
DB00788,Antirheumatic Agents,DrugBank
DB00788,Arylpropionic acid NSAIDS,DrugBank
DB00788,BSEP/ABCB11 Substrates,DrugBank
DB00788,Central Nervous System Agents,DrugBank
DB00788,Cyclooxygenase Inhibitors,DrugBank
DB00788,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00788,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00788,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00788,Cytochrome P-450 Substrates,DrugBank
DB00788,Drugs causing inadvertant photosensitivity,DrugBank
DB00788,Enzyme Inhibitors,DrugBank
DB00788,Genito Urinary System and Sex Hormones,DrugBank
DB00788,Musculo-Skeletal System,DrugBank
DB00788,Naphthaleneacetic Acids,DrugBank
DB00788,Naphthalenes,DrugBank
DB00788,Nephrotoxic agents,DrugBank
DB00788,Nervous System,DrugBank
DB00788,Non COX-2 selective NSAIDS,DrugBank
DB00788,OAT1/SLC22A6 inhibitors,DrugBank
DB00788,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00788,P-glycoprotein inhibitors,DrugBank
DB00788,Peripheral Nervous System Agents,DrugBank
DB00788,Photosensitizing Agents,DrugBank
DB00788,Propionates,DrugBank
DB00788,Sensory System Agents,DrugBank
DB00788,Topical Products for Joint and Muscular Pain,DrugBank
DB00788,UGT1A1 Substrates,DrugBank
DB00788,UGT1A3 substrates,DrugBank
DB00788,UGT1A6 substrate,DrugBank
DB00788,UGT1A9 Substrates,DrugBank
DB00788,UGT2B7 substrates,DrugBank
DB00789,Acetates,DrugBank
DB00789,"Acids, Acyclic",DrugBank
DB00789,Amines,DrugBank
DB00789,"Compounds used in a research, industrial, or household setting",DrugBank
DB00789,Contrast Media,DrugBank
DB00789,Coordination Complexes,DrugBank
DB00789,Diagnostic Uses of Chemicals,DrugBank
DB00789,Drugs that are Mainly Renally Excreted,DrugBank
DB00789,Magnetic Resonance Contrast Activity,DrugBank
DB00789,Magnetic Resonance Imaging Contrast Media,DrugBank
DB00789,Miscellaneous Therapeutic Agents,DrugBank
DB00789,Other Diagnostics,DrugBank
DB00789,Paramagnetic Contrast Agent,DrugBank
DB00789,Paramagnetic Contrast Media,DrugBank
DB00789,Polyamines,DrugBank
DB00790,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB00790,ACE Inhibitors and Diuretics,DrugBank
DB00790,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00790,Agents causing angioedema,DrugBank
DB00790,Agents causing hyperkalemia,DrugBank
DB00790,Alkanes,DrugBank
DB00790,Amines,DrugBank
DB00790,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00790,Antihypertensive Agents,DrugBank
DB00790,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00790,Butanes,DrugBank
DB00790,Cardiovascular Agents,DrugBank
DB00790,Cholinesterase Inhibitors,DrugBank
DB00790,Drugs that are Mainly Renally Excreted,DrugBank
DB00790,Enzyme Inhibitors,DrugBank
DB00790,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00790,"Hydrocarbons, Acyclic",DrugBank
DB00790,Hypotensive Agents,DrugBank
DB00790,Indoles,DrugBank
DB00790,Lipid Modifying Agents,DrugBank
DB00790,Protease Inhibitors,DrugBank
DB00791,Alkylating Drugs,DrugBank
DB00791,Antineoplastic Agents,DrugBank
DB00791,"Antineoplastic Agents, Alkylating",DrugBank
DB00791,Antineoplastic and Immunomodulating Agents,DrugBank
DB00791,"Hydrocarbons, Halogenated",DrugBank
DB00791,Mustard Compounds,DrugBank
DB00791,Narrow Therapeutic Index Drugs,DrugBank
DB00791,Nitrogen Mustard Compounds,DrugBank
DB00791,Nitrosoureas,DrugBank
DB00791,Noxae,DrugBank
DB00791,Pyrimidines,DrugBank
DB00791,Pyrimidinones,DrugBank
DB00791,Toxic Actions,DrugBank
DB00792,Amines,DrugBank
DB00792,Aminopyridines,DrugBank
DB00792,Anti-Allergic Agents,DrugBank
DB00792,Antihistamines for Systemic Use,DrugBank
DB00792,Antihistamines for Topical Use,DrugBank
DB00792,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB00792,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00792,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00792,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00792,Dermatologicals,DrugBank
DB00792,Diamines,DrugBank
DB00792,Ethylenediamine Derivatives,DrugBank
DB00792,Ethylenediamines,DrugBank
DB00792,Histamine Agents,DrugBank
DB00792,Histamine Antagonists,DrugBank
DB00792,Histamine H1 Antagonists,DrugBank
DB00792,Neurotransmitter Agents,DrugBank
DB00792,Polyamines,DrugBank
DB00792,Pyridines,DrugBank
DB00792,Substituted Ethylene Diamines,DrugBank
DB00793,Anti-Infective Agents,DrugBank
DB00793,Antifungal Agents,DrugBank
DB00793,Antifungals for Dermatological Use,DrugBank
DB00793,Antifungals for Topical Use,DrugBank
DB00793,Benzene Derivatives,DrugBank
DB00793,Dermatologicals,DrugBank
DB00793,Ethers,DrugBank
DB00793,Phenols,DrugBank
DB00794,Anti-epileptic Agent,DrugBank
DB00794,Anticholinergic Agents,DrugBank
DB00794,Anticonvulsants,DrugBank
DB00794,Barbiturates,DrugBank
DB00794,Barbiturates and Derivatives,DrugBank
DB00794,Central Nervous System Agents,DrugBank
DB00794,Central Nervous System Depressants,DrugBank
DB00794,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB00794,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB00794,Cytochrome P-450 CYP1A2 Inducers (strong),DrugBank
DB00794,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00794,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00794,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00794,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00794,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00794,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00794,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00794,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00794,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00794,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00794,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00794,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00794,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00794,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00794,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00794,Cytochrome P-450 Substrates,DrugBank
DB00794,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00794,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB00794,GABA Agents,DrugBank
DB00794,GABA Modulators,DrugBank
DB00794,Hypnotics and Sedatives,DrugBank
DB00794,Nervous System,DrugBank
DB00794,Neurotransmitter Agents,DrugBank
DB00794,Nicotinic Antagonists,DrugBank
DB00794,Phenobarbital and similars,DrugBank
DB00794,Psycholeptics,DrugBank
DB00794,Pyrimidines,DrugBank
DB00794,Pyrimidinones,DrugBank
DB00794,UGT1A1 Inducers,DrugBank
DB00795,Agents causing hyperkalemia,DrugBank
DB00795,Agents that produce hypertension,DrugBank
DB00795,Alimentary Tract and Metabolism,DrugBank
DB00795,Amides,DrugBank
DB00795,Aminosalicylate,DrugBank
DB00795,Anti-Inflammatory Agents,DrugBank
DB00795,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00795,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00795,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00795,Antirheumatic Agents,DrugBank
DB00795,BCRP/ABCG2 Inhibitors,DrugBank
DB00795,BCRP/ABCG2 Substrates,DrugBank
DB00795,Gastrointestinal Agents,DrugBank
DB00795,Immunosuppressive Agents,DrugBank
DB00795,Intestinal Antiinflammatory Agents,DrugBank
DB00795,Methemoglobinemia Associated Agents,DrugBank
DB00795,Nephrotoxic agents,DrugBank
DB00795,Non COX-2 selective NSAIDS,DrugBank
DB00795,NTCP Inhibitors,DrugBank
DB00795,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00795,OATP1B3 inhibitors,DrugBank
DB00795,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00795,Salicylates,DrugBank
DB00795,Sulfonamides,DrugBank
DB00795,Sulfones,DrugBank
DB00795,Sulfur Compounds,DrugBank
DB00796,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00796,Agents causing hyperkalemia,DrugBank
DB00796,Angiotensin 2 Receptor Blocker,DrugBank
DB00796,Angiotensin II Antagonists and Diuretics,DrugBank
DB00796,Angiotensin II receptor antagonists,DrugBank
DB00796,Angiotensin Receptor Antagonists,DrugBank
DB00796,Antihypertensive Agents,DrugBank
DB00796,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00796,Benzene Derivatives,DrugBank
DB00796,Cardiovascular Agents,DrugBank
DB00796,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00796,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00796,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00796,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00796,Cytochrome P-450 Substrates,DrugBank
DB00796,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00796,Hypotensive Agents,DrugBank
DB00796,P-glycoprotein inhibitors,DrugBank
DB00796,UGT1A3 substrates,DrugBank
DB00797,Adrenergic Agents,DrugBank
DB00797,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00797,Adrenergic alpha-Antagonists,DrugBank
DB00797,Adrenergic Antagonists,DrugBank
DB00797,Agents that produce hypertension,DrugBank
DB00797,Antihypertensive Agents,DrugBank
DB00797,Cardiovascular Agents,DrugBank
DB00797,Hypotensive Agents,DrugBank
DB00797,Imidazoles,DrugBank
DB00797,Imidazoline Derivatives,DrugBank
DB00797,Imidazolines,DrugBank
DB00797,Musculo-Skeletal System,DrugBank
DB00797,Neurotransmitter Agents,DrugBank
DB00797,Peripheral alpha-1 blockers,DrugBank
DB00797,Peripheral Vasodilators,DrugBank
DB00797,Topical Products for Joint and Muscular Pain,DrugBank
DB00797,Vasodilating Agents,DrugBank
DB00798,Agents that produce neuromuscular block (indirect),DrugBank
DB00798,"alpha-Galactosidase, antagonists & inhibitors",DrugBank
DB00798,Aminoglycoside Antibacterials,DrugBank
DB00798,Anti-Bacterial Agents,DrugBank
DB00798,Anti-Infective Agents,DrugBank
DB00798,Antibacterials for Systemic Use,DrugBank
DB00798,Antibiotics for Topical Use,DrugBank
DB00798,Antiinfectives for Systemic Use,DrugBank
DB00798,Carbohydrates,DrugBank
DB00798,Dermatologicals,DrugBank
DB00798,Drugs that are Mainly Renally Excreted,DrugBank
DB00798,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00798,Enzyme Inhibitors,DrugBank
DB00798,Gentamicins,DrugBank
DB00798,Glycosides,DrugBank
DB00798,Narrow Therapeutic Index Drugs,DrugBank
DB00798,Nephrotoxic agents,DrugBank
DB00798,OCT2 Substrates,DrugBank
DB00798,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00798,Ophthalmological and Otological Preparations,DrugBank
DB00798,Ophthalmologicals,DrugBank
DB00798,Otologicals,DrugBank
DB00798,Protein Synthesis Inhibitors,DrugBank
DB00798,Sensory Organs,DrugBank
DB00799,Antipsoriatics,DrugBank
DB00799,Antipsoriatics for Topical Use,DrugBank
DB00799,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00799,Cytochrome P-450 Substrates,DrugBank
DB00799,Dermatologicals,DrugBank
DB00799,Keratolytic Agents,DrugBank
DB00799,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00799,Noxae,DrugBank
DB00799,Prodrugs,DrugBank
DB00799,Pyridines,DrugBank
DB00799,Retinoids,DrugBank
DB00799,Teratogens,DrugBank
DB00799,Toxic Actions,DrugBank
DB00800,Adrenergic and Dopaminergic Agents,DrugBank
DB00800,Antihypertensive Agents,DrugBank
DB00800,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00800,Benzazepines,DrugBank
DB00800,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00800,Cardiac Therapy,DrugBank
DB00800,Cardiovascular Agents,DrugBank
DB00800,Dopamine Agents,DrugBank
DB00800,Dopamine Agonists,DrugBank
DB00800,Dopamine D1 Receptor Agonists,DrugBank
DB00800,Drugs that are Mainly Renally Excreted,DrugBank
DB00800,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00800,Hypotensive Agents,DrugBank
DB00800,Neurotransmitter Agents,DrugBank
DB00800,Vasodilating Agents,DrugBank
DB00801,Anti-Anxiety Agents,DrugBank
DB00801,Benzazepines,DrugBank
DB00801,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00801,Central Nervous System Agents,DrugBank
DB00801,Central Nervous System Depressants,DrugBank
DB00801,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00801,Nervous System,DrugBank
DB00801,Psycholeptics,DrugBank
DB00801,Psychotropic Drugs,DrugBank
DB00801,Tranquilizing Agents,DrugBank
DB00802,Agents that produce hypertension,DrugBank
DB00802,Analgesics,DrugBank
DB00802,Anesthetics,DrugBank
DB00802,"Anesthetics, General",DrugBank
DB00802,"Anesthetics, Intravenous",DrugBank
DB00802,Bradycardia-Causing Agents,DrugBank
DB00802,Central Nervous System Agents,DrugBank
DB00802,Central Nervous System Depressants,DrugBank
DB00802,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00802,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00802,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00802,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00802,Cytochrome P-450 Substrates,DrugBank
DB00802,Fentanyl and fentanyl analogues,DrugBank
DB00802,High-risk opioids,DrugBank
DB00802,Narcotics,DrugBank
DB00802,Nervous System,DrugBank
DB00802,Opiate Agonists,DrugBank
DB00802,Opioid Agonist,DrugBank
DB00802,Opioid Anesthetics,DrugBank
DB00802,Opioids,DrugBank
DB00802,"Opioids, Anilidopiperidine",DrugBank
DB00802,P-glycoprotein inhibitors,DrugBank
DB00802,Peripheral Nervous System Agents,DrugBank
DB00802,Phenylpiperidine opioids,DrugBank
DB00802,Piperidines,DrugBank
DB00802,Sensory System Agents,DrugBank
DB00802,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00803,Agents that produce neuromuscular block (indirect),DrugBank
DB00803,Alimentary Tract and Metabolism,DrugBank
DB00803,"Amino Acids, Peptides, and Proteins",DrugBank
DB00803,Aminoglycoside Antibacterials,DrugBank
DB00803,Anti-Bacterial Agents,DrugBank
DB00803,Anti-Infective Agents,DrugBank
DB00803,Antibacterials for Systemic Use,DrugBank
DB00803,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00803,Antiinfectives for Systemic Use,DrugBank
DB00803,Antimicrobial Cationic Peptides,DrugBank
DB00803,Antimicrobial Peptides,DrugBank
DB00803,Drugs that are Mainly Renally Excreted,DrugBank
DB00803,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00803,Intestinal Antiinfectives,DrugBank
DB00803,Lipids,DrugBank
DB00803,Lipopeptides,DrugBank
DB00803,Membrane Proteins,DrugBank
DB00803,Narrow Therapeutic Index Drugs,DrugBank
DB00803,Nephrotoxic agents,DrugBank
DB00803,Peptides,DrugBank
DB00803,"Peptides, Cyclic",DrugBank
DB00803,Polymyxins,DrugBank
DB00803,Pore Forming Cytotoxic Proteins,DrugBank
DB00803,Proteins,DrugBank
DB00804,"Acids, Carbocyclic",DrugBank
DB00804,Agents producing tachycardia,DrugBank
DB00804,Alimentary Tract and Metabolism,DrugBank
DB00804,Anticholinergic Agents,DrugBank
DB00804,Antimuscarinics Antispasmodics,DrugBank
DB00804,Autonomic Agents,DrugBank
DB00804,Cholinergic Agents,DrugBank
DB00804,Cyclohexanecarboxylic Acids,DrugBank
DB00804,Cyclohexanes,DrugBank
DB00804,Cycloparaffins,DrugBank
DB00804,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00804,Drugs that are Mainly Renally Excreted,DrugBank
DB00804,Muscarinic Antagonists,DrugBank
DB00804,Neurotransmitter Agents,DrugBank
DB00804,Parasympatholytics,DrugBank
DB00804,Peripheral Nervous System Agents,DrugBank
DB00804,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB00805,Agents that produce hypertension,DrugBank
DB00805,Agents that reduce seizure threshold,DrugBank
DB00805,Antidepressive Agents,DrugBank
DB00805,Central Nervous System Agents,DrugBank
DB00805,Central Nervous System Depressants,DrugBank
DB00805,Central Nervous System Stimulants,DrugBank
DB00805,Cholinesterase Inhibitors,DrugBank
DB00805,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00805,Cytochrome P-450 Substrates,DrugBank
DB00805,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00805,Monoamine Oxidase Inhibitors,DrugBank
DB00805,Nervous System,DrugBank
DB00805,Psychoanaleptics,DrugBank
DB00805,Psychotropic Drugs,DrugBank
DB00805,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00805,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00805,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00805,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00805,Serotonin Agents,DrugBank
DB00805,Serotonin Receptor Antagonists,DrugBank
DB00806,Alkaloids,DrugBank
DB00806,Antioxidants,DrugBank
DB00806,Antiplatelet agents,DrugBank
DB00806,Blood Viscosity Reducer,DrugBank
DB00806,Cardiovascular Agents,DrugBank
DB00806,"Compounds used in a research, industrial, or household setting",DrugBank
DB00806,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00806,Cytochrome P-450 Substrates,DrugBank
DB00806,Drugs for Obstructive Airway Diseases,DrugBank
DB00806,Drugs that are Mainly Renally Excreted,DrugBank
DB00806,Enzyme Inhibitors,DrugBank
DB00806,Free Radical Scavengers,DrugBank
DB00806,Hematologic Activity Alteration,DrugBank
DB00806,Hematologic Agents,DrugBank
DB00806,Hemorrheologic Agents,DrugBank
DB00806,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00806,Peripheral Vasodilators,DrugBank
DB00806,Phosphodiesterase 5 Inhibitors,DrugBank
DB00806,Phosphodiesterase Inhibitors,DrugBank
DB00806,Protective Agents,DrugBank
DB00806,Purine Derivatives,DrugBank
DB00806,Purines,DrugBank
DB00806,Purinones,DrugBank
DB00806,Radiation-Protective Agents,DrugBank
DB00806,Vasodilating Agents,DrugBank
DB00806,Xanthine derivatives,DrugBank
DB00807,"Acids, Carbocyclic",DrugBank
DB00807,Aminobenzoates,DrugBank
DB00807,Anesthetics,DrugBank
DB00807,"Anesthetics, Local",DrugBank
DB00807,Benzene Derivatives,DrugBank
DB00807,Benzoates,DrugBank
DB00807,Central Nervous System Agents,DrugBank
DB00807,Central Nervous System Depressants,DrugBank
DB00807,Ethers,DrugBank
DB00807,Hydroxy Acids,DrugBank
DB00807,Hydroxybenzoate Ethers,DrugBank
DB00807,Hydroxybenzoates,DrugBank
DB00807,Isomerism,DrugBank
DB00807,Local Anesthesia,DrugBank
DB00807,Ophthalmologicals,DrugBank
DB00807,para-Aminobenzoates,DrugBank
DB00807,Peripheral Nervous System Agents,DrugBank
DB00807,Phenols,DrugBank
DB00807,Phenyl Ethers,DrugBank
DB00807,Sensory Organs,DrugBank
DB00807,Sensory System Agents,DrugBank
DB00808,Amides,DrugBank
DB00808,Antihypertensive Agents,DrugBank
DB00808,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00808,Cardiovascular Agents,DrugBank
DB00808,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00808,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00808,Cytochrome P-450 Substrates,DrugBank
DB00808,Diuretics,DrugBank
DB00808,Drugs causing inadvertant photosensitivity,DrugBank
DB00808,Drugs that are Mainly Renally Excreted,DrugBank
DB00808,Genito Urinary System and Sex Hormones,DrugBank
DB00808,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00808,Hyperglycemia-Associated Agents,DrugBank
DB00808,Hypotensive Agents,DrugBank
DB00808,Increased Diuresis,DrugBank
DB00808,Indoles,DrugBank
DB00808,Lipid Modifying Agents,DrugBank
DB00808,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB00808,Membrane Transport Modulators,DrugBank
DB00808,Natriuretic Agents,DrugBank
DB00808,Non Potassium Sparing Diuretics,DrugBank
DB00808,Photosensitizing Agents,DrugBank
DB00808,Potential QTc-Prolonging Agents,DrugBank
DB00808,QTc Prolonging Agents,DrugBank
DB00808,Sodium Chloride Symporter Inhibitors,DrugBank
DB00808,Sulfonamides,DrugBank
DB00808,Sulfones,DrugBank
DB00808,Sulfur Compounds,DrugBank
DB00808,Thiazide-like Diuretic,DrugBank
DB00809,Anticholinergic Agents,DrugBank
DB00809,Autonomic Agents,DrugBank
DB00809,Cholinergic Agents,DrugBank
DB00809,Muscarinic Antagonists,DrugBank
DB00809,Mydriatics,DrugBank
DB00809,Mydriatics and Cycloplegics,DrugBank
DB00809,Neurotransmitter Agents,DrugBank
DB00809,Ophthalmologicals,DrugBank
DB00809,Peripheral Nervous System Agents,DrugBank
DB00809,Pyridines,DrugBank
DB00809,Sensory Organs,DrugBank
DB00810,Agents producing tachycardia,DrugBank
DB00810,Anti-Dyskinesia Agents,DrugBank
DB00810,Anti-Parkinson Drugs,DrugBank
DB00810,Anticholinergic Agents,DrugBank
DB00810,Autonomic Agents,DrugBank
DB00810,Aza Compounds,DrugBank
DB00810,Azabicyclo Compounds,DrugBank
DB00810,Bridged-Ring Compounds,DrugBank
DB00810,Central Nervous System Agents,DrugBank
DB00810,Cholinergic Agents,DrugBank
DB00810,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00810,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00810,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00810,Muscarinic Antagonists,DrugBank
DB00810,Nervous System,DrugBank
DB00810,Neurotransmitter Agents,DrugBank
DB00810,Nicotinic Antagonists,DrugBank
DB00810,Parasympatholytics,DrugBank
DB00810,Peripheral Nervous System Agents,DrugBank
DB00810,Piperidines,DrugBank
DB00810,Tertiary Amines,DrugBank
DB00811,Anti-Infective Agents,DrugBank
DB00811,Antiinfectives for Systemic Use,DrugBank
DB00811,Antimetabolites,DrugBank
DB00811,Antiviral Agents,DrugBank
DB00811,Antivirals for Systemic Use,DrugBank
DB00811,Antivirals for treatment of HCV infections,DrugBank
DB00811,Direct Acting Antivirals,DrugBank
DB00811,Drugs that are Mainly Renally Excreted,DrugBank
DB00811,Noxae,DrugBank
DB00811,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00811,Nucleoside Analog Antiviral,DrugBank
DB00811,Nucleosides,DrugBank
DB00811,Nucleosides and Nucleotides,DrugBank
DB00811,Ribonucleosides,DrugBank
DB00811,Toxic Actions,DrugBank
DB00811,Treatments for Hepatitis C,DrugBank
DB00812,Agents causing hyperkalemia,DrugBank
DB00812,Agents that produce hypertension,DrugBank
DB00812,Analgesics,DrugBank
DB00812,"Analgesics, Non-Narcotic",DrugBank
DB00812,Anti-Inflammatory Agents,DrugBank
DB00812,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00812,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00812,Antiinflammatory and Antirheumatic Products,DrugBank
DB00812,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00812,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00812,Antirheumatic Agents,DrugBank
DB00812,Butylpyrazolidines,DrugBank
DB00812,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00812,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00812,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00812,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00812,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00812,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00812,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00812,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00812,Cytochrome P-450 Substrates,DrugBank
DB00812,Musculo-Skeletal System,DrugBank
DB00812,Nephrotoxic agents,DrugBank
DB00812,Non COX-2 selective NSAIDS,DrugBank
DB00812,OAT1/SLC22A6 inhibitors,DrugBank
DB00812,OAT3/SLC22A8 Inhibitors,DrugBank
DB00812,Peripheral Nervous System Agents,DrugBank
DB00812,Pyrazoles,DrugBank
DB00812,Pyrazolones,DrugBank
DB00812,Sensory System Agents,DrugBank
DB00812,Topical Products for Joint and Muscular Pain,DrugBank
DB00813,Adjuvants,DrugBank
DB00813,"Adjuvants, Anesthesia",DrugBank
DB00813,Agents that produce hypertension,DrugBank
DB00813,Agents that reduce seizure threshold,DrugBank
DB00813,Analgesics,DrugBank
DB00813,Anesthetics,DrugBank
DB00813,"Anesthetics, General",DrugBank
DB00813,"Anesthetics, Intravenous",DrugBank
DB00813,Antidepressive Agents,DrugBank
DB00813,Bradycardia-Causing Agents,DrugBank
DB00813,Central Nervous System Agents,DrugBank
DB00813,Central Nervous System Depressants,DrugBank
DB00813,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00813,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00813,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00813,Cytochrome P-450 Substrates,DrugBank
DB00813,Drugs that are Mainly Renally Excreted,DrugBank
DB00813,Fentanyl and fentanyl analogues,DrugBank
DB00813,High-risk opioids,DrugBank
DB00813,Narcotics,DrugBank
DB00813,Nervous System,DrugBank
DB00813,Neuraxial Anesthetics,DrugBank
DB00813,Opiate Agonists,DrugBank
DB00813,Opioid Agonist,DrugBank
DB00813,Opioid Anesthetics,DrugBank
DB00813,Opioids,DrugBank
DB00813,"Opioids, Anilidopiperidine",DrugBank
DB00813,P-glycoprotein inhibitors,DrugBank
DB00813,Peripheral Nervous System Agents,DrugBank
DB00813,Phenylpiperidine opioids,DrugBank
DB00813,Piperidines,DrugBank
DB00813,Sensory System Agents,DrugBank
DB00813,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00813,Serotonin Agents,DrugBank
DB00813,Serotonin Modulators,DrugBank
DB00814,Agents causing hyperkalemia,DrugBank
DB00814,Agents that produce hypertension,DrugBank
DB00814,Amides,DrugBank
DB00814,Analgesics,DrugBank
DB00814,"Analgesics, Non-Narcotic",DrugBank
DB00814,Anesthetics,DrugBank
DB00814,"Anesthetics, Local",DrugBank
DB00814,Anti-Inflammatory Agents,DrugBank
DB00814,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00814,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00814,Antiinflammatory and Antirheumatic Products,DrugBank
DB00814,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00814,Antirheumatic Agents,DrugBank
DB00814,COX-2 Inhibitors,DrugBank
DB00814,Cyclooxygenase Inhibitors,DrugBank
DB00814,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00814,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00814,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00814,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00814,Cytochrome P-450 Substrates,DrugBank
DB00814,Musculo-Skeletal System,DrugBank
DB00814,Nephrotoxic agents,DrugBank
DB00814,Nervous System,DrugBank
DB00814,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00814,Oxicams,DrugBank
DB00814,Peripheral Nervous System Agents,DrugBank
DB00814,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00814,Sensory System Agents,DrugBank
DB00814,Sulfur Compounds,DrugBank
DB00814,Thiazines,DrugBank
DB00814,Thiazoles,DrugBank
DB00816,Adrenergic Agents,DrugBank
DB00816,Adrenergic Agonists,DrugBank
DB00816,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00816,Adrenergic beta-Agonists,DrugBank
DB00816,Adrenergics for Systemic Use,DrugBank
DB00816,"Adrenergics, Inhalants",DrugBank
DB00816,Agents producing tachycardia,DrugBank
DB00816,Agents that produce hypertension,DrugBank
DB00816,Agents to Treat Airway Disease,DrugBank
DB00816,Alcohols,DrugBank
DB00816,Amines,DrugBank
DB00816,Amino Alcohols,DrugBank
DB00816,Anti-Asthmatic Agents,DrugBank
DB00816,Autonomic Agents,DrugBank
DB00816,Benzene Derivatives,DrugBank
DB00816,Bronchodilator Agents,DrugBank
DB00816,Catecholamines,DrugBank
DB00816,Catechols,DrugBank
DB00816,Drugs for Obstructive Airway Diseases,DrugBank
DB00816,Ethanolamines,DrugBank
DB00816,Neurotransmitter Agents,DrugBank
DB00816,Non-selective Beta-adrenergic Agonists,DrugBank
DB00816,Peripheral Nervous System Agents,DrugBank
DB00816,Phenols,DrugBank
DB00816,Reproductive Control Agents,DrugBank
DB00816,Respiratory System Agents,DrugBank
DB00816,Selective Beta 2-adrenergic Agonists,DrugBank
DB00816,Sympathomimetics,DrugBank
DB00816,Tocolytic Agents,DrugBank
DB00817,Anti-Bacterial Agents,DrugBank
DB00817,Anti-Infective Agents,DrugBank
DB00817,Antibacterials for Systemic Use,DrugBank
DB00817,Antiinfectives for Systemic Use,DrugBank
DB00817,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00817,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00817,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00817,Fluoroquinolones,DrugBank
DB00817,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00817,Potential QTc-Prolonging Agents,DrugBank
DB00817,QTc Prolonging Agents,DrugBank
DB00817,Quinolines,DrugBank
DB00818,Agents Causing Muscle Toxicity,DrugBank
DB00818,Agents that produce hypertension,DrugBank
DB00818,Agents that reduce seizure threshold,DrugBank
DB00818,Anesthetics,DrugBank
DB00818,"Anesthetics, General",DrugBank
DB00818,"Anesthetics, Intravenous",DrugBank
DB00818,Benzene Derivatives,DrugBank
DB00818,Central Nervous System Agents,DrugBank
DB00818,Central Nervous System Depressants,DrugBank
DB00818,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00818,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00818,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00818,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00818,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00818,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00818,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00818,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00818,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00818,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00818,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00818,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00818,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00818,Cytochrome P-450 Substrates,DrugBank
DB00818,Hypnotics and Sedatives,DrugBank
DB00818,Hypotensive Agents,DrugBank
DB00818,Miscellaneous General Anesthetics,DrugBank
DB00818,Nervous System,DrugBank
DB00818,P-glycoprotein inducers,DrugBank
DB00818,Phenols,DrugBank
DB00818,Potential QTc-Prolonging Agents,DrugBank
DB00818,QTc Prolonging Agents,DrugBank
DB00818,UGT1A1 Inhibitors,DrugBank
DB00818,UGT1A1 Substrates,DrugBank
DB00818,UGT1A6 substrate,DrugBank
DB00818,UGT1A9 Substrates,DrugBank
DB00819,Anticonvulsants,DrugBank
DB00819,Antiglaucoma Agents,DrugBank
DB00819,Antiglaucoma Preparations and Miotics,DrugBank
DB00819,Carbonic Anhydrase Inhibitors,DrugBank
DB00819,Cardiovascular Agents,DrugBank
DB00819,Central Nervous System Agents,DrugBank
DB00819,Central Nervous System Depressants,DrugBank
DB00819,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00819,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00819,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00819,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00819,Diuretics,DrugBank
DB00819,Drugs causing inadvertant photosensitivity,DrugBank
DB00819,Enzyme Inhibitors,DrugBank
DB00819,Genito Urinary System and Sex Hormones,DrugBank
DB00819,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00819,Natriuretic Agents,DrugBank
DB00819,OAT1/SLC22A6 inhibitors,DrugBank
DB00819,Ophthalmologicals,DrugBank
DB00819,Photosensitizing Agents,DrugBank
DB00819,Sensory Organs,DrugBank
DB00819,Sulfonamides,DrugBank
DB00819,Sulfur Compounds,DrugBank
DB00819,Thiadiazoles,DrugBank
DB00819,Thiazoles,DrugBank
DB00820,5-alpha Reductase Inhibitors,DrugBank
DB00820,Antihypertensive Agents,DrugBank
DB00820,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB00820,Carbolines,DrugBank
DB00820,Cardiovascular Agents,DrugBank
DB00820,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00820,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00820,Cytochrome P-450 Substrates,DrugBank
DB00820,Drugs that are Mainly Renally Excreted,DrugBank
DB00820,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB00820,Drugs Used in Erectile Dysfunction,DrugBank
DB00820,Enzyme Inhibitors,DrugBank
DB00820,Genito Urinary System and Sex Hormones,DrugBank
DB00820,Genitourinary Agents,DrugBank
DB00820,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00820,Indole Alkaloids,DrugBank
DB00820,Indoles,DrugBank
DB00820,Phosphodiesterase 5 Inhibitors,DrugBank
DB00820,Phosphodiesterase Inhibitors,DrugBank
DB00820,Pyridines,DrugBank
DB00820,Urological Agents,DrugBank
DB00820,Urologicals,DrugBank
DB00820,Vasodilating Agents,DrugBank
DB00821,Agents causing hyperkalemia,DrugBank
DB00821,Agents that produce hypertension,DrugBank
DB00821,Analgesics,DrugBank
DB00821,"Analgesics, Non-Narcotic",DrugBank
DB00821,Anti-Inflammatory Agents,DrugBank
DB00821,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00821,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00821,Antirheumatic Agents,DrugBank
DB00821,Dermatologicals,DrugBank
DB00821,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00821,Indoles,DrugBank
DB00821,Nephrotoxic agents,DrugBank
DB00821,OAT1/SLC22A6 inhibitors,DrugBank
DB00821,Peripheral Nervous System Agents,DrugBank
DB00821,Photosensitizing Agents,DrugBank
DB00821,Radiation-Sensitizing Agents,DrugBank
DB00821,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00821,Sensory System Agents,DrugBank
DB00822,Acetyl Aldehyde Dehydrogenase Inhibitors,DrugBank
DB00822,"Acids, Acyclic",DrugBank
DB00822,Agents that reduce seizure threshold,DrugBank
DB00822,Alcohol Deterrents,DrugBank
DB00822,Aldehyde Dehydrogenase Inhibitor,DrugBank
DB00822,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00822,BSEP/ABCB11 Substrates,DrugBank
DB00822,Carbamates,DrugBank
DB00822,Central Nervous System Agents,DrugBank
DB00822,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00822,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00822,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00822,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00822,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00822,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00822,Cytochrome P-450 Substrates,DrugBank
DB00822,Disulfides,DrugBank
DB00822,Drugs Used in Addictive Disorders,DrugBank
DB00822,Drugs Used in Alcohol Dependence,DrugBank
DB00822,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB00822,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB00822,Enzyme Inhibitors,DrugBank
DB00822,Nervous System,DrugBank
DB00822,Potential QTc-Prolonging Agents,DrugBank
DB00822,QTc Prolonging Agents,DrugBank
DB00822,Sulfides,DrugBank
DB00822,Sulfur Compounds,DrugBank
DB00822,Sulfur Containing Products,DrugBank
DB00822,Thiocarbamates,DrugBank
DB00823,Adrenal Cortex Hormones,DrugBank
DB00823,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00823,"Contraceptive Agents, Female",DrugBank
DB00823,"Contraceptive Agents, Hormonal",DrugBank
DB00823,"Contraceptives, Oral",DrugBank
DB00823,"Contraceptives, Oral, Hormonal",DrugBank
DB00823,"Contraceptives, Oral, Synthetic",DrugBank
DB00823,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00823,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00823,Cytochrome P-450 Substrates,DrugBank
DB00823,Fused-Ring Compounds,DrugBank
DB00823,Genito Urinary System and Sex Hormones,DrugBank
DB00823,Hormonal Contraceptives for Systemic Use,DrugBank
DB00823,Hyperglycemia-Associated Agents,DrugBank
DB00823,Norpregnanes,DrugBank
DB00823,Norpregnenes,DrugBank
DB00823,Norsteroids,DrugBank
DB00823,Progestin Contraceptives,DrugBank
DB00823,Progestins,DrugBank
DB00823,Reproductive Control Agents,DrugBank
DB00823,Sex Hormones and Modulators of the Genital System,DrugBank
DB00823,Steroids,DrugBank
DB00825,Agents causing hyperkalemia,DrugBank
DB00825,Antiarrhythmic agents,DrugBank
DB00825,Antipruritics,DrugBank
DB00825,Antipruritics and Local Anesthetics,DrugBank
DB00825,Basic Lotions and Liniments,DrugBank
DB00825,Bradycardia-Causing Agents,DrugBank
DB00825,Calcium Channel Blockers,DrugBank
DB00825,Cyclohexanes,DrugBank
DB00825,Cyclohexanols,DrugBank
DB00825,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00825,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00825,Cytochrome P-450 Substrates,DrugBank
DB00825,"EENT Drugs, Miscellaneous",DrugBank
DB00825,Herbs and Natural Products,DrugBank
DB00825,Other Analgesics,DrugBank
DB00825,Other Cold and Cough Preparations,DrugBank
DB00825,Potential QTc-Prolonging Agents,DrugBank
DB00825,QTc Prolonging Agents,DrugBank
DB00825,Vasodilating Agents,DrugBank
DB00826,Alimentary Tract and Metabolism,DrugBank
DB00826,Anti-Bacterial Agents,DrugBank
DB00826,Anti-Infective Agents,DrugBank
DB00826,"Anti-Infective Agents, Local",DrugBank
DB00826,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00826,Antifungal Agents,DrugBank
DB00826,Antifungals for Dermatological Use,DrugBank
DB00826,Antifungals for Topical Use,DrugBank
DB00826,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00826,Dermatologicals,DrugBank
DB00826,Genito Urinary System and Sex Hormones,DrugBank
DB00826,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00826,Intestinal Antiinfectives,DrugBank
DB00826,Lactones,DrugBank
DB00826,Ophthalmologicals,DrugBank
DB00826,Polyene Antifungal,DrugBank
DB00826,Polyene Antimicrobial,DrugBank
DB00826,Sensory Organs,DrugBank
DB00826,Stomatological Preparations,DrugBank
DB00827,Anti-Bacterial Agents,DrugBank
DB00827,Anti-Infective Agents,DrugBank
DB00827,Antibacterials for Systemic Use,DrugBank
DB00827,Antiinfectives for Systemic Use,DrugBank
DB00827,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00827,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00827,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00827,Enzyme Inhibitors,DrugBank
DB00827,Fluoroquinolones,DrugBank
DB00827,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00827,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00827,OAT1/SLC22A6 inhibitors,DrugBank
DB00827,QTc Prolonging Agents,DrugBank
DB00827,Topoisomerase II Inhibitors,DrugBank
DB00827,Topoisomerase Inhibitors,DrugBank
DB00828,Anti-Bacterial Agents,DrugBank
DB00828,Anti-Infective Agents,DrugBank
DB00828,"Anti-Infective Agents, Urinary",DrugBank
DB00828,Antibacterials for Systemic Use,DrugBank
DB00828,Antiinfectives for Systemic Use,DrugBank
DB00828,Drugs that are Mainly Renally Excreted,DrugBank
DB00828,Organophosphonates,DrugBank
DB00828,Organophosphorus Compounds,DrugBank
DB00828,Otologicals,DrugBank
DB00828,Sensory Organs,DrugBank
DB00829,"Adjuvants, Anesthesia",DrugBank
DB00829,Anesthetics,DrugBank
DB00829,"Anesthetics, General",DrugBank
DB00829,"Anesthetics, Intravenous",DrugBank
DB00829,Anti-Anxiety Agents,DrugBank
DB00829,Anticonvulsants,DrugBank
DB00829,Autonomic Agents,DrugBank
DB00829,Benzazepines,DrugBank
DB00829,Benzodiazepine hypnotics and sedatives,DrugBank
DB00829,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00829,Benzodiazepinones,DrugBank
DB00829,Central Nervous System Agents,DrugBank
DB00829,Central Nervous System Depressants,DrugBank
DB00829,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00829,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00829,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00829,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00829,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00829,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00829,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00829,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00829,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00829,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00829,Cytochrome P-450 Substrates,DrugBank
DB00829,Drugs that are Mainly Renally Excreted,DrugBank
DB00829,GABA Agents,DrugBank
DB00829,GABA Modulators,DrugBank
DB00829,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00829,Hypnotics and Sedatives,DrugBank
DB00829,Muscle Relaxants,DrugBank
DB00829,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00829,Nervous System,DrugBank
DB00829,P-glycoprotein substrates,DrugBank
DB00829,Peripheral Nervous System Agents,DrugBank
DB00829,Psycholeptics,DrugBank
DB00829,Psychotropic Drugs,DrugBank
DB00829,Tranquilizing Agents,DrugBank
DB00830,Agents producing tachycardia,DrugBank
DB00830,Agents that produce hypertension,DrugBank
DB00830,Anti-Obesity Agents,DrugBank
DB00830,Appetite Depressants,DrugBank
DB00830,Autonomic Agents,DrugBank
DB00830,Central Nervous System Agents,DrugBank
DB00830,Central Nervous System Stimulants,DrugBank
DB00830,Morpholines,DrugBank
DB00830,Oxazines,DrugBank
DB00830,Peripheral Nervous System Agents,DrugBank
DB00830,Sympathomimetics,DrugBank
DB00831,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00831,Adrenergic alpha-Antagonists,DrugBank
DB00831,Adrenergic Antagonists,DrugBank
DB00831,Agents that produce hypertension,DrugBank
DB00831,Antiemetics,DrugBank
DB00831,Antipsychotic Agents,DrugBank
DB00831,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00831,Autonomic Agents,DrugBank
DB00831,Central Nervous System Agents,DrugBank
DB00831,Central Nervous System Depressants,DrugBank
DB00831,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00831,Cytochrome P-450 Substrates,DrugBank
DB00831,Dopamine Agents,DrugBank
DB00831,Dopamine Antagonists,DrugBank
DB00831,Dopamine D2 Receptor Antagonists,DrugBank
DB00831,Drugs causing inadvertant photosensitivity,DrugBank
DB00831,Gastrointestinal Agents,DrugBank
DB00831,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00831,Nervous System,DrugBank
DB00831,Neurotoxic agents,DrugBank
DB00831,Neurotransmitter Agents,DrugBank
DB00831,P-glycoprotein inhibitors,DrugBank
DB00831,P-glycoprotein substrates,DrugBank
DB00831,Peripheral Nervous System Agents,DrugBank
DB00831,Phenothiazines,DrugBank
DB00831,Phenothiazines With Piperazine Structure,DrugBank
DB00831,Photosensitizing Agents,DrugBank
DB00831,Psycholeptics,DrugBank
DB00831,Psychotropic Drugs,DrugBank
DB00831,Sulfur Compounds,DrugBank
DB00831,Tranquilizing Agents,DrugBank
DB00831,UGT1A4 substrates,DrugBank
DB00832,Anticonvulsants,DrugBank
DB00832,Central Nervous System Depressants,DrugBank
DB00832,Imides,DrugBank
DB00832,Nervous System,DrugBank
DB00832,Pyrrolidines,DrugBank
DB00832,Pyrrolidinones,DrugBank
DB00832,Succinimide Derivatives,DrugBank
DB00833,Amides,DrugBank
DB00833,Anti-Bacterial Agents,DrugBank
DB00833,Anti-Infective Agents,DrugBank
DB00833,Antibacterials for Systemic Use,DrugBank
DB00833,Antiinfectives for Systemic Use,DrugBank
DB00833,beta-Lactams,DrugBank
DB00833,BSEP/ABCB11 Substrates,DrugBank
DB00833,Cephalosporins,DrugBank
DB00833,Drugs that are Mainly Renally Excreted,DrugBank
DB00833,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00833,Lactams,DrugBank
DB00833,Nephrotoxic agents,DrugBank
DB00833,OAT3/SLC22A8 Inhibitors,DrugBank
DB00833,OAT3/SLC22A8 Substrates,DrugBank
DB00833,Second-Generation Cephalosporins,DrugBank
DB00833,Sulfur Compounds,DrugBank
DB00833,Thiazines,DrugBank
DB00834,Abortifacient Agents,DrugBank
DB00834,"Abortifacient Agents, Steroidal",DrugBank
DB00834,Adrenal Cortex Hormones,DrugBank
DB00834,Blood Glucose Lowering Agents,DrugBank
DB00834,BSEP/ABCB11 Substrates,DrugBank
DB00834,"Contraceptive Agents, Female",DrugBank
DB00834,"Contraceptive Agents, Hormonal",DrugBank
DB00834,"Contraceptives, Oral",DrugBank
DB00834,"Contraceptives, Oral, Synthetic",DrugBank
DB00834,"Contraceptives, Postcoital",DrugBank
DB00834,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00834,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00834,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00834,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00834,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00834,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00834,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00834,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00834,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00834,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00834,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB00834,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB00834,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00834,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00834,Cytochrome P-450 Substrates,DrugBank
DB00834,Estranes,DrugBank
DB00834,Estrenes,DrugBank
DB00834,Fused-Ring Compounds,DrugBank
DB00834,Genito Urinary System and Sex Hormones,DrugBank
DB00834,Highest Risk QTc-Prolonging Agents,DrugBank
DB00834,Hormonal Contraceptives for Systemic Use,DrugBank
DB00834,Hormone Antagonists,DrugBank
DB00834,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00834,Hypoglycemia-Associated Agents,DrugBank
DB00834,Luteolytic Agents,DrugBank
DB00834,Menstruation-Inducing Agents,DrugBank
DB00834,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00834,OATP1B3 inhibitors,DrugBank
DB00834,P-glycoprotein inducers,DrugBank
DB00834,P-glycoprotein inhibitors,DrugBank
DB00834,Progestational Hormone Receptor Antagonists,DrugBank
DB00834,Progesterone Receptor Modulators,DrugBank
DB00834,Progestin Antagonist,DrugBank
DB00834,QTc Prolonging Agents,DrugBank
DB00834,Reproductive Control Agents,DrugBank
DB00834,Sex Hormones and Modulators of the Genital System,DrugBank
DB00834,Steroids,DrugBank
DB00835,Agents producing tachycardia,DrugBank
DB00835,Anti-Allergic Agents,DrugBank
DB00835,Anticholinergic Agents,DrugBank
DB00835,Antihistamines for Systemic Use,DrugBank
DB00835,Central Nervous System Depressants,DrugBank
DB00835,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00835,Cytochrome P-450 Substrates,DrugBank
DB00835,Histamine Agents,DrugBank
DB00835,Histamine Antagonists,DrugBank
DB00835,Histamine H1 Antagonists,DrugBank
DB00835,Muscarinic Antagonists,DrugBank
DB00835,Neurotransmitter Agents,DrugBank
DB00835,Potential QTc-Prolonging Agents,DrugBank
DB00835,Propylamine Derivatives,DrugBank
DB00835,Pyridines,DrugBank
DB00835,QTc Prolonging Agents,DrugBank
DB00835,Substituted Alkylamines,DrugBank
DB00836,Agents causing hyperkalemia,DrugBank
DB00836,Alimentary Tract and Metabolism,DrugBank
DB00836,Antiarrhythmic agents,DrugBank
DB00836,Antidiarrheals,DrugBank
DB00836,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00836,Antipropulsives,DrugBank
DB00836,Bradycardia-Causing Agents,DrugBank
DB00836,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00836,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00836,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00836,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00836,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00836,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00836,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00836,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00836,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00836,Cytochrome P-450 Substrates,DrugBank
DB00836,Gastrointestinal Agents,DrugBank
DB00836,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00836,Opioid Agonist,DrugBank
DB00836,P-glycoprotein substrates,DrugBank
DB00836,Piperidines,DrugBank
DB00836,QTc Prolonging Agents,DrugBank
DB00837,"Acids, Acyclic",DrugBank
DB00837,Amino Acids,DrugBank
DB00837,"Amino Acids, Peptides, and Proteins",DrugBank
DB00837,Aminobutyrates,DrugBank
DB00837,Anti-Dyskinesia Agents,DrugBank
DB00837,Anti-Parkinson Drugs,DrugBank
DB00837,Anticonvulsants,DrugBank
DB00837,Antidepressive Agents,DrugBank
DB00837,Butyrates,DrugBank
DB00837,Central Nervous System Agents,DrugBank
DB00837,Central Nervous System Depressants,DrugBank
DB00837,Fatty Acid Derivatives,DrugBank
DB00837,GABA Agents,DrugBank
DB00837,GABA Agonists,DrugBank
DB00837,Nervous System,DrugBank
DB00837,Neurotransmitter Agents,DrugBank
DB00837,Psychotropic Drugs,DrugBank
DB00838,Adrenal Cortex Hormones,DrugBank
DB00838,Anti-Inflammatory Agents,DrugBank
DB00838,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00838,Corticosteroids,DrugBank
DB00838,"Corticosteroids, Dermatological Preparations",DrugBank
DB00838,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB00838,Dermatologicals,DrugBank
DB00838,Fused-Ring Compounds,DrugBank
DB00838,Hormones,DrugBank
DB00838,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00838,Immunosuppressive Agents,DrugBank
DB00838,Pregnadienediols,DrugBank
DB00838,Pregnadienes,DrugBank
DB00838,Pregnanes,DrugBank
DB00838,Steroids,DrugBank
DB00838,"Steroids, Fluorinated",DrugBank
DB00839,Alimentary Tract and Metabolism,DrugBank
DB00839,Amides,DrugBank
DB00839,Benzene Derivatives,DrugBank
DB00839,Benzenesulfonamides,DrugBank
DB00839,Blood Glucose Lowering Agents,DrugBank
DB00839,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00839,Cytochrome P-450 Substrates,DrugBank
DB00839,Drugs that are Mainly Renally Excreted,DrugBank
DB00839,Drugs Used in Diabetes,DrugBank
DB00839,Genito Urinary System and Sex Hormones,DrugBank
DB00839,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00839,Hypoglycemia-Associated Agents,DrugBank
DB00839,Insulin Secretagogues,DrugBank
DB00839,Oral Hypoglycemics,DrugBank
DB00839,Sulfonamides,DrugBank
DB00839,Sulfones,DrugBank
DB00839,Sulfonylureas,DrugBank
DB00839,Sulfur Compounds,DrugBank
DB00841,Adrenergic Agents,DrugBank
DB00841,Adrenergic Agonists,DrugBank
DB00841,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00841,Adrenergic alpha-Agonists,DrugBank
DB00841,Adrenergic and Dopaminergic Agents,DrugBank
DB00841,Adrenergic beta-1 Receptor Agonists,DrugBank
DB00841,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00841,Adrenergic beta-Agonists,DrugBank
DB00841,Agents producing tachycardia,DrugBank
DB00841,Agents that produce hypertension,DrugBank
DB00841,Amines,DrugBank
DB00841,Autonomic Agents,DrugBank
DB00841,Benzene Derivatives,DrugBank
DB00841,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00841,Cardiac Therapy,DrugBank
DB00841,Cardiotonic Agents,DrugBank
DB00841,Cardiovascular Agents,DrugBank
DB00841,Catecholamines,DrugBank
DB00841,Catechols,DrugBank
DB00841,"Compounds used in a research, industrial, or household setting",DrugBank
DB00841,COMT Substrates,DrugBank
DB00841,Drugs that are Mainly Renally Excreted,DrugBank
DB00841,Ethylamines,DrugBank
DB00841,Neurotransmitter Agents,DrugBank
DB00841,Peripheral Nervous System Agents,DrugBank
DB00841,Phenethylamines,DrugBank
DB00841,Phenols,DrugBank
DB00841,Protective Agents,DrugBank
DB00841,Selective Beta 1-adrenergic Agonists,DrugBank
DB00841,Sympathomimetic (Adrenergic) Agents,DrugBank
DB00841,Sympathomimetics,DrugBank
DB00842,Anti-Anxiety Agents,DrugBank
DB00842,Benzazepines,DrugBank
DB00842,Benzodiazepine hypnotics and sedatives,DrugBank
DB00842,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00842,Benzodiazepinones,DrugBank
DB00842,Central Nervous System Agents,DrugBank
DB00842,Central Nervous System Depressants,DrugBank
DB00842,Drugs that are Mainly Renally Excreted,DrugBank
DB00842,GABA Agents,DrugBank
DB00842,GABA Modulators,DrugBank
DB00842,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00842,Hypnotics and Sedatives,DrugBank
DB00842,Nervous System,DrugBank
DB00842,Neurotransmitter Agents,DrugBank
DB00842,Psycholeptics,DrugBank
DB00842,Psychotropic Drugs,DrugBank
DB00842,Tranquilizing Agents,DrugBank
DB00842,UGT1A9 Substrates,DrugBank
DB00842,UGT2B7 substrates,DrugBank
DB00843,Anti-Dementia Drugs,DrugBank
DB00843,BCRP/ABCG2 Substrates,DrugBank
DB00843,Bradycardia-Causing Agents,DrugBank
DB00843,Central Nervous System Agents,DrugBank
DB00843,Central Nervous System Depressants,DrugBank
DB00843,Cholinergic Agents,DrugBank
DB00843,Cholinesterase Inhibitors,DrugBank
DB00843,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00843,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00843,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00843,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00843,Cytochrome P-450 Substrates,DrugBank
DB00843,Enzyme Inhibitors,DrugBank
DB00843,Indans,DrugBank
DB00843,Indenes,DrugBank
DB00843,Muscle Relaxants,DrugBank
DB00843,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00843,Nervous System,DrugBank
DB00843,Neurotransmitter Agents,DrugBank
DB00843,Nootropic Agents,DrugBank
DB00843,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB00843,Piperidines,DrugBank
DB00843,Psychoanaleptics,DrugBank
DB00844,Alkaloids,DrugBank
DB00844,Analgesics,DrugBank
DB00844,Central Nervous System Agents,DrugBank
DB00844,Central Nervous System Depressants,DrugBank
DB00844,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00844,Mixed Agonist / Antagonist Opioids,DrugBank
DB00844,Morphinan Derivatives,DrugBank
DB00844,Morphinans,DrugBank
DB00844,Narcotics,DrugBank
DB00844,Nervous System,DrugBank
DB00844,Opiate Alkaloids,DrugBank
DB00844,Opiate Partial Agonists,DrugBank
DB00844,Opioid Agonist/Antagonist,DrugBank
DB00844,Opioid Antagonists,DrugBank
DB00844,Opioids,DrugBank
DB00844,Peripheral Nervous System Agents,DrugBank
DB00844,Phenanthrenes,DrugBank
DB00844,Semi-synthetic Opioids,DrugBank
DB00844,Sensory System Agents,DrugBank
DB00844,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00845,Anti-Bacterial Agents,DrugBank
DB00845,Anti-Infective Agents,DrugBank
DB00845,Anti-Inflammatory Agents,DrugBank
DB00845,Antiinfectives for Systemic Use,DrugBank
DB00845,Antimycobacterials,DrugBank
DB00845,BCRP/ABCG2 Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00845,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00845,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00845,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00845,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB00845,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00845,Drugs causing inadvertant photosensitivity,DrugBank
DB00845,Drugs for Treatment of Lepra,DrugBank
DB00845,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00845,Leprostatic Agents,DrugBank
DB00845,P-glycoprotein inhibitors,DrugBank
DB00845,P-glycoprotein substrates,DrugBank
DB00845,Phenazines,DrugBank
DB00845,Photosensitizing Agents,DrugBank
DB00845,Potential QTc-Prolonging Agents,DrugBank
DB00845,QTc Prolonging Agents,DrugBank
DB00846,Adrenal Cortex Hormones,DrugBank
DB00846,Anti-Inflammatory Agents,DrugBank
DB00846,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00846,Corticosteroids,DrugBank
DB00846,"Corticosteroids, Dermatological Preparations",DrugBank
DB00846,"Corticosteroids, Potent (Group III)",DrugBank
DB00846,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00846,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00846,Cytochrome P-450 Substrates,DrugBank
DB00846,Dermatologicals,DrugBank
DB00846,Fused-Ring Compounds,DrugBank
DB00846,Hormones,DrugBank
DB00846,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00846,Immunosuppressive Agents,DrugBank
DB00846,Pregnanes,DrugBank
DB00846,Pregnenediones,DrugBank
DB00846,Pregnenes,DrugBank
DB00846,Steroids,DrugBank
DB00846,"Steroids, Fluorinated",DrugBank
DB00849,Anticholinergic Agents,DrugBank
DB00849,Anticonvulsants,DrugBank
DB00849,Barbiturates,DrugBank
DB00849,Barbiturates and Derivatives,DrugBank
DB00849,Central Nervous System Agents,DrugBank
DB00849,Central Nervous System Depressants,DrugBank
DB00849,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00849,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00849,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00849,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00849,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00849,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00849,Cytochrome P-450 Substrates,DrugBank
DB00849,GABA Agents,DrugBank
DB00849,GABA Modulators,DrugBank
DB00849,Hypnotics and Sedatives,DrugBank
DB00849,Nervous System,DrugBank
DB00849,Neurotransmitter Agents,DrugBank
DB00849,Nicotinic Antagonists,DrugBank
DB00849,Phenobarbital and similars,DrugBank
DB00849,Psycholeptics,DrugBank
DB00849,Pyrimidines,DrugBank
DB00849,Pyrimidinones,DrugBank
DB00850,Antipsychotic Agents,DrugBank
DB00850,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00850,Central Nervous System Agents,DrugBank
DB00850,Central Nervous System Depressants,DrugBank
DB00850,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00850,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00850,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00850,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00850,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00850,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00850,Cytochrome P-450 Substrates,DrugBank
DB00850,Dopamine Agents,DrugBank
DB00850,Dopamine Antagonists,DrugBank
DB00850,Dopamine D2 Receptor Antagonists,DrugBank
DB00850,Drugs causing inadvertant photosensitivity,DrugBank
DB00850,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00850,Nervous System,DrugBank
DB00850,Neurotoxic agents,DrugBank
DB00850,Neurotransmitter Agents,DrugBank
DB00850,Phenothiazines,DrugBank
DB00850,Phenothiazines With Piperazine Structure,DrugBank
DB00850,Photosensitizing Agents,DrugBank
DB00850,Psycholeptics,DrugBank
DB00850,Psychotropic Drugs,DrugBank
DB00850,Sulfur Compounds,DrugBank
DB00850,Tranquilizing Agents,DrugBank
DB00851,Alkylating Activity,DrugBank
DB00851,Alkylating Drugs,DrugBank
DB00851,Antineoplastic Agents,DrugBank
DB00851,"Antineoplastic Agents, Alkylating",DrugBank
DB00851,Antineoplastic and Immunomodulating Agents,DrugBank
DB00851,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00851,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00851,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB00851,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00851,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00851,Cytochrome P-450 Substrates,DrugBank
DB00851,Drugs that are Mainly Renally Excreted,DrugBank
DB00851,Imidazoles,DrugBank
DB00851,Immunosuppressive Agents,DrugBank
DB00851,Myelosuppressive Agents,DrugBank
DB00851,Narrow Therapeutic Index Drugs,DrugBank
DB00851,Noxae,DrugBank
DB00851,Toxic Actions,DrugBank
DB00851,Triazenes,DrugBank
DB00852,Adrenergic Agonists,DrugBank
DB00852,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00852,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00852,Adrenergic alpha-Agonists,DrugBank
DB00852,Adrenergic beta-Agonists,DrugBank
DB00852,Agents producing tachycardia,DrugBank
DB00852,Agents that produce hypertension,DrugBank
DB00852,Alcohols,DrugBank
DB00852,Alpha-and Beta-adrenergic Agonists,DrugBank
DB00852,Amines,DrugBank
DB00852,Amino Alcohols,DrugBank
DB00852,Amphetamines,DrugBank
DB00852,Anti-Asthmatic Agents,DrugBank
DB00852,Autonomic Agents,DrugBank
DB00852,Bronchodilator Agents,DrugBank
DB00852,Cardiovascular Agents,DrugBank
DB00852,Ethylamines,DrugBank
DB00852,Hyperglycemia-Associated Agents,DrugBank
DB00852,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00852,Nasal Decongestants,DrugBank
DB00852,Nasal Decongestants for Systemic Use,DrugBank
DB00852,Nasal Preparations,DrugBank
DB00852,Norepinephrine Releasing Agents,DrugBank
DB00852,Peripheral Nervous System Agents,DrugBank
DB00852,Phenethylamines,DrugBank
DB00852,Propanolamines,DrugBank
DB00852,Propanols,DrugBank
DB00852,Respiratory System Agents,DrugBank
DB00852,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00852,Sympathomimetic (Adrenergic) Agents,DrugBank
DB00852,Sympathomimetics,DrugBank
DB00852,Tumor Necrosis Factor Blockers,DrugBank
DB00852,Vasoconstrictor Agents,DrugBank
DB00853,Alkylating Activity,DrugBank
DB00853,Alkylating Drugs,DrugBank
DB00853,Antineoplastic Agents,DrugBank
DB00853,"Antineoplastic Agents, Alkylating",DrugBank
DB00853,Antineoplastic and Immunomodulating Agents,DrugBank
DB00853,BCRP/ABCG2 Substrates,DrugBank
DB00853,Drugs that are Mainly Renally Excreted,DrugBank
DB00853,Imidazoles,DrugBank
DB00853,Immunosuppressive Agents,DrugBank
DB00853,Myelosuppressive Agents,DrugBank
DB00853,Narrow Therapeutic Index Drugs,DrugBank
DB00853,Noxae,DrugBank
DB00853,P-glycoprotein substrates,DrugBank
DB00853,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00853,Toxic Actions,DrugBank
DB00853,Triazenes,DrugBank
DB00854,Alkaloids,DrugBank
DB00854,Analgesics,DrugBank
DB00854,Central Nervous System Agents,DrugBank
DB00854,Central Nervous System Depressants,DrugBank
DB00854,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00854,Morphinans,DrugBank
DB00854,Narcotics,DrugBank
DB00854,Opiate Alkaloids,DrugBank
DB00854,Opioid Agonist,DrugBank
DB00854,Opioids,DrugBank
DB00854,Peripheral Nervous System Agents,DrugBank
DB00854,Phenanthrenes,DrugBank
DB00854,Sensory System Agents,DrugBank
DB00854,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00855,Amino Acids,DrugBank
DB00855,"Amino Acids, Peptides, and Proteins",DrugBank
DB00855,Antineoplastic Agents,DrugBank
DB00855,Antineoplastic and Immunomodulating Agents,DrugBank
DB00855,Dermatologicals,DrugBank
DB00855,Enkephalins,DrugBank
DB00855,Keto Acids,DrugBank
DB00855,Levulinic Acids,DrugBank
DB00855,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00855,Nerve Tissue Proteins,DrugBank
DB00855,Neuropeptides,DrugBank
DB00855,Opioid Peptides,DrugBank
DB00855,Optical Imaging Agent,DrugBank
DB00855,Peptides,DrugBank
DB00855,Photosensitizing Agents,DrugBank
DB00855,Photosensitizing Agents for Phototherapy,DrugBank
DB00855,Porphyrin Precursor,DrugBank
DB00855,Proteins,DrugBank
DB00855,Radiation-Sensitizing Agents,DrugBank
DB00855,Roentgenography,DrugBank
DB00855,Sensitizers Used in Photodynamic/radiation Therapy,DrugBank
DB00856,Alcohols,DrugBank
DB00856,Antifungals for Dermatological Use,DrugBank
DB00856,Antifungals for Topical Use,DrugBank
DB00856,Central Nervous System Agents,DrugBank
DB00856,Central Nervous System Depressants,DrugBank
DB00856,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00856,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00856,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00856,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00856,Dermatologicals,DrugBank
DB00856,Glycols,DrugBank
DB00856,Muscle Relaxants,DrugBank
DB00856,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00856,Peripheral Nervous System Agents,DrugBank
DB00856,Propylene Glycols,DrugBank
DB00857,Agents Causing Muscle Toxicity,DrugBank
DB00857,Allylamine Antifungal,DrugBank
DB00857,Allylamines,DrugBank
DB00857,Anti-Infective Agents,DrugBank
DB00857,Antifungal Agents,DrugBank
DB00857,Antifungals for Dermatological Use,DrugBank
DB00857,Antifungals for Systemic Use,DrugBank
DB00857,Antifungals for Topical Use,DrugBank
DB00857,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00857,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00857,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00857,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00857,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00857,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00857,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00857,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00857,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00857,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00857,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00857,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00857,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00857,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00857,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00857,Cytochrome P-450 Substrates,DrugBank
DB00857,Dermatologicals,DrugBank
DB00857,Enzyme Inhibitors,DrugBank
DB00857,Naphthalenes,DrugBank
DB00859,Agents Causing Muscle Toxicity,DrugBank
DB00859,Amino Acids,DrugBank
DB00859,"Amino Acids, Peptides, and Proteins",DrugBank
DB00859,"Amino Acids, Sulfur",DrugBank
DB00859,Antidotes,DrugBank
DB00859,Antiinflammatory and Antirheumatic Products,DrugBank
DB00859,Antirheumatic Agents,DrugBank
DB00859,Chelating Agents,DrugBank
DB00859,"Compounds used in a research, industrial, or household setting",DrugBank
DB00859,Heavy Metal Antagonists,DrugBank
DB00859,Immunosuppressive Agents,DrugBank
DB00859,Musculo-Skeletal System,DrugBank
DB00859,Myelosuppressive Agents,DrugBank
DB00859,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00859,Penicillamine and Similar Agents,DrugBank
DB00859,Protective Agents,DrugBank
DB00859,Sequestering Agents,DrugBank
DB00859,Specific Antirheumatic Agents,DrugBank
DB00859,Sulfur Compounds,DrugBank
DB00860,Adrenal Cortex Hormones,DrugBank
DB00860,Adrenals,DrugBank
DB00860,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00860,Alimentary Tract and Metabolism,DrugBank
DB00860,Anti-Inflammatory Agents,DrugBank
DB00860,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00860,Antidotes,DrugBank
DB00860,Antineoplastic Agents,DrugBank
DB00860,"Antineoplastic Agents, Hormonal",DrugBank
DB00860,Antineoplastic and Immunomodulating Agents,DrugBank
DB00860,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00860,Corticosteroids,DrugBank
DB00860,Corticosteroids Acting Locally,DrugBank
DB00860,Corticosteroids for Local Oral Treatment,DrugBank
DB00860,Corticosteroids for Systemic Use,DrugBank
DB00860,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00860,"Corticosteroids, Dermatological Preparations",DrugBank
DB00860,"Corticosteroids, Weak (Group I)",DrugBank
DB00860,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00860,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00860,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00860,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00860,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00860,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00860,Cytochrome P-450 Substrates,DrugBank
DB00860,Dermatologicals,DrugBank
DB00860,Endocrine Therapy,DrugBank
DB00860,Fused-Ring Compounds,DrugBank
DB00860,Hormone Antagonists and Related Agents,DrugBank
DB00860,Hormones,DrugBank
DB00860,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00860,Hyperglycemia-Associated Agents,DrugBank
DB00860,Immunosuppressive Agents,DrugBank
DB00860,Intestinal Antiinflammatory Agents,DrugBank
DB00860,Nasal Preparations,DrugBank
DB00860,Ophthalmological and Otological Preparations,DrugBank
DB00860,Ophthalmologicals,DrugBank
DB00860,Otologicals,DrugBank
DB00860,P-glycoprotein substrates,DrugBank
DB00860,Prednisolone and Prodrugs,DrugBank
DB00860,Pregnadienes,DrugBank
DB00860,Pregnadienetriols,DrugBank
DB00860,Pregnanes,DrugBank
DB00860,Sensory Organs,DrugBank
DB00860,Steroids,DrugBank
DB00860,Stomatological Preparations,DrugBank
DB00860,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00860,Vasoprotectives,DrugBank
DB00861,Agents causing hyperkalemia,DrugBank
DB00861,Agents that produce hypertension,DrugBank
DB00861,Analgesics,DrugBank
DB00861,"Analgesics, Non-Narcotic",DrugBank
DB00861,Anti-Inflammatory Agents,DrugBank
DB00861,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00861,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00861,Antirheumatic Agents,DrugBank
DB00861,Benzene Derivatives,DrugBank
DB00861,Cyclooxygenase Inhibitors,DrugBank
DB00861,Drugs causing inadvertant photosensitivity,DrugBank
DB00861,Drugs that are Mainly Renally Excreted,DrugBank
DB00861,Enzyme Inhibitors,DrugBank
DB00861,Hydroxybenzoates,DrugBank
DB00861,Nephrotoxic agents,DrugBank
DB00861,Nervous System,DrugBank
DB00861,Non COX-2 selective NSAIDS,DrugBank
DB00861,OAT1/SLC22A6 inhibitors,DrugBank
DB00861,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00861,Peripheral Nervous System Agents,DrugBank
DB00861,Phenols,DrugBank
DB00861,Photosensitizing Agents,DrugBank
DB00861,Salicylates,DrugBank
DB00861,Salicylic Acid and Derivatives,DrugBank
DB00861,Sensory System Agents,DrugBank
DB00861,UGT1A9 Inhibitors,DrugBank
DB00862,Cardiovascular Agents,DrugBank
DB00862,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00862,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00862,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB00862,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00862,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00862,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00862,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00862,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00862,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00862,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00862,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00862,Cytochrome P-450 Substrates,DrugBank
DB00862,Drugs Used in Erectile Dysfunction,DrugBank
DB00862,Enzyme Inhibitors,DrugBank
DB00862,Genito Urinary System and Sex Hormones,DrugBank
DB00862,Genitourinary Agents,DrugBank
DB00862,Imidazoles,DrugBank
DB00862,P-glycoprotein inhibitors,DrugBank
DB00862,P-glycoprotein substrates,DrugBank
DB00862,Phosphodiesterase 5 Inhibitors,DrugBank
DB00862,Phosphodiesterase Inhibitors,DrugBank
DB00862,Piperazines,DrugBank
DB00862,Potential QTc-Prolonging Agents,DrugBank
DB00862,QTc Prolonging Agents,DrugBank
DB00862,Urological Agents,DrugBank
DB00862,Urologicals,DrugBank
DB00862,Vasodilating Agents,DrugBank
DB00863,Acid Reducers,DrugBank
DB00863,Agents Causing Muscle Toxicity,DrugBank
DB00863,Alimentary Tract and Metabolism,DrugBank
DB00863,Anti-Ulcer Agents,DrugBank
DB00863,Cholinesterase Inhibitors,DrugBank
DB00863,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00863,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00863,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00863,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00863,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00863,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00863,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00863,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00863,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00863,Cytochrome P-450 Substrates,DrugBank
DB00863,Drugs for Acid Related Disorders,DrugBank
DB00863,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00863,Drugs that are Mainly Renally Excreted,DrugBank
DB00863,Furans,DrugBank
DB00863,Gastric Acid Lowering Agents,DrugBank
DB00863,Gastrointestinal Agents,DrugBank
DB00863,Histamine Antagonists,DrugBank
DB00863,Histamine H2 Antagonists,DrugBank
DB00863,OAT1/SLC22A6 inhibitors,DrugBank
DB00863,OAT1/SLC22A6 Substrates,DrugBank
DB00863,OAT3/SLC22A8 Substrates,DrugBank
DB00863,OCT1 inhibitors,DrugBank
DB00863,OCT1 substrates,DrugBank
DB00863,OCT2 Inhibitors,DrugBank
DB00863,OCT2 Substrates,DrugBank
DB00863,P-glycoprotein inhibitors,DrugBank
DB00863,P-glycoprotein substrates,DrugBank
DB00864,Agents causing hyperkalemia,DrugBank
DB00864,Agents Causing Muscle Toxicity,DrugBank
DB00864,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB00864,Antineoplastic and Immunomodulating Agents,DrugBank
DB00864,Calcineurin Inhibitor Immunosuppressant,DrugBank
DB00864,Calcineurin Inhibitors,DrugBank
DB00864,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00864,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00864,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00864,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00864,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00864,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00864,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00864,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00864,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00864,Cytochrome P-450 Substrates,DrugBank
DB00864,Dermatologicals,DrugBank
DB00864,Drugs causing inadvertant photosensitivity,DrugBank
DB00864,Enzyme Inhibitors,DrugBank
DB00864,Hyperglycemia-Associated Agents,DrugBank
DB00864,Immunologic Factors,DrugBank
DB00864,Immunosuppressive Agents,DrugBank
DB00864,Lactones,DrugBank
DB00864,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00864,Myelosuppressive Agents,DrugBank
DB00864,Narrow Therapeutic Index Drugs,DrugBank
DB00864,Nephrotoxic agents,DrugBank
DB00864,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00864,P-glycoprotein inducers,DrugBank
DB00864,P-glycoprotein inhibitors,DrugBank
DB00864,P-glycoprotein substrates,DrugBank
DB00864,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00864,Photosensitizing Agents,DrugBank
DB00864,Polyketides,DrugBank
DB00864,Potential QTc-Prolonging Agents,DrugBank
DB00864,QTc Prolonging Agents,DrugBank
DB00865,Adrenergic Agents,DrugBank
DB00865,Adrenergic Agonists,DrugBank
DB00865,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00865,Adrenergic alpha-Agonists,DrugBank
DB00865,Adrenergic Uptake Inhibitors,DrugBank
DB00865,Agents producing tachycardia,DrugBank
DB00865,Agents that produce hypertension,DrugBank
DB00865,Amines,DrugBank
DB00865,Amphetamines,DrugBank
DB00865,Antidepressive Agents,DrugBank
DB00865,Appetite Suppression,DrugBank
DB00865,Autonomic Agents,DrugBank
DB00865,Central Nervous System Agents,DrugBank
DB00865,Central Nervous System Depressants,DrugBank
DB00865,Central Nervous System Stimulants,DrugBank
DB00865,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00865,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00865,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00865,Cytochrome P-450 Substrates,DrugBank
DB00865,Dopamine Agents,DrugBank
DB00865,Dopamine Uptake Inhibitors,DrugBank
DB00865,Ethylamines,DrugBank
DB00865,Increased Sympathetic Activity,DrugBank
DB00865,Membrane Transport Modulators,DrugBank
DB00865,Neurotransmitter Agents,DrugBank
DB00865,Neurotransmitter Uptake Inhibitors,DrugBank
DB00865,Peripheral Nervous System Agents,DrugBank
DB00865,Phenethylamines,DrugBank
DB00865,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00865,Sympathomimetic Amine Anorectic,DrugBank
DB00865,Sympathomimetics,DrugBank
DB00866,Adrenergic Agents,DrugBank
DB00866,Adrenergic Antagonists,DrugBank
DB00866,Adrenergic beta-Antagonists,DrugBank
DB00866,Agents causing hyperkalemia,DrugBank
DB00866,Alcohols,DrugBank
DB00866,Amines,DrugBank
DB00866,Amino Alcohols,DrugBank
DB00866,Antiarrhythmic agents,DrugBank
DB00866,Antidepressive Agents,DrugBank
DB00866,Antihypertensive Agents,DrugBank
DB00866,Autonomic Agents,DrugBank
DB00866,"Beta Blocking Agents, Non-Selective",DrugBank
DB00866,Bradycardia-Causing Agents,DrugBank
DB00866,Cardiovascular Agents,DrugBank
DB00866,Central Nervous System Depressants,DrugBank
DB00866,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00866,Cytochrome P-450 Substrates,DrugBank
DB00866,Neurotransmitter Agents,DrugBank
DB00866,Peripheral Nervous System Agents,DrugBank
DB00866,Phenoxypropanolamines,DrugBank
DB00866,Propanolamines,DrugBank
DB00866,Propanols,DrugBank
DB00866,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00866,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00866,Serotonin Agents,DrugBank
DB00866,Serotonin Receptor Antagonists,DrugBank
DB00866,Sympatholytics,DrugBank
DB00867,Adrenergic Agents,DrugBank
DB00867,Adrenergic Agonists,DrugBank
DB00867,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00867,Adrenergic beta-Agonists,DrugBank
DB00867,Agents producing tachycardia,DrugBank
DB00867,Agents that produce hypertension,DrugBank
DB00867,Alcohols,DrugBank
DB00867,Amines,DrugBank
DB00867,Amino Alcohols,DrugBank
DB00867,Autonomic Agents,DrugBank
DB00867,Ethylamines,DrugBank
DB00867,Genito Urinary System and Sex Hormones,DrugBank
DB00867,Neurotransmitter Agents,DrugBank
DB00867,Peripheral Nervous System Agents,DrugBank
DB00867,Phenethylamines,DrugBank
DB00867,Propanolamines,DrugBank
DB00867,Propanols,DrugBank
DB00867,Reproductive Control Agents,DrugBank
DB00867,Sympathomimetics,DrugBank
DB00867,"Sympathomimetics, Labour Repressants",DrugBank
DB00867,Tocolytic Agents,DrugBank
DB00868,Alkanes,DrugBank
DB00868,Amines,DrugBank
DB00868,Antitussive Agents,DrugBank
DB00868,Butanes,DrugBank
DB00868,Central Nervous System Agents,DrugBank
DB00868,Cholinesterase substrates,DrugBank
DB00868,Cough and Cold Preparations,DrugBank
DB00868,Decreased Tracheobronchial Stretch Receptor Activity,DrugBank
DB00868,"Hydrocarbons, Acyclic",DrugBank
DB00868,Non-narcotic Antitussive,DrugBank
DB00868,Respiratory System Agents,DrugBank
DB00869,Amides,DrugBank
DB00869,Antiglaucoma Preparations and Miotics,DrugBank
DB00869,Antihypertensive Agents,DrugBank
DB00869,Carbonic Anhydrase Inhibitors,DrugBank
DB00869,Cardiovascular Agents,DrugBank
DB00869,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00869,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00869,Cytochrome P-450 Substrates,DrugBank
DB00869,Diuretics,DrugBank
DB00869,Drugs that are Mainly Renally Excreted,DrugBank
DB00869,Enzyme Inhibitors,DrugBank
DB00869,Genito Urinary System and Sex Hormones,DrugBank
DB00869,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00869,"Intraocular Pressure, drug effects",DrugBank
DB00869,Ophthalmologicals,DrugBank
DB00869,"Prostaglandins, Synthetic",DrugBank
DB00869,Sensory Organs,DrugBank
DB00869,Sulfonamides,DrugBank
DB00869,Sulfones,DrugBank
DB00869,Sulfur Compounds,DrugBank
DB00870,"Acids, Carbocyclic",DrugBank
DB00870,Agents causing hyperkalemia,DrugBank
DB00870,Analgesics,DrugBank
DB00870,"Analgesics, Non-Narcotic",DrugBank
DB00870,Anti-Inflammatory Agents,DrugBank
DB00870,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00870,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00870,Antiinflammatory and Antirheumatic Products,DrugBank
DB00870,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00870,Antirheumatic Agents,DrugBank
DB00870,Cyclooxygenase Inhibitors,DrugBank
DB00870,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00870,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00870,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00870,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00870,Cytochrome P-450 Substrates,DrugBank
DB00870,Enzyme Inhibitors,DrugBank
DB00870,Musculo-Skeletal System,DrugBank
DB00870,Nephrotoxic agents,DrugBank
DB00870,Non COX-2 selective NSAIDS,DrugBank
DB00870,Peripheral Nervous System Agents,DrugBank
DB00870,Phenylpropionates,DrugBank
DB00870,Propionates,DrugBank
DB00870,Sensory System Agents,DrugBank
DB00870,UGT1A1 Substrates,DrugBank
DB00870,UGT2B7 substrates,DrugBank
DB00871,Adrenergic Agents,DrugBank
DB00871,Adrenergic Agonists,DrugBank
DB00871,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00871,Adrenergic beta-Agonists,DrugBank
DB00871,Adrenergics for Systemic Use,DrugBank
DB00871,"Adrenergics, Inhalants",DrugBank
DB00871,Agents producing tachycardia,DrugBank
DB00871,Agents that produce hypertension,DrugBank
DB00871,Agents to Treat Airway Disease,DrugBank
DB00871,Alcohols,DrugBank
DB00871,Amines,DrugBank
DB00871,Amino Alcohols,DrugBank
DB00871,Anti-Asthmatic Agents,DrugBank
DB00871,Autonomic Agents,DrugBank
DB00871,Bronchodilator Agents,DrugBank
DB00871,Cholinesterase Inhibitors,DrugBank
DB00871,Drugs for Obstructive Airway Diseases,DrugBank
DB00871,Drugs that are Mainly Renally Excreted,DrugBank
DB00871,Ethanolamines,DrugBank
DB00871,Neurotransmitter Agents,DrugBank
DB00871,OCT2 Substrates,DrugBank
DB00871,Peripheral Nervous System Agents,DrugBank
DB00871,Potential QTc-Prolonging Agents,DrugBank
DB00871,QTc Prolonging Agents,DrugBank
DB00871,Reproductive Control Agents,DrugBank
DB00871,Respiratory System Agents,DrugBank
DB00871,Selective Beta 2-adrenergic Agonists,DrugBank
DB00871,Sympathomimetics,DrugBank
DB00871,Tocolytic Agents,DrugBank
DB00872,Antidiuretic Hormone Receptor Antagonists,DrugBank
DB00872,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00872,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00872,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00872,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00872,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00872,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00872,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00872,Cytochrome P-450 Substrates,DrugBank
DB00872,Diuretics,DrugBank
DB00872,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00872,Hypotensive Agents,DrugBank
DB00872,Narrow Therapeutic Index Drugs,DrugBank
DB00872,Natriuretic Agents,DrugBank
DB00872,P-glycoprotein inhibitors,DrugBank
DB00875,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00875,Adrenergic alpha-Antagonists,DrugBank
DB00875,Adrenergic Antagonists,DrugBank
DB00875,Agents producing tachycardia,DrugBank
DB00875,Agents that produce hypertension,DrugBank
DB00875,Anticholinergic Agents,DrugBank
DB00875,Antidepressive Agents,DrugBank
DB00875,Antipsychotic Agents,DrugBank
DB00875,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00875,Central Nervous System Agents,DrugBank
DB00875,Central Nervous System Depressants,DrugBank
DB00875,Dopamine Agents,DrugBank
DB00875,Dopamine Antagonists,DrugBank
DB00875,Dopamine D2 Receptor Antagonists,DrugBank
DB00875,Drugs causing inadvertant photosensitivity,DrugBank
DB00875,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00875,Highest Risk QTc-Prolonging Agents,DrugBank
DB00875,Muscarinic Antagonists,DrugBank
DB00875,Nervous System,DrugBank
DB00875,Neurotoxic agents,DrugBank
DB00875,Neurotransmitter Agents,DrugBank
DB00875,P-glycoprotein inhibitors,DrugBank
DB00875,Photosensitizing Agents,DrugBank
DB00875,Piperazines,DrugBank
DB00875,Psycholeptics,DrugBank
DB00875,Psychotropic Drugs,DrugBank
DB00875,QTc Prolonging Agents,DrugBank
DB00875,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00875,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00875,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00875,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00875,Serotonin Agents,DrugBank
DB00875,Serotonin Receptor Antagonists,DrugBank
DB00875,Sulfur Compounds,DrugBank
DB00875,Thioxanthene Derivatives,DrugBank
DB00875,Thioxanthenes,DrugBank
DB00875,Tranquilizing Agents,DrugBank
DB00875,Xanthenes,DrugBank
DB00876,"Acids, Acyclic",DrugBank
DB00876,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00876,Agents causing angioedema,DrugBank
DB00876,Agents causing hyperkalemia,DrugBank
DB00876,Agents Causing Muscle Toxicity,DrugBank
DB00876,Angiotensin 2 Receptor Blocker,DrugBank
DB00876,Angiotensin II receptor antagonists,DrugBank
DB00876,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB00876,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB00876,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB00876,Angiotensin Receptor Antagonists,DrugBank
DB00876,Antihypertensive Agents,DrugBank
DB00876,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00876,Cardiovascular Agents,DrugBank
DB00876,Hypotensive Agents,DrugBank
DB00876,Sulfur Compounds,DrugBank
DB00877,Agents causing angioedema,DrugBank
DB00877,Anti-Bacterial Agents,DrugBank
DB00877,Anti-Infective Agents,DrugBank
DB00877,"Antibiotics, Antineoplastic",DrugBank
DB00877,Antifungal Agents,DrugBank
DB00877,Antineoplastic and Immunomodulating Agents,DrugBank
DB00877,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00877,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00877,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00877,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00877,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB00877,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00877,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00877,Cytochrome P-450 Substrates,DrugBank
DB00877,Decreased Immunologic Activity,DrugBank
DB00877,Hyperglycemia-Associated Agents,DrugBank
DB00877,Immunologic Factors,DrugBank
DB00877,Immunosuppressive Agents,DrugBank
DB00877,Immunotherapy,DrugBank
DB00877,Kinase Inhibitor,DrugBank
DB00877,Lactones,DrugBank
DB00877,Macrolides,DrugBank
DB00877,Mammalian target of rapamycin (mTOR) kinase inhibitors,DrugBank
DB00877,mTOR Inhibitor Immunosuppressant,DrugBank
DB00877,mTOR Inhibitors,DrugBank
DB00877,Myelosuppressive Agents,DrugBank
DB00877,Narrow Therapeutic Index Drugs,DrugBank
DB00877,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00877,Ophthalmologicals,DrugBank
DB00877,P-glycoprotein inducers,DrugBank
DB00877,P-glycoprotein inhibitors,DrugBank
DB00877,P-glycoprotein substrates,DrugBank
DB00877,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00877,Polyketides,DrugBank
DB00877,Protein Kinase Inhibitors,DrugBank
DB00877,Selective Immunosuppressants,DrugBank
DB00877,Sensory Organs,DrugBank
DB00877,Sirolimus and Prodrugs,DrugBank
DB00879,Anti-HIV Agents,DrugBank
DB00879,Anti-Infective Agents,DrugBank
DB00879,Anti-Retroviral Agents,DrugBank
DB00879,Antiinfectives for Systemic Use,DrugBank
DB00879,Antiviral Agents,DrugBank
DB00879,Antivirals for Systemic Use,DrugBank
DB00879,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB00879,Carbohydrates,DrugBank
DB00879,Deoxycytidine,DrugBank
DB00879,Deoxyribonucleosides,DrugBank
DB00879,Dideoxynucleosides,DrugBank
DB00879,Direct Acting Antivirals,DrugBank
DB00879,Enzyme Inhibitors,DrugBank
DB00879,Glycosides,DrugBank
DB00879,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00879,MATE 1 Substrates,DrugBank
DB00879,MATE substrates,DrugBank
DB00879,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00879,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00879,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00879,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00879,Nucleosides,DrugBank
DB00879,Pyrimidine Nucleosides,DrugBank
DB00879,Pyrimidines,DrugBank
DB00879,Reverse Transcriptase Inhibitors,DrugBank
DB00879,Ribonucleosides,DrugBank
DB00880,Antihypertensive Agents,DrugBank
DB00880,Benzothiadiazines,DrugBank
DB00880,Cardiovascular Agents,DrugBank
DB00880,Diuretics,DrugBank
DB00880,Drugs causing inadvertant photosensitivity,DrugBank
DB00880,Genito Urinary System and Sex Hormones,DrugBank
DB00880,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00880,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00880,Hyperglycemia-Associated Agents,DrugBank
DB00880,Hypotensive Agents,DrugBank
DB00880,Increased Diuresis,DrugBank
DB00880,Membrane Transport Modulators,DrugBank
DB00880,Natriuretic Agents,DrugBank
DB00880,OAT1/SLC22A6 inhibitors,DrugBank
DB00880,Photosensitizing Agents,DrugBank
DB00880,Sodium Chloride Symporter Inhibitors,DrugBank
DB00880,Sulfonamides,DrugBank
DB00880,Sulfones,DrugBank
DB00880,Sulfur Compounds,DrugBank
DB00880,Thiazides,DrugBank
DB00881,ACE Inhibitors and Diuretics,DrugBank
DB00881,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00881,Agents causing angioedema,DrugBank
DB00881,Agents causing hyperkalemia,DrugBank
DB00881,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00881,Antihypertensive Agents,DrugBank
DB00881,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00881,Cardiovascular Agents,DrugBank
DB00881,Enzyme Inhibitors,DrugBank
DB00881,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00881,Hypotensive Agents,DrugBank
DB00881,Isoquinolines,DrugBank
DB00881,OAT3/SLC22A8 Substrates,DrugBank
DB00881,Protease Inhibitors,DrugBank
DB00881,Tetrahydroisoquinolines,DrugBank
DB00882,Benzene Derivatives,DrugBank
DB00882,Benzylidene Compounds,DrugBank
DB00882,Clomiphene,DrugBank
DB00882,Estrogen Agonist-antagonists,DrugBank
DB00882,Estrogen Agonist/Antagonist,DrugBank
DB00882,Estrogen Antagonists,DrugBank
DB00882,Estrogen Receptor Modulators,DrugBank
DB00882,Fertility Agents,DrugBank
DB00882,"Fertility Agents, Female",DrugBank
DB00882,Genito Urinary System and Sex Hormones,DrugBank
DB00882,Hormone Antagonists,DrugBank
DB00882,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00882,"Ovulation Stimulants, Synthetic",DrugBank
DB00882,P-glycoprotein substrates,DrugBank
DB00882,Reproductive Control Agents,DrugBank
DB00882,Selective Estrogen Receptor Modulators,DrugBank
DB00882,Sex Hormones and Modulators of the Genital System,DrugBank
DB00882,Stilbenes,DrugBank
DB00883,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB00883,Alcohols,DrugBank
DB00883,Antianginal Agents,DrugBank
DB00883,Carbohydrates,DrugBank
DB00883,Cardiac Therapy,DrugBank
DB00883,Cardiovascular Agents,DrugBank
DB00883,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00883,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00883,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00883,Hypotensive Agents,DrugBank
DB00883,Methemoglobinemia Associated Agents,DrugBank
DB00883,Nitrate Vasodilator,DrugBank
DB00883,Nitrates and Nitrites,DrugBank
DB00883,Nitric Oxide Donors,DrugBank
DB00883,Organic Nitrates,DrugBank
DB00883,Sugar Alcohols,DrugBank
DB00883,Vasodilating Agents,DrugBank
DB00883,Vasodilation,DrugBank
DB00883,Vasodilators Used in Cardiac Diseases,DrugBank
DB00883,Vasoprotectives,DrugBank
DB00884,Agents Causing Muscle Toxicity,DrugBank
DB00884,Bisphosphonates,DrugBank
DB00884,Bone Density Conservation Agents,DrugBank
DB00884,Calcium-Regulating Hormones and Agents,DrugBank
DB00884,Cardiovascular Agents,DrugBank
DB00884,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB00884,Drugs for Treatment of Bone Diseases,DrugBank
DB00884,Membrane Transport Modulators,DrugBank
DB00884,Musculo-Skeletal System,DrugBank
DB00884,Organophosphonates,DrugBank
DB00884,Organophosphorus Compounds,DrugBank
DB00884,Pyridines,DrugBank
DB00886,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00886,Agents causing angioedema,DrugBank
DB00886,Agents causing hyperkalemia,DrugBank
DB00886,Agents that produce hypertension,DrugBank
DB00886,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB00886,Antihypertensive Agents,DrugBank
DB00886,Azepines,DrugBank
DB00886,Cardiovascular Agents,DrugBank
DB00886,Enzyme Inhibitors,DrugBank
DB00886,"Metalloendopeptidases, antagonists & inhibitors",DrugBank
DB00886,Protease Inhibitors,DrugBank
DB00886,Sulfur Compounds,DrugBank
DB00886,Thiepins,DrugBank
DB00886,Vasopeptidase Inhibitors,DrugBank
DB00887,"Acids, Carbocyclic",DrugBank
DB00887,Agents Causing Muscle Toxicity,DrugBank
DB00887,Amides,DrugBank
DB00887,Aminobenzoates,DrugBank
DB00887,Benzene Derivatives,DrugBank
DB00887,Benzoates,DrugBank
DB00887,Cardiovascular Agents,DrugBank
DB00887,Diuretics,DrugBank
DB00887,Drugs causing inadvertant photosensitivity,DrugBank
DB00887,Drugs that are Mainly Renally Excreted,DrugBank
DB00887,Genito Urinary System and Sex Hormones,DrugBank
DB00887,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00887,High-Ceiling Diuretics,DrugBank
DB00887,High-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00887,Hyperglycemia-Associated Agents,DrugBank
DB00887,Hypotensive Agents,DrugBank
DB00887,Increased Diuresis at Loop of Henle,DrugBank
DB00887,Membrane Transport Modulators,DrugBank
DB00887,meta-Aminobenzoates,DrugBank
DB00887,Natriuretic Agents,DrugBank
DB00887,Nephrotoxic agents,DrugBank
DB00887,Non Potassium Sparing Diuretics,DrugBank
DB00887,OAT1/SLC22A6 inhibitors,DrugBank
DB00887,OAT3/SLC22A8 Inhibitors,DrugBank
DB00887,OAT3/SLC22A8 Substrates,DrugBank
DB00887,Photosensitizing Agents,DrugBank
DB00887,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB00887,Sulfonamides,DrugBank
DB00887,Sulfones,DrugBank
DB00887,Sulfur Compounds,DrugBank
DB00888,Alkylating Activity,DrugBank
DB00888,Alkylating Drugs,DrugBank
DB00888,Antineoplastic Agents,DrugBank
DB00888,"Antineoplastic Agents, Alkylating",DrugBank
DB00888,Antineoplastic and Immunomodulating Agents,DrugBank
DB00888,Cardiotoxic antineoplastic agents,DrugBank
DB00888,Cholinesterase Inhibitors,DrugBank
DB00888,"Compounds used in a research, industrial, or household setting",DrugBank
DB00888,"Hydrocarbons, Halogenated",DrugBank
DB00888,Immunosuppressive Agents,DrugBank
DB00888,Irritants,DrugBank
DB00888,Mustard Compounds,DrugBank
DB00888,Myelosuppressive Agents,DrugBank
DB00888,Narrow Therapeutic Index Drugs,DrugBank
DB00888,Nitrogen Mustard Analogues,DrugBank
DB00888,Nitrogen Mustard Compounds,DrugBank
DB00888,Noxae,DrugBank
DB00888,Poisons,DrugBank
DB00888,Toxic Actions,DrugBank
DB00889,Alimentary Tract and Metabolism,DrugBank
DB00889,Antidepressive Agents,DrugBank
DB00889,Antiemetic Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00889,Antiemetics,DrugBank
DB00889,Antiemetics and Antinauseants,DrugBank
DB00889,Autonomic Agents,DrugBank
DB00889,Aza Compounds,DrugBank
DB00889,Azabicyclo Compounds,DrugBank
DB00889,Central Nervous System Agents,DrugBank
DB00889,Central Nervous System Depressants,DrugBank
DB00889,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00889,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00889,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00889,Cytochrome P-450 Substrates,DrugBank
DB00889,Gastrointestinal Agents,DrugBank
DB00889,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00889,Indazoles,DrugBank
DB00889,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00889,Neurotransmitter Agents,DrugBank
DB00889,Peripheral Nervous System Agents,DrugBank
DB00889,Pyrazoles,DrugBank
DB00889,QTc Prolonging Agents,DrugBank
DB00889,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00889,Serotonin 3 Receptor Antagonists,DrugBank
DB00889,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00889,Serotonin Agents,DrugBank
DB00889,Serotonin Receptor Antagonists,DrugBank
DB00890,Benzene Derivatives,DrugBank
DB00890,Benzyl Compounds,DrugBank
DB00890,Benzylidene Compounds,DrugBank
DB00890,Bibenzyls,DrugBank
DB00890,Dihydrostilbenoids,DrugBank
DB00890,Estrogens,DrugBank
DB00890,"Estrogens, Non-Steroidal",DrugBank
DB00890,Genito Urinary System and Sex Hormones,DrugBank
DB00890,Hormones,DrugBank
DB00890,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00890,Phenols,DrugBank
DB00890,Sex Hormones and Modulators of the Genital System,DrugBank
DB00890,Stilbenes,DrugBank
DB00890,Stilbestrols,DrugBank
DB00890,"Synthetic Estrogens, Plain",DrugBank
DB00891,Amides,DrugBank
DB00891,Amines,DrugBank
DB00891,Aniline Compounds,DrugBank
DB00891,Anti-Infective Agents,DrugBank
DB00891,Antibacterials for Systemic Use,DrugBank
DB00891,Antiinfectives for Systemic Use,DrugBank
DB00891,Benzene Derivatives,DrugBank
DB00891,Benzenesulfonamides,DrugBank
DB00891,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00891,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00891,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00891,Dermatologicals,DrugBank
DB00891,Genito Urinary System and Sex Hormones,DrugBank
DB00891,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00891,Methemoglobinemia Associated Agents,DrugBank
DB00891,Short-Acting Antibacterial Sulfonamides,DrugBank
DB00891,Sulfanilamides,DrugBank
DB00891,Sulfonamides,DrugBank
DB00891,Sulfonamides and trimethoprim,DrugBank
DB00891,Sulfones,DrugBank
DB00891,Sulfur Compounds,DrugBank
DB00892,"Acids, Carbocyclic",DrugBank
DB00892,Aminobenzoates,DrugBank
DB00892,Anesthetics,DrugBank
DB00892,Anesthetics for Topical Use,DrugBank
DB00892,"Anesthetics, Local",DrugBank
DB00892,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB00892,Benzene Derivatives,DrugBank
DB00892,Benzoates,DrugBank
DB00892,Central Nervous System Agents,DrugBank
DB00892,Central Nervous System Depressants,DrugBank
DB00892,Cholinesterase substrates,DrugBank
DB00892,Dermatologicals,DrugBank
DB00892,Local Anesthetics (Ester),DrugBank
DB00892,Ophthalmologicals,DrugBank
DB00892,para-Aminobenzoates,DrugBank
DB00892,Peripheral Nervous System Agents,DrugBank
DB00892,Sensory Organs,DrugBank
DB00892,Sensory System Agents,DrugBank
DB00893,"Compounds used in a research, industrial, or household setting",DrugBank
DB00893,Dextrans,DrugBank
DB00893,Hematinics,DrugBank
DB00893,Iron Compounds,DrugBank
DB00893,Iron Preparations,DrugBank
DB00893,Parenteral Iron Replacement,DrugBank
DB00893,Supplements,DrugBank
DB00894,Androstadienes,DrugBank
DB00894,Androstanes,DrugBank
DB00894,Androstenes,DrugBank
DB00894,Antineoplastic Agents,DrugBank
DB00894,"Antineoplastic Agents, Hormonal",DrugBank
DB00894,Aromatase Inhibitors,DrugBank
DB00894,Drugs that are Mainly Renally Excreted,DrugBank
DB00894,Fused-Ring Compounds,DrugBank
DB00894,Homosteroids,DrugBank
DB00894,Steroids,DrugBank
DB00895,Acetamides,DrugBank
DB00895,Amides,DrugBank
DB00895,Anti-Bacterial Agents,DrugBank
DB00895,Antibacterials for Systemic Use,DrugBank
DB00895,Antiinfectives for Systemic Use,DrugBank
DB00895,Benzene Derivatives,DrugBank
DB00895,beta-Lactams,DrugBank
DB00895,Drug Hypersensitivity,DrugBank
DB00895,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00895,Lactams,DrugBank
DB00895,Penicillins,DrugBank
DB00895,Sulfur Compounds,DrugBank
DB00896,Adrenal Cortex Hormones,DrugBank
DB00896,Anti-Inflammatory Agents,DrugBank
DB00896,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00896,Corticosteroids,DrugBank
DB00896,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00896,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00896,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB00896,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00896,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00896,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB00896,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00896,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB00896,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB00896,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00896,Cytochrome P-450 Substrates,DrugBank
DB00896,Fused-Ring Compounds,DrugBank
DB00896,Glucocorticoids,DrugBank
DB00896,Hormones,DrugBank
DB00896,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00896,Hyperglycemia-Associated Agents,DrugBank
DB00896,Immunosuppressive Agents,DrugBank
DB00896,Ophthalmologicals,DrugBank
DB00896,Pregnanes,DrugBank
DB00896,Sensory Organs,DrugBank
DB00896,Steroids,DrugBank
DB00896,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00896,Thyroxine-binding globulin inhibitors,DrugBank
DB00897,"Adjuvants, Anesthesia",DrugBank
DB00897,Agents Causing Muscle Toxicity,DrugBank
DB00897,Anti-Anxiety Agents,DrugBank
DB00897,Benzazepines,DrugBank
DB00897,Benzodiazepine hypnotics and sedatives,DrugBank
DB00897,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB00897,Central Nervous System Agents,DrugBank
DB00897,Central Nervous System Depressants,DrugBank
DB00897,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00897,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00897,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00897,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00897,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00897,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00897,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00897,Cytochrome P-450 Substrates,DrugBank
DB00897,Drugs that are Mainly Renally Excreted,DrugBank
DB00897,GABA Agents,DrugBank
DB00897,GABA Modulators,DrugBank
DB00897,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00897,Hypnotics and Sedatives,DrugBank
DB00897,Nervous System,DrugBank
DB00897,Neurotransmitter Agents,DrugBank
DB00897,Psycholeptics,DrugBank
DB00897,Psychotropic Drugs,DrugBank
DB00897,Tranquilizing Agents,DrugBank
DB00897,Triazolobenzodiazepines,DrugBank
DB00898,Agents Causing Muscle Toxicity,DrugBank
DB00898,Alcohols,DrugBank
DB00898,Anti-Infective Agents,DrugBank
DB00898,"Anti-Infective Agents, Local",DrugBank
DB00898,Antidotes,DrugBank
DB00898,Antiseptics and Disinfectants,DrugBank
DB00898,Central Nervous System Agents,DrugBank
DB00898,Central Nervous System Depressants,DrugBank
DB00898,"Compounds used in a research, industrial, or household setting",DrugBank
DB00898,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00898,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00898,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00898,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00898,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00898,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00898,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00898,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00898,Cytochrome P-450 CYP2E1 Inducers (moderate),DrugBank
DB00898,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00898,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00898,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00898,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00898,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00898,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00898,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00898,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00898,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00898,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00898,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00898,Cytochrome P-450 Substrates,DrugBank
DB00898,Dermatologicals,DrugBank
DB00898,Miscellaneous Local Anti-infectives,DrugBank
DB00898,Miscellaneous Therapeutic Agents,DrugBank
DB00898,Nerve Depressants,DrugBank
DB00898,Neurotoxic agents,DrugBank
DB00898,NMDA Receptor Antagonists,DrugBank
DB00898,Solvents,DrugBank
DB00899,"Acids, Acyclic",DrugBank
DB00899,Agents producing tachycardia,DrugBank
DB00899,Agents that produce hypertension,DrugBank
DB00899,Analgesics,DrugBank
DB00899,Anesthetics,DrugBank
DB00899,"Anesthetics, General",DrugBank
DB00899,"Anesthetics, Intravenous",DrugBank
DB00899,Bradycardia-Causing Agents,DrugBank
DB00899,Central Nervous System Agents,DrugBank
DB00899,Central Nervous System Depressants,DrugBank
DB00899,Fentanyl and fentanyl analogues,DrugBank
DB00899,High-risk opioids,DrugBank
DB00899,Hypnotics and Sedatives,DrugBank
DB00899,Hypotensive Agents,DrugBank
DB00899,Narcotics,DrugBank
DB00899,Nervous System,DrugBank
DB00899,Opiate Agonists,DrugBank
DB00899,Opioid Agonist,DrugBank
DB00899,Opioid Anesthetics,DrugBank
DB00899,Opioids,DrugBank
DB00899,"Opioids, Anilidopiperidine",DrugBank
DB00899,Peripheral Nervous System Agents,DrugBank
DB00899,Phenylpiperidine opioids,DrugBank
DB00899,Piperidines,DrugBank
DB00899,Propionates,DrugBank
DB00899,Sensory System Agents,DrugBank
DB00899,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00900,Anti-HIV Agents,DrugBank
DB00900,Anti-Infective Agents,DrugBank
DB00900,Anti-Retroviral Agents,DrugBank
DB00900,Antiinfectives for Systemic Use,DrugBank
DB00900,Antimetabolites,DrugBank
DB00900,Antiviral Agents,DrugBank
DB00900,Antivirals for Systemic Use,DrugBank
DB00900,Deoxyribonucleosides,DrugBank
DB00900,Dideoxynucleosides,DrugBank
DB00900,Direct Acting Antivirals,DrugBank
DB00900,Drugs that are Mainly Renally Excreted,DrugBank
DB00900,Enzyme Inhibitors,DrugBank
DB00900,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00900,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB00900,Neurotoxic agents,DrugBank
DB00900,Noxae,DrugBank
DB00900,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00900,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00900,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00900,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00900,Nucleosides,DrugBank
DB00900,OAT1/SLC22A6 Substrates,DrugBank
DB00900,Purine Nucleosides,DrugBank
DB00900,Purines,DrugBank
DB00900,Reverse Transcriptase Inhibitors,DrugBank
DB00900,Ribonucleosides,DrugBank
DB00900,Toxic Actions,DrugBank
DB00901,Adrenergic Agents,DrugBank
DB00901,Adrenergic Agonists,DrugBank
DB00901,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00901,Adrenergic beta-Agonists,DrugBank
DB00901,"Adrenergics, Inhalants",DrugBank
DB00901,Agents producing tachycardia,DrugBank
DB00901,Agents that produce hypertension,DrugBank
DB00901,Alcohols,DrugBank
DB00901,Amines,DrugBank
DB00901,Amino Alcohols,DrugBank
DB00901,Anti-Asthmatic Agents,DrugBank
DB00901,Autonomic Agents,DrugBank
DB00901,Bronchodilator Agents,DrugBank
DB00901,Drugs for Obstructive Airway Diseases,DrugBank
DB00901,Neurotransmitter Agents,DrugBank
DB00901,Peripheral Nervous System Agents,DrugBank
DB00901,Respiratory System Agents,DrugBank
DB00901,Selective Beta 2-adrenergic Agonists,DrugBank
DB00902,Agents that reduce seizure threshold,DrugBank
DB00902,Antihistamines for Systemic Use,DrugBank
DB00902,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00902,Histamine Antagonists,DrugBank
DB00902,Histamine H1 Antagonists,DrugBank
DB00902,Phenothiazine Derivatives,DrugBank
DB00902,Sulfur Compounds,DrugBank
DB00903,Acetates,DrugBank
DB00903,"Acids, Acyclic",DrugBank
DB00903,Agents that produce neuromuscular block (indirect),DrugBank
DB00903,Aryloxyacetic Acid Derivatives,DrugBank
DB00903,Diuretics,DrugBank
DB00903,Enzyme Inhibitors,DrugBank
DB00903,Glycolates,DrugBank
DB00903,High-Ceiling Diuretics,DrugBank
DB00903,Hydroxy Acids,DrugBank
DB00903,Hyperglycemia-Associated Agents,DrugBank
DB00903,Hypotensive Agents,DrugBank
DB00903,Increased Diuresis at Loop of Henle,DrugBank
DB00903,Natriuretic Agents,DrugBank
DB00903,Nephrotoxic agents,DrugBank
DB00903,Non Potassium Sparing Diuretics,DrugBank
DB00903,OAT1/SLC22A6 inhibitors,DrugBank
DB00903,Ototoxic agents,DrugBank
DB00903,Phenoxyacetates,DrugBank
DB00903,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB00904,Anti-Anxiety Agents,DrugBank
DB00904,Antidepressive Agents,DrugBank
DB00904,Antiemetic Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00904,Antiemetics,DrugBank
DB00904,Antiemetics and Antinauseants,DrugBank
DB00904,Carbazoles,DrugBank
DB00904,Central Nervous System Agents,DrugBank
DB00904,Central Nervous System Depressants,DrugBank
DB00904,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00904,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00904,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00904,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00904,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00904,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00904,Cytochrome P-450 Substrates,DrugBank
DB00904,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00904,Imidazoles,DrugBank
DB00904,Indoles,DrugBank
DB00904,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00904,Peripheral Nervous System Agents,DrugBank
DB00904,Psychotropic Drugs,DrugBank
DB00904,QTc Prolonging Agents,DrugBank
DB00904,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00904,Serotonin 3 Receptor Antagonists,DrugBank
DB00904,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00904,Serotonin Agents,DrugBank
DB00904,Serotonin Receptor Antagonists,DrugBank
DB00905,Amides,DrugBank
DB00905,Antiglaucoma Preparations and Miotics,DrugBank
DB00905,Antihypertensive Agents,DrugBank
DB00905,Autacoids,DrugBank
DB00905,Biological Factors,DrugBank
DB00905,Cardiovascular Agents,DrugBank
DB00905,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00905,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00905,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00905,Cytochrome P-450 Substrates,DrugBank
DB00905,Drugs that are Mainly Renally Excreted,DrugBank
DB00905,Eicosanoids,DrugBank
DB00905,Fatty Acids,DrugBank
DB00905,"Fatty Acids, Unsaturated",DrugBank
DB00905,Inflammation Mediators,DrugBank
DB00905,Lipids,DrugBank
DB00905,Ophthalmologicals,DrugBank
DB00905,Prostaglandin analogs reducing intraocular pressure (IOP),DrugBank
DB00905,Prostaglandins,DrugBank
DB00905,"Prostaglandins F, Synthetic",DrugBank
DB00905,"Prostaglandins, Synthetic",DrugBank
DB00905,Sensory Organs,DrugBank
DB00906,Anti-epileptic Agent,DrugBank
DB00906,Anticonvulsants,DrugBank
DB00906,Central Nervous System Agents,DrugBank
DB00906,Central Nervous System Depressants,DrugBank
DB00906,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00906,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00906,Cytochrome P-450 Substrates,DrugBank
DB00906,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00906,Fatty Acid Derivatives,DrugBank
DB00906,GABA Agents,DrugBank
DB00906,GABA Uptake Inhibitors,DrugBank
DB00906,Membrane Transport Modulators,DrugBank
DB00906,Nervous System,DrugBank
DB00906,Neurotransmitter Agents,DrugBank
DB00906,Neurotransmitter Uptake Inhibitors,DrugBank
DB00906,Nipecotic Acid and Derivatives,DrugBank
DB00906,Piperidines,DrugBank
DB00906,UGT1A1 Substrates,DrugBank
DB00907,Agents producing tachycardia,DrugBank
DB00907,Agents that reduce seizure threshold,DrugBank
DB00907,Alkaloids,DrugBank
DB00907,Analgesics and Anesthetics,DrugBank
DB00907,Anesthetics,DrugBank
DB00907,"Anesthetics, Local",DrugBank
DB00907,Anticholinergic Agents,DrugBank
DB00907,Aza Compounds,DrugBank
DB00907,Azabicyclo Compounds,DrugBank
DB00907,Cardiovascular Agents,DrugBank
DB00907,Central Nervous System Agents,DrugBank
DB00907,Central Nervous System Stimulants,DrugBank
DB00907,Cholinesterase substrates,DrugBank
DB00907,"Cocaine, antagonists & inhibitors",DrugBank
DB00907,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00907,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00907,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00907,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00907,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00907,Cytochrome P-450 Substrates,DrugBank
DB00907,Dopamine Agents,DrugBank
DB00907,Dopamine Uptake Inhibitors,DrugBank
DB00907,Esters of Benzoic Acid,DrugBank
DB00907,Highest Risk QTc-Prolonging Agents,DrugBank
DB00907,Local Anesthetics (Ester),DrugBank
DB00907,Membrane Transport Modulators,DrugBank
DB00907,Muscarinic Antagonists,DrugBank
DB00907,Nervous System,DrugBank
DB00907,Neurotransmitter Agents,DrugBank
DB00907,Neurotransmitter Uptake Inhibitors,DrugBank
DB00907,OCT2 Inhibitors,DrugBank
DB00907,Ophthalmologicals,DrugBank
DB00907,QTc Prolonging Agents,DrugBank
DB00907,Sensory Organs,DrugBank
DB00907,Sensory System Agents,DrugBank
DB00907,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00907,Throat Preparations,DrugBank
DB00907,Tropanes,DrugBank
DB00907,Vasoconstrictor Agents,DrugBank
DB00908,Adrenergic Agents,DrugBank
DB00908,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00908,Adrenergic alpha-Antagonists,DrugBank
DB00908,Adrenergic Antagonists,DrugBank
DB00908,Agents producing tachycardia,DrugBank
DB00908,Agents that produce hypertension,DrugBank
DB00908,Agents that produce neuromuscular block (indirect),DrugBank
DB00908,Agents that reduce seizure threshold,DrugBank
DB00908,Alkaloids,DrugBank
DB00908,Anti-Infective Agents,DrugBank
DB00908,Antiarrhythmic agents,DrugBank
DB00908,"Antiarrhythmics, Class I",DrugBank
DB00908,"Antiarrhythmics, Class Ia",DrugBank
DB00908,Anticholinergic Agents,DrugBank
DB00908,Antimalarials,DrugBank
DB00908,Antiparasitic Agents,DrugBank
DB00908,Antiprotozoals,DrugBank
DB00908,Biological Products,DrugBank
DB00908,Biopolymers,DrugBank
DB00908,BSEP/ABCB11 Inhibitors,DrugBank
DB00908,Carbohydrates,DrugBank
DB00908,Cardiac Therapy,DrugBank
DB00908,Cardiovascular Agents,DrugBank
DB00908,Cholinergic Agents,DrugBank
DB00908,Cinchona Alkaloids,DrugBank
DB00908,Complex Mixtures,DrugBank
DB00908,"Compounds used in a research, industrial, or household setting",DrugBank
DB00908,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB00908,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00908,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00908,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB00908,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB00908,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00908,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00908,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00908,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB00908,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00908,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB00908,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00908,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00908,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00908,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00908,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00908,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00908,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB00908,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00908,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00908,Cytochrome P-450 Substrates,DrugBank
DB00908,Drugs causing inadvertant photosensitivity,DrugBank
DB00908,Drugs that are Mainly Renally Excreted,DrugBank
DB00908,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00908,Enzyme Inhibitors,DrugBank
DB00908,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00908,Highest Risk QTc-Prolonging Agents,DrugBank
DB00908,Macromolecular Substances,DrugBank
DB00908,Membrane Transport Modulators,DrugBank
DB00908,Muscarinic Antagonists,DrugBank
DB00908,Narrow Therapeutic Index Drugs,DrugBank
DB00908,Negative Inotrope,DrugBank
DB00908,Neurotransmitter Agents,DrugBank
DB00908,OAT3/SLC22A8 Inhibitors,DrugBank
DB00908,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00908,OCT1 inhibitors,DrugBank
DB00908,OCT2 Inhibitors,DrugBank
DB00908,P-glycoprotein inhibitors,DrugBank
DB00908,P-glycoprotein substrates,DrugBank
DB00908,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00908,Pharmaceutical Preparations,DrugBank
DB00908,Photosensitizing Agents,DrugBank
DB00908,Plant Extracts,DrugBank
DB00908,Plant Preparations,DrugBank
DB00908,Polymers,DrugBank
DB00908,Polysaccharides,DrugBank
DB00908,QTc Prolonging Agents,DrugBank
DB00908,Quinolines,DrugBank
DB00908,Quinuclidines,DrugBank
DB00908,Sodium Channel Blockers,DrugBank
DB00908,Voltage-Gated Sodium Channel Blockers,DrugBank
DB00909,Agents causing hyperkalemia,DrugBank
DB00909,Amides,DrugBank
DB00909,Anti-epileptic Agent,DrugBank
DB00909,Antiarrhythmic agents,DrugBank
DB00909,Anticonvulsants,DrugBank
DB00909,Bradycardia-Causing Agents,DrugBank
DB00909,Calcium Channel Blockers,DrugBank
DB00909,Calcium-Regulating Hormones and Agents,DrugBank
DB00909,Carbonic Anhydrase Inhibitors,DrugBank
DB00909,Cardiovascular Agents,DrugBank
DB00909,Central Nervous System Agents,DrugBank
DB00909,Central Nervous System Depressants,DrugBank
DB00909,"Compounds used in a research, industrial, or household setting",DrugBank
DB00909,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00909,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00909,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00909,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00909,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00909,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00909,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00909,Cytochrome P-450 Substrates,DrugBank
DB00909,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00909,Diuretics,DrugBank
DB00909,Drugs that are Mainly Renally Excreted,DrugBank
DB00909,Isoxazoles,DrugBank
DB00909,Membrane Transport Modulators,DrugBank
DB00909,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB00909,Nervous System,DrugBank
DB00909,P-glycoprotein inhibitors,DrugBank
DB00909,Potential QTc-Prolonging Agents,DrugBank
DB00909,QTc Prolonging Agents,DrugBank
DB00909,Sulfonamides,DrugBank
DB00909,Sulfones,DrugBank
DB00909,Sulfur Compounds,DrugBank
DB00909,UGT1A1 Substrates,DrugBank
DB00910,Anti-Parathyroid Agents,DrugBank
DB00910,Bone Density Conservation Agents,DrugBank
DB00910,Calcium Homeostasis,DrugBank
DB00910,Cholestanes,DrugBank
DB00910,Cholestenes,DrugBank
DB00910,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00910,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00910,Cytochrome P-450 Substrates,DrugBank
DB00910,Fused-Ring Compounds,DrugBank
DB00910,Lipids,DrugBank
DB00910,Membrane Lipids,DrugBank
DB00910,Secosteroids,DrugBank
DB00910,Steroids,DrugBank
DB00910,Sterols,DrugBank
DB00910,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00910,UGT1A4 substrates,DrugBank
DB00910,Vitamin D and Analogues,DrugBank
DB00910,Vitamins,DrugBank
DB00910,Vitamins (Fat Soluble),DrugBank
DB00911,Alimentary Tract and Metabolism,DrugBank
DB00911,Alkylating Drugs,DrugBank
DB00911,Anti-Bacterial Agents,DrugBank
DB00911,Anti-Infective Agents,DrugBank
DB00911,Antibacterials for Systemic Use,DrugBank
DB00911,Antiinfectives for Systemic Use,DrugBank
DB00911,Antiparasitic Agents,DrugBank
DB00911,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00911,Antiprotozoals,DrugBank
DB00911,Antitrichomonal Agents,DrugBank
DB00911,BSEP/ABCB11 Substrates,DrugBank
DB00911,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00911,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00911,Cytochrome P-450 Substrates,DrugBank
DB00911,Drugs for Acid Related Disorders,DrugBank
DB00911,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00911,Drugs that are Mainly Renally Excreted,DrugBank
DB00911,Genito Urinary System and Sex Hormones,DrugBank
DB00911,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00911,Imidazole Derivatives,DrugBank
DB00911,Imidazoles,DrugBank
DB00911,Nitro Compounds,DrugBank
DB00911,Nitroimidazole Antimicrobial,DrugBank
DB00911,Nitroimidazole Derivatives,DrugBank
DB00911,Nitroimidazoles,DrugBank
DB00911,Noxae,DrugBank
DB00911,Toxic Actions,DrugBank
DB00912,"Acids, Acyclic",DrugBank
DB00912,Alimentary Tract and Metabolism,DrugBank
DB00912,Blood Glucose Lowering Agents,DrugBank
DB00912,BSEP/ABCB11 Substrates,DrugBank
DB00912,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00912,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00912,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00912,Cytochrome P-450 Substrates,DrugBank
DB00912,Drugs Used in Diabetes,DrugBank
DB00912,Glinide,DrugBank
DB00912,Hypoglycemia-Associated Agents,DrugBank
DB00912,Insulin Secretagogues,DrugBank
DB00912,Meglitinides,DrugBank
DB00912,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00912,Oral Hypoglycemics,DrugBank
DB00912,Potassium Channel Blockers,DrugBank
DB00912,Stereoisomerism,DrugBank
DB00913,Anesthetics,DrugBank
DB00913,"Anesthetics, General",DrugBank
DB00913,Nervous System,DrugBank
DB00913,Opioid Anesthetics,DrugBank
DB00913,Piperidines,DrugBank
DB00914,Alimentary Tract and Metabolism,DrugBank
DB00914,Amidines,DrugBank
DB00914,Biguanides,DrugBank
DB00914,Blood Glucose Lowering Agents,DrugBank
DB00914,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00914,Cytochrome P-450 Substrates,DrugBank
DB00914,Drugs Used in Diabetes,DrugBank
DB00914,Guanidines,DrugBank
DB00914,OCT1 inhibitors,DrugBank
DB00914,OCT1 substrates,DrugBank
DB00914,OCT2 Inhibitors,DrugBank
DB00914,Oral Hypoglycemics,DrugBank
DB00915,Adamantane Derivatives,DrugBank
DB00915,Adamantanes,DrugBank
DB00915,Analgesics,DrugBank
DB00915,"Analgesics, Non-Narcotic",DrugBank
DB00915,Anti-Dyskinesia Agents,DrugBank
DB00915,Anti-Infective Agents,DrugBank
DB00915,Anti-Parkinson Drugs,DrugBank
DB00915,Anticholinergic Agents,DrugBank
DB00915,Antiviral Agents,DrugBank
DB00915,Bridged-Ring Compounds,DrugBank
DB00915,Central Nervous System Agents,DrugBank
DB00915,Dopamine Agents,DrugBank
DB00915,Drugs that are Mainly Renally Excreted,DrugBank
DB00915,Influenza A M2 Protein Inhibitor,DrugBank
DB00915,M2 Protein Inhibitors,DrugBank
DB00915,Nervous System,DrugBank
DB00915,Neurotransmitter Agents,DrugBank
DB00915,Nicotinic Antagonists,DrugBank
DB00915,NMDA Receptor Antagonists,DrugBank
DB00915,OCT1 inhibitors,DrugBank
DB00915,OCT1 substrates,DrugBank
DB00915,OCT2 Inhibitors,DrugBank
DB00915,OCT2 Substrates,DrugBank
DB00915,Peripheral Nervous System Agents,DrugBank
DB00915,Potential QTc-Prolonging Agents,DrugBank
DB00915,QTc Prolonging Agents,DrugBank
DB00915,Sensory System Agents,DrugBank
DB00915,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00916,Agents that reduce seizure threshold,DrugBank
DB00916,Alimentary Tract and Metabolism,DrugBank
DB00916,Anti-Bacterial Agents,DrugBank
DB00916,Anti-Infective Agents,DrugBank
DB00916,Antibacterials for Systemic Use,DrugBank
DB00916,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00916,Antiinfectives for Systemic Use,DrugBank
DB00916,Antiparasitic Agents,DrugBank
DB00916,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB00916,Antiprotozoals,DrugBank
DB00916,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00916,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00916,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00916,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00916,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00916,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00916,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00916,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00916,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00916,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00916,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00916,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00916,Cytochrome P-450 Substrates,DrugBank
DB00916,Dermatologicals,DrugBank
DB00916,Drugs for Acid Related Disorders,DrugBank
DB00916,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00916,Genito Urinary System and Sex Hormones,DrugBank
DB00916,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00916,Imidazole Derivatives,DrugBank
DB00916,Imidazoles,DrugBank
DB00916,Miscellaneous Antiprotozoals,DrugBank
DB00916,Miscellaneous Local Anti-infectives,DrugBank
DB00916,Nitro Compounds,DrugBank
DB00916,Nitroimidazole Antimicrobial,DrugBank
DB00916,Nitroimidazole Derivatives,DrugBank
DB00916,Nitroimidazoles,DrugBank
DB00916,P-glycoprotein inhibitors,DrugBank
DB00916,Potential QTc-Prolonging Agents,DrugBank
DB00916,QTc Prolonging Agents,DrugBank
DB00916,Stomatological Preparations,DrugBank
DB00916,UGT1A1 Substrates,DrugBank
DB00917,Autacoids,DrugBank
DB00917,Biological Factors,DrugBank
DB00917,"Dinoprostone, antagonists & inhibitors",DrugBank
DB00917,Eicosanoids,DrugBank
DB00917,Fatty Acids,DrugBank
DB00917,"Fatty Acids, Unsaturated",DrugBank
DB00917,Genito Urinary System and Sex Hormones,DrugBank
DB00917,Inflammation Mediators,DrugBank
DB00917,Lipids,DrugBank
DB00917,OAT1/SLC22A6 inhibitors,DrugBank
DB00917,OAT1/SLC22A6 Substrates,DrugBank
DB00917,OAT3/SLC22A8 Inhibitors,DrugBank
DB00917,OAT3/SLC22A8 Substrates,DrugBank
DB00917,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00917,OATP2B1/SLCO2B1 substrates,DrugBank
DB00917,OCT1 inhibitors,DrugBank
DB00917,OCT2 Inhibitors,DrugBank
DB00917,Prostaglandins,DrugBank
DB00917,Prostaglandins E,DrugBank
DB00917,"Prostaglandins, Synthetic",DrugBank
DB00917,Reproductive Control Agents,DrugBank
DB00917,Uterotonic agents,DrugBank
DB00918,Agents that produce hypertension,DrugBank
DB00918,Amines,DrugBank
DB00918,Analgesics,DrugBank
DB00918,Antidepressive Agents,DrugBank
DB00918,Antimigraine Preparations,DrugBank
DB00918,Biogenic Amines,DrugBank
DB00918,Biogenic Monoamines,DrugBank
DB00918,Central Nervous System Depressants,DrugBank
DB00918,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00918,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00918,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00918,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00918,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00918,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00918,Cytochrome P-450 Substrates,DrugBank
DB00918,Drugs that are Mainly Renally Excreted,DrugBank
DB00918,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00918,Indoles,DrugBank
DB00918,Migraine Disorders,DrugBank
DB00918,Monoamine Oxidase A Substrates,DrugBank
DB00918,Nervous System,DrugBank
DB00918,Neurotransmitter Agents,DrugBank
DB00918,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00918,Selective Serotonin Agonists,DrugBank
DB00918,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00918,Serotonin 1b Receptor Agonists,DrugBank
DB00918,Serotonin 1d Receptor Agonists,DrugBank
DB00918,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00918,Serotonin Agents,DrugBank
DB00918,Serotonin Modulators,DrugBank
DB00918,Serotonin Receptor Agonists,DrugBank
DB00918,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00918,Triptans,DrugBank
DB00919,Anti-Bacterial Agents,DrugBank
DB00919,Anti-Infective Agents,DrugBank
DB00919,Antibacterials for Systemic Use,DrugBank
DB00919,Antiinfectives for Systemic Use,DrugBank
DB00919,Carbohydrates,DrugBank
DB00919,Dioxanes,DrugBank
DB00919,Glycosides,DrugBank
DB00919,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00920,Anti-Allergic Agents,DrugBank
DB00920,Anti-Asthmatic Agents,DrugBank
DB00920,Antihistamine Drugs,DrugBank
DB00920,Antihistamines for Systemic Use,DrugBank
DB00920,Antipruritics,DrugBank
DB00920,Decongestants and Antiallergics,DrugBank
DB00920,Histamine Agents,DrugBank
DB00920,Histamine Antagonists,DrugBank
DB00920,Histamine H1 Antagonists,DrugBank
DB00920,Histamine H1 Inhibitors,DrugBank
DB00920,Ophthalmologicals,DrugBank
DB00920,Other Antihistamines,DrugBank
DB00920,Piperidines,DrugBank
DB00920,Sensory Organs,DrugBank
DB00920,Sulfur Compounds,DrugBank
DB00920,Thiophenes,DrugBank
DB00920,UGT1A3 substrates,DrugBank
DB00920,UGT1A4 substrates,DrugBank
DB00921,Alkaloids,DrugBank
DB00921,Analgesics,DrugBank
DB00921,BCRP/ABCG2 Inhibitors,DrugBank
DB00921,Central Nervous System Agents,DrugBank
DB00921,Central Nervous System Depressants,DrugBank
DB00921,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00921,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00921,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00921,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00921,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00921,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00921,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00921,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB00921,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00921,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00921,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00921,Cytochrome P-450 Substrates,DrugBank
DB00921,Drugs Used in Addictive Disorders,DrugBank
DB00921,Drugs Used in Opioid Dependence,DrugBank
DB00921,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00921,Mixed Agonist / Antagonist Opioids,DrugBank
DB00921,Morphinans,DrugBank
DB00921,Narcotics,DrugBank
DB00921,Nervous System,DrugBank
DB00921,Opiate Agonists,DrugBank
DB00921,Opiate Alkaloids,DrugBank
DB00921,Opiate Partial Agonists,DrugBank
DB00921,Opioid Antagonists,DrugBank
DB00921,Opioids,DrugBank
DB00921,Oripavine Derivatives,DrugBank
DB00921,P-glycoprotein inhibitors,DrugBank
DB00921,Peripheral Nervous System Agents,DrugBank
DB00921,Phenanthrenes,DrugBank
DB00921,Sensory System Agents,DrugBank
DB00921,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00921,UGT1A1 Substrates,DrugBank
DB00921,UGT1A9 Substrates,DrugBank
DB00922,Antiarrhythmic agents,DrugBank
DB00922,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00922,Cardiac Therapy,DrugBank
DB00922,Cardiotonic Agents,DrugBank
DB00922,Cardiovascular Agents,DrugBank
DB00922,"Compounds used in a research, industrial, or household setting",DrugBank
DB00922,Enzyme Inhibitors,DrugBank
DB00922,Hydrazines,DrugBank
DB00922,Hydrazones,DrugBank
DB00922,Hypotensive Agents,DrugBank
DB00922,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00922,Phosphodiesterase 3 Inhibitors,DrugBank
DB00922,Phosphodiesterase Inhibitors,DrugBank
DB00922,Protective Agents,DrugBank
DB00922,Pyridazines,DrugBank
DB00922,QTc Prolonging Agents,DrugBank
DB00922,Vasodilating Agents,DrugBank
DB00923,Amides,DrugBank
DB00923,Anti-Bacterial Agents,DrugBank
DB00923,Anti-Infective Agents,DrugBank
DB00923,Antibacterials for Systemic Use,DrugBank
DB00923,Antiinfectives for Systemic Use,DrugBank
DB00923,beta-Lactams,DrugBank
DB00923,Cephalosporins,DrugBank
DB00923,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00923,Lactams,DrugBank
DB00923,Nephrotoxic agents,DrugBank
DB00923,Second-Generation Cephalosporins,DrugBank
DB00923,Sulfur Compounds,DrugBank
DB00923,Thiazines,DrugBank
DB00924,Agents that reduce seizure threshold,DrugBank
DB00924,Antidepressive Agents,DrugBank
DB00924,Benzocycloheptenes,DrugBank
DB00924,Central Nervous System Agents,DrugBank
DB00924,Central Nervous System Depressants,DrugBank
DB00924,Centrally-mediated Muscle Relaxation,DrugBank
DB00924,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00924,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00924,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00924,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00924,Cytochrome P-450 Substrates,DrugBank
DB00924,Dibenzocycloheptenes,DrugBank
DB00924,Drugs causing inadvertant photosensitivity,DrugBank
DB00924,Muscle Relaxants,DrugBank
DB00924,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB00924,Musculo-Skeletal System,DrugBank
DB00924,Neurotoxic agents,DrugBank
DB00924,Photosensitizing Agents,DrugBank
DB00924,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00924,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00924,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00924,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB00924,Serotonin Agents,DrugBank
DB00924,Serotonin Receptor Antagonists,DrugBank
DB00924,Tranquilizing Agents,DrugBank
DB00924,UGT1A4 substrates,DrugBank
DB00925,Adrenergic Agents,DrugBank
DB00925,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB00925,Adrenergic alpha-Antagonists,DrugBank
DB00925,Adrenergic Antagonists,DrugBank
DB00925,Agents that produce hypertension,DrugBank
DB00925,Amines,DrugBank
DB00925,Antihypertensive Agents,DrugBank
DB00925,Cardiovascular Agents,DrugBank
DB00925,Ethylamines,DrugBank
DB00925,Hypotensive Agents,DrugBank
DB00925,Neurotransmitter Agents,DrugBank
DB00925,OCT1 inhibitors,DrugBank
DB00925,OCT2 Inhibitors,DrugBank
DB00925,Peripheral alpha-1 blockers,DrugBank
DB00925,Peripheral Vasodilators,DrugBank
DB00925,Vasodilating Agents,DrugBank
DB00927,Acid Reducers,DrugBank
DB00927,Alimentary Tract and Metabolism,DrugBank
DB00927,Anti-Ulcer Agents,DrugBank
DB00927,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00927,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB00927,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00927,Drugs for Acid Related Disorders,DrugBank
DB00927,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB00927,Gastric Acid Lowering Agents,DrugBank
DB00927,Gastrointestinal Agents,DrugBank
DB00927,Histamine Agents,DrugBank
DB00927,Histamine Antagonists,DrugBank
DB00927,Histamine H2 Antagonists,DrugBank
DB00927,MATE 1 Inhibitors,DrugBank
DB00927,MATE inhibitors,DrugBank
DB00927,Neurotransmitter Agents,DrugBank
DB00927,OAT3/SLC22A8 Inhibitors,DrugBank
DB00927,OAT3/SLC22A8 Substrates,DrugBank
DB00927,OCT2 Inhibitors,DrugBank
DB00927,Potential QTc-Prolonging Agents,DrugBank
DB00927,QTc Prolonging Agents,DrugBank
DB00927,Sulfur Compounds,DrugBank
DB00927,Thiazoles,DrugBank
DB00928,Antimetabolites,DrugBank
DB00928,Antineoplastic Agents,DrugBank
DB00928,Antineoplastic and Immunomodulating Agents,DrugBank
DB00928,Aza Compounds,DrugBank
DB00928,Cytidine Deaminase Substrates,DrugBank
DB00928,Drugs that are Mainly Renally Excreted,DrugBank
DB00928,Enzyme Inhibitors,DrugBank
DB00928,Immunosuppressive Agents,DrugBank
DB00928,Myelosuppressive Agents,DrugBank
DB00928,Narrow Therapeutic Index Drugs,DrugBank
DB00928,Noxae,DrugBank
DB00928,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00928,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00928,Nucleoside Metabolic Inhibitor,DrugBank
DB00928,Nucleosides,DrugBank
DB00928,Pyrimidine Analogues,DrugBank
DB00928,Pyrimidine Nucleosides,DrugBank
DB00928,Pyrimidines,DrugBank
DB00928,Ribonucleosides,DrugBank
DB00928,Toxic Actions,DrugBank
DB00930,Alkenes,DrugBank
DB00930,Allyl Compounds,DrugBank
DB00930,Allylamine,DrugBank
DB00930,Amines,DrugBank
DB00930,Anticholesteremic Agents,DrugBank
DB00930,Bile Acid Sequestrants,DrugBank
DB00930,Bile-acid Binding Activity,DrugBank
DB00930,"Hydrocarbons, Acyclic",DrugBank
DB00930,Hypolipidemic Agents,DrugBank
DB00930,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00930,Lipid Modifying Agents,DrugBank
DB00930,"Lipid Modifying Agents, Plain",DrugBank
DB00930,Lipid Regulating Agents,DrugBank
DB00930,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00931,Agents that produce neuromuscular block (indirect),DrugBank
DB00931,Anti-Bacterial Agents,DrugBank
DB00931,Anti-Infective Agents,DrugBank
DB00931,Antibacterials for Systemic Use,DrugBank
DB00931,Antiinfectives for Systemic Use,DrugBank
DB00931,Naphthacenes,DrugBank
DB00931,Tetracyclines,DrugBank
DB00932,Amides,DrugBank
DB00932,Anti-HIV Agents,DrugBank
DB00932,Anti-Infective Agents,DrugBank
DB00932,Anti-Retroviral Agents,DrugBank
DB00932,Antiinfectives for Systemic Use,DrugBank
DB00932,Antiviral Agents,DrugBank
DB00932,Antivirals for Systemic Use,DrugBank
DB00932,BSEP/ABCB11 Inhibitors,DrugBank
DB00932,BSEP/ABCB11 Substrates,DrugBank
DB00932,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00932,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00932,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00932,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00932,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB00932,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00932,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00932,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00932,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00932,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00932,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00932,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00932,Cytochrome P-450 Substrates,DrugBank
DB00932,Direct Acting Antivirals,DrugBank
DB00932,Drugs causing inadvertant photosensitivity,DrugBank
DB00932,Enzyme Inhibitors,DrugBank
DB00932,Hepatotoxic Agents,DrugBank
DB00932,HIV Protease Inhibitors,DrugBank
DB00932,Hyperglycemia-Associated Agents,DrugBank
DB00932,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00932,OATP1B3 inhibitors,DrugBank
DB00932,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00932,P-glycoprotein inducers,DrugBank
DB00932,P-glycoprotein inhibitors,DrugBank
DB00932,P-glycoprotein substrates,DrugBank
DB00932,Photosensitizing Agents,DrugBank
DB00932,Protease Inhibitors,DrugBank
DB00932,Pyrans,DrugBank
DB00932,Sulfones,DrugBank
DB00932,Sulfur Compounds,DrugBank
DB00932,UGT1A1 Inducers,DrugBank
DB00933,Antidepressive Agents,DrugBank
DB00933,Antipsychotic Agents,DrugBank
DB00933,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB00933,Central Nervous System Agents,DrugBank
DB00933,Central Nervous System Depressants,DrugBank
DB00933,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00933,Cytochrome P-450 Substrates,DrugBank
DB00933,Dopamine Agents,DrugBank
DB00933,Dopamine Antagonists,DrugBank
DB00933,Dopamine D2 Receptor Antagonists,DrugBank
DB00933,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00933,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00933,Nervous System,DrugBank
DB00933,Neurotoxic agents,DrugBank
DB00933,Neurotransmitter Agents,DrugBank
DB00933,Phenothiazines,DrugBank
DB00933,Phenothiazines With Piperidine Structure,DrugBank
DB00933,Psycholeptics,DrugBank
DB00933,Psychotropic Drugs,DrugBank
DB00933,QTc Prolonging Agents,DrugBank
DB00933,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB00933,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB00933,Serotonin Agents,DrugBank
DB00933,Serotonin Receptor Antagonists,DrugBank
DB00933,Sulfur Compounds,DrugBank
DB00933,Tranquilizing Agents,DrugBank
DB00934,Adrenergic Agents,DrugBank
DB00934,Adrenergic Uptake Inhibitors,DrugBank
DB00934,Agents producing tachycardia,DrugBank
DB00934,Agents that reduce seizure threshold,DrugBank
DB00934,Anthracenes,DrugBank
DB00934,Anticholinergic Agents,DrugBank
DB00934,Antidepressive Agents,DrugBank
DB00934,Antidepressive Agents Indicated for Depression,DrugBank
DB00934,"Antidepressive Agents, Second-Generation",DrugBank
DB00934,"Antidepressive Agents, Tetracyclic",DrugBank
DB00934,Central Nervous System Agents,DrugBank
DB00934,Central Nervous System Depressants,DrugBank
DB00934,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00934,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00934,Cytochrome P-450 Substrates,DrugBank
DB00934,Drugs that are Mainly Renally Excreted,DrugBank
DB00934,Histamine Antagonists,DrugBank
DB00934,Histamine H1 Antagonists,DrugBank
DB00934,Membrane Transport Modulators,DrugBank
DB00934,Muscarinic Antagonists,DrugBank
DB00934,Nervous System,DrugBank
DB00934,Neurotransmitter Agents,DrugBank
DB00934,Neurotransmitter Uptake Inhibitors,DrugBank
DB00934,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB00934,Potential QTc-Prolonging Agents,DrugBank
DB00934,Psychoanaleptics,DrugBank
DB00934,Psychotropic Drugs,DrugBank
DB00934,QTc Prolonging Agents,DrugBank
DB00934,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00934,Serotonin Agents,DrugBank
DB00934,Serotonin Modulators,DrugBank
DB00934,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB00935,Adrenergic Agents,DrugBank
DB00935,Adrenergic Agonists,DrugBank
DB00935,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00935,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00935,Adrenergic alpha-Agonists,DrugBank
DB00935,Agents producing tachycardia,DrugBank
DB00935,Agents that produce hypertension,DrugBank
DB00935,Autonomic Agents,DrugBank
DB00935,Cardiovascular Agents,DrugBank
DB00935,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00935,Cytochrome P-450 Substrates,DrugBank
DB00935,Decongestants and Antiallergics,DrugBank
DB00935,Dermatologicals,DrugBank
DB00935,Imidazoles,DrugBank
DB00935,Increased Sympathetic Activity,DrugBank
DB00935,Nasal Decongestants,DrugBank
DB00935,Nasal Preparations,DrugBank
DB00935,Neurotransmitter Agents,DrugBank
DB00935,Ophthalmologicals,DrugBank
DB00935,Peripheral Nervous System Agents,DrugBank
DB00935,Respiratory System Agents,DrugBank
DB00935,Sensory Organs,DrugBank
DB00935,Sympathomimetics,DrugBank
DB00935,Sympathomimetics Used as Decongestants,DrugBank
DB00935,"Sympathomimetics, Plain",DrugBank
DB00935,UGT1A9 Substrates,DrugBank
DB00935,Vasoconstriction,DrugBank
DB00935,Vasoconstrictor Agents,DrugBank
DB00936,"Acids, Carbocyclic",DrugBank
DB00936,Agents causing hyperkalemia,DrugBank
DB00936,Agents that produce hypertension,DrugBank
DB00936,Analgesics,DrugBank
DB00936,"Analgesics, Non-Narcotic",DrugBank
DB00936,Anti-Infective Agents,DrugBank
DB00936,Anti-Inflammatory Agents,DrugBank
DB00936,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00936,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00936,Antifungal Agents,DrugBank
DB00936,Antifungals for Dermatological Use,DrugBank
DB00936,Antifungals for Topical Use,DrugBank
DB00936,Benzene Derivatives,DrugBank
DB00936,Benzoates,DrugBank
DB00936,Cyclooxygenase Inhibitors,DrugBank
DB00936,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00936,Cytochrome P-450 Substrates,DrugBank
DB00936,Dermatologicals,DrugBank
DB00936,Enzyme Inhibitors,DrugBank
DB00936,Genito Urinary System and Sex Hormones,DrugBank
DB00936,Hydroxy Acids,DrugBank
DB00936,Hydroxybenzoates,DrugBank
DB00936,Keratolytic Agents,DrugBank
DB00936,Nephrotoxic agents,DrugBank
DB00936,Nervous System,DrugBank
DB00936,Non COX-2 selective NSAIDS,DrugBank
DB00936,OAT1/SLC22A6 inhibitors,DrugBank
DB00936,OAT3/SLC22A8 Inhibitors,DrugBank
DB00936,OATP2B1/SLCO2B1 substrates,DrugBank
DB00936,Ophthalmologicals,DrugBank
DB00936,Peripheral Nervous System Agents,DrugBank
DB00936,Phenols,DrugBank
DB00936,Salicylates,DrugBank
DB00936,Salicylic Acid and Derivatives,DrugBank
DB00936,Sclerosing Solutions,DrugBank
DB00936,Sensory Organs,DrugBank
DB00936,Sensory System Agents,DrugBank
DB00936,Urologicals,DrugBank
DB00937,Agents producing tachycardia,DrugBank
DB00937,Agents that produce hypertension,DrugBank
DB00937,Alimentary Tract and Metabolism,DrugBank
DB00937,Amines,DrugBank
DB00937,Amphetamines,DrugBank
DB00937,Anti-Obesity Agents,DrugBank
DB00937,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB00937,Appetite Depressants,DrugBank
DB00937,Appetite Suppression,DrugBank
DB00937,Central Nervous System Depressants,DrugBank
DB00937,Centrally Acting Antiobesity Products,DrugBank
DB00937,Ethylamines,DrugBank
DB00937,Increased Sympathetic Activity,DrugBank
DB00937,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00937,Stimulants,DrugBank
DB00937,Sympathomimetic Amine Anorectic,DrugBank
DB00937,Sympathomimetics,DrugBank
DB00938,Adrenergic Agents,DrugBank
DB00938,Adrenergic Agonists,DrugBank
DB00938,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00938,Adrenergic beta-Agonists,DrugBank
DB00938,"Adrenergics, Inhalants",DrugBank
DB00938,Agents Causing Muscle Toxicity,DrugBank
DB00938,Agents producing tachycardia,DrugBank
DB00938,Agents that produce hypertension,DrugBank
DB00938,Agents to Treat Airway Disease,DrugBank
DB00938,Alcohols,DrugBank
DB00938,Amines,DrugBank
DB00938,Amino Alcohols,DrugBank
DB00938,Anti-Asthmatic Agents,DrugBank
DB00938,Autonomic Agents,DrugBank
DB00938,Bronchodilator Agents,DrugBank
DB00938,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00938,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB00938,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00938,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00938,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00938,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00938,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00938,Cytochrome P-450 Substrates,DrugBank
DB00938,Drugs for Obstructive Airway Diseases,DrugBank
DB00938,Ethanolamines,DrugBank
DB00938,Ethylamines,DrugBank
DB00938,Long-acting beta-adrenoceptor agonists,DrugBank
DB00938,Neurotransmitter Agents,DrugBank
DB00938,OCT1 inhibitors,DrugBank
DB00938,OCT1 substrates,DrugBank
DB00938,OCT2 Inhibitors,DrugBank
DB00938,Peripheral Nervous System Agents,DrugBank
DB00938,Phenethylamines,DrugBank
DB00938,Potential QTc-Prolonging Agents,DrugBank
DB00938,QTc Prolonging Agents,DrugBank
DB00938,Respiratory System Agents,DrugBank
DB00938,Selective Beta 2-adrenergic Agonists,DrugBank
DB00938,Sympathomimetic (Adrenergic) Agents,DrugBank
DB00939,"Acids, Carbocyclic",DrugBank
DB00939,Agents causing hyperkalemia,DrugBank
DB00939,Agents that produce hypertension,DrugBank
DB00939,Aminobenzoates,DrugBank
DB00939,Analgesics,DrugBank
DB00939,"Analgesics, Non-Narcotic",DrugBank
DB00939,Anti-Inflammatory Agents,DrugBank
DB00939,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00939,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00939,Antiinflammatory and Antirheumatic Products,DrugBank
DB00939,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00939,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB00939,Antirheumatic Agents,DrugBank
DB00939,Benzene Derivatives,DrugBank
DB00939,Benzoates,DrugBank
DB00939,Cyclooxygenase Inhibitors,DrugBank
DB00939,Drugs that are Mainly Renally Excreted,DrugBank
DB00939,Enzyme Inhibitors,DrugBank
DB00939,Fenamates,DrugBank
DB00939,Musculo-Skeletal System,DrugBank
DB00939,Nephrotoxic agents,DrugBank
DB00939,Non COX-2 selective NSAIDS,DrugBank
DB00939,OAT1/SLC22A6 inhibitors,DrugBank
DB00939,ortho-Aminobenzoates,DrugBank
DB00939,Peripheral Nervous System Agents,DrugBank
DB00939,Sensory System Agents,DrugBank
DB00939,Thyroxine-binding globulin substrates,DrugBank
DB00939,Topical Products for Joint and Muscular Pain,DrugBank
DB00940,Acid Reducers,DrugBank
DB00940,Agents producing tachycardia,DrugBank
DB00940,Alimentary Tract and Metabolism,DrugBank
DB00940,Amines,DrugBank
DB00940,Anticholinergic Agents,DrugBank
DB00940,Cholinergic Agents,DrugBank
DB00940,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00940,Gastric Acid Lowering Agents,DrugBank
DB00940,Histamine Antagonists,DrugBank
DB00940,Histamine H2 Antagonists,DrugBank
DB00940,Muscarinic Antagonists,DrugBank
DB00940,Neurotransmitter Agents,DrugBank
DB00940,Onium Compounds,DrugBank
DB00940,Quaternary Ammonium Compounds,DrugBank
DB00940,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB00941,Amines,DrugBank
DB00941,Anticholinergic Agents,DrugBank
DB00941,Bis-Trimethylammonium Compounds,DrugBank
DB00941,Central Nervous System Depressants,DrugBank
DB00941,Cholinergic Agents,DrugBank
DB00941,Cholinesterase Inhibitors,DrugBank
DB00941,Muscle Relaxants,DrugBank
DB00941,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB00941,Musculo-Skeletal System,DrugBank
DB00941,Neurotransmitter Agents,DrugBank
DB00941,Nicotinic Antagonists,DrugBank
DB00941,Onium Compounds,DrugBank
DB00941,Quaternary Ammonium Compounds,DrugBank
DB00942,Agents producing tachycardia,DrugBank
DB00942,Anticholinergic Agents,DrugBank
DB00942,Muscarinic Antagonists,DrugBank
DB00943,Anti-HIV Agents,DrugBank
DB00943,Anti-Infective Agents,DrugBank
DB00943,Anti-Retroviral Agents,DrugBank
DB00943,Antiinfectives for Systemic Use,DrugBank
DB00943,Antimetabolites,DrugBank
DB00943,Antiviral Agents,DrugBank
DB00943,Antivirals for Systemic Use,DrugBank
DB00943,Deoxycytidine,DrugBank
DB00943,Deoxyribonucleosides,DrugBank
DB00943,Dideoxynucleosides,DrugBank
DB00943,Direct Acting Antivirals,DrugBank
DB00943,Enzyme Inhibitors,DrugBank
DB00943,Noxae,DrugBank
DB00943,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00943,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00943,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB00943,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB00943,Nucleosides,DrugBank
DB00943,OAT1/SLC22A6 Substrates,DrugBank
DB00943,Pyrimidine Nucleosides,DrugBank
DB00943,Pyrimidines,DrugBank
DB00943,Reverse Transcriptase Inhibitors,DrugBank
DB00943,Toxic Actions,DrugBank
DB00944,Amines,DrugBank
DB00944,Ammonium Compounds,DrugBank
DB00944,Antiglaucoma Preparations and Miotics,DrugBank
DB00944,Cholinergic Agents,DrugBank
DB00944,Cholinesterase Inhibitors,DrugBank
DB00944,Enzyme Inhibitors,DrugBank
DB00944,Neurotransmitter Agents,DrugBank
DB00944,Nitrogen Compounds,DrugBank
DB00944,Onium Compounds,DrugBank
DB00944,Ophthalmologicals,DrugBank
DB00944,Parasympathomimetics,DrugBank
DB00944,Sensory Organs,DrugBank
DB00945,"Acids, Carbocyclic",DrugBank
DB00945,Agents causing angioedema,DrugBank
DB00945,Agents causing hyperkalemia,DrugBank
DB00945,Agents that produce hypertension,DrugBank
DB00945,Alimentary Tract and Metabolism,DrugBank
DB00945,Analgesics,DrugBank
DB00945,"Analgesics, Non-Narcotic",DrugBank
DB00945,Anti-Inflammatory Agents,DrugBank
DB00945,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00945,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00945,Antiinflammatory and Antirheumatic Products,DrugBank
DB00945,Antiplatelet agents,DrugBank
DB00945,Antipyretics,DrugBank
DB00945,Benzene Derivatives,DrugBank
DB00945,Blood and Blood Forming Organs,DrugBank
DB00945,Cardiovascular Agents,DrugBank
DB00945,Cyclooxygenase Inhibitors,DrugBank
DB00945,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00945,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00945,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00945,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00945,Cytochrome P-450 Substrates,DrugBank
DB00945,Decreased Platelet Aggregation,DrugBank
DB00945,Decreased Prostaglandin Production,DrugBank
DB00945,Drugs that are Mainly Renally Excreted,DrugBank
DB00945,Hematologic Agents,DrugBank
DB00945,Hydroxybenzoates,DrugBank
DB00945,Musculo-Skeletal System,DrugBank
DB00945,Nephrotoxic agents,DrugBank
DB00945,Non COX-2 selective NSAIDS,DrugBank
DB00945,OAT1/SLC22A6 inhibitors,DrugBank
DB00945,OAT3/SLC22A8 Inhibitors,DrugBank
DB00945,P-glycoprotein inducers,DrugBank
DB00945,P-glycoprotein substrates,DrugBank
DB00945,Peripheral Nervous System Agents,DrugBank
DB00945,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00945,Salicylates,DrugBank
DB00945,Salicylic Acid and Derivatives,DrugBank
DB00945,Sensory System Agents,DrugBank
DB00945,Stomatological Preparations,DrugBank
DB00945,UGT1A6 substrate,DrugBank
DB00946,4-Hydroxycoumarins,DrugBank
DB00946,Anticoagulants,DrugBank
DB00946,Benzopyrans,DrugBank
DB00946,Blood and Blood Forming Organs,DrugBank
DB00946,Coumarins,DrugBank
DB00946,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00946,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB00946,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00946,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB00946,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00946,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00946,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00946,Cytochrome P-450 Substrates,DrugBank
DB00946,Hematologic Agents,DrugBank
DB00946,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00946,Narrow Therapeutic Index Drugs,DrugBank
DB00946,Pyrans,DrugBank
DB00946,Vitamin K Antagonists,DrugBank
DB00946,Vitamin K Inhibitors,DrugBank
DB00947,Anti-Estrogens,DrugBank
DB00947,Antineoplastic Agents,DrugBank
DB00947,"Antineoplastic Agents, Hormonal",DrugBank
DB00947,Antineoplastic and Immunomodulating Agents,DrugBank
DB00947,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00947,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00947,Cytochrome P-450 Substrates,DrugBank
DB00947,Endocrine Therapy,DrugBank
DB00947,Estradiol Congeners,DrugBank
DB00947,Estranes,DrugBank
DB00947,Estrenes,DrugBank
DB00947,Estrogen Antagonists,DrugBank
DB00947,Estrogen Receptor Antagonists,DrugBank
DB00947,Fused-Ring Compounds,DrugBank
DB00947,Gonadal Hormones,DrugBank
DB00947,Gonadal Steroid Hormones,DrugBank
DB00947,Hormone Antagonists,DrugBank
DB00947,Hormone Antagonists and Related Agents,DrugBank
DB00947,Hormones,DrugBank
DB00947,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00947,Selective Estrogen Receptor Modulators,DrugBank
DB00947,Steroids,DrugBank
DB00947,UGT1A1 Substrates,DrugBank
DB00948,Amides,DrugBank
DB00948,Anti-Bacterial Agents,DrugBank
DB00948,Anti-Infective Agents,DrugBank
DB00948,Antibacterials for Systemic Use,DrugBank
DB00948,Antiinfectives for Systemic Use,DrugBank
DB00948,Beta-Lactam Antibacterials,DrugBank
DB00948,beta-Lactams,DrugBank
DB00948,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00948,Lactams,DrugBank
DB00948,Penicillin G,DrugBank
DB00948,Penicillins,DrugBank
DB00948,Penicillins With Extended Spectrum,DrugBank
DB00948,Sulfur Compounds,DrugBank
DB00949,"Acids, Acyclic",DrugBank
DB00949,Alcohols,DrugBank
DB00949,Anti-epileptic Agent,DrugBank
DB00949,Anticonvulsants,DrugBank
DB00949,Carbamates,DrugBank
DB00949,Central Nervous System Agents,DrugBank
DB00949,Central Nervous System Depressants,DrugBank
DB00949,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00949,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00949,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00949,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB00949,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00949,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00949,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00949,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00949,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB00949,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00949,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00949,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00949,Cytochrome P-450 Substrates,DrugBank
DB00949,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00949,Excitatory Amino Acid Agents,DrugBank
DB00949,Excitatory Amino Acid Antagonists,DrugBank
DB00949,Glycols,DrugBank
DB00949,Nervous System,DrugBank
DB00949,Neurotransmitter Agents,DrugBank
DB00949,NMDA Receptor Antagonists,DrugBank
DB00949,Phenylcarbamates,DrugBank
DB00949,Potential QTc-Prolonging Agents,DrugBank
DB00949,Propylene Glycols,DrugBank
DB00949,QTc Prolonging Agents,DrugBank
DB00950,Anti-Allergic Agents,DrugBank
DB00950,Antihistamines for Systemic Use,DrugBank
DB00950,Benzene Derivatives,DrugBank
DB00950,Benzhydryl Compounds,DrugBank
DB00950,Histamine Agents,DrugBank
DB00950,Histamine Antagonists,DrugBank
DB00950,Histamine H1 Antagonists,DrugBank
DB00950,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00950,Neurotransmitter Agents,DrugBank
DB00950,OAT3/SLC22A8 Substrates,DrugBank
DB00950,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00950,OATP1B3 substrates,DrugBank
DB00950,OATP2B1/SLCO2B1 substrates,DrugBank
DB00950,P-glycoprotein substrates,DrugBank
DB00950,Piperidines,DrugBank
DB00951,Agents Causing Muscle Toxicity,DrugBank
DB00951,Agents that reduce seizure threshold,DrugBank
DB00951,Anti-Bacterial Agents,DrugBank
DB00951,Anti-Infective Agents,DrugBank
DB00951,Antiinfectives for Systemic Use,DrugBank
DB00951,Antimycobacterials,DrugBank
DB00951,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00951,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00951,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB00951,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB00951,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00951,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00951,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00951,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB00951,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB00951,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP2E1 Inhibitors (moderate),DrugBank
DB00951,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB00951,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00951,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB00951,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00951,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00951,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00951,Cytochrome P-450 Substrates,DrugBank
DB00951,Drugs for Treatment of Tuberculosis,DrugBank
DB00951,Drugs that are Mainly Renally Excreted,DrugBank
DB00951,Fatty Acid Synthesis Inhibitors,DrugBank
DB00951,Hepatotoxic Agents,DrugBank
DB00951,Hydrazides,DrugBank
DB00951,Hydrazines,DrugBank
DB00951,Hyperglycemia-Associated Agents,DrugBank
DB00951,Hypolipidemic Agents,DrugBank
DB00951,Isonicotinic Acids,DrugBank
DB00951,Pyridines,DrugBank
DB00951,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00952,Agents that produce hypertension,DrugBank
DB00952,Amines,DrugBank
DB00952,Analgesics,DrugBank
DB00952,Antidepressive Agents,DrugBank
DB00952,Antimigraine Preparations,DrugBank
DB00952,Biogenic Amines,DrugBank
DB00952,Biogenic Monoamines,DrugBank
DB00952,Cardiovascular Agents,DrugBank
DB00952,Central Nervous System Depressants,DrugBank
DB00952,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00952,Indoles,DrugBank
DB00952,Monoamine Oxidase A Substrates,DrugBank
DB00952,Nervous System,DrugBank
DB00952,Neurotransmitter Agents,DrugBank
DB00952,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00952,Selective Serotonin Agonists,DrugBank
DB00952,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00952,Serotonin 1b Receptor Agonists,DrugBank
DB00952,Serotonin 1d Receptor Agonists,DrugBank
DB00952,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00952,Serotonin Agents,DrugBank
DB00952,Serotonin Modulators,DrugBank
DB00952,Serotonin Receptor Agonists,DrugBank
DB00952,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00952,Triptans,DrugBank
DB00952,Vasoconstrictor Agents,DrugBank
DB00953,Agents that produce hypertension,DrugBank
DB00953,Amines,DrugBank
DB00953,Analgesics,DrugBank
DB00953,Antidepressive Agents,DrugBank
DB00953,Antimigraine Preparations,DrugBank
DB00953,Biogenic Amines,DrugBank
DB00953,Biogenic Monoamines,DrugBank
DB00953,Central Nervous System Depressants,DrugBank
DB00953,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00953,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00953,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00953,Drugs that are Mainly Renally Excreted,DrugBank
DB00953,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00953,Indoles,DrugBank
DB00953,Migraine Disorders,DrugBank
DB00953,Monoamine Oxidase A Substrates,DrugBank
DB00953,Nervous System,DrugBank
DB00953,Neurotransmitter Agents,DrugBank
DB00953,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00953,Selective Serotonin Agonists,DrugBank
DB00953,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00953,Serotonin 1b Receptor Agonists,DrugBank
DB00953,Serotonin 1d Receptor Agonists,DrugBank
DB00953,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00953,Serotonin Agents,DrugBank
DB00953,Serotonin Modulators,DrugBank
DB00953,Serotonin Receptor Agonists,DrugBank
DB00953,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00953,Triptans,DrugBank
DB00954,Anti-Bacterial Agents,DrugBank
DB00954,Anti-Infective Agents,DrugBank
DB00954,Antibacterials for Systemic Use,DrugBank
DB00954,Antiinfectives for Systemic Use,DrugBank
DB00954,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00954,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00954,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00954,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00954,Lactones,DrugBank
DB00954,Macrolides,DrugBank
DB00954,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB00954,Polyketides,DrugBank
DB00955,Agents that produce neuromuscular block (indirect),DrugBank
DB00955,Aminoglycoside Antibacterials,DrugBank
DB00955,Anti-Bacterial Agents,DrugBank
DB00955,Anti-Infective Agents,DrugBank
DB00955,Antibacterials for Systemic Use,DrugBank
DB00955,Antiinfectives for Systemic Use,DrugBank
DB00955,Carbohydrates,DrugBank
DB00955,Drugs that are Mainly Renally Excreted,DrugBank
DB00955,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00955,Enzyme Inhibitors,DrugBank
DB00955,Gentamicins,DrugBank
DB00955,Glycosides,DrugBank
DB00955,Narrow Therapeutic Index Drugs,DrugBank
DB00955,Nephrotoxic agents,DrugBank
DB00955,Ophthalmologicals,DrugBank
DB00955,Protein Synthesis Inhibitors,DrugBank
DB00955,Sensory Organs,DrugBank
DB00956,Alkaloids,DrugBank
DB00956,Analgesics,DrugBank
DB00956,Antitussive Agents,DrugBank
DB00956,Central Nervous System Agents,DrugBank
DB00956,Central Nervous System Depressants,DrugBank
DB00956,Cough and Cold Preparations,DrugBank
DB00956,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00956,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00956,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00956,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00956,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00956,Cytochrome P-450 Substrates,DrugBank
DB00956,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00956,Morphinans,DrugBank
DB00956,Morphine Derivatives,DrugBank
DB00956,Narcotics,DrugBank
DB00956,Nervous System,DrugBank
DB00956,Opiate Alkaloids,DrugBank
DB00956,Opioid Agonist,DrugBank
DB00956,Opioids,DrugBank
DB00956,Opium Alkaloids and Derivatives,DrugBank
DB00956,Peripheral Nervous System Agents,DrugBank
DB00956,Respiratory System Agents,DrugBank
DB00956,Semi-synthetic Opioids,DrugBank
DB00956,Sensory System Agents,DrugBank
DB00956,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00957,Adrenal Cortex Hormones,DrugBank
DB00957,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB00957,"Contraceptive Agents, Female",DrugBank
DB00957,"Contraceptive Agents, Hormonal",DrugBank
DB00957,"Contraceptives, Oral",DrugBank
DB00957,"Contraceptives, Oral, Synthetic",DrugBank
DB00957,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00957,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00957,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00957,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00957,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00957,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00957,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00957,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00957,Cytochrome P-450 Substrates,DrugBank
DB00957,Fused-Ring Compounds,DrugBank
DB00957,Genito Urinary System and Sex Hormones,DrugBank
DB00957,Hormonal Contraceptives for Systemic Use,DrugBank
DB00957,Hyperglycemia-Associated Agents,DrugBank
DB00957,Norpregnanes,DrugBank
DB00957,Norpregnenes,DrugBank
DB00957,Norsteroids,DrugBank
DB00957,P-glycoprotein inhibitors,DrugBank
DB00957,Progestin Contraceptives,DrugBank
DB00957,Progestins,DrugBank
DB00957,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00957,Reproductive Control Agents,DrugBank
DB00957,Sex Hormones and Modulators of the Genital System,DrugBank
DB00957,Steroids,DrugBank
DB00957,UGT1A1 Substrates,DrugBank
DB00958,Antineoplastic Agents,DrugBank
DB00958,Antineoplastic and Immunomodulating Agents,DrugBank
DB00958,BCRP/ABCG2 Substrates,DrugBank
DB00958,"Compounds used in a research, industrial, or household setting",DrugBank
DB00958,Coordination Complexes,DrugBank
DB00958,Cross-Linking Reagents,DrugBank
DB00958,Cytotoxins,DrugBank
DB00958,Drugs that are Mainly Renally Excreted,DrugBank
DB00958,Immunosuppressive Agents,DrugBank
DB00958,Indicators and Reagents,DrugBank
DB00958,Laboratory Chemicals,DrugBank
DB00958,Myelosuppressive Agents,DrugBank
DB00958,Narrow Therapeutic Index Drugs,DrugBank
DB00958,Nephrotoxic agents,DrugBank
DB00958,Organometallic Compounds,DrugBank
DB00958,Platinum Compounds,DrugBank
DB00959,Adrenal Cortex Hormones,DrugBank
DB00959,Adrenals,DrugBank
DB00959,Anti-Acne Preparations,DrugBank
DB00959,Anti-Acne Preparations for Topical Use,DrugBank
DB00959,Anti-Inflammatory Agents,DrugBank
DB00959,Antiemetics,DrugBank
DB00959,Antineoplastic Agents,DrugBank
DB00959,Autonomic Agents,DrugBank
DB00959,Central Nervous System Agents,DrugBank
DB00959,"Compounds used in a research, industrial, or household setting",DrugBank
DB00959,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00959,Corticosteroids,DrugBank
DB00959,Corticosteroids for Systemic Use,DrugBank
DB00959,"Corticosteroids for Systemic Use, Plain",DrugBank
DB00959,"Corticosteroids, Dermatological Preparations",DrugBank
DB00959,"Corticosteroids, Weak (Group I)",DrugBank
DB00959,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB00959,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB00959,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB00959,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB00959,Cytochrome P-450 CYP3A Inducers,DrugBank
DB00959,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00959,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB00959,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB00959,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00959,Cytochrome P-450 Enzyme Inducers,DrugBank
DB00959,Cytochrome P-450 Substrates,DrugBank
DB00959,Dermatologicals,DrugBank
DB00959,Experimental Unapproved Treatments for COVID-19,DrugBank
DB00959,Fused-Ring Compounds,DrugBank
DB00959,Gastrointestinal Agents,DrugBank
DB00959,Hormones,DrugBank
DB00959,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00959,Hyperglycemia-Associated Agents,DrugBank
DB00959,Immunosuppressive Agents,DrugBank
DB00959,Neuroprotective Agents,DrugBank
DB00959,Ophthalmological and Otological Preparations,DrugBank
DB00959,Ophthalmologicals,DrugBank
DB00959,P-glycoprotein inducers,DrugBank
DB00959,P-glycoprotein substrates,DrugBank
DB00959,Peripheral Nervous System Agents,DrugBank
DB00959,Pregnadienes,DrugBank
DB00959,Pregnadienetriols,DrugBank
DB00959,Pregnanes,DrugBank
DB00959,Protective Agents,DrugBank
DB00959,Sensory Organs,DrugBank
DB00959,Steroids,DrugBank
DB00959,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB00960,Adrenergic Agents,DrugBank
DB00960,Adrenergic Antagonists,DrugBank
DB00960,Adrenergic beta-Antagonists,DrugBank
DB00960,Agents causing hyperkalemia,DrugBank
DB00960,Alcohols,DrugBank
DB00960,Amines,DrugBank
DB00960,Amino Alcohols,DrugBank
DB00960,Antidepressive Agents,DrugBank
DB00960,Antihypertensive Agents,DrugBank
DB00960,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00960,"Beta Blocking Agents, Non-Selective",DrugBank
DB00960,Bradycardia-Causing Agents,DrugBank
DB00960,Cardiovascular Agents,DrugBank
DB00960,Central Nervous System Depressants,DrugBank
DB00960,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00960,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB00960,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00960,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00960,Cytochrome P-450 Substrates,DrugBank
DB00960,Drugs that are Mainly Renally Excreted,DrugBank
DB00960,Hypotensive Agents,DrugBank
DB00960,Neurotransmitter Agents,DrugBank
DB00960,OCT2 Substrates,DrugBank
DB00960,Phenoxypropanolamines,DrugBank
DB00960,Propanolamines,DrugBank
DB00960,Propanols,DrugBank
DB00960,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00960,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB00960,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB00960,Serotonin Agents,DrugBank
DB00960,Serotonin Receptor Antagonists,DrugBank
DB00960,Vasodilating Agents,DrugBank
DB00961,Amides,DrugBank
DB00961,Anesthetics,DrugBank
DB00961,"Anesthetics, Local",DrugBank
DB00961,Central Nervous System Agents,DrugBank
DB00961,Central Nervous System Depressants,DrugBank
DB00961,Drugs that are Mainly Renally Excreted,DrugBank
DB00961,Local Anesthesia,DrugBank
DB00961,Local Anesthetics (Amide),DrugBank
DB00961,Methemoglobinemia Associated Agents,DrugBank
DB00961,Nervous System,DrugBank
DB00961,Peripheral Nervous System Agents,DrugBank
DB00961,Piperidines,DrugBank
DB00961,Sensory System Agents,DrugBank
DB00962,Acetates,DrugBank
DB00962,"Acids, Acyclic",DrugBank
DB00962,Amides,DrugBank
DB00962,Anticonvulsants,DrugBank
DB00962,Benzodiazepine hypnotics and sedatives,DrugBank
DB00962,Central Nervous System Agents,DrugBank
DB00962,Central Nervous System Depressants,DrugBank
DB00962,Central Nervous System Depression,DrugBank
DB00962,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00962,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00962,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00962,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00962,Cytochrome P-450 Substrates,DrugBank
DB00962,Drugs that are Mainly Renally Excreted,DrugBank
DB00962,GABA Agents,DrugBank
DB00962,GABA Agonists,DrugBank
DB00962,GABA Modulators,DrugBank
DB00962,GABA-A Receptor Agonists,DrugBank
DB00962,gamma-Aminobutyric Acid A Receptor Agonist,DrugBank
DB00962,Hypnotics (Nonbenzodiazepine),DrugBank
DB00962,Hypnotics and Sedatives,DrugBank
DB00962,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB00962,Nervous System,DrugBank
DB00962,Neurotransmitter Agents,DrugBank
DB00962,Psycholeptics,DrugBank
DB00963,Agents causing hyperkalemia,DrugBank
DB00963,Analgesics,DrugBank
DB00963,"Analgesics, Non-Narcotic",DrugBank
DB00963,Anti-Inflammatory Agents,DrugBank
DB00963,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00963,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00963,Antirheumatic Agents,DrugBank
DB00963,Benzene Derivatives,DrugBank
DB00963,Central Nervous System Agents,DrugBank
DB00963,Cyclooxygenase Inhibitors,DrugBank
DB00963,"Hydrocarbons, Brominated",DrugBank
DB00963,"Hydrocarbons, Halogenated",DrugBank
DB00963,Ketones,DrugBank
DB00963,Nephrotoxic agents,DrugBank
DB00963,Ophthalmologicals,DrugBank
DB00963,Peripheral Nervous System Agents,DrugBank
DB00963,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB00963,Sensory Organs,DrugBank
DB00963,Sensory System Agents,DrugBank
DB00964,Adrenergic Agents,DrugBank
DB00964,Adrenergic Agonists,DrugBank
DB00964,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB00964,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00964,Adrenergic alpha-Agonists,DrugBank
DB00964,Antiglaucoma Preparations and Miotics,DrugBank
DB00964,"EENT Drugs, Miscellaneous",DrugBank
DB00964,Hypotensive Agents,DrugBank
DB00964,Imidazoles,DrugBank
DB00964,Imidazolines,DrugBank
DB00964,Neurotransmitter Agents,DrugBank
DB00964,Ophthalmics,DrugBank
DB00964,Ophthalmologicals,DrugBank
DB00964,Sensory Organs,DrugBank
DB00964,Sympathomimetics in Glaucoma Therapy,DrugBank
DB00966,Agents Acting on the Renin-Angiotensin System,DrugBank
DB00966,Agents causing angioedema,DrugBank
DB00966,Agents causing hyperkalemia,DrugBank
DB00966,Angiotensin 2 Receptor Blocker,DrugBank
DB00966,Angiotensin II receptor antagonists,DrugBank
DB00966,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB00966,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB00966,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB00966,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB00966,Angiotensin II Type 2 Receptor Blockers,DrugBank
DB00966,Angiotensin Receptor Antagonists,DrugBank
DB00966,Antihypertensive Agents,DrugBank
DB00966,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00966,BCRP/ABCG2 Inhibitors,DrugBank
DB00966,Benzene Derivatives,DrugBank
DB00966,Benzimidazoles,DrugBank
DB00966,Biphenyl Compounds,DrugBank
DB00966,BSEP/ABCB11 Substrates,DrugBank
DB00966,Cardiovascular Agents,DrugBank
DB00966,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00966,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00966,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00966,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00966,Hypotensive Agents,DrugBank
DB00966,Lipid Modifying Agents,DrugBank
DB00966,P-glycoprotein inhibitors,DrugBank
DB00966,UGT1A3 substrates,DrugBank
DB00967,Anticholinergic Agents,DrugBank
DB00967,Antihistamines for Systemic Use,DrugBank
DB00967,Benzocycloheptenes,DrugBank
DB00967,Central Nervous System Depressants,DrugBank
DB00967,Cholinergic Agents,DrugBank
DB00967,Dibenzocycloheptenes,DrugBank
DB00967,Histamine Agents,DrugBank
DB00967,Histamine Antagonists,DrugBank
DB00967,Histamine H1 Antagonists,DrugBank
DB00967,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00967,Loratadine and derivatives,DrugBank
DB00967,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00967,Neurotransmitter Agents,DrugBank
DB00967,P-glycoprotein inhibitors,DrugBank
DB00967,Piperidines,DrugBank
DB00967,QTc Prolonging Agents,DrugBank
DB00968,Adrenergic Agents,DrugBank
DB00968,Adrenergic Agonists,DrugBank
DB00968,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB00968,Adrenergic alpha-Agonists,DrugBank
DB00968,Agents Causing Muscle Toxicity,DrugBank
DB00968,Amines,DrugBank
DB00968,Amino Acids,DrugBank
DB00968,"Amino Acids, Aromatic",DrugBank
DB00968,"Amino Acids, Cyclic",DrugBank
DB00968,"Amino Acids, Peptides, and Proteins",DrugBank
DB00968,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB00968,Antihypertensive Agents,DrugBank
DB00968,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00968,Aromatic L-amino Acid Decarboxylase Inhibitors,DrugBank
DB00968,Autonomic Agents,DrugBank
DB00968,Benzene Derivatives,DrugBank
DB00968,Bradycardia-Causing Agents,DrugBank
DB00968,Cardiovascular Agents,DrugBank
DB00968,Catecholamines,DrugBank
DB00968,Catechols,DrugBank
DB00968,Central alpha-2 Adrenergic Agonist,DrugBank
DB00968,Central Alpha-agonists,DrugBank
DB00968,COMT Substrates,DrugBank
DB00968,Dihydroxyphenylalanine,DrugBank
DB00968,Drugs that are Mainly Renally Excreted,DrugBank
DB00968,Enzyme Inhibitors,DrugBank
DB00968,Hypotensive Agents,DrugBank
DB00968,Neurotransmitter Agents,DrugBank
DB00968,Peripheral Nervous System Agents,DrugBank
DB00968,Phenols,DrugBank
DB00968,Sympatholytics,DrugBank
DB00969,Alimentary Tract and Metabolism,DrugBank
DB00969,Antidepressive Agents,DrugBank
DB00969,Antiemetic Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00969,Antiemetics,DrugBank
DB00969,Central Nervous System Depressants,DrugBank
DB00969,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00969,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB00969,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00969,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00969,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00969,Cytochrome P-450 CYP2E1 Inhibitors (moderate),DrugBank
DB00969,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00969,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00969,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00969,Cytochrome P-450 Substrates,DrugBank
DB00969,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00969,Gastrointestinal Agents,DrugBank
DB00969,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00969,Indole Alkaloids,DrugBank
DB00969,Indoles,DrugBank
DB00969,Neurotransmitter Agents,DrugBank
DB00969,Pyridines,DrugBank
DB00969,Serotonin 3 Receptor Antagonists,DrugBank
DB00969,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB00969,Serotonin Agents,DrugBank
DB00969,Serotonin Receptor Antagonists,DrugBank
DB00970,Actinomycin,DrugBank
DB00970,Actinomycines,DrugBank
DB00970,"Amino Acids, Peptides, and Proteins",DrugBank
DB00970,Anti-Infective Agents,DrugBank
DB00970,"Antibiotics, Antineoplastic",DrugBank
DB00970,Antineoplastic Agents,DrugBank
DB00970,Antineoplastic and Immunomodulating Agents,DrugBank
DB00970,BCRP/ABCG2 Substrates,DrugBank
DB00970,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00970,Cytotoxins,DrugBank
DB00970,Enzyme Inhibitors,DrugBank
DB00970,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00970,Immunosuppressive Agents,DrugBank
DB00970,Myelosuppressive Agents,DrugBank
DB00970,Narrow Therapeutic Index Drugs,DrugBank
DB00970,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00970,P-glycoprotein inhibitors,DrugBank
DB00970,P-glycoprotein substrates,DrugBank
DB00970,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00970,Peptides,DrugBank
DB00970,"Peptides, Cyclic",DrugBank
DB00970,Protein Synthesis Inhibitors,DrugBank
DB00972,Anti-Allergic Agents,DrugBank
DB00972,"Antiallergic Agents, Excl. Corticosteroids",DrugBank
DB00972,Antihistamines for Systemic Use,DrugBank
DB00972,Autonomic Agents,DrugBank
DB00972,Central Nervous System Depressants,DrugBank
DB00972,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00972,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00972,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00972,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00972,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00972,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00972,Cytochrome P-450 Substrates,DrugBank
DB00972,Decongestants and Antiallergics,DrugBank
DB00972,Enzyme Inhibitors,DrugBank
DB00972,Histamine Agents,DrugBank
DB00972,Histamine Antagonists,DrugBank
DB00972,Histamine H1 Antagonists,DrugBank
DB00972,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB00972,Nasal Preparations,DrugBank
DB00972,Neurotransmitter Agents,DrugBank
DB00972,Ophthalmologicals,DrugBank
DB00972,P-glycoprotein inhibitors,DrugBank
DB00972,Pyridazines,DrugBank
DB00972,Respiratory System Agents,DrugBank
DB00972,Sensory Organs,DrugBank
DB00973,Anticholesteremic Agents,DrugBank
DB00973,Azetines,DrugBank
DB00973,BCRP/ABCG2 Substrates,DrugBank
DB00973,BSEP/ABCB11 Substrates,DrugBank
DB00973,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00973,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00973,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00973,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00973,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00973,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00973,Decreased Cholesterol Absorption,DrugBank
DB00973,Dietary Cholesterol Absorption Inhibitor,DrugBank
DB00973,Hypolipidemic Agents,DrugBank
DB00973,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00973,Lipid Modifying Agents,DrugBank
DB00973,"Lipid Modifying Agents, Plain",DrugBank
DB00973,Lipid Regulating Agents,DrugBank
DB00973,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB00973,OATP1B1/SLCO1B1 Substrates,DrugBank
DB00973,P-glycoprotein substrates,DrugBank
DB00973,UGT1A1 Substrates,DrugBank
DB00973,UGT1A3 substrates,DrugBank
DB00973,UGT2B7 substrates,DrugBank
DB00974,Acetates,DrugBank
DB00974,"Acids, Acyclic",DrugBank
DB00974,Amines,DrugBank
DB00974,Anticoagulants,DrugBank
DB00974,Calcium Chelating Activity,DrugBank
DB00974,Calcium Chelating Agents,DrugBank
DB00974,Chelating Agents,DrugBank
DB00974,"Compounds used in a research, industrial, or household setting",DrugBank
DB00974,Decreased Coagulation Factor Activity,DrugBank
DB00974,Diamines,DrugBank
DB00974,"Diet, Food, and Nutrition",DrugBank
DB00974,Ethylenediamines,DrugBank
DB00974,Food,DrugBank
DB00974,Food Additives,DrugBank
DB00974,Food Ingredients,DrugBank
DB00974,Heavy Metal Antagonists,DrugBank
DB00974,Hematologic Agents,DrugBank
DB00974,Lead Chelating Activity,DrugBank
DB00974,Lead Chelator,DrugBank
DB00974,Physiological Phenomena,DrugBank
DB00974,Polyamines,DrugBank
DB00974,Sequestering Agents,DrugBank
DB00975,Anticoagulants,DrugBank
DB00975,Antiplatelet agents,DrugBank
DB00975,Blood and Blood Forming Organs,DrugBank
DB00975,BSEP/ABCB11 Substrates,DrugBank
DB00975,Cardiovascular Agents,DrugBank
DB00975,Decreased Platelet Aggregation,DrugBank
DB00975,Enzyme Inhibitors,DrugBank
DB00975,Hematologic Agents,DrugBank
DB00975,Hypotensive Agents,DrugBank
DB00975,Miscellaneous Vasodilatating Agents,DrugBank
DB00975,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00975,OATP1B3 inhibitors,DrugBank
DB00975,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB00975,P-glycoprotein inhibitors,DrugBank
DB00975,P-glycoprotein substrates,DrugBank
DB00975,Phosphodiesterase 5 Inhibitors,DrugBank
DB00975,Phosphodiesterase Inhibitors,DrugBank
DB00975,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB00975,Pyrimidines,DrugBank
DB00975,Vasodilating Agents,DrugBank
DB00976,Anti-Bacterial Agents,DrugBank
DB00976,Anti-Infective Agents,DrugBank
DB00976,Antibacterials for Systemic Use,DrugBank
DB00976,Antiinfectives for Systemic Use,DrugBank
DB00976,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00976,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00976,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00976,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB00976,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00976,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB00976,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00976,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB00976,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00976,Cytochrome P-450 Substrates,DrugBank
DB00976,Erythromycin and similars,DrugBank
DB00976,Ketolide Antibacterial,DrugBank
DB00976,Ketolides,DrugBank
DB00976,Lactones,DrugBank
DB00976,Macrolides,DrugBank
DB00976,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB00976,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00976,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB00976,OATP1B3 inhibitors,DrugBank
DB00976,Polyketides,DrugBank
DB00976,Protein Synthesis Inhibitors,DrugBank
DB00976,QTc Prolonging Agents,DrugBank
DB00977,Adrenal Cortex Hormones,DrugBank
DB00977,Antineoplastic and Immunomodulating Agents,DrugBank
DB00977,BSEP/ABCB11 inducers,DrugBank
DB00977,BSEP/ABCB11 Inhibitors,DrugBank
DB00977,COMT Substrates,DrugBank
DB00977,"Contraceptive Agents, Female",DrugBank
DB00977,"Contraceptive Agents, Hormonal",DrugBank
DB00977,"Contraceptives, Oral",DrugBank
DB00977,"Contraceptives, Oral, Hormonal",DrugBank
DB00977,"Contraceptives, Postcoital",DrugBank
DB00977,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00977,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB00977,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB00977,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB00977,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB00977,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB00977,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00977,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00977,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00977,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB00977,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00977,Cytochrome P-450 Substrates,DrugBank
DB00977,Endocrine Therapy,DrugBank
DB00977,Estradiol Congeners,DrugBank
DB00977,Estrogen Contraceptives,DrugBank
DB00977,"Estrogenic Steroids, Alkylated",DrugBank
DB00977,Estrogens,DrugBank
DB00977,Fused-Ring Compounds,DrugBank
DB00977,Genito Urinary System and Sex Hormones,DrugBank
DB00977,Gonadal Hormones,DrugBank
DB00977,Gonadal Steroid Hormones,DrugBank
DB00977,Hormonal Contraceptives for Systemic Use,DrugBank
DB00977,Hormones,DrugBank
DB00977,Hormones and Related Agents,DrugBank
DB00977,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00977,Hyperglycemia-Associated Agents,DrugBank
DB00977,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB00977,Norpregnanes,DrugBank
DB00977,Norpregnatrienes,DrugBank
DB00977,Norsteroids,DrugBank
DB00977,P-glycoprotein substrates,DrugBank
DB00977,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB00977,Reproductive Control Agents,DrugBank
DB00977,Sex Hormones and Modulators of the Genital System,DrugBank
DB00977,Steroids,DrugBank
DB00977,Thyroxine-binding globulin inducers,DrugBank
DB00977,UGT1A1 Inducers,DrugBank
DB00977,UGT1A1 Substrates,DrugBank
DB00977,UGT1A4 substrates,DrugBank
DB00977,UGT1A9 Substrates,DrugBank
DB00977,UGT2B7 substrates,DrugBank
DB00978,4-Quinolones,DrugBank
DB00978,Anti-Bacterial Agents,DrugBank
DB00978,Anti-Infective Agents,DrugBank
DB00978,"Anti-Infective Agents, Urinary",DrugBank
DB00978,Antibacterials for Systemic Use,DrugBank
DB00978,Antiinfectives for Systemic Use,DrugBank
DB00978,Antimycobacterials,DrugBank
DB00978,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB00978,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB00978,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00978,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00978,Cytochrome P-450 Substrates,DrugBank
DB00978,Drugs causing inadvertant photosensitivity,DrugBank
DB00978,Drugs for Treatment of Tuberculosis,DrugBank
DB00978,Enzyme Inhibitors,DrugBank
DB00978,Fluoroquinolone Antibacterial,DrugBank
DB00978,Fluoroquinolones,DrugBank
DB00978,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00978,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00978,Ophthalmologicals,DrugBank
DB00978,Photosensitizing Agents,DrugBank
DB00978,QTc Prolonging Agents,DrugBank
DB00978,Quinolines,DrugBank
DB00978,Quinolones,DrugBank
DB00978,Sensory Organs,DrugBank
DB00978,Topoisomerase II Inhibitors,DrugBank
DB00978,Topoisomerase Inhibitors,DrugBank
DB00979,"Acids, Carbocyclic",DrugBank
DB00979,Anticholinergic Agents,DrugBank
DB00979,Autonomic Agents,DrugBank
DB00979,Cholinergic Agents,DrugBank
DB00979,Cholinesterase substrates,DrugBank
DB00979,Muscarinic Antagonists,DrugBank
DB00979,Mydriatics,DrugBank
DB00979,Mydriatics and Cycloplegics,DrugBank
DB00979,Neurotransmitter Agents,DrugBank
DB00979,Ophthalmologicals,DrugBank
DB00979,Parasympatholytics,DrugBank
DB00979,Peripheral Nervous System Agents,DrugBank
DB00979,Phenylacetates,DrugBank
DB00979,Sensory Organs,DrugBank
DB00980,Central Nervous System Depressants,DrugBank
DB00980,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00980,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00980,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00980,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00980,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00980,Cytochrome P-450 Substrates,DrugBank
DB00980,Drugs that are Mainly Renally Excreted,DrugBank
DB00980,Hypnotics and Sedatives,DrugBank
DB00980,Melatonin Receptor Agonists,DrugBank
DB00980,Nervous System,DrugBank
DB00980,Psycholeptics,DrugBank
DB00981,"Acids, Acyclic",DrugBank
DB00981,Alkaloids,DrugBank
DB00981,Antidotes,DrugBank
DB00981,Antiglaucoma Preparations and Miotics,DrugBank
DB00981,Autonomic Agents,DrugBank
DB00981,Carbamates,DrugBank
DB00981,Cholinergic Agents,DrugBank
DB00981,Cholinesterase Inhibitors,DrugBank
DB00981,Enzyme Inhibitors,DrugBank
DB00981,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00981,Indole Alkaloids,DrugBank
DB00981,Indoles,DrugBank
DB00981,Indolizidines,DrugBank
DB00981,Indolizines,DrugBank
DB00981,Miotics,DrugBank
DB00981,Neurotransmitter Agents,DrugBank
DB00981,Ophthalmologicals,DrugBank
DB00981,Parasympathomimetics,DrugBank
DB00981,Peripheral Nervous System Agents,DrugBank
DB00981,Phenylcarbamates,DrugBank
DB00981,Sensory Organs,DrugBank
DB00982,Agents Causing Muscle Toxicity,DrugBank
DB00982,Alkenes,DrugBank
DB00982,Anti-Acne Preparations,DrugBank
DB00982,Anti-Acne Preparations for Systemic Use,DrugBank
DB00982,Anti-Acne Preparations for Topical Use,DrugBank
DB00982,Biological Factors,DrugBank
DB00982,Carotenoids,DrugBank
DB00982,Cyclohexanes,DrugBank
DB00982,Cyclohexenes,DrugBank
DB00982,Cycloparaffins,DrugBank
DB00982,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00982,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00982,Cytochrome P-450 Substrates,DrugBank
DB00982,Dermatologicals,DrugBank
DB00982,Drugs causing inadvertant photosensitivity,DrugBank
DB00982,Drugs that are Mainly Renally Excreted,DrugBank
DB00982,"Hydrocarbons, Acyclic",DrugBank
DB00982,Misc. Skin and Mucous Membrane Agents,DrugBank
DB00982,Noxae,DrugBank
DB00982,Photosensitizing Agents,DrugBank
DB00982,"Pigments, Biological",DrugBank
DB00982,Polyenes,DrugBank
DB00982,Retinoids,DrugBank
DB00982,Retinoids for Topical Use in Acne,DrugBank
DB00982,Retinoids for Treatment of Acne,DrugBank
DB00982,Teratogens,DrugBank
DB00982,Terpenes,DrugBank
DB00982,Toxic Actions,DrugBank
DB00983,Adrenergic Agents,DrugBank
DB00983,Adrenergic Agonists,DrugBank
DB00983,Adrenergic beta-2 Receptor Agonists,DrugBank
DB00983,Adrenergic beta-Agonists,DrugBank
DB00983,Adrenergics for Systemic Use,DrugBank
DB00983,"Adrenergics, Inhalants",DrugBank
DB00983,Agents producing tachycardia,DrugBank
DB00983,Agents that produce hypertension,DrugBank
DB00983,Agents to Treat Airway Disease,DrugBank
DB00983,Alcohols,DrugBank
DB00983,Amines,DrugBank
DB00983,Amino Alcohols,DrugBank
DB00983,Anti-Asthmatic Agents,DrugBank
DB00983,Autonomic Agents,DrugBank
DB00983,Bronchodilator Agents,DrugBank
DB00983,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB00983,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00983,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00983,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00983,Cytochrome P-450 Substrates,DrugBank
DB00983,Drugs for Obstructive Airway Diseases,DrugBank
DB00983,Ethanolamines,DrugBank
DB00983,Long-acting beta-adrenoceptor agonists,DrugBank
DB00983,OCT1 inhibitors,DrugBank
DB00983,OCT1 substrates,DrugBank
DB00983,Potential QTc-Prolonging Agents,DrugBank
DB00983,QTc Prolonging Agents,DrugBank
DB00983,Respiratory System Agents,DrugBank
DB00983,Selective Beta 2-adrenergic Agonists,DrugBank
DB00983,UGT1A1 Substrates,DrugBank
DB00983,UGT1A9 Substrates,DrugBank
DB00983,UGT2B7 substrates,DrugBank
DB00984,Anabolic Agents,DrugBank
DB00984,Androgens,DrugBank
DB00984,Estranes,DrugBank
DB00984,Estrenes,DrugBank
DB00984,Fused-Ring Compounds,DrugBank
DB00984,Gonadal Hormones,DrugBank
DB00984,Gonadal Steroid Hormones,DrugBank
DB00984,Hormones,DrugBank
DB00984,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00984,Nandrolone and esters,DrugBank
DB00984,Steroids,DrugBank
DB00984,Testosterone Congeners,DrugBank
DB00984,Thyroxine-binding globulin inhibitors,DrugBank
DB00985,Alkaloids,DrugBank
DB00985,Amines,DrugBank
DB00985,Aminoalkyl Ethers,DrugBank
DB00985,Antiemetics,DrugBank
DB00985,Antihistamines for Systemic Use,DrugBank
DB00985,Autonomic Agents,DrugBank
DB00985,Benzene Derivatives,DrugBank
DB00985,Benzhydryl Compounds,DrugBank
DB00985,Central Nervous System Agents,DrugBank
DB00985,Central Nervous System Depressants,DrugBank
DB00985,Ethanolamine Derivatives,DrugBank
DB00985,Ethylamines,DrugBank
DB00985,Gastrointestinal Agents,DrugBank
DB00985,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00985,Histamine Agents,DrugBank
DB00985,Histamine Antagonists,DrugBank
DB00985,Histamine H1 Antagonists,DrugBank
DB00985,Moderate Risk QTc-Prolonging Agents,DrugBank
DB00985,Neurotransmitter Agents,DrugBank
DB00985,Peripheral Nervous System Agents,DrugBank
DB00985,Pharmaceutical Preparations,DrugBank
DB00985,Purines,DrugBank
DB00985,Purinones,DrugBank
DB00985,QTc Prolonging Agents,DrugBank
DB00986,"Adjuvants, Anesthesia",DrugBank
DB00986,"Adrenergics, Inhalants",DrugBank
DB00986,Agents producing tachycardia,DrugBank
DB00986,Alimentary Tract and Metabolism,DrugBank
DB00986,Amines,DrugBank
DB00986,Ammonium Compounds,DrugBank
DB00986,Anticholinergic Agents,DrugBank
DB00986,Antihidrotics,DrugBank
DB00986,Antimuscarinics Antispasmodics,DrugBank
DB00986,Central Nervous System Agents,DrugBank
DB00986,Cholinergic Agents,DrugBank
DB00986,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00986,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00986,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00986,Cytochrome P-450 Substrates,DrugBank
DB00986,Dermatologicals,DrugBank
DB00986,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB00986,Drugs for Obstructive Airway Diseases,DrugBank
DB00986,MATE 1 Substrates,DrugBank
DB00986,MATE substrates,DrugBank
DB00986,Muscarinic Antagonists,DrugBank
DB00986,Neurotransmitter Agents,DrugBank
DB00986,Nitrogen Compounds,DrugBank
DB00986,OCT2 Substrates,DrugBank
DB00986,Onium Compounds,DrugBank
DB00986,Pyrrolidines,DrugBank
DB00986,Quaternary Ammonium Compounds,DrugBank
DB00986,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB00987,Agents Causing Muscle Toxicity,DrugBank
DB00987,Anti-Infective Agents,DrugBank
DB00987,Antimetabolites,DrugBank
DB00987,Antineoplastic Agents,DrugBank
DB00987,Antineoplastic and Immunomodulating Agents,DrugBank
DB00987,Arabinonucleosides,DrugBank
DB00987,Cardiotoxic antineoplastic agents,DrugBank
DB00987,Cytidine Deaminase Substrates,DrugBank
DB00987,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00987,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00987,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00987,Cytochrome P-450 Substrates,DrugBank
DB00987,Immunologic Factors,DrugBank
DB00987,Immunosuppressive Agents,DrugBank
DB00987,Myelosuppressive Agents,DrugBank
DB00987,Narrow Therapeutic Index Drugs,DrugBank
DB00987,Noxae,DrugBank
DB00987,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00987,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00987,Nucleoside Metabolic Inhibitor,DrugBank
DB00987,Nucleosides,DrugBank
DB00987,OCT1 substrates,DrugBank
DB00987,Pyrimidine Analogues,DrugBank
DB00987,Pyrimidine Nucleosides,DrugBank
DB00987,Pyrimidines,DrugBank
DB00987,Toxic Actions,DrugBank
DB00988,Adrenergic and Dopaminergic Agents,DrugBank
DB00988,Agents producing tachycardia,DrugBank
DB00988,Agents that produce hypertension,DrugBank
DB00988,Amines,DrugBank
DB00988,Autonomic Agents,DrugBank
DB00988,Benzene Derivatives,DrugBank
DB00988,Biogenic Amines,DrugBank
DB00988,Biogenic Monoamines,DrugBank
DB00988,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB00988,Cardiac Therapy,DrugBank
DB00988,Cardiotonic Agents,DrugBank
DB00988,Cardiovascular Agents,DrugBank
DB00988,Catecholamines,DrugBank
DB00988,Catechols,DrugBank
DB00988,"Compounds used in a research, industrial, or household setting",DrugBank
DB00988,COMT Substrates,DrugBank
DB00988,Dopamine Agents,DrugBank
DB00988,"Dopamine, metabolism",DrugBank
DB00988,Drugs that are Mainly Renally Excreted,DrugBank
DB00988,Monoamine Oxidase A Substrates,DrugBank
DB00988,Neurotransmitter Agents,DrugBank
DB00988,OCT1 substrates,DrugBank
DB00988,OCT2 Inhibitors,DrugBank
DB00988,OCT2 Substrates,DrugBank
DB00988,Peripheral Nervous System Agents,DrugBank
DB00988,Phenols,DrugBank
DB00988,Protective Agents,DrugBank
DB00988,Selective Beta 1-adrenergic Agonists,DrugBank
DB00988,Sympathomimetics,DrugBank
DB00989,"Acids, Acyclic",DrugBank
DB00989,Anti-Dementia Drugs,DrugBank
DB00989,Bradycardia-Causing Agents,DrugBank
DB00989,Carbamates,DrugBank
DB00989,Central Nervous System Agents,DrugBank
DB00989,Cholinergic Agents,DrugBank
DB00989,Cholinesterase Inhibitors,DrugBank
DB00989,"Compounds used in a research, industrial, or household setting",DrugBank
DB00989,Enzyme Inhibitors,DrugBank
DB00989,Nervous System,DrugBank
DB00989,Neuroprotective Agents,DrugBank
DB00989,Neurotransmitter Agents,DrugBank
DB00989,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB00989,Phenylcarbamates,DrugBank
DB00989,Protective Agents,DrugBank
DB00989,Psychoanaleptics,DrugBank
DB00990,Androstanes,DrugBank
DB00990,Androstenes,DrugBank
DB00990,Antineoplastic Agents,DrugBank
DB00990,Antineoplastic and Immunomodulating Agents,DrugBank
DB00990,Aromatase Inhibitors,DrugBank
DB00990,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00990,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00990,Cytochrome P-450 Substrates,DrugBank
DB00990,Endocrine Therapy,DrugBank
DB00990,Enzyme Inhibitors,DrugBank
DB00990,Estrogen Antagonists,DrugBank
DB00990,Fused-Ring Compounds,DrugBank
DB00990,Hormone Antagonists,DrugBank
DB00990,Hormone Antagonists and Related Agents,DrugBank
DB00990,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB00990,Steroid Synthesis Inhibitors,DrugBank
DB00990,Steroids,DrugBank
DB00991,"Acids, Acyclic",DrugBank
DB00991,Agents causing hyperkalemia,DrugBank
DB00991,Agents that produce hypertension,DrugBank
DB00991,Analgesics,DrugBank
DB00991,"Analgesics, Non-Narcotic",DrugBank
DB00991,Anti-Inflammatory Agents,DrugBank
DB00991,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB00991,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB00991,Antiinflammatory and Antirheumatic Products,DrugBank
DB00991,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB00991,Antirheumatic Agents,DrugBank
DB00991,Arylpropionic acid NSAIDS,DrugBank
DB00991,Cyclooxygenase Inhibitors,DrugBank
DB00991,Drugs causing inadvertant photosensitivity,DrugBank
DB00991,Drugs that are Mainly Renally Excreted,DrugBank
DB00991,Enzyme Inhibitors,DrugBank
DB00991,Musculo-Skeletal System,DrugBank
DB00991,Nephrotoxic agents,DrugBank
DB00991,Non COX-2 selective NSAIDS,DrugBank
DB00991,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB00991,Oxazoles,DrugBank
DB00991,Peripheral Nervous System Agents,DrugBank
DB00991,Photosensitizing Agents,DrugBank
DB00991,Propionates,DrugBank
DB00991,Sensory System Agents,DrugBank
DB00993,Antimetabolites,DrugBank
DB00993,Antineoplastic and Immunomodulating Agents,DrugBank
DB00993,Antirheumatic Agents,DrugBank
DB00993,Carbohydrates,DrugBank
DB00993,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00993,Cytochrome P-450 Substrates,DrugBank
DB00993,Drugs that are Mainly Renally Excreted,DrugBank
DB00993,Glycosides,DrugBank
DB00993,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00993,Immunologic Factors,DrugBank
DB00993,Immunosuppressive Agents,DrugBank
DB00993,Immunotherapy,DrugBank
DB00993,Noxae,DrugBank
DB00993,Nucleic Acid Synthesis Inhibitors,DrugBank
DB00993,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB00993,Nucleosides,DrugBank
DB00993,P-glycoprotein substrates,DrugBank
DB00993,Purine Antimetabolite,DrugBank
DB00993,Purines,DrugBank
DB00993,Sulfhydryl Compounds,DrugBank
DB00993,Sulfur Compounds,DrugBank
DB00993,Thionucleosides,DrugBank
DB00993,Thiopurine Analogs,DrugBank
DB00993,Toxic Actions,DrugBank
DB00994,Agents that produce neuromuscular block (indirect),DrugBank
DB00994,Alimentary Tract and Metabolism,DrugBank
DB00994,Aminoglycoside Antibacterials,DrugBank
DB00994,Anti-Bacterial Agents,DrugBank
DB00994,Anti-Infective Agents,DrugBank
DB00994,Antibacterials for Systemic Use,DrugBank
DB00994,Antibiotics for Topical Use,DrugBank
DB00994,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00994,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB00994,Antiinfectives for Systemic Use,DrugBank
DB00994,Blood and Blood Forming Organs,DrugBank
DB00994,Blood Substitutes and Perfusion Solutions,DrugBank
DB00994,Carbohydrates,DrugBank
DB00994,Dermatologicals,DrugBank
DB00994,Drugs that are Mainly Renally Excreted,DrugBank
DB00994,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB00994,Enzyme Inhibitors,DrugBank
DB00994,Glycosides,DrugBank
DB00994,Intestinal Antiinfectives,DrugBank
DB00994,Irrigating Solutions,DrugBank
DB00994,Narrow Therapeutic Index Drugs,DrugBank
DB00994,Nephrotoxic agents,DrugBank
DB00994,Neurotoxic agents,DrugBank
DB00994,Ophthalmological and Otological Preparations,DrugBank
DB00994,Ophthalmologicals,DrugBank
DB00994,Otologicals,DrugBank
DB00994,Ototoxic agents,DrugBank
DB00994,Protein Synthesis Inhibitors,DrugBank
DB00994,Sensory Organs,DrugBank
DB00994,Stomatological Preparations,DrugBank
DB00994,Throat Preparations,DrugBank
DB00995,Antiinflammatory and Antirheumatic Products,DrugBank
DB00995,Antirheumatic Agents,DrugBank
DB00995,Drugs that are Mainly Renally Excreted,DrugBank
DB00995,Gold Compounds,DrugBank
DB00995,Gold Preparations,DrugBank
DB00995,Musculo-Skeletal System,DrugBank
DB00995,Organogold Compounds,DrugBank
DB00995,Organometallic Compounds,DrugBank
DB00995,Specific Antirheumatic Agents,DrugBank
DB00996,"Acids, Acyclic",DrugBank
DB00996,"Acids, Carbocyclic",DrugBank
DB00996,Amines,DrugBank
DB00996,Amino Acids,DrugBank
DB00996,"Amino Acids, Peptides, and Proteins",DrugBank
DB00996,Aminobutyrates,DrugBank
DB00996,Analgesics,DrugBank
DB00996,Anti-epileptic Agent,DrugBank
DB00996,Anticonvulsants,DrugBank
DB00996,Butyrates,DrugBank
DB00996,Central Nervous System Agents,DrugBank
DB00996,Central Nervous System Depressants,DrugBank
DB00996,Cyclohexanecarboxylic Acids,DrugBank
DB00996,Cyclohexanes,DrugBank
DB00996,Cycloparaffins,DrugBank
DB00996,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB00996,Drugs causing inadvertant photosensitivity,DrugBank
DB00996,Gabapentin and Prodrugs,DrugBank
DB00996,Gabapentinoids,DrugBank
DB00996,Miscellaneous Anticonvulsants,DrugBank
DB00996,Nervous System,DrugBank
DB00996,Neurotransmitter Agents,DrugBank
DB00996,Peripheral Nervous System Agents,DrugBank
DB00996,Photosensitizing Agents,DrugBank
DB00996,Psychotropic Drugs,DrugBank
DB00996,Sensory System Agents,DrugBank
DB00996,Tranquilizing Agents,DrugBank
DB00997,Anthracycline Topoisomerase Inhibitor,DrugBank
DB00997,Anthracyclines,DrugBank
DB00997,Anthracyclines and Related Substances,DrugBank
DB00997,"Antibiotics, Antineoplastic",DrugBank
DB00997,Antineoplastic Agents,DrugBank
DB00997,Antineoplastic and Immunomodulating Agents,DrugBank
DB00997,BCRP/ABCG2 Substrates,DrugBank
DB00997,BSEP/ABCB11 Substrates,DrugBank
DB00997,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB00997,Carbohydrates,DrugBank
DB00997,Cardiotoxic antineoplastic agents,DrugBank
DB00997,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB00997,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB00997,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB00997,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB00997,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB00997,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB00997,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB00997,Cytochrome P-450 CYP3A Substrates,DrugBank
DB00997,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB00997,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB00997,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB00997,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB00997,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB00997,Cytochrome P-450 Substrates,DrugBank
DB00997,Cytotoxic Antibiotics and Related Substances,DrugBank
DB00997,Cytotoxins,DrugBank
DB00997,Drugs causing inadvertant photosensitivity,DrugBank
DB00997,Enzyme Inhibitors,DrugBank
DB00997,Glycosides,DrugBank
DB00997,Immunosuppressive Agents,DrugBank
DB00997,Myelosuppressive Agents,DrugBank
DB00997,Narrow Therapeutic Index Drugs,DrugBank
DB00997,P-glycoprotein inducers,DrugBank
DB00997,P-glycoprotein inhibitors,DrugBank
DB00997,P-glycoprotein substrates,DrugBank
DB00997,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB00997,Photosensitizing Agents,DrugBank
DB00997,Topoisomerase II Inhibitors,DrugBank
DB00997,Topoisomerase Inhibitors,DrugBank
DB00998,Agents that produce hypertension,DrugBank
DB00998,Amines,DrugBank
DB00998,Analgesics,DrugBank
DB00998,Antidepressive Agents,DrugBank
DB00998,Antimigraine Preparations,DrugBank
DB00998,Biogenic Amines,DrugBank
DB00998,Biogenic Monoamines,DrugBank
DB00998,Central Nervous System Depressants,DrugBank
DB00998,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB00998,Cytochrome P-450 Substrates,DrugBank
DB00998,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00998,Indoles,DrugBank
DB00998,Migraine Disorders,DrugBank
DB00998,Nervous System,DrugBank
DB00998,Neurotransmitter Agents,DrugBank
DB00998,Selective Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00998,Selective Serotonin Agonists,DrugBank
DB00998,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB00998,Serotonin 1b Receptor Agonists,DrugBank
DB00998,Serotonin 1d Receptor Agonists,DrugBank
DB00998,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB00998,Serotonin Agents,DrugBank
DB00998,Serotonin Modulators,DrugBank
DB00998,Serotonin Receptor Agonists,DrugBank
DB00998,Serotonin-1b and Serotonin-1d Receptor Agonist,DrugBank
DB00998,Triptans,DrugBank
DB00999,Amides,DrugBank
DB00999,Antihypertensive Agents,DrugBank
DB00999,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB00999,Benzothiadiazines,DrugBank
DB00999,Cardiovascular Agents,DrugBank
DB00999,Diuretics,DrugBank
DB00999,Drugs causing inadvertant photosensitivity,DrugBank
DB00999,Genito Urinary System and Sex Hormones,DrugBank
DB00999,Gynecological Antiinfectives and Antiseptics,DrugBank
DB00999,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB00999,Hyperglycemia-Associated Agents,DrugBank
DB00999,Hypotensive Agents,DrugBank
DB00999,Increased Diuresis,DrugBank
DB00999,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB00999,Membrane Transport Modulators,DrugBank
DB00999,Natriuretic Agents,DrugBank
DB00999,Nephrotoxic agents,DrugBank
DB00999,Non Potassium Sparing Diuretics,DrugBank
DB00999,OAT1/SLC22A6 inhibitors,DrugBank
DB00999,OAT3/SLC22A8 Substrates,DrugBank
DB00999,Photosensitizing Agents,DrugBank
DB00999,Potential QTc-Prolonging Agents,DrugBank
DB00999,QTc Prolonging Agents,DrugBank
DB00999,Sodium Chloride Symporter Inhibitors,DrugBank
DB00999,Sulfonamides,DrugBank
DB00999,Sulfones,DrugBank
DB00999,Sulfur Compounds,DrugBank
DB00999,Thiazides,DrugBank
DB01000,Amides,DrugBank
DB01000,Anti-Bacterial Agents,DrugBank
DB01000,Anti-Infective Agents,DrugBank
DB01000,Antibacterials for Systemic Use,DrugBank
DB01000,Antiinfectives for Systemic Use,DrugBank
DB01000,Beta-Lactam Antibacterials,DrugBank
DB01000,beta-Lactams,DrugBank
DB01000,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01000,Lactams,DrugBank
DB01000,Penicillins,DrugBank
DB01000,Sulfur Compounds,DrugBank
DB01001,Adrenergic Agents,DrugBank
DB01001,Adrenergic Agonists,DrugBank
DB01001,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01001,Adrenergic beta-Agonists,DrugBank
DB01001,"Adrenergics, Inhalants",DrugBank
DB01001,Agents producing tachycardia,DrugBank
DB01001,Agents that produce hypertension,DrugBank
DB01001,Agents to Treat Airway Disease,DrugBank
DB01001,Alcohols,DrugBank
DB01001,Amines,DrugBank
DB01001,Amino Alcohols,DrugBank
DB01001,Anti-Asthmatic Agents,DrugBank
DB01001,Autonomic Agents,DrugBank
DB01001,Bronchodilator Agents,DrugBank
DB01001,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01001,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01001,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01001,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01001,Drugs for Obstructive Airway Diseases,DrugBank
DB01001,Drugs that are Mainly Renally Excreted,DrugBank
DB01001,Ethanolamines,DrugBank
DB01001,Peripheral Nervous System Agents,DrugBank
DB01001,Phenethylamines,DrugBank
DB01001,Potential QTc-Prolonging Agents,DrugBank
DB01001,QTc Prolonging Agents,DrugBank
DB01001,Reproductive Control Agents,DrugBank
DB01001,Respiratory System Agents,DrugBank
DB01001,Selective Beta 2-adrenergic Agonists,DrugBank
DB01001,Sympathomimetic (Adrenergic) Agents,DrugBank
DB01001,Tocolytic Agents,DrugBank
DB01002,Amides,DrugBank
DB01002,Amines,DrugBank
DB01002,Anesthetics,DrugBank
DB01002,"Anesthetics, Local",DrugBank
DB01002,Anilides,DrugBank
DB01002,Aniline Compounds,DrugBank
DB01002,Central Nervous System Agents,DrugBank
DB01002,Central Nervous System Depressants,DrugBank
DB01002,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01002,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01002,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01002,Cytochrome P-450 Substrates,DrugBank
DB01002,Drugs that are Mainly Renally Excreted,DrugBank
DB01002,Hypotensive Agents,DrugBank
DB01002,Nervous System,DrugBank
DB01002,Neuraxial Anesthetics,DrugBank
DB01002,Peripheral Nervous System Agents,DrugBank
DB01002,Sensory System Agents,DrugBank
DB01004,Agents Causing Muscle Toxicity,DrugBank
DB01004,Agents that reduce seizure threshold,DrugBank
DB01004,Anti-Infective Agents,DrugBank
DB01004,Antiinfectives for Systemic Use,DrugBank
DB01004,Antiviral Agents,DrugBank
DB01004,Antivirals for Systemic Use,DrugBank
DB01004,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB01004,Direct Acting Antivirals,DrugBank
DB01004,Drugs that are Mainly Renally Excreted,DrugBank
DB01004,Ganciclovir and prodrug,DrugBank
DB01004,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01004,MATE 1 Substrates,DrugBank
DB01004,MATE 2 Substrates,DrugBank
DB01004,MATE substrates,DrugBank
DB01004,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01004,Nucleoside Analog Antiviral,DrugBank
DB01004,Nucleosides and Nucleotides,DrugBank
DB01004,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB01004,OAT1/SLC22A6 inhibitors,DrugBank
DB01004,OAT3/SLC22A8 Inhibitors,DrugBank
DB01004,OCT1 inhibitors,DrugBank
DB01004,OCT1 substrates,DrugBank
DB01004,Ophthalmologicals,DrugBank
DB01004,Purines,DrugBank
DB01004,Purinones,DrugBank
DB01004,Sensory Organs,DrugBank
DB01005,Amides,DrugBank
DB01005,Antineoplastic Agents,DrugBank
DB01005,Antineoplastic and Immunomodulating Agents,DrugBank
DB01005,Antisickling Agents,DrugBank
DB01005,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01005,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01005,Enzyme Inhibitors,DrugBank
DB01005,Hematologic Agents,DrugBank
DB01005,Immunosuppressive Agents,DrugBank
DB01005,Methemoglobinemia Associated Agents,DrugBank
DB01005,Myelosuppressive Agents,DrugBank
DB01005,Narrow Therapeutic Index Drugs,DrugBank
DB01005,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01005,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01006,Agents Causing Muscle Toxicity,DrugBank
DB01006,Antineoplastic Agents,DrugBank
DB01006,Antineoplastic and Immunomodulating Agents,DrugBank
DB01006,Aromatase Inhibitors,DrugBank
DB01006,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01006,Cytochrome P-450 CYP2A6 Inhibitors (strong),DrugBank
DB01006,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01006,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01006,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01006,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01006,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01006,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01006,Cytochrome P-450 Substrates,DrugBank
DB01006,Endocrine Therapy,DrugBank
DB01006,Enzyme Inhibitors,DrugBank
DB01006,Estrogen Antagonists,DrugBank
DB01006,Hormone Antagonists,DrugBank
DB01006,Hormone Antagonists and Related Agents,DrugBank
DB01006,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01006,Nitriles,DrugBank
DB01006,P-glycoprotein substrates,DrugBank
DB01006,Steroid Synthesis Inhibitors,DrugBank
DB01006,Triazoles,DrugBank
DB01006,UGT2B7 substrates,DrugBank
DB01007,14-alpha Demethylase Inhibitors,DrugBank
DB01007,Anti-Infective Agents,DrugBank
DB01007,Antifungal Agents,DrugBank
DB01007,Antifungal Agents (Vaginal),DrugBank
DB01007,Antifungals for Dermatological Use,DrugBank
DB01007,Antifungals for Topical Use,DrugBank
DB01007,Azole Antifungals,DrugBank
DB01007,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01007,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB01007,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01007,Cytochrome P-450 CYP2E1 Inhibitors (strong),DrugBank
DB01007,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01007,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01007,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01007,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01007,Dermatologicals,DrugBank
DB01007,Enzyme Inhibitors,DrugBank
DB01007,Genito Urinary System and Sex Hormones,DrugBank
DB01007,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01007,Hormone Antagonists,DrugBank
DB01007,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01007,Imidazole and Triazole Derivatives,DrugBank
DB01007,Imidazole Derivatives,DrugBank
DB01007,Steroid Synthesis Inhibitors,DrugBank
DB01008,Alcohols,DrugBank
DB01008,Alkanes,DrugBank
DB01008,Alkanesulfonates,DrugBank
DB01008,Alkanesulfonic Acids,DrugBank
DB01008,Alkylating Activity,DrugBank
DB01008,Alkylating Drugs,DrugBank
DB01008,Antineoplastic Agents,DrugBank
DB01008,"Antineoplastic Agents, Alkylating",DrugBank
DB01008,Antineoplastic and Immunomodulating Agents,DrugBank
DB01008,Butylene Glycols,DrugBank
DB01008,Cardiotoxic antineoplastic agents,DrugBank
DB01008,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01008,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01008,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01008,Cytochrome P-450 Substrates,DrugBank
DB01008,Glycols,DrugBank
DB01008,"Hydrocarbons, Acyclic",DrugBank
DB01008,Immunologic Factors,DrugBank
DB01008,Immunosuppressive Agents,DrugBank
DB01008,Mesylates,DrugBank
DB01008,Myeloablative Agonists,DrugBank
DB01008,Myelosuppressive Agents,DrugBank
DB01008,Narrow Therapeutic Index Drugs,DrugBank
DB01008,Noxae,DrugBank
DB01008,Sulfonic Acids,DrugBank
DB01008,Sulfur Acids,DrugBank
DB01008,Sulfur Compounds,DrugBank
DB01008,Toxic Actions,DrugBank
DB01009,"Acids, Carbocyclic",DrugBank
DB01009,Agents causing hyperkalemia,DrugBank
DB01009,Agents that produce hypertension,DrugBank
DB01009,Amino Acids,DrugBank
DB01009,"Amino Acids, Basic",DrugBank
DB01009,"Amino Acids, Diamino",DrugBank
DB01009,"Amino Acids, Peptides, and Proteins",DrugBank
DB01009,Analgesics,DrugBank
DB01009,"Analgesics, Non-Narcotic",DrugBank
DB01009,Anti-Inflammatory Agents,DrugBank
DB01009,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01009,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01009,Antiinflammatory and Antirheumatic Products,DrugBank
DB01009,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01009,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB01009,Antirheumatic Agents,DrugBank
DB01009,Arylpropionic acid NSAIDS,DrugBank
DB01009,Cyclooxygenase Inhibitors,DrugBank
DB01009,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01009,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01009,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01009,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01009,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01009,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01009,Cytochrome P-450 Substrates,DrugBank
DB01009,Drugs causing inadvertant photosensitivity,DrugBank
DB01009,Drugs that are Mainly Renally Excreted,DrugBank
DB01009,Enzyme Inhibitors,DrugBank
DB01009,Musculo-Skeletal System,DrugBank
DB01009,Nephrotoxic agents,DrugBank
DB01009,Non COX-2 selective NSAIDS,DrugBank
DB01009,OAT1/SLC22A6 inhibitors,DrugBank
DB01009,OAT3/SLC22A8 Inhibitors,DrugBank
DB01009,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB01009,Peripheral Nervous System Agents,DrugBank
DB01009,Phenylpropionates,DrugBank
DB01009,Photosensitizing Agents,DrugBank
DB01009,Propionates,DrugBank
DB01009,Sensory System Agents,DrugBank
DB01009,Topical Products for Joint and Muscular Pain,DrugBank
DB01009,UGT1A1 Substrates,DrugBank
DB01010,Amines,DrugBank
DB01010,Antidotes,DrugBank
DB01010,Cholinergic Agents,DrugBank
DB01010,Cholinesterase Inhibitors,DrugBank
DB01010,"Compounds used in a research, industrial, or household setting",DrugBank
DB01010,Diagnostic Agents,DrugBank
DB01010,Drugs that are Mainly Renally Excreted,DrugBank
DB01010,Enzyme Inhibitors,DrugBank
DB01010,Neurotransmitter Agents,DrugBank
DB01010,Onium Compounds,DrugBank
DB01010,Phenylammonium Compounds,DrugBank
DB01010,Protective Agents,DrugBank
DB01010,Quaternary Ammonium Compounds,DrugBank
DB01011,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01011,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB01011,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01011,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01011,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01011,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01011,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01011,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01011,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01011,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01011,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01011,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01011,Diagnostic Agents,DrugBank
DB01011,Drugs that are Mainly Renally Excreted,DrugBank
DB01011,Enzyme Inhibitors,DrugBank
DB01011,Noxae,DrugBank
DB01011,Pyridines,DrugBank
DB01011,Steroid Synthesis Inhibitors,DrugBank
DB01011,Tests for Pituitary Function,DrugBank
DB01011,Toxic Actions,DrugBank
DB01012,Anti-Parathyroid Agents,DrugBank
DB01012,Calcimimetic Agents,DrugBank
DB01012,Calcium Homeostasis,DrugBank
DB01012,Calcium-Regulating Hormones and Agents,DrugBank
DB01012,Calcium-sensing Receptor Agonist,DrugBank
DB01012,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01012,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01012,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01012,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01012,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01012,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01012,Cytochrome P-450 Substrates,DrugBank
DB01012,Hormone Antagonists,DrugBank
DB01012,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01012,Increased Calcium-sensing Receptor Sensitivity,DrugBank
DB01012,Naphthalenes,DrugBank
DB01012,Other Miscellaneous Therapeutic Agents,DrugBank
DB01012,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01013,Adrenal Cortex Hormones,DrugBank
DB01013,Anti-Inflammatory Agents,DrugBank
DB01013,Corticosteroids,DrugBank
DB01013,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01013,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01013,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01013,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01013,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01013,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01013,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB01013,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01013,Cytochrome P-450 Substrates,DrugBank
DB01013,Fused-Ring Compounds,DrugBank
DB01013,Glucocorticoids,DrugBank
DB01013,Hormones,DrugBank
DB01013,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01013,Hyperglycemia-Associated Agents,DrugBank
DB01013,Immunosuppressive Agents,DrugBank
DB01013,Pregnadienes,DrugBank
DB01013,Pregnadienetriols,DrugBank
DB01013,Pregnanes,DrugBank
DB01013,Steroids,DrugBank
DB01013,"Steroids, Fluorinated",DrugBank
DB01013,Thyroxine-binding globulin inhibitors,DrugBank
DB01014,"Acids, Carbocyclic",DrugBank
DB01014,Agents causing hyperkalemia,DrugBank
DB01014,Agents that produce hypertension,DrugBank
DB01014,Alimentary Tract and Metabolism,DrugBank
DB01014,Aminobenzoates,DrugBank
DB01014,Aminosalicylate,DrugBank
DB01014,Aminosalicylic Acids,DrugBank
DB01014,Analgesics,DrugBank
DB01014,"Analgesics, Non-Narcotic",DrugBank
DB01014,Anti-Inflammatory Agents,DrugBank
DB01014,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01014,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01014,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01014,Benzene Derivatives,DrugBank
DB01014,Benzoates,DrugBank
DB01014,"Colitis, Ulcerative",DrugBank
DB01014,Gastrointestinal Agents,DrugBank
DB01014,Hydrazines,DrugBank
DB01014,Hydroxy Acids,DrugBank
DB01014,Hydroxybenzoates,DrugBank
DB01014,Inflammatory Bowel Diseases,DrugBank
DB01014,Intestinal Antiinflammatory Agents,DrugBank
DB01014,meta-Aminobenzoates,DrugBank
DB01014,Nephrotoxic agents,DrugBank
DB01014,Non COX-2 selective NSAIDS,DrugBank
DB01014,Peripheral Nervous System Agents,DrugBank
DB01014,Phenols,DrugBank
DB01014,Prodrugs,DrugBank
DB01014,Salicylates,DrugBank
DB01014,Sensory System Agents,DrugBank
DB01015,Agents causing hyperkalemia,DrugBank
DB01015,Agents Causing Muscle Toxicity,DrugBank
DB01015,Amines,DrugBank
DB01015,Aniline Compounds,DrugBank
DB01015,Anti-Bacterial Agents,DrugBank
DB01015,Anti-Infective Agents,DrugBank
DB01015,Antibacterials for Systemic Use,DrugBank
DB01015,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB01015,Antiinfectives for Systemic Use,DrugBank
DB01015,Antimycobacterials,DrugBank
DB01015,Benzene Derivatives,DrugBank
DB01015,Benzenesulfonamides,DrugBank
DB01015,Blood Glucose Lowering Agents,DrugBank
DB01015,BSEP/ABCB11 Inhibitors,DrugBank
DB01015,BSEP/ABCB11 Substrates,DrugBank
DB01015,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01015,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01015,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01015,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01015,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01015,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01015,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01015,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01015,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01015,Cytochrome P-450 Substrates,DrugBank
DB01015,Drugs causing inadvertant photosensitivity,DrugBank
DB01015,Drugs for Treatment of Tuberculosis,DrugBank
DB01015,Drugs that are Mainly Renally Excreted,DrugBank
DB01015,Genito Urinary System and Sex Hormones,DrugBank
DB01015,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01015,Hypoglycemia-Associated Agents,DrugBank
DB01015,Intermediate-Acting Antibacterial Sulfonamides,DrugBank
DB01015,Methemoglobinemia Associated Agents,DrugBank
DB01015,Photosensitizing Agents,DrugBank
DB01015,Potential QTc-Prolonging Agents,DrugBank
DB01015,QTc Prolonging Agents,DrugBank
DB01015,Sulfanilamides,DrugBank
DB01015,Sulfonamide Antibacterial,DrugBank
DB01015,Sulfonamides,DrugBank
DB01015,Sulfonamides and trimethoprim,DrugBank
DB01015,Sulfones,DrugBank
DB01015,Sulfur Compounds,DrugBank
DB01016,Alimentary Tract and Metabolism,DrugBank
DB01016,Amides,DrugBank
DB01016,BCRP/ABCG2 Substrates,DrugBank
DB01016,Blood Glucose Lowering Agents,DrugBank
DB01016,BSEP/ABCB11 Inhibitors,DrugBank
DB01016,BSEP/ABCB11 Substrates,DrugBank
DB01016,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01016,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01016,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01016,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01016,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01016,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01016,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01016,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01016,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01016,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01016,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01016,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01016,Cytochrome P-450 Substrates,DrugBank
DB01016,Drugs causing inadvertant photosensitivity,DrugBank
DB01016,Drugs Used in Diabetes,DrugBank
DB01016,Hypoglycemia-Associated Agents,DrugBank
DB01016,Insulin Secretagogues,DrugBank
DB01016,OAT1/SLC22A6 inhibitors,DrugBank
DB01016,OATP2B1/SLCO2B1 substrates,DrugBank
DB01016,Oral Hypoglycemics,DrugBank
DB01016,P-glycoprotein inhibitors,DrugBank
DB01016,Photosensitizing Agents,DrugBank
DB01016,Sulfones,DrugBank
DB01016,Sulfonylureas,DrugBank
DB01016,Sulfur Compounds,DrugBank
DB01017,Agents Causing Muscle Toxicity,DrugBank
DB01017,Agents that produce neuromuscular block (indirect),DrugBank
DB01017,Alimentary Tract and Metabolism,DrugBank
DB01017,Anti-Acne Preparations,DrugBank
DB01017,Anti-Acne Preparations for Topical Use,DrugBank
DB01017,Anti-Bacterial Agents,DrugBank
DB01017,Anti-Infective Agents,DrugBank
DB01017,Antibacterials for Systemic Use,DrugBank
DB01017,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB01017,Antiinfectives for Systemic Use,DrugBank
DB01017,Antiinfectives for Treatment of Acne,DrugBank
DB01017,Dermatologicals,DrugBank
DB01017,Drugs causing inadvertant photosensitivity,DrugBank
DB01017,Naphthacenes,DrugBank
DB01017,OAT1/SLC22A6 inhibitors,DrugBank
DB01017,OAT3/SLC22A8 Inhibitors,DrugBank
DB01017,Photosensitizing Agents,DrugBank
DB01017,Stomatological Preparations,DrugBank
DB01017,Tetracyclines,DrugBank
DB01018,Adrenergic Agents,DrugBank
DB01018,Adrenergic Agonists,DrugBank
DB01018,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB01018,Adrenergic alpha-Agonists,DrugBank
DB01018,Agents producing tachycardia,DrugBank
DB01018,Agents that produce hypertension,DrugBank
DB01018,Amidines,DrugBank
DB01018,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB01018,Antihypertensive Agents,DrugBank
DB01018,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01018,Bradycardia-Causing Agents,DrugBank
DB01018,Cardiovascular Agents,DrugBank
DB01018,Central alpha-2 Adrenergic Agonist,DrugBank
DB01018,Central Alpha-agonists,DrugBank
DB01018,Central Nervous System Depressants,DrugBank
DB01018,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01018,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01018,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01018,Cytochrome P-450 Substrates,DrugBank
DB01018,Drugs that are Mainly Renally Excreted,DrugBank
DB01018,Guanidines,DrugBank
DB01018,Hypotensive Agents,DrugBank
DB01018,Imidazoline Receptor Agonists,DrugBank
DB01018,MATE 1 Inhibitors,DrugBank
DB01018,MATE inhibitors,DrugBank
DB01018,Neurotransmitter Agents,DrugBank
DB01018,OCT1 inhibitors,DrugBank
DB01018,OCT1 substrates,DrugBank
DB01018,OCT2 Substrates,DrugBank
DB01019,"Acids, Acyclic",DrugBank
DB01019,Amines,DrugBank
DB01019,Ammonium Compounds,DrugBank
DB01019,Autonomic Agents,DrugBank
DB01019,Bethanechol Compounds,DrugBank
DB01019,Carbamates,DrugBank
DB01019,Choline Esters,DrugBank
DB01019,Cholinergic Agents,DrugBank
DB01019,Cholinergic Agonists,DrugBank
DB01019,Muscarinic Agonists,DrugBank
DB01019,Nervous System,DrugBank
DB01019,Neurotransmitter Agents,DrugBank
DB01019,Nitrogen Compounds,DrugBank
DB01019,Onium Compounds,DrugBank
DB01019,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB01019,Parasympathomimetics,DrugBank
DB01019,Peripheral Nervous System Agents,DrugBank
DB01019,Quaternary Ammonium Compounds,DrugBank
DB01019,Trimethyl Ammonium Compounds,DrugBank
DB01020,Alcohols,DrugBank
DB01020,Antianginal Agents,DrugBank
DB01020,Carbohydrates,DrugBank
DB01020,Cardiac Therapy,DrugBank
DB01020,Cardiovascular Agents,DrugBank
DB01020,Delayed-Action Preparations,DrugBank
DB01020,Drugs that are Mainly Renally Excreted,DrugBank
DB01020,Hypotensive Agents,DrugBank
DB01020,Methemoglobinemia Associated Agents,DrugBank
DB01020,Nitrate Vasodilator,DrugBank
DB01020,Nitrates and Nitrites,DrugBank
DB01020,Nitric Oxide Donors,DrugBank
DB01020,Organic Nitrates,DrugBank
DB01020,Sugar Alcohols,DrugBank
DB01020,Vasodilating Agents,DrugBank
DB01020,Vasodilation,DrugBank
DB01020,Vasodilators Used in Cardiac Diseases,DrugBank
DB01021,Antihypertensive Agents,DrugBank
DB01021,Benzothiadiazines,DrugBank
DB01021,Cardiovascular Agents,DrugBank
DB01021,Diuretics,DrugBank
DB01021,Genito Urinary System and Sex Hormones,DrugBank
DB01021,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01021,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01021,Hyperglycemia-Associated Agents,DrugBank
DB01021,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB01021,Membrane Transport Modulators,DrugBank
DB01021,Natriuretic Agents,DrugBank
DB01021,Sodium Chloride Symporter Inhibitors,DrugBank
DB01021,Sulfonamides,DrugBank
DB01021,Sulfones,DrugBank
DB01021,Sulfur Compounds,DrugBank
DB01021,Thiazides,DrugBank
DB01022,Blood and Blood Forming Organs,DrugBank
DB01022,Coagulants,DrugBank
DB01022,"Diet, Food, and Nutrition",DrugBank
DB01022,Diterpenes,DrugBank
DB01022,Drugs that are Mainly Renally Excreted,DrugBank
DB01022,Fibrin Modulating Agents,DrugBank
DB01022,Food,DrugBank
DB01022,Growth Substances,DrugBank
DB01022,Hematologic Agents,DrugBank
DB01022,Hemostatics,DrugBank
DB01022,Increased Prothrombin Activity,DrugBank
DB01022,Micronutrients,DrugBank
DB01022,Naphthalenes,DrugBank
DB01022,Naphthoquinones,DrugBank
DB01022,Physiological Phenomena,DrugBank
DB01022,Phytol,DrugBank
DB01022,Quinones,DrugBank
DB01022,Reversed Anticoagulation Activity,DrugBank
DB01022,Terpenes,DrugBank
DB01022,Vitamin K,DrugBank
DB01022,Vitamins,DrugBank
DB01022,Vitamins (Fat Soluble),DrugBank
DB01022,Warfarin Reversal Agent,DrugBank
DB01023,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB01023,Agents causing hyperkalemia,DrugBank
DB01023,Antiarrhythmic agents,DrugBank
DB01023,Antihypertensive Agents,DrugBank
DB01023,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01023,Beta blocking agents and calcium channel blockers,DrugBank
DB01023,Bradycardia-Causing Agents,DrugBank
DB01023,BSEP/ABCB11 Substrates,DrugBank
DB01023,Calcium Channel Blockers,DrugBank
DB01023,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB01023,Calcium-Regulating Hormones and Agents,DrugBank
DB01023,Cardiovascular Agents,DrugBank
DB01023,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01023,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB01023,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01023,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01023,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01023,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01023,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01023,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01023,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01023,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01023,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01023,Cytochrome P-450 Substrates,DrugBank
DB01023,Dihydropyridine Derivatives,DrugBank
DB01023,Dihydropyridines,DrugBank
DB01023,Hypotensive Agents,DrugBank
DB01023,Membrane Transport Modulators,DrugBank
DB01023,P-glycoprotein inhibitors,DrugBank
DB01023,Potential QTc-Prolonging Agents,DrugBank
DB01023,Pyridines,DrugBank
DB01023,QTc Prolonging Agents,DrugBank
DB01023,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB01023,Vasodilating Agents,DrugBank
DB01024,"Acids, Acyclic",DrugBank
DB01024,Anti-Bacterial Agents,DrugBank
DB01024,Anti-Infective Agents,DrugBank
DB01024,"Antibiotics, Antineoplastic",DrugBank
DB01024,Antimetabolite Immunosuppressant,DrugBank
DB01024,Antineoplastic and Immunomodulating Agents,DrugBank
DB01024,Caproates,DrugBank
DB01024,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01024,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01024,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01024,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01024,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,Cytochrome P-450 Substrates,DrugBank
DB01024,Drugs that are Mainly Renally Excreted,DrugBank
DB01024,Enzyme Inhibitors,DrugBank
DB01024,Fatty Acids,DrugBank
DB01024,Immunosuppressive Agents,DrugBank
DB01024,Mycophenolic Acid and Prodrugs,DrugBank
DB01024,Narrow Therapeutic Index Drugs,DrugBank
DB01024,Selective Immunosuppressants,DrugBank
DB01024,UGT1A1 Substrates,DrugBank
DB01024,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,UGT1A6 substrate,DrugBank
DB01024,UGT1A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,UGT1A9 Substrates,DrugBank
DB01024,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01024,UGT2B7 substrates,DrugBank
DB01024,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01026,14-alpha Demethylase Inhibitors,DrugBank
DB01026,Agents causing hyperkalemia,DrugBank
DB01026,Anti-Infective Agents,DrugBank
DB01026,Antiadrenal Preparations,DrugBank
DB01026,Anticorticosteroids,DrugBank
DB01026,Antifungal Agents,DrugBank
DB01026,Antifungals for Dermatological Use,DrugBank
DB01026,Antifungals for Topical Use,DrugBank
DB01026,Antiinfectives for Systemic Use,DrugBank
DB01026,Antimycotics for Systemic Use,DrugBank
DB01026,Azole Antifungals,DrugBank
DB01026,BSEP/ABCB11 Inhibitors,DrugBank
DB01026,BSEP/ABCB11 Substrates,DrugBank
DB01026,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2A6 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01026,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB01026,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB01026,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01026,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01026,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01026,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01026,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB01026,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01026,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB01026,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01026,Cytochrome P-450 Substrates,DrugBank
DB01026,Dermatologicals,DrugBank
DB01026,Drugs causing inadvertant photosensitivity,DrugBank
DB01026,Enzyme Inhibitors,DrugBank
DB01026,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01026,Hepatotoxic Agents,DrugBank
DB01026,Imidazole and Triazole Derivatives,DrugBank
DB01026,Imidazole Derivatives,DrugBank
DB01026,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01026,P-glycoprotein inhibitors,DrugBank
DB01026,P-glycoprotein substrates,DrugBank
DB01026,Photosensitizing Agents,DrugBank
DB01026,Piperazines,DrugBank
DB01026,Potential QTc-Prolonging Agents,DrugBank
DB01026,QTc Prolonging Agents,DrugBank
DB01026,Steroid Synthesis Inhibitors,DrugBank
DB01026,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01026,UGT1A1 Inhibitors,DrugBank
DB01026,UGT2B7 Inhibitors,DrugBank
DB01028,Agents that produce hypertension,DrugBank
DB01028,Analgesics,DrugBank
DB01028,Anesthetics,DrugBank
DB01028,"Anesthetics, General",DrugBank
DB01028,"Anesthetics, Inhalation",DrugBank
DB01028,Central Nervous System Agents,DrugBank
DB01028,Central Nervous System Depressants,DrugBank
DB01028,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01028,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01028,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01028,Cytochrome P-450 Substrates,DrugBank
DB01028,Ethers,DrugBank
DB01028,Ethyl Ethers,DrugBank
DB01028,Methyl Ethers,DrugBank
DB01028,Miscellaneous Analgesics and Antipyretics,DrugBank
DB01028,Nervous System,DrugBank
DB01029,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01029,Agents causing hyperkalemia,DrugBank
DB01029,Angiotensin 2 Receptor Blocker,DrugBank
DB01029,Angiotensin II receptor antagonists,DrugBank
DB01029,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB01029,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB01029,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB01029,Angiotensin II Type 2 Receptor Blockers,DrugBank
DB01029,Angiotensin Receptor Antagonists,DrugBank
DB01029,Antihypertensive Agents,DrugBank
DB01029,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01029,Benzene Derivatives,DrugBank
DB01029,Biphenyl Compounds,DrugBank
DB01029,Cardiovascular Agents,DrugBank
DB01029,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01029,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01029,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01029,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01029,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01029,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01029,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01029,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01029,Cytochrome P-450 Substrates,DrugBank
DB01029,Hypotensive Agents,DrugBank
DB01029,Spiro Compounds,DrugBank
DB01029,Tetrazoles,DrugBank
DB01029,UGT1A3 substrates,DrugBank
DB01030,Alkaloids,DrugBank
DB01030,Antineoplastic Agents,DrugBank
DB01030,Antineoplastic and Immunomodulating Agents,DrugBank
DB01030,BCRP/ABCG2 Substrates,DrugBank
DB01030,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01030,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01030,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01030,Drugs that are Mainly Renally Excreted,DrugBank
DB01030,Enzyme Inhibitors,DrugBank
DB01030,Immunosuppressive Agents,DrugBank
DB01030,MATE 1 Inhibitors,DrugBank
DB01030,MATE 1 Substrates,DrugBank
DB01030,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01030,MATE 2 Substrates,DrugBank
DB01030,MATE 2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01030,MATE inhibitors,DrugBank
DB01030,MATE substrates,DrugBank
DB01030,Myelosuppressive Agents,DrugBank
DB01030,Narrow Therapeutic Index Drugs,DrugBank
DB01030,P-glycoprotein substrates,DrugBank
DB01030,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01030,Topoisomerase 1 (TOP1) inhibitors,DrugBank
DB01030,Topoisomerase I Inhibitors,DrugBank
DB01030,Topoisomerase Inhibitors,DrugBank
DB01032,"Adjuvants, Pharmaceutic",DrugBank
DB01032,Amides,DrugBank
DB01032,Antigout Preparations,DrugBank
DB01032,Antirheumatic Agents,DrugBank
DB01032,"Compounds used in a research, industrial, or household setting",DrugBank
DB01032,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01032,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01032,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01032,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01032,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01032,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01032,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01032,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01032,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01032,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01032,Drugs that are Mainly Renally Excreted,DrugBank
DB01032,Genito Urinary System and Sex Hormones,DrugBank
DB01032,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01032,Musculo-Skeletal System,DrugBank
DB01032,OAT1/SLC22A6 inhibitors,DrugBank
DB01032,OAT3/SLC22A8 Inhibitors,DrugBank
DB01032,OCT1 inhibitors,DrugBank
DB01032,OCT2 Inhibitors,DrugBank
DB01032,Pharmaceutic Aids,DrugBank
DB01032,Pharmaceutical Preparations,DrugBank
DB01032,Preparations Increasing Uric Acid Excretion,DrugBank
DB01032,Preparations With No Effect on Uric Acid Metabolism,DrugBank
DB01032,Sulfonamides,DrugBank
DB01032,Sulfones,DrugBank
DB01032,Sulfur Compounds,DrugBank
DB01032,UGT1A1 Inhibitors,DrugBank
DB01032,Uricosuric Agents,DrugBank
DB01033,Antimetabolites,DrugBank
DB01033,Antineoplastic Agents,DrugBank
DB01033,Antineoplastic and Immunomodulating Agents,DrugBank
DB01033,Cytotoxins,DrugBank
DB01033,Drugs for Obstructive Airway Diseases,DrugBank
DB01033,Enzyme Inhibitors,DrugBank
DB01033,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01033,Immunologic Factors,DrugBank
DB01033,Immunosuppressive Agents,DrugBank
DB01033,Myelosuppressive Agents,DrugBank
DB01033,Narrow Therapeutic Index Drugs,DrugBank
DB01033,Noxae,DrugBank
DB01033,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01033,Nucleoside Metabolic Inhibitor,DrugBank
DB01033,OAT3/SLC22A8 Inhibitors,DrugBank
DB01033,OAT3/SLC22A8 Substrates,DrugBank
DB01033,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01033,Purine Analogues,DrugBank
DB01033,Purines,DrugBank
DB01033,Sulfhydryl Compounds,DrugBank
DB01033,Sulfur Compounds,DrugBank
DB01033,Thiopurine Analogs,DrugBank
DB01033,Toxic Actions,DrugBank
DB01033,Xanthine derivatives,DrugBank
DB01034,Amides,DrugBank
DB01034,Anti-Infective Agents,DrugBank
DB01034,Antifungal Agents,DrugBank
DB01034,Fatty Acid Synthesis Inhibitors,DrugBank
DB01034,Hypolipidemic Agents,DrugBank
DB01034,Lipid Regulating Agents,DrugBank
DB01035,"Acids, Carbocyclic",DrugBank
DB01035,Agents Causing Muscle Toxicity,DrugBank
DB01035,Agents that produce neuromuscular block (indirect),DrugBank
DB01035,Amides,DrugBank
DB01035,Aminobenzoates,DrugBank
DB01035,Antiarrhythmic agents,DrugBank
DB01035,"Antiarrhythmics, Class I",DrugBank
DB01035,"Antiarrhythmics, Class Ia",DrugBank
DB01035,Benzamides and benzamide derivatives,DrugBank
DB01035,Benzene Derivatives,DrugBank
DB01035,Benzoates,DrugBank
DB01035,Cardiac Therapy,DrugBank
DB01035,Cardiovascular Agents,DrugBank
DB01035,Cholinesterase Inhibitors,DrugBank
DB01035,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01035,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01035,Cytochrome P-450 Substrates,DrugBank
DB01035,Drugs that are Mainly Renally Excreted,DrugBank
DB01035,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB01035,Highest Risk QTc-Prolonging Agents,DrugBank
DB01035,MATE 1 Substrates,DrugBank
DB01035,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01035,MATE 2 Substrates,DrugBank
DB01035,MATE 2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01035,MATE substrates,DrugBank
DB01035,Membrane Transport Modulators,DrugBank
DB01035,Narrow Therapeutic Index Drugs,DrugBank
DB01035,Negative Inotrope,DrugBank
DB01035,OCT1 inhibitors,DrugBank
DB01035,OCT2 Inhibitors,DrugBank
DB01035,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01035,para-Aminobenzoates,DrugBank
DB01035,QTc Prolonging Agents,DrugBank
DB01035,Sodium Channel Blockers,DrugBank
DB01035,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01036,Agents producing tachycardia,DrugBank
DB01036,Alcohols,DrugBank
DB01036,Amines,DrugBank
DB01036,Amino Alcohols,DrugBank
DB01036,Anticholinergic Agents,DrugBank
DB01036,Benzene Derivatives,DrugBank
DB01036,Benzhydryl Compounds,DrugBank
DB01036,Cholinergic Agents,DrugBank
DB01036,Cresols,DrugBank
DB01036,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01036,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01036,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01036,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01036,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01036,Cytochrome P-450 Substrates,DrugBank
DB01036,Drugs for Urinary Frequency and Incontinence,DrugBank
DB01036,Drugs that are Mainly Renally Excreted,DrugBank
DB01036,Genito Urinary System and Sex Hormones,DrugBank
DB01036,Genitourinary Agents,DrugBank
DB01036,Genitourinary Smooth Muscle Relaxants,DrugBank
DB01036,Muscarinic Antagonists,DrugBank
DB01036,Neurotransmitter Agents,DrugBank
DB01036,Phenols,DrugBank
DB01036,Potential QTc-Prolonging Agents,DrugBank
DB01036,Propanolamines,DrugBank
DB01036,Propanols,DrugBank
DB01036,QTc Prolonging Agents,DrugBank
DB01036,Urological Agents,DrugBank
DB01036,Urologicals,DrugBank
DB01037,Agents that produce hypertension,DrugBank
DB01037,Agents that reduce seizure threshold,DrugBank
DB01037,Amines,DrugBank
DB01037,Anti-Dyskinesia Agents,DrugBank
DB01037,Anti-Parkinson Drugs,DrugBank
DB01037,Antidepressive Agents,DrugBank
DB01037,Antidepressive Agents Indicated for Depression,DrugBank
DB01037,Central Nervous System Agents,DrugBank
DB01037,Central Nervous System Depressants,DrugBank
DB01037,"Compounds used in a research, industrial, or household setting",DrugBank
DB01037,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01037,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01037,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01037,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB01037,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01037,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01037,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01037,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01037,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01037,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01037,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01037,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01037,Cytochrome P-450 Substrates,DrugBank
DB01037,Dopamine Agents,DrugBank
DB01037,Enzyme Inhibitors,DrugBank
DB01037,Ethylamines,DrugBank
DB01037,Hypotensive Agents,DrugBank
DB01037,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01037,Monoamine Oxidase B Inhibitors,DrugBank
DB01037,Monoamine Oxidase Inhibitors,DrugBank
DB01037,Nervous System,DrugBank
DB01037,Neuroprotective Agents,DrugBank
DB01037,P-glycoprotein inhibitors,DrugBank
DB01037,Phenethylamines,DrugBank
DB01037,Protective Agents,DrugBank
DB01037,Psychotropic Drugs,DrugBank
DB01037,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01037,Serotonin Agents,DrugBank
DB01037,Serotonin Modulators,DrugBank
DB01038,Dopamine Antagonists,DrugBank
DB01038,Dopamine D2 Receptor Antagonists,DrugBank
DB01039,"Acids, Acyclic",DrugBank
DB01039,Agents Causing Muscle Toxicity,DrugBank
DB01039,Benzene Derivatives,DrugBank
DB01039,Benzophenones,DrugBank
DB01039,BSEP/ABCB11 Substrates,DrugBank
DB01039,Butyrates,DrugBank
DB01039,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01039,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB01039,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01039,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB01039,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01039,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01039,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01039,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01039,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01039,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01039,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01039,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01039,Cytochrome P-450 Substrates,DrugBank
DB01039,Drugs that are Mainly Renally Excreted,DrugBank
DB01039,Ethers,DrugBank
DB01039,Fatty Acids,DrugBank
DB01039,"Fatty Acids, Volatile",DrugBank
DB01039,Fibric Acid Derivatives,DrugBank
DB01039,Fibric Acids,DrugBank
DB01039,Hypolipidemic Agents,DrugBank
DB01039,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01039,Isobutyrates,DrugBank
DB01039,Ketones,DrugBank
DB01039,Lipid Modifying Agents,DrugBank
DB01039,"Lipid Modifying Agents, Plain",DrugBank
DB01039,Lipid Regulating Agents,DrugBank
DB01039,Lipids,DrugBank
DB01039,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01039,Noxae,DrugBank
DB01039,P-glycoprotein inhibitors,DrugBank
DB01039,Peroxisome Proliferator Receptor alpha Agonist,DrugBank
DB01039,Peroxisome Proliferator-activated Receptor alpha Agonists,DrugBank
DB01039,Phenols,DrugBank
DB01039,Phenyl Ethers,DrugBank
DB01039,Toxic Actions,DrugBank
DB01039,UGT1A9 Substrates,DrugBank
DB01041,Angiogenesis Inhibitors,DrugBank
DB01041,Angiogenesis Modulating Agents,DrugBank
DB01041,Antineoplastic Agents,DrugBank
DB01041,Antineoplastic and Immunomodulating Agents,DrugBank
DB01041,Cardiotoxic antineoplastic agents,DrugBank
DB01041,Central Nervous System Depressants,DrugBank
DB01041,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01041,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01041,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01041,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01041,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01041,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01041,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01041,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01041,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01041,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01041,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01041,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01041,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01041,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01041,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB01041,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01041,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01041,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01041,Cytochrome P-450 Substrates,DrugBank
DB01041,Drugs causing inadvertant photosensitivity,DrugBank
DB01041,Growth Inhibitors,DrugBank
DB01041,Growth Substances,DrugBank
DB01041,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01041,Hypotensive Agents,DrugBank
DB01041,Immunologic Factors,DrugBank
DB01041,Immunomodulatory Agents,DrugBank
DB01041,Immunosuppressive Agents,DrugBank
DB01041,Isoindoles,DrugBank
DB01041,Leprostatic Agents,DrugBank
DB01041,Myelosuppressive Agents,DrugBank
DB01041,Noxae,DrugBank
DB01041,Photosensitizing Agents,DrugBank
DB01041,Phthalimides,DrugBank
DB01041,Teratogens,DrugBank
DB01041,Toxic Actions,DrugBank
DB01041,Tumor Necrosis Factor Blockers,DrugBank
DB01042,Alkylating Activity,DrugBank
DB01042,Alkylating Drugs,DrugBank
DB01042,Amino Acids,DrugBank
DB01042,"Amino Acids, Aromatic",DrugBank
DB01042,"Amino Acids, Cyclic",DrugBank
DB01042,"Amino Acids, Peptides, and Proteins",DrugBank
DB01042,Antineoplastic Agents,DrugBank
DB01042,"Antineoplastic Agents, Alkylating",DrugBank
DB01042,Antineoplastic and Immunomodulating Agents,DrugBank
DB01042,"Hydrocarbons, Halogenated",DrugBank
DB01042,Immunologic Factors,DrugBank
DB01042,Immunosuppressive Agents,DrugBank
DB01042,Mustard Compounds,DrugBank
DB01042,Myeloablative Agonists,DrugBank
DB01042,Myelosuppressive Agents,DrugBank
DB01042,Narrow Therapeutic Index Drugs,DrugBank
DB01042,Nitrogen Mustard Analogues,DrugBank
DB01042,Nitrogen Mustard Compounds,DrugBank
DB01042,Noxae,DrugBank
DB01042,Toxic Actions,DrugBank
DB01043,Anti-Dementia Drugs,DrugBank
DB01043,Anti-Dyskinesia Agents,DrugBank
DB01043,Anti-Parkinson Drugs,DrugBank
DB01043,Bridged-Ring Compounds,DrugBank
DB01043,Central Nervous System Agents,DrugBank
DB01043,Cholinesterase Inhibitors,DrugBank
DB01043,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01043,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB01043,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01043,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB01043,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01043,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB01043,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01043,Dopamine Agents,DrugBank
DB01043,Drugs that are Mainly Renally Excreted,DrugBank
DB01043,Excitatory Amino Acid Antagonists,DrugBank
DB01043,Miscellaneous Central Nervous System Agents,DrugBank
DB01043,N-methyl-D-aspartate Receptor Antagonist,DrugBank
DB01043,Nervous System,DrugBank
DB01043,Neurotransmitter Agents,DrugBank
DB01043,NMDA Receptor Antagonists,DrugBank
DB01043,OCT2 Substrates,DrugBank
DB01043,Psychoanaleptics,DrugBank
DB01044,4-Quinolones,DrugBank
DB01044,Anti-Bacterial Agents,DrugBank
DB01044,Anti-Infective Agents,DrugBank
DB01044,Antibacterials for Systemic Use,DrugBank
DB01044,Antiinfectives for Systemic Use,DrugBank
DB01044,"Compounds used in a research, industrial, or household setting",DrugBank
DB01044,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01044,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB01044,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01044,Enzyme Inhibitors,DrugBank
DB01044,Fluoroquinolones,DrugBank
DB01044,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01044,Hypoglycemia-Associated Agents,DrugBank
DB01044,Ophthalmic Solutions,DrugBank
DB01044,Ophthalmologicals,DrugBank
DB01044,Pharmaceutical Preparations,DrugBank
DB01044,Pharmaceutical Solutions,DrugBank
DB01044,Potential QTc-Prolonging Agents,DrugBank
DB01044,QTc Prolonging Agents,DrugBank
DB01044,Quinolines,DrugBank
DB01044,Quinolone Antimicrobial,DrugBank
DB01044,Quinolones,DrugBank
DB01044,Sensory Organs,DrugBank
DB01044,Solutions,DrugBank
DB01044,Topoisomerase II Inhibitors,DrugBank
DB01044,Topoisomerase Inhibitors,DrugBank
DB01045,Amides,DrugBank
DB01045,Anti-Bacterial Agents,DrugBank
DB01045,Anti-Infective Agents,DrugBank
DB01045,"Antibiotics, Antitubercular",DrugBank
DB01045,Antiinfectives for Systemic Use,DrugBank
DB01045,Antimycobacterials,DrugBank
DB01045,BSEP/ABCB11 Inhibitors,DrugBank
DB01045,Chemically-Induced Disorders,DrugBank
DB01045,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP1A2 Inducers (moderate),DrugBank
DB01045,Cytochrome P-450 CYP1A2 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2A6 Inducers (moderate),DrugBank
DB01045,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2B6 Inducers (moderate),DrugBank
DB01045,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB01045,Cytochrome P-450 CYP2C19 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2C8 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01045,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01045,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2C9 Inducers (moderate),DrugBank
DB01045,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB01045,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01045,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP3A5 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB01045,Cytochrome P-450 CYP3A7 Inducers (strong),DrugBank
DB01045,Cytochrome P-450 CYP3A7 Inducers (weak),DrugBank
DB01045,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01045,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01045,Drugs for Treatment of Lepra,DrugBank
DB01045,Drugs for Treatment of Tuberculosis,DrugBank
DB01045,Enzyme Inhibitors,DrugBank
DB01045,Hepatotoxic Agents,DrugBank
DB01045,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01045,"Lactams, Macrocyclic",DrugBank
DB01045,Leprostatic Agents,DrugBank
DB01045,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01045,OAT1/SLC22A6 inhibitors,DrugBank
DB01045,OAT3/SLC22A8 Inhibitors,DrugBank
DB01045,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01045,OATP1B3 inhibitors,DrugBank
DB01045,OATP1B3 substrates,DrugBank
DB01045,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01045,P-glycoprotein inducers,DrugBank
DB01045,Rifamycin Antibacterial,DrugBank
DB01045,Rifamycin Antimycobacterial,DrugBank
DB01045,Rifamycins,DrugBank
DB01045,UGT1A1 Inducers,DrugBank
DB01045,UGT1A9 Inducers,DrugBank
DB01045,UGT1A9 Inhibitors,DrugBank
DB01046,Alimentary Tract and Metabolism,DrugBank
DB01046,Chloride Channel Agonists,DrugBank
DB01046,Drugs for Constipation,DrugBank
DB01046,Drugs that are Mainly Renally Excreted,DrugBank
DB01046,Fatty Acids,DrugBank
DB01046,"Fatty Acids, Monounsaturated",DrugBank
DB01046,"Fatty Acids, Unsaturated",DrugBank
DB01046,Laxatives,DrugBank
DB01046,Lipids,DrugBank
DB01046,Membrane Transport Modulators,DrugBank
DB01046,Miscellaneous GI Drugs,DrugBank
DB01046,Prostaglandins E,DrugBank
DB01047,Adrenal Cortex Hormones,DrugBank
DB01047,Anti-Allergic Agents,DrugBank
DB01047,Anti-Inflammatory Agents,DrugBank
DB01047,Corticosteroid Hormone Receptor Agonists,DrugBank
DB01047,Corticosteroids,DrugBank
DB01047,"Corticosteroids, Dermatological Preparations",DrugBank
DB01047,"Corticosteroids, Potent (Group III)",DrugBank
DB01047,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01047,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01047,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01047,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01047,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01047,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01047,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB01047,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01047,Cytochrome P-450 Substrates,DrugBank
DB01047,Dermatologicals,DrugBank
DB01047,Fused-Ring Compounds,DrugBank
DB01047,Glucocorticoids,DrugBank
DB01047,Hormones,DrugBank
DB01047,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01047,Immunosuppressive Agents,DrugBank
DB01047,Pregnadienes,DrugBank
DB01047,Pregnanes,DrugBank
DB01047,Steroids,DrugBank
DB01047,"Steroids, Fluorinated",DrugBank
DB01047,Thyroxine-binding globulin inhibitors,DrugBank
DB01048,Anti-HIV Agents,DrugBank
DB01048,Anti-Infective Agents,DrugBank
DB01048,Anti-Retroviral Agents,DrugBank
DB01048,Antiinfectives for Systemic Use,DrugBank
DB01048,Antiviral Agents,DrugBank
DB01048,Antivirals for Systemic Use,DrugBank
DB01048,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB01048,Cycloparaffins,DrugBank
DB01048,Deoxyadenosines,DrugBank
DB01048,Deoxyribonucleosides,DrugBank
DB01048,Dideoxynucleosides,DrugBank
DB01048,Direct Acting Antivirals,DrugBank
DB01048,Drugs that are Mainly Renally Excreted,DrugBank
DB01048,Enzyme Inhibitors,DrugBank
DB01048,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01048,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB01048,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01048,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01048,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB01048,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB01048,Nucleosides,DrugBank
DB01048,Purine Nucleosides,DrugBank
DB01048,Purines,DrugBank
DB01048,Reverse Transcriptase Inhibitors,DrugBank
DB01048,UGT1A1 Substrates,DrugBank
DB01049,Adrenergic Agents,DrugBank
DB01049,Adrenergic alpha-Antagonists,DrugBank
DB01049,Adrenergic Antagonists,DrugBank
DB01049,Agents that produce hypertension,DrugBank
DB01049,Alkaloids,DrugBank
DB01049,Antidepressive Agents,DrugBank
DB01049,Cardiovascular Agents,DrugBank
DB01049,Central Nervous System Agents,DrugBank
DB01049,Central Nervous System Depressants,DrugBank
DB01049,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01049,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01049,Cytochrome P-450 Substrates,DrugBank
DB01049,Dihydroergotoxine,DrugBank
DB01049,Dopamine Agents,DrugBank
DB01049,Dopamine Agonists,DrugBank
DB01049,Ergot Alkaloids and Derivatives,DrugBank
DB01049,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB01049,Ergotamines,DrugBank
DB01049,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01049,Neurotransmitter Agents,DrugBank
DB01049,Nootropic Agents,DrugBank
DB01049,Peripheral Vasodilators,DrugBank
DB01049,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01049,Serotonin Agents,DrugBank
DB01049,Serotonin Modulators,DrugBank
DB01049,Sympatholytic (Adrenergic Blocking) Agents,DrugBank
DB01049,Vasodilating Agents,DrugBank
DB01050,"Acids, Carbocyclic",DrugBank
DB01050,Agents causing angioedema,DrugBank
DB01050,Agents causing hyperkalemia,DrugBank
DB01050,Agents that produce hypertension,DrugBank
DB01050,Analgesics,DrugBank
DB01050,"Analgesics, Non-Narcotic",DrugBank
DB01050,Anti-Inflammatory Agents,DrugBank
DB01050,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01050,Antiinflammatory and Antirheumatic Products,DrugBank
DB01050,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01050,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB01050,Antiinflammatory Products for Vaginal Administration,DrugBank
DB01050,Antirheumatic Agents,DrugBank
DB01050,Arylpropionic acid NSAIDS,DrugBank
DB01050,Central Nervous System Agents,DrugBank
DB01050,COX-1 Inhibitors,DrugBank
DB01050,COX-2 Inhibitors,DrugBank
DB01050,Cyclooxygenase Inhibitors,DrugBank
DB01050,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01050,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01050,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01050,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01050,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01050,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01050,Cytochrome P-450 Substrates,DrugBank
DB01050,Drugs that are Mainly Renally Excreted,DrugBank
DB01050,Enzyme Inhibitors,DrugBank
DB01050,Experimental Unapproved Treatments for COVID-19,DrugBank
DB01050,Nephrotoxic agents,DrugBank
DB01050,Nervous System,DrugBank
DB01050,Non COX-2 selective NSAIDS,DrugBank
DB01050,OAT1/SLC22A6 inhibitors,DrugBank
DB01050,OAT3/SLC22A8 Inhibitors,DrugBank
DB01050,OATP2B1/SLCO2B1 substrates,DrugBank
DB01050,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB01050,P-glycoprotein inhibitors,DrugBank
DB01050,P-glycoprotein substrates,DrugBank
DB01050,Peripheral Nervous System Agents,DrugBank
DB01050,Pharmaceutical Preparations,DrugBank
DB01050,Phenylpropionates,DrugBank
DB01050,Propionates,DrugBank
DB01050,Sensory System Agents,DrugBank
DB01050,Throat Preparations,DrugBank
DB01050,Topical Products for Joint and Muscular Pain,DrugBank
DB01050,UDP Glucuronosyltransferases Inhibitors,DrugBank
DB01050,UGT1A1 Substrates,DrugBank
DB01050,UGT1A3 substrates,DrugBank
DB01050,UGT1A9 Substrates,DrugBank
DB01050,UGT2B17 Inhibitors,DrugBank
DB01050,UGT2B7 substrates,DrugBank
DB01051,Aminocoumarins,DrugBank
DB01051,Anti-Bacterial Agents,DrugBank
DB01051,Anti-Infective Agents,DrugBank
DB01051,BCRP/ABCG2 Inhibitors,DrugBank
DB01051,Benzopyrans,DrugBank
DB01051,Carbohydrates,DrugBank
DB01051,Coumarins,DrugBank
DB01051,Enzyme Inhibitors,DrugBank
DB01051,Glycosides,DrugBank
DB01051,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01051,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01051,OAT1/SLC22A6 inhibitors,DrugBank
DB01051,OAT3/SLC22A8 Inhibitors,DrugBank
DB01051,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01051,OATP1B3 inhibitors,DrugBank
DB01051,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01051,Pyrans,DrugBank
DB01053,Amides,DrugBank
DB01053,Anti-Bacterial Agents,DrugBank
DB01053,Anti-Infective Agents,DrugBank
DB01053,Antibacterials for Systemic Use,DrugBank
DB01053,Antiinfectives for Systemic Use,DrugBank
DB01053,Beta-Lactam Antibacterials,DrugBank
DB01053,Beta-Lactamase Sensitive Penicillins,DrugBank
DB01053,beta-Lactams,DrugBank
DB01053,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01053,Lactams,DrugBank
DB01053,Natural Penicillins,DrugBank
DB01053,OAT1/SLC22A6 inhibitors,DrugBank
DB01053,OAT3/SLC22A8 Inhibitors,DrugBank
DB01053,OAT3/SLC22A8 Substrates,DrugBank
DB01053,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01053,OATP2B1/SLCO2B1 substrates,DrugBank
DB01053,Ophthalmologicals,DrugBank
DB01053,Penicillin G,DrugBank
DB01053,Penicillins,DrugBank
DB01053,Sensory Organs,DrugBank
DB01053,Sulfur Compounds,DrugBank
DB01054,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB01054,Agents causing hyperkalemia,DrugBank
DB01054,Antiarrhythmic agents,DrugBank
DB01054,Antihypertensive Agents,DrugBank
DB01054,Bradycardia-Causing Agents,DrugBank
DB01054,BSEP/ABCB11 Substrates,DrugBank
DB01054,Calcium Channel Blockers,DrugBank
DB01054,Calcium-Regulating Hormones and Agents,DrugBank
DB01054,Cardiovascular Agents,DrugBank
DB01054,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01054,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01054,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01054,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01054,Cytochrome P-450 Substrates,DrugBank
DB01054,Dihydropyridine Derivatives,DrugBank
DB01054,Dihydropyridines,DrugBank
DB01054,Hypotensive Agents,DrugBank
DB01054,Membrane Transport Modulators,DrugBank
DB01054,P-glycoprotein inhibitors,DrugBank
DB01054,Potential QTc-Prolonging Agents,DrugBank
DB01054,Pyridines,DrugBank
DB01054,QTc Prolonging Agents,DrugBank
DB01054,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB01054,Vasodilating Agents,DrugBank
DB01056,Amides,DrugBank
DB01056,Amines,DrugBank
DB01056,Anilides,DrugBank
DB01056,Aniline Compounds,DrugBank
DB01056,Antiarrhythmic agents,DrugBank
DB01056,"Antiarrhythmics, Class I",DrugBank
DB01056,"Antiarrhythmics, Class Ib",DrugBank
DB01056,Cardiac Therapy,DrugBank
DB01056,Cardiovascular Agents,DrugBank
DB01056,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01056,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB01056,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01056,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01056,Cytochrome P-450 Substrates,DrugBank
DB01056,Membrane Transport Modulators,DrugBank
DB01056,Sodium Channel Blockers,DrugBank
DB01056,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01057,Antiglaucoma Preparations and Miotics,DrugBank
DB01057,Autonomic Agents,DrugBank
DB01057,Cholinergic Agents,DrugBank
DB01057,Cholinesterase Inhibitors,DrugBank
DB01057,Enzyme Inhibitors,DrugBank
DB01057,Miotics,DrugBank
DB01057,Neurotransmitter Agents,DrugBank
DB01057,Ophthalmologicals,DrugBank
DB01057,Organophosphates,DrugBank
DB01057,Organophosphorus Compounds,DrugBank
DB01057,Organothiophosphates,DrugBank
DB01057,Organothiophosphorus Compounds,DrugBank
DB01057,Parasympathomimetics,DrugBank
DB01057,Peripheral Nervous System Agents,DrugBank
DB01057,Potential QTc-Prolonging Agents,DrugBank
DB01057,QTc Prolonging Agents,DrugBank
DB01057,Sensory Organs,DrugBank
DB01057,Sulfur Compounds,DrugBank
DB01058,Anthelmintics,DrugBank
DB01058,Anti-Infective Agents,DrugBank
DB01058,Antihelminthic,DrugBank
DB01058,Antiparasitic Agents,DrugBank
DB01058,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01058,Antitrematodals,DrugBank
DB01058,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01058,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01058,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01058,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01058,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01058,Cytochrome P-450 Substrates,DrugBank
DB01058,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01058,Isoquinolines,DrugBank
DB01058,Quinoline Derivatives and Related Substances,DrugBank
DB01059,4-Quinolones,DrugBank
DB01059,Agents Causing Muscle Toxicity,DrugBank
DB01059,Anti-Bacterial Agents,DrugBank
DB01059,Anti-Infective Agents,DrugBank
DB01059,Antibacterials for Systemic Use,DrugBank
DB01059,Antiinfectives for Systemic Use,DrugBank
DB01059,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01059,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01059,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01059,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01059,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01059,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01059,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB01059,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01059,Enzyme Inhibitors,DrugBank
DB01059,Fluoroquinolones,DrugBank
DB01059,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01059,OAT1/SLC22A6 inhibitors,DrugBank
DB01059,Ophthalmologicals,DrugBank
DB01059,Potential QTc-Prolonging Agents,DrugBank
DB01059,QTc Prolonging Agents,DrugBank
DB01059,Quinolines,DrugBank
DB01059,Quinolone Antimicrobial,DrugBank
DB01059,Quinolones,DrugBank
DB01059,Sensory Organs,DrugBank
DB01059,Topoisomerase II Inhibitors,DrugBank
DB01059,Topoisomerase Inhibitors,DrugBank
DB01060,Alimentary Tract and Metabolism,DrugBank
DB01060,Amides,DrugBank
DB01060,Aminopenicillins,DrugBank
DB01060,Anti-Bacterial Agents,DrugBank
DB01060,Anti-Infective Agents,DrugBank
DB01060,Antibacterials for Systemic Use,DrugBank
DB01060,Antiinfectives for Systemic Use,DrugBank
DB01060,Beta-Lactam Antibacterials,DrugBank
DB01060,beta-Lactams,DrugBank
DB01060,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01060,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01060,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01060,Drugs for Acid Related Disorders,DrugBank
DB01060,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB01060,Drugs that are Mainly Renally Excreted,DrugBank
DB01060,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01060,Lactams,DrugBank
DB01060,OAT1/SLC22A6 inhibitors,DrugBank
DB01060,Penicillin G,DrugBank
DB01060,Penicillins,DrugBank
DB01060,Penicillins With Extended Spectrum,DrugBank
DB01060,Sulfur Compounds,DrugBank
DB01061,Agents that reduce seizure threshold,DrugBank
DB01061,Amides,DrugBank
DB01061,Anti-Bacterial Agents,DrugBank
DB01061,Anti-Infective Agents,DrugBank
DB01061,Antibacterials for Systemic Use,DrugBank
DB01061,Antiinfectives for Systemic Use,DrugBank
DB01061,Beta-Lactam Antibacterials,DrugBank
DB01061,beta-Lactams,DrugBank
DB01061,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01061,Lactams,DrugBank
DB01061,Penicillin G,DrugBank
DB01061,Penicillins,DrugBank
DB01061,Penicillins With Extended Spectrum,DrugBank
DB01061,Sulfur Compounds,DrugBank
DB01062,"Acids, Carbocyclic",DrugBank
DB01062,Agents producing tachycardia,DrugBank
DB01062,Anticholinergic Agents,DrugBank
DB01062,Autonomic Agents,DrugBank
DB01062,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01062,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01062,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01062,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01062,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01062,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01062,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01062,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01062,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01062,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01062,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01062,Cytochrome P-450 Substrates,DrugBank
DB01062,Drugs for Urinary Frequency and Incontinence,DrugBank
DB01062,Genito Urinary System and Sex Hormones,DrugBank
DB01062,Genitourinary Agents,DrugBank
DB01062,Hydroxy Acids,DrugBank
DB01062,Muscarinic Antagonists,DrugBank
DB01062,Neurotransmitter Agents,DrugBank
DB01062,Parasympatholytics,DrugBank
DB01062,Peripheral Nervous System Agents,DrugBank
DB01062,Urological Agents,DrugBank
DB01062,Urologicals,DrugBank
DB01063,Antipsychotic Agents,DrugBank
DB01063,Central Nervous System Depressants,DrugBank
DB01063,Dopamine Antagonists,DrugBank
DB01063,Dopamine D2 Receptor Antagonists,DrugBank
DB01063,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01063,Nervous System,DrugBank
DB01063,Neurotoxic agents,DrugBank
DB01063,Phenothiazines,DrugBank
DB01063,Phenothiazines With Piperazine Structure,DrugBank
DB01063,Psycholeptics,DrugBank
DB01063,Sulfur Compounds,DrugBank
DB01064,Adrenergic Agents,DrugBank
DB01064,Adrenergic Agonists,DrugBank
DB01064,Adrenergic and Dopaminergic Agents,DrugBank
DB01064,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01064,Adrenergic beta-Agonists,DrugBank
DB01064,Adrenergics for Systemic Use,DrugBank
DB01064,"Adrenergics, Inhalants",DrugBank
DB01064,Agents producing tachycardia,DrugBank
DB01064,Agents that produce hypertension,DrugBank
DB01064,Alcohols,DrugBank
DB01064,Amines,DrugBank
DB01064,Amino Alcohols,DrugBank
DB01064,Anti-Asthmatic Agents,DrugBank
DB01064,Autonomic Agents,DrugBank
DB01064,Benzene Derivatives,DrugBank
DB01064,Bronchodilator Agents,DrugBank
DB01064,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB01064,Cardiac Therapy,DrugBank
DB01064,Cardiotonic Agents,DrugBank
DB01064,Cardiovascular Agents,DrugBank
DB01064,Catecholamines,DrugBank
DB01064,Catechols,DrugBank
DB01064,Cholinesterase Inhibitors,DrugBank
DB01064,"Compounds used in a research, industrial, or household setting",DrugBank
DB01064,COMT Substrates,DrugBank
DB01064,Drugs for Obstructive Airway Diseases,DrugBank
DB01064,Ethanolamines,DrugBank
DB01064,Neurotransmitter Agents,DrugBank
DB01064,Non-selective Beta-adrenergic Agonists,DrugBank
DB01064,Peripheral Nervous System Agents,DrugBank
DB01064,Phenols,DrugBank
DB01064,Protective Agents,DrugBank
DB01064,Respiratory System Agents,DrugBank
DB01064,Sympathomimetics,DrugBank
DB01065,Amines,DrugBank
DB01065,Antioxidants,DrugBank
DB01065,Biogenic Amines,DrugBank
DB01065,Biogenic Monoamines,DrugBank
DB01065,Biological Factors,DrugBank
DB01065,Central Nervous System Agents,DrugBank
DB01065,Central Nervous System Depressants,DrugBank
DB01065,"Compounds used in a research, industrial, or household setting",DrugBank
DB01065,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01065,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01065,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01065,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01065,Cytochrome P-450 Substrates,DrugBank
DB01065,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01065,Hormones,DrugBank
DB01065,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01065,Hypnotics and Sedatives,DrugBank
DB01065,Indoles,DrugBank
DB01065,Melatonin Receptor Agonists,DrugBank
DB01065,"Melatonin, agonists",DrugBank
DB01065,Nervous System,DrugBank
DB01065,OAT3/SLC22A8 Inhibitors,DrugBank
DB01065,Protective Agents,DrugBank
DB01065,Psycholeptics,DrugBank
DB01065,Tryptamines,DrugBank
DB01066,Amides,DrugBank
DB01066,Anti-Bacterial Agents,DrugBank
DB01066,Anti-Infective Agents,DrugBank
DB01066,Antibacterials for Systemic Use,DrugBank
DB01066,Antiinfectives for Systemic Use,DrugBank
DB01066,beta-Lactams,DrugBank
DB01066,Cephalosporins,DrugBank
DB01066,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01066,Lactams,DrugBank
DB01066,Nephrotoxic agents,DrugBank
DB01066,Sulfur Compounds,DrugBank
DB01066,Thiazines,DrugBank
DB01066,Third-Generation Cephalosporins,DrugBank
DB01067,Alimentary Tract and Metabolism,DrugBank
DB01067,Blood Glucose Lowering Agents,DrugBank
DB01067,BSEP/ABCB11 Substrates,DrugBank
DB01067,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01067,Cytochrome P-450 Substrates,DrugBank
DB01067,Drugs that are Mainly Renally Excreted,DrugBank
DB01067,Drugs Used in Diabetes,DrugBank
DB01067,Hypoglycemia-Associated Agents,DrugBank
DB01067,Insulin Secretagogues,DrugBank
DB01067,Oral Hypoglycemics,DrugBank
DB01067,Sulfones,DrugBank
DB01067,Sulfonylureas,DrugBank
DB01067,Sulfur Compounds,DrugBank
DB01067,UGT1A1 Substrates,DrugBank
DB01068,Anticonvulsants,DrugBank
DB01068,Benzazepines,DrugBank
DB01068,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01068,Benzodiazepinones,DrugBank
DB01068,Central Nervous System Agents,DrugBank
DB01068,Central Nervous System Depressants,DrugBank
DB01068,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01068,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01068,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01068,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01068,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01068,Cytochrome P-450 Substrates,DrugBank
DB01068,Drugs that are Mainly Renally Excreted,DrugBank
DB01068,GABA Agents,DrugBank
DB01068,GABA Modulators,DrugBank
DB01068,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01068,Muscle Relaxants,DrugBank
DB01068,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01068,Nervous System,DrugBank
DB01069,Acid Reducers,DrugBank
DB01069,Agents producing tachycardia,DrugBank
DB01069,Agents that reduce seizure threshold,DrugBank
DB01069,Amines,DrugBank
DB01069,Anti-Allergic Agents,DrugBank
DB01069,Anticholinergic Agents,DrugBank
DB01069,Antidepressive Agents,DrugBank
DB01069,Antidotes,DrugBank
DB01069,Antihistamines for Systemic Use,DrugBank
DB01069,Antihistamines for Topical Use,DrugBank
DB01069,Antipruritics,DrugBank
DB01069,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB01069,Antipsychotic Agents,DrugBank
DB01069,Central Nervous System Depressants,DrugBank
DB01069,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01069,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01069,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01069,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01069,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01069,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01069,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01069,Cytochrome P-450 Substrates,DrugBank
DB01069,Dermatologicals,DrugBank
DB01069,Dopamine Antagonists,DrugBank
DB01069,Dopamine D2 Receptor Antagonists,DrugBank
DB01069,Drugs causing inadvertant photosensitivity,DrugBank
DB01069,Drugs that are Mainly Renally Excreted,DrugBank
DB01069,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01069,Histamine Agents,DrugBank
DB01069,Histamine Antagonists,DrugBank
DB01069,Histamine H1 Antagonists,DrugBank
DB01069,Histamine H2 Antagonists,DrugBank
DB01069,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB01069,Muscarinic Antagonists,DrugBank
DB01069,Neurotoxic agents,DrugBank
DB01069,Neurotransmitter Agents,DrugBank
DB01069,P-glycoprotein inhibitors,DrugBank
DB01069,Phenothiazine Derivatives,DrugBank
DB01069,Phenothiazines,DrugBank
DB01069,Photosensitizing Agents,DrugBank
DB01069,Potential QTc-Prolonging Agents,DrugBank
DB01069,Propylamines,DrugBank
DB01069,QTc Prolonging Agents,DrugBank
DB01069,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01069,Serotonin Agents,DrugBank
DB01069,Serotonin Modulators,DrugBank
DB01069,Sulfur Compounds,DrugBank
DB01070,Alimentary Tract and Metabolism,DrugBank
DB01070,Bone Density Conservation Agents,DrugBank
DB01070,Cholestanes,DrugBank
DB01070,Cholestenes,DrugBank
DB01070,"Diet, Food, and Nutrition",DrugBank
DB01070,Food,DrugBank
DB01070,Fused-Ring Compounds,DrugBank
DB01070,Lipids,DrugBank
DB01070,Membrane Lipids,DrugBank
DB01070,Micronutrients,DrugBank
DB01070,Physiological Phenomena,DrugBank
DB01070,Secosteroids,DrugBank
DB01070,Steroids,DrugBank
DB01070,Sterols,DrugBank
DB01070,Vitamin D and Analogues,DrugBank
DB01070,Vitamins,DrugBank
DB01070,Vitamins (Fat Soluble),DrugBank
DB01071,Anti-Allergic Agents,DrugBank
DB01071,Antihistamines for Systemic Use,DrugBank
DB01071,Bronchodilator Agents,DrugBank
DB01071,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01071,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01071,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01071,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01071,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01071,Cytochrome P-450 Substrates,DrugBank
DB01071,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01071,Histamine Agents,DrugBank
DB01071,Histamine Antagonists,DrugBank
DB01071,Histamine H1 Antagonists,DrugBank
DB01071,Neurotransmitter Agents,DrugBank
DB01071,Phenothiazine Derivatives,DrugBank
DB01071,Potential QTc-Prolonging Agents,DrugBank
DB01071,QTc Prolonging Agents,DrugBank
DB01071,Sulfur Compounds,DrugBank
DB01072,"Amino Acids, Peptides, and Proteins",DrugBank
DB01072,Anti-HIV Agents,DrugBank
DB01072,Anti-Infective Agents,DrugBank
DB01072,Anti-Retroviral Agents,DrugBank
DB01072,Antiinfectives for Systemic Use,DrugBank
DB01072,Antiviral Agents,DrugBank
DB01072,Antivirals for Systemic Use,DrugBank
DB01072,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB01072,BSEP/ABCB11 Substrates,DrugBank
DB01072,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01072,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01072,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01072,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01072,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01072,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01072,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01072,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01072,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB01072,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01072,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB01072,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01072,Cytochrome P-450 Substrates,DrugBank
DB01072,Direct Acting Antivirals,DrugBank
DB01072,Enzyme Inhibitors,DrugBank
DB01072,HIV Protease Inhibitors,DrugBank
DB01072,Hyperglycemia-Associated Agents,DrugBank
DB01072,Nephrotoxic agents,DrugBank
DB01072,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01072,OATP1B3 inhibitors,DrugBank
DB01072,Oligopeptides,DrugBank
DB01072,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01072,P-glycoprotein inducers,DrugBank
DB01072,P-glycoprotein inhibitors,DrugBank
DB01072,P-glycoprotein substrates,DrugBank
DB01072,Peptides,DrugBank
DB01072,Potential QTc-Prolonging Agents,DrugBank
DB01072,Protease Inhibitors,DrugBank
DB01072,Pyridines,DrugBank
DB01072,QTc Prolonging Agents,DrugBank
DB01072,UDP Glucuronosyltransferases Inhibitors,DrugBank
DB01072,UGT1A1 Inhibitors,DrugBank
DB01072,Viral Protease Inhibitors,DrugBank
DB01073,Adenine Nucleotides,DrugBank
DB01073,Antimetabolites,DrugBank
DB01073,Antineoplastic Agents,DrugBank
DB01073,Antineoplastic and Immunomodulating Agents,DrugBank
DB01073,Arabinonucleosides,DrugBank
DB01073,Arabinonucleotides,DrugBank
DB01073,Cardiotoxic antineoplastic agents,DrugBank
DB01073,"DNA (Cytosine-5-)-Methyltransferases, antagonists & inhibitors",DrugBank
DB01073,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01073,Immunologic Factors,DrugBank
DB01073,Immunosuppressive Agents,DrugBank
DB01073,Myeloablative Agonists,DrugBank
DB01073,Myelosuppressive Agents,DrugBank
DB01073,Narrow Therapeutic Index Drugs,DrugBank
DB01073,Noxae,DrugBank
DB01073,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01073,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01073,Nucleoside Metabolic Inhibitor,DrugBank
DB01073,Nucleosides,DrugBank
DB01073,Nucleotides,DrugBank
DB01073,Purine Analogues,DrugBank
DB01073,Purine Nucleosides,DrugBank
DB01073,Purine Nucleotides,DrugBank
DB01073,Purines,DrugBank
DB01073,Toxic Actions,DrugBank
DB01074,Agents causing hyperkalemia,DrugBank
DB01074,Antiarrhythmic agents,DrugBank
DB01074,Bradycardia-Causing Agents,DrugBank
DB01074,Calcium Channel Blockers,DrugBank
DB01074,Calcium-Regulating Hormones and Agents,DrugBank
DB01074,Cardiovascular Agents,DrugBank
DB01074,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01074,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01074,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB01074,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01074,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01074,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01074,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01074,Cytochrome P-450 Substrates,DrugBank
DB01074,Membrane Transport Modulators,DrugBank
DB01074,Negative Inotrope,DrugBank
DB01074,Non-Selective Calcium Channel Blockers,DrugBank
DB01074,Piperidines,DrugBank
DB01074,Potential QTc-Prolonging Agents,DrugBank
DB01074,QTc Prolonging Agents,DrugBank
DB01074,Vasodilating Agents,DrugBank
DB01075,Agents producing tachycardia,DrugBank
DB01075,Amines,DrugBank
DB01075,Aminoalkyl Ethers,DrugBank
DB01075,Anesthetics,DrugBank
DB01075,"Anesthetics, Local",DrugBank
DB01075,Anti-Allergic Agents,DrugBank
DB01075,Anticholinergic Agents,DrugBank
DB01075,Antiemetics,DrugBank
DB01075,Antihistamines for Systemic Use,DrugBank
DB01075,Antihistamines for Topical Use,DrugBank
DB01075,Antiinflammatory and Antirheumatic Products,DrugBank
DB01075,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01075,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB01075,Benzene Derivatives,DrugBank
DB01075,Benzhydryl Compounds,DrugBank
DB01075,Central Nervous System Agents,DrugBank
DB01075,Central Nervous System Depressants,DrugBank
DB01075,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01075,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01075,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01075,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01075,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01075,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01075,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01075,Cytochrome P-450 Substrates,DrugBank
DB01075,Dermatologicals,DrugBank
DB01075,Drugs causing inadvertant photosensitivity,DrugBank
DB01075,Ethanolamine Derivatives,DrugBank
DB01075,Ethylamines,DrugBank
DB01075,First Generation Antihistamines,DrugBank
DB01075,Gastrointestinal Agents,DrugBank
DB01075,Histamine Agents,DrugBank
DB01075,Histamine Antagonists,DrugBank
DB01075,Histamine H1 Antagonists,DrugBank
DB01075,Hypnotics and Sedatives,DrugBank
DB01075,Muscarinic Antagonists,DrugBank
DB01075,Musculo-Skeletal System,DrugBank
DB01075,OCT2 Inhibitors,DrugBank
DB01075,Photosensitizing Agents,DrugBank
DB01075,Potential QTc-Prolonging Agents,DrugBank
DB01075,Propionates,DrugBank
DB01075,QTc Prolonging Agents,DrugBank
DB01075,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01075,"Sleep Aids, Pharmaceutical",DrugBank
DB01076,Agents Causing Muscle Toxicity,DrugBank
DB01076,Anticholesteremic Agents,DrugBank
DB01076,BSEP/ABCB11 Substrates,DrugBank
DB01076,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01076,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01076,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01076,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01076,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01076,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01076,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01076,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01076,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01076,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01076,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01076,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01076,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01076,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01076,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01076,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01076,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01076,Cytochrome P-450 Substrates,DrugBank
DB01076,Enzyme Inhibitors,DrugBank
DB01076,Fatty Acids,DrugBank
DB01076,Heptanoic Acids,DrugBank
DB01076,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB01076,Hypolipidemic Agents,DrugBank
DB01076,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01076,Lipid Modifying Agents,DrugBank
DB01076,"Lipid Modifying Agents, Plain",DrugBank
DB01076,Lipid Regulating Agents,DrugBank
DB01076,Lipids,DrugBank
DB01076,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01076,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01076,OATP1B3 substrates,DrugBank
DB01076,OATP2B1/SLCO2B1 substrates,DrugBank
DB01076,P-glycoprotein inhibitors,DrugBank
DB01076,P-glycoprotein substrates,DrugBank
DB01076,Toxic Actions,DrugBank
DB01076,UGT1A1 Substrates,DrugBank
DB01076,UGT1A3 substrates,DrugBank
DB01077,Bisphosphonates,DrugBank
DB01077,Bone Density Conservation Agents,DrugBank
DB01077,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB01077,Drugs for Treatment of Bone Diseases,DrugBank
DB01077,Musculo-Skeletal System,DrugBank
DB01077,Organophosphonates,DrugBank
DB01077,Organophosphorus Compounds,DrugBank
DB01078,Antiarrhythmic agents,DrugBank
DB01078,Carbohydrates,DrugBank
DB01078,Cardanolides,DrugBank
DB01078,Cardenolides,DrugBank
DB01078,Cardiac Glycosides,DrugBank
DB01078,Cardiac Therapy,DrugBank
DB01078,Cardiotonic Agents,DrugBank
DB01078,Cardiovascular Agents,DrugBank
DB01078,"Compounds used in a research, industrial, or household setting",DrugBank
DB01078,Digitalis Glycosides,DrugBank
DB01078,Enzyme Inhibitors,DrugBank
DB01078,Fused-Ring Compounds,DrugBank
DB01078,Glycosides,DrugBank
DB01078,Lanatosides,DrugBank
DB01078,Protective Agents,DrugBank
DB01078,Steroids,DrugBank
DB01079,Alimentary Tract and Metabolism,DrugBank
DB01079,Antidepressive Agents,DrugBank
DB01079,BCRP/ABCG2 Substrates,DrugBank
DB01079,Central Nervous System Depressants,DrugBank
DB01079,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01079,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01079,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01079,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01079,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01079,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB01079,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01079,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01079,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB01079,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01079,Cytochrome P-450 Substrates,DrugBank
DB01079,Drugs for Constipation,DrugBank
DB01079,Gastrointestinal Agents,DrugBank
DB01079,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01079,Laxatives,DrugBank
DB01079,P-glycoprotein substrates,DrugBank
DB01079,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01079,Serotonin 4 Receptor Agonists,DrugBank
DB01079,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01079,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01079,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01079,Serotonin Agents,DrugBank
DB01079,Serotonin Receptor Antagonists,DrugBank
DB01079,Serotonin-4 Receptor Agonist,DrugBank
DB01080,"Acids, Acyclic",DrugBank
DB01080,Aminobutyrates,DrugBank
DB01080,Anti-epileptic Agent,DrugBank
DB01080,Anticonvulsants,DrugBank
DB01080,Butyrates,DrugBank
DB01080,Central Nervous System Agents,DrugBank
DB01080,Central Nervous System Depressants,DrugBank
DB01080,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01080,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01080,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01080,Enzyme Inhibitors,DrugBank
DB01080,Fatty Acid Derivatives,DrugBank
DB01080,Fatty Acids,DrugBank
DB01080,GABA Agents,DrugBank
DB01080,Lipids,DrugBank
DB01080,Miscellaneous Anticonvulsants,DrugBank
DB01080,Nervous System,DrugBank
DB01080,Neurotransmitter Agents,DrugBank
DB01081,Alimentary Tract and Metabolism,DrugBank
DB01081,Analgesics,DrugBank
DB01081,Antidiarrheals,DrugBank
DB01081,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01081,Antipropulsives,DrugBank
DB01081,Central Nervous System Agents,DrugBank
DB01081,Central Nervous System Depressants,DrugBank
DB01081,Gastrointestinal Agents,DrugBank
DB01081,Isonipecotic Acids,DrugBank
DB01081,Opioids,DrugBank
DB01081,Peripheral Nervous System Agents,DrugBank
DB01081,Piperidines,DrugBank
DB01081,Sensory System Agents,DrugBank
DB01081,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01082,Agents that produce neuromuscular block (indirect),DrugBank
DB01082,Alimentary Tract and Metabolism,DrugBank
DB01082,Aminoglycoside Antibacterials,DrugBank
DB01082,Anti-Bacterial Agents,DrugBank
DB01082,Anti-Infective Agents,DrugBank
DB01082,Antibacterials for Systemic Use,DrugBank
DB01082,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01082,Antiinfectives for Systemic Use,DrugBank
DB01082,Antimycobacterials,DrugBank
DB01082,Drugs for Treatment of Tuberculosis,DrugBank
DB01082,Drugs that are Mainly Renally Excreted,DrugBank
DB01082,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB01082,Glycosides,DrugBank
DB01082,Intestinal Antiinfectives,DrugBank
DB01082,Narrow Therapeutic Index Drugs,DrugBank
DB01082,Nephrotoxic agents,DrugBank
DB01082,OAT1/SLC22A6 inhibitors,DrugBank
DB01082,Protein Synthesis Inhibitors,DrugBank
DB01082,Streptomycins,DrugBank
DB01083,Alimentary Tract and Metabolism,DrugBank
DB01083,Anti-Obesity Agents,DrugBank
DB01083,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB01083,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01083,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01083,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01083,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01083,Enzyme Inhibitors,DrugBank
DB01083,Intestinal Lipase Inhibitor,DrugBank
DB01083,Lactones,DrugBank
DB01083,Lipase Inhibitors,DrugBank
DB01083,Lipid Regulating Agents,DrugBank
DB01083,Miscellaneous GI Drugs,DrugBank
DB01083,Peripherally Acting Antiobesity Products,DrugBank
DB01084,Anti-Allergic Agents,DrugBank
DB01084,Decongestants and Antiallergics,DrugBank
DB01084,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01084,Histamine Agents,DrugBank
DB01084,Histamine Antagonists,DrugBank
DB01084,Histamine H1 Antagonists,DrugBank
DB01084,Histamine H1 Inhibitors,DrugBank
DB01084,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01084,Neurotransmitter Agents,DrugBank
DB01084,Ophthalmologicals,DrugBank
DB01084,QTc Prolonging Agents,DrugBank
DB01084,Sensory Organs,DrugBank
DB01085,Alkaloids,DrugBank
DB01085,Antiglaucoma Preparations and Miotics,DrugBank
DB01085,Autonomic Agents,DrugBank
DB01085,Cholinergic Agents,DrugBank
DB01085,Cholinergic Agonists,DrugBank
DB01085,Cholinergic Receptor Agonist,DrugBank
DB01085,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01085,Cytochrome P-450 CYP2A6 Inhibitors (strong),DrugBank
DB01085,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01085,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01085,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01085,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01085,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01085,Cytochrome P-450 Substrates,DrugBank
DB01085,Miotics,DrugBank
DB01085,Muscarinic Agonists,DrugBank
DB01085,Nervous System,DrugBank
DB01085,Neurotransmitter Agents,DrugBank
DB01085,Ophthalmologicals,DrugBank
DB01085,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB01085,Parasympathomimetics,DrugBank
DB01085,Peripheral Nervous System Agents,DrugBank
DB01085,Sensory Organs,DrugBank
DB01086,"Acids, Carbocyclic",DrugBank
DB01086,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB01086,Aminobenzoates,DrugBank
DB01086,Anesthetics,DrugBank
DB01086,Anesthetics for Topical Use,DrugBank
DB01086,"Anesthetics, Local",DrugBank
DB01086,Antipruritics and Local Anesthetics,DrugBank
DB01086,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB01086,Benzene Derivatives,DrugBank
DB01086,Benzoates,DrugBank
DB01086,Cell-mediated Immunity,DrugBank
DB01086,Central Nervous System Agents,DrugBank
DB01086,Central Nervous System Depressants,DrugBank
DB01086,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01086,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01086,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01086,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01086,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01086,Cytochrome P-450 Substrates,DrugBank
DB01086,Dermatologicals,DrugBank
DB01086,Esters of Aminobenzoic Acid,DrugBank
DB01086,Increased Histamine Release,DrugBank
DB01086,Local Anesthetics (Ester),DrugBank
DB01086,Methemoglobinemia Associated Agents,DrugBank
DB01086,Nervous System,DrugBank
DB01086,P-glycoprotein inhibitors,DrugBank
DB01086,para-Aminobenzoates,DrugBank
DB01086,Peripheral Nervous System Agents,DrugBank
DB01086,Sensory System Agents,DrugBank
DB01086,Standardized Chemical Allergen,DrugBank
DB01086,Throat Preparations,DrugBank
DB01086,Vasoprotectives,DrugBank
DB01087,Aminoquinolines,DrugBank
DB01087,Anti-Infective Agents,DrugBank
DB01087,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB01087,Antimalarials,DrugBank
DB01087,Antiparasitic Agents,DrugBank
DB01087,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01087,Antiprotozoals,DrugBank
DB01087,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01087,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01087,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01087,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01087,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB01087,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01087,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01087,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01087,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01087,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01087,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01087,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01087,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01087,Cytochrome P-450 Substrates,DrugBank
DB01087,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01087,Methemoglobinemia Associated Agents,DrugBank
DB01087,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01087,P-glycoprotein inhibitors,DrugBank
DB01087,QTc Prolonging Agents,DrugBank
DB01087,Quinolines,DrugBank
DB01088,Agents Causing Muscle Toxicity,DrugBank
DB01088,Antiplatelet agents,DrugBank
DB01088,Autacoids,DrugBank
DB01088,Biological Factors,DrugBank
DB01088,Blood and Blood Forming Organs,DrugBank
DB01088,Cardiovascular Agents,DrugBank
DB01088,Eicosanoids,DrugBank
DB01088,Fatty Acids,DrugBank
DB01088,"Fatty Acids, Unsaturated",DrugBank
DB01088,Hematologic Agents,DrugBank
DB01088,Hypotensive Agents,DrugBank
DB01088,Inflammation Mediators,DrugBank
DB01088,Lipids,DrugBank
DB01088,OATP2B1/SLCO2B1 substrates,DrugBank
DB01088,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB01088,Prostacyclin Analogues,DrugBank
DB01088,Prostaglandins,DrugBank
DB01088,"Prostaglandins, Synthetic",DrugBank
DB01088,Vasodilating Agents,DrugBank
DB01089,Alkaloids,DrugBank
DB01089,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB01089,Antihypertensive Agents,DrugBank
DB01089,Catecholamine-depleting Sympatholytic,DrugBank
DB01089,Decreased Sympathetic Activity,DrugBank
DB01089,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01089,Indole Alkaloids,DrugBank
DB01089,Indoles,DrugBank
DB01089,Indolizidines,DrugBank
DB01089,Indolizines,DrugBank
DB01089,Secologanin Tryptamine Alkaloids,DrugBank
DB01090,Anticholinergic Agents,DrugBank
DB01090,Antihypertensive Agents,DrugBank
DB01090,Autonomic Agents,DrugBank
DB01090,Cardiovascular Agents,DrugBank
DB01090,Cholinergic Agents,DrugBank
DB01090,Ganglion Blockers,DrugBank
DB01090,Neurotransmitter Agents,DrugBank
DB01090,Nicotinic Antagonists,DrugBank
DB01090,Peripheral Nervous System Agents,DrugBank
DB01090,Pyrrolidines,DrugBank
DB01092,Carbohydrates,DrugBank
DB01092,Cardanolides,DrugBank
DB01092,Cardenolides,DrugBank
DB01092,Cardiac Glycosides,DrugBank
DB01092,Cardiac Therapy,DrugBank
DB01092,Cardiotonic Agents,DrugBank
DB01092,Cardiovascular Agents,DrugBank
DB01092,"Compounds used in a research, industrial, or household setting",DrugBank
DB01092,Enzyme Inhibitors,DrugBank
DB01092,Fused-Ring Compounds,DrugBank
DB01092,Glycosides,DrugBank
DB01092,OAT3/SLC22A8 Inhibitors,DrugBank
DB01092,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01092,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01092,OATP1B3 substrates,DrugBank
DB01092,Protective Agents,DrugBank
DB01092,Steroids,DrugBank
DB01092,Strophanthins,DrugBank
DB01092,Strophanthus Glycosides,DrugBank
DB01093,Antioxidants,DrugBank
DB01093,"Compounds used in a research, industrial, or household setting",DrugBank
DB01093,Cryoprotective Agents,DrugBank
DB01093,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01093,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01093,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01093,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01093,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01093,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01093,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01093,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01093,Drugs that are Mainly Renally Excreted,DrugBank
DB01093,Free Radical Scavengers,DrugBank
DB01093,Genito Urinary System and Sex Hormones,DrugBank
DB01093,Kinase Inhibitor,DrugBank
DB01093,Miscellaneous Therapeutic Agents,DrugBank
DB01093,Musculo-Skeletal System,DrugBank
DB01093,Protective Agents,DrugBank
DB01093,Solvents,DrugBank
DB01093,Sulfoxides,DrugBank
DB01093,Sulfur Compounds,DrugBank
DB01093,Topical Products for Joint and Muscular Pain,DrugBank
DB01093,Urologicals,DrugBank
DB01094,BCRP/ABCG2 Inhibitors,DrugBank
DB01094,Benzopyrans,DrugBank
DB01094,Carbohydrates,DrugBank
DB01094,Chromones,DrugBank
DB01094,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01094,Cytochrome P-450 Substrates,DrugBank
DB01094,Flavanones,DrugBank
DB01094,Flavonoids,DrugBank
DB01094,Glycosides,DrugBank
DB01094,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01094,Pyrans,DrugBank
DB01095,Agents Causing Muscle Toxicity,DrugBank
DB01095,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01095,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01095,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01095,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01095,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01095,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01095,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01095,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01095,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01095,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01095,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01095,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01095,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01095,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01095,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01095,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01095,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01095,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01095,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01095,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01095,Cytochrome P-450 Substrates,DrugBank
DB01095,Fatty Acids,DrugBank
DB01095,Heptanoic Acids,DrugBank
DB01095,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01095,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB01095,Hypolipidemic Agents,DrugBank
DB01095,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01095,Indoles,DrugBank
DB01095,Lipid Modifying Agents,DrugBank
DB01095,"Lipid Modifying Agents, Plain",DrugBank
DB01095,Lipid Regulating Agents,DrugBank
DB01095,Lipids,DrugBank
DB01095,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01095,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01095,OATP1B3 substrates,DrugBank
DB01095,UGT1A1 Substrates,DrugBank
DB01095,UGT1A3 substrates,DrugBank
DB01095,UGT2B7 substrates,DrugBank
DB01096,Anthelmintics,DrugBank
DB01096,Anti-Infective Agents,DrugBank
DB01096,Antihelminthic,DrugBank
DB01096,Antiparasitic Agents,DrugBank
DB01096,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01096,Antiplatyhelmintic Agents,DrugBank
DB01096,Antitrematodals,DrugBank
DB01096,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01096,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01096,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01096,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01096,Cytochrome P-450 Substrates,DrugBank
DB01096,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01096,Hydroxyquinolines,DrugBank
DB01096,Nitroquinolines,DrugBank
DB01096,Quinoline Derivatives and Related Substances,DrugBank
DB01096,Quinolines,DrugBank
DB01096,Schistosomicides,DrugBank
DB01097,Adjuvants,DrugBank
DB01097,Agents Causing Muscle Toxicity,DrugBank
DB01097,Antineoplastic and Immunomodulating Agents,DrugBank
DB01097,Antirheumatic Agents,DrugBank
DB01097,BCRP/ABCG2 Substrates,DrugBank
DB01097,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01097,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01097,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01097,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01097,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01097,Cytochrome P-450 Substrates,DrugBank
DB01097,Dihydroorotate dehydrogenase (DHODH) inhibitors,DrugBank
DB01097,Disease-modifying Antirheumatic Agents,DrugBank
DB01097,Enzyme Inhibitors,DrugBank
DB01097,Hepatotoxic Agents,DrugBank
DB01097,Immunologic Factors,DrugBank
DB01097,Immunosuppressive Agents,DrugBank
DB01097,Isoxazoles,DrugBank
DB01097,Selective Immunosuppressants,DrugBank
DB01098,Agents Causing Muscle Toxicity,DrugBank
DB01098,Alimentary Tract and Metabolism,DrugBank
DB01098,Amides,DrugBank
DB01098,Anticholesteremic Agents,DrugBank
DB01098,BCRP/ABCG2 Substrates,DrugBank
DB01098,BSEP/ABCB11 Substrates,DrugBank
DB01098,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01098,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01098,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01098,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01098,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01098,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01098,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01098,Cytochrome P-450 Substrates,DrugBank
DB01098,Drugs Used in Diabetes,DrugBank
DB01098,Enzyme Inhibitors,DrugBank
DB01098,Fluorobenzenes,DrugBank
DB01098,Genito Urinary System and Sex Hormones,DrugBank
DB01098,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01098,"Hydrocarbons, Fluorinated",DrugBank
DB01098,"Hydrocarbons, Halogenated",DrugBank
DB01098,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB01098,Hypolipidemic Agents,DrugBank
DB01098,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01098,Lipid Modifying Agents,DrugBank
DB01098,"Lipid Modifying Agents, Plain",DrugBank
DB01098,Lipid Regulating Agents,DrugBank
DB01098,OAT3/SLC22A8 Inhibitors,DrugBank
DB01098,OAT3/SLC22A8 Substrates,DrugBank
DB01098,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01098,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01098,Pyrimidines,DrugBank
DB01098,Sulfonamides,DrugBank
DB01098,Sulfones,DrugBank
DB01098,Sulfur Compounds,DrugBank
DB01099,Anti-Infective Agents,DrugBank
DB01099,Antifungal Agents,DrugBank
DB01099,Antifungals for Dermatological Use,DrugBank
DB01099,Antifungals for Topical Use,DrugBank
DB01099,Antiinfectives for Systemic Use,DrugBank
DB01099,Antimetabolites,DrugBank
DB01099,Antimycotics for Systemic Use,DrugBank
DB01099,Cytosine,DrugBank
DB01099,Dermatologicals,DrugBank
DB01099,Drugs causing inadvertant photosensitivity,DrugBank
DB01099,Drugs that are Mainly Renally Excreted,DrugBank
DB01099,Fluorouracil and prodrugs,DrugBank
DB01099,Immunosuppressive Agents,DrugBank
DB01099,Myelosuppressive Agents,DrugBank
DB01099,Noxae,DrugBank
DB01099,Nucleoside Analog Antifungal,DrugBank
DB01099,Photosensitizing Agents,DrugBank
DB01099,Pyrimidines,DrugBank
DB01099,Pyrimidinones,DrugBank
DB01099,Toxic Actions,DrugBank
DB01100,Agents that reduce seizure threshold,DrugBank
DB01100,Anti-Dyskinesia Agents,DrugBank
DB01100,Antipsychotic Agents,DrugBank
DB01100,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01100,Benzimidazoles,DrugBank
DB01100,Central Nervous System Agents,DrugBank
DB01100,Central Nervous System Depressants,DrugBank
DB01100,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01100,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01100,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01100,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01100,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01100,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01100,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01100,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01100,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01100,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01100,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01100,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01100,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01100,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01100,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01100,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01100,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01100,Cytochrome P-450 Substrates,DrugBank
DB01100,Diphenylbutylpiperidine Derivatives,DrugBank
DB01100,Dopamine Agents,DrugBank
DB01100,Dopamine Antagonists,DrugBank
DB01100,Dopamine D2 Receptor Antagonists,DrugBank
DB01100,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01100,Highest Risk QTc-Prolonging Agents,DrugBank
DB01100,Miscellaneous Antipsychotics,DrugBank
DB01100,Narrow Therapeutic Index Drugs,DrugBank
DB01100,Nervous System,DrugBank
DB01100,Neurotoxic agents,DrugBank
DB01100,Neurotransmitter Agents,DrugBank
DB01100,P-glycoprotein inhibitors,DrugBank
DB01100,Psycholeptics,DrugBank
DB01100,Psychotropic Drugs,DrugBank
DB01100,QTc Prolonging Agents,DrugBank
DB01100,Tranquilizing Agents,DrugBank
DB01101,Antimetabolites,DrugBank
DB01101,Antineoplastic Agents,DrugBank
DB01101,Antineoplastic and Immunomodulating Agents,DrugBank
DB01101,Cardiotoxic antineoplastic agents,DrugBank
DB01101,Cytidine Deaminase Substrates,DrugBank
DB01101,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01101,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01101,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB01101,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01101,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01101,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01101,Cytochrome P-450 Substrates,DrugBank
DB01101,Drugs that are Mainly Renally Excreted,DrugBank
DB01101,Fluoropyrimidines,DrugBank
DB01101,Fluorouracil and prodrugs,DrugBank
DB01101,Immunosuppressive Agents,DrugBank
DB01101,Myelosuppressive Agents,DrugBank
DB01101,Narrow Therapeutic Index Drugs,DrugBank
DB01101,Noxae,DrugBank
DB01101,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01101,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01101,Nucleoside Metabolic Inhibitor,DrugBank
DB01101,Pyrimidine Analogues,DrugBank
DB01101,Toxic Actions,DrugBank
DB01102,Adrenergic Agents,DrugBank
DB01102,Adrenergic Agonists,DrugBank
DB01102,Adrenergic and Dopaminergic Agents,DrugBank
DB01102,Adrenergic beta-1 Receptor Agonists,DrugBank
DB01102,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01102,Adrenergic beta-3 Receptor Agonists,DrugBank
DB01102,Adrenergic beta-Agonists,DrugBank
DB01102,Agents producing tachycardia,DrugBank
DB01102,Agents that produce hypertension,DrugBank
DB01102,Amines,DrugBank
DB01102,Benzene Derivatives,DrugBank
DB01102,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB01102,Cardiac Therapy,DrugBank
DB01102,Cardiotonic Agents,DrugBank
DB01102,Cardiovascular Agents,DrugBank
DB01102,Catechols,DrugBank
DB01102,"Compounds used in a research, industrial, or household setting",DrugBank
DB01102,Neurotransmitter Agents,DrugBank
DB01102,Phenols,DrugBank
DB01102,Protective Agents,DrugBank
DB01103,Acridines,DrugBank
DB01103,Aminoacridines,DrugBank
DB01103,Anti-Infective Agents,DrugBank
DB01103,Anticestodal Agents,DrugBank
DB01103,Antimalarials,DrugBank
DB01103,Antinematodal Agents,DrugBank
DB01103,Antiparasitic Agents,DrugBank
DB01103,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01103,Antiplatyhelmintic Agents,DrugBank
DB01103,Antiprotozoals,DrugBank
DB01103,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01103,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01103,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01103,Cytochrome P-450 Substrates,DrugBank
DB01103,Enzyme Inhibitors,DrugBank
DB01103,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01103,OCT2 Inhibitors,DrugBank
DB01103,P-glycoprotein inhibitors,DrugBank
DB01104,Agents that reduce seizure threshold,DrugBank
DB01104,Amines,DrugBank
DB01104,Antidepressive Agents,DrugBank
DB01104,Antidepressive Agents Indicated for Depression,DrugBank
DB01104,Central Nervous System Agents,DrugBank
DB01104,Central Nervous System Depressants,DrugBank
DB01104,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01104,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01104,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB01104,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01104,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01104,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01104,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01104,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01104,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01104,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01104,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01104,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01104,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01104,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01104,Cytochrome P-450 Substrates,DrugBank
DB01104,Drugs causing inadvertant photosensitivity,DrugBank
DB01104,Hypoglycemia-Associated Agents,DrugBank
DB01104,Membrane Transport Modulators,DrugBank
DB01104,Monoamine Oxidase A Substrates,DrugBank
DB01104,Naphthalenes,DrugBank
DB01104,Nervous System,DrugBank
DB01104,Neurotransmitter Agents,DrugBank
DB01104,Neurotransmitter Uptake Inhibitors,DrugBank
DB01104,P-glycoprotein inhibitors,DrugBank
DB01104,Photosensitizing Agents,DrugBank
DB01104,Psychoanaleptics,DrugBank
DB01104,Psychotropic Drugs,DrugBank
DB01104,QTc Prolonging Agents,DrugBank
DB01104,Selective Serotonin Reuptake Inhibitors,DrugBank
DB01104,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01104,Serotonin Agents,DrugBank
DB01104,Serotonin Modulators,DrugBank
DB01105,Agents producing tachycardia,DrugBank
DB01105,Alimentary Tract and Metabolism,DrugBank
DB01105,Anti-Obesity Agents,DrugBank
DB01105,Antidepressive Agents,DrugBank
DB01105,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB01105,Appetite Depressants,DrugBank
DB01105,Appetite Suppression,DrugBank
DB01105,Central Nervous System Agents,DrugBank
DB01105,Central Nervous System Depressants,DrugBank
DB01105,Centrally Acting Antiobesity Products,DrugBank
DB01105,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01105,Cycloparaffins,DrugBank
DB01105,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01105,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01105,Cytochrome P-450 Substrates,DrugBank
DB01105,Dopamine Uptake Inhibitors,DrugBank
DB01105,Drugs that are Mainly Renally Excreted,DrugBank
DB01105,Norepinephrine Uptake Inhibitors,DrugBank
DB01105,"Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic",DrugBank
DB01105,Psychotropic Drugs,DrugBank
DB01105,Selective Serotonin Reuptake Inhibitors,DrugBank
DB01105,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01105,Serotonin Agents,DrugBank
DB01105,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB01105,Serotonin Modulators,DrugBank
DB01105,Stimulants,DrugBank
DB01106,Anti-Allergic Agents,DrugBank
DB01106,"Antiallergic Agents, Excl. Corticosteroids",DrugBank
DB01106,Central Nervous System Depressants,DrugBank
DB01106,Decongestants and Antiallergics,DrugBank
DB01106,Histamine Agents,DrugBank
DB01106,Histamine Antagonists,DrugBank
DB01106,Histamine H1 Antagonists,DrugBank
DB01106,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB01106,Nasal Preparations,DrugBank
DB01106,Neurotransmitter Agents,DrugBank
DB01106,Ophthalmologicals,DrugBank
DB01106,Potential QTc-Prolonging Agents,DrugBank
DB01106,QTc Prolonging Agents,DrugBank
DB01106,Sensory Organs,DrugBank
DB01107,Central Nervous System Depressants,DrugBank
DB01107,Hypnotics and Sedatives,DrugBank
DB01107,Nervous System,DrugBank
DB01107,Piperidinedione Derivatives,DrugBank
DB01107,Piperidines,DrugBank
DB01107,Psycholeptics,DrugBank
DB01108,Abortifacient Agents,DrugBank
DB01108,"Abortifacient Agents, Steroidal",DrugBank
DB01108,Adrenal Cortex Hormones,DrugBank
DB01108,Androstanes,DrugBank
DB01108,Androstanols,DrugBank
DB01108,Antiadrenal Preparations,DrugBank
DB01108,Anticorticosteroids,DrugBank
DB01108,Antineoplastic Agents,DrugBank
DB01108,Corticosteroids,DrugBank
DB01108,Corticosteroids for Systemic Use,DrugBank
DB01108,Enzyme Inhibitors,DrugBank
DB01108,Fused-Ring Compounds,DrugBank
DB01108,Gonadal Hormones,DrugBank
DB01108,Gonadal Steroid Hormones,DrugBank
DB01108,Hormones,DrugBank
DB01108,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01108,Immunosuppressive Agents,DrugBank
DB01108,Narrow Therapeutic Index Drugs,DrugBank
DB01108,Oxidative Phosphorylation Coupling Factors,DrugBank
DB01108,Reproductive Control Agents,DrugBank
DB01108,Steroids,DrugBank
DB01108,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01108,Testosterone Congeners,DrugBank
DB01109,Agents causing hyperkalemia,DrugBank
DB01109,Anticoagulants,DrugBank
DB01109,Antivaricose Therapy,DrugBank
DB01109,Blood and Blood Forming Organs,DrugBank
DB01109,Carbohydrates,DrugBank
DB01109,Cardiovascular Agents,DrugBank
DB01109,Fibrin Modulating Agents,DrugBank
DB01109,Glycosaminoglycans,DrugBank
DB01109,Hematologic Agents,DrugBank
DB01109,Heparin and similars,DrugBank
DB01109,Heparin Group,DrugBank
DB01109,Heparins or Heparinoids for Topical Use,DrugBank
DB01109,Miscellaneous Therapeutic Agents,DrugBank
DB01109,Narrow Therapeutic Index Drugs,DrugBank
DB01109,Ophthalmologicals,DrugBank
DB01109,Polysaccharides,DrugBank
DB01109,Sensory Organs,DrugBank
DB01109,Thyroxine-binding globulin substrates,DrugBank
DB01109,Vasoprotectives,DrugBank
DB01110,14-alpha Demethylase Inhibitors,DrugBank
DB01110,Anti-Infective Agents,DrugBank
DB01110,Antifungal Agents,DrugBank
DB01110,Antifungal Agents (Vaginal),DrugBank
DB01110,Antifungals for Dermatological Use,DrugBank
DB01110,Antifungals for Topical Use,DrugBank
DB01110,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB01110,Azole Antifungals,DrugBank
DB01110,Chemically-Induced Disorders,DrugBank
DB01110,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2A6 Inhibitors (strong),DrugBank
DB01110,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01110,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB01110,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01110,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB01110,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB01110,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01110,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP2E1 Inhibitors (strong),DrugBank
DB01110,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01110,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01110,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01110,Dermatologicals,DrugBank
DB01110,Enzyme Inhibitors,DrugBank
DB01110,Genito Urinary System and Sex Hormones,DrugBank
DB01110,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01110,Hormone Antagonists,DrugBank
DB01110,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01110,Imidazole and Triazole Derivatives,DrugBank
DB01110,Imidazole Derivatives,DrugBank
DB01110,Imidazoles,DrugBank
DB01110,Intestinal Antiinfectives,DrugBank
DB01110,Otologicals,DrugBank
DB01110,P-glycoprotein inhibitors,DrugBank
DB01110,Sensory Organs,DrugBank
DB01110,Steroid Synthesis Inhibitors,DrugBank
DB01110,Stomatological Preparations,DrugBank
DB01110,"Vaginal Creams, Foams, and Jellies",DrugBank
DB01111,Agents that produce neuromuscular block (indirect),DrugBank
DB01111,"Amino Acids, Peptides, and Proteins",DrugBank
DB01111,Antimicrobial Cationic Peptides,DrugBank
DB01111,Antimicrobial Peptides,DrugBank
DB01111,Lipids,DrugBank
DB01111,Lipopeptides,DrugBank
DB01111,Membrane Proteins,DrugBank
DB01111,Nephrotoxic agents,DrugBank
DB01111,Peptides,DrugBank
DB01111,"Peptides, Cyclic",DrugBank
DB01111,Polymyxin-class Antibacterial,DrugBank
DB01111,Polymyxins,DrugBank
DB01111,Pore Forming Cytotoxic Proteins,DrugBank
DB01111,Proteins,DrugBank
DB01112,Amides,DrugBank
DB01112,Anti-Bacterial Agents,DrugBank
DB01112,Anti-Infective Agents,DrugBank
DB01112,Antibacterials for Systemic Use,DrugBank
DB01112,Antiinfectives for Systemic Use,DrugBank
DB01112,beta-Lactams,DrugBank
DB01112,Cephalosporins,DrugBank
DB01112,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01112,Lactams,DrugBank
DB01112,Nephrotoxic agents,DrugBank
DB01112,Ophthalmologicals,DrugBank
DB01112,Second-Generation Cephalosporins,DrugBank
DB01112,Sensory Organs,DrugBank
DB01112,Sulfur Compounds,DrugBank
DB01112,Thiazines,DrugBank
DB01113,Alimentary Tract and Metabolism,DrugBank
DB01113,Alkaloids,DrugBank
DB01113,Benzylisoquinolines,DrugBank
DB01113,Cardiovascular Agents,DrugBank
DB01113,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01113,Drugs Used in Erectile Dysfunction,DrugBank
DB01113,Enzyme Inhibitors,DrugBank
DB01113,Genito Urinary System and Sex Hormones,DrugBank
DB01113,Genitourinary Agents,DrugBank
DB01113,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01113,Hypotensive Agents,DrugBank
DB01113,Isoquinolines,DrugBank
DB01113,Miscellaneous Vasodilatating Agents,DrugBank
DB01113,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01113,Opiate Alkaloids,DrugBank
DB01113,Papaverine and Derivatives,DrugBank
DB01113,Phosphodiesterase Inhibitors,DrugBank
DB01113,QTc Prolonging Agents,DrugBank
DB01113,Urological Agents,DrugBank
DB01113,Urologicals,DrugBank
DB01113,Vasodilating Agents,DrugBank
DB01114,Anti-Allergic Agents,DrugBank
DB01114,Antidepressive Agents,DrugBank
DB01114,Antihistamines for Systemic Use,DrugBank
DB01114,Antipruritics,DrugBank
DB01114,Central Nervous System Depressants,DrugBank
DB01114,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01114,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01114,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01114,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01114,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01114,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01114,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01114,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01114,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01114,Cytochrome P-450 Substrates,DrugBank
DB01114,Dermatologicals,DrugBank
DB01114,Histamine Agents,DrugBank
DB01114,Histamine Antagonists,DrugBank
DB01114,Histamine H1 Antagonists,DrugBank
DB01114,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01114,Neurotransmitter Agents,DrugBank
DB01114,OCT1 inhibitors,DrugBank
DB01114,OCT2 Inhibitors,DrugBank
DB01114,Propylamine Derivatives,DrugBank
DB01114,Pyridines,DrugBank
DB01114,QTc Prolonging Agents,DrugBank
DB01114,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01114,Serotonin Agents,DrugBank
DB01114,Serotonin Modulators,DrugBank
DB01114,Substituted Alkylamines,DrugBank
DB01115,Agents causing hyperkalemia,DrugBank
DB01115,Antiarrhythmic agents,DrugBank
DB01115,Antihypertensive Agents,DrugBank
DB01115,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01115,Beta blocking agents and calcium channel blockers,DrugBank
DB01115,Bradycardia-Causing Agents,DrugBank
DB01115,BSEP/ABCB11 Inhibitors,DrugBank
DB01115,BSEP/ABCB11 Substrates,DrugBank
DB01115,Calcium Channel Blockers,DrugBank
DB01115,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB01115,Calcium Channel Blockers and Diuretics,DrugBank
DB01115,Calcium-Regulating Hormones and Agents,DrugBank
DB01115,Cardiovascular Agents,DrugBank
DB01115,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01115,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01115,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01115,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01115,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01115,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01115,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01115,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01115,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01115,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01115,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01115,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01115,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01115,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01115,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01115,Cytochrome P-450 Substrates,DrugBank
DB01115,Dihydropyridine Derivatives,DrugBank
DB01115,Dihydropyridines,DrugBank
DB01115,Drugs that are Mainly Renally Excreted,DrugBank
DB01115,Hypotensive Agents,DrugBank
DB01115,Membrane Transport Modulators,DrugBank
DB01115,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01115,Negative Inotrope,DrugBank
DB01115,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01115,P-glycoprotein inducers,DrugBank
DB01115,P-glycoprotein inhibitors,DrugBank
DB01115,P-glycoprotein substrates,DrugBank
DB01115,Pyridines,DrugBank
DB01115,QTc Prolonging Agents,DrugBank
DB01115,Reproductive Control Agents,DrugBank
DB01115,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB01115,Tocolytic Agents,DrugBank
DB01115,Vasodilating Agents,DrugBank
DB01116,"Adjuvants, Anesthesia",DrugBank
DB01116,"Antiadrenergic Agents, Ganglion-Blocking",DrugBank
DB01116,Anticholinergic Agents,DrugBank
DB01116,Antihypertensive Agents,DrugBank
DB01116,Autonomic Agents,DrugBank
DB01116,Cardiovascular Agents,DrugBank
DB01116,Central Nervous System Agents,DrugBank
DB01116,Cholinergic Agents,DrugBank
DB01116,Cholinesterase substrates,DrugBank
DB01116,Ganglion Blockers,DrugBank
DB01116,Imidazoles,DrugBank
DB01116,Neurotransmitter Agents,DrugBank
DB01116,Nicotinic Antagonists,DrugBank
DB01116,Peripheral Nervous System Agents,DrugBank
DB01116,Sulfonium Derivatives,DrugBank
DB01116,Vasodilating Agents,DrugBank
DB01117,Anti-Infective Agents,DrugBank
DB01117,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB01117,Antimalarials,DrugBank
DB01117,Antiparasitic Agents,DrugBank
DB01117,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01117,Antiprotozoals,DrugBank
DB01117,Biguanides,DrugBank
DB01117,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01117,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01117,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01117,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01117,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01117,Cytochrome P-450 Substrates,DrugBank
DB01117,Enzyme Inhibitors,DrugBank
DB01117,Miscellaneous Antiprotozoals,DrugBank
DB01117,Naphthalenes,DrugBank
DB01117,Naphthoquinones,DrugBank
DB01117,P-glycoprotein inhibitors,DrugBank
DB01117,Quinones,DrugBank
DB01118,Agents causing hyperkalemia,DrugBank
DB01118,Agents Causing Muscle Toxicity,DrugBank
DB01118,"alpha-Galactosidase, antagonists & inhibitors",DrugBank
DB01118,Antiarrhythmic agents,DrugBank
DB01118,"Antiarrhythmics, Class III",DrugBank
DB01118,Benzofurans,DrugBank
DB01118,Bradycardia-Causing Agents,DrugBank
DB01118,BSEP/ABCB11 Inhibitors,DrugBank
DB01118,BSEP/ABCB11 Substrates,DrugBank
DB01118,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB01118,Calcium Channel Blockers,DrugBank
DB01118,Cardiac Therapy,DrugBank
DB01118,Cardiovascular Agents,DrugBank
DB01118,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01118,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB01118,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP2A6 Inhibitors (moderate),DrugBank
DB01118,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01118,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB01118,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01118,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01118,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01118,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01118,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB01118,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01118,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01118,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01118,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01118,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01118,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01118,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01118,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01118,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01118,Cytochrome P-450 Substrates,DrugBank
DB01118,Drugs causing inadvertant photosensitivity,DrugBank
DB01118,Enzyme Inhibitors,DrugBank
DB01118,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01118,Highest Risk QTc-Prolonging Agents,DrugBank
DB01118,Hypotensive Agents,DrugBank
DB01118,Membrane Transport Modulators,DrugBank
DB01118,Narrow Therapeutic Index Drugs,DrugBank
DB01118,OCT2 Inhibitors,DrugBank
DB01118,P-glycoprotein inducers,DrugBank
DB01118,P-glycoprotein inhibitors,DrugBank
DB01118,Photosensitizing Agents,DrugBank
DB01118,Potassium Channel Blockers,DrugBank
DB01118,QTc Prolonging Agents,DrugBank
DB01118,Sodium Channel Blockers,DrugBank
DB01118,Vasodilating Agents,DrugBank
DB01119,Antihypertensive Agents,DrugBank
DB01119,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB01119,BCRP/ABCG2 Substrates,DrugBank
DB01119,Benzothiadiazines,DrugBank
DB01119,Cardiovascular Agents,DrugBank
DB01119,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01119,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01119,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01119,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01119,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01119,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01119,Cytochrome P-450 Substrates,DrugBank
DB01119,Direct Vasodilators,DrugBank
DB01119,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01119,Hyperglycemia-Associated Agents,DrugBank
DB01119,Hypoglycemia-Treating Agents,DrugBank
DB01119,Hypotensive Agents,DrugBank
DB01119,OAT1/SLC22A6 inhibitors,DrugBank
DB01119,OAT3/SLC22A8 Inhibitors,DrugBank
DB01119,OAT3/SLC22A8 Substrates,DrugBank
DB01119,Potassium Channel Opener,DrugBank
DB01119,Sulfonamides,DrugBank
DB01119,Sulfones,DrugBank
DB01119,Sulfur Compounds,DrugBank
DB01119,Thiazide Derivatives,DrugBank
DB01119,Vasodilating Agents,DrugBank
DB01120,Alimentary Tract and Metabolism,DrugBank
DB01120,Amides,DrugBank
DB01120,Benzene Derivatives,DrugBank
DB01120,Benzenesulfonamides,DrugBank
DB01120,Blood Glucose Lowering Agents,DrugBank
DB01120,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01120,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01120,Cytochrome P-450 Substrates,DrugBank
DB01120,Drugs Used in Diabetes,DrugBank
DB01120,Genito Urinary System and Sex Hormones,DrugBank
DB01120,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01120,Hypoglycemia-Associated Agents,DrugBank
DB01120,Insulin Secretagogues,DrugBank
DB01120,Oral Hypoglycemics,DrugBank
DB01120,Sulfonamides,DrugBank
DB01120,Sulfones,DrugBank
DB01120,Sulfonylureas,DrugBank
DB01120,Sulfur Compounds,DrugBank
DB01121,Acetamides,DrugBank
DB01121,Amides,DrugBank
DB01121,Anticonvulsants,DrugBank
DB01121,Benzene Derivatives,DrugBank
DB01121,Central Nervous System Depressants,DrugBank
DB01121,Nervous System,DrugBank
DB01122,Amines,DrugBank
DB01122,Autonomic Agents,DrugBank
DB01122,Benzylammonium Compounds,DrugBank
DB01122,Cholinergic Agents,DrugBank
DB01122,Cholinesterase Inhibitors,DrugBank
DB01122,Enzyme Inhibitors,DrugBank
DB01122,Nervous System,DrugBank
DB01122,Neurotransmitter Agents,DrugBank
DB01122,Onium Compounds,DrugBank
DB01122,Parasympathomimetics,DrugBank
DB01122,Peripheral Nervous System Agents,DrugBank
DB01122,Quaternary Ammonium Compounds,DrugBank
DB01124,Alimentary Tract and Metabolism,DrugBank
DB01124,Amides,DrugBank
DB01124,Benzene Derivatives,DrugBank
DB01124,Benzenesulfonamides,DrugBank
DB01124,Blood Glucose Lowering Agents,DrugBank
DB01124,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01124,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01124,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01124,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01124,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01124,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01124,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01124,Cytochrome P-450 Substrates,DrugBank
DB01124,Diagnostic Agents,DrugBank
DB01124,Drugs that are Mainly Renally Excreted,DrugBank
DB01124,Drugs Used in Diabetes,DrugBank
DB01124,Genito Urinary System and Sex Hormones,DrugBank
DB01124,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01124,Hypoglycemia-Associated Agents,DrugBank
DB01124,Insulin Secretagogues,DrugBank
DB01124,OAT1/SLC22A6 inhibitors,DrugBank
DB01124,OATP2B1/SLCO2B1 substrates,DrugBank
DB01124,Oral Hypoglycemics,DrugBank
DB01124,Sulfonamides,DrugBank
DB01124,Sulfones,DrugBank
DB01124,Sulfonylureas,DrugBank
DB01124,Sulfur Compounds,DrugBank
DB01124,Tests for Diabetes,DrugBank
DB01126,5-alpha Reductase Inhibitors,DrugBank
DB01126,Adrenergic alpha-Antagonists,DrugBank
DB01126,Adrenergic Antagonists,DrugBank
DB01126,Agents that produce hypertension,DrugBank
DB01126,Azasteroids,DrugBank
DB01126,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01126,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01126,Cytochrome P-450 Substrates,DrugBank
DB01126,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB01126,Enzyme Inhibitors,DrugBank
DB01126,Fused-Ring Compounds,DrugBank
DB01126,Genito Urinary System and Sex Hormones,DrugBank
DB01126,Hormone Antagonists,DrugBank
DB01126,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01126,Steroid Synthesis Inhibitors,DrugBank
DB01126,Steroids,DrugBank
DB01126,Urologicals,DrugBank
DB01127,14-alpha Demethylase Inhibitors,DrugBank
DB01127,Anti-Infective Agents,DrugBank
DB01127,Antifungal Agents,DrugBank
DB01127,Antifungal Agents (Vaginal),DrugBank
DB01127,Antifungals for Dermatological Use,DrugBank
DB01127,Antifungals for Topical Use,DrugBank
DB01127,Azole Antifungals,DrugBank
DB01127,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01127,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01127,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01127,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01127,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01127,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01127,Dermatologicals,DrugBank
DB01127,Enzyme Inhibitors,DrugBank
DB01127,Genito Urinary System and Sex Hormones,DrugBank
DB01127,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01127,Hormone Antagonists,DrugBank
DB01127,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01127,Imidazole and Triazole Derivatives,DrugBank
DB01127,Imidazole Derivatives,DrugBank
DB01127,Imidazoles,DrugBank
DB01127,P-glycoprotein inhibitors,DrugBank
DB01127,Steroid Synthesis Inhibitors,DrugBank
DB01128,Amides,DrugBank
DB01128,Amines,DrugBank
DB01128,Androgen Receptor Antagonists,DrugBank
DB01128,Androgen Receptor Inhibitors,DrugBank
DB01128,Aniline Compounds,DrugBank
DB01128,Antiandrogens,DrugBank
DB01128,"Antiandrogens, non-steroidal",DrugBank
DB01128,Antineoplastic Agents,DrugBank
DB01128,Antineoplastic and Immunomodulating Agents,DrugBank
DB01128,Benzene Derivatives,DrugBank
DB01128,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01128,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01128,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01128,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01128,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01128,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01128,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01128,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01128,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01128,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01128,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01128,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01128,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01128,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01128,Cytochrome P-450 Substrates,DrugBank
DB01128,Endocrine Therapy,DrugBank
DB01128,Hormone Antagonists,DrugBank
DB01128,Hormone Antagonists and Related Agents,DrugBank
DB01128,Hormones and Related Agents,DrugBank
DB01128,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01128,Narrow Therapeutic Index Drugs,DrugBank
DB01128,P-glycoprotein inhibitors,DrugBank
DB01128,Sulfones,DrugBank
DB01128,Sulfur Compounds,DrugBank
DB01129,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB01129,Acetates,DrugBank
DB01129,Acid Reducers,DrugBank
DB01129,"Acids, Acyclic",DrugBank
DB01129,Alimentary Tract and Metabolism,DrugBank
DB01129,Anti-Ulcer Agents,DrugBank
DB01129,Antiinflammatory and Antirheumatic Products,DrugBank
DB01129,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01129,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB01129,BCRP/ABCG2 Inhibitors,DrugBank
DB01129,Benzimidazoles,DrugBank
DB01129,Butylpyrazolidines,DrugBank
DB01129,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01129,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01129,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01129,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01129,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01129,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01129,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01129,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01129,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01129,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01129,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01129,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01129,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01129,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01129,Cytochrome P-450 Substrates,DrugBank
DB01129,Drugs for Acid Related Disorders,DrugBank
DB01129,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB01129,Drugs that are Mainly Renally Excreted,DrugBank
DB01129,Enzyme Inhibitors,DrugBank
DB01129,Gastric Acid Lowering Agents,DrugBank
DB01129,Gastrointestinal Agents,DrugBank
DB01129,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01129,Hydroxy Acids,DrugBank
DB01129,Musculo-Skeletal System,DrugBank
DB01129,Proton Pump Inhibitors,DrugBank
DB01129,Proton-pump Inhibitors,DrugBank
DB01129,Pyrazoles,DrugBank
DB01129,Pyrazolones,DrugBank
DB01129,Pyridines,DrugBank
DB01129,Sulfoxides,DrugBank
DB01129,Sulfur Compounds,DrugBank
DB01129,Topical Products for Joint and Muscular Pain,DrugBank
DB01130,Adrenal Cortex Hormones,DrugBank
DB01130,Anti-Inflammatory Agents,DrugBank
DB01130,Corticosteroid Hormone Receptor Agonists,DrugBank
DB01130,Corticosteroids,DrugBank
DB01130,"Corticosteroids, Dermatological Preparations",DrugBank
DB01130,"Corticosteroids, Potent (Group III)",DrugBank
DB01130,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01130,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01130,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01130,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01130,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01130,Cytochrome P-450 Substrates,DrugBank
DB01130,Dermatologicals,DrugBank
DB01130,Fused-Ring Compounds,DrugBank
DB01130,Hormones,DrugBank
DB01130,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01130,Immunosuppressive Agents,DrugBank
DB01130,Pregnadienes,DrugBank
DB01130,Pregnadienetriols,DrugBank
DB01130,Pregnanes,DrugBank
DB01130,Steroids,DrugBank
DB01131,Amidines,DrugBank
DB01131,Anti-Infective Agents,DrugBank
DB01131,Antimalarials,DrugBank
DB01131,Antimetabolites,DrugBank
DB01131,Antiparasitic Agents,DrugBank
DB01131,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01131,Antiprotozoals,DrugBank
DB01131,Biguanides,DrugBank
DB01131,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01131,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01131,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01131,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01131,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01131,Cytochrome P-450 Substrates,DrugBank
DB01131,Folic Acid Antagonists,DrugBank
DB01131,Guanidines,DrugBank
DB01131,Noxae,DrugBank
DB01131,Toxic Actions,DrugBank
DB01132,Alimentary Tract and Metabolism,DrugBank
DB01132,Blood Glucose Lowering Agents,DrugBank
DB01132,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01132,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01132,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01132,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01132,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01132,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01132,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01132,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01132,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01132,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01132,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01132,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01132,Cytochrome P-450 Substrates,DrugBank
DB01132,Drugs Used in Diabetes,DrugBank
DB01132,Hypoglycemia-Associated Agents,DrugBank
DB01132,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01132,OATP1B3 inhibitors,DrugBank
DB01132,Oral Hypoglycemics,DrugBank
DB01132,Peroxisome Proliferator Receptor gamma Agonist,DrugBank
DB01132,Peroxisome Proliferator-activated Receptor Activity,DrugBank
DB01132,Sulfur Compounds,DrugBank
DB01132,Thiazoles,DrugBank
DB01132,Thiazolidinediones,DrugBank
DB01133,Bisphosphonates,DrugBank
DB01133,Bone Density Conservation Agents,DrugBank
DB01133,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB01133,Drugs for Treatment of Bone Diseases,DrugBank
DB01133,Drugs that are Mainly Renally Excreted,DrugBank
DB01133,Musculo-Skeletal System,DrugBank
DB01133,Organophosphonates,DrugBank
DB01133,Organophosphorus Compounds,DrugBank
DB01133,"Phospholipases A, antagonists & inhibitors",DrugBank
DB01134,Adrenal Cortex Hormones,DrugBank
DB01134,Corticosteroids,DrugBank
DB01134,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01134,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01134,Cytochrome P-450 Substrates,DrugBank
DB01134,Fused-Ring Compounds,DrugBank
DB01134,Hormones,DrugBank
DB01134,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01134,Hydroxycorticosteroids,DrugBank
DB01134,Pregnanes,DrugBank
DB01134,Pregnenediones,DrugBank
DB01134,Pregnenes,DrugBank
DB01134,Steroids,DrugBank
DB01135,Anticholinergic Agents,DrugBank
DB01135,Central Nervous System Depressants,DrugBank
DB01135,Cholinesterase substrates,DrugBank
DB01135,Drugs that are Mainly Renally Excreted,DrugBank
DB01135,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01135,Muscarinic Antagonists,DrugBank
DB01135,Muscle Relaxants,DrugBank
DB01135,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01135,Musculo-Skeletal System,DrugBank
DB01135,Neuromuscular Agents,DrugBank
DB01135,Neuromuscular Blocking Agents,DrugBank
DB01135,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01135,Nicotinic Antagonists,DrugBank
DB01135,Peripheral Nervous System Agents,DrugBank
DB01136,Adrenergic Agents,DrugBank
DB01136,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01136,Adrenergic alpha-Antagonists,DrugBank
DB01136,Adrenergic Antagonists,DrugBank
DB01136,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB01136,Adrenergic beta-Antagonists,DrugBank
DB01136,Adrenergic beta2-Antagonists,DrugBank
DB01136,Agents causing hyperkalemia,DrugBank
DB01136,Alcohols,DrugBank
DB01136,Alpha and Beta Blocking Agents,DrugBank
DB01136,Amines,DrugBank
DB01136,Amino Alcohols,DrugBank
DB01136,Antiarrhythmic agents,DrugBank
DB01136,Antihypertensive Agents,DrugBank
DB01136,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01136,Antioxidants,DrugBank
DB01136,Biological Factors,DrugBank
DB01136,Bradycardia-Causing Agents,DrugBank
DB01136,Calcium Channel Blockers,DrugBank
DB01136,Calcium-Regulating Hormones and Agents,DrugBank
DB01136,Carbazoles,DrugBank
DB01136,Cardiovascular Agents,DrugBank
DB01136,"Compounds used in a research, industrial, or household setting",DrugBank
DB01136,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01136,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01136,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01136,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01136,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01136,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01136,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01136,Cytochrome P-450 Substrates,DrugBank
DB01136,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01136,Hypotensive Agents,DrugBank
DB01136,Indoles,DrugBank
DB01136,Membrane Transport Modulators,DrugBank
DB01136,Negative Inotrope,DrugBank
DB01136,Neurotransmitter Agents,DrugBank
DB01136,P-glycoprotein inhibitors,DrugBank
DB01136,Propanolamines,DrugBank
DB01136,Propanols,DrugBank
DB01136,Protective Agents,DrugBank
DB01136,UGT1A1 Substrates,DrugBank
DB01136,UGT2B7 substrates,DrugBank
DB01136,Vasodilating Agents,DrugBank
DB01137,4-Quinolones,DrugBank
DB01137,Alimentary Tract and Metabolism,DrugBank
DB01137,Anti-Bacterial Agents,DrugBank
DB01137,Anti-Infective Agents,DrugBank
DB01137,"Anti-Infective Agents, Urinary",DrugBank
DB01137,Antibacterials for Systemic Use,DrugBank
DB01137,Antiinfectives for Systemic Use,DrugBank
DB01137,Antimycobacterials,DrugBank
DB01137,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01137,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01137,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01137,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01137,Drugs causing inadvertant photosensitivity,DrugBank
DB01137,Drugs for Treatment of Tuberculosis,DrugBank
DB01137,Drugs that are Mainly Renally Excreted,DrugBank
DB01137,Enzyme Inhibitors,DrugBank
DB01137,Fluoroquinolone Antibacterial,DrugBank
DB01137,Fluoroquinolones,DrugBank
DB01137,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01137,MATE 1 Inhibitors,DrugBank
DB01137,MATE 1 Substrates,DrugBank
DB01137,MATE 2 Inhibitors,DrugBank
DB01137,MATE inhibitors,DrugBank
DB01137,MATE substrates,DrugBank
DB01137,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01137,OAT1/SLC22A6 Substrates,DrugBank
DB01137,OCT1 inhibitors,DrugBank
DB01137,OCT2 Inhibitors,DrugBank
DB01137,Ophthalmologicals,DrugBank
DB01137,P-glycoprotein inhibitors,DrugBank
DB01137,P-glycoprotein substrates,DrugBank
DB01137,Photosensitizing Agents,DrugBank
DB01137,QTc Prolonging Agents,DrugBank
DB01137,Quinolines,DrugBank
DB01137,Quinolone Antimicrobial,DrugBank
DB01137,Quinolones,DrugBank
DB01137,Renal Agents,DrugBank
DB01137,Sensory Organs,DrugBank
DB01137,Topoisomerase II Inhibitors,DrugBank
DB01137,Topoisomerase Inhibitors,DrugBank
DB01138,Antigout Preparations,DrugBank
DB01138,Antiplatelet agents,DrugBank
DB01138,BSEP/ABCB11 Substrates,DrugBank
DB01138,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01138,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01138,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01138,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01138,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01138,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB01138,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01138,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01138,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01138,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01138,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01138,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01138,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01138,Cytochrome P-450 Substrates,DrugBank
DB01138,Musculo-Skeletal System,DrugBank
DB01138,Preparations Increasing Uric Acid Excretion,DrugBank
DB01138,Pyrazoles,DrugBank
DB01138,Pyrazolones,DrugBank
DB01138,Uricosuric Agents,DrugBank
DB01139,Amides,DrugBank
DB01139,Anti-Bacterial Agents,DrugBank
DB01139,Anti-Infective Agents,DrugBank
DB01139,Antibacterials for Systemic Use,DrugBank
DB01139,Antiinfectives for Systemic Use,DrugBank
DB01139,beta-Lactams,DrugBank
DB01139,Cephalosporins,DrugBank
DB01139,First-Generation Cephalosporins,DrugBank
DB01139,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01139,Lactams,DrugBank
DB01139,Nephrotoxic agents,DrugBank
DB01139,Sulfur Compounds,DrugBank
DB01139,Thiazines,DrugBank
DB01140,Amides,DrugBank
DB01140,Anti-Bacterial Agents,DrugBank
DB01140,Anti-Infective Agents,DrugBank
DB01140,Antibacterials for Systemic Use,DrugBank
DB01140,Antiinfectives for Systemic Use,DrugBank
DB01140,beta-Lactams,DrugBank
DB01140,Cephalosporins,DrugBank
DB01140,Drugs that are Mainly Renally Excreted,DrugBank
DB01140,First-Generation Cephalosporins,DrugBank
DB01140,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01140,Lactams,DrugBank
DB01140,Nephrotoxic agents,DrugBank
DB01140,OAT1/SLC22A6 inhibitors,DrugBank
DB01140,OAT3/SLC22A8 Inhibitors,DrugBank
DB01140,Sulfur Compounds,DrugBank
DB01140,Thiazines,DrugBank
DB01141,"Amino Acids, Peptides, and Proteins",DrugBank
DB01141,Anti-Infective Agents,DrugBank
DB01141,Antifungal Agents,DrugBank
DB01141,Antiinfectives for Systemic Use,DrugBank
DB01141,Antimycotics for Systemic Use,DrugBank
DB01141,COMT Substrates,DrugBank
DB01141,Echinocandin Antifungal,DrugBank
DB01141,Echinocandins,DrugBank
DB01141,Lipids,DrugBank
DB01141,Lipopeptides,DrugBank
DB01141,Peptides,DrugBank
DB01141,"Peptides, Cyclic",DrugBank
DB01142,Acid Reducers,DrugBank
DB01142,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01142,Adrenergic alpha-Antagonists,DrugBank
DB01142,Adrenergic Antagonists,DrugBank
DB01142,Agents producing tachycardia,DrugBank
DB01142,Agents that produce hypertension,DrugBank
DB01142,Agents that reduce seizure threshold,DrugBank
DB01142,Anticholinergic Agents,DrugBank
DB01142,Antidepressive Agents,DrugBank
DB01142,Antidepressive Agents Indicated for Depression,DrugBank
DB01142,"Antidepressive Agents, Tricyclic",DrugBank
DB01142,Antipruritics and Local Anesthetics,DrugBank
DB01142,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB01142,Central Nervous System Agents,DrugBank
DB01142,Central Nervous System Depressants,DrugBank
DB01142,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01142,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01142,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01142,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01142,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01142,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01142,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01142,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01142,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01142,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01142,Cytochrome P-450 Substrates,DrugBank
DB01142,Dermatologicals,DrugBank
DB01142,Dibenzoxepins,DrugBank
DB01142,Drugs that are Mainly Renally Excreted,DrugBank
DB01142,"Ethers, Cyclic",DrugBank
DB01142,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01142,Histamine Agents,DrugBank
DB01142,Histamine Antagonists,DrugBank
DB01142,Histamine H1 Antagonists,DrugBank
DB01142,Histamine H2 Antagonists,DrugBank
DB01142,Hypnotics and Sedatives,DrugBank
DB01142,Muscarinic Antagonists,DrugBank
DB01142,Nervous System,DrugBank
DB01142,Neurotoxic agents,DrugBank
DB01142,Neurotransmitter Agents,DrugBank
DB01142,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB01142,P-glycoprotein substrates,DrugBank
DB01142,Potential QTc-Prolonging Agents,DrugBank
DB01142,Psychoanaleptics,DrugBank
DB01142,Psychotropic Drugs,DrugBank
DB01142,QTc Prolonging Agents,DrugBank
DB01142,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01142,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01142,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01142,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01142,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01142,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01142,Serotonin Agents,DrugBank
DB01142,Serotonin Modulators,DrugBank
DB01142,Serotonin Receptor Antagonists,DrugBank
DB01142,"Sleep Aids, Pharmaceutical",DrugBank
DB01142,Tertiary amine tricyclic antidepressants,DrugBank
DB01142,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB01143,"Compounds used in a research, industrial, or household setting",DrugBank
DB01143,Cytoprotective Agent,DrugBank
DB01143,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB01143,Free Radical Scavenging Activity,DrugBank
DB01143,Hypotensive Agents,DrugBank
DB01143,Organophosphates,DrugBank
DB01143,Organophosphorus Compounds,DrugBank
DB01143,Organothiophosphates,DrugBank
DB01143,Organothiophosphorus Compounds,DrugBank
DB01143,Protective Agents,DrugBank
DB01143,Radiation-Protective Agents,DrugBank
DB01143,Sulfur Compounds,DrugBank
DB01144,Amides,DrugBank
DB01144,Antiglaucoma Preparations and Miotics,DrugBank
DB01144,Carbonic Anhydrase Inhibitors,DrugBank
DB01144,Diuretics,DrugBank
DB01144,Enzyme Inhibitors,DrugBank
DB01144,Genito Urinary System and Sex Hormones,DrugBank
DB01144,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01144,Hypotensive Agents,DrugBank
DB01144,Ophthalmics,DrugBank
DB01144,Ophthalmologicals,DrugBank
DB01144,Sensory Organs,DrugBank
DB01144,Sulfonamides,DrugBank
DB01144,Sulfones,DrugBank
DB01144,Sulfur Compounds,DrugBank
DB01146,Aminoalkyl Ethers,DrugBank
DB01146,Antihistamines for Systemic Use,DrugBank
DB01146,Histamine Antagonists,DrugBank
DB01146,Histamine H1 Antagonists,DrugBank
DB01147,Amides,DrugBank
DB01147,Anti-Bacterial Agents,DrugBank
DB01147,Anti-Infective Agents,DrugBank
DB01147,Antibacterials for Systemic Use,DrugBank
DB01147,Antiinfectives for Systemic Use,DrugBank
DB01147,Beta-Lactam Antibacterials,DrugBank
DB01147,Beta-Lactamase Resistant Penicillins,DrugBank
DB01147,beta-Lactams,DrugBank
DB01147,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01147,Lactams,DrugBank
DB01147,OAT3/SLC22A8 Inhibitors,DrugBank
DB01147,OAT3/SLC22A8 Substrates,DrugBank
DB01147,Penicillinase-resistant Penicillins,DrugBank
DB01147,Penicillins,DrugBank
DB01147,Sulfur Compounds,DrugBank
DB01148,Agents producing tachycardia,DrugBank
DB01148,Anticholinergic Agents,DrugBank
DB01148,Autonomic Agents,DrugBank
DB01148,Benzopyrans,DrugBank
DB01148,Chromones,DrugBank
DB01148,Drugs for Urinary Frequency and Incontinence,DrugBank
DB01148,Drugs that are Mainly Renally Excreted,DrugBank
DB01148,Flavones,DrugBank
DB01148,Flavonoids,DrugBank
DB01148,Genito Urinary System and Sex Hormones,DrugBank
DB01148,Genitourinary Agents,DrugBank
DB01148,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01148,Muscarinic Antagonists,DrugBank
DB01148,Parasympatholytics,DrugBank
DB01148,Peripheral Nervous System Agents,DrugBank
DB01148,Pyrans,DrugBank
DB01148,Urological Agents,DrugBank
DB01148,Urologicals,DrugBank
DB01149,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01149,Adrenergic alpha-Antagonists,DrugBank
DB01149,Adrenergic Antagonists,DrugBank
DB01149,Agents that produce hypertension,DrugBank
DB01149,Analgesics,DrugBank
DB01149,Antidepressive Agents,DrugBank
DB01149,Antidepressive Agents Indicated for Depression,DrugBank
DB01149,"Antidepressive Agents, Second-Generation",DrugBank
DB01149,"Antidepressive Agents, Triazolopyridine",DrugBank
DB01149,BSEP/ABCB11 Substrates,DrugBank
DB01149,Central Nervous System Agents,DrugBank
DB01149,Central Nervous System Depressants,DrugBank
DB01149,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01149,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01149,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01149,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01149,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01149,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01149,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01149,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01149,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01149,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01149,Cytochrome P-450 Substrates,DrugBank
DB01149,Drugs that are Mainly Renally Excreted,DrugBank
DB01149,Hypoglycemia-Associated Agents,DrugBank
DB01149,Membrane Transport Modulators,DrugBank
DB01149,Nervous System,DrugBank
DB01149,Neurotransmitter Agents,DrugBank
DB01149,Neurotransmitter Uptake Inhibitors,DrugBank
DB01149,OATP1B3 inhibitors,DrugBank
DB01149,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01149,P-glycoprotein inducers,DrugBank
DB01149,P-glycoprotein inhibitors,DrugBank
DB01149,Psychoanaleptics,DrugBank
DB01149,Psychotropic Drugs,DrugBank
DB01149,Selective Serotonin Reuptake Inhibitors,DrugBank
DB01149,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01149,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01149,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01149,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01149,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01149,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01149,Serotonin Agents,DrugBank
DB01149,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB01149,Serotonin antagonist and reuptake inhibitors (SARIs),DrugBank
DB01149,Serotonin Modulators,DrugBank
DB01149,Serotonin Receptor Antagonists,DrugBank
DB01150,Amides,DrugBank
DB01150,Anti-Bacterial Agents,DrugBank
DB01150,Anti-Infective Agents,DrugBank
DB01150,Antibacterials for Systemic Use,DrugBank
DB01150,Antiinfectives for Systemic Use,DrugBank
DB01150,beta Lactam Antibiotics,DrugBank
DB01150,beta-Lactams,DrugBank
DB01150,Cephalosporins,DrugBank
DB01150,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01150,Lactams,DrugBank
DB01150,Nephrotoxic agents,DrugBank
DB01150,Second-Generation Cephalosporins,DrugBank
DB01150,Sulfur Compounds,DrugBank
DB01150,Thiazines,DrugBank
DB01151,Adrenergic Agents,DrugBank
DB01151,Adrenergic Uptake Inhibitors,DrugBank
DB01151,Agents producing tachycardia,DrugBank
DB01151,Agents that produce hypertension,DrugBank
DB01151,Agents that reduce seizure threshold,DrugBank
DB01151,Anticholinergic Agents,DrugBank
DB01151,Antidepressive Agents,DrugBank
DB01151,Antidepressive Agents Indicated for Depression,DrugBank
DB01151,"Antidepressive Agents, Tricyclic",DrugBank
DB01151,Central Nervous System Agents,DrugBank
DB01151,Central Nervous System Depressants,DrugBank
DB01151,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01151,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01151,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01151,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01151,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB01151,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01151,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01151,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01151,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01151,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01151,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB01151,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01151,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01151,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01151,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01151,Cytochrome P-450 Substrates,DrugBank
DB01151,Dibenzazepines,DrugBank
DB01151,Drugs that are Mainly Renally Excreted,DrugBank
DB01151,Enzyme Inhibitors,DrugBank
DB01151,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01151,Histamine Antagonists,DrugBank
DB01151,Histamine H1 Antagonists,DrugBank
DB01151,Membrane Transport Modulators,DrugBank
DB01151,Muscarinic Antagonists,DrugBank
DB01151,Narrow Therapeutic Index Drugs,DrugBank
DB01151,Nervous System,DrugBank
DB01151,Neurotoxic agents,DrugBank
DB01151,Neurotransmitter Agents,DrugBank
DB01151,Neurotransmitter Uptake Inhibitors,DrugBank
DB01151,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB01151,OCT1 inhibitors,DrugBank
DB01151,OCT2 Inhibitors,DrugBank
DB01151,P-glycoprotein inhibitors,DrugBank
DB01151,Potential QTc-Prolonging Agents,DrugBank
DB01151,Psychoanaleptics,DrugBank
DB01151,Psychotropic Drugs,DrugBank
DB01151,QTc Prolonging Agents,DrugBank
DB01151,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01151,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01151,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01151,Serotonin Agents,DrugBank
DB01151,Serotonin Modulators,DrugBank
DB01151,Serotonin Receptor Antagonists,DrugBank
DB01151,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB01152,Anti-Bacterial Agents,DrugBank
DB01152,Anti-Infective Agents,DrugBank
DB01152,Antifungal Agents,DrugBank
DB01152,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01152,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01152,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01152,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01152,Genito Urinary System and Sex Hormones,DrugBank
DB01152,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01152,Lactones,DrugBank
DB01152,Macrolides,DrugBank
DB01152,Polyketides,DrugBank
DB01154,Anesthetics,DrugBank
DB01154,"Anesthetics, General",DrugBank
DB01154,"Anesthetics, Intravenous",DrugBank
DB01154,Anticonvulsants,DrugBank
DB01154,Barbiturates,DrugBank
DB01154,Central Nervous System Agents,DrugBank
DB01154,Central Nervous System Depressants,DrugBank
DB01154,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01154,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01154,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01154,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01154,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01154,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01154,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01154,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01154,Cytochrome P-450 Substrates,DrugBank
DB01154,GABA Agents,DrugBank
DB01154,GABA Modulators,DrugBank
DB01154,Hypnotics and Sedatives,DrugBank
DB01154,Nervous System,DrugBank
DB01154,Neurotransmitter Agents,DrugBank
DB01154,Psycholeptics,DrugBank
DB01154,Pyrimidines,DrugBank
DB01154,Pyrimidinones,DrugBank
DB01154,Thiobarbiturates,DrugBank
DB01155,4-Quinolones,DrugBank
DB01155,Anti-Bacterial Agents,DrugBank
DB01155,Anti-Infective Agents,DrugBank
DB01155,Antibacterials for Systemic Use,DrugBank
DB01155,Antiinfectives for Systemic Use,DrugBank
DB01155,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01155,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01155,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01155,Enzyme Inhibitors,DrugBank
DB01155,Fluoroquinolones,DrugBank
DB01155,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01155,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01155,Naphthyridines,DrugBank
DB01155,QTc Prolonging Agents,DrugBank
DB01155,Quinolines,DrugBank
DB01155,Quinolone Antimicrobial,DrugBank
DB01155,Quinolones,DrugBank
DB01155,Topoisomerase II Inhibitors,DrugBank
DB01155,Topoisomerase Inhibitors,DrugBank
DB01156,Agents that reduce seizure threshold,DrugBank
DB01156,Aminoketone Antidepressants,DrugBank
DB01156,Antidepressive Agents,DrugBank
DB01156,Antidepressive Agents Indicated for Depression,DrugBank
DB01156,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB01156,Central Nervous System Agents,DrugBank
DB01156,Central Nervous System Depressants,DrugBank
DB01156,Centrally Acting Antiobesity Products,DrugBank
DB01156,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01156,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01156,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01156,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01156,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01156,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01156,Cytochrome P-450 Substrates,DrugBank
DB01156,Dopamine Agents,DrugBank
DB01156,Dopamine And Norepinephrine Reuptake Inhibitors,DrugBank
DB01156,Dopamine Uptake Inhibitors,DrugBank
DB01156,Drugs causing inadvertant photosensitivity,DrugBank
DB01156,Drugs that are Mainly Renally Excreted,DrugBank
DB01156,Enzyme Inhibitors,DrugBank
DB01156,Increased Dopamine Activity,DrugBank
DB01156,Increased Norepinephrine Activity,DrugBank
DB01156,Ketones,DrugBank
DB01156,Miscellaneous Antidepressants,DrugBank
DB01156,Nervous System,DrugBank
DB01156,Neurotransmitter Uptake Inhibitors,DrugBank
DB01156,Norepinephrine Uptake Inhibitors,DrugBank
DB01156,OCT2 Inhibitors,DrugBank
DB01156,Photosensitizing Agents,DrugBank
DB01156,Psychoanaleptics,DrugBank
DB01156,Psychotropic Drugs,DrugBank
DB01156,Smoking Cessation Agents,DrugBank
DB01157,"Acids, Acyclic",DrugBank
DB01157,"Acids, Aldehydic",DrugBank
DB01157,Anti-Infective Agents,DrugBank
DB01157,Antimetabolites,DrugBank
DB01157,Antineoplastic Agents,DrugBank
DB01157,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01157,Antiprotozoals,DrugBank
DB01157,Carbohydrates,DrugBank
DB01157,Drugs that are Mainly Renally Excreted,DrugBank
DB01157,Enzyme Inhibitors,DrugBank
DB01157,Folic Acid Antagonists,DrugBank
DB01157,Hepatotoxic Agents,DrugBank
DB01157,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01157,Hydroxy Acids,DrugBank
DB01157,Narrow Therapeutic Index Drugs,DrugBank
DB01157,Noxae,DrugBank
DB01157,Pharmaceutical Preparations,DrugBank
DB01157,Quinazolines,DrugBank
DB01157,Sugar Acids,DrugBank
DB01157,Toxic Actions,DrugBank
DB01157,Uronic Acids,DrugBank
DB01158,Adrenergic Agents,DrugBank
DB01158,Adrenergic Antagonists,DrugBank
DB01158,Amines,DrugBank
DB01158,Antiarrhythmic agents,DrugBank
DB01158,"Antiarrhythmics, Class III",DrugBank
DB01158,Antihypertensive Agents,DrugBank
DB01158,Benzylammonium Compounds,DrugBank
DB01158,Bradycardia-Causing Agents,DrugBank
DB01158,Bretylium Compounds,DrugBank
DB01158,Cardiac Therapy,DrugBank
DB01158,Cardiovascular Agents,DrugBank
DB01158,Hypotensive Agents,DrugBank
DB01158,Neurotransmitter Agents,DrugBank
DB01158,Potential QTc-Prolonging Agents,DrugBank
DB01158,QTc Prolonging Agents,DrugBank
DB01158,Quaternary Ammonium Compounds,DrugBank
DB01159,Agents that produce hypertension,DrugBank
DB01159,Anesthetics,DrugBank
DB01159,"Anesthetics, General",DrugBank
DB01159,"Anesthetics, Inhalation",DrugBank
DB01159,Central Nervous System Agents,DrugBank
DB01159,Central Nervous System Depressants,DrugBank
DB01159,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01159,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01159,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01159,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01159,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01159,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01159,Cytochrome P-450 Substrates,DrugBank
DB01159,"Hydrocarbons, Halogenated",DrugBank
DB01159,Hypotensive Agents,DrugBank
DB01159,Nervous System,DrugBank
DB01159,NMDA Receptor Antagonists,DrugBank
DB01161,"Acids, Carbocyclic",DrugBank
DB01161,Aminobenzoates,DrugBank
DB01161,Anesthetics,DrugBank
DB01161,"Anesthetics, Local",DrugBank
DB01161,Benzene Derivatives,DrugBank
DB01161,Benzoates,DrugBank
DB01161,Central Nervous System Agents,DrugBank
DB01161,Central Nervous System Depressants,DrugBank
DB01161,Cholinesterase substrates,DrugBank
DB01161,Esters of Aminobenzoic Acid,DrugBank
DB01161,Local Anesthesia,DrugBank
DB01161,Local Anesthetics (Ester),DrugBank
DB01161,Nervous System,DrugBank
DB01161,Ophthalmologicals,DrugBank
DB01161,para-Aminobenzoates,DrugBank
DB01161,Peripheral Nervous System Agents,DrugBank
DB01161,Sensory Organs,DrugBank
DB01161,Sensory System Agents,DrugBank
DB01162,Adrenergic Agents,DrugBank
DB01162,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01162,Adrenergic alpha-Antagonists,DrugBank
DB01162,Adrenergic Antagonists,DrugBank
DB01162,Antihypertensive Agents,DrugBank
DB01162,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01162,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB01162,Genito Urinary System and Sex Hormones,DrugBank
DB01162,Genitourinary Agents,DrugBank
DB01162,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01162,Hypotensive Agents,DrugBank
DB01162,Neurotransmitter Agents,DrugBank
DB01162,P-glycoprotein inhibitors,DrugBank
DB01162,Peripheral alpha-1 blockers,DrugBank
DB01162,Quinazolines,DrugBank
DB01162,Urological Agents,DrugBank
DB01162,Urologicals,DrugBank
DB01163,Amides,DrugBank
DB01163,Anti-Bacterial Agents,DrugBank
DB01163,Anti-Infective Agents,DrugBank
DB01163,"Anti-Infective Agents, Urinary",DrugBank
DB01163,Antibacterials for Systemic Use,DrugBank
DB01163,Antiinfectives for Systemic Use,DrugBank
DB01163,Beta-Lactam Antibacterials,DrugBank
DB01163,beta-Lactams,DrugBank
DB01163,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01163,Lactams,DrugBank
DB01163,Penicillins,DrugBank
DB01163,Penicillins With Extended Spectrum,DrugBank
DB01163,Sulfur Compounds,DrugBank
DB01164,Acidifying Agents,DrugBank
DB01164,Alimentary Tract and Metabolism,DrugBank
DB01164,Blood and Blood Forming Organs,DrugBank
DB01164,Blood Substitutes and Perfusion Solutions,DrugBank
DB01164,Calcium Compounds,DrugBank
DB01164,Calcium Salts,DrugBank
DB01164,Chlorides,DrugBank
DB01164,Chlorine Compounds,DrugBank
DB01164,Electrolyte Solutions,DrugBank
DB01164,Genito Urinary System and Sex Hormones,DrugBank
DB01164,Hemodialysis Solution,DrugBank
DB01164,I.V. Solution Additives,DrugBank
DB01164,Mineral Supplements,DrugBank
DB01164,Replacement Preparations,DrugBank
DB01164,Supplements,DrugBank
DB01164,Urologicals,DrugBank
DB01165,4-Quinolones,DrugBank
DB01165,Agents Causing Muscle Toxicity,DrugBank
DB01165,Anti-Bacterial Agents,DrugBank
DB01165,Anti-Infective Agents,DrugBank
DB01165,"Anti-Infective Agents, Urinary",DrugBank
DB01165,Antibacterials for Systemic Use,DrugBank
DB01165,Antiinfectives for Systemic Use,DrugBank
DB01165,BSEP/ABCB11 Substrates,DrugBank
DB01165,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01165,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01165,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01165,Enzyme Inhibitors,DrugBank
DB01165,Fluoroquinolones,DrugBank
DB01165,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01165,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01165,OAT1/SLC22A6 inhibitors,DrugBank
DB01165,Ophthalmologicals,DrugBank
DB01165,Otologicals,DrugBank
DB01165,QTc Prolonging Agents,DrugBank
DB01165,Quinolines,DrugBank
DB01165,Quinolone Antimicrobial,DrugBank
DB01165,Quinolones,DrugBank
DB01165,Sensory Organs,DrugBank
DB01165,Topoisomerase II Inhibitors,DrugBank
DB01165,Topoisomerase Inhibitors,DrugBank
DB01166,Agents producing tachycardia,DrugBank
DB01166,Anti-Asthmatic Agents,DrugBank
DB01166,Antiplatelet agents,DrugBank
DB01166,Autonomic Agents,DrugBank
DB01166,Blood and Blood Forming Organs,DrugBank
DB01166,Bronchodilator Agents,DrugBank
DB01166,Cardiovascular Agents,DrugBank
DB01166,Central Nervous System Agents,DrugBank
DB01166,"Compounds used in a research, industrial, or household setting",DrugBank
DB01166,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01166,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01166,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01166,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01166,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01166,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01166,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01166,Cytochrome P-450 Substrates,DrugBank
DB01166,Drugs that are Mainly Renally Excreted,DrugBank
DB01166,Enzyme Inhibitors,DrugBank
DB01166,Fibrin Modulating Agents,DrugBank
DB01166,Hematologic Agents,DrugBank
DB01166,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01166,Neuroprotective Agents,DrugBank
DB01166,Peripheral Nervous System Agents,DrugBank
DB01166,Phosphodiesterase 3 Inhibitors,DrugBank
DB01166,Phosphodiesterase Inhibitors,DrugBank
DB01166,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB01166,Potential QTc-Prolonging Agents,DrugBank
DB01166,Protective Agents,DrugBank
DB01166,QTc Prolonging Agents,DrugBank
DB01166,Quinolines,DrugBank
DB01166,Respiratory System Agents,DrugBank
DB01166,Tetrazoles,DrugBank
DB01166,Vasodilating Agents,DrugBank
DB01167,14-alpha Demethylase Inhibitors,DrugBank
DB01167,Agents causing hyperkalemia,DrugBank
DB01167,Anti-Infective Agents,DrugBank
DB01167,Antifungal Agents,DrugBank
DB01167,Antiinfectives for Systemic Use,DrugBank
DB01167,Antimycotics for Systemic Use,DrugBank
DB01167,Azole Antifungals,DrugBank
DB01167,BCRP/ABCG2 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB01167,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB01167,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01167,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01167,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01167,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB01167,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01167,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB01167,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01167,Cytochrome P-450 Substrates,DrugBank
DB01167,Drugs causing inadvertant photosensitivity,DrugBank
DB01167,Enzyme Inhibitors,DrugBank
DB01167,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01167,P-glycoprotein inhibitors,DrugBank
DB01167,Photosensitizing Agents,DrugBank
DB01167,Piperazines,DrugBank
DB01167,Potential QTc-Prolonging Agents,DrugBank
DB01167,QTc Prolonging Agents,DrugBank
DB01167,Steroid Synthesis Inhibitors,DrugBank
DB01167,Triazole and tetrazole derivatives,DrugBank
DB01167,Triazole Derivatives,DrugBank
DB01167,Triazoles,DrugBank
DB01168,"Acids, Carbocyclic",DrugBank
DB01168,Agents Causing Muscle Toxicity,DrugBank
DB01168,Alkylating Activity,DrugBank
DB01168,Alkylating Drugs,DrugBank
DB01168,Amides,DrugBank
DB01168,Antidepressive Agents,DrugBank
DB01168,Antineoplastic Agents,DrugBank
DB01168,Antineoplastic and Immunomodulating Agents,DrugBank
DB01168,Benzamides and benzamide derivatives,DrugBank
DB01168,Benzene Derivatives,DrugBank
DB01168,Benzoates,DrugBank
DB01168,Central Nervous System Depressants,DrugBank
DB01168,Immunosuppressive Agents,DrugBank
DB01168,Methylhydrazines,DrugBank
DB01168,Monoamine Oxidase Inhibitors,DrugBank
DB01168,Myelosuppressive Agents,DrugBank
DB01168,Narrow Therapeutic Index Drugs,DrugBank
DB01168,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01168,Serotonin Agents,DrugBank
DB01168,Serotonin Modulators,DrugBank
DB01169,Antineoplastic Agents,DrugBank
DB01169,Antineoplastic and Immunomodulating Agents,DrugBank
DB01169,Arsenicals,DrugBank
DB01169,Cardiotoxic antineoplastic agents,DrugBank
DB01169,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01169,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01169,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01169,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01169,Drugs that are Mainly Renally Excreted,DrugBank
DB01169,Highest Risk QTc-Prolonging Agents,DrugBank
DB01169,Hyperglycemia-Associated Agents,DrugBank
DB01169,Hypotensive Agents,DrugBank
DB01169,Immunosuppressive Agents,DrugBank
DB01169,Myelosuppressive Agents,DrugBank
DB01169,Narrow Therapeutic Index Drugs,DrugBank
DB01169,Oxides,DrugBank
DB01169,Oxygen Compounds,DrugBank
DB01169,P-glycoprotein inhibitors,DrugBank
DB01169,QTc Prolonging Agents,DrugBank
DB01170,Adrenergic Agents,DrugBank
DB01170,Adrenergic Antagonists,DrugBank
DB01170,Amidines,DrugBank
DB01170,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB01170,Antiglaucoma Preparations and Miotics,DrugBank
DB01170,Antihypertensive Agents,DrugBank
DB01170,Autonomic Agents,DrugBank
DB01170,Cardiovascular Agents,DrugBank
DB01170,Catecholamine-depleting Sympatholytic,DrugBank
DB01170,Drugs that are Mainly Renally Excreted,DrugBank
DB01170,Gastrointestinal Acidifying Agents,DrugBank
DB01170,Guanidine Derivatives,DrugBank
DB01170,Guanidine Derivatives and Diuretics,DrugBank
DB01170,Guanidines,DrugBank
DB01170,Neurotransmitter Agents,DrugBank
DB01170,Ophthalmologicals,DrugBank
DB01170,Peripheral Nervous System Agents,DrugBank
DB01170,Sensory Organs,DrugBank
DB01170,Sympatholytics,DrugBank
DB01171,"Acids, Carbocyclic",DrugBank
DB01171,Agents that produce hypertension,DrugBank
DB01171,Agents that reduce seizure threshold,DrugBank
DB01171,Amides,DrugBank
DB01171,Antidepressive Agents,DrugBank
DB01171,Antidepressive Agents Indicated for Depression,DrugBank
DB01171,Benzamides and benzamide derivatives,DrugBank
DB01171,Benzene Derivatives,DrugBank
DB01171,Benzoates,DrugBank
DB01171,Central Nervous System Agents,DrugBank
DB01171,Central Nervous System Depressants,DrugBank
DB01171,Chlorobenzoates,DrugBank
DB01171,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01171,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01171,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01171,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01171,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01171,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01171,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01171,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01171,Cytochrome P-450 Substrates,DrugBank
DB01171,Enzyme Inhibitors,DrugBank
DB01171,Monoamine Oxidase A Inhibitors,DrugBank
DB01171,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01171,Monoamine Oxidase Inhibitors,DrugBank
DB01171,Nervous System,DrugBank
DB01171,Psychoanaleptics,DrugBank
DB01171,Psychotropic Drugs,DrugBank
DB01171,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01171,Serotonin Agents,DrugBank
DB01171,Serotonin Modulators,DrugBank
DB01172,Agents that produce neuromuscular block (indirect),DrugBank
DB01172,Alimentary Tract and Metabolism,DrugBank
DB01172,Aminoglycoside Antibacterials,DrugBank
DB01172,Anti-Bacterial Agents,DrugBank
DB01172,Anti-Infective Agents,DrugBank
DB01172,Antibacterials for Systemic Use,DrugBank
DB01172,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01172,Antiinfectives for Systemic Use,DrugBank
DB01172,Carbohydrates,DrugBank
DB01172,Drugs that are Mainly Renally Excreted,DrugBank
DB01172,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB01172,Enzyme Inhibitors,DrugBank
DB01172,Glycosides,DrugBank
DB01172,Intestinal Antiinfectives,DrugBank
DB01172,Narrow Therapeutic Index Drugs,DrugBank
DB01172,Nephrotoxic agents,DrugBank
DB01172,Ophthalmologicals,DrugBank
DB01172,Protein Synthesis Inhibitors,DrugBank
DB01172,Sensory Organs,DrugBank
DB01173,Agents producing tachycardia,DrugBank
DB01173,Amines,DrugBank
DB01173,Anti-Dyskinesia Agents,DrugBank
DB01173,Anti-Parkinson Drugs,DrugBank
DB01173,Anticholinergic Agents,DrugBank
DB01173,Autonomic Agents,DrugBank
DB01173,Benzene Derivatives,DrugBank
DB01173,Benzhydryl Compounds,DrugBank
DB01173,Central Nervous System Agents,DrugBank
DB01173,Central Nervous System Depressants,DrugBank
DB01173,Centrally-mediated Muscle Relaxation,DrugBank
DB01173,Cholinergic Agents,DrugBank
DB01173,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01173,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB01173,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01173,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01173,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01173,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01173,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01173,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01173,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01173,Cytochrome P-450 Substrates,DrugBank
DB01173,Enzyme Inhibitors,DrugBank
DB01173,"Ethers, Chemically Close to Antihistamines",DrugBank
DB01173,Ethylamines,DrugBank
DB01173,Histamine Antagonists,DrugBank
DB01173,Histamine H1 Antagonists,DrugBank
DB01173,Miscellaneous Skeletal Muscle Relaxants,DrugBank
DB01173,Muscarinic Antagonists,DrugBank
DB01173,Muscle Relaxants,DrugBank
DB01173,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01173,Musculo-Skeletal System,DrugBank
DB01173,Nervous System,DrugBank
DB01173,Neurotransmitter Agents,DrugBank
DB01173,NMDA Receptor Antagonists,DrugBank
DB01173,Parasympatholytics,DrugBank
DB01173,Peripheral Nervous System Agents,DrugBank
DB01173,Potential QTc-Prolonging Agents,DrugBank
DB01173,QTc Prolonging Agents,DrugBank
DB01174,Anticholinergic Agents,DrugBank
DB01174,Anticonvulsants,DrugBank
DB01174,Barbiturates,DrugBank
DB01174,Barbiturates and Derivatives,DrugBank
DB01174,BSEP/ABCB11 inducers,DrugBank
DB01174,Central Nervous System Agents,DrugBank
DB01174,Central Nervous System Depressants,DrugBank
DB01174,Chemically-Induced Disorders,DrugBank
DB01174,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2B6 Inducers (strong),DrugBank
DB01174,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01174,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB01174,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01174,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01174,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01174,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01174,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 CYP2E1 Inducers (weak),DrugBank
DB01174,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01174,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01174,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01174,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01174,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01174,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP3A5 Inducers (strong),DrugBank
DB01174,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB01174,Cytochrome P-450 CYP3A7 Inducers (strength unknown),DrugBank
DB01174,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01174,Cytochrome P-450 Substrates,DrugBank
DB01174,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB01174,Excitatory Amino Acid Agents,DrugBank
DB01174,Excitatory Amino Acid Antagonists,DrugBank
DB01174,GABA Agents,DrugBank
DB01174,GABA Modulators,DrugBank
DB01174,Hypnotics and Sedatives,DrugBank
DB01174,Methemoglobinemia Associated Agents,DrugBank
DB01174,Narrow Therapeutic Index Drugs,DrugBank
DB01174,Nervous System,DrugBank
DB01174,Neurotransmitter Agents,DrugBank
DB01174,Nicotinic Antagonists,DrugBank
DB01174,P-glycoprotein inducers,DrugBank
DB01174,P-glycoprotein substrates,DrugBank
DB01174,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01174,Phenobarbital and similars,DrugBank
DB01174,Psycholeptics,DrugBank
DB01174,Pyrimidines,DrugBank
DB01174,Pyrimidinones,DrugBank
DB01174,UGT1A1 Inducers,DrugBank
DB01174,UGT2B7 inducers,DrugBank
DB01175,Amines,DrugBank
DB01175,Anticholinergic Agents,DrugBank
DB01175,Antidepressive Agents,DrugBank
DB01175,Antidepressive Agents Indicated for Depression,DrugBank
DB01175,"Antidepressive Agents, Second-Generation",DrugBank
DB01175,Benzofurans,DrugBank
DB01175,Central Nervous System Agents,DrugBank
DB01175,Central Nervous System Depressants,DrugBank
DB01175,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01175,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01175,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01175,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01175,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01175,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01175,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01175,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01175,Cytochrome P-450 Substrates,DrugBank
DB01175,Drugs causing inadvertant photosensitivity,DrugBank
DB01175,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01175,Highest Risk QTc-Prolonging Agents,DrugBank
DB01175,Hypoglycemia-Associated Agents,DrugBank
DB01175,Membrane Transport Modulators,DrugBank
DB01175,Monoamine Oxidase A Substrates,DrugBank
DB01175,Muscarinic Antagonists,DrugBank
DB01175,Nervous System,DrugBank
DB01175,Neurotransmitter Agents,DrugBank
DB01175,Neurotransmitter Uptake Inhibitors,DrugBank
DB01175,Nitriles,DrugBank
DB01175,P-glycoprotein substrates,DrugBank
DB01175,Photosensitizing Agents,DrugBank
DB01175,Propylamines,DrugBank
DB01175,Psychoanaleptics,DrugBank
DB01175,Psychotropic Drugs,DrugBank
DB01175,QTc Prolonging Agents,DrugBank
DB01175,Selective Serotonin Reuptake Inhibitors,DrugBank
DB01175,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01175,Serotonin Agents,DrugBank
DB01175,Serotonin Modulators,DrugBank
DB01176,Antiemetics,DrugBank
DB01176,Antihistamines for Systemic Use,DrugBank
DB01176,Autonomic Agents,DrugBank
DB01176,Central Nervous System Agents,DrugBank
DB01176,Central Nervous System Depressants,DrugBank
DB01176,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01176,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01176,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01176,Gastrointestinal Agents,DrugBank
DB01176,Histamine Agents,DrugBank
DB01176,Histamine Antagonists,DrugBank
DB01176,Histamine H1 Antagonists,DrugBank
DB01176,Neurotransmitter Agents,DrugBank
DB01176,Peripheral Nervous System Agents,DrugBank
DB01176,Piperazine Derivatives,DrugBank
DB01176,Piperazines,DrugBank
DB01176,Potential QTc-Prolonging Agents,DrugBank
DB01176,QTc Prolonging Agents,DrugBank
DB01177,Anthracycline Topoisomerase Inhibitor,DrugBank
DB01177,Anthracyclines,DrugBank
DB01177,Anthracyclines and Related Substances,DrugBank
DB01177,"Antibiotics, Antineoplastic",DrugBank
DB01177,Antineoplastic Agents,DrugBank
DB01177,Antineoplastic and Immunomodulating Agents,DrugBank
DB01177,Carbohydrates,DrugBank
DB01177,Cardiotoxic antineoplastic agents,DrugBank
DB01177,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01177,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01177,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01177,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01177,Cytochrome P-450 Substrates,DrugBank
DB01177,Cytotoxic Antibiotics and Related Substances,DrugBank
DB01177,Cytotoxins,DrugBank
DB01177,Enzyme Inhibitors,DrugBank
DB01177,Glycosides,DrugBank
DB01177,Immunosuppressive Agents,DrugBank
DB01177,Myelosuppressive Agents,DrugBank
DB01177,Naphthacenes,DrugBank
DB01177,Narrow Therapeutic Index Drugs,DrugBank
DB01177,Topoisomerase II Inhibitors,DrugBank
DB01177,Topoisomerase Inhibitors,DrugBank
DB01178,Anti-Anxiety Agents,DrugBank
DB01178,Central Nervous System Agents,DrugBank
DB01178,Central Nervous System Depressants,DrugBank
DB01178,Muscle Relaxants,DrugBank
DB01178,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01178,Musculo-Skeletal System,DrugBank
DB01178,Neuromuscular Agents,DrugBank
DB01178,"Oxazol, Thiazine, and Triazine Derivatives",DrugBank
DB01178,Peripheral Nervous System Agents,DrugBank
DB01178,Psychotropic Drugs,DrugBank
DB01178,Sulfur Compounds,DrugBank
DB01178,Thiazines,DrugBank
DB01178,Tranquilizing Agents,DrugBank
DB01180,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01180,Agents causing angioedema,DrugBank
DB01180,Agents causing hyperkalemia,DrugBank
DB01180,Agents that produce hypertension,DrugBank
DB01180,Alkaloids,DrugBank
DB01180,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB01180,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB01180,Antihypertensive Agents,DrugBank
DB01180,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01180,Indole Alkaloids,DrugBank
DB01180,Indoles,DrugBank
DB01180,Indolizidines,DrugBank
DB01180,Indolizines,DrugBank
DB01180,Secologanin Tryptamine Alkaloids,DrugBank
DB01181,Alkylating Activity,DrugBank
DB01181,Alkylating Drugs,DrugBank
DB01181,Antineoplastic Agents,DrugBank
DB01181,"Antineoplastic Agents, Alkylating",DrugBank
DB01181,Antineoplastic and Immunomodulating Agents,DrugBank
DB01181,Cardiotoxic antineoplastic agents,DrugBank
DB01181,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01181,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01181,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01181,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01181,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01181,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01181,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01181,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01181,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01181,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01181,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01181,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01181,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01181,Cytochrome P-450 Substrates,DrugBank
DB01181,Drugs that are Mainly Renally Excreted,DrugBank
DB01181,"Hydrocarbons, Halogenated",DrugBank
DB01181,Immunosuppressive Agents,DrugBank
DB01181,Methemoglobinemia Associated Agents,DrugBank
DB01181,Mustard Compounds,DrugBank
DB01181,Myelosuppressive Agents,DrugBank
DB01181,Narrow Therapeutic Index Drugs,DrugBank
DB01181,Nitrogen Mustard Analogues,DrugBank
DB01181,Nitrogen Mustard Compounds,DrugBank
DB01181,Noxae,DrugBank
DB01181,Organophosphorus Compounds,DrugBank
DB01181,Oxazines,DrugBank
DB01181,Phosphoramide Mustards,DrugBank
DB01181,Phosphoramides,DrugBank
DB01181,Toxic Actions,DrugBank
DB01182,Adrenergic Antagonists,DrugBank
DB01182,Adrenergic beta-Antagonists,DrugBank
DB01182,Agents causing hyperkalemia,DrugBank
DB01182,Agents that produce hypertension,DrugBank
DB01182,Antiarrhythmic agents,DrugBank
DB01182,"Antiarrhythmics, Class I",DrugBank
DB01182,"Antiarrhythmics, Class Ic",DrugBank
DB01182,Bradycardia-Causing Agents,DrugBank
DB01182,Cardiac Therapy,DrugBank
DB01182,Cardiovascular Agents,DrugBank
DB01182,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01182,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01182,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01182,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01182,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01182,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01182,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01182,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01182,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01182,Cytochrome P-450 Substrates,DrugBank
DB01182,Ketones,DrugBank
DB01182,Membrane Transport Modulators,DrugBank
DB01182,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01182,P-glycoprotein inhibitors,DrugBank
DB01182,Propiophenones,DrugBank
DB01182,QTc Prolonging Agents,DrugBank
DB01182,Sodium Channel Blockers,DrugBank
DB01182,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01183,Alimentary Tract and Metabolism,DrugBank
DB01183,Alkaloids,DrugBank
DB01183,Analgesics,DrugBank
DB01183,Antidotes,DrugBank
DB01183,Benzomorphan Derivatives,DrugBank
DB01183,Central Nervous System Agents,DrugBank
DB01183,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01183,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01183,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01183,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01183,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01183,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01183,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01183,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01183,Cytochrome P-450 Substrates,DrugBank
DB01183,Drugs for Constipation,DrugBank
DB01183,Drugs that are Mainly Renally Excreted,DrugBank
DB01183,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01183,Morphinans,DrugBank
DB01183,Natural Opium Alkaloids,DrugBank
DB01183,Nervous System,DrugBank
DB01183,Opiate Alkaloids,DrugBank
DB01183,Opiate Antagonists,DrugBank
DB01183,Opioid Antagonists,DrugBank
DB01183,P-glycoprotein substrates,DrugBank
DB01183,Peripheral Nervous System Agents,DrugBank
DB01183,Peripheral Opioid Receptor Antagonists,DrugBank
DB01183,Phenanthrenes,DrugBank
DB01183,Sensory System Agents,DrugBank
DB01183,UGT1A1 Substrates,DrugBank
DB01184,Alimentary Tract and Metabolism,DrugBank
DB01184,Antiemetics,DrugBank
DB01184,Autonomic Agents,DrugBank
DB01184,Benzimidazoles,DrugBank
DB01184,Central Nervous System Agents,DrugBank
DB01184,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01184,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01184,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01184,Cytochrome P-450 Substrates,DrugBank
DB01184,Dopamine Agents,DrugBank
DB01184,Dopamine Antagonists,DrugBank
DB01184,Dopamine D2 Receptor Antagonists,DrugBank
DB01184,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01184,Gastrointestinal Agents,DrugBank
DB01184,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01184,Highest Risk QTc-Prolonging Agents,DrugBank
DB01184,Neurotransmitter Agents,DrugBank
DB01184,P-glycoprotein substrates,DrugBank
DB01184,Peripheral Nervous System Agents,DrugBank
DB01184,Piperidines,DrugBank
DB01184,Prokinetic Agents,DrugBank
DB01184,Propulsives,DrugBank
DB01184,QTc Prolonging Agents,DrugBank
DB01185,3-Oxoandrosten (4) Derivatives,DrugBank
DB01185,Anabolic Agents,DrugBank
DB01185,Androgens,DrugBank
DB01185,Androstanes,DrugBank
DB01185,Androstenediols,DrugBank
DB01185,Androstenes,DrugBank
DB01185,Androstenols,DrugBank
DB01185,Fused-Ring Compounds,DrugBank
DB01185,Genito Urinary System and Sex Hormones,DrugBank
DB01185,Hormones,DrugBank
DB01185,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01185,Sex Hormones and Modulators of the Genital System,DrugBank
DB01185,Steroids,DrugBank
DB01185,"Steroids, Fluorinated",DrugBank
DB01186,Adrenergic Agonists,DrugBank
DB01186,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01186,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB01186,Adrenergic alpha-Agonists,DrugBank
DB01186,Agents producing tachycardia,DrugBank
DB01186,Agents that produce hypertension,DrugBank
DB01186,Alkaloids,DrugBank
DB01186,Anti-Parkinson Drugs,DrugBank
DB01186,Antidepressive Agents,DrugBank
DB01186,Central Nervous System Depressants,DrugBank
DB01186,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01186,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01186,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01186,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01186,Dopamine Agents,DrugBank
DB01186,Dopamine Agonists,DrugBank
DB01186,Ergolines,DrugBank
DB01186,Ergot Alkaloids and Derivatives,DrugBank
DB01186,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB01186,Ergot-derived Dopamine Receptor Agonist,DrugBank
DB01186,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01186,Nervous System,DrugBank
DB01186,Neurotransmitter Agents,DrugBank
DB01186,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01186,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB01186,Serotonin Agents,DrugBank
DB01186,Serotonin Receptor Agonists,DrugBank
DB01188,Anti-Infective Agents,DrugBank
DB01188,Antifungal Agents,DrugBank
DB01188,Antifungals for Dermatological Use,DrugBank
DB01188,Antifungals for Topical Use,DrugBank
DB01188,Cyclohexanes,DrugBank
DB01188,Cycloparaffins,DrugBank
DB01188,Decreased DNA Replication,DrugBank
DB01188,Decreased Protein Synthesis,DrugBank
DB01188,Decreased RNA Replication,DrugBank
DB01188,Dermatologicals,DrugBank
DB01188,Genito Urinary System and Sex Hormones,DrugBank
DB01188,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01188,Hydroxypyridones,DrugBank
DB01188,Protein Synthesis Inhibitors,DrugBank
DB01188,Pyridines,DrugBank
DB01188,Pyridones,DrugBank
DB01188,"Vaginal Creams, Foams, and Jellies",DrugBank
DB01189,Agents that produce hypertension,DrugBank
DB01189,Anesthetics,DrugBank
DB01189,"Anesthetics, General",DrugBank
DB01189,"Anesthetics, Inhalation",DrugBank
DB01189,Central Nervous System Agents,DrugBank
DB01189,Central Nervous System Depressants,DrugBank
DB01189,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01189,Cytochrome P-450 Substrates,DrugBank
DB01189,Ethers,DrugBank
DB01189,Ethyl Ethers,DrugBank
DB01189,"Hydrocarbons, Fluorinated",DrugBank
DB01189,"Hydrocarbons, Halogenated",DrugBank
DB01189,Hypotensive Agents,DrugBank
DB01189,Methyl Ethers,DrugBank
DB01189,Nervous System,DrugBank
DB01189,Potential QTc-Prolonging Agents,DrugBank
DB01189,QTc Prolonging Agents,DrugBank
DB01190,Agents that produce neuromuscular block (indirect),DrugBank
DB01190,Anti-Acne Preparations,DrugBank
DB01190,Anti-Acne Preparations for Topical Use,DrugBank
DB01190,Anti-Bacterial Agents,DrugBank
DB01190,Anti-Infective Agents,DrugBank
DB01190,Antibacterials for Systemic Use,DrugBank
DB01190,Antibiotics for Pneumocystis Pneumonia,DrugBank
DB01190,Antiinfectives for Systemic Use,DrugBank
DB01190,Antiinfectives for Treatment of Acne,DrugBank
DB01190,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01190,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01190,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01190,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01190,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01190,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01190,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01190,Cytochrome P-450 Substrates,DrugBank
DB01190,Decreased Sebaceous Gland Activity,DrugBank
DB01190,Dermatologicals,DrugBank
DB01190,Enzyme Inhibitors,DrugBank
DB01190,Genito Urinary System and Sex Hormones,DrugBank
DB01190,Glycosides,DrugBank
DB01190,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01190,Lincomycins,DrugBank
DB01190,Lincosamide Antibacterial,DrugBank
DB01190,Lincosamides,DrugBank
DB01190,Macrolides,DrugBank
DB01190,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB01190,Neuromuscular Blockade,DrugBank
DB01190,Neurotoxic agents,DrugBank
DB01190,P-glycoprotein substrates,DrugBank
DB01190,Protein Synthesis Inhibitors,DrugBank
DB01190,Pyrrolidines,DrugBank
DB01191,Alimentary Tract and Metabolism,DrugBank
DB01191,Amines,DrugBank
DB01191,Antidepressive Agents,DrugBank
DB01191,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB01191,Central Nervous System Depressants,DrugBank
DB01191,Centrally Acting Antiobesity Products,DrugBank
DB01191,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01191,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01191,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01191,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01191,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01191,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01191,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB01191,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01191,Cytochrome P-450 Substrates,DrugBank
DB01191,Ethylamines,DrugBank
DB01191,Neurotransmitter Agents,DrugBank
DB01191,Phenethylamines,DrugBank
DB01191,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01191,Serotonin Agents,DrugBank
DB01192,Adjuvants,DrugBank
DB01192,"Adjuvants, Anesthesia",DrugBank
DB01192,Alkaloids,DrugBank
DB01192,Analgesics,DrugBank
DB01192,Central Nervous System Agents,DrugBank
DB01192,Central Nervous System Depressants,DrugBank
DB01192,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01192,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01192,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01192,Cytochrome P-450 Substrates,DrugBank
DB01192,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01192,High-risk opioids,DrugBank
DB01192,Morphinans,DrugBank
DB01192,Morphine Derivatives,DrugBank
DB01192,Narcotics,DrugBank
DB01192,Natural Opium Alkaloids,DrugBank
DB01192,Nervous System,DrugBank
DB01192,Opiate Agonists,DrugBank
DB01192,Opiate Alkaloids,DrugBank
DB01192,Opioid Agonist,DrugBank
DB01192,Opioids,DrugBank
DB01192,Peripheral Nervous System Agents,DrugBank
DB01192,Phenanthrenes,DrugBank
DB01192,Sensory System Agents,DrugBank
DB01192,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01193,Adrenergic Agents,DrugBank
DB01193,Adrenergic Antagonists,DrugBank
DB01193,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB01193,Adrenergic beta-Antagonists,DrugBank
DB01193,Agents causing hyperkalemia,DrugBank
DB01193,Alcohols,DrugBank
DB01193,Amines,DrugBank
DB01193,Amino Alcohols,DrugBank
DB01193,Antiarrhythmic agents,DrugBank
DB01193,Antihypertensive Agents,DrugBank
DB01193,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01193,Autonomic Agents,DrugBank
DB01193,Beta Blocking Agents and Thiazides,DrugBank
DB01193,"Beta Blocking Agents, Selective",DrugBank
DB01193,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB01193,Beta-Blockers (Beta1 Selective),DrugBank
DB01193,Bradycardia-Causing Agents,DrugBank
DB01193,Cardiovascular Agents,DrugBank
DB01193,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01193,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01193,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01193,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01193,Cytochrome P-450 Substrates,DrugBank
DB01193,Hypotensive Agents,DrugBank
DB01193,Neurotransmitter Agents,DrugBank
DB01193,P-glycoprotein substrates,DrugBank
DB01193,Peripheral Nervous System Agents,DrugBank
DB01193,Phenoxypropanolamines,DrugBank
DB01193,Propanolamines,DrugBank
DB01193,Propanols,DrugBank
DB01193,QTc Prolonging Agents,DrugBank
DB01193,Sympathomimetics,DrugBank
DB01194,Amides,DrugBank
DB01194,Antiglaucoma Preparations and Miotics,DrugBank
DB01194,Carbonic Anhydrase Inhibitors,DrugBank
DB01194,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01194,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01194,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01194,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01194,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01194,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01194,Cytochrome P-450 Substrates,DrugBank
DB01194,Diuretics,DrugBank
DB01194,Enzyme Inhibitors,DrugBank
DB01194,Genito Urinary System and Sex Hormones,DrugBank
DB01194,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01194,Ophthalmics,DrugBank
DB01194,Ophthalmologicals,DrugBank
DB01194,Sensory Organs,DrugBank
DB01194,Sulfonamides,DrugBank
DB01194,Sulfones,DrugBank
DB01194,Sulfur Compounds,DrugBank
DB01195,Antiarrhythmic agents,DrugBank
DB01195,"Antiarrhythmics, Class I",DrugBank
DB01195,"Antiarrhythmics, Class Ic",DrugBank
DB01195,Cardiac Therapy,DrugBank
DB01195,Cardiovascular Agents,DrugBank
DB01195,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01195,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01195,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01195,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01195,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01195,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01195,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01195,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01195,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01195,Cytochrome P-450 Substrates,DrugBank
DB01195,MATE 1 Inhibitors,DrugBank
DB01195,MATE 1 Substrates,DrugBank
DB01195,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01195,MATE inhibitors,DrugBank
DB01195,MATE substrates,DrugBank
DB01195,Membrane Transport Modulators,DrugBank
DB01195,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01195,Narrow Therapeutic Index Drugs,DrugBank
DB01195,Negative Inotrope,DrugBank
DB01195,P-glycoprotein substrates,DrugBank
DB01195,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01195,Piperidines,DrugBank
DB01195,QTc Prolonging Agents,DrugBank
DB01195,Sodium Channel Blockers,DrugBank
DB01195,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01196,Alkylating Activity,DrugBank
DB01196,Alkylating Drugs,DrugBank
DB01196,Antineoplastic Agents,DrugBank
DB01196,"Antineoplastic Agents, Alkylating",DrugBank
DB01196,"Antineoplastic Agents, Hormonal",DrugBank
DB01196,Antineoplastic and Immunomodulating Agents,DrugBank
DB01196,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01196,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01196,Cytochrome P-450 Substrates,DrugBank
DB01196,Estradiol Congeners,DrugBank
DB01196,Estranes,DrugBank
DB01196,Estrenes,DrugBank
DB01196,Fused-Ring Compounds,DrugBank
DB01196,"Hydrocarbons, Halogenated",DrugBank
DB01196,Immunosuppressive Agents,DrugBank
DB01196,Mustard Compounds,DrugBank
DB01196,Nitrogen Mustard Compounds,DrugBank
DB01196,Noxae,DrugBank
DB01196,P-glycoprotein inhibitors,DrugBank
DB01196,Steroids,DrugBank
DB01196,Toxic Actions,DrugBank
DB01197,ACE Inhibitors and Diuretics,DrugBank
DB01197,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01197,Agents causing angioedema,DrugBank
DB01197,Agents causing hyperkalemia,DrugBank
DB01197,Agents Causing Muscle Toxicity,DrugBank
DB01197,Amino Acids,DrugBank
DB01197,"Amino Acids, Cyclic",DrugBank
DB01197,"Amino Acids, Peptides, and Proteins",DrugBank
DB01197,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB01197,Antihypertensive Agents,DrugBank
DB01197,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01197,Cardiovascular Agents,DrugBank
DB01197,Drugs causing inadvertant photosensitivity,DrugBank
DB01197,Enzyme Inhibitors,DrugBank
DB01197,Hypotensive Agents,DrugBank
DB01197,Imino Acids,DrugBank
DB01197,OAT1/SLC22A6 inhibitors,DrugBank
DB01197,OAT1/SLC22A6 Substrates,DrugBank
DB01197,OAT3/SLC22A8 Substrates,DrugBank
DB01197,P-glycoprotein inhibitors,DrugBank
DB01197,Photosensitizing Agents,DrugBank
DB01197,Protease Inhibitors,DrugBank
DB01198,Aza Compounds,DrugBank
DB01198,Benzodiazepine hypnotics and sedatives,DrugBank
DB01198,Central Nervous System Agents,DrugBank
DB01198,Central Nervous System Depressants,DrugBank
DB01198,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01198,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01198,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01198,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01198,Cytochrome P-450 Substrates,DrugBank
DB01198,Drugs causing inadvertant photosensitivity,DrugBank
DB01198,Hypnotics (Nonbenzodiazepine),DrugBank
DB01198,Hypnotics and Sedatives,DrugBank
DB01198,Methemoglobinemia Associated Agents,DrugBank
DB01198,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB01198,Nervous System,DrugBank
DB01198,Photosensitizing Agents,DrugBank
DB01198,Psycholeptics,DrugBank
DB01198,Sleep Initiation and Maintenance Disorders,DrugBank
DB01198,Zopiclone and prodrugs,DrugBank
DB01199,Alkaloids,DrugBank
DB01199,Amines,DrugBank
DB01199,Anticholinergic Agents,DrugBank
DB01199,Benzylisoquinolines,DrugBank
DB01199,Central Nervous System Depressants,DrugBank
DB01199,Cholinergic Agents,DrugBank
DB01199,Cholinesterase Inhibitors,DrugBank
DB01199,Cholinesterase substrates,DrugBank
DB01199,Curare Alkaloids,DrugBank
DB01199,Ganglion Blockers,DrugBank
DB01199,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01199,Isoquinolines,DrugBank
DB01199,Muscle Relaxants,DrugBank
DB01199,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01199,Musculo-Skeletal System,DrugBank
DB01199,Neuromuscular Agents,DrugBank
DB01199,Neuromuscular Blocking Agents,DrugBank
DB01199,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01199,Neurotoxic agents,DrugBank
DB01199,Neurotransmitter Agents,DrugBank
DB01199,Nicotinic Antagonists,DrugBank
DB01199,OCT1 substrates,DrugBank
DB01199,Onium Compounds,DrugBank
DB01199,Peripheral Nervous System Agents,DrugBank
DB01199,Quaternary Ammonium Compounds,DrugBank
DB01199,Tetrahydroisoquinolines,DrugBank
DB01200,Adrenergic Agonists,DrugBank
DB01200,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01200,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01200,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB01200,Adrenergic alpha-Agonists,DrugBank
DB01200,Adrenergic alpha-Antagonists,DrugBank
DB01200,Adrenergic Antagonists,DrugBank
DB01200,Agents producing tachycardia,DrugBank
DB01200,Agents that produce hypertension,DrugBank
DB01200,Alkaloids,DrugBank
DB01200,Anti-Dyskinesia Agents,DrugBank
DB01200,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB01200,Anti-Parkinson Drugs,DrugBank
DB01200,Antidepressive Agents,DrugBank
DB01200,Blood Glucose Lowering Agents,DrugBank
DB01200,Central Nervous System Agents,DrugBank
DB01200,Central Nervous System Depressants,DrugBank
DB01200,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01200,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01200,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01200,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01200,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01200,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01200,Cytochrome P-450 Substrates,DrugBank
DB01200,Dopamine Agents,DrugBank
DB01200,Dopamine Agonists,DrugBank
DB01200,Ergolines,DrugBank
DB01200,Ergot Alkaloids and Derivatives,DrugBank
DB01200,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB01200,Ergotamines,DrugBank
DB01200,Genito Urinary System and Sex Hormones,DrugBank
DB01200,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01200,Hormone Antagonists,DrugBank
DB01200,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01200,Hypotensive Agents,DrugBank
DB01200,Nervous System,DrugBank
DB01200,Neurotransmitter Agents,DrugBank
DB01200,P-glycoprotein inhibitors,DrugBank
DB01200,P-glycoprotein substrates,DrugBank
DB01200,Prolactine Inhibitors,DrugBank
DB01200,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB01200,Serotonin Agents,DrugBank
DB01200,Serotonin Modulators,DrugBank
DB01200,Serotonin Receptor Agonists,DrugBank
DB01201,Anti-Bacterial Agents,DrugBank
DB01201,Anti-Infective Agents,DrugBank
DB01201,"Antibiotics, Antitubercular",DrugBank
DB01201,Antiinfectives for Systemic Use,DrugBank
DB01201,Antimycobacterials,DrugBank
DB01201,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01201,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01201,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01201,Cytochrome P-450 CYP2C19 Inducers (strong),DrugBank
DB01201,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01201,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01201,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01201,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01201,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01201,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01201,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01201,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01201,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01201,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01201,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01201,Cytochrome P-450 Substrates,DrugBank
DB01201,Drugs for Treatment of Tuberculosis,DrugBank
DB01201,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01201,"Lactams, Macrocyclic",DrugBank
DB01201,Leprostatic Agents,DrugBank
DB01201,Rifamycin Antimycobacterial,DrugBank
DB01201,Rifamycins,DrugBank
DB01202,Acetamides,DrugBank
DB01202,Amides,DrugBank
DB01202,Anticonvulsants,DrugBank
DB01202,Central Nervous System Agents,DrugBank
DB01202,Central Nervous System Depressants,DrugBank
DB01202,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB01202,Miscellaneous Anticonvulsants,DrugBank
DB01202,Nervous System,DrugBank
DB01202,P-glycoprotein substrates,DrugBank
DB01202,Pyrrolidines,DrugBank
DB01202,Pyrrolidinones,DrugBank
DB01203,Adrenergic Agents,DrugBank
DB01203,Adrenergic Antagonists,DrugBank
DB01203,Adrenergic beta-Antagonists,DrugBank
DB01203,Agents causing hyperkalemia,DrugBank
DB01203,Alcohols,DrugBank
DB01203,Amines,DrugBank
DB01203,Amino Alcohols,DrugBank
DB01203,Antiarrhythmic agents,DrugBank
DB01203,Antihypertensive Agents,DrugBank
DB01203,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01203,Autonomic Agents,DrugBank
DB01203,Beta Blocking Agents and Thiazides,DrugBank
DB01203,"Beta Blocking Agents, Non-Selective",DrugBank
DB01203,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB01203,Bradycardia-Causing Agents,DrugBank
DB01203,Cardiovascular Agents,DrugBank
DB01203,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01203,Cytochrome P-450 Substrates,DrugBank
DB01203,Drugs causing inadvertant photosensitivity,DrugBank
DB01203,Drugs that are Mainly Renally Excreted,DrugBank
DB01203,Hypotensive Agents,DrugBank
DB01203,MATE 1 Substrates,DrugBank
DB01203,MATE 2 Substrates,DrugBank
DB01203,MATE substrates,DrugBank
DB01203,Negative Inotrope,DrugBank
DB01203,Neurotransmitter Agents,DrugBank
DB01203,P-glycoprotein substrates,DrugBank
DB01203,Peripheral Nervous System Agents,DrugBank
DB01203,Phenoxypropanolamines,DrugBank
DB01203,Photosensitizing Agents,DrugBank
DB01203,Propanolamines,DrugBank
DB01203,Propanols,DrugBank
DB01203,Sympatholytics,DrugBank
DB01204,Analgesics,DrugBank
DB01204,Anthracenes,DrugBank
DB01204,Anthracyclines and Related Substances,DrugBank
DB01204,Anthraquinones,DrugBank
DB01204,Antineoplastic Agents,DrugBank
DB01204,Antineoplastic and Immunomodulating Agents,DrugBank
DB01204,BCRP/ABCG2 Substrates,DrugBank
DB01204,Cardiotoxic antineoplastic agents,DrugBank
DB01204,Central Nervous System Agents,DrugBank
DB01204,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01204,Cytochrome P-450 CYP2E1 Inducers (weak),DrugBank
DB01204,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01204,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01204,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01204,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01204,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01204,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01204,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01204,Cytochrome P-450 Substrates,DrugBank
DB01204,Cytotoxic Antibiotics and Related Substances,DrugBank
DB01204,Cytotoxins,DrugBank
DB01204,Enzyme Inhibitors,DrugBank
DB01204,Immunosuppressive Agents,DrugBank
DB01204,Myelosuppressive Agents,DrugBank
DB01204,Narrow Therapeutic Index Drugs,DrugBank
DB01204,P-glycoprotein inducers,DrugBank
DB01204,P-glycoprotein inhibitors,DrugBank
DB01204,P-glycoprotein substrates,DrugBank
DB01204,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01204,Peripheral Nervous System Agents,DrugBank
DB01204,Quinones,DrugBank
DB01204,Sensory System Agents,DrugBank
DB01204,Topoisomerase II Inhibitors,DrugBank
DB01204,Topoisomerase Inhibitors,DrugBank
DB01205,Antidotes,DrugBank
DB01205,Benzazepines,DrugBank
DB01205,Benzodiazepine Antagonist,DrugBank
DB01205,Benzodiazepinones,DrugBank
DB01205,"Compounds used in a research, industrial, or household setting",DrugBank
DB01205,Drugs that are Mainly Renally Excreted,DrugBank
DB01205,GABA Agents,DrugBank
DB01205,GABA Modulators,DrugBank
DB01205,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01205,Miscellaneous Central Nervous System Agents,DrugBank
DB01205,Neurotransmitter Agents,DrugBank
DB01205,Protective Agents,DrugBank
DB01206,Alkylating Activity,DrugBank
DB01206,Alkylating Drugs,DrugBank
DB01206,Amides,DrugBank
DB01206,Antineoplastic Agents,DrugBank
DB01206,"Antineoplastic Agents, Alkylating",DrugBank
DB01206,Antineoplastic and Immunomodulating Agents,DrugBank
DB01206,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01206,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01206,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01206,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01206,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01206,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01206,Immunosuppressive Agents,DrugBank
DB01206,Myelosuppressive Agents,DrugBank
DB01206,Narrow Therapeutic Index Drugs,DrugBank
DB01206,Nitroso Compounds,DrugBank
DB01206,Nitrosourea Compounds,DrugBank
DB01206,Nitrosoureas,DrugBank
DB01206,Noxae,DrugBank
DB01206,Toxic Actions,DrugBank
DB01207,"Acids, Acyclic",DrugBank
DB01207,Antiplatelet agents,DrugBank
DB01207,Enzyme Inhibitors,DrugBank
DB01207,Fatty Acids,DrugBank
DB01207,"Fatty Acids, Volatile",DrugBank
DB01207,Gastrointestinal Agents,DrugBank
DB01207,Hematologic Agents,DrugBank
DB01207,Lipids,DrugBank
DB01207,"Thromboxane-A Synthase, antagonists & inhibitors",DrugBank
DB01207,Valerates,DrugBank
DB01208,4-Quinolones,DrugBank
DB01208,Anti-Bacterial Agents,DrugBank
DB01208,Anti-Infective Agents,DrugBank
DB01208,Antibacterials for Systemic Use,DrugBank
DB01208,Antiinfectives for Systemic Use,DrugBank
DB01208,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01208,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01208,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01208,Drugs for Treatment of Tuberculosis,DrugBank
DB01208,Enzyme Inhibitors,DrugBank
DB01208,Fluoroquinolones,DrugBank
DB01208,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01208,Highest Risk QTc-Prolonging Agents,DrugBank
DB01208,P-glycoprotein substrates,DrugBank
DB01208,QTc Prolonging Agents,DrugBank
DB01208,Quinolines,DrugBank
DB01208,Quinolones,DrugBank
DB01208,Topoisomerase II Inhibitors,DrugBank
DB01208,Topoisomerase Inhibitors,DrugBank
DB01209,Analgesics,DrugBank
DB01209,Central Nervous System Agents,DrugBank
DB01209,Central Nervous System Depressants,DrugBank
DB01209,Naphthalenes,DrugBank
DB01209,Narcotics,DrugBank
DB01209,Nervous System,DrugBank
DB01209,Opioid Antagonists,DrugBank
DB01209,Opioids,DrugBank
DB01209,Peripheral Nervous System Agents,DrugBank
DB01209,Sensory System Agents,DrugBank
DB01209,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01210,Adrenergic Agents,DrugBank
DB01210,Adrenergic Antagonists,DrugBank
DB01210,Adrenergic beta-Antagonists,DrugBank
DB01210,Agents causing hyperkalemia,DrugBank
DB01210,Alcohols,DrugBank
DB01210,Amines,DrugBank
DB01210,Amino Alcohols,DrugBank
DB01210,Antiglaucoma Preparations and Miotics,DrugBank
DB01210,Autonomic Agents,DrugBank
DB01210,Beta-adrenergic Agents,DrugBank
DB01210,Bradycardia-Causing Agents,DrugBank
DB01210,Bunolol,DrugBank
DB01210,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01210,Cytochrome P-450 Substrates,DrugBank
DB01210,Hypotensive Agents,DrugBank
DB01210,Naphthalenes,DrugBank
DB01210,Neurotransmitter Agents,DrugBank
DB01210,Ophthalmologicals,DrugBank
DB01210,Peripheral Nervous System Agents,DrugBank
DB01210,Phenoxypropanolamines,DrugBank
DB01210,Propanolamines,DrugBank
DB01210,Propanols,DrugBank
DB01210,Sensory Organs,DrugBank
DB01210,Sympatholytics,DrugBank
DB01210,Tetrahydronaphthalenes,DrugBank
DB01211,Alimentary Tract and Metabolism,DrugBank
DB01211,Anti-Bacterial Agents,DrugBank
DB01211,Anti-Infective Agents,DrugBank
DB01211,Antibacterials for Systemic Use,DrugBank
DB01211,Antiinfectives for Systemic Use,DrugBank
DB01211,BSEP/ABCB11 Substrates,DrugBank
DB01211,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01211,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01211,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01211,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01211,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01211,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01211,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB01211,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01211,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01211,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01211,Cytochrome P-450 Substrates,DrugBank
DB01211,Drugs for Acid Related Disorders,DrugBank
DB01211,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB01211,Enzyme Inhibitors,DrugBank
DB01211,Erythromycin and similars,DrugBank
DB01211,Lactones,DrugBank
DB01211,Macrolide Antimicrobial,DrugBank
DB01211,Macrolides,DrugBank
DB01211,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB01211,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01211,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01211,OATP1B3 inhibitors,DrugBank
DB01211,Other Macrolides,DrugBank
DB01211,P-glycoprotein inhibitors,DrugBank
DB01211,P-glycoprotein substrates,DrugBank
DB01211,Polyketides,DrugBank
DB01211,Protein Synthesis Inhibitors,DrugBank
DB01211,QTc Prolonging Agents,DrugBank
DB01212,Amides,DrugBank
DB01212,Anti-Bacterial Agents,DrugBank
DB01212,Anti-Infective Agents,DrugBank
DB01212,Antibacterials for Systemic Use,DrugBank
DB01212,Antiinfectives for Systemic Use,DrugBank
DB01212,beta Lactam Antibiotics,DrugBank
DB01212,beta-Lactams,DrugBank
DB01212,Cephalosporins,DrugBank
DB01212,Drugs that are Mainly Renally Excreted,DrugBank
DB01212,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01212,Lactams,DrugBank
DB01212,Nephrotoxic agents,DrugBank
DB01212,OAT1/SLC22A6 inhibitors,DrugBank
DB01212,OAT3/SLC22A8 Inhibitors,DrugBank
DB01212,P-glycoprotein inhibitors,DrugBank
DB01212,Sulfur Compounds,DrugBank
DB01212,Thiazines,DrugBank
DB01212,Third-Generation Cephalosporins,DrugBank
DB01213,Antidotes,DrugBank
DB01213,"Compounds used in a research, industrial, or household setting",DrugBank
DB01213,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB01213,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB01213,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01213,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB01213,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01213,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01213,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01213,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01213,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01213,Cytochrome P-450 Substrates,DrugBank
DB01213,Drugs that are Mainly Renally Excreted,DrugBank
DB01213,Enzyme Inhibitors,DrugBank
DB01213,Protective Agents,DrugBank
DB01213,Pyrazoles,DrugBank
DB01214,Adrenergic Agents,DrugBank
DB01214,Adrenergic Antagonists,DrugBank
DB01214,Adrenergic beta-Antagonists,DrugBank
DB01214,Agents causing hyperkalemia,DrugBank
DB01214,Alcohols,DrugBank
DB01214,Amines,DrugBank
DB01214,Amino Alcohols,DrugBank
DB01214,Antiarrhythmic agents,DrugBank
DB01214,Antiglaucoma Preparations and Miotics,DrugBank
DB01214,Antihypertensive Agents,DrugBank
DB01214,Autonomic Agents,DrugBank
DB01214,Beta Blocking Agents and Thiazides,DrugBank
DB01214,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB01214,Bradycardia-Causing Agents,DrugBank
DB01214,Cardiovascular Agents,DrugBank
DB01214,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01214,Cytochrome P-450 Substrates,DrugBank
DB01214,Hypotensive Agents,DrugBank
DB01214,Neurotransmitter Agents,DrugBank
DB01214,Ophthalmologicals,DrugBank
DB01214,Peripheral Nervous System Agents,DrugBank
DB01214,Phenoxypropanolamines,DrugBank
DB01214,Propanolamines,DrugBank
DB01214,Propanols,DrugBank
DB01214,Sensory Organs,DrugBank
DB01214,Sympatholytics,DrugBank
DB01215,Anti-Anxiety Agents,DrugBank
DB01215,Anticonvulsants,DrugBank
DB01215,Benzazepines,DrugBank
DB01215,Benzodiazepine hypnotics and sedatives,DrugBank
DB01215,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01215,Central Nervous System Agents,DrugBank
DB01215,Central Nervous System Depressants,DrugBank
DB01215,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01215,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01215,Cytochrome P-450 Substrates,DrugBank
DB01215,Drugs causing inadvertant photosensitivity,DrugBank
DB01215,Drugs that are Mainly Renally Excreted,DrugBank
DB01215,GABA Agents,DrugBank
DB01215,GABA Modulators,DrugBank
DB01215,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01215,Hypnotics and Sedatives,DrugBank
DB01215,Nervous System,DrugBank
DB01215,Neurotransmitter Agents,DrugBank
DB01215,Photosensitizing Agents,DrugBank
DB01215,Psycholeptics,DrugBank
DB01215,Psychotropic Drugs,DrugBank
DB01215,Tranquilizing Agents,DrugBank
DB01215,Triazolobenzodiazepines,DrugBank
DB01216,5-alpha Reductase Inhibitors,DrugBank
DB01216,Adrenergic alpha-Antagonists,DrugBank
DB01216,Adrenergic Antagonists,DrugBank
DB01216,Agents that produce hypertension,DrugBank
DB01216,Androstanes,DrugBank
DB01216,Androstenes,DrugBank
DB01216,Azasteroids,DrugBank
DB01216,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01216,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01216,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01216,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01216,Cytochrome P-450 Substrates,DrugBank
DB01216,Dermatologicals,DrugBank
DB01216,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB01216,Enzyme Inhibitors,DrugBank
DB01216,Fused-Ring Compounds,DrugBank
DB01216,Genito Urinary System and Sex Hormones,DrugBank
DB01216,Genitourinary Agents,DrugBank
DB01216,Hormone Antagonists,DrugBank
DB01216,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01216,Misc. Skin and Mucous Membrane Agents,DrugBank
DB01216,Steroid Synthesis Inhibitors,DrugBank
DB01216,Steroids,DrugBank
DB01216,Urological Agents,DrugBank
DB01216,Urologicals,DrugBank
DB01217,Antineoplastic Agents,DrugBank
DB01217,"Antineoplastic Agents, Hormonal",DrugBank
DB01217,Antineoplastic and Immunomodulating Agents,DrugBank
DB01217,Aromatase Inhibitors,DrugBank
DB01217,Cardiotoxic antineoplastic agents,DrugBank
DB01217,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01217,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01217,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01217,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01217,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01217,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01217,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01217,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01217,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01217,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01217,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01217,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01217,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01217,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01217,Cytochrome P-450 Substrates,DrugBank
DB01217,Endocrine Therapy,DrugBank
DB01217,Enzyme Inhibitors,DrugBank
DB01217,Estrogen Antagonists,DrugBank
DB01217,Hormone Antagonists,DrugBank
DB01217,Hormone Antagonists and Related Agents,DrugBank
DB01217,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01217,Nitriles,DrugBank
DB01217,P-glycoprotein substrates,DrugBank
DB01217,Steroid Synthesis Inhibitors,DrugBank
DB01217,Triazoles,DrugBank
DB01217,UGT1A3 substrates,DrugBank
DB01217,UGT1A4 substrates,DrugBank
DB01217,UGT2B7 substrates,DrugBank
DB01218,Agents that reduce seizure threshold,DrugBank
DB01218,Anti-Infective Agents,DrugBank
DB01218,Antimalarials,DrugBank
DB01218,Antiparasitic Agents,DrugBank
DB01218,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01218,Antiprotozoals,DrugBank
DB01218,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01218,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01218,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01218,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01218,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01218,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01218,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01218,Cytochrome P-450 Substrates,DrugBank
DB01218,Highest Risk QTc-Prolonging Agents,DrugBank
DB01218,QTc Prolonging Agents,DrugBank
DB01219,Agents causing hyperkalemia,DrugBank
DB01219,Agents that produce neuromuscular block (indirect),DrugBank
DB01219,Central Nervous System Agents,DrugBank
DB01219,Central Nervous System Depressants,DrugBank
DB01219,Dantrolene and Derivatives,DrugBank
DB01219,Decreased Striated Muscle Contraction,DrugBank
DB01219,Decreased Striated Muscle Tone,DrugBank
DB01219,Direct-acting Skeletal Muscle Relaxants,DrugBank
DB01219,Hepatotoxic Agents,DrugBank
DB01219,Hydantoins,DrugBank
DB01219,Imidazoles,DrugBank
DB01219,Imidazolidines,DrugBank
DB01219,Muscle Relaxants,DrugBank
DB01219,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01219,Musculo-Skeletal System,DrugBank
DB01219,Neuromuscular Agents,DrugBank
DB01219,Peripheral Nervous System Agents,DrugBank
DB01219,Thyroxine-binding globulin substrates,DrugBank
DB01220,Alimentary Tract and Metabolism,DrugBank
DB01220,Anti-Bacterial Agents,DrugBank
DB01220,Anti-Infective Agents,DrugBank
DB01220,Antibiotics for Topical Use,DrugBank
DB01220,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01220,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01220,Cytochrome P-450 CYP2C19 Inducers (strong),DrugBank
DB01220,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01220,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01220,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01220,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01220,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01220,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01220,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01220,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01220,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01220,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01220,Cytochrome P-450 Substrates,DrugBank
DB01220,Dermatologicals,DrugBank
DB01220,Gastrointestinal Agents,DrugBank
DB01220,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01220,Intestinal Antiinfectives,DrugBank
DB01220,"Lactams, Macrocyclic",DrugBank
DB01220,Rifamycin Antibacterial,DrugBank
DB01220,Rifamycins,DrugBank
DB01221,Agents producing tachycardia,DrugBank
DB01221,Amino Acids,DrugBank
DB01221,"Amino Acids, Acidic",DrugBank
DB01221,"Amino Acids, Dicarboxylic",DrugBank
DB01221,"Amino Acids, Peptides, and Proteins",DrugBank
DB01221,Analgesics,DrugBank
DB01221,Anesthetics,DrugBank
DB01221,"Anesthetics, Dissociative",DrugBank
DB01221,"Anesthetics, General",DrugBank
DB01221,"Anesthetics, Intravenous",DrugBank
DB01221,Central Nervous System Agents,DrugBank
DB01221,Central Nervous System Depressants,DrugBank
DB01221,Cholinesterase Inhibitors,DrugBank
DB01221,Cyclohexanes,DrugBank
DB01221,Cycloparaffins,DrugBank
DB01221,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01221,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01221,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01221,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01221,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01221,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01221,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01221,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01221,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01221,Cytochrome P-450 Substrates,DrugBank
DB01221,Drugs that are Mainly Renally Excreted,DrugBank
DB01221,Excitatory Amino Acid Agents,DrugBank
DB01221,Excitatory Amino Acid Agonists,DrugBank
DB01221,Excitatory Amino Acid Antagonists,DrugBank
DB01221,Miscellaneous General Anesthetics,DrugBank
DB01221,"N-Methylaspartate, agonists",DrugBank
DB01221,"N-Methylaspartate, antagonists & inhibitors",DrugBank
DB01221,Nervous System,DrugBank
DB01221,Neurotransmitter Agents,DrugBank
DB01221,NMDA Receptor Antagonists,DrugBank
DB01221,Peripheral Nervous System Agents,DrugBank
DB01221,Sensory System Agents,DrugBank
DB01221,Vasodilating Agents,DrugBank
DB01222,Adrenal Cortex Hormones,DrugBank
DB01222,Adrenals,DrugBank
DB01222,Agents to Treat Airway Disease,DrugBank
DB01222,Alimentary Tract and Metabolism,DrugBank
DB01222,Anti-Asthmatic Agents,DrugBank
DB01222,Anti-Inflammatory Agents,DrugBank
DB01222,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01222,Autonomic Agents,DrugBank
DB01222,Bronchodilator Agents,DrugBank
DB01222,BSEP/ABCB11 Substrates,DrugBank
DB01222,Corticosteroid Hormone Receptor Agonists,DrugBank
DB01222,Corticosteroids,DrugBank
DB01222,Corticosteroids Acting Locally,DrugBank
DB01222,Corticosteroids for Systemic Use,DrugBank
DB01222,"Corticosteroids, Dermatological Preparations",DrugBank
DB01222,"Corticosteroids, Potent (Group III)",DrugBank
DB01222,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01222,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB01222,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01222,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01222,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01222,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01222,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01222,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01222,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01222,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB01222,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01222,Cytochrome P-450 Substrates,DrugBank
DB01222,Dermatologicals,DrugBank
DB01222,Drugs for Obstructive Airway Diseases,DrugBank
DB01222,Drugs that are Mainly Renally Excreted,DrugBank
DB01222,Fused-Ring Compounds,DrugBank
DB01222,Hormones,DrugBank
DB01222,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01222,Immunosuppressive Agents,DrugBank
DB01222,Intestinal Antiinflammatory Agents,DrugBank
DB01222,Nasal Preparations,DrugBank
DB01222,OAT3/SLC22A8 Substrates,DrugBank
DB01222,P-glycoprotein substrates,DrugBank
DB01222,Peripheral Nervous System Agents,DrugBank
DB01222,Pregnanes,DrugBank
DB01222,Pregnenediones,DrugBank
DB01222,Pregnenes,DrugBank
DB01222,Respiratory System Agents,DrugBank
DB01222,Steroids,DrugBank
DB01223,Agents that reduce seizure threshold,DrugBank
DB01223,Amines,DrugBank
DB01223,Anti-Asthmatic Agents,DrugBank
DB01223,Autonomic Agents,DrugBank
DB01223,Bronchodilator Agents,DrugBank
DB01223,Cardiotonic Agents,DrugBank
DB01223,Cardiovascular Agents,DrugBank
DB01223,"Compounds used in a research, industrial, or household setting",DrugBank
DB01223,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01223,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01223,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01223,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB01223,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01223,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01223,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01223,Cytochrome P-450 Substrates,DrugBank
DB01223,Diamines,DrugBank
DB01223,Drugs for Obstructive Airway Diseases,DrugBank
DB01223,Enzyme Inhibitors,DrugBank
DB01223,Ethylenediamines,DrugBank
DB01223,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01223,Narrow Therapeutic Index Drugs,DrugBank
DB01223,Neurotransmitter Agents,DrugBank
DB01223,Peripheral Nervous System Agents,DrugBank
DB01223,Pharmaceutical Preparations,DrugBank
DB01223,Phosphodiesterase Inhibitors,DrugBank
DB01223,Polyamines,DrugBank
DB01223,Protective Agents,DrugBank
DB01223,Purinergic Agents,DrugBank
DB01223,Purinergic Antagonists,DrugBank
DB01223,Purinergic P1 Receptor Antagonists,DrugBank
DB01223,Purines,DrugBank
DB01223,Purinones,DrugBank
DB01223,Respiratory Smooth Muscle Relaxants,DrugBank
DB01223,Respiratory System Agents,DrugBank
DB01223,Xanthine derivatives,DrugBank
DB01223,Xanthines and Adrenergics,DrugBank
DB01224,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01224,Adrenergic alpha-Antagonists,DrugBank
DB01224,Adrenergic Antagonists,DrugBank
DB01224,Agents producing tachycardia,DrugBank
DB01224,Agents that produce hypertension,DrugBank
DB01224,Anticholinergic Agents,DrugBank
DB01224,Antidepressive Agents,DrugBank
DB01224,Antidepressive Agents Indicated for Depression,DrugBank
DB01224,Antipsychotic Agents,DrugBank
DB01224,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB01224,Azepines,DrugBank
DB01224,Central Nervous System Agents,DrugBank
DB01224,Central Nervous System Depressants,DrugBank
DB01224,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01224,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01224,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01224,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01224,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01224,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01224,Cytochrome P-450 Substrates,DrugBank
DB01224,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB01224,Dibenzothiazepines,DrugBank
DB01224,Dopamine Antagonists,DrugBank
DB01224,Dopamine D2 Receptor Antagonists,DrugBank
DB01224,Drugs that are Mainly Renally Excreted,DrugBank
DB01224,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01224,Histamine Antagonists,DrugBank
DB01224,Histamine H1 Antagonists,DrugBank
DB01224,Hyperglycemia-Associated Agents,DrugBank
DB01224,Hypotensive Agents,DrugBank
DB01224,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01224,Muscarinic Antagonists,DrugBank
DB01224,Nervous System,DrugBank
DB01224,P-glycoprotein substrates,DrugBank
DB01224,Psycholeptics,DrugBank
DB01224,Psychotropic Drugs,DrugBank
DB01224,QTc Prolonging Agents,DrugBank
DB01224,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01224,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01224,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01224,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01224,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01224,Serotonin Agents,DrugBank
DB01224,Serotonin Receptor Antagonists,DrugBank
DB01224,Thiazepines,DrugBank
DB01224,Thiepins,DrugBank
DB01224,Tranquilizing Agents,DrugBank
DB01225,Agents causing hyperkalemia,DrugBank
DB01225,Anticoagulants,DrugBank
DB01225,Blood and Blood Forming Organs,DrugBank
DB01225,Cardiovascular Agents,DrugBank
DB01225,Fibrin Modulating Agents,DrugBank
DB01225,Glycosaminoglycans,DrugBank
DB01225,Hematologic Agents,DrugBank
DB01225,Heparin (Low Molecular Weight),DrugBank
DB01225,Heparin and similars,DrugBank
DB01225,Heparin Group,DrugBank
DB01226,Agents producing tachycardia,DrugBank
DB01226,Anticholinergic Agents,DrugBank
DB01226,Central Nervous System Depressants,DrugBank
DB01226,Cholinergic Agents,DrugBank
DB01226,Cholinesterase substrates,DrugBank
DB01226,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01226,Isoquinolines,DrugBank
DB01226,Muscarinic Antagonists,DrugBank
DB01226,Muscle Relaxants,DrugBank
DB01226,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01226,Musculo-Skeletal System,DrugBank
DB01226,Neuromuscular Agents,DrugBank
DB01226,Neuromuscular Blocking Agents,DrugBank
DB01226,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01226,Nicotinic Antagonists,DrugBank
DB01226,Peripheral Nervous System Agents,DrugBank
DB01227,Analgesics,DrugBank
DB01227,Anticholinergic Agents,DrugBank
DB01227,Central Nervous System Agents,DrugBank
DB01227,Central Nervous System Depressants,DrugBank
DB01227,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01227,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01227,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01227,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01227,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01227,Cytochrome P-450 Substrates,DrugBank
DB01227,Drugs Used in Addictive Disorders,DrugBank
DB01227,Drugs Used in Opioid Dependence,DrugBank
DB01227,Ketones,DrugBank
DB01227,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01227,Narcotics,DrugBank
DB01227,Narrow Therapeutic Index Drugs,DrugBank
DB01227,Nervous System,DrugBank
DB01227,Nicotinic Antagonists,DrugBank
DB01227,Opioids,DrugBank
DB01227,Peripheral Nervous System Agents,DrugBank
DB01227,QTc Prolonging Agents,DrugBank
DB01227,Sensory System Agents,DrugBank
DB01227,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01228,Amides,DrugBank
DB01228,Amines,DrugBank
DB01228,Anilides,DrugBank
DB01228,Aniline Compounds,DrugBank
DB01228,Antiarrhythmic agents,DrugBank
DB01228,"Antiarrhythmics, Class I",DrugBank
DB01228,"Antiarrhythmics, Class Ic",DrugBank
DB01228,Cardiac Therapy,DrugBank
DB01228,Cardiovascular Agents,DrugBank
DB01228,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01228,Cytochrome P-450 Substrates,DrugBank
DB01228,Membrane Transport Modulators,DrugBank
DB01228,Potential QTc-Prolonging Agents,DrugBank
DB01228,QTc Prolonging Agents,DrugBank
DB01228,Sodium Channel Blockers,DrugBank
DB01228,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01229,Agents Causing Muscle Toxicity,DrugBank
DB01229,Albumins,DrugBank
DB01229,"Amino Acids, Peptides, and Proteins",DrugBank
DB01229,Antimitotic Agents,DrugBank
DB01229,Antineoplastic Agents,DrugBank
DB01229,"Antineoplastic Agents, Phytogenic",DrugBank
DB01229,Antineoplastic and Immunomodulating Agents,DrugBank
DB01229,BSEP/ABCB11 Inhibitors,DrugBank
DB01229,BSEP/ABCB11 Substrates,DrugBank
DB01229,BSEP/ABCB11 Substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Cardiotoxic antineoplastic agents,DrugBank
DB01229,Cyclodecanes,DrugBank
DB01229,Cycloparaffins,DrugBank
DB01229,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01229,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01229,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01229,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01229,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01229,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01229,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01229,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01229,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01229,Cytochrome P-450 Substrates,DrugBank
DB01229,Cytotoxins,DrugBank
DB01229,Diterpenes,DrugBank
DB01229,Hypotensive Agents,DrugBank
DB01229,Immunosuppressive Agents,DrugBank
DB01229,Microtubule Inhibition,DrugBank
DB01229,Microtubule Inhibitors,DrugBank
DB01229,Mitosis Modulators,DrugBank
DB01229,Myelosuppressive Agents,DrugBank
DB01229,Narrow Therapeutic Index Drugs,DrugBank
DB01229,Neurotoxic agents,DrugBank
DB01229,OATP1B3 substrates,DrugBank
DB01229,P-glycoprotein inhibitors,DrugBank
DB01229,P-glycoprotein substrates,DrugBank
DB01229,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01229,Proteins,DrugBank
DB01229,Taxane Derivatives,DrugBank
DB01229,Taxoids,DrugBank
DB01229,Terpenes,DrugBank
DB01229,Tubulin Modulators,DrugBank
DB01231,Agents producing tachycardia,DrugBank
DB01231,Anticholinergic Agents,DrugBank
DB01231,Antiemetics,DrugBank
DB01231,Autonomic Agents,DrugBank
DB01231,Central Nervous System Agents,DrugBank
DB01231,Emesis Suppression,DrugBank
DB01231,Gastrointestinal Agents,DrugBank
DB01231,Muscarinic Antagonists,DrugBank
DB01231,Peripheral Nervous System Agents,DrugBank
DB01232,Agents Causing Muscle Toxicity,DrugBank
DB01232,Anti-HIV Agents,DrugBank
DB01232,Anti-Infective Agents,DrugBank
DB01232,Anti-Retroviral Agents,DrugBank
DB01232,Antiinfectives for Systemic Use,DrugBank
DB01232,Antiviral Agents,DrugBank
DB01232,Antivirals for Systemic Use,DrugBank
DB01232,BCRP/ABCG2 Inhibitors,DrugBank
DB01232,BSEP/ABCB11 Substrates,DrugBank
DB01232,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01232,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01232,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01232,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01232,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01232,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01232,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01232,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB01232,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB01232,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01232,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01232,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB01232,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB01232,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01232,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01232,Cytochrome P-450 Substrates,DrugBank
DB01232,Direct Acting Antivirals,DrugBank
DB01232,Enzyme Inhibitors,DrugBank
DB01232,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01232,HIV Protease Inhibitors,DrugBank
DB01232,Hyperglycemia-Associated Agents,DrugBank
DB01232,Isoquinolines,DrugBank
DB01232,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01232,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01232,OCT1 inhibitors,DrugBank
DB01232,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01232,P-glycoprotein inducers,DrugBank
DB01232,P-glycoprotein inhibitors,DrugBank
DB01232,P-glycoprotein substrates,DrugBank
DB01232,Protease Inhibitors,DrugBank
DB01232,QTc Prolonging Agents,DrugBank
DB01232,Quinolines,DrugBank
DB01232,Viral Protease Inhibitors,DrugBank
DB01233,"Acids, Carbocyclic",DrugBank
DB01233,Agents Causing Muscle Toxicity,DrugBank
DB01233,Alimentary Tract and Metabolism,DrugBank
DB01233,Amides,DrugBank
DB01233,Aminobenzoates,DrugBank
DB01233,Antiemetics,DrugBank
DB01233,Autonomic Agents,DrugBank
DB01233,Benzamides and benzamide derivatives,DrugBank
DB01233,Benzoates,DrugBank
DB01233,Central Nervous System Agents,DrugBank
DB01233,Central Nervous System Depressants,DrugBank
DB01233,Chlorobenzoates,DrugBank
DB01233,Cholinesterase Inhibitors,DrugBank
DB01233,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01233,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01233,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01233,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01233,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01233,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01233,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01233,Cytochrome P-450 Substrates,DrugBank
DB01233,Dopamine Agents,DrugBank
DB01233,Dopamine Antagonists,DrugBank
DB01233,Dopamine D2 Receptor Antagonists,DrugBank
DB01233,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01233,Drugs that are Mainly Renally Excreted,DrugBank
DB01233,Gastrointestinal Agents,DrugBank
DB01233,Hydroxybenzoates,DrugBank
DB01233,Methemoglobinemia Associated Agents,DrugBank
DB01233,Neurotransmitter Agents,DrugBank
DB01233,P-glycoprotein substrates,DrugBank
DB01233,para-Aminobenzoates,DrugBank
DB01233,Peripheral Nervous System Agents,DrugBank
DB01233,Potential QTc-Prolonging Agents,DrugBank
DB01233,Prokinetic Agents,DrugBank
DB01233,Propulsives,DrugBank
DB01233,QTc Prolonging Agents,DrugBank
DB01233,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01234,Adrenal Cortex Hormones,DrugBank
DB01234,Adrenals,DrugBank
DB01234,Agents Causing Muscle Toxicity,DrugBank
DB01234,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB01234,Alimentary Tract and Metabolism,DrugBank
DB01234,Anti-Acne Preparations,DrugBank
DB01234,Anti-Acne Preparations for Topical Use,DrugBank
DB01234,Anti-Inflammatory Agents,DrugBank
DB01234,Antiemetics,DrugBank
DB01234,Antineoplastic Agents,DrugBank
DB01234,"Antineoplastic Agents, Hormonal",DrugBank
DB01234,Autonomic Agents,DrugBank
DB01234,BCRP/ABCG2 Inhibitors,DrugBank
DB01234,BSEP/ABCB11 inducers,DrugBank
DB01234,Central Nervous System Agents,DrugBank
DB01234,Corticosteroid Hormone Receptor Agonists,DrugBank
DB01234,Corticosteroids,DrugBank
DB01234,Corticosteroids for Local Oral Treatment,DrugBank
DB01234,Corticosteroids for Systemic Use,DrugBank
DB01234,"Corticosteroids for Systemic Use, Plain",DrugBank
DB01234,"Corticosteroids, Dermatological Preparations",DrugBank
DB01234,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB01234,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB01234,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB01234,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01234,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB01234,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01234,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01234,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01234,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01234,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB01234,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01234,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01234,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01234,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01234,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB01234,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01234,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB01234,Cytochrome P-450 CYP3A7 Inducers (strength unknown),DrugBank
DB01234,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01234,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01234,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01234,Cytochrome P-450 Substrates,DrugBank
DB01234,Dermatologicals,DrugBank
DB01234,Experimental Unapproved Treatments for COVID-19,DrugBank
DB01234,Fused-Ring Compounds,DrugBank
DB01234,Gastrointestinal Agents,DrugBank
DB01234,Hormones,DrugBank
DB01234,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01234,Hyperglycemia-Associated Agents,DrugBank
DB01234,Immunosuppressive Agents,DrugBank
DB01234,Inducers of Drug Clearance,DrugBank
DB01234,Nasal Preparations,DrugBank
DB01234,OAT3/SLC22A8 Substrates,DrugBank
DB01234,Ophthalmological and Otological Preparations,DrugBank
DB01234,Ophthalmologicals,DrugBank
DB01234,Otologicals,DrugBank
DB01234,P-glycoprotein inducers,DrugBank
DB01234,P-glycoprotein inhibitors,DrugBank
DB01234,P-glycoprotein substrates,DrugBank
DB01234,Peripheral Nervous System Agents,DrugBank
DB01234,Pregnadienes,DrugBank
DB01234,Pregnadienetriols,DrugBank
DB01234,Pregnanes,DrugBank
DB01234,Sensory Organs,DrugBank
DB01234,Steroids,DrugBank
DB01234,"Steroids, Fluorinated",DrugBank
DB01234,Stomatological Preparations,DrugBank
DB01234,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01234,Vasoprotectives,DrugBank
DB01235,Amines,DrugBank
DB01235,Amino Acids,DrugBank
DB01235,"Amino Acids, Aromatic",DrugBank
DB01235,"Amino Acids, Cyclic",DrugBank
DB01235,"Amino Acids, Peptides, and Proteins",DrugBank
DB01235,Anti-Dyskinesia Agents,DrugBank
DB01235,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB01235,Anti-Parkinson Drugs,DrugBank
DB01235,Benzene Derivatives,DrugBank
DB01235,Biogenic Amines,DrugBank
DB01235,Biogenic Monoamines,DrugBank
DB01235,Catecholamines,DrugBank
DB01235,Catechols,DrugBank
DB01235,Central Nervous System Agents,DrugBank
DB01235,Central Nervous System Depressants,DrugBank
DB01235,Dihydroxyphenylalanine,DrugBank
DB01235,Dopa and Dopa Derivatives,DrugBank
DB01235,Dopamine Agents,DrugBank
DB01235,Hypotensive Agents,DrugBank
DB01235,"Levodopa, antagonists & inhibitors",DrugBank
DB01235,Nervous System,DrugBank
DB01235,Neurotransmitter Agents,DrugBank
DB01235,Phenols,DrugBank
DB01235,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01236,Agents that produce hypertension,DrugBank
DB01236,Anesthetics,DrugBank
DB01236,"Anesthetics, General",DrugBank
DB01236,"Anesthetics, Inhalation",DrugBank
DB01236,Central Nervous System Agents,DrugBank
DB01236,Central Nervous System Depressants,DrugBank
DB01236,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01236,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01236,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01236,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01236,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01236,Cytochrome P-450 Substrates,DrugBank
DB01236,Ethers,DrugBank
DB01236,"Hydrocarbons, Fluorinated",DrugBank
DB01236,"Hydrocarbons, Halogenated",DrugBank
DB01236,Hypotensive Agents,DrugBank
DB01236,Methyl Ethers,DrugBank
DB01236,Nervous System,DrugBank
DB01236,Potential QTc-Prolonging Agents,DrugBank
DB01236,QTc Prolonging Agents,DrugBank
DB01237,Amines,DrugBank
DB01237,Aminoalkyl Ethers,DrugBank
DB01237,Antihistamines for Systemic Use,DrugBank
DB01237,Benzene Derivatives,DrugBank
DB01237,Benzhydryl Compounds,DrugBank
DB01237,Ethylamines,DrugBank
DB01237,Histamine Antagonists,DrugBank
DB01237,Histamine H1 Antagonists,DrugBank
DB01238,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01238,Adrenergic alpha-Antagonists,DrugBank
DB01238,Adrenergic Antagonists,DrugBank
DB01238,Agents producing tachycardia,DrugBank
DB01238,Agents that produce hypertension,DrugBank
DB01238,Anticholinergic Agents,DrugBank
DB01238,Antidepressive Agents,DrugBank
DB01238,Antidepressive Agents Indicated for Depression,DrugBank
DB01238,Antipsychotic Agents,DrugBank
DB01238,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB01238,Aripiprazole and prodrugs,DrugBank
DB01238,Central Nervous System Agents,DrugBank
DB01238,Central Nervous System Depressants,DrugBank
DB01238,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01238,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01238,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01238,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01238,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01238,Cytochrome P-450 Substrates,DrugBank
DB01238,Dopamine Agents,DrugBank
DB01238,Dopamine Agonists,DrugBank
DB01238,Dopamine Antagonists,DrugBank
DB01238,Dopamine D2 Receptor Antagonists,DrugBank
DB01238,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01238,Histamine Antagonists,DrugBank
DB01238,Histamine H1 Antagonists,DrugBank
DB01238,Hyperglycemia-Associated Agents,DrugBank
DB01238,Muscarinic Antagonists,DrugBank
DB01238,Nervous System,DrugBank
DB01238,Neurotoxic agents,DrugBank
DB01238,Neurotransmitter Agents,DrugBank
DB01238,P-glycoprotein inhibitors,DrugBank
DB01238,Piperazines,DrugBank
DB01238,Potential QTc-Prolonging Agents,DrugBank
DB01238,Psycholeptics,DrugBank
DB01238,Psychotropic Drugs,DrugBank
DB01238,QTc Prolonging Agents,DrugBank
DB01238,QTc shortening agents,DrugBank
DB01238,Quinolines,DrugBank
DB01238,Quinolones,DrugBank
DB01238,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01238,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB01238,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01238,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB01238,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01238,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01238,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01238,Serotonin Agents,DrugBank
DB01238,Serotonin Receptor Agonists,DrugBank
DB01238,Serotonin Receptor Antagonists,DrugBank
DB01238,Tranquilizing Agents,DrugBank
DB01239,Agents producing tachycardia,DrugBank
DB01239,Anticholinergic Agents,DrugBank
DB01239,Antidepressive Agents,DrugBank
DB01239,Antipsychotic Agents,DrugBank
DB01239,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01239,Central Nervous System Agents,DrugBank
DB01239,Central Nervous System Depressants,DrugBank
DB01239,Dopamine Agents,DrugBank
DB01239,Dopamine Antagonists,DrugBank
DB01239,Dopamine D2 Receptor Antagonists,DrugBank
DB01239,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01239,Histamine Antagonists,DrugBank
DB01239,Histamine H1 Antagonists,DrugBank
DB01239,Muscarinic Antagonists,DrugBank
DB01239,Nervous System,DrugBank
DB01239,Neurotoxic agents,DrugBank
DB01239,Neurotransmitter Agents,DrugBank
DB01239,P-glycoprotein inhibitors,DrugBank
DB01239,Potential QTc-Prolonging Agents,DrugBank
DB01239,Psycholeptics,DrugBank
DB01239,Psychotropic Drugs,DrugBank
DB01239,QTc Prolonging Agents,DrugBank
DB01239,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01239,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01239,Serotonin Agents,DrugBank
DB01239,Serotonin Receptor Antagonists,DrugBank
DB01239,Sulfur Compounds,DrugBank
DB01239,Thioxanthene Derivatives,DrugBank
DB01239,Thioxanthenes,DrugBank
DB01239,Tranquilizing Agents,DrugBank
DB01239,Xanthenes,DrugBank
DB01240,Anticoagulants,DrugBank
DB01240,Antihypertensive Agents,DrugBank
DB01240,Antiplatelet agents,DrugBank
DB01240,Autacoids,DrugBank
DB01240,Biological Factors,DrugBank
DB01240,Blood and Blood Forming Organs,DrugBank
DB01240,Cardiovascular Agents,DrugBank
DB01240,Drugs that are Mainly Renally Excreted,DrugBank
DB01240,Eicosanoids,DrugBank
DB01240,Fatty Acids,DrugBank
DB01240,"Fatty Acids, Unsaturated",DrugBank
DB01240,Hematologic Agents,DrugBank
DB01240,Hypotensive Agents,DrugBank
DB01240,Inflammation Mediators,DrugBank
DB01240,Lipids,DrugBank
DB01240,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB01240,Prostacyclin Analogues,DrugBank
DB01240,Prostacycline Vasodilator,DrugBank
DB01240,Prostaglandins,DrugBank
DB01240,Prostaglandins I,DrugBank
DB01240,Vasodilating Agents,DrugBank
DB01240,Vasodilation,DrugBank
DB01241,"Acids, Acyclic",DrugBank
DB01241,Agents Causing Muscle Toxicity,DrugBank
DB01241,Benzene Derivatives,DrugBank
DB01241,Butyrates,DrugBank
DB01241,Chemically-Induced Disorders,DrugBank
DB01241,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01241,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01241,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01241,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB01241,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB01241,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB01241,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01241,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB01241,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01241,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB01241,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01241,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01241,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01241,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01241,Cytochrome P-450 Substrates,DrugBank
DB01241,Drugs causing inadvertant photosensitivity,DrugBank
DB01241,Drugs that are Mainly Renally Excreted,DrugBank
DB01241,Enzyme Inhibitors,DrugBank
DB01241,Ethers,DrugBank
DB01241,Fatty Acids,DrugBank
DB01241,"Fatty Acids, Volatile",DrugBank
DB01241,Fibric Acid Derivatives,DrugBank
DB01241,Fibric Acids,DrugBank
DB01241,Hypolipidemic Agents,DrugBank
DB01241,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01241,Isobutyrates,DrugBank
DB01241,Lipid Modifying Agents,DrugBank
DB01241,"Lipid Modifying Agents, Plain",DrugBank
DB01241,Lipid Regulating Agents,DrugBank
DB01241,Lipids,DrugBank
DB01241,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01241,Noxae,DrugBank
DB01241,OAT3/SLC22A8 Inhibitors,DrugBank
DB01241,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01241,OATP1B3 inhibitors,DrugBank
DB01241,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01241,Pentanoic Acids,DrugBank
DB01241,Peroxisome Proliferator Receptor alpha Agonist,DrugBank
DB01241,Peroxisome Proliferator-activated Receptor alpha Agonists,DrugBank
DB01241,Phenols,DrugBank
DB01241,Phenyl Ethers,DrugBank
DB01241,Photosensitizing Agents,DrugBank
DB01241,Toxic Actions,DrugBank
DB01241,UGT1A1 Inhibitors,DrugBank
DB01241,UGT1A1 Substrates,DrugBank
DB01241,UGT1A3 Inhibitors,DrugBank
DB01241,UGT1A3 substrates,DrugBank
DB01241,UGT1A9 Substrates,DrugBank
DB01241,UGT2B17 substrates,DrugBank
DB01241,UGT2B7 substrates,DrugBank
DB01241,Valerates,DrugBank
DB01242,Agents that produce hypertension,DrugBank
DB01242,Agents that reduce seizure threshold,DrugBank
DB01242,Antidepressive Agents,DrugBank
DB01242,Antidepressive Agents Indicated for Depression,DrugBank
DB01242,"Antidepressive Agents, Tricyclic",DrugBank
DB01242,Central Nervous System Agents,DrugBank
DB01242,Central Nervous System Depressants,DrugBank
DB01242,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB01242,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01242,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01242,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01242,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB01242,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01242,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01242,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01242,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01242,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01242,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB01242,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01242,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01242,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01242,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01242,Cytochrome P-450 Substrates,DrugBank
DB01242,Dibenzazepines,DrugBank
DB01242,Drugs that are Mainly Renally Excreted,DrugBank
DB01242,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01242,Hypotensive Agents,DrugBank
DB01242,Membrane Transport Modulators,DrugBank
DB01242,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01242,Narrow Therapeutic Index Drugs,DrugBank
DB01242,Nervous System,DrugBank
DB01242,Neurotoxic agents,DrugBank
DB01242,Neurotransmitter Agents,DrugBank
DB01242,Neurotransmitter Uptake Inhibitors,DrugBank
DB01242,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB01242,P-glycoprotein inhibitors,DrugBank
DB01242,Psychoanaleptics,DrugBank
DB01242,Psychotropic Drugs,DrugBank
DB01242,QTc Prolonging Agents,DrugBank
DB01242,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01242,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01242,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01242,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01242,Serotonin Agents,DrugBank
DB01242,Serotonin Modulators,DrugBank
DB01242,Serotonin Receptor Antagonists,DrugBank
DB01242,Tertiary amine tricyclic antidepressants,DrugBank
DB01242,Tricyclics and Other Norepinephrine-reuptake Inhibitors,DrugBank
DB01244,Agents causing hyperkalemia,DrugBank
DB01244,Antiarrhythmic agents,DrugBank
DB01244,Antihypertensive Agents,DrugBank
DB01244,Bradycardia-Causing Agents,DrugBank
DB01244,Calcium Channel Blockers,DrugBank
DB01244,Calcium-Regulating Hormones and Agents,DrugBank
DB01244,Cardiovascular Agents,DrugBank
DB01244,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01244,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01244,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01244,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01244,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01244,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01244,Cytochrome P-450 Substrates,DrugBank
DB01244,Highest Risk QTc-Prolonging Agents,DrugBank
DB01244,Hypotensive Agents,DrugBank
DB01244,Membrane Transport Modulators,DrugBank
DB01244,Non-Selective Calcium Channel Blockers,DrugBank
DB01244,P-glycoprotein inhibitors,DrugBank
DB01244,Phenylalkylamine Derivatives,DrugBank
DB01244,Pyrrolidines,DrugBank
DB01244,QTc Prolonging Agents,DrugBank
DB01244,Vasodilating Agents,DrugBank
DB01245,Amines,DrugBank
DB01245,Bis-Trimethylammonium Compounds,DrugBank
DB01245,Central Nervous System Depressants,DrugBank
DB01245,Cholinesterase Inhibitors,DrugBank
DB01245,Neuromuscular Agents,DrugBank
DB01245,Neuromuscular Blocking Agents,DrugBank
DB01245,Neuromuscular Depolarizing Agents,DrugBank
DB01245,Neurotoxic agents,DrugBank
DB01245,Onium Compounds,DrugBank
DB01245,Peripheral Nervous System Agents,DrugBank
DB01245,Quaternary Ammonium Compounds,DrugBank
DB01246,Antihistamines for Systemic Use,DrugBank
DB01246,Antipruritics,DrugBank
DB01246,Antipsychotic Agents,DrugBank
DB01246,Central Nervous System Depressants,DrugBank
DB01246,Dermatologicals,DrugBank
DB01246,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01246,Histamine Agents,DrugBank
DB01246,Histamine Antagonists,DrugBank
DB01246,Histamine H1 Antagonists,DrugBank
DB01246,Neurotoxic agents,DrugBank
DB01246,Neurotransmitter Agents,DrugBank
DB01246,Phenothiazine Derivatives,DrugBank
DB01246,Phenothiazines,DrugBank
DB01246,Potential QTc-Prolonging Agents,DrugBank
DB01246,QTc Prolonging Agents,DrugBank
DB01246,Sulfur Compounds,DrugBank
DB01247,Agents that produce hypertension,DrugBank
DB01247,Agents that reduce seizure threshold,DrugBank
DB01247,Antidepressive Agents,DrugBank
DB01247,Antidepressive Agents Indicated for Depression,DrugBank
DB01247,Central Nervous System Agents,DrugBank
DB01247,Central Nervous System Depressants,DrugBank
DB01247,Drugs causing inadvertant photosensitivity,DrugBank
DB01247,Enzyme Inhibitors,DrugBank
DB01247,Hypotensive Agents,DrugBank
DB01247,Isoxazoles,DrugBank
DB01247,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01247,Monoamine Oxidase Inhibitors,DrugBank
DB01247,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB01247,Nervous System,DrugBank
DB01247,Photosensitizing Agents,DrugBank
DB01247,Psychoanaleptics,DrugBank
DB01247,Psychotropic Drugs,DrugBank
DB01247,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01247,Serotonin Agents,DrugBank
DB01247,Serotonin Modulators,DrugBank
DB01248,Agents Causing Muscle Toxicity,DrugBank
DB01248,Antimitotic Agents,DrugBank
DB01248,Antineoplastic Agents,DrugBank
DB01248,Antineoplastic and Immunomodulating Agents,DrugBank
DB01248,BCRP/ABCG2 Substrates,DrugBank
DB01248,Cardiotoxic antineoplastic agents,DrugBank
DB01248,Cyclodecanes,DrugBank
DB01248,Cycloparaffins,DrugBank
DB01248,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01248,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01248,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01248,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01248,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01248,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01248,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01248,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01248,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01248,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01248,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01248,Cytochrome P-450 Substrates,DrugBank
DB01248,Cytotoxins,DrugBank
DB01248,Diterpenes,DrugBank
DB01248,Hepatotoxic Agents,DrugBank
DB01248,Immunosuppressive Agents,DrugBank
DB01248,Microtubule Inhibition,DrugBank
DB01248,Microtubule Inhibitors,DrugBank
DB01248,Mitosis Modulators,DrugBank
DB01248,Myelosuppressive Agents,DrugBank
DB01248,Narrow Therapeutic Index Drugs,DrugBank
DB01248,OATP1B3 substrates,DrugBank
DB01248,P-glycoprotein substrates,DrugBank
DB01248,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01248,Taxane Derivatives,DrugBank
DB01248,Taxoids,DrugBank
DB01248,Terpenes,DrugBank
DB01248,Tubulin Modulators,DrugBank
DB01249,"Acids, Carbocyclic",DrugBank
DB01249,Benzene Derivatives,DrugBank
DB01249,Benzoates,DrugBank
DB01249,"Compounds used in a research, industrial, or household setting",DrugBank
DB01249,Contrast Media,DrugBank
DB01249,Diagnostic Uses of Chemicals,DrugBank
DB01249,Drugs that are Mainly Renally Excreted,DrugBank
DB01249,Iodinated Contrast Agents,DrugBank
DB01249,Iodobenzoates,DrugBank
DB01249,Radiographic Contrast Agent,DrugBank
DB01249,Roentgenography,DrugBank
DB01249,"Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media",DrugBank
DB01249,X-Ray Contrast Activity,DrugBank
DB01249,"X-Ray Contrast Media, Iodinated",DrugBank
DB01250,"Acids, Carbocyclic",DrugBank
DB01250,Agents causing hyperkalemia,DrugBank
DB01250,Agents that produce hypertension,DrugBank
DB01250,Alimentary Tract and Metabolism,DrugBank
DB01250,Aminosalicylate,DrugBank
DB01250,Analgesics,DrugBank
DB01250,"Analgesics, Non-Narcotic",DrugBank
DB01250,Anti-Inflammatory Agents,DrugBank
DB01250,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01250,Benzene Derivatives,DrugBank
DB01250,Benzoates,DrugBank
DB01250,Gastrointestinal Agents,DrugBank
DB01250,Hydroxy Acids,DrugBank
DB01250,Hydroxybenzoates,DrugBank
DB01250,Intestinal Antiinflammatory Agents,DrugBank
DB01250,Nephrotoxic agents,DrugBank
DB01250,Non COX-2 selective NSAIDS,DrugBank
DB01250,Peripheral Nervous System Agents,DrugBank
DB01250,Phenols,DrugBank
DB01250,Salicylates,DrugBank
DB01250,Sensory System Agents,DrugBank
DB01251,Alimentary Tract and Metabolism,DrugBank
DB01251,Amides,DrugBank
DB01251,Blood Glucose Lowering Agents,DrugBank
DB01251,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01251,Cytochrome P-450 Substrates,DrugBank
DB01251,Drugs Used in Diabetes,DrugBank
DB01251,Insulin Secretagogues,DrugBank
DB01251,Oral Hypoglycemics,DrugBank
DB01251,Sulfones,DrugBank
DB01251,Sulfonylureas,DrugBank
DB01251,Sulfur Compounds,DrugBank
DB01252,Alimentary Tract and Metabolism,DrugBank
DB01252,Blood Glucose Lowering Agents,DrugBank
DB01252,Drugs Used in Diabetes,DrugBank
DB01252,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01252,Oral Hypoglycemics,DrugBank
DB01252,UGT1A3 substrates,DrugBank
DB01252,UGT2B7 substrates,DrugBank
DB01253,Adrenergic Agonists,DrugBank
DB01253,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01253,Adrenergic alpha-Agonists,DrugBank
DB01253,Agents producing tachycardia,DrugBank
DB01253,Agents that produce hypertension,DrugBank
DB01253,Alkaloids,DrugBank
DB01253,Antidepressive Agents,DrugBank
DB01253,Central Nervous System Depressants,DrugBank
DB01253,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01253,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01253,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01253,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01253,Cytochrome P-450 Substrates,DrugBank
DB01253,Ergolines,DrugBank
DB01253,Ergot Alkaloids and Derivatives,DrugBank
DB01253,Genito Urinary System and Sex Hormones,DrugBank
DB01253,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01253,P-glycoprotein inhibitors,DrugBank
DB01253,Reproductive Control Agents,DrugBank
DB01253,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01253,Serotonin Agents,DrugBank
DB01253,Serotonin Modulators,DrugBank
DB01253,Uterotonic agents,DrugBank
DB01254,Antineoplastic Agents,DrugBank
DB01254,Antineoplastic and Immunomodulating Agents,DrugBank
DB01254,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB01254,BCRP/ABCG2 Inhibitors,DrugBank
DB01254,BCRP/ABCG2 Substrates,DrugBank
DB01254,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01254,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01254,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01254,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01254,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01254,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01254,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01254,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01254,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01254,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01254,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01254,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01254,Cytochrome P-450 Substrates,DrugBank
DB01254,Drugs causing inadvertant photosensitivity,DrugBank
DB01254,Enzyme Inhibitors,DrugBank
DB01254,Immunosuppressive Agents,DrugBank
DB01254,Kinase Inhibitor,DrugBank
DB01254,Myelosuppressive Agents,DrugBank
DB01254,Narrow Therapeutic Index Drugs,DrugBank
DB01254,P-glycoprotein inhibitors,DrugBank
DB01254,P-glycoprotein substrates,DrugBank
DB01254,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01254,Photosensitizing Agents,DrugBank
DB01254,Potential QTc-Prolonging Agents,DrugBank
DB01254,Protein Kinase Inhibitors,DrugBank
DB01254,Pyrimidines,DrugBank
DB01254,QTc Prolonging Agents,DrugBank
DB01254,Sulfur Compounds,DrugBank
DB01254,Thiazoles,DrugBank
DB01254,Tyrosine Kinase Inhibitors,DrugBank
DB01255,Agents producing tachycardia,DrugBank
DB01255,Agents that produce hypertension,DrugBank
DB01255,Amines,DrugBank
DB01255,Amphetamines,DrugBank
DB01255,Central Nervous System Agents,DrugBank
DB01255,Central Nervous System Stimulants,DrugBank
DB01255,Central Nervous System Stimulation,DrugBank
DB01255,Centrally Acting Sympathomimetics,DrugBank
DB01255,Dopamine Agents,DrugBank
DB01255,Dopamine Uptake Inhibitors,DrugBank
DB01255,Ethylamines,DrugBank
DB01255,Membrane Transport Modulators,DrugBank
DB01255,Nervous System,DrugBank
DB01255,Neurotransmitter Agents,DrugBank
DB01255,Neurotransmitter Uptake Inhibitors,DrugBank
DB01255,Phenethylamines,DrugBank
DB01255,Psychoanaleptics,DrugBank
DB01255,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB01255,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01255,Sympathomimetics,DrugBank
DB01256,Anti-Bacterial Agents,DrugBank
DB01256,Anti-Infective Agents,DrugBank
DB01256,Antibiotics for Topical Use,DrugBank
DB01256,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01256,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01256,Cytochrome P-450 Substrates,DrugBank
DB01256,Dermatologicals,DrugBank
DB01256,Pleuromutilin Antibacterial,DrugBank
DB01256,Terpenes,DrugBank
DB01257,"Amino Acids, Peptides, and Proteins",DrugBank
DB01257,Antibodies,DrugBank
DB01257,"Antibodies, Monoclonal",DrugBank
DB01257,"Antibodies, Monoclonal, Humanized",DrugBank
DB01257,Antineoplastic and Immunomodulating Agents,DrugBank
DB01257,Blood Proteins,DrugBank
DB01257,Complement C5 inhibitors,DrugBank
DB01257,Complement Inactivating Agents,DrugBank
DB01257,Globulins,DrugBank
DB01257,Immunoglobulins,DrugBank
DB01257,Immunologic Factors,DrugBank
DB01257,Immunoproteins,DrugBank
DB01257,Immunosuppressive Agents,DrugBank
DB01257,Immunotherapy,DrugBank
DB01257,Proteins,DrugBank
DB01257,Selective Immunosuppressants,DrugBank
DB01257,Serum Globulins,DrugBank
DB01259,Antineoplastic Agents,DrugBank
DB01259,Antineoplastic and Immunomodulating Agents,DrugBank
DB01259,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01259,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01259,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01259,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01259,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01259,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01259,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01259,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01259,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01259,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01259,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01259,Cytochrome P-450 Substrates,DrugBank
DB01259,Enzyme Inhibitors,DrugBank
DB01259,Hepatotoxic Agents,DrugBank
DB01259,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01259,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,DrugBank
DB01259,Kinase Inhibitor,DrugBank
DB01259,P-glycoprotein inhibitors,DrugBank
DB01259,Potential QTc-Prolonging Agents,DrugBank
DB01259,Protein Kinase Inhibitors,DrugBank
DB01259,QTc Prolonging Agents,DrugBank
DB01259,Quinazolines,DrugBank
DB01259,Tyrosine Kinase Inhibitors,DrugBank
DB01260,Adrenal Cortex Hormones,DrugBank
DB01260,Anti-Inflammatory Agents,DrugBank
DB01260,Corticosteroid Hormone Receptor Agonists,DrugBank
DB01260,Corticosteroids,DrugBank
DB01260,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB01260,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01260,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01260,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01260,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01260,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01260,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01260,Cytochrome P-450 Substrates,DrugBank
DB01260,Dermatologicals,DrugBank
DB01260,Fused-Ring Compounds,DrugBank
DB01260,Immunosuppressive Agents,DrugBank
DB01260,Ophthalmologicals,DrugBank
DB01260,Pregnadienes,DrugBank
DB01260,Pregnadienetriols,DrugBank
DB01260,Pregnanes,DrugBank
DB01260,Sensory Organs,DrugBank
DB01260,Steroids,DrugBank
DB01261,Agents causing angioedema,DrugBank
DB01261,Alimentary Tract and Metabolism,DrugBank
DB01261,Blood Glucose Lowering Agents,DrugBank
DB01261,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01261,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01261,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01261,Cytochrome P-450 Substrates,DrugBank
DB01261,DPP-IV Inhibitors,DrugBank
DB01261,Drugs that are Mainly Renally Excreted,DrugBank
DB01261,Drugs Used in Diabetes,DrugBank
DB01261,Enzyme Inhibitors,DrugBank
DB01261,Hormones,DrugBank
DB01261,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01261,Hypoglycemia-Associated Agents,DrugBank
DB01261,Incretins,DrugBank
DB01261,OAT3/SLC22A8 Substrates,DrugBank
DB01261,Oral Hypoglycemics,DrugBank
DB01261,P-glycoprotein substrates,DrugBank
DB01261,Protease Inhibitors,DrugBank
DB01261,Triazoles,DrugBank
DB01262,Antimetabolites,DrugBank
DB01262,Antineoplastic Agents,DrugBank
DB01262,Antineoplastic and Immunomodulating Agents,DrugBank
DB01262,Aza Compounds,DrugBank
DB01262,Carbohydrates,DrugBank
DB01262,Cytidine Deaminase Substrates,DrugBank
DB01262,Enzyme Inhibitors,DrugBank
DB01262,Glycosides,DrugBank
DB01262,Immunosuppressive Agents,DrugBank
DB01262,Myelosuppressive Agents,DrugBank
DB01262,Narrow Therapeutic Index Drugs,DrugBank
DB01262,Noxae,DrugBank
DB01262,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01262,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01262,Nucleoside Metabolic Inhibitor,DrugBank
DB01262,Nucleosides,DrugBank
DB01262,Pyrimidine Analogues,DrugBank
DB01262,Pyrimidine Nucleosides,DrugBank
DB01262,Pyrimidines,DrugBank
DB01262,Ribonucleosides,DrugBank
DB01262,Toxic Actions,DrugBank
DB01263,14-alpha Demethylase Inhibitors,DrugBank
DB01263,Anti-Infective Agents,DrugBank
DB01263,Antifungal Agents,DrugBank
DB01263,Antiinfectives for Systemic Use,DrugBank
DB01263,Antimycotics for Systemic Use,DrugBank
DB01263,Antiparasitic Agents,DrugBank
DB01263,Antiprotozoals,DrugBank
DB01263,Azole Antifungals,DrugBank
DB01263,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01263,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01263,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01263,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01263,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01263,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01263,Cytochrome P-450 Substrates,DrugBank
DB01263,Enzyme Inhibitors,DrugBank
DB01263,Hormone Antagonists,DrugBank
DB01263,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01263,P-glycoprotein inhibitors,DrugBank
DB01263,P-glycoprotein substrates,DrugBank
DB01263,Potential QTc-Prolonging Agents,DrugBank
DB01263,QTc Prolonging Agents,DrugBank
DB01263,Steroid Synthesis Inhibitors,DrugBank
DB01263,Triazole and tetrazole derivatives,DrugBank
DB01263,Triazole Derivatives,DrugBank
DB01263,Trypanocidal Agents,DrugBank
DB01264,Amides,DrugBank
DB01264,Anti-HIV Agents,DrugBank
DB01264,Anti-Infective Agents,DrugBank
DB01264,Anti-Retroviral Agents,DrugBank
DB01264,Antiinfectives for Systemic Use,DrugBank
DB01264,Antiviral Agents,DrugBank
DB01264,Antivirals for Systemic Use,DrugBank
DB01264,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB01264,Carbamates,DrugBank
DB01264,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01264,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01264,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01264,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01264,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01264,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01264,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01264,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01264,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01264,Cytochrome P-450 Substrates,DrugBank
DB01264,Direct Acting Antivirals,DrugBank
DB01264,Enzyme Inhibitors,DrugBank
DB01264,Experimental Unapproved Treatments for COVID-19,DrugBank
DB01264,Furans,DrugBank
DB01264,Genito Urinary System and Sex Hormones,DrugBank
DB01264,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01264,HIV Protease Inhibitors,DrugBank
DB01264,Hyperglycemia-Associated Agents,DrugBank
DB01264,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01264,P-glycoprotein inducers,DrugBank
DB01264,P-glycoprotein inhibitors,DrugBank
DB01264,P-glycoprotein substrates,DrugBank
DB01264,Protease Inhibitors,DrugBank
DB01264,Sulfonamides,DrugBank
DB01264,Sulfones,DrugBank
DB01264,Sulfur Compounds,DrugBank
DB01264,Viral Protease Inhibitors,DrugBank
DB01267,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01267,Adrenergic alpha-Antagonists,DrugBank
DB01267,Adrenergic Antagonists,DrugBank
DB01267,Agents that produce hypertension,DrugBank
DB01267,Antidepressive Agents,DrugBank
DB01267,Antipsychotic Agents,DrugBank
DB01267,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB01267,Central Nervous System Agents,DrugBank
DB01267,Central Nervous System Depressants,DrugBank
DB01267,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01267,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01267,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01267,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01267,Cytochrome P-450 Substrates,DrugBank
DB01267,Dopamine Agents,DrugBank
DB01267,Dopamine Antagonists,DrugBank
DB01267,Dopamine D2 Receptor Antagonists,DrugBank
DB01267,Drugs that are Mainly Renally Excreted,DrugBank
DB01267,Highest Risk QTc-Prolonging Agents,DrugBank
DB01267,Hyperglycemia-Associated Agents,DrugBank
DB01267,Isoxazoles,DrugBank
DB01267,Nervous System,DrugBank
DB01267,Neurotoxic agents,DrugBank
DB01267,Neurotransmitter Agents,DrugBank
DB01267,P-glycoprotein inhibitors,DrugBank
DB01267,P-glycoprotein substrates,DrugBank
DB01267,Psycholeptics,DrugBank
DB01267,Psychotropic Drugs,DrugBank
DB01267,Pyrimidines,DrugBank
DB01267,QTc Prolonging Agents,DrugBank
DB01267,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01267,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01267,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01267,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB01267,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01267,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01267,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01267,Serotonin Agents,DrugBank
DB01267,Serotonin Receptor Antagonists,DrugBank
DB01267,Tranquilizing Agents,DrugBank
DB01268,Angiogenesis Inhibitors,DrugBank
DB01268,Angiogenesis Modulating Agents,DrugBank
DB01268,Antineoplastic Agents,DrugBank
DB01268,Antineoplastic and Immunomodulating Agents,DrugBank
DB01268,BCRP/ABCG2 Inhibitors,DrugBank
DB01268,Blood Glucose Lowering Agents,DrugBank
DB01268,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01268,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01268,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01268,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01268,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01268,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01268,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB01268,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB01268,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01268,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB01268,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01268,Cytochrome P-450 Substrates,DrugBank
DB01268,Enzyme Inhibitors,DrugBank
DB01268,Growth Inhibitors,DrugBank
DB01268,Growth Substances,DrugBank
DB01268,Hepatotoxic Agents,DrugBank
DB01268,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01268,Hypoglycemia-Associated Agents,DrugBank
DB01268,Immunosuppressive Agents,DrugBank
DB01268,Indoles,DrugBank
DB01268,Kinase Inhibitor,DrugBank
DB01268,Narrow Therapeutic Index Drugs,DrugBank
DB01268,P-glycoprotein inhibitors,DrugBank
DB01268,P-glycoprotein substrates,DrugBank
DB01268,Potential QTc-Prolonging Agents,DrugBank
DB01268,Protein Kinase Inhibitors,DrugBank
DB01268,QTc Prolonging Agents,DrugBank
DB01268,Tyrosine Kinase Inhibitors,DrugBank
DB01269,"Amino Acids, Peptides, and Proteins",DrugBank
DB01269,Antibodies,DrugBank
DB01269,"Antibodies, Monoclonal",DrugBank
DB01269,"Antibodies, Monoclonal, Humanized",DrugBank
DB01269,Antineoplastic Agents,DrugBank
DB01269,"Antineoplastic Agents, Immunological",DrugBank
DB01269,Antineoplastic and Immunomodulating Agents,DrugBank
DB01269,Blood Proteins,DrugBank
DB01269,Cancer immunotherapy,DrugBank
DB01269,EGFR (Epidermal Growth Factor Receptor) inhibitors,DrugBank
DB01269,Epidermal Growth Factor Receptor Antagonist,DrugBank
DB01269,Globulins,DrugBank
DB01269,HER1 Antagonists,DrugBank
DB01269,Immunoglobulins,DrugBank
DB01269,Immunoproteins,DrugBank
DB01269,Immunotherapy,DrugBank
DB01269,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB01269,Proteins,DrugBank
DB01269,Serum Globulins,DrugBank
DB01270,"Amino Acids, Peptides, and Proteins",DrugBank
DB01270,Angiogenesis Inhibitors,DrugBank
DB01270,Angiogenesis Modulating Agents,DrugBank
DB01270,Antibodies,DrugBank
DB01270,"Antibodies, Monoclonal",DrugBank
DB01270,"Antibodies, Monoclonal, Humanized",DrugBank
DB01270,Antineovascularisation Agents,DrugBank
DB01270,Blood Proteins,DrugBank
DB01270,"EENT Drugs, Miscellaneous",DrugBank
DB01270,Globulins,DrugBank
DB01270,Growth Inhibitors,DrugBank
DB01270,Growth Substances,DrugBank
DB01270,Immunoglobulins,DrugBank
DB01270,Immunoproteins,DrugBank
DB01270,Ocular Vascular Disorder Agents,DrugBank
DB01270,Ophthalmics,DrugBank
DB01270,Ophthalmologicals,DrugBank
DB01270,Proteins,DrugBank
DB01270,Sensory Organs,DrugBank
DB01270,Serum Globulins,DrugBank
DB01270,Vascular Endothelial Growth Factor Inhibitor,DrugBank
DB01270,Vascular Endothelial Growth Factor Inhibitors,DrugBank
DB01273,Benzazepines,DrugBank
DB01273,Cholinergic Agents,DrugBank
DB01273,Cholinergic Agonists,DrugBank
DB01273,Cholinergic Receptor Agonist,DrugBank
DB01273,Drugs that are Mainly Renally Excreted,DrugBank
DB01273,Drugs Used in Addictive Disorders,DrugBank
DB01273,Drugs Used in Nicotine Dependence,DrugBank
DB01273,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01273,Miscellaneous Autonomic Drugs,DrugBank
DB01273,Nervous System,DrugBank
DB01273,Neurotransmitter Agents,DrugBank
DB01273,Nicotinic Agonists,DrugBank
DB01273,OCT2 Inhibitors,DrugBank
DB01273,OCT2 Substrates,DrugBank
DB01273,Ophthalmologicals,DrugBank
DB01273,Partial Cholinergic Nicotinic Agonist,DrugBank
DB01273,Partial Cholinergic Nicotinic Agonists,DrugBank
DB01273,Quinoxalines,DrugBank
DB01273,Sensory Organs,DrugBank
DB01273,Smoking Cessation Agents,DrugBank
DB01274,Adrenergic Agents,DrugBank
DB01274,Adrenergic Agonists,DrugBank
DB01274,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01274,Adrenergic beta-Agonists,DrugBank
DB01274,Agents producing tachycardia,DrugBank
DB01274,Agents that produce hypertension,DrugBank
DB01274,Agents to Treat Airway Disease,DrugBank
DB01274,Alcohols,DrugBank
DB01274,Amines,DrugBank
DB01274,Amino Alcohols,DrugBank
DB01274,Autonomic Agents,DrugBank
DB01274,Bronchodilator Agents,DrugBank
DB01274,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01274,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01274,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01274,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01274,Cytochrome P-450 Substrates,DrugBank
DB01274,Drugs that are Mainly Renally Excreted,DrugBank
DB01274,Ethanolamines,DrugBank
DB01274,Long-acting beta-adrenoceptor agonists,DrugBank
DB01274,Peripheral Nervous System Agents,DrugBank
DB01274,Potential QTc-Prolonging Agents,DrugBank
DB01274,QTc Prolonging Agents,DrugBank
DB01274,Respiratory System Agents,DrugBank
DB01275,Antihypertensive Agents,DrugBank
DB01275,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01275,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB01275,Arteriolar Vasodilation,DrugBank
DB01275,Arteriolar Vasodilator,DrugBank
DB01275,Cardiovascular Agents,DrugBank
DB01275,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01275,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01275,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01275,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01275,Direct Vasodilators,DrugBank
DB01275,Drugs that are Mainly Renally Excreted,DrugBank
DB01275,Hydrazinophthalazine Derivatives,DrugBank
DB01275,Hydrazinophthalazine Derivatives and Diuretics,DrugBank
DB01275,Hypotensive Agents,DrugBank
DB01275,Phthalazines,DrugBank
DB01275,Pyridazines,DrugBank
DB01275,Vasodilating Agents,DrugBank
DB01276,Alimentary Tract and Metabolism,DrugBank
DB01276,"Amino Acids, Peptides, and Proteins",DrugBank
DB01276,Anti-Obesity Agents,DrugBank
DB01276,Biological Factors,DrugBank
DB01276,Blood Glucose Lowering Agents,DrugBank
DB01276,Bodily Secretions,DrugBank
DB01276,Drugs Used in Diabetes,DrugBank
DB01276,Fluids and Secretions,DrugBank
DB01276,GLP-1 Agonists,DrugBank
DB01276,Glucagon-Like Peptide 1,DrugBank
DB01276,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB01276,Hormones,DrugBank
DB01276,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01276,Hypoglycemia-Associated Agents,DrugBank
DB01276,Incretin Mimetics,DrugBank
DB01276,Incretins,DrugBank
DB01276,Peptides,DrugBank
DB01276,"Toxins, Biological",DrugBank
DB01276,Venoms,DrugBank
DB01277,"Amino Acids, Peptides, and Proteins",DrugBank
DB01277,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB01277,Biological Factors,DrugBank
DB01277,Blood Glucose Lowering Agents,DrugBank
DB01277,Blood Proteins,DrugBank
DB01277,Growth Substances,DrugBank
DB01277,Human Insulin-like Growth Factor Analogs,DrugBank
DB01277,Hypoglycemia-Associated Agents,DrugBank
DB01277,Insulin-like growth factor,DrugBank
DB01277,Intercellular Signaling Peptides and Proteins,DrugBank
DB01277,Peptides,DrugBank
DB01277,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB01277,Proteins,DrugBank
DB01277,Recombinant Human Insulin-like Growth Factor-1,DrugBank
DB01277,Somatomedins,DrugBank
DB01277,Somatotropin Agonists,DrugBank
DB01277,Somatropin and Somatropin Agonists,DrugBank
DB01277,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01278,Alimentary Tract and Metabolism,DrugBank
DB01278,"Amino Acids, Peptides, and Proteins",DrugBank
DB01278,Amylin Agonists,DrugBank
DB01278,Amylin Analog,DrugBank
DB01278,Amyloid,DrugBank
DB01278,Amyloidogenic Proteins,DrugBank
DB01278,Blood Glucose Lowering Agents,DrugBank
DB01278,Drugs Used in Diabetes,DrugBank
DB01278,Hormones,DrugBank
DB01278,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01278,Hypoglycemia-Associated Agents,DrugBank
DB01278,Pancreatic Hormones,DrugBank
DB01278,Peptide Hormones,DrugBank
DB01278,Peptides,DrugBank
DB01278,Proteins,DrugBank
DB01280,Antimetabolites,DrugBank
DB01280,Antineoplastic Agents,DrugBank
DB01280,Antineoplastic and Immunomodulating Agents,DrugBank
DB01280,Immunosuppressive Agents,DrugBank
DB01280,Myelosuppressive Agents,DrugBank
DB01280,Narrow Therapeutic Index Drugs,DrugBank
DB01280,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01280,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01280,Nucleoside Metabolic Inhibitor,DrugBank
DB01280,Nucleosides,DrugBank
DB01280,Purine Analogues,DrugBank
DB01281,Agents reducing cytokine levels,DrugBank
DB01281,"Amino Acids, Peptides, and Proteins",DrugBank
DB01281,Antibodies,DrugBank
DB01281,"Antineoplastic Agents, Immunological",DrugBank
DB01281,Antineoplastic and Immunomodulating Agents,DrugBank
DB01281,Antirheumatic Agents,DrugBank
DB01281,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB01281,Blood Proteins,DrugBank
DB01281,CD80-directed Antibody Interactions,DrugBank
DB01281,CD86-directed Antibody Interactions,DrugBank
DB01281,Decreased Cytokine Activity,DrugBank
DB01281,Disease-modifying Antirheumatic Agents,DrugBank
DB01281,Globulins,DrugBank
DB01281,Immune Checkpoint Inhibitors,DrugBank
DB01281,Immunoconjugates,DrugBank
DB01281,Immunologic Factors,DrugBank
DB01281,Immunosuppressive Agents,DrugBank
DB01281,Proteins,DrugBank
DB01281,Selective Immunosuppressants,DrugBank
DB01281,Selective T Cell Costimulation Modulator,DrugBank
DB01281,Serum Globulins,DrugBank
DB01282,"Amino Acids, Peptides, and Proteins",DrugBank
DB01282,Delayed-Action Preparations,DrugBank
DB01282,Drug Delivery Systems,DrugBank
DB01282,Hormones,DrugBank
DB01282,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01282,Hypotensive Agents,DrugBank
DB01282,Oxytocin and Analogues,DrugBank
DB01282,Peptide Hormones,DrugBank
DB01282,Peptides,DrugBank
DB01282,Pharmaceutical Preparations,DrugBank
DB01282,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB01282,Pituitary Hormones,DrugBank
DB01282,"Pituitary Hormones, Posterior",DrugBank
DB01282,Posterior Pituitary Lobe Hormones,DrugBank
DB01282,Reproductive Control Agents,DrugBank
DB01282,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01282,Uterotonic agents,DrugBank
DB01283,"Acids, Carbocyclic",DrugBank
DB01283,Agents causing hyperkalemia,DrugBank
DB01283,Agents that produce hypertension,DrugBank
DB01283,Analgesics,DrugBank
DB01283,"Analgesics, Non-Narcotic",DrugBank
DB01283,Anti-Inflammatory Agents,DrugBank
DB01283,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01283,Antiinflammatory and Antirheumatic Products,DrugBank
DB01283,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01283,Antirheumatic Agents,DrugBank
DB01283,COX-2 Inhibitors,DrugBank
DB01283,Cyclooxygenase Inhibitors,DrugBank
DB01283,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01283,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01283,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01283,Cytochrome P-450 Substrates,DrugBank
DB01283,Enzyme Inhibitors,DrugBank
DB01283,Musculo-Skeletal System,DrugBank
DB01283,Nephrotoxic agents,DrugBank
DB01283,Peripheral Nervous System Agents,DrugBank
DB01283,Phenylacetates,DrugBank
DB01283,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB01283,Sensory System Agents,DrugBank
DB01283,UGT1A9 Substrates,DrugBank
DB01284,Adrenals,DrugBank
DB01284,Adrenocortical Insufficiency,DrugBank
DB01284,Adrenocorticotropic Hormone,DrugBank
DB01284,"Amino Acids, Peptides, and Proteins",DrugBank
DB01284,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB01284,Hormones,DrugBank
DB01284,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01284,Melanocortins,DrugBank
DB01284,Nerve Tissue Proteins,DrugBank
DB01284,Neuropeptides,DrugBank
DB01284,Peptide Hormones,DrugBank
DB01284,Peptides,DrugBank
DB01284,Pituitary,DrugBank
DB01284,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB01284,Pituitary Hormones,DrugBank
DB01284,"Pituitary Hormones, Anterior",DrugBank
DB01284,Pro-Opiomelanocortin,DrugBank
DB01284,Proteins,DrugBank
DB01284,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01285,Adrenal Cortex Hormones,DrugBank
DB01285,Adrenocorticotropic Hormone,DrugBank
DB01285,"Amino Acids, Peptides, and Proteins",DrugBank
DB01285,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB01285,Corticosteroids,DrugBank
DB01285,Corticosteroids for Systemic Use,DrugBank
DB01285,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01285,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01285,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01285,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01285,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01285,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01285,Cytochrome P-450 Substrates,DrugBank
DB01285,Fused-Ring Compounds,DrugBank
DB01285,Hormones,DrugBank
DB01285,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01285,Hyperglycemia-Associated Agents,DrugBank
DB01285,Immunosuppressive Agents,DrugBank
DB01285,Melanocortins,DrugBank
DB01285,Nerve Tissue Proteins,DrugBank
DB01285,Neuropeptides,DrugBank
DB01285,Peptide Hormones,DrugBank
DB01285,Peptides,DrugBank
DB01285,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB01285,Pituitary Hormones,DrugBank
DB01285,"Pituitary Hormones, Anterior",DrugBank
DB01285,Pro-Opiomelanocortin,DrugBank
DB01285,Proteins,DrugBank
DB01285,Steroids,DrugBank
DB01285,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01288,Adrenergic Agents,DrugBank
DB01288,Adrenergic Agonists,DrugBank
DB01288,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01288,Adrenergic beta-Agonists,DrugBank
DB01288,Adrenergics for Systemic Use,DrugBank
DB01288,"Adrenergics, Inhalants",DrugBank
DB01288,Agents producing tachycardia,DrugBank
DB01288,Agents that produce hypertension,DrugBank
DB01288,Agents to Treat Airway Disease,DrugBank
DB01288,Alcohols,DrugBank
DB01288,Amines,DrugBank
DB01288,Amino Alcohols,DrugBank
DB01288,Anti-Asthmatic Agents,DrugBank
DB01288,Anticholinergic Agents,DrugBank
DB01288,Autonomic Agents,DrugBank
DB01288,Benzene Derivatives,DrugBank
DB01288,Bronchodilator Agents,DrugBank
DB01288,Catechols,DrugBank
DB01288,Drugs for Obstructive Airway Diseases,DrugBank
DB01288,Ethanolamines,DrugBank
DB01288,Genito Urinary System and Sex Hormones,DrugBank
DB01288,Metaproterenol,DrugBank
DB01288,Neurotransmitter Agents,DrugBank
DB01288,Peripheral Nervous System Agents,DrugBank
DB01288,Phenols,DrugBank
DB01288,Reproductive Control Agents,DrugBank
DB01288,Respiratory System Agents,DrugBank
DB01288,Selective Beta 2-adrenergic Agonists,DrugBank
DB01288,Sympathomimetics,DrugBank
DB01288,"Sympathomimetics, Labour Repressants",DrugBank
DB01288,Tocolytic Agents,DrugBank
DB01289,Alimentary Tract and Metabolism,DrugBank
DB01289,Amides,DrugBank
DB01289,Blood Glucose Lowering Agents,DrugBank
DB01289,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01289,Cytochrome P-450 Substrates,DrugBank
DB01289,Drugs Used in Diabetes,DrugBank
DB01289,Insulin Secretagogues,DrugBank
DB01289,Oral Hypoglycemics,DrugBank
DB01289,Sulfones,DrugBank
DB01289,Sulfonylureas,DrugBank
DB01289,Sulfur Compounds,DrugBank
DB01291,Adrenergic Agents,DrugBank
DB01291,Adrenergic Agonists,DrugBank
DB01291,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01291,Adrenergic beta-Agonists,DrugBank
DB01291,Adrenergics for Systemic Use,DrugBank
DB01291,"Adrenergics, Inhalants",DrugBank
DB01291,Agents producing tachycardia,DrugBank
DB01291,Agents that produce hypertension,DrugBank
DB01291,Agents to Treat Airway Disease,DrugBank
DB01291,Alcohols,DrugBank
DB01291,Amines,DrugBank
DB01291,Amino Alcohols,DrugBank
DB01291,Anti-Asthmatic Agents,DrugBank
DB01291,Autonomic Agents,DrugBank
DB01291,Bronchodilator Agents,DrugBank
DB01291,Cardiotonic Agents,DrugBank
DB01291,Cardiovascular Agents,DrugBank
DB01291,"Compounds used in a research, industrial, or household setting",DrugBank
DB01291,Drugs for Obstructive Airway Diseases,DrugBank
DB01291,Neurotransmitter Agents,DrugBank
DB01291,Peripheral Nervous System Agents,DrugBank
DB01291,Protective Agents,DrugBank
DB01291,Respiratory System Agents,DrugBank
DB01291,Selective Beta 2-adrenergic Agonists,DrugBank
DB01294,"Acids, Carbocyclic",DrugBank
DB01294,Antacids and Adsorbents,DrugBank
DB01294,Antidiarrheals,DrugBank
DB01294,Benzene Derivatives,DrugBank
DB01294,Benzoates,DrugBank
DB01294,Bismuth containing drugs,DrugBank
DB01294,Elements,DrugBank
DB01294,"Elements, Radioactive",DrugBank
DB01294,Gastrointestinal Agents,DrugBank
DB01294,Helicobacter Infections,DrugBank
DB01294,Hydroxy Acids,DrugBank
DB01294,Hydroxybenzoates,DrugBank
DB01294,Isotopes,DrugBank
DB01294,Metals,DrugBank
DB01294,"Metals, Heavy",DrugBank
DB01294,Neurotoxic agents,DrugBank
DB01294,Phenols,DrugBank
DB01294,Radioisotopes,DrugBank
DB01294,Salicylates,DrugBank
DB01295,Adrenergic Agents,DrugBank
DB01295,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01295,Adrenergic alpha-Antagonists,DrugBank
DB01295,Adrenergic Antagonists,DrugBank
DB01295,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB01295,Adrenergic beta-Antagonists,DrugBank
DB01295,Agents causing hyperkalemia,DrugBank
DB01295,Alcohols,DrugBank
DB01295,Amines,DrugBank
DB01295,Amino Alcohols,DrugBank
DB01295,Antihypertensive Agents,DrugBank
DB01295,Beta Blocking Agents and Thiazides,DrugBank
DB01295,"Beta Blocking Agents, Selective",DrugBank
DB01295,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB01295,Bradycardia-Causing Agents,DrugBank
DB01295,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01295,Cytochrome P-450 Substrates,DrugBank
DB01295,Neurotransmitter Agents,DrugBank
DB01295,Propanols,DrugBank
DB01296,Amino Sugars,DrugBank
DB01296,Antiinflammatory and Antirheumatic Products,DrugBank
DB01296,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01296,Carbohydrates,DrugBank
DB01296,Hexosamines,DrugBank
DB01296,Musculo-Skeletal System,DrugBank
DB01297,Acetanilides,DrugBank
DB01297,Adrenergic Agents,DrugBank
DB01297,Adrenergic Antagonists,DrugBank
DB01297,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB01297,Adrenergic beta-Antagonists,DrugBank
DB01297,Agents causing hyperkalemia,DrugBank
DB01297,Alcohols,DrugBank
DB01297,Amides,DrugBank
DB01297,Amines,DrugBank
DB01297,Amino Alcohols,DrugBank
DB01297,Anilides,DrugBank
DB01297,Aniline Compounds,DrugBank
DB01297,Antiarrhythmic agents,DrugBank
DB01297,Antihypertensive Agents,DrugBank
DB01297,"Beta Blocking Agents, Selective",DrugBank
DB01297,Bradycardia-Causing Agents,DrugBank
DB01297,Cardiovascular Agents,DrugBank
DB01297,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01297,Cytochrome P-450 Substrates,DrugBank
DB01297,Neurotransmitter Agents,DrugBank
DB01297,Phenoxypropanolamines,DrugBank
DB01297,Propanolamines,DrugBank
DB01297,Propanols,DrugBank
DB01298,Amides,DrugBank
DB01298,Amines,DrugBank
DB01298,Aniline Compounds,DrugBank
DB01298,Genito Urinary System and Sex Hormones,DrugBank
DB01298,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01298,Sulfonamides,DrugBank
DB01298,Sulfones,DrugBank
DB01298,Sulfur Compounds,DrugBank
DB01299,Amides,DrugBank
DB01299,Amines,DrugBank
DB01299,Aniline Compounds,DrugBank
DB01299,Anti-Infective Agents,DrugBank
DB01299,"Anti-Infective Agents, Urinary",DrugBank
DB01299,Antimalarials,DrugBank
DB01299,Antiparasitic Agents,DrugBank
DB01299,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01299,Antiprotozoals,DrugBank
DB01299,Benzene Derivatives,DrugBank
DB01299,Benzenesulfonamides,DrugBank
DB01299,Genito Urinary System and Sex Hormones,DrugBank
DB01299,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01299,Long-Acting Antibacterial Sulfonamides,DrugBank
DB01299,Sulfanilamides,DrugBank
DB01299,Sulfonamides,DrugBank
DB01299,Sulfones,DrugBank
DB01299,Sulfur Compounds,DrugBank
DB01301,Agents that produce neuromuscular block (indirect),DrugBank
DB01301,Anti-Bacterial Agents,DrugBank
DB01301,Anti-Infective Agents,DrugBank
DB01301,Antibacterials for Systemic Use,DrugBank
DB01301,Antiinfectives for Systemic Use,DrugBank
DB01301,Naphthacenes,DrugBank
DB01301,Tetracyclines,DrugBank
DB01303,Alcohols,DrugBank
DB01303,Alkaloids,DrugBank
DB01303,Amines,DrugBank
DB01303,Amino Alcohols,DrugBank
DB01303,Anti-Asthmatic Agents,DrugBank
DB01303,Autonomic Agents,DrugBank
DB01303,Bronchodilator Agents,DrugBank
DB01303,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01303,Cytochrome P-450 Substrates,DrugBank
DB01303,Drugs for Obstructive Airway Diseases,DrugBank
DB01303,Ethanolamines,DrugBank
DB01303,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01303,Onium Compounds,DrugBank
DB01303,Peripheral Nervous System Agents,DrugBank
DB01303,Purines,DrugBank
DB01303,Purinones,DrugBank
DB01303,Quaternary Ammonium Compounds,DrugBank
DB01303,Respiratory Smooth Muscle Relaxants,DrugBank
DB01303,Respiratory System Agents,DrugBank
DB01303,Trimethyl Ammonium Compounds,DrugBank
DB01303,Xanthine derivatives,DrugBank
DB01303,Xanthines and Adrenergics,DrugBank
DB01306,Alimentary Tract and Metabolism,DrugBank
DB01306,"Amino Acids, Peptides, and Proteins",DrugBank
DB01306,Blood Glucose Lowering Agents,DrugBank
DB01306,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01306,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01306,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01306,Drugs Used in Diabetes,DrugBank
DB01306,Hormones,DrugBank
DB01306,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01306,Hypoglycemia-Associated Agents,DrugBank
DB01306,Insulin,DrugBank
DB01306,Insulin Analog,DrugBank
DB01306,"Insulin, Short-Acting",DrugBank
DB01306,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB01306,Pancreatic Hormones,DrugBank
DB01306,Peptide Hormones,DrugBank
DB01306,Peptides,DrugBank
DB01307,Alimentary Tract and Metabolism,DrugBank
DB01307,"Amino Acids, Peptides, and Proteins",DrugBank
DB01307,Blood Glucose Lowering Agents,DrugBank
DB01307,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01307,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01307,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01307,Drugs Used in Diabetes,DrugBank
DB01307,Hormones,DrugBank
DB01307,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01307,Hypoglycemia-Associated Agents,DrugBank
DB01307,Insulin,DrugBank
DB01307,Insulin Analog,DrugBank
DB01307,"Insulin, Long-Acting",DrugBank
DB01307,Pancreatic Hormones,DrugBank
DB01307,Peptide Hormones,DrugBank
DB01307,Peptides,DrugBank
DB01309,Alimentary Tract and Metabolism,DrugBank
DB01309,"Amino Acids, Peptides, and Proteins",DrugBank
DB01309,Blood Glucose Lowering Agents,DrugBank
DB01309,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01309,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01309,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01309,Drugs Used in Diabetes,DrugBank
DB01309,Hormones,DrugBank
DB01309,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01309,Hypoglycemia-Associated Agents,DrugBank
DB01309,Insulin,DrugBank
DB01309,Insulin Analog,DrugBank
DB01309,"Insulin, Short-Acting",DrugBank
DB01309,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB01309,Pancreatic Hormones,DrugBank
DB01309,Peptide Hormones,DrugBank
DB01309,Peptides,DrugBank
DB01309,Proteins,DrugBank
DB01319,"Acids, Acyclic",DrugBank
DB01319,Amides,DrugBank
DB01319,Amprenavir and Prodrugs,DrugBank
DB01319,Anti-HIV Agents,DrugBank
DB01319,Anti-Infective Agents,DrugBank
DB01319,Anti-Retroviral Agents,DrugBank
DB01319,Antiinfectives for Systemic Use,DrugBank
DB01319,Antiviral Agents,DrugBank
DB01319,Antivirals for Systemic Use,DrugBank
DB01319,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01319,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01319,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01319,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01319,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01319,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01319,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01319,Cytochrome P-450 Substrates,DrugBank
DB01319,Direct Acting Antivirals,DrugBank
DB01319,Enzyme Inhibitors,DrugBank
DB01319,HIV Protease Inhibitors,DrugBank
DB01319,Hyperglycemia-Associated Agents,DrugBank
DB01319,Protease Inhibitors,DrugBank
DB01319,Sulfones,DrugBank
DB01319,Sulfur Compounds,DrugBank
DB01319,Viral Protease Inhibitors,DrugBank
DB01320,Anti-epileptic Agent,DrugBank
DB01320,Anticonvulsants,DrugBank
DB01320,Cardiovascular Agents,DrugBank
DB01320,Central Nervous System Agents,DrugBank
DB01320,Central Nervous System Depressants,DrugBank
DB01320,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB01320,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB01320,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB01320,Cytochrome P-450 CYP2B6 Inducers (strong),DrugBank
DB01320,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01320,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01320,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01320,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB01320,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01320,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01320,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01320,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01320,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01320,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01320,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01320,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01320,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01320,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01320,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01320,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01320,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01320,Cytochrome P-450 Substrates,DrugBank
DB01320,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB01320,Enzyme Inducing Antiepileptic Drugs,DrugBank
DB01320,Hydantoins,DrugBank
DB01320,Imidazoles,DrugBank
DB01320,Imidazolidines,DrugBank
DB01320,Membrane Transport Modulators,DrugBank
DB01320,Narrow Therapeutic Index Drugs,DrugBank
DB01320,Nervous System,DrugBank
DB01320,Phenytoin and Prodrugs,DrugBank
DB01320,Prodrugs,DrugBank
DB01320,Sodium Channel Blockers,DrugBank
DB01320,Thyroxine-binding globulin substrates,DrugBank
DB01320,UGT1A6 Inhibitors,DrugBank
DB01320,UGT1A9 Inhibitors,DrugBank
DB01321,Anti-Bacterial Agents,DrugBank
DB01321,Anti-Infective Agents,DrugBank
DB01321,Antibacterials for Systemic Use,DrugBank
DB01321,Antiinfectives for Systemic Use,DrugBank
DB01321,Lactones,DrugBank
DB01321,Macrolides,DrugBank
DB01321,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB01321,Polyketides,DrugBank
DB01323,Angiosperms,DrugBank
DB01323,Antidepressive Agents,DrugBank
DB01323,Antidepressive Agents Indicated for Depression,DrugBank
DB01323,Biological Products,DrugBank
DB01323,Central Nervous System Depressants,DrugBank
DB01323,Clusiaceae,DrugBank
DB01323,Complex Mixtures,DrugBank
DB01323,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01323,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB01323,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01323,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01323,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01323,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01323,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB01323,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01323,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01323,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB01323,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01323,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01323,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01323,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01323,Cytochrome P-450 Substrates,DrugBank
DB01323,Embryophyta,DrugBank
DB01323,Eukaryota,DrugBank
DB01323,Herbs and Natural Products,DrugBank
DB01323,Hyperglycemia-Associated Agents,DrugBank
DB01323,Nervous System,DrugBank
DB01323,P-glycoprotein inducers,DrugBank
DB01323,Pharmaceutical Preparations,DrugBank
DB01323,Plant Preparations,DrugBank
DB01323,Psychoanaleptics,DrugBank
DB01323,Rosanae,DrugBank
DB01323,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01323,Streptophyta,DrugBank
DB01323,Tracheophyta,DrugBank
DB01323,Viridiplantae,DrugBank
DB01324,Amides,DrugBank
DB01324,Antihypertensive Agents,DrugBank
DB01324,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01324,Benzothiadiazines,DrugBank
DB01324,Cardiovascular Agents,DrugBank
DB01324,Diuretics,DrugBank
DB01324,Drugs causing inadvertant photosensitivity,DrugBank
DB01324,Genito Urinary System and Sex Hormones,DrugBank
DB01324,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01324,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01324,Hyperglycemia-Associated Agents,DrugBank
DB01324,Increased Diuresis,DrugBank
DB01324,Membrane Transport Modulators,DrugBank
DB01324,Natriuretic Agents,DrugBank
DB01324,OAT3/SLC22A8 Substrates,DrugBank
DB01324,Photosensitizing Agents,DrugBank
DB01324,Sodium Chloride Symporter Inhibitors,DrugBank
DB01324,Sulfonamides,DrugBank
DB01324,Sulfones,DrugBank
DB01324,Sulfur Compounds,DrugBank
DB01324,Thiazides,DrugBank
DB01325,Amides,DrugBank
DB01325,Cardiovascular Agents,DrugBank
DB01325,Diuretics,DrugBank
DB01325,Genito Urinary System and Sex Hormones,DrugBank
DB01325,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01325,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01325,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB01325,Membrane Transport Modulators,DrugBank
DB01325,Natriuretic Agents,DrugBank
DB01325,Sodium Chloride Symporter Inhibitors,DrugBank
DB01325,Sulfonamides,DrugBank
DB01325,Sulfones,DrugBank
DB01325,Sulfur Compounds,DrugBank
DB01326,Amides,DrugBank
DB01326,Anti-Bacterial Agents,DrugBank
DB01326,Anti-Infective Agents,DrugBank
DB01326,Antibacterials for Systemic Use,DrugBank
DB01326,Antiinfectives for Systemic Use,DrugBank
DB01326,beta-Lactams,DrugBank
DB01326,Cephalosporins,DrugBank
DB01326,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01326,Lactams,DrugBank
DB01326,Nephrotoxic agents,DrugBank
DB01326,OAT1/SLC22A6 inhibitors,DrugBank
DB01326,OAT3/SLC22A8 Inhibitors,DrugBank
DB01326,Second-Generation Cephalosporins,DrugBank
DB01326,Sulfur Compounds,DrugBank
DB01326,Thiazines,DrugBank
DB01327,Amides,DrugBank
DB01327,Anti-Bacterial Agents,DrugBank
DB01327,Anti-Infective Agents,DrugBank
DB01327,Antibacterials for Systemic Use,DrugBank
DB01327,Antiinfectives for Systemic Use,DrugBank
DB01327,beta-Lactams,DrugBank
DB01327,Cephalosporins,DrugBank
DB01327,First-Generation Cephalosporins,DrugBank
DB01327,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01327,Lactams,DrugBank
DB01327,Nephrotoxic agents,DrugBank
DB01327,OAT1/SLC22A6 inhibitors,DrugBank
DB01327,OAT1/SLC22A6 Substrates,DrugBank
DB01327,OAT3/SLC22A8 Inhibitors,DrugBank
DB01327,OAT3/SLC22A8 Substrates,DrugBank
DB01327,Sulfur Compounds,DrugBank
DB01327,Thiazines,DrugBank
DB01328,Amides,DrugBank
DB01328,Anti-Bacterial Agents,DrugBank
DB01328,Anti-Infective Agents,DrugBank
DB01328,Antibacterials for Systemic Use,DrugBank
DB01328,Antiinfectives for Systemic Use,DrugBank
DB01328,beta-Lactams,DrugBank
DB01328,Cephalosporins,DrugBank
DB01328,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01328,Lactams,DrugBank
DB01328,Nephrotoxic agents,DrugBank
DB01328,Second-Generation Cephalosporins,DrugBank
DB01328,Sulfur Compounds,DrugBank
DB01328,Thiazines,DrugBank
DB01329,Amides,DrugBank
DB01329,Anti-Bacterial Agents,DrugBank
DB01329,Anti-Infective Agents,DrugBank
DB01329,Antibacterials for Systemic Use,DrugBank
DB01329,Antiinfectives for Systemic Use,DrugBank
DB01329,beta-Lactams,DrugBank
DB01329,Cephalosporins,DrugBank
DB01329,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01329,Lactams,DrugBank
DB01329,Nephrotoxic agents,DrugBank
DB01329,OAT1/SLC22A6 inhibitors,DrugBank
DB01329,OAT3/SLC22A8 Inhibitors,DrugBank
DB01329,Sulfur Compounds,DrugBank
DB01329,Thiazines,DrugBank
DB01329,Third-Generation Cephalosporins,DrugBank
DB01330,Amides,DrugBank
DB01330,Anti-Bacterial Agents,DrugBank
DB01330,Anti-Infective Agents,DrugBank
DB01330,Antibacterials for Systemic Use,DrugBank
DB01330,Antiinfectives for Systemic Use,DrugBank
DB01330,beta-Lactams,DrugBank
DB01330,Cephalosporins,DrugBank
DB01330,Cephamycins,DrugBank
DB01330,Drugs that are Mainly Renally Excreted,DrugBank
DB01330,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01330,Lactams,DrugBank
DB01330,Nephrotoxic agents,DrugBank
DB01330,Second-Generation Cephalosporins,DrugBank
DB01330,Sulfur Compounds,DrugBank
DB01330,Tetrazoles,DrugBank
DB01330,Thiazines,DrugBank
DB01331,Amides,DrugBank
DB01331,Anti-Bacterial Agents,DrugBank
DB01331,Anti-Infective Agents,DrugBank
DB01331,Antibacterials for Systemic Use,DrugBank
DB01331,Antiinfectives for Systemic Use,DrugBank
DB01331,beta-Lactams,DrugBank
DB01331,Cephalosporins,DrugBank
DB01331,Cephamycins,DrugBank
DB01331,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01331,Lactams,DrugBank
DB01331,Nephrotoxic agents,DrugBank
DB01331,Second-Generation Cephalosporins,DrugBank
DB01331,Sulfur Compounds,DrugBank
DB01331,Thiazines,DrugBank
DB01332,Amides,DrugBank
DB01332,Anti-Bacterial Agents,DrugBank
DB01332,Anti-Infective Agents,DrugBank
DB01332,Antibacterials for Systemic Use,DrugBank
DB01332,Antiinfectives for Systemic Use,DrugBank
DB01332,beta-Lactams,DrugBank
DB01332,Cephalosporins,DrugBank
DB01332,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01332,Lactams,DrugBank
DB01332,Nephrotoxic agents,DrugBank
DB01332,OAT1/SLC22A6 inhibitors,DrugBank
DB01332,OAT1/SLC22A6 Substrates,DrugBank
DB01332,OAT3/SLC22A8 Inhibitors,DrugBank
DB01332,OAT3/SLC22A8 Substrates,DrugBank
DB01332,Sulfur Compounds,DrugBank
DB01332,Thiazines,DrugBank
DB01332,Third-Generation Cephalosporins,DrugBank
DB01333,Amides,DrugBank
DB01333,Anti-Bacterial Agents,DrugBank
DB01333,Anti-Infective Agents,DrugBank
DB01333,Antibacterials for Systemic Use,DrugBank
DB01333,Antiinfectives for Systemic Use,DrugBank
DB01333,beta-Lactams,DrugBank
DB01333,Cephalosporins,DrugBank
DB01333,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01333,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01333,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01333,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01333,Drugs that are Mainly Renally Excreted,DrugBank
DB01333,First-Generation Cephalosporins,DrugBank
DB01333,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01333,Lactams,DrugBank
DB01333,MATE 1 Substrates,DrugBank
DB01333,MATE substrates,DrugBank
DB01333,Nephrotoxic agents,DrugBank
DB01333,OAT1/SLC22A6 inhibitors,DrugBank
DB01333,Sulfur Compounds,DrugBank
DB01333,Thiazines,DrugBank
DB01336,Agents producing tachycardia,DrugBank
DB01336,Alkaloids,DrugBank
DB01336,Amines,DrugBank
DB01336,Anticholinergic Agents,DrugBank
DB01336,Benzylisoquinolines,DrugBank
DB01336,Central Nervous System Depressants,DrugBank
DB01336,Curare Alkaloids,DrugBank
DB01336,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01336,Isoquinolines,DrugBank
DB01336,Muscarinic Antagonists,DrugBank
DB01336,Muscle Relaxants,DrugBank
DB01336,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01336,Musculo-Skeletal System,DrugBank
DB01336,Neuromuscular Agents,DrugBank
DB01336,Neuromuscular Blocking Agents,DrugBank
DB01336,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01336,Nicotinic Antagonists,DrugBank
DB01336,Onium Compounds,DrugBank
DB01336,Peripheral Nervous System Agents,DrugBank
DB01336,Quaternary Ammonium Compounds,DrugBank
DB01336,Tetrahydroisoquinolines,DrugBank
DB01337,Agents producing tachycardia,DrugBank
DB01337,Androstanes,DrugBank
DB01337,Androstanols,DrugBank
DB01337,Anticholinergic Agents,DrugBank
DB01337,Central Nervous System Depressants,DrugBank
DB01337,Cholinergic Agents,DrugBank
DB01337,Cholinesterase Inhibitors,DrugBank
DB01337,Fused-Ring Compounds,DrugBank
DB01337,Muscarinic Antagonists,DrugBank
DB01337,Muscle Relaxants,DrugBank
DB01337,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01337,Musculo-Skeletal System,DrugBank
DB01337,Neuromuscular Agents,DrugBank
DB01337,Neuromuscular Blocking Agents,DrugBank
DB01337,Neuromuscular Nondepolarizing Blockade,DrugBank
DB01337,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01337,Neurotransmitter Agents,DrugBank
DB01337,Nicotinic Antagonists,DrugBank
DB01337,OCT1 inhibitors,DrugBank
DB01337,OCT1 substrates,DrugBank
DB01337,Peripheral Nervous System Agents,DrugBank
DB01337,Steroids,DrugBank
DB01338,Agents producing tachycardia,DrugBank
DB01338,Anticholinergic Agents,DrugBank
DB01338,Central Nervous System Depressants,DrugBank
DB01338,Cholinergic Agents,DrugBank
DB01338,Cholinesterase Inhibitors,DrugBank
DB01338,Muscarinic Antagonists,DrugBank
DB01338,Muscle Relaxants,DrugBank
DB01338,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01338,Musculo-Skeletal System,DrugBank
DB01338,Neuromuscular Agents,DrugBank
DB01338,Neuromuscular Blocking Agents,DrugBank
DB01338,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01338,Neurotransmitter Agents,DrugBank
DB01338,Nicotinic Antagonists,DrugBank
DB01338,Peripheral Nervous System Agents,DrugBank
DB01338,Piperazines,DrugBank
DB01339,Androstanes,DrugBank
DB01339,Androstanols,DrugBank
DB01339,Anticholinergic Agents,DrugBank
DB01339,Central Nervous System Depressants,DrugBank
DB01339,Cholinergic Agents,DrugBank
DB01339,Fused-Ring Compounds,DrugBank
DB01339,Muscle Relaxants,DrugBank
DB01339,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB01339,Musculo-Skeletal System,DrugBank
DB01339,Neuromuscular Agents,DrugBank
DB01339,Neuromuscular Blocking Agents,DrugBank
DB01339,Neuromuscular Nondepolarizing Blockade,DrugBank
DB01339,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB01339,Neurotransmitter Agents,DrugBank
DB01339,Nicotinic Antagonists,DrugBank
DB01339,P-glycoprotein substrates,DrugBank
DB01339,Peripheral Nervous System Agents,DrugBank
DB01339,Steroids,DrugBank
DB01340,ACE Inhibitors and Diuretics,DrugBank
DB01340,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01340,Agents causing angioedema,DrugBank
DB01340,Agents causing hyperkalemia,DrugBank
DB01340,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB01340,Antihypertensive Agents,DrugBank
DB01340,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB01340,Cardiovascular Agents,DrugBank
DB01340,Enzyme Inhibitors,DrugBank
DB01340,Hypotensive Agents,DrugBank
DB01340,P-glycoprotein inhibitors,DrugBank
DB01340,Protease Inhibitors,DrugBank
DB01340,Pyridazines,DrugBank
DB01342,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01342,Agents causing angioedema,DrugBank
DB01342,Agents causing hyperkalemia,DrugBank
DB01342,Angiotensin II receptor antagonists,DrugBank
DB01342,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB01342,Angiotensin Receptor Antagonists,DrugBank
DB01344,Acids,DrugBank
DB01344,"Acids, Noncarboxylic",DrugBank
DB01344,Benzene Derivatives,DrugBank
DB01344,Benzylidene Compounds,DrugBank
DB01344,Cation Exchange Resins,DrugBank
DB01344,Chelating Agents,DrugBank
DB01344,"Compounds used in a research, industrial, or household setting",DrugBank
DB01344,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB01344,Ion Exchange Resins,DrugBank
DB01344,Laboratory Chemicals,DrugBank
DB01344,Macromolecular Substances,DrugBank
DB01344,Plastics,DrugBank
DB01344,Polymers,DrugBank
DB01344,Polystyrene Sulfonates,DrugBank
DB01344,Potassium Binder,DrugBank
DB01344,Potassium Ion Exchange Activity,DrugBank
DB01344,Potassium-removing Agents,DrugBank
DB01344,Sequestering Agents,DrugBank
DB01344,Styrene,DrugBank
DB01344,Styrenes,DrugBank
DB01344,Sulfur Acids,DrugBank
DB01344,Sulfur Compounds,DrugBank
DB01345,Agents causing hyperkalemia,DrugBank
DB01345,Diuretics,DrugBank
DB01345,Drugs that are Mainly Renally Excreted,DrugBank
DB01345,Increased Large Intestinal Motility,DrugBank
DB01345,Inhibition Large Intestine Fluid/Electrolyte Absorption,DrugBank
DB01345,Minerals,DrugBank
DB01345,Osmotic Activity,DrugBank
DB01345,Potassium Salt,DrugBank
DB01345,Replacement Preparations,DrugBank
DB01347,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01347,Agents causing angioedema,DrugBank
DB01347,Agents causing hyperkalemia,DrugBank
DB01347,Angiotensin II receptor antagonists,DrugBank
DB01347,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB01347,Angiotensin Receptor Antagonists,DrugBank
DB01347,Antihypertensive Agents,DrugBank
DB01347,Cardiovascular Agents,DrugBank
DB01347,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01348,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01348,Agents causing angioedema,DrugBank
DB01348,Agents causing hyperkalemia,DrugBank
DB01348,"Amino Acids, Peptides, and Proteins",DrugBank
DB01348,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB01348,Antihypertensive Agents,DrugBank
DB01348,Cardiovascular Agents,DrugBank
DB01348,Dipeptides,DrugBank
DB01348,Enzyme Inhibitors,DrugBank
DB01348,Oligopeptides,DrugBank
DB01348,Peptides,DrugBank
DB01348,Protease Inhibitors,DrugBank
DB01349,Agents Acting on the Renin-Angiotensin System,DrugBank
DB01349,Agents causing hyperkalemia,DrugBank
DB01349,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB01349,Angiotensin Receptor Antagonists,DrugBank
DB01349,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01349,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01349,Cytochrome P-450 Substrates,DrugBank
DB01351,Anticholinergic Agents,DrugBank
DB01351,Anticonvulsants,DrugBank
DB01351,Barbiturates,DrugBank
DB01351,"Barbiturates, Plain",DrugBank
DB01351,Central Nervous System Agents,DrugBank
DB01351,Central Nervous System Depressants,DrugBank
DB01351,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01351,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01351,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01351,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01351,GABA Agents,DrugBank
DB01351,GABA Modulators,DrugBank
DB01351,Hypnotics and Sedatives,DrugBank
DB01351,Nervous System,DrugBank
DB01351,Neurotransmitter Agents,DrugBank
DB01351,Nicotinic Antagonists,DrugBank
DB01351,Psycholeptics,DrugBank
DB01351,Pyrimidines,DrugBank
DB01351,Pyrimidinones,DrugBank
DB01352,Anticholinergic Agents,DrugBank
DB01352,"Barbiturates, Plain",DrugBank
DB01352,Central Nervous System Depressants,DrugBank
DB01352,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01352,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01352,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01352,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01352,Hypnotics and Sedatives,DrugBank
DB01352,Nervous System,DrugBank
DB01352,Nicotinic Antagonists,DrugBank
DB01352,Psycholeptics,DrugBank
DB01352,Pyrimidines,DrugBank
DB01352,Pyrimidinones,DrugBank
DB01353,Anticholinergic Agents,DrugBank
DB01353,"Barbiturates, Plain",DrugBank
DB01353,Central Nervous System Agents,DrugBank
DB01353,Central Nervous System Depressants,DrugBank
DB01353,Hypnotics and Sedatives,DrugBank
DB01353,Nervous System,DrugBank
DB01353,Nicotinic Antagonists,DrugBank
DB01353,Psycholeptics,DrugBank
DB01353,Pyrimidines,DrugBank
DB01353,Pyrimidinones,DrugBank
DB01354,Anticholinergic Agents,DrugBank
DB01354,"Barbiturates, Plain",DrugBank
DB01354,Central Nervous System Depressants,DrugBank
DB01354,Hypnotics and Sedatives,DrugBank
DB01354,Nervous System,DrugBank
DB01354,Nicotinic Antagonists,DrugBank
DB01354,Psycholeptics,DrugBank
DB01354,Pyrimidines,DrugBank
DB01354,Pyrimidinones,DrugBank
DB01355,Adjuvants,DrugBank
DB01355,Anesthetics,DrugBank
DB01355,"Anesthetics, General",DrugBank
DB01355,Anticholinergic Agents,DrugBank
DB01355,Anticonvulsants,DrugBank
DB01355,Barbiturates,DrugBank
DB01355,"Barbiturates, Plain",DrugBank
DB01355,Central Nervous System Agents,DrugBank
DB01355,Central Nervous System Depressants,DrugBank
DB01355,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01355,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01355,Cytochrome P-450 Substrates,DrugBank
DB01355,GABA Agents,DrugBank
DB01355,GABA Modulators,DrugBank
DB01355,Hypnotics and Sedatives,DrugBank
DB01355,Nervous System,DrugBank
DB01355,Neurotransmitter Agents,DrugBank
DB01355,Nicotinic Antagonists,DrugBank
DB01355,Psycholeptics,DrugBank
DB01355,Pyrimidines,DrugBank
DB01355,Pyrimidinones,DrugBank
DB01356,Antidepressive Agents,DrugBank
DB01356,Antimanic Agents,DrugBank
DB01356,Antipsychotic Agents,DrugBank
DB01356,Central Nervous System Depressants,DrugBank
DB01356,Highest Risk QTc-Prolonging Agents,DrugBank
DB01356,Lithium Compounds,DrugBank
DB01356,Mood Stabilizer,DrugBank
DB01356,Nephrotoxic agents,DrugBank
DB01356,Neurotoxic agents,DrugBank
DB01356,Psychotropic Drugs,DrugBank
DB01356,QTc Prolonging Agents,DrugBank
DB01356,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01356,Serotonin Agents,DrugBank
DB01356,Serotonin Modulators,DrugBank
DB01357,Adrenal Cortex Hormones,DrugBank
DB01357,"Contraceptive Agents, Female",DrugBank
DB01357,"Contraceptive Agents, Hormonal",DrugBank
DB01357,"Contraceptives, Oral",DrugBank
DB01357,"Contraceptives, Oral, Hormonal",DrugBank
DB01357,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01357,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01357,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01357,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01357,Cytochrome P-450 Substrates,DrugBank
DB01357,Estradiol Congeners,DrugBank
DB01357,Estrogen Contraceptives,DrugBank
DB01357,"Estrogenic Steroids, Alkylated",DrugBank
DB01357,Estrogens,DrugBank
DB01357,Ethinyl Estradiol,DrugBank
DB01357,Fused-Ring Compounds,DrugBank
DB01357,Gonadal Hormones,DrugBank
DB01357,Gonadal Steroid Hormones,DrugBank
DB01357,Hormonal Contraceptives for Systemic Use,DrugBank
DB01357,Hormones,DrugBank
DB01357,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01357,Hyperglycemia-Associated Agents,DrugBank
DB01357,Norpregnanes,DrugBank
DB01357,Norpregnatrienes,DrugBank
DB01357,Norsteroids,DrugBank
DB01357,Reproductive Control Agents,DrugBank
DB01357,Steroids,DrugBank
DB01357,Thyroxine-binding globulin inducers,DrugBank
DB01359,Adrenergic Agents,DrugBank
DB01359,Adrenergic Antagonists,DrugBank
DB01359,Adrenergic beta-Antagonists,DrugBank
DB01359,Agents causing hyperkalemia,DrugBank
DB01359,Alcohols,DrugBank
DB01359,Amines,DrugBank
DB01359,Amino Alcohols,DrugBank
DB01359,Antidepressive Agents,DrugBank
DB01359,Antihypertensive Agents,DrugBank
DB01359,"Beta Blocking Agents, Non-Selective",DrugBank
DB01359,Bradycardia-Causing Agents,DrugBank
DB01359,Cardiovascular Agents,DrugBank
DB01359,Central Nervous System Depressants,DrugBank
DB01359,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01359,Cytochrome P-450 Substrates,DrugBank
DB01359,Drugs that are Mainly Renally Excreted,DrugBank
DB01359,Hypotensive Agents,DrugBank
DB01359,Negative Inotrope,DrugBank
DB01359,Neurotransmitter Agents,DrugBank
DB01359,Phenoxypropanolamines,DrugBank
DB01359,Propanolamines,DrugBank
DB01359,Propanols,DrugBank
DB01359,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01359,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01359,Serotonin Agents,DrugBank
DB01359,Serotonin Receptor Antagonists,DrugBank
DB01362,"Acids, Carbocyclic",DrugBank
DB01362,Agents that reduce seizure threshold,DrugBank
DB01362,Benzene Derivatives,DrugBank
DB01362,Benzoates,DrugBank
DB01362,"Compounds used in a research, industrial, or household setting",DrugBank
DB01362,Contrast Media,DrugBank
DB01362,Diagnostic Uses of Chemicals,DrugBank
DB01362,Iodinated Contrast Agents,DrugBank
DB01362,Iodobenzoates,DrugBank
DB01362,Radiographic Contrast Agent,DrugBank
DB01362,Roentgenography,DrugBank
DB01362,Triiodobenzoic Acids,DrugBank
DB01362,"Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media",DrugBank
DB01362,X-Ray Contrast Activity,DrugBank
DB01362,"X-Ray Contrast Media, Iodinated",DrugBank
DB01363,Adrenergic Agonists,DrugBank
DB01363,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB01363,Adrenergic alpha-Agonists,DrugBank
DB01363,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01363,Adrenergic beta-Agonists,DrugBank
DB01363,Agents producing tachycardia,DrugBank
DB01363,Agents that produce hypertension,DrugBank
DB01363,Alpha-and Beta-adrenergic Agonists,DrugBank
DB01363,Biological Products,DrugBank
DB01363,Complex Mixtures,DrugBank
DB01363,Cycadopsida,DrugBank
DB01363,"Drugs, Chinese Herbal",DrugBank
DB01363,Embryophyta,DrugBank
DB01363,Ephedra,DrugBank
DB01363,Eukaryota,DrugBank
DB01363,Gnetophyta,DrugBank
DB01363,Herbs and Natural Products,DrugBank
DB01363,Hyperglycemia-Associated Agents,DrugBank
DB01363,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01363,Pharmaceutical Preparations,DrugBank
DB01363,Plant Extracts,DrugBank
DB01363,Plant Preparations,DrugBank
DB01363,Streptophyta,DrugBank
DB01363,Sympathomimetic (Adrenergic) Agents,DrugBank
DB01363,Viridiplantae,DrugBank
DB01364,Adrenergic Agents,DrugBank
DB01364,Adrenergic Agonists,DrugBank
DB01364,Adrenergic alpha-Agonists,DrugBank
DB01364,Adrenergic and Dopaminergic Agents,DrugBank
DB01364,Adrenergic beta-Agonists,DrugBank
DB01364,Adrenergics for Systemic Use,DrugBank
DB01364,Agents producing tachycardia,DrugBank
DB01364,Agents that produce hypertension,DrugBank
DB01364,Alcohols,DrugBank
DB01364,Alimentary Tract and Metabolism,DrugBank
DB01364,Alpha-and Beta-adrenergic Agonists,DrugBank
DB01364,Amines,DrugBank
DB01364,Amino Alcohols,DrugBank
DB01364,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB01364,Autonomic Agents,DrugBank
DB01364,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB01364,Cardiac Therapy,DrugBank
DB01364,Cardiovascular Agents,DrugBank
DB01364,Central Nervous System Agents,DrugBank
DB01364,Central Nervous System Stimulants,DrugBank
DB01364,Centrally Acting Antiobesity Products,DrugBank
DB01364,Cholinesterase substrates,DrugBank
DB01364,Drugs for Obstructive Airway Diseases,DrugBank
DB01364,Epinephrine and similars,DrugBank
DB01364,Ethylamines,DrugBank
DB01364,Herbs and Natural Products,DrugBank
DB01364,Increased Norepinephrine Activity,DrugBank
DB01364,Mydriatics and Cycloplegics,DrugBank
DB01364,Nasal Preparations,DrugBank
DB01364,Neurotransmitter Agents,DrugBank
DB01364,Norepinephrine Releasing Agents,DrugBank
DB01364,Ophthalmologicals,DrugBank
DB01364,Peripheral Nervous System Agents,DrugBank
DB01364,Phenethylamines,DrugBank
DB01364,Propanolamines,DrugBank
DB01364,Propanols,DrugBank
DB01364,Sensory Organs,DrugBank
DB01364,Sympathomimetic (Adrenergic) Agents,DrugBank
DB01364,Sympathomimetics,DrugBank
DB01364,Sympathomimetics Excl. Antiglaucoma Preparations,DrugBank
DB01364,"Sympathomimetics, Plain",DrugBank
DB01364,Vasoconstrictor Agents,DrugBank
DB01365,Adrenergic Agents,DrugBank
DB01365,Adrenergic Agonists,DrugBank
DB01365,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01365,Adrenergic alpha-Agonists,DrugBank
DB01365,Adrenergic and Dopaminergic Agents,DrugBank
DB01365,Agents producing tachycardia,DrugBank
DB01365,Agents that produce hypertension,DrugBank
DB01365,Amines,DrugBank
DB01365,Amphetamines,DrugBank
DB01365,Autonomic Agents,DrugBank
DB01365,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB01365,Cardiac Therapy,DrugBank
DB01365,Cardiovascular Agents,DrugBank
DB01365,Ethylamines,DrugBank
DB01365,Neurotransmitter Agents,DrugBank
DB01365,Peripheral Nervous System Agents,DrugBank
DB01365,Phenethylamines,DrugBank
DB01365,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01365,Sympathomimetics,DrugBank
DB01365,Vasoconstrictor Agents,DrugBank
DB01366,Adrenergic Agents,DrugBank
DB01366,Adrenergic Agonists,DrugBank
DB01366,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01366,Adrenergic beta-Agonists,DrugBank
DB01366,Adrenergics for Systemic Use,DrugBank
DB01366,"Adrenergics, Inhalants",DrugBank
DB01366,Agents producing tachycardia,DrugBank
DB01366,Agents that produce hypertension,DrugBank
DB01366,Alcohols,DrugBank
DB01366,Amines,DrugBank
DB01366,Amino Alcohols,DrugBank
DB01366,Anti-Asthmatic Agents,DrugBank
DB01366,Autonomic Agents,DrugBank
DB01366,Bronchodilator Agents,DrugBank
DB01366,Drugs for Obstructive Airway Diseases,DrugBank
DB01366,Ethanolamines,DrugBank
DB01366,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01366,Hydroxyquinolines,DrugBank
DB01366,Neurotransmitter Agents,DrugBank
DB01366,Peripheral Nervous System Agents,DrugBank
DB01366,Quinolines,DrugBank
DB01366,Respiratory System Agents,DrugBank
DB01366,Selective Beta 2-adrenergic Agonists,DrugBank
DB01366,Sympathomimetics,DrugBank
DB01367,Agents that produce hypertension,DrugBank
DB01367,Agents that reduce seizure threshold,DrugBank
DB01367,Anti-Parkinson Drugs,DrugBank
DB01367,Antidepressive Agents,DrugBank
DB01367,Central Nervous System Agents,DrugBank
DB01367,Central Nervous System Depressants,DrugBank
DB01367,"Compounds used in a research, industrial, or household setting",DrugBank
DB01367,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01367,Cytochrome P-450 Substrates,DrugBank
DB01367,Dopamine Agents,DrugBank
DB01367,Drugs that are Mainly Renally Excreted,DrugBank
DB01367,Enzyme Inhibitors,DrugBank
DB01367,Hypotensive Agents,DrugBank
DB01367,Indenes,DrugBank
DB01367,Monoamine Oxidase B Inhibitors,DrugBank
DB01367,Monoamine Oxidase Inhibitors,DrugBank
DB01367,Nervous System,DrugBank
DB01367,Neuroprotective Agents,DrugBank
DB01367,Protective Agents,DrugBank
DB01367,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01367,Serotonin Agents,DrugBank
DB01367,Serotonin Modulators,DrugBank
DB01369,"Amino Acids, Peptides, and Proteins",DrugBank
DB01369,Anti-Bacterial Agents,DrugBank
DB01369,Anti-Infective Agents,DrugBank
DB01369,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01369,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01369,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01369,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01369,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01369,Peptides,DrugBank
DB01369,"Peptides, Cyclic",DrugBank
DB01369,Streptogramin Antibacterial,DrugBank
DB01369,Streptogramins,DrugBank
DB01370,Aluminium Compounds,DrugBank
DB01370,Aluminum and magnesium containing antacids,DrugBank
DB01370,Antacids,DrugBank
DB01370,Elements,DrugBank
DB01370,Gastric Acid Lowering Agents,DrugBank
DB01370,Metal cations,DrugBank
DB01370,Metal divalent cations,DrugBank
DB01370,Metals,DrugBank
DB01370,"Metals, Light",DrugBank
DB01373,Alimentary Tract and Metabolism,DrugBank
DB01373,Antacids and Adsorbents,DrugBank
DB01373,Biological Factors,DrugBank
DB01373,Blood Coagulation Factors,DrugBank
DB01373,Calcium Salts,DrugBank
DB01373,Calcium-Regulating Hormones and Agents,DrugBank
DB01373,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB01373,Drugs for Treatment of Bone Diseases,DrugBank
DB01373,Elements,DrugBank
DB01373,Metals,DrugBank
DB01373,"Metals, Alkaline Earth",DrugBank
DB01373,Minerals,DrugBank
DB01373,Musculo-Skeletal System,DrugBank
DB01373,Phosphate Binder,DrugBank
DB01373,Phosphate Chelating Activity,DrugBank
DB01373,Replacement Preparations,DrugBank
DB01377,Agents that produce neuromuscular block (indirect),DrugBank
DB01377,Alimentary Tract and Metabolism,DrugBank
DB01377,Aluminum and magnesium containing antacids,DrugBank
DB01377,Antacids,DrugBank
DB01377,Drugs for Acid Related Disorders,DrugBank
DB01377,Drugs for Constipation,DrugBank
DB01377,Gastric Acid Lowering Agents,DrugBank
DB01377,Gastrointestinal Agents,DrugBank
DB01377,Laxatives,DrugBank
DB01377,"Laxatives, magnesium containing",DrugBank
DB01377,Magnesium Compounds,DrugBank
DB01377,Magnesium Salts,DrugBank
DB01377,Metal cations,DrugBank
DB01377,Metal divalent cations,DrugBank
DB01377,Mineral Supplements,DrugBank
DB01377,Minerals,DrugBank
DB01377,Osmotic Laxatives,DrugBank
DB01377,Oxides,DrugBank
DB01377,Oxygen Compounds,DrugBank
DB01378,Agents that produce neuromuscular block (indirect),DrugBank
DB01378,Calculi Dissolution Agent,DrugBank
DB01378,Increased Large Intestinal Motility,DrugBank
DB01378,Inhibition Large Intestine Fluid/Electrolyte Absorption,DrugBank
DB01378,Inhibition Small Intestine Fluid/Electrolyte Absorption,DrugBank
DB01378,Laxatives,DrugBank
DB01378,Magnesium Ion Exchange Activity,DrugBank
DB01378,Minerals,DrugBank
DB01378,Osmotic Activity,DrugBank
DB01378,Osmotic Laxatives,DrugBank
DB01378,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB01378,Stimulation Large Intestine Fluid/Electrolyte Secretion,DrugBank
DB01380,17-Hydroxycorticosteroids,DrugBank
DB01380,Adrenal Cortex Hormones,DrugBank
DB01380,Adrenals,DrugBank
DB01380,Anti-Inflammatory Agents,DrugBank
DB01380,Corticosteroids,DrugBank
DB01380,Corticosteroids for Systemic Use,DrugBank
DB01380,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01380,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01380,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01380,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01380,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01380,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01380,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB01380,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01380,Cytochrome P-450 Substrates,DrugBank
DB01380,Fused-Ring Compounds,DrugBank
DB01380,Glucocorticoids,DrugBank
DB01380,Hormones,DrugBank
DB01380,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01380,Hydroxycorticosteroids,DrugBank
DB01380,Hyperglycemia-Associated Agents,DrugBank
DB01380,Immunosuppressive Agents,DrugBank
DB01380,OAT3/SLC22A8 Substrates,DrugBank
DB01380,P-glycoprotein inducers,DrugBank
DB01380,P-glycoprotein substrates,DrugBank
DB01380,Pregnanes,DrugBank
DB01380,Pregnenes,DrugBank
DB01380,Steroids,DrugBank
DB01381,Anti-Dementia Drugs,DrugBank
DB01381,Biological Products,DrugBank
DB01381,Blood Circulation,DrugBank
DB01381,Cardiovascular Agents,DrugBank
DB01381,Cholinesterase Inhibitors,DrugBank
DB01381,Complex Mixtures,DrugBank
DB01381,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01381,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01381,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01381,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01381,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01381,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01381,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01381,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01381,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01381,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01381,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01381,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01381,Embryophyta,DrugBank
DB01381,Eukaryota,DrugBank
DB01381,Ginkgolides,DrugBank
DB01381,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01381,Nervous System,DrugBank
DB01381,Pharmaceutical Preparations,DrugBank
DB01381,Plant Extracts,DrugBank
DB01381,Plant Preparations,DrugBank
DB01381,Psychoanaleptics,DrugBank
DB01381,Streptophyta,DrugBank
DB01381,Tracheophyta,DrugBank
DB01381,Viridiplantae,DrugBank
DB01382,Alimentary Tract and Metabolism,DrugBank
DB01382,Amides,DrugBank
DB01382,Blood Glucose Lowering Agents,DrugBank
DB01382,Drugs Used in Diabetes,DrugBank
DB01382,Genito Urinary System and Sex Hormones,DrugBank
DB01382,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01382,Oral Hypoglycemics,DrugBank
DB01382,Sulfonamides,DrugBank
DB01382,Sulfones,DrugBank
DB01382,Sulfur Compounds,DrugBank
DB01384,Adrenal Cortex Hormones,DrugBank
DB01384,Anti-Inflammatory Agents,DrugBank
DB01384,Corticosteroids,DrugBank
DB01384,Corticosteroids for Systemic Use,DrugBank
DB01384,"Corticosteroids for Systemic Use, Plain",DrugBank
DB01384,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01384,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01384,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01384,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01384,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01384,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01384,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01384,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01384,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB01384,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB01384,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01384,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01384,Cytochrome P-450 Substrates,DrugBank
DB01384,Fused-Ring Compounds,DrugBank
DB01384,Glucocorticoids,DrugBank
DB01384,Hormones,DrugBank
DB01384,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01384,Hyperglycemia-Associated Agents,DrugBank
DB01384,Immunosuppressive Agents,DrugBank
DB01384,Pregnadienes,DrugBank
DB01384,Pregnadienetriols,DrugBank
DB01384,Pregnanes,DrugBank
DB01384,Steroids,DrugBank
DB01384,"Steroids, Fluorinated",DrugBank
DB01384,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB01388,Agents causing hyperkalemia,DrugBank
DB01388,Antiarrhythmic agents,DrugBank
DB01388,Antihypertensive Agents,DrugBank
DB01388,Benzimidazoles,DrugBank
DB01388,Bradycardia-Causing Agents,DrugBank
DB01388,Calcium Channel Blockers,DrugBank
DB01388,Calcium-Regulating Hormones and Agents,DrugBank
DB01388,Cardiovascular Agents,DrugBank
DB01388,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01388,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01388,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01388,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01388,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01388,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB01388,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01388,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB01388,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01388,Cytochrome P-450 Substrates,DrugBank
DB01388,Enzyme Inhibitors,DrugBank
DB01388,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01388,Membrane Transport Modulators,DrugBank
DB01388,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01388,Naphthalenes,DrugBank
DB01388,P-glycoprotein inhibitors,DrugBank
DB01388,P-glycoprotein substrates,DrugBank
DB01388,QTc Prolonging Agents,DrugBank
DB01388,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB01388,Tetrahydronaphthalenes,DrugBank
DB01388,Vasodilating Agents,DrugBank
DB01390,Antacids,DrugBank
DB01390,Antacids and Adsorbents,DrugBank
DB01390,Bicarbonates,DrugBank
DB01390,Blood and Blood Forming Organs,DrugBank
DB01390,Blood Substitutes and Perfusion Solutions,DrugBank
DB01390,"Carbon Compounds, Inorganic",DrugBank
DB01390,Carbonates,DrugBank
DB01390,Carbonic Acid,DrugBank
DB01390,Electrolyte Solutions,DrugBank
DB01390,Gastric Acid Lowering Agents,DrugBank
DB01390,Hemodialysis Solution,DrugBank
DB01390,I.V. Solution Additives,DrugBank
DB01390,Irrigating Solutions,DrugBank
DB01390,Salt Solutions,DrugBank
DB01390,Sodium Compounds,DrugBank
DB01390,Urinary Alkalinisers,DrugBank
DB01392,Adrenergic Agents,DrugBank
DB01392,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB01392,Adrenergic alpha-Antagonists,DrugBank
DB01392,Adrenergic Antagonists,DrugBank
DB01392,Agents that produce hypertension,DrugBank
DB01392,Alkaloids,DrugBank
DB01392,Antidepressive Agents,DrugBank
DB01392,Autonomic Agents,DrugBank
DB01392,Central Nervous System Depressants,DrugBank
DB01392,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01392,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01392,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01392,Cytochrome P-450 Substrates,DrugBank
DB01392,Dopamine Antagonists,DrugBank
DB01392,Dopamine D2 Receptor Antagonists,DrugBank
DB01392,Drugs Used in Erectile Dysfunction,DrugBank
DB01392,Genito Urinary System and Sex Hormones,DrugBank
DB01392,Genitourinary Agents,DrugBank
DB01392,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01392,Indole Alkaloids,DrugBank
DB01392,Indoles,DrugBank
DB01392,Indolizidines,DrugBank
DB01392,Indolizines,DrugBank
DB01392,Mydriatics,DrugBank
DB01392,Neurotransmitter Agents,DrugBank
DB01392,Other Miscellaneous Therapeutic Agents,DrugBank
DB01392,P-glycoprotein inhibitors,DrugBank
DB01392,Peripheral Nervous System Agents,DrugBank
DB01392,Secologanin Tryptamine Alkaloids,DrugBank
DB01392,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01392,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01392,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01392,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01392,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01392,Serotonin Agents,DrugBank
DB01392,Serotonin Receptor Antagonists,DrugBank
DB01392,Urological Agents,DrugBank
DB01392,Urologicals,DrugBank
DB01393,"Acids, Acyclic",DrugBank
DB01393,"Acids, Carbocyclic",DrugBank
DB01393,Agents Causing Muscle Toxicity,DrugBank
DB01393,Amides,DrugBank
DB01393,Benzamides and benzamide derivatives,DrugBank
DB01393,Benzene Derivatives,DrugBank
DB01393,Benzoates,DrugBank
DB01393,Butyrates,DrugBank
DB01393,Chlorobenzoates,DrugBank
DB01393,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01393,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01393,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB01393,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01393,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01393,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01393,Cytochrome P-450 Substrates,DrugBank
DB01393,Ethers,DrugBank
DB01393,Fibric Acid Derivatives,DrugBank
DB01393,Fibric Acids,DrugBank
DB01393,Hypolipidemic Agents,DrugBank
DB01393,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01393,Isobutyrates,DrugBank
DB01393,Lipid Modifying Agents,DrugBank
DB01393,"Lipid Modifying Agents, Plain",DrugBank
DB01393,Lipid Regulating Agents,DrugBank
DB01393,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01393,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01393,Phenols,DrugBank
DB01393,Phenyl Ethers,DrugBank
DB01394,Agents Causing Muscle Toxicity,DrugBank
DB01394,Alkaloids,DrugBank
DB01394,Antigout Preparations,DrugBank
DB01394,Antimitotic Agents,DrugBank
DB01394,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01394,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01394,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01394,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01394,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB01394,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB01394,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01394,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01394,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01394,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01394,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01394,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01394,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01394,Cytochrome P-450 Substrates,DrugBank
DB01394,Drugs that are Mainly Renally Excreted,DrugBank
DB01394,Experimental Unapproved Treatments for COVID-19,DrugBank
DB01394,Mitosis Modulators,DrugBank
DB01394,Musculo-Skeletal System,DrugBank
DB01394,P-glycoprotein inducers,DrugBank
DB01394,P-glycoprotein substrates,DrugBank
DB01394,Preparations With No Effect on Uric Acid Metabolism,DrugBank
DB01394,Tubulin Modulators,DrugBank
DB01395,Adrenal Cortex Hormones,DrugBank
DB01395,Agents causing hyperkalemia,DrugBank
DB01395,Androstanes,DrugBank
DB01395,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB01395,"Contraceptive Agents, Female",DrugBank
DB01395,"Contraceptives, Oral",DrugBank
DB01395,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01395,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01395,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01395,Cytochrome P-450 Substrates,DrugBank
DB01395,Diuretics,DrugBank
DB01395,Fused-Ring Compounds,DrugBank
DB01395,Genito Urinary System and Sex Hormones,DrugBank
DB01395,Hormonal Contraceptives for Systemic Use,DrugBank
DB01395,Hormone Antagonists,DrugBank
DB01395,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01395,Hyperglycemia-Associated Agents,DrugBank
DB01395,Mineralocorticoid Receptor Antagonists,DrugBank
DB01395,Natriuretic Agents,DrugBank
DB01395,Progesterone Congeners,DrugBank
DB01395,Progestin Contraceptives,DrugBank
DB01395,Progestins,DrugBank
DB01395,Sex Hormones and Modulators of the Genital System,DrugBank
DB01395,Steroids,DrugBank
DB01396,Antiarrhythmic agents,DrugBank
DB01396,Carbohydrates,DrugBank
DB01396,Cardanolides,DrugBank
DB01396,Cardenolides,DrugBank
DB01396,Cardiac Glycosides,DrugBank
DB01396,Cardiac Therapy,DrugBank
DB01396,Cardiotonic Agents,DrugBank
DB01396,Cardiovascular Agents,DrugBank
DB01396,"Compounds used in a research, industrial, or household setting",DrugBank
DB01396,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01396,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01396,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01396,Cytochrome P-450 Substrates,DrugBank
DB01396,Digitalis Glycosides,DrugBank
DB01396,Enzyme Inhibitors,DrugBank
DB01396,Fused-Ring Compounds,DrugBank
DB01396,Glycosides,DrugBank
DB01396,Narrow Therapeutic Index Drugs,DrugBank
DB01396,P-glycoprotein substrates,DrugBank
DB01396,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01396,Potential QTc-Prolonging Agents,DrugBank
DB01396,Protective Agents,DrugBank
DB01396,QTc Prolonging Agents,DrugBank
DB01396,Steroids,DrugBank
DB01397,"Acids, Carbocyclic",DrugBank
DB01397,Agents causing hyperkalemia,DrugBank
DB01397,Agents that produce hypertension,DrugBank
DB01397,Analgesics,DrugBank
DB01397,"Analgesics, Non-Narcotic",DrugBank
DB01397,Anti-Inflammatory Agents,DrugBank
DB01397,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01397,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01397,Antirheumatic Agents,DrugBank
DB01397,Benzene Derivatives,DrugBank
DB01397,Benzoates,DrugBank
DB01397,Cyclooxygenase Inhibitors,DrugBank
DB01397,Enzyme Inhibitors,DrugBank
DB01397,Hydroxy Acids,DrugBank
DB01397,Hydroxybenzoates,DrugBank
DB01397,Magnesium Compounds,DrugBank
DB01397,Magnesium Salts,DrugBank
DB01397,Metal cations,DrugBank
DB01397,Metal divalent cations,DrugBank
DB01397,Nephrotoxic agents,DrugBank
DB01397,Nervous System,DrugBank
DB01397,Non COX-2 selective NSAIDS,DrugBank
DB01397,Peripheral Nervous System Agents,DrugBank
DB01397,Phenols,DrugBank
DB01397,Salicylic Acid and Derivatives,DrugBank
DB01397,Sensory System Agents,DrugBank
DB01399,"Acids, Carbocyclic",DrugBank
DB01399,Agents causing hyperkalemia,DrugBank
DB01399,Agents that produce hypertension,DrugBank
DB01399,Analgesics,DrugBank
DB01399,"Analgesics, Non-Narcotic",DrugBank
DB01399,Anti-Inflammatory Agents,DrugBank
DB01399,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01399,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01399,Antirheumatic Agents,DrugBank
DB01399,Benzene Derivatives,DrugBank
DB01399,Benzoates,DrugBank
DB01399,Hydroxy Acids,DrugBank
DB01399,Hydroxybenzoates,DrugBank
DB01399,Nephrotoxic agents,DrugBank
DB01399,Nervous System,DrugBank
DB01399,Non COX-2 selective NSAIDS,DrugBank
DB01399,Peripheral Nervous System Agents,DrugBank
DB01399,Phenols,DrugBank
DB01399,Salicylic Acid and Derivatives,DrugBank
DB01399,Sensory System Agents,DrugBank
DB01400,Amines,DrugBank
DB01400,Antiglaucoma Preparations and Miotics,DrugBank
DB01400,Autonomic Agents,DrugBank
DB01400,Cholinergic Agents,DrugBank
DB01400,Cholinesterase Inhibitors,DrugBank
DB01400,Enzyme Inhibitors,DrugBank
DB01400,Nervous System,DrugBank
DB01400,Neurotransmitter Agents,DrugBank
DB01400,Onium Compounds,DrugBank
DB01400,Ophthalmologicals,DrugBank
DB01400,Parasympathomemetic (Cholinergic) Agents,DrugBank
DB01400,Parasympathomimetics,DrugBank
DB01400,Peripheral Nervous System Agents,DrugBank
DB01400,Phenylammonium Compounds,DrugBank
DB01400,Quaternary Ammonium Compounds,DrugBank
DB01400,Sensory Organs,DrugBank
DB01401,"Acids, Carbocyclic",DrugBank
DB01401,Agents causing hyperkalemia,DrugBank
DB01401,Agents that produce hypertension,DrugBank
DB01401,Alcohols,DrugBank
DB01401,Amines,DrugBank
DB01401,Amino Alcohols,DrugBank
DB01401,Analgesics,DrugBank
DB01401,"Analgesics, Non-Narcotic",DrugBank
DB01401,Anti-Inflammatory Agents,DrugBank
DB01401,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01401,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01401,Antirheumatic Agents,DrugBank
DB01401,Benzene Derivatives,DrugBank
DB01401,Benzoates,DrugBank
DB01401,Central Nervous System Agents,DrugBank
DB01401,Ethanolamines,DrugBank
DB01401,Hydroxy Acids,DrugBank
DB01401,Hydroxybenzoates,DrugBank
DB01401,Nephrotoxic agents,DrugBank
DB01401,Non COX-2 selective NSAIDS,DrugBank
DB01401,Onium Compounds,DrugBank
DB01401,Peripheral Nervous System Agents,DrugBank
DB01401,Phenols,DrugBank
DB01401,Quaternary Ammonium Compounds,DrugBank
DB01401,Sensory System Agents,DrugBank
DB01401,Trimethyl Ammonium Compounds,DrugBank
DB01403,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01403,Adrenergic alpha-Antagonists,DrugBank
DB01403,Adrenergic Antagonists,DrugBank
DB01403,Agents producing tachycardia,DrugBank
DB01403,Agents that produce hypertension,DrugBank
DB01403,Analgesics,DrugBank
DB01403,"Analgesics, Non-Narcotic",DrugBank
DB01403,Anticholinergic Agents,DrugBank
DB01403,Antidepressive Agents,DrugBank
DB01403,Antipsychotic Agents,DrugBank
DB01403,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01403,Central Nervous System Agents,DrugBank
DB01403,Central Nervous System Depressants,DrugBank
DB01403,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01403,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB01403,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01403,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01403,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01403,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01403,Cytochrome P-450 Substrates,DrugBank
DB01403,Dopamine Agents,DrugBank
DB01403,Dopamine Antagonists,DrugBank
DB01403,Dopamine D2 Receptor Antagonists,DrugBank
DB01403,Drugs causing inadvertant photosensitivity,DrugBank
DB01403,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01403,Histamine Antagonists,DrugBank
DB01403,Histamine H1 Antagonists,DrugBank
DB01403,Hyperglycemia-Associated Agents,DrugBank
DB01403,Muscarinic Antagonists,DrugBank
DB01403,Nervous System,DrugBank
DB01403,Neurotoxic agents,DrugBank
DB01403,Neurotransmitter Agents,DrugBank
DB01403,Peripheral Nervous System Agents,DrugBank
DB01403,Phenothiazines,DrugBank
DB01403,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB01403,Photosensitizing Agents,DrugBank
DB01403,Potential QTc-Prolonging Agents,DrugBank
DB01403,Psycholeptics,DrugBank
DB01403,Psychotropic Drugs,DrugBank
DB01403,QTc Prolonging Agents,DrugBank
DB01403,Sensory System Agents,DrugBank
DB01403,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01403,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01403,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01403,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB01403,Serotonin Agents,DrugBank
DB01403,Serotonin Receptor Antagonists,DrugBank
DB01403,Sulfur Compounds,DrugBank
DB01403,Tranquilizing Agents,DrugBank
DB01404,Angiosperms,DrugBank
DB01404,Araliaceae,DrugBank
DB01404,Biological Products,DrugBank
DB01404,Complex Mixtures,DrugBank
DB01404,Embryophyta,DrugBank
DB01404,Eukaryota,DrugBank
DB01404,Ginseng & Ginseng Extracts,DrugBank
DB01404,Herbs and Natural Products,DrugBank
DB01404,Pharmaceutical Preparations,DrugBank
DB01404,Plant Extracts,DrugBank
DB01404,Plant Preparations,DrugBank
DB01404,Streptophyta,DrugBank
DB01404,Tracheophyta,DrugBank
DB01404,Viridiplantae,DrugBank
DB01405,4-Quinolones,DrugBank
DB01405,Anti-Bacterial Agents,DrugBank
DB01405,Anti-Infective Agents,DrugBank
DB01405,Antibacterials for Systemic Use,DrugBank
DB01405,Antiinfectives for Systemic Use,DrugBank
DB01405,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01405,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01405,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01405,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01405,Cytochrome P-450 Substrates,DrugBank
DB01405,Enzyme Inhibitors,DrugBank
DB01405,Fluoroquinolones,DrugBank
DB01405,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01405,Highest Risk QTc-Prolonging Agents,DrugBank
DB01405,QTc Prolonging Agents,DrugBank
DB01405,Quinolines,DrugBank
DB01405,Quinolones,DrugBank
DB01405,Topoisomerase II Inhibitors,DrugBank
DB01405,Topoisomerase Inhibitors,DrugBank
DB01406,Androgens,DrugBank
DB01406,Antigonadotropins and Similar Agents,DrugBank
DB01406,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01406,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01406,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB01406,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01406,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01406,Estrogen Antagonists,DrugBank
DB01406,Fused-Ring Compounds,DrugBank
DB01406,Genito Urinary System and Sex Hormones,DrugBank
DB01406,Hormone Antagonists,DrugBank
DB01406,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01406,Hyperglycemia-Associated Agents,DrugBank
DB01406,Pregnadienes,DrugBank
DB01406,Pregnanes,DrugBank
DB01406,Sex Hormones and Modulators of the Genital System,DrugBank
DB01406,Steroids,DrugBank
DB01406,Thyroxine-binding globulin inhibitors,DrugBank
DB01407,Adrenergic Agents,DrugBank
DB01407,Adrenergic Agonists,DrugBank
DB01407,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01407,Adrenergic beta-Agonists,DrugBank
DB01407,Adrenergics for Systemic Use,DrugBank
DB01407,"Adrenergics, Inhalants",DrugBank
DB01407,Agents producing tachycardia,DrugBank
DB01407,Agents that produce hypertension,DrugBank
DB01407,Agents to Treat Airway Disease,DrugBank
DB01407,Alcohols,DrugBank
DB01407,Amines,DrugBank
DB01407,Amino Alcohols,DrugBank
DB01407,Anti-Asthmatic Agents,DrugBank
DB01407,Autonomic Agents,DrugBank
DB01407,Bronchodilator Agents,DrugBank
DB01407,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01407,Cytochrome P-450 Substrates,DrugBank
DB01407,Drugs for Obstructive Airway Diseases,DrugBank
DB01407,Ethanolamines,DrugBank
DB01407,Long-acting beta-adrenoceptor agonists,DrugBank
DB01407,Neurotransmitter Agents,DrugBank
DB01407,Peripheral Nervous System Agents,DrugBank
DB01407,Respiratory System Agents,DrugBank
DB01407,Selective Beta 2-adrenergic Agonists,DrugBank
DB01407,Sympathomimetics,DrugBank
DB01408,Adrenergic Agonists,DrugBank
DB01408,Adrenergic beta-2 Receptor Agonists,DrugBank
DB01408,Adrenergic beta-Agonists,DrugBank
DB01408,Adrenergics for Systemic Use,DrugBank
DB01408,Agents producing tachycardia,DrugBank
DB01408,Agents that produce hypertension,DrugBank
DB01408,Agents to Treat Airway Disease,DrugBank
DB01408,Alcohols,DrugBank
DB01408,Amines,DrugBank
DB01408,Amino Alcohols,DrugBank
DB01408,Anti-Asthmatic Agents,DrugBank
DB01408,Autonomic Agents,DrugBank
DB01408,Bronchodilator Agents,DrugBank
DB01408,Cholinesterase Inhibitors,DrugBank
DB01408,Cholinesterase substrates,DrugBank
DB01408,Delayed-Action Preparations,DrugBank
DB01408,Drugs for Obstructive Airway Diseases,DrugBank
DB01408,Ethanolamines,DrugBank
DB01408,Long-acting beta-adrenoceptor agonists,DrugBank
DB01408,Peripheral Nervous System Agents,DrugBank
DB01408,Prodrugs,DrugBank
DB01408,Respiratory System Agents,DrugBank
DB01408,Selective Beta 2-adrenergic Agonists,DrugBank
DB01409,"Adrenergics, Inhalants",DrugBank
DB01409,Agents producing tachycardia,DrugBank
DB01409,Agents to Treat Airway Disease,DrugBank
DB01409,Alkaloids,DrugBank
DB01409,Anti-Asthmatic Agents,DrugBank
DB01409,Anticholinergic Agents,DrugBank
DB01409,Antimuscarinics Antispasmodics,DrugBank
DB01409,Autonomic Agents,DrugBank
DB01409,Aza Compounds,DrugBank
DB01409,Azabicyclo Compounds,DrugBank
DB01409,Bronchodilator Agents,DrugBank
DB01409,Cholinergic Agents,DrugBank
DB01409,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01409,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01409,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01409,Cytochrome P-450 Substrates,DrugBank
DB01409,Drugs for Obstructive Airway Diseases,DrugBank
DB01409,Drugs that are Mainly Renally Excreted,DrugBank
DB01409,Muscarinic Antagonists,DrugBank
DB01409,Neurotransmitter Agents,DrugBank
DB01409,Parasympatholytics,DrugBank
DB01409,Peripheral Nervous System Agents,DrugBank
DB01409,Respiratory System Agents,DrugBank
DB01409,Scopolamine Derivatives,DrugBank
DB01409,Tropanes,DrugBank
DB01410,Adrenal Cortex Hormones,DrugBank
DB01410,Adrenals,DrugBank
DB01410,Agents to Treat Airway Disease,DrugBank
DB01410,Anti-Allergic Agents,DrugBank
DB01410,Corticosteroids,DrugBank
DB01410,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01410,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01410,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01410,Cytochrome P-450 Substrates,DrugBank
DB01410,Drugs for Obstructive Airway Diseases,DrugBank
DB01410,Fused-Ring Compounds,DrugBank
DB01410,Glucocorticoids,DrugBank
DB01410,Hormones,DrugBank
DB01410,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01410,Hyperglycemia-Associated Agents,DrugBank
DB01410,Immunosuppressive Agents,DrugBank
DB01410,Nasal Preparations,DrugBank
DB01410,Pregnanes,DrugBank
DB01410,Pregnenes,DrugBank
DB01410,Steroids,DrugBank
DB01410,Thyroxine-binding globulin inhibitors,DrugBank
DB01411,Agents to Treat Airway Disease,DrugBank
DB01411,Anti-Asthmatic Agents,DrugBank
DB01411,Benzopyrans,DrugBank
DB01411,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01411,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01411,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01411,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01411,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01411,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01411,Cytochrome P-450 Substrates,DrugBank
DB01411,Drugs for Obstructive Airway Diseases,DrugBank
DB01411,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01411,Hormone Antagonists,DrugBank
DB01411,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01411,Leukotriene Antagonists,DrugBank
DB01411,Pyrans,DrugBank
DB01411,Respiratory System Agents,DrugBank
DB01412,Alkaloids,DrugBank
DB01412,Anti-Asthmatic Agents,DrugBank
DB01412,Autonomic Agents,DrugBank
DB01412,Bronchodilator Agents,DrugBank
DB01412,Cardiovascular Agents,DrugBank
DB01412,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01412,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01412,Cytochrome P-450 Substrates,DrugBank
DB01412,Diuretics,DrugBank
DB01412,Drugs for Obstructive Airway Diseases,DrugBank
DB01412,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01412,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB01412,Peripheral Nervous System Agents,DrugBank
DB01412,Purines,DrugBank
DB01412,Purinones,DrugBank
DB01412,Respiratory System Agents,DrugBank
DB01412,Vasodilating Agents,DrugBank
DB01412,Xanthine derivatives,DrugBank
DB01413,Amides,DrugBank
DB01413,Anti-Bacterial Agents,DrugBank
DB01413,Anti-Infective Agents,DrugBank
DB01413,Antibacterials for Systemic Use,DrugBank
DB01413,Antiinfectives for Systemic Use,DrugBank
DB01413,beta-Lactams,DrugBank
DB01413,Cephalosporins,DrugBank
DB01413,Fourth-Generation Cephalosporins,DrugBank
DB01413,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01413,Lactams,DrugBank
DB01413,Nephrotoxic agents,DrugBank
DB01413,Neurotoxic agents,DrugBank
DB01413,Sulfur Compounds,DrugBank
DB01413,Thiazines,DrugBank
DB01414,Amides,DrugBank
DB01414,Anti-Bacterial Agents,DrugBank
DB01414,Anti-Infective Agents,DrugBank
DB01414,Antibacterials for Systemic Use,DrugBank
DB01414,Antiinfectives for Systemic Use,DrugBank
DB01414,beta-Lactams,DrugBank
DB01414,Cephalosporins,DrugBank
DB01414,First-Generation Cephalosporins,DrugBank
DB01414,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01414,Lactams,DrugBank
DB01414,Nephrotoxic agents,DrugBank
DB01414,OAT1/SLC22A6 inhibitors,DrugBank
DB01414,OAT1/SLC22A6 Substrates,DrugBank
DB01414,OAT3/SLC22A8 Inhibitors,DrugBank
DB01414,OAT3/SLC22A8 Substrates,DrugBank
DB01414,Sulfur Compounds,DrugBank
DB01414,Thiazines,DrugBank
DB01415,Amides,DrugBank
DB01415,Anti-Bacterial Agents,DrugBank
DB01415,Anti-Infective Agents,DrugBank
DB01415,Antibacterials for Systemic Use,DrugBank
DB01415,Antiinfectives for Systemic Use,DrugBank
DB01415,beta-Lactams,DrugBank
DB01415,Cephalosporins,DrugBank
DB01415,Drugs that are Mainly Renally Excreted,DrugBank
DB01415,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01415,Lactams,DrugBank
DB01415,Nephrotoxic agents,DrugBank
DB01415,OAT1/SLC22A6 Substrates,DrugBank
DB01415,OAT3/SLC22A8 Inhibitors,DrugBank
DB01415,OAT3/SLC22A8 Substrates,DrugBank
DB01415,Sulfur Compounds,DrugBank
DB01415,Thiazines,DrugBank
DB01415,Third-Generation Cephalosporins,DrugBank
DB01416,Amides,DrugBank
DB01416,Anti-Bacterial Agents,DrugBank
DB01416,Anti-Infective Agents,DrugBank
DB01416,Antibacterials for Systemic Use,DrugBank
DB01416,Antiinfectives for Systemic Use,DrugBank
DB01416,beta Lactam Antibiotics,DrugBank
DB01416,beta-Lactams,DrugBank
DB01416,Cefpodoxime,DrugBank
DB01416,Cephalosporins,DrugBank
DB01416,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01416,Lactams,DrugBank
DB01416,Nephrotoxic agents,DrugBank
DB01416,Prodrugs,DrugBank
DB01416,Sulfur Compounds,DrugBank
DB01416,Thiazines,DrugBank
DB01416,Third-Generation Cephalosporins,DrugBank
DB01418,4-Hydroxycoumarins,DrugBank
DB01418,Anticoagulants,DrugBank
DB01418,Benzopyrans,DrugBank
DB01418,Blood and Blood Forming Organs,DrugBank
DB01418,Coumarins,DrugBank
DB01418,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01418,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB01418,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01418,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB01418,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01418,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB01418,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01418,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01418,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01418,Cytochrome P-450 Substrates,DrugBank
DB01418,Hematologic Agents,DrugBank
DB01418,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01418,Narrow Therapeutic Index Drugs,DrugBank
DB01418,P-glycoprotein substrates,DrugBank
DB01418,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01418,Pyrans,DrugBank
DB01418,Vitamin K Antagonists,DrugBank
DB01419,Agents causing hyperkalemia,DrugBank
DB01419,Agents that produce hypertension,DrugBank
DB01419,Anti-Inflammatory Agents,DrugBank
DB01419,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01419,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01419,Nephrotoxic agents,DrugBank
DB01419,Non COX-2 selective NSAIDS,DrugBank
DB01420,Androgens,DrugBank
DB01420,Androstanes,DrugBank
DB01420,Androstenes,DrugBank
DB01420,Androstenols,DrugBank
DB01420,COMT Inhibitors,DrugBank
DB01420,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01420,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01420,Cytochrome P-450 Substrates,DrugBank
DB01420,Drugs that are Mainly Renally Excreted,DrugBank
DB01420,Fused-Ring Compounds,DrugBank
DB01420,Gonadal Hormones,DrugBank
DB01420,Gonadal Steroid Hormones,DrugBank
DB01420,Hormones,DrugBank
DB01420,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01420,P-glycoprotein substrates,DrugBank
DB01420,Steroids,DrugBank
DB01420,Testosterone and derivatives,DrugBank
DB01420,Testosterone Congeners,DrugBank
DB01420,Thyroxine-binding globulin inhibitors,DrugBank
DB01420,UGT1A1 Inducers,DrugBank
DB01421,Agents that produce neuromuscular block (indirect),DrugBank
DB01421,Alimentary Tract and Metabolism,DrugBank
DB01421,Amebicides,DrugBank
DB01421,Aminoglycoside Antibacterials,DrugBank
DB01421,Anti-Bacterial Agents,DrugBank
DB01421,Anti-Infective Agents,DrugBank
DB01421,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01421,Antiparasitic Agents,DrugBank
DB01421,Antiprotozoals,DrugBank
DB01421,Carbohydrates,DrugBank
DB01421,Glycosides,DrugBank
DB01421,Intestinal Antiinfectives,DrugBank
DB01421,Nephrotoxic agents,DrugBank
DB01422,Anti-Infective Agents,DrugBank
DB01422,"Anti-Infective Agents, Urinary",DrugBank
DB01422,Antibacterials for Systemic Use,DrugBank
DB01422,Antifungal Agents,DrugBank
DB01422,Antiinfectives for Systemic Use,DrugBank
DB01422,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01422,Nitro Compounds,DrugBank
DB01422,Quinolines,DrugBank
DB01423,Amino Acids,DrugBank
DB01423,"Amino Acids, Peptides, and Proteins",DrugBank
DB01423,Anions,DrugBank
DB01423,Anti-Infective Agents,DrugBank
DB01423,Cough and Cold Preparations,DrugBank
DB01423,Electrolytes,DrugBank
DB01423,Expectorants,DrugBank
DB01423,Hydrogen Sulfide,DrugBank
DB01423,Immunologic Factors,DrugBank
DB01423,Immunosuppressive Agents,DrugBank
DB01423,Ions,DrugBank
DB01423,Respiratory System Agents,DrugBank
DB01423,Sulfur Compounds,DrugBank
DB01424,Agents causing hyperkalemia,DrugBank
DB01424,Agents that produce hypertension,DrugBank
DB01424,Analgesics,DrugBank
DB01424,Anti-Inflammatory Agents,DrugBank
DB01424,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01424,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01424,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01424,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01424,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01424,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01424,Cytochrome P-450 Substrates,DrugBank
DB01424,Nephrotoxic agents,DrugBank
DB01424,Nervous System,DrugBank
DB01424,Non COX-2 selective NSAIDS,DrugBank
DB01424,OAT1/SLC22A6 inhibitors,DrugBank
DB01424,Pyrazoles,DrugBank
DB01424,Pyrazolones,DrugBank
DB01425,Alimentary Tract and Metabolism,DrugBank
DB01425,Antiemetics,DrugBank
DB01425,Autonomic Agents,DrugBank
DB01425,Central Nervous System Agents,DrugBank
DB01425,Dopamine Antagonists,DrugBank
DB01425,Dopamine D2 Receptor Antagonists,DrugBank
DB01425,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01425,Gastrointestinal Agents,DrugBank
DB01425,Peripheral Nervous System Agents,DrugBank
DB01425,Propulsives,DrugBank
DB01426,Ajmaline and derivatives,DrugBank
DB01426,Alkaloids,DrugBank
DB01426,Antiarrhythmic agents,DrugBank
DB01426,"Antiarrhythmics, Class I",DrugBank
DB01426,"Antiarrhythmics, Class Ia",DrugBank
DB01426,"Antiarrhythmics, Class Ic",DrugBank
DB01426,Cardiac Therapy,DrugBank
DB01426,Cardiovascular Agents,DrugBank
DB01426,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01426,Indole Alkaloids,DrugBank
DB01426,Indoles,DrugBank
DB01426,Indolizidines,DrugBank
DB01426,Indolizines,DrugBank
DB01426,Membrane Transport Modulators,DrugBank
DB01426,Potential QTc-Prolonging Agents,DrugBank
DB01426,QTc Prolonging Agents,DrugBank
DB01426,Secologanin Tryptamine Alkaloids,DrugBank
DB01426,Sodium Channel Blockers,DrugBank
DB01426,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01427,Amines,DrugBank
DB01427,Aminopyridines,DrugBank
DB01427,Calcium-Regulating Hormones and Agents,DrugBank
DB01427,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB01427,Cardiac Therapy,DrugBank
DB01427,Cardiotonic Agents,DrugBank
DB01427,Cardiovascular Agents,DrugBank
DB01427,"Compounds used in a research, industrial, or household setting",DrugBank
DB01427,Drugs that are Mainly Renally Excreted,DrugBank
DB01427,Enzyme Inhibitors,DrugBank
DB01427,Membrane Transport Modulators,DrugBank
DB01427,Phosphodiesterase 3 Inhibitors,DrugBank
DB01427,Phosphodiesterase Inhibitors,DrugBank
DB01427,Protective Agents,DrugBank
DB01427,Pyridines,DrugBank
DB01427,Tumor Necrosis Factor Blockers,DrugBank
DB01427,Vasodilating Agents,DrugBank
DB01428,Benzene Derivatives,DrugBank
DB01428,"Compounds used in a research, industrial, or household setting",DrugBank
DB01428,Cosmetics,DrugBank
DB01428,Dermatologicals,DrugBank
DB01428,Drugs that are Mainly Renally Excreted,DrugBank
DB01428,Ketones,DrugBank
DB01428,Protective Agents,DrugBank
DB01428,Radiation-Protective Agents,DrugBank
DB01428,Sunscreen Agents,DrugBank
DB01429,Antiarrhythmic agents,DrugBank
DB01429,"Antiarrhythmics, Class I",DrugBank
DB01429,"Antiarrhythmics, Class Ib",DrugBank
DB01429,Cardiac Therapy,DrugBank
DB01429,Cardiovascular Agents,DrugBank
DB01429,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01429,Cytochrome P-450 Substrates,DrugBank
DB01429,Indans,DrugBank
DB01429,Indenes,DrugBank
DB01429,Membrane Transport Modulators,DrugBank
DB01429,Sodium Channel Blockers,DrugBank
DB01429,Voltage-Gated Sodium Channel Blockers,DrugBank
DB01431,Adrenal Cortex Hormones,DrugBank
DB01431,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01431,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01431,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01431,Cytochrome P-450 Substrates,DrugBank
DB01431,Drugs that are Mainly Renally Excreted,DrugBank
DB01431,Estranes,DrugBank
DB01431,Estren Derivatives,DrugBank
DB01431,Estrenes,DrugBank
DB01431,Fused-Ring Compounds,DrugBank
DB01431,Genito Urinary System and Sex Hormones,DrugBank
DB01431,Hormones,DrugBank
DB01431,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01431,Progestins,DrugBank
DB01431,Sex Hormones and Modulators of the Genital System,DrugBank
DB01431,Steroids,DrugBank
DB01432,Anion Exchange Resins,DrugBank
DB01432,Anticholesteremic Agents,DrugBank
DB01432,Bile Acid Sequestrants,DrugBank
DB01432,Bile-acid Binding Activity,DrugBank
DB01432,"Compounds used in a research, industrial, or household setting",DrugBank
DB01432,Hypolipidemic Agents,DrugBank
DB01432,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01432,Ion Exchange Resins,DrugBank
DB01432,Laboratory Chemicals,DrugBank
DB01432,Lipid Modifying Agents,DrugBank
DB01432,"Lipid Modifying Agents, Plain",DrugBank
DB01432,Lipid Regulating Agents,DrugBank
DB01432,Macromolecular Substances,DrugBank
DB01432,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB01432,Plastics,DrugBank
DB01432,Polymers,DrugBank
DB01432,Polystyrenes,DrugBank
DB01433,Analgesics,DrugBank
DB01433,Central Nervous System Agents,DrugBank
DB01433,Central Nervous System Depressants,DrugBank
DB01433,Ketones,DrugBank
DB01433,Narcotics,DrugBank
DB01433,Opioids,DrugBank
DB01433,Peripheral Nervous System Agents,DrugBank
DB01433,Sensory System Agents,DrugBank
DB01433,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01434,17-Ketosteroids,DrugBank
DB01434,Adrenal Cortex Hormones,DrugBank
DB01434,Androstanes,DrugBank
DB01434,Androstenes,DrugBank
DB01434,Fused-Ring Compounds,DrugBank
DB01434,Gonadal Hormones,DrugBank
DB01434,Gonadal Steroid Hormones,DrugBank
DB01434,Hormones,DrugBank
DB01434,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01434,Ketosteroids,DrugBank
DB01434,Steroids,DrugBank
DB01434,Testosterone Congeners,DrugBank
DB01435,Agents causing hyperkalemia,DrugBank
DB01435,Agents that produce hypertension,DrugBank
DB01435,Analgesics,DrugBank
DB01435,Analgesics and Anesthetics,DrugBank
DB01435,"Analgesics, Non-Narcotic",DrugBank
DB01435,Anti-Inflammatory Agents,DrugBank
DB01435,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01435,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01435,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01435,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB01435,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01435,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01435,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01435,Cytochrome P-450 Substrates,DrugBank
DB01435,Methemoglobinemia Associated Agents,DrugBank
DB01435,Nephrotoxic agents,DrugBank
DB01435,Nervous System,DrugBank
DB01435,Non COX-2 selective NSAIDS,DrugBank
DB01435,OAT1/SLC22A6 inhibitors,DrugBank
DB01435,Otologicals,DrugBank
DB01435,Peripheral Nervous System Agents,DrugBank
DB01435,Pyrazoles,DrugBank
DB01435,Pyrazolones,DrugBank
DB01435,Sensory Organs,DrugBank
DB01435,Sensory System Agents,DrugBank
DB01436,Alimentary Tract and Metabolism,DrugBank
DB01436,Bone Density Conservation Agents,DrugBank
DB01436,Cholestanes,DrugBank
DB01436,Cholestenes,DrugBank
DB01436,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB01436,Drugs for Treatment of Bone Diseases,DrugBank
DB01436,Fused-Ring Compounds,DrugBank
DB01436,Lipids,DrugBank
DB01436,Membrane Lipids,DrugBank
DB01436,Musculo-Skeletal System,DrugBank
DB01436,Secosteroids,DrugBank
DB01436,Steroids,DrugBank
DB01436,Sterols,DrugBank
DB01436,Vitamin D and Analogues,DrugBank
DB01436,Vitamins,DrugBank
DB01436,Vitamins (Fat Soluble),DrugBank
DB01437,Central Nervous System Agents,DrugBank
DB01437,Central Nervous System Depressants,DrugBank
DB01437,Hypnotics and Sedatives,DrugBank
DB01437,Nervous System,DrugBank
DB01437,Piperidinedione Derivatives,DrugBank
DB01437,Piperidines,DrugBank
DB01437,Piperidones,DrugBank
DB01437,Psycholeptics,DrugBank
DB01438,Amines,DrugBank
DB01438,Aminopyridines,DrugBank
DB01438,Antipruritics and Local Anesthetics,DrugBank
DB01438,Drugs that are Mainly Renally Excreted,DrugBank
DB01438,Genito Urinary System and Sex Hormones,DrugBank
DB01438,Methemoglobinemia Associated Agents,DrugBank
DB01438,Nephrotoxic agents,DrugBank
DB01438,Pyridines,DrugBank
DB01438,Urologicals,DrugBank
DB01440,"Acids, Acyclic",DrugBank
DB01440,"Adjuvants, Anesthesia",DrugBank
DB01440,Anesthetics,DrugBank
DB01440,"Anesthetics, General",DrugBank
DB01440,"Anesthetics, Intravenous",DrugBank
DB01440,Butyrates,DrugBank
DB01440,Central Nervous System Agents,DrugBank
DB01440,Central Nervous System Depressants,DrugBank
DB01440,Central Nervous System Depression,DrugBank
DB01440,Decreased Central Nervous System Organized Electrical Activity,DrugBank
DB01440,Fatty Acids,DrugBank
DB01440,"Fatty Acids, Volatile",DrugBank
DB01440,Hydroxy Acids,DrugBank
DB01440,Hydroxybutyrates,DrugBank
DB01440,Lipids,DrugBank
DB01442,Agents producing tachycardia,DrugBank
DB01442,Agents that produce hypertension,DrugBank
DB01442,Amines,DrugBank
DB01442,Amphetamines,DrugBank
DB01442,Antidepressive Agents,DrugBank
DB01442,Central Nervous System Depressants,DrugBank
DB01442,Ethylamines,DrugBank
DB01442,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01442,Phenethylamines,DrugBank
DB01442,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01442,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB01442,Serotonin Agents,DrugBank
DB01442,Serotonin Receptor Agonists,DrugBank
DB01442,Sympathomimetics,DrugBank
DB01445,Amphibian Venoms,DrugBank
DB01445,Antidepressive Agents,DrugBank
DB01445,Biological Factors,DrugBank
DB01445,Central Nervous System Agents,DrugBank
DB01445,Central Nervous System Depressants,DrugBank
DB01445,Complex Mixtures,DrugBank
DB01445,Hallucinogens,DrugBank
DB01445,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01445,Indoles,DrugBank
DB01445,Monoamine Oxidase A Substrates,DrugBank
DB01445,"N,N-Dimethyltryptamine",DrugBank
DB01445,Neurotransmitter Agents,DrugBank
DB01445,Psychotropic Drugs,DrugBank
DB01445,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01445,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB01445,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01445,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01445,Serotonin Agents,DrugBank
DB01445,Serotonin Receptor Antagonists,DrugBank
DB01445,"Toxins, Biological",DrugBank
DB01445,Tryptamines,DrugBank
DB01445,Venoms,DrugBank
DB01450,Alkaloids,DrugBank
DB01450,Analgesics,DrugBank
DB01450,Central Nervous System Agents,DrugBank
DB01450,Central Nervous System Depressants,DrugBank
DB01450,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01450,Morphinans,DrugBank
DB01450,Narcotics,DrugBank
DB01450,Opiate Alkaloids,DrugBank
DB01450,Opioids,DrugBank
DB01450,Peripheral Nervous System Agents,DrugBank
DB01450,Phenanthrenes,DrugBank
DB01450,Sensory System Agents,DrugBank
DB01450,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01452,Alkaloids,DrugBank
DB01452,Analgesics,DrugBank
DB01452,Central Nervous System Agents,DrugBank
DB01452,Central Nervous System Depressants,DrugBank
DB01452,Drugs Used in Addictive Disorders,DrugBank
DB01452,Drugs Used in Opioid Dependence,DrugBank
DB01452,"Heroin, agonists",DrugBank
DB01452,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01452,Morphinans,DrugBank
DB01452,Morphine Derivatives,DrugBank
DB01452,Narcotics,DrugBank
DB01452,Nervous System,DrugBank
DB01452,Opiate Agonists,DrugBank
DB01452,Opiate Alkaloids,DrugBank
DB01452,Opioids,DrugBank
DB01452,Peripheral Nervous System Agents,DrugBank
DB01452,Phenanthrenes,DrugBank
DB01452,Sensory System Agents,DrugBank
DB01452,Thyroxine-binding globulin inducers,DrugBank
DB01454,Adrenergic Agents,DrugBank
DB01454,Adrenergic Uptake Inhibitors,DrugBank
DB01454,Agents producing tachycardia,DrugBank
DB01454,Agents that produce hypertension,DrugBank
DB01454,Amines,DrugBank
DB01454,Amphetamines,DrugBank
DB01454,Antidepressive Agents,DrugBank
DB01454,Central Nervous System Agents,DrugBank
DB01454,Central Nervous System Depressants,DrugBank
DB01454,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01454,Cytochrome P-450 Substrates,DrugBank
DB01454,Ethylamines,DrugBank
DB01454,Hallucinogens,DrugBank
DB01454,Membrane Transport Modulators,DrugBank
DB01454,Neurotransmitter Agents,DrugBank
DB01454,Neurotransmitter Uptake Inhibitors,DrugBank
DB01454,Phenethylamines,DrugBank
DB01454,Psychotropic Drugs,DrugBank
DB01454,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01454,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB01454,Serotonin Agents,DrugBank
DB01454,Serotonin Receptor Agonists,DrugBank
DB01454,Sympathomimetics,DrugBank
DB01456,17-Ketosteroids,DrugBank
DB01456,Adrenal Cortex Hormones,DrugBank
DB01456,Androstanes,DrugBank
DB01456,Androstenes,DrugBank
DB01456,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01456,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01456,Cytochrome P-450 Substrates,DrugBank
DB01456,Fused-Ring Compounds,DrugBank
DB01456,Gonadal Hormones,DrugBank
DB01456,Gonadal Steroid Hormones,DrugBank
DB01456,Hormones,DrugBank
DB01456,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01456,Ketosteroids,DrugBank
DB01456,Steroids,DrugBank
DB01456,Testosterone Congeners,DrugBank
DB01459,Analgesics,DrugBank
DB01459,Central Nervous System Agents,DrugBank
DB01459,Diphenylpropylamine Derivatives,DrugBank
DB01459,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01459,Nervous System,DrugBank
DB01459,Opioids,DrugBank
DB01459,Peripheral Nervous System Agents,DrugBank
DB01459,Sensory System Agents,DrugBank
DB01459,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01463,Bridged-Ring Compounds,DrugBank
DB01463,Central Nervous System Agents,DrugBank
DB01463,Central Nervous System Depressants,DrugBank
DB01463,Central Nervous System Stimulants,DrugBank
DB01463,Centrally Acting Sympathomimetics,DrugBank
DB01463,Nervous System,DrugBank
DB01463,Psychoanaleptics,DrugBank
DB01463,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB01463,Psychotropic Drugs,DrugBank
DB01463,Tranquilizing Agents,DrugBank
DB01466,Alkaloids,DrugBank
DB01466,Analgesics,DrugBank
DB01466,Antitussive Agents,DrugBank
DB01466,Central Nervous System Agents,DrugBank
DB01466,Central Nervous System Depressants,DrugBank
DB01466,Cough and Cold Preparations,DrugBank
DB01466,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01466,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01466,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01466,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01466,Cytochrome P-450 Substrates,DrugBank
DB01466,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01466,Morphinans,DrugBank
DB01466,Morphine Derivatives,DrugBank
DB01466,Narcotics,DrugBank
DB01466,Ophthalmologicals,DrugBank
DB01466,Opiate Alkaloids,DrugBank
DB01466,Opioids,DrugBank
DB01466,Opium Alkaloids and Derivatives,DrugBank
DB01466,Peripheral Nervous System Agents,DrugBank
DB01466,Phenanthrenes,DrugBank
DB01466,Respiratory System Agents,DrugBank
DB01466,Sensory Organs,DrugBank
DB01466,Sensory System Agents,DrugBank
DB01466,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01467,Agents producing tachycardia,DrugBank
DB01467,Agents that produce hypertension,DrugBank
DB01467,Amines,DrugBank
DB01467,Amphetamines,DrugBank
DB01467,Ethylamines,DrugBank
DB01467,Phenethylamines,DrugBank
DB01467,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01467,Sympathomimetics,DrugBank
DB01471,Anabolic Agents,DrugBank
DB01471,Androstanes,DrugBank
DB01471,Androstenes,DrugBank
DB01471,Androstenols,DrugBank
DB01471,Fused-Ring Compounds,DrugBank
DB01471,Gonadal Hormones,DrugBank
DB01471,Gonadal Steroid Hormones,DrugBank
DB01471,Hormones,DrugBank
DB01471,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01471,Steroids,DrugBank
DB01471,Testosterone Congeners,DrugBank
DB01472,Adrenergic Agonists,DrugBank
DB01472,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01472,Adrenergic alpha-Agonists,DrugBank
DB01472,Agents producing tachycardia,DrugBank
DB01472,Agents that produce hypertension,DrugBank
DB01472,Amines,DrugBank
DB01472,Central Nervous System Agents,DrugBank
DB01472,Central Nervous System Depressants,DrugBank
DB01472,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01472,Cytochrome P-450 Substrates,DrugBank
DB01472,Ethylamines,DrugBank
DB01472,Hallucinogens,DrugBank
DB01472,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01472,Phenethylamines,DrugBank
DB01472,Psychotropic Drugs,DrugBank
DB01481,Androstanes,DrugBank
DB01481,Androstenes,DrugBank
DB01481,Androstenols,DrugBank
DB01481,Fused-Ring Compounds,DrugBank
DB01481,Gonadal Hormones,DrugBank
DB01481,Gonadal Steroid Hormones,DrugBank
DB01481,Hormones,DrugBank
DB01481,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01481,Steroids,DrugBank
DB01481,Testosterone and derivatives,DrugBank
DB01481,Testosterone Congeners,DrugBank
DB01482,Alkaloids,DrugBank
DB01482,Amines,DrugBank
DB01482,Central Nervous System Agents,DrugBank
DB01482,Central Nervous System Stimulants,DrugBank
DB01482,Centrally Acting Sympathomimetics,DrugBank
DB01482,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01482,Cytochrome P-450 Substrates,DrugBank
DB01482,Ethylamines,DrugBank
DB01482,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01482,Nervous System,DrugBank
DB01482,Phenethylamines,DrugBank
DB01482,Psychoanaleptics,DrugBank
DB01482,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB01482,Purines,DrugBank
DB01482,Purinones,DrugBank
DB01482,Xanthine derivatives,DrugBank
DB01483,Anticholinergic Agents,DrugBank
DB01483,Anticonvulsants,DrugBank
DB01483,Barbiturates,DrugBank
DB01483,"Barbiturates, Plain",DrugBank
DB01483,Central Nervous System Agents,DrugBank
DB01483,Central Nervous System Depressants,DrugBank
DB01483,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB01483,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB01483,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01483,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01483,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01483,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01483,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01483,Cytochrome P-450 Substrates,DrugBank
DB01483,GABA Agents,DrugBank
DB01483,GABA Modulators,DrugBank
DB01483,Hypnotics and Sedatives,DrugBank
DB01483,Nervous System,DrugBank
DB01483,Neurotransmitter Agents,DrugBank
DB01483,Nicotinic Antagonists,DrugBank
DB01483,Psycholeptics,DrugBank
DB01483,Pyrimidines,DrugBank
DB01483,Pyrimidinones,DrugBank
DB01484,Agents producing tachycardia,DrugBank
DB01484,Agents that produce hypertension,DrugBank
DB01484,Amines,DrugBank
DB01484,Amphetamines,DrugBank
DB01484,Antidepressive Agents,DrugBank
DB01484,Central Nervous System Agents,DrugBank
DB01484,Central Nervous System Depressants,DrugBank
DB01484,Ethylamines,DrugBank
DB01484,Hallucinogens,DrugBank
DB01484,Neurotransmitter Agents,DrugBank
DB01484,Phenethylamines,DrugBank
DB01484,Psychotropic Drugs,DrugBank
DB01484,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01484,Serotonin Agents,DrugBank
DB01484,Serotonin Receptor Agonists,DrugBank
DB01484,Sympathomimetics,DrugBank
DB01485,Androstanes,DrugBank
DB01485,Androstenes,DrugBank
DB01485,Androstenols,DrugBank
DB01485,Fused-Ring Compounds,DrugBank
DB01485,Steroids,DrugBank
DB01485,Testosterone and derivatives,DrugBank
DB01485,Testosterone Congeners,DrugBank
DB01488,Amines,DrugBank
DB01488,Antidepressive Agents,DrugBank
DB01488,Biogenic Amines,DrugBank
DB01488,Biogenic Monoamines,DrugBank
DB01488,Central Nervous System Agents,DrugBank
DB01488,Central Nervous System Depressants,DrugBank
DB01488,Hallucinogens,DrugBank
DB01488,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01488,Indoles,DrugBank
DB01488,Neurotransmitter Agents,DrugBank
DB01488,Psychotropic Drugs,DrugBank
DB01488,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01488,Serotonin Agents,DrugBank
DB01488,Serotonin Receptor Agonists,DrugBank
DB01488,Serotonin Receptor Antagonists,DrugBank
DB01488,Tryptamines,DrugBank
DB01489,Anti-Anxiety Agents,DrugBank
DB01489,Benzazepines,DrugBank
DB01489,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01489,Benzodiazepinones,DrugBank
DB01489,Central Nervous System Depressants,DrugBank
DB01489,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01489,Nervous System,DrugBank
DB01489,Psycholeptics,DrugBank
DB01495,Alcohols,DrugBank
DB01495,Central Nervous System Depressants,DrugBank
DB01495,Ethylene Glycols,DrugBank
DB01495,Glycols,DrugBank
DB01495,Hypnotics and Sedatives,DrugBank
DB01495,Nervous System,DrugBank
DB01495,Psycholeptics,DrugBank
DB01495,Pyrazoles,DrugBank
DB01495,Pyrazolones,DrugBank
DB01496,Anticholinergic Agents,DrugBank
DB01496,Nicotinic Antagonists,DrugBank
DB01497,Alkaloids,DrugBank
DB01497,Analgesics,DrugBank
DB01497,Central Nervous System Agents,DrugBank
DB01497,Central Nervous System Depressants,DrugBank
DB01497,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01497,Morphinans,DrugBank
DB01497,Narcotics,DrugBank
DB01497,Opiate Alkaloids,DrugBank
DB01497,Opioids,DrugBank
DB01497,Peripheral Nervous System Agents,DrugBank
DB01497,Phenanthrenes,DrugBank
DB01497,Sensory System Agents,DrugBank
DB01497,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01501,Alimentary Tract and Metabolism,DrugBank
DB01501,Antidiarrheals,DrugBank
DB01501,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01501,Antipropulsives,DrugBank
DB01501,Central Nervous System Depressants,DrugBank
DB01501,Isonipecotic Acids,DrugBank
DB01501,Piperidines,DrugBank
DB01509,Adrenergic Agents,DrugBank
DB01509,Adrenergic Uptake Inhibitors,DrugBank
DB01509,Agents producing tachycardia,DrugBank
DB01509,Agents that produce hypertension,DrugBank
DB01509,Amines,DrugBank
DB01509,Amphetamines,DrugBank
DB01509,Antidepressive Agents,DrugBank
DB01509,Central Nervous System Agents,DrugBank
DB01509,Central Nervous System Depressants,DrugBank
DB01509,Ethylamines,DrugBank
DB01509,Hallucinogens,DrugBank
DB01509,Membrane Transport Modulators,DrugBank
DB01509,Neurotransmitter Agents,DrugBank
DB01509,Neurotransmitter Uptake Inhibitors,DrugBank
DB01509,Phenethylamines,DrugBank
DB01509,Psychotropic Drugs,DrugBank
DB01509,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01509,Serotonin Agents,DrugBank
DB01509,Serotonin Modulators,DrugBank
DB01509,Sympathomimetics,DrugBank
DB01510,Testosterone and derivatives,DrugBank
DB01511,Anticonvulsants,DrugBank
DB01511,Benzazepines,DrugBank
DB01511,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01511,Benzodiazepinones,DrugBank
DB01511,Central Nervous System Agents,DrugBank
DB01511,Central Nervous System Depressants,DrugBank
DB01511,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01521,Androstanes,DrugBank
DB01521,Androstenes,DrugBank
DB01521,Androstenols,DrugBank
DB01521,Fused-Ring Compounds,DrugBank
DB01521,Gonadal Hormones,DrugBank
DB01521,Gonadal Steroid Hormones,DrugBank
DB01521,Hormones,DrugBank
DB01521,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01521,Steroids,DrugBank
DB01521,Testosterone Congeners,DrugBank
DB01524,Anabolic Agents,DrugBank
DB01524,Androstanes,DrugBank
DB01524,Androstenediols,DrugBank
DB01524,Androstenes,DrugBank
DB01524,Androstenols,DrugBank
DB01524,Fused-Ring Compounds,DrugBank
DB01524,Gonadal Hormones,DrugBank
DB01524,Gonadal Steroid Hormones,DrugBank
DB01524,Hormones,DrugBank
DB01524,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01524,Steroids,DrugBank
DB01524,Testosterone Congeners,DrugBank
DB01525,Alkaloids,DrugBank
DB01525,Analgesics,DrugBank
DB01525,Aza Compounds,DrugBank
DB01525,Azabicyclo Compounds,DrugBank
DB01525,Central Nervous System Agents,DrugBank
DB01525,Central Nervous System Depressants,DrugBank
DB01525,Narcotics,DrugBank
DB01525,Peripheral Nervous System Agents,DrugBank
DB01525,Sensory System Agents,DrugBank
DB01525,Tropanes,DrugBank
DB01529,Analgesics,DrugBank
DB01529,Central Nervous System Agents,DrugBank
DB01529,Central Nervous System Depressants,DrugBank
DB01529,Diphenylpropylamine Derivatives,DrugBank
DB01529,Morpholines,DrugBank
DB01529,Narcotics,DrugBank
DB01529,Nervous System,DrugBank
DB01529,Opioids,DrugBank
DB01529,Oxazines,DrugBank
DB01529,Peripheral Nervous System Agents,DrugBank
DB01529,Sensory System Agents,DrugBank
DB01529,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01531,Alkaloids,DrugBank
DB01531,Analgesics,DrugBank
DB01531,Central Nervous System Agents,DrugBank
DB01531,Central Nervous System Depressants,DrugBank
DB01531,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01531,Illicit Drugs,DrugBank
DB01531,Morphinans,DrugBank
DB01531,Morphine Derivatives,DrugBank
DB01531,Narcotics,DrugBank
DB01531,Opiate Alkaloids,DrugBank
DB01531,Opioids,DrugBank
DB01531,Peripheral Nervous System Agents,DrugBank
DB01531,Phenanthrenes,DrugBank
DB01531,Sensory System Agents,DrugBank
DB01531,Street Drugs,DrugBank
DB01534,Aldehydes,DrugBank
DB01534,Central Nervous System Depressants,DrugBank
DB01534,Hypnotics and Sedatives,DrugBank
DB01534,Nervous System,DrugBank
DB01534,Psycholeptics,DrugBank
DB01535,Analgesics,DrugBank
DB01535,Carbon Radioisotopes,DrugBank
DB01535,Central Nervous System Agents,DrugBank
DB01535,Central Nervous System Depressants,DrugBank
DB01535,High-risk opioids,DrugBank
DB01535,Narcotics,DrugBank
DB01535,Opioids,DrugBank
DB01535,Peripheral Nervous System Agents,DrugBank
DB01535,Phenylpiperidine opioids,DrugBank
DB01535,Piperidines,DrugBank
DB01535,Sensory System Agents,DrugBank
DB01535,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01536,17-Ketosteroids,DrugBank
DB01536,Adrenal Cortex Hormones,DrugBank
DB01536,Androstanes,DrugBank
DB01536,Androstenes,DrugBank
DB01536,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01536,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01536,Cytochrome P-450 Substrates,DrugBank
DB01536,Fused-Ring Compounds,DrugBank
DB01536,Gonadal Hormones,DrugBank
DB01536,Gonadal Steroid Hormones,DrugBank
DB01536,Hormones,DrugBank
DB01536,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01536,Ketosteroids,DrugBank
DB01536,Steroids,DrugBank
DB01536,Testosterone Congeners,DrugBank
DB01537,Adrenergic Agents,DrugBank
DB01537,Adrenergic Agonists,DrugBank
DB01537,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01537,Adrenergic alpha-Agonists,DrugBank
DB01537,Amines,DrugBank
DB01537,Antidepressive Agents,DrugBank
DB01537,Central Nervous System Depressants,DrugBank
DB01537,Ethylamines,DrugBank
DB01537,Neurotransmitter Agents,DrugBank
DB01537,Phenethylamines,DrugBank
DB01537,Serotonin Agents,DrugBank
DB01541,Anabolic Agents,DrugBank
DB01541,Androstanes,DrugBank
DB01541,Androstenes,DrugBank
DB01541,Androstenols,DrugBank
DB01541,Fused-Ring Compounds,DrugBank
DB01541,Gonadal Hormones,DrugBank
DB01541,Gonadal Steroid Hormones,DrugBank
DB01541,Hormones,DrugBank
DB01541,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01541,Steroids,DrugBank
DB01541,Testosterone and derivatives,DrugBank
DB01541,Testosterone Congeners,DrugBank
DB01543,Testosterone and derivatives,DrugBank
DB01544,Anti-Anxiety Agents,DrugBank
DB01544,Benzazepines,DrugBank
DB01544,Benzodiazepine hypnotics and sedatives,DrugBank
DB01544,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01544,Benzodiazepinones,DrugBank
DB01544,Central Nervous System Agents,DrugBank
DB01544,Central Nervous System Depressants,DrugBank
DB01544,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB01544,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01544,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01544,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01544,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01544,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01544,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01544,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01544,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01544,Cytochrome P-450 Substrates,DrugBank
DB01544,GABA Agents,DrugBank
DB01544,GABA Modulators,DrugBank
DB01544,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01544,Hypnotics and Sedatives,DrugBank
DB01544,Muscle Relaxants,DrugBank
DB01544,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01544,Nervous System,DrugBank
DB01544,Neurotransmitter Agents,DrugBank
DB01544,Psycholeptics,DrugBank
DB01544,Psychotropic Drugs,DrugBank
DB01544,Tranquilizing Agents,DrugBank
DB01544,UGT1A1 Inhibitors,DrugBank
DB01544,UGT1A3 Inhibitors,DrugBank
DB01544,UGT2B7 Inhibitors,DrugBank
DB01545,Anti-Anxiety Agents,DrugBank
DB01545,Benzazepines,DrugBank
DB01545,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01545,Central Nervous System Agents,DrugBank
DB01545,Central Nervous System Depressants,DrugBank
DB01545,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01545,Nervous System,DrugBank
DB01545,Psycholeptics,DrugBank
DB01545,Psychotropic Drugs,DrugBank
DB01545,Tranquilizing Agents,DrugBank
DB01547,Alkaloids,DrugBank
DB01547,Analgesics,DrugBank
DB01547,Central Nervous System Agents,DrugBank
DB01547,Central Nervous System Depressants,DrugBank
DB01547,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01547,Morphinans,DrugBank
DB01547,Morphine Derivatives,DrugBank
DB01547,Narcotics,DrugBank
DB01547,Opiate Alkaloids,DrugBank
DB01547,Peripheral Nervous System Agents,DrugBank
DB01547,Phenanthrenes,DrugBank
DB01547,Sensory System Agents,DrugBank
DB01550,Amines,DrugBank
DB01550,Drugs that are Mainly Renally Excreted,DrugBank
DB01550,Ethylamines,DrugBank
DB01550,Phenethylamines,DrugBank
DB01550,Stimulants,DrugBank
DB01551,Alkaloids,DrugBank
DB01551,Analgesics,DrugBank
DB01551,Central Nervous System Agents,DrugBank
DB01551,Central Nervous System Depressants,DrugBank
DB01551,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01551,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01551,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01551,Cytochrome P-450 Substrates,DrugBank
DB01551,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01551,Morphinans,DrugBank
DB01551,Morphine Derivatives,DrugBank
DB01551,Narcotics,DrugBank
DB01551,Natural Opium Alkaloids,DrugBank
DB01551,Nervous System,DrugBank
DB01551,Opiate Alkaloids,DrugBank
DB01551,Opioid Agonist,DrugBank
DB01551,Opioids,DrugBank
DB01551,Peripheral Nervous System Agents,DrugBank
DB01551,Phenanthrenes,DrugBank
DB01551,Semi-synthetic Opioids,DrugBank
DB01551,Sensory System Agents,DrugBank
DB01551,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01553,Anti-Anxiety Agents,DrugBank
DB01553,Benzazepines,DrugBank
DB01553,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01553,Central Nervous System Depressants,DrugBank
DB01553,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01553,Nervous System,DrugBank
DB01553,Psycholeptics,DrugBank
DB01554,Estranes,DrugBank
DB01554,Estrenes,DrugBank
DB01554,Fused-Ring Compounds,DrugBank
DB01554,Gonadal Hormones,DrugBank
DB01554,Gonadal Steroid Hormones,DrugBank
DB01554,Hormones,DrugBank
DB01554,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01554,Steroids,DrugBank
DB01554,Testosterone Congeners,DrugBank
DB01555,Analgesics,DrugBank
DB01555,Central Nervous System Agents,DrugBank
DB01555,Central Nervous System Depressants,DrugBank
DB01555,Ketones,DrugBank
DB01555,Narcotics,DrugBank
DB01555,Opioids,DrugBank
DB01555,Peripheral Nervous System Agents,DrugBank
DB01555,Sensory System Agents,DrugBank
DB01555,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01556,Agents producing tachycardia,DrugBank
DB01556,Agents that produce hypertension,DrugBank
DB01556,Amines,DrugBank
DB01556,Amphetamines,DrugBank
DB01556,Autonomic Agents,DrugBank
DB01556,Ethylamines,DrugBank
DB01556,Peripheral Nervous System Agents,DrugBank
DB01556,Phenethylamines,DrugBank
DB01556,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01556,Sympathomimetics,DrugBank
DB01558,Anti-Anxiety Agents,DrugBank
DB01558,Benzazepines,DrugBank
DB01558,Benzodiazepine hypnotics and sedatives,DrugBank
DB01558,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01558,Benzodiazepinones,DrugBank
DB01558,Central Nervous System Agents,DrugBank
DB01558,Central Nervous System Depressants,DrugBank
DB01558,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01558,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01558,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01558,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01558,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01558,Cytochrome P-450 Substrates,DrugBank
DB01558,Drugs that are Mainly Renally Excreted,DrugBank
DB01558,GABA Agents,DrugBank
DB01558,GABA Modulators,DrugBank
DB01558,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01558,Hypnotics and Sedatives,DrugBank
DB01558,Muscle Relaxants,DrugBank
DB01558,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01558,Nervous System,DrugBank
DB01558,Neurotransmitter Agents,DrugBank
DB01558,Psycholeptics,DrugBank
DB01558,Psychotropic Drugs,DrugBank
DB01558,Tranquilizing Agents,DrugBank
DB01559,Anti-Anxiety Agents,DrugBank
DB01559,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01559,Central Nervous System Depressants,DrugBank
DB01559,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB01559,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB01559,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01559,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01559,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01559,Cytochrome P-450 Substrates,DrugBank
DB01559,Nervous System,DrugBank
DB01559,Psycholeptics,DrugBank
DB01560,Central Nervous System Agents,DrugBank
DB01560,Central Nervous System Depressants,DrugBank
DB01560,Central Nervous System Stimulants,DrugBank
DB01560,Psychotropic Drugs,DrugBank
DB01562,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01562,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01562,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01563,Alcohols,DrugBank
DB01563,Central Nervous System Agents,DrugBank
DB01563,Central Nervous System Depressants,DrugBank
DB01563,Drugs that are Mainly Renally Excreted,DrugBank
DB01563,Ethylene Glycols,DrugBank
DB01563,Glycols,DrugBank
DB01563,Hypnotics and Sedatives,DrugBank
DB01563,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB01563,Nervous System,DrugBank
DB01563,Psycholeptics,DrugBank
DB01564,Androstanes,DrugBank
DB01564,Androstenes,DrugBank
DB01564,Androstenols,DrugBank
DB01564,Fused-Ring Compounds,DrugBank
DB01564,Steroids,DrugBank
DB01564,Testosterone and derivatives,DrugBank
DB01564,Testosterone Congeners,DrugBank
DB01565,Alkaloids,DrugBank
DB01565,Analgesics,DrugBank
DB01565,Central Nervous System Agents,DrugBank
DB01565,Central Nervous System Depressants,DrugBank
DB01565,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01565,Morphinans,DrugBank
DB01565,Morphine Derivatives,DrugBank
DB01565,Narcotics,DrugBank
DB01565,Opiate Alkaloids,DrugBank
DB01565,Opioids,DrugBank
DB01565,Peripheral Nervous System Agents,DrugBank
DB01565,Phenanthrenes,DrugBank
DB01565,Semi-synthetic Opioids,DrugBank
DB01565,Sensory System Agents,DrugBank
DB01565,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01566,Adrenergic Agents,DrugBank
DB01566,Amines,DrugBank
DB01566,Amphetamines,DrugBank
DB01566,Ethylamines,DrugBank
DB01566,Membrane Transport Modulators,DrugBank
DB01566,Neurotransmitter Agents,DrugBank
DB01566,Neurotransmitter Uptake Inhibitors,DrugBank
DB01566,Phenethylamines,DrugBank
DB01566,Sympathomimetics,DrugBank
DB01567,Anti-Anxiety Agents,DrugBank
DB01567,Benzazepines,DrugBank
DB01567,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01567,Benzodiazepinones,DrugBank
DB01567,Central Nervous System Agents,DrugBank
DB01567,Central Nervous System Depressants,DrugBank
DB01567,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01567,Muscle Relaxants,DrugBank
DB01567,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01567,Nervous System,DrugBank
DB01567,Peripheral Nervous System Agents,DrugBank
DB01567,Psycholeptics,DrugBank
DB01567,Psychotropic Drugs,DrugBank
DB01567,Tranquilizing Agents,DrugBank
DB01569,Androstanes,DrugBank
DB01569,Androstenes,DrugBank
DB01569,Androstenols,DrugBank
DB01569,Fused-Ring Compounds,DrugBank
DB01569,Steroids,DrugBank
DB01569,Testosterone and derivatives,DrugBank
DB01572,Testosterone and derivatives,DrugBank
DB01575,Alimentary Tract and Metabolism,DrugBank
DB01575,Aluminium Compounds,DrugBank
DB01575,Aluminum Silicates,DrugBank
DB01575,Antidiarrheals,DrugBank
DB01575,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB01575,Gastrointestinal Agents,DrugBank
DB01575,Intestinal Adsorbents,DrugBank
DB01575,Metal cations,DrugBank
DB01575,Metal divalent cations,DrugBank
DB01575,Minerals,DrugBank
DB01575,Oxides,DrugBank
DB01575,Oxygen Compounds,DrugBank
DB01575,Silicates,DrugBank
DB01575,Silicon Compounds,DrugBank
DB01576,Agents producing tachycardia,DrugBank
DB01576,Agents that produce hypertension,DrugBank
DB01576,Amines,DrugBank
DB01576,Amphetamines,DrugBank
DB01576,Central Nervous System Agents,DrugBank
DB01576,Central Nervous System Stimulants,DrugBank
DB01576,Central Nervous System Stimulation,DrugBank
DB01576,Centrally Acting Sympathomimetics,DrugBank
DB01576,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01576,Cytochrome P-450 Substrates,DrugBank
DB01576,Dopamine Agents,DrugBank
DB01576,Dopamine Uptake Inhibitors,DrugBank
DB01576,Ethylamines,DrugBank
DB01576,Membrane Transport Modulators,DrugBank
DB01576,Nervous System,DrugBank
DB01576,Neurotransmitter Agents,DrugBank
DB01576,Neurotransmitter Uptake Inhibitors,DrugBank
DB01576,Phenethylamines,DrugBank
DB01576,Psychoanaleptics,DrugBank
DB01576,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB01576,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01576,Sympathomimetics,DrugBank
DB01577,Adrenergic Agents,DrugBank
DB01577,Adrenergic Agonists,DrugBank
DB01577,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB01577,Adrenergic alpha-Agonists,DrugBank
DB01577,Adrenergic Uptake Inhibitors,DrugBank
DB01577,Agents producing tachycardia,DrugBank
DB01577,Agents that produce hypertension,DrugBank
DB01577,Amines,DrugBank
DB01577,Amphetamine Anorectic,DrugBank
DB01577,Amphetamines,DrugBank
DB01577,Antidepressive Agents,DrugBank
DB01577,Appetite Suppression,DrugBank
DB01577,Autonomic Agents,DrugBank
DB01577,Central Nervous System Agents,DrugBank
DB01577,Central Nervous System Depressants,DrugBank
DB01577,Central Nervous System Stimulants,DrugBank
DB01577,Central Nervous System Stimulation,DrugBank
DB01577,Centrally Acting Sympathomimetics,DrugBank
DB01577,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01577,Cytochrome P-450 Substrates,DrugBank
DB01577,Dopamine Agents,DrugBank
DB01577,Dopamine Uptake Inhibitors,DrugBank
DB01577,Drugs that are Mainly Renally Excreted,DrugBank
DB01577,Ethylamines,DrugBank
DB01577,Increased Sympathetic Activity,DrugBank
DB01577,Membrane Transport Modulators,DrugBank
DB01577,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01577,Nervous System,DrugBank
DB01577,Neurotransmitter Agents,DrugBank
DB01577,Neurotransmitter Uptake Inhibitors,DrugBank
DB01577,Peripheral Nervous System Agents,DrugBank
DB01577,Phenethylamines,DrugBank
DB01577,Psychoanaleptics,DrugBank
DB01577,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB01577,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01577,Sympathomimetics,DrugBank
DB01579,Adrenergic Agonists,DrugBank
DB01579,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB01579,Adrenergic alpha-Agonists,DrugBank
DB01579,Agents producing tachycardia,DrugBank
DB01579,Agents that produce hypertension,DrugBank
DB01579,Amphetamines,DrugBank
DB01579,Appetite Suppression,DrugBank
DB01579,Central Nervous System Agents,DrugBank
DB01579,Central Nervous System Stimulants,DrugBank
DB01579,Increased Sympathetic Activity,DrugBank
DB01579,Oxazines,DrugBank
DB01579,Sympathomimetic Amine Anorectic,DrugBank
DB01579,Sympathomimetics,DrugBank
DB01580,Adrenergic Agents,DrugBank
DB01580,Adrenergic Antagonists,DrugBank
DB01580,Adrenergic beta-Antagonists,DrugBank
DB01580,Agents causing hyperkalemia,DrugBank
DB01580,Alcohols,DrugBank
DB01580,Amines,DrugBank
DB01580,Amino Alcohols,DrugBank
DB01580,Anti-Anxiety Agents,DrugBank
DB01580,Antiarrhythmic agents,DrugBank
DB01580,Antihypertensive Agents,DrugBank
DB01580,Autonomic Agents,DrugBank
DB01580,Beta Blocking Agents and Thiazides,DrugBank
DB01580,"Beta Blocking Agents, Non-Selective",DrugBank
DB01580,"Beta Blocking Agents, Non-Selective, and Thiazides",DrugBank
DB01580,Bradycardia-Causing Agents,DrugBank
DB01580,Cardiovascular Agents,DrugBank
DB01580,Central Nervous System Agents,DrugBank
DB01580,Central Nervous System Depressants,DrugBank
DB01580,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01580,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01580,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01580,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01580,Cytochrome P-450 Substrates,DrugBank
DB01580,Hypotensive Agents,DrugBank
DB01580,Negative Inotrope,DrugBank
DB01580,Neurotransmitter Agents,DrugBank
DB01580,OCT2 Inhibitors,DrugBank
DB01580,Peripheral Nervous System Agents,DrugBank
DB01580,Phenoxypropanolamines,DrugBank
DB01580,Propanolamines,DrugBank
DB01580,Propanols,DrugBank
DB01580,QTc Prolonging Agents,DrugBank
DB01580,Sympatholytics,DrugBank
DB01580,Tranquilizing Agents,DrugBank
DB01580,Vasodilating Agents,DrugBank
DB01581,Amides,DrugBank
DB01581,Amines,DrugBank
DB01581,Aniline Compounds,DrugBank
DB01581,Anti-Bacterial Agents,DrugBank
DB01581,Anti-Infective Agents,DrugBank
DB01581,Antibacterials for Systemic Use,DrugBank
DB01581,Antiinfectives for Systemic Use,DrugBank
DB01581,Benzene Derivatives,DrugBank
DB01581,Benzenesulfonamides,DrugBank
DB01581,Dermatologicals,DrugBank
DB01581,Genito Urinary System and Sex Hormones,DrugBank
DB01581,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01581,Long-Acting Antibacterial Sulfonamides,DrugBank
DB01581,Sulfanilamides,DrugBank
DB01581,Sulfonamide Antibacterial,DrugBank
DB01581,Sulfonamides,DrugBank
DB01581,Sulfonamides and trimethoprim,DrugBank
DB01581,Sulfones,DrugBank
DB01581,Sulfur Compounds,DrugBank
DB01582,Amides,DrugBank
DB01582,Amines,DrugBank
DB01582,Aniline Compounds,DrugBank
DB01582,Anti-Infective Agents,DrugBank
DB01582,Antibacterials for Systemic Use,DrugBank
DB01582,Antiinfectives for Systemic Use,DrugBank
DB01582,Benzene Derivatives,DrugBank
DB01582,Benzenesulfonamides,DrugBank
DB01582,Genito Urinary System and Sex Hormones,DrugBank
DB01582,Gynecological Antiinfectives and Antiseptics,DrugBank
DB01582,Short-Acting Antibacterial Sulfonamides,DrugBank
DB01582,Sulfanilamides,DrugBank
DB01582,Sulfonamides,DrugBank
DB01582,Sulfonamides and trimethoprim,DrugBank
DB01582,Sulfones,DrugBank
DB01582,Sulfur Compounds,DrugBank
DB01583,Agents used to treat hypothyroidism,DrugBank
DB01583,Amino Acids,DrugBank
DB01583,"Amino Acids, Aromatic",DrugBank
DB01583,"Amino Acids, Cyclic",DrugBank
DB01583,"Amino Acids, Peptides, and Proteins",DrugBank
DB01583,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01583,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01583,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01583,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01583,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01583,Cytochrome P-450 Substrates,DrugBank
DB01583,Hormones,DrugBank
DB01583,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01583,l-Triiodothyronine,DrugBank
DB01583,OAT3/SLC22A8 Inhibitors,DrugBank
DB01583,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01583,OATP1B3 substrates,DrugBank
DB01583,P-glycoprotein inducers,DrugBank
DB01583,Pharmaceutical Preparations,DrugBank
DB01583,Thyroid Products,DrugBank
DB01583,Thyronines,DrugBank
DB01583,Thyroxine-binding globulin substrates,DrugBank
DB01586,Alimentary Tract and Metabolism,DrugBank
DB01586,Bile Acid Preparations,DrugBank
DB01586,Bile acids and derivatives,DrugBank
DB01586,Bile Acids and Salts,DrugBank
DB01586,Bile and Liver Therapy,DrugBank
DB01586,Bile Therapy,DrugBank
DB01586,BSEP/ABCB11 inducers,DrugBank
DB01586,BSEP/ABCB11 Inhibitors,DrugBank
DB01586,BSEP/ABCB11 Substrates,DrugBank
DB01586,Cholagogues and Choleretics,DrugBank
DB01586,Cholanes,DrugBank
DB01586,Cholelitholytic Agents,DrugBank
DB01586,Cholic Acids,DrugBank
DB01586,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01586,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01586,Fused-Ring Compounds,DrugBank
DB01586,Gastrointestinal Agents,DrugBank
DB01586,Steroids,DrugBank
DB01587,Anti-Anxiety Agents,DrugBank
DB01587,Benzazepines,DrugBank
DB01587,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01587,Central Nervous System Agents,DrugBank
DB01587,Central Nervous System Depressants,DrugBank
DB01587,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01587,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01587,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01587,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01587,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01587,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01587,Cytochrome P-450 Substrates,DrugBank
DB01587,Drugs that are Mainly Renally Excreted,DrugBank
DB01587,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01587,Nervous System,DrugBank
DB01587,P-glycoprotein substrates,DrugBank
DB01587,Psycholeptics,DrugBank
DB01587,Psychotropic Drugs,DrugBank
DB01587,Tranquilizing Agents,DrugBank
DB01588,Anti-Anxiety Agents,DrugBank
DB01588,Benzazepines,DrugBank
DB01588,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01588,Benzodiazepinones,DrugBank
DB01588,Central Nervous System Agents,DrugBank
DB01588,Central Nervous System Depressants,DrugBank
DB01588,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01588,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01588,Cytochrome P-450 Substrates,DrugBank
DB01588,GABA Agents,DrugBank
DB01588,GABA Modulators,DrugBank
DB01588,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01588,Nervous System,DrugBank
DB01588,Neurotransmitter Agents,DrugBank
DB01588,Psycholeptics,DrugBank
DB01588,Psychotropic Drugs,DrugBank
DB01588,Tranquilizing Agents,DrugBank
DB01589,Benzazepines,DrugBank
DB01589,Benzodiazepine hypnotics and sedatives,DrugBank
DB01589,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01589,Central Nervous System Agents,DrugBank
DB01589,Central Nervous System Depressants,DrugBank
DB01589,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01589,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01589,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01589,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01589,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01589,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01589,Cytochrome P-450 Substrates,DrugBank
DB01589,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01589,Hypnotics and Sedatives,DrugBank
DB01589,Nervous System,DrugBank
DB01589,Psycholeptics,DrugBank
DB01590,Anti-Bacterial Agents,DrugBank
DB01590,Antineoplastic Agents,DrugBank
DB01590,Antineoplastic and Immunomodulating Agents,DrugBank
DB01590,Cancer immunotherapy,DrugBank
DB01590,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01590,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01590,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01590,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01590,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01590,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01590,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB01590,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01590,Cytochrome P-450 Substrates,DrugBank
DB01590,Decreased Immunologic Activity,DrugBank
DB01590,Enzyme Inhibitors,DrugBank
DB01590,Hyperglycemia-Associated Agents,DrugBank
DB01590,Immunologic Factors,DrugBank
DB01590,Immunosuppressive Agents,DrugBank
DB01590,Immunotherapy,DrugBank
DB01590,Kinase Inhibitor,DrugBank
DB01590,Lactones,DrugBank
DB01590,Macrolides,DrugBank
DB01590,Mammalian target of rapamycin (mTOR) kinase inhibitors,DrugBank
DB01590,mTOR Inhibitor Immunosuppressant,DrugBank
DB01590,mTOR Inhibitors,DrugBank
DB01590,Myelosuppressive Agents,DrugBank
DB01590,Narrow Therapeutic Index Drugs,DrugBank
DB01590,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01590,OATP1B3 inhibitors,DrugBank
DB01590,P-glycoprotein inhibitors,DrugBank
DB01590,P-glycoprotein substrates,DrugBank
DB01590,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB01590,Polyketides,DrugBank
DB01590,Protein Kinase Inhibitors,DrugBank
DB01590,Selective Immunosuppressants,DrugBank
DB01591,Agents producing tachycardia,DrugBank
DB01591,Agents that produce hypertension,DrugBank
DB01591,Anticholinergic Agents,DrugBank
DB01591,Cholinergic Agents,DrugBank
DB01591,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB01591,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01591,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01591,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01591,Cytochrome P-450 Substrates,DrugBank
DB01591,Drugs for Urinary Frequency and Incontinence,DrugBank
DB01591,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB01591,Genito Urinary System and Sex Hormones,DrugBank
DB01591,Genitourinary Agents,DrugBank
DB01591,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01591,Isoquinolines,DrugBank
DB01591,Muscarinic Antagonists,DrugBank
DB01591,Neurotransmitter Agents,DrugBank
DB01591,Potential QTc-Prolonging Agents,DrugBank
DB01591,QTc Prolonging Agents,DrugBank
DB01591,Quinuclidines,DrugBank
DB01591,Tetrahydroisoquinolines,DrugBank
DB01591,Urological Agents,DrugBank
DB01591,Urologicals,DrugBank
DB01592,Alimentary Tract and Metabolism,DrugBank
DB01592,Antianemia Drugs,DrugBank
DB01592,Antianemic Preparations,DrugBank
DB01592,Blood and Blood Forming Organs,DrugBank
DB01592,"Diet, Food, and Nutrition",DrugBank
DB01592,Elements,DrugBank
DB01592,Food,DrugBank
DB01592,Iron Compounds,DrugBank
DB01592,Iron Preparations,DrugBank
DB01592,Metals,DrugBank
DB01592,"Metals, Heavy",DrugBank
DB01592,Micronutrients,DrugBank
DB01592,Minerals,DrugBank
DB01592,Physiological Phenomena,DrugBank
DB01592,Supplements,DrugBank
DB01592,Trace Elements,DrugBank
DB01592,Transition Elements,DrugBank
DB01593,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB01593,"Diet, Food, and Nutrition",DrugBank
DB01593,Elements,DrugBank
DB01593,Food,DrugBank
DB01593,Metal cations,DrugBank
DB01593,Metal divalent cations,DrugBank
DB01593,Metals,DrugBank
DB01593,"Metals, Heavy",DrugBank
DB01593,Micronutrients,DrugBank
DB01593,Minerals,DrugBank
DB01593,Physiological Phenomena,DrugBank
DB01593,Trace Elements,DrugBank
DB01593,Transition Elements,DrugBank
DB01593,Vasoprotectives,DrugBank
DB01593,Zinc Compounds,DrugBank
DB01594,Benzazepines,DrugBank
DB01594,Benzodiazepine hypnotics and sedatives,DrugBank
DB01594,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01594,Central Nervous System Depressants,DrugBank
DB01594,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01594,Hypnotics and Sedatives,DrugBank
DB01594,Nervous System,DrugBank
DB01594,Psycholeptics,DrugBank
DB01595,Anti-Anxiety Agents,DrugBank
DB01595,Anticonvulsants,DrugBank
DB01595,Benzazepines,DrugBank
DB01595,Benzodiazepine hypnotics and sedatives,DrugBank
DB01595,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB01595,Benzodiazepinones,DrugBank
DB01595,Central Nervous System Agents,DrugBank
DB01595,Central Nervous System Depressants,DrugBank
DB01595,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01595,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB01595,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01595,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01595,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01595,Cytochrome P-450 Substrates,DrugBank
DB01595,GABA Agents,DrugBank
DB01595,GABA Modulators,DrugBank
DB01595,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01595,Hypnotics and Sedatives,DrugBank
DB01595,Muscle Relaxants,DrugBank
DB01595,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB01595,Nervous System,DrugBank
DB01595,Neurotransmitter Agents,DrugBank
DB01595,Psycholeptics,DrugBank
DB01595,Psychotropic Drugs,DrugBank
DB01595,Tranquilizing Agents,DrugBank
DB01597,Cycloparaffins,DrugBank
DB01597,Cyclopropanes,DrugBank
DB01597,Dipeptidase Inhibitors,DrugBank
DB01597,Enzyme Inhibitors,DrugBank
DB01597,OAT1/SLC22A6 inhibitors,DrugBank
DB01597,OAT3/SLC22A8 Inhibitors,DrugBank
DB01597,Protease Inhibitors,DrugBank
DB01597,Renal Dehydropeptidase Inhibitor,DrugBank
DB01598,Agents that reduce seizure threshold,DrugBank
DB01598,Amides,DrugBank
DB01598,Anti-Bacterial Agents,DrugBank
DB01598,Anti-Infective Agents,DrugBank
DB01598,Antibacterials for Systemic Use,DrugBank
DB01598,Antiinfectives for Systemic Use,DrugBank
DB01598,Beta-Lactam Antibacterials,DrugBank
DB01598,beta-Lactams,DrugBank
DB01598,Carbapenems,DrugBank
DB01598,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01598,Lactams,DrugBank
DB01598,Neurotoxic agents,DrugBank
DB01598,Penem Antibacterial,DrugBank
DB01598,Sulfur Compounds,DrugBank
DB01598,Thienamycins,DrugBank
DB01599,Anticholesteremic Agents,DrugBank
DB01599,Antioxidants,DrugBank
DB01599,Benzene Derivatives,DrugBank
DB01599,Biological Factors,DrugBank
DB01599,"Compounds used in a research, industrial, or household setting",DrugBank
DB01599,Hypolipidemic Agents,DrugBank
DB01599,Lipid Modifying Agents,DrugBank
DB01599,"Lipid Modifying Agents, Plain",DrugBank
DB01599,Lipid Regulating Agents,DrugBank
DB01599,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01599,Phenols,DrugBank
DB01599,Protective Agents,DrugBank
DB01599,QTc Prolonging Agents,DrugBank
DB01600,"Acids, Acyclic",DrugBank
DB01600,Agents causing hyperkalemia,DrugBank
DB01600,Agents that produce hypertension,DrugBank
DB01600,Analgesics,DrugBank
DB01600,"Analgesics, Non-Narcotic",DrugBank
DB01600,Anti-Inflammatory Agents,DrugBank
DB01600,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01600,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB01600,Antiinflammatory and Antirheumatic Products,DrugBank
DB01600,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01600,Antirheumatic Agents,DrugBank
DB01600,Fatty Acids,DrugBank
DB01600,"Fatty Acids, Volatile",DrugBank
DB01600,Lipids,DrugBank
DB01600,Musculo-Skeletal System,DrugBank
DB01600,Nephrotoxic agents,DrugBank
DB01600,Non COX-2 selective NSAIDS,DrugBank
DB01600,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB01600,Peripheral Nervous System Agents,DrugBank
DB01600,Photosensitizing Agents,DrugBank
DB01600,Propionates,DrugBank
DB01600,Prostaglandin Antagonists,DrugBank
DB01600,Sensory System Agents,DrugBank
DB01601,Anti-HIV Agents,DrugBank
DB01601,Anti-Infective Agents,DrugBank
DB01601,Anti-Retroviral Agents,DrugBank
DB01601,Antiinfectives for Systemic Use,DrugBank
DB01601,Antiviral Agents,DrugBank
DB01601,Antivirals for Systemic Use,DrugBank
DB01601,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB01601,BSEP/ABCB11 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01601,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01601,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB01601,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB01601,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB01601,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB01601,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB01601,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB01601,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01601,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01601,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01601,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB01601,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01601,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01601,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01601,Cytochrome P-450 Substrates,DrugBank
DB01601,Direct Acting Antivirals,DrugBank
DB01601,Enzyme Inhibitors,DrugBank
DB01601,Experimental Unapproved Treatments for COVID-19,DrugBank
DB01601,HIV Protease Inhibitors,DrugBank
DB01601,Hyperglycemia-Associated Agents,DrugBank
DB01601,Nephrotoxic agents,DrugBank
DB01601,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01601,OATP1B3 inhibitors,DrugBank
DB01601,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB01601,P-glycoprotein inducers,DrugBank
DB01601,P-glycoprotein inhibitors,DrugBank
DB01601,Potential QTc-Prolonging Agents,DrugBank
DB01601,Protease Inhibitors,DrugBank
DB01601,Pyrimidinones,DrugBank
DB01601,QTc Prolonging Agents,DrugBank
DB01601,Viral Protease Inhibitors,DrugBank
DB01602,Amides,DrugBank
DB01602,Anti-Bacterial Agents,DrugBank
DB01602,Anti-Infective Agents,DrugBank
DB01602,Antibacterials for Systemic Use,DrugBank
DB01602,Antiinfectives for Systemic Use,DrugBank
DB01602,Beta-Lactam Antibacterials,DrugBank
DB01602,beta-Lactams,DrugBank
DB01602,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01602,Lactams,DrugBank
DB01602,Penicillin G,DrugBank
DB01602,Penicillins,DrugBank
DB01602,Penicillins With Extended Spectrum,DrugBank
DB01602,Sulfur Compounds,DrugBank
DB01603,Amides,DrugBank
DB01603,Anti-Bacterial Agents,DrugBank
DB01603,Anti-Infective Agents,DrugBank
DB01603,Antibacterials for Systemic Use,DrugBank
DB01603,Antiinfectives for Systemic Use,DrugBank
DB01603,Beta-Lactam Antibacterials,DrugBank
DB01603,Beta-Lactamase Resistant Penicillins,DrugBank
DB01603,beta-Lactams,DrugBank
DB01603,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01603,Lactams,DrugBank
DB01603,Penicillins,DrugBank
DB01603,Sulfur Compounds,DrugBank
DB01604,Amides,DrugBank
DB01604,Anti-Bacterial Agents,DrugBank
DB01604,Anti-Infective Agents,DrugBank
DB01604,Antibacterials for Systemic Use,DrugBank
DB01604,Antiinfectives for Systemic Use,DrugBank
DB01604,Beta-Lactam Antibacterials,DrugBank
DB01604,beta-Lactams,DrugBank
DB01604,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01604,Lactams,DrugBank
DB01604,Penicillin G,DrugBank
DB01604,Penicillins,DrugBank
DB01604,Penicillins With Extended Spectrum,DrugBank
DB01604,Sulfur Compounds,DrugBank
DB01605,Amides,DrugBank
DB01605,Anti-Bacterial Agents,DrugBank
DB01605,Anti-Infective Agents,DrugBank
DB01605,"Anti-Infective Agents, Urinary",DrugBank
DB01605,Antibacterials for Systemic Use,DrugBank
DB01605,Antiinfectives for Systemic Use,DrugBank
DB01605,Beta-Lactam Antibacterials,DrugBank
DB01605,beta-Lactams,DrugBank
DB01605,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01605,Lactams,DrugBank
DB01605,Penicillins,DrugBank
DB01605,Penicillins With Extended Spectrum,DrugBank
DB01605,Sulfur Compounds,DrugBank
DB01606,Amides,DrugBank
DB01606,Anti-Infective Agents,DrugBank
DB01606,Antibacterials for Systemic Use,DrugBank
DB01606,Antiinfectives for Systemic Use,DrugBank
DB01606,Aza Compounds,DrugBank
DB01606,Azabicyclo Compounds,DrugBank
DB01606,Beta-Lactam Antibacterials,DrugBank
DB01606,beta-Lactamase Inhibitors,DrugBank
DB01606,beta-Lactams,DrugBank
DB01606,Enzyme Inhibitors,DrugBank
DB01606,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01606,Lactams,DrugBank
DB01606,OAT1/SLC22A6 inhibitors,DrugBank
DB01606,OAT1/SLC22A6 Substrates,DrugBank
DB01606,OAT3/SLC22A8 Inhibitors,DrugBank
DB01606,OAT3/SLC22A8 Substrates,DrugBank
DB01606,Sulfones,DrugBank
DB01606,Sulfur Compounds,DrugBank
DB01607,Amides,DrugBank
DB01607,Anti-Bacterial Agents,DrugBank
DB01607,Anti-Infective Agents,DrugBank
DB01607,Antibacterials for Systemic Use,DrugBank
DB01607,Antiinfectives for Systemic Use,DrugBank
DB01607,Beta-Lactam Antibacterials,DrugBank
DB01607,beta-Lactams,DrugBank
DB01607,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01607,Lactams,DrugBank
DB01607,Penicillins,DrugBank
DB01607,Penicillins With Extended Spectrum,DrugBank
DB01607,Sulfur Compounds,DrugBank
DB01608,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01608,Adrenergic alpha-Antagonists,DrugBank
DB01608,Adrenergic Antagonists,DrugBank
DB01608,Agents that produce hypertension,DrugBank
DB01608,Antipsychotic Agents,DrugBank
DB01608,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01608,Central Nervous System Depressants,DrugBank
DB01608,Dopamine Antagonists,DrugBank
DB01608,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01608,Nervous System,DrugBank
DB01608,Neurotoxic agents,DrugBank
DB01608,Phenothiazines,DrugBank
DB01608,Phenothiazines With Piperidine Structure,DrugBank
DB01608,Psycholeptics,DrugBank
DB01608,Sulfur Compounds,DrugBank
DB01609,"Acids, Carbocyclic",DrugBank
DB01609,Benzene Derivatives,DrugBank
DB01609,Benzoates,DrugBank
DB01609,Chelating Agents,DrugBank
DB01609,"Compounds used in a research, industrial, or household setting",DrugBank
DB01609,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01609,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB01609,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01609,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB01609,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01609,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01609,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01609,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01609,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01609,Heavy Metal Antagonists,DrugBank
DB01609,Iron Chelating Activity,DrugBank
DB01609,Iron Chelating Agents,DrugBank
DB01609,Sequestering Agents,DrugBank
DB01609,Triazoles,DrugBank
DB01609,UGT1A1 Inhibitors,DrugBank
DB01609,UGT1A1 Substrates,DrugBank
DB01609,UGT1A3 Inhibitors,DrugBank
DB01609,UGT1A9 Inhibitors,DrugBank
DB01610,Agents that reduce seizure threshold,DrugBank
DB01610,Anti-Infective Agents,DrugBank
DB01610,Antiinfectives for Systemic Use,DrugBank
DB01610,Antiviral Agents,DrugBank
DB01610,Antivirals for Systemic Use,DrugBank
DB01610,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB01610,Direct Acting Antivirals,DrugBank
DB01610,Drugs that are Mainly Renally Excreted,DrugBank
DB01610,Ganciclovir and prodrug,DrugBank
DB01610,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01610,Nucleic Acid Synthesis Inhibitors,DrugBank
DB01610,Nucleoside Analog Antiviral,DrugBank
DB01610,Nucleosides and Nucleotides,DrugBank
DB01610,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB01610,Purines,DrugBank
DB01610,Purinones,DrugBank
DB01611,Aminoquinolines,DrugBank
DB01611,Anti-Infective Agents,DrugBank
DB01611,Antimalarials,DrugBank
DB01611,Antiparasitic Agents,DrugBank
DB01611,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB01611,Antiprotozoals,DrugBank
DB01611,Antirheumatic Agents,DrugBank
DB01611,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB01611,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01611,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01611,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01611,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01611,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01611,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01611,Cytochrome P-450 Substrates,DrugBank
DB01611,Drugs causing inadvertant photosensitivity,DrugBank
DB01611,Enzyme Inhibitors,DrugBank
DB01611,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01611,Immunosuppressive Agents,DrugBank
DB01611,Neurotoxic agents,DrugBank
DB01611,P-glycoprotein inhibitors,DrugBank
DB01611,Photosensitizing Agents,DrugBank
DB01611,Potential QTc-Prolonging Agents,DrugBank
DB01611,QTc Prolonging Agents,DrugBank
DB01611,Quinolines,DrugBank
DB01612,Antianginal Agents,DrugBank
DB01612,Antidotes,DrugBank
DB01612,Cardiovascular Agents,DrugBank
DB01612,Hypotensive Agents,DrugBank
DB01612,Methemoglobinemia Associated Agents,DrugBank
DB01612,Nitrites,DrugBank
DB01612,Organic Nitrates,DrugBank
DB01612,Vasodilating Agents,DrugBank
DB01613,Alcohols,DrugBank
DB01613,Antianginal Agents,DrugBank
DB01613,Carbohydrates,DrugBank
DB01613,Cardiac Therapy,DrugBank
DB01613,Cardiovascular Agents,DrugBank
DB01613,Nitrates,DrugBank
DB01613,Organic Nitrates,DrugBank
DB01613,Sugar Alcohols,DrugBank
DB01613,Vasodilating Agents,DrugBank
DB01613,Vasodilators Used in Cardiac Diseases,DrugBank
DB01614,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01614,Adrenergic alpha-Antagonists,DrugBank
DB01614,Adrenergic Antagonists,DrugBank
DB01614,Agents that produce hypertension,DrugBank
DB01614,Antidepressive Agents,DrugBank
DB01614,Antipsychotic Agents,DrugBank
DB01614,Central Nervous System Agents,DrugBank
DB01614,Central Nervous System Depressants,DrugBank
DB01614,Dopamine Agents,DrugBank
DB01614,Dopamine Antagonists,DrugBank
DB01614,Dopamine D2 Receptor Antagonists,DrugBank
DB01614,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01614,Nervous System,DrugBank
DB01614,Neurotoxic agents,DrugBank
DB01614,Neurotransmitter Agents,DrugBank
DB01614,Phenothiazines,DrugBank
DB01614,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB01614,Psycholeptics,DrugBank
DB01614,Psychotropic Drugs,DrugBank
DB01614,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01614,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01614,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01614,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01614,Serotonin Agents,DrugBank
DB01614,Serotonin Receptor Antagonists,DrugBank
DB01614,Sulfur Compounds,DrugBank
DB01614,Tranquilizing Agents,DrugBank
DB01615,Antipsychotic Agents,DrugBank
DB01615,Central Nervous System Agents,DrugBank
DB01615,Central Nervous System Depressants,DrugBank
DB01615,Dopamine Agents,DrugBank
DB01615,Dopamine Antagonists,DrugBank
DB01615,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01615,Histamine Antagonists,DrugBank
DB01615,Histamine H1 Antagonists,DrugBank
DB01615,Moderate Risk QTc-Prolonging Agents,DrugBank
DB01615,Neurotoxic agents,DrugBank
DB01615,Neurotransmitter Agents,DrugBank
DB01615,Phenothiazines,DrugBank
DB01615,Psychotropic Drugs,DrugBank
DB01615,QTc Prolonging Agents,DrugBank
DB01615,Sulfur Compounds,DrugBank
DB01615,Tranquilizing Agents,DrugBank
DB01616,Alimentary Tract and Metabolism,DrugBank
DB01616,Amines,DrugBank
DB01616,Antidepressive Agents,DrugBank
DB01616,Autonomic Agents,DrugBank
DB01616,Central Nervous System Depressants,DrugBank
DB01616,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01616,Parasympatholytics,DrugBank
DB01616,Peripheral Nervous System Agents,DrugBank
DB01616,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01616,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01616,Serotonin Agents,DrugBank
DB01616,Serotonin Receptor Antagonists,DrugBank
DB01618,Antidepressive Agents,DrugBank
DB01618,Antipsychotic Agents,DrugBank
DB01618,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01618,Central Nervous System Agents,DrugBank
DB01618,Central Nervous System Depressants,DrugBank
DB01618,Dopamine Antagonists,DrugBank
DB01618,Dopamine D2 Receptor Antagonists,DrugBank
DB01618,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01618,Indole Derivatives,DrugBank
DB01618,Indoles,DrugBank
DB01618,Nervous System,DrugBank
DB01618,Neurotoxic agents,DrugBank
DB01618,Psycholeptics,DrugBank
DB01618,Psychotropic Drugs,DrugBank
DB01618,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01618,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01618,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01618,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01618,Serotonin Agents,DrugBank
DB01618,Serotonin Receptor Antagonists,DrugBank
DB01618,Tranquilizing Agents,DrugBank
DB01619,Antihistamines for Systemic Use,DrugBank
DB01619,Histamine Agents,DrugBank
DB01619,Histamine Antagonists,DrugBank
DB01619,Histamine H1 Antagonists,DrugBank
DB01619,Neurotransmitter Agents,DrugBank
DB01620,Anti-Allergic Agents,DrugBank
DB01620,Antihistamines for Systemic Use,DrugBank
DB01620,Antihistamines for Topical Use,DrugBank
DB01620,Antipruritics,DrugBank
DB01620,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB01620,Dermatologicals,DrugBank
DB01620,Histamine Agents,DrugBank
DB01620,Histamine Antagonists,DrugBank
DB01620,Histamine H1 Antagonists,DrugBank
DB01620,Histamine H1 Inverse Agonists,DrugBank
DB01620,Potential QTc-Prolonging Agents,DrugBank
DB01620,Pyridines,DrugBank
DB01620,QTc Prolonging Agents,DrugBank
DB01621,Antidepressive Agents,DrugBank
DB01621,Antipsychotic Agents,DrugBank
DB01621,Central Nervous System Depressants,DrugBank
DB01621,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB01621,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01621,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01621,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01621,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01621,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01621,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01621,Cytochrome P-450 Substrates,DrugBank
DB01621,Dopamine Antagonists,DrugBank
DB01621,Dopamine D2 Receptor Antagonists,DrugBank
DB01621,Drugs causing inadvertant photosensitivity,DrugBank
DB01621,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01621,Hyperglycemia-Associated Agents,DrugBank
DB01621,Nervous System,DrugBank
DB01621,Neurotoxic agents,DrugBank
DB01621,Phenothiazines,DrugBank
DB01621,Phenothiazines With Piperidine Structure,DrugBank
DB01621,Photosensitizing Agents,DrugBank
DB01621,Psycholeptics,DrugBank
DB01621,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01621,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB01621,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01621,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01621,Serotonin Agents,DrugBank
DB01621,Serotonin Receptor Antagonists,DrugBank
DB01621,Sulfur Compounds,DrugBank
DB01622,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01622,Adrenergic alpha-Antagonists,DrugBank
DB01622,Adrenergic Antagonists,DrugBank
DB01622,Agents that produce hypertension,DrugBank
DB01622,Antidepressive Agents,DrugBank
DB01622,Antipsychotic Agents,DrugBank
DB01622,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01622,Central Nervous System Depressants,DrugBank
DB01622,Dopamine Antagonists,DrugBank
DB01622,Dopamine D2 Receptor Antagonists,DrugBank
DB01622,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01622,Nervous System,DrugBank
DB01622,Neurotoxic agents,DrugBank
DB01622,Phenothiazines,DrugBank
DB01622,Phenothiazines With Piperazine Structure,DrugBank
DB01622,Psycholeptics,DrugBank
DB01622,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB01622,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01622,Serotonin Agents,DrugBank
DB01622,Serotonin Receptor Antagonists,DrugBank
DB01622,Sulfur Compounds,DrugBank
DB01623,Antidepressive Agents,DrugBank
DB01623,Antipsychotic Agents,DrugBank
DB01623,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01623,Central Nervous System Agents,DrugBank
DB01623,Central Nervous System Depressants,DrugBank
DB01623,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01623,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01623,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB01623,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01623,Cytochrome P-450 Substrates,DrugBank
DB01623,Dopamine Agents,DrugBank
DB01623,Dopamine Antagonists,DrugBank
DB01623,Dopamine D2 Receptor Antagonists,DrugBank
DB01623,Drugs causing inadvertant photosensitivity,DrugBank
DB01623,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01623,Nervous System,DrugBank
DB01623,Neurotoxic agents,DrugBank
DB01623,Neurotransmitter Agents,DrugBank
DB01623,Photosensitizing Agents,DrugBank
DB01623,Potential QTc-Prolonging Agents,DrugBank
DB01623,Psycholeptics,DrugBank
DB01623,Psychotropic Drugs,DrugBank
DB01623,QTc Prolonging Agents,DrugBank
DB01623,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01623,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01623,Serotonin Agents,DrugBank
DB01623,Serotonin Receptor Antagonists,DrugBank
DB01623,Sulfur Compounds,DrugBank
DB01623,Thioxanthene Derivatives,DrugBank
DB01623,Thioxanthenes,DrugBank
DB01623,Tranquilizing Agents,DrugBank
DB01623,Xanthenes,DrugBank
DB01624,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB01624,Adrenergic alpha-Antagonists,DrugBank
DB01624,Adrenergic Antagonists,DrugBank
DB01624,Agents that produce hypertension,DrugBank
DB01624,Antidepressive Agents,DrugBank
DB01624,Antipsychotic Agents,DrugBank
DB01624,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB01624,Central Nervous System Agents,DrugBank
DB01624,Central Nervous System Depressants,DrugBank
DB01624,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB01624,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01624,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01624,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01624,Cytochrome P-450 Substrates,DrugBank
DB01624,Dopamine Agents,DrugBank
DB01624,Dopamine Antagonists,DrugBank
DB01624,Dopamine D2 Receptor Antagonists,DrugBank
DB01624,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01624,Highest Risk QTc-Prolonging Agents,DrugBank
DB01624,Histamine Antagonists,DrugBank
DB01624,Histamine H1 Antagonists,DrugBank
DB01624,Nervous System,DrugBank
DB01624,Neurotoxic agents,DrugBank
DB01624,Neurotransmitter Agents,DrugBank
DB01624,Psycholeptics,DrugBank
DB01624,Psychotropic Drugs,DrugBank
DB01624,QTc Prolonging Agents,DrugBank
DB01624,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01624,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB01624,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB01624,Serotonin Agents,DrugBank
DB01624,Serotonin Receptor Antagonists,DrugBank
DB01624,Sulfur Compounds,DrugBank
DB01624,Thioxanthene Derivatives,DrugBank
DB01624,Thioxanthenes,DrugBank
DB01624,Tranquilizing Agents,DrugBank
DB01624,Xanthenes,DrugBank
DB01625,Agents producing tachycardia,DrugBank
DB01625,Alimentary Tract and Metabolism,DrugBank
DB01625,Amines,DrugBank
DB01625,Ammonium Compounds,DrugBank
DB01625,Anticholinergic Agents,DrugBank
DB01625,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB01625,Muscarinic Antagonists,DrugBank
DB01625,Nitrogen Compounds,DrugBank
DB01625,Onium Compounds,DrugBank
DB01625,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB01626,Agents that produce hypertension,DrugBank
DB01626,Agents that reduce seizure threshold,DrugBank
DB01626,Amines,DrugBank
DB01626,Antidepressive Agents,DrugBank
DB01626,Antihypertensive Agents,DrugBank
DB01626,Benzene Derivatives,DrugBank
DB01626,Benzyl Compounds,DrugBank
DB01626,Benzylamines,DrugBank
DB01626,Cardiovascular Agents,DrugBank
DB01626,Central Nervous System Depressants,DrugBank
DB01626,Enzyme Inhibitors,DrugBank
DB01626,MAO Inhibitors and Diuretics,DrugBank
DB01626,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB01626,Monoamine Oxidase Inhibitors,DrugBank
DB01626,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB01627,Agents that produce neuromuscular block (indirect),DrugBank
DB01627,Anti-Bacterial Agents,DrugBank
DB01627,Anti-Infective Agents,DrugBank
DB01627,Antibacterials for Systemic Use,DrugBank
DB01627,Antiinfectives for Systemic Use,DrugBank
DB01627,Carbohydrates,DrugBank
DB01627,Enzyme Inhibitors,DrugBank
DB01627,Glycosides,DrugBank
DB01627,Lincosamide Antibacterial,DrugBank
DB01627,Lincosamides,DrugBank
DB01627,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB01627,Neurotoxic agents,DrugBank
DB01627,Protein Synthesis Inhibitors,DrugBank
DB01627,Pyrrolidines,DrugBank
DB01628,Agents causing hyperkalemia,DrugBank
DB01628,Agents that produce hypertension,DrugBank
DB01628,Analgesics,DrugBank
DB01628,"Analgesics, Non-Narcotic",DrugBank
DB01628,Anti-Inflammatory Agents,DrugBank
DB01628,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB01628,Antiinflammatory and Antirheumatic Products,DrugBank
DB01628,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB01628,Antirheumatic Agents,DrugBank
DB01628,COX-2 Inhibitors,DrugBank
DB01628,Cyclooxygenase Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01628,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB01628,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01628,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB01628,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB01628,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB01628,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01628,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01628,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01628,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01628,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01628,Cytochrome P-450 Substrates,DrugBank
DB01628,Enzyme Inhibitors,DrugBank
DB01628,Musculo-Skeletal System,DrugBank
DB01628,Nephrotoxic agents,DrugBank
DB01628,Peripheral Nervous System Agents,DrugBank
DB01628,Pyridines,DrugBank
DB01628,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB01628,Sensory System Agents,DrugBank
DB01628,Sulfones,DrugBank
DB01628,Sulfur Compounds,DrugBank
DB01629,Fluorouracil and prodrugs,DrugBank
DB01629,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01629,Nucleosides,DrugBank
DB01629,Pyrimidine Nucleosides,DrugBank
DB01629,Pyrimidines,DrugBank
DB01629,Ribonucleosides,DrugBank
DB01629,Thyroxine-binding globulin inducers,DrugBank
DB01638,Alcohols,DrugBank
DB01638,Alimentary Tract and Metabolism,DrugBank
DB01638,Blood and Blood Forming Organs,DrugBank
DB01638,Blood Substitutes and Perfusion Solutions,DrugBank
DB01638,Carbohydrates,DrugBank
DB01638,"Compounds used in a research, industrial, or household setting",DrugBank
DB01638,Diagnostic Agents,DrugBank
DB01638,"Diet, Food, and Nutrition",DrugBank
DB01638,Drugs for Constipation,DrugBank
DB01638,Drugs that are Mainly Renally Excreted,DrugBank
DB01638,Enemas,DrugBank
DB01638,Flavoring Agents,DrugBank
DB01638,Food,DrugBank
DB01638,Food Additives,DrugBank
DB01638,Food Ingredients,DrugBank
DB01638,Gastrointestinal Agents,DrugBank
DB01638,Indicators and Reagents,DrugBank
DB01638,Irrigating Solutions,DrugBank
DB01638,Laboratory Chemicals,DrugBank
DB01638,Laxatives,DrugBank
DB01638,Osmotic Laxatives,DrugBank
DB01638,Physiological Phenomena,DrugBank
DB01638,Sugar Alcohols,DrugBank
DB01638,Sweetening Agents,DrugBank
DB01638,Tests for Bile Duct Patency,DrugBank
DB01645,Anticarcinogenic Agents,DrugBank
DB01645,Antineoplastic Agents,DrugBank
DB01645,BCRP/ABCG2 Inhibitors,DrugBank
DB01645,Benzopyrans,DrugBank
DB01645,Chromones,DrugBank
DB01645,"Compounds used in a research, industrial, or household setting",DrugBank
DB01645,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB01645,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB01645,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01645,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01645,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01645,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01645,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01645,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01645,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01645,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB01645,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01645,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01645,Cytochrome P-450 Substrates,DrugBank
DB01645,Enzyme Inhibitors,DrugBank
DB01645,"Estrogens, Non-Steroidal",DrugBank
DB01645,Flavonoids,DrugBank
DB01645,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01645,Hormones,DrugBank
DB01645,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01645,Isoflavones,DrugBank
DB01645,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01645,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB01645,P-glycoprotein inhibitors,DrugBank
DB01645,Phytoestrogens,DrugBank
DB01645,Protective Agents,DrugBank
DB01645,Protein Kinase Inhibitors,DrugBank
DB01645,Pyrans,DrugBank
DB01645,Tyrosine Kinase Inhibitors,DrugBank
DB01650,OAT3/SLC22A8 Inhibitors,DrugBank
DB01656,"Acids, Carbocyclic",DrugBank
DB01656,Agents to Treat Airway Disease,DrugBank
DB01656,Amides,DrugBank
DB01656,Amines,DrugBank
DB01656,Antipsoriatics,DrugBank
DB01656,Antipsoriatics for Topical Use,DrugBank
DB01656,Benzene Derivatives,DrugBank
DB01656,Benzoates,DrugBank
DB01656,Cycloparaffins,DrugBank
DB01656,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01656,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01656,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01656,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01656,Cytochrome P-450 Substrates,DrugBank
DB01656,Dermatologicals,DrugBank
DB01656,Drugs for Obstructive Airway Diseases,DrugBank
DB01656,Drugs that are Mainly Renally Excreted,DrugBank
DB01656,Phosphodiesterase 4 Inhibitors,DrugBank
DB01656,Phosphodiesterase Inhibitors,DrugBank
DB01656,Pyridines,DrugBank
DB01667,Antimetabolites,DrugBank
DB01667,Antineoplastic Agents,DrugBank
DB01667,Aza Compounds,DrugBank
DB01667,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB01667,Cytochrome P-450 Substrates,DrugBank
DB01667,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01667,Noxae,DrugBank
DB01667,Purines,DrugBank
DB01667,Purinones,DrugBank
DB01667,Toxic Actions,DrugBank
DB01667,Xanthine derivatives,DrugBank
DB01669,"Amino Acids, Peptides, and Proteins",DrugBank
DB01669,Anti-Bacterial Agents,DrugBank
DB01669,Anti-Infective Agents,DrugBank
DB01669,Peptides,DrugBank
DB01669,"Peptides, Cyclic",DrugBank
DB01669,Streptogramin Group A,DrugBank
DB01669,Streptogramins,DrugBank
DB01685,BCRP/ABCG2 Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB01685,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB01685,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB01685,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01685,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01685,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01685,Drugs that are Mainly Renally Excreted,DrugBank
DB01685,Enzyme Inhibitors,DrugBank
DB01685,OAT1/SLC22A6 inhibitors,DrugBank
DB01685,OAT3/SLC22A8 Inhibitors,DrugBank
DB01685,UGT1A9 Substrates,DrugBank
DB01698,Benzopyrans,DrugBank
DB01698,Capillary Stabilizing Agents,DrugBank
DB01698,Chromones,DrugBank
DB01698,Cytochrome P-450 CYP3A Inducers,DrugBank
DB01698,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01698,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB01698,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB01698,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01698,Cytochrome P-450 Enzyme Inducers,DrugBank
DB01698,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01698,Flavonoids,DrugBank
DB01698,Flavonols,DrugBank
DB01698,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01698,Pyrans,DrugBank
DB01698,Vasoprotectives,DrugBank
DB01700,Blood Glucose Lowering Agents,DrugBank
DB01700,Imidazoles,DrugBank
DB01700,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01700,Nucleotides,DrugBank
DB01708,17-Ketosteroids,DrugBank
DB01708,"Adjuvants, Immunologic",DrugBank
DB01708,Adrenal Cortex Hormones,DrugBank
DB01708,Alimentary Tract and Metabolism,DrugBank
DB01708,Anabolic Agents for Systemic Use,DrugBank
DB01708,Anabolic Steroids,DrugBank
DB01708,Androgens and Estrogens,DrugBank
DB01708,Androstan Derivatives,DrugBank
DB01708,Androstanes,DrugBank
DB01708,Androstenes,DrugBank
DB01708,Androstenols,DrugBank
DB01708,BCRP/ABCG2 Substrates,DrugBank
DB01708,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01708,Cytochrome P-450 CYP3A Substrates,DrugBank
DB01708,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB01708,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB01708,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB01708,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB01708,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB01708,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01708,Cytochrome P-450 Substrates,DrugBank
DB01708,Fused-Ring Compounds,DrugBank
DB01708,Genito Urinary System and Sex Hormones,DrugBank
DB01708,Gonadal Hormones,DrugBank
DB01708,Gonadal Steroid Hormones,DrugBank
DB01708,Hormones,DrugBank
DB01708,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB01708,Immunologic Factors,DrugBank
DB01708,Ketosteroids,DrugBank
DB01708,OATP1B1/SLCO1B1 Substrates,DrugBank
DB01708,OATP1B3 substrates,DrugBank
DB01708,OATP2B1/SLCO2B1 substrates,DrugBank
DB01708,Sex Hormones and Modulators of the Genital System,DrugBank
DB01708,Steroids,DrugBank
DB01708,Testosterone Congeners,DrugBank
DB01764,"Amino Acids, Peptides, and Proteins",DrugBank
DB01764,Anti-Bacterial Agents,DrugBank
DB01764,Anti-Infective Agents,DrugBank
DB01764,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01764,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01764,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB01764,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01764,Peptides,DrugBank
DB01764,"Peptides, Cyclic",DrugBank
DB01764,Streptogramin Antibacterial,DrugBank
DB01764,Streptogramins,DrugBank
DB01783,Alanine,DrugBank
DB01783,Alimentary Tract and Metabolism,DrugBank
DB01783,Amino Acids,DrugBank
DB01783,"Amino Acids, Peptides, and Proteins",DrugBank
DB01783,Blood Coagulation Factors,DrugBank
DB01783,Cicatrizants,DrugBank
DB01783,Dermatologicals,DrugBank
DB01783,Imides,DrugBank
DB01783,Micronutrients,DrugBank
DB01783,Preparations for Treatment of Wounds and Ulcers,DrugBank
DB01783,Vitamin B Complex,DrugBank
DB01783,Vitamins,DrugBank
DB01791,"Acids, Carbocyclic",DrugBank
DB01791,Amides,DrugBank
DB01791,Benzene Derivatives,DrugBank
DB01791,Benzoates,DrugBank
DB01791,Enzyme Inhibitors,DrugBank
DB01791,Phosphodiesterase 4 Inhibitors,DrugBank
DB01791,Phosphodiesterase Inhibitors,DrugBank
DB01816,Analgesics,DrugBank
DB01816,"Analgesics, Non-Narcotic",DrugBank
DB01816,Anti-Inflammatory Agents,DrugBank
DB01816,"beta-Glucosidase, antagonists & inhibitors",DrugBank
DB01816,Enzyme Inhibitors,DrugBank
DB01816,"Glucosylceramidase, antagonists & inhibitors",DrugBank
DB01816,Glycoside Hydrolase Inhibitors,DrugBank
DB01816,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01816,Immunologic Factors,DrugBank
DB01816,Immunosuppressive Agents,DrugBank
DB01816,Indolizines,DrugBank
DB01816,Peripheral Nervous System Agents,DrugBank
DB01816,Sensory System Agents,DrugBank
DB01839,Alcohols,DrugBank
DB01839,"Compounds used in a research, industrial, or household setting",DrugBank
DB01839,Drug Delivery Systems,DrugBank
DB01839,Glycols,DrugBank
DB01839,Pegylated agents,DrugBank
DB01839,Pharmaceutic Aids,DrugBank
DB01839,Pharmaceutical Preparations,DrugBank
DB01839,Pharmaceutical Vehicles,DrugBank
DB01839,Propylene Glycols,DrugBank
DB01839,Solvents,DrugBank
DB01873,Anti-Bacterial Agents,DrugBank
DB01873,Antimitotic Agents,DrugBank
DB01873,Antineoplastic Agents,DrugBank
DB01873,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB01873,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB01873,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB01873,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB01873,Lactones,DrugBank
DB01873,Macrolides,DrugBank
DB01873,Mitosis Modulators,DrugBank
DB01873,Polyketides,DrugBank
DB01873,Tubulin Modulators,DrugBank
DB01892,Benzene Derivatives,DrugBank
DB01892,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB01892,Phenols,DrugBank
DB01910,Anti-Infective Agents,DrugBank
DB01910,Antifungal Agents,DrugBank
DB01910,Antiparasitic Agents,DrugBank
DB01910,Antiprotozoals,DrugBank
DB01910,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01910,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB01910,Nucleosides,DrugBank
DB01910,Purine Nucleosides,DrugBank
DB01910,Purines,DrugBank
DB01910,Ribonucleosides,DrugBank
DB01933,Alkaloids,DrugBank
DB01933,Antineoplastic Agents,DrugBank
DB01933,Carbazoles,DrugBank
DB01933,Enzyme Inhibitors,DrugBank
DB01933,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01933,Indole Alkaloids,DrugBank
DB01933,Indoles,DrugBank
DB01933,Indolizidines,DrugBank
DB01933,Indolizines,DrugBank
DB01933,"Protein Kinase C, antagonists & inhibitors",DrugBank
DB01933,Protein Kinase Inhibitors,DrugBank
DB01942,"Acids, Acyclic",DrugBank
DB01942,Blood Coagulation Factors,DrugBank
DB01942,Hemostatics,DrugBank
DB01954,Antidepressive Agents,DrugBank
DB01954,Central Nervous System Agents,DrugBank
DB01954,Central Nervous System Depressants,DrugBank
DB01954,Enzyme Inhibitors,DrugBank
DB01954,Phosphodiesterase 4 Inhibitors,DrugBank
DB01954,Phosphodiesterase Inhibitors,DrugBank
DB01954,Psychotropic Drugs,DrugBank
DB01954,Pyrrolidines,DrugBank
DB01954,Pyrrolidinones,DrugBank
DB01978,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB01978,Purines,DrugBank
DB01978,Purinones,DrugBank
DB01978,Xanthine derivatives,DrugBank
DB02031,Folic Acid and Derivatives,DrugBank
DB02031,Vitamin B Complex,DrugBank
DB02031,Vitamins,DrugBank
DB02032,Agents that produce hypertension,DrugBank
DB02032,Amino Acids,DrugBank
DB02032,"Amino Acids, Cyclic",DrugBank
DB02032,"Amino Acids, Peptides, and Proteins",DrugBank
DB02032,Antihypertensive Agents,DrugBank
DB02032,Cardiovascular Agents,DrugBank
DB02032,Enzyme Inhibitors,DrugBank
DB02032,Imino Acids,DrugBank
DB02032,Protease Inhibitors,DrugBank
DB02056,Autacoids,DrugBank
DB02056,Biological Factors,DrugBank
DB02056,Eicosanoids,DrugBank
DB02056,Fatty Acids,DrugBank
DB02056,"Fatty Acids, Unsaturated",DrugBank
DB02056,Inflammation Mediators,DrugBank
DB02056,Lipids,DrugBank
DB02056,"Prostaglandin D2, antagonists & inhibitors",DrugBank
DB02056,Prostaglandins,DrugBank
DB02056,Prostaglandins D,DrugBank
DB02067,Folic Acid and Derivatives,DrugBank
DB02067,Vitamin B Complex,DrugBank
DB02067,Vitamins,DrugBank
DB02105,Anti-Dyskinesia Agents,DrugBank
DB02105,Anti-Parkinson Drugs,DrugBank
DB02105,Benzene Derivatives,DrugBank
DB02105,Central Nervous System Agents,DrugBank
DB02105,COMT Inhibitors,DrugBank
DB02105,Enzyme Inhibitors,DrugBank
DB02105,Phenols,DrugBank
DB02109,Amino Acids,DrugBank
DB02109,"Amino Acids, Peptides, and Proteins",DrugBank
DB02109,"Antibiotics, Antineoplastic",DrugBank
DB02109,Antineoplastic Agents,DrugBank
DB02109,Noxae,DrugBank
DB02109,Teratogens,DrugBank
DB02109,Toxic Actions,DrugBank
DB02115,Alcohol Deterrents,DrugBank
DB02115,BCRP/ABCG2 Inhibitors,DrugBank
DB02115,Benzopyrans,DrugBank
DB02115,Central Nervous System Agents,DrugBank
DB02115,Chromones,DrugBank
DB02115,Enzyme Inhibitors,DrugBank
DB02115,Flavonoids,DrugBank
DB02115,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02115,Pyrans,DrugBank
DB02123,Amino Acids,DrugBank
DB02123,"Amino Acids, Peptides, and Proteins",DrugBank
DB02123,Bile Acids and Salts,DrugBank
DB02123,BSEP/ABCB11 Inhibitors,DrugBank
DB02123,BSEP/ABCB11 Substrates,DrugBank
DB02123,Cholanes,DrugBank
DB02123,Cholic Acids,DrugBank
DB02123,"Compounds used in a research, industrial, or household setting",DrugBank
DB02123,Detergents,DrugBank
DB02123,Fused-Ring Compounds,DrugBank
DB02123,Glycodeoxycholic Acid,DrugBank
DB02123,Household Products,DrugBank
DB02123,N-substituted Glycines,DrugBank
DB02123,Steroids,DrugBank
DB02123,Surface-Active Agents,DrugBank
DB02134,Alkaloids,DrugBank
DB02134,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB02134,Cytochrome P-450 Substrates,DrugBank
DB02134,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02134,Purines,DrugBank
DB02134,Purinones,DrugBank
DB02134,Xanthine derivatives,DrugBank
DB02136,Agents that reduce seizure threshold,DrugBank
DB02187,17-Ketosteroids,DrugBank
DB02187,Adrenal Cortex Hormones,DrugBank
DB02187,Cytochrome P-450 CYP3A Substrates,DrugBank
DB02187,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB02187,Cytochrome P-450 Substrates,DrugBank
DB02187,Estradiol Congeners,DrugBank
DB02187,Estranes,DrugBank
DB02187,Estrenes,DrugBank
DB02187,Fused-Ring Compounds,DrugBank
DB02187,Gonadal Hormones,DrugBank
DB02187,Gonadal Steroid Hormones,DrugBank
DB02187,Hormones,DrugBank
DB02187,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB02187,Ketosteroids,DrugBank
DB02187,Steroids,DrugBank
DB02207,Analgesics,DrugBank
DB02207,Anti-Anxiety Agents,DrugBank
DB02207,Anticonvulsants,DrugBank
DB02207,Central Nervous System Agents,DrugBank
DB02207,Central Nervous System Depressants,DrugBank
DB02207,"Compounds used in a research, industrial, or household setting",DrugBank
DB02207,Enzyme Inhibitors,DrugBank
DB02207,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02207,Neuroprotective Agents,DrugBank
DB02207,"Nitric Oxide Synthase, antagonists & inhibitors",DrugBank
DB02207,Peripheral Nervous System Agents,DrugBank
DB02207,Protective Agents,DrugBank
DB02207,Psychotropic Drugs,DrugBank
DB02207,Pyrazoles,DrugBank
DB02207,Sensory System Agents,DrugBank
DB02207,Tranquilizing Agents,DrugBank
DB02224,Agents that produce hypertension,DrugBank
DB02224,Analgesics,DrugBank
DB02224,"Analgesics, Non-Narcotic",DrugBank
DB02224,Anti-Inflammatory Agents,DrugBank
DB02224,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB02224,Antirheumatic Agents,DrugBank
DB02224,Benzopyrans,DrugBank
DB02224,Chromones,DrugBank
DB02224,Flavonoids,DrugBank
DB02224,Flavonols,DrugBank
DB02224,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02224,Non COX-2 selective NSAIDS,DrugBank
DB02224,Peripheral Nervous System Agents,DrugBank
DB02224,Pyrans,DrugBank
DB02224,Sensory System Agents,DrugBank
DB02234,Amides,DrugBank
DB02234,Cardiovascular Agents,DrugBank
DB02234,Central Nervous System Agents,DrugBank
DB02234,Central Nervous System Depressants,DrugBank
DB02234,Enzyme Inhibitors,DrugBank
DB02234,Hypnotics and Sedatives,DrugBank
DB02234,"Nitric Oxide Synthase, antagonists & inhibitors",DrugBank
DB02234,Sulfur Compounds,DrugBank
DB02234,Thiourea,DrugBank
DB02234,Vasoconstrictor Agents,DrugBank
DB02237,Anti-Bacterial Agents,DrugBank
DB02237,Anti-Infective Agents,DrugBank
DB02237,Carbohydrates,DrugBank
DB02237,"Compounds used in a research, industrial, or household setting",DrugBank
DB02237,Disaccharides,DrugBank
DB02237,Glucans,DrugBank
DB02237,Oligosaccharides,DrugBank
DB02237,Polysaccharides,DrugBank
DB02245,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02245,Purines,DrugBank
DB02245,Purinones,DrugBank
DB02245,Xanthine derivatives,DrugBank
DB02247,Nephrotoxic agents,DrugBank
DB02261,Adrenergic Agents,DrugBank
DB02261,Alcohols,DrugBank
DB02261,Amines,DrugBank
DB02261,Amino Alcohols,DrugBank
DB02261,Autacoids,DrugBank
DB02261,Biological Factors,DrugBank
DB02261,Blood Coagulation Factors,DrugBank
DB02261,Cardiovascular Agents,DrugBank
DB02261,Ethanolamines,DrugBank
DB02261,Glycerophosphates,DrugBank
DB02261,Glycerophospholipids,DrugBank
DB02261,Inflammation Mediators,DrugBank
DB02261,Lipids,DrugBank
DB02261,Membrane Lipids,DrugBank
DB02261,Neurotransmitter Agents,DrugBank
DB02261,Onium Compounds,DrugBank
DB02261,P-glycoprotein inducers,DrugBank
DB02261,P-glycoprotein substrates,DrugBank
DB02261,Phosphatidic Acids,DrugBank
DB02261,Phospholipid Ethers,DrugBank
DB02261,Phospholipids,DrugBank
DB02261,"Platelet Activating Factor, antagonists & inhibitors",DrugBank
DB02261,Quaternary Ammonium Compounds,DrugBank
DB02261,Trimethyl Ammonium Compounds,DrugBank
DB02266,"Acids, Carbocyclic",DrugBank
DB02266,Aminobenzoates,DrugBank
DB02266,Anti-Inflammatory Agents,DrugBank
DB02266,Antiinflammatory and Antirheumatic Products,DrugBank
DB02266,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB02266,Benzene Derivatives,DrugBank
DB02266,Benzoates,DrugBank
DB02266,Fenamates,DrugBank
DB02266,Musculo-Skeletal System,DrugBank
DB02266,OAT1/SLC22A6 inhibitors,DrugBank
DB02266,ortho-Aminobenzoates,DrugBank
DB02282,Amino Acids,DrugBank
DB02282,"Amino Acids, Acidic",DrugBank
DB02282,"Amino Acids, Dicarboxylic",DrugBank
DB02282,"Amino Acids, Peptides, and Proteins",DrugBank
DB02282,Anti-Infective Agents,DrugBank
DB02282,Antineoplastic Agents,DrugBank
DB02282,Antiparasitic Agents,DrugBank
DB02282,Antiprotozoals,DrugBank
DB02282,Deoxyribonucleosides,DrugBank
DB02282,Enzyme Inhibitors,DrugBank
DB02282,Folic Acid Antagonists,DrugBank
DB02282,Glutamates,DrugBank
DB02282,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02282,Nucleic Acid Synthesis Inhibitors,DrugBank
DB02282,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB02282,Nucleosides,DrugBank
DB02282,"Protein O-Methyltransferase, antagonists & inhibitors",DrugBank
DB02282,Purine Nucleosides,DrugBank
DB02282,Purines,DrugBank
DB02282,Purinones,DrugBank
DB02282,Sulfur Compounds,DrugBank
DB02282,Xanthine derivatives,DrugBank
DB02304,Autacoids,DrugBank
DB02304,Biological Factors,DrugBank
DB02304,Eicosanoids,DrugBank
DB02304,Fatty Acids,DrugBank
DB02304,"Fatty Acids, Unsaturated",DrugBank
DB02304,Inflammation Mediators,DrugBank
DB02304,Lipids,DrugBank
DB02304,Prostaglandins,DrugBank
DB02329,Alimentary Tract and Metabolism,DrugBank
DB02329,Anti-Ulcer Agents,DrugBank
DB02329,Drugs for Acid Related Disorders,DrugBank
DB02329,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB02329,Gastrointestinal Agents,DrugBank
DB02329,Pentacyclic Triterpenes,DrugBank
DB02329,Terpenes,DrugBank
DB02329,Triterpenes,DrugBank
DB02342,Antimitotic Agents,DrugBank
DB02342,Antineoplastic Agents,DrugBank
DB02342,Estradiol Congeners,DrugBank
DB02342,Estranes,DrugBank
DB02342,Estrenes,DrugBank
DB02342,Fused-Ring Compounds,DrugBank
DB02342,Gonadal Hormones,DrugBank
DB02342,Gonadal Steroid Hormones,DrugBank
DB02342,Hormones,DrugBank
DB02342,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB02342,Mitosis Modulators,DrugBank
DB02342,Steroids,DrugBank
DB02342,Tubulin Modulators,DrugBank
DB02365,Chelating Agents,DrugBank
DB02365,Cholinergic Agents,DrugBank
DB02365,Cholinesterase Inhibitors,DrugBank
DB02365,"Compounds used in a research, industrial, or household setting",DrugBank
DB02365,Cross-Linking Reagents,DrugBank
DB02365,Enzyme Inhibitors,DrugBank
DB02365,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02365,Indicators and Reagents,DrugBank
DB02365,Intercalating Agents,DrugBank
DB02365,Iron Chelating Agents,DrugBank
DB02365,Laboratory Chemicals,DrugBank
DB02365,Neurotransmitter Agents,DrugBank
DB02365,Sequestering Agents,DrugBank
DB02369,Phosphate salts,DrugBank
DB02377,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02377,Purines,DrugBank
DB02377,Purinones,DrugBank
DB02377,Xanthine derivatives,DrugBank
DB02423,Acids,DrugBank
DB02423,"Acids, Noncarboxylic",DrugBank
DB02423,Anions,DrugBank
DB02423,Electrolytes,DrugBank
DB02423,Ions,DrugBank
DB02423,Phosphate salts,DrugBank
DB02423,Phosphoric Acids,DrugBank
DB02423,Phosphorus Acids,DrugBank
DB02423,Phosphorus Compounds,DrugBank
DB02423,Polyphosphates,DrugBank
DB02424,Amides,DrugBank
DB02424,Anti-Infective Agents,DrugBank
DB02424,"Antibiotics, Antineoplastic",DrugBank
DB02424,Antineoplastic Agents,DrugBank
DB02424,Cysteine Proteinase Inhibitors,DrugBank
DB02424,Enzyme Inhibitors,DrugBank
DB02424,Lactams,DrugBank
DB02424,Protease Inhibitors,DrugBank
DB02424,Quinones,DrugBank
DB02424,Tyrosine Kinase Inhibitors,DrugBank
DB02489,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB02489,Cytochrome P-450 Substrates,DrugBank
DB02489,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02489,Purines,DrugBank
DB02489,Purinones,DrugBank
DB02489,Xanthine derivatives,DrugBank
DB02513,Anti-Infective Agents,DrugBank
DB02513,"Anti-Infective Agents, Local",DrugBank
DB02513,Antifungal Agents,DrugBank
DB02513,Benzene Derivatives,DrugBank
DB02513,Monoterpenes,DrugBank
DB02513,Phenols,DrugBank
DB02513,Terpenes,DrugBank
DB02520,"Acids, Acyclic",DrugBank
DB02520,"Adjuvants, Immunologic",DrugBank
DB02520,Anti-Infective Agents,DrugBank
DB02520,Carbamates,DrugBank
DB02520,Chelating Agents,DrugBank
DB02520,"Compounds used in a research, industrial, or household setting",DrugBank
DB02520,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB02520,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB02520,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB02520,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB02520,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB02520,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB02520,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB02520,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB02520,Immunologic Factors,DrugBank
DB02520,Sequestering Agents,DrugBank
DB02520,Sulfur Compounds,DrugBank
DB02520,Thiocarbamates,DrugBank
DB02527,Adenine Nucleotides,DrugBank
DB02527,Cyclic AMP,DrugBank
DB02527,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02527,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB02527,Nucleotides,DrugBank
DB02527,"Nucleotides, Cyclic",DrugBank
DB02527,OAT1/SLC22A6 Substrates,DrugBank
DB02527,OAT3/SLC22A8 Substrates,DrugBank
DB02527,Purine Nucleotides,DrugBank
DB02527,Purines,DrugBank
DB02527,Ribonucleotides,DrugBank
DB02546,Amides,DrugBank
DB02546,Amines,DrugBank
DB02546,Anilides,DrugBank
DB02546,Aniline Compounds,DrugBank
DB02546,Antineoplastic Agents,DrugBank
DB02546,Antineoplastic and Immunomodulating Agents,DrugBank
DB02546,Enzyme Inhibitors,DrugBank
DB02546,Histone deacetylase (HDAC) inhibitors,DrugBank
DB02546,Histone Deacetylase Inhibitors,DrugBank
DB02546,Hydroxamic Acids,DrugBank
DB02546,Hydroxy Acids,DrugBank
DB02546,Hydroxylamines,DrugBank
DB02546,Hyperglycemia-Associated Agents,DrugBank
DB02546,Immunosuppressive Agents,DrugBank
DB02546,Myelosuppressive Agents,DrugBank
DB02546,Narrow Therapeutic Index Drugs,DrugBank
DB02546,Potential QTc-Prolonging Agents,DrugBank
DB02546,QTc Prolonging Agents,DrugBank
DB02552,Acids,DrugBank
DB02552,"Acids, Noncarboxylic",DrugBank
DB02552,Anions,DrugBank
DB02552,Electrolytes,DrugBank
DB02552,Ions,DrugBank
DB02552,Phosphate salts,DrugBank
DB02552,Phosphoric Acids,DrugBank
DB02552,Phosphorus Acids,DrugBank
DB02552,Phosphorus Compounds,DrugBank
DB02552,Polyphosphates,DrugBank
DB02552,Terpenes,DrugBank
DB02568,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB02568,Cytochrome P-450 Substrates,DrugBank
DB02568,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02568,"N-Glycosyl Hydrolases, antagonists & inhibitors",DrugBank
DB02568,Purines,DrugBank
DB02568,Purinones,DrugBank
DB02568,Xanthine derivatives,DrugBank
DB02587,"Adjuvants, Immunologic",DrugBank
DB02587,Anti-Asthmatic Agents,DrugBank
DB02587,Autonomic Agents,DrugBank
DB02587,Bronchodilator Agents,DrugBank
DB02587,Cardiotonic Agents,DrugBank
DB02587,Cardiovascular Agents,DrugBank
DB02587,"Compounds used in a research, industrial, or household setting",DrugBank
DB02587,Diterpenes,DrugBank
DB02587,Immunologic Factors,DrugBank
DB02587,P-glycoprotein inhibitors,DrugBank
DB02587,Peripheral Nervous System Agents,DrugBank
DB02587,Protective Agents,DrugBank
DB02587,Respiratory System Agents,DrugBank
DB02587,Terpenes,DrugBank
DB02587,Vasodilating Agents,DrugBank
DB02638,"Amino Acids, Peptides, and Proteins",DrugBank
DB02638,Cardiovascular Agents,DrugBank
DB02638,Hormones,DrugBank
DB02638,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB02638,Moderate Risk QTc-Prolonging Agents,DrugBank
DB02638,Nerve Tissue Proteins,DrugBank
DB02638,Neuropeptides,DrugBank
DB02638,Oligopeptides,DrugBank
DB02638,Peptide Hormones,DrugBank
DB02638,Peptides,DrugBank
DB02638,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB02638,Pituitary Hormones,DrugBank
DB02638,"Pituitary Hormones, Posterior",DrugBank
DB02638,Posterior Pituitary Lobe Hormones,DrugBank
DB02638,Proteins,DrugBank
DB02638,QTc Prolonging Agents,DrugBank
DB02638,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB02638,Vasoconstrictor Agents,DrugBank
DB02638,Vasopressin and Analogues,DrugBank
DB02638,Vasopressin Receptor Agonist,DrugBank
DB02638,Vasopressins,DrugBank
DB02640,Angiogenesis Inhibitors,DrugBank
DB02640,Angiogenesis Modulating Agents,DrugBank
DB02640,Anti-Infective Agents,DrugBank
DB02640,Antineoplastic Agents,DrugBank
DB02640,Antiparasitic Agents,DrugBank
DB02640,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB02640,Antiprotozoals,DrugBank
DB02640,Cycloparaffins,DrugBank
DB02640,Fatty Acids,DrugBank
DB02640,Growth Inhibitors,DrugBank
DB02640,Growth Substances,DrugBank
DB02640,Lipids,DrugBank
DB02640,Terpenes,DrugBank
DB02659,Alimentary Tract and Metabolism,DrugBank
DB02659,Bile Acid Preparations,DrugBank
DB02659,Bile acids and derivatives,DrugBank
DB02659,Bile Acids and Salts,DrugBank
DB02659,Bile and Liver Therapy,DrugBank
DB02659,Bile Therapy,DrugBank
DB02659,BSEP/ABCB11 inducers,DrugBank
DB02659,BSEP/ABCB11 Inhibitors,DrugBank
DB02659,BSEP/ABCB11 Substrates,DrugBank
DB02659,Cholanes,DrugBank
DB02659,Cholic Acids,DrugBank
DB02659,Fused-Ring Compounds,DrugBank
DB02659,OAT3/SLC22A8 Inhibitors,DrugBank
DB02659,OAT3/SLC22A8 Substrates,DrugBank
DB02659,OATP1B1/SLCO1B1 Inducers,DrugBank
DB02659,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB02659,OATP1B1/SLCO1B1 Substrates,DrugBank
DB02659,OATP1B3 substrates,DrugBank
DB02659,P-glycoprotein inducers,DrugBank
DB02659,Steroids,DrugBank
DB02691,Amino Acids,DrugBank
DB02691,"Amino Acids, Peptides, and Proteins",DrugBank
DB02691,Bile Acids and Salts,DrugBank
DB02691,Cholagogues and Choleretics,DrugBank
DB02691,Cholanes,DrugBank
DB02691,Cholic Acids,DrugBank
DB02691,"Compounds used in a research, industrial, or household setting",DrugBank
DB02691,Detergents,DrugBank
DB02691,Fused-Ring Compounds,DrugBank
DB02691,Gastrointestinal Agents,DrugBank
DB02691,Household Products,DrugBank
DB02691,N-substituted Glycines,DrugBank
DB02691,Steroids,DrugBank
DB02691,Surface-Active Agents,DrugBank
DB02703,Agents Causing Muscle Toxicity,DrugBank
DB02703,Anti-Bacterial Agents,DrugBank
DB02703,Anti-Infective Agents,DrugBank
DB02703,Antibacterials for Systemic Use,DrugBank
DB02703,Antibiotics for Topical Use,DrugBank
DB02703,Antiinfectives for Systemic Use,DrugBank
DB02703,BCRP/ABCG2 Inhibitors,DrugBank
DB02703,BSEP/ABCB11 Inhibitors,DrugBank
DB02703,Cholestadienes,DrugBank
DB02703,Cholestadienols,DrugBank
DB02703,Cholestanes,DrugBank
DB02703,Cholestenes,DrugBank
DB02703,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB02703,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB02703,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB02703,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB02703,Cytochrome P-450 CYP3A Substrates,DrugBank
DB02703,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB02703,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB02703,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB02703,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB02703,Cytochrome P-450 Substrates,DrugBank
DB02703,Dermatologicals,DrugBank
DB02703,Enzyme Inhibitors,DrugBank
DB02703,Fused-Ring Compounds,DrugBank
DB02703,Lipids,DrugBank
DB02703,Medicated Dressings,DrugBank
DB02703,Medicated Dressings With Antiinfectives,DrugBank
DB02703,Membrane Lipids,DrugBank
DB02703,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB02703,Ophthalmologicals,DrugBank
DB02703,Other Miscellaneous Antibacterial Agents,DrugBank
DB02703,Protein Synthesis Inhibitors,DrugBank
DB02703,Sensory Organs,DrugBank
DB02703,Steroid Antibacterials,DrugBank
DB02703,Steroids,DrugBank
DB02703,Sterols,DrugBank
DB02703,UGT1A1 Substrates,DrugBank
DB02709,Angiogenesis Inhibitors,DrugBank
DB02709,Anticarcinogenic Agents,DrugBank
DB02709,Antioxidants,DrugBank
DB02709,Antiplatelet agents,DrugBank
DB02709,Antirheumatic Agents,DrugBank
DB02709,Benzene Derivatives,DrugBank
DB02709,Benzylidene Compounds,DrugBank
DB02709,Biological Factors,DrugBank
DB02709,"Compounds used in a research, industrial, or household setting",DrugBank
DB02709,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB02709,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB02709,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB02709,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB02709,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB02709,Cytochrome P-450 Enzyme Inducers,DrugBank
DB02709,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB02709,Cytochrome P-450 Substrates,DrugBank
DB02709,Enzyme Inhibitors,DrugBank
DB02709,Hematologic Agents,DrugBank
DB02709,Phenols,DrugBank
DB02709,Polyphenols,DrugBank
DB02709,Protective Agents,DrugBank
DB02709,Stilbenes,DrugBank
DB02709,Stilbestrols,DrugBank
DB02709,Vasodilating Agents,DrugBank
DB02756,Antifungal Agents,DrugBank
DB02756,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB02789,Adrenal Cortex Hormones,DrugBank
DB02789,Cytochrome P-450 CYP3A Substrates,DrugBank
DB02789,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB02789,Cytochrome P-450 Substrates,DrugBank
DB02789,Fused-Ring Compounds,DrugBank
DB02789,Gonadal Hormones,DrugBank
DB02789,Gonadal Steroid Hormones,DrugBank
DB02789,Hormones,DrugBank
DB02789,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB02789,Hydroxycorticosteroids,DrugBank
DB02789,Pregnanes,DrugBank
DB02789,Pregnenes,DrugBank
DB02789,Progesterone Congeners,DrugBank
DB02789,Steroids,DrugBank
DB02806,Alcohols,DrugBank
DB02806,Glycols,DrugBank
DB02806,Immunologic Factors,DrugBank
DB02806,Immunosuppressive Agents,DrugBank
DB02806,Noxae,DrugBank
DB02806,Solvents,DrugBank
DB02806,Teratogens,DrugBank
DB02806,Toxic Actions,DrugBank
DB02845,Acids,DrugBank
DB02845,"Acids, Noncarboxylic",DrugBank
DB02845,Cholinesterase Inhibitors,DrugBank
DB02845,Organophosphorus Compounds,DrugBank
DB02845,Phosphorus Acids,DrugBank
DB02845,Phosphorus Compounds,DrugBank
DB02852,Central Nervous System Depressants,DrugBank
DB02852,Neuromuscular Agents,DrugBank
DB02852,Neurotoxins,DrugBank
DB02852,Peripheral Nervous System Agents,DrugBank
DB02852,Pyrrolidines,DrugBank
DB02860,Biological Factors,DrugBank
DB02860,Carcinogens,DrugBank
DB02860,Cardiovascular Agents,DrugBank
DB02860,Enzyme Inhibitors,DrugBank
DB02860,Noxae,DrugBank
DB02860,"Phosphoprotein Phosphatases, antagonists & inhibitors",DrugBank
DB02860,Toxic Actions,DrugBank
DB02860,"Toxins, Biological",DrugBank
DB02860,Vasoconstrictor Agents,DrugBank
DB02901,5-Androstanon (3) Derivatives,DrugBank
DB02901,Alimentary Tract and Metabolism,DrugBank
DB02901,Anabolic Agents for Systemic Use,DrugBank
DB02901,Anabolic Steroids,DrugBank
DB02901,Androgens,DrugBank
DB02901,Androstan Derivatives,DrugBank
DB02901,Androstanes,DrugBank
DB02901,Androstanols,DrugBank
DB02901,Fused-Ring Compounds,DrugBank
DB02901,Genito Urinary System and Sex Hormones,DrugBank
DB02901,Gonadal Hormones,DrugBank
DB02901,Gonadal Steroid Hormones,DrugBank
DB02901,Hormones,DrugBank
DB02901,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB02901,P-glycoprotein substrates,DrugBank
DB02901,Sex Hormones and Modulators of the Genital System,DrugBank
DB02901,Steroids,DrugBank
DB02901,Testosterone and derivatives,DrugBank
DB02901,Testosterone Congeners,DrugBank
DB02901,Thyroxine-binding globulin inhibitors,DrugBank
DB02925,Amides,DrugBank
DB02925,Cardiovascular Agents,DrugBank
DB02925,Diuretics,DrugBank
DB02925,Genito Urinary System and Sex Hormones,DrugBank
DB02925,Gynecological Antiinfectives and Antiseptics,DrugBank
DB02925,High-Ceiling Diuretics,DrugBank
DB02925,Membrane Transport Modulators,DrugBank
DB02925,Natriuretic Agents,DrugBank
DB02925,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB02925,Sulfonamides,DrugBank
DB02925,Sulfones,DrugBank
DB02925,Sulfur Compounds,DrugBank
DB02948,Anti-Bacterial Agents,DrugBank
DB02948,Anti-Infective Agents,DrugBank
DB02948,Organophosphonates,DrugBank
DB02948,Organophosphorus Compounds,DrugBank
DB02959,Amino Acids,DrugBank
DB02959,"Amino Acids, Aromatic",DrugBank
DB02959,"Amino Acids, Cyclic",DrugBank
DB02959,"Amino Acids, Peptides, and Proteins",DrugBank
DB02959,Antidepressive Agents,DrugBank
DB02959,"Antidepressive Agents, Second-Generation",DrugBank
DB02959,Central Nervous System Agents,DrugBank
DB02959,Central Nervous System Depressants,DrugBank
DB02959,Nervous System,DrugBank
DB02959,Psychoanaleptics,DrugBank
DB02959,Psychotropic Drugs,DrugBank
DB02968,Agents causing hyperkalemia,DrugBank
DB02975,"Amino Acids, Peptides, and Proteins",DrugBank
DB02975,Anti-Bacterial Agents,DrugBank
DB02975,Anti-Infective Agents,DrugBank
DB02975,Peptides,DrugBank
DB02975,Sulfur Compounds,DrugBank
DB03010,Anti-Bacterial Agents,DrugBank
DB03010,Antimitotic Agents,DrugBank
DB03010,Antineoplastic Agents,DrugBank
DB03010,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB03010,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB03010,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB03010,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB03010,Lactones,DrugBank
DB03010,Macrolides,DrugBank
DB03010,Mitosis Modulators,DrugBank
DB03010,Polyketides,DrugBank
DB03010,Tubulin Modulators,DrugBank
DB03128,Amines,DrugBank
DB03128,Antiglaucoma Preparations and Miotics,DrugBank
DB03128,Biogenic Amines,DrugBank
DB03128,Cardiovascular Agents,DrugBank
DB03128,Cholinergic Agents,DrugBank
DB03128,Cholinergic Agonists,DrugBank
DB03128,Cholinergic Receptor Agonist,DrugBank
DB03128,Cholinesterase substrates,DrugBank
DB03128,Miotics,DrugBank
DB03128,Neurotransmitter Agents,DrugBank
DB03128,OCT1 substrates,DrugBank
DB03128,Ophthalmologicals,DrugBank
DB03128,Parasympathomimetics,DrugBank
DB03128,Sensory Organs,DrugBank
DB03128,Vasodilating Agents,DrugBank
DB03166,Acetates,DrugBank
DB03166,"Acids, Acyclic",DrugBank
DB03166,Anti-Bacterial Agents,DrugBank
DB03166,Anti-Infective Agents,DrugBank
DB03166,"Compounds used in a research, industrial, or household setting",DrugBank
DB03166,Fatty Acids,DrugBank
DB03166,"Fatty Acids, Volatile",DrugBank
DB03166,Genito Urinary System and Sex Hormones,DrugBank
DB03166,Gynecological Antiinfectives and Antiseptics,DrugBank
DB03166,Indicators and Reagents,DrugBank
DB03166,Laboratory Chemicals,DrugBank
DB03166,Lipids,DrugBank
DB03166,OATP2B1/SLCO2B1 substrates,DrugBank
DB03166,Organic Acids,DrugBank
DB03166,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB03166,Otologicals,DrugBank
DB03166,Sensory Organs,DrugBank
DB03172,"Antibiotics, Antineoplastic",DrugBank
DB03172,Antimetabolites,DrugBank
DB03172,Antineoplastic Agents,DrugBank
DB03172,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03172,Noxae,DrugBank
DB03172,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB03172,Nucleosides,DrugBank
DB03172,Purine Nucleosides,DrugBank
DB03172,Purines,DrugBank
DB03172,Ribonucleosides,DrugBank
DB03172,Toxic Actions,DrugBank
DB03255,Anesthetics,DrugBank
DB03255,"Anesthetics, Local",DrugBank
DB03255,Anti-Infective Agents,DrugBank
DB03255,"Anti-Infective Agents, Local",DrugBank
DB03255,Antiseptics and Disinfectants,DrugBank
DB03255,Antivaricose Therapy,DrugBank
DB03255,Benzene Derivatives,DrugBank
DB03255,Cardiovascular Agents,DrugBank
DB03255,"Compounds used in a research, industrial, or household setting",DrugBank
DB03255,Dermatologicals,DrugBank
DB03255,Disinfectants,DrugBank
DB03255,Miscellaneous Therapeutic Agents,DrugBank
DB03255,Nervous System,DrugBank
DB03255,Pharmaceutical Preparations,DrugBank
DB03255,Pharmaceutical Solutions,DrugBank
DB03255,Phenol and Derivatives,DrugBank
DB03255,Phenols,DrugBank
DB03255,Sclerosing Agents for Local Injection,DrugBank
DB03255,Sclerosing Solutions,DrugBank
DB03255,Solutions,DrugBank
DB03255,Throat Preparations,DrugBank
DB03255,Vasoprotectives,DrugBank
DB03256,Folic Acid and Derivatives,DrugBank
DB03256,Vitamin B Complex,DrugBank
DB03256,Vitamins,DrugBank
DB03313,Agents that reduce seizure threshold,DrugBank
DB03313,Amides,DrugBank
DB03313,beta-Lactams,DrugBank
DB03313,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03313,Lactams,DrugBank
DB03313,Sulfur Compounds,DrugBank
DB03313,Thiazines,DrugBank
DB03322,Adrenergic Agents,DrugBank
DB03322,Adrenergic Antagonists,DrugBank
DB03322,Adrenergic beta-Antagonists,DrugBank
DB03322,Alcohols,DrugBank
DB03322,Amines,DrugBank
DB03322,Amino Alcohols,DrugBank
DB03322,Antiarrhythmic agents,DrugBank
DB03322,Antihypertensive Agents,DrugBank
DB03322,Cardiovascular Agents,DrugBank
DB03322,Naphthalenes,DrugBank
DB03322,Neurotransmitter Agents,DrugBank
DB03322,Phenoxypropanolamines,DrugBank
DB03322,Propanolamines,DrugBank
DB03322,Propanols,DrugBank
DB03322,Vasodilating Agents,DrugBank
DB03374,Antithyroid agents,DrugBank
DB03374,Thyroid Products,DrugBank
DB03394,Pegylated agents,DrugBank
DB03395,Agents Acting on the Renin-Angiotensin System,DrugBank
DB03395,"Amino Acids, Peptides, and Proteins",DrugBank
DB03395,Enzyme Inhibitors,DrugBank
DB03395,Oligopeptides,DrugBank
DB03395,Peptides,DrugBank
DB03395,Protease Inhibitors,DrugBank
DB03395,Renin Inhibitors,DrugBank
DB03404,Biological Factors,DrugBank
DB03404,Blood and Blood Forming Organs,DrugBank
DB03404,Heme,DrugBank
DB03404,Heme products,DrugBank
DB03404,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03404,Metalloporphyrins,DrugBank
DB03404,"Pigments, Biological",DrugBank
DB03404,Porphyrins,DrugBank
DB03410,Anticoagulants,DrugBank
DB03410,Benzopyrans,DrugBank
DB03410,Coumarins,DrugBank
DB03410,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03410,Pyrans,DrugBank
DB03410,Vitamin K Antagonists,DrugBank
DB03419,Fluorouracil and prodrugs,DrugBank
DB03419,Pyrimidines,DrugBank
DB03419,Pyrimidinones,DrugBank
DB03424,"Adjuvants, Immunologic",DrugBank
DB03424,Amino Acids,DrugBank
DB03424,"Amino Acids, Branched-Chain",DrugBank
DB03424,"Amino Acids, Peptides, and Proteins",DrugBank
DB03424,"Aminopeptidases, antagonists & inhibitors",DrugBank
DB03424,Anti-Bacterial Agents,DrugBank
DB03424,Anti-HIV Agents,DrugBank
DB03424,Anti-Infective Agents,DrugBank
DB03424,"Antibiotics, Antineoplastic",DrugBank
DB03424,Enzyme Inhibitors,DrugBank
DB03424,Immunologic Factors,DrugBank
DB03424,Protease Inhibitors,DrugBank
DB03450,Nephrotoxic agents,DrugBank
DB03451,Antineoplastic Agents,DrugBank
DB03451,Cholestanes,DrugBank
DB03451,Cholestenes,DrugBank
DB03451,Fused-Ring Compounds,DrugBank
DB03451,Immunologic Factors,DrugBank
DB03451,Immunosuppressive Agents,DrugBank
DB03451,Lipids,DrugBank
DB03451,Membrane Lipids,DrugBank
DB03451,Secosteroids,DrugBank
DB03451,Steroids,DrugBank
DB03451,Sterols,DrugBank
DB03451,Vitamin D and Analogues,DrugBank
DB03451,Vitamins,DrugBank
DB03451,Vitamins (Fat Soluble),DrugBank
DB03459,Acetates,DrugBank
DB03459,"Acids, Acyclic",DrugBank
DB03459,Amino Acids,DrugBank
DB03459,"Amino Acids, Acidic",DrugBank
DB03459,"Amino Acids, Dicarboxylic",DrugBank
DB03459,"Amino Acids, Peptides, and Proteins",DrugBank
DB03459,Anti-Infective Agents,DrugBank
DB03459,Antimetabolites,DrugBank
DB03459,Antineoplastic Agents,DrugBank
DB03459,Enzyme Inhibitors,DrugBank
DB03459,Excitatory Amino Acids,DrugBank
DB03459,Noxae,DrugBank
DB03459,Organophosphonates,DrugBank
DB03459,Organophosphorus Compounds,DrugBank
DB03459,Toxic Actions,DrugBank
DB03467,Anti-Ulcer Agents,DrugBank
DB03467,BCRP/ABCG2 Inhibitors,DrugBank
DB03467,Benzopyrans,DrugBank
DB03467,Chromones,DrugBank
DB03467,Estrogen Antagonists,DrugBank
DB03467,Flavonoids,DrugBank
DB03467,Gastrointestinal Agents,DrugBank
DB03467,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03467,Hormone Antagonists,DrugBank
DB03467,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB03467,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB03467,Pyrans,DrugBank
DB03496,Antineoplastic Agents,DrugBank
DB03496,BCRP/ABCG2 Substrates,DrugBank
DB03496,Benzopyrans,DrugBank
DB03496,Chromones,DrugBank
DB03496,"Cyclin-Dependent Kinases, antagonists & inhibitors",DrugBank
DB03496,Enzyme Inhibitors,DrugBank
DB03496,Growth Inhibitors,DrugBank
DB03496,Growth Substances,DrugBank
DB03496,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03496,Protein Kinase Inhibitors,DrugBank
DB03496,Pyrans,DrugBank
DB03496,UGT1A1 Substrates,DrugBank
DB03509,Antineoplastic Agents,DrugBank
DB03509,Enzyme Inhibitors,DrugBank
DB03509,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03509,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB03515,17-Ketosteroids,DrugBank
DB03515,Adrenal Cortex Hormones,DrugBank
DB03515,Cytochrome P-450 CYP3A Substrates,DrugBank
DB03515,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB03515,Cytochrome P-450 Substrates,DrugBank
DB03515,Estradiol Congeners,DrugBank
DB03515,Estranes,DrugBank
DB03515,Estrenes,DrugBank
DB03515,Fused-Ring Compounds,DrugBank
DB03515,Gonadal Hormones,DrugBank
DB03515,Gonadal Steroid Hormones,DrugBank
DB03515,Hormones,DrugBank
DB03515,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB03515,Ketosteroids,DrugBank
DB03515,Steroids,DrugBank
DB03523,Antineoplastic Agents,DrugBank
DB03523,Benzene Derivatives,DrugBank
DB03523,Enzyme Inhibitors,DrugBank
DB03523,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03523,Immunologic Factors,DrugBank
DB03523,Immunosuppressive Agents,DrugBank
DB03523,Oxidoreductases,DrugBank
DB03523,Quinolines,DrugBank
DB03553,"Acids, Acyclic",DrugBank
DB03553,Dicarboxylic Acids,DrugBank
DB03553,OAT1/SLC22A6 inhibitors,DrugBank
DB03553,OAT1/SLC22A6 Substrates,DrugBank
DB03553,OAT3/SLC22A8 Inhibitors,DrugBank
DB03553,OAT3/SLC22A8 Substrates,DrugBank
DB03566,Amines,DrugBank
DB03566,Biogenic Amines,DrugBank
DB03566,Biogenic Polyamines,DrugBank
DB03566,OCT1 substrates,DrugBank
DB03566,Polyamines,DrugBank
DB03575,Central Nervous System Agents,DrugBank
DB03575,Central Nervous System Depressants,DrugBank
DB03575,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB03575,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB03575,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB03575,Enzyme Inhibitors,DrugBank
DB03575,Excitatory Amino Acid Agents,DrugBank
DB03575,Excitatory Amino Acid Antagonists,DrugBank
DB03575,Hallucinogens,DrugBank
DB03575,Neurotransmitter Agents,DrugBank
DB03575,NMDA Receptor Antagonists,DrugBank
DB03575,"Phencyclidine, antagonists & inhibitors",DrugBank
DB03575,Piperidines,DrugBank
DB03575,Psychotropic Drugs,DrugBank
DB03585,Agents causing hyperkalemia,DrugBank
DB03585,Agents that produce hypertension,DrugBank
DB03585,Analgesics,DrugBank
DB03585,"Analgesics, Non-Narcotic",DrugBank
DB03585,Anti-Inflammatory Agents,DrugBank
DB03585,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB03585,Antiinflammatory and Antirheumatic Products,DrugBank
DB03585,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB03585,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB03585,Antirheumatic Agents,DrugBank
DB03585,Butylpyrazolidines,DrugBank
DB03585,Musculo-Skeletal System,DrugBank
DB03585,Nephrotoxic agents,DrugBank
DB03585,Non COX-2 selective NSAIDS,DrugBank
DB03585,OAT1/SLC22A6 inhibitors,DrugBank
DB03585,Ophthalmologicals,DrugBank
DB03585,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB03585,Peripheral Nervous System Agents,DrugBank
DB03585,Pyrazoles,DrugBank
DB03585,Pyrazolones,DrugBank
DB03585,Sensory Organs,DrugBank
DB03585,Sensory System Agents,DrugBank
DB03585,Topical Products for Joint and Muscular Pain,DrugBank
DB03600,Anti-Infective Agents,DrugBank
DB03600,Antifungal Agents,DrugBank
DB03600,Fatty Acids,DrugBank
DB03600,Lipids,DrugBank
DB03604,Agents used to treat hypothyroidism,DrugBank
DB03604,Amino Acids,DrugBank
DB03604,"Amino Acids, Aromatic",DrugBank
DB03604,"Amino Acids, Cyclic",DrugBank
DB03604,"Amino Acids, Peptides, and Proteins",DrugBank
DB03604,Cytochrome P-450 CYP3A Inducers,DrugBank
DB03604,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB03604,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB03604,Cytochrome P-450 Enzyme Inducers,DrugBank
DB03604,Dermatologicals,DrugBank
DB03604,Hormones,DrugBank
DB03604,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB03604,NTCP Inhibitors,DrugBank
DB03604,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB03604,Thyroid Products,DrugBank
DB03604,Thyronines,DrugBank
DB03615,Agents that produce neuromuscular block (indirect),DrugBank
DB03615,Aminoglycoside Antibacterials,DrugBank
DB03615,Anti-Bacterial Agents,DrugBank
DB03615,Anti-Infective Agents,DrugBank
DB03615,Antibacterials for Systemic Use,DrugBank
DB03615,Antiinfectives for Systemic Use,DrugBank
DB03615,Carbohydrates,DrugBank
DB03615,Drugs that are Mainly Renally Excreted,DrugBank
DB03615,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB03615,Glycosides,DrugBank
DB03615,Narrow Therapeutic Index Drugs,DrugBank
DB03615,Nephrotoxic agents,DrugBank
DB03619,Bile Acids and Salts,DrugBank
DB03619,BSEP/ABCB11 inducers,DrugBank
DB03619,Cholagogues and Choleretics,DrugBank
DB03619,Cholanes,DrugBank
DB03619,Cholic Acids,DrugBank
DB03619,Cytolytic Agent,DrugBank
DB03619,Decreased Cell Membrane Integrity,DrugBank
DB03619,Dermatologicals,DrugBank
DB03619,Fused-Ring Compounds,DrugBank
DB03619,Gastrointestinal Agents,DrugBank
DB03619,Other Miscellaneous Therapeutic Agents,DrugBank
DB03619,Steroids,DrugBank
DB03695,Antineoplastic Agents,DrugBank
DB03695,Enzyme Inhibitors,DrugBank
DB03695,Folic Acid Antagonists,DrugBank
DB03701,Antiarrhythmic agents,DrugBank
DB03701,Cytochrome P-450 CYP3A Substrates,DrugBank
DB03701,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB03701,Cytochrome P-450 Substrates,DrugBank
DB03701,Dopamine Agents,DrugBank
DB03701,Dopamine Uptake Inhibitors,DrugBank
DB03701,Membrane Transport Modulators,DrugBank
DB03701,Neurotransmitter Agents,DrugBank
DB03701,Neurotransmitter Uptake Inhibitors,DrugBank
DB03754,Alcohols,DrugBank
DB03754,Blood and Blood Forming Organs,DrugBank
DB03754,Blood Substitutes and Perfusion Solutions,DrugBank
DB03754,Buffers,DrugBank
DB03754,"Compounds used in a research, industrial, or household setting",DrugBank
DB03754,Excipients,DrugBank
DB03754,Glycols,DrugBank
DB03754,I.V. Solution Additives,DrugBank
DB03754,i.v. Solutions,DrugBank
DB03754,Laboratory Chemicals,DrugBank
DB03754,Pharmaceutic Aids,DrugBank
DB03754,Pharmaceutical Preparations,DrugBank
DB03754,Pharmaceutical Vehicles,DrugBank
DB03754,Propylene Glycols,DrugBank
DB03754,Solutions Affecting the Electrolyte Balance,DrugBank
DB03756,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB03756,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB03756,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB03756,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB03756,Cytochrome P-450 Substrates,DrugBank
DB03756,Dietary Fats,DrugBank
DB03756,"Dietary Fats, Unsaturated",DrugBank
DB03756,Fats,DrugBank
DB03756,Fatty Acids,DrugBank
DB03756,"Fatty Acids, Omega-3",DrugBank
DB03756,"Fatty Acids, Unsaturated",DrugBank
DB03756,Fish Oils,DrugBank
DB03756,Lipids,DrugBank
DB03756,Oils,DrugBank
DB03758,Anti-Infective Agents,DrugBank
DB03758,Antifungal Agents,DrugBank
DB03758,Antiparasitic Agents,DrugBank
DB03758,Antiprotozoals,DrugBank
DB03758,Enzyme Inhibitors,DrugBank
DB03758,Lactones,DrugBank
DB03758,Polyketides,DrugBank
DB03758,Tyrosine Kinase Inhibitors,DrugBank
DB03783,Acetanilides,DrugBank
DB03783,Amides,DrugBank
DB03783,Amines,DrugBank
DB03783,Analgesics,DrugBank
DB03783,"Analgesics, Non-Narcotic",DrugBank
DB03783,Anilides,DrugBank
DB03783,Aniline Compounds,DrugBank
DB03783,Central Nervous System Agents,DrugBank
DB03783,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB03783,Cytochrome P-450 CYP3A Substrates,DrugBank
DB03783,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB03783,Cytochrome P-450 Substrates,DrugBank
DB03783,Nervous System,DrugBank
DB03783,OAT1/SLC22A6 inhibitors,DrugBank
DB03783,Peripheral Nervous System Agents,DrugBank
DB03783,Sensory System Agents,DrugBank
DB03793,"Acids, Carbocyclic",DrugBank
DB03793,Alimentary Tract and Metabolism,DrugBank
DB03793,Ammonium Ion Binding Activity,DrugBank
DB03793,Anti-Infective Agents,DrugBank
DB03793,Antifungal Agents,DrugBank
DB03793,Benzene Derivatives,DrugBank
DB03793,Benzoates,DrugBank
DB03793,"Compounds used in a research, industrial, or household setting",DrugBank
DB03793,Diagnostic Agents,DrugBank
DB03793,"Diet, Food, and Nutrition",DrugBank
DB03793,Food,DrugBank
DB03793,Food Additives,DrugBank
DB03793,Food Ingredients,DrugBank
DB03793,Food Preservatives,DrugBank
DB03793,Nitrogen Binding Agent,DrugBank
DB03793,OAT3/SLC22A8 Inhibitors,DrugBank
DB03793,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB03793,Physiological Phenomena,DrugBank
DB03793,Tests for Gastric Secretion,DrugBank
DB03793,Urea Cycle Disorder Agents,DrugBank
DB03793,Various Alimentary Tract and Metabolism Products,DrugBank
DB03819,Amides,DrugBank
DB03819,Anti-Infective Agents,DrugBank
DB03819,Antifungal Agents,DrugBank
DB03819,Antiparasitic Agents,DrugBank
DB03819,Antiprotozoals,DrugBank
DB03819,Trypanocidal Agents,DrugBank
DB03825,Antineoplastic Agents,DrugBank
DB03825,Coloring Agents,DrugBank
DB03825,"Compounds used in a research, industrial, or household setting",DrugBank
DB03825,Fluorescent Dyes,DrugBank
DB03825,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03825,Indicators and Reagents,DrugBank
DB03825,Laboratory Chemicals,DrugBank
DB03825,Luminescent Agents,DrugBank
DB03825,P-glycoprotein substrates,DrugBank
DB03825,Xanthenes,DrugBank
DB03849,"Acids, Carbocyclic",DrugBank
DB03849,Cyclohexanes,DrugBank
DB03849,Cycloparaffins,DrugBank
DB03849,Enzyme Inhibitors,DrugBank
DB03849,Phosphodiesterase 4 Inhibitors,DrugBank
DB03849,Phosphodiesterase Inhibitors,DrugBank
DB03866,Anions,DrugBank
DB03866,Autacoids,DrugBank
DB03866,Biological Factors,DrugBank
DB03866,Eicosanoids,DrugBank
DB03866,Electrolytes,DrugBank
DB03866,Fatty Acids,DrugBank
DB03866,"Fatty Acids, Unsaturated",DrugBank
DB03866,Free Radicals,DrugBank
DB03866,Inflammation Mediators,DrugBank
DB03866,Ions,DrugBank
DB03866,Lipids,DrugBank
DB03866,Oxides,DrugBank
DB03866,Oxygen Compounds,DrugBank
DB03866,Peroxides,DrugBank
DB03866,Prostaglandin Endoperoxides,DrugBank
DB03866,Prostaglandins,DrugBank
DB03866,Reactive Oxygen Species,DrugBank
DB03880,Amino Acids,DrugBank
DB03880,"Amino Acids, Aromatic",DrugBank
DB03880,"Amino Acids, Cyclic",DrugBank
DB03880,"Amino Acids, Peptides, and Proteins",DrugBank
DB03880,Antineoplastic Agents,DrugBank
DB03880,Enzyme Inhibitors,DrugBank
DB03880,"Metalloendopeptidases, antagonists & inhibitors",DrugBank
DB03880,Protease Inhibitors,DrugBank
DB03880,Sulfur Compounds,DrugBank
DB03902,"Acids, Acyclic",DrugBank
DB03902,"Compounds used in a research, industrial, or household setting",DrugBank
DB03902,Dicarboxylic Acids,DrugBank
DB03902,Indicators and Reagents,DrugBank
DB03902,Laboratory Chemicals,DrugBank
DB03902,OAT3/SLC22A8 Substrates,DrugBank
DB03902,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB03902,Oxalates,DrugBank
DB03902,Reducing Agents,DrugBank
DB03938,Agents that reduce seizure threshold,DrugBank
DB03938,Amides,DrugBank
DB03938,beta-Lactams,DrugBank
DB03938,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03938,Lactams,DrugBank
DB03938,Sulfur Compounds,DrugBank
DB03938,Thiazines,DrugBank
DB03946,"Acids, Carbocyclic",DrugBank
DB03946,Anticarcinogenic Agents,DrugBank
DB03946,Antineoplastic Agents,DrugBank
DB03946,Benzene Derivatives,DrugBank
DB03946,Benzoates,DrugBank
DB03946,"Compounds used in a research, industrial, or household setting",DrugBank
DB03946,"Drugs, Chinese Herbal",DrugBank
DB03946,Hydroxy Acids,DrugBank
DB03946,Phenols,DrugBank
DB03946,Plant Extracts,DrugBank
DB03946,Protective Agents,DrugBank
DB03966,Aminocoumarins,DrugBank
DB03966,Benzopyrans,DrugBank
DB03966,Carbohydrates,DrugBank
DB03966,Coumarins,DrugBank
DB03966,Glycosides,DrugBank
DB03966,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB03966,Pyrans,DrugBank
DB04017,Agents that produce hypertension,DrugBank
DB04017,Amines,DrugBank
DB04017,Antidepressive Agents,DrugBank
DB04017,Central Nervous System Agents,DrugBank
DB04017,Central Nervous System Depressants,DrugBank
DB04017,Enzyme Inhibitors,DrugBank
DB04017,Monoamine Oxidase A Inhibitors,DrugBank
DB04017,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB04017,Monoamine Oxidase Inhibitors,DrugBank
DB04017,Propylamines,DrugBank
DB04017,Psychotropic Drugs,DrugBank
DB04017,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04070,Anti-Bacterial Agents,DrugBank
DB04070,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04070,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04070,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB04070,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04070,Lactones,DrugBank
DB04070,Macrolides,DrugBank
DB04070,Polyketides,DrugBank
DB04076,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04076,Cytochrome P-450 Substrates,DrugBank
DB04076,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04076,Purines,DrugBank
DB04076,Purinones,DrugBank
DB04076,Xanthine derivatives,DrugBank
DB04106,Alkylating Drugs,DrugBank
DB04106,Amides,DrugBank
DB04106,Antineoplastic Agents,DrugBank
DB04106,Antineoplastic and Immunomodulating Agents,DrugBank
DB04106,Nitroso Compounds,DrugBank
DB04106,Nitrosoureas,DrugBank
DB04124,Alkenes,DrugBank
DB04124,Anti-Bacterial Agents,DrugBank
DB04124,Anti-Infective Agents,DrugBank
DB04124,"Hydrocarbons, Acyclic",DrugBank
DB04124,Polyenes,DrugBank
DB04145,Cardiovascular Agents,DrugBank
DB04145,Lipid Modifying Agents,DrugBank
DB04145,"Lipid Modifying Agents, Plain",DrugBank
DB04145,Nicotinic Acid and Derivatives,DrugBank
DB04145,Peripheral Vasodilators,DrugBank
DB04145,Pyridines,DrugBank
DB04145,Vasodilating Agents,DrugBank
DB04160,Acids,DrugBank
DB04160,"Acids, Noncarboxylic",DrugBank
DB04160,Anions,DrugBank
DB04160,Electrolytes,DrugBank
DB04160,Ions,DrugBank
DB04160,Phosphate salts,DrugBank
DB04160,Phosphoric Acids,DrugBank
DB04160,Phosphorus Acids,DrugBank
DB04160,Phosphorus Compounds,DrugBank
DB04160,Polyphosphates,DrugBank
DB04165,"Acids, Acyclic",DrugBank
DB04165,Anticonvulsants,DrugBank
DB04165,Central Nervous System Agents,DrugBank
DB04165,Central Nervous System Depressants,DrugBank
DB04165,Fatty Acid Derivatives,DrugBank
DB04165,Fatty Acids,DrugBank
DB04165,"Fatty Acids, Volatile",DrugBank
DB04165,Lipids,DrugBank
DB04165,Nervous System,DrugBank
DB04165,Pentanoic Acids,DrugBank
DB04165,Valerates,DrugBank
DB04209,Anti-Bacterial Agents,DrugBank
DB04209,Anti-Infective Agents,DrugBank
DB04209,"Anti-Infective Agents, Local",DrugBank
DB04209,Antiseptics and Disinfectants,DrugBank
DB04209,Dermatologicals,DrugBank
DB04209,Genito Urinary System and Sex Hormones,DrugBank
DB04209,Gynecological Antiinfectives and Antiseptics,DrugBank
DB04209,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04209,Miscellaneous Anti-infectives,DrugBank
DB04209,Quinoline Derivatives,DrugBank
DB04209,Quinolines,DrugBank
DB04209,Quinolinium Compounds,DrugBank
DB04209,Throat Preparations,DrugBank
DB04216,Antioxidants,DrugBank
DB04216,BCRP/ABCG2 Inhibitors,DrugBank
DB04216,Benzopyrans,DrugBank
DB04216,Biological Factors,DrugBank
DB04216,Chromones,DrugBank
DB04216,"Compounds used in a research, industrial, or household setting",DrugBank
DB04216,COMT Inhibitors,DrugBank
DB04216,COMT Substrates,DrugBank
DB04216,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB04216,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB04216,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB04216,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB04216,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB04216,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB04216,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB04216,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04216,Flavonoids,DrugBank
DB04216,Flavonols,DrugBank
DB04216,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04216,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04216,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB04216,P-glycoprotein inhibitors,DrugBank
DB04216,Protective Agents,DrugBank
DB04216,Pyrans,DrugBank
DB04222,"Antibiotics, Antineoplastic",DrugBank
DB04222,Antineoplastic Agents,DrugBank
DB04222,Enzyme Inhibitors,DrugBank
DB04222,Protein Synthesis Inhibitors,DrugBank
DB04222,Pyrimidines,DrugBank
DB04222,Pyrimidinones,DrugBank
DB04250,Amines,DrugBank
DB04250,Cholinesterase substrates,DrugBank
DB04250,Onium Compounds,DrugBank
DB04250,Quaternary Ammonium Compounds,DrugBank
DB04250,Sulfhydryl Compounds,DrugBank
DB04250,Sulfur Compounds,DrugBank
DB04250,Thiocholine,DrugBank
DB04250,Trimethyl Ammonium Compounds,DrugBank
DB04253,Antineoplastic Agents,DrugBank
DB04253,Azirines,DrugBank
DB04253,Prodrugs,DrugBank
DB04253,Radiation-Sensitizing Agents,DrugBank
DB04258,Antineoplastic Agents,DrugBank
DB04258,Cholestanes,DrugBank
DB04258,Cholestenes,DrugBank
DB04258,Fused-Ring Compounds,DrugBank
DB04258,Immunologic Factors,DrugBank
DB04258,Immunosuppressive Agents,DrugBank
DB04258,Lipids,DrugBank
DB04258,Membrane Lipids,DrugBank
DB04258,Secosteroids,DrugBank
DB04258,Steroids,DrugBank
DB04258,Sterols,DrugBank
DB04258,Vitamin D and Analogues,DrugBank
DB04258,Vitamins,DrugBank
DB04258,Vitamins (Fat Soluble),DrugBank
DB04263,Agents that produce neuromuscular block (indirect),DrugBank
DB04263,Amebicides,DrugBank
DB04263,Aminoglycoside Antibacterials,DrugBank
DB04263,Anti-Bacterial Agents,DrugBank
DB04263,Anti-Infective Agents,DrugBank
DB04263,Antiparasitic Agents,DrugBank
DB04263,Antiprotozoals,DrugBank
DB04263,Carbohydrates,DrugBank
DB04263,Coccidiostats,DrugBank
DB04263,Glycosides,DrugBank
DB04263,Nephrotoxic agents,DrugBank
DB04272,Acid Preparations,DrugBank
DB04272,Acidifying Activity,DrugBank
DB04272,"Acids, Acyclic",DrugBank
DB04272,Alimentary Tract and Metabolism,DrugBank
DB04272,Calcium Chelating Activity,DrugBank
DB04272,Calcium Chelating Agents,DrugBank
DB04272,Calculi Dissolution Agent,DrugBank
DB04272,Chelating Agents,DrugBank
DB04272,Citrates,DrugBank
DB04272,"Compounds used in a research, industrial, or household setting",DrugBank
DB04272,Decreased Coagulation Factor Activity,DrugBank
DB04272,"Digestives, Incl. Enzymes",DrugBank
DB04272,Disinfectants (For Agents Used on Object),DrugBank
DB04272,Hematologic Agents,DrugBank
DB04272,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB04272,Sequestering Agents,DrugBank
DB04272,Tricarboxylic Acids,DrugBank
DB04272,Urinary Acidifying Agents,DrugBank
DB04272,Urinary Alkalinisers,DrugBank
DB04297,Amines,DrugBank
DB04297,Anti-Infective Agents,DrugBank
DB04297,Antifungal Agents,DrugBank
DB04297,Antineoplastic Agents,DrugBank
DB04297,Benzene Derivatives,DrugBank
DB04297,Enzyme Inhibitors,DrugBank
DB04297,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04297,Histone Deacetylase Inhibitors,DrugBank
DB04297,Hydroxy Acids,DrugBank
DB04297,Hydroxylamines,DrugBank
DB04297,Protein Synthesis Inhibitors,DrugBank
DB04297,Pyrans,DrugBank
DB04325,Amines,DrugBank
DB04325,Central Nervous System Agents,DrugBank
DB04325,Central Nervous System Depressants,DrugBank
DB04325,Ethylamines,DrugBank
DB04325,Psychotropic Drugs,DrugBank
DB04331,Antimitotic Agents,DrugBank
DB04331,Antineoplastic Agents,DrugBank
DB04331,Enzyme Inhibitors,DrugBank
DB04331,Mitosis Modulators,DrugBank
DB04331,Sulfur Compounds,DrugBank
DB04348,Acids,DrugBank
DB04348,"Acids, Noncarboxylic",DrugBank
DB04348,Alkanes,DrugBank
DB04348,Alkanesulfonic Acids,DrugBank
DB04348,BCRP/ABCG2 Inhibitors,DrugBank
DB04348,Bile Acids and Salts,DrugBank
DB04348,BSEP/ABCB11 inducers,DrugBank
DB04348,BSEP/ABCB11 Substrates,DrugBank
DB04348,Cholagogues and Choleretics,DrugBank
DB04348,Cholanes,DrugBank
DB04348,Cholic Acids,DrugBank
DB04348,"Compounds used in a research, industrial, or household setting",DrugBank
DB04348,Detergents,DrugBank
DB04348,Fused-Ring Compounds,DrugBank
DB04348,Gastrointestinal Agents,DrugBank
DB04348,Household Products,DrugBank
DB04348,"Hydrocarbons, Acyclic",DrugBank
DB04348,OAT1/SLC22A6 inhibitors,DrugBank
DB04348,OAT1/SLC22A6 Substrates,DrugBank
DB04348,OAT3/SLC22A8 Inhibitors,DrugBank
DB04348,OAT3/SLC22A8 Substrates,DrugBank
DB04348,OATP1B1/SLCO1B1 Inducers,DrugBank
DB04348,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04348,OATP1B1/SLCO1B1 Substrates,DrugBank
DB04348,OATP1B3 substrates,DrugBank
DB04348,OATP2B1/SLCO2B1 substrates,DrugBank
DB04348,P-glycoprotein inhibitors,DrugBank
DB04348,P-glycoprotein substrates,DrugBank
DB04348,Steroids,DrugBank
DB04348,Sulfonic Acids,DrugBank
DB04348,Sulfur Acids,DrugBank
DB04348,Sulfur Compounds,DrugBank
DB04348,Surface-Active Agents,DrugBank
DB04356,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04356,Cytochrome P-450 Substrates,DrugBank
DB04356,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04356,Purines,DrugBank
DB04356,Purinones,DrugBank
DB04356,Xanthine derivatives,DrugBank
DB04365,Alkaloids,DrugBank
DB04365,Cholinergic Agents,DrugBank
DB04365,Cholinergic Agonists,DrugBank
DB04365,Neurotransmitter Agents,DrugBank
DB04365,Nicotinic Acids,DrugBank
DB04365,Pyridines,DrugBank
DB04440,Anti-Infective Agents,DrugBank
DB04440,Antineoplastic Agents,DrugBank
DB04440,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04440,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB04440,Nucleosides,DrugBank
DB04440,Purine Nucleosides,DrugBank
DB04440,Purines,DrugBank
DB04468,Androstanes,DrugBank
DB04468,Androstenes,DrugBank
DB04468,Androstenols,DrugBank
DB04468,Antineoplastic Agents,DrugBank
DB04468,Benzene Derivatives,DrugBank
DB04468,Benzylidene Compounds,DrugBank
DB04468,Estrogen Antagonists,DrugBank
DB04468,Estrogen Receptor Modulators,DrugBank
DB04468,Fused-Ring Compounds,DrugBank
DB04468,Hormone Antagonists,DrugBank
DB04468,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04468,"Receptors, Estrogen, agonists",DrugBank
DB04468,Selective Estrogen Receptor Modulators,DrugBank
DB04468,Steroids,DrugBank
DB04468,Stilbenes,DrugBank
DB04513,Amides,DrugBank
DB04513,"Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors",DrugBank
DB04513,Cardiovascular Agents,DrugBank
DB04513,Enzyme Inhibitors,DrugBank
DB04513,Sulfones,DrugBank
DB04513,Sulfur Compounds,DrugBank
DB04513,Vasodilating Agents,DrugBank
DB04519,"Acids, Acyclic",DrugBank
DB04519,Fatty Acids,DrugBank
DB04519,Lipids,DrugBank
DB04519,OAT1/SLC22A6 inhibitors,DrugBank
DB04519,OAT3/SLC22A8 Inhibitors,DrugBank
DB04540,BCRP/ABCG2 Inducers,DrugBank
DB04540,Cholestanes,DrugBank
DB04540,Cholestenes,DrugBank
DB04540,Fused-Ring Compounds,DrugBank
DB04540,Lipids,DrugBank
DB04540,Membrane Lipids,DrugBank
DB04540,P-glycoprotein inhibitors,DrugBank
DB04540,Steroids,DrugBank
DB04540,Sterols,DrugBank
DB04552,"Acids, Carbocyclic",DrugBank
DB04552,Agents causing hyperkalemia,DrugBank
DB04552,Agents that produce hypertension,DrugBank
DB04552,Aminobenzoates,DrugBank
DB04552,Analgesics,DrugBank
DB04552,"Analgesics, Non-Narcotic",DrugBank
DB04552,Anti-Inflammatory Agents,DrugBank
DB04552,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB04552,Antiinflammatory and Antirheumatic Products,DrugBank
DB04552,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB04552,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB04552,Antirheumatic Agents,DrugBank
DB04552,Benzene Derivatives,DrugBank
DB04552,Benzoates,DrugBank
DB04552,Cyclooxygenase Inhibitors,DrugBank
DB04552,Enzyme Inhibitors,DrugBank
DB04552,Fenamates,DrugBank
DB04552,Musculo-Skeletal System,DrugBank
DB04552,Nephrotoxic agents,DrugBank
DB04552,Nicotinic Acids,DrugBank
DB04552,Niflumic Acid and Prodrugs,DrugBank
DB04552,ortho-Aminobenzoates,DrugBank
DB04552,Peripheral Nervous System Agents,DrugBank
DB04552,Pyridines,DrugBank
DB04552,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB04552,Sensory System Agents,DrugBank
DB04552,Topical Products for Joint and Muscular Pain,DrugBank
DB04552,UGT1A9 Inhibitors,DrugBank
DB04557,Arachidonic Acids,DrugBank
DB04557,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04557,Cytochrome P-450 Substrates,DrugBank
DB04557,Eicosanoids,DrugBank
DB04557,Fatty Acids,DrugBank
DB04557,"Fatty Acids, Essential",DrugBank
DB04557,"Fatty Acids, Unsaturated",DrugBank
DB04557,Lipids,DrugBank
DB04570,Amides,DrugBank
DB04570,Anti-Bacterial Agents,DrugBank
DB04570,Anti-Infective Agents,DrugBank
DB04570,Antibacterials for Systemic Use,DrugBank
DB04570,Antiinfectives for Systemic Use,DrugBank
DB04570,beta-Lactams,DrugBank
DB04570,Cephalosporins,DrugBank
DB04570,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04570,Lactams,DrugBank
DB04570,Nephrotoxic agents,DrugBank
DB04570,Sulfides,DrugBank
DB04570,Sulfur Compounds,DrugBank
DB04570,Third-Generation Cephalosporins,DrugBank
DB04571,Antipsoriatics,DrugBank
DB04571,Antipsoriatics for Systemic Use,DrugBank
DB04571,Antipsoriatics for Topical Use,DrugBank
DB04571,Benzopyrans,DrugBank
DB04571,Coumarins,DrugBank
DB04571,Dermatologicals,DrugBank
DB04571,Furocoumarins,DrugBank
DB04571,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04571,Photosensitizing Agents,DrugBank
DB04571,Photosensitizing Agents for Phototherapy,DrugBank
DB04571,Psoralens for Systemic Use,DrugBank
DB04571,Psoralens for Topical Use,DrugBank
DB04571,Pyrans,DrugBank
DB04571,Radiation-Sensitizing Agents,DrugBank
DB04572,Alkylating Activity,DrugBank
DB04572,Alkylating Drugs,DrugBank
DB04572,Antineoplastic Agents,DrugBank
DB04572,"Antineoplastic Agents, Alkylating",DrugBank
DB04572,Antineoplastic and Immunomodulating Agents,DrugBank
DB04572,Aziridines,DrugBank
DB04572,Azirines,DrugBank
DB04572,Cholinesterase Inhibitors,DrugBank
DB04572,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB04572,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB04572,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04572,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04572,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB04572,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04572,Cytochrome P-450 Substrates,DrugBank
DB04572,Ethylene Imines,DrugBank
DB04572,Immunologic Factors,DrugBank
DB04572,Immunosuppressive Agents,DrugBank
DB04572,Myeloablative Agonists,DrugBank
DB04572,Myelosuppressive Agents,DrugBank
DB04572,Narrow Therapeutic Index Drugs,DrugBank
DB04572,Noxae,DrugBank
DB04572,Organophosphorus Compounds,DrugBank
DB04572,Phosphoramides,DrugBank
DB04572,Toxic Actions,DrugBank
DB04572,Triethylenephosphoramide,DrugBank
DB04573,Estradiol Congeners,DrugBank
DB04573,Estranes,DrugBank
DB04573,Estrenes,DrugBank
DB04573,Estrogens,DrugBank
DB04573,Fused-Ring Compounds,DrugBank
DB04573,Genito Urinary System and Sex Hormones,DrugBank
DB04573,Gonadal Hormones,DrugBank
DB04573,Gonadal Steroid Hormones,DrugBank
DB04573,Hormones,DrugBank
DB04573,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04573,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB04573,P-glycoprotein inducers,DrugBank
DB04573,P-glycoprotein substrates,DrugBank
DB04573,Sex Hormones and Modulators of the Genital System,DrugBank
DB04573,Steroids,DrugBank
DB04573,Thyroxine-binding globulin inducers,DrugBank
DB04574,17-Ketosteroids,DrugBank
DB04574,Adrenal Cortex Hormones,DrugBank
DB04574,"Contraceptive Agents, Hormonal",DrugBank
DB04574,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB04574,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB04574,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04574,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04574,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04574,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04574,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04574,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04574,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04574,Cytochrome P-450 Substrates,DrugBank
DB04574,Drugs that are Mainly Renally Excreted,DrugBank
DB04574,Estradiol Congeners,DrugBank
DB04574,Estranes,DrugBank
DB04574,Estrenes,DrugBank
DB04574,Estrogens,DrugBank
DB04574,"Estrogens, Conjugated (USP)",DrugBank
DB04574,Fused-Ring Compounds,DrugBank
DB04574,Gonadal Hormones,DrugBank
DB04574,Gonadal Steroid Hormones,DrugBank
DB04574,Hormonal Contraceptives for Systemic Use,DrugBank
DB04574,Hormones,DrugBank
DB04574,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04574,Hyperglycemia-Associated Agents,DrugBank
DB04574,Ketosteroids,DrugBank
DB04574,MATE 1 Substrates,DrugBank
DB04574,MATE 2 Substrates,DrugBank
DB04574,MATE substrates,DrugBank
DB04574,NTCP Inhibitors,DrugBank
DB04574,Reproductive Control Agents,DrugBank
DB04574,Steroids,DrugBank
DB04574,Thyroxine-binding globulin inducers,DrugBank
DB04575,Estradiol Congeners,DrugBank
DB04575,"Estrogenic Steroids, Alkylated",DrugBank
DB04575,Estrogens,DrugBank
DB04575,Ethinyl Estradiol,DrugBank
DB04575,Fused-Ring Compounds,DrugBank
DB04575,Gonadal Hormones,DrugBank
DB04575,Gonadal Steroid Hormones,DrugBank
DB04575,Hormones,DrugBank
DB04575,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04575,Norpregnanes,DrugBank
DB04575,Norpregnatrienes,DrugBank
DB04575,Norsteroids,DrugBank
DB04575,Steroids,DrugBank
DB04575,Thyroxine-binding globulin inducers,DrugBank
DB04576,4-Quinolones,DrugBank
DB04576,Anti-Bacterial Agents,DrugBank
DB04576,Anti-Infective Agents,DrugBank
DB04576,Antibacterials for Systemic Use,DrugBank
DB04576,Antiinfectives for Systemic Use,DrugBank
DB04576,Antineoplastic Agents,DrugBank
DB04576,Enzyme Inhibitors,DrugBank
DB04576,Fluoroquinolones,DrugBank
DB04576,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04576,Potential QTc-Prolonging Agents,DrugBank
DB04576,QTc Prolonging Agents,DrugBank
DB04576,Quinolines,DrugBank
DB04576,Quinolones,DrugBank
DB04576,Topoisomerase II Inhibitors,DrugBank
DB04576,Topoisomerase Inhibitors,DrugBank
DB04581,Adrenergic Agents,DrugBank
DB04581,Adrenergic alpha-Antagonists,DrugBank
DB04581,Adrenergic Antagonists,DrugBank
DB04581,Agents that produce hypertension,DrugBank
DB04581,Neurotransmitter Agents,DrugBank
DB04599,Antidepressive Agents,DrugBank
DB04599,Central Nervous System Agents,DrugBank
DB04599,Central Nervous System Depressants,DrugBank
DB04599,Nervous System,DrugBank
DB04599,Nootropic Agents,DrugBank
DB04599,Psychoanaleptics,DrugBank
DB04599,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB04599,Psychotropic Drugs,DrugBank
DB04599,Pyrrolidines,DrugBank
DB04626,Agents that produce neuromuscular block (indirect),DrugBank
DB04626,Aminoglycoside Antibacterials,DrugBank
DB04626,Anti-Bacterial Agents,DrugBank
DB04626,Anti-Infective Agents,DrugBank
DB04626,Carbohydrates,DrugBank
DB04626,Glycosides,DrugBank
DB04626,Nephrotoxic agents,DrugBank
DB04630,11-Hydroxycorticosteroids,DrugBank
DB04630,Adrenal Cortex Hormones,DrugBank
DB04630,Corticosteroids,DrugBank
DB04630,Corticosteroids for Systemic Use,DrugBank
DB04630,"Corticosteroids for Systemic Use, Plain",DrugBank
DB04630,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04630,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04630,Cytochrome P-450 Substrates,DrugBank
DB04630,Fused-Ring Compounds,DrugBank
DB04630,Hormones,DrugBank
DB04630,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04630,Hydroxycorticosteroids,DrugBank
DB04630,Immunosuppressive Agents,DrugBank
DB04630,Mineralocorticoids,DrugBank
DB04630,P-glycoprotein inducers,DrugBank
DB04630,P-glycoprotein substrates,DrugBank
DB04630,Pregnanes,DrugBank
DB04630,Pregnenediones,DrugBank
DB04630,Pregnenes,DrugBank
DB04630,Steroids,DrugBank
DB04630,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB04652,11-Hydroxycorticosteroids,DrugBank
DB04652,Adrenal Cortex Hormones,DrugBank
DB04652,Anti-Inflammatory Agents,DrugBank
DB04652,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04652,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04652,Cytochrome P-450 Substrates,DrugBank
DB04652,Fused-Ring Compounds,DrugBank
DB04652,Hormones,DrugBank
DB04652,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04652,Hydroxycorticosteroids,DrugBank
DB04652,Pregnanes,DrugBank
DB04652,Pregnenediones,DrugBank
DB04652,Pregnenes,DrugBank
DB04652,Steroids,DrugBank
DB04655,Antineoplastic Agents,DrugBank
DB04655,Enzyme Inhibitors,DrugBank
DB04655,Folic Acid Antagonists,DrugBank
DB04655,Pyrimidines,DrugBank
DB04665,Anticoagulants,DrugBank
DB04665,Benzopyrans,DrugBank
DB04665,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04665,Cytochrome P-450 Substrates,DrugBank
DB04665,"Edema, drug therapy",DrugBank
DB04665,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04665,Pyrans,DrugBank
DB04665,Vitamin K Antagonists,DrugBank
DB04682,Adrenal Cortex Hormones,DrugBank
DB04682,Alcohols,DrugBank
DB04682,Antifoaming Agents,DrugBank
DB04682,Antispermatogenic Agents,DrugBank
DB04682,"Compounds used in a research, industrial, or household setting",DrugBank
DB04682,"Contraceptive Agents, Female",DrugBank
DB04682,"Contraceptive Agents, Male",DrugBank
DB04682,Detergents,DrugBank
DB04682,Ethylene Glycols,DrugBank
DB04682,Excipients,DrugBank
DB04682,Glycols,DrugBank
DB04682,Hormonal Contraceptives for Systemic Use,DrugBank
DB04682,Household Products,DrugBank
DB04682,Macromolecular Substances,DrugBank
DB04682,Noxae,DrugBank
DB04682,Pharmaceutic Aids,DrugBank
DB04682,Pharmaceutical Preparations,DrugBank
DB04682,Pharmaceutical Vehicles,DrugBank
DB04682,Polyethylene Glycols,DrugBank
DB04682,Polymers,DrugBank
DB04682,Reproductive Control Agents,DrugBank
DB04682,Spermatocidal Agents,DrugBank
DB04682,Surface-Active Agents,DrugBank
DB04682,Toxic Actions,DrugBank
DB04688,Alkaloids,DrugBank
DB04688,Analgesics,DrugBank
DB04688,Aza Compounds,DrugBank
DB04688,Azabicyclo Compounds,DrugBank
DB04688,Central Nervous System Agents,DrugBank
DB04688,Central Nervous System Depressants,DrugBank
DB04688,Narcotics,DrugBank
DB04688,Peripheral Nervous System Agents,DrugBank
DB04688,Sensory System Agents,DrugBank
DB04688,Tropanes,DrugBank
DB04690,Alkaloids,DrugBank
DB04690,Antineoplastic Agents,DrugBank
DB04690,"Antineoplastic Agents, Phytogenic",DrugBank
DB04690,BCRP/ABCG2 Substrates,DrugBank
DB04690,Enzyme Inhibitors,DrugBank
DB04690,P-glycoprotein substrates,DrugBank
DB04690,Topoisomerase I Inhibitors,DrugBank
DB04690,Topoisomerase Inhibitors,DrugBank
DB04695,Organophosphates,DrugBank
DB04695,Organophosphorus Compounds,DrugBank
DB04695,Potential QTc-Prolonging Agents,DrugBank
DB04695,QTc Prolonging Agents,DrugBank
DB04695,Terpenes,DrugBank
DB04707,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04707,Isoquinolines,DrugBank
DB04707,Piperazines,DrugBank
DB04707,Sulfonamides,DrugBank
DB04707,Sulfones,DrugBank
DB04707,Sulfur Compounds,DrugBank
DB04725,Analgesics,DrugBank
DB04725,"Analgesics, Non-Narcotic",DrugBank
DB04725,Anti-Inflammatory Agents,DrugBank
DB04725,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB04725,Antirheumatic Agents,DrugBank
DB04725,Central Nervous System Agents,DrugBank
DB04725,Cyclooxygenase Inhibitors,DrugBank
DB04725,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB04725,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB04725,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB04725,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04725,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04725,Cytochrome P-450 Substrates,DrugBank
DB04725,Enzyme Inhibitors,DrugBank
DB04725,Lipoxygenase Inhibitors,DrugBank
DB04725,Peripheral Nervous System Agents,DrugBank
DB04725,Sensory System Agents,DrugBank
DB04725,UGT1A3 substrates,DrugBank
DB04729,Agents that produce neuromuscular block (indirect),DrugBank
DB04729,Aminoglycoside Antibacterials,DrugBank
DB04729,Anti-Bacterial Agents,DrugBank
DB04729,Carbohydrates,DrugBank
DB04729,Drugs that are Mainly Renally Excreted,DrugBank
DB04729,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB04729,Glycosides,DrugBank
DB04729,Narrow Therapeutic Index Drugs,DrugBank
DB04729,Nephrotoxic agents,DrugBank
DB04741,"Acids, Acyclic",DrugBank
DB04741,Acrylates,DrugBank
DB04741,Anti-Infective Agents,DrugBank
DB04741,Antifungal Agents,DrugBank
DB04741,"Electron Transport Complex III, antagonists & inhibitors",DrugBank
DB04741,Enzyme Inhibitors,DrugBank
DB04741,Sulfur Compounds,DrugBank
DB04743,Agents causing hyperkalemia,DrugBank
DB04743,Agents that produce hypertension,DrugBank
DB04743,Amides,DrugBank
DB04743,Analgesics,DrugBank
DB04743,"Analgesics, Non-Narcotic",DrugBank
DB04743,Anti-Inflammatory Agents,DrugBank
DB04743,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB04743,Antiarrhythmic agents,DrugBank
DB04743,Antiinflammatory and Antirheumatic Products,DrugBank
DB04743,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB04743,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB04743,Antiplatelet agents,DrugBank
DB04743,Antirheumatic Agents,DrugBank
DB04743,Bradycardia-Causing Agents,DrugBank
DB04743,Calcium Channel Blockers,DrugBank
DB04743,Cyclooxygenase Inhibitors,DrugBank
DB04743,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04743,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04743,Cytochrome P-450 Substrates,DrugBank
DB04743,Enzyme Inhibitors,DrugBank
DB04743,Musculo-Skeletal System,DrugBank
DB04743,Nephrotoxic agents,DrugBank
DB04743,Peripheral Nervous System Agents,DrugBank
DB04743,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB04743,Sensory System Agents,DrugBank
DB04743,Sulfones,DrugBank
DB04743,Sulfur Compounds,DrugBank
DB04743,Topical Products for Joint and Muscular Pain,DrugBank
DB04744,Anti-Infective Agents,DrugBank
DB04744,Antifungal Agents,DrugBank
DB04744,Coloring Agents,DrugBank
DB04744,"Compounds used in a research, industrial, or household setting",DrugBank
DB04744,Cosmetics,DrugBank
DB04744,Dermatologicals,DrugBank
DB04744,Enzyme Inhibitors,DrugBank
DB04744,Naphthalenes,DrugBank
DB04744,Oxidoreductases,DrugBank
DB04744,Protective Agents,DrugBank
DB04744,Quinones,DrugBank
DB04744,Radiation-Protective Agents,DrugBank
DB04744,Sunscreen Agents,DrugBank
DB04785,Anti-Bacterial Agents,DrugBank
DB04785,Anti-Infective Agents,DrugBank
DB04785,Carbohydrates,DrugBank
DB04785,Glycosides,DrugBank
DB04786,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB04786,Anti-Infective Agents,DrugBank
DB04786,Antinematodal Agents,DrugBank
DB04786,Antineoplastic Agents,DrugBank
DB04786,Antiparasitic Agents,DrugBank
DB04786,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB04786,Antiprotozoals,DrugBank
DB04786,Arylsulfonates,DrugBank
DB04786,Arylsulfonic Acids,DrugBank
DB04786,Naphthalenes,DrugBank
DB04786,Naphthalenesulfonates,DrugBank
DB04786,Sulfonic Acids,DrugBank
DB04786,Sulfur Acids,DrugBank
DB04786,Sulfur Compounds,DrugBank
DB04786,Trypanocidal Agents,DrugBank
DB04789,Coenzymes,DrugBank
DB04789,Enzymes and Coenzymes,DrugBank
DB04789,Folic Acid and Derivatives,DrugBank
DB04789,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04789,Pteridines,DrugBank
DB04789,Pterins,DrugBank
DB04789,Vitamin B Complex,DrugBank
DB04789,Vitamins,DrugBank
DB04794,Anti-Infective Agents,DrugBank
DB04794,Antifungal Agents,DrugBank
DB04794,Antifungals for Dermatological Use,DrugBank
DB04794,Antifungals for Topical Use,DrugBank
DB04794,Azole Antifungals,DrugBank
DB04794,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB04794,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB04794,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04794,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04794,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04794,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04794,Dermatologicals,DrugBank
DB04794,Imidazole and Triazole Derivatives,DrugBank
DB04796,Cholestanes,DrugBank
DB04796,Cholestenes,DrugBank
DB04796,Fused-Ring Compounds,DrugBank
DB04796,"Hydrocarbons, Acyclic",DrugBank
DB04796,Lipids,DrugBank
DB04796,Membrane Lipids,DrugBank
DB04796,Secosteroids,DrugBank
DB04796,Steroids,DrugBank
DB04796,Sterols,DrugBank
DB04796,Vitamin D and Analogues,DrugBank
DB04796,Vitamins,DrugBank
DB04796,Vitamins (Fat Soluble),DrugBank
DB04808,Agents that produce neuromuscular block (indirect),DrugBank
DB04808,Aminoglycoside Antibacterials,DrugBank
DB04808,Anti-Bacterial Agents,DrugBank
DB04808,Carbohydrates,DrugBank
DB04808,Glycosides,DrugBank
DB04808,Nephrotoxic agents,DrugBank
DB04812,"Acids, Acyclic",DrugBank
DB04812,Agents causing hyperkalemia,DrugBank
DB04812,Agents that produce hypertension,DrugBank
DB04812,Analgesics,DrugBank
DB04812,"Analgesics, Non-Narcotic",DrugBank
DB04812,Anti-Inflammatory Agents,DrugBank
DB04812,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB04812,Antiinflammatory and Antirheumatic Products,DrugBank
DB04812,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB04812,Antirheumatic Agents,DrugBank
DB04812,Dermatologicals,DrugBank
DB04812,Enzyme Inhibitors,DrugBank
DB04812,Fatty Acids,DrugBank
DB04812,"Fatty Acids, Volatile",DrugBank
DB04812,Lipids,DrugBank
DB04812,Lipoxygenase Inhibitors,DrugBank
DB04812,Musculo-Skeletal System,DrugBank
DB04812,Nephrotoxic agents,DrugBank
DB04812,Peripheral Nervous System Agents,DrugBank
DB04812,Propionates,DrugBank
DB04812,Sensory System Agents,DrugBank
DB04816,Alimentary Tract and Metabolism,DrugBank
DB04816,Anthracenes,DrugBank
DB04816,Contact Laxatives,DrugBank
DB04816,Drugs for Constipation,DrugBank
DB04816,Enemas,DrugBank
DB04816,Gastrointestinal Agents,DrugBank
DB04816,Laxatives,DrugBank
DB04816,Mutagens,DrugBank
DB04816,Noxae,DrugBank
DB04816,Quinones,DrugBank
DB04816,Toxic Actions,DrugBank
DB04817,Agents causing hyperkalemia,DrugBank
DB04817,Agents that produce hypertension,DrugBank
DB04817,Aminopyrine,DrugBank
DB04817,Analgesics,DrugBank
DB04817,"Analgesics, Non-Narcotic",DrugBank
DB04817,Anti-Inflammatory Agents,DrugBank
DB04817,Antipyretics,DrugBank
DB04817,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB04817,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB04817,Cytochrome P-450 CYP3A Inducers,DrugBank
DB04817,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB04817,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB04817,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04817,Nephrotoxic agents,DrugBank
DB04817,Nervous System,DrugBank
DB04817,Peripheral Nervous System Agents,DrugBank
DB04817,Pyrazoles,DrugBank
DB04817,Pyrazolones,DrugBank
DB04817,Sensory System Agents,DrugBank
DB04818,Agents that produce hypertension,DrugBank
DB04818,Agents that reduce seizure threshold,DrugBank
DB04818,Antidepressive Agents,DrugBank
DB04818,Central Nervous System Agents,DrugBank
DB04818,Central Nervous System Depressants,DrugBank
DB04818,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04818,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB04818,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04818,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB04818,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04818,Enzyme Inhibitors,DrugBank
DB04818,Hydrazines,DrugBank
DB04818,Isonicotinic Acids,DrugBank
DB04818,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB04818,Monoamine Oxidase Inhibitors,DrugBank
DB04818,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB04818,Nervous System,DrugBank
DB04818,Psychoanaleptics,DrugBank
DB04818,Psychotropic Drugs,DrugBank
DB04818,Pyridines,DrugBank
DB04818,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04819,Amines,DrugBank
DB04819,Aminopyridines,DrugBank
DB04819,Anti-Allergic Agents,DrugBank
DB04819,Antihistamines for Systemic Use,DrugBank
DB04819,Central Nervous System Agents,DrugBank
DB04819,Central Nervous System Depressants,DrugBank
DB04819,Diamines,DrugBank
DB04819,Ethylenediamines,DrugBank
DB04819,Histamine Agents,DrugBank
DB04819,Histamine Antagonists,DrugBank
DB04819,Histamine H1 Antagonists,DrugBank
DB04819,Hypnotics and Sedatives,DrugBank
DB04819,Neurotransmitter Agents,DrugBank
DB04819,Polyamines,DrugBank
DB04819,Pyridines,DrugBank
DB04819,Substituted Ethylene Diamines,DrugBank
DB04820,Agents that produce hypertension,DrugBank
DB04820,Agents that reduce seizure threshold,DrugBank
DB04820,Antidepressive Agents,DrugBank
DB04820,Central Nervous System Agents,DrugBank
DB04820,Central Nervous System Depressants,DrugBank
DB04820,Enzyme Inhibitors,DrugBank
DB04820,Isonicotinic Acids,DrugBank
DB04820,Monoamine Oxidase Inhibitors,DrugBank
DB04820,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB04820,Nervous System,DrugBank
DB04820,Psychoanaleptics,DrugBank
DB04820,Psychotropic Drugs,DrugBank
DB04820,Pyridines,DrugBank
DB04820,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04821,Antidepressive Agents,DrugBank
DB04821,Central Nervous System Depressants,DrugBank
DB04821,Dopamine Agents,DrugBank
DB04821,Dopamine Uptake Inhibitors,DrugBank
DB04821,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04821,Isoquinolines,DrugBank
DB04821,Membrane Transport Modulators,DrugBank
DB04821,Nervous System,DrugBank
DB04821,Neurotransmitter Agents,DrugBank
DB04821,Neurotransmitter Uptake Inhibitors,DrugBank
DB04821,Psychoanaleptics,DrugBank
DB04823,Alimentary Tract and Metabolism,DrugBank
DB04823,Contact Laxatives,DrugBank
DB04823,Drugs for Constipation,DrugBank
DB04823,Gastrointestinal Agents,DrugBank
DB04823,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04823,Indoles,DrugBank
DB04823,Laxatives,DrugBank
DB04824,Alimentary Tract and Metabolism,DrugBank
DB04824,Benzene Derivatives,DrugBank
DB04824,"Compounds used in a research, industrial, or household setting",DrugBank
DB04824,Contact Laxatives,DrugBank
DB04824,Drugs for Constipation,DrugBank
DB04824,Indicators and Reagents,DrugBank
DB04824,Laboratory Chemicals,DrugBank
DB04824,Laxatives,DrugBank
DB04824,Phenolphthaleins,DrugBank
DB04824,Phenols,DrugBank
DB04825,Adrenergic Agents,DrugBank
DB04825,Agents causing hyperkalemia,DrugBank
DB04825,Amines,DrugBank
DB04825,Antiarrhythmic agents,DrugBank
DB04825,Bradycardia-Causing Agents,DrugBank
DB04825,Calcium Channel Blockers,DrugBank
DB04825,Calcium-Regulating Hormones and Agents,DrugBank
DB04825,"Calmodulin, antagonists & inhibitors",DrugBank
DB04825,Cardiac Therapy,DrugBank
DB04825,Cardiovascular Agents,DrugBank
DB04825,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04825,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04825,Cytochrome P-450 Substrates,DrugBank
DB04825,Ethylamines,DrugBank
DB04825,Hydroxy Acids,DrugBank
DB04825,Membrane Transport Modulators,DrugBank
DB04825,Moderate Risk QTc-Prolonging Agents,DrugBank
DB04825,Neurotransmitter Agents,DrugBank
DB04825,Phenethylamines,DrugBank
DB04825,QTc Prolonging Agents,DrugBank
DB04825,Vasodilating Agents,DrugBank
DB04825,Vasodilators Used in Cardiac Diseases,DrugBank
DB04826,Antihistamines for Systemic Use,DrugBank
DB04826,Antihistamines for Topical Use,DrugBank
DB04826,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB04826,Dermatologicals,DrugBank
DB04827,"Acids, Acyclic",DrugBank
DB04827,Anesthetics,DrugBank
DB04827,"Anesthetics, General",DrugBank
DB04827,"Anesthetics, Intravenous",DrugBank
DB04827,Antineoplastic Agents,DrugBank
DB04827,Carbamates,DrugBank
DB04827,Carcinogens,DrugBank
DB04827,Central Nervous System Agents,DrugBank
DB04827,Central Nervous System Depressants,DrugBank
DB04827,Noxae,DrugBank
DB04827,Toxic Actions,DrugBank
DB04828,Acetic Acid Derivatives and Related Substances,DrugBank
DB04828,Agents causing hyperkalemia,DrugBank
DB04828,Agents that produce hypertension,DrugBank
DB04828,Analgesics,DrugBank
DB04828,"Analgesics, Non-Narcotic",DrugBank
DB04828,Anti-Inflammatory Agents,DrugBank
DB04828,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB04828,Antiinflammatory and Antirheumatic Products,DrugBank
DB04828,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB04828,Antirheumatic Agents,DrugBank
DB04828,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04828,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04828,Cytochrome P-450 Substrates,DrugBank
DB04828,Musculo-Skeletal System,DrugBank
DB04828,Nephrotoxic agents,DrugBank
DB04828,Non COX-2 selective NSAIDS,DrugBank
DB04828,Peripheral Nervous System Agents,DrugBank
DB04828,Sensory System Agents,DrugBank
DB04829,Agents that produce hypertension,DrugBank
DB04829,Alkaloids,DrugBank
DB04829,Antidepressive Agents,DrugBank
DB04829,Central Nervous System Agents,DrugBank
DB04829,Central Nervous System Depressants,DrugBank
DB04829,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04829,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04829,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04829,Cytochrome P-450 Substrates,DrugBank
DB04829,Ergolines,DrugBank
DB04829,Ergot Alkaloids and Derivatives,DrugBank
DB04829,Hallucinogens,DrugBank
DB04829,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04829,Lysergic Acid,DrugBank
DB04829,Neurotransmitter Agents,DrugBank
DB04829,Psychotropic Drugs,DrugBank
DB04829,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04829,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB04829,Serotonin Agents,DrugBank
DB04829,Serotonin Receptor Agonists,DrugBank
DB04829,Serotonin Receptor Antagonists,DrugBank
DB04830,Alimentary Tract and Metabolism,DrugBank
DB04830,Amidines,DrugBank
DB04830,Biguanides,DrugBank
DB04830,Blood Glucose Lowering Agents,DrugBank
DB04830,Drugs Used in Diabetes,DrugBank
DB04830,Guanidines,DrugBank
DB04830,OCT1 substrates,DrugBank
DB04830,Oral Hypoglycemics,DrugBank
DB04831,Acetates,DrugBank
DB04831,"Acids, Acyclic",DrugBank
DB04831,Antigout Preparations,DrugBank
DB04831,Antihypertensive Agents,DrugBank
DB04831,Antirheumatic Agents,DrugBank
DB04831,Aryloxyacetic Acid Derivatives,DrugBank
DB04831,Cardiovascular Agents,DrugBank
DB04831,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04831,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04831,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04831,Diuretics,DrugBank
DB04831,Glycolates,DrugBank
DB04831,High-Ceiling Diuretics,DrugBank
DB04831,Hydroxy Acids,DrugBank
DB04831,Natriuretic Agents,DrugBank
DB04831,Phenoxyacetates,DrugBank
DB04831,Sulfur Compounds,DrugBank
DB04831,Thiophenes,DrugBank
DB04831,Uricosuric Agents,DrugBank
DB04832,Antidepressive Agents,DrugBank
DB04832,Central Nervous System Depressants,DrugBank
DB04832,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04832,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04832,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB04832,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04832,Hypoglycemia-Associated Agents,DrugBank
DB04832,Membrane Transport Modulators,DrugBank
DB04832,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB04832,Nervous System,DrugBank
DB04832,Neurotransmitter Agents,DrugBank
DB04832,Neurotransmitter Uptake Inhibitors,DrugBank
DB04832,P-glycoprotein inhibitors,DrugBank
DB04832,Psychoanaleptics,DrugBank
DB04832,Pyridines,DrugBank
DB04832,Selective Serotonin Reuptake Inhibitors,DrugBank
DB04832,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04832,Serotonin Agents,DrugBank
DB04832,Serotonin Modulators,DrugBank
DB04833,Central Nervous System Agents,DrugBank
DB04833,Central Nervous System Depressants,DrugBank
DB04833,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04833,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04833,Cytochrome P-450 Substrates,DrugBank
DB04833,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04833,Hypnotics and Sedatives,DrugBank
DB04833,Muscle Relaxants,DrugBank
DB04833,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB04833,Nervous System,DrugBank
DB04833,Psycholeptics,DrugBank
DB04833,Quinazolines,DrugBank
DB04833,Quinazolinones,DrugBank
DB04834,Agents producing tachycardia,DrugBank
DB04834,Androstanes,DrugBank
DB04834,Androstanols,DrugBank
DB04834,Anticholinergic Agents,DrugBank
DB04834,Central Nervous System Depressants,DrugBank
DB04834,Fused-Ring Compounds,DrugBank
DB04834,Muscarinic Antagonists,DrugBank
DB04834,Neuromuscular Agents,DrugBank
DB04834,Neuromuscular Blocking Agents,DrugBank
DB04834,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB04834,Peripheral Nervous System Agents,DrugBank
DB04834,Steroids,DrugBank
DB04835,Anti-HIV Agents,DrugBank
DB04835,Anti-Infective Agents,DrugBank
DB04835,Anti-Retroviral Agents,DrugBank
DB04835,Antiinfectives for Systemic Use,DrugBank
DB04835,Antiviral Agents,DrugBank
DB04835,Antivirals for Systemic Use,DrugBank
DB04835,CCR5 Co-receptor Antagonist,DrugBank
DB04835,CCR5 Receptor Antagonists,DrugBank
DB04835,Cyclohexanes,DrugBank
DB04835,Cycloparaffins,DrugBank
DB04835,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04835,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04835,Cytochrome P-450 Substrates,DrugBank
DB04835,Direct Acting Antivirals,DrugBank
DB04835,Hepatotoxic Agents,DrugBank
DB04835,HIV Fusion Inhibitors,DrugBank
DB04835,Triazoles,DrugBank
DB04835,Viral Fusion Protein Inhibitors,DrugBank
DB04836,Agents that produce hypertension,DrugBank
DB04836,Agents that reduce seizure threshold,DrugBank
DB04836,Antidepressive Agents,DrugBank
DB04836,"Antidepressive Agents, Tricyclic",DrugBank
DB04836,Benzocycloheptenes,DrugBank
DB04836,Central Nervous System Agents,DrugBank
DB04836,Central Nervous System Depressants,DrugBank
DB04836,Narrow Therapeutic Index Drugs,DrugBank
DB04836,Nervous System,DrugBank
DB04836,Neurotoxic agents,DrugBank
DB04836,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB04836,Psychoanaleptics,DrugBank
DB04836,Psychotropic Drugs,DrugBank
DB04836,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04837,Alcohols,DrugBank
DB04837,Amines,DrugBank
DB04837,Amino Alcohols,DrugBank
DB04837,Antitussive Agents,DrugBank
DB04837,Cough and Cold Preparations,DrugBank
DB04837,Histamine Antagonists,DrugBank
DB04837,Histamine H1 Antagonists,DrugBank
DB04837,Propanols,DrugBank
DB04838,"Acids, Carbocyclic",DrugBank
DB04838,Agents causing hyperkalemia,DrugBank
DB04838,Antiarrhythmic agents,DrugBank
DB04838,Bradycardia-Causing Agents,DrugBank
DB04838,Calcium Channel Blockers,DrugBank
DB04838,Cardiovascular Agents,DrugBank
DB04838,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04838,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04838,Cytochrome P-450 Substrates,DrugBank
DB04838,Hydroxy Acids,DrugBank
DB04838,Mandelic Acids,DrugBank
DB04838,Peripheral Vasodilators,DrugBank
DB04838,Vasodilating Agents,DrugBank
DB04839,Adrenal Cortex Hormones,DrugBank
DB04839,Antiandrogens,DrugBank
DB04839,Antiandrogens and Estrogens,DrugBank
DB04839,Antineoplastic Agents,DrugBank
DB04839,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB04839,"Contraceptive Agents, Female",DrugBank
DB04839,"Contraceptive Agents, Male",DrugBank
DB04839,"Contraceptives, Oral",DrugBank
DB04839,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04839,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04839,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04839,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04839,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04839,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04839,Cytochrome P-450 Substrates,DrugBank
DB04839,Fused-Ring Compounds,DrugBank
DB04839,Genito Urinary System and Sex Hormones,DrugBank
DB04839,Hormonal Contraceptives for Systemic Use,DrugBank
DB04839,Hormone Antagonists,DrugBank
DB04839,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04839,Hyperglycemia-Associated Agents,DrugBank
DB04839,Other Miscellaneous Therapeutic Agents,DrugBank
DB04839,Pregnadienes,DrugBank
DB04839,Pregnanes,DrugBank
DB04839,Progestin Contraceptives,DrugBank
DB04839,Progestins,DrugBank
DB04839,Reproductive Control Agents,DrugBank
DB04839,Sex Hormones and Modulators of the Genital System,DrugBank
DB04839,Steroids,DrugBank
DB04839,"Steroids, Chlorinated",DrugBank
DB04840,Adrenergic Agents,DrugBank
DB04840,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB04840,Antihypertensive Agents,DrugBank
DB04840,Autonomic Agents,DrugBank
DB04840,Cardiovascular Agents,DrugBank
DB04840,Catecholamines,DrugBank
DB04840,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04840,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04840,Cytochrome P-450 Substrates,DrugBank
DB04840,Guanidine Derivatives,DrugBank
DB04840,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04840,Isoquinolines,DrugBank
DB04840,Neurotransmitter Agents,DrugBank
DB04840,P-glycoprotein substrates,DrugBank
DB04840,Peripheral Nervous System Agents,DrugBank
DB04840,Sympatholytics,DrugBank
DB04841,Agents causing hyperkalemia,DrugBank
DB04841,Antiarrhythmic agents,DrugBank
DB04841,Anticonvulsants,DrugBank
DB04841,"Antimigraine Agents, Miscellaneous",DrugBank
DB04841,Antivertigo Preparations,DrugBank
DB04841,Bradycardia-Causing Agents,DrugBank
DB04841,Calcium Channel Blockers,DrugBank
DB04841,Calcium-Regulating Hormones and Agents,DrugBank
DB04841,Cardiovascular Agents,DrugBank
DB04841,Central Nervous System Agents,DrugBank
DB04841,Central Nervous System Depressants,DrugBank
DB04841,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04841,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04841,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB04841,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04841,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04841,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04841,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04841,Cytochrome P-450 Substrates,DrugBank
DB04841,Histamine Agents,DrugBank
DB04841,Histamine Antagonists,DrugBank
DB04841,Histamine H1 Antagonists,DrugBank
DB04841,Membrane Transport Modulators,DrugBank
DB04841,Nervous System,DrugBank
DB04841,Neurotransmitter Agents,DrugBank
DB04841,Piperazine Derivatives,DrugBank
DB04841,Piperazines,DrugBank
DB04841,Vasodilating Agents,DrugBank
DB04842,Agents causing hyperkalemia,DrugBank
DB04842,Antiarrhythmic agents,DrugBank
DB04842,Antidepressive Agents,DrugBank
DB04842,Antipsychotic Agents,DrugBank
DB04842,Bradycardia-Causing Agents,DrugBank
DB04842,Calcium Channel Blockers,DrugBank
DB04842,Central Nervous System Agents,DrugBank
DB04842,Central Nervous System Depressants,DrugBank
DB04842,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04842,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04842,Cytochrome P-450 Substrates,DrugBank
DB04842,Diphenylbutylpiperidine Derivatives,DrugBank
DB04842,Dopamine Agents,DrugBank
DB04842,Dopamine Antagonists,DrugBank
DB04842,Dopamine D2 Receptor Antagonists,DrugBank
DB04842,Imidazoles,DrugBank
DB04842,Moderate Risk QTc-Prolonging Agents,DrugBank
DB04842,Nervous System,DrugBank
DB04842,Neurotoxic agents,DrugBank
DB04842,Neurotransmitter Agents,DrugBank
DB04842,Piperidines,DrugBank
DB04842,Psycholeptics,DrugBank
DB04842,Psychotropic Drugs,DrugBank
DB04842,QTc Prolonging Agents,DrugBank
DB04842,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04842,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB04842,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB04842,Serotonin Agents,DrugBank
DB04842,Serotonin Receptor Antagonists,DrugBank
DB04842,Spiro Compounds,DrugBank
DB04842,Tranquilizing Agents,DrugBank
DB04843,"Acids, Carbocyclic",DrugBank
DB04843,Agents producing tachycardia,DrugBank
DB04843,Alimentary Tract and Metabolism,DrugBank
DB04843,Anticholinergic Agents,DrugBank
DB04843,Diphenylacetic Acids,DrugBank
DB04843,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB04843,Hydroxy Acids,DrugBank
DB04843,Muscarinic Antagonists,DrugBank
DB04843,Phenylacetates,DrugBank
DB04843,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB04844,Adrenergic Agents,DrugBank
DB04844,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04844,Cytochrome P-450 Substrates,DrugBank
DB04844,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04844,Highest Risk QTc-Prolonging Agents,DrugBank
DB04844,Membrane Transport Modulators,DrugBank
DB04844,Miscellaneous Central Nervous System Agents,DrugBank
DB04844,Nervous System,DrugBank
DB04844,Neurotransmitter Agents,DrugBank
DB04844,Neurotransmitter Uptake Inhibitors,DrugBank
DB04844,QTc Prolonging Agents,DrugBank
DB04844,Quinolizines,DrugBank
DB04844,Vesicular Monoamine Transporter 2 Inhibitor,DrugBank
DB04844,Vesicular Monoamine Transporter 2 Inhibitors,DrugBank
DB04845,Anti-Bacterial Agents,DrugBank
DB04845,Antineoplastic Agents,DrugBank
DB04845,Antineoplastic and Immunomodulating Agents,DrugBank
DB04845,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04845,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04845,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB04845,Cytochrome P-450 Substrates,DrugBank
DB04845,Cytotoxic Antibiotics and Related Substances,DrugBank
DB04845,Cytotoxins,DrugBank
DB04845,Immunosuppressive Agents,DrugBank
DB04845,Lactones,DrugBank
DB04845,Macrolides,DrugBank
DB04845,Microtubule Inhibition,DrugBank
DB04845,Microtubule Inhibitors,DrugBank
DB04845,Myelosuppressive Agents,DrugBank
DB04845,Narrow Therapeutic Index Drugs,DrugBank
DB04845,P-glycoprotein inhibitors,DrugBank
DB04845,P-glycoprotein substrates,DrugBank
DB04845,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB04845,Polyketides,DrugBank
DB04845,Tubulin Modulators,DrugBank
DB04846,Adrenergic Agents,DrugBank
DB04846,Adrenergic Agonists,DrugBank
DB04846,Adrenergic Antagonists,DrugBank
DB04846,Adrenergic beta-1 Receptor Antagonists,DrugBank
DB04846,Adrenergic beta-2 Receptor Agonists,DrugBank
DB04846,Adrenergic beta-3 Receptor Agonists,DrugBank
DB04846,Adrenergic beta-Agonists,DrugBank
DB04846,Adrenergic beta-Antagonists,DrugBank
DB04846,Agents causing hyperkalemia,DrugBank
DB04846,Alcohols,DrugBank
DB04846,Amides,DrugBank
DB04846,Amines,DrugBank
DB04846,Amino Alcohols,DrugBank
DB04846,Antiarrhythmic agents,DrugBank
DB04846,Antihypertensive Agents,DrugBank
DB04846,Autonomic Agents,DrugBank
DB04846,Benzene Derivatives,DrugBank
DB04846,"Beta Blocking Agents, Selective",DrugBank
DB04846,Beta-Blockers (Beta1 Selective),DrugBank
DB04846,Bradycardia-Causing Agents,DrugBank
DB04846,Cardiovascular Agents,DrugBank
DB04846,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04846,Cytochrome P-450 Substrates,DrugBank
DB04846,Neurotransmitter Agents,DrugBank
DB04846,Peripheral Nervous System Agents,DrugBank
DB04846,Phenoxypropanolamines,DrugBank
DB04846,Phenylurea Compounds,DrugBank
DB04846,Potential QTc-Prolonging Agents,DrugBank
DB04846,Propanolamines,DrugBank
DB04846,Propanols,DrugBank
DB04846,QTc Prolonging Agents,DrugBank
DB04846,Sympathomimetics,DrugBank
DB04846,Vasodilating Agents,DrugBank
DB04847,Amino Acids,DrugBank
DB04847,"Amino Acids, Peptides, and Proteins",DrugBank
DB04847,Antianemic Preparations,DrugBank
DB04847,BCRP/ABCG2 Inhibitors,DrugBank
DB04847,Blood and Blood Forming Organs,DrugBank
DB04847,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB04847,Cytochrome P-450 Substrates,DrugBank
DB04847,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04847,"Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors",DrugBank
DB04847,OAT1/SLC22A6 Substrates,DrugBank
DB04847,OAT3/SLC22A8 Substrates,DrugBank
DB04847,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04847,UGT1A9 Substrates,DrugBank
DB04849,Antineoplastic Agents,DrugBank
DB04849,Antineoplastic and Immunomodulating Agents,DrugBank
DB04849,Enzyme Inhibitors,DrugBank
DB04849,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04849,Protein Kinase Inhibitors,DrugBank
DB04849,Tyrosine Kinase Inhibitors,DrugBank
DB04849,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,DrugBank
DB04850,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04850,Oxazoles,DrugBank
DB04851,P-glycoprotein inhibitors,DrugBank
DB04854,Antigout Preparations,DrugBank
DB04854,Antirheumatic Agents,DrugBank
DB04854,BCRP/ABCG2 Inhibitors,DrugBank
DB04854,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04854,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB04854,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04854,Cytochrome P-450 Substrates,DrugBank
DB04854,Drugs causing inadvertant photosensitivity,DrugBank
DB04854,Musculo-Skeletal System,DrugBank
DB04854,Photosensitizing Agents,DrugBank
DB04854,Preparations Inhibiting Uric Acid Production,DrugBank
DB04854,Sulfur Compounds,DrugBank
DB04854,Thiazoles,DrugBank
DB04854,UGT1A1 Substrates,DrugBank
DB04854,UGT1A3 substrates,DrugBank
DB04854,UGT1A9 Substrates,DrugBank
DB04854,UGT2B7 substrates,DrugBank
DB04854,Xanthine Oxidase Inhibitors,DrugBank
DB04855,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB04855,Adrenergic alpha-Antagonists,DrugBank
DB04855,Adrenergic Antagonists,DrugBank
DB04855,Agents that produce hypertension,DrugBank
DB04855,Antiarrhythmic agents,DrugBank
DB04855,"Antiarrhythmics, Class III",DrugBank
DB04855,Benzofurans,DrugBank
DB04855,Bradycardia-Causing Agents,DrugBank
DB04855,Cardiac Therapy,DrugBank
DB04855,Cardiovascular Agents,DrugBank
DB04855,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04855,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB04855,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04855,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB04855,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04855,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04855,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04855,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB04855,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04855,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB04855,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB04855,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB04855,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB04855,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB04855,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04855,Cytochrome P-450 Substrates,DrugBank
DB04855,Drugs causing inadvertant photosensitivity,DrugBank
DB04855,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04855,Highest Risk QTc-Prolonging Agents,DrugBank
DB04855,Narrow Therapeutic Index Drugs,DrugBank
DB04855,OAT3/SLC22A8 Inhibitors,DrugBank
DB04855,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04855,OATP1B3 inhibitors,DrugBank
DB04855,OCT1 inhibitors,DrugBank
DB04855,OCT2 Inhibitors,DrugBank
DB04855,P-glycoprotein inhibitors,DrugBank
DB04855,Photosensitizing Agents,DrugBank
DB04855,QTc Prolonging Agents,DrugBank
DB04856,"Acids, Acyclic",DrugBank
DB04856,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB04856,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04856,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04856,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04856,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB04856,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04856,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04856,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB04856,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04856,Cytochrome P-450 Substrates,DrugBank
DB04856,Fatty Acids,DrugBank
DB04856,"Fatty Acids, Volatile",DrugBank
DB04856,Lipids,DrugBank
DB04856,Valerates,DrugBank
DB04858,Antineoplastic Agents,DrugBank
DB04858,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB04858,Cytochrome P-450 Substrates,DrugBank
DB04858,Radiation-Sensitizing Agents,DrugBank
DB04858,Triazines,DrugBank
DB04861,Adrenergic Agents,DrugBank
DB04861,Adrenergic Agonists,DrugBank
DB04861,Adrenergic Antagonists,DrugBank
DB04861,Adrenergic beta-1 Receptor Agonists,DrugBank
DB04861,Adrenergic beta-Agonists,DrugBank
DB04861,Adrenergic beta-Antagonists,DrugBank
DB04861,Agents causing hyperkalemia,DrugBank
DB04861,Alcohols,DrugBank
DB04861,Amines,DrugBank
DB04861,Amino Alcohols,DrugBank
DB04861,Antiarrhythmic agents,DrugBank
DB04861,Antihypertensive Agents,DrugBank
DB04861,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB04861,Benzopyrans,DrugBank
DB04861,Beta blocking agents and calcium channel blockers,DrugBank
DB04861,Beta Blocking Agents and Thiazides,DrugBank
DB04861,"Beta Blocking Agents, Selective",DrugBank
DB04861,"Beta Blocking Agents, Selective, and Thiazides",DrugBank
DB04861,Beta-Blockers (Beta1 Selective),DrugBank
DB04861,Bradycardia-Causing Agents,DrugBank
DB04861,Cardiovascular Agents,DrugBank
DB04861,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB04861,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04861,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04861,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04861,Cytochrome P-450 Substrates,DrugBank
DB04861,Ethanolamines,DrugBank
DB04861,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04861,Hypotensive Agents,DrugBank
DB04861,Lipid Modifying Agents,DrugBank
DB04861,Neurotransmitter Agents,DrugBank
DB04861,Pyrans,DrugBank
DB04861,Vasodilating Agents,DrugBank
DB04863,Antianginal Agents,DrugBank
DB04863,Benzene Derivatives,DrugBank
DB04863,"Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors",DrugBank
DB04863,Vasodilating Agents,DrugBank
DB04864,Central Nervous System Agents,DrugBank
DB04864,Cholinergic Agents,DrugBank
DB04864,Cholinesterase Inhibitors,DrugBank
DB04864,"Compounds used in a research, industrial, or household setting",DrugBank
DB04864,Enzyme Inhibitors,DrugBank
DB04864,Neuroprotective Agents,DrugBank
DB04864,Neurotransmitter Agents,DrugBank
DB04864,Protective Agents,DrugBank
DB04864,Terpenes,DrugBank
DB04865,Alkaloids,DrugBank
DB04865,Antineoplastic Agents,DrugBank
DB04865,"Antineoplastic Agents, Phytogenic",DrugBank
DB04865,Antineoplastic and Immunomodulating Agents,DrugBank
DB04865,Benzazepines,DrugBank
DB04865,Enzyme Inhibitors,DrugBank
DB04865,Harringtonines,DrugBank
DB04865,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04865,Narrow Therapeutic Index Drugs,DrugBank
DB04865,Protein Synthesis Inhibitors,DrugBank
DB04866,Angiogenesis Inhibitors,DrugBank
DB04866,Angiogenesis Modulating Agents,DrugBank
DB04866,Anti-Infective Agents,DrugBank
DB04866,Antineoplastic Agents,DrugBank
DB04866,Antiparasitic Agents,DrugBank
DB04866,Antiprotozoals,DrugBank
DB04866,Coccidiostats,DrugBank
DB04866,Enzyme Inhibitors,DrugBank
DB04866,Growth Inhibitors,DrugBank
DB04866,Growth Substances,DrugBank
DB04866,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04866,Protein Synthesis Inhibitors,DrugBank
DB04866,Quinazolines,DrugBank
DB04868,Antineoplastic Agents,DrugBank
DB04868,Antineoplastic and Immunomodulating Agents,DrugBank
DB04868,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB04868,BCRP/ABCG2 Inhibitors,DrugBank
DB04868,BCRP/ABCG2 Substrates,DrugBank
DB04868,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB04868,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB04868,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB04868,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB04868,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB04868,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB04868,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04868,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04868,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04868,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB04868,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04868,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04868,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04868,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB04868,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB04868,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04868,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB04868,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04868,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04868,Cytochrome P-450 Substrates,DrugBank
DB04868,Drugs causing inadvertant photosensitivity,DrugBank
DB04868,Enzyme Inhibitors,DrugBank
DB04868,Highest Risk QTc-Prolonging Agents,DrugBank
DB04868,Hyperglycemia-Associated Agents,DrugBank
DB04868,Immunosuppressive Agents,DrugBank
DB04868,Kinase Inhibitor,DrugBank
DB04868,Myelosuppressive Agents,DrugBank
DB04868,Narrow Therapeutic Index Drugs,DrugBank
DB04868,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04868,P-glycoprotein inhibitors,DrugBank
DB04868,P-glycoprotein substrates,DrugBank
DB04868,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB04868,Photosensitizing Agents,DrugBank
DB04868,Protein Kinase Inhibitors,DrugBank
DB04868,QTc Prolonging Agents,DrugBank
DB04868,Tyrosine Kinase Inhibitors,DrugBank
DB04868,UGT1A1 Inhibitors,DrugBank
DB04871,Alimentary Tract and Metabolism,DrugBank
DB04871,Antidepressive Agents,DrugBank
DB04871,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB04871,Central Nervous System Depressants,DrugBank
DB04871,Centrally Acting Antiobesity Products,DrugBank
DB04871,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04871,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB04871,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04871,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04871,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04871,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04871,Cytochrome P-450 Substrates,DrugBank
DB04871,Drugs that are Mainly Renally Excreted,DrugBank
DB04871,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04871,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04871,Serotonin 2c Receptor Agonists,DrugBank
DB04871,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB04871,Serotonin 5-HT2C Receptor Agonists,DrugBank
DB04871,Serotonin Agents,DrugBank
DB04871,Serotonin Modulators,DrugBank
DB04871,Serotonin Receptor Agonists,DrugBank
DB04872,Antipsychotic Agents,DrugBank
DB04872,Central Nervous System Agents,DrugBank
DB04872,Central Nervous System Depressants,DrugBank
DB04872,Neurotoxic agents,DrugBank
DB04872,Psychotropic Drugs,DrugBank
DB04872,Tranquilizing Agents,DrugBank
DB04876,Agents causing angioedema,DrugBank
DB04876,Alimentary Tract and Metabolism,DrugBank
DB04876,Blood Glucose Lowering Agents,DrugBank
DB04876,Bridged-Ring Compounds,DrugBank
DB04876,Cycloparaffins,DrugBank
DB04876,DPP-IV Inhibitors,DrugBank
DB04876,Drugs Used in Diabetes,DrugBank
DB04876,Enzyme Inhibitors,DrugBank
DB04876,Glucagon-Like Peptide 1,DrugBank
DB04876,Nitriles,DrugBank
DB04876,Oral Hypoglycemics,DrugBank
DB04876,P-glycoprotein substrates,DrugBank
DB04876,Protease Inhibitors,DrugBank
DB04876,Pyrrolidines,DrugBank
DB04878,Alcohols,DrugBank
DB04878,Alimentary Tract and Metabolism,DrugBank
DB04878,Blood Glucose Lowering Agents,DrugBank
DB04878,Carbohydrates,DrugBank
DB04878,Cyclohexanes,DrugBank
DB04878,Cycloparaffins,DrugBank
DB04878,Drugs Used in Diabetes,DrugBank
DB04878,Enzyme Inhibitors,DrugBank
DB04878,Fatty Alcohols,DrugBank
DB04878,Glycoside Hydrolase Inhibitors,DrugBank
DB04878,Hexanols,DrugBank
DB04878,Lipids,DrugBank
DB04878,Oral Hypoglycemics,DrugBank
DB04878,Sugar Alcohols,DrugBank
DB04880,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB04880,Cardiac Therapy,DrugBank
DB04880,Cardiotonic Agents,DrugBank
DB04880,Cardiovascular Agents,DrugBank
DB04880,"Compounds used in a research, industrial, or household setting",DrugBank
DB04880,Drugs causing inadvertant photosensitivity,DrugBank
DB04880,Enzyme Inhibitors,DrugBank
DB04880,Imidazoles,DrugBank
DB04880,Phosphodiesterase 3 Inhibitors,DrugBank
DB04880,Phosphodiesterase Inhibitors,DrugBank
DB04880,Photosensitizing Agents,DrugBank
DB04880,Protective Agents,DrugBank
DB04880,Vasodilating Agents,DrugBank
DB04881,BCRP/ABCG2 Inhibitors,DrugBank
DB04881,Benzocycloheptenes,DrugBank
DB04881,"Drug Resistance, Multiple",DrugBank
DB04881,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04881,Isoquinolines,DrugBank
DB04881,P-glycoprotein inhibitors,DrugBank
DB04884,Amines,DrugBank
DB04884,Antidepressive Agents,DrugBank
DB04884,Benzene Derivatives,DrugBank
DB04884,Benzyl Compounds,DrugBank
DB04884,Central Nervous System Depressants,DrugBank
DB04884,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04884,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04884,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04884,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04884,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04884,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04884,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04884,Cytochrome P-450 Substrates,DrugBank
DB04884,Genito Urinary System and Sex Hormones,DrugBank
DB04884,Hypoglycemia-Associated Agents,DrugBank
DB04884,Selective Serotonin Reuptake Inhibitors,DrugBank
DB04884,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04884,Serotonin Agents,DrugBank
DB04884,Serotonin Modulators,DrugBank
DB04884,Urologicals,DrugBank
DB04885,Alimentary Tract and Metabolism,DrugBank
DB04885,Antidepressive Agents,DrugBank
DB04885,Central Nervous System Depressants,DrugBank
DB04885,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB04885,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04885,Indoles,DrugBank
DB04885,Serotonin Agents,DrugBank
DB04885,Serotonin Receptor Antagonists,DrugBank
DB04886,Anti-HIV Agents,DrugBank
DB04886,Anti-Infective Agents,DrugBank
DB04886,Anti-Retroviral Agents,DrugBank
DB04886,Antiviral Agents,DrugBank
DB04886,Benzopyrans,DrugBank
DB04886,Calophyllum,DrugBank
DB04886,Coumarins,DrugBank
DB04886,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04886,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04886,Cytochrome P-450 Substrates,DrugBank
DB04886,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04886,Plant Extracts,DrugBank
DB04886,Pyrans,DrugBank
DB04888,Antipsychotic Agents,DrugBank
DB04888,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB04888,Central Nervous System Depressants,DrugBank
DB04888,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04888,Neurotoxic agents,DrugBank
DB04889,Analgesics,DrugBank
DB04889,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04889,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04889,Cytochrome P-450 Substrates,DrugBank
DB04889,Monoamine Oxidase A Substrates,DrugBank
DB04890,Anti-Allergic Agents,DrugBank
DB04890,Drugs that are Mainly Renally Excreted,DrugBank
DB04890,Histamine Antagonists,DrugBank
DB04890,Histamine H1 Antagonists,DrugBank
DB04890,Mast Cell Stabilizers,DrugBank
DB04891,Cholestanes,DrugBank
DB04891,Cholestenes,DrugBank
DB04891,Fused-Ring Compounds,DrugBank
DB04891,Lipids,DrugBank
DB04891,Membrane Lipids,DrugBank
DB04891,Secosteroids,DrugBank
DB04891,Steroids,DrugBank
DB04891,Sterols,DrugBank
DB04891,Vitamin D and Analogues,DrugBank
DB04891,Vitamins,DrugBank
DB04891,Vitamins (Fat Soluble),DrugBank
DB04892,"Acids, Acyclic",DrugBank
DB04892,Alkaloids,DrugBank
DB04892,Carbamates,DrugBank
DB04892,Cholinergic Agents,DrugBank
DB04892,Cholinesterase Inhibitors,DrugBank
DB04892,Enzyme Inhibitors,DrugBank
DB04892,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04892,Indole Alkaloids,DrugBank
DB04892,Indoles,DrugBank
DB04892,Indolizidines,DrugBank
DB04892,Indolizines,DrugBank
DB04892,Neurotransmitter Agents,DrugBank
DB04892,Phenylcarbamates,DrugBank
DB04892,Stereoisomerism,DrugBank
DB04894,"Amino Acids, Peptides, and Proteins",DrugBank
DB04894,Analgesics,DrugBank
DB04894,Antineoplastic Agents,DrugBank
DB04894,Central Nervous System Agents,DrugBank
DB04894,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04894,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04894,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04894,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04894,Hormones,DrugBank
DB04894,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04894,Hypothalamic Hormones,DrugBank
DB04894,Nerve Tissue Proteins,DrugBank
DB04894,Neuropeptides,DrugBank
DB04894,Pancreatic Hormones,DrugBank
DB04894,Peptide Hormones,DrugBank
DB04894,Peptides,DrugBank
DB04894,Peripheral Nervous System Agents,DrugBank
DB04894,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB04894,Pituitary Hormone Release Inhibiting Hormones,DrugBank
DB04894,Proteins,DrugBank
DB04894,Sensory System Agents,DrugBank
DB04894,Somatostatin and Analogues,DrugBank
DB04894,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB04895,Antineovascularisation Agents,DrugBank
DB04895,Carbohydrates,DrugBank
DB04895,Drugs that are Mainly Renally Excreted,DrugBank
DB04895,Glycosides,DrugBank
DB04895,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB04895,Nucleotides,DrugBank
DB04895,Ocular Vascular Disorder Agents,DrugBank
DB04895,Oligonucleotides,DrugBank
DB04895,Ophthalmologicals,DrugBank
DB04895,Pegylated agents,DrugBank
DB04895,Polynucleotides,DrugBank
DB04895,Sensory Organs,DrugBank
DB04895,Vascular Endothelial Growth Factor A,DrugBank
DB04896,Adrenergic Agents,DrugBank
DB04896,Adrenergic Uptake Inhibitors,DrugBank
DB04896,Agents producing tachycardia,DrugBank
DB04896,Analgesics,DrugBank
DB04896,"Analgesics, Non-Narcotic",DrugBank
DB04896,Antidepressive Agents,DrugBank
DB04896,Central Nervous System Agents,DrugBank
DB04896,Central Nervous System Depressants,DrugBank
DB04896,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB04896,Cyclopropanes,DrugBank
DB04896,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04896,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04896,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04896,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB04896,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04896,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04896,Cytochrome P-450 Substrates,DrugBank
DB04896,Drugs that are Mainly Renally Excreted,DrugBank
DB04896,Hypoglycemia-Associated Agents,DrugBank
DB04896,Membrane Transport Modulators,DrugBank
DB04896,Nervous System,DrugBank
DB04896,Neurotransmitter Agents,DrugBank
DB04896,Neurotransmitter Uptake Inhibitors,DrugBank
DB04896,Norepinephrine Uptake Inhibitors,DrugBank
DB04896,Peripheral Nervous System Agents,DrugBank
DB04896,Psychoanaleptics,DrugBank
DB04896,Psychotropic Drugs,DrugBank
DB04896,Selective Serotonin Reuptake Inhibitors,DrugBank
DB04896,Sensory System Agents,DrugBank
DB04896,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04896,Serotonin Agents,DrugBank
DB04896,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB04896,Serotonin Modulators,DrugBank
DB04897,Alcohols,DrugBank
DB04897,"Amino Acids, Peptides, and Proteins",DrugBank
DB04897,Biological Factors,DrugBank
DB04897,Bradycardia-Causing Agents,DrugBank
DB04897,Glycerophosphates,DrugBank
DB04897,Glycerophospholipids,DrugBank
DB04897,Lipids,DrugBank
DB04897,Membrane Lipids,DrugBank
DB04897,Peptides,DrugBank
DB04897,Pharmaceutical Preparations,DrugBank
DB04897,Phosphatidic Acids,DrugBank
DB04897,Phospholipids,DrugBank
DB04897,Proteins,DrugBank
DB04897,Pulmonary Surfactants,DrugBank
DB04898,Amines,DrugBank
DB04898,Anticoagulants,DrugBank
DB04898,Antithrombins,DrugBank
DB04898,Azetines,DrugBank
DB04898,Benzene Derivatives,DrugBank
DB04898,Benzyl Compounds,DrugBank
DB04898,Blood and Blood Forming Organs,DrugBank
DB04898,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04898,Cytochrome P-450 Substrates,DrugBank
DB04898,Enzyme Inhibitors,DrugBank
DB04898,Hematologic Agents,DrugBank
DB04898,Protease Inhibitors,DrugBank
DB04898,Serine Protease Inhibitors,DrugBank
DB04899,"Amino Acids, Peptides, and Proteins",DrugBank
DB04899,Cardiac Therapy,DrugBank
DB04899,Cardiovascular Agents,DrugBank
DB04899,Hormones,DrugBank
DB04899,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04899,Hypotensive Agents,DrugBank
DB04899,Natriuretic Agents,DrugBank
DB04899,"Natriuretic Peptide, Brain",DrugBank
DB04899,Natriuretic Peptides,DrugBank
DB04899,Nerve Tissue Proteins,DrugBank
DB04899,Peptide Hormones,DrugBank
DB04899,Peptides,DrugBank
DB04899,Proteins,DrugBank
DB04899,Vasodilators Used in Cardiac Diseases,DrugBank
DB04900,"Adjuvants, Immunologic",DrugBank
DB04900,"Amino Acids, Peptides, and Proteins",DrugBank
DB04900,Antineoplastic Agents,DrugBank
DB04900,Hormones,DrugBank
DB04900,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04900,Immunologic Factors,DrugBank
DB04900,Peptide Hormones,DrugBank
DB04900,Peptides,DrugBank
DB04900,Proteins,DrugBank
DB04900,Thymus Hormones,DrugBank
DB04901,"Amino Acids, Peptides, and Proteins",DrugBank
DB04901,Anti-Inflammatory Agents,DrugBank
DB04901,Antibodies,DrugBank
DB04901,Antineoplastic Agents,DrugBank
DB04901,Blood Proteins,DrugBank
DB04901,Globulins,DrugBank
DB04901,Immunoglobulins,DrugBank
DB04901,Immunoproteins,DrugBank
DB04901,Proteins,DrugBank
DB04901,Serum Globulins,DrugBank
DB04903,Central Nervous System Depressants,DrugBank
DB04903,GABA Agents,DrugBank
DB04903,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04903,Hypnotics (Nonbenzodiazepine),DrugBank
DB04903,Hypnotics and Sedatives,DrugBank
DB04905,Antiplatelet agents,DrugBank
DB04905,Benzene Derivatives,DrugBank
DB04905,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04905,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04905,Cytochrome P-450 CYP3A Inducers,DrugBank
DB04905,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04905,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04905,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB04905,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB04905,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04905,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB04905,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04905,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04905,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04905,Cytochrome P-450 Substrates,DrugBank
DB04905,Ethers,DrugBank
DB04905,Hematologic Agents,DrugBank
DB04905,Histamine Agents,DrugBank
DB04905,Neurotransmitter Agents,DrugBank
DB04905,P-glycoprotein inducers,DrugBank
DB04905,P-glycoprotein inhibitors,DrugBank
DB04905,Phenols,DrugBank
DB04907,Antineoplastic Agents,DrugBank
DB04907,Antineoplastic and Immunomodulating Agents,DrugBank
DB04907,Antineoplastic cell and gene therapy,DrugBank
DB04907,Enzymes,DrugBank
DB04907,Enzymes and Coenzymes,DrugBank
DB04907,Genetic Therapy,DrugBank
DB04907,Phosphotransferases,DrugBank
DB04907,Phosphotransferases (Alcohol Group Acceptor),DrugBank
DB04907,Transferases,DrugBank
DB04908,Agents that produce hypertension,DrugBank
DB04908,Antidepressive Agents,DrugBank
DB04908,Central Nervous System Depressants,DrugBank
DB04908,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04908,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04908,Cytochrome P-450 Substrates,DrugBank
DB04908,Genito Urinary System and Sex Hormones,DrugBank
DB04908,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04908,Miscellaneous Central Nervous System Agents,DrugBank
DB04908,P-glycoprotein inhibitors,DrugBank
DB04908,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04908,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB04908,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB04908,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB04908,Serotonin Agents,DrugBank
DB04908,Serotonin Modulators,DrugBank
DB04908,Serotonin Receptor Agonists,DrugBank
DB04908,Serotonin Receptor Antagonists,DrugBank
DB04911,"Amino Acids, Peptides, and Proteins",DrugBank
DB04911,Anti-Bacterial Agents,DrugBank
DB04911,Anti-Infective Agents,DrugBank
DB04911,Antibacterials for Systemic Use,DrugBank
DB04911,Antiinfectives for Systemic Use,DrugBank
DB04911,Carbohydrates,DrugBank
DB04911,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB04911,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB04911,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04911,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB04911,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04911,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB04911,Cytochrome P-450 CYP3A Inducers,DrugBank
DB04911,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04911,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB04911,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB04911,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04911,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04911,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04911,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04911,Glycoconjugates,DrugBank
DB04911,Glycopeptide Antibacterials,DrugBank
DB04911,Glycopeptides,DrugBank
DB04911,Lipids,DrugBank
DB04911,Lipoglycopeptide Antibacterial,DrugBank
DB04911,Lipopeptides,DrugBank
DB04911,Peptides,DrugBank
DB04914,"Amino Acids, Peptides, and Proteins",DrugBank
DB04914,Biological Products,DrugBank
DB04914,Complex Mixtures,DrugBank
DB04914,Gastrointestinal Hormones,DrugBank
DB04914,Hormones,DrugBank
DB04914,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB04914,Immunization,DrugBank
DB04914,Nerve Tissue Proteins,DrugBank
DB04914,Neuropeptides,DrugBank
DB04914,Peptide Hormones,DrugBank
DB04914,Peptides,DrugBank
DB04914,Proteins,DrugBank
DB04914,Vaccines,DrugBank
DB04917,"Acids, Carbocyclic",DrugBank
DB04917,Amides,DrugBank
DB04917,Antidepressive Agents,DrugBank
DB04917,Benzene Derivatives,DrugBank
DB04917,Benzoates,DrugBank
DB04917,Central Nervous System Depressants,DrugBank
DB04917,Neurotransmitter Agents,DrugBank
DB04917,Serotonin 5-HT4 Receptor Agonists,DrugBank
DB04917,Serotonin Agents,DrugBank
DB04917,Serotonin Receptor Agonists,DrugBank
DB04917,Serotonin Receptor Antagonists,DrugBank
DB04918,Amides,DrugBank
DB04918,Anti-Bacterial Agents,DrugBank
DB04918,Anti-Infective Agents,DrugBank
DB04918,beta-Lactams,DrugBank
DB04918,BSEP/ABCB11 Inhibitors,DrugBank
DB04918,Cephalosporins,DrugBank
DB04918,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04918,Lactams,DrugBank
DB04918,Nephrotoxic agents,DrugBank
DB04918,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB04918,OATP1B3 inhibitors,DrugBank
DB04918,Sulfur Compounds,DrugBank
DB04918,Thiazines,DrugBank
DB04920,Agents causing hyperkalemia,DrugBank
DB04920,Antiarrhythmic agents,DrugBank
DB04920,Antihypertensive Agents,DrugBank
DB04920,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB04920,Bradycardia-Causing Agents,DrugBank
DB04920,Calcium Channel Blockers,DrugBank
DB04920,Calcium Channel Blockers (Dihydropyridine),DrugBank
DB04920,Calcium-Regulating Hormones and Agents,DrugBank
DB04920,Cardiovascular Agents,DrugBank
DB04920,Cholinesterase substrates,DrugBank
DB04920,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB04920,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB04920,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04920,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04920,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04920,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB04920,Cytochrome P-450 CYP3A Inducers,DrugBank
DB04920,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04920,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04920,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB04920,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB04920,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04920,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB04920,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04920,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04920,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04920,Cytochrome P-450 Substrates,DrugBank
DB04920,Dihydropyridine Derivatives,DrugBank
DB04920,Dihydropyridines,DrugBank
DB04920,Drugs that are Mainly Renally Excreted,DrugBank
DB04920,Hypotensive Agents,DrugBank
DB04920,Membrane Transport Modulators,DrugBank
DB04920,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB04920,Vasodilating Agents,DrugBank
DB04925,"Amino Acids, Peptides, and Proteins",DrugBank
DB04925,Anticoagulants,DrugBank
DB04925,Blood Proteins,DrugBank
DB04925,Cardiovascular Agents,DrugBank
DB04925,Endopeptidases,DrugBank
DB04925,Enzymes,DrugBank
DB04925,Enzymes and Coenzymes,DrugBank
DB04925,Fibrin Modulating Agents,DrugBank
DB04925,Fibrinolytic Agents,DrugBank
DB04925,Hematologic Agents,DrugBank
DB04925,Hydrolases,DrugBank
DB04925,Peptide Hydrolases,DrugBank
DB04925,Proteins,DrugBank
DB04925,Recombinant Proteins,DrugBank
DB04925,Serine Endopeptidases,DrugBank
DB04925,Serine Proteases,DrugBank
DB04930,Agrochemicals,DrugBank
DB04930,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB04930,Benzene Derivatives,DrugBank
DB04930,"Compounds used in a research, industrial, or household setting",DrugBank
DB04930,Cyclopentane Monoterpenes,DrugBank
DB04930,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB04930,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB04930,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB04930,Cytochrome P-450 Enzyme Inducers,DrugBank
DB04930,Cytochrome P-450 Substrates,DrugBank
DB04930,Drugs that are Mainly Renally Excreted,DrugBank
DB04930,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB04930,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB04930,Enzyme Inhibitors,DrugBank
DB04930,Ethers,DrugBank
DB04930,Insecticides,DrugBank
DB04930,Monoterpenes,DrugBank
DB04930,Pesticides,DrugBank
DB04930,Phenols,DrugBank
DB04930,Phenyl Ethers,DrugBank
DB04930,"Pyrethrines, Incl. Synthetic Compounds",DrugBank
DB04930,Pyrethrins,DrugBank
DB04930,Scabicides and Pediculicides,DrugBank
DB04930,Terpenes,DrugBank
DB04930,Toxic Actions,DrugBank
DB04932,Anti-Inflammatory Agents,DrugBank
DB04932,Anticoagulants,DrugBank
DB04932,Antiplatelet agents,DrugBank
DB04932,"Aptamers, Nucleotide",DrugBank
DB04932,Blood and Blood Forming Organs,DrugBank
DB04932,Cardiovascular Agents,DrugBank
DB04932,Fibrin Modulating Agents,DrugBank
DB04932,Fibrinolytic Agents,DrugBank
DB04932,Hematologic Agents,DrugBank
DB04932,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB04932,Nucleotides,DrugBank
DB04932,Polynucleotides,DrugBank
DB04934,Anti-Bacterial Agents,DrugBank
DB04934,Anti-Infective Agents,DrugBank
DB04934,"Antibiotics, Antitubercular",DrugBank
DB04934,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04934,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04934,Cytochrome P-450 Substrates,DrugBank
DB04934,Drugs for Treatment of Tuberculosis,DrugBank
DB04934,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04934,"Lactams, Macrocyclic",DrugBank
DB04934,Leprostatic Agents,DrugBank
DB04938,Benzene Derivatives,DrugBank
DB04938,Benzylidene Compounds,DrugBank
DB04938,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB04938,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB04938,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04938,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04938,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB04938,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04938,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04938,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04938,Cytochrome P-450 Substrates,DrugBank
DB04938,Estrogen Agonist-antagonists,DrugBank
DB04938,Estrogen Agonist/Antagonist,DrugBank
DB04938,Genito Urinary System and Sex Hormones,DrugBank
DB04938,Selective Estrogen Receptor Modulators,DrugBank
DB04938,Sex Hormones and Modulators of the Genital System,DrugBank
DB04938,Stilbenes,DrugBank
DB04946,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB04946,Adrenergic alpha-Antagonists,DrugBank
DB04946,Adrenergic Antagonists,DrugBank
DB04946,Agents that produce hypertension,DrugBank
DB04946,Antidepressive Agents,DrugBank
DB04946,Antipsychotic Agents,DrugBank
DB04946,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB04946,Central Nervous System Agents,DrugBank
DB04946,Central Nervous System Depressants,DrugBank
DB04946,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04946,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04946,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04946,Cytochrome P-450 Substrates,DrugBank
DB04946,Dopamine Antagonists,DrugBank
DB04946,Dopamine D2 Receptor Antagonists,DrugBank
DB04946,Highest Risk QTc-Prolonging Agents,DrugBank
DB04946,Histamine Antagonists,DrugBank
DB04946,Histamine H1 Antagonists,DrugBank
DB04946,Hyperglycemia-Associated Agents,DrugBank
DB04946,Nervous System,DrugBank
DB04946,Neurotoxic agents,DrugBank
DB04946,Psycholeptics,DrugBank
DB04946,Psychotropic Drugs,DrugBank
DB04946,QTc Prolonging Agents,DrugBank
DB04946,Schizophrenia,DrugBank
DB04946,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04946,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB04946,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB04946,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB04946,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB04946,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB04946,Serotonin Agents,DrugBank
DB04946,Serotonin Receptor Antagonists,DrugBank
DB04946,Tranquilizing Agents,DrugBank
DB04948,Adrenergic Agents,DrugBank
DB04948,Adrenergic Agonists,DrugBank
DB04948,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB04948,Adrenergic alpha-Agonists,DrugBank
DB04948,Agents producing tachycardia,DrugBank
DB04948,Agents that produce hypertension,DrugBank
DB04948,Antidepressive Agents,DrugBank
DB04948,Antihypertensive Agents,DrugBank
DB04948,Cardiovascular Agents,DrugBank
DB04948,Central alpha-2 Adrenergic Agonist,DrugBank
DB04948,Central Nervous System Agents,DrugBank
DB04948,Central Nervous System Depressants,DrugBank
DB04948,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04948,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB04948,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04948,Cytochrome P-450 Substrates,DrugBank
DB04948,Drugs that are Mainly Renally Excreted,DrugBank
DB04948,Drugs Used in Addictive Disorders,DrugBank
DB04948,Drugs Used in Opioid Dependence,DrugBank
DB04948,Hypotensive Agents,DrugBank
DB04948,Imidazoles,DrugBank
DB04948,Imidazolines,DrugBank
DB04948,MATE 1 Inhibitors,DrugBank
DB04948,MATE inhibitors,DrugBank
DB04948,Moderate Risk QTc-Prolonging Agents,DrugBank
DB04948,Nervous System,DrugBank
DB04948,Neurotransmitter Agents,DrugBank
DB04948,Peripheral Nervous System Agents,DrugBank
DB04948,QTc Prolonging Agents,DrugBank
DB04948,Sensory System Agents,DrugBank
DB04948,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB04948,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB04948,Serotonin Agents,DrugBank
DB04948,Serotonin Receptor Agonists,DrugBank
DB04949,"Amino Acids, Peptides, and Proteins",DrugBank
DB04949,Antibodies,DrugBank
DB04949,"Antibodies, Monoclonal",DrugBank
DB04949,"Antibodies, Monoclonal, Humanized",DrugBank
DB04949,Blood Proteins,DrugBank
DB04949,Globulins,DrugBank
DB04949,Immunoglobulin Fab Fragments,DrugBank
DB04949,Immunoglobulin Fragments,DrugBank
DB04949,Immunoglobulin Variable Region,DrugBank
DB04949,Immunoglobulins,DrugBank
DB04949,Immunoproteins,DrugBank
DB04949,Peptide Fragments,DrugBank
DB04949,Peptides,DrugBank
DB04949,Proteins,DrugBank
DB04949,Serum Globulins,DrugBank
DB04950,Antineoplastic Agents,DrugBank
DB04950,Egg Proteins,DrugBank
DB04950,Enzyme Inhibitors,DrugBank
DB04950,Enzymes,DrugBank
DB04950,Enzymes and Coenzymes,DrugBank
DB04950,Esterases,DrugBank
DB04950,Hydrolases,DrugBank
DB04950,Protein Synthesis Inhibitors,DrugBank
DB04950,Rana pipiens,DrugBank
DB04951,Analgesics,DrugBank
DB04951,"Analgesics, Non-Narcotic",DrugBank
DB04951,Anti-Inflammatory Agents,DrugBank
DB04951,Antifibrotic Agents,DrugBank
DB04951,Antineoplastic Agents,DrugBank
DB04951,Antineoplastic and Immunomodulating Agents,DrugBank
DB04951,Antirheumatic Agents,DrugBank
DB04951,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB04951,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB04951,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB04951,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB04951,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB04951,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB04951,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB04951,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04951,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB04951,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB04951,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB04951,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB04951,Cytochrome P-450 Substrates,DrugBank
DB04951,Immunosuppressive Agents,DrugBank
DB04951,P-glycoprotein inhibitors,DrugBank
DB04951,Peripheral Nervous System Agents,DrugBank
DB04951,Pyridines,DrugBank
DB04951,Pyridones,DrugBank
DB04951,Sensory System Agents,DrugBank
DB04951,Tumor Necrosis Factor Blockers,DrugBank
DB04952,"Amino Acids, Peptides, and Proteins",DrugBank
DB04952,Anti-Bacterial Agents,DrugBank
DB04952,Anti-Infective Agents,DrugBank
DB04952,Peptides,DrugBank
DB04952,"Peptides, Cyclic",DrugBank
DB04953,"Acids, Acyclic",DrugBank
DB04953,Amines,DrugBank
DB04953,Aniline Compounds,DrugBank
DB04953,Anticonvulsants,DrugBank
DB04953,Central Nervous System Agents,DrugBank
DB04953,Central Nervous System Depressants,DrugBank
DB04953,Diamines,DrugBank
DB04953,Drugs that are Mainly Renally Excreted,DrugBank
DB04953,Membrane Transport Modulators,DrugBank
DB04953,Nervous System,DrugBank
DB04953,Polyamines,DrugBank
DB04953,Potassium Channel Opener,DrugBank
DB04953,Potential QTc-Prolonging Agents,DrugBank
DB04953,QTc Prolonging Agents,DrugBank
DB04953,UGT1A1 Substrates,DrugBank
DB04953,UGT1A3 substrates,DrugBank
DB04953,UGT1A4 substrates,DrugBank
DB04953,UGT1A9 Substrates,DrugBank
DB04956,Agents reducing cytokine levels,DrugBank
DB04956,"Amino Acids, Peptides, and Proteins",DrugBank
DB04956,Antibodies,DrugBank
DB04956,Antineoplastic and Immunomodulating Agents,DrugBank
DB04956,Blood Proteins,DrugBank
DB04956,Globulins,DrugBank
DB04956,Immunoglobulins,DrugBank
DB04956,Immunologic Factors,DrugBank
DB04956,Immunoproteins,DrugBank
DB04956,Immunosuppressive Agents,DrugBank
DB04956,Proteins,DrugBank
DB04956,Serum Globulins,DrugBank
DB04956,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB04956,Tumor Necrosis Factor Blockers,DrugBank
DB04957,Antiarrhythmic agents,DrugBank
DB04957,"Antiarrhythmics, Class III",DrugBank
DB04957,Calcium-Regulating Hormones and Agents,DrugBank
DB04957,Cardiovascular Agents,DrugBank
DB04957,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04957,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB04957,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04957,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04957,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB04957,Cytochrome P-450 Substrates,DrugBank
DB04957,Imidazoles,DrugBank
DB04957,Imidazolidines,DrugBank
DB04957,Membrane Transport Modulators,DrugBank
DB04957,Moderate Risk QTc-Prolonging Agents,DrugBank
DB04957,QTc Prolonging Agents,DrugBank
DB04958,"Amino Acids, Peptides, and Proteins",DrugBank
DB04958,Antibodies,DrugBank
DB04958,"Antibodies, Monoclonal",DrugBank
DB04958,"Antibodies, Monoclonal, Humanized",DrugBank
DB04958,Antineoplastic Agents,DrugBank
DB04958,"Antineoplastic Agents, Immunological",DrugBank
DB04958,Blood Proteins,DrugBank
DB04958,Globulins,DrugBank
DB04958,Immunoglobulins,DrugBank
DB04958,Immunoproteins,DrugBank
DB04958,Proteins,DrugBank
DB04958,Serum Globulins,DrugBank
DB04960,Antineoplastic Agents,DrugBank
DB04960,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB04960,P-glycoprotein inhibitors,DrugBank
DB04960,Quinolines,DrugBank
DB04961,Anti-HIV Agents,DrugBank
DB04961,Anti-Infective Agents,DrugBank
DB04961,Antineoplastic Agents,DrugBank
DB04961,Dioxoles,DrugBank
DB04961,Pyrimidines,DrugBank
DB04961,Pyrimidinones,DrugBank
DB04962,"Amino Acids, Peptides, and Proteins",DrugBank
DB04962,Antibodies,DrugBank
DB04962,Blood Proteins,DrugBank
DB04962,Globulins,DrugBank
DB04962,Immunoglobulins,DrugBank
DB04962,Immunoproteins,DrugBank
DB04962,Proteins,DrugBank
DB04962,Serum Globulins,DrugBank
DB04964,"Amino Acids, Peptides, and Proteins",DrugBank
DB04964,Antibodies,DrugBank
DB04964,"Antibodies, Monoclonal",DrugBank
DB04964,Antineoplastic Agents,DrugBank
DB04964,"Antineoplastic Agents, Immunological",DrugBank
DB04964,Blood Proteins,DrugBank
DB04964,CA-125 Antigen,DrugBank
DB04964,Globulins,DrugBank
DB04964,Immunoglobulins,DrugBank
DB04964,Immunoproteins,DrugBank
DB04964,Proteins,DrugBank
DB04964,Serum Globulins,DrugBank
DB04975,Anthracenes,DrugBank
DB04975,Antineoplastic Agents,DrugBank
DB04975,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB04975,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB04975,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04975,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04975,Cytochrome P-450 Substrates,DrugBank
DB04975,Quinones,DrugBank
DB04977,"Amino Acids, Peptides, and Proteins",DrugBank
DB04977,Antineoplastic Agents,DrugBank
DB04977,Antineoplastic and Immunomodulating Agents,DrugBank
DB04977,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB04977,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB04977,Cytochrome P-450 CYP3A Substrates,DrugBank
DB04977,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB04977,Cytochrome P-450 Substrates,DrugBank
DB04977,Peptides,DrugBank
DB04977,"Peptides, Cyclic",DrugBank
DB04988,"Amino Acids, Peptides, and Proteins",DrugBank
DB04988,Antibodies,DrugBank
DB04988,Blood Proteins,DrugBank
DB04988,Globulins,DrugBank
DB04988,Immunoglobulins,DrugBank
DB04988,Immunoproteins,DrugBank
DB04988,Proteins,DrugBank
DB04988,Serum Globulins,DrugBank
DB04996,Antineoplastic Agents,DrugBank
DB04996,Antineoplastic and Immunomodulating Agents,DrugBank
DB04996,Organometallic Compounds,DrugBank
DB04996,Platinum Compounds,DrugBank
DB05006,"Amino Acids, Peptides, and Proteins",DrugBank
DB05006,Antibodies,DrugBank
DB05006,"Antibodies, Monoclonal",DrugBank
DB05006,Antigens,DrugBank
DB05006,"Antigens, Surface",DrugBank
DB05006,Biological Factors,DrugBank
DB05006,Blood Proteins,DrugBank
DB05006,Carbohydrates,DrugBank
DB05006,Globulins,DrugBank
DB05006,Glycoconjugates,DrugBank
DB05006,Glycoproteins,DrugBank
DB05006,Immunoglobulins,DrugBank
DB05006,Immunoproteins,DrugBank
DB05006,Membrane Glycoproteins,DrugBank
DB05006,Membrane Proteins,DrugBank
DB05006,Proteins,DrugBank
DB05006,Serum Globulins,DrugBank
DB05015,Amides,DrugBank
DB05015,Amines,DrugBank
DB05015,Antineoplastic Agents,DrugBank
DB05015,Antineoplastic and Immunomodulating Agents,DrugBank
DB05015,Cancer immunotherapy,DrugBank
DB05015,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB05015,Cytochrome P-450 CYP1A2 Inducers (weak),DrugBank
DB05015,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB05015,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB05015,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB05015,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB05015,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB05015,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB05015,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05015,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05015,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB05015,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05015,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05015,Cytochrome P-450 Substrates,DrugBank
DB05015,Enzyme Inhibitors,DrugBank
DB05015,Histone deacetylase (HDAC) inhibitors,DrugBank
DB05015,Histone Deacetylase Inhibitors,DrugBank
DB05015,Hydroxy Acids,DrugBank
DB05015,Hydroxylamines,DrugBank
DB05015,Immunosuppressive Agents,DrugBank
DB05015,Immunotherapy,DrugBank
DB05015,Myelosuppressive Agents,DrugBank
DB05015,Narrow Therapeutic Index Drugs,DrugBank
DB05015,P-glycoprotein substrates,DrugBank
DB05015,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB05015,Sulfones,DrugBank
DB05015,Sulfur Compounds,DrugBank
DB05015,UGT1A1 Substrates,DrugBank
DB05015,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB05016,Musculo-Skeletal System,DrugBank
DB05016,OAT1/SLC22A6 inhibitors,DrugBank
DB05016,OAT3/SLC22A8 Inhibitors,DrugBank
DB05016,OATP1B3 inhibitors,DrugBank
DB05016,Oxazoles,DrugBank
DB05016,UGT1A9 Substrates,DrugBank
DB05018,Alimentary Tract and Metabolism,DrugBank
DB05018,Alkaloids,DrugBank
DB05018,Alpha-Galactosidase A (alpha-Gal A) Pharmacological Chaperones,DrugBank
DB05018,Carbohydrates,DrugBank
DB05018,Drugs that are Mainly Renally Excreted,DrugBank
DB05018,Imino Pyranoses,DrugBank
DB05018,Imino Sugars,DrugBank
DB05018,Piperidines,DrugBank
DB05018,Various Alimentary Tract and Metabolism Products,DrugBank
DB05022,Anti-Infective Agents,DrugBank
DB05022,Antineoplastic Agents,DrugBank
DB05022,"Compounds used in a research, industrial, or household setting",DrugBank
DB05022,Enzyme Inhibitors,DrugBank
DB05022,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05022,Indicators and Reagents,DrugBank
DB05022,Intercalating Agents,DrugBank
DB05022,Laboratory Chemicals,DrugBank
DB05022,Organophosphorus Compounds,DrugBank
DB05022,Purines,DrugBank
DB05025,Amines,DrugBank
DB05025,MATE 1 Substrates,DrugBank
DB05025,MATE 2 Substrates,DrugBank
DB05025,MATE substrates,DrugBank
DB05025,Nervous System,DrugBank
DB05025,OCT2 Inhibitors,DrugBank
DB05034,"Amino Acids, Peptides, and Proteins",DrugBank
DB05034,Anti-Asthmatic Agents,DrugBank
DB05034,Autonomic Agents,DrugBank
DB05034,Bronchodilator Agents,DrugBank
DB05034,Diuretics,DrugBank
DB05034,Hormones,DrugBank
DB05034,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05034,Natriuretic Agents,DrugBank
DB05034,Natriuretic Peptides,DrugBank
DB05034,Peptide Hormones,DrugBank
DB05034,Peptides,DrugBank
DB05034,Peripheral Nervous System Agents,DrugBank
DB05034,Respiratory System Agents,DrugBank
DB05039,Adrenergic Agonists,DrugBank
DB05039,Adrenergic beta-2 Receptor Agonists,DrugBank
DB05039,Adrenergic beta-Agonists,DrugBank
DB05039,"Adrenergics, Inhalants",DrugBank
DB05039,Agents producing tachycardia,DrugBank
DB05039,Agents that produce hypertension,DrugBank
DB05039,Agents to Treat Airway Disease,DrugBank
DB05039,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05039,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05039,Cytochrome P-450 Substrates,DrugBank
DB05039,Drugs for Obstructive Airway Diseases,DrugBank
DB05039,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05039,Indenes,DrugBank
DB05039,Long-acting beta-adrenoceptor agonists,DrugBank
DB05039,P-glycoprotein substrates,DrugBank
DB05039,Potential QTc-Prolonging Agents,DrugBank
DB05039,QTc Prolonging Agents,DrugBank
DB05039,Quinolines,DrugBank
DB05039,Selective Beta 2-adrenergic Agonists,DrugBank
DB05039,UGT1A1 Substrates,DrugBank
DB05076,Alkenes,DrugBank
DB05076,Anticarcinogenic Agents,DrugBank
DB05076,Antineoplastic Agents,DrugBank
DB05076,Biological Factors,DrugBank
DB05076,Carotenoids,DrugBank
DB05076,"Compounds used in a research, industrial, or household setting",DrugBank
DB05076,Cyclohexanes,DrugBank
DB05076,Cyclohexenes,DrugBank
DB05076,Cycloparaffins,DrugBank
DB05076,"Hydrocarbons, Acyclic",DrugBank
DB05076,"Pigments, Biological",DrugBank
DB05076,Polyenes,DrugBank
DB05076,Protective Agents,DrugBank
DB05076,Retinoids,DrugBank
DB05076,Terpenes,DrugBank
DB05077,Agents producing tachycardia,DrugBank
DB05077,Amides,DrugBank
DB05077,Cannabinoid Receptor Antagonists,DrugBank
DB05077,Cannabinoids and similars,DrugBank
DB05077,"Receptor, Cannabinoid, CB1, antagonists & inhibitors",DrugBank
DB05077,Sulfones,DrugBank
DB05077,Sulfur Compounds,DrugBank
DB05084,"Amino Acids, Peptides, and Proteins",DrugBank
DB05084,Analogs/Derivatives,DrugBank
DB05084,Biological Factors,DrugBank
DB05084,Bone Density Conservation Agents,DrugBank
DB05084,Calcium Homeostasis,DrugBank
DB05084,Hormones,DrugBank
DB05084,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05084,Hypotensive Agents,DrugBank
DB05084,Intercellular Signaling Peptides and Proteins,DrugBank
DB05084,Parathyroid Hormone-Related Protein,DrugBank
DB05084,Parathyroid Hormones and Analogues,DrugBank
DB05084,Peptide Hormones,DrugBank
DB05084,Peptides,DrugBank
DB05084,Proteins,DrugBank
DB05084,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB05084,Thyroid Products,DrugBank
DB05087,Anticonvulsants,DrugBank
DB05087,Central Nervous System Depressants,DrugBank
DB05087,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB05087,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05087,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB05087,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05087,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05087,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB05087,Cytochrome P-450 Substrates,DrugBank
DB05087,Fused-Ring Compounds,DrugBank
DB05087,GABA Agents,DrugBank
DB05087,GABA Modulators,DrugBank
DB05087,Nervous System,DrugBank
DB05087,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,DrugBank
DB05087,Neurotransmitter Agents,DrugBank
DB05087,Pregnanes,DrugBank
DB05087,Steroids,DrugBank
DB05088,"Adenosine Triphosphatases, antagonists & inhibitors",DrugBank
DB05088,Angiogenesis Modulating Agents,DrugBank
DB05088,Antineoplastic Agents,DrugBank
DB05088,Chelating Agents,DrugBank
DB05088,"Compounds used in a research, industrial, or household setting",DrugBank
DB05088,Elements,DrugBank
DB05088,Enzyme Inhibitors,DrugBank
DB05088,Growth Inhibitors,DrugBank
DB05088,Growth Substances,DrugBank
DB05088,Metals,DrugBank
DB05088,"Metals, Heavy",DrugBank
DB05088,Sequestering Agents,DrugBank
DB05088,Transition Elements,DrugBank
DB05095,Agents causing hyperkalemia,DrugBank
DB05095,Agents that produce hypertension,DrugBank
DB05095,Amides,DrugBank
DB05095,Anti-Inflammatory Agents,DrugBank
DB05095,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB05095,Nephrotoxic agents,DrugBank
DB05095,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB05095,Sulfones,DrugBank
DB05095,Sulfur Compounds,DrugBank
DB05097,"Amino Acids, Peptides, and Proteins",DrugBank
DB05097,Antibodies,DrugBank
DB05097,"Antibodies, Monoclonal",DrugBank
DB05097,"Antibodies, Monoclonal, Humanized",DrugBank
DB05097,Antineoplastic Agents,DrugBank
DB05097,"Antineoplastic Agents, Immunological",DrugBank
DB05097,Blood Proteins,DrugBank
DB05097,Globulins,DrugBank
DB05097,Immunoglobulins,DrugBank
DB05097,Immunoproteins,DrugBank
DB05097,Proteins,DrugBank
DB05097,Serum Globulins,DrugBank
DB05099,Anticoagulants,DrugBank
DB05099,Biological Factors,DrugBank
DB05099,Blood and Blood Forming Organs,DrugBank
DB05099,Cardiovascular Agents,DrugBank
DB05099,Complex Mixtures,DrugBank
DB05099,Crotalid Venoms,DrugBank
DB05099,Endopeptidases,DrugBank
DB05099,Enzymes,DrugBank
DB05099,Enzymes and Coenzymes,DrugBank
DB05099,Fibrin Modulating Agents,DrugBank
DB05099,Fibrinolytic Agents,DrugBank
DB05099,Hematologic Agents,DrugBank
DB05099,Hydrolases,DrugBank
DB05099,Peptide Hydrolases,DrugBank
DB05099,Serine Endopeptidases,DrugBank
DB05099,Serine Proteases,DrugBank
DB05099,Snake Venoms,DrugBank
DB05099,"Toxins, Biological",DrugBank
DB05099,Venombin A,DrugBank
DB05099,Venoms,DrugBank
DB05099,Viper Venoms,DrugBank
DB05101,"Amino Acids, Peptides, and Proteins",DrugBank
DB05101,Antibodies,DrugBank
DB05101,"Antibodies, Monoclonal",DrugBank
DB05101,"Antibodies, Monoclonal, Humanized",DrugBank
DB05101,Blood Proteins,DrugBank
DB05101,Globulins,DrugBank
DB05101,Immunoglobulins,DrugBank
DB05101,Immunoproteins,DrugBank
DB05101,Proteins,DrugBank
DB05101,Serum Globulins,DrugBank
DB05107,17-Ketosteroids,DrugBank
DB05107,Adrenal Cortex Hormones,DrugBank
DB05107,Androstanes,DrugBank
DB05107,Androstanols,DrugBank
DB05107,Fused-Ring Compounds,DrugBank
DB05107,Gonadal Hormones,DrugBank
DB05107,Gonadal Steroid Hormones,DrugBank
DB05107,Hormones,DrugBank
DB05107,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05107,Ketosteroids,DrugBank
DB05107,Steroids,DrugBank
DB05107,Testosterone Congeners,DrugBank
DB05109,Agents Causing Muscle Toxicity,DrugBank
DB05109,Alkylating Activity,DrugBank
DB05109,Alkylating Drugs,DrugBank
DB05109,Antineoplastic Agents,DrugBank
DB05109,"Antineoplastic Agents, Alkylating",DrugBank
DB05109,Antineoplastic and Immunomodulating Agents,DrugBank
DB05109,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05109,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB05109,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB05109,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB05109,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB05109,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB05109,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB05109,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB05109,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05109,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05109,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB05109,Cytochrome P-450 Substrates,DrugBank
DB05109,Dioxoles,DrugBank
DB05109,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05109,Immunosuppressive Agents,DrugBank
DB05109,Isoquinolines,DrugBank
DB05109,Myelosuppressive Agents,DrugBank
DB05109,Narrow Therapeutic Index Drugs,DrugBank
DB05109,Noxae,DrugBank
DB05109,Tetrahydroisoquinolines,DrugBank
DB05109,Toxic Actions,DrugBank
DB05111,"Amino Acids, Peptides, and Proteins",DrugBank
DB05111,Antibodies,DrugBank
DB05111,"Antibodies, Monoclonal",DrugBank
DB05111,"Antibodies, Monoclonal, Humanized",DrugBank
DB05111,Blood Proteins,DrugBank
DB05111,Globulins,DrugBank
DB05111,Immunoglobulins,DrugBank
DB05111,Immunoproteins,DrugBank
DB05111,Proteins,DrugBank
DB05111,Serum Globulins,DrugBank
DB05115,"Amino Acids, Peptides, and Proteins",DrugBank
DB05115,Blood Glucose Lowering Agents,DrugBank
DB05115,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB05115,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB05115,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05115,Hormones,DrugBank
DB05115,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05115,Insulin,DrugBank
DB05115,"Insulin, Long-Acting",DrugBank
DB05115,Pancreatic Hormones,DrugBank
DB05115,Peptide Hormones,DrugBank
DB05115,Peptides,DrugBank
DB05129,"Antibiotics, Antineoplastic",DrugBank
DB05129,Antineoplastic Agents,DrugBank
DB05129,Carbohydrates,DrugBank
DB05129,Glycosides,DrugBank
DB05136,"Amino Acids, Peptides, and Proteins",DrugBank
DB05136,Antibodies,DrugBank
DB05136,Antineoplastic Agents,DrugBank
DB05136,"Antineoplastic Agents, Immunological",DrugBank
DB05136,Blood Proteins,DrugBank
DB05136,Globulins,DrugBank
DB05136,Immunoglobulins,DrugBank
DB05136,Immunoproteins,DrugBank
DB05136,Proteins,DrugBank
DB05136,Serum Globulins,DrugBank
DB05137,Alkaloids,DrugBank
DB05137,Autonomic Agents,DrugBank
DB05137,Cholinergic Agents,DrugBank
DB05137,Cholinergic Agonists,DrugBank
DB05137,Ganglionic Stimulants,DrugBank
DB05137,Neurotransmitter Agents,DrugBank
DB05137,Nicotinic Agonists,DrugBank
DB05137,Peripheral Nervous System Agents,DrugBank
DB05137,Piperidines,DrugBank
DB05137,Respiratory System Agents,DrugBank
DB05139,"Amino Acids, Peptides, and Proteins",DrugBank
DB05139,Antibodies,DrugBank
DB05139,"Antibodies, Monoclonal",DrugBank
DB05139,Blood Proteins,DrugBank
DB05139,Globulins,DrugBank
DB05139,Immunoglobulins,DrugBank
DB05139,Immunoproteins,DrugBank
DB05139,Proteins,DrugBank
DB05139,Serum Globulins,DrugBank
DB05143,Acids,DrugBank
DB05143,"Acids, Noncarboxylic",DrugBank
DB05143,Anions,DrugBank
DB05143,Benzene Derivatives,DrugBank
DB05143,Benzylidene Compounds,DrugBank
DB05143,Electrolytes,DrugBank
DB05143,Ions,DrugBank
DB05143,Phosphate salts,DrugBank
DB05143,Phosphoric Acids,DrugBank
DB05143,Phosphorus Acids,DrugBank
DB05143,Phosphorus Compounds,DrugBank
DB05143,Polyphosphates,DrugBank
DB05144,Vaccines,DrugBank
DB05152,Cholinergic Agents,DrugBank
DB05152,Cholinergic Agonists,DrugBank
DB05152,Muscarinic Agonists,DrugBank
DB05152,Neurotransmitter Agents,DrugBank
DB05152,Sulfur Compounds,DrugBank
DB05154,Antiinfectives for Systemic Use,DrugBank
DB05154,Antimycobacterials,DrugBank
DB05154,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05154,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05154,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB05154,Cytochrome P-450 Substrates,DrugBank
DB05154,Drugs for Treatment of Tuberculosis,DrugBank
DB05154,Imidazoles,DrugBank
DB05154,Nitro Compounds,DrugBank
DB05154,OAT3/SLC22A8 Inhibitors,DrugBank
DB05168,Alkaloids,DrugBank
DB05168,Antineoplastic Agents,DrugBank
DB05168,Antineoplastic and Immunomodulating Agents,DrugBank
DB05168,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05168,Indole Alkaloids,DrugBank
DB05168,Indoles,DrugBank
DB05168,Indolizidines,DrugBank
DB05168,Indolizines,DrugBank
DB05168,Pteridines,DrugBank
DB05168,Pterins,DrugBank
DB05168,Secologanin Tryptamine Alkaloids,DrugBank
DB05168,Vinca Alkaloids,DrugBank
DB05187,"Acids, Acyclic",DrugBank
DB05187,Alimentary Tract and Metabolism,DrugBank
DB05187,BCRP/ABCG2 Inhibitors,DrugBank
DB05187,BCRP/ABCG2 Substrates,DrugBank
DB05187,Benzopyrans,DrugBank
DB05187,Bile and Liver Therapy,DrugBank
DB05187,Bile Therapy,DrugBank
DB05187,BSEP/ABCB11 Inhibitors,DrugBank
DB05187,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB05187,Cytochrome P-450 CYP3A Inducers,DrugBank
DB05187,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB05187,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB05187,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05187,Cytochrome P-450 Substrates,DrugBank
DB05187,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05187,Ketones,DrugBank
DB05187,Peroxisome Proliferator-activated Receptor Agonist,DrugBank
DB05187,"PPAR alpha, agonists",DrugBank
DB05187,"PPAR delta, agonists",DrugBank
DB05187,Propiophenones,DrugBank
DB05187,Pyrans,DrugBank
DB05187,UGT1A3 substrates,DrugBank
DB05187,UGT1A4 substrates,DrugBank
DB05187,UGT1A6 Inhibitors,DrugBank
DB05187,UGT2B7 substrates,DrugBank
DB05202,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB05202,Nucleotides,DrugBank
DB05202,Oligonucleotides,DrugBank
DB05202,Pegylated agents,DrugBank
DB05202,Polynucleotides,DrugBank
DB05209,"Amino Acids, Peptides, and Proteins",DrugBank
DB05209,Antibodies,DrugBank
DB05209,Blood Proteins,DrugBank
DB05209,Globulins,DrugBank
DB05209,Immunoglobulin Isotypes,DrugBank
DB05209,Immunoglobulins,DrugBank
DB05209,Immunoproteins,DrugBank
DB05209,Proteins,DrugBank
DB05209,Serum Globulins,DrugBank
DB05212,17-Ketosteroids,DrugBank
DB05212,Adrenal Cortex Hormones,DrugBank
DB05212,Androstanes,DrugBank
DB05212,Androstenes,DrugBank
DB05212,Androstenols,DrugBank
DB05212,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05212,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05212,Cytochrome P-450 Substrates,DrugBank
DB05212,Fused-Ring Compounds,DrugBank
DB05212,Gonadal Hormones,DrugBank
DB05212,Gonadal Steroid Hormones,DrugBank
DB05212,Hormones,DrugBank
DB05212,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05212,Ketosteroids,DrugBank
DB05212,Steroids,DrugBank
DB05223,Antineoplastic Agents,DrugBank
DB05223,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05223,Histone Deacetylase Inhibitors,DrugBank
DB05223,Moderate Risk QTc-Prolonging Agents,DrugBank
DB05223,QTc Prolonging Agents,DrugBank
DB05227,"Acids, Carbocyclic",DrugBank
DB05227,Amides,DrugBank
DB05227,Antidepressive Agents,DrugBank
DB05227,Benzene Derivatives,DrugBank
DB05227,Benzoates,DrugBank
DB05227,Central Nervous System Depressants,DrugBank
DB05227,Neurotransmitter Agents,DrugBank
DB05227,Oxazines,DrugBank
DB05227,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB05227,Serotonin Agents,DrugBank
DB05227,Serotonin Receptor Antagonists,DrugBank
DB05229,Anticoagulants,DrugBank
DB05229,Antiplatelet agents,DrugBank
DB05229,Autacoids,DrugBank
DB05229,Biological Factors,DrugBank
DB05229,Blood and Blood Forming Organs,DrugBank
DB05229,Cardiovascular Agents,DrugBank
DB05229,Cryoprotective Agents,DrugBank
DB05229,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB05229,Cytochrome P-450 Substrates,DrugBank
DB05229,Eicosanoids,DrugBank
DB05229,Fatty Acids,DrugBank
DB05229,"Fatty Acids, Unsaturated",DrugBank
DB05229,Hematologic Agents,DrugBank
DB05229,Inflammation Mediators,DrugBank
DB05229,Lipids,DrugBank
DB05229,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB05229,Prostacyclin Analogues,DrugBank
DB05229,Prostaglandins,DrugBank
DB05229,Prostaglandins I,DrugBank
DB05229,Vasodilating Agents,DrugBank
DB05232,Anesthetics,DrugBank
DB05232,"Anesthetics, Local",DrugBank
DB05232,Biological Factors,DrugBank
DB05232,Cardiovascular Agents,DrugBank
DB05232,Central Nervous System Agents,DrugBank
DB05232,Central Nervous System Depressants,DrugBank
DB05232,"Compounds used in a research, industrial, or household setting",DrugBank
DB05232,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05232,Marine Toxins,DrugBank
DB05232,Membrane Transport Modulators,DrugBank
DB05232,Noxae,DrugBank
DB05232,Peripheral Nervous System Agents,DrugBank
DB05232,Poisons,DrugBank
DB05232,Quinazolines,DrugBank
DB05232,Sensory System Agents,DrugBank
DB05232,Sodium Channel Blockers,DrugBank
DB05232,Toxic Actions,DrugBank
DB05232,"Toxins, Biological",DrugBank
DB05239,Antineoplastic Agents,DrugBank
DB05239,Antineoplastic and Immunomodulating Agents,DrugBank
DB05239,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB05239,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB05239,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05239,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05239,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05239,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05239,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05239,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB05239,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB05239,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05239,Cytochrome P-450 Substrates,DrugBank
DB05239,Drugs causing inadvertant photosensitivity,DrugBank
DB05239,Kinase Inhibitor,DrugBank
DB05239,"MAP Kinase Kinase 1, antagonists & inhibitors",DrugBank
DB05239,Mitogen-activated protein kinase (MEK) inhibitors,DrugBank
DB05239,Narrow Therapeutic Index Drugs,DrugBank
DB05239,OATP1B3 inhibitors,DrugBank
DB05239,P-glycoprotein substrates,DrugBank
DB05239,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB05239,Photosensitizing Agents,DrugBank
DB05239,Protein Kinase Inhibitors,DrugBank
DB05239,UGT2B7 substrates,DrugBank
DB05239,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB05245,Amides,DrugBank
DB05245,Amines,DrugBank
DB05245,Aniline Compounds,DrugBank
DB05245,Anti-Bacterial Agents,DrugBank
DB05245,Anti-Infective Agents,DrugBank
DB05245,"Anti-Infective Agents, Local",DrugBank
DB05245,Benzene Derivatives,DrugBank
DB05245,Benzenesulfonamides,DrugBank
DB05245,Dermatologicals,DrugBank
DB05245,Genito Urinary System and Sex Hormones,DrugBank
DB05245,Gynecological Antiinfectives and Antiseptics,DrugBank
DB05245,Miscellaneous Local Anti-infectives,DrugBank
DB05245,Sulfanilamides,DrugBank
DB05245,Sulfonamide Antibacterial,DrugBank
DB05245,Sulfonamides,DrugBank
DB05245,Sulfones,DrugBank
DB05245,Sulfur Compounds,DrugBank
DB05246,Agents causing hyperkalemia,DrugBank
DB05246,Anti-epileptic Agent,DrugBank
DB05246,Antiarrhythmic agents,DrugBank
DB05246,Anticonvulsants,DrugBank
DB05246,Bradycardia-Causing Agents,DrugBank
DB05246,Calcium Channel Blockers,DrugBank
DB05246,Central Nervous System Agents,DrugBank
DB05246,Central Nervous System Depressants,DrugBank
DB05246,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05246,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB05246,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05246,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05246,Cytochrome P-450 Substrates,DrugBank
DB05246,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB05246,Imides,DrugBank
DB05246,Nervous System,DrugBank
DB05246,Potential QTc-Prolonging Agents,DrugBank
DB05246,Pyrrolidines,DrugBank
DB05246,Pyrrolidinones,DrugBank
DB05246,QTc Prolonging Agents,DrugBank
DB05246,Succinimide Derivatives,DrugBank
DB05254,Anticoagulants,DrugBank
DB05254,Blood and Blood Forming Organs,DrugBank
DB05254,Cardiovascular Agents,DrugBank
DB05254,Endopeptidases,DrugBank
DB05254,Enzymes,DrugBank
DB05254,Enzymes and Coenzymes,DrugBank
DB05254,Fibrin Modulating Agents,DrugBank
DB05254,"Fibrinolysin, antagonists & inhibitors",DrugBank
DB05254,Fibrinolytic Agents,DrugBank
DB05254,Hematologic Agents,DrugBank
DB05254,Hydrolases,DrugBank
DB05254,Peptide Hydrolases,DrugBank
DB05254,Serine Endopeptidases,DrugBank
DB05254,Serine Proteases,DrugBank
DB05258,"Amino Acids, Peptides, and Proteins",DrugBank
DB05258,Anti-Infective Agents,DrugBank
DB05258,Antiviral Agents,DrugBank
DB05258,Biological Factors,DrugBank
DB05258,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05258,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB05258,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05258,Cytokines,DrugBank
DB05258,Immunologic Factors,DrugBank
DB05258,Immunosuppressive Agents,DrugBank
DB05258,Intercellular Signaling Peptides and Proteins,DrugBank
DB05258,Interferon Type I,DrugBank
DB05258,Interferon-alpha,DrugBank
DB05258,Interferons,DrugBank
DB05258,Myelosuppressive Agents,DrugBank
DB05258,Peptides,DrugBank
DB05258,Proteins,DrugBank
DB05259,"Adjuvants, Immunologic",DrugBank
DB05259,"Amino Acids, Peptides, and Proteins",DrugBank
DB05259,Antineoplastic and Immunomodulating Agents,DrugBank
DB05259,Immunologic Factors,DrugBank
DB05259,Immunomodulatory Agents,DrugBank
DB05259,Immunosuppressive Agents,DrugBank
DB05259,Peptides,DrugBank
DB05259,Proteins,DrugBank
DB05265,Anti-Infective Agents,DrugBank
DB05265,Anti-Ulcer Agents,DrugBank
DB05265,Anticarcinogenic Agents,DrugBank
DB05265,Antineoplastic Agents,DrugBank
DB05265,"Compounds used in a research, industrial, or household setting",DrugBank
DB05265,Diterpenes,DrugBank
DB05265,Enzyme Inhibitors,DrugBank
DB05265,Gastrointestinal Agents,DrugBank
DB05265,"Pepsin A, antagonists & inhibitors",DrugBank
DB05265,Phenanthrenes,DrugBank
DB05265,Protease Inhibitors,DrugBank
DB05265,Protective Agents,DrugBank
DB05265,Terpenes,DrugBank
DB05266,Anti-Asthmatic Agents,DrugBank
DB05266,Antiplatelet agents,DrugBank
DB05266,Autonomic Agents,DrugBank
DB05266,Bronchodilator Agents,DrugBank
DB05266,Cardiovascular Agents,DrugBank
DB05266,Drugs for Obstructive Airway Diseases,DrugBank
DB05266,Enzyme Inhibitors,DrugBank
DB05266,Hematologic Agents,DrugBank
DB05266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05266,Leukotriene Antagonists,DrugBank
DB05266,Peripheral Nervous System Agents,DrugBank
DB05266,Phosphodiesterase 5 Inhibitors,DrugBank
DB05266,Phosphodiesterase Inhibitors,DrugBank
DB05266,Respiratory System Agents,DrugBank
DB05266,Vasodilating Agents,DrugBank
DB05271,Agents that produce hypertension,DrugBank
DB05271,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB05271,Anti-Parkinson Drugs,DrugBank
DB05271,Antidepressive Agents,DrugBank
DB05271,Central Nervous System Depressants,DrugBank
DB05271,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05271,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB05271,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB05271,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB05271,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB05271,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05271,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05271,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05271,Cytochrome P-450 Substrates,DrugBank
DB05271,Dopamine Agents,DrugBank
DB05271,Dopamine Agonists,DrugBank
DB05271,Hypotensive Agents,DrugBank
DB05271,Naphthalenes,DrugBank
DB05271,Nervous System,DrugBank
DB05271,Neurotransmitter Agents,DrugBank
DB05271,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB05271,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB05271,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB05271,Serotonin Agents,DrugBank
DB05271,Serotonin Receptor Agonists,DrugBank
DB05271,Sulfur Compounds,DrugBank
DB05276,"Amino Acids, Peptides, and Proteins",DrugBank
DB05276,Antiinfectives for Systemic Use,DrugBank
DB05276,Blood Proteins,DrugBank
DB05276,Globulins,DrugBank
DB05276,Human Immunoglobulin,DrugBank
DB05276,Immune Sera and Immunoglobulins,DrugBank
DB05276,"Immunization, Passive",DrugBank
DB05276,Immunoglobulins,DrugBank
DB05276,Immunoproteins,DrugBank
DB05276,Passively Acquired Immunity,DrugBank
DB05276,Proteins,DrugBank
DB05276,Serum,DrugBank
DB05276,Serum Globulins,DrugBank
DB05276,Specific Immunoglobulins,DrugBank
DB05276,Virus Neutralization,DrugBank
DB05294,Antineoplastic Agents,DrugBank
DB05294,Antineoplastic and Immunomodulating Agents,DrugBank
DB05294,BCRP/ABCG2 Inhibitors,DrugBank
DB05294,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05294,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05294,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB05294,Cytochrome P-450 Substrates,DrugBank
DB05294,Drugs causing inadvertant photosensitivity,DrugBank
DB05294,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05294,Highest Risk QTc-Prolonging Agents,DrugBank
DB05294,Kinase Inhibitor,DrugBank
DB05294,Narrow Therapeutic Index Drugs,DrugBank
DB05294,OCT2 Inhibitors,DrugBank
DB05294,P-glycoprotein inhibitors,DrugBank
DB05294,Photosensitizing Agents,DrugBank
DB05294,Protein Kinase Inhibitors,DrugBank
DB05294,QTc Prolonging Agents,DrugBank
DB05294,Tyrosine Kinase Inhibitors,DrugBank
DB05295,Bone Density Conservation Agents,DrugBank
DB05295,Fused-Ring Compounds,DrugBank
DB05295,Secosteroids,DrugBank
DB05295,Steroids,DrugBank
DB05295,Vitamin D and Analogues,DrugBank
DB05295,Vitamins,DrugBank
DB05295,Vitamins (Fat Soluble),DrugBank
DB05304,"Amino Acids, Peptides, and Proteins",DrugBank
DB05304,Antibodies,DrugBank
DB05304,Blood Proteins,DrugBank
DB05304,Globulins,DrugBank
DB05304,Immunoglobulins,DrugBank
DB05304,Immunoproteins,DrugBank
DB05304,Proteins,DrugBank
DB05304,Serum Globulins,DrugBank
DB05306,Antianginal Agents,DrugBank
DB05306,Vasodilating Agents,DrugBank
DB05316,Amides,DrugBank
DB05316,Antidepressive Agents,DrugBank
DB05316,Central Nervous System Agents,DrugBank
DB05316,Central Nervous System Depressants,DrugBank
DB05316,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB05316,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05316,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05316,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB05316,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB05316,Cytochrome P-450 Substrates,DrugBank
DB05316,Nervous System,DrugBank
DB05316,Neurotoxic agents,DrugBank
DB05316,Neurotransmitter Agents,DrugBank
DB05316,Psycholeptics,DrugBank
DB05316,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB05316,Serotonin Agents,DrugBank
DB05316,Serotonin Receptor Antagonists,DrugBank
DB05321,Alcohols,DrugBank
DB05321,"Compounds used in a research, industrial, or household setting",DrugBank
DB05321,Enzymes,DrugBank
DB05321,Enzymes and Coenzymes,DrugBank
DB05321,"Enzymes, Immobilized",DrugBank
DB05321,Ethylene Glycols,DrugBank
DB05321,Glycols,DrugBank
DB05321,Macromolecular Substances,DrugBank
DB05321,Oxidoreductases,DrugBank
DB05321,Pegylated agents,DrugBank
DB05321,Polymers,DrugBank
DB05325,Biological Products,DrugBank
DB05325,Complex Mixtures,DrugBank
DB05325,Vaccines,DrugBank
DB05332,"Amino Acids, Peptides, and Proteins",DrugBank
DB05332,Biological Factors,DrugBank
DB05332,Blood and Blood Forming Organs,DrugBank
DB05332,Carbohydrates,DrugBank
DB05332,Colony-Stimulating Factors,DrugBank
DB05332,Cytokines,DrugBank
DB05332,Glycoconjugates,DrugBank
DB05332,Glycoproteins,DrugBank
DB05332,Hematopoietic Cell Growth Factors,DrugBank
DB05332,Hemostatics,DrugBank
DB05332,Increased Megakaryocyte Maturation,DrugBank
DB05332,Increased Platelet Production,DrugBank
DB05332,Intercellular Signaling Peptides and Proteins,DrugBank
DB05332,Membrane Proteins,DrugBank
DB05332,Peptides,DrugBank
DB05332,Proteins,DrugBank
DB05332,"Receptors, Thrombopoietin, agonists",DrugBank
DB05332,Recombinant Proteins,DrugBank
DB05332,Thrombopoietin Receptor Agonist,DrugBank
DB05332,Thrombopoietin Receptor Agonists,DrugBank
DB05336,"Amino Acids, Peptides, and Proteins",DrugBank
DB05336,Anthrax Protective Antigen-directed Antibody,DrugBank
DB05336,Anthrax Protective Antigen-directed Antibody Interactions,DrugBank
DB05336,Antibacterial monoclonal antibodies,DrugBank
DB05336,Antibodies,DrugBank
DB05336,Antiinfectives for Systemic Use,DrugBank
DB05336,Biological Products,DrugBank
DB05336,Blood Proteins,DrugBank
DB05336,Body Fluids,DrugBank
DB05336,Complex Mixtures,DrugBank
DB05336,Globulins,DrugBank
DB05336,Immune Sera,DrugBank
DB05336,Immune Sera and Immunoglobulins,DrugBank
DB05336,Immunoglobulins,DrugBank
DB05336,Immunoproteins,DrugBank
DB05336,Proteins,DrugBank
DB05336,Serum Globulins,DrugBank
DB05336,Specific Immunoglobulins,DrugBank
DB05351,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB05351,Acid Reducers,DrugBank
DB05351,Alimentary Tract and Metabolism,DrugBank
DB05351,Anti-Ulcer Agents,DrugBank
DB05351,Benzimidazoles,DrugBank
DB05351,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05351,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB05351,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05351,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05351,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05351,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05351,Cytochrome P-450 Substrates,DrugBank
DB05351,Drugs for Acid Related Disorders,DrugBank
DB05351,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB05351,Enzyme Inhibitors,DrugBank
DB05351,Gastric Acid Lowering Agents,DrugBank
DB05351,Gastrointestinal Agents,DrugBank
DB05351,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05351,Proton Pump Inhibitors,DrugBank
DB05351,Proton-pump Inhibitors,DrugBank
DB05351,Pyridines,DrugBank
DB05351,Sulfoxides,DrugBank
DB05351,Sulfur Compounds,DrugBank
DB05361,Anticoagulants,DrugBank
DB05361,Carbohydrates,DrugBank
DB05361,Heparin and similars,DrugBank
DB05374,Antineoplastic Agents,DrugBank
DB05374,"Antineoplastic Agents, Immunological",DrugBank
DB05374,Biological Products,DrugBank
DB05374,Complex Mixtures,DrugBank
DB05374,Vaccines,DrugBank
DB05381,"Adjuvants, Immunologic",DrugBank
DB05381,Amines,DrugBank
DB05381,Antineoplastic and Immunomodulating Agents,DrugBank
DB05381,Autacoids,DrugBank
DB05381,Biogenic Amines,DrugBank
DB05381,Biogenic Monoamines,DrugBank
DB05381,Biological Factors,DrugBank
DB05381,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05381,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05381,Diagnostic Agents,DrugBank
DB05381,Ethylamines,DrugBank
DB05381,Gastric Function,DrugBank
DB05381,Histamine Agents,DrugBank
DB05381,Histamine Agonists,DrugBank
DB05381,Imidazoles,DrugBank
DB05381,Inflammation Mediators,DrugBank
DB05381,Neurotransmitter Agents,DrugBank
DB05381,OCT1 substrates,DrugBank
DB05381,OCT2 Inhibitors,DrugBank
DB05381,OCT2 Substrates,DrugBank
DB05381,Other Diagnostics,DrugBank
DB05381,Tests for Gastric Secretion,DrugBank
DB05383,Amidines,DrugBank
DB05383,Enzyme Inhibitors,DrugBank
DB05383,"Nitric Oxide Synthase, antagonists & inhibitors",DrugBank
DB05383,OCT2 Inhibitors,DrugBank
DB05386,"Amino Acids, Peptides, and Proteins",DrugBank
DB05386,Biological Factors,DrugBank
DB05386,Carbohydrates,DrugBank
DB05386,Cholinesterase Inhibitors,DrugBank
DB05386,Colony-Stimulating Factors,DrugBank
DB05386,Cytokines,DrugBank
DB05386,Glycoconjugates,DrugBank
DB05386,Glycoproteins,DrugBank
DB05386,Granulocyte-Macrophage Colony-Stimulating Factor,DrugBank
DB05386,Hematopoietic Cell Growth Factors,DrugBank
DB05386,Intercellular Signaling Peptides and Proteins,DrugBank
DB05386,Peptides,DrugBank
DB05386,Proteins,DrugBank
DB05395,"Acids, Acyclic",DrugBank
DB05395,Adrenergic Agents,DrugBank
DB05395,Adrenergic Agonists,DrugBank
DB05395,Adrenergic beta-3 Receptor Agonists,DrugBank
DB05395,Adrenergic beta-Agonists,DrugBank
DB05395,Agents producing tachycardia,DrugBank
DB05395,Agents that produce hypertension,DrugBank
DB05395,Antidepressive Agents,DrugBank
DB05395,Central Nervous System Depressants,DrugBank
DB05395,Fatty Acids,DrugBank
DB05395,"Fatty Acids, Volatile",DrugBank
DB05395,Lipids,DrugBank
DB05395,Naphthalenes,DrugBank
DB05395,Neurotransmitter Agents,DrugBank
DB05396,"Adjuvants, Immunologic",DrugBank
DB05396,"Amino Acids, Peptides, and Proteins",DrugBank
DB05396,Antineoplastic and Immunomodulating Agents,DrugBank
DB05396,Biological Factors,DrugBank
DB05396,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05396,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB05396,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05396,Cytokines,DrugBank
DB05396,Intercellular Signaling Peptides and Proteins,DrugBank
DB05396,Interferon Type I,DrugBank
DB05396,Interferons,DrugBank
DB05396,Peptides,DrugBank
DB05396,Proteins,DrugBank
DB05405,"Amino Acids, Peptides, and Proteins",DrugBank
DB05405,Antibodies,DrugBank
DB05405,Blood Proteins,DrugBank
DB05405,Globulins,DrugBank
DB05405,Immunoglobulins,DrugBank
DB05405,Immunoproteins,DrugBank
DB05405,Proteins,DrugBank
DB05405,Serum Globulins,DrugBank
DB05424,"Acids, Acyclic",DrugBank
DB05424,Anesthetics,DrugBank
DB05424,Antineoplastic Agents,DrugBank
DB05424,Cardiotonic Agents,DrugBank
DB05424,Cardiovascular Agents,DrugBank
DB05424,Central Nervous System Agents,DrugBank
DB05424,Central Nervous System Depressants,DrugBank
DB05424,"Compounds used in a research, industrial, or household setting",DrugBank
DB05424,Oxazines,DrugBank
DB05424,Peripheral Nervous System Agents,DrugBank
DB05424,Protective Agents,DrugBank
DB05424,Sensory System Agents,DrugBank
DB05424,Tyrosine Kinase Inhibitors,DrugBank
DB05426,"Amino Acids, Peptides, and Proteins",DrugBank
DB05426,"Animal Proteins, Dietary",DrugBank
DB05426,Antineoplastic Agents,DrugBank
DB05426,Carbohydrates,DrugBank
DB05426,Carrier Proteins,DrugBank
DB05426,Dietary Proteins,DrugBank
DB05426,Endopeptidases,DrugBank
DB05426,Enzymes,DrugBank
DB05426,Enzymes and Coenzymes,DrugBank
DB05426,Globulins,DrugBank
DB05426,Glycoconjugates,DrugBank
DB05426,Glycoproteins,DrugBank
DB05426,Hydrolases,DrugBank
DB05426,Iron-Binding Proteins,DrugBank
DB05426,Lactoglobulins,DrugBank
DB05426,Metalloproteins,DrugBank
DB05426,Milk Proteins,DrugBank
DB05426,Peptide Hydrolases,DrugBank
DB05426,Proteins,DrugBank
DB05426,Recombinant Proteins,DrugBank
DB05426,Serine Endopeptidases,DrugBank
DB05426,Serine Proteases,DrugBank
DB05426,Transferrins,DrugBank
DB05426,Whey Proteins,DrugBank
DB05428,Antineoplastic Agents,DrugBank
DB05428,Biological Factors,DrugBank
DB05428,"Compounds used in a research, industrial, or household setting",DrugBank
DB05428,Contrast Media,DrugBank
DB05428,Coordination Complexes,DrugBank
DB05428,Dermatologicals,DrugBank
DB05428,Diagnostic Uses of Chemicals,DrugBank
DB05428,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05428,Photosensitizing Agents,DrugBank
DB05428,"Pigments, Biological",DrugBank
DB05428,Porphyrins,DrugBank
DB05428,Radiation-Sensitizing Agents,DrugBank
DB05437,"Amino Acids, Peptides, and Proteins",DrugBank
DB05437,Antibodies,DrugBank
DB05437,Blood Proteins,DrugBank
DB05437,Globulins,DrugBank
DB05437,Immunoglobulins,DrugBank
DB05437,Immunoproteins,DrugBank
DB05437,Proteins,DrugBank
DB05437,Serum Globulins,DrugBank
DB05440,Biological Products,DrugBank
DB05440,Complex Mixtures,DrugBank
DB05440,Vaccines,DrugBank
DB05459,"Amino Acids, Peptides, and Proteins",DrugBank
DB05459,Antibodies,DrugBank
DB05459,"Antibodies, Monoclonal",DrugBank
DB05459,Antineoplastic and Immunomodulating Agents,DrugBank
DB05459,Blood Proteins,DrugBank
DB05459,Globulins,DrugBank
DB05459,Immunoglobulins,DrugBank
DB05459,Immunoproteins,DrugBank
DB05459,Immunosuppressive Agents,DrugBank
DB05459,Interleukin Inhibitors,DrugBank
DB05459,Proteins,DrugBank
DB05459,Serum Globulins,DrugBank
DB05465,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05465,Potential QTc-Prolonging Agents,DrugBank
DB05465,QTc Prolonging Agents,DrugBank
DB05465,Tyrosine Kinase Inhibitors,DrugBank
DB05467,BCRP/ABCG2 Inhibitors,DrugBank
DB05467,Benzene Derivatives,DrugBank
DB05467,Benzylidene Compounds,DrugBank
DB05467,BSEP/ABCB11 Inhibitors,DrugBank
DB05467,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB05467,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB05467,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05467,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB05467,Cytochrome P-450 CYP3A Inducers,DrugBank
DB05467,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05467,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB05467,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB05467,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05467,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05467,Cytochrome P-450 Substrates,DrugBank
DB05467,Musculo-Skeletal System,DrugBank
DB05467,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB05467,OATP1B3 inhibitors,DrugBank
DB05467,OCT1 inhibitors,DrugBank
DB05467,Retinoids,DrugBank
DB05472,Immunosuppressive Agents,DrugBank
DB05472,Myelosuppressive Agents,DrugBank
DB05482,Alkaloids,DrugBank
DB05482,Antineoplastic Agents,DrugBank
DB05482,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05482,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05482,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05482,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05482,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05482,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05482,Cytochrome P-450 Substrates,DrugBank
DB05482,Enzyme Inhibitors,DrugBank
DB05482,Topoisomerase I Inhibitors,DrugBank
DB05482,Topoisomerase Inhibitors,DrugBank
DB05488,4-Quinolones,DrugBank
DB05488,Anti-Bacterial Agents,DrugBank
DB05488,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05488,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB05488,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05488,Fluoroquinolones,DrugBank
DB05488,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05488,Moderate Risk QTc-Prolonging Agents,DrugBank
DB05488,Organometallic Compounds,DrugBank
DB05488,QTc Prolonging Agents,DrugBank
DB05488,Quinolines,DrugBank
DB05488,Quinolones,DrugBank
DB05496,"Amino Acids, Peptides, and Proteins",DrugBank
DB05496,Antibodies,DrugBank
DB05496,"Antibodies, Monoclonal",DrugBank
DB05496,Blood Proteins,DrugBank
DB05496,Globulins,DrugBank
DB05496,Immunoglobulins,DrugBank
DB05496,Immunoproteins,DrugBank
DB05496,Proteins,DrugBank
DB05496,Serum Globulins,DrugBank
DB05501,"Adjuvants, Immunologic",DrugBank
DB05501,Alkanes,DrugBank
DB05501,Amines,DrugBank
DB05501,Antineoplastic and Immunomodulating Agents,DrugBank
DB05501,Butanes,DrugBank
DB05501,CXC Chemokine Receptor 4 Antagonist,DrugBank
DB05501,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB05501,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05501,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB05501,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05501,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05501,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB05501,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB05501,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB05501,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05501,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05501,Cytochrome P-450 Substrates,DrugBank
DB05501,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05501,"Hydrocarbons, Acyclic",DrugBank
DB05501,MATE 1 Inhibitors,DrugBank
DB05501,MATE inhibitors,DrugBank
DB05501,Moderate Risk QTc-Prolonging Agents,DrugBank
DB05501,OCT2 Inhibitors,DrugBank
DB05501,P-glycoprotein inhibitors,DrugBank
DB05501,P-glycoprotein substrates,DrugBank
DB05501,QTc Prolonging Agents,DrugBank
DB05501,Quinolines,DrugBank
DB05501,"Receptors, CXCR4, antagonists & inhibitors",DrugBank
DB05521,"Amino Acids, Peptides, and Proteins",DrugBank
DB05521,Antiinfectives for Systemic Use,DrugBank
DB05521,Antiviral Agents,DrugBank
DB05521,Antivirals for Systemic Use,DrugBank
DB05521,Antivirals for treatment of HCV infections,DrugBank
DB05521,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05521,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05521,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05521,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB05521,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05521,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB05521,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05521,Cytochrome P-450 Substrates,DrugBank
DB05521,Direct Acting Antivirals,DrugBank
DB05521,Enzyme Inhibitors,DrugBank
DB05521,HCV NS3/4A Protease Inhibitors,DrugBank
DB05521,NS3/4A Protease Inhibitors,DrugBank
DB05521,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB05521,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB05521,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB05521,P-glycoprotein inhibitors,DrugBank
DB05521,P-glycoprotein substrates,DrugBank
DB05521,Peptides,DrugBank
DB05521,Protease Inhibitors,DrugBank
DB05524,Amines,DrugBank
DB05524,Antineoplastic Agents,DrugBank
DB05524,Enzyme Inhibitors,DrugBank
DB05524,"ErbB Receptors, antagonists & inhibitors",DrugBank
DB05524,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05524,Protein Kinase Inhibitors,DrugBank
DB05524,Quinolines,DrugBank
DB05528,Anticholesteremic Agents,DrugBank
DB05528,Antisense Elements (Genetics),DrugBank
DB05528,Antisense Oligonucleotides,DrugBank
DB05528,Apolipoprotein B-100 Synthesis Inhibitor,DrugBank
DB05528,"Compounds used in a research, industrial, or household setting",DrugBank
DB05528,Decreased Protein Synthesis,DrugBank
DB05528,"DNA, Antisense",DrugBank
DB05528,Hepatotoxic Agents,DrugBank
DB05528,Hypolipidemic Agents,DrugBank
DB05528,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB05528,Laboratory Chemicals,DrugBank
DB05528,Lipid Modifying Agents,DrugBank
DB05528,"Lipid Modifying Agents, Plain",DrugBank
DB05528,Lipid Regulating Agents,DrugBank
DB05528,Molecular Probes,DrugBank
DB05528,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB05528,Nucleic Acid Probes,DrugBank
DB05528,Nucleic Acids,DrugBank
DB05528,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB05528,Nucleotides,DrugBank
DB05528,"Oligodeoxyribonucleotides, Antisense",DrugBank
DB05528,Oligonucleotides,DrugBank
DB05528,Polynucleotides,DrugBank
DB05540,Amino Acids,DrugBank
DB05540,"Amino Acids, Peptides, and Proteins",DrugBank
DB05540,"Antibiotics, Antineoplastic",DrugBank
DB05540,Antineoplastic Agents,DrugBank
DB05540,Chelating Agents,DrugBank
DB05540,"Compounds used in a research, industrial, or household setting",DrugBank
DB05540,Sequestering Agents,DrugBank
DB05541,Anticonvulsants,DrugBank
DB05541,Central Nervous System Agents,DrugBank
DB05541,Central Nervous System Depressants,DrugBank
DB05541,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB05541,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB05541,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB05541,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05541,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05541,Cytochrome P-450 Substrates,DrugBank
DB05541,Drugs that are Mainly Renally Excreted,DrugBank
DB05541,Epoxide Hydrolase Inhibitors,DrugBank
DB05541,Miscellaneous Anticonvulsants,DrugBank
DB05541,Nervous System,DrugBank
DB05541,Pyrrolidines,DrugBank
DB05542,"Acids, Carbocyclic",DrugBank
DB05542,Amides,DrugBank
DB05542,Antidepressive Agents,DrugBank
DB05542,Benzene Derivatives,DrugBank
DB05542,Benzoates,DrugBank
DB05542,Central Nervous System Depressants,DrugBank
DB05542,Neurotransmitter Agents,DrugBank
DB05542,Serotonin 5-HT4 Receptor Agonists,DrugBank
DB05542,Serotonin Agents,DrugBank
DB05542,Serotonin Receptor Agonists,DrugBank
DB05545,"Amino Acids, Peptides, and Proteins",DrugBank
DB05545,Antibodies,DrugBank
DB05545,Blood Proteins,DrugBank
DB05545,Globulins,DrugBank
DB05545,Immunoglobulins,DrugBank
DB05545,Immunoproteins,DrugBank
DB05545,Interleukin-1 Receptor Antagonist,DrugBank
DB05545,Proteins,DrugBank
DB05545,"Receptors, Interleukin-1, antagonists & inhibitors",DrugBank
DB05545,Serum Globulins,DrugBank
DB05550,"Amino Acids, Peptides, and Proteins",DrugBank
DB05550,Antibodies,DrugBank
DB05550,Blood Proteins,DrugBank
DB05550,Globulins,DrugBank
DB05550,Immunoglobulins,DrugBank
DB05550,Immunoproteins,DrugBank
DB05550,Proteins,DrugBank
DB05550,Serum Globulins,DrugBank
DB05555,"Amino Acids, Peptides, and Proteins",DrugBank
DB05555,Antibodies,DrugBank
DB05555,"Antibodies, Monoclonal",DrugBank
DB05555,"Antibodies, Monoclonal, Humanized",DrugBank
DB05555,Blood Proteins,DrugBank
DB05555,Globulins,DrugBank
DB05555,Immunoglobulins,DrugBank
DB05555,Immunoproteins,DrugBank
DB05555,Proteins,DrugBank
DB05555,Serum Globulins,DrugBank
DB05562,Agents that produce hypertension,DrugBank
DB05562,Amides,DrugBank
DB05562,Antidepressive Agents,DrugBank
DB05562,Central Nervous System Depressants,DrugBank
DB05562,Neurotransmitter Agents,DrugBank
DB05562,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB05562,Serotonin Agents,DrugBank
DB05562,Serotonin Receptor Agonists,DrugBank
DB05562,Sulfones,DrugBank
DB05562,Sulfur Compounds,DrugBank
DB05578,"Amino Acids, Peptides, and Proteins",DrugBank
DB05578,Angiogenesis Inhibitors,DrugBank
DB05578,Angiogenesis Modulating Agents,DrugBank
DB05578,Antibodies,DrugBank
DB05578,"Antibodies, Monoclonal",DrugBank
DB05578,"Antibodies, Monoclonal, Humanized",DrugBank
DB05578,Antineoplastic Agents,DrugBank
DB05578,Antineoplastic and Immunomodulating Agents,DrugBank
DB05578,Blood Proteins,DrugBank
DB05578,Cancer immunotherapy,DrugBank
DB05578,Globulins,DrugBank
DB05578,Growth Inhibitors,DrugBank
DB05578,Growth Substances,DrugBank
DB05578,Immunoglobulins,DrugBank
DB05578,Immunoproteins,DrugBank
DB05578,Immunotherapy,DrugBank
DB05578,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB05578,Narrow Therapeutic Index Drugs,DrugBank
DB05578,Proteins,DrugBank
DB05578,Serum Globulins,DrugBank
DB05578,Vascular Endothelial Growth Factor Receptor 2 Antagonist,DrugBank
DB05578,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,DrugBank
DB05578,VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors,DrugBank
DB05578,VEGFR2 Inhibitors,DrugBank
DB05595,"Amino Acids, Peptides, and Proteins",DrugBank
DB05595,Antibodies,DrugBank
DB05595,"Antibodies, Monoclonal",DrugBank
DB05595,"Antibodies, Monoclonal, Humanized",DrugBank
DB05595,Antineoplastic Agents,DrugBank
DB05595,Blood Proteins,DrugBank
DB05595,Globulins,DrugBank
DB05595,Immunoglobulins,DrugBank
DB05595,Immunoproteins,DrugBank
DB05595,Proteins,DrugBank
DB05595,Serum Globulins,DrugBank
DB05607,Antidepressive Agents,DrugBank
DB05607,Central Nervous System Depressants,DrugBank
DB05607,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB05607,Serotonin Agents,DrugBank
DB05607,Serotonin Receptor Antagonists,DrugBank
DB05607,Sulfur Compounds,DrugBank
DB05656,"Amino Acids, Peptides, and Proteins",DrugBank
DB05656,Antibodies,DrugBank
DB05656,"Antibodies, Monoclonal",DrugBank
DB05656,"Antibodies, Monoclonal, Humanized",DrugBank
DB05656,Antineoplastic Agents,DrugBank
DB05656,Blood Proteins,DrugBank
DB05656,Globulins,DrugBank
DB05656,Immunoglobulins,DrugBank
DB05656,Immunoproteins,DrugBank
DB05656,Proteins,DrugBank
DB05656,Serum Globulins,DrugBank
DB05667,Adrenal Cortex Hormones,DrugBank
DB05667,Antiadrenal Preparations,DrugBank
DB05667,Anticorticosteroids,DrugBank
DB05667,Antifungal Agents,DrugBank
DB05667,Azole Antifungals,DrugBank
DB05667,Corticosteroids,DrugBank
DB05667,Corticosteroids for Systemic Use,DrugBank
DB05667,Cortisol Synthesis Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB05667,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB05667,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB05667,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB05667,Cytochrome P-450 CYP3A Inducers,DrugBank
DB05667,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05667,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB05667,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB05667,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB05667,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05667,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB05667,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB05667,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB05667,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB05667,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05667,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05667,Cytochrome P-450 Substrates,DrugBank
DB05667,MATE 1 Inhibitors,DrugBank
DB05667,MATE inhibitors,DrugBank
DB05667,OCT2 Inhibitors,DrugBank
DB05667,P-glycoprotein inhibitors,DrugBank
DB05667,QTc Prolonging Agents,DrugBank
DB05667,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB05668,Alkylating Drugs,DrugBank
DB05668,Amino Acids,DrugBank
DB05668,"Amino Acids, Basic",DrugBank
DB05668,"Amino Acids, Diamino",DrugBank
DB05668,"Amino Acids, Peptides, and Proteins",DrugBank
DB05668,Antineoplastic Agents,DrugBank
DB05668,"Antineoplastic Agents, Alkylating",DrugBank
DB05668,"Hydrocarbons, Halogenated",DrugBank
DB05668,Mustard Compounds,DrugBank
DB05668,Nitrogen Mustard Compounds,DrugBank
DB05668,Noxae,DrugBank
DB05668,Organophosphorus Compounds,DrugBank
DB05668,Oxazines,DrugBank
DB05668,Phosphoramide Mustards,DrugBank
DB05668,Phosphoramides,DrugBank
DB05668,Toxic Actions,DrugBank
DB05676,Agents reducing cytokine levels,DrugBank
DB05676,Anti-Inflammatory Agents,DrugBank
DB05676,Antineoplastic and Immunomodulating Agents,DrugBank
DB05676,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB05676,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB05676,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05676,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05676,Cytochrome P-450 Substrates,DrugBank
DB05676,Disease-modifying Antirheumatic Agents,DrugBank
DB05676,Drugs that are Mainly Renally Excreted,DrugBank
DB05676,Enzyme Inhibitors,DrugBank
DB05676,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05676,Immunosuppressive Agents,DrugBank
DB05676,Immunotherapy,DrugBank
DB05676,Isoindoles,DrugBank
DB05676,P-glycoprotein substrates,DrugBank
DB05676,Phosphodiesterase 4 Inhibitors,DrugBank
DB05676,Phosphodiesterase Inhibitors,DrugBank
DB05676,Phthalimides,DrugBank
DB05676,Selective Immunosuppressants,DrugBank
DB05679,"Amino Acids, Peptides, and Proteins",DrugBank
DB05679,Antibodies,DrugBank
DB05679,"Antibodies, Monoclonal",DrugBank
DB05679,"Antibodies, Monoclonal, Humanized",DrugBank
DB05679,Antineoplastic and Immunomodulating Agents,DrugBank
DB05679,Biologics for psoriasis treatment,DrugBank
DB05679,Blood Proteins,DrugBank
DB05679,Dermatologicals,DrugBank
DB05679,Globulins,DrugBank
DB05679,Immunoglobulins,DrugBank
DB05679,Immunomodulatory Agents,DrugBank
DB05679,Immunoproteins,DrugBank
DB05679,Immunosuppressive Agents,DrugBank
DB05679,Interleukin Inhibitors,DrugBank
DB05679,Interleukin-12 Antagonist,DrugBank
DB05679,Interleukin-23 Antagonist,DrugBank
DB05679,Misc. Skin and Mucous Membrane Agents,DrugBank
DB05679,Proteins,DrugBank
DB05679,Serum Globulins,DrugBank
DB05687,"Acids, Acyclic",DrugBank
DB05687,Amino Acids,DrugBank
DB05687,"Amino Acids, Peptides, and Proteins",DrugBank
DB05687,Aminobutyrates,DrugBank
DB05687,Antipsychotic Agents,DrugBank
DB05687,Butyrates,DrugBank
DB05687,Central Nervous System Depressants,DrugBank
DB05687,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05687,Neurotoxic agents,DrugBank
DB05687,Phenothiazines,DrugBank
DB05687,Sulfur Compounds,DrugBank
DB05697,Antineoplastic Agents,DrugBank
DB05697,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB05697,Nucleotides,DrugBank
DB05697,Oligonucleotides,DrugBank
DB05697,Polynucleotides,DrugBank
DB05697,Sulfur Compounds,DrugBank
DB05708,Benzene Derivatives,DrugBank
DB05708,Cholinergic Agents,DrugBank
DB05708,Cholinergic Agonists,DrugBank
DB05708,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB05708,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB05708,Cytochrome P-450 Substrates,DrugBank
DB05708,Neurotransmitter Agents,DrugBank
DB05708,Nicotinic Agonists,DrugBank
DB05710,Anticholinergic Agents,DrugBank
DB05710,Central Nervous System Depressants,DrugBank
DB05710,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05710,Muscle Relaxants,DrugBank
DB05710,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB05710,Nicotinic Antagonists,DrugBank
DB05718,Alcohols,DrugBank
DB05718,"Amino Acids, Peptides, and Proteins",DrugBank
DB05718,Biological Factors,DrugBank
DB05718,Carbohydrates,DrugBank
DB05718,Colony-Stimulating Factors,DrugBank
DB05718,"Compounds used in a research, industrial, or household setting",DrugBank
DB05718,Cytokines,DrugBank
DB05718,Ethylene Glycols,DrugBank
DB05718,Glycoconjugates,DrugBank
DB05718,Glycols,DrugBank
DB05718,Glycoproteins,DrugBank
DB05718,Hematopoietic Cell Growth Factors,DrugBank
DB05718,Intercellular Signaling Peptides and Proteins,DrugBank
DB05718,Macromolecular Substances,DrugBank
DB05718,Peptides,DrugBank
DB05718,Polymers,DrugBank
DB05718,Proteins,DrugBank
DB05718,Recombinant Proteins,DrugBank
DB05767,Acanthaceae,DrugBank
DB05767,Analgesics,DrugBank
DB05767,"Analgesics, Non-Narcotic",DrugBank
DB05767,Andrographis,DrugBank
DB05767,Angiosperms,DrugBank
DB05767,Anti-Infective Agents,DrugBank
DB05767,Anti-Inflammatory Agents,DrugBank
DB05767,Antiparasitic Agents,DrugBank
DB05767,Antiplatelet agents,DrugBank
DB05767,Antiprotozoals,DrugBank
DB05767,Antirheumatic Agents,DrugBank
DB05767,Biological Products,DrugBank
DB05767,"Colitis, Ulcerative",DrugBank
DB05767,"Colitis, Ulcerative, drug therapy",DrugBank
DB05767,Complex Mixtures,DrugBank
DB05767,Embryophyta,DrugBank
DB05767,Eukaryota,DrugBank
DB05767,Hematologic Agents,DrugBank
DB05767,Lamiales,DrugBank
DB05767,Peripheral Nervous System Agents,DrugBank
DB05767,Pharmaceutical Preparations,DrugBank
DB05767,Plant Preparations,DrugBank
DB05767,Sensory System Agents,DrugBank
DB05767,Stereoisomerism,DrugBank
DB05767,Streptophyta,DrugBank
DB05767,Terpenes,DrugBank
DB05767,Tracheophyta,DrugBank
DB05767,Viridiplantae,DrugBank
DB05773,"Amino Acids, Peptides, and Proteins",DrugBank
DB05773,Antibodies,DrugBank
DB05773,"Antibodies, Monoclonal",DrugBank
DB05773,"Antibodies, Monoclonal, Humanized",DrugBank
DB05773,Antibody-drug Conjugates,DrugBank
DB05773,Antimitotic Agents,DrugBank
DB05773,Antineoplastic Agents,DrugBank
DB05773,"Antineoplastic Agents, Immunological",DrugBank
DB05773,Antineoplastic and Immunomodulating Agents,DrugBank
DB05773,Blood Proteins,DrugBank
DB05773,Cancer immunotherapy,DrugBank
DB05773,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05773,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05773,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB05773,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB05773,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB05773,Cytochrome P-450 Substrates,DrugBank
DB05773,Globulins,DrugBank
DB05773,Hepatotoxic Agents,DrugBank
DB05773,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB05773,HER2 Receptor Antagonists,DrugBank
DB05773,HER2-targeted Antibodies,DrugBank
DB05773,Immunoconjugates,DrugBank
DB05773,Immunoglobulins,DrugBank
DB05773,Immunologic Factors,DrugBank
DB05773,Immunoproteins,DrugBank
DB05773,Immunosuppressive Agents,DrugBank
DB05773,Immunotherapy,DrugBank
DB05773,Immunotoxins,DrugBank
DB05773,"Lactams, Macrocyclic",DrugBank
DB05773,Lactones,DrugBank
DB05773,Maytansine,DrugBank
DB05773,Microtubule Inhibitors,DrugBank
DB05773,Mitosis Modulators,DrugBank
DB05773,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB05773,Myelosuppressive Agents,DrugBank
DB05773,Narrow Therapeutic Index Drugs,DrugBank
DB05773,Noxae,DrugBank
DB05773,P-glycoprotein substrates,DrugBank
DB05773,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB05773,Proteins,DrugBank
DB05773,Serum Globulins,DrugBank
DB05773,Toxic Actions,DrugBank
DB05773,Trastuzumab,DrugBank
DB05773,Tubulin Modulators,DrugBank
DB05779,"Adjuvants, Immunologic",DrugBank
DB05779,"Amino Acids, Peptides, and Proteins",DrugBank
DB05779,Angiogenesis Modulating Agents,DrugBank
DB05779,Antidotes,DrugBank
DB05779,Antineoplastic Agents,DrugBank
DB05779,Cardiovascular Agents,DrugBank
DB05779,"Compounds used in a research, industrial, or household setting",DrugBank
DB05779,Growth Inhibitors,DrugBank
DB05779,Growth Substances,DrugBank
DB05779,Immunologic Factors,DrugBank
DB05779,Oligopeptides,DrugBank
DB05779,Peptides,DrugBank
DB05779,Protective Agents,DrugBank
DB05786,Alkylating Drugs,DrugBank
DB05786,Antineoplastic Agents,DrugBank
DB05786,"Antineoplastic Agents, Alkylating",DrugBank
DB05786,Noxae,DrugBank
DB05786,Radiation-Sensitizing Agents,DrugBank
DB05786,Terpenes,DrugBank
DB05786,Toxic Actions,DrugBank
DB05793,"Amino Acids, Peptides, and Proteins",DrugBank
DB05793,Antigens,DrugBank
DB05793,"Antigens, Surface",DrugBank
DB05793,Biological Factors,DrugBank
DB05793,Blood Proteins,DrugBank
DB05793,Carbohydrates,DrugBank
DB05793,Cell Adhesion Molecules,DrugBank
DB05793,Globulins,DrugBank
DB05793,Glycoconjugates,DrugBank
DB05793,Glycoproteins,DrugBank
DB05793,HIV Fusion Inhibitors,DrugBank
DB05793,Immunoglobulin Constant Regions,DrugBank
DB05793,Immunoglobulin Fc Fragments,DrugBank
DB05793,Immunoglobulin Fragments,DrugBank
DB05793,Immunoglobulins,DrugBank
DB05793,Immunoproteins,DrugBank
DB05793,Membrane Glycoproteins,DrugBank
DB05793,Membrane Proteins,DrugBank
DB05793,Peptide Fragments,DrugBank
DB05793,Peptides,DrugBank
DB05793,Proteins,DrugBank
DB05793,Recombinant Fusion Proteins,DrugBank
DB05793,Recombinant Proteins,DrugBank
DB05793,Serum Globulins,DrugBank
DB05797,"Amino Acids, Peptides, and Proteins",DrugBank
DB05797,Antibodies,DrugBank
DB05797,"Antibodies, Monoclonal",DrugBank
DB05797,Blood Proteins,DrugBank
DB05797,Globulins,DrugBank
DB05797,Immunoglobulins,DrugBank
DB05797,Immunoproteins,DrugBank
DB05797,Proteins,DrugBank
DB05797,Serum Globulins,DrugBank
DB05804,17-Ketosteroids,DrugBank
DB05804,Adrenal Cortex Hormones,DrugBank
DB05804,Androstanes,DrugBank
DB05804,Androstanols,DrugBank
DB05804,Androstenes,DrugBank
DB05804,Androstenols,DrugBank
DB05804,BSEP/ABCB11 Substrates,DrugBank
DB05804,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB05804,Dehydroepiandrosterone,DrugBank
DB05804,Fused-Ring Compounds,DrugBank
DB05804,Gonadal Hormones,DrugBank
DB05804,Gonadal Steroid Hormones,DrugBank
DB05804,Hormones,DrugBank
DB05804,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05804,Ketosteroids,DrugBank
DB05804,Steroids,DrugBank
DB05804,Testosterone Congeners,DrugBank
DB05812,Androstanes,DrugBank
DB05812,Androstenes,DrugBank
DB05812,Antineoplastic Agents,DrugBank
DB05812,Antineoplastic and Immunomodulating Agents,DrugBank
DB05812,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB05812,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB05812,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB05812,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB05812,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB05812,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05812,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05812,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05812,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB05812,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB05812,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05812,Cytochrome P-450 Substrates,DrugBank
DB05812,Cytochrome P450 17A1 Inhibitors,DrugBank
DB05812,Endocrine Therapy,DrugBank
DB05812,Enzyme Inhibitors,DrugBank
DB05812,Fused-Ring Compounds,DrugBank
DB05812,Hormone Antagonists,DrugBank
DB05812,Hormone Antagonists and Related Agents,DrugBank
DB05812,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05812,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB05812,P-glycoprotein inhibitors,DrugBank
DB05812,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB05812,Steroid Synthesis Inhibitors,DrugBank
DB05812,Steroids,DrugBank
DB05814,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05814,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05814,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05814,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05814,Lactones,DrugBank
DB05829,"Amino Acids, Peptides, and Proteins",DrugBank
DB05829,Calcium Homeostasis,DrugBank
DB05829,Calcium-Regulating Hormones and Agents,DrugBank
DB05829,Hormones,DrugBank
DB05829,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05829,Parathyroid Hormones and Analogues,DrugBank
DB05829,Peptide Hormones,DrugBank
DB05829,Peptides,DrugBank
DB05829,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB05829,Thyroid Products,DrugBank
DB05830,Adrenal Cortex Hormones,DrugBank
DB05830,"Contraceptive Agents, Hormonal",DrugBank
DB05830,"Contraceptive Agents, Male",DrugBank
DB05830,Estranes,DrugBank
DB05830,Estrenes,DrugBank
DB05830,Fused-Ring Compounds,DrugBank
DB05830,Gonadal Hormones,DrugBank
DB05830,Gonadal Steroid Hormones,DrugBank
DB05830,Hormonal Contraceptives for Systemic Use,DrugBank
DB05830,Hormones,DrugBank
DB05830,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB05830,Reproductive Control Agents,DrugBank
DB05830,Steroids,DrugBank
DB05830,Testosterone Congeners,DrugBank
DB05860,Pegylated agents,DrugBank
DB05875,"Amino Acids, Peptides, and Proteins",DrugBank
DB05875,Autacoids,DrugBank
DB05875,Biological Factors,DrugBank
DB05875,Cholinesterase substrates,DrugBank
DB05875,Inflammation Mediators,DrugBank
DB05875,Intercellular Signaling Peptides and Proteins,DrugBank
DB05875,Kinins,DrugBank
DB05875,Nerve Tissue Proteins,DrugBank
DB05875,Neuropeptides,DrugBank
DB05875,Oligopeptides,DrugBank
DB05875,Peptides,DrugBank
DB05875,Proteins,DrugBank
DB05875,"Receptors, Neurokinin-3, antagonists & inhibitors",DrugBank
DB05875,Tachykinins,DrugBank
DB05885,Agents causing hyperkalemia,DrugBank
DB05885,Antiarrhythmic agents,DrugBank
DB05885,Bradycardia-Causing Agents,DrugBank
DB05885,Calcium Channel Blockers,DrugBank
DB05885,Cytochrome P-450 CYP3A Substrates,DrugBank
DB05885,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB05885,Cytochrome P-450 Substrates,DrugBank
DB05885,Pyrrolidines,DrugBank
DB05885,Vasodilating Agents,DrugBank
DB05889,"Amino Acids, Peptides, and Proteins",DrugBank
DB05889,"Antibiotics, Antineoplastic",DrugBank
DB05889,Antibodies,DrugBank
DB05889,"Antibodies, Monoclonal",DrugBank
DB05889,"Antibodies, Monoclonal, Humanized",DrugBank
DB05889,Antibody-drug Conjugates,DrugBank
DB05889,Antineoplastic Agents,DrugBank
DB05889,"Antineoplastic Agents, Immunological",DrugBank
DB05889,Antineoplastic and Immunomodulating Agents,DrugBank
DB05889,Blood Proteins,DrugBank
DB05889,Calicheamicins,DrugBank
DB05889,Cancer immunotherapy,DrugBank
DB05889,Carbohydrates,DrugBank
DB05889,CD22 (Clusters of Differentiation 22) inhibitors,DrugBank
DB05889,CD22-directed Antibody Interactions,DrugBank
DB05889,CD22-directed Immunoconjugate,DrugBank
DB05889,Decreased DNA Integrity,DrugBank
DB05889,Globulins,DrugBank
DB05889,Glycosides,DrugBank
DB05889,Hepatotoxic Agents,DrugBank
DB05889,Immunoconjugates,DrugBank
DB05889,Immunoglobulins,DrugBank
DB05889,Immunologic Factors,DrugBank
DB05889,Immunoproteins,DrugBank
DB05889,Immunotherapy,DrugBank
DB05889,Immunotoxins,DrugBank
DB05889,Increased Cellular Death,DrugBank
DB05889,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB05889,Narrow Therapeutic Index Drugs,DrugBank
DB05889,Noxae,DrugBank
DB05889,P-glycoprotein substrates,DrugBank
DB05889,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB05889,Proteins,DrugBank
DB05889,QTc Prolonging Agents,DrugBank
DB05889,Serum Globulins,DrugBank
DB05889,Toxic Actions,DrugBank
DB05892,"Amino Acids, Peptides, and Proteins",DrugBank
DB05892,Analgesics,DrugBank
DB05892,Antibodies,DrugBank
DB05892,"Antibodies, Monoclonal",DrugBank
DB05892,Blood Proteins,DrugBank
DB05892,Central Nervous System Agents,DrugBank
DB05892,Globulins,DrugBank
DB05892,Immunoglobulins,DrugBank
DB05892,Immunoproteins,DrugBank
DB05892,Peripheral Nervous System Agents,DrugBank
DB05892,Proteins,DrugBank
DB05892,"Receptor, Nerve Growth Factor, antagonists & inhibitors",DrugBank
DB05892,Sensory System Agents,DrugBank
DB05892,Serum Globulins,DrugBank
DB05903,Anti-Bacterial Agents,DrugBank
DB05903,Antineoplastic Agents,DrugBank
DB05903,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05903,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05903,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB05903,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05903,Lactones,DrugBank
DB05903,Macrolides,DrugBank
DB05903,Polyketides,DrugBank
DB05915,"Amino Acids, Peptides, and Proteins",DrugBank
DB05915,Blood Proteins,DrugBank
DB05915,Globulins,DrugBank
DB05915,Immunoglobulins,DrugBank
DB05915,Immunoproteins,DrugBank
DB05915,Proteins,DrugBank
DB05915,Serum Globulins,DrugBank
DB05916,"Amino Acids, Peptides, and Proteins",DrugBank
DB05916,Antibodies,DrugBank
DB05916,Antineoplastic Agents,DrugBank
DB05916,"Antineoplastic Agents, Immunological",DrugBank
DB05916,Blood Proteins,DrugBank
DB05916,Globulins,DrugBank
DB05916,Immunoglobulins,DrugBank
DB05916,Immunoproteins,DrugBank
DB05916,Proteins,DrugBank
DB05916,Serum Globulins,DrugBank
DB05928,BCRP/ABCG2 Inducers,DrugBank
DB05928,BCRP/ABCG2 Inhibitors,DrugBank
DB05928,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB05928,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB05928,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB05928,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB05928,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB05928,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB05928,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB05928,Cytochrome P-450 Enzyme Inducers,DrugBank
DB05928,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05928,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB05928,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB05928,OATP1B3 inhibitors,DrugBank
DB05928,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB05928,P-glycoprotein inhibitors,DrugBank
DB05928,Quinolines,DrugBank
DB05928,Tyrosine Kinase Inhibitors,DrugBank
DB05928,UGT1A3 Inhibitors,DrugBank
DB05928,UGT2B7 Inhibitors,DrugBank
DB05941,"Amino Acids, Peptides, and Proteins",DrugBank
DB05941,Anti-HIV Agents,DrugBank
DB05941,Anti-Infective Agents,DrugBank
DB05941,Anti-Retroviral Agents,DrugBank
DB05941,Antibodies,DrugBank
DB05941,"Antibodies, Monoclonal",DrugBank
DB05941,"Antibodies, Monoclonal, Humanized",DrugBank
DB05941,"Antibodies, Viral",DrugBank
DB05941,Antiviral Agents,DrugBank
DB05941,Blood Proteins,DrugBank
DB05941,Deltaretrovirus Antibodies,DrugBank
DB05941,Experimental Unapproved Treatments for COVID-19,DrugBank
DB05941,Globulins,DrugBank
DB05941,HIV Fusion Inhibitors,DrugBank
DB05941,Immunoglobulins,DrugBank
DB05941,Immunoproteins,DrugBank
DB05941,Proteins,DrugBank
DB05941,"Receptors, CCR5",DrugBank
DB05941,Serum Globulins,DrugBank
DB05941,Viral Fusion Protein Inhibitors,DrugBank
DB05942,"Amino Acids, Peptides, and Proteins",DrugBank
DB05942,Antigens,DrugBank
DB05942,Biological Factors,DrugBank
DB05942,Biological Products,DrugBank
DB05942,Complex Mixtures,DrugBank
DB05942,Proteins,DrugBank
DB05942,Recombinant Proteins,DrugBank
DB05942,Vaccines,DrugBank
DB05974,Alkenes,DrugBank
DB05974,Anticarcinogenic Agents,DrugBank
DB05974,Antineoplastic Agents,DrugBank
DB05974,Antioxidants,DrugBank
DB05974,Biological Factors,DrugBank
DB05974,Carotenoids,DrugBank
DB05974,"Compounds used in a research, industrial, or household setting",DrugBank
DB05974,Cyclohexanes,DrugBank
DB05974,Cyclohexenes,DrugBank
DB05974,Cycloparaffins,DrugBank
DB05974,Diterpenes,DrugBank
DB05974,"Hydrocarbons, Acyclic",DrugBank
DB05974,"Pigments, Biological",DrugBank
DB05974,Polyenes,DrugBank
DB05974,Protective Agents,DrugBank
DB05974,Retinoids,DrugBank
DB05974,Terpenes,DrugBank
DB05990,Alimentary Tract and Metabolism,DrugBank
DB05990,Bile Acid Preparations,DrugBank
DB05990,Bile acids and derivatives,DrugBank
DB05990,Bile Acids and Salts,DrugBank
DB05990,Bile and Liver Therapy,DrugBank
DB05990,Bile Therapy,DrugBank
DB05990,BSEP/ABCB11 inducers,DrugBank
DB05990,BSEP/ABCB11 Inhibitors,DrugBank
DB05990,Cholanes,DrugBank
DB05990,Cholic Acids,DrugBank
DB05990,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB05990,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB05990,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB05990,Farnesoid X Receptor Agonist,DrugBank
DB05990,Farnesoid X Receptor Agonists,DrugBank
DB05990,Fused-Ring Compounds,DrugBank
DB05990,Miscellaneous GI Drugs,DrugBank
DB05996,"Amino Acids, Peptides, and Proteins",DrugBank
DB05996,Antibodies,DrugBank
DB05996,Antineoplastic Agents,DrugBank
DB05996,"Antineoplastic Agents, Immunological",DrugBank
DB05996,Blood Proteins,DrugBank
DB05996,Globulins,DrugBank
DB05996,Immunoglobulins,DrugBank
DB05996,Immunologic Factors,DrugBank
DB05996,Immunoproteins,DrugBank
DB05996,Proteins,DrugBank
DB05996,Serum Globulins,DrugBank
DB06011,Agents causing angioedema,DrugBank
DB06011,Benzocycloheptenes,DrugBank
DB06011,Blood Glucose Lowering Agents,DrugBank
DB06011,DPP-IV Inhibitors,DrugBank
DB06013,Anthracyclines,DrugBank
DB06013,Antineoplastic Agents,DrugBank
DB06013,Carbohydrates,DrugBank
DB06013,Cardiotoxic antineoplastic agents,DrugBank
DB06013,Glycosides,DrugBank
DB06013,Hydrazines,DrugBank
DB06013,Naphthacenes,DrugBank
DB06016,Agents that produce hypertension,DrugBank
DB06016,Antidepressive Agents,DrugBank
DB06016,Antipsychotic Agents,DrugBank
DB06016,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB06016,Central Nervous System Agents,DrugBank
DB06016,Central Nervous System Depressants,DrugBank
DB06016,Chlorobenzenes,DrugBank
DB06016,Cyclohexanes,DrugBank
DB06016,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06016,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06016,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06016,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06016,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06016,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06016,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06016,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06016,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB06016,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB06016,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06016,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06016,Cytochrome P-450 Substrates,DrugBank
DB06016,Dopamine Agonists,DrugBank
DB06016,Dopamine D2/D3 receptor modulators,DrugBank
DB06016,Histamine Antagonists,DrugBank
DB06016,Histamine H1 Antagonists,DrugBank
DB06016,Nervous System,DrugBank
DB06016,Neurotoxic agents,DrugBank
DB06016,P-glycoprotein inhibitors,DrugBank
DB06016,Piperazines,DrugBank
DB06016,Psycholeptics,DrugBank
DB06016,Psychotropic Drugs,DrugBank
DB06016,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06016,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB06016,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06016,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06016,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06016,Serotonin Agents,DrugBank
DB06016,Serotonin Receptor Agonists,DrugBank
DB06016,Serotonin Receptor Antagonists,DrugBank
DB06016,Tranquilizing Agents,DrugBank
DB06021,Antineoplastic Agents,DrugBank
DB06021,Enzyme Inhibitors,DrugBank
DB06021,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06021,Protein Kinase Inhibitors,DrugBank
DB06021,"Receptor, ErbB-2, antagonists & inhibitors",DrugBank
DB06022,Pegylated agents,DrugBank
DB06040,Antimitotic Agents,DrugBank
DB06040,Antineoplastic Agents,DrugBank
DB06040,Mitosis Modulators,DrugBank
DB06040,Sulfur Compounds,DrugBank
DB06040,Thiazoles,DrugBank
DB06043,"Amino Acids, Peptides, and Proteins",DrugBank
DB06043,Antibodies,DrugBank
DB06043,"Antibodies, Monoclonal",DrugBank
DB06043,Antineoplastic Agents,DrugBank
DB06043,Antineoplastic and Immunomodulating Agents,DrugBank
DB06043,Blood Proteins,DrugBank
DB06043,Cancer immunotherapy,DrugBank
DB06043,Globulins,DrugBank
DB06043,Immunoglobulins,DrugBank
DB06043,Immunoproteins,DrugBank
DB06043,Immunotherapy,DrugBank
DB06043,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06043,Platelet-derived Growth Factor Receptor alpha Antagonist,DrugBank
DB06043,Proteins,DrugBank
DB06043,Serum Globulins,DrugBank
DB06045,Amino Acids,DrugBank
DB06045,"Amino Acids, Acidic",DrugBank
DB06045,"Amino Acids, Dicarboxylic",DrugBank
DB06045,"Amino Acids, Peptides, and Proteins",DrugBank
DB06045,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06045,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06045,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06045,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06045,Nervous System,DrugBank
DB06045,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06045,OATP1B3 inhibitors,DrugBank
DB06045,Peptides,DrugBank
DB06045,UGT1A9 Inhibitors,DrugBank
DB06045,UGT2B15 Inhibitors,DrugBank
DB06045,UGT2B7 Inhibitors,DrugBank
DB06049,"Amino Acids, Peptides, and Proteins",DrugBank
DB06049,Antibodies,DrugBank
DB06049,"Antibodies, Monoclonal",DrugBank
DB06049,Blood Proteins,DrugBank
DB06049,Globulins,DrugBank
DB06049,Immunoglobulins,DrugBank
DB06049,Immunoproteins,DrugBank
DB06049,Proteins,DrugBank
DB06049,Serum Globulins,DrugBank
DB06050,"Amino Acids, Peptides, and Proteins",DrugBank
DB06050,Antibodies,DrugBank
DB06050,"Antibodies, Monoclonal",DrugBank
DB06050,Blood Proteins,DrugBank
DB06050,Globulins,DrugBank
DB06050,Immunoglobulins,DrugBank
DB06050,Immunoproteins,DrugBank
DB06050,Proteins,DrugBank
DB06050,Serum Globulins,DrugBank
DB06077,Antidepressive Agents,DrugBank
DB06077,Antipsychotic Agents,DrugBank
DB06077,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB06077,Butyrophenone Derivatives,DrugBank
DB06077,Central Nervous System Depressants,DrugBank
DB06077,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06077,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06077,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06077,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06077,Cytochrome P-450 Substrates,DrugBank
DB06077,Dopamine Agonists,DrugBank
DB06077,Dopamine Antagonists,DrugBank
DB06077,Dopamine D2 Receptor Agonists,DrugBank
DB06077,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06077,Nervous System,DrugBank
DB06077,Neurotoxic agents,DrugBank
DB06077,Psycholeptics,DrugBank
DB06077,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06077,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06077,Serotonin Agents,DrugBank
DB06077,Serotonin Modulators,DrugBank
DB06077,Serotonin Receptor Antagonists,DrugBank
DB06077,UGT1A1 Substrates,DrugBank
DB06077,UGT1A4 substrates,DrugBank
DB06081,"Amino Acids, Peptides, and Proteins",DrugBank
DB06081,Antibodies,DrugBank
DB06081,"Antibodies, Monoclonal",DrugBank
DB06081,"Antibodies, Monoclonal, Humanized",DrugBank
DB06081,Antiplatelet agents,DrugBank
DB06081,"Antithrombotic Agents, Misc.",DrugBank
DB06081,Blood and Blood Forming Organs,DrugBank
DB06081,Blood Proteins,DrugBank
DB06081,Globulins,DrugBank
DB06081,Immunoglobulin Fab Fragments,DrugBank
DB06081,Immunoglobulin Fragments,DrugBank
DB06081,Immunoglobulin Variable Region,DrugBank
DB06081,Immunoglobulins,DrugBank
DB06081,Immunoproteins,DrugBank
DB06081,Peptide Fragments,DrugBank
DB06081,Peptides,DrugBank
DB06081,Proteins,DrugBank
DB06081,Serum Globulins,DrugBank
DB06081,von Willebrand Factor (vWF)-directed Antibodies,DrugBank
DB06081,"von Willebrand Factor, antagonists & inhibitors",DrugBank
DB06101,"Amino Acids, Peptides, and Proteins",DrugBank
DB06101,Blood Proteins,DrugBank
DB06101,Globulins,DrugBank
DB06101,Immunoglobulins,DrugBank
DB06101,Immunoproteins,DrugBank
DB06101,Proteins,DrugBank
DB06101,Serum Globulins,DrugBank
DB06109,Antidepressive Agents,DrugBank
DB06109,Central Nervous System Depressants,DrugBank
DB06109,Dopamine Agents,DrugBank
DB06109,Dopamine Antagonists,DrugBank
DB06109,Dopamine D2 Receptor Antagonists,DrugBank
DB06109,Neurotransmitter Agents,DrugBank
DB06109,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06109,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06109,Serotonin Agents,DrugBank
DB06109,Serotonin Receptor Antagonists,DrugBank
DB06116,"Amino Acids, Peptides, and Proteins",DrugBank
DB06116,Antibodies,DrugBank
DB06116,"Antibodies, Monoclonal",DrugBank
DB06116,Blood Proteins,DrugBank
DB06116,Chemokine CXCL10,DrugBank
DB06116,Globulins,DrugBank
DB06116,Immunoglobulins,DrugBank
DB06116,Immunoproteins,DrugBank
DB06116,Proteins,DrugBank
DB06116,Serum Globulins,DrugBank
DB06117,Cholestanes,DrugBank
DB06117,Cholestenes,DrugBank
DB06117,Fused-Ring Compounds,DrugBank
DB06117,Lipids,DrugBank
DB06117,Membrane Lipids,DrugBank
DB06117,Secosteroids,DrugBank
DB06117,Steroids,DrugBank
DB06117,Sterols,DrugBank
DB06117,Vitamin D and Analogues,DrugBank
DB06117,Vitamins,DrugBank
DB06117,Vitamins (Fat Soluble),DrugBank
DB06119,"Acids, Acyclic",DrugBank
DB06119,Anticonvulsants,DrugBank
DB06119,Benzene Derivatives,DrugBank
DB06119,Central Nervous System Agents,DrugBank
DB06119,Central Nervous System Depressants,DrugBank
DB06119,Chlorobenzenes,DrugBank
DB06119,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB06119,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06119,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB06119,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06119,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06119,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06119,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB06119,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06119,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06119,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06119,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06119,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06119,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06119,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06119,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06119,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06119,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06119,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06119,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06119,Cytochrome P-450 Substrates,DrugBank
DB06119,GABA Modulators,DrugBank
DB06119,Nervous System,DrugBank
DB06119,Phenols,DrugBank
DB06119,UGT2B7 substrates,DrugBank
DB06119,Voltage-Gated Sodium Channel Blockers,DrugBank
DB06127,Agents causing angioedema,DrugBank
DB06127,Blood Glucose Lowering Agents,DrugBank
DB06127,DPP-IV Inhibitors,DrugBank
DB06144,Antidepressive Agents,DrugBank
DB06144,Antipsychotic Agents,DrugBank
DB06144,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB06144,Central Nervous System Agents,DrugBank
DB06144,Central Nervous System Depressants,DrugBank
DB06144,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06144,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06144,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06144,Cytochrome P-450 Substrates,DrugBank
DB06144,Dopamine Antagonists,DrugBank
DB06144,Dopamine D2 Receptor Antagonists,DrugBank
DB06144,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06144,Indole Derivatives,DrugBank
DB06144,Nervous System,DrugBank
DB06144,Neurotoxic agents,DrugBank
DB06144,Psycholeptics,DrugBank
DB06144,Psychotropic Drugs,DrugBank
DB06144,QTc Prolonging Agents,DrugBank
DB06144,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06144,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06144,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06144,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06144,Serotonin Agents,DrugBank
DB06144,Serotonin Receptor Antagonists,DrugBank
DB06144,Tranquilizing Agents,DrugBank
DB06145,Anti-Bacterial Agents,DrugBank
DB06145,Anti-Infective Agents,DrugBank
DB06145,Antibacterials for Systemic Use,DrugBank
DB06145,Antiinfectives for Systemic Use,DrugBank
DB06145,Antiparasitic Agents,DrugBank
DB06145,Antiprotozoals,DrugBank
DB06145,Carbohydrates,DrugBank
DB06145,Coccidiostats,DrugBank
DB06145,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06145,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06145,Glycosides,DrugBank
DB06145,Lactones,DrugBank
DB06145,Leucomycins,DrugBank
DB06145,Macrolide Antimicrobial,DrugBank
DB06145,Macrolides,DrugBank
DB06145,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB06145,Polyketides,DrugBank
DB06147,Amides,DrugBank
DB06147,Amines,DrugBank
DB06147,Aniline Compounds,DrugBank
DB06147,Anti-Infective Agents,DrugBank
DB06147,Antibacterials for Systemic Use,DrugBank
DB06147,Antiinfectives for Systemic Use,DrugBank
DB06147,Benzene Derivatives,DrugBank
DB06147,Benzenesulfonamides,DrugBank
DB06147,Dermatologicals,DrugBank
DB06147,Genito Urinary System and Sex Hormones,DrugBank
DB06147,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06147,Short-Acting Antibacterial Sulfonamides,DrugBank
DB06147,Sulfanilamides,DrugBank
DB06147,Sulfathiazoles,DrugBank
DB06147,Sulfonamides,DrugBank
DB06147,Sulfonamides and trimethoprim,DrugBank
DB06147,Sulfones,DrugBank
DB06147,Sulfur Compounds,DrugBank
DB06147,Thiazoles,DrugBank
DB06148,Adrenergic Agents,DrugBank
DB06148,Agents that produce hypertension,DrugBank
DB06148,Antidepressive Agents,DrugBank
DB06148,"Antidepressive Agents, Second-Generation",DrugBank
DB06148,"Antidepressive Agents, Tetracyclic",DrugBank
DB06148,Central Nervous System Agents,DrugBank
DB06148,Central Nervous System Depressants,DrugBank
DB06148,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB06148,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06148,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06148,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06148,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06148,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06148,Cytochrome P-450 Substrates,DrugBank
DB06148,Dibenzazepines,DrugBank
DB06148,Dopamine Antagonists,DrugBank
DB06148,Dopamine D2 Receptor Antagonists,DrugBank
DB06148,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06148,Histamine Agents,DrugBank
DB06148,Histamine Antagonists,DrugBank
DB06148,Histamine H1 Antagonists,DrugBank
DB06148,Nervous System,DrugBank
DB06148,Neurotransmitter Agents,DrugBank
DB06148,Psychoanaleptics,DrugBank
DB06148,Psychotropic Drugs,DrugBank
DB06148,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06148,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06148,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06148,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06148,Serotonin Agents,DrugBank
DB06148,Serotonin Modulators,DrugBank
DB06148,Serotonin Receptor Antagonists,DrugBank
DB06149,"Amino Acids, Peptides, and Proteins",DrugBank
DB06149,Anti-Bacterial Agents,DrugBank
DB06149,Anti-Infective Agents,DrugBank
DB06149,Antibacterials for Systemic Use,DrugBank
DB06149,Antiinfectives for Systemic Use,DrugBank
DB06149,Carbohydrates,DrugBank
DB06149,Glycoconjugates,DrugBank
DB06149,Glycopeptide Antibacterials,DrugBank
DB06149,Glycopeptides,DrugBank
DB06149,Lipoglycopeptides,DrugBank
DB06149,Narrow Therapeutic Index Drugs,DrugBank
DB06149,Peptides,DrugBank
DB06150,Amides,DrugBank
DB06150,Amines,DrugBank
DB06150,Aniline Compounds,DrugBank
DB06150,Anti-Infective Agents,DrugBank
DB06150,Antibacterials for Systemic Use,DrugBank
DB06150,Antiinfectives for Systemic Use,DrugBank
DB06150,Benzene Derivatives,DrugBank
DB06150,Benzenesulfonamides,DrugBank
DB06150,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06150,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06150,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06150,Genito Urinary System and Sex Hormones,DrugBank
DB06150,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06150,Long-Acting Antibacterial Sulfonamides,DrugBank
DB06150,Sulfanilamides,DrugBank
DB06150,Sulfonamides,DrugBank
DB06150,Sulfonamides and trimethoprim,DrugBank
DB06150,Sulfones,DrugBank
DB06150,Sulfur Compounds,DrugBank
DB06151,Amino Acids,DrugBank
DB06151,"Amino Acids, Neutral",DrugBank
DB06151,"Amino Acids, Peptides, and Proteins",DrugBank
DB06151,"Amino Acids, Sulfur",DrugBank
DB06151,Antidote for Acetaminophen Overdose,DrugBank
DB06151,Antidotes,DrugBank
DB06151,Antioxidants,DrugBank
DB06151,"Compounds used in a research, industrial, or household setting",DrugBank
DB06151,Cough and Cold Preparations,DrugBank
DB06151,Cysteine,DrugBank
DB06151,Decreased Respiratory Secretion Viscosity,DrugBank
DB06151,Expectorants,DrugBank
DB06151,Free Radical Scavengers,DrugBank
DB06151,Increased Glutathione Concentration,DrugBank
DB06151,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06151,Ophthalmologicals,DrugBank
DB06151,Protective Agents,DrugBank
DB06151,Reduction Activity,DrugBank
DB06151,Respiratory System Agents,DrugBank
DB06151,Sensory Organs,DrugBank
DB06151,Sulfhydryl Compounds,DrugBank
DB06151,Sulfur Compounds,DrugBank
DB06152,2-Amino-1-Phenylethanol Derivatives,DrugBank
DB06152,Adrenergic Agents,DrugBank
DB06152,Adrenergic Agonists,DrugBank
DB06152,Adrenergic beta-Agonists,DrugBank
DB06152,Agents causing hyperkalemia,DrugBank
DB06152,Agents producing tachycardia,DrugBank
DB06152,Agents that produce hypertension,DrugBank
DB06152,Alcohols,DrugBank
DB06152,Amines,DrugBank
DB06152,Amino Alcohols,DrugBank
DB06152,Antiarrhythmic agents,DrugBank
DB06152,Autonomic Agents,DrugBank
DB06152,Bradycardia-Causing Agents,DrugBank
DB06152,Calcium Channel Blockers,DrugBank
DB06152,Cardiovascular Agents,DrugBank
DB06152,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06152,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06152,Cytochrome P-450 Substrates,DrugBank
DB06152,Ethylamines,DrugBank
DB06152,Genito Urinary System and Sex Hormones,DrugBank
DB06152,Miscellaneous Vasodilatating Agents,DrugBank
DB06152,Neurotransmitter Agents,DrugBank
DB06152,Peripheral Nervous System Agents,DrugBank
DB06152,Peripheral Vasodilators,DrugBank
DB06152,Phenethylamines,DrugBank
DB06152,Propanolamines,DrugBank
DB06152,Propanols,DrugBank
DB06152,Reproductive Control Agents,DrugBank
DB06152,Sympathomimetics,DrugBank
DB06152,"Sympathomimetics, Labour Repressants",DrugBank
DB06152,Tocolytic Agents,DrugBank
DB06152,Vasodilating Agents,DrugBank
DB06153,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB06153,Adrenergic alpha-Antagonists,DrugBank
DB06153,Adrenergic Antagonists,DrugBank
DB06153,Agents producing tachycardia,DrugBank
DB06153,Agents that produce hypertension,DrugBank
DB06153,Analgesics,DrugBank
DB06153,"Analgesics, Non-Narcotic",DrugBank
DB06153,Anticholinergic Agents,DrugBank
DB06153,Antidepressive Agents,DrugBank
DB06153,"Antimigraine Agents, Miscellaneous",DrugBank
DB06153,Antimigraine Preparations,DrugBank
DB06153,Central Nervous System Agents,DrugBank
DB06153,Central Nervous System Depressants,DrugBank
DB06153,Histamine Antagonists,DrugBank
DB06153,Histamine H1 Antagonists,DrugBank
DB06153,Muscarinic Antagonists,DrugBank
DB06153,Nervous System,DrugBank
DB06153,Neurotransmitter Agents,DrugBank
DB06153,Peripheral Nervous System Agents,DrugBank
DB06153,Psychotropic Drugs,DrugBank
DB06153,Sensory System Agents,DrugBank
DB06153,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06153,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB06153,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06153,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06153,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06153,Serotonin Agents,DrugBank
DB06153,Serotonin Receptor Antagonists,DrugBank
DB06153,Sulfur Compounds,DrugBank
DB06153,Thiophenes,DrugBank
DB06154,Alcohols,DrugBank
DB06154,Antianginal Agents,DrugBank
DB06154,Carbohydrates,DrugBank
DB06154,Cardiac Therapy,DrugBank
DB06154,Cardiovascular Agents,DrugBank
DB06154,Drugs that are Mainly Renally Excreted,DrugBank
DB06154,Fibrin Modulating Agents,DrugBank
DB06154,Glycols,DrugBank
DB06154,Hematologic Agents,DrugBank
DB06154,Organic Nitrates,DrugBank
DB06154,Polysaccharides,DrugBank
DB06154,Propylene Glycols,DrugBank
DB06154,Vasodilating Agents,DrugBank
DB06154,Vasodilators Used in Cardiac Diseases,DrugBank
DB06155,Agents producing tachycardia,DrugBank
DB06155,Alimentary Tract and Metabolism,DrugBank
DB06155,Anti-Obesity Agents,DrugBank
DB06155,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB06155,Cannabinoid Receptor Antagonists,DrugBank
DB06155,Cannabinoids and similars,DrugBank
DB06155,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06155,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06155,Cytochrome P-450 Substrates,DrugBank
DB06155,Hormones,DrugBank
DB06155,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06155,Neurotransmitter Agents,DrugBank
DB06155,Piperidines,DrugBank
DB06155,Pyrazoles,DrugBank
DB06155,"Receptor, Cannabinoid, CB1, antagonists & inhibitors",DrugBank
DB06159,Alkaloids,DrugBank
DB06159,Antineoplastic Agents,DrugBank
DB06159,Enzyme Inhibitors,DrugBank
DB06159,Topoisomerase I Inhibitors,DrugBank
DB06159,Topoisomerase Inhibitors,DrugBank
DB06160,4-Quinolones,DrugBank
DB06160,Anti-Bacterial Agents,DrugBank
DB06160,Anti-Infective Agents,DrugBank
DB06160,Antibacterials for Systemic Use,DrugBank
DB06160,Antiinfectives for Systemic Use,DrugBank
DB06160,Antineoplastic Agents,DrugBank
DB06160,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06160,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06160,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06160,Enzyme Inhibitors,DrugBank
DB06160,Fluoroquinolones,DrugBank
DB06160,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06160,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06160,QTc Prolonging Agents,DrugBank
DB06160,Quinolines,DrugBank
DB06160,Quinolones,DrugBank
DB06160,Topoisomerase II Inhibitors,DrugBank
DB06160,Topoisomerase Inhibitors,DrugBank
DB06162,"Amino Acids, Peptides, and Proteins",DrugBank
DB06162,Antibodies,DrugBank
DB06162,Blood Proteins,DrugBank
DB06162,Globulins,DrugBank
DB06162,Immunoglobulins,DrugBank
DB06162,Immunoproteins,DrugBank
DB06162,Proteins,DrugBank
DB06162,Serum Globulins,DrugBank
DB06163,Antineoplastic Agents,DrugBank
DB06163,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06168,Agents reducing cytokine levels,DrugBank
DB06168,"Amino Acids, Peptides, and Proteins",DrugBank
DB06168,Antibodies,DrugBank
DB06168,"Antibodies, Monoclonal",DrugBank
DB06168,Antineoplastic and Immunomodulating Agents,DrugBank
DB06168,Blood Proteins,DrugBank
DB06168,Globulins,DrugBank
DB06168,Immunoglobulins,DrugBank
DB06168,Immunoproteins,DrugBank
DB06168,Immunosuppressive Agents,DrugBank
DB06168,Interleukin Inhibitors,DrugBank
DB06168,Interleukin-1 Blockers,DrugBank
DB06168,"Interleukin-1beta, antagonists & inhibitors",DrugBank
DB06168,Interleukin-1 Blockers,DrugBank
DB06168,Proteins,DrugBank
DB06168,Serum Globulins,DrugBank
DB06171,"Amino Acids, Peptides, and Proteins",DrugBank
DB06171,Antineoplastic Agents,DrugBank
DB06171,Cardiotoxic antineoplastic agents,DrugBank
DB06171,Cyclodecanes,DrugBank
DB06171,Cycloparaffins,DrugBank
DB06171,Diterpenes,DrugBank
DB06171,Taxoids,DrugBank
DB06171,Terpenes,DrugBank
DB06174,Alkaloids,DrugBank
DB06174,Antitussive Agents,DrugBank
DB06174,Central Nervous System Agents,DrugBank
DB06174,Cough and Cold Preparations,DrugBank
DB06174,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06174,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06174,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06174,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06174,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06174,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06174,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06174,Isoquinolines,DrugBank
DB06174,Opiate Alkaloids,DrugBank
DB06174,Opium Alkaloids and Derivatives,DrugBank
DB06174,Respiratory System Agents,DrugBank
DB06176,"Amino Acids, Peptides, and Proteins",DrugBank
DB06176,"Antibiotics, Antineoplastic",DrugBank
DB06176,Antineoplastic Agents,DrugBank
DB06176,Antineoplastic and Immunomodulating Agents,DrugBank
DB06176,Bile Salt Export Pump Inhibitors,DrugBank
DB06176,BSEP/ABCB11 Inhibitors,DrugBank
DB06176,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB06176,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06176,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB06176,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06176,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB06176,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06176,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06176,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06176,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06176,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB06176,Cytochrome P-450 Substrates,DrugBank
DB06176,Depsipeptides,DrugBank
DB06176,Enzyme Inhibitors,DrugBank
DB06176,Highest Risk QTc-Prolonging Agents,DrugBank
DB06176,Histone deacetylase (HDAC) inhibitors,DrugBank
DB06176,Histone Deacetylase Inhibitors,DrugBank
DB06176,Narrow Therapeutic Index Drugs,DrugBank
DB06176,OAT1/SLC22A6 inhibitors,DrugBank
DB06176,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06176,OATP1B3 inhibitors,DrugBank
DB06176,OCT2 Inhibitors,DrugBank
DB06176,Organic Anion Transporter 1 Inhibitors,DrugBank
DB06176,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB06176,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB06176,P-glycoprotein substrates,DrugBank
DB06176,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06176,Peptides,DrugBank
DB06176,"Peptides, Cyclic",DrugBank
DB06176,QTc Prolonging Agents,DrugBank
DB06181,Antineoplastic Agents,DrugBank
DB06181,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06181,Nucleotides,DrugBank
DB06181,Polynucleotides,DrugBank
DB06181,"Toll-Like Receptor 9, agonists",DrugBank
DB06186,"Adjuvants, Immunologic",DrugBank
DB06186,"Amino Acids, Peptides, and Proteins",DrugBank
DB06186,Antibodies,DrugBank
DB06186,"Antibodies, Monoclonal",DrugBank
DB06186,"Antibodies, Monoclonal, Humanized",DrugBank
DB06186,Antineoplastic Agents,DrugBank
DB06186,"Antineoplastic Agents, Immunological",DrugBank
DB06186,Antineoplastic and Immunomodulating Agents,DrugBank
DB06186,Blood Proteins,DrugBank
DB06186,Cancer immunotherapy,DrugBank
DB06186,CTLA-4-directed Antibody Interactions,DrugBank
DB06186,CTLA-4-directed Blocking Antibody,DrugBank
DB06186,Drugs that are Mainly Renally Excreted,DrugBank
DB06186,Globulins,DrugBank
DB06186,Immune Checkpoint Inhibitors,DrugBank
DB06186,Immunoglobulin G,DrugBank
DB06186,Immunoglobulins,DrugBank
DB06186,Immunoproteins,DrugBank
DB06186,Immunotherapy,DrugBank
DB06186,Increased T Lymphocyte Activation,DrugBank
DB06186,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06186,Narrow Therapeutic Index Drugs,DrugBank
DB06186,Proteins,DrugBank
DB06186,Serum Globulins,DrugBank
DB06190,"Acids, Carbocyclic",DrugBank
DB06190,Adrenergic Agents,DrugBank
DB06190,Adrenergic Agonists,DrugBank
DB06190,Adrenergic beta-3 Receptor Agonists,DrugBank
DB06190,Adrenergic beta-Agonists,DrugBank
DB06190,Agents producing tachycardia,DrugBank
DB06190,Agents that produce hypertension,DrugBank
DB06190,Amines,DrugBank
DB06190,Benzene Derivatives,DrugBank
DB06190,Drugs for Urinary Frequency and Incontinence,DrugBank
DB06190,Neurotransmitter Agents,DrugBank
DB06191,Benzocycloheptenes,DrugBank
DB06191,"Drug Resistance, Multiple",DrugBank
DB06191,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06191,P-glycoprotein inhibitors,DrugBank
DB06192,"Amino Acids, Peptides, and Proteins",DrugBank
DB06192,Antibodies,DrugBank
DB06192,"Antibodies, Monoclonal",DrugBank
DB06192,"Antibodies, Monoclonal, Humanized",DrugBank
DB06192,Antineoplastic Agents,DrugBank
DB06192,"Antineoplastic Agents, Immunological",DrugBank
DB06192,Blood Proteins,DrugBank
DB06192,Globulins,DrugBank
DB06192,Immunoglobulins,DrugBank
DB06192,Immunoproteins,DrugBank
DB06192,Proteins,DrugBank
DB06192,Serum Globulins,DrugBank
DB06193,Anthracyclines and Related Substances,DrugBank
DB06193,Antineoplastic Agents,DrugBank
DB06193,Antineoplastic and Immunomodulating Agents,DrugBank
DB06193,Cytotoxic Antibiotics and Related Substances,DrugBank
DB06193,Cytotoxins,DrugBank
DB06193,Enzyme Inhibitors,DrugBank
DB06193,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06193,Narrow Therapeutic Index Drugs,DrugBank
DB06193,Topoisomerase II Inhibitors,DrugBank
DB06193,Topoisomerase Inhibitors,DrugBank
DB06194,Cholestanes,DrugBank
DB06194,Cholestenes,DrugBank
DB06194,Fused-Ring Compounds,DrugBank
DB06194,Lipids,DrugBank
DB06194,Membrane Lipids,DrugBank
DB06194,Secosteroids,DrugBank
DB06194,Steroids,DrugBank
DB06194,Sterols,DrugBank
DB06194,Vitamin D and Analogues,DrugBank
DB06194,Vitamins,DrugBank
DB06194,Vitamins (Fat Soluble),DrugBank
DB06195,Anti-Infective Agents,DrugBank
DB06195,Antineoplastic Agents,DrugBank
DB06195,Enzyme Inhibitors,DrugBank
DB06195,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06195,Protein Kinase Inhibitors,DrugBank
DB06195,Purines,DrugBank
DB06196,Agents causing angioedema,DrugBank
DB06196,"Amino Acids, Peptides, and Proteins",DrugBank
DB06196,Analgesics,DrugBank
DB06196,"Analgesics, Non-Narcotic",DrugBank
DB06196,Anti-Inflammatory Agents,DrugBank
DB06196,Antirheumatic Agents,DrugBank
DB06196,Autacoids,DrugBank
DB06196,Biological Factors,DrugBank
DB06196,Bradykinin B2 Receptor Antagonists,DrugBank
DB06196,Bradykinin Receptor Antagonists,DrugBank
DB06196,Complement Inactivating Agents,DrugBank
DB06196,Drugs that are Mainly Renally Excreted,DrugBank
DB06196,Drugs Used in Hereditary Angioedema,DrugBank
DB06196,Immunologic Factors,DrugBank
DB06196,Inflammation Mediators,DrugBank
DB06196,Intercellular Signaling Peptides and Proteins,DrugBank
DB06196,Kinins,DrugBank
DB06196,Nerve Tissue Proteins,DrugBank
DB06196,Neuropeptides,DrugBank
DB06196,Oligopeptides,DrugBank
DB06196,Peptides,DrugBank
DB06196,Peripheral Nervous System Agents,DrugBank
DB06196,Proteins,DrugBank
DB06196,Sensory System Agents,DrugBank
DB06199,Antineoplastic Agents,DrugBank
DB06199,Benzodioxoles,DrugBank
DB06199,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06199,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB06199,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB06199,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB06199,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06199,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06199,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06199,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06199,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06199,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06199,Dioxoles,DrugBank
DB06199,Endothelin A Receptor Antagonists,DrugBank
DB06199,Endothelin Receptor Antagonists,DrugBank
DB06199,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06199,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06199,OATP1B1/SLCO1B1 Substrates,DrugBank
DB06199,OATP1B3 inhibitors,DrugBank
DB06199,OATP1B3 substrates,DrugBank
DB06199,P-glycoprotein inhibitors,DrugBank
DB06199,P-glycoprotein substrates,DrugBank
DB06199,Pyrrolidines,DrugBank
DB06200,Antiarrhythmic agents,DrugBank
DB06200,"Antiarrhythmics, Class III",DrugBank
DB06200,Cardiac Therapy,DrugBank
DB06200,Cardiotonic Agents,DrugBank
DB06200,Cardiovascular Agents,DrugBank
DB06200,"Compounds used in a research, industrial, or household setting",DrugBank
DB06200,Cycloparaffins,DrugBank
DB06200,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06200,Protective Agents,DrugBank
DB06200,QTc Prolonging Agents,DrugBank
DB06201,Anticonvulsants,DrugBank
DB06201,Carboxamide Derivatives,DrugBank
DB06201,Cardiovascular Agents,DrugBank
DB06201,Central Nervous System Agents,DrugBank
DB06201,Central Nervous System Depressants,DrugBank
DB06201,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB06201,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB06201,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06201,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06201,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB06201,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06201,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06201,Membrane Transport Modulators,DrugBank
DB06201,Miscellaneous Anticonvulsants,DrugBank
DB06201,Nervous System,DrugBank
DB06201,Sodium Channel Blockers,DrugBank
DB06201,Voltage-Gated Sodium Channel Blockers,DrugBank
DB06203,Agents causing angioedema,DrugBank
DB06203,Alimentary Tract and Metabolism,DrugBank
DB06203,Blood Glucose Lowering Agents,DrugBank
DB06203,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06203,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06203,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06203,Cytochrome P-450 Substrates,DrugBank
DB06203,DPP-IV Inhibitors,DrugBank
DB06203,Drugs that are Mainly Renally Excreted,DrugBank
DB06203,Drugs Used in Diabetes,DrugBank
DB06203,Enzyme Inhibitors,DrugBank
DB06203,Hormones,DrugBank
DB06203,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06203,Incretins,DrugBank
DB06203,Oral Hypoglycemics,DrugBank
DB06203,Protease Inhibitors,DrugBank
DB06203,Pyrimidines,DrugBank
DB06203,Pyrimidinones,DrugBank
DB06204,Adrenergic Agents,DrugBank
DB06204,Adrenergic Uptake Inhibitors,DrugBank
DB06204,Analgesics,DrugBank
DB06204,Antidepressive Agents,DrugBank
DB06204,Benzene Derivatives,DrugBank
DB06204,Central Nervous System Agents,DrugBank
DB06204,Central Nervous System Depressants,DrugBank
DB06204,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB06204,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06204,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06204,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06204,Cytochrome P-450 Substrates,DrugBank
DB06204,Membrane Transport Modulators,DrugBank
DB06204,Narcotics,DrugBank
DB06204,Nervous System,DrugBank
DB06204,Neurotransmitter Agents,DrugBank
DB06204,Neurotransmitter Uptake Inhibitors,DrugBank
DB06204,Opiate Agonists,DrugBank
DB06204,Opioid Agonist,DrugBank
DB06204,Opioids,DrugBank
DB06204,Peripheral Nervous System Agents,DrugBank
DB06204,Phenols,DrugBank
DB06204,Sensory System Agents,DrugBank
DB06204,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06204,Serotonin Agents,DrugBank
DB06204,Serotonin Modulators,DrugBank
DB06204,UGT1A9 Substrates,DrugBank
DB06204,UGT2B7 substrates,DrugBank
DB06205,Blood and Blood Forming Organs,DrugBank
DB06205,Carbon-Oxygen Lyases,DrugBank
DB06205,Enzymes,DrugBank
DB06205,Enzymes and Coenzymes,DrugBank
DB06205,Glycoside Hydrolases,DrugBank
DB06205,"Hyaluronoglucosaminidase, antagonists & inhibitors",DrugBank
DB06205,Hydrolases,DrugBank
DB06205,Lyases,DrugBank
DB06205,Polysaccharide-Lyases,DrugBank
DB06206,Antidotes,DrugBank
DB06206,Carbohydrates,DrugBank
DB06206,"Compounds used in a research, industrial, or household setting",DrugBank
DB06206,Cyclodextrins,DrugBank
DB06206,Dextrins,DrugBank
DB06206,gamma-Cyclodextrins,DrugBank
DB06206,Glucans,DrugBank
DB06206,Polysaccharides,DrugBank
DB06206,Starch,DrugBank
DB06207,Adrenergic Agents,DrugBank
DB06207,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB06207,Adrenergic alpha-Antagonists,DrugBank
DB06207,Adrenergic Antagonists,DrugBank
DB06207,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06207,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06207,Cytochrome P-450 Substrates,DrugBank
DB06207,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB06207,Genito Urinary System and Sex Hormones,DrugBank
DB06207,Genitourinary Agents,DrugBank
DB06207,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06207,Neurotransmitter Agents,DrugBank
DB06207,P-glycoprotein substrates,DrugBank
DB06207,Peripheral alpha-1 blockers,DrugBank
DB06207,Selective Alfa-1-adrenergic Blocking Agents,DrugBank
DB06207,UGT2B7 substrates,DrugBank
DB06207,Urological Agents,DrugBank
DB06207,Urologicals,DrugBank
DB06209,Anticoagulants,DrugBank
DB06209,Antiplatelet agents,DrugBank
DB06209,Blood and Blood Forming Organs,DrugBank
DB06209,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06209,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06209,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06209,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06209,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06209,Cytochrome P-450 Substrates,DrugBank
DB06209,Decreased Platelet Aggregation,DrugBank
DB06209,Drugs that are Mainly Renally Excreted,DrugBank
DB06209,Hematologic Agents,DrugBank
DB06209,P2Y12 Platelet Inhibitor,DrugBank
DB06209,Piperazines,DrugBank
DB06209,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB06209,Purinergic P2Y Receptor Antagonists,DrugBank
DB06209,Sulfur Compounds,DrugBank
DB06209,Thiophenes,DrugBank
DB06210,"Acids, Carbocyclic",DrugBank
DB06210,BCRP/ABCG2 Inhibitors,DrugBank
DB06210,Benzene Derivatives,DrugBank
DB06210,Blood and Blood Forming Organs,DrugBank
DB06210,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06210,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06210,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB06210,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06210,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06210,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06210,Cytochrome P-450 Substrates,DrugBank
DB06210,Hematinics,DrugBank
DB06210,Hemostatics,DrugBank
DB06210,Increased Megakaryocyte Maturation,DrugBank
DB06210,Increased Platelet Production,DrugBank
DB06210,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06210,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB06210,Thrombopoietin Receptor Agonist,DrugBank
DB06210,Thrombopoietin Receptor Agonists,DrugBank
DB06210,UGT1A1 Inhibitors,DrugBank
DB06210,UGT1A1 Substrates,DrugBank
DB06210,UGT1A3 Inhibitors,DrugBank
DB06210,UGT1A3 substrates,DrugBank
DB06210,UGT1A4 Inhibitors,DrugBank
DB06210,UGT1A6 Inhibitors,DrugBank
DB06210,UGT1A9 Inhibitors,DrugBank
DB06210,UGT2B15 Inhibitors,DrugBank
DB06210,UGT2B7 Inhibitors,DrugBank
DB06211,Amides,DrugBank
DB06211,Anti-Bacterial Agents,DrugBank
DB06211,Anti-Infective Agents,DrugBank
DB06211,Antibacterials for Systemic Use,DrugBank
DB06211,Antiinfectives for Systemic Use,DrugBank
DB06211,beta-Lactams,DrugBank
DB06211,Carbapenems,DrugBank
DB06211,Drugs that are Mainly Renally Excreted,DrugBank
DB06211,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06211,Lactams,DrugBank
DB06211,OAT3/SLC22A8 Substrates,DrugBank
DB06211,Penem Antibacterial,DrugBank
DB06211,Sulfur Compounds,DrugBank
DB06212,Agents causing hyperkalemia,DrugBank
DB06212,Antidiuretic Hormone Receptor Antagonists,DrugBank
DB06212,Benzazepines,DrugBank
DB06212,Cardiovascular Agents,DrugBank
DB06212,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06212,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06212,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06212,Cytochrome P-450 Substrates,DrugBank
DB06212,Diuretics,DrugBank
DB06212,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06212,Narrow Therapeutic Index Drugs,DrugBank
DB06212,Natriuretic Agents,DrugBank
DB06212,P-glycoprotein inhibitors,DrugBank
DB06212,P-glycoprotein substrates,DrugBank
DB06212,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06212,Vasopressin V2 Receptor Antagonist,DrugBank
DB06212,Vasopressin V2 Receptor Antagonists,DrugBank
DB06213,Adenosine A receptor agonists,DrugBank
DB06213,Adenosine A2 Receptor Agonists,DrugBank
DB06213,Cardiac Therapy,DrugBank
DB06213,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06213,Neurotransmitter Agents,DrugBank
DB06213,Pharmacologic Cardiac Stress Test Agent,DrugBank
DB06213,Purinergic Agents,DrugBank
DB06213,Purinergic Agonists,DrugBank
DB06213,Purinergic P1 Receptor Agonists,DrugBank
DB06215,"Compounds used in a research, industrial, or household setting",DrugBank
DB06215,Ferric Compounds,DrugBank
DB06215,Ferrous Compounds,DrugBank
DB06215,Hematinics,DrugBank
DB06215,Hematologic Agents,DrugBank
DB06215,Iron Compounds,DrugBank
DB06215,Magnetic Resonance Contrast Activity,DrugBank
DB06215,Minerals,DrugBank
DB06215,Paramagnetic Contrast Agent,DrugBank
DB06215,Parenteral Iron Replacement,DrugBank
DB06215,Parenteral Nutrition Solutions,DrugBank
DB06215,Pharmaceutical Preparations,DrugBank
DB06215,Pharmaceutical Solutions,DrugBank
DB06215,Solutions,DrugBank
DB06216,Acid Reducers,DrugBank
DB06216,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB06216,Adrenergic alpha-Antagonists,DrugBank
DB06216,Adrenergic Antagonists,DrugBank
DB06216,Agents that produce hypertension,DrugBank
DB06216,Antidepressive Agents,DrugBank
DB06216,Antipsychotic Agents,DrugBank
DB06216,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB06216,Benzocycloheptenes,DrugBank
DB06216,Central Nervous System Agents,DrugBank
DB06216,Central Nervous System Depressants,DrugBank
DB06216,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06216,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06216,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06216,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06216,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06216,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06216,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06216,Cytochrome P-450 Substrates,DrugBank
DB06216,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB06216,Dopamine Antagonists,DrugBank
DB06216,Dopamine D2 Receptor Antagonists,DrugBank
DB06216,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06216,Highest Risk QTc-Prolonging Agents,DrugBank
DB06216,Histamine Antagonists,DrugBank
DB06216,Histamine H1 Antagonists,DrugBank
DB06216,Histamine H2 Antagonists,DrugBank
DB06216,Hyperglycemia-Associated Agents,DrugBank
DB06216,Nervous System,DrugBank
DB06216,Neurotoxic agents,DrugBank
DB06216,Psycholeptics,DrugBank
DB06216,Psychotropic Drugs,DrugBank
DB06216,QTc Prolonging Agents,DrugBank
DB06216,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06216,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB06216,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB06216,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06216,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06216,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06216,Serotonin Agents,DrugBank
DB06216,Serotonin Receptor Agonists,DrugBank
DB06216,Serotonin Receptor Antagonists,DrugBank
DB06216,Tranquilizing Agents,DrugBank
DB06216,UGT1A4 substrates,DrugBank
DB06217,Antiarrhythmic agents,DrugBank
DB06217,"Antiarrhythmics, Class III",DrugBank
DB06217,Benzene Derivatives,DrugBank
DB06217,Cardiac Therapy,DrugBank
DB06217,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06217,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06217,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06217,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06217,Cytochrome P-450 Substrates,DrugBank
DB06217,Ethers,DrugBank
DB06217,Methyl Ethers,DrugBank
DB06217,Phenols,DrugBank
DB06217,Phenyl Ethers,DrugBank
DB06217,Potential QTc-Prolonging Agents,DrugBank
DB06217,QTc Prolonging Agents,DrugBank
DB06218,Acetamides,DrugBank
DB06218,Acetates,DrugBank
DB06218,"Acids, Acyclic",DrugBank
DB06218,Alkanes,DrugBank
DB06218,Amides,DrugBank
DB06218,Anti-epileptic Agent,DrugBank
DB06218,Anticonvulsants,DrugBank
DB06218,Bradycardia-Causing Agents,DrugBank
DB06218,Cardiovascular Agents,DrugBank
DB06218,Central Nervous System Agents,DrugBank
DB06218,Central Nervous System Depressants,DrugBank
DB06218,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06218,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06218,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06218,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06218,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB06218,Cytochrome P-450 Substrates,DrugBank
DB06218,Decreased Central Nervous System Disorganized Electrical Activity,DrugBank
DB06218,"Hydrocarbons, Acyclic",DrugBank
DB06218,Membrane Transport Modulators,DrugBank
DB06218,Miscellaneous Anticonvulsants,DrugBank
DB06218,Nervous System,DrugBank
DB06218,Sodium Channel Blockers,DrugBank
DB06218,Voltage-Gated Sodium Channel Blockers,DrugBank
DB06219,"Amino Acids, Peptides, and Proteins",DrugBank
DB06219,Anti-Bacterial Agents,DrugBank
DB06219,Anti-Infective Agents,DrugBank
DB06219,Antibacterials for Systemic Use,DrugBank
DB06219,Antiinfectives for Systemic Use,DrugBank
DB06219,Carbohydrates,DrugBank
DB06219,Glycoconjugates,DrugBank
DB06219,Glycopeptide Antibacterials,DrugBank
DB06219,Glycopeptides,DrugBank
DB06219,Lipoglycopeptide Antibacterial,DrugBank
DB06219,Lipoglycopeptides,DrugBank
DB06219,Peptides,DrugBank
DB06228,Anticoagulants,DrugBank
DB06228,Antithrombins,DrugBank
DB06228,BCRP/ABCG2 Substrates,DrugBank
DB06228,Blood and Blood Forming Organs,DrugBank
DB06228,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06228,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06228,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06228,Cytochrome P-450 Substrates,DrugBank
DB06228,Direct factor Xa inhibitors,DrugBank
DB06228,Drugs that are Mainly Renally Excreted,DrugBank
DB06228,Enzyme Inhibitors,DrugBank
DB06228,Factor Xa Inhibitors,DrugBank
DB06228,Hematologic Agents,DrugBank
DB06228,Morpholines,DrugBank
DB06228,Oxazines,DrugBank
DB06228,P-glycoprotein substrates,DrugBank
DB06228,Protease Inhibitors,DrugBank
DB06228,Serine Protease Inhibitors,DrugBank
DB06228,Sulfur Compounds,DrugBank
DB06228,Thiophenes,DrugBank
DB06230,Alkaloids,DrugBank
DB06230,Antidotes,DrugBank
DB06230,Antipruritics,DrugBank
DB06230,Central Nervous System Agents,DrugBank
DB06230,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06230,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06230,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06230,Cytochrome P-450 Substrates,DrugBank
DB06230,Drugs that are Mainly Renally Excreted,DrugBank
DB06230,Drugs Used in Addictive Disorders,DrugBank
DB06230,Drugs Used in Alcohol Dependence,DrugBank
DB06230,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06230,Morphinans,DrugBank
DB06230,Nervous System,DrugBank
DB06230,Opiate Alkaloids,DrugBank
DB06230,Opioid Antagonists,DrugBank
DB06230,Peripheral Nervous System Agents,DrugBank
DB06230,Phenanthrenes,DrugBank
DB06230,Sensory System Agents,DrugBank
DB06230,UGT1A3 substrates,DrugBank
DB06230,UGT2B7 substrates,DrugBank
DB06233,Anti-Bacterial Agents,DrugBank
DB06233,Antineoplastic Agents,DrugBank
DB06233,Antineoplastic and Immunomodulating Agents,DrugBank
DB06233,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06233,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06233,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06233,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06233,Lactones,DrugBank
DB06233,Macrolides,DrugBank
DB06233,Mammalian target of rapamycin (mTOR) kinase inhibitors,DrugBank
DB06233,mTOR Inhibitors,DrugBank
DB06233,Protein Kinase Inhibitors,DrugBank
DB06234,Anti-Infective Agents,DrugBank
DB06234,Antiinfectives for Systemic Use,DrugBank
DB06234,Antiviral Agents,DrugBank
DB06234,Antivirals for Systemic Use,DrugBank
DB06234,BCRP/ABCG2 Inhibitors,DrugBank
DB06234,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06234,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06234,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06234,Cytochrome P-450 Substrates,DrugBank
DB06234,Cytomegalovirus pUL97 Kinase Inhibitor,DrugBank
DB06234,Direct Acting Antivirals,DrugBank
DB06234,Glycosides,DrugBank
DB06234,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06234,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06234,Nucleosides,DrugBank
DB06234,P-glycoprotein inhibitors,DrugBank
DB06234,Ribonucleosides,DrugBank
DB06235,Antineoplastic Agents,DrugBank
DB06235,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06235,Cytochrome P-450 Substrates,DrugBank
DB06235,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06235,UGT1A9 Substrates,DrugBank
DB06235,UGT2B7 substrates,DrugBank
DB06235,Xanthenes,DrugBank
DB06237,BCRP/ABCG2 Inhibitors,DrugBank
DB06237,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06237,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06237,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06237,Cytochrome P-450 Substrates,DrugBank
DB06237,Drugs Used in Erectile Dysfunction,DrugBank
DB06237,Genito Urinary System and Sex Hormones,DrugBank
DB06237,P-glycoprotein substrates,DrugBank
DB06237,Phosphodiesterase 5 Inhibitors,DrugBank
DB06237,Phosphodiesterase Inhibitors,DrugBank
DB06237,Urologicals,DrugBank
DB06237,Vasodilating Agents,DrugBank
DB06240,"Drug Resistance, Multiple",DrugBank
DB06240,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06240,P-glycoprotein inhibitors,DrugBank
DB06241,"Amino Acids, Peptides, and Proteins",DrugBank
DB06241,Antibodies,DrugBank
DB06241,"Antigens, CD4",DrugBank
DB06241,Blood Proteins,DrugBank
DB06241,Globulins,DrugBank
DB06241,Immunoglobulins,DrugBank
DB06241,Immunoproteins,DrugBank
DB06241,Proteins,DrugBank
DB06241,Serum Globulins,DrugBank
DB06243,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB06243,Amino Acids,DrugBank
DB06243,"Amino Acids, Basic",DrugBank
DB06243,"Amino Acids, Diamino",DrugBank
DB06243,"Amino Acids, Peptides, and Proteins",DrugBank
DB06243,Anti-Infective Agents,DrugBank
DB06243,Antineoplastic Agents,DrugBank
DB06243,Antineoplastic and Immunomodulating Agents,DrugBank
DB06243,Antiparasitic Agents,DrugBank
DB06243,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06243,Antiprotozoals,DrugBank
DB06243,Decarboxylase Inhibitor,DrugBank
DB06243,Decarboxylase Inhibitors,DrugBank
DB06243,Dermatologicals,DrugBank
DB06243,Enzyme Inhibitors,DrugBank
DB06243,Misc. Skin and Mucous Membrane Agents,DrugBank
DB06243,Ornithine Decarboxylase Inhibitors,DrugBank
DB06243,Trypanocidal Agents,DrugBank
DB06245,Agents causing angioedema,DrugBank
DB06245,"Amino Acids, Peptides, and Proteins",DrugBank
DB06245,Biological Factors,DrugBank
DB06245,Blood Proteins,DrugBank
DB06245,Endopeptidases,DrugBank
DB06245,Enzymes,DrugBank
DB06245,Enzymes and Coenzymes,DrugBank
DB06245,Hydrolases,DrugBank
DB06245,Peptide Hydrolases,DrugBank
DB06245,Plasminogen Activators,DrugBank
DB06245,Proteins,DrugBank
DB06245,Serine Endopeptidases,DrugBank
DB06245,Serine Proteases,DrugBank
DB06246,Analgesics,DrugBank
DB06246,"Analgesics, Non-Narcotic",DrugBank
DB06246,Anti-Inflammatory Agents,DrugBank
DB06246,Anticarcinogenic Agents,DrugBank
DB06246,Antineoplastic Agents,DrugBank
DB06246,Antirheumatic Agents,DrugBank
DB06246,"Compounds used in a research, industrial, or household setting",DrugBank
DB06246,Cyclooxygenase Inhibitors,DrugBank
DB06246,Enzyme Inhibitors,DrugBank
DB06246,Indenes,DrugBank
DB06246,Peripheral Nervous System Agents,DrugBank
DB06246,Protective Agents,DrugBank
DB06246,Sensory System Agents,DrugBank
DB06250,17-Ketosteroids,DrugBank
DB06250,Adrenal Cortex Hormones,DrugBank
DB06250,Androstanes,DrugBank
DB06250,Androstenes,DrugBank
DB06250,Androstenols,DrugBank
DB06250,Fused-Ring Compounds,DrugBank
DB06250,Gonadal Hormones,DrugBank
DB06250,Gonadal Steroid Hormones,DrugBank
DB06250,Hormones,DrugBank
DB06250,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06250,Ketosteroids,DrugBank
DB06250,Steroids,DrugBank
DB06250,Testosterone Congeners,DrugBank
DB06251,"Acids, Carbocyclic",DrugBank
DB06251,Benzene Derivatives,DrugBank
DB06251,Benzoates,DrugBank
DB06251,Hydroxy Acids,DrugBank
DB06251,Hydroxybenzoates,DrugBank
DB06251,Phenols,DrugBank
DB06251,"Platelet Activating Factor, antagonists & inhibitors",DrugBank
DB06251,Salicylates,DrugBank
DB06255,Antineoplastic Agents,DrugBank
DB06255,Bisphosphonates,DrugBank
DB06255,Bone Density Conservation Agents,DrugBank
DB06255,Organophosphonates,DrugBank
DB06255,Organophosphorus Compounds,DrugBank
DB06262,Adrenergic Agonists,DrugBank
DB06262,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB06262,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB06262,Adrenergic alpha-Agonists,DrugBank
DB06262,Adrenergic and Dopaminergic Agents,DrugBank
DB06262,Adrenergic beta-1 Receptor Agonists,DrugBank
DB06262,Adrenergic beta-2 Receptor Agonists,DrugBank
DB06262,Adrenergic beta-3 Receptor Agonists,DrugBank
DB06262,Adrenergic beta-Agonists,DrugBank
DB06262,Agents producing tachycardia,DrugBank
DB06262,Agents that produce hypertension,DrugBank
DB06262,Amines,DrugBank
DB06262,Amino Acids,DrugBank
DB06262,"Amino Acids, Neutral",DrugBank
DB06262,"Amino Acids, Peptides, and Proteins",DrugBank
DB06262,Anti-Dyskinesia Agents,DrugBank
DB06262,Benzene Derivatives,DrugBank
DB06262,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB06262,Cardiac Therapy,DrugBank
DB06262,Catecholamines,DrugBank
DB06262,Catechols,DrugBank
DB06262,Central Nervous System Agents,DrugBank
DB06262,Drugs that are Mainly Renally Excreted,DrugBank
DB06262,Epinephrine and similars,DrugBank
DB06262,Increased Blood Pressure,DrugBank
DB06262,Phenols,DrugBank
DB06263,Anthracyclines and Related Substances,DrugBank
DB06263,Antineoplastic Agents,DrugBank
DB06263,Antineoplastic and Immunomodulating Agents,DrugBank
DB06263,Carbohydrates,DrugBank
DB06263,Cytotoxic Antibiotics and Related Substances,DrugBank
DB06263,Cytotoxins,DrugBank
DB06263,Glycosides,DrugBank
DB06263,Naphthacenes,DrugBank
DB06264,Central Nervous System Agents,DrugBank
DB06264,Central Nervous System Depressants,DrugBank
DB06264,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06264,Cytochrome P-450 Substrates,DrugBank
DB06264,Ketones,DrugBank
DB06264,Muscle Relaxants,DrugBank
DB06264,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB06264,Musculo-Skeletal System,DrugBank
DB06264,Neuromuscular Agents,DrugBank
DB06264,Peripheral Nervous System Agents,DrugBank
DB06264,Propiophenones,DrugBank
DB06264,Pyridines,DrugBank
DB06264,Topical Products for Joint and Muscular Pain,DrugBank
DB06266,Adrenal Cortex Hormones,DrugBank
DB06266,Anti-Infective Agents,DrugBank
DB06266,Antineoplastic Agents,DrugBank
DB06266,Antineoplastic and Immunomodulating Agents,DrugBank
DB06266,Antiparasitic Agents,DrugBank
DB06266,Antiprotozoals,DrugBank
DB06266,Antispermatogenic Agents,DrugBank
DB06266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06266,Noxae,DrugBank
DB06266,Pyrazoles,DrugBank
DB06266,Radiation-Sensitizing Agents,DrugBank
DB06266,Reproductive Control Agents,DrugBank
DB06266,Toxic Actions,DrugBank
DB06266,Trypanocidal Agents,DrugBank
DB06267,Amides,DrugBank
DB06267,Benzene Derivatives,DrugBank
DB06267,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06267,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06267,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06267,Cytochrome P-450 Substrates,DrugBank
DB06267,Drugs Used in Erectile Dysfunction,DrugBank
DB06267,Enzyme Inhibitors,DrugBank
DB06267,Genito Urinary System and Sex Hormones,DrugBank
DB06267,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06267,Phosphodiesterase 5 Inhibitors,DrugBank
DB06267,Phosphodiesterase Inhibitors,DrugBank
DB06267,Sulfonamides,DrugBank
DB06267,Sulfones,DrugBank
DB06267,Sulfur Compounds,DrugBank
DB06267,Urologicals,DrugBank
DB06267,Vasodilating Agents,DrugBank
DB06268,Antihypertensive Agents,DrugBank
DB06268,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB06268,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06268,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06268,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB06268,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06268,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06268,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06268,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06268,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06268,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06268,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06268,Cytochrome P-450 Substrates,DrugBank
DB06268,Endothelin Receptor Antagonists,DrugBank
DB06268,Sulfur Compounds,DrugBank
DB06271,Agents causing hyperkalemia,DrugBank
DB06271,Anticoagulants,DrugBank
DB06271,Blood and Blood Forming Organs,DrugBank
DB06271,Carbohydrates,DrugBank
DB06271,Cardiovascular Agents,DrugBank
DB06271,Fibrin Modulating Agents,DrugBank
DB06271,Fibrinolytic Agents,DrugBank
DB06271,Hematologic Agents,DrugBank
DB06271,Heparin and similars,DrugBank
DB06271,Heparin Group,DrugBank
DB06271,Polysaccharides,DrugBank
DB06272,Anticarcinogenic Agents,DrugBank
DB06272,Antineoplastic Agents,DrugBank
DB06272,Cholestanes,DrugBank
DB06272,Cholestenes,DrugBank
DB06272,"Compounds used in a research, industrial, or household setting",DrugBank
DB06272,Dermatologicals,DrugBank
DB06272,Fused-Ring Compounds,DrugBank
DB06272,Lipids,DrugBank
DB06272,Membrane Lipids,DrugBank
DB06272,Protective Agents,DrugBank
DB06272,Secosteroids,DrugBank
DB06272,Steroids,DrugBank
DB06272,Sterols,DrugBank
DB06272,Vitamin D and Analogues,DrugBank
DB06272,Vitamins,DrugBank
DB06272,Vitamins (Fat Soluble),DrugBank
DB06273,Agents reducing cytokine levels,DrugBank
DB06273,"Amino Acids, Peptides, and Proteins",DrugBank
DB06273,Antibodies,DrugBank
DB06273,"Antibodies, Monoclonal",DrugBank
DB06273,"Antibodies, Monoclonal, Humanized",DrugBank
DB06273,Antineoplastic and Immunomodulating Agents,DrugBank
DB06273,Antirheumatic Agents,DrugBank
DB06273,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB06273,Blood Proteins,DrugBank
DB06273,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06273,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06273,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06273,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB06273,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06273,Disease-modifying Antirheumatic Agents,DrugBank
DB06273,Experimental Unapproved Treatments for COVID-19,DrugBank
DB06273,Globulins,DrugBank
DB06273,Immunoglobulins,DrugBank
DB06273,Immunoproteins,DrugBank
DB06273,Immunosuppressive Agents,DrugBank
DB06273,Interleukin Inhibitors,DrugBank
DB06273,Interleukin-6 Receptor Antagonist,DrugBank
DB06273,Proteins,DrugBank
DB06273,Serum Globulins,DrugBank
DB06282,Antihistamines for Systemic Use,DrugBank
DB06282,Central Nervous System Depressants,DrugBank
DB06282,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06282,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06282,Cytochrome P-450 Substrates,DrugBank
DB06282,Drugs that are Mainly Renally Excreted,DrugBank
DB06282,Histamine Agents,DrugBank
DB06282,Histamine Antagonists,DrugBank
DB06282,Histamine H1 Antagonists,DrugBank
DB06282,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB06282,Neurotransmitter Agents,DrugBank
DB06282,Piperazine Derivatives,DrugBank
DB06282,Piperazines,DrugBank
DB06282,Potential QTc-Prolonging Agents,DrugBank
DB06282,QTc Prolonging Agents,DrugBank
DB06283,Analgesics,DrugBank
DB06283,"Analgesics, Non-Narcotic",DrugBank
DB06283,Antiarrhythmic agents,DrugBank
DB06283,Calcium Channel Blockers,DrugBank
DB06283,"Calcium Channels, N-Type",DrugBank
DB06283,Calcium-Regulating Hormones and Agents,DrugBank
DB06283,Central Nervous System Agents,DrugBank
DB06283,Central Nervous System Depressants,DrugBank
DB06283,Complex Mixtures,DrugBank
DB06283,"Compounds used in a research, industrial, or household setting",DrugBank
DB06283,Conotoxins,DrugBank
DB06283,Fluids and Secretions,DrugBank
DB06283,Marine Toxins,DrugBank
DB06283,Membrane Transport Modulators,DrugBank
DB06283,Mollusk Venoms,DrugBank
DB06283,N-Calcium Channel Receptor Antagonists,DrugBank
DB06283,Narrow Therapeutic Index Drugs,DrugBank
DB06283,Nervous System,DrugBank
DB06283,Neuroprotective Agents,DrugBank
DB06283,Peripheral Nervous System Agents,DrugBank
DB06283,Protective Agents,DrugBank
DB06283,Sensory System Agents,DrugBank
DB06283,"Toxins, Biological",DrugBank
DB06283,Vasodilating Agents,DrugBank
DB06283,Venoms,DrugBank
DB06285,"Amino Acids, Peptides, and Proteins",DrugBank
DB06285,Bone Anabolic Agents,DrugBank
DB06285,Bone Density Conservation Agents,DrugBank
DB06285,Calcium Homeostasis,DrugBank
DB06285,Calcium-Regulating Hormones and Agents,DrugBank
DB06285,Hormones,DrugBank
DB06285,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06285,Parathyroid Agents,DrugBank
DB06285,Parathyroid Hormones and Analogues,DrugBank
DB06285,Peptide Hormones,DrugBank
DB06285,Peptides,DrugBank
DB06285,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB06285,Thyroid Products,DrugBank
DB06287,Agents causing angioedema,DrugBank
DB06287,Anti-Bacterial Agents,DrugBank
DB06287,Antineoplastic Agents,DrugBank
DB06287,Antineoplastic and Immunomodulating Agents,DrugBank
DB06287,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06287,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06287,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06287,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06287,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06287,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06287,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06287,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06287,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06287,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB06287,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB06287,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB06287,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06287,Cytochrome P-450 Substrates,DrugBank
DB06287,Enzyme Inhibitors,DrugBank
DB06287,Hyperglycemia-Associated Agents,DrugBank
DB06287,Immunologic Factors,DrugBank
DB06287,Immunosuppressive Agents,DrugBank
DB06287,Kinase Inhibitor,DrugBank
DB06287,Lactones,DrugBank
DB06287,Macrolides,DrugBank
DB06287,Mammalian target of rapamycin (mTOR) kinase inhibitors,DrugBank
DB06287,mTOR Inhibitors,DrugBank
DB06287,Myelosuppressive Agents,DrugBank
DB06287,Narrow Therapeutic Index Drugs,DrugBank
DB06287,P-glycoprotein inhibitors,DrugBank
DB06287,P-glycoprotein substrates,DrugBank
DB06287,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06287,Polyketides,DrugBank
DB06287,Protein Kinase Inhibitors,DrugBank
DB06287,Sirolimus and Prodrugs,DrugBank
DB06288,"Acids, Carbocyclic",DrugBank
DB06288,Amides,DrugBank
DB06288,Antidepressive Agents,DrugBank
DB06288,"Antidepressive Agents, Second-Generation",DrugBank
DB06288,Antiemetics,DrugBank
DB06288,Antipsychotic Agents,DrugBank
DB06288,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB06288,BCRP/ABCG2 Substrates,DrugBank
DB06288,Benzamides and benzamide derivatives,DrugBank
DB06288,Benzene Derivatives,DrugBank
DB06288,Benzoates,DrugBank
DB06288,Central Nervous System Agents,DrugBank
DB06288,Central Nervous System Depressants,DrugBank
DB06288,Dopamine Agents,DrugBank
DB06288,Dopamine Antagonists,DrugBank
DB06288,Dopamine D2 Receptor Antagonists,DrugBank
DB06288,MATE 1 Inhibitors,DrugBank
DB06288,MATE 1 Substrates,DrugBank
DB06288,MATE 2 Inhibitors,DrugBank
DB06288,MATE 2 Substrates,DrugBank
DB06288,MATE inhibitors,DrugBank
DB06288,MATE substrates,DrugBank
DB06288,Nervous System,DrugBank
DB06288,Neurotoxic agents,DrugBank
DB06288,Neurotransmitter Agents,DrugBank
DB06288,OCT1 substrates,DrugBank
DB06288,Opioid Agonist,DrugBank
DB06288,P-glycoprotein substrates,DrugBank
DB06288,Potential QTc-Prolonging Agents,DrugBank
DB06288,Psycholeptics,DrugBank
DB06288,Psychotropic Drugs,DrugBank
DB06288,QTc Prolonging Agents,DrugBank
DB06288,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06288,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06288,Serotonin Agents,DrugBank
DB06288,Serotonin Receptor Antagonists,DrugBank
DB06288,Tranquilizing Agents,DrugBank
DB06290,Anti-Infective Agents,DrugBank
DB06290,Antiinfectives for Systemic Use,DrugBank
DB06290,Antiviral Agents,DrugBank
DB06290,Antivirals for Systemic Use,DrugBank
DB06290,Antivirals for treatment of HCV infections,DrugBank
DB06290,BCRP/ABCG2 Inhibitors,DrugBank
DB06290,BCRP/ABCG2 Substrates,DrugBank
DB06290,BSEP/ABCB11 Inhibitors,DrugBank
DB06290,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06290,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB06290,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06290,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06290,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06290,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB06290,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06290,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06290,Cytochrome P-450 Substrates,DrugBank
DB06290,Direct Acting Antivirals,DrugBank
DB06290,Drugs causing inadvertant photosensitivity,DrugBank
DB06290,Enzyme Inhibitors,DrugBank
DB06290,Genito Urinary System and Sex Hormones,DrugBank
DB06290,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06290,HCV NS3/4A Protease Inhibitors,DrugBank
DB06290,HCV Protease Inhibitors,DrugBank
DB06290,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06290,NS3/4A Protease Inhibitors,DrugBank
DB06290,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06290,OATP1B1/SLCO1B1 Substrates,DrugBank
DB06290,OATP1B3 inhibitors,DrugBank
DB06290,OATP1B3 substrates,DrugBank
DB06290,OATP2B1/SLCO2B1 substrates,DrugBank
DB06290,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB06290,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB06290,P-glycoprotein inhibitors,DrugBank
DB06290,P-glycoprotein substrates,DrugBank
DB06290,Photosensitizing Agents,DrugBank
DB06290,Protease Inhibitors,DrugBank
DB06290,Sulfonamides,DrugBank
DB06290,Sulfones,DrugBank
DB06290,Sulfur Compounds,DrugBank
DB06292,Alimentary Tract and Metabolism,DrugBank
DB06292,Benzene Derivatives,DrugBank
DB06292,Blood Glucose Lowering Agents,DrugBank
DB06292,Carbohydrates,DrugBank
DB06292,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB06292,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06292,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB06292,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06292,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06292,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06292,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06292,Cytochrome P-450 Substrates,DrugBank
DB06292,Diuretics,DrugBank
DB06292,Drugs Used in Diabetes,DrugBank
DB06292,Glycosides,DrugBank
DB06292,Hypotensive Agents,DrugBank
DB06292,Oral Hypoglycemics,DrugBank
DB06292,P-glycoprotein substrates,DrugBank
DB06292,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB06292,"Sodium-Glucose Transport Proteins, antagonists & inhibitors",DrugBank
DB06292,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB06292,UGT1A9 Substrates,DrugBank
DB06292,UGT2B7 substrates,DrugBank
DB06293,"Factor IXa, antagonists & inhibitors",DrugBank
DB06293,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06293,Nucleotides,DrugBank
DB06293,Oligonucleotides,DrugBank
DB06293,Pegylated agents,DrugBank
DB06293,Polynucleotides,DrugBank
DB06294,Anticoagulants,DrugBank
DB06294,Carbohydrates,DrugBank
DB06294,Cardiovascular Agents,DrugBank
DB06294,Fibrin Modulating Agents,DrugBank
DB06294,Glycosaminoglycans,DrugBank
DB06294,Hematologic Agents,DrugBank
DB06294,Heparin and similars,DrugBank
DB06294,Polysaccharides,DrugBank
DB06304,"Amino Acids, Peptides, and Proteins",DrugBank
DB06304,Antibodies,DrugBank
DB06304,Blood Proteins,DrugBank
DB06304,Globulins,DrugBank
DB06304,Immunoglobulins,DrugBank
DB06304,Immunologic Factors,DrugBank
DB06304,Immunoproteins,DrugBank
DB06304,Proteins,DrugBank
DB06304,Serum Globulins,DrugBank
DB06305,"Amino Acids, Peptides, and Proteins",DrugBank
DB06305,Antibodies,DrugBank
DB06305,"Antibodies, Monoclonal",DrugBank
DB06305,"Antibodies, Monoclonal, Humanized",DrugBank
DB06305,Blood Proteins,DrugBank
DB06305,Globulins,DrugBank
DB06305,Immunoglobulins,DrugBank
DB06305,Immunoproteins,DrugBank
DB06305,Proteins,DrugBank
DB06305,Serum Globulins,DrugBank
DB06310,"Amino Acids, Peptides, and Proteins",DrugBank
DB06310,Antibodies,DrugBank
DB06310,"Antibodies, Monoclonal",DrugBank
DB06310,"Antibodies, Monoclonal, Humanized",DrugBank
DB06310,Antiinfectives for Systemic Use,DrugBank
DB06310,Antiviral monoclonal antibodies,DrugBank
DB06310,Blood Proteins,DrugBank
DB06310,Globulins,DrugBank
DB06310,Immune Sera and Immunoglobulins,DrugBank
DB06310,Immunoglobulins,DrugBank
DB06310,Immunoproteins,DrugBank
DB06310,Proteins,DrugBank
DB06310,Serum Globulins,DrugBank
DB06310,Specific Immunoglobulins,DrugBank
DB06317,"Amino Acids, Peptides, and Proteins",DrugBank
DB06317,Antibodies,DrugBank
DB06317,"Antibodies, Monoclonal",DrugBank
DB06317,"Antibodies, Monoclonal, Humanized",DrugBank
DB06317,Antineoplastic Agents,DrugBank
DB06317,Antineoplastic and Immunomodulating Agents,DrugBank
DB06317,Blood Proteins,DrugBank
DB06317,Cancer immunotherapy,DrugBank
DB06317,Globulins,DrugBank
DB06317,Immunoglobulins,DrugBank
DB06317,Immunoproteins,DrugBank
DB06317,Immunotherapy,DrugBank
DB06317,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06317,Narrow Therapeutic Index Drugs,DrugBank
DB06317,Proteins,DrugBank
DB06317,Serum Globulins,DrugBank
DB06317,SLAMF7-directed Antibody Interactions,DrugBank
DB06317,SLAMF7-directed Immunostimulatory Antibody,DrugBank
DB06318,"Amino Acids, Peptides, and Proteins",DrugBank
DB06318,Anti-Bacterial Agents,DrugBank
DB06318,Antibodies,DrugBank
DB06318,"Antibodies, Monoclonal",DrugBank
DB06318,Blood Proteins,DrugBank
DB06318,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06318,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06318,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06318,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06318,Globulins,DrugBank
DB06318,Immunoglobulins,DrugBank
DB06318,Immunoproteins,DrugBank
DB06318,"Lactams, Macrocyclic",DrugBank
DB06318,Lactones,DrugBank
DB06318,Macrolides,DrugBank
DB06318,Proteins,DrugBank
DB06318,Serum Globulins,DrugBank
DB06322,"Amino Acids, Peptides, and Proteins",DrugBank
DB06322,Antibodies,DrugBank
DB06322,Blood Proteins,DrugBank
DB06322,Globulins,DrugBank
DB06322,Immunoglobulins,DrugBank
DB06322,Immunoproteins,DrugBank
DB06322,Proteins,DrugBank
DB06322,Serum Globulins,DrugBank
DB06324,"Amino Acids, Peptides, and Proteins",DrugBank
DB06324,Antibodies,DrugBank
DB06324,"Antibodies, Monoclonal",DrugBank
DB06324,Blood Proteins,DrugBank
DB06324,Globulins,DrugBank
DB06324,Immunoglobulins,DrugBank
DB06324,Immunoproteins,DrugBank
DB06324,Proteins,DrugBank
DB06324,Serum Globulins,DrugBank
DB06325,Pegylated agents,DrugBank
DB06334,"Acids, Carbocyclic",DrugBank
DB06334,Amides,DrugBank
DB06334,Amines,DrugBank
DB06334,Antineoplastic Agents,DrugBank
DB06334,Antineoplastic and Immunomodulating Agents,DrugBank
DB06334,Benzene Derivatives,DrugBank
DB06334,Benzoates,DrugBank
DB06334,Histone deacetylase (HDAC) inhibitors,DrugBank
DB06334,Histone Deacetylase Inhibitors,DrugBank
DB06334,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06334,Pyridines,DrugBank
DB06334,QTc Prolonging Agents,DrugBank
DB06335,Agents causing angioedema,DrugBank
DB06335,Alimentary Tract and Metabolism,DrugBank
DB06335,"Amino Acids, Peptides, and Proteins",DrugBank
DB06335,Blood Glucose Lowering Agents,DrugBank
DB06335,Bridged-Ring Compounds,DrugBank
DB06335,Cycloparaffins,DrugBank
DB06335,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06335,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06335,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06335,Cytochrome P-450 Substrates,DrugBank
DB06335,DPP-IV Inhibitors,DrugBank
DB06335,Drugs that are Mainly Renally Excreted,DrugBank
DB06335,Drugs Used in Diabetes,DrugBank
DB06335,Enzyme Inhibitors,DrugBank
DB06335,Hormones,DrugBank
DB06335,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06335,Hypoglycemia-Associated Agents,DrugBank
DB06335,Incretins,DrugBank
DB06335,OAT3/SLC22A8 Substrates,DrugBank
DB06335,Oligopeptides,DrugBank
DB06335,Oral Hypoglycemics,DrugBank
DB06335,Peptides,DrugBank
DB06335,Protease Inhibitors,DrugBank
DB06342,"Amino Acids, Peptides, and Proteins",DrugBank
DB06342,Anti-Bacterial Agents,DrugBank
DB06342,Antibodies,DrugBank
DB06342,"Antibodies, Monoclonal",DrugBank
DB06342,Antibody-drug Conjugates,DrugBank
DB06342,Blood Proteins,DrugBank
DB06342,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06342,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06342,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06342,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06342,Globulins,DrugBank
DB06342,Immunoglobulins,DrugBank
DB06342,Immunoproteins,DrugBank
DB06342,Immunotoxins,DrugBank
DB06342,"Lactams, Macrocyclic",DrugBank
DB06342,Lactones,DrugBank
DB06342,Macrolides,DrugBank
DB06342,Proteins,DrugBank
DB06342,Serum Globulins,DrugBank
DB06343,"Amino Acids, Peptides, and Proteins",DrugBank
DB06343,Antibodies,DrugBank
DB06343,"Antibodies, Monoclonal",DrugBank
DB06343,Antineoplastic and Immunomodulating Agents,DrugBank
DB06343,Blood Proteins,DrugBank
DB06343,Globulins,DrugBank
DB06343,Hyperglycemia-Associated Agents,DrugBank
DB06343,Immunoglobulins,DrugBank
DB06343,Immunoproteins,DrugBank
DB06343,Immunosuppressive Agents,DrugBank
DB06343,Insulin-like Growth Factor-1 Receptor Inhibitor,DrugBank
DB06343,Insulin-like Growth Factor-1 Receptor Inhibitors,DrugBank
DB06343,Ototoxic agents,DrugBank
DB06343,Proteins,DrugBank
DB06343,Selective Immunosuppressants,DrugBank
DB06343,Serum Globulins,DrugBank
DB06360,"Amino Acids, Peptides, and Proteins",DrugBank
DB06360,Antibodies,DrugBank
DB06360,"Antibodies, Monoclonal",DrugBank
DB06360,Blood Proteins,DrugBank
DB06360,Globulins,DrugBank
DB06360,Immunoglobulins,DrugBank
DB06360,Immunoproteins,DrugBank
DB06360,"Multiple Myeloma, drug therapy",DrugBank
DB06360,Proteins,DrugBank
DB06360,Serum Globulins,DrugBank
DB06365,Antineoplastic Agents,DrugBank
DB06365,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06365,Nucleosides,DrugBank
DB06365,Pyrimidines,DrugBank
DB06365,Pyrimidinones,DrugBank
DB06366,"Amino Acids, Peptides, and Proteins",DrugBank
DB06366,Antibodies,DrugBank
DB06366,"Antibodies, Monoclonal",DrugBank
DB06366,"Antibodies, Monoclonal, Humanized",DrugBank
DB06366,Antineoplastic Agents,DrugBank
DB06366,"Antineoplastic Agents, Immunological",DrugBank
DB06366,Antineoplastic and Immunomodulating Agents,DrugBank
DB06366,Blood Proteins,DrugBank
DB06366,Breast Neoplasms,DrugBank
DB06366,Cancer immunotherapy,DrugBank
DB06366,Cardiotoxic antineoplastic agents,DrugBank
DB06366,Globulins,DrugBank
DB06366,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB06366,HER2 Receptor Antagonists,DrugBank
DB06366,HER2/Neu/cerbB2 Antagonists,DrugBank
DB06366,Immunoglobulins,DrugBank
DB06366,Immunoproteins,DrugBank
DB06366,Immunotherapy,DrugBank
DB06366,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06366,Proteins,DrugBank
DB06366,"Receptor, ErbB-2, antagonists & inhibitors",DrugBank
DB06366,Serum Globulins,DrugBank
DB06370,Amides,DrugBank
DB06370,Antineoplastic Agents,DrugBank
DB06370,Carbonic Anhydrase Inhibitors,DrugBank
DB06370,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06370,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06370,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06370,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB06370,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB06370,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06370,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06370,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06370,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06370,Cytochrome P-450 Substrates,DrugBank
DB06370,Diuretics,DrugBank
DB06370,Enzyme Inhibitors,DrugBank
DB06370,Sulfonamides,DrugBank
DB06370,Sulfones,DrugBank
DB06370,Sulfur Compounds,DrugBank
DB06371,"Amino Acids, Peptides, and Proteins",DrugBank
DB06371,Antibodies,DrugBank
DB06371,"Antibodies, Monoclonal",DrugBank
DB06371,"Antibodies, Monoclonal, Humanized",DrugBank
DB06371,Blood Proteins,DrugBank
DB06371,Globulins,DrugBank
DB06371,Immunoglobulins,DrugBank
DB06371,Immunoproteins,DrugBank
DB06371,Proteins,DrugBank
DB06371,Serum Globulins,DrugBank
DB06372,Agents reducing cytokine levels,DrugBank
DB06372,"Amino Acids, Peptides, and Proteins",DrugBank
DB06372,Anti-Inflammatory Agents,DrugBank
DB06372,Antineoplastic and Immunomodulating Agents,DrugBank
DB06372,Immunosuppressive Agents,DrugBank
DB06372,Immunotherapy,DrugBank
DB06372,Interleukin Inhibitors,DrugBank
DB06372,Interleukin-1 Blockers,DrugBank
DB06372,Interleukin-1 Receptor Accessory Protein,DrugBank
DB06372,Proteins,DrugBank
DB06372,"Receptors, Interleukin-1 Type I",DrugBank
DB06372,Recombinant Proteins,DrugBank
DB06374,Anti-Estrogens,DrugBank
DB06374,Antineoplastic Agents,DrugBank
DB06374,Antineoplastic and Immunomodulating Agents,DrugBank
DB06374,BCRP/ABCG2 Inhibitors,DrugBank
DB06374,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB06374,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06374,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06374,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06374,Cytochrome P-450 Substrates,DrugBank
DB06374,Endocrine Therapy,DrugBank
DB06374,Estrogen Receptor Antagonists,DrugBank
DB06374,"Estrogens, Non-Steroidal",DrugBank
DB06374,Hormone Antagonists and Related Agents,DrugBank
DB06374,Naphthalenes,DrugBank
DB06374,OATP2B1/SLCO2B1 substrates,DrugBank
DB06374,P-glycoprotein inhibitors,DrugBank
DB06374,Selective Estrogen Receptor Degraders,DrugBank
DB06379,"Amino Acids, Peptides, and Proteins",DrugBank
DB06379,"Calcitonin Gene-Related Peptide, antagonists & inhibitors",DrugBank
DB06379,Cardiovascular Agents,DrugBank
DB06379,Nerve Tissue Proteins,DrugBank
DB06379,Neuropeptides,DrugBank
DB06379,Peptides,DrugBank
DB06379,Proteins,DrugBank
DB06379,Vasodilating Agents,DrugBank
DB06395,Antifungal Agents,DrugBank
DB06395,Azole Antifungals,DrugBank
DB06395,Sulfur Compounds,DrugBank
DB06400,"Amino Acids, Peptides, and Proteins",DrugBank
DB06400,Biological Products,DrugBank
DB06400,Complex Mixtures,DrugBank
DB06400,Molecular Chaperones,DrugBank
DB06400,Proteins,DrugBank
DB06400,Vaccines,DrugBank
DB06401,Bone Density Conservation Agents,DrugBank
DB06401,Estrogen Agonist/Antagonist,DrugBank
DB06401,Estrogen Receptor Modulators,DrugBank
DB06401,Genito Urinary System and Sex Hormones,DrugBank
DB06401,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06401,Hormone Antagonists,DrugBank
DB06401,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06401,Selective Estrogen Receptor Modulators,DrugBank
DB06401,Sex Hormones and Modulators of the Genital System,DrugBank
DB06401,UGT1A1 Substrates,DrugBank
DB06401,UGT1A4 substrates,DrugBank
DB06402,"Amino Acids, Peptides, and Proteins",DrugBank
DB06402,Anti-Bacterial Agents,DrugBank
DB06402,Anti-Infective Agents,DrugBank
DB06402,Antibacterials for Systemic Use,DrugBank
DB06402,Antiinfectives for Systemic Use,DrugBank
DB06402,Carbohydrates,DrugBank
DB06402,Drugs that are Mainly Renally Excreted,DrugBank
DB06402,Glycoconjugates,DrugBank
DB06402,Glycopeptide Antibacterials,DrugBank
DB06402,Glycopeptides,DrugBank
DB06402,Glycosides,DrugBank
DB06402,Lipoglycopeptide Antibacterial,DrugBank
DB06402,Lipopeptides,DrugBank
DB06402,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06402,Peptides,DrugBank
DB06402,QTc Prolonging Agents,DrugBank
DB06403,"Acids, Carbocyclic",DrugBank
DB06403,Antihypertensive Agents,DrugBank
DB06403,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB06403,Cardiovascular Agents,DrugBank
DB06403,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06403,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06403,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06403,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06403,Cytochrome P-450 Substrates,DrugBank
DB06403,Endothelin Receptor Antagonists,DrugBank
DB06403,"Hypertension, Pulmonary",DrugBank
DB06403,OATP1B1/SLCO1B1 Substrates,DrugBank
DB06403,OATP1B3 substrates,DrugBank
DB06403,P-glycoprotein substrates,DrugBank
DB06403,UGT1A3 substrates,DrugBank
DB06403,UGT1A9 Substrates,DrugBank
DB06403,UGT2B7 substrates,DrugBank
DB06403,Vasodilating Agents,DrugBank
DB06406,Anticoagulants,DrugBank
DB06406,Antithrombins,DrugBank
DB06406,Carbohydrates,DrugBank
DB06406,Enzyme Inhibitors,DrugBank
DB06406,Factor Xa Inhibitors,DrugBank
DB06406,Hematologic Agents,DrugBank
DB06406,Polysaccharides,DrugBank
DB06406,Protease Inhibitors,DrugBank
DB06406,Serine Protease Inhibitors,DrugBank
DB06410,Anti-Parathyroid Agents,DrugBank
DB06410,Bone Density Conservation Agents,DrugBank
DB06410,Calcium Homeostasis,DrugBank
DB06410,Cholestanes,DrugBank
DB06410,Cholestenes,DrugBank
DB06410,"Diet, Food, and Nutrition",DrugBank
DB06410,Food,DrugBank
DB06410,Fused-Ring Compounds,DrugBank
DB06410,Lipids,DrugBank
DB06410,Membrane Lipids,DrugBank
DB06410,Micronutrients,DrugBank
DB06410,Physiological Phenomena,DrugBank
DB06410,Secosteroids,DrugBank
DB06410,Steroids,DrugBank
DB06410,Sterols,DrugBank
DB06410,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB06410,Vitamin D and Analogues,DrugBank
DB06410,Vitamins,DrugBank
DB06410,Vitamins (Fat Soluble),DrugBank
DB06412,Alimentary Tract and Metabolism,DrugBank
DB06412,Anabolic Agents,DrugBank
DB06412,Anabolic Agents for Systemic Use,DrugBank
DB06412,Anabolic Steroids,DrugBank
DB06412,Androgens,DrugBank
DB06412,Androstan Derivatives,DrugBank
DB06412,Androstanes,DrugBank
DB06412,Androstanols,DrugBank
DB06412,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06412,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06412,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06412,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06412,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06412,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06412,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06412,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB06412,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB06412,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06412,Fused-Ring Compounds,DrugBank
DB06412,Hormones,DrugBank
DB06412,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06412,Steroids,DrugBank
DB06412,Thyroxine-binding globulin inhibitors,DrugBank
DB06413,Benzene Derivatives,DrugBank
DB06413,Benzhydryl Compounds,DrugBank
DB06413,Central Nervous System Agents,DrugBank
DB06413,Central Nervous System Stimulants,DrugBank
DB06413,Centrally Acting Sympathomimetics,DrugBank
DB06413,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB06413,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB06413,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06413,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB06413,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06413,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB06413,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06413,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06413,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06413,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06413,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB06413,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB06413,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB06413,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06413,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06413,Nervous System,DrugBank
DB06413,Psychoanaleptics,DrugBank
DB06413,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB06413,Wakefulness-Promoting Agents,DrugBank
DB06414,Anti-Infective Agents,DrugBank
DB06414,Anti-Retroviral Agents,DrugBank
DB06414,Antiinfectives for Systemic Use,DrugBank
DB06414,Antiviral Agents,DrugBank
DB06414,Antivirals for Systemic Use,DrugBank
DB06414,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06414,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06414,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06414,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06414,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06414,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06414,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06414,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06414,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06414,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB06414,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06414,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06414,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06414,Cytochrome P-450 Substrates,DrugBank
DB06414,Direct Acting Antivirals,DrugBank
DB06414,Enzyme Inhibitors,DrugBank
DB06414,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB06414,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB06414,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB06414,Nucleic Acid Synthesis Inhibitors,DrugBank
DB06414,P-glycoprotein inhibitors,DrugBank
DB06414,Reverse Transcriptase Inhibitors,DrugBank
DB06415,Alveolar Surface Tension Reduction,DrugBank
DB06415,Bradycardia-Causing Agents,DrugBank
DB06415,Complex Mixtures,DrugBank
DB06415,Lipids,DrugBank
DB06415,Membrane Lipids,DrugBank
DB06415,Pulmonary Surfactants,DrugBank
DB06415,Respiratory System Agents,DrugBank
DB06415,Surface-Active Agents,DrugBank
DB06415,Surfactant Activity,DrugBank
DB06419,Anti-Bacterial Agents,DrugBank
DB06419,Anti-Infective Agents,DrugBank
DB06419,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06419,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06419,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06419,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06419,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06419,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06419,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06419,Cytochrome P-450 Substrates,DrugBank
DB06419,Erythromycin and similars,DrugBank
DB06419,Lactones,DrugBank
DB06419,Macrolides,DrugBank
DB06419,P-glycoprotein inhibitors,DrugBank
DB06419,P-glycoprotein substrates,DrugBank
DB06419,Polyketides,DrugBank
DB06419,Protein Synthesis Inhibitors,DrugBank
DB06419,"RNA, Ribosomal, 23S",DrugBank
DB06420,Anthracyclines,DrugBank
DB06420,"Antibiotics, Antineoplastic",DrugBank
DB06420,Antineoplastic Agents,DrugBank
DB06420,Carbohydrates,DrugBank
DB06420,Glycosides,DrugBank
DB06420,Naphthacenes,DrugBank
DB06420,P-glycoprotein inhibitors,DrugBank
DB06423,"Amino Acids, Peptides, and Proteins",DrugBank
DB06423,Angiogenesis Inhibitors,DrugBank
DB06423,Angiogenesis Modulating Agents,DrugBank
DB06423,Angiogenic Proteins,DrugBank
DB06423,Angiostatic Proteins,DrugBank
DB06423,Antineoplastic Agents,DrugBank
DB06423,Biological Factors,DrugBank
DB06423,Collagen,DrugBank
DB06423,Collagen Type XVIII,DrugBank
DB06423,"Compounds used in a research, industrial, or household setting",DrugBank
DB06423,Extracellular Matrix Proteins,DrugBank
DB06423,Growth Inhibitors,DrugBank
DB06423,Growth Substances,DrugBank
DB06423,Intercellular Signaling Peptides and Proteins,DrugBank
DB06423,Non-Fibrillar Collagens,DrugBank
DB06423,Peptides,DrugBank
DB06423,Proteins,DrugBank
DB06423,Scleroproteins,DrugBank
DB06433,Antineoplastic Agents,DrugBank
DB06433,Deoxyribonucleosides,DrugBank
DB06433,Enzyme Inhibitors,DrugBank
DB06433,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06433,Nucleosides,DrugBank
DB06433,Pyrimidine Nucleosides,DrugBank
DB06433,Pyrimidines,DrugBank
DB06433,Radiation-Sensitizing Agents,DrugBank
DB06433,"Ribonucleoside Diphosphate Reductase, antagonists & inhibitors",DrugBank
DB06436,Angiogenesis Inhibitors,DrugBank
DB06436,Angiogenesis Modulating Agents,DrugBank
DB06436,Antineoplastic Agents,DrugBank
DB06436,Enzyme Inhibitors,DrugBank
DB06436,Growth Inhibitors,DrugBank
DB06436,Growth Substances,DrugBank
DB06436,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06436,Protein Kinase Inhibitors,DrugBank
DB06440,Antifungal Agents,DrugBank
DB06440,Azole Antifungals,DrugBank
DB06440,Sulfur Compounds,DrugBank
DB06441,Adenine Nucleotides,DrugBank
DB06441,Anticoagulants,DrugBank
DB06441,Antiplatelet agents,DrugBank
DB06441,Blood and Blood Forming Organs,DrugBank
DB06441,Decreased Platelet Aggregation,DrugBank
DB06441,Hematologic Agents,DrugBank
DB06441,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06441,Neurotransmitter Agents,DrugBank
DB06441,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06441,Nucleotides,DrugBank
DB06441,P2Y12 Platelet Inhibitor,DrugBank
DB06441,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB06441,Purine Nucleotides,DrugBank
DB06441,Purinergic Agents,DrugBank
DB06441,Purinergic Antagonists,DrugBank
DB06441,Purinergic P2 Receptor Antagonists,DrugBank
DB06441,Purinergic P2Y Receptor Antagonists,DrugBank
DB06441,Purines,DrugBank
DB06441,Ribonucleotides,DrugBank
DB06442,Acetates,DrugBank
DB06442,"Acids, Acyclic",DrugBank
DB06442,Amides,DrugBank
DB06442,Arteriosclerosis,DrugBank
DB06442,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06442,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06442,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06442,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06442,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06442,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06442,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06442,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06442,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB06442,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06442,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06442,Sulfones,DrugBank
DB06442,Sulfur Compounds,DrugBank
DB06445,Amines,DrugBank
DB06445,Antihypertensive Agents,DrugBank
DB06445,Antineoplastic Agents,DrugBank
DB06445,Biogenic Amines,DrugBank
DB06445,Biogenic Polyamines,DrugBank
DB06445,Cardiovascular Agents,DrugBank
DB06445,Polyamines,DrugBank
DB06446,Agents causing hyperkalemia,DrugBank
DB06446,Antiarrhythmic agents,DrugBank
DB06446,Antidepressive Agents,DrugBank
DB06446,Benzene Derivatives,DrugBank
DB06446,Bradycardia-Causing Agents,DrugBank
DB06446,Calcium Channel Blockers,DrugBank
DB06446,Calcium-Regulating Hormones and Agents,DrugBank
DB06446,Cardiovascular Agents,DrugBank
DB06446,Central Nervous System Depressants,DrugBank
DB06446,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06446,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06446,Cytochrome P-450 Substrates,DrugBank
DB06446,Membrane Transport Modulators,DrugBank
DB06446,Neurotransmitter Agents,DrugBank
DB06446,Serotonin Agents,DrugBank
DB06446,Serotonin Receptor Antagonists,DrugBank
DB06446,Vasodilating Agents,DrugBank
DB06448,Alimentary Tract and Metabolism,DrugBank
DB06448,BCRP/ABCG2 Inhibitors,DrugBank
DB06448,Benzocycloheptenes,DrugBank
DB06448,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06448,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06448,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06448,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06448,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06448,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06448,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06448,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB06448,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06448,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06448,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB06448,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06448,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06448,Cytochrome P-450 Substrates,DrugBank
DB06448,Enzyme Inhibitors,DrugBank
DB06448,Farnesyltransferase Inhibitor,DrugBank
DB06448,Farnesyltransferase Inhibitors,DrugBank
DB06448,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06448,OATP1B3 inhibitors,DrugBank
DB06448,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB06448,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB06448,P-glycoprotein inhibitors,DrugBank
DB06448,P-glycoprotein substrates,DrugBank
DB06448,Various Alimentary Tract and Metabolism Products,DrugBank
DB06458,Acetates,DrugBank
DB06458,"Acids, Acyclic",DrugBank
DB06458,Amides,DrugBank
DB06458,Anticonvulsants,DrugBank
DB06458,Central Nervous System Agents,DrugBank
DB06458,Central Nervous System Depressants,DrugBank
DB06458,"Compounds used in a research, industrial, or household setting",DrugBank
DB06458,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06458,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06458,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06458,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06458,Neuroprotective Agents,DrugBank
DB06458,Protective Agents,DrugBank
DB06461,Angiogenesis Inhibitors,DrugBank
DB06461,Angiogenesis Modulating Agents,DrugBank
DB06461,Anti-Bacterial Agents,DrugBank
DB06461,Anti-Infective Agents,DrugBank
DB06461,Anticarcinogenic Agents,DrugBank
DB06461,Antineoplastic Agents,DrugBank
DB06461,Cholestanes,DrugBank
DB06461,"Compounds used in a research, industrial, or household setting",DrugBank
DB06461,Fused-Ring Compounds,DrugBank
DB06461,Growth Inhibitors,DrugBank
DB06461,Growth Substances,DrugBank
DB06461,Hydroxy Acids,DrugBank
DB06461,Protective Agents,DrugBank
DB06461,Steroids,DrugBank
DB06467,"Amino Acids, Peptides, and Proteins",DrugBank
DB06467,Antibodies,DrugBank
DB06467,"Antibodies, Monoclonal",DrugBank
DB06467,"Antibodies, Monoclonal, Humanized",DrugBank
DB06467,Blood Proteins,DrugBank
DB06467,Globulins,DrugBank
DB06467,Immunoglobulins,DrugBank
DB06467,Immunoproteins,DrugBank
DB06467,Proteins,DrugBank
DB06467,Serum Globulins,DrugBank
DB06468,Amidines,DrugBank
DB06468,Antiarrhythmic agents,DrugBank
DB06468,Cardiovascular Agents,DrugBank
DB06468,Potential QTc-Prolonging Agents,DrugBank
DB06468,QTc Prolonging Agents,DrugBank
DB06468,Sulfur Compounds,DrugBank
DB06469,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06469,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06469,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06469,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06469,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06469,Indoles,DrugBank
DB06469,Tyrosine Kinase Inhibitors,DrugBank
DB06470,Anticonvulsants,DrugBank
DB06470,Central Nervous System Agents,DrugBank
DB06470,Central Nervous System Depressants,DrugBank
DB06470,"Compounds used in a research, industrial, or household setting",DrugBank
DB06470,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB06470,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06470,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06470,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06470,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06470,Cytochrome P-450 Substrates,DrugBank
DB06470,GABA Agents,DrugBank
DB06470,GABA Modulators,DrugBank
DB06470,Hypnotics and Sedatives,DrugBank
DB06470,Nervous System,DrugBank
DB06470,Neuroprotective Agents,DrugBank
DB06470,Neurotransmitter Agents,DrugBank
DB06470,Protective Agents,DrugBank
DB06470,Psycholeptics,DrugBank
DB06470,Sulfur Compounds,DrugBank
DB06470,Thiazoles,DrugBank
DB06474,"Amino Acids, Peptides, and Proteins",DrugBank
DB06474,Antibodies,DrugBank
DB06474,"Antibodies, Monoclonal",DrugBank
DB06474,"Antibodies, Monoclonal, Humanized",DrugBank
DB06474,Blood Proteins,DrugBank
DB06474,Globulins,DrugBank
DB06474,Immunoglobulins,DrugBank
DB06474,Immunoproteins,DrugBank
DB06474,Proteins,DrugBank
DB06474,Serum Globulins,DrugBank
DB06478,"Antibiotics, Antineoplastic",DrugBank
DB06478,Antineoplastic Agents,DrugBank
DB06478,Azirines,DrugBank
DB06478,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06478,Indolequinones,DrugBank
DB06478,Indoles,DrugBank
DB06478,Mitomycins,DrugBank
DB06478,Quinones,DrugBank
DB06479,Alkaloids,DrugBank
DB06479,Anti-Ulcer Agents,DrugBank
DB06479,Central Nervous System Agents,DrugBank
DB06479,"Compounds used in a research, industrial, or household setting",DrugBank
DB06479,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06479,Cytochrome P-450 Substrates,DrugBank
DB06479,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06479,Nervous System,DrugBank
DB06479,Neuroprotective Agents,DrugBank
DB06479,Protective Agents,DrugBank
DB06479,Psychoanaleptics,DrugBank
DB06479,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB06479,Purines,DrugBank
DB06479,Purinones,DrugBank
DB06479,Xanthine derivatives,DrugBank
DB06480,Alimentary Tract and Metabolism,DrugBank
DB06480,Antidepressive Agents,DrugBank
DB06480,Central Nervous System Depressants,DrugBank
DB06480,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06480,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06480,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB06480,Cytochrome P-450 Substrates,DrugBank
DB06480,Drugs for Constipation,DrugBank
DB06480,Drugs that are Mainly Renally Excreted,DrugBank
DB06480,Gastrointestinal Agents,DrugBank
DB06480,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06480,Laxatives,DrugBank
DB06480,Miscellaneous GI Drugs,DrugBank
DB06480,Neurotransmitter Agents,DrugBank
DB06480,P-glycoprotein substrates,DrugBank
DB06480,Serotonin 4 Receptor Agonists,DrugBank
DB06480,Serotonin 5-HT4 Receptor Agonists,DrugBank
DB06480,Serotonin Agents,DrugBank
DB06480,Serotonin Receptor Agonists,DrugBank
DB06480,Serotonin-4 Receptor Agonist,DrugBank
DB06506,Antidepressive Agents,DrugBank
DB06506,Central Nervous System Depressants,DrugBank
DB06506,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06506,Cytochrome P-450 Substrates,DrugBank
DB06506,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06506,Neurotransmitter Agents,DrugBank
DB06506,Pyrans,DrugBank
DB06506,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB06506,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB06506,Serotonin Agents,DrugBank
DB06506,Serotonin Receptor Antagonists,DrugBank
DB06506,Sulfur Compounds,DrugBank
DB06510,Amino Acids,DrugBank
DB06510,"Amino Acids, Peptides, and Proteins",DrugBank
DB06510,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06510,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06510,Cytochrome P-450 Substrates,DrugBank
DB06510,"PPAR alpha, agonists",DrugBank
DB06510,"PPAR gamma, agonists",DrugBank
DB06510,UGT1A1 Substrates,DrugBank
DB06510,UGT1A3 substrates,DrugBank
DB06512,Anti-Anxiety Agents,DrugBank
DB06512,Anticonvulsants,DrugBank
DB06512,Antidepressive Agents,DrugBank
DB06512,Bicyclic Monoterpenes,DrugBank
DB06512,Bridged-Ring Compounds,DrugBank
DB06512,Central Nervous System Agents,DrugBank
DB06512,Central Nervous System Depressants,DrugBank
DB06512,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06512,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06512,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06512,Monoterpenes,DrugBank
DB06512,Neurotransmitter Agents,DrugBank
DB06512,Norbornanes,DrugBank
DB06512,Psychotropic Drugs,DrugBank
DB06512,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06512,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB06512,Serotonin Agents,DrugBank
DB06512,Serotonin Receptor Antagonists,DrugBank
DB06512,Terpenes,DrugBank
DB06512,Tranquilizing Agents,DrugBank
DB06517,Antineoplastic Agents,DrugBank
DB06517,Enzyme Inhibitors,DrugBank
DB06517,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06517,Topoisomerase I Inhibitors,DrugBank
DB06517,Topoisomerase II Inhibitors,DrugBank
DB06517,Topoisomerase Inhibitors,DrugBank
DB06527,Alkanes,DrugBank
DB06527,Alkanesulfonic Acids,DrugBank
DB06527,Anticonvulsants,DrugBank
DB06527,Carbohydrates,DrugBank
DB06527,Central Nervous System Agents,DrugBank
DB06527,Central Nervous System Depressants,DrugBank
DB06527,GABA Agents,DrugBank
DB06527,GABA Agonists,DrugBank
DB06527,"Hydrocarbons, Acyclic",DrugBank
DB06527,Neurotransmitter Agents,DrugBank
DB06527,Sulfonic Acids,DrugBank
DB06527,Sulfur Acids,DrugBank
DB06527,Sulfur Compounds,DrugBank
DB06529,Central Nervous System Depressants,DrugBank
DB06529,Hypnotics (Nonbenzodiazepine),DrugBank
DB06529,Hypnotics and Sedatives,DrugBank
DB06534,"Amino Acids, Peptides, and Proteins",DrugBank
DB06534,Biological Factors,DrugBank
DB06534,Carbohydrates,DrugBank
DB06534,Colony-Stimulating Factors,DrugBank
DB06534,Cytokines,DrugBank
DB06534,Glycoconjugates,DrugBank
DB06534,Glycoproteins,DrugBank
DB06534,Hematopoietic Cell Growth Factors,DrugBank
DB06534,Intercellular Signaling Peptides and Proteins,DrugBank
DB06534,Peptides,DrugBank
DB06534,Proteins,DrugBank
DB06534,"Thrombopoietin, antagonists & inhibitors",DrugBank
DB06543,Alkenes,DrugBank
DB06543,Anticoagulants,DrugBank
DB06543,Biological Factors,DrugBank
DB06543,Carotenoids,DrugBank
DB06543,Cyclohexanes,DrugBank
DB06543,Cyclohexenes,DrugBank
DB06543,Cycloparaffins,DrugBank
DB06543,Fibrinolytic Agents,DrugBank
DB06543,"Hydrocarbons, Acyclic",DrugBank
DB06543,"Pigments, Biological",DrugBank
DB06543,Polyenes,DrugBank
DB06543,Terpenes,DrugBank
DB06550,"Amino Acids, Peptides, and Proteins",DrugBank
DB06550,Antibodies,DrugBank
DB06550,"Antibodies, Monoclonal",DrugBank
DB06550,"Antibodies, Monoclonal, Humanized",DrugBank
DB06550,Blood Proteins,DrugBank
DB06550,Globulins,DrugBank
DB06550,Immunoglobulins,DrugBank
DB06550,Immunoproteins,DrugBank
DB06550,Proteins,DrugBank
DB06550,Serum Globulins,DrugBank
DB06554,Analgesics,DrugBank
DB06554,Anesthetics,DrugBank
DB06554,Anticonvulsants,DrugBank
DB06554,Appetite Depressants,DrugBank
DB06554,Central Nervous System Agents,DrugBank
DB06554,Central Nervous System Depressants,DrugBank
DB06554,GABA Agents,DrugBank
DB06554,GABA Agonists,DrugBank
DB06554,Neurotransmitter Agents,DrugBank
DB06554,Peripheral Nervous System Agents,DrugBank
DB06554,Sensory System Agents,DrugBank
DB06557,"Amino Acids, Peptides, and Proteins",DrugBank
DB06557,Antibodies,DrugBank
DB06557,"Antibodies, Monoclonal",DrugBank
DB06557,Blood Proteins,DrugBank
DB06557,Globulins,DrugBank
DB06557,Immunoglobulins,DrugBank
DB06557,Immunoproteins,DrugBank
DB06557,Proteins,DrugBank
DB06557,Serum Globulins,DrugBank
DB06558,Cardiovascular Agents,DrugBank
DB06558,"Receptors, Endothelin",DrugBank
DB06558,Vasodilating Agents,DrugBank
DB06575,Antiviral Agents,DrugBank
DB06575,Herpes Zoster,DrugBank
DB06575,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06575,Purines,DrugBank
DB06575,Purinones,DrugBank
DB06575,Varicellovirus,DrugBank
DB06575,Xanthine derivatives,DrugBank
DB06579,Anti-Anxiety Agents,DrugBank
DB06579,Central Nervous System Agents,DrugBank
DB06579,Central Nervous System Depressants,DrugBank
DB06579,GABA Agents,DrugBank
DB06579,GABA Agonists,DrugBank
DB06579,Neurotransmitter Agents,DrugBank
DB06579,Psychotropic Drugs,DrugBank
DB06579,Tranquilizing Agents,DrugBank
DB06582,Antidepressive Agents,DrugBank
DB06582,Benzazepines,DrugBank
DB06582,Central Nervous System Agents,DrugBank
DB06582,Central Nervous System Depressants,DrugBank
DB06582,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06582,Psychotropic Drugs,DrugBank
DB06582,Stereoisomerism,DrugBank
DB06584,"Amino Acids, Peptides, and Proteins",DrugBank
DB06584,Biological Products,DrugBank
DB06584,Carbohydrates,DrugBank
DB06584,Complex Mixtures,DrugBank
DB06584,Glycoconjugates,DrugBank
DB06584,Glycoproteins,DrugBank
DB06584,Membrane Proteins,DrugBank
DB06584,Proteins,DrugBank
DB06584,Vaccines,DrugBank
DB06587,Anti-Bacterial Agents,DrugBank
DB06587,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06587,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06587,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06587,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06587,Lactones,DrugBank
DB06587,Macrolides,DrugBank
DB06587,Polyketides,DrugBank
DB06589,Amides,DrugBank
DB06589,Angiogenesis Inhibitors,DrugBank
DB06589,Antineoplastic Agents,DrugBank
DB06589,Antineoplastic and Immunomodulating Agents,DrugBank
DB06589,BCRP/ABCG2 Substrates,DrugBank
DB06589,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06589,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB06589,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06589,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB06589,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06589,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB06589,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06589,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06589,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06589,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06589,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06589,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06589,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06589,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06589,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06589,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06589,Cytochrome P-450 Substrates,DrugBank
DB06589,Hepatotoxic Agents,DrugBank
DB06589,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06589,Immunosuppressive Agents,DrugBank
DB06589,Kinase Inhibitor,DrugBank
DB06589,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06589,Narrow Therapeutic Index Drugs,DrugBank
DB06589,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06589,P-glycoprotein substrates,DrugBank
DB06589,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06589,Protein Kinase Inhibitors,DrugBank
DB06589,Pyrazoles,DrugBank
DB06589,QTc Prolonging Agents,DrugBank
DB06589,"Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors",DrugBank
DB06589,Sulfones,DrugBank
DB06589,Sulfur Compounds,DrugBank
DB06589,Tyrosine Kinase Inhibitors,DrugBank
DB06589,UGT1A1 Inhibitors,DrugBank
DB06590,Amides,DrugBank
DB06590,Anti-Bacterial Agents,DrugBank
DB06590,Anti-Infective Agents,DrugBank
DB06590,Antibacterials for Systemic Use,DrugBank
DB06590,Antiinfectives for Systemic Use,DrugBank
DB06590,beta Lactam Antibiotics,DrugBank
DB06590,beta-Lactams,DrugBank
DB06590,Cephalosporins,DrugBank
DB06590,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06590,Lactams,DrugBank
DB06590,Nephrotoxic agents,DrugBank
DB06590,Sulfur Compounds,DrugBank
DB06590,Thiazines,DrugBank
DB06594,Acetates,DrugBank
DB06594,"Acids, Acyclic",DrugBank
DB06594,Amides,DrugBank
DB06594,Antidepressive Agents,DrugBank
DB06594,Central Nervous System Agents,DrugBank
DB06594,Central Nervous System Depressants,DrugBank
DB06594,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06594,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06594,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06594,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06594,Cytochrome P-450 Substrates,DrugBank
DB06594,"Melatonin, agonists",DrugBank
DB06594,Nervous System,DrugBank
DB06594,Psychoanaleptics,DrugBank
DB06594,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06594,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB06594,Serotonin Agents,DrugBank
DB06594,Serotonin Receptor Antagonists,DrugBank
DB06595,Alkaloids,DrugBank
DB06595,Antineoplastic Agents,DrugBank
DB06595,Antineoplastic and Immunomodulating Agents,DrugBank
DB06595,Carbazoles,DrugBank
DB06595,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB06595,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB06595,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB06595,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP2E1 Inhibitors (strong),DrugBank
DB06595,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06595,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB06595,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06595,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB06595,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06595,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB06595,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06595,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06595,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB06595,Cytochrome P-450 CYP3A7 Inducers (strength unknown),DrugBank
DB06595,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06595,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06595,Cytochrome P-450 Substrates,DrugBank
DB06595,Enzyme Inhibitors,DrugBank
DB06595,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06595,Indole Alkaloids,DrugBank
DB06595,Indoles,DrugBank
DB06595,Indolizidines,DrugBank
DB06595,Indolizines,DrugBank
DB06595,Kinase Inhibitor,DrugBank
DB06595,Narrow Therapeutic Index Drugs,DrugBank
DB06595,"Protein Kinase C, antagonists & inhibitors",DrugBank
DB06595,Protein Kinase Inhibitors,DrugBank
DB06595,Receptor Tyrosine Kinase Inhibitors,DrugBank
DB06595,Tyrosine Kinase Inhibitors,DrugBank
DB06599,"Amino Acids, Peptides, and Proteins",DrugBank
DB06599,Antibodies,DrugBank
DB06599,Blood Proteins,DrugBank
DB06599,Globulins,DrugBank
DB06599,Immunoglobulins,DrugBank
DB06599,Immunologic Factors,DrugBank
DB06599,Immunoproteins,DrugBank
DB06599,Proteins,DrugBank
DB06599,"Receptors, TNF-Related Apoptosis-Inducing Ligand",DrugBank
DB06599,Serum Globulins,DrugBank
DB06600,Anti-Bacterial Agents,DrugBank
DB06600,Anti-Infective Agents,DrugBank
DB06600,Antibacterials for Systemic Use,DrugBank
DB06600,Antiinfectives for Systemic Use,DrugBank
DB06600,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06600,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06600,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06600,Fluoroquinolones,DrugBank
DB06600,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06600,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06600,QTc Prolonging Agents,DrugBank
DB06600,Quinolines,DrugBank
DB06602,"Amino Acids, Peptides, and Proteins",DrugBank
DB06602,Anti-Asthmatic Agents,DrugBank
DB06602,Antibodies,DrugBank
DB06602,"Antibodies, Monoclonal",DrugBank
DB06602,"Antibodies, Monoclonal, Humanized",DrugBank
DB06602,Blood Proteins,DrugBank
DB06602,Drugs for Obstructive Airway Diseases,DrugBank
DB06602,Globulins,DrugBank
DB06602,Immunoglobulins,DrugBank
DB06602,Immunoproteins,DrugBank
DB06602,Interleukin Antagonists,DrugBank
DB06602,Interleukin-5 Antagonist,DrugBank
DB06602,Proteins,DrugBank
DB06602,Respiratory System Agents,DrugBank
DB06602,Serum Globulins,DrugBank
DB06603,Amines,DrugBank
DB06603,Antineoplastic Agents,DrugBank
DB06603,Antineoplastic and Immunomodulating Agents,DrugBank
DB06603,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06603,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB06603,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06603,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06603,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06603,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06603,Cytochrome P-450 Substrates,DrugBank
DB06603,Enzyme Inhibitors,DrugBank
DB06603,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06603,Histone deacetylase (HDAC) inhibitors,DrugBank
DB06603,Histone Deacetylase Inhibitors,DrugBank
DB06603,Hydroxamic Acids,DrugBank
DB06603,Hydroxy Acids,DrugBank
DB06603,Hydroxylamines,DrugBank
DB06603,Immunosuppressive Agents,DrugBank
DB06603,Indoles,DrugBank
DB06603,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06603,Narrow Therapeutic Index Drugs,DrugBank
DB06603,P-glycoprotein substrates,DrugBank
DB06603,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06603,QTc Prolonging Agents,DrugBank
DB06605,Anticoagulants,DrugBank
DB06605,Antithrombins,DrugBank
DB06605,BCRP/ABCG2 Substrates,DrugBank
DB06605,Blood and Blood Forming Organs,DrugBank
DB06605,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06605,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06605,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06605,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06605,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06605,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06605,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06605,Cytochrome P-450 Substrates,DrugBank
DB06605,Direct factor Xa inhibitors,DrugBank
DB06605,Enzyme Inhibitors,DrugBank
DB06605,Factor Xa Inhibitors,DrugBank
DB06605,Hematologic Agents,DrugBank
DB06605,P-glycoprotein substrates,DrugBank
DB06605,Protease Inhibitors,DrugBank
DB06605,Pyridines,DrugBank
DB06605,Serine Protease Inhibitors,DrugBank
DB06606,Alimentary Tract and Metabolism,DrugBank
DB06606,"Amino Acids, Peptides, and Proteins",DrugBank
DB06606,Antibodies,DrugBank
DB06606,"Antibodies, Monoclonal",DrugBank
DB06606,"Antibodies, Monoclonal, Humanized",DrugBank
DB06606,Blood Proteins,DrugBank
DB06606,CD3-directed Antibody,DrugBank
DB06606,CD3-directed Antibody Interactions,DrugBank
DB06606,Drugs Used in Diabetes,DrugBank
DB06606,Globulins,DrugBank
DB06606,Immunoglobulins,DrugBank
DB06606,Immunoproteins,DrugBank
DB06606,Proteins,DrugBank
DB06606,Serum Globulins,DrugBank
DB06607,"Amino Acids, Peptides, and Proteins",DrugBank
DB06607,Antibodies,DrugBank
DB06607,"Antibodies, Monoclonal",DrugBank
DB06607,Antineoplastic Agents,DrugBank
DB06607,Antineoplastic and Immunomodulating Agents,DrugBank
DB06607,Bispecific Monoclonal Antibodies,DrugBank
DB06607,Blood Proteins,DrugBank
DB06607,Cancer immunotherapy,DrugBank
DB06607,Gastrointestinal Agents,DrugBank
DB06607,Globulins,DrugBank
DB06607,Immunoglobulins,DrugBank
DB06607,Immunoproteins,DrugBank
DB06607,Immunotherapy,DrugBank
DB06607,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06607,Proteins,DrugBank
DB06607,Serum Globulins,DrugBank
DB06608,Aminoquinolines,DrugBank
DB06608,Anti-Infective Agents,DrugBank
DB06608,Antimalarials,DrugBank
DB06608,Antiparasitic Agents,DrugBank
DB06608,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06608,Antiprotozoals,DrugBank
DB06608,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06608,Cytochrome P-450 Substrates,DrugBank
DB06608,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06608,MATE 1 Inhibitors,DrugBank
DB06608,MATE 2 Inhibitors,DrugBank
DB06608,MATE inhibitors,DrugBank
DB06608,OCT2 Inhibitors,DrugBank
DB06608,Quinolines,DrugBank
DB06611,Alcohols,DrugBank
DB06611,"Amino Acids, Peptides, and Proteins",DrugBank
DB06611,"Compounds used in a research, industrial, or household setting",DrugBank
DB06611,Ethylene Glycols,DrugBank
DB06611,Glycols,DrugBank
DB06611,Macromolecular Substances,DrugBank
DB06611,Membrane Proteins,DrugBank
DB06611,Pegylated agents,DrugBank
DB06611,Polymers,DrugBank
DB06611,Proteins,DrugBank
DB06611,"Receptors, Death Domain",DrugBank
DB06611,Recombinant Proteins,DrugBank
DB06612,"Amino Acids, Peptides, and Proteins",DrugBank
DB06612,Antibodies,DrugBank
DB06612,"Antibodies, Monoclonal",DrugBank
DB06612,"Antibodies, Monoclonal, Humanized",DrugBank
DB06612,Blood Proteins,DrugBank
DB06612,Drugs for Obstructive Airway Diseases,DrugBank
DB06612,Globulins,DrugBank
DB06612,Immunoglobulins,DrugBank
DB06612,Immunoproteins,DrugBank
DB06612,Immunosuppressive Agents,DrugBank
DB06612,Interleukin-5 Antagonist,DrugBank
DB06612,Proteins,DrugBank
DB06612,Serum Globulins,DrugBank
DB06616,Amines,DrugBank
DB06616,Antineoplastic Agents,DrugBank
DB06616,Antineoplastic and Immunomodulating Agents,DrugBank
DB06616,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB06616,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06616,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB06616,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06616,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06616,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06616,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06616,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06616,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06616,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06616,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06616,Cytochrome P-450 Substrates,DrugBank
DB06616,Enzyme Inhibitors,DrugBank
DB06616,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06616,Immunosuppressive Agents,DrugBank
DB06616,Kinase Inhibitor,DrugBank
DB06616,Myelosuppressive Agents,DrugBank
DB06616,Narrow Therapeutic Index Drugs,DrugBank
DB06616,P-glycoprotein substrates,DrugBank
DB06616,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06616,Protein Kinase Inhibitors,DrugBank
DB06616,Tyrosine Kinase Inhibitors,DrugBank
DB06623,Amines,DrugBank
DB06623,Analgesics,DrugBank
DB06623,Central Nervous System Agents,DrugBank
DB06623,Drugs that are Mainly Renally Excreted,DrugBank
DB06623,Nervous System,DrugBank
DB06623,Peripheral Nervous System Agents,DrugBank
DB06623,Pyridines,DrugBank
DB06623,Sensory System Agents,DrugBank
DB06624,Cannabinoid Receptor Agonists,DrugBank
DB06624,Cannabinoids and similars,DrugBank
DB06624,Hormones,DrugBank
DB06624,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06624,Neurotransmitter Agents,DrugBank
DB06626,"Acids, Carbocyclic",DrugBank
DB06626,Amides,DrugBank
DB06626,Antineoplastic Agents,DrugBank
DB06626,Antineoplastic and Immunomodulating Agents,DrugBank
DB06626,Benzamides and benzamide derivatives,DrugBank
DB06626,Benzene Derivatives,DrugBank
DB06626,Benzoates,DrugBank
DB06626,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06626,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06626,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06626,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06626,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06626,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Cytochrome P-450 Substrates,DrugBank
DB06626,Enzyme Inhibitors,DrugBank
DB06626,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06626,Indazoles,DrugBank
DB06626,Kinase Inhibitor,DrugBank
DB06626,Narrow Therapeutic Index Drugs,DrugBank
DB06626,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06626,OATP1B1/SLCO1B1 Substrates,DrugBank
DB06626,P-glycoprotein inhibitors,DrugBank
DB06626,P-glycoprotein substrates,DrugBank
DB06626,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Protein Kinase Inhibitors,DrugBank
DB06626,Pyrazoles,DrugBank
DB06626,Receptor Tyrosine Kinase Inhibitors,DrugBank
DB06626,Tyrosine Kinase Inhibitors,DrugBank
DB06626,UGT1A1 Substrates,DrugBank
DB06626,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB06626,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,DrugBank
DB06635,Anticoagulants,DrugBank
DB06635,Antithrombins,DrugBank
DB06635,Enzyme Inhibitors,DrugBank
DB06635,Factor Xa Inhibitors,DrugBank
DB06635,Hematologic Agents,DrugBank
DB06635,Protease Inhibitors,DrugBank
DB06635,Serine Protease Inhibitors,DrugBank
DB06636,Anti-Infective Agents,DrugBank
DB06636,Antifungal Agents,DrugBank
DB06636,Azole Antifungals,DrugBank
DB06636,BCRP/ABCG2 Inhibitors,DrugBank
DB06636,Cholinesterase substrates,DrugBank
DB06636,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06636,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB06636,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB06636,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06636,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06636,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06636,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06636,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06636,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB06636,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06636,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06636,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06636,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06636,Cytochrome P-450 Substrates,DrugBank
DB06636,Isavuconazole and Prodrugs,DrugBank
DB06636,OCT2 Inhibitors,DrugBank
DB06636,P-glycoprotein inhibitors,DrugBank
DB06637,Amines,DrugBank
DB06637,Aminopyridines,DrugBank
DB06637,Cardiovascular Agents,DrugBank
DB06637,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06637,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB06637,Cytochrome P-450 Substrates,DrugBank
DB06637,Drugs that are Mainly Renally Excreted,DrugBank
DB06637,Membrane Transport Modulators,DrugBank
DB06637,Narrow Therapeutic Index Drugs,DrugBank
DB06637,Nervous System,DrugBank
DB06637,OCT2 Substrates,DrugBank
DB06637,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB06637,Other Miscellaneous Therapeutic Agents,DrugBank
DB06637,Potassium Channel Blockers,DrugBank
DB06637,Pyridines,DrugBank
DB06643,"Amino Acids, Peptides, and Proteins",DrugBank
DB06643,Antibodies,DrugBank
DB06643,"Antibodies, Monoclonal",DrugBank
DB06643,"Antibodies, Monoclonal, Humanized",DrugBank
DB06643,Biological Products,DrugBank
DB06643,Blood Proteins,DrugBank
DB06643,Bone Density Conservation Agents,DrugBank
DB06643,Cancer immunotherapy,DrugBank
DB06643,Complex Mixtures,DrugBank
DB06643,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB06643,Drugs for Treatment of Bone Diseases,DrugBank
DB06643,Globulins,DrugBank
DB06643,Immunoglobulins,DrugBank
DB06643,Immunoproteins,DrugBank
DB06643,Immunosuppressive Agents,DrugBank
DB06643,Immunotherapy,DrugBank
DB06643,Musculo-Skeletal System,DrugBank
DB06643,Proteins,DrugBank
DB06643,RANK Ligand Blocking Activity,DrugBank
DB06643,RANK Ligand Inhibitor,DrugBank
DB06643,Serum Globulins,DrugBank
DB06647,"Amino Acids, Peptides, and Proteins",DrugBank
DB06647,Angiogenesis Inhibitors,DrugBank
DB06647,Angiogenesis Modulating Agents,DrugBank
DB06647,Antibodies,DrugBank
DB06647,Antineoplastic Agents,DrugBank
DB06647,Blood Proteins,DrugBank
DB06647,Globulins,DrugBank
DB06647,Growth Inhibitors,DrugBank
DB06647,Growth Substances,DrugBank
DB06647,Immunoglobulins,DrugBank
DB06647,Immunoproteins,DrugBank
DB06647,Proteins,DrugBank
DB06647,Serum Globulins,DrugBank
DB06650,"Amino Acids, Peptides, and Proteins",DrugBank
DB06650,Antibodies,DrugBank
DB06650,"Antibodies, Monoclonal",DrugBank
DB06650,"Antigens, CD20",DrugBank
DB06650,Antineoplastic Agents,DrugBank
DB06650,Antineoplastic and Immunomodulating Agents,DrugBank
DB06650,Blood Proteins,DrugBank
DB06650,Cancer immunotherapy,DrugBank
DB06650,CD20 (Clusters of Differentiation 20) inhibitors,DrugBank
DB06650,CD20-directed Antibody Interactions,DrugBank
DB06650,CD20-directed Cytolytic Antibody,DrugBank
DB06650,Globulins,DrugBank
DB06650,Immunoglobulins,DrugBank
DB06650,Immunoproteins,DrugBank
DB06650,Immunosuppressive Agents,DrugBank
DB06650,Immunotherapy,DrugBank
DB06650,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB06650,Proteins,DrugBank
DB06650,Selective Immunosuppressants,DrugBank
DB06650,Serum Globulins,DrugBank
DB06652,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06652,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06652,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06652,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06652,Cytochrome P-450 Substrates,DrugBank
DB06654,Agents that produce hypertension,DrugBank
DB06654,Agents that reduce seizure threshold,DrugBank
DB06654,Amines,DrugBank
DB06654,Amino Acids,DrugBank
DB06654,"Amino Acids, Peptides, and Proteins",DrugBank
DB06654,Anti-Parkinson Drugs,DrugBank
DB06654,Antidepressive Agents,DrugBank
DB06654,BCRP/ABCG2 Inhibitors,DrugBank
DB06654,Benzene Derivatives,DrugBank
DB06654,Benzyl Compounds,DrugBank
DB06654,Central Nervous System Depressants,DrugBank
DB06654,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06654,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06654,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06654,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06654,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06654,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06654,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06654,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06654,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06654,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06654,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06654,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06654,Cytochrome P-450 Substrates,DrugBank
DB06654,Dopamine Agents,DrugBank
DB06654,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB06654,Monoamine Oxidase B Inhibitors,DrugBank
DB06654,Monoamine Oxidase Inhibitors,DrugBank
DB06654,Nervous System,DrugBank
DB06654,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06655,Alimentary Tract and Metabolism,DrugBank
DB06655,"Amino Acids, Peptides, and Proteins",DrugBank
DB06655,Blood Glucose Lowering Agents,DrugBank
DB06655,Drugs Used in Diabetes,DrugBank
DB06655,Gastrointestinal Hormones,DrugBank
DB06655,GLP-1 Agonists,DrugBank
DB06655,Glucagon-Like Peptide 1,DrugBank
DB06655,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB06655,Glucagon-Like Peptides,DrugBank
DB06655,Hormones,DrugBank
DB06655,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06655,Hypoglycemia-Associated Agents,DrugBank
DB06655,Incretin Mimetics,DrugBank
DB06655,Incretins,DrugBank
DB06655,Pancreatic Hormones,DrugBank
DB06655,Peptide Hormones,DrugBank
DB06655,Peptides,DrugBank
DB06655,Proglucagon,DrugBank
DB06655,Protein Precursors,DrugBank
DB06655,Proteins,DrugBank
DB06660,"Acids, Carbocyclic",DrugBank
DB06660,Amides,DrugBank
DB06660,Antidepressive Agents,DrugBank
DB06660,Benzene Derivatives,DrugBank
DB06660,Benzoates,DrugBank
DB06660,Central Nervous System Depressants,DrugBank
DB06660,"Receptors, Neurokinin-2, antagonists & inhibitors",DrugBank
DB06662,Antineoplastic and Immunomodulating Agents,DrugBank
DB06662,Immunologic Factors,DrugBank
DB06662,Immunosuppressive Agents,DrugBank
DB06662,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB06662,Nucleotides,DrugBank
DB06662,Polynucleotides,DrugBank
DB06662,Selective Immunosuppressants,DrugBank
DB06663,"Amino Acids, Peptides, and Proteins",DrugBank
DB06663,Bradycardia-Causing Agents,DrugBank
DB06663,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06663,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06663,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06663,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06663,Hormones,DrugBank
DB06663,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06663,Hyperglycemia-Associated Agents,DrugBank
DB06663,Hypoglycemia-Associated Agents,DrugBank
DB06663,Hypothalamic Hormones,DrugBank
DB06663,Nerve Tissue Proteins,DrugBank
DB06663,Neuropeptides,DrugBank
DB06663,Pancreatic Hormones,DrugBank
DB06663,Peptide Hormones,DrugBank
DB06663,Peptides,DrugBank
DB06663,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB06663,Pituitary Hormone Release Inhibiting Hormones,DrugBank
DB06663,Potential QTc-Prolonging Agents,DrugBank
DB06663,Proteins,DrugBank
DB06663,QTc Prolonging Agents,DrugBank
DB06663,Somatostatin Agonists,DrugBank
DB06663,Somatostatin and Analogues,DrugBank
DB06663,Somatostatin Receptor Agonists,DrugBank
DB06663,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB06670,Benzene Derivatives,DrugBank
DB06670,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06670,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06670,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06670,Cytochrome P-450 Substrates,DrugBank
DB06670,P-glycoprotein substrates,DrugBank
DB06674,Agents reducing cytokine levels,DrugBank
DB06674,"Amino Acids, Peptides, and Proteins",DrugBank
DB06674,Anti-Inflammatory Agents,DrugBank
DB06674,Antibodies,DrugBank
DB06674,"Antibodies, Monoclonal",DrugBank
DB06674,Antineoplastic and Immunomodulating Agents,DrugBank
DB06674,Antirheumatic Agents,DrugBank
DB06674,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB06674,Blood Proteins,DrugBank
DB06674,Disease-modifying Antirheumatic Agents,DrugBank
DB06674,Globulins,DrugBank
DB06674,Immunoglobulins,DrugBank
DB06674,Immunologic Factors,DrugBank
DB06674,Immunoproteins,DrugBank
DB06674,Immunosuppressive Agents,DrugBank
DB06674,Proteins,DrugBank
DB06674,Serum Globulins,DrugBank
DB06674,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB06674,Tumor Necrosis Factor Blockers,DrugBank
DB06674,Tumor Necrosis Factor Receptor Blocking Activity,DrugBank
DB06678,Adrenergic Agents,DrugBank
DB06678,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB06678,Adrenergic alpha-Antagonists,DrugBank
DB06678,Adrenergic Antagonists,DrugBank
DB06678,Agents that produce hypertension,DrugBank
DB06678,Anti-Anxiety Agents,DrugBank
DB06678,Antidepressive Agents,DrugBank
DB06678,"Antidepressive Agents, Tetracyclic",DrugBank
DB06678,Central Nervous System Agents,DrugBank
DB06678,Central Nervous System Depressants,DrugBank
DB06678,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06678,Cytochrome P-450 Substrates,DrugBank
DB06678,Dibenzazepines,DrugBank
DB06678,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06678,Histamine Agents,DrugBank
DB06678,Histamine Antagonists,DrugBank
DB06678,Histamine H1 Antagonists,DrugBank
DB06678,Neurotransmitter Agents,DrugBank
DB06678,Psychotropic Drugs,DrugBank
DB06678,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB06678,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB06678,Serotonin Agents,DrugBank
DB06678,Serotonin Receptor Antagonists,DrugBank
DB06678,Tranquilizing Agents,DrugBank
DB06679,Agents causing angioedema,DrugBank
DB06679,"Amino Acids, Peptides, and Proteins",DrugBank
DB06679,Anticoagulants,DrugBank
DB06679,Biological Factors,DrugBank
DB06679,Blood Proteins,DrugBank
DB06679,Endopeptidases,DrugBank
DB06679,Enzymes,DrugBank
DB06679,Enzymes and Coenzymes,DrugBank
DB06679,Fibrinolytic Agents,DrugBank
DB06679,Hydrolases,DrugBank
DB06679,Peptide Hydrolases,DrugBank
DB06679,Plasminogen Activators,DrugBank
DB06679,Proteins,DrugBank
DB06679,Serine Endopeptidases,DrugBank
DB06679,Serine Proteases,DrugBank
DB06681,"Amino Acids, Peptides, and Proteins",DrugBank
DB06681,Antibodies,DrugBank
DB06681,"Antineoplastic Agents, Immunological",DrugBank
DB06681,Antineoplastic and Immunomodulating Agents,DrugBank
DB06681,Antirheumatic Agents,DrugBank
DB06681,Blood Proteins,DrugBank
DB06681,CD80-directed Antibody Interactions,DrugBank
DB06681,CD86-directed Antibody Interactions,DrugBank
DB06681,Globulins,DrugBank
DB06681,Immune Checkpoint Inhibitors,DrugBank
DB06681,Immunoconjugates,DrugBank
DB06681,Immunologic Factors,DrugBank
DB06681,Immunosuppressive Agents,DrugBank
DB06681,Proteins,DrugBank
DB06681,Selective Immunosuppressants,DrugBank
DB06681,Selective T Cell Costimulation Blocker,DrugBank
DB06681,Serum Globulins,DrugBank
DB06681,T Lymphocyte Costimulation Activity Blockade,DrugBank
DB06684,Agents that produce hypertension,DrugBank
DB06684,Antidepressive Agents,DrugBank
DB06684,Antidepressive Agents Indicated for Depression,DrugBank
DB06684,Benzofurans,DrugBank
DB06684,Central Nervous System Agents,DrugBank
DB06684,Central Nervous System Depressants,DrugBank
DB06684,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06684,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06684,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB06684,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06684,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06684,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06684,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06684,Cytochrome P-450 Substrates,DrugBank
DB06684,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06684,Indoles,DrugBank
DB06684,Membrane Transport Modulators,DrugBank
DB06684,Nervous System,DrugBank
DB06684,Neurotransmitter Agents,DrugBank
DB06684,Neurotransmitter Uptake Inhibitors,DrugBank
DB06684,Piperazines,DrugBank
DB06684,Psychoanaleptics,DrugBank
DB06684,Psychotropic Drugs,DrugBank
DB06684,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06684,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB06684,Serotonin Agents,DrugBank
DB06684,Serotonin antagonist and reuptake inhibitors (SARIs),DrugBank
DB06684,Serotonin Modulators,DrugBank
DB06684,Serotonin Receptor Agonists,DrugBank
DB06685,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06685,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06685,Cytochrome P-450 Substrates,DrugBank
DB06685,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06685,Nervous System,DrugBank
DB06685,Quinolines,DrugBank
DB06688,"Adjuvants, Immunologic",DrugBank
DB06688,Antineoplastic and Immunomodulating Agents,DrugBank
DB06688,Autologous Cellular Immunotherapy,DrugBank
DB06688,Cancer immunotherapy,DrugBank
DB06688,Cancer Vaccines,DrugBank
DB06688,Cell-mediated Immunity,DrugBank
DB06688,Complex Mixtures,DrugBank
DB06688,Immunotherapy,DrugBank
DB06688,Intercellular Adhesion Molecule-1,DrugBank
DB06690,Agents that produce hypertension,DrugBank
DB06690,Analgesics,DrugBank
DB06690,"Analgesics, Non-Narcotic",DrugBank
DB06690,Anesthetics,DrugBank
DB06690,"Anesthetics, General",DrugBank
DB06690,"Anesthetics, Inhalation",DrugBank
DB06690,Central Nervous System Agents,DrugBank
DB06690,Central Nervous System Depressants,DrugBank
DB06690,Gases,DrugBank
DB06690,Methemoglobinemia Associated Agents,DrugBank
DB06690,Nervous System,DrugBank
DB06690,Nitrogen Compounds,DrugBank
DB06690,Nitrogen Oxides,DrugBank
DB06690,Oxides,DrugBank
DB06690,Oxygen Compounds,DrugBank
DB06690,Peripheral Nervous System Agents,DrugBank
DB06690,Sensory System Agents,DrugBank
DB06691,Amines,DrugBank
DB06691,Aminopyridines,DrugBank
DB06691,Anti-Allergic Agents,DrugBank
DB06691,Antihistamines for Systemic Use,DrugBank
DB06691,Antihistamines for Topical Use,DrugBank
DB06691,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB06691,Central Nervous System Agents,DrugBank
DB06691,Central Nervous System Depressants,DrugBank
DB06691,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06691,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06691,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06691,Dermatologicals,DrugBank
DB06691,Histamine Agents,DrugBank
DB06691,Histamine Antagonists,DrugBank
DB06691,Histamine H1 Antagonists,DrugBank
DB06691,Hypnotics and Sedatives,DrugBank
DB06691,Neurotransmitter Agents,DrugBank
DB06691,Potential QTc-Prolonging Agents,DrugBank
DB06691,Pyridines,DrugBank
DB06691,QTc Prolonging Agents,DrugBank
DB06691,"Sleep Aids, Pharmaceutical",DrugBank
DB06691,Substituted Ethylene Diamines,DrugBank
DB06692,"Amino Acids, Peptides, and Proteins",DrugBank
DB06692,Antifibrinolytic Agents,DrugBank
DB06692,Blood and Blood Forming Organs,DrugBank
DB06692,Cholinesterase Inhibitors,DrugBank
DB06692,Coagulants,DrugBank
DB06692,Decreased Fibrinolysis,DrugBank
DB06692,Enzyme Inhibitors,DrugBank
DB06692,Hematologic Agents,DrugBank
DB06692,Hemostatics,DrugBank
DB06692,Protease Inhibitors,DrugBank
DB06692,Proteinase Inhibitors,DrugBank
DB06692,Proteins,DrugBank
DB06692,Serine Protease Inhibitors,DrugBank
DB06692,Trypsin Inhibitors,DrugBank
DB06693,Agents Causing Muscle Toxicity,DrugBank
DB06693,Anti-Infective Agents,DrugBank
DB06693,Anticholesteremic Agents,DrugBank
DB06693,Antifungal Agents,DrugBank
DB06693,Enzyme Inhibitors,DrugBank
DB06693,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB06693,Hypolipidemic Agents,DrugBank
DB06693,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB06693,Lipid Regulating Agents,DrugBank
DB06693,Naphthalenes,DrugBank
DB06694,Adrenergic Agonists,DrugBank
DB06694,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB06694,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB06694,Adrenergic alpha-Agonists,DrugBank
DB06694,Agents producing tachycardia,DrugBank
DB06694,Agents that produce hypertension,DrugBank
DB06694,Antiarrhythmic agents,DrugBank
DB06694,Antihistamine Drugs,DrugBank
DB06694,Calcium Channel Blockers,DrugBank
DB06694,Cardiovascular Agents,DrugBank
DB06694,Decongestants and Antiallergics,DrugBank
DB06694,Nasal Decongestants,DrugBank
DB06694,Nasal Preparations,DrugBank
DB06694,Ophthalmologicals,DrugBank
DB06694,Respiratory System Agents,DrugBank
DB06694,Sensory Organs,DrugBank
DB06694,Sympathomimetics Used as Decongestants,DrugBank
DB06694,"Sympathomimetics, Plain",DrugBank
DB06694,Vasoconstrictor Agents,DrugBank
DB06694,Vasodilating Agents,DrugBank
DB06695,Anticoagulants,DrugBank
DB06695,Antithrombins,DrugBank
DB06695,Benzimidazoles,DrugBank
DB06695,Blood and Blood Forming Organs,DrugBank
DB06695,Drugs that are Mainly Renally Excreted,DrugBank
DB06695,Enzyme Inhibitors,DrugBank
DB06695,Hematologic Agents,DrugBank
DB06695,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06695,P-glycoprotein substrates,DrugBank
DB06695,Protease Inhibitors,DrugBank
DB06695,Pyridines,DrugBank
DB06695,Serine Protease Inhibitors,DrugBank
DB06695,UGT1A9 Substrates,DrugBank
DB06695,UGT2B7 substrates,DrugBank
DB06696,Agents that produce neuromuscular block (indirect),DrugBank
DB06696,Aminoglycoside Antibacterials,DrugBank
DB06696,Anti-Bacterial Agents,DrugBank
DB06696,Anti-Infective Agents,DrugBank
DB06696,Antibacterials for Systemic Use,DrugBank
DB06696,Antiinfectives for Systemic Use,DrugBank
DB06696,Carbohydrates,DrugBank
DB06696,Drugs that are Mainly Renally Excreted,DrugBank
DB06696,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB06696,Glycosides,DrugBank
DB06696,Narrow Therapeutic Index Drugs,DrugBank
DB06696,Nephrotoxic agents,DrugBank
DB06697,Anti-Infective Agents,DrugBank
DB06697,Antimalarials,DrugBank
DB06697,Antiparasitic Agents,DrugBank
DB06697,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06697,Antiprotozoals,DrugBank
DB06697,Artemisinin and derivatives,DrugBank
DB06697,Artemisinins,DrugBank
DB06697,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB06697,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB06697,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06697,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB06697,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06697,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06697,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06697,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06697,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06697,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB06697,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06697,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06697,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06697,Cytochrome P-450 Substrates,DrugBank
DB06697,Free Radicals,DrugBank
DB06697,Highest Risk QTc-Prolonging Agents,DrugBank
DB06697,Peroxides,DrugBank
DB06697,QTc Prolonging Agents,DrugBank
DB06697,Reactive Oxygen Species,DrugBank
DB06697,Sesquiterpenes,DrugBank
DB06697,Terpenes,DrugBank
DB06698,Antivertigo Preparations,DrugBank
DB06698,Histamine Agents,DrugBank
DB06698,Histamine Agonists,DrugBank
DB06698,Histamine Antagonists,DrugBank
DB06698,Miscellaneous Central Nervous System Agents,DrugBank
DB06698,Miscellaneous Therapeutic Agents,DrugBank
DB06698,Nervous System,DrugBank
DB06698,Neurotransmitter Agents,DrugBank
DB06698,Pyridines,DrugBank
DB06698,Vasodilating Agents,DrugBank
DB06699,"Amino Acids, Peptides, and Proteins",DrugBank
DB06699,Antineoplastic Agents,DrugBank
DB06699,Antineoplastic and Immunomodulating Agents,DrugBank
DB06699,Decreased GnRH Secretion,DrugBank
DB06699,Endocrine Therapy,DrugBank
DB06699,Gonadotropin Releasing Hormone Receptor Antagonists,DrugBank
DB06699,Gonadotropin-releasing Hormone Antagonists,DrugBank
DB06699,"Gonadotropin-Releasing Hormone, antagonists & inhibitors",DrugBank
DB06699,Hormone Antagonists and Related Agents,DrugBank
DB06699,Peptides,DrugBank
DB06699,Potential QTc-Prolonging Agents,DrugBank
DB06699,QTc Prolonging Agents,DrugBank
DB06700,Agents producing tachycardia,DrugBank
DB06700,Agents that reduce seizure threshold,DrugBank
DB06700,Alcohols,DrugBank
DB06700,Antidepressive Agents,DrugBank
DB06700,Antidepressive Agents Indicated for Depression,DrugBank
DB06700,Benzene Derivatives,DrugBank
DB06700,Central Nervous System Agents,DrugBank
DB06700,Central Nervous System Depressants,DrugBank
DB06700,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB06700,Cyclohexanes,DrugBank
DB06700,Cyclohexanols,DrugBank
DB06700,Cycloparaffins,DrugBank
DB06700,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06700,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06700,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB06700,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06700,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06700,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06700,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB06700,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06700,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06700,Cytochrome P-450 Substrates,DrugBank
DB06700,Drugs that are Mainly Renally Excreted,DrugBank
DB06700,Fatty Alcohols,DrugBank
DB06700,Hexanols,DrugBank
DB06700,Hypoglycemia-Associated Agents,DrugBank
DB06700,Lipids,DrugBank
DB06700,Membrane Transport Modulators,DrugBank
DB06700,Nervous System,DrugBank
DB06700,Neurotransmitter Agents,DrugBank
DB06700,Neurotransmitter Uptake Inhibitors,DrugBank
DB06700,Norepinephrine Uptake Inhibitors,DrugBank
DB06700,Phenols,DrugBank
DB06700,Psychoanaleptics,DrugBank
DB06700,Psychotropic Drugs,DrugBank
DB06700,Selective Serotonin Reuptake Inhibitors,DrugBank
DB06700,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06700,Serotonin Agents,DrugBank
DB06700,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB06700,Serotonin Modulators,DrugBank
DB06700,UGT1A1 Substrates,DrugBank
DB06700,UGT1A3 substrates,DrugBank
DB06700,UGT2B17 substrates,DrugBank
DB06701,Agents that produce hypertension,DrugBank
DB06701,Antidepressive Agents,DrugBank
DB06701,Central Nervous System Agents,DrugBank
DB06701,Central Nervous System Depressants,DrugBank
DB06701,Central Nervous System Stimulants,DrugBank
DB06701,Central Nervous System Stimulation,DrugBank
DB06701,Centrally Acting Sympathomimetics,DrugBank
DB06701,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB06701,Dopamine Agents,DrugBank
DB06701,Dopamine Uptake Inhibitors,DrugBank
DB06701,Membrane Transport Modulators,DrugBank
DB06701,Methylphenidate and isomer,DrugBank
DB06701,Nervous System,DrugBank
DB06701,Neurotransmitter Agents,DrugBank
DB06701,Neurotransmitter Uptake Inhibitors,DrugBank
DB06701,Phenylacetates,DrugBank
DB06701,Piperidines,DrugBank
DB06701,Psychoanaleptics,DrugBank
DB06701,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB06701,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06701,Serotonin Agents,DrugBank
DB06701,Serotonin Modulators,DrugBank
DB06702,Agents producing tachycardia,DrugBank
DB06702,Anticholinergic Agents,DrugBank
DB06702,Benzene Derivatives,DrugBank
DB06702,Cholinergic Agents,DrugBank
DB06702,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06702,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06702,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06702,Cytochrome P-450 Substrates,DrugBank
DB06702,Drugs for Urinary Frequency and Incontinence,DrugBank
DB06702,Drugs that are Mainly Renally Excreted,DrugBank
DB06702,Genito Urinary System and Sex Hormones,DrugBank
DB06702,Genitourinary Agents,DrugBank
DB06702,Muscarinic Antagonists,DrugBank
DB06702,Neurotransmitter Agents,DrugBank
DB06702,P-glycoprotein substrates,DrugBank
DB06702,Urological Agents,DrugBank
DB06702,Urologicals,DrugBank
DB06704,Amidines,DrugBank
DB06704,Benzene Derivatives,DrugBank
DB06704,"Compounds used in a research, industrial, or household setting",DrugBank
DB06704,Diagnostic Radiopharmaceuticals,DrugBank
DB06704,Diagnostic Uses of Chemicals,DrugBank
DB06704,Enzyme Inhibitors,DrugBank
DB06704,Guanidines,DrugBank
DB06704,"Hydrocarbons, Halogenated",DrugBank
DB06704,"Hydrocarbons, Iodinated",DrugBank
DB06704,Indicators and Reagents,DrugBank
DB06704,Iodine (131I) Compounds,DrugBank
DB06704,Iodobenzenes,DrugBank
DB06704,Laboratory Chemicals,DrugBank
DB06704,Narrow Therapeutic Index Drugs,DrugBank
DB06704,Radioactive Diagnostic Agent,DrugBank
DB06704,Radiopharmaceutical Activity,DrugBank
DB06704,Radiopharmaceuticals,DrugBank
DB06704,Therapeutic Radiopharmaceuticals,DrugBank
DB06704,Tumour Detection,DrugBank
DB06705,"Compounds used in a research, industrial, or household setting",DrugBank
DB06705,Contrast Media,DrugBank
DB06705,Diagnostic Uses of Chemicals,DrugBank
DB06705,Drugs that are Mainly Renally Excreted,DrugBank
DB06705,Elements,DrugBank
DB06705,Gadolinium-based Contrast Agent,DrugBank
DB06705,Lanthanoid Series Elements,DrugBank
DB06705,Magnetic Resonance Angiography,DrugBank
DB06705,Magnetic Resonance Contrast Activity,DrugBank
DB06705,Magnetic Resonance Imaging Contrast Media,DrugBank
DB06705,Metals,DrugBank
DB06705,"Metals, Rare Earth",DrugBank
DB06705,Paramagnetic Contrast Agent,DrugBank
DB06705,Paramagnetic Contrast Media,DrugBank
DB06706,Adrenergic Agonists,DrugBank
DB06706,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB06706,Adrenergic alpha-Agonists,DrugBank
DB06706,Agents producing tachycardia,DrugBank
DB06706,Agents that produce hypertension,DrugBank
DB06706,Alimentary Tract and Metabolism,DrugBank
DB06706,Amines,DrugBank
DB06706,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB06706,Methemoglobinemia Associated Agents,DrugBank
DB06707,Adrenergic Agonists,DrugBank
DB06707,Agents producing tachycardia,DrugBank
DB06707,Agents that produce hypertension,DrugBank
DB06707,Amines,DrugBank
DB06707,Benzene Derivatives,DrugBank
DB06707,Cardiovascular Agents,DrugBank
DB06707,Catecholamines,DrugBank
DB06707,Catechols,DrugBank
DB06707,Epinephrine and similars,DrugBank
DB06707,Phenols,DrugBank
DB06707,Sympathomimetics,DrugBank
DB06707,Vasoconstrictor Agents,DrugBank
DB06708,Anti-Infective Agents,DrugBank
DB06708,Antimalarials,DrugBank
DB06708,Antiparasitic Agents,DrugBank
DB06708,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06708,Antiprotozoals,DrugBank
DB06708,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06708,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB06708,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06708,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06708,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06708,Cytochrome P-450 Substrates,DrugBank
DB06708,Fluorenes,DrugBank
DB06708,Highest Risk QTc-Prolonging Agents,DrugBank
DB06708,QTc Prolonging Agents,DrugBank
DB06709,Amines,DrugBank
DB06709,Ammonium Compounds,DrugBank
DB06709,Autonomic Agents,DrugBank
DB06709,Bronchoconstrictor Agents,DrugBank
DB06709,Cholinergic Agents,DrugBank
DB06709,Cholinergic Agonists,DrugBank
DB06709,Cholinergic Receptor Agonist,DrugBank
DB06709,Diagnostic Agents,DrugBank
DB06709,Methacholine Compounds,DrugBank
DB06709,Miotics,DrugBank
DB06709,Muscarinic Agonists,DrugBank
DB06709,Neurotransmitter Agents,DrugBank
DB06709,Nitrogen Compounds,DrugBank
DB06709,Onium Compounds,DrugBank
DB06709,Other Diagnostics,DrugBank
DB06709,Parasympathomimetics,DrugBank
DB06709,Peripheral Nervous System Agents,DrugBank
DB06709,Quaternary Ammonium Compounds,DrugBank
DB06709,Respiratory System Agents,DrugBank
DB06709,Trimethyl Ammonium Compounds,DrugBank
DB06710,3-Oxoandrosten (4) Derivatives,DrugBank
DB06710,Anabolic Agents,DrugBank
DB06710,Androgens,DrugBank
DB06710,Androgens and Estrogens,DrugBank
DB06710,Androstanes,DrugBank
DB06710,Androstenes,DrugBank
DB06710,Androstenols,DrugBank
DB06710,Antineoplastic Agents,DrugBank
DB06710,"Antineoplastic Agents, Hormonal",DrugBank
DB06710,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06710,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06710,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06710,Cytochrome P-450 Substrates,DrugBank
DB06710,Drugs that are Mainly Renally Excreted,DrugBank
DB06710,Fused-Ring Compounds,DrugBank
DB06710,Genito Urinary System and Sex Hormones,DrugBank
DB06710,Hormones,DrugBank
DB06710,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06710,OAT3/SLC22A8 Inducers,DrugBank
DB06710,Sex Hormones and Modulators of the Genital System,DrugBank
DB06710,Steroids,DrugBank
DB06710,Testosterone Congeners,DrugBank
DB06710,Thyroxine-binding globulin inhibitors,DrugBank
DB06711,Adrenergic Agents,DrugBank
DB06711,Adrenergic Agonists,DrugBank
DB06711,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB06711,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB06711,Adrenergic alpha-Agonists,DrugBank
DB06711,Agents producing tachycardia,DrugBank
DB06711,Agents that produce hypertension,DrugBank
DB06711,Cardiovascular Agents,DrugBank
DB06711,Decongestants and Antiallergics,DrugBank
DB06711,Imidazoles,DrugBank
DB06711,Nasal Decongestants,DrugBank
DB06711,Nasal Preparations,DrugBank
DB06711,Neurotransmitter Agents,DrugBank
DB06711,Ophthalmologicals,DrugBank
DB06711,Respiratory System Agents,DrugBank
DB06711,Sensory Organs,DrugBank
DB06711,Sympathomimetics,DrugBank
DB06711,Sympathomimetics Used as Decongestants,DrugBank
DB06711,"Sympathomimetics, Plain",DrugBank
DB06711,Vasoconstrictor Agents,DrugBank
DB06712,Agents causing hyperkalemia,DrugBank
DB06712,Antiarrhythmic agents,DrugBank
DB06712,Antihypertensive Agents,DrugBank
DB06712,Bradycardia-Causing Agents,DrugBank
DB06712,Calcium Channel Blockers,DrugBank
DB06712,Calcium-Regulating Hormones and Agents,DrugBank
DB06712,Cardiovascular Agents,DrugBank
DB06712,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB06712,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB06712,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06712,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB06712,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06712,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06712,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06712,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06712,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06712,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06712,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB06712,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06712,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06712,Cytochrome P-450 Substrates,DrugBank
DB06712,Dihydropyridine Derivatives,DrugBank
DB06712,Dihydropyridines,DrugBank
DB06712,Hypotensive Agents,DrugBank
DB06712,Membrane Transport Modulators,DrugBank
DB06712,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06712,Pyridines,DrugBank
DB06712,QTc Prolonging Agents,DrugBank
DB06712,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB06712,Vasodilating Agents,DrugBank
DB06713,Adrenal Cortex Hormones,DrugBank
DB06713,Amines,DrugBank
DB06713,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB06713,"Contraceptive Agents, Female",DrugBank
DB06713,"Contraceptive Agents, Hormonal",DrugBank
DB06713,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06713,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06713,Cytochrome P-450 Substrates,DrugBank
DB06713,Fused-Ring Compounds,DrugBank
DB06713,Genito Urinary System and Sex Hormones,DrugBank
DB06713,Hormonal Contraceptives for Systemic Use,DrugBank
DB06713,Hydroxylamines,DrugBank
DB06713,Norpregnanes,DrugBank
DB06713,Norpregnenes,DrugBank
DB06713,Norsteroids,DrugBank
DB06713,Pharmaceutical Preparations,DrugBank
DB06713,Progestins,DrugBank
DB06713,Reproductive Control Agents,DrugBank
DB06713,Sex Hormones and Modulators of the Genital System,DrugBank
DB06713,Steroids,DrugBank
DB06714,Adrenergic Agonists,DrugBank
DB06714,Adrenergic alpha-Agonists,DrugBank
DB06714,Amines,DrugBank
DB06715,Anions,DrugBank
DB06715,Antidotes,DrugBank
DB06715,Antithyroid agents,DrugBank
DB06715,Cough and Cold Preparations,DrugBank
DB06715,Electrolytes,DrugBank
DB06715,Expectorants,DrugBank
DB06715,Iodides,DrugBank
DB06715,Iodine Compounds,DrugBank
DB06715,Ions,DrugBank
DB06715,Minerals,DrugBank
DB06715,Ophthalmologicals,DrugBank
DB06715,Potassium Compounds,DrugBank
DB06715,Potassium Salt,DrugBank
DB06715,Sensory Organs,DrugBank
DB06715,Thyroid Products,DrugBank
DB06716,Agents that reduce seizure threshold,DrugBank
DB06716,Anesthetics,DrugBank
DB06716,"Anesthetics, General",DrugBank
DB06716,Benzene Derivatives,DrugBank
DB06716,Central Nervous System Agents,DrugBank
DB06716,Central Nervous System Depressants,DrugBank
DB06716,Hypnotics and Sedatives,DrugBank
DB06716,Phenols,DrugBank
DB06717,Antiemetics,DrugBank
DB06717,Aprepitant and Prodrugs,DrugBank
DB06717,Autonomic Agents,DrugBank
DB06717,Central Nervous System Agents,DrugBank
DB06717,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB06717,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB06717,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06717,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06717,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06717,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06717,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06717,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06717,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06717,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06717,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB06717,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06717,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06717,Cytochrome P-450 Substrates,DrugBank
DB06717,Gastrointestinal Agents,DrugBank
DB06717,Miscellaneous Antiemetics,DrugBank
DB06717,Morpholines,DrugBank
DB06717,Neurokinin 1 Antagonists,DrugBank
DB06717,Neurokinin-1 Receptor Antagonists,DrugBank
DB06717,Neurotransmitter Agents,DrugBank
DB06717,Oxazines,DrugBank
DB06717,Peripheral Nervous System Agents,DrugBank
DB06717,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB06718,Alimentary Tract and Metabolism,DrugBank
DB06718,Anabolic Agents,DrugBank
DB06718,Anabolic Agents for Systemic Use,DrugBank
DB06718,Anabolic Steroids,DrugBank
DB06718,Androgens,DrugBank
DB06718,Androstan Derivatives,DrugBank
DB06718,Androstanes,DrugBank
DB06718,Androstanols,DrugBank
DB06718,Fused-Ring Compounds,DrugBank
DB06718,Hormones,DrugBank
DB06718,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06718,Steroids,DrugBank
DB06718,Thyroxine-binding globulin inhibitors,DrugBank
DB06719,Adrenal Cortex Hormones,DrugBank
DB06719,"Amino Acids, Peptides, and Proteins",DrugBank
DB06719,Antineoplastic Agents,DrugBank
DB06719,Antineoplastic and Immunomodulating Agents,DrugBank
DB06719,Endocrine Therapy,DrugBank
DB06719,Fertility Agents,DrugBank
DB06719,"Fertility Agents, Female",DrugBank
DB06719,Gonadotropin-releasing hormone agonist,DrugBank
DB06719,Hormones,DrugBank
DB06719,Hormones and Related Agents,DrugBank
DB06719,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06719,Hyperglycemia-Associated Agents,DrugBank
DB06719,Hypothalamic Hormones,DrugBank
DB06719,Miscellaneous Therapeutic Agents,DrugBank
DB06719,Nerve Tissue Proteins,DrugBank
DB06719,Neuropeptides,DrugBank
DB06719,Oligopeptides,DrugBank
DB06719,Peptide Hormones,DrugBank
DB06719,Peptides,DrugBank
DB06719,Pituitary Hormone-Releasing Hormones,DrugBank
DB06719,Potential QTc-Prolonging Agents,DrugBank
DB06719,Proteins,DrugBank
DB06719,QTc Prolonging Agents,DrugBank
DB06719,Reproductive Control Agents,DrugBank
DB06721,Alkaloids,DrugBank
DB06721,OATP1B1/SLCO1B1 Substrates,DrugBank
DB06723,"Adjuvants, Immunologic",DrugBank
DB06723,Alimentary Tract and Metabolism,DrugBank
DB06723,Alkalies,DrugBank
DB06723,Aluminium Compounds,DrugBank
DB06723,Aluminum and magnesium containing antacids,DrugBank
DB06723,Anions,DrugBank
DB06723,Antacids,DrugBank
DB06723,Antacids and Adsorbents,DrugBank
DB06723,"Carbon Compounds, Inorganic",DrugBank
DB06723,Carbonic Acid,DrugBank
DB06723,Drugs for Acid Related Disorders,DrugBank
DB06723,Electrolytes,DrugBank
DB06723,Gastric Acid Lowering Agents,DrugBank
DB06723,Gastrointestinal Agents,DrugBank
DB06723,Hydroxides,DrugBank
DB06723,Immunologic Factors,DrugBank
DB06723,Ions,DrugBank
DB06723,Metal cations,DrugBank
DB06723,Metal divalent cations,DrugBank
DB06723,Miscellaneous Local Anti-infectives,DrugBank
DB06724,Alimentary Tract and Metabolism,DrugBank
DB06724,Antacids,DrugBank
DB06724,Antacids and Adsorbents,DrugBank
DB06724,Calcium Compounds,DrugBank
DB06724,Calcium Salts,DrugBank
DB06724,"Carbon Compounds, Inorganic",DrugBank
DB06724,Carbonates,DrugBank
DB06724,Carbonic Acid,DrugBank
DB06724,Drugs for Acid Related Disorders,DrugBank
DB06724,Gastric Acid Lowering Agents,DrugBank
DB06724,Gastrointestinal Agents,DrugBank
DB06724,Mineral Supplements,DrugBank
DB06724,Minerals,DrugBank
DB06724,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB06724,Replacement Preparations,DrugBank
DB06725,Agents causing hyperkalemia,DrugBank
DB06725,Agents that produce hypertension,DrugBank
DB06725,Analgesics,DrugBank
DB06725,"Analgesics, Non-Narcotic",DrugBank
DB06725,Anti-Inflammatory Agents,DrugBank
DB06725,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB06725,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB06725,Antiinflammatory and Antirheumatic Products,DrugBank
DB06725,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB06725,Antirheumatic Agents,DrugBank
DB06725,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06725,Cytochrome P-450 Substrates,DrugBank
DB06725,Musculo-Skeletal System,DrugBank
DB06725,Nephrotoxic agents,DrugBank
DB06725,Non COX-2 selective NSAIDS,DrugBank
DB06725,Oxicams,DrugBank
DB06725,Peripheral Nervous System Agents,DrugBank
DB06725,Sensory System Agents,DrugBank
DB06725,Sulfur Compounds,DrugBank
DB06725,Thiazines,DrugBank
DB06726,Adrenergic Agents,DrugBank
DB06726,Adrenergic Antagonists,DrugBank
DB06726,Adrenergic beta-Antagonists,DrugBank
DB06726,Agents causing hyperkalemia,DrugBank
DB06726,Alcohols,DrugBank
DB06726,Amines,DrugBank
DB06726,Amino Alcohols,DrugBank
DB06726,Bradycardia-Causing Agents,DrugBank
DB06726,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06726,Cytochrome P-450 Substrates,DrugBank
DB06726,Neurotransmitter Agents,DrugBank
DB06727,Alkaloids,DrugBank
DB06727,Antiarrhythmic agents,DrugBank
DB06727,"Antiarrhythmics, Class I",DrugBank
DB06727,"Antiarrhythmics, Class Ia",DrugBank
DB06727,Cardiac Therapy,DrugBank
DB06727,Cardiovascular Agents,DrugBank
DB06727,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06727,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB06727,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06727,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06727,Cytochrome P-450 Substrates,DrugBank
DB06727,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06727,Quinolizidine Alkaloids,DrugBank
DB06727,Quinolizidines,DrugBank
DB06727,Quinolizines,DrugBank
DB06727,Reproductive Control Agents,DrugBank
DB06728,Amines,DrugBank
DB06728,Carcinogens,DrugBank
DB06728,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06728,Cytochrome P-450 Substrates,DrugBank
DB06728,Noxae,DrugBank
DB06728,Toxic Actions,DrugBank
DB06729,Amides,DrugBank
DB06729,Amines,DrugBank
DB06729,Aniline Compounds,DrugBank
DB06729,Anti-Infective Agents,DrugBank
DB06729,Antibacterials for Systemic Use,DrugBank
DB06729,Antiinfectives for Systemic Use,DrugBank
DB06729,Benzene Derivatives,DrugBank
DB06729,Benzenesulfonamides,DrugBank
DB06729,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB06729,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB06729,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB06729,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB06729,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06729,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06729,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB06729,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06729,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB06729,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06729,Genito Urinary System and Sex Hormones,DrugBank
DB06729,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06729,Intermediate-Acting Antibacterial Sulfonamides,DrugBank
DB06729,Long-Acting Antibacterial Sulfonamides,DrugBank
DB06729,Ophthalmologicals,DrugBank
DB06729,Pyrazoles,DrugBank
DB06729,Sensory Organs,DrugBank
DB06729,Sulfanilamides,DrugBank
DB06729,Sulfonamides,DrugBank
DB06729,Sulfonamides and trimethoprim,DrugBank
DB06729,Sulfones,DrugBank
DB06729,Sulfur Compounds,DrugBank
DB06730,Adrenal Cortex Hormones,DrugBank
DB06730,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB06730,"Contraceptive Agents, Female",DrugBank
DB06730,"Contraceptive Agents, Hormonal",DrugBank
DB06730,"Contraceptives, Oral",DrugBank
DB06730,"Contraceptives, Oral, Hormonal",DrugBank
DB06730,"Contraceptives, Oral, Synthetic",DrugBank
DB06730,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06730,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06730,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06730,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06730,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06730,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06730,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06730,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06730,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06730,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB06730,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB06730,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06730,Cytochrome P-450 Substrates,DrugBank
DB06730,Fused-Ring Compounds,DrugBank
DB06730,Genito Urinary System and Sex Hormones,DrugBank
DB06730,Hormonal Contraceptives for Systemic Use,DrugBank
DB06730,Hormones,DrugBank
DB06730,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06730,Norpregnanes,DrugBank
DB06730,Norsteroids,DrugBank
DB06730,Progestin Contraceptives,DrugBank
DB06730,Progestins,DrugBank
DB06730,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB06730,Reproductive Control Agents,DrugBank
DB06730,Sex Hormones and Modulators of the Genital System,DrugBank
DB06730,Steroids,DrugBank
DB06731,Antidepressive Agents,DrugBank
DB06731,Central Nervous System Depressants,DrugBank
DB06731,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB06731,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB06731,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB06731,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB06731,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB06731,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB06731,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06731,Selective Serotonin Reuptake Inhibitors,DrugBank
DB06731,Serotonin Agents,DrugBank
DB06731,Serotonin Modulators,DrugBank
DB06732,Benzoflavones,DrugBank
DB06732,Benzopyrans,DrugBank
DB06732,Chromones,DrugBank
DB06732,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB06732,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB06732,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06732,Enzyme Inhibitors,DrugBank
DB06732,Flavonoids,DrugBank
DB06732,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06732,Pyrans,DrugBank
DB06733,Anti-Infective Agents,DrugBank
DB06733,Antifungal Agents,DrugBank
DB06733,Enzyme Inhibitors,DrugBank
DB06733,Lactones,DrugBank
DB06733,Polyketides,DrugBank
DB06733,"Proton-Translocating ATPases, antagonists & inhibitors",DrugBank
DB06735,Benzene Derivatives,DrugBank
DB06735,Benzylidene Compounds,DrugBank
DB06735,Clomiphene,DrugBank
DB06735,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06735,Cytochrome P-450 Substrates,DrugBank
DB06735,Estrogen Antagonists,DrugBank
DB06735,Estrogen Receptor Modulators,DrugBank
DB06735,Fertility Agents,DrugBank
DB06735,"Fertility Agents, Female",DrugBank
DB06735,Hormone Antagonists,DrugBank
DB06735,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06735,Reproductive Control Agents,DrugBank
DB06735,Selective Estrogen Receptor Modulators,DrugBank
DB06735,Stilbenes,DrugBank
DB06736,Acetic Acid Derivatives and Related Substances,DrugBank
DB06736,"Acids, Carbocyclic",DrugBank
DB06736,Agents causing hyperkalemia,DrugBank
DB06736,Agents that produce hypertension,DrugBank
DB06736,Analgesics,DrugBank
DB06736,"Analgesics, Non-Narcotic",DrugBank
DB06736,Anti-Inflammatory Agents,DrugBank
DB06736,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB06736,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB06736,Antiinflammatory and Antirheumatic Products,DrugBank
DB06736,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB06736,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB06736,Antirheumatic Agents,DrugBank
DB06736,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06736,Cytochrome P-450 Substrates,DrugBank
DB06736,Drugs that are Mainly Renally Excreted,DrugBank
DB06736,Musculo-Skeletal System,DrugBank
DB06736,Nephrotoxic agents,DrugBank
DB06736,Peripheral Nervous System Agents,DrugBank
DB06736,Phenylacetates,DrugBank
DB06736,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB06736,Sensory System Agents,DrugBank
DB06736,Topical Products for Joint and Muscular Pain,DrugBank
DB06737,"Acids, Acyclic",DrugBank
DB06737,Agents causing hyperkalemia,DrugBank
DB06737,Agents that produce hypertension,DrugBank
DB06737,Analgesics,DrugBank
DB06737,"Analgesics, Non-Narcotic",DrugBank
DB06737,Anti-Inflammatory Agents,DrugBank
DB06737,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB06737,Antigout Preparations,DrugBank
DB06737,Antirheumatic Agents,DrugBank
DB06737,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06737,Cytochrome P-450 Substrates,DrugBank
DB06737,Fatty Acids,DrugBank
DB06737,"Fatty Acids, Volatile",DrugBank
DB06737,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06737,Lipids,DrugBank
DB06737,Nephrotoxic agents,DrugBank
DB06737,Non COX-2 selective NSAIDS,DrugBank
DB06737,Peripheral Nervous System Agents,DrugBank
DB06737,Pyrans,DrugBank
DB06737,Sensory System Agents,DrugBank
DB06737,Sulfur Compounds,DrugBank
DB06737,UGT2B7 substrates,DrugBank
DB06738,Analgesics,DrugBank
DB06738,Central Nervous System Agents,DrugBank
DB06738,Central Nervous System Depressants,DrugBank
DB06738,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06738,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06738,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06738,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06738,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06738,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06738,Cytochrome P-450 Substrates,DrugBank
DB06738,Excitatory Amino Acid Agents,DrugBank
DB06738,Excitatory Amino Acid Antagonists,DrugBank
DB06738,Isonipecotic Acids,DrugBank
DB06738,Narcotics,DrugBank
DB06738,Nervous System,DrugBank
DB06738,Neurotransmitter Agents,DrugBank
DB06738,Opioids,DrugBank
DB06738,Peripheral Nervous System Agents,DrugBank
DB06738,Phenylpiperidine opioids,DrugBank
DB06738,Piperidines,DrugBank
DB06738,Sensory System Agents,DrugBank
DB06738,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB06738,UGT1A9 Substrates,DrugBank
DB06739,Analgesics,DrugBank
DB06739,"Analgesics, Non-Narcotic",DrugBank
DB06739,Anti-Asthmatic Agents,DrugBank
DB06739,Anti-Inflammatory Agents,DrugBank
DB06739,Antirheumatic Agents,DrugBank
DB06739,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB06739,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB06739,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB06739,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB06739,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06739,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06739,Cytochrome P-450 CYP3A Inducers,DrugBank
DB06739,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06739,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB06739,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB06739,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06739,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06739,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06739,Cytochrome P-450 Substrates,DrugBank
DB06739,Drugs for Obstructive Airway Diseases,DrugBank
DB06739,Fatty Acids,DrugBank
DB06739,Hormone Antagonists,DrugBank
DB06739,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06739,Lipids,DrugBank
DB06739,Peripheral Nervous System Agents,DrugBank
DB06739,Prostaglandin Antagonists,DrugBank
DB06739,Quinones,DrugBank
DB06739,Respiratory System Agents,DrugBank
DB06739,Sensory System Agents,DrugBank
DB06739,UGT1A9 Substrates,DrugBank
DB06741,Excitatory Amino Acid Agents,DrugBank
DB06741,Excitatory Amino Acid Antagonists,DrugBank
DB06741,Glycine Agents,DrugBank
DB06741,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06741,Neurotransmitter Agents,DrugBank
DB06741,UGT1A1 Substrates,DrugBank
DB06741,UGT1A3 substrates,DrugBank
DB06741,UGT1A9 Substrates,DrugBank
DB06742,Adrenergics for Systemic Use,DrugBank
DB06742,Amines,DrugBank
DB06742,Anesthetics,DrugBank
DB06742,"Anesthetics, Local",DrugBank
DB06742,Aniline Compounds,DrugBank
DB06742,Cough and Cold Preparations,DrugBank
DB06742,Cyclohexanes,DrugBank
DB06742,Cyclohexylamines,DrugBank
DB06742,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06742,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06742,Cytochrome P-450 Substrates,DrugBank
DB06742,Drugs for Obstructive Airway Diseases,DrugBank
DB06742,Expectorants,DrugBank
DB06742,Respiratory System Agents,DrugBank
DB06742,Selective Beta 2-adrenergic Agonists,DrugBank
DB06742,Throat Preparations,DrugBank
DB06748,Antineoplastic Agents,DrugBank
DB06748,Carbohydrates,DrugBank
DB06748,Glycosides,DrugBank
DB06748,Hypolipidemic Agents,DrugBank
DB06748,Lipid Regulating Agents,DrugBank
DB06748,Panax,DrugBank
DB06748,Saponins,DrugBank
DB06748,Terpenes,DrugBank
DB06748,Triterpenes,DrugBank
DB06749,Carbohydrates,DrugBank
DB06749,Glycosides,DrugBank
DB06749,OATP1B3 inhibitors,DrugBank
DB06749,Panax,DrugBank
DB06749,Saponins,DrugBank
DB06749,Terpenes,DrugBank
DB06749,Triterpenes,DrugBank
DB06751,Alimentary Tract and Metabolism,DrugBank
DB06751,Alkaloids,DrugBank
DB06751,Analgesics,DrugBank
DB06751,Autonomic Agents,DrugBank
DB06751,Benzylisoquinolines,DrugBank
DB06751,Cardiovascular Agents,DrugBank
DB06751,Central Nervous System Agents,DrugBank
DB06751,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB06751,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06751,Isoquinolines,DrugBank
DB06751,Opiate Alkaloids,DrugBank
DB06751,Papaverine and Derivatives,DrugBank
DB06751,Parasympatholytics,DrugBank
DB06751,Peripheral Nervous System Agents,DrugBank
DB06751,Phosphodiesterase 4 Inhibitors,DrugBank
DB06751,Phosphodiesterase Inhibitors,DrugBank
DB06751,Sensory System Agents,DrugBank
DB06751,Vasodilating Agents,DrugBank
DB06753,Central Nervous System Depressants,DrugBank
DB06753,Hypnotics and Sedatives,DrugBank
DB06753,Nervous System,DrugBank
DB06753,Organophosphorus Compounds,DrugBank
DB06753,Psycholeptics,DrugBank
DB06754,Agents causing hyperkalemia,DrugBank
DB06754,Anticoagulants,DrugBank
DB06754,Blood and Blood Forming Organs,DrugBank
DB06754,Carbohydrates,DrugBank
DB06754,Cardiovascular Agents,DrugBank
DB06754,Chondroitin,DrugBank
DB06754,Fibrin Modulating Agents,DrugBank
DB06754,Glycosaminoglycans,DrugBank
DB06754,Hematologic Agents,DrugBank
DB06754,Heparin and similars,DrugBank
DB06754,Heparinoids,DrugBank
DB06754,Polysaccharides,DrugBank
DB06756,Acid Preparations,DrugBank
DB06756,Alimentary Tract and Metabolism,DrugBank
DB06756,Amines,DrugBank
DB06756,Amino Acids and Derivatives,DrugBank
DB06756,Cholinesterase Inhibitors,DrugBank
DB06756,"Digestives, Incl. Enzymes",DrugBank
DB06756,Gastrointestinal Agents,DrugBank
DB06756,Lipid Regulating Agents,DrugBank
DB06756,Lipotropic Agents,DrugBank
DB06756,Methylating Activity,DrugBank
DB06756,Methylating Agent,DrugBank
DB06756,Onium Compounds,DrugBank
DB06756,Other Miscellaneous Therapeutic Agents,DrugBank
DB06756,Quaternary Ammonium Compounds,DrugBank
DB06756,Trimethyl Ammonium Compounds,DrugBank
DB06761,Alveolar Surface Tension Reduction,DrugBank
DB06761,Bradycardia-Causing Agents,DrugBank
DB06761,Complex Mixtures,DrugBank
DB06761,Pulmonary Surfactants,DrugBank
DB06761,Respiratory System Agents,DrugBank
DB06761,Surface-Active Agents,DrugBank
DB06761,Surfactant Activity,DrugBank
DB06762,Amidines,DrugBank
DB06762,Antihypertensive Agents,DrugBank
DB06762,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB06762,Cardiovascular Agents,DrugBank
DB06762,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06762,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06762,Cytochrome P-450 Substrates,DrugBank
DB06762,Guanidine Derivatives,DrugBank
DB06762,Guanidines,DrugBank
DB06762,Membrane Transport Modulators,DrugBank
DB06762,Potassium Channel Opener,DrugBank
DB06762,Vasodilating Agents,DrugBank
DB06763,Agents Acting on the Renin-Angiotensin System,DrugBank
DB06763,Agents causing hyperkalemia,DrugBank
DB06763,Agents that produce hypertension,DrugBank
DB06763,"Amino Acids, Peptides, and Proteins",DrugBank
DB06763,Angiotensin Receptor Antagonists,DrugBank
DB06763,Angiotensins,DrugBank
DB06763,Autacoids,DrugBank
DB06763,Biological Factors,DrugBank
DB06763,Inflammation Mediators,DrugBank
DB06763,Oligopeptides,DrugBank
DB06763,Peptides,DrugBank
DB06764,Adrenergic Agonists,DrugBank
DB06764,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB06764,Adrenergic alpha-Agonists,DrugBank
DB06764,Agents producing tachycardia,DrugBank
DB06764,Agents that produce hypertension,DrugBank
DB06764,Autonomic Agents,DrugBank
DB06764,Cardiovascular Agents,DrugBank
DB06764,"Compounds used in a research, industrial, or household setting",DrugBank
DB06764,Decongestants and Antiallergics,DrugBank
DB06764,Nasal Decongestants,DrugBank
DB06764,Nasal Preparations,DrugBank
DB06764,Ophthalmic Solutions,DrugBank
DB06764,Ophthalmologicals,DrugBank
DB06764,Peripheral Nervous System Agents,DrugBank
DB06764,Pharmaceutical Preparations,DrugBank
DB06764,Pharmaceutical Solutions,DrugBank
DB06764,Respiratory System Agents,DrugBank
DB06764,Sensory Organs,DrugBank
DB06764,Solutions,DrugBank
DB06764,Sympathomimetics,DrugBank
DB06764,Sympathomimetics Used as Decongestants,DrugBank
DB06764,"Sympathomimetics, Plain",DrugBank
DB06764,Vasoconstrictor Agents,DrugBank
DB06766,Decongestants and Antiallergics,DrugBank
DB06766,Drugs that are Mainly Renally Excreted,DrugBank
DB06766,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06766,Histamine Agents,DrugBank
DB06766,Histamine Antagonists,DrugBank
DB06766,Histamine H1 Antagonists,DrugBank
DB06766,Neurotransmitter Agents,DrugBank
DB06766,Ophthalmologicals,DrugBank
DB06766,Potential QTc-Prolonging Agents,DrugBank
DB06766,QTc Prolonging Agents,DrugBank
DB06766,Sensory Organs,DrugBank
DB06767,Acidifying Agents,DrugBank
DB06767,Agents causing hyperkalemia,DrugBank
DB06767,Ammonium Compounds,DrugBank
DB06767,Blood and Blood Forming Organs,DrugBank
DB06767,Blood Substitutes and Perfusion Solutions,DrugBank
DB06767,Chlorides,DrugBank
DB06767,Chlorine Compounds,DrugBank
DB06767,Drugs that are Mainly Renally Excreted,DrugBank
DB06767,Electrolyte Solutions,DrugBank
DB06767,Genito Urinary System and Sex Hormones,DrugBank
DB06767,I.V. Solution Additives,DrugBank
DB06767,Nitrogen Compounds,DrugBank
DB06767,Urinary Acidifying Agents,DrugBank
DB06767,Urologicals,DrugBank
DB06769,"Acids, Acyclic",DrugBank
DB06769,Alkylating Activity,DrugBank
DB06769,Alkylating Drugs,DrugBank
DB06769,Antineoplastic Agents,DrugBank
DB06769,"Antineoplastic Agents, Alkylating",DrugBank
DB06769,Antineoplastic and Immunomodulating Agents,DrugBank
DB06769,Benzimidazoles,DrugBank
DB06769,Butyrates,DrugBank
DB06769,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06769,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB06769,Cytochrome P-450 Substrates,DrugBank
DB06769,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06769,"Hydrocarbons, Halogenated",DrugBank
DB06769,Immunosuppressive Agents,DrugBank
DB06769,Mustard Compounds,DrugBank
DB06769,Myelosuppressive Agents,DrugBank
DB06769,Narrow Therapeutic Index Drugs,DrugBank
DB06769,Nitrogen Mustard Analogues,DrugBank
DB06769,Nitrogen Mustard Compounds,DrugBank
DB06769,Noxae,DrugBank
DB06769,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06769,Toxic Actions,DrugBank
DB06770,Alcohols,DrugBank
DB06770,Anesthetics,DrugBank
DB06770,"Anesthetics, Local",DrugBank
DB06770,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06770,Benzene Derivatives,DrugBank
DB06770,Benzyl Alcohols,DrugBank
DB06770,Benzyl Compounds,DrugBank
DB06770,Central Nervous System Agents,DrugBank
DB06770,Central Nervous System Depressants,DrugBank
DB06770,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06770,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06770,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB06770,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06770,Cytochrome P-450 Substrates,DrugBank
DB06770,Dental Agents,DrugBank
DB06770,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB06770,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB06770,Miscellaneous Local Anti-infectives,DrugBank
DB06770,Pediculicides,DrugBank
DB06770,Peripheral Nervous System Agents,DrugBank
DB06770,Sensory System Agents,DrugBank
DB06771,4-Quinolones,DrugBank
DB06771,Anti-Bacterial Agents,DrugBank
DB06771,Anti-Infective Agents,DrugBank
DB06771,Antineoplastic Agents,DrugBank
DB06771,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06771,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06771,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06771,Enzyme Inhibitors,DrugBank
DB06771,Fluoroquinolones,DrugBank
DB06771,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06771,Moderate Risk QTc-Prolonging Agents,DrugBank
DB06771,Ophthalmologicals,DrugBank
DB06771,QTc Prolonging Agents,DrugBank
DB06771,Quinolines,DrugBank
DB06771,Quinolone Antimicrobial,DrugBank
DB06771,Quinolones,DrugBank
DB06771,Sensory Organs,DrugBank
DB06771,Topoisomerase II Inhibitors,DrugBank
DB06771,Topoisomerase Inhibitors,DrugBank
DB06772,Antineoplastic Agents,DrugBank
DB06772,Antineoplastic and Immunomodulating Agents,DrugBank
DB06772,BCRP/ABCG2 Inhibitors,DrugBank
DB06772,Cardiotoxic antineoplastic agents,DrugBank
DB06772,Cyclodecanes,DrugBank
DB06772,Cycloparaffins,DrugBank
DB06772,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB06772,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB06772,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06772,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06772,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB06772,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06772,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB06772,Cytochrome P-450 Substrates,DrugBank
DB06772,Diterpenes,DrugBank
DB06772,Immunosuppressive Agents,DrugBank
DB06772,Microtubule Inhibition,DrugBank
DB06772,Microtubule Inhibitors,DrugBank
DB06772,Myelosuppressive Agents,DrugBank
DB06772,Narrow Therapeutic Index Drugs,DrugBank
DB06772,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB06772,OATP1B3 inhibitors,DrugBank
DB06772,P-glycoprotein inhibitors,DrugBank
DB06772,P-glycoprotein substrates,DrugBank
DB06772,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB06772,Taxane Derivatives,DrugBank
DB06772,Taxoids,DrugBank
DB06772,Terpenes,DrugBank
DB06774,Alkaloids,DrugBank
DB06774,Alkenes,DrugBank
DB06774,Amides,DrugBank
DB06774,Analgesics,DrugBank
DB06774,Anesthetics,DrugBank
DB06774,"Anesthetics, Local",DrugBank
DB06774,Antipruritics,DrugBank
DB06774,Basic Lotions and Liniments,DrugBank
DB06774,Benzene Derivatives,DrugBank
DB06774,Capsaicin and Similar Agents,DrugBank
DB06774,Cholinesterase Inhibitors,DrugBank
DB06774,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB06774,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB06774,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB06774,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB06774,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06774,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06774,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB06774,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06774,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06774,Cytochrome P-450 Substrates,DrugBank
DB06774,Dermatologicals,DrugBank
DB06774,Lipids,DrugBank
DB06774,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB06774,Peripheral Nervous System Agents,DrugBank
DB06774,Phenols,DrugBank
DB06774,Polyunsaturated Alkamides,DrugBank
DB06774,Sensory System Agents,DrugBank
DB06774,Solanaceous Alkaloids,DrugBank
DB06774,Topical Products for Joint and Muscular Pain,DrugBank
DB06774,TRPV1 Channel Agonists,DrugBank
DB06777,Alimentary Tract and Metabolism,DrugBank
DB06777,Bile Acid Preparations,DrugBank
DB06777,Bile acids and derivatives,DrugBank
DB06777,Bile Acids and Salts,DrugBank
DB06777,Bile and Liver Therapy,DrugBank
DB06777,Bile Therapy,DrugBank
DB06777,Cholanes,DrugBank
DB06777,Cholic Acids,DrugBank
DB06777,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06777,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06777,Cytochrome P-450 Substrates,DrugBank
DB06777,Fused-Ring Compounds,DrugBank
DB06777,Gastrointestinal Agents,DrugBank
DB06777,Steroids,DrugBank
DB06777,UGT2B7 Inhibitors,DrugBank
DB06779,Agents causing hyperkalemia,DrugBank
DB06779,Anticoagulants,DrugBank
DB06779,Blood and Blood Forming Organs,DrugBank
DB06779,Carbohydrates,DrugBank
DB06779,Cardiovascular Agents,DrugBank
DB06779,Fibrin Modulating Agents,DrugBank
DB06779,Glycosaminoglycans,DrugBank
DB06779,Hematologic Agents,DrugBank
DB06779,Heparin (Low Molecular Weight),DrugBank
DB06779,Heparin and similars,DrugBank
DB06779,Polysaccharides,DrugBank
DB06780,Adrenal Cortex Hormones,DrugBank
DB06780,Corticosteroids,DrugBank
DB06780,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06780,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06780,Cytochrome P-450 Substrates,DrugBank
DB06780,Desoxycorticosterone,DrugBank
DB06780,Fused-Ring Compounds,DrugBank
DB06780,Hormones,DrugBank
DB06780,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06780,Hydroxycorticosteroids,DrugBank
DB06780,Mineralocorticoids,DrugBank
DB06780,Pregnanes,DrugBank
DB06780,Pregnenediones,DrugBank
DB06780,Pregnenes,DrugBank
DB06780,Steroids,DrugBank
DB06781,Adrenal Cortex Hormones,DrugBank
DB06781,Anti-Inflammatory Agents,DrugBank
DB06781,Corticosteroids,DrugBank
DB06781,"Corticosteroids, Dermatological Preparations",DrugBank
DB06781,"Corticosteroids, Potent (Group III)",DrugBank
DB06781,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06781,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06781,Cytochrome P-450 Substrates,DrugBank
DB06781,Dermatologicals,DrugBank
DB06781,Fused-Ring Compounds,DrugBank
DB06781,Hormones,DrugBank
DB06781,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06781,Immunosuppressive Agents,DrugBank
DB06781,Ophthalmologicals,DrugBank
DB06781,Pregnadienes,DrugBank
DB06781,Pregnadienetriols,DrugBank
DB06781,Pregnanes,DrugBank
DB06781,Sensory Organs,DrugBank
DB06781,Steroids,DrugBank
DB06781,"Steroids, Fluorinated",DrugBank
DB06782,Antidotes,DrugBank
DB06782,Chelating Agents,DrugBank
DB06782,"Compounds used in a research, industrial, or household setting",DrugBank
DB06782,Drugs that are Mainly Renally Excreted,DrugBank
DB06782,Heavy Metal Antagonists,DrugBank
DB06782,Metal Chelating Activity,DrugBank
DB06782,Metal Chelator,DrugBank
DB06782,Sequestering Agents,DrugBank
DB06782,Sulfhydryl Compounds,DrugBank
DB06782,Sulfur Compounds,DrugBank
DB06783,Anions,DrugBank
DB06783,Antidotes,DrugBank
DB06783,Chelating Activity,DrugBank
DB06783,Coloring Agents,DrugBank
DB06783,"Compounds used in a research, industrial, or household setting",DrugBank
DB06783,Cyanides,DrugBank
DB06783,Decorporation Agent,DrugBank
DB06783,Electrolytes,DrugBank
DB06783,Ferrous Compounds,DrugBank
DB06783,Ion Exchange Activity,DrugBank
DB06783,Ions,DrugBank
DB06783,Iron Compounds,DrugBank
DB06783,Nitrogen Compounds,DrugBank
DB06783,Protective Agents,DrugBank
DB06786,Adrenal Cortex Hormones,DrugBank
DB06786,Anti-Inflammatory Agents,DrugBank
DB06786,Corticosteroid Hormone Receptor Agonists,DrugBank
DB06786,Corticosteroids,DrugBank
DB06786,"Corticosteroids, Dermatological Preparations",DrugBank
DB06786,"Corticosteroids, Very Potent (Group IV)",DrugBank
DB06786,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06786,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06786,Cytochrome P-450 Substrates,DrugBank
DB06786,Dermatologicals,DrugBank
DB06786,Fused-Ring Compounds,DrugBank
DB06786,Immunosuppressive Agents,DrugBank
DB06786,Pregnanes,DrugBank
DB06786,Pregnenediones,DrugBank
DB06786,Pregnenes,DrugBank
DB06786,Steroids,DrugBank
DB06787,Agents producing tachycardia,DrugBank
DB06787,Alimentary Tract and Metabolism,DrugBank
DB06787,Anticholinergic Agents,DrugBank
DB06787,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB06787,Muscarinic Antagonists,DrugBank
DB06787,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB06788,Adrenal Cortex Hormones,DrugBank
DB06788,"Amino Acids, Peptides, and Proteins",DrugBank
DB06788,Antineoplastic and Immunomodulating Agents,DrugBank
DB06788,Endocrine Therapy,DrugBank
DB06788,Gonadotropin Releasing Hormone Receptor Agonist,DrugBank
DB06788,Gonadotropin Releasing Hormone Receptor Agonists,DrugBank
DB06788,Gonadotropin-releasing hormone agonist,DrugBank
DB06788,Hormones,DrugBank
DB06788,Hormones and Related Agents,DrugBank
DB06788,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06788,Hyperglycemia-Associated Agents,DrugBank
DB06788,Hypothalamic Hormones,DrugBank
DB06788,Nerve Tissue Proteins,DrugBank
DB06788,Neuropeptides,DrugBank
DB06788,Oligopeptides,DrugBank
DB06788,Peptide Hormones,DrugBank
DB06788,Peptides,DrugBank
DB06788,Potential QTc-Prolonging Agents,DrugBank
DB06788,Proteins,DrugBank
DB06788,QTc Prolonging Agents,DrugBank
DB06789,Adrenal Cortex Hormones,DrugBank
DB06789,Antineoplastic Agents,DrugBank
DB06789,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB06789,"Contraceptive Agents, Female",DrugBank
DB06789,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB06789,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB06789,Cytochrome P-450 CYP3A Substrates,DrugBank
DB06789,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB06789,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB06789,Cytochrome P-450 Enzyme Inducers,DrugBank
DB06789,Cytochrome P-450 Substrates,DrugBank
DB06789,Estrogen Antagonists,DrugBank
DB06789,Fused-Ring Compounds,DrugBank
DB06789,Gonadal Hormones,DrugBank
DB06789,Gonadal Steroid Hormones,DrugBank
DB06789,Hormonal Contraceptives for Systemic Use,DrugBank
DB06789,Hormone Antagonists,DrugBank
DB06789,Hormones,DrugBank
DB06789,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06789,Hydroxyprogesterones,DrugBank
DB06789,Hyperglycemia-Associated Agents,DrugBank
DB06789,Pregnanes,DrugBank
DB06789,Pregnenediones,DrugBank
DB06789,Pregnenes,DrugBank
DB06789,Progesterone and Derivatives,DrugBank
DB06789,Progesterone Congeners,DrugBank
DB06789,Progestin Contraceptives,DrugBank
DB06789,Progestins,DrugBank
DB06789,Steroids,DrugBank
DB06791,Acromegaly,DrugBank
DB06791,"Amino Acids, Peptides, and Proteins",DrugBank
DB06791,Antineoplastic Agents,DrugBank
DB06791,Bradycardia-Causing Agents,DrugBank
DB06791,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB06791,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB06791,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB06791,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06791,Hormones,DrugBank
DB06791,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06791,Hyperglycemia-Associated Agents,DrugBank
DB06791,Hypoglycemia-Associated Agents,DrugBank
DB06791,Hypothalamic Hormones,DrugBank
DB06791,Nerve Tissue Proteins,DrugBank
DB06791,Neuropeptides,DrugBank
DB06791,Other Miscellaneous Therapeutic Agents,DrugBank
DB06791,Pancreatic Hormones,DrugBank
DB06791,Peptide Hormones,DrugBank
DB06791,Peptides,DrugBank
DB06791,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB06791,Pituitary Hormone Release Inhibiting Hormones,DrugBank
DB06791,Proteins,DrugBank
DB06791,Somatostatin and Analogues,DrugBank
DB06791,Somatostatin Receptor Agonists,DrugBank
DB06791,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB06792,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB06792,Elements,DrugBank
DB06792,"Kidney Failure, Chronic",DrugBank
DB06792,Lanthanoid Series Elements,DrugBank
DB06792,Metal cations,DrugBank
DB06792,Metals,DrugBank
DB06792,"Metals, Rare Earth",DrugBank
DB06792,Phosphate Binder,DrugBank
DB06792,Phosphate-removing Agents,DrugBank
DB06793,"Acids, Acyclic",DrugBank
DB06793,Agents that reduce seizure threshold,DrugBank
DB06793,Antitussive Agents,DrugBank
DB06793,Central Nervous System Agents,DrugBank
DB06793,Propionates,DrugBank
DB06793,Respiratory System Agents,DrugBank
DB06796,Acetates,DrugBank
DB06796,"Acids, Acyclic",DrugBank
DB06796,Amines,DrugBank
DB06796,Coenzymes,DrugBank
DB06796,"Compounds used in a research, industrial, or household setting",DrugBank
DB06796,Contrast Media,DrugBank
DB06796,Diagnostic Uses of Chemicals,DrugBank
DB06796,Diamines,DrugBank
DB06796,Drugs that are Mainly Renally Excreted,DrugBank
DB06796,Enzymes and Coenzymes,DrugBank
DB06796,Ethylenediamines,DrugBank
DB06796,Magnetic Resonance Contrast Activity,DrugBank
DB06796,Magnetic Resonance Imaging Contrast Media,DrugBank
DB06796,Paramagnetic Contrast Agent,DrugBank
DB06796,Paramagnetic Contrast Media,DrugBank
DB06796,Picolines,DrugBank
DB06796,Polyamines,DrugBank
DB06796,Pyridines,DrugBank
DB06797,Anti-Anxiety Agents,DrugBank
DB06797,Carbamates,DrugBank
DB06797,Central Nervous System Depressants,DrugBank
DB06797,Nervous System,DrugBank
DB06797,Psycholeptics,DrugBank
DB06799,"Acids, Carbocyclic",DrugBank
DB06799,Amides,DrugBank
DB06799,Amines,DrugBank
DB06799,Anti-Bacterial Agents,DrugBank
DB06799,Anti-Infective Agents,DrugBank
DB06799,"Anti-Infective Agents, Urinary",DrugBank
DB06799,Antibacterials for Systemic Use,DrugBank
DB06799,Antiinfectives for Systemic Use,DrugBank
DB06799,Benzene Derivatives,DrugBank
DB06799,Benzoates,DrugBank
DB06799,Bridged-Ring Compounds,DrugBank
DB06799,Genito Urinary System and Sex Hormones,DrugBank
DB06799,Hydroxy Acids,DrugBank
DB06799,Keto Acids,DrugBank
DB06799,Polyamines,DrugBank
DB06799,Urinary Acidifying Agents,DrugBank
DB06799,Urologicals,DrugBank
DB06800,Alimentary Tract and Metabolism,DrugBank
DB06800,Alkaloids,DrugBank
DB06800,Amines,DrugBank
DB06800,Ammonium Compounds,DrugBank
DB06800,Central Nervous System Agents,DrugBank
DB06800,Drugs for Constipation,DrugBank
DB06800,Drugs that are Mainly Renally Excreted,DrugBank
DB06800,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06800,Miscellaneous GI Drugs,DrugBank
DB06800,Morphinans,DrugBank
DB06800,Nitrogen Compounds,DrugBank
DB06800,Onium Compounds,DrugBank
DB06800,Opiate Alkaloids,DrugBank
DB06800,Opioid Antagonists,DrugBank
DB06800,Opioids,DrugBank
DB06800,Peripheral Nervous System Agents,DrugBank
DB06800,Peripheral Opioid Receptor Antagonists,DrugBank
DB06800,Phenanthrenes,DrugBank
DB06800,Sensory System Agents,DrugBank
DB06802,Acetamides,DrugBank
DB06802,Acetates,DrugBank
DB06802,"Acids, Acyclic",DrugBank
DB06802,"Acids, Carbocyclic",DrugBank
DB06802,Agents causing hyperkalemia,DrugBank
DB06802,Amides,DrugBank
DB06802,Analgesics,DrugBank
DB06802,"Analgesics, Non-Narcotic",DrugBank
DB06802,Anti-Inflammatory Agents,DrugBank
DB06802,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB06802,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB06802,Antirheumatic Agents,DrugBank
DB06802,Benzene Derivatives,DrugBank
DB06802,Central Nervous System Agents,DrugBank
DB06802,Cyclooxygenase Inhibitors,DrugBank
DB06802,Nephrotoxic agents,DrugBank
DB06802,Ophthalmologicals,DrugBank
DB06802,Peripheral Nervous System Agents,DrugBank
DB06802,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB06802,Sensory Organs,DrugBank
DB06802,Sensory System Agents,DrugBank
DB06803,Agrochemicals,DrugBank
DB06803,Amides,DrugBank
DB06803,Amines,DrugBank
DB06803,Anilides,DrugBank
DB06803,Aniline Compounds,DrugBank
DB06803,Anthelmintics,DrugBank
DB06803,Anti-Infective Agents,DrugBank
DB06803,Anticestodal Agents,DrugBank
DB06803,Anticestodals,DrugBank
DB06803,Antinematodal Agents,DrugBank
DB06803,Antiparasitic Agents,DrugBank
DB06803,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB06803,Antiplatyhelmintic Agents,DrugBank
DB06803,"Compounds used in a research, industrial, or household setting",DrugBank
DB06803,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB06803,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB06803,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB06803,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06803,Cytochrome P-450 Substrates,DrugBank
DB06803,Molluscacides,DrugBank
DB06803,Pesticides,DrugBank
DB06803,Salicylamides,DrugBank
DB06803,Salicylanilide and Derivatives,DrugBank
DB06803,Salicylic Acid Derivatives,DrugBank
DB06803,Toxic Actions,DrugBank
DB06804,Adrenal Cortex Hormones,DrugBank
DB06804,Alcohols,DrugBank
DB06804,Antispermatogenic Agents,DrugBank
DB06804,"Compounds used in a research, industrial, or household setting",DrugBank
DB06804,"Contraceptive Agents, Female",DrugBank
DB06804,"Contraceptive Agents, Male",DrugBank
DB06804,Ethylene Glycols,DrugBank
DB06804,Glycols,DrugBank
DB06804,Hormonal Contraceptives for Systemic Use,DrugBank
DB06804,Macromolecular Substances,DrugBank
DB06804,Noxae,DrugBank
DB06804,Polyethylene Glycols,DrugBank
DB06804,Polymers,DrugBank
DB06804,Reproductive Control Agents,DrugBank
DB06804,Spermatocidal Agents,DrugBank
DB06804,Surface-Active Agents,DrugBank
DB06804,Toxic Actions,DrugBank
DB06807,"Acids, Carbocyclic",DrugBank
DB06807,Benzene Derivatives,DrugBank
DB06807,Benzoates,DrugBank
DB06807,Hydroxy Acids,DrugBank
DB06807,Hydroxybenzoates,DrugBank
DB06807,Phenols,DrugBank
DB06807,Salicylates,DrugBank
DB06809,"Adjuvants, Immunologic",DrugBank
DB06809,Amines,DrugBank
DB06809,Anti-HIV Agents,DrugBank
DB06809,Anti-Infective Agents,DrugBank
DB06809,Antineoplastic and Immunomodulating Agents,DrugBank
DB06809,Benzene Derivatives,DrugBank
DB06809,Benzyl Compounds,DrugBank
DB06809,Drugs that are Mainly Renally Excreted,DrugBank
DB06809,Hematinics,DrugBank
DB06809,Hematopoietic Stem Cell Mobilizer,DrugBank
DB06809,Increased Hematopoietic Stem Cell Mobilization,DrugBank
DB06809,Polyamines,DrugBank
DB06810,Anthracyclines,DrugBank
DB06810,"Antibiotics, Antineoplastic",DrugBank
DB06810,Antineoplastic Agents,DrugBank
DB06810,Antineoplastic and Immunomodulating Agents,DrugBank
DB06810,Calcium-Regulating Hormones and Agents,DrugBank
DB06810,Carbohydrates,DrugBank
DB06810,Coloring Agents,DrugBank
DB06810,"Compounds used in a research, industrial, or household setting",DrugBank
DB06810,Cytotoxic Antibiotics and Related Substances,DrugBank
DB06810,Cytotoxins,DrugBank
DB06810,Enzyme Inhibitors,DrugBank
DB06810,Fluorescent Dyes,DrugBank
DB06810,Glycosides,DrugBank
DB06810,Indicators and Reagents,DrugBank
DB06810,Laboratory Chemicals,DrugBank
DB06810,Luminescent Agents,DrugBank
DB06810,Naphthacenes,DrugBank
DB06810,Nucleic Acid Synthesis Inhibitors,DrugBank
DB06810,Protein Synthesis Inhibitors,DrugBank
DB06811,Alcohols,DrugBank
DB06811,Antivaricose Therapy,DrugBank
DB06811,Cardiovascular Agents,DrugBank
DB06811,"Compounds used in a research, industrial, or household setting",DrugBank
DB06811,Detergents,DrugBank
DB06811,Ethylene Glycols,DrugBank
DB06811,Glycols,DrugBank
DB06811,Household Products,DrugBank
DB06811,Macromolecular Substances,DrugBank
DB06811,Pegylated agents,DrugBank
DB06811,Pharmaceutical Preparations,DrugBank
DB06811,Pharmaceutical Solutions,DrugBank
DB06811,Polyethylene Glycols,DrugBank
DB06811,Polymers,DrugBank
DB06811,Sclerosing Activity,DrugBank
DB06811,Sclerosing Agents for Local Injection,DrugBank
DB06811,Sclerosing Solutions,DrugBank
DB06811,Solutions,DrugBank
DB06811,Surface-Active Agents,DrugBank
DB06811,Vascular Sclerosing Activity,DrugBank
DB06811,Vasoprotectives,DrugBank
DB06813,Antimetabolites,DrugBank
DB06813,Antineoplastic Agents,DrugBank
DB06813,Antineoplastic and Immunomodulating Agents,DrugBank
DB06813,BCRP/ABCG2 Substrates,DrugBank
DB06813,Drugs that are Mainly Renally Excreted,DrugBank
DB06813,Folic Acid Analogues,DrugBank
DB06813,Folic Acid Antagonists,DrugBank
DB06813,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB06813,Immunosuppressive Agents,DrugBank
DB06813,Narrow Therapeutic Index Drugs,DrugBank
DB06813,OATP1B3 substrates,DrugBank
DB06813,Pteridines,DrugBank
DB06813,Pterins,DrugBank
DB06814,Adrenergic Agonists,DrugBank
DB06814,Adrenergic beta-2 Receptor Agonists,DrugBank
DB06814,Adrenergic beta-Agonists,DrugBank
DB06814,Agents producing tachycardia,DrugBank
DB06814,Agents to Treat Airway Disease,DrugBank
DB06814,Alcohols,DrugBank
DB06814,Amines,DrugBank
DB06814,Amino Alcohols,DrugBank
DB06814,Benzene Derivatives,DrugBank
DB06814,Biogenic Amines,DrugBank
DB06814,Biogenic Monoamines,DrugBank
DB06814,Catecholamines,DrugBank
DB06814,Catechols,DrugBank
DB06814,Dioxoles,DrugBank
DB06814,Epinephrine and similars,DrugBank
DB06814,Ethanolamines,DrugBank
DB06814,Long-acting beta-adrenoceptor agonists,DrugBank
DB06814,Phenols,DrugBank
DB06817,Agents Causing Muscle Toxicity,DrugBank
DB06817,Anti-HIV Agents,DrugBank
DB06817,Anti-Infective Agents,DrugBank
DB06817,Anti-Retroviral Agents,DrugBank
DB06817,Antiinfectives for Systemic Use,DrugBank
DB06817,Antiviral Agents,DrugBank
DB06817,Antivirals for Systemic Use,DrugBank
DB06817,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB06817,Direct Acting Antivirals,DrugBank
DB06817,Enzyme Inhibitors,DrugBank
DB06817,HIV Integrase Inhibitors,DrugBank
DB06817,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,DrugBank
DB06817,Integrase Inhibitors,DrugBank
DB06817,Pyrrolidines,DrugBank
DB06817,Pyrrolidinones,DrugBank
DB06817,UGT1A1 Substrates,DrugBank
DB06819,"Acids, Carbocyclic",DrugBank
DB06819,Alimentary Tract and Metabolism,DrugBank
DB06819,Ammonium Ion Binding Activity,DrugBank
DB06819,Antineoplastic Agents,DrugBank
DB06819,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB06819,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB06819,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB06819,Nervous System,DrugBank
DB06819,Nitrogen Binding Agent,DrugBank
DB06819,Urea Cycle Disorder Agents,DrugBank
DB06819,Various Alimentary Tract and Metabolism Products,DrugBank
DB06821,Amides,DrugBank
DB06821,Amines,DrugBank
DB06821,Aniline Compounds,DrugBank
DB06821,Anti-Bacterial Agents,DrugBank
DB06821,Anti-Infective Agents,DrugBank
DB06821,"Anti-Infective Agents, Urinary",DrugBank
DB06821,Antibacterials for Systemic Use,DrugBank
DB06821,Antiinfectives for Systemic Use,DrugBank
DB06821,Benzene Derivatives,DrugBank
DB06821,Benzenesulfonamides,DrugBank
DB06821,Genito Urinary System and Sex Hormones,DrugBank
DB06821,Gynecological Antiinfectives and Antiseptics,DrugBank
DB06821,Leprostatic Agents,DrugBank
DB06821,Long-Acting Antibacterial Sulfonamides,DrugBank
DB06821,Sulfanilamides,DrugBank
DB06821,Sulfonamide Antibacterial,DrugBank
DB06821,Sulfonamides,DrugBank
DB06821,Sulfonamides and trimethoprim,DrugBank
DB06821,Sulfones,DrugBank
DB06821,Sulfur Compounds,DrugBank
DB06822,Agents causing hyperkalemia,DrugBank
DB06822,Anticoagulants,DrugBank
DB06822,Blood and Blood Forming Organs,DrugBank
DB06822,Carbohydrates,DrugBank
DB06822,Cardiovascular Agents,DrugBank
DB06822,Fibrin Modulating Agents,DrugBank
DB06822,Glycosaminoglycans,DrugBank
DB06822,Hematologic Agents,DrugBank
DB06822,Heparin (Low Molecular Weight),DrugBank
DB06822,Heparin and similars,DrugBank
DB06822,Polysaccharides,DrugBank
DB06823,Amino Acids,DrugBank
DB06823,"Amino Acids, Peptides, and Proteins",DrugBank
DB06823,"Amino Acids, Sulfur",DrugBank
DB06823,Cystine Disulfide Reduction,DrugBank
DB06823,Drugs that are Mainly Renally Excreted,DrugBank
DB06823,Genito Urinary System and Sex Hormones,DrugBank
DB06823,N-substituted Glycines,DrugBank
DB06823,Reducing and Complexing Thiol,DrugBank
DB06823,Sulfur Compounds,DrugBank
DB06823,Urologicals,DrugBank
DB06824,Alimentary Tract and Metabolism,DrugBank
DB06824,Amines,DrugBank
DB06824,Chelating Agents,DrugBank
DB06824,"Compounds used in a research, industrial, or household setting",DrugBank
DB06824,Copper Chelator,DrugBank
DB06824,Diamines,DrugBank
DB06824,Drugs that are Mainly Renally Excreted,DrugBank
DB06824,Ethylenediamines,DrugBank
DB06824,Heavy Metal Antagonists,DrugBank
DB06824,Metal Chelating Activity,DrugBank
DB06824,Metal Chelator,DrugBank
DB06824,Polyamines,DrugBank
DB06824,Sequestering Agents,DrugBank
DB06824,Various Alimentary Tract and Metabolism Products,DrugBank
DB06825,Adrenal Cortex Hormones,DrugBank
DB06825,"Amino Acids, Peptides, and Proteins",DrugBank
DB06825,Antineoplastic Agents,DrugBank
DB06825,"Antineoplastic Agents, Hormonal",DrugBank
DB06825,Antineoplastic and Immunomodulating Agents,DrugBank
DB06825,"Contraceptive Agents, Hormonal",DrugBank
DB06825,Endocrine Therapy,DrugBank
DB06825,Gonadotropin Releasing Hormone Receptor Agonist,DrugBank
DB06825,Gonadotropin Releasing Hormone Receptor Agonists,DrugBank
DB06825,Gonadotropin-releasing hormone agonist,DrugBank
DB06825,Hormones,DrugBank
DB06825,Hormones and Related Agents,DrugBank
DB06825,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB06825,Hyperglycemia-Associated Agents,DrugBank
DB06825,Hypothalamic Hormones,DrugBank
DB06825,Luteolytic Agents,DrugBank
DB06825,Nerve Tissue Proteins,DrugBank
DB06825,Neuropeptides,DrugBank
DB06825,Oligopeptides,DrugBank
DB06825,Peptide Hormones,DrugBank
DB06825,Peptides,DrugBank
DB06825,Pituitary Hormone-Releasing Hormones,DrugBank
DB06825,Potential QTc-Prolonging Agents,DrugBank
DB06825,Proteins,DrugBank
DB06825,QTc Prolonging Agents,DrugBank
DB06825,Reproductive Control Agents,DrugBank
DB06826,Antiglaucoma Preparations and Miotics,DrugBank
DB06826,Antihypertensive Agents,DrugBank
DB06826,Autacoids,DrugBank
DB06826,Biological Factors,DrugBank
DB06826,Cardiovascular Agents,DrugBank
DB06826,Eicosanoids,DrugBank
DB06826,Fatty Acids,DrugBank
DB06826,"Fatty Acids, Unsaturated",DrugBank
DB06826,Inflammation Mediators,DrugBank
DB06826,Lipids,DrugBank
DB06826,Ophthalmologicals,DrugBank
DB06826,Prostaglandins,DrugBank
DB06826,Prostaglandins F,DrugBank
DB06826,"Prostaglandins, Synthetic",DrugBank
DB06826,Sensory Organs,DrugBank
DB06827,Agents that produce neuromuscular block (indirect),DrugBank
DB06827,"Amino Acids, Peptides, and Proteins",DrugBank
DB06827,Anti-Bacterial Agents,DrugBank
DB06827,Anti-Infective Agents,DrugBank
DB06827,"Antibiotics, Antitubercular",DrugBank
DB06827,Drugs for Treatment of Tuberculosis,DrugBank
DB06827,Enzyme Inhibitors,DrugBank
DB06827,Neurotoxic agents,DrugBank
DB06827,Peptides,DrugBank
DB06827,"Peptides, Cyclic",DrugBank
DB06827,Protein Synthesis Inhibitors,DrugBank
DB07101,"Acids, Carbocyclic",DrugBank
DB07101,Amides,DrugBank
DB07101,Amines,DrugBank
DB07101,Aniline Compounds,DrugBank
DB07101,Antineoplastic Agents,DrugBank
DB07101,Antineoplastic and Immunomodulating Agents,DrugBank
DB07101,BCRP/ABCG2 Substrates,DrugBank
DB07101,Benzene Derivatives,DrugBank
DB07101,Benzoates,DrugBank
DB07101,Kinase Inhibitor,DrugBank
DB07101,Mitogen-activated protein kinase (MEK) inhibitors,DrugBank
DB07101,P-glycoprotein substrates,DrugBank
DB07101,Protein Kinase Inhibitors,DrugBank
DB07101,UGT1A6 substrate,DrugBank
DB07101,UGT2B7 substrates,DrugBank
DB07118,Alimentary Tract and Metabolism,DrugBank
DB07118,Benzopyrans,DrugBank
DB07118,Bile and Liver Therapy,DrugBank
DB07118,Bile Therapy,DrugBank
DB07118,"Compounds used in a research, industrial, or household setting",DrugBank
DB07118,Coumarins,DrugBank
DB07118,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB07118,Indicators and Reagents,DrugBank
DB07118,Laboratory Chemicals,DrugBank
DB07118,Pyrans,DrugBank
DB07118,Umbelliferones,DrugBank
DB07232,Antineoplastic Agents,DrugBank
DB07232,Antineoplastic and Immunomodulating Agents,DrugBank
DB07232,Enzyme Inhibitors,DrugBank
DB07232,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB07232,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB07232,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB07348,Anti-Bacterial Agents,DrugBank
DB07348,Anti-Infective Agents,DrugBank
DB07348,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB07348,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB07348,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB07348,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB07348,Enzyme Inhibitors,DrugBank
DB07348,Lactones,DrugBank
DB07348,Macrolides,DrugBank
DB07348,P-glycoprotein inhibitors,DrugBank
DB07348,Polyketides,DrugBank
DB07348,Protein Synthesis Inhibitors,DrugBank
DB07374,Anti-Bacterial Agents,DrugBank
DB07374,Anti-Infective Agents,DrugBank
DB07374,Antiparasitic Agents,DrugBank
DB07374,Antiprotozoals,DrugBank
DB07374,Enzyme Inhibitors,DrugBank
DB07374,Nucleic Acid Synthesis Inhibitors,DrugBank
DB07374,Protein Synthesis Inhibitors,DrugBank
DB07374,Pyrrolidines,DrugBank
DB07402,Agents causing hyperkalemia,DrugBank
DB07402,Agents that produce hypertension,DrugBank
DB07402,Analgesics,DrugBank
DB07402,"Analgesics, Non-Narcotic",DrugBank
DB07402,Anti-Inflammatory Agents,DrugBank
DB07402,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB07402,Antigout Preparations,DrugBank
DB07402,Antiinflammatory and Antirheumatic Products,DrugBank
DB07402,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB07402,Antirheumatic Agents,DrugBank
DB07402,Musculo-Skeletal System,DrugBank
DB07402,Nephrotoxic agents,DrugBank
DB07402,Peripheral Nervous System Agents,DrugBank
DB07402,Sensory System Agents,DrugBank
DB07402,Triazines,DrugBank
DB07402,Uricosuric Agents,DrugBank
DB07447,Testosterone and derivatives,DrugBank
DB07477,"Acids, Carbocyclic",DrugBank
DB07477,Agents causing hyperkalemia,DrugBank
DB07477,Agents that produce hypertension,DrugBank
DB07477,Analgesics,DrugBank
DB07477,"Analgesics, Non-Narcotic",DrugBank
DB07477,Anti-Inflammatory Agents,DrugBank
DB07477,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB07477,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB07477,Antirheumatic Agents,DrugBank
DB07477,Musculo-Skeletal System,DrugBank
DB07477,Nephrotoxic agents,DrugBank
DB07477,Non COX-2 selective NSAIDS,DrugBank
DB07477,Peripheral Nervous System Agents,DrugBank
DB07477,Sensory System Agents,DrugBank
DB07477,Topical Products for Joint and Muscular Pain,DrugBank
DB07565,Alcohols,DrugBank
DB07565,Anti-Bacterial Agents,DrugBank
DB07565,Anti-Infective Agents,DrugBank
DB07565,Benzene Derivatives,DrugBank
DB07565,Glycols,DrugBank
DB07565,Narrow Therapeutic Index Drugs,DrugBank
DB07565,Nitro Compounds,DrugBank
DB07565,Nitrobenzenes,DrugBank
DB07565,P-glycoprotein substrates,DrugBank
DB07565,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB07565,Propylene Glycols,DrugBank
DB07615,"Acids, Carbocyclic",DrugBank
DB07615,Agents causing hyperkalemia,DrugBank
DB07615,Aminobenzoates,DrugBank
DB07615,Analgesics,DrugBank
DB07615,"Analgesics, Non-Narcotic",DrugBank
DB07615,Anti-Allergic Agents,DrugBank
DB07615,Anti-Inflammatory Agents,DrugBank
DB07615,Antiarrhythmic agents,DrugBank
DB07615,Antiplatelet agents,DrugBank
DB07615,Antirheumatic Agents,DrugBank
DB07615,Benzene Derivatives,DrugBank
DB07615,Benzoates,DrugBank
DB07615,Bradycardia-Causing Agents,DrugBank
DB07615,Calcium Channel Blockers,DrugBank
DB07615,Calcium-Regulating Hormones and Agents,DrugBank
DB07615,Cardiovascular Agents,DrugBank
DB07615,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB07615,Cytochrome P-450 CYP3A Substrates,DrugBank
DB07615,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB07615,Cytochrome P-450 Substrates,DrugBank
DB07615,Hematologic Agents,DrugBank
DB07615,Histamine Agents,DrugBank
DB07615,Membrane Transport Modulators,DrugBank
DB07615,Neurotransmitter Agents,DrugBank
DB07615,Peripheral Nervous System Agents,DrugBank
DB07615,Sensory System Agents,DrugBank
DB07637,Antithyroid agents,DrugBank
DB07637,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB07637,Thyroid Products,DrugBank
DB07715,Anthracenes,DrugBank
DB07715,Anthraquinones,DrugBank
DB07715,Biological Products,DrugBank
DB07715,Enzyme Inhibitors,DrugBank
DB07715,Gastrointestinal Agents,DrugBank
DB07715,Laxatives,DrugBank
DB07715,Plant Extracts,DrugBank
DB07715,Plant Preparations,DrugBank
DB07715,Protein Kinase Inhibitors,DrugBank
DB07715,Quinones,DrugBank
DB07720,Analgesics,DrugBank
DB07720,"Analgesics, Non-Narcotic",DrugBank
DB07720,Central Nervous System Agents,DrugBank
DB07720,Cholinergic Agents,DrugBank
DB07720,Cholinergic Agonists,DrugBank
DB07720,Neurotransmitter Agents,DrugBank
DB07720,Nicotinic Agonists,DrugBank
DB07720,Peripheral Nervous System Agents,DrugBank
DB07720,Sensory System Agents,DrugBank
DB07767,"Acids, Carbocyclic",DrugBank
DB07767,Analgesics,DrugBank
DB07767,"Analgesics, Non-Narcotic",DrugBank
DB07767,Anti-Inflammatory Agents,DrugBank
DB07767,Anticoagulants,DrugBank
DB07767,Antihypertensive Agents,DrugBank
DB07767,Antioxidants,DrugBank
DB07767,Antirheumatic Agents,DrugBank
DB07767,Cardiovascular Agents,DrugBank
DB07767,Cholagogues and Choleretics,DrugBank
DB07767,Cinnamates,DrugBank
DB07767,"Compounds used in a research, industrial, or household setting",DrugBank
DB07767,Free Radical Scavengers,DrugBank
DB07767,Gastrointestinal Agents,DrugBank
DB07767,Hematologic Agents,DrugBank
DB07767,Indicators and Reagents,DrugBank
DB07767,Laboratory Chemicals,DrugBank
DB07767,Peripheral Nervous System Agents,DrugBank
DB07767,Plants,DrugBank
DB07767,Sensory System Agents,DrugBank
DB07768,Androstanes,DrugBank
DB07768,Androstenes,DrugBank
DB07768,Androstenols,DrugBank
DB07768,Fused-Ring Compounds,DrugBank
DB07768,Gonadal Hormones,DrugBank
DB07768,Gonadal Steroid Hormones,DrugBank
DB07768,Hormones,DrugBank
DB07768,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB07768,Steroids,DrugBank
DB07768,Testosterone Congeners,DrugBank
DB07780,Organophosphates,DrugBank
DB07780,Organophosphorus Compounds,DrugBank
DB07780,Potential QTc-Prolonging Agents,DrugBank
DB07780,QTc Prolonging Agents,DrugBank
DB07780,Terpenes,DrugBank
DB07841,Organophosphates,DrugBank
DB07841,Organophosphorus Compounds,DrugBank
DB07841,Phosphate salts,DrugBank
DB07841,Potential QTc-Prolonging Agents,DrugBank
DB07841,QTc Prolonging Agents,DrugBank
DB07841,Terpenes,DrugBank
DB07931,Antineoplastic Agents,DrugBank
DB07931,"Antineoplastic Agents, Hormonal",DrugBank
DB07931,Benzene Derivatives,DrugBank
DB07931,Benzyl Compounds,DrugBank
DB07931,Benzylidene Compounds,DrugBank
DB07931,Bibenzyls,DrugBank
DB07931,Dihydrostilbenoids,DrugBank
DB07931,Estrogens,DrugBank
DB07931,"Estrogens, Non-Steroidal",DrugBank
DB07931,Hormones,DrugBank
DB07931,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB07931,Stilbenes,DrugBank
DB07931,Stilbestrols,DrugBank
DB07931,Thyroxine-binding globulin inducers,DrugBank
DB07954,Enzyme Inhibitors,DrugBank
DB07954,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB07954,Phosphodiesterase Inhibitors,DrugBank
DB07954,Purines,DrugBank
DB07954,Purinones,DrugBank
DB07954,Xanthine derivatives,DrugBank
DB07996,Enzyme Inhibitors,DrugBank
DB07996,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB07996,Isoquinolines,DrugBank
DB07996,Piperazines,DrugBank
DB07996,Sulfonamides,DrugBank
DB07996,Sulfones,DrugBank
DB07996,Sulfur Compounds,DrugBank
DB08059,Androstadienes,DrugBank
DB08059,Androstanes,DrugBank
DB08059,Androstenes,DrugBank
DB08059,Anti-Infective Agents,DrugBank
DB08059,Antidepressive Agents,DrugBank
DB08059,Antifungal Agents,DrugBank
DB08059,Central Nervous System Depressants,DrugBank
DB08059,Enzyme Inhibitors,DrugBank
DB08059,Fused-Ring Compounds,DrugBank
DB08059,Hormone Antagonists,DrugBank
DB08059,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08059,Immunologic Factors,DrugBank
DB08059,Immunosuppressive Agents,DrugBank
DB08059,Insulin Antagonists,DrugBank
DB08059,Protein Kinase Inhibitors,DrugBank
DB08059,Radiation-Sensitizing Agents,DrugBank
DB08059,Serotonin Agents,DrugBank
DB08059,Serotonin Receptor Antagonists,DrugBank
DB08059,Steroids,DrugBank
DB08162,Antiarrhythmic agents,DrugBank
DB08162,Calcium Channel Blockers,DrugBank
DB08162,Calcium-Regulating Hormones and Agents,DrugBank
DB08162,Cardiovascular Agents,DrugBank
DB08162,Enzyme Inhibitors,DrugBank
DB08162,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08162,Isoquinolines,DrugBank
DB08162,Membrane Transport Modulators,DrugBank
DB08162,Peripheral Vasodilators,DrugBank
DB08162,Piperazines,DrugBank
DB08162,Protein Kinase Inhibitors,DrugBank
DB08162,Sulfonamides,DrugBank
DB08162,Sulfones,DrugBank
DB08162,Sulfur Compounds,DrugBank
DB08162,Vasodilating Agents,DrugBank
DB08167,Oxidation-Reduction Activity,DrugBank
DB08167,Oxidation-Reduction Agent,DrugBank
DB08167,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08313,Antimitotic Agents,DrugBank
DB08313,Antineoplastic Agents,DrugBank
DB08313,Benzimidazoles,DrugBank
DB08313,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08313,Mitosis Modulators,DrugBank
DB08313,Tubulin Modulators,DrugBank
DB08329,Amides,DrugBank
DB08329,Anticonvulsants,DrugBank
DB08329,Benzene Derivatives,DrugBank
DB08329,Central Nervous System Agents,DrugBank
DB08329,Central Nervous System Depressants,DrugBank
DB08329,Genito Urinary System and Sex Hormones,DrugBank
DB08329,Gynecological Antiinfectives and Antiseptics,DrugBank
DB08329,Nervous System,DrugBank
DB08329,Sulfonamides,DrugBank
DB08329,Sulfones,DrugBank
DB08329,Sulfur Compounds,DrugBank
DB08382,Agents causing angioedema,DrugBank
DB08382,Blood Glucose Lowering Agents,DrugBank
DB08382,"Diabetes Mellitus, Type 2, drug therapy",DrugBank
DB08382,DPP-IV Inhibitors,DrugBank
DB08437,"Acids, Carbocyclic",DrugBank
DB08437,Agents that produce neuromuscular block (indirect),DrugBank
DB08437,Aminoglycoside Antibacterials,DrugBank
DB08437,Anti-Bacterial Agents,DrugBank
DB08437,Anti-Infective Agents,DrugBank
DB08437,Antimetabolites,DrugBank
DB08437,Antineoplastic Agents,DrugBank
DB08437,Antiparasitic Agents,DrugBank
DB08437,Antiprotozoals,DrugBank
DB08437,Carbohydrates,DrugBank
DB08437,Cinnamates,DrugBank
DB08437,Enzyme Inhibitors,DrugBank
DB08437,Glycosides,DrugBank
DB08437,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08437,Nephrotoxic agents,DrugBank
DB08437,Noxae,DrugBank
DB08437,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB08437,Nucleosides,DrugBank
DB08437,Protein Synthesis Inhibitors,DrugBank
DB08437,Purine Nucleosides,DrugBank
DB08437,Purines,DrugBank
DB08437,Toxic Actions,DrugBank
DB08437,Trypanocidal Agents,DrugBank
DB08439,Agents causing hyperkalemia,DrugBank
DB08439,Agents that produce hypertension,DrugBank
DB08439,Analgesics,DrugBank
DB08439,"Analgesics, Non-Narcotic",DrugBank
DB08439,Anti-Inflammatory Agents,DrugBank
DB08439,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08439,Antiinflammatory and Antirheumatic Products,DrugBank
DB08439,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB08439,Antirheumatic Agents,DrugBank
DB08439,COX-2 Inhibitors,DrugBank
DB08439,Cyclooxygenase Inhibitors,DrugBank
DB08439,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08439,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08439,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08439,Cytochrome P-450 Substrates,DrugBank
DB08439,Enzyme Inhibitors,DrugBank
DB08439,Musculo-Skeletal System,DrugBank
DB08439,Nephrotoxic agents,DrugBank
DB08439,Peripheral Nervous System Agents,DrugBank
DB08439,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB08439,Sensory System Agents,DrugBank
DB08486,"Acids, Acyclic",DrugBank
DB08486,Amines,DrugBank
DB08486,Antineoplastic Agents,DrugBank
DB08486,Antineoplastic and Immunomodulating Agents,DrugBank
DB08486,Antisickling Agents,DrugBank
DB08486,Fatty Acids,DrugBank
DB08486,"Fatty Acids, Volatile",DrugBank
DB08486,Hematologic Agents,DrugBank
DB08486,Lipids,DrugBank
DB08486,Photosensitizing Agents,DrugBank
DB08486,Radiation-Sensitizing Agents,DrugBank
DB08486,Sensitizers Used in Photodynamic/radiation Therapy,DrugBank
DB08496,Anticoagulants,DrugBank
DB08496,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08496,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08496,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08496,Cytochrome P-450 Substrates,DrugBank
DB08496,Vitamin K Antagonists,DrugBank
DB08502,Anti-HIV Agents,DrugBank
DB08502,Anti-Infective Agents,DrugBank
DB08502,Anti-Retroviral Agents,DrugBank
DB08502,Antiviral Agents,DrugBank
DB08502,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08502,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08502,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08502,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08502,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08502,Cytochrome P-450 Substrates,DrugBank
DB08502,Enzyme Inhibitors,DrugBank
DB08502,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB08502,Nucleic Acid Synthesis Inhibitors,DrugBank
DB08502,Reverse Transcriptase Inhibitors,DrugBank
DB08550,Antidepressive Agents,DrugBank
DB08550,Central Nervous System Depressants,DrugBank
DB08550,Enzyme Inhibitors,DrugBank
DB08550,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08550,Isoquinolines,DrugBank
DB08550,Monoamine Oxidase Inhibitors,DrugBank
DB08550,"Phenylethanolamine N-Methyltransferase, antagonists & inhibitors",DrugBank
DB08550,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08619,Androstanes,DrugBank
DB08619,Androstenes,DrugBank
DB08619,Androstenols,DrugBank
DB08619,Fused-Ring Compounds,DrugBank
DB08619,Gonadal Hormones,DrugBank
DB08619,Gonadal Steroid Hormones,DrugBank
DB08619,Hormones,DrugBank
DB08619,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08619,Steroids,DrugBank
DB08619,Testosterone and derivatives,DrugBank
DB08619,Testosterone Congeners,DrugBank
DB08619,Thyroxine-binding globulin inhibitors,DrugBank
DB08621,Alcohols,DrugBank
DB08621,Amphenicols,DrugBank
DB08621,Anti-Bacterial Agents,DrugBank
DB08621,Anti-Infective Agents,DrugBank
DB08621,Antibacterials for Systemic Use,DrugBank
DB08621,Antiinfectives for Systemic Use,DrugBank
DB08621,Benzene Derivatives,DrugBank
DB08621,Glycols,DrugBank
DB08621,Nitro Compounds,DrugBank
DB08621,Nitrobenzenes,DrugBank
DB08621,Propylene Glycols,DrugBank
DB08633,Angiogenesis Inhibitors,DrugBank
DB08633,Angiogenesis Modulating Agents,DrugBank
DB08633,"Antibiotics, Antineoplastic",DrugBank
DB08633,Antineoplastic Agents,DrugBank
DB08633,Cyclohexanes,DrugBank
DB08633,Cycloparaffins,DrugBank
DB08633,Growth Inhibitors,DrugBank
DB08633,Growth Substances,DrugBank
DB08633,Sesquiterpenes,DrugBank
DB08633,Terpenes,DrugBank
DB08794,4-Hydroxycoumarins,DrugBank
DB08794,Anticoagulants,DrugBank
DB08794,Benzopyrans,DrugBank
DB08794,Blood and Blood Forming Organs,DrugBank
DB08794,Coumarins,DrugBank
DB08794,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08794,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08794,Cytochrome P-450 Substrates,DrugBank
DB08794,Hematologic Agents,DrugBank
DB08794,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08794,Pyrans,DrugBank
DB08794,Vitamin K Antagonists,DrugBank
DB08795,Amides,DrugBank
DB08795,Anti-Bacterial Agents,DrugBank
DB08795,Antibacterials for Systemic Use,DrugBank
DB08795,Antiinfectives for Systemic Use,DrugBank
DB08795,Beta-Lactam Antibacterials,DrugBank
DB08795,Beta-Lactamase Sensitive Penicillins,DrugBank
DB08795,beta-Lactams,DrugBank
DB08795,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08795,Lactams,DrugBank
DB08795,Penicillins,DrugBank
DB08795,Sulfur Compounds,DrugBank
DB08797,"Acids, Carbocyclic",DrugBank
DB08797,Agents causing hyperkalemia,DrugBank
DB08797,Agents that produce hypertension,DrugBank
DB08797,Amides,DrugBank
DB08797,Analgesics,DrugBank
DB08797,"Analgesics, Non-Narcotic",DrugBank
DB08797,Anti-Inflammatory Agents,DrugBank
DB08797,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08797,Antirheumatic Agents,DrugBank
DB08797,Benzene Derivatives,DrugBank
DB08797,Benzoates,DrugBank
DB08797,Cyclooxygenase Inhibitors,DrugBank
DB08797,Ligands,DrugBank
DB08797,Nephrotoxic agents,DrugBank
DB08797,Nervous System,DrugBank
DB08797,Non COX-2 selective NSAIDS,DrugBank
DB08797,Peripheral Nervous System Agents,DrugBank
DB08797,Salicylic Acid and Derivatives,DrugBank
DB08797,Sensory System Agents,DrugBank
DB08798,Amides,DrugBank
DB08798,Amines,DrugBank
DB08798,Aniline Compounds,DrugBank
DB08798,Anti-Infective Agents,DrugBank
DB08798,Antibacterials for Systemic Use,DrugBank
DB08798,Antiinfectives for Systemic Use,DrugBank
DB08798,Benzene Derivatives,DrugBank
DB08798,Benzenesulfonamides,DrugBank
DB08798,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08798,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08798,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08798,Intermediate-Acting Antibacterial Sulfonamides,DrugBank
DB08798,Sulfanilamides,DrugBank
DB08798,Sulfonamides,DrugBank
DB08798,Sulfonamides and trimethoprim,DrugBank
DB08798,Sulfones,DrugBank
DB08798,Sulfur Compounds,DrugBank
DB08799,Anti-Allergic Agents,DrugBank
DB08799,"Antiallergic Agents, Excl. Corticosteroids",DrugBank
DB08799,Antihistamines for Systemic Use,DrugBank
DB08799,Histamine Agents,DrugBank
DB08799,Histamine Antagonists,DrugBank
DB08799,Histamine H1 Antagonists,DrugBank
DB08799,Imidazoles,DrugBank
DB08799,Moderate Risk QTc-Prolonging Agents,DrugBank
DB08799,Nasal Preparations,DrugBank
DB08799,Neurotransmitter Agents,DrugBank
DB08799,QTc Prolonging Agents,DrugBank
DB08800,Amines,DrugBank
DB08800,Antihistamines for Systemic Use,DrugBank
DB08800,Antihistamines for Topical Use,DrugBank
DB08800,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB08800,Dermatologicals,DrugBank
DB08800,Diamines,DrugBank
DB08800,Histamine Agents,DrugBank
DB08800,Histamine Antagonists,DrugBank
DB08800,Histamine H1 Antagonists,DrugBank
DB08800,Neurotransmitter Agents,DrugBank
DB08800,Polyamines,DrugBank
DB08800,Substituted Ethylene Diamines,DrugBank
DB08801,Agents producing tachycardia,DrugBank
DB08801,Anti-Allergic Agents,DrugBank
DB08801,Anticholinergic Agents,DrugBank
DB08801,Antihistamines for Systemic Use,DrugBank
DB08801,Antihistamines for Topical Use,DrugBank
DB08801,Antipruritics,DrugBank
DB08801,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB08801,Dermatologicals,DrugBank
DB08801,Histamine Agents,DrugBank
DB08801,Histamine Antagonists,DrugBank
DB08801,Histamine H1 Antagonists,DrugBank
DB08801,Indenes,DrugBank
DB08801,Muscarinic Antagonists,DrugBank
DB08801,Neurotransmitter Agents,DrugBank
DB08801,Pyridines,DrugBank
DB08801,Substituted Alkylamines,DrugBank
DB08802,Antihistamines for Systemic Use,DrugBank
DB08802,Antihistamines for Topical Use,DrugBank
DB08802,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB08802,Dermatologicals,DrugBank
DB08802,Histamine Agents,DrugBank
DB08802,Histamine Antagonists,DrugBank
DB08802,Histamine H1 Antagonists,DrugBank
DB08802,Neurotransmitter Agents,DrugBank
DB08802,Phenothiazine Derivatives,DrugBank
DB08802,Sulfur Compounds,DrugBank
DB08804,Anabolic Agents,DrugBank
DB08804,Androgens,DrugBank
DB08804,Bone Density Conservation Agents,DrugBank
DB08804,Estranes,DrugBank
DB08804,Estrenes,DrugBank
DB08804,Fused-Ring Compounds,DrugBank
DB08804,Gonadal Hormones,DrugBank
DB08804,Gonadal Steroid Hormones,DrugBank
DB08804,Hormones,DrugBank
DB08804,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08804,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB08804,Nandrolone and esters,DrugBank
DB08804,Steroids,DrugBank
DB08804,Testosterone Congeners,DrugBank
DB08804,Thyroxine-binding globulin inhibitors,DrugBank
DB08804,UGT1A1 Substrates,DrugBank
DB08804,UGT1A3 substrates,DrugBank
DB08804,UGT1A4 substrates,DrugBank
DB08804,UGT2B7 substrates,DrugBank
DB08805,Acid Reducers,DrugBank
DB08805,Amides,DrugBank
DB08805,Anti-Ulcer Agents,DrugBank
DB08805,Gastric Acid Lowering Agents,DrugBank
DB08805,Gastrointestinal Agents,DrugBank
DB08805,Histamine Agents,DrugBank
DB08805,Histamine Antagonists,DrugBank
DB08805,Histamine H2 Antagonists,DrugBank
DB08805,Neurotransmitter Agents,DrugBank
DB08805,Sulfur Compounds,DrugBank
DB08805,Thiourea,DrugBank
DB08806,Acid Reducers,DrugBank
DB08806,Alimentary Tract and Metabolism,DrugBank
DB08806,Anti-Ulcer Agents,DrugBank
DB08806,Drugs for Acid Related Disorders,DrugBank
DB08806,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB08806,Gastric Acid Lowering Agents,DrugBank
DB08806,Gastrointestinal Agents,DrugBank
DB08806,Histamine Agents,DrugBank
DB08806,Histamine Antagonists,DrugBank
DB08806,Histamine H2 Antagonists,DrugBank
DB08806,Neurotransmitter Agents,DrugBank
DB08807,Adrenergic Agents,DrugBank
DB08807,Adrenergic Antagonists,DrugBank
DB08807,Adrenergic beta-Antagonists,DrugBank
DB08807,Agents causing hyperkalemia,DrugBank
DB08807,Alcohols,DrugBank
DB08807,Amines,DrugBank
DB08807,Amino Alcohols,DrugBank
DB08807,"Beta Blocking Agents, Non-Selective",DrugBank
DB08807,Bradycardia-Causing Agents,DrugBank
DB08807,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08807,Cytochrome P-450 Substrates,DrugBank
DB08807,Neurotransmitter Agents,DrugBank
DB08807,Phenoxypropanolamines,DrugBank
DB08807,Propanolamines,DrugBank
DB08807,Propanols,DrugBank
DB08808,Adrenergic Agents,DrugBank
DB08808,Adrenergic Antagonists,DrugBank
DB08808,Adrenergic beta-Antagonists,DrugBank
DB08808,Agents causing hyperkalemia,DrugBank
DB08808,Alcohols,DrugBank
DB08808,Amines,DrugBank
DB08808,Amino Alcohols,DrugBank
DB08808,Antiarrhythmic agents,DrugBank
DB08808,Antihypertensive Agents,DrugBank
DB08808,"Beta Blocking Agents, Non-Selective",DrugBank
DB08808,Bradycardia-Causing Agents,DrugBank
DB08808,Cardiovascular Agents,DrugBank
DB08808,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08808,Cytochrome P-450 Substrates,DrugBank
DB08808,Neurotransmitter Agents,DrugBank
DB08808,Phenoxypropanolamines,DrugBank
DB08808,Potential QTc-Prolonging Agents,DrugBank
DB08808,Propanolamines,DrugBank
DB08808,Propanols,DrugBank
DB08808,QTc Prolonging Agents,DrugBank
DB08810,"Acids, Carbocyclic",DrugBank
DB08810,Agents that produce hypertension,DrugBank
DB08810,Alimentary Tract and Metabolism,DrugBank
DB08810,Amides,DrugBank
DB08810,Anti-Ulcer Agents,DrugBank
DB08810,Antidepressive Agents,DrugBank
DB08810,Benzene Derivatives,DrugBank
DB08810,Benzoates,DrugBank
DB08810,Central Nervous System Depressants,DrugBank
DB08810,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB08810,Gastrointestinal Agents,DrugBank
DB08810,Propulsives,DrugBank
DB08810,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08810,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB08810,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB08810,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB08810,Serotonin Agents,DrugBank
DB08810,Serotonin Receptor Agonists,DrugBank
DB08810,Serotonin Receptor Antagonists,DrugBank
DB08811,Anti-Anxiety Agents,DrugBank
DB08811,Antidepressive Agents,DrugBank
DB08811,Benzazepines,DrugBank
DB08811,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB08811,Central Nervous System Agents,DrugBank
DB08811,Central Nervous System Depressants,DrugBank
DB08811,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08811,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08811,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08811,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08811,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08811,Nervous System,DrugBank
DB08811,Psycholeptics,DrugBank
DB08811,Psychotropic Drugs,DrugBank
DB08811,Stereoisomerism,DrugBank
DB08813,Agents causing hyperkalemia,DrugBank
DB08813,Anticoagulants,DrugBank
DB08813,Blood and Blood Forming Organs,DrugBank
DB08813,Carbohydrates,DrugBank
DB08813,Cardiovascular Agents,DrugBank
DB08813,Fibrin Modulating Agents,DrugBank
DB08813,Glycosaminoglycans,DrugBank
DB08813,Hematologic Agents,DrugBank
DB08813,Heparin (Low Molecular Weight),DrugBank
DB08813,Heparin and similars,DrugBank
DB08813,Polysaccharides,DrugBank
DB08814,"Acids, Carbocyclic",DrugBank
DB08814,Anticoagulants,DrugBank
DB08814,Antiplatelet agents,DrugBank
DB08814,Benzene Derivatives,DrugBank
DB08814,Benzoates,DrugBank
DB08814,Blood and Blood Forming Organs,DrugBank
DB08814,Hematologic Agents,DrugBank
DB08814,Hydroxy Acids,DrugBank
DB08814,Hydroxybenzoates,DrugBank
DB08814,Phenols,DrugBank
DB08814,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB08815,Adrenergic Agents,DrugBank
DB08815,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB08815,Adrenergic alpha-Antagonists,DrugBank
DB08815,Adrenergic Antagonists,DrugBank
DB08815,Agents that produce hypertension,DrugBank
DB08815,Antidepressive Agents,DrugBank
DB08815,Antipsychotic Agents,DrugBank
DB08815,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB08815,Central Nervous System Agents,DrugBank
DB08815,Central Nervous System Depressants,DrugBank
DB08815,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08815,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08815,Cytochrome P-450 Substrates,DrugBank
DB08815,Dopamine Agents,DrugBank
DB08815,Dopamine Antagonists,DrugBank
DB08815,Dopamine D2 Receptor Antagonists,DrugBank
DB08815,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08815,Hyperglycemia-Associated Agents,DrugBank
DB08815,Indole Derivatives,DrugBank
DB08815,Isoindoles,DrugBank
DB08815,Nervous System,DrugBank
DB08815,Neurotoxic agents,DrugBank
DB08815,Neurotransmitter Agents,DrugBank
DB08815,Potential QTc-Prolonging Agents,DrugBank
DB08815,Psycholeptics,DrugBank
DB08815,Psychotropic Drugs,DrugBank
DB08815,QTc Prolonging Agents,DrugBank
DB08815,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08815,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB08815,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB08815,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB08815,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB08815,Serotonin Agents,DrugBank
DB08815,Serotonin Receptor Antagonists,DrugBank
DB08815,Sulfur Compounds,DrugBank
DB08815,Thiazoles,DrugBank
DB08815,Tranquilizing Agents,DrugBank
DB08816,Anticoagulants,DrugBank
DB08816,Antiplatelet agents,DrugBank
DB08816,Blood and Blood Forming Organs,DrugBank
DB08816,Carbohydrates,DrugBank
DB08816,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB08816,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB08816,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB08816,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB08816,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB08816,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08816,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB08816,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08816,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08816,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08816,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08816,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB08816,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08816,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB08816,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08816,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08816,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08816,Cytochrome P-450 Substrates,DrugBank
DB08816,Decreased Platelet Aggregation,DrugBank
DB08816,Glycosides,DrugBank
DB08816,Hematologic Agents,DrugBank
DB08816,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08816,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB08816,Nucleosides,DrugBank
DB08816,P-glycoprotein inhibitors,DrugBank
DB08816,P-glycoprotein substrates,DrugBank
DB08816,P2Y12 Platelet Inhibitor,DrugBank
DB08816,Phenylalanine Hydroxylase Activators,DrugBank
DB08816,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB08816,Purine Nucleosides,DrugBank
DB08816,Purinergic Agents,DrugBank
DB08816,Purinergic Antagonists,DrugBank
DB08816,Purinergic P2 Receptor Antagonists,DrugBank
DB08816,Purinergic P2Y Receptor Antagonists,DrugBank
DB08816,Purines,DrugBank
DB08816,Ribonucleosides,DrugBank
DB08819,Antiglaucoma Preparations and Miotics,DrugBank
DB08819,Autacoids,DrugBank
DB08819,Biological Factors,DrugBank
DB08819,Eicosanoids,DrugBank
DB08819,Fatty Acids,DrugBank
DB08819,"Fatty Acids, Unsaturated",DrugBank
DB08819,Increased Prostaglandin Activity,DrugBank
DB08819,Inflammation Mediators,DrugBank
DB08819,Lipids,DrugBank
DB08819,Ophthalmics,DrugBank
DB08819,Ophthalmologicals,DrugBank
DB08819,Prostaglandin analogs reducing intraocular pressure (IOP),DrugBank
DB08819,Prostaglandin Receptor Agonists,DrugBank
DB08819,Prostaglandins,DrugBank
DB08819,"Prostaglandins, Synthetic",DrugBank
DB08819,Sensory Organs,DrugBank
DB08820,Amines,DrugBank
DB08820,Aniline Compounds,DrugBank
DB08820,Benzene Derivatives,DrugBank
DB08820,Chloride Channel Activation Potentiators,DrugBank
DB08820,Chloride Channel Agonists,DrugBank
DB08820,Cystic Fibrosis Transmembrane Conductance Regulator Potentiators,DrugBank
DB08820,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08820,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08820,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08820,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08820,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08820,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB08820,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08820,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB08820,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB08820,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08820,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08820,Cytochrome P-450 Substrates,DrugBank
DB08820,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08820,Membrane Transport Modulators,DrugBank
DB08820,P-glycoprotein inhibitors,DrugBank
DB08820,Phenols,DrugBank
DB08820,Quinolines,DrugBank
DB08822,Agents Acting on the Renin-Angiotensin System,DrugBank
DB08822,Agents causing angioedema,DrugBank
DB08822,Agents causing hyperkalemia,DrugBank
DB08822,Angiotensin 2 Receptor Blocker,DrugBank
DB08822,Angiotensin II receptor antagonists,DrugBank
DB08822,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB08822,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB08822,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB08822,Angiotensin Receptor Antagonists,DrugBank
DB08822,Antihypertensive Agents,DrugBank
DB08822,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB08822,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB08822,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08822,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08822,Cytochrome P-450 Substrates,DrugBank
DB08822,Decreased Blood Pressure,DrugBank
DB08822,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08822,Hypotensive Agents,DrugBank
DB08822,Oxazoles,DrugBank
DB08822,P-glycoprotein inhibitors,DrugBank
DB08822,Teratogens,DrugBank
DB08824,Alkaloids,DrugBank
DB08824,Aza Compounds,DrugBank
DB08824,Azabicyclo Compounds,DrugBank
DB08824,Central Nervous System,DrugBank
DB08824,Diagnostic Radiopharmaceuticals,DrugBank
DB08824,Diagnostic Uses of Chemicals,DrugBank
DB08824,Drugs that are Mainly Renally Excreted,DrugBank
DB08824,Iodine (123I) Compounds,DrugBank
DB08824,Iodine Radioisotopes,DrugBank
DB08824,Radioactive Diagnostic Agent,DrugBank
DB08824,Radiopharmaceutical Activity,DrugBank
DB08824,Tropanes,DrugBank
DB08826,Chelating Agents,DrugBank
DB08826,"Compounds used in a research, industrial, or household setting",DrugBank
DB08826,Drugs that are Mainly Renally Excreted,DrugBank
DB08826,Heavy Metal Antagonists,DrugBank
DB08826,Iron Chelating Activity,DrugBank
DB08826,Iron Chelating Agents,DrugBank
DB08826,Pyridines,DrugBank
DB08826,Pyridones,DrugBank
DB08826,Sequestering Agents,DrugBank
DB08826,UGT1A6 substrate,DrugBank
DB08827,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08827,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08827,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08827,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB08827,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08827,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB08827,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08827,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08827,Cytochrome P-450 Substrates,DrugBank
DB08827,Hepatotoxic Agents,DrugBank
DB08827,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08827,Hypolipidemic Agents,DrugBank
DB08827,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB08827,Lipid Modifying Agents,DrugBank
DB08827,"Lipid Modifying Agents, Plain",DrugBank
DB08827,Microsomal Triglyceride Transfer Protein Inhibitor,DrugBank
DB08827,Microsomal Triglyceride Transfer Protein Inhibitors,DrugBank
DB08827,Narrow Therapeutic Index Drugs,DrugBank
DB08827,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB08827,P-glycoprotein inhibitors,DrugBank
DB08828,Amides,DrugBank
DB08828,Amines,DrugBank
DB08828,Aniline Compounds,DrugBank
DB08828,Antineoplastic Agents,DrugBank
DB08828,Antineoplastic and Immunomodulating Agents,DrugBank
DB08828,BCRP/ABCG2 Inhibitors,DrugBank
DB08828,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB08828,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB08828,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08828,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB08828,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08828,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08828,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08828,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08828,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08828,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08828,Cytochrome P-450 Substrates,DrugBank
DB08828,Hedgehog Pathway Inhibitor,DrugBank
DB08828,Hedgehog pathway inhibitors,DrugBank
DB08828,P-glycoprotein substrates,DrugBank
DB08828,Smoothened Receptor Antagonists,DrugBank
DB08830,"Acids, Acyclic",DrugBank
DB08830,Carbohydrates,DrugBank
DB08830,"Diet, Food, and Nutrition",DrugBank
DB08830,Food,DrugBank
DB08830,Hydroxy Acids,DrugBank
DB08830,Lactones,DrugBank
DB08830,Micronutrients,DrugBank
DB08830,Physiological Phenomena,DrugBank
DB08830,Sugar Acids,DrugBank
DB08830,Urinary Acidifying Agents,DrugBank
DB08830,Vitamin C and analogues,DrugBank
DB08830,Vitamins,DrugBank
DB08833,Alkanes,DrugBank
DB08833,Alkanesulfonic Acids,DrugBank
DB08833,Bile Acids and Salts,DrugBank
DB08833,Cholagogues and Choleretics,DrugBank
DB08833,Cholanes,DrugBank
DB08833,Cholic Acids,DrugBank
DB08833,"Compounds used in a research, industrial, or household setting",DrugBank
DB08833,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08833,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08833,Cytochrome P-450 Substrates,DrugBank
DB08833,Detergents,DrugBank
DB08833,Fused-Ring Compounds,DrugBank
DB08833,Gastrointestinal Agents,DrugBank
DB08833,Household Products,DrugBank
DB08833,"Hydrocarbons, Acyclic",DrugBank
DB08833,Steroids,DrugBank
DB08833,Sulfonic Acids,DrugBank
DB08833,Sulfur Acids,DrugBank
DB08833,Sulfur Compounds,DrugBank
DB08833,Surface-Active Agents,DrugBank
DB08833,Taurodeoxycholic Acid,DrugBank
DB08834,Alimentary Tract and Metabolism,DrugBank
DB08834,Bile acids and derivatives,DrugBank
DB08834,Bile Acids and Salts,DrugBank
DB08834,Bile and Liver Therapy,DrugBank
DB08834,Bile Therapy,DrugBank
DB08834,Cholagogues and Choleretics,DrugBank
DB08834,Cholanes,DrugBank
DB08834,Cholic Acids,DrugBank
DB08834,Gastrointestinal Agents,DrugBank
DB08834,Isomerism,DrugBank
DB08834,Nervous System,DrugBank
DB08834,Sulfur Compounds,DrugBank
DB08834,Taurodeoxycholic Acid,DrugBank
DB08836,Agents Acting on the Renin-Angiotensin System,DrugBank
DB08836,Agents causing angioedema,DrugBank
DB08836,Agents causing hyperkalemia,DrugBank
DB08836,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB08836,Antihypertensive Agents,DrugBank
DB08836,Azepines,DrugBank
DB08836,Cardiovascular Agents,DrugBank
DB08836,Enzyme Inhibitors,DrugBank
DB08836,OATP1B1/SLCO1B1 Substrates,DrugBank
DB08836,Protease Inhibitors,DrugBank
DB08836,Sulfur Compounds,DrugBank
DB08836,Thiepins,DrugBank
DB08838,Agents causing hyperkalemia,DrugBank
DB08838,Amidines,DrugBank
DB08838,Antiarrhythmic agents,DrugBank
DB08838,Anticholinergic Agents,DrugBank
DB08838,Bradycardia-Causing Agents,DrugBank
DB08838,Calcium Channel Blockers,DrugBank
DB08838,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08838,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08838,Cytochrome P-450 Substrates,DrugBank
DB08838,Guanidines,DrugBank
DB08838,Nicotinic Antagonists,DrugBank
DB08838,NMDA Receptor Antagonists,DrugBank
DB08838,OCT1 substrates,DrugBank
DB08838,OCT2 Substrates,DrugBank
DB08838,Vasodilating Agents,DrugBank
DB08839,Amines,DrugBank
DB08839,Antidepressive Agents,DrugBank
DB08839,Autacoids,DrugBank
DB08839,Biogenic Amines,DrugBank
DB08839,Biogenic Monoamines,DrugBank
DB08839,Biological Factors,DrugBank
DB08839,Central Nervous System Depressants,DrugBank
DB08839,Complex Mixtures,DrugBank
DB08839,Endopeptidases,DrugBank
DB08839,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08839,Indoles,DrugBank
DB08839,Inflammation Mediators,DrugBank
DB08839,Neurotransmitter Agents,DrugBank
DB08839,Serine Proteases,DrugBank
DB08839,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08839,Serotonin Agents,DrugBank
DB08839,Serotonin Receptor Agonists,DrugBank
DB08839,Snake Venoms,DrugBank
DB08839,"Toxins, Biological",DrugBank
DB08839,Tryptamines,DrugBank
DB08839,Venoms,DrugBank
DB08839,Viper Venoms,DrugBank
DB08840,Alimentary Tract and Metabolism,DrugBank
DB08840,Bile and Liver Therapy,DrugBank
DB08840,Bile Therapy,DrugBank
DB08840,Drugs that are Mainly Renally Excreted,DrugBank
DB08840,MATE 1 Substrates,DrugBank
DB08840,MATE 2 Substrates,DrugBank
DB08840,MATE substrates,DrugBank
DB08840,Nicotinic Acids,DrugBank
DB08840,Preparations for Biliary Tract Therapy,DrugBank
DB08840,Pyridines,DrugBank
DB08841,Adrenergic Agents,DrugBank
DB08841,Agents producing tachycardia,DrugBank
DB08841,Agents that produce hypertension,DrugBank
DB08841,Amines,DrugBank
DB08841,Autonomic Agents,DrugBank
DB08841,Biogenic Amines,DrugBank
DB08841,Biogenic Monoamines,DrugBank
DB08841,Membrane Transport Modulators,DrugBank
DB08841,Neurotransmitter Agents,DrugBank
DB08841,Neurotransmitter Uptake Inhibitors,DrugBank
DB08841,Peripheral Nervous System Agents,DrugBank
DB08841,Sympathomimetics,DrugBank
DB08844,Alkaloids,DrugBank
DB08844,Antioxidants,DrugBank
DB08844,Biological Factors,DrugBank
DB08844,"Compounds used in a research, industrial, or household setting",DrugBank
DB08844,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08844,Protective Agents,DrugBank
DB08844,Purines,DrugBank
DB08844,Purinones,DrugBank
DB08844,Xanthine derivatives,DrugBank
DB08846,Benzopyrans,DrugBank
DB08846,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB08846,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB08846,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08846,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08846,OAT1/SLC22A6 inhibitors,DrugBank
DB08846,OAT1/SLC22A6 Substrates,DrugBank
DB08846,OAT3/SLC22A8 Substrates,DrugBank
DB08846,Pyrans,DrugBank
DB08857,Bile Acids and Salts,DrugBank
DB08857,Cholanes,DrugBank
DB08857,Cholic Acids,DrugBank
DB08857,Fused-Ring Compounds,DrugBank
DB08857,Organometallic Compounds,DrugBank
DB08857,Steroids,DrugBank
DB08860,Agents Causing Muscle Toxicity,DrugBank
DB08860,Anticholesteremic Agents,DrugBank
DB08860,BCRP/ABCG2 Substrates,DrugBank
DB08860,BSEP/ABCB11 Substrates,DrugBank
DB08860,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08860,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08860,Cytochrome P-450 Substrates,DrugBank
DB08860,Enzyme Inhibitors,DrugBank
DB08860,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08860,Hydroxymethylglutaryl-CoA Reductase Inhibitors,DrugBank
DB08860,Hypolipidemic Agents,DrugBank
DB08860,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB08860,Lipid Modifying Agents,DrugBank
DB08860,"Lipid Modifying Agents, Plain",DrugBank
DB08860,Lipid Regulating Agents,DrugBank
DB08860,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08860,OATP1B1/SLCO1B1 Substrates,DrugBank
DB08860,OATP1B3 substrates,DrugBank
DB08860,OATP2B1/SLCO2B1 substrates,DrugBank
DB08860,P-glycoprotein substrates,DrugBank
DB08860,Toxic Actions,DrugBank
DB08860,UGT1A3 substrates,DrugBank
DB08860,UGT2B7 substrates,DrugBank
DB08861,"Amino Acids, Peptides, and Proteins",DrugBank
DB08861,Analgesics,DrugBank
DB08861,Central Nervous System Agents,DrugBank
DB08861,Central Nervous System Depressants,DrugBank
DB08861,Enkephalins,DrugBank
DB08861,Narcotics,DrugBank
DB08861,Nerve Tissue Proteins,DrugBank
DB08861,Neuropeptides,DrugBank
DB08861,Neurotransmitter Agents,DrugBank
DB08861,Opioid Peptides,DrugBank
DB08861,Opioids,DrugBank
DB08861,Peptides,DrugBank
DB08861,Peripheral Nervous System Agents,DrugBank
DB08861,Proteins,DrugBank
DB08861,Sensory System Agents,DrugBank
DB08861,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08862,"Amino Acids, Peptides, and Proteins",DrugBank
DB08862,Cholagogues and Choleretics,DrugBank
DB08862,"Cholecystokinin, agonists",DrugBank
DB08862,"Cholecystokinin, antagonists & inhibitors",DrugBank
DB08862,Diagnostic Agents,DrugBank
DB08862,Gastrointestinal Agents,DrugBank
DB08862,Gastrointestinal Hormones,DrugBank
DB08862,Hormones,DrugBank
DB08862,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08862,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08862,OATP1B1/SLCO1B1 Substrates,DrugBank
DB08862,OATP1B3 substrates,DrugBank
DB08862,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB08862,Peptides,DrugBank
DB08862,Tests for Pancreatic Function,DrugBank
DB08864,Anti-HIV Agents,DrugBank
DB08864,Anti-Infective Agents,DrugBank
DB08864,Anti-Retroviral Agents,DrugBank
DB08864,Antiinfectives for Systemic Use,DrugBank
DB08864,Antiviral Agents,DrugBank
DB08864,Antivirals for Systemic Use,DrugBank
DB08864,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB08864,BCRP/ABCG2 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2B6 Inhibitors (strong),DrugBank
DB08864,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08864,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08864,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08864,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08864,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08864,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08864,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB08864,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08864,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08864,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08864,Cytochrome P-450 Substrates,DrugBank
DB08864,Direct Acting Antivirals,DrugBank
DB08864,Enzyme Inhibitors,DrugBank
DB08864,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB08864,Nitriles,DrugBank
DB08864,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB08864,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB08864,Nucleic Acid Synthesis Inhibitors,DrugBank
DB08864,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08864,OATP1B3 inhibitors,DrugBank
DB08864,P-glycoprotein inhibitors,DrugBank
DB08864,Potential QTc-Prolonging Agents,DrugBank
DB08864,Pyrimidines,DrugBank
DB08864,QTc Prolonging Agents,DrugBank
DB08864,Reverse Transcriptase Inhibitors,DrugBank
DB08865,Aminopyridines,DrugBank
DB08865,Anaplastic lymphoma kinase (ALK) inhibitors,DrugBank
DB08865,Antineoplastic Agents,DrugBank
DB08865,Antineoplastic and Immunomodulating Agents,DrugBank
DB08865,Bradycardia-Causing Agents,DrugBank
DB08865,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB08865,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB08865,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08865,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08865,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08865,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08865,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08865,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08865,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB08865,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB08865,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08865,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB08865,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08865,Cytochrome P-450 Substrates,DrugBank
DB08865,Enzyme Inhibitors,DrugBank
DB08865,Kinase Inhibitor,DrugBank
DB08865,Moderate Risk QTc-Prolonging Agents,DrugBank
DB08865,Narrow Therapeutic Index Drugs,DrugBank
DB08865,OCT2 Inhibitors,DrugBank
DB08865,Organic Cation Transporter 1 Inhibitors,DrugBank
DB08865,P-glycoprotein inhibitors,DrugBank
DB08865,P-glycoprotein substrates,DrugBank
DB08865,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08865,Piperidines,DrugBank
DB08865,Protein Kinase Inhibitors,DrugBank
DB08865,Pyridines,DrugBank
DB08865,QTc Prolonging Agents,DrugBank
DB08865,Receptor Tyrosine Kinase Inhibitors,DrugBank
DB08865,ROS1 tyrosine kinase inhibitors,DrugBank
DB08865,Tyrosine Kinase Inhibitors,DrugBank
DB08867,Adrenal Cortex Hormones,DrugBank
DB08867,"Contraceptive Agents, Female",DrugBank
DB08867,"Contraceptive Agents, Hormonal",DrugBank
DB08867,"Contraceptives, Postcoital",DrugBank
DB08867,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB08867,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08867,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08867,Cytochrome P-450 Substrates,DrugBank
DB08867,Fused-Ring Compounds,DrugBank
DB08867,Genito Urinary System and Sex Hormones,DrugBank
DB08867,Hormonal Contraceptives for Systemic Use,DrugBank
DB08867,Norpregnanes,DrugBank
DB08867,Norsteroids,DrugBank
DB08867,Progesterone Agonist/Antagonist,DrugBank
DB08867,Progesterone Receptor Modulators,DrugBank
DB08867,Reproductive Control Agents,DrugBank
DB08867,Selective Progesterone Receptor Modulators,DrugBank
DB08867,Sex Hormones and Modulators of the Genital System,DrugBank
DB08867,Steroids,DrugBank
DB08868,Alcohols,DrugBank
DB08868,Amines,DrugBank
DB08868,Amino Alcohols,DrugBank
DB08868,Antineoplastic and Immunomodulating Agents,DrugBank
DB08868,Bradycardia-Causing Agents,DrugBank
DB08868,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB08868,Cytochrome P-450 Substrates,DrugBank
DB08868,Experimental Unapproved Treatments for COVID-19,DrugBank
DB08868,Glycols,DrugBank
DB08868,Immunologic Factors,DrugBank
DB08868,Immunomodulatory Agents,DrugBank
DB08868,Immunosuppressive Agents,DrugBank
DB08868,P-glycoprotein inducers,DrugBank
DB08868,P-glycoprotein inhibitors,DrugBank
DB08868,Propylene Glycols,DrugBank
DB08868,Selective Immunosuppressants,DrugBank
DB08868,Sphingosine 1 Phosphate Receptor Modulators,DrugBank
DB08868,Sphingosine 1-phosphate Receptor Modulator,DrugBank
DB08868,Sphingosine-1-phosphate (S1P) receptor modulators,DrugBank
DB08869,"Amino Acids, Peptides, and Proteins",DrugBank
DB08869,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB08869,Growth Hormone Releasing Factor Analog,DrugBank
DB08869,Growth Hormone-Releasing Hormone,DrugBank
DB08869,Growth Substances,DrugBank
DB08869,Hormones,DrugBank
DB08869,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08869,Hypothalamic Hormones,DrugBank
DB08869,Increased GHRH Activity,DrugBank
DB08869,Lipodystrophy,DrugBank
DB08869,Nerve Tissue Proteins,DrugBank
DB08869,Neuropeptides,DrugBank
DB08869,Peptide Hormones,DrugBank
DB08869,Peptides,DrugBank
DB08869,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB08869,Pituitary Hormone-Releasing Hormones,DrugBank
DB08869,Proteins,DrugBank
DB08869,Somatotropin Agonists,DrugBank
DB08869,Somatropin and Somatropin Agonists,DrugBank
DB08869,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB08870,"Amino Acids, Peptides, and Proteins",DrugBank
DB08870,Antibodies,DrugBank
DB08870,"Antibodies, Monoclonal",DrugBank
DB08870,"Antibodies, Monoclonal, Humanized",DrugBank
DB08870,Antibody-drug Conjugates,DrugBank
DB08870,Antineoplastic Agents,DrugBank
DB08870,"Antineoplastic Agents, Immunological",DrugBank
DB08870,Antineoplastic and Immunomodulating Agents,DrugBank
DB08870,Blood Proteins,DrugBank
DB08870,Cancer immunotherapy,DrugBank
DB08870,CD30-directed Antibody Interactions,DrugBank
DB08870,CD30-directed Immunoconjugate,DrugBank
DB08870,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08870,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08870,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08870,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08870,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08870,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08870,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08870,Cytochrome P-450 Substrates,DrugBank
DB08870,Globulins,DrugBank
DB08870,Immunoconjugates,DrugBank
DB08870,Immunoglobulins,DrugBank
DB08870,Immunologic Factors,DrugBank
DB08870,Immunoproteins,DrugBank
DB08870,Immunosuppressive Agents,DrugBank
DB08870,Immunotherapy,DrugBank
DB08870,Immunotoxins,DrugBank
DB08870,Microtubule Inhibition,DrugBank
DB08870,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB08870,Narrow Therapeutic Index Drugs,DrugBank
DB08870,Noxae,DrugBank
DB08870,Oligopeptides,DrugBank
DB08870,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08870,Peptides,DrugBank
DB08870,Proteins,DrugBank
DB08870,Serum Globulins,DrugBank
DB08870,Toxic Actions,DrugBank
DB08871,Antineoplastic Agents,DrugBank
DB08871,Antineoplastic and Immunomodulating Agents,DrugBank
DB08871,Ethers,DrugBank
DB08871,"Ethers, Cyclic",DrugBank
DB08871,Immunosuppressive Agents,DrugBank
DB08871,Lactones,DrugBank
DB08871,Microtubule Inhibition,DrugBank
DB08871,Microtubule Inhibitors,DrugBank
DB08871,Myelosuppressive Agents,DrugBank
DB08871,Narrow Therapeutic Index Drugs,DrugBank
DB08871,Polyketides,DrugBank
DB08871,Potential QTc-Prolonging Agents,DrugBank
DB08871,QTc Prolonging Agents,DrugBank
DB08872,"Acids, Acyclic",DrugBank
DB08872,Amino Acids,DrugBank
DB08872,"Amino Acids, Peptides, and Proteins",DrugBank
DB08872,Aminobutyrates,DrugBank
DB08872,Anti-epileptic Agent,DrugBank
DB08872,Butyrates,DrugBank
DB08872,Central Nervous System Depressants,DrugBank
DB08872,Drugs that are Mainly Renally Excreted,DrugBank
DB08872,Gabapentin and Prodrugs,DrugBank
DB08873,Amino Acids,DrugBank
DB08873,"Amino Acids, Cyclic",DrugBank
DB08873,"Amino Acids, Peptides, and Proteins",DrugBank
DB08873,Antiinfectives for Systemic Use,DrugBank
DB08873,Antiviral Agents,DrugBank
DB08873,Antivirals for Systemic Use,DrugBank
DB08873,Antivirals for treatment of HCV infections,DrugBank
DB08873,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08873,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08873,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08873,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB08873,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08873,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB08873,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB08873,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08873,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08873,Cytochrome P-450 Substrates,DrugBank
DB08873,Direct Acting Antivirals,DrugBank
DB08873,Enzyme Inhibitors,DrugBank
DB08873,HCV NS3/4A Protease Inhibitors,DrugBank
DB08873,Imino Acids,DrugBank
DB08873,NS3/4A Protease Inhibitors,DrugBank
DB08873,P-glycoprotein inhibitors,DrugBank
DB08873,Protease Inhibitors,DrugBank
DB08874,Alimentary Tract and Metabolism,DrugBank
DB08874,Anti-Bacterial Agents,DrugBank
DB08874,Anti-Infective Agents,DrugBank
DB08874,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB08874,Carbohydrates,DrugBank
DB08874,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08874,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08874,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08874,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08874,Intestinal Antiinfectives,DrugBank
DB08874,Lactones,DrugBank
DB08874,Macrolide Antibacterial,DrugBank
DB08874,Macrolides,DrugBank
DB08874,Other Macrolides,DrugBank
DB08874,P-glycoprotein substrates,DrugBank
DB08874,Polyketides,DrugBank
DB08875,Amides,DrugBank
DB08875,Amines,DrugBank
DB08875,Aniline Compounds,DrugBank
DB08875,Antineoplastic Agents,DrugBank
DB08875,Antineoplastic and Immunomodulating Agents,DrugBank
DB08875,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08875,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB08875,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08875,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB08875,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08875,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08875,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08875,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08875,Cytochrome P-450 Substrates,DrugBank
DB08875,Kinase Inhibitor,DrugBank
DB08875,Narrow Therapeutic Index Drugs,DrugBank
DB08875,Protein Kinase Inhibitors,DrugBank
DB08875,"Receptor Protein-Tyrosine Kinases, antagonists & inhibitors",DrugBank
DB08875,Tyrosine Kinase Inhibitors,DrugBank
DB08877,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB08877,Antineoplastic Agents,DrugBank
DB08877,Antineoplastic and Immunomodulating Agents,DrugBank
DB08877,Cancer immunotherapy,DrugBank
DB08877,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08877,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB08877,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08877,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08877,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08877,Cytochrome P-450 Substrates,DrugBank
DB08877,Dermatologicals,DrugBank
DB08877,Drugs that are Mainly Renally Excreted,DrugBank
DB08877,Immunosuppressive Agents,DrugBank
DB08877,Immunotherapy,DrugBank
DB08877,Janus Kinase Inhibitor,DrugBank
DB08877,"Janus Kinases, antagonists & inhibitors",DrugBank
DB08877,Kinase Inhibitor,DrugBank
DB08877,Myelosuppressive Agents,DrugBank
DB08877,Narrow Therapeutic Index Drugs,DrugBank
DB08877,Protein Kinase Inhibitors,DrugBank
DB08877,Tyrosine Kinase Inhibitors,DrugBank
DB08879,"Amino Acids, Peptides, and Proteins",DrugBank
DB08879,Antibodies,DrugBank
DB08879,"Antibodies, Monoclonal",DrugBank
DB08879,Antineoplastic and Immunomodulating Agents,DrugBank
DB08879,B Lymphocyte Stimulator-directed Antibody Interactions,DrugBank
DB08879,B Lymphocyte Stimulator-specific Inhibitor,DrugBank
DB08879,Blood Proteins,DrugBank
DB08879,Decreased B Lymphocyte Activation,DrugBank
DB08879,Globulins,DrugBank
DB08879,Immunoglobulins,DrugBank
DB08879,Immunologic Factors,DrugBank
DB08879,Immunoproteins,DrugBank
DB08879,Immunosuppressive Agents,DrugBank
DB08879,Proteins,DrugBank
DB08879,Selective Immunosuppressants,DrugBank
DB08879,Serum Globulins,DrugBank
DB08880,"Acids, Acyclic",DrugBank
DB08880,Amines,DrugBank
DB08880,Analgesics,DrugBank
DB08880,"Analgesics, Non-Narcotic",DrugBank
DB08880,Aniline Compounds,DrugBank
DB08880,Anti-Inflammatory Agents,DrugBank
DB08880,Antineoplastic and Immunomodulating Agents,DrugBank
DB08880,Antirheumatic Agents,DrugBank
DB08880,BCRP/ABCG2 Inhibitors,DrugBank
DB08880,BCRP/ABCG2 Substrates,DrugBank
DB08880,Benzene Derivatives,DrugBank
DB08880,Butyrates,DrugBank
DB08880,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB08880,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB08880,Cytochrome P-450 CYP1A2 Inducers (weak),DrugBank
DB08880,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08880,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB08880,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08880,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08880,Dihydroorotate dehydrogenase (DHODH) inhibitors,DrugBank
DB08880,Dihydroorotate Dehydrogenase Inhibitors,DrugBank
DB08880,Fatty Acids,DrugBank
DB08880,"Fatty Acids, Volatile",DrugBank
DB08880,Hepatotoxic Agents,DrugBank
DB08880,Hydroxy Acids,DrugBank
DB08880,Immunologic Factors,DrugBank
DB08880,Immunomodulatory Agents,DrugBank
DB08880,Immunosuppressive Agents,DrugBank
DB08880,Lipids,DrugBank
DB08880,OAT3/SLC22A8 Inhibitors,DrugBank
DB08880,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08880,Peripheral Nervous System Agents,DrugBank
DB08880,Pyrimidine Synthesis Inhibitor,DrugBank
DB08880,Selective Immunosuppressants,DrugBank
DB08880,Sensory System Agents,DrugBank
DB08881,Amides,DrugBank
DB08881,Antineoplastic Agents,DrugBank
DB08881,Antineoplastic and Immunomodulating Agents,DrugBank
DB08881,B-Raf serine-threonine kinase (BRAF) inhibitors,DrugBank
DB08881,BCRP/ABCG2 Inhibitors,DrugBank
DB08881,BCRP/ABCG2 Substrates,DrugBank
DB08881,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB08881,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB08881,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB08881,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB08881,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08881,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB08881,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08881,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08881,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB08881,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB08881,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08881,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08881,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08881,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08881,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08881,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08881,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08881,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08881,Cytochrome P-450 Substrates,DrugBank
DB08881,Drugs causing inadvertant photosensitivity,DrugBank
DB08881,Enzyme Inhibitors,DrugBank
DB08881,Genito Urinary System and Sex Hormones,DrugBank
DB08881,Gynecological Antiinfectives and Antiseptics,DrugBank
DB08881,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08881,Highest Risk QTc-Prolonging Agents,DrugBank
DB08881,Indoles,DrugBank
DB08881,Kinase Inhibitor,DrugBank
DB08881,Narrow Therapeutic Index Drugs,DrugBank
DB08881,P-glycoprotein inhibitors,DrugBank
DB08881,P-glycoprotein substrates,DrugBank
DB08881,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08881,Photosensitizing Agents,DrugBank
DB08881,Protein Kinase Inhibitors,DrugBank
DB08881,QTc Prolonging Agents,DrugBank
DB08881,Sulfonamides,DrugBank
DB08881,Sulfones,DrugBank
DB08881,Sulfur Compounds,DrugBank
DB08881,Tyrosine Kinase Inhibitors,DrugBank
DB08882,Agents causing angioedema,DrugBank
DB08882,Alimentary Tract and Metabolism,DrugBank
DB08882,Blood Glucose Lowering Agents,DrugBank
DB08882,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08882,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08882,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08882,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB08882,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08882,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB08882,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08882,Cytochrome P-450 Substrates,DrugBank
DB08882,DPP-IV Inhibitors,DrugBank
DB08882,Drugs Used in Diabetes,DrugBank
DB08882,Enzyme Inhibitors,DrugBank
DB08882,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08882,Hormones,DrugBank
DB08882,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08882,Incretins,DrugBank
DB08882,OCT1 inhibitors,DrugBank
DB08882,OCT2 Inhibitors,DrugBank
DB08882,OCT2 Substrates,DrugBank
DB08882,Oral Hypoglycemics,DrugBank
DB08882,P-glycoprotein inhibitors,DrugBank
DB08882,P-glycoprotein substrates,DrugBank
DB08882,Protease Inhibitors,DrugBank
DB08882,Purines,DrugBank
DB08882,Quinazolines,DrugBank
DB08883,AMPA Receptor Antagonists,DrugBank
DB08883,Anticonvulsants,DrugBank
DB08883,Central Nervous System Depressants,DrugBank
DB08883,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB08883,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB08883,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB08883,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB08883,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08883,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08883,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08883,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08883,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08883,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08883,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08883,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08883,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08883,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08883,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08883,Cytochrome P-450 Substrates,DrugBank
DB08883,Miscellaneous Anticonvulsants,DrugBank
DB08883,Nervous System,DrugBank
DB08883,Noncompetitive AMPA Glutamate Receptor Antagonist,DrugBank
DB08883,Pyridines,DrugBank
DB08883,"Receptors, AMPA, antagonists & inhibitors",DrugBank
DB08883,UGT1A9 Inhibitors,DrugBank
DB08883,UGT2B7 Inhibitors,DrugBank
DB08884,Acetates,DrugBank
DB08884,"Acids, Acyclic",DrugBank
DB08884,Amines,DrugBank
DB08884,"Compounds used in a research, industrial, or household setting",DrugBank
DB08884,Contrast Media,DrugBank
DB08884,Coordination Complexes,DrugBank
DB08884,Diagnostic Uses of Chemicals,DrugBank
DB08884,Gadolinium-based Contrast Agent,DrugBank
DB08884,Magnetic Resonance Contrast Activity,DrugBank
DB08884,Magnetic Resonance Imaging Contrast Media,DrugBank
DB08884,OATP1B1/SLCO1B1 Substrates,DrugBank
DB08884,OATP1B3 substrates,DrugBank
DB08884,Other Diagnostics,DrugBank
DB08884,Paramagnetic Contrast Agent,DrugBank
DB08884,Paramagnetic Contrast Media,DrugBank
DB08884,Polyamines,DrugBank
DB08886,Amidohydrolases,DrugBank
DB08886,Antineoplastic Agents,DrugBank
DB08886,Asparaginase,DrugBank
DB08886,Asparagine-specific Enzyme,DrugBank
DB08886,Enzymes,DrugBank
DB08886,Enzymes and Coenzymes,DrugBank
DB08886,Hepatotoxic Agents,DrugBank
DB08886,Hydrolases,DrugBank
DB08886,Narrow Therapeutic Index Drugs,DrugBank
DB08886,Thyroxine-binding globulin inhibitors,DrugBank
DB08887,Antiplatelet agents,DrugBank
DB08887,Dietary Fats,DrugBank
DB08887,"Dietary Fats, Unsaturated",DrugBank
DB08887,Eicosanoids,DrugBank
DB08887,Fats,DrugBank
DB08887,Fatty Acids,DrugBank
DB08887,"Fatty Acids, Omega-3",DrugBank
DB08887,"Fatty Acids, Unsaturated",DrugBank
DB08887,Fish Oils,DrugBank
DB08887,Hematologic Agents,DrugBank
DB08887,Hypolipidemic Agents,DrugBank
DB08887,Lipid Regulating Agents,DrugBank
DB08887,Lipids,DrugBank
DB08887,Miscellaneous Antilipemic Agents,DrugBank
DB08887,Oils,DrugBank
DB08889,"Amino Acids, Peptides, and Proteins",DrugBank
DB08889,Antineoplastic Agents,DrugBank
DB08889,Antineoplastic and Immunomodulating Agents,DrugBank
DB08889,Immunosuppressive Agents,DrugBank
DB08889,Myelosuppressive Agents,DrugBank
DB08889,Narrow Therapeutic Index Drugs,DrugBank
DB08889,P-glycoprotein inhibitors,DrugBank
DB08889,P-glycoprotein substrates,DrugBank
DB08889,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08889,Peptides,DrugBank
DB08889,Proteasome Inhibitors,DrugBank
DB08890,Alimentary Tract and Metabolism,DrugBank
DB08890,"Amino Acids, Peptides, and Proteins",DrugBank
DB08890,Drugs for Constipation,DrugBank
DB08890,Enzyme Activators,DrugBank
DB08890,Gastrointestinal Agents,DrugBank
DB08890,Guanylate Cyclase Activators,DrugBank
DB08890,Guanylate Cyclase-C Agonist,DrugBank
DB08890,Guanylyl Cyclase C Agonists,DrugBank
DB08890,Laxatives,DrugBank
DB08890,Miscellaneous GI Drugs,DrugBank
DB08892,"Acids, Acyclic",DrugBank
DB08892,Aminobutyrates,DrugBank
DB08892,Butyrates,DrugBank
DB08892,Central Nervous System Agents,DrugBank
DB08892,Central Nervous System Depressants,DrugBank
DB08892,GABA Agents,DrugBank
DB08892,GABA Agonists,DrugBank
DB08892,GABA-B Receptor Agonists,DrugBank
DB08892,Muscle Relaxants,DrugBank
DB08892,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB08892,Neuromuscular Agents,DrugBank
DB08892,Neurotransmitter Agents,DrugBank
DB08892,Peripheral Nervous System Agents,DrugBank
DB08893,Adrenergic Agents,DrugBank
DB08893,Adrenergic Agonists,DrugBank
DB08893,Adrenergic beta-3 Receptor Agonists,DrugBank
DB08893,Adrenergic beta-Agonists,DrugBank
DB08893,Agents producing tachycardia,DrugBank
DB08893,Agents that produce hypertension,DrugBank
DB08893,Amides,DrugBank
DB08893,Amines,DrugBank
DB08893,Anilides,DrugBank
DB08893,Aniline Compounds,DrugBank
DB08893,Cholinesterase substrates,DrugBank
DB08893,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB08893,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB08893,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08893,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08893,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08893,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08893,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08893,Cytochrome P-450 Substrates,DrugBank
DB08893,Drugs for Urinary Frequency and Incontinence,DrugBank
DB08893,Drugs that are Mainly Renally Excreted,DrugBank
DB08893,Genito Urinary System and Sex Hormones,DrugBank
DB08893,Genitourinary Agents,DrugBank
DB08893,OCT1 substrates,DrugBank
DB08893,OCT2 Substrates,DrugBank
DB08893,P-glycoprotein inhibitors,DrugBank
DB08893,P-glycoprotein substrates,DrugBank
DB08893,Potential QTc-Prolonging Agents,DrugBank
DB08893,QTc Prolonging Agents,DrugBank
DB08893,Selective Beta 3-adrenergic Agonists,DrugBank
DB08893,Sulfur Compounds,DrugBank
DB08893,UGT1A3 substrates,DrugBank
DB08893,UGT2B7 substrates,DrugBank
DB08893,Urological Agents,DrugBank
DB08893,Urologicals,DrugBank
DB08894,Alcohols,DrugBank
DB08894,"Amino Acids, Peptides, and Proteins",DrugBank
DB08894,Antianemic Preparations,DrugBank
DB08894,Blood and Blood Forming Organs,DrugBank
DB08894,"Compounds used in a research, industrial, or household setting",DrugBank
DB08894,Drugs that are Mainly Renally Excreted,DrugBank
DB08894,Erythropoiesis-Stimulating Agents,DrugBank
DB08894,Ethylene Glycols,DrugBank
DB08894,Glycols,DrugBank
DB08894,Increased Erythroid Cell Production,DrugBank
DB08894,Macromolecular Substances,DrugBank
DB08894,Pegylated agents,DrugBank
DB08894,Polymers,DrugBank
DB08895,Antineoplastic and Immunomodulating Agents,DrugBank
DB08895,Antirheumatic Agents,DrugBank
DB08895,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB08895,Bradycardia-Causing Agents,DrugBank
DB08895,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08895,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08895,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08895,Cytochrome P-450 Substrates,DrugBank
DB08895,Disease-modifying Antirheumatic Agents,DrugBank
DB08895,Enzyme Inhibitors,DrugBank
DB08895,Immunosuppressive Agents,DrugBank
DB08895,Janus Kinase Inhibitor,DrugBank
DB08895,Janus Kinase Inhibitors,DrugBank
DB08895,"Janus Kinases, antagonists & inhibitors",DrugBank
DB08895,Myelosuppressive Agents,DrugBank
DB08895,Protein Kinase Inhibitors,DrugBank
DB08895,Selective Immunosuppressants,DrugBank
DB08896,Amides,DrugBank
DB08896,Antineoplastic Agents,DrugBank
DB08896,Antineoplastic and Immunomodulating Agents,DrugBank
DB08896,BCRP/ABCG2 Inhibitors,DrugBank
DB08896,Benzene Derivatives,DrugBank
DB08896,Bradycardia-Causing Agents,DrugBank
DB08896,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB08896,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB08896,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB08896,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08896,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08896,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08896,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08896,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08896,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08896,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08896,Cytochrome P-450 Substrates,DrugBank
DB08896,Hepatotoxic Agents,DrugBank
DB08896,Kinase Inhibitor,DrugBank
DB08896,Narrow Therapeutic Index Drugs,DrugBank
DB08896,P-glycoprotein inhibitors,DrugBank
DB08896,P-glycoprotein substrates,DrugBank
DB08896,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08896,Protein Kinase Inhibitors,DrugBank
DB08896,Tyrosine Kinase Inhibitors,DrugBank
DB08896,UGT1A1 Inhibitors,DrugBank
DB08896,UGT1A9 Inhibitors,DrugBank
DB08896,UGT1A9 Substrates,DrugBank
DB08896,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB08897,"Adrenergics, Inhalants",DrugBank
DB08897,Agents producing tachycardia,DrugBank
DB08897,Agents to Treat Airway Disease,DrugBank
DB08897,Alkaloids,DrugBank
DB08897,Anticholinergic Agents,DrugBank
DB08897,Antimuscarinics Antispasmodics,DrugBank
DB08897,Aza Compounds,DrugBank
DB08897,Azabicyclo Compounds,DrugBank
DB08897,Cholinesterase substrates,DrugBank
DB08897,Drugs for Obstructive Airway Diseases,DrugBank
DB08897,Drugs that are Mainly Renally Excreted,DrugBank
DB08897,Muscarinic Antagonists,DrugBank
DB08899,Amides,DrugBank
DB08899,Androgen Receptor Antagonists,DrugBank
DB08899,Androgen Receptor Inhibitors,DrugBank
DB08899,Antiandrogens,DrugBank
DB08899,"Antiandrogens, non-steroidal",DrugBank
DB08899,Antineoplastic Agents,DrugBank
DB08899,Antineoplastic and Immunomodulating Agents,DrugBank
DB08899,Benzene Derivatives,DrugBank
DB08899,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB08899,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB08899,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB08899,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB08899,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08899,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB08899,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08899,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB08899,Cytochrome P-450 CYP2C9 Inducers (moderate),DrugBank
DB08899,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08899,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08899,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB08899,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08899,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08899,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB08899,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08899,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB08899,Cytochrome P-450 CYP3A5 Inducers (strong),DrugBank
DB08899,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08899,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08899,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08899,Cytochrome P-450 Substrates,DrugBank
DB08899,Drugs that are Mainly Renally Excreted,DrugBank
DB08899,Endocrine Therapy,DrugBank
DB08899,Hormone Antagonists and Related Agents,DrugBank
DB08899,Hydantoins,DrugBank
DB08899,Imidazoles,DrugBank
DB08899,Imidazolidines,DrugBank
DB08899,P-glycoprotein inhibitors,DrugBank
DB08899,Thyroxine-binding globulin substrates,DrugBank
DB08900,Alimentary Tract and Metabolism,DrugBank
DB08900,"Amino Acids, Peptides, and Proteins",DrugBank
DB08900,Analogs/Derivatives,DrugBank
DB08900,"Compounds used in a research, industrial, or household setting",DrugBank
DB08900,Drugs that are Mainly Renally Excreted,DrugBank
DB08900,Gastrointestinal Agents,DrugBank
DB08900,Gastrointestinal Hormones,DrugBank
DB08900,GLP-2 Analog,DrugBank
DB08900,Glucagon-Like Peptide 2,DrugBank
DB08900,Glucagon-like Peptide-2 (GLP-2) Agonists,DrugBank
DB08900,Glucagon-Like Peptides,DrugBank
DB08900,Hormones,DrugBank
DB08900,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08900,Miscellaneous GI Drugs,DrugBank
DB08900,Proglucagon,DrugBank
DB08900,Protective Agents,DrugBank
DB08900,Radiation-Protective Agents,DrugBank
DB08900,Various Alimentary Tract and Metabolism Products,DrugBank
DB08901,Antineoplastic Agents,DrugBank
DB08901,Antineoplastic and Immunomodulating Agents,DrugBank
DB08901,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB08901,BCRP/ABCG2 Inhibitors,DrugBank
DB08901,BCRP/ABCG2 Substrates,DrugBank
DB08901,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08901,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB08901,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08901,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB08901,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08901,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08901,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08901,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08901,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB08901,Cytochrome P-450 Substrates,DrugBank
DB08901,Enzyme Inhibitors,DrugBank
DB08901,Hepatotoxic Agents,DrugBank
DB08901,Immunosuppressive Agents,DrugBank
DB08901,Kinase Inhibitor,DrugBank
DB08901,Myelosuppressive Agents,DrugBank
DB08901,Narrow Therapeutic Index Drugs,DrugBank
DB08901,P-glycoprotein inhibitors,DrugBank
DB08901,P-glycoprotein substrates,DrugBank
DB08901,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08901,Protein Kinase Inhibitors,DrugBank
DB08901,Tyrosine Kinase Inhibitors,DrugBank
DB08902,"Amino Acids, Peptides, and Proteins",DrugBank
DB08902,Anthrax Protective Antigen-directed Antibody,DrugBank
DB08902,Anthrax Protective Antigen-directed Antibody Interactions,DrugBank
DB08902,Antibacterial monoclonal antibodies,DrugBank
DB08902,Antibodies,DrugBank
DB08902,"Antibodies, Monoclonal",DrugBank
DB08902,Antiinfectives for Systemic Use,DrugBank
DB08902,Blood Proteins,DrugBank
DB08902,Globulins,DrugBank
DB08902,Immune Sera and Immunoglobulins,DrugBank
DB08902,Immunoglobulins,DrugBank
DB08902,Immunoproteins,DrugBank
DB08902,Proteins,DrugBank
DB08902,Serum Globulins,DrugBank
DB08902,Specific Immunoglobulins,DrugBank
DB08903,Anti-Bacterial Agents,DrugBank
DB08903,Anti-Infective Agents,DrugBank
DB08903,Antiinfectives for Systemic Use,DrugBank
DB08903,Antimycobacterials,DrugBank
DB08903,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08903,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08903,Cytochrome P-450 Substrates,DrugBank
DB08903,Diarylquinoline Antimycobacterial,DrugBank
DB08903,Drugs for Treatment of Tuberculosis,DrugBank
DB08903,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08903,Moderate Risk QTc-Prolonging Agents,DrugBank
DB08903,QTc Prolonging Agents,DrugBank
DB08903,Quinolines,DrugBank
DB08904,Agents reducing cytokine levels,DrugBank
DB08904,Alcohols,DrugBank
DB08904,"Amino Acids, Peptides, and Proteins",DrugBank
DB08904,Anti-Inflammatory Agents,DrugBank
DB08904,Antibodies,DrugBank
DB08904,"Antibodies, Monoclonal",DrugBank
DB08904,"Antibodies, Monoclonal, Humanized",DrugBank
DB08904,Antineoplastic and Immunomodulating Agents,DrugBank
DB08904,Antirheumatic Agents,DrugBank
DB08904,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB08904,Blood Proteins,DrugBank
DB08904,Disease-modifying Antirheumatic Agents,DrugBank
DB08904,Drugs that are Mainly Renally Excreted,DrugBank
DB08904,Ethylene Glycols,DrugBank
DB08904,Globulins,DrugBank
DB08904,Glycols,DrugBank
DB08904,Immunoglobulin Fab Fragments,DrugBank
DB08904,Immunoglobulin Fragments,DrugBank
DB08904,Immunoglobulins,DrugBank
DB08904,Immunologic Factors,DrugBank
DB08904,Immunoproteins,DrugBank
DB08904,Immunosuppressive Agents,DrugBank
DB08904,Immunotherapy,DrugBank
DB08904,Macromolecular Substances,DrugBank
DB08904,Pegylated agents,DrugBank
DB08904,Peptide Fragments,DrugBank
DB08904,Peptides,DrugBank
DB08904,Polyethylene Glycols,DrugBank
DB08904,Polymers,DrugBank
DB08904,Proteins,DrugBank
DB08904,Serum Globulins,DrugBank
DB08904,Tumor necrosis factor alpha (TNF-alpha) inhibitors,DrugBank
DB08904,Tumor Necrosis Factor Blockers,DrugBank
DB08904,Tumor Necrosis Factor Receptor Blocking Activity,DrugBank
DB08905,17-Ketosteroids,DrugBank
DB08905,Adrenal Cortex Hormones,DrugBank
DB08905,Androstanes,DrugBank
DB08905,Androstenes,DrugBank
DB08905,Antineoplastic Agents,DrugBank
DB08905,Antineoplastic and Immunomodulating Agents,DrugBank
DB08905,Aromatase Inhibitors,DrugBank
DB08905,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08905,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08905,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08905,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08905,Drugs that are Mainly Renally Excreted,DrugBank
DB08905,Endocrine Therapy,DrugBank
DB08905,Enzyme Inhibitors,DrugBank
DB08905,Estrogen Antagonists,DrugBank
DB08905,Fused-Ring Compounds,DrugBank
DB08905,Gonadal Hormones,DrugBank
DB08905,Gonadal Steroid Hormones,DrugBank
DB08905,Hormone Antagonists,DrugBank
DB08905,Hormone Antagonists and Related Agents,DrugBank
DB08905,Hormones,DrugBank
DB08905,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08905,Ketosteroids,DrugBank
DB08905,Steroid Synthesis Inhibitors,DrugBank
DB08905,Steroids,DrugBank
DB08905,Testosterone Congeners,DrugBank
DB08906,Adrenal Cortex Hormones,DrugBank
DB08906,Agents to Treat Airway Disease,DrugBank
DB08906,Androstanes,DrugBank
DB08906,Androstenes,DrugBank
DB08906,Corticosteroids,DrugBank
DB08906,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08906,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB08906,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08906,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08906,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08906,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08906,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08906,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08906,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08906,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08906,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB08906,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB08906,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB08906,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB08906,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB08906,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB08906,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08906,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08906,Cytochrome P-450 Substrates,DrugBank
DB08906,Drugs for Obstructive Airway Diseases,DrugBank
DB08906,Fused-Ring Compounds,DrugBank
DB08906,Glucocorticoids,DrugBank
DB08906,Hyperglycemia-Associated Agents,DrugBank
DB08906,Immunosuppressive Agents,DrugBank
DB08906,Nasal Preparations,DrugBank
DB08906,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08906,P-glycoprotein inducers,DrugBank
DB08906,P-glycoprotein substrates,DrugBank
DB08906,Steroids,DrugBank
DB08906,Thyroxine-binding globulin inhibitors,DrugBank
DB08907,Agents causing hyperkalemia,DrugBank
DB08907,Alimentary Tract and Metabolism,DrugBank
DB08907,Blood Glucose Lowering Agents,DrugBank
DB08907,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08907,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08907,Cytochrome P-450 Substrates,DrugBank
DB08907,Diuretics,DrugBank
DB08907,Drugs that are Mainly Renally Excreted,DrugBank
DB08907,Drugs Used in Diabetes,DrugBank
DB08907,Glucosides,DrugBank
DB08907,Hypotensive Agents,DrugBank
DB08907,Oral Hypoglycemics,DrugBank
DB08907,P-glycoprotein inhibitors,DrugBank
DB08907,P-glycoprotein substrates,DrugBank
DB08907,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB08907,Sulfur Compounds,DrugBank
DB08907,Thiophenes,DrugBank
DB08907,UGT1A9 Substrates,DrugBank
DB08908,"Acids, Acyclic",DrugBank
DB08908,Anti-Inflammatory Agents,DrugBank
DB08908,Antineoplastic and Immunomodulating Agents,DrugBank
DB08908,Cytoprotective Agent,DrugBank
DB08908,Dermatologicals,DrugBank
DB08908,Dicarboxylic Acids,DrugBank
DB08908,Fumarates,DrugBank
DB08908,Immunologic Factors,DrugBank
DB08908,Immunomodulatory Agents,DrugBank
DB08908,Immunosuppressive Agents,DrugBank
DB08908,Miscellaneous Central Nervous System Agents,DrugBank
DB08908,Radiation-Sensitizing Agents,DrugBank
DB08909,"Acids, Carbocyclic",DrugBank
DB08909,Alcohols,DrugBank
DB08909,Alimentary Tract and Metabolism,DrugBank
DB08909,Carbohydrates,DrugBank
DB08909,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB08909,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB08909,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08909,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08909,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB08909,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08909,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08909,Drugs that are Mainly Renally Excreted,DrugBank
DB08909,Nitrogen Binding Agent,DrugBank
DB08909,Sugar Alcohols,DrugBank
DB08909,Triose Sugar Alcohols,DrugBank
DB08909,Urea Cycle Disorder Agents,DrugBank
DB08909,Various Alimentary Tract and Metabolism Products,DrugBank
DB08910,"Acids, Carbocyclic",DrugBank
DB08910,Angiogenesis Inhibitors,DrugBank
DB08910,Angiogenesis Modulating Agents,DrugBank
DB08910,Antineoplastic Agents,DrugBank
DB08910,Antineoplastic and Immunomodulating Agents,DrugBank
DB08910,Cancer immunotherapy,DrugBank
DB08910,Central Nervous System Depressants,DrugBank
DB08910,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB08910,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB08910,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08910,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08910,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08910,Cytochrome P-450 Substrates,DrugBank
DB08910,Drugs that are Mainly Renally Excreted,DrugBank
DB08910,Growth Inhibitors,DrugBank
DB08910,Growth Substances,DrugBank
DB08910,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08910,Imides,DrugBank
DB08910,Immunologic Factors,DrugBank
DB08910,Immunosuppressive Agents,DrugBank
DB08910,Immunotherapy,DrugBank
DB08910,Isoindoles,DrugBank
DB08910,Myelosuppressive Agents,DrugBank
DB08910,Narrow Therapeutic Index Drugs,DrugBank
DB08910,P-glycoprotein substrates,DrugBank
DB08910,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08910,Phthalic Acids,DrugBank
DB08910,Phthalimides,DrugBank
DB08910,Piperidines,DrugBank
DB08910,Piperidones,DrugBank
DB08910,Thalidomide Analog,DrugBank
DB08910,Tumor Necrosis Factor Blockers,DrugBank
DB08911,Antineoplastic Agents,DrugBank
DB08911,Antineoplastic and Immunomodulating Agents,DrugBank
DB08911,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08911,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB08911,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08911,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08911,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08911,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08911,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08911,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08911,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08911,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08911,Cytochrome P-450 Substrates,DrugBank
DB08911,Drugs that are Mainly Renally Excreted,DrugBank
DB08911,Enzyme Inhibitors,DrugBank
DB08911,Kinase Inhibitor,DrugBank
DB08911,"MAP Kinase Kinase 1, antagonists & inhibitors",DrugBank
DB08911,"MAP Kinase Kinase 2, antagonists & inhibitors",DrugBank
DB08911,Mitogen-activated protein kinase (MEK) inhibitors,DrugBank
DB08911,Narrow Therapeutic Index Drugs,DrugBank
DB08911,Protein Kinase Inhibitors,DrugBank
DB08911,Pyridines,DrugBank
DB08911,Pyrimidines,DrugBank
DB08912,Amines,DrugBank
DB08912,Antineoplastic Agents,DrugBank
DB08912,Antineoplastic and Immunomodulating Agents,DrugBank
DB08912,B-Raf serine-threonine kinase (BRAF) inhibitors,DrugBank
DB08912,BCRP/ABCG2 Inhibitors,DrugBank
DB08912,BCRP/ABCG2 Substrates,DrugBank
DB08912,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB08912,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB08912,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08912,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB08912,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB08912,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB08912,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB08912,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08912,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB08912,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB08912,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2C9 Inducers (strong),DrugBank
DB08912,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08912,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB08912,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08912,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08912,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08912,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08912,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08912,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08912,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB08912,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08912,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08912,Cytochrome P-450 Substrates,DrugBank
DB08912,Drugs causing inadvertant photosensitivity,DrugBank
DB08912,Enzyme Inhibitors,DrugBank
DB08912,Hydroxylamines,DrugBank
DB08912,Hyperglycemia-Associated Agents,DrugBank
DB08912,Kinase Inhibitor,DrugBank
DB08912,Narrow Therapeutic Index Drugs,DrugBank
DB08912,OAT1/SLC22A6 inhibitors,DrugBank
DB08912,OAT3/SLC22A8 Inhibitors,DrugBank
DB08912,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08912,OATP1B1/SLCO1B1 Substrates,DrugBank
DB08912,OATP1B3 inhibitors,DrugBank
DB08912,OATP1B3 substrates,DrugBank
DB08912,OCT2 Inhibitors,DrugBank
DB08912,Organic Anion Transporter 1 Inhibitors,DrugBank
DB08912,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB08912,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB08912,P-glycoprotein substrates,DrugBank
DB08912,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB08912,Photosensitizing Agents,DrugBank
DB08912,Potential QTc-Prolonging Agents,DrugBank
DB08912,Protein Kinase Inhibitors,DrugBank
DB08912,"Proto-Oncogene Proteins B-raf, antagonists & inhibitors",DrugBank
DB08912,QTc Prolonging Agents,DrugBank
DB08912,UGT1A1 Inhibitors,DrugBank
DB08913,Antineoplastic Agents,DrugBank
DB08913,Elements,DrugBank
DB08913,"Elements, Radioactive",DrugBank
DB08913,Isotopes,DrugBank
DB08913,Metals,DrugBank
DB08913,"Metals, Alkaline Earth",DrugBank
DB08913,"Metals, Heavy",DrugBank
DB08913,Radioactive alpha-Particle Emitting Therapeutic Agent,DrugBank
DB08913,Radioisotopes,DrugBank
DB08916,Amides,DrugBank
DB08916,Antineoplastic Agents,DrugBank
DB08916,Antineoplastic and Immunomodulating Agents,DrugBank
DB08916,BCRP/ABCG2 Inhibitors,DrugBank
DB08916,BCRP/ABCG2 Substrates,DrugBank
DB08916,Enzyme Inhibitors,DrugBank
DB08916,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB08916,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08916,Kinase Inhibitor,DrugBank
DB08916,P-glycoprotein inhibitors,DrugBank
DB08916,P-glycoprotein substrates,DrugBank
DB08916,Protein Kinase Inhibitors,DrugBank
DB08916,Quinazolines,DrugBank
DB08916,Tyrosine Kinase Inhibitors,DrugBank
DB08917,Carbohydrates,DrugBank
DB08917,"Compounds used in a research, industrial, or household setting",DrugBank
DB08917,Disaccharides,DrugBank
DB08917,Glucans,DrugBank
DB08917,Iron Compounds,DrugBank
DB08917,Oligosaccharides,DrugBank
DB08917,Parenteral Iron Replacement,DrugBank
DB08917,Polysaccharides,DrugBank
DB08918,Adrenergic Uptake Inhibitors,DrugBank
DB08918,Agents producing tachycardia,DrugBank
DB08918,Antidepressive Agents,DrugBank
DB08918,Antidepressive Agents Indicated for Depression,DrugBank
DB08918,Central Nervous System Agents,DrugBank
DB08918,Central Nervous System Depressants,DrugBank
DB08918,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB08918,Cycloparaffins,DrugBank
DB08918,Cyclopropanes,DrugBank
DB08918,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08918,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08918,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08918,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08918,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08918,Cytochrome P-450 Substrates,DrugBank
DB08918,Drugs that are Mainly Renally Excreted,DrugBank
DB08918,Hypoglycemia-Associated Agents,DrugBank
DB08918,Membrane Transport Modulators,DrugBank
DB08918,Miscellaneous Antidepressants,DrugBank
DB08918,Nervous System,DrugBank
DB08918,Neurotransmitter Agents,DrugBank
DB08918,Neurotransmitter Uptake Inhibitors,DrugBank
DB08918,Norepinephrine Uptake Inhibitors,DrugBank
DB08918,P-glycoprotein substrates,DrugBank
DB08918,Psychoanaleptics,DrugBank
DB08918,Psychotropic Drugs,DrugBank
DB08918,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08918,Serotonin Agents,DrugBank
DB08918,Serotonin and Noradrenaline Reuptake Inhibitors,DrugBank
DB08918,Serotonin Modulators,DrugBank
DB08922,Antipsychotic Agents,DrugBank
DB08922,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB08922,Central Nervous System Agents,DrugBank
DB08922,Central Nervous System Depressants,DrugBank
DB08922,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB08922,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08922,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08922,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08922,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08922,Cytochrome P-450 Substrates,DrugBank
DB08922,Dopamine Antagonists,DrugBank
DB08922,Dopamine D2 Receptor Antagonists,DrugBank
DB08922,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08922,Neurotoxic agents,DrugBank
DB08922,Psychotropic Drugs,DrugBank
DB08922,Sulfur Compounds,DrugBank
DB08922,Tranquilizing Agents,DrugBank
DB08925,Adrenergic Agents,DrugBank
DB08925,Adrenergic Agonists,DrugBank
DB08925,Adrenergic alpha-Agonists,DrugBank
DB08925,Agents producing tachycardia,DrugBank
DB08925,Agents that produce hypertension,DrugBank
DB08925,Amines,DrugBank
DB08925,Hydroxy Acids,DrugBank
DB08925,Hydroxylamines,DrugBank
DB08925,Nervous System,DrugBank
DB08925,Neurotransmitter Agents,DrugBank
DB08925,Psychoanaleptics,DrugBank
DB08925,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB08925,Sympathomimetic-like Agent,DrugBank
DB08927,Antidepressive Agents,DrugBank
DB08927,Antipsychotic Agents,DrugBank
DB08927,Central Nervous System Agents,DrugBank
DB08927,Central Nervous System Depressants,DrugBank
DB08927,Neurotoxic agents,DrugBank
DB08927,Neurotransmitter Agents,DrugBank
DB08927,Psychotropic Drugs,DrugBank
DB08927,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB08927,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB08927,Serotonin Agents,DrugBank
DB08927,Serotonin Receptor Antagonists,DrugBank
DB08927,Tranquilizing Agents,DrugBank
DB08930,Anti-HIV Agents,DrugBank
DB08930,Anti-Infective Agents,DrugBank
DB08930,Anti-Retroviral Agents,DrugBank
DB08930,Antiinfectives for Systemic Use,DrugBank
DB08930,Antiviral Agents,DrugBank
DB08930,Antivirals for Systemic Use,DrugBank
DB08930,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB08930,BCRP/ABCG2 Substrates,DrugBank
DB08930,Direct Acting Antivirals,DrugBank
DB08930,Enzyme Inhibitors,DrugBank
DB08930,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08930,HIV Integrase Inhibitors,DrugBank
DB08930,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,DrugBank
DB08930,Integrase Inhibitors,DrugBank
DB08930,MATE 1 Inhibitors,DrugBank
DB08930,MATE inhibitors,DrugBank
DB08930,OAT1/SLC22A6 inhibitors,DrugBank
DB08930,OAT3/SLC22A8 Inhibitors,DrugBank
DB08930,OCT2 Inhibitors,DrugBank
DB08930,P-glycoprotein substrates,DrugBank
DB08930,UGT1A1 Substrates,DrugBank
DB08930,UGT1A3 substrates,DrugBank
DB08930,UGT1A9 Substrates,DrugBank
DB08931,Antihypertensive Agents,DrugBank
DB08931,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB08931,BCRP/ABCG2 Substrates,DrugBank
DB08931,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB08931,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08931,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08931,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08931,Cytochrome P-450 Substrates,DrugBank
DB08931,Enzyme Activators,DrugBank
DB08931,Guanylate Cyclase,DrugBank
DB08931,Guanylate Cyclase Stimulators,DrugBank
DB08931,Hypotensive Agents,DrugBank
DB08931,P-glycoprotein substrates,DrugBank
DB08931,Soluble Guanylate Cyclase Stimulator,DrugBank
DB08931,Vasodilating Agents,DrugBank
DB08932,Amides,DrugBank
DB08932,Antihypertensive Agents,DrugBank
DB08932,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB08932,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB08932,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB08932,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08932,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08932,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08932,Cytochrome P-450 Substrates,DrugBank
DB08932,Drugs that are Mainly Renally Excreted,DrugBank
DB08932,Endothelin A Receptor Antagonists,DrugBank
DB08932,Endothelin B Receptor Antagonists,DrugBank
DB08932,Endothelin Receptor Antagonists,DrugBank
DB08932,Sulfones,DrugBank
DB08932,Sulfur Compounds,DrugBank
DB08932,Vasodilating Agents,DrugBank
DB08933,Anti-Infective Agents,DrugBank
DB08933,Antifungal Agents,DrugBank
DB08933,Antifungals for Dermatological Use,DrugBank
DB08933,Antifungals for Topical Use,DrugBank
DB08933,Azole Antifungals,DrugBank
DB08933,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB08933,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB08933,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08933,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08933,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB08933,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08933,Dermatologicals,DrugBank
DB08933,Imidazole and Triazole Derivatives,DrugBank
DB08934,Anti-Infective Agents,DrugBank
DB08934,Antiinfectives for Systemic Use,DrugBank
DB08934,Antiviral Agents,DrugBank
DB08934,Antivirals for Systemic Use,DrugBank
DB08934,Antivirals for treatment of HCV infections,DrugBank
DB08934,BCRP/ABCG2 Substrates,DrugBank
DB08934,Direct Acting Antivirals,DrugBank
DB08934,Drugs that are Mainly Renally Excreted,DrugBank
DB08934,Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor,DrugBank
DB08934,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB08934,Nucleosides,DrugBank
DB08934,Nucleotides,DrugBank
DB08934,P-glycoprotein substrates,DrugBank
DB08934,Pyrimidine Nucleosides,DrugBank
DB08934,Pyrimidine Nucleotides,DrugBank
DB08934,Pyrimidines,DrugBank
DB08934,Ribonucleosides,DrugBank
DB08934,Ribonucleotides,DrugBank
DB08934,RNA Replicase Inhibitors,DrugBank
DB08934,Treatments for Hepatitis C,DrugBank
DB08934,Uracil Nucleotides,DrugBank
DB08935,"Amino Acids, Peptides, and Proteins",DrugBank
DB08935,Antibodies,DrugBank
DB08935,"Antibodies, Monoclonal",DrugBank
DB08935,"Antibodies, Monoclonal, Humanized",DrugBank
DB08935,"Antigens, CD20",DrugBank
DB08935,Antineoplastic Agents,DrugBank
DB08935,"Antineoplastic Agents, Immunological",DrugBank
DB08935,Antineoplastic and Immunomodulating Agents,DrugBank
DB08935,Blood Proteins,DrugBank
DB08935,Cancer immunotherapy,DrugBank
DB08935,CD20 (Clusters of Differentiation 20) inhibitors,DrugBank
DB08935,CD20-directed Antibody Interactions,DrugBank
DB08935,CD20-directed Cytolytic Antibody,DrugBank
DB08935,Globulins,DrugBank
DB08935,Hypotensive Agents,DrugBank
DB08935,Immunoglobulins,DrugBank
DB08935,Immunoproteins,DrugBank
DB08935,Immunosuppressive Agents,DrugBank
DB08935,Immunotherapy,DrugBank
DB08935,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB08935,Myelosuppressive Agents,DrugBank
DB08935,Proteins,DrugBank
DB08935,Serum Globulins,DrugBank
DB08936,Antihistamines for Systemic Use,DrugBank
DB08936,Histamine Antagonists,DrugBank
DB08936,Histamine H1 Antagonists,DrugBank
DB08936,Piperazine Derivatives,DrugBank
DB08936,Potential QTc-Prolonging Agents,DrugBank
DB08936,QTc Prolonging Agents,DrugBank
DB08938,Alimentary Tract and Metabolism,DrugBank
DB08938,Alkalies,DrugBank
DB08938,Aluminium Compounds,DrugBank
DB08938,Aluminum and magnesium containing antacids,DrugBank
DB08938,Anions,DrugBank
DB08938,Antacids,DrugBank
DB08938,Antacids With Antiflatulents,DrugBank
DB08938,Drugs for Acid Related Disorders,DrugBank
DB08938,Electrolytes,DrugBank
DB08938,Gastric Acid Lowering Agents,DrugBank
DB08938,Gastrointestinal Agents,DrugBank
DB08938,Hydroxides,DrugBank
DB08938,Ions,DrugBank
DB08938,Magnesium Compounds,DrugBank
DB08938,Metal cations,DrugBank
DB08938,Metal divalent cations,DrugBank
DB08940,Agents causing hyperkalemia,DrugBank
DB08940,Agents that produce hypertension,DrugBank
DB08940,Analgesics,DrugBank
DB08940,"Analgesics, Non-Narcotic",DrugBank
DB08940,Anti-Inflammatory Agents,DrugBank
DB08940,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08940,Antiinflammatory and Antirheumatic Products,DrugBank
DB08940,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB08940,Antirheumatic Agents,DrugBank
DB08940,Butylpyrazolidines,DrugBank
DB08940,Musculo-Skeletal System,DrugBank
DB08940,Nephrotoxic agents,DrugBank
DB08940,Non COX-2 selective NSAIDS,DrugBank
DB08940,Peripheral Nervous System Agents,DrugBank
DB08940,Pyrazoles,DrugBank
DB08940,Pyrazolones,DrugBank
DB08940,Sensory System Agents,DrugBank
DB08941,2-Amino-1-Phenylethanol Derivatives,DrugBank
DB08941,Adrenergic Agents,DrugBank
DB08941,Adrenergic Agonists,DrugBank
DB08941,Adrenergic beta-Agonists,DrugBank
DB08941,Agents producing tachycardia,DrugBank
DB08941,Agents that produce hypertension,DrugBank
DB08941,Alcohols,DrugBank
DB08941,Amines,DrugBank
DB08941,Amino Alcohols,DrugBank
DB08941,Autonomic Agents,DrugBank
DB08941,Cardiovascular Agents,DrugBank
DB08941,Ethylamines,DrugBank
DB08941,Hypotensive Agents,DrugBank
DB08941,Neurotransmitter Agents,DrugBank
DB08941,Peripheral Nervous System Agents,DrugBank
DB08941,Peripheral Vasodilators,DrugBank
DB08941,Phenethylamines,DrugBank
DB08941,Propanolamines,DrugBank
DB08941,Propanols,DrugBank
DB08941,Reproductive Control Agents,DrugBank
DB08941,Sympathomimetics,DrugBank
DB08941,Tocolytic Agents,DrugBank
DB08941,Vasodilating Agents,DrugBank
DB08942,Agents causing hyperkalemia,DrugBank
DB08942,Agents that produce hypertension,DrugBank
DB08942,Analgesics,DrugBank
DB08942,"Analgesics, Non-Narcotic",DrugBank
DB08942,Anti-Inflammatory Agents,DrugBank
DB08942,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08942,Antirheumatic Agents,DrugBank
DB08942,Nephrotoxic agents,DrugBank
DB08942,Non COX-2 selective NSAIDS,DrugBank
DB08942,Peripheral Nervous System Agents,DrugBank
DB08942,Sensory System Agents,DrugBank
DB08942,Sulfur Compounds,DrugBank
DB08942,Thiazines,DrugBank
DB08949,Cardiovascular Agents,DrugBank
DB08949,Nicotinic Acid and Derivatives,DrugBank
DB08949,Other Nutritional Agents,DrugBank
DB08949,Peripheral Vasodilators,DrugBank
DB08949,Pyridines,DrugBank
DB08949,Vasodilating Agents,DrugBank
DB08949,Vitamin B Complex,DrugBank
DB08949,Vitamins,DrugBank
DB08950,"Acids, Carbocyclic",DrugBank
DB08950,Adrenergic Agents,DrugBank
DB08950,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB08950,Adrenergic alpha-Antagonists,DrugBank
DB08950,Adrenergic Antagonists,DrugBank
DB08950,Agents that produce hypertension,DrugBank
DB08950,Amides,DrugBank
DB08950,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB08950,Antihypertensive Agents,DrugBank
DB08950,Benzamides and benzamide derivatives,DrugBank
DB08950,Benzene Derivatives,DrugBank
DB08950,Benzoates,DrugBank
DB08950,Cardiovascular Agents,DrugBank
DB08950,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08950,Hypotensive Agents,DrugBank
DB08950,Indoles,DrugBank
DB08950,Neurotransmitter Agents,DrugBank
DB08950,Peripheral alpha-1 blockers,DrugBank
DB08950,Piperidines,DrugBank
DB08951,"Acids, Carbocyclic",DrugBank
DB08951,Agents causing hyperkalemia,DrugBank
DB08951,Agents that produce hypertension,DrugBank
DB08951,Analgesics,DrugBank
DB08951,"Analgesics, Non-Narcotic",DrugBank
DB08951,Anti-Inflammatory Agents,DrugBank
DB08951,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08951,Antiinflammatory and Antirheumatic Products,DrugBank
DB08951,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB08951,Antirheumatic Agents,DrugBank
DB08951,Cyclooxygenase Inhibitors,DrugBank
DB08951,Enzyme Inhibitors,DrugBank
DB08951,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08951,Isoindoles,DrugBank
DB08951,Musculo-Skeletal System,DrugBank
DB08951,Nephrotoxic agents,DrugBank
DB08951,Non COX-2 selective NSAIDS,DrugBank
DB08951,Peripheral Nervous System Agents,DrugBank
DB08951,Phenylpropionates,DrugBank
DB08951,Propionates,DrugBank
DB08951,Sensory System Agents,DrugBank
DB08952,Adrenergic Agents,DrugBank
DB08952,Adrenergic Antagonists,DrugBank
DB08952,Adrenergic beta-Antagonists,DrugBank
DB08952,Agents causing hyperkalemia,DrugBank
DB08952,Alcohols,DrugBank
DB08952,Amines,DrugBank
DB08952,Amino Alcohols,DrugBank
DB08952,Antiarrhythmic agents,DrugBank
DB08952,Antihypertensive Agents,DrugBank
DB08952,Bradycardia-Causing Agents,DrugBank
DB08952,Cardiovascular Agents,DrugBank
DB08952,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB08952,Cytochrome P-450 Substrates,DrugBank
DB08952,Neurotransmitter Agents,DrugBank
DB08952,Potential QTc-Prolonging Agents,DrugBank
DB08952,Propanols,DrugBank
DB08952,QTc Prolonging Agents,DrugBank
DB08952,Vasodilating Agents,DrugBank
DB08953,Antidepressive Agents,DrugBank
DB08953,Central Nervous System Agents,DrugBank
DB08953,Central Nervous System Depressants,DrugBank
DB08953,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08953,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08953,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08953,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB08953,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08953,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08953,Cytochrome P-450 Substrates,DrugBank
DB08953,Hypoglycemia-Associated Agents,DrugBank
DB08953,Membrane Transport Modulators,DrugBank
DB08953,Neurotransmitter Agents,DrugBank
DB08953,Neurotransmitter Uptake Inhibitors,DrugBank
DB08953,Psychotropic Drugs,DrugBank
DB08953,Selective Serotonin Reuptake Inhibitors,DrugBank
DB08953,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08953,Serotonin Agents,DrugBank
DB08953,Serotonin Modulators,DrugBank
DB08954,Adrenergic Agents,DrugBank
DB08954,Adrenergic alpha-Antagonists,DrugBank
DB08954,Adrenergic Antagonists,DrugBank
DB08954,Agents that produce hypertension,DrugBank
DB08954,Anti-Parkinson Drugs,DrugBank
DB08954,Anticonvulsants,DrugBank
DB08954,Cardiovascular Agents,DrugBank
DB08954,Central Nervous System Depressants,DrugBank
DB08954,Excitatory Amino Acid Agents,DrugBank
DB08954,Excitatory Amino Acid Antagonists,DrugBank
DB08954,Experimental Unapproved Treatments for COVID-19,DrugBank
DB08954,Neurotransmitter Agents,DrugBank
DB08954,NMDA Receptor Antagonists,DrugBank
DB08954,Peripheral Vasodilators,DrugBank
DB08954,Vasodilating Agents,DrugBank
DB08955,Acetamides,DrugBank
DB08955,Agents causing hyperkalemia,DrugBank
DB08955,Agents that produce hypertension,DrugBank
DB08955,Amides,DrugBank
DB08955,Amines,DrugBank
DB08955,Analgesics,DrugBank
DB08955,"Analgesics, Non-Narcotic",DrugBank
DB08955,Anti-Inflammatory Agents,DrugBank
DB08955,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08955,Antiinflammatory and Antirheumatic Products,DrugBank
DB08955,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB08955,Antirheumatic Agents,DrugBank
DB08955,Benzene Derivatives,DrugBank
DB08955,Hydroxy Acids,DrugBank
DB08955,Hydroxylamines,DrugBank
DB08955,Musculo-Skeletal System,DrugBank
DB08955,Nephrotoxic agents,DrugBank
DB08955,Non COX-2 selective NSAIDS,DrugBank
DB08955,Peripheral Nervous System Agents,DrugBank
DB08955,Propionates,DrugBank
DB08955,Sensory System Agents,DrugBank
DB08957,Adrenergic Agents,DrugBank
DB08957,Adrenergic Agonists,DrugBank
DB08957,Adrenergic beta-2 Receptor Agonists,DrugBank
DB08957,Adrenergic beta-Agonists,DrugBank
DB08957,Adrenergics for Systemic Use,DrugBank
DB08957,"Adrenergics, Inhalants",DrugBank
DB08957,Agents producing tachycardia,DrugBank
DB08957,Agents that produce hypertension,DrugBank
DB08957,Amines,DrugBank
DB08957,Anti-Asthmatic Agents,DrugBank
DB08957,Autonomic Agents,DrugBank
DB08957,Bronchodilator Agents,DrugBank
DB08957,Drugs for Obstructive Airway Diseases,DrugBank
DB08957,Ethylamines,DrugBank
DB08957,Neurotransmitter Agents,DrugBank
DB08957,Peripheral Nervous System Agents,DrugBank
DB08957,Phenethylamines,DrugBank
DB08957,Reproductive Control Agents,DrugBank
DB08957,Respiratory System Agents,DrugBank
DB08957,Selective Beta 2-adrenergic Agonists,DrugBank
DB08957,Tocolytic Agents,DrugBank
DB08958,Alimentary Tract and Metabolism,DrugBank
DB08958,Anti-Infective Agents,DrugBank
DB08958,"Anti-Infective Agents, Local",DrugBank
DB08958,Antifungal Agents,DrugBank
DB08958,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB08958,Genito Urinary System and Sex Hormones,DrugBank
DB08958,Gynecological Antiinfectives and Antiseptics,DrugBank
DB08958,Pyrimidines,DrugBank
DB08958,Stomatological Preparations,DrugBank
DB08960,Amines,DrugBank
DB08960,Anticholinergic Agents,DrugBank
DB08960,Antihypertensive Agents,DrugBank
DB08960,Autonomic Agents,DrugBank
DB08960,Bis-Trimethylammonium Compounds,DrugBank
DB08960,Cardiovascular Agents,DrugBank
DB08960,Central Nervous System Depressants,DrugBank
DB08960,Cholinergic Agents,DrugBank
DB08960,Ganglion Blockers,DrugBank
DB08960,Hexamethonium Compounds,DrugBank
DB08960,Muscle Relaxants,DrugBank
DB08960,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB08960,Neurotransmitter Agents,DrugBank
DB08960,Nicotinic Antagonists,DrugBank
DB08960,Onium Compounds,DrugBank
DB08960,Peripheral Nervous System Agents,DrugBank
DB08960,Quaternary Ammonium Compounds,DrugBank
DB08961,Amides,DrugBank
DB08961,Amines,DrugBank
DB08961,Aniline Compounds,DrugBank
DB08961,Benzene Derivatives,DrugBank
DB08961,Diuretics,DrugBank
DB08961,Natriuretic Agents,DrugBank
DB08961,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB08961,Sulfonamides,DrugBank
DB08961,Sulfones,DrugBank
DB08961,Sulfur Compounds,DrugBank
DB08962,Alimentary Tract and Metabolism,DrugBank
DB08962,Amides,DrugBank
DB08962,Blood Glucose Lowering Agents,DrugBank
DB08962,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB08962,Cytochrome P-450 Substrates,DrugBank
DB08962,Drugs Used in Diabetes,DrugBank
DB08962,Insulin Secretagogues,DrugBank
DB08962,Oral Hypoglycemics,DrugBank
DB08962,Sulfones,DrugBank
DB08962,Sulfonylureas,DrugBank
DB08962,Sulfur Compounds,DrugBank
DB08965,"Amino Acids, Peptides, and Proteins",DrugBank
DB08965,Anti-Bacterial Agents,DrugBank
DB08965,Anti-Infective Agents,DrugBank
DB08965,Peptides,DrugBank
DB08965,"Peptides, Cyclic",DrugBank
DB08965,Throat Preparations,DrugBank
DB08967,Analgesics,DrugBank
DB08967,Antimigraine Preparations,DrugBank
DB08967,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08967,Histamine Agents,DrugBank
DB08967,Histamine Antagonists,DrugBank
DB08967,Histamine H1 Antagonists,DrugBank
DB08967,Nervous System,DrugBank
DB08967,Neurotransmitter Agents,DrugBank
DB08967,Sulfur Compounds,DrugBank
DB08970,Adrenal Cortex Hormones,DrugBank
DB08970,Corticosteroids,DrugBank
DB08970,"Corticosteroids, Dermatological Preparations",DrugBank
DB08970,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB08970,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08970,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08970,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08970,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08970,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08970,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB08970,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB08970,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08970,Cytochrome P-450 Substrates,DrugBank
DB08970,Dermatologicals,DrugBank
DB08970,Fused-Ring Compounds,DrugBank
DB08970,Glucocorticoids,DrugBank
DB08970,Hyperglycemia-Associated Agents,DrugBank
DB08970,Immunosuppressive Agents,DrugBank
DB08970,Steroids,DrugBank
DB08971,Adrenal Cortex Hormones,DrugBank
DB08971,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB08971,Anti-Inflammatory Agents,DrugBank
DB08971,Corticosteroids,DrugBank
DB08971,"Corticosteroids for Systemic Use, Plain",DrugBank
DB08971,"Corticosteroids, Dermatological Preparations",DrugBank
DB08971,"Corticosteroids, Potent (Group III)",DrugBank
DB08971,Cytochrome P-450 CYP3A Inducers,DrugBank
DB08971,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08971,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB08971,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB08971,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08971,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB08971,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB08971,Cytochrome P-450 Enzyme Inducers,DrugBank
DB08971,Cytochrome P-450 Substrates,DrugBank
DB08971,Dermatologicals,DrugBank
DB08971,Fused-Ring Compounds,DrugBank
DB08971,Glucocorticoids,DrugBank
DB08971,Hormones,DrugBank
DB08971,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB08971,Hyperglycemia-Associated Agents,DrugBank
DB08971,Immunosuppressive Agents,DrugBank
DB08971,Ophthalmologicals,DrugBank
DB08971,Pregnadienediols,DrugBank
DB08971,Pregnadienes,DrugBank
DB08971,Pregnanes,DrugBank
DB08971,Sensory Organs,DrugBank
DB08971,Steroids,DrugBank
DB08971,"Steroids, Fluorinated",DrugBank
DB08971,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB08971,Vasoprotectives,DrugBank
DB08972,4-Quinolones,DrugBank
DB08972,Anti-Bacterial Agents,DrugBank
DB08972,Anti-Infective Agents,DrugBank
DB08972,"Anti-Infective Agents, Urinary",DrugBank
DB08972,Antibacterials for Systemic Use,DrugBank
DB08972,Antiinfectives for Systemic Use,DrugBank
DB08972,Antineoplastic Agents,DrugBank
DB08972,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB08972,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB08972,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08972,Enzyme Inhibitors,DrugBank
DB08972,Fluoroquinolones,DrugBank
DB08972,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08972,Potential QTc-Prolonging Agents,DrugBank
DB08972,QTc Prolonging Agents,DrugBank
DB08972,Quinolines,DrugBank
DB08972,Quinolones,DrugBank
DB08972,Topoisomerase II Inhibitors,DrugBank
DB08972,Topoisomerase Inhibitors,DrugBank
DB08976,"Acids, Carbocyclic",DrugBank
DB08976,Agents causing hyperkalemia,DrugBank
DB08976,Agents that produce hypertension,DrugBank
DB08976,Aminobenzoates,DrugBank
DB08976,Analgesics,DrugBank
DB08976,"Analgesics, Non-Narcotic",DrugBank
DB08976,Anti-Inflammatory Agents,DrugBank
DB08976,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08976,Antirheumatic Agents,DrugBank
DB08976,Benzene Derivatives,DrugBank
DB08976,Benzoates,DrugBank
DB08976,Miscellaneous Analgesics and Antipyretics,DrugBank
DB08976,Nephrotoxic agents,DrugBank
DB08976,Nervous System,DrugBank
DB08976,Non COX-2 selective NSAIDS,DrugBank
DB08976,Peripheral Nervous System Agents,DrugBank
DB08976,Sensory System Agents,DrugBank
DB08980,Agents causing hyperkalemia,DrugBank
DB08980,Amines,DrugBank
DB08980,Antiarrhythmic agents,DrugBank
DB08980,Bradycardia-Causing Agents,DrugBank
DB08980,Calcium Channel Blockers,DrugBank
DB08980,Calcium-Regulating Hormones and Agents,DrugBank
DB08980,Cardiovascular Agents,DrugBank
DB08980,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08980,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08980,Cytochrome P-450 Substrates,DrugBank
DB08980,Ethylamines,DrugBank
DB08980,Membrane Transport Modulators,DrugBank
DB08980,Moderate Risk QTc-Prolonging Agents,DrugBank
DB08980,Non-Selective Calcium Channel Blockers,DrugBank
DB08980,Phenethylamines,DrugBank
DB08980,Phenylalkylamine Derivatives,DrugBank
DB08980,QTc Prolonging Agents,DrugBank
DB08980,Vasodilating Agents,DrugBank
DB08981,"Acids, Carbocyclic",DrugBank
DB08981,Agents causing hyperkalemia,DrugBank
DB08981,Agents that produce hypertension,DrugBank
DB08981,Analgesics,DrugBank
DB08981,"Analgesics, Non-Narcotic",DrugBank
DB08981,Anti-Inflammatory Agents,DrugBank
DB08981,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08981,Antiinflammatory and Antirheumatic Products,DrugBank
DB08981,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB08981,Antirheumatic Agents,DrugBank
DB08981,Cyclooxygenase Inhibitors,DrugBank
DB08981,Enzyme Inhibitors,DrugBank
DB08981,Musculo-Skeletal System,DrugBank
DB08981,Nephrotoxic agents,DrugBank
DB08981,Non COX-2 selective NSAIDS,DrugBank
DB08981,Peripheral Nervous System Agents,DrugBank
DB08981,Propionates,DrugBank
DB08981,Sensory System Agents,DrugBank
DB08983,"Acids, Acyclic",DrugBank
DB08983,Agents Causing Muscle Toxicity,DrugBank
DB08983,Anticholesteremic Agents,DrugBank
DB08983,Benzene Derivatives,DrugBank
DB08983,Butyrates,DrugBank
DB08983,Ethers,DrugBank
DB08983,Fibric Acids,DrugBank
DB08983,Hypolipidemic Agents,DrugBank
DB08983,Isobutyrates,DrugBank
DB08983,Lipid Modifying Agents,DrugBank
DB08983,"Lipid Modifying Agents, Plain",DrugBank
DB08983,Lipid Regulating Agents,DrugBank
DB08983,Phenols,DrugBank
DB08983,Phenyl Ethers,DrugBank
DB08984,"Acids, Carbocyclic",DrugBank
DB08984,Agents causing hyperkalemia,DrugBank
DB08984,Agents that produce hypertension,DrugBank
DB08984,Aminobenzoates,DrugBank
DB08984,Analgesics,DrugBank
DB08984,"Analgesics, Non-Narcotic",DrugBank
DB08984,Anti-Inflammatory Agents,DrugBank
DB08984,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08984,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB08984,Antirheumatic Agents,DrugBank
DB08984,Benzene Derivatives,DrugBank
DB08984,Benzoates,DrugBank
DB08984,Fenamates,DrugBank
DB08984,Musculo-Skeletal System,DrugBank
DB08984,Nephrotoxic agents,DrugBank
DB08984,Non COX-2 selective NSAIDS,DrugBank
DB08984,ortho-Aminobenzoates,DrugBank
DB08984,Peripheral Nervous System Agents,DrugBank
DB08984,Sensory System Agents,DrugBank
DB08984,Thyroxine-binding globulin substrates,DrugBank
DB08984,Topical Products for Joint and Muscular Pain,DrugBank
DB08985,Adrenergic Agents,DrugBank
DB08985,Adrenergic Agonists,DrugBank
DB08985,Adrenergic alpha-Agonists,DrugBank
DB08985,Adrenergic and Dopaminergic Agents,DrugBank
DB08985,Adrenergic beta-1 Receptor Agonists,DrugBank
DB08985,Adrenergic beta-Agonists,DrugBank
DB08985,Agents producing tachycardia,DrugBank
DB08985,Agents that produce hypertension,DrugBank
DB08985,Alcohols,DrugBank
DB08985,Amines,DrugBank
DB08985,Amino Alcohols,DrugBank
DB08985,Autonomic Agents,DrugBank
DB08985,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB08985,Cardiac Therapy,DrugBank
DB08985,Cardiotonic Agents,DrugBank
DB08985,Cardiovascular Agents,DrugBank
DB08985,"Compounds used in a research, industrial, or household setting",DrugBank
DB08985,Ethanolamines,DrugBank
DB08985,Neurotransmitter Agents,DrugBank
DB08985,Peripheral Nervous System Agents,DrugBank
DB08985,Protective Agents,DrugBank
DB08985,Sympathomimetics,DrugBank
DB08985,Vasoconstrictor Agents,DrugBank
DB08986,Anti-Anxiety Agents,DrugBank
DB08986,Central Nervous System Agents,DrugBank
DB08986,Central Nervous System Depressants,DrugBank
DB08986,Nervous System,DrugBank
DB08986,Psycholeptics,DrugBank
DB08986,Psychotropic Drugs,DrugBank
DB08986,Tranquilizing Agents,DrugBank
DB08987,Acetanilides,DrugBank
DB08987,Amides,DrugBank
DB08987,Amines,DrugBank
DB08987,Anesthetics,DrugBank
DB08987,"Anesthetics, Local",DrugBank
DB08987,Anilides,DrugBank
DB08987,Aniline Compounds,DrugBank
DB08987,Central Nervous System Agents,DrugBank
DB08987,Central Nervous System Depressants,DrugBank
DB08987,Local Anesthetics (Amide),DrugBank
DB08987,Nervous System,DrugBank
DB08987,Peripheral Nervous System Agents,DrugBank
DB08987,Sensory System Agents,DrugBank
DB08991,Agents causing hyperkalemia,DrugBank
DB08991,Agents that produce hypertension,DrugBank
DB08991,Analgesics,DrugBank
DB08991,"Analgesics, Non-Narcotic",DrugBank
DB08991,Anti-Inflammatory Agents,DrugBank
DB08991,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB08991,Antirheumatic Agents,DrugBank
DB08991,Nephrotoxic agents,DrugBank
DB08991,Non COX-2 selective NSAIDS,DrugBank
DB08991,Peripheral Nervous System Agents,DrugBank
DB08991,Pyrazoles,DrugBank
DB08991,Pyrimidines,DrugBank
DB08991,Sensory System Agents,DrugBank
DB08992,Agents causing hyperkalemia,DrugBank
DB08992,Antiarrhythmic agents,DrugBank
DB08992,Autonomic Agents,DrugBank
DB08992,Bradycardia-Causing Agents,DrugBank
DB08992,Calcium Channel Blockers,DrugBank
DB08992,Calcium-Regulating Hormones and Agents,DrugBank
DB08992,Cardiovascular Agents,DrugBank
DB08992,Central Nervous System Agents,DrugBank
DB08992,Central Nervous System Depressants,DrugBank
DB08992,Cytochrome P-450 CYP3A Substrates,DrugBank
DB08992,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB08992,Cytochrome P-450 Substrates,DrugBank
DB08992,Ketones,DrugBank
DB08992,Membrane Transport Modulators,DrugBank
DB08992,Moderate Risk QTc-Prolonging Agents,DrugBank
DB08992,Muscle Relaxants,DrugBank
DB08992,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB08992,Musculo-Skeletal System,DrugBank
DB08992,Neuromuscular Agents,DrugBank
DB08992,Parasympatholytics,DrugBank
DB08992,Peripheral Nervous System Agents,DrugBank
DB08992,QTc Prolonging Agents,DrugBank
DB08992,Vasodilating Agents,DrugBank
DB08993,"Amino Acids, Peptides, and Proteins",DrugBank
DB08993,Anti-Bacterial Agents,DrugBank
DB08993,Anti-Infective Agents,DrugBank
DB08993,"Antibiotics, Antitubercular",DrugBank
DB08993,Antiinfectives for Systemic Use,DrugBank
DB08993,Antimycobacterials,DrugBank
DB08993,Drugs for Treatment of Tuberculosis,DrugBank
DB08993,Peptides,DrugBank
DB08993,"Peptides, Cyclic",DrugBank
DB08994,Anticoagulants,DrugBank
DB08994,Blood and Blood Forming Organs,DrugBank
DB08994,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB08995,Benzopyrans,DrugBank
DB08995,Capillary Stabilizing Agents,DrugBank
DB08995,Chromones,DrugBank
DB08995,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB08995,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB08995,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB08995,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB08995,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB08995,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB08995,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB08995,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB08995,Flavones,DrugBank
DB08995,Flavonoids,DrugBank
DB08995,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08995,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB08995,P-glycoprotein inhibitors,DrugBank
DB08995,Pyrans,DrugBank
DB08995,Vasoprotectives,DrugBank
DB08996,Agents that produce hypertension,DrugBank
DB08996,Agents that reduce seizure threshold,DrugBank
DB08996,Antidepressive Agents,DrugBank
DB08996,"Antidepressive Agents, Tricyclic",DrugBank
DB08996,Central Nervous System Depressants,DrugBank
DB08996,Drugs that are Mainly Renally Excreted,DrugBank
DB08996,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB08996,Nervous System,DrugBank
DB08996,Neurotoxic agents,DrugBank
DB08996,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB08996,Psychoanaleptics,DrugBank
DB08996,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB08997,Agents producing tachycardia,DrugBank
DB08997,Anti-Dyskinesia Agents,DrugBank
DB08997,Anti-Parkinson Drugs,DrugBank
DB08997,Anticholinergic Agents,DrugBank
DB08997,Autonomic Agents,DrugBank
DB08997,Central Nervous System Agents,DrugBank
DB08997,Cholinergic Agents,DrugBank
DB08997,Muscarinic Antagonists,DrugBank
DB08997,Nervous System,DrugBank
DB08997,Neurotransmitter Agents,DrugBank
DB08997,Parasympatholytics,DrugBank
DB08997,Peripheral Nervous System Agents,DrugBank
DB08997,Piperidines,DrugBank
DB08997,Piperidones,DrugBank
DB08997,Tertiary Amines,DrugBank
DB08999,Cycloparaffins,DrugBank
DB08999,Ganglion Blockers,DrugBank
DB08999,Nasal Preparations,DrugBank
DB08999,"Sympathomimetics, Plain",DrugBank
DB09000,Anti-Anxiety Agents,DrugBank
DB09000,Antidepressive Agents,DrugBank
DB09000,Antipsychotic Agents,DrugBank
DB09000,Central Nervous System Depressants,DrugBank
DB09000,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09000,Nervous System,DrugBank
DB09000,Neurotoxic agents,DrugBank
DB09000,Phenothiazines,DrugBank
DB09000,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB09000,Photosensitizing Agents,DrugBank
DB09000,Psycholeptics,DrugBank
DB09000,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB09000,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB09000,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09000,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09000,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB09000,Serotonin Agents,DrugBank
DB09000,Serotonin Receptor Antagonists,DrugBank
DB09000,Sulfur Compounds,DrugBank
DB09001,Anticonvulsants,DrugBank
DB09001,Barbiturates,DrugBank
DB09001,Barbiturates and Derivatives,DrugBank
DB09001,Central Nervous System Depressants,DrugBank
DB09001,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09001,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09001,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09001,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09001,Nervous System,DrugBank
DB09001,Pyrimidines,DrugBank
DB09001,Pyrimidinones,DrugBank
DB09007,Agents producing tachycardia,DrugBank
DB09007,Amines,DrugBank
DB09007,Aminoalkyl Ethers,DrugBank
DB09007,Anticholinergic Agents,DrugBank
DB09007,Antihistamines for Systemic Use,DrugBank
DB09007,Antihistamines for Topical Use,DrugBank
DB09007,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB09007,Cholinergic Agents,DrugBank
DB09007,Dermatologicals,DrugBank
DB09007,Histamine Agents,DrugBank
DB09007,Histamine Antagonists,DrugBank
DB09007,Muscarinic Antagonists,DrugBank
DB09007,Neurotransmitter Agents,DrugBank
DB09008,Amides,DrugBank
DB09008,Anti-Bacterial Agents,DrugBank
DB09008,Anti-Infective Agents,DrugBank
DB09008,Antibacterials for Systemic Use,DrugBank
DB09008,Antiinfectives for Systemic Use,DrugBank
DB09008,beta-Lactams,DrugBank
DB09008,Cephalosporins,DrugBank
DB09008,First-Generation Cephalosporins,DrugBank
DB09008,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09008,Lactams,DrugBank
DB09008,Nephrotoxic agents,DrugBank
DB09008,OAT1/SLC22A6 Substrates,DrugBank
DB09008,OAT3/SLC22A8 Inhibitors,DrugBank
DB09008,OAT3/SLC22A8 Substrates,DrugBank
DB09008,Sulfur Compounds,DrugBank
DB09008,Thiazines,DrugBank
DB09009,Amides,DrugBank
DB09009,Anesthetics,DrugBank
DB09009,"Anesthetics, Local",DrugBank
DB09009,Central Nervous System Agents,DrugBank
DB09009,Central Nervous System Depressants,DrugBank
DB09009,Hyperglycemia-Associated Agents,DrugBank
DB09009,Local Anesthesia,DrugBank
DB09009,Local Anesthetics (Amide),DrugBank
DB09009,Methemoglobinemia Associated Agents,DrugBank
DB09009,Nervous System,DrugBank
DB09009,Peripheral Nervous System Agents,DrugBank
DB09009,Sensory System Agents,DrugBank
DB09009,Sulfur Compounds,DrugBank
DB09009,Thiophenes,DrugBank
DB09010,Antimetabolites,DrugBank
DB09010,Antineoplastic Agents,DrugBank
DB09010,Antineoplastic and Immunomodulating Agents,DrugBank
DB09010,Fluoropyrimidines,DrugBank
DB09010,Pyrimidine Analogues,DrugBank
DB09010,Pyrimidines,DrugBank
DB09010,Pyrimidinones,DrugBank
DB09011,"Acids, Acyclic",DrugBank
DB09011,Anticonvulsants,DrugBank
DB09011,Central Nervous System Depressants,DrugBank
DB09011,Fatty Acids,DrugBank
DB09011,"Fatty Acids, Volatile",DrugBank
DB09011,Lipids,DrugBank
DB09011,Nervous System,DrugBank
DB09013,Adrenergic Agents,DrugBank
DB09013,Adrenergic Agonists,DrugBank
DB09013,Adrenergic Antagonists,DrugBank
DB09013,Adrenergic beta-Agonists,DrugBank
DB09013,Adrenergic beta-Antagonists,DrugBank
DB09013,Agents causing hyperkalemia,DrugBank
DB09013,Alcohols,DrugBank
DB09013,Amines,DrugBank
DB09013,Amino Alcohols,DrugBank
DB09013,Antiglaucoma Preparations and Miotics,DrugBank
DB09013,Bradycardia-Causing Agents,DrugBank
DB09013,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09013,Cytochrome P-450 Substrates,DrugBank
DB09013,Neurotransmitter Agents,DrugBank
DB09013,Ophthalmologicals,DrugBank
DB09013,Propanols,DrugBank
DB09013,Sensory Organs,DrugBank
DB09014,Anti-Anxiety Agents,DrugBank
DB09014,Antidepressive Agents,DrugBank
DB09014,Central Nervous System Depressants,DrugBank
DB09014,Diphenylmethane Derivatives,DrugBank
DB09014,Nervous System,DrugBank
DB09014,Psycholeptics,DrugBank
DB09014,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09014,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB09014,Serotonin Agents,DrugBank
DB09014,Serotonin Receptor Antagonists,DrugBank
DB09015,Agents causing hyperkalemia,DrugBank
DB09015,Diuretics,DrugBank
DB09015,Fused-Ring Compounds,DrugBank
DB09015,Hormone Antagonists,DrugBank
DB09015,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09015,Mineralocorticoid Receptor Antagonists,DrugBank
DB09015,Natriuretic Agents,DrugBank
DB09015,Potassium-Sparing Diuretics,DrugBank
DB09015,Pregnadienes,DrugBank
DB09015,Pregnanes,DrugBank
DB09015,Steroids,DrugBank
DB09016,Agents that produce hypertension,DrugBank
DB09016,Agents that reduce seizure threshold,DrugBank
DB09016,Anti-Anxiety Agents,DrugBank
DB09016,Antidepressive Agents,DrugBank
DB09016,"Antidepressive Agents, Tricyclic",DrugBank
DB09016,Benzocycloheptenes,DrugBank
DB09016,Central Nervous System Agents,DrugBank
DB09016,Central Nervous System Depressants,DrugBank
DB09016,Histamine Antagonists,DrugBank
DB09016,Histamine H1 Antagonists,DrugBank
DB09016,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09016,Narrow Therapeutic Index Drugs,DrugBank
DB09016,Nervous System,DrugBank
DB09016,Neurotoxic agents,DrugBank
DB09016,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB09016,Psychoanaleptics,DrugBank
DB09016,Psychotropic Drugs,DrugBank
DB09016,QTc Prolonging Agents,DrugBank
DB09016,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09016,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09016,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09016,Serotonin Agents,DrugBank
DB09016,Serotonin Receptor Antagonists,DrugBank
DB09016,Tertiary amine tricyclic antidepressants,DrugBank
DB09016,Tranquilizing Agents,DrugBank
DB09017,Benzodiazepine hypnotics and sedatives,DrugBank
DB09017,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB09017,Central Nervous System Agents,DrugBank
DB09017,Central Nervous System Depressants,DrugBank
DB09017,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09017,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09017,Cytochrome P-450 Substrates,DrugBank
DB09017,Hypnotics and Sedatives,DrugBank
DB09017,Nervous System,DrugBank
DB09017,Psycholeptics,DrugBank
DB09018,"Acids, Carbocyclic",DrugBank
DB09018,Alimentary Tract and Metabolism,DrugBank
DB09018,Amides,DrugBank
DB09018,Aminobenzoates,DrugBank
DB09018,Antiemetics,DrugBank
DB09018,Autonomic Agents,DrugBank
DB09018,Benzamides and benzamide derivatives,DrugBank
DB09018,Benzene Derivatives,DrugBank
DB09018,Benzoates,DrugBank
DB09018,Central Nervous System Agents,DrugBank
DB09018,Chlorobenzoates,DrugBank
DB09018,Dopamine Agents,DrugBank
DB09018,Dopamine Antagonists,DrugBank
DB09018,Dopamine D2 Receptor Antagonists,DrugBank
DB09018,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB09018,Gastrointestinal Agents,DrugBank
DB09018,Hydroxy Acids,DrugBank
DB09018,Hydroxybenzoate Ethers,DrugBank
DB09018,Hydroxybenzoates,DrugBank
DB09018,Neurotransmitter Agents,DrugBank
DB09018,para-Aminobenzoates,DrugBank
DB09018,Peripheral Nervous System Agents,DrugBank
DB09018,Phenols,DrugBank
DB09018,Phenyl Ethers,DrugBank
DB09018,Propulsives,DrugBank
DB09020,Alimentary Tract and Metabolism,DrugBank
DB09020,Benzene Derivatives,DrugBank
DB09020,Contact Laxatives,DrugBank
DB09020,Cresols,DrugBank
DB09020,Drugs for Constipation,DrugBank
DB09020,Enemas,DrugBank
DB09020,Gastrointestinal Agents,DrugBank
DB09020,Increased Large Intestinal Motility,DrugBank
DB09020,Laxatives,DrugBank
DB09020,Phenols,DrugBank
DB09020,Stimulation Large Intestine Fluid/Electrolyte Secretion,DrugBank
DB09021,Anti-Anxiety Agents,DrugBank
DB09021,Central Nervous System Depressants,DrugBank
DB09021,Dibenzo-Bicyclo-Octadiene Derivatives,DrugBank
DB09021,Nervous System,DrugBank
DB09021,Psycholeptics,DrugBank
DB09022,Alimentary Tract and Metabolism,DrugBank
DB09022,Amines,DrugBank
DB09022,Anti-Obesity Agents,DrugBank
DB09022,Appetite Depressants,DrugBank
DB09022,Blood Glucose Lowering Agents,DrugBank
DB09022,Drugs Used in Diabetes,DrugBank
DB09022,Ethylamines,DrugBank
DB09022,Hypolipidemic Agents,DrugBank
DB09022,Lipid Regulating Agents,DrugBank
DB09022,Oral Hypoglycemics,DrugBank
DB09022,Phenethylamines,DrugBank
DB09023,"Acids, Carbocyclic",DrugBank
DB09023,Agents producing tachycardia,DrugBank
DB09023,Anticholinergic Agents,DrugBank
DB09023,Antidepressive Agents,DrugBank
DB09023,Autonomic Agents,DrugBank
DB09023,Benzilates,DrugBank
DB09023,Central Nervous System Agents,DrugBank
DB09023,Central Nervous System Depressants,DrugBank
DB09023,Cholinergic Agents,DrugBank
DB09023,Diphenylacetic Acids,DrugBank
DB09023,Hydroxy Acids,DrugBank
DB09023,Muscarinic Antagonists,DrugBank
DB09023,Neurotransmitter Agents,DrugBank
DB09023,Parasympatholytics,DrugBank
DB09023,Peripheral Nervous System Agents,DrugBank
DB09023,Phenylacetates,DrugBank
DB09023,Psychotropic Drugs,DrugBank
DB09026,"Acids, Acyclic",DrugBank
DB09026,Agents Acting on the Renin-Angiotensin System,DrugBank
DB09026,Agents causing hyperkalemia,DrugBank
DB09026,Antihypertensive Agents,DrugBank
DB09026,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB09026,Benzene Derivatives,DrugBank
DB09026,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09026,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09026,Cytochrome P-450 Substrates,DrugBank
DB09026,Dicarboxylic Acids,DrugBank
DB09026,Enzyme Inhibitors,DrugBank
DB09026,Ethers,DrugBank
DB09026,Hypotensive Agents,DrugBank
DB09026,Methyl Ethers,DrugBank
DB09026,P-glycoprotein substrates,DrugBank
DB09026,Protease Inhibitors,DrugBank
DB09026,Renin Inhibitors,DrugBank
DB09027,Anti-Infective Agents,DrugBank
DB09027,Antiinfectives for Systemic Use,DrugBank
DB09027,Antiviral Agents,DrugBank
DB09027,Antivirals for Systemic Use,DrugBank
DB09027,Antivirals for treatment of HCV infections,DrugBank
DB09027,BCRP/ABCG2 Inhibitors,DrugBank
DB09027,Direct Acting Antivirals,DrugBank
DB09027,Drugs that are Mainly Renally Excreted,DrugBank
DB09027,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB09027,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09027,P-glycoprotein inhibitors,DrugBank
DB09027,P-glycoprotein substrates,DrugBank
DB09027,Treatments for Hepatitis C,DrugBank
DB09029,Agents reducing cytokine levels,DrugBank
DB09029,"Amino Acids, Peptides, and Proteins",DrugBank
DB09029,Antibodies,DrugBank
DB09029,"Antibodies, Monoclonal",DrugBank
DB09029,Antineoplastic and Immunomodulating Agents,DrugBank
DB09029,Antipsoriatics,DrugBank
DB09029,Blood Proteins,DrugBank
DB09029,Globulins,DrugBank
DB09029,Immunoglobulins,DrugBank
DB09029,Immunoproteins,DrugBank
DB09029,Immunosuppressive Agents,DrugBank
DB09029,Immunotherapy,DrugBank
DB09029,Interleukin Inhibitors,DrugBank
DB09029,"Interleukin-17, antagonists & inhibitors",DrugBank
DB09029,Interleukin-17A Antagonist,DrugBank
DB09029,Proteins,DrugBank
DB09029,Serum Globulins,DrugBank
DB09030,Anticoagulants,DrugBank
DB09030,Antiplatelet agents,DrugBank
DB09030,Blood and Blood Forming Organs,DrugBank
DB09030,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09030,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09030,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09030,Cytochrome P-450 Substrates,DrugBank
DB09030,Hematologic Agents,DrugBank
DB09030,P-glycoprotein inhibitors,DrugBank
DB09030,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB09030,Protease-activated Receptor-1 Antagonist,DrugBank
DB09030,Protease-activated Receptor-1 Antagonists,DrugBank
DB09030,"Receptor, PAR-1, antagonists & inhibitors",DrugBank
DB09030,"Receptors, Thrombin, antagonists & inhibitors",DrugBank
DB09031,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB09031,Amines,DrugBank
DB09031,Anti-Infective Agents,DrugBank
DB09031,Antifungal Agents,DrugBank
DB09031,Antileishmanial,DrugBank
DB09031,Antineoplastic Agents,DrugBank
DB09031,Antiparasitic Agents,DrugBank
DB09031,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB09031,Antiprotozoals,DrugBank
DB09031,Onium Compounds,DrugBank
DB09031,P-glycoprotein substrates,DrugBank
DB09031,Quaternary Ammonium Compounds,DrugBank
DB09031,Trimethyl Ammonium Compounds,DrugBank
DB09033,"Amino Acids, Peptides, and Proteins",DrugBank
DB09033,Antibodies,DrugBank
DB09033,"Antibodies, Monoclonal",DrugBank
DB09033,"Antibodies, Monoclonal, Humanized",DrugBank
DB09033,Antineoplastic and Immunomodulating Agents,DrugBank
DB09033,Blood Proteins,DrugBank
DB09033,Cancer immunotherapy,DrugBank
DB09033,Gastrointestinal Agents,DrugBank
DB09033,Globulins,DrugBank
DB09033,Immunoglobulins,DrugBank
DB09033,Immunoproteins,DrugBank
DB09033,Immunosuppressive Agents,DrugBank
DB09033,Immunotherapy,DrugBank
DB09033,Integrin Receptor Antagonist,DrugBank
DB09033,Miscellaneous GI Drugs,DrugBank
DB09033,Proteins,DrugBank
DB09033,Selective Immunosuppressants,DrugBank
DB09033,Serum Globulins,DrugBank
DB09034,Central Nervous System Agents,DrugBank
DB09034,Central Nervous System Depressants,DrugBank
DB09034,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09034,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09034,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09034,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09034,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09034,Cytochrome P-450 Substrates,DrugBank
DB09034,Hypnotics and Sedatives,DrugBank
DB09034,Miscellaneous Anxiolytics Sedatives and Hypnotics,DrugBank
DB09034,Nervous System,DrugBank
DB09034,Neurotransmitter Agents,DrugBank
DB09034,Orexin Receptor Antagonists,DrugBank
DB09034,P-glycoprotein inhibitors,DrugBank
DB09034,Psycholeptics,DrugBank
DB09034,"Sleep Aids, Pharmaceutical",DrugBank
DB09035,"Adjuvants, Immunologic",DrugBank
DB09035,"Amino Acids, Peptides, and Proteins",DrugBank
DB09035,Antibodies,DrugBank
DB09035,"Antibodies, Monoclonal",DrugBank
DB09035,"Antibodies, Monoclonal, Humanized",DrugBank
DB09035,Antineoplastic Agents,DrugBank
DB09035,"Antineoplastic Agents, Immunological",DrugBank
DB09035,Antineoplastic and Immunomodulating Agents,DrugBank
DB09035,Blood Proteins,DrugBank
DB09035,Cancer immunotherapy,DrugBank
DB09035,Globulins,DrugBank
DB09035,Immune Checkpoint Inhibitors,DrugBank
DB09035,Immunoglobulin G,DrugBank
DB09035,Immunoglobulins,DrugBank
DB09035,Immunoproteins,DrugBank
DB09035,Immunotherapy,DrugBank
DB09035,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09035,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB09035,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB09035,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB09035,Programmed Death Receptor-1-directed Antibody Interactions,DrugBank
DB09035,Proteins,DrugBank
DB09035,Serum Globulins,DrugBank
DB09036,Agents reducing cytokine levels,DrugBank
DB09036,"Amino Acids, Peptides, and Proteins",DrugBank
DB09036,Antibodies,DrugBank
DB09036,Antineoplastic Agents,DrugBank
DB09036,Antineoplastic and Immunomodulating Agents,DrugBank
DB09036,Blood Proteins,DrugBank
DB09036,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09036,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09036,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09036,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB09036,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09036,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09036,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09036,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09036,Globulins,DrugBank
DB09036,Immunoglobulins,DrugBank
DB09036,Immunoproteins,DrugBank
DB09036,Immunosuppressive Agents,DrugBank
DB09036,Immunotherapy,DrugBank
DB09036,Interleukin Inhibitors,DrugBank
DB09036,Interleukin-6 Antagonist,DrugBank
DB09036,Proteins,DrugBank
DB09036,Serum Globulins,DrugBank
DB09037,"Amino Acids, Peptides, and Proteins",DrugBank
DB09037,Antibodies,DrugBank
DB09037,"Antibodies, Monoclonal",DrugBank
DB09037,"Antibodies, Monoclonal, Humanized",DrugBank
DB09037,Antineoplastic Agents,DrugBank
DB09037,"Antineoplastic Agents, Immunological",DrugBank
DB09037,Antineoplastic and Immunomodulating Agents,DrugBank
DB09037,Blood Proteins,DrugBank
DB09037,Cancer immunotherapy,DrugBank
DB09037,Globulins,DrugBank
DB09037,Immune Checkpoint Inhibitors,DrugBank
DB09037,Immunoglobulins,DrugBank
DB09037,Immunoproteins,DrugBank
DB09037,Immunotherapy,DrugBank
DB09037,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09037,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB09037,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB09037,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB09037,Programmed Death Receptor-1-directed Antibody Interactions,DrugBank
DB09037,Proteins,DrugBank
DB09037,Serum Globulins,DrugBank
DB09038,Alimentary Tract and Metabolism,DrugBank
DB09038,BCRP/ABCG2 Substrates,DrugBank
DB09038,Benzene Derivatives,DrugBank
DB09038,Blood Glucose Lowering Agents,DrugBank
DB09038,Diuretics,DrugBank
DB09038,Drugs that are Mainly Renally Excreted,DrugBank
DB09038,Drugs Used in Diabetes,DrugBank
DB09038,Glycosides,DrugBank
DB09038,Hypotensive Agents,DrugBank
DB09038,OAT3/SLC22A8 Substrates,DrugBank
DB09038,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09038,OATP1B3 substrates,DrugBank
DB09038,Oral Hypoglycemics,DrugBank
DB09038,P-glycoprotein substrates,DrugBank
DB09038,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB09038,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB09038,UGT1A3 substrates,DrugBank
DB09038,UGT1A9 Substrates,DrugBank
DB09038,UGT2B7 substrates,DrugBank
DB09039,Alimentary Tract and Metabolism,DrugBank
DB09039,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09039,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09039,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09039,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09039,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09039,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09039,Cytochrome P-450 Substrates,DrugBank
DB09039,Enzyme Inhibitors,DrugBank
DB09039,Gaucher Disease,DrugBank
DB09039,Glucosylceramide Synthase Inhibitor,DrugBank
DB09039,Glucosylceramide Synthase Inhibitors,DrugBank
DB09039,Highest Risk QTc-Prolonging Agents,DrugBank
DB09039,Other Miscellaneous Therapeutic Agents,DrugBank
DB09039,P-glycoprotein inhibitors,DrugBank
DB09039,P-glycoprotein substrates,DrugBank
DB09039,QTc Prolonging Agents,DrugBank
DB09039,Various Alimentary Tract and Metabolism Products,DrugBank
DB09042,Anti-Bacterial Agents,DrugBank
DB09042,Anti-Infective Agents,DrugBank
DB09042,Antidepressive Agents,DrugBank
DB09042,Central Nervous System Depressants,DrugBank
DB09042,Immunosuppressive Agents,DrugBank
DB09042,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB09042,Myelosuppressive Agents,DrugBank
DB09042,Organophosphorus Compounds,DrugBank
DB09042,Oxazolidinone Antibacterial,DrugBank
DB09042,Oxazolidinones,DrugBank
DB09042,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09042,Serotonin Agents,DrugBank
DB09042,Serotonin Modulators,DrugBank
DB09043,Alimentary Tract and Metabolism,DrugBank
DB09043,Blood Glucose Lowering Agents,DrugBank
DB09043,Drugs Used in Diabetes,DrugBank
DB09043,Gastrointestinal Hormones,DrugBank
DB09043,GLP-1 Agonists,DrugBank
DB09043,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB09043,Glucagon-Like Peptides,DrugBank
DB09043,Hormones,DrugBank
DB09043,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09043,Incretin Mimetics,DrugBank
DB09043,Incretins,DrugBank
DB09043,Proglucagon,DrugBank
DB09043,Recombinant Proteins,DrugBank
DB09045,Alimentary Tract and Metabolism,DrugBank
DB09045,"Amino Acids, Peptides, and Proteins",DrugBank
DB09045,Blood Glucose Lowering Agents,DrugBank
DB09045,Blood Proteins,DrugBank
DB09045,Drugs Used in Diabetes,DrugBank
DB09045,Gastrointestinal Hormones,DrugBank
DB09045,Globulins,DrugBank
DB09045,GLP-1 Agonists,DrugBank
DB09045,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB09045,Hormones,DrugBank
DB09045,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09045,Immunoglobulin Fragments,DrugBank
DB09045,Immunoglobulins,DrugBank
DB09045,Immunoproteins,DrugBank
DB09045,Incretin Mimetics,DrugBank
DB09045,Pancreatic Hormones,DrugBank
DB09045,Peptide Fragments,DrugBank
DB09045,Peptide Hormones,DrugBank
DB09045,Peptides,DrugBank
DB09045,Proglucagon,DrugBank
DB09045,Protein Precursors,DrugBank
DB09045,Proteins,DrugBank
DB09045,Recombinant Proteins,DrugBank
DB09045,Serum Globulins,DrugBank
DB09046,Adipokines,DrugBank
DB09046,Alimentary Tract and Metabolism,DrugBank
DB09046,Amino Acids and Derivatives,DrugBank
DB09046,"Amino Acids, Peptides, and Proteins",DrugBank
DB09046,Analogs/Derivatives,DrugBank
DB09046,Biological Factors,DrugBank
DB09046,Hormones,DrugBank
DB09046,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09046,Intercellular Signaling Peptides and Proteins,DrugBank
DB09046,Leptin Analog,DrugBank
DB09046,"Obesity, drug therapy",DrugBank
DB09046,Peptide Hormones,DrugBank
DB09046,Peptides,DrugBank
DB09046,Proteins,DrugBank
DB09047,4-Quinolones,DrugBank
DB09047,Anti-Bacterial Agents,DrugBank
DB09047,Anti-Infective Agents,DrugBank
DB09047,"Anti-Infective Agents, Urinary",DrugBank
DB09047,Antineoplastic Agents,DrugBank
DB09047,Enzyme Inhibitors,DrugBank
DB09047,Fluoroquinolones,DrugBank
DB09047,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09047,Quinolines,DrugBank
DB09047,Quinolone Antimicrobial,DrugBank
DB09047,Quinolones,DrugBank
DB09047,Topoisomerase II Inhibitors,DrugBank
DB09047,Topoisomerase Inhibitors,DrugBank
DB09048,Acetamides,DrugBank
DB09048,Amides,DrugBank
DB09048,BCRP/ABCG2 Inhibitors,DrugBank
DB09048,Benzene Derivatives,DrugBank
DB09048,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09048,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09048,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09048,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09048,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09048,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB09048,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09048,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09048,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09048,Cytochrome P-450 Substrates,DrugBank
DB09048,Netupitant and prodrug,DrugBank
DB09048,Neurokinin 1 Antagonists,DrugBank
DB09048,P-glycoprotein inhibitors,DrugBank
DB09048,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB09049,Alcohols,DrugBank
DB09049,Alimentary Tract and Metabolism,DrugBank
DB09049,Alkaloids,DrugBank
DB09049,Central Nervous System Agents,DrugBank
DB09049,"Compounds used in a research, industrial, or household setting",DrugBank
DB09049,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09049,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB09049,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09049,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09049,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09049,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09049,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09049,Cytochrome P-450 Substrates,DrugBank
DB09049,Drugs for Constipation,DrugBank
DB09049,Ethylene Glycols,DrugBank
DB09049,Glycols,DrugBank
DB09049,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09049,Macromolecular Substances,DrugBank
DB09049,Miscellaneous GI Drugs,DrugBank
DB09049,Opiate Alkaloids,DrugBank
DB09049,Opioid Antagonists,DrugBank
DB09049,Opioids,DrugBank
DB09049,Peripheral Nervous System Agents,DrugBank
DB09049,Peripheral Opioid Receptor Antagonists,DrugBank
DB09049,Phenanthrenes,DrugBank
DB09049,Polymers,DrugBank
DB09049,Sensory System Agents,DrugBank
DB09050,Amides,DrugBank
DB09050,Anti-Bacterial Agents,DrugBank
DB09050,Anti-Infective Agents,DrugBank
DB09050,Aza Compounds,DrugBank
DB09050,Azabicyclo Compounds,DrugBank
DB09050,beta-Lactams,DrugBank
DB09050,Cephalosporins,DrugBank
DB09050,Drugs that are Mainly Renally Excreted,DrugBank
DB09050,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09050,Sulfur Compounds,DrugBank
DB09050,Thiazines,DrugBank
DB09052,"Amino Acids, Peptides, and Proteins",DrugBank
DB09052,Antibodies,DrugBank
DB09052,"Antibodies, Monoclonal",DrugBank
DB09052,Antineoplastic Agents,DrugBank
DB09052,Antineoplastic and Immunomodulating Agents,DrugBank
DB09052,Bispecific CD19-directed CD3-directed T Cell Engager,DrugBank
DB09052,Blood Proteins,DrugBank
DB09052,Cancer immunotherapy,DrugBank
DB09052,CD19-directed Antibody Interactions,DrugBank
DB09052,CD3-directed Antibody Interactions,DrugBank
DB09052,Globulins,DrugBank
DB09052,Immunoglobulins,DrugBank
DB09052,Immunoproteins,DrugBank
DB09052,Immunosuppressive Agents,DrugBank
DB09052,Immunotherapy,DrugBank
DB09052,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09052,Myelosuppressive Agents,DrugBank
DB09052,Narrow Therapeutic Index Drugs,DrugBank
DB09052,Proteins,DrugBank
DB09052,Serum Globulins,DrugBank
DB09053,Antineoplastic Agents,DrugBank
DB09053,Antineoplastic and Immunomodulating Agents,DrugBank
DB09053,Bruton's tyrosine kinase (BTK) inhibitors,DrugBank
DB09053,Cancer immunotherapy,DrugBank
DB09053,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09053,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09053,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09053,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09053,Cytochrome P-450 Substrates,DrugBank
DB09053,Enzyme Inhibitors,DrugBank
DB09053,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09053,Immunosuppressive Agents,DrugBank
DB09053,Immunotherapy,DrugBank
DB09053,Kinase Inhibitor,DrugBank
DB09053,Myelosuppressive Agents,DrugBank
DB09053,Protein Kinase Inhibitors,DrugBank
DB09053,Purines,DrugBank
DB09053,Tyrosine Kinase Inhibitors,DrugBank
DB09054,Antineoplastic Agents,DrugBank
DB09054,Antineoplastic and Immunomodulating Agents,DrugBank
DB09054,BCRP/ABCG2 Substrates,DrugBank
DB09054,Cancer immunotherapy,DrugBank
DB09054,"Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors",DrugBank
DB09054,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB09054,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB09054,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09054,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09054,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09054,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB09054,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09054,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09054,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09054,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB09054,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB09054,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB09054,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB09054,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB09054,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09054,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09054,Cytochrome P-450 Substrates,DrugBank
DB09054,Enzyme Inhibitors,DrugBank
DB09054,Hepatotoxic Agents,DrugBank
DB09054,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09054,Immunosuppressive Agents,DrugBank
DB09054,Immunotherapy,DrugBank
DB09054,Kinase Inhibitor,DrugBank
DB09054,Narrow Therapeutic Index Drugs,DrugBank
DB09054,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09054,OATP1B3 inhibitors,DrugBank
DB09054,P-glycoprotein inhibitors,DrugBank
DB09054,P-glycoprotein substrates,DrugBank
DB09054,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09054,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,DrugBank
DB09054,Protein Kinase Inhibitors,DrugBank
DB09054,Quinazolines,DrugBank
DB09054,UGT1A4 Inhibitors,DrugBank
DB09054,UGT1A4 substrates,DrugBank
DB09055,Agents Causing Muscle Toxicity,DrugBank
DB09055,Hypolipidemic Agents,DrugBank
DB09055,Lipid Modifying Agents,DrugBank
DB09055,"Lipid Modifying Agents, Plain",DrugBank
DB09055,Lipid Regulating Agents,DrugBank
DB09055,Nicotinic Acid and Derivatives,DrugBank
DB09056,Anti-Infective Agents,DrugBank
DB09056,Antifungal Agents,DrugBank
DB09056,Antifungals for Dermatological Use,DrugBank
DB09056,Antifungals for Topical Use,DrugBank
DB09056,Dermatologicals,DrugBank
DB09056,Oxazines,DrugBank
DB09057,"Amino Acids, Peptides, and Proteins",DrugBank
DB09057,Blood Proteins,DrugBank
DB09057,Human Immunoglobulin,DrugBank
DB09057,Immunoglobulins,DrugBank
DB09057,Proteins,DrugBank
DB09057,Serum,DrugBank
DB09057,Serum Globulins,DrugBank
DB09057,Vaccines,DrugBank
DB09059,"Amino Acids, Peptides, and Proteins",DrugBank
DB09059,Genito Urinary System and Sex Hormones,DrugBank
DB09059,Hormone Antagonists,DrugBank
DB09059,Hormones,DrugBank
DB09059,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09059,Peptide Hormones,DrugBank
DB09059,Peptides,DrugBank
DB09059,Pituitary Hormones,DrugBank
DB09059,"Pituitary Hormones, Posterior",DrugBank
DB09059,Reproductive Control Agents,DrugBank
DB09059,Tocolytic Agents,DrugBank
DB09060,Anti-Infective Agents,DrugBank
DB09060,Aza Compounds,DrugBank
DB09060,beta-Lactamase Inhibitors,DrugBank
DB09060,Enzyme Inhibitors,DrugBank
DB09060,OAT3/SLC22A8 Substrates,DrugBank
DB09061,Agents producing tachycardia,DrugBank
DB09061,Agents that produce hypertension,DrugBank
DB09061,Anticonvulsants,DrugBank
DB09061,Antidepressive Agents,DrugBank
DB09061,BCRP/ABCG2 Inhibitors,DrugBank
DB09061,Cannabinoids and similars,DrugBank
DB09061,Central Nervous System Agents,DrugBank
DB09061,Central Nervous System Depressants,DrugBank
DB09061,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09061,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2A6 Inhibitors (weak),DrugBank
DB09061,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09061,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09061,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB09061,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB09061,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09061,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09061,Cytochrome P-450 Substrates,DrugBank
DB09061,Nervous System,DrugBank
DB09061,P-glycoprotein inhibitors,DrugBank
DB09061,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09061,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB09061,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB09061,Serotonin Agents,DrugBank
DB09061,Serotonin Receptor Agonists,DrugBank
DB09061,Terpenes,DrugBank
DB09061,UGT1A9 Inhibitors,DrugBank
DB09061,UGT1A9 Substrates,DrugBank
DB09061,UGT2B17 substrates,DrugBank
DB09061,UGT2B7 Inhibitors,DrugBank
DB09061,UGT2B7 substrates,DrugBank
DB09062,Amides,DrugBank
DB09062,Anti-Bacterial Agents,DrugBank
DB09062,Anti-Infective Agents,DrugBank
DB09062,Antibacterials for Systemic Use,DrugBank
DB09062,Antiinfectives for Systemic Use,DrugBank
DB09062,beta-Lactams,DrugBank
DB09062,Cephalosporins,DrugBank
DB09062,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09062,Lactams,DrugBank
DB09062,Nephrotoxic agents,DrugBank
DB09062,Second-Generation Cephalosporins,DrugBank
DB09062,Sulfur Compounds,DrugBank
DB09062,Thiazines,DrugBank
DB09063,Anaplastic lymphoma kinase (ALK) inhibitors,DrugBank
DB09063,Antineoplastic Agents,DrugBank
DB09063,Antineoplastic and Immunomodulating Agents,DrugBank
DB09063,Bradycardia-Causing Agents,DrugBank
DB09063,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09063,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09063,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09063,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09063,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09063,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09063,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09063,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09063,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09063,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09063,Cytochrome P-450 Substrates,DrugBank
DB09063,Enzyme Inhibitors,DrugBank
DB09063,Hyperglycemia-Associated Agents,DrugBank
DB09063,Kinase Inhibitor,DrugBank
DB09063,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09063,Narrow Therapeutic Index Drugs,DrugBank
DB09063,P-glycoprotein substrates,DrugBank
DB09063,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09063,Protein Kinase Inhibitors,DrugBank
DB09063,QTc Prolonging Agents,DrugBank
DB09063,"Receptor Protein-Tyrosine Kinases, antagonists & inhibitors",DrugBank
DB09063,ROS1 tyrosine kinase inhibitors,DrugBank
DB09063,Sulfur Compounds,DrugBank
DB09063,Tyrosine Kinase Inhibitors,DrugBank
DB09064,"Acids, Acyclic",DrugBank
DB09064,Agents Causing Muscle Toxicity,DrugBank
DB09064,Benzene Derivatives,DrugBank
DB09064,Butyrates,DrugBank
DB09064,Carcinogens,DrugBank
DB09064,Ethers,DrugBank
DB09064,Fibric Acids,DrugBank
DB09064,Hypolipidemic Agents,DrugBank
DB09064,Isobutyrates,DrugBank
DB09064,Lipid Modifying Agents,DrugBank
DB09064,"Lipid Modifying Agents, Plain",DrugBank
DB09064,Lipid Regulating Agents,DrugBank
DB09064,Noxae,DrugBank
DB09064,Peroxisome Proliferators,DrugBank
DB09064,Phenols,DrugBank
DB09064,Phenyl Ethers,DrugBank
DB09064,Toxic Actions,DrugBank
DB09065,"Acids, Acyclic",DrugBank
DB09065,Anti-HIV Agents,DrugBank
DB09065,Anti-Infective Agents,DrugBank
DB09065,Antiinfectives for Systemic Use,DrugBank
DB09065,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB09065,BCRP/ABCG2 Inhibitors,DrugBank
DB09065,Carbamates,DrugBank
DB09065,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09065,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB09065,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09065,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09065,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09065,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09065,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09065,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09065,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09065,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB09065,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09065,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB09065,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB09065,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB09065,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09065,Cytochrome P-450 Substrates,DrugBank
DB09065,Enzyme Inhibitors,DrugBank
DB09065,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09065,OATP1B3 inhibitors,DrugBank
DB09065,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB09065,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB09065,Other Miscellaneous Therapeutic Agents,DrugBank
DB09065,P-glycoprotein inhibitors,DrugBank
DB09065,Sulfur Compounds,DrugBank
DB09065,Thiazoles,DrugBank
DB09066,Drugs that are Mainly Renally Excreted,DrugBank
DB09066,Follicle Stimulating Hormone,DrugBank
DB09066,Genito Urinary System and Sex Hormones,DrugBank
DB09066,Gonadotropins,DrugBank
DB09066,"Gonadotropins, Pituitary",DrugBank
DB09066,Hormones,DrugBank
DB09066,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09066,Peptide Hormones,DrugBank
DB09066,Pituitary Hormones,DrugBank
DB09066,"Pituitary Hormones, Anterior",DrugBank
DB09066,Recombinant Proteins,DrugBank
DB09066,Sex Hormones and Modulators of the Genital System,DrugBank
DB09067,"Amino Acids, Peptides, and Proteins",DrugBank
DB09067,Diagnostic Agents,DrugBank
DB09067,Hormones,DrugBank
DB09067,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09067,Hypothalamic Hormones,DrugBank
DB09067,Nerve Tissue Proteins,DrugBank
DB09067,Neuropeptides,DrugBank
DB09067,Peptide Hormones,DrugBank
DB09067,Peptides,DrugBank
DB09067,Pituitary Hormone-Releasing Hormones,DrugBank
DB09067,Proteins,DrugBank
DB09067,Tests for Pituitary Function,DrugBank
DB09068,Agents that produce hypertension,DrugBank
DB09068,Anti-Anxiety Agents,DrugBank
DB09068,Antidepressive Agents,DrugBank
DB09068,Antidepressive Agents Indicated for Depression,DrugBank
DB09068,Central Nervous System Agents,DrugBank
DB09068,Central Nervous System Depressants,DrugBank
DB09068,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09068,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09068,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09068,Cytochrome P-450 Substrates,DrugBank
DB09068,Drugs that are Mainly Renally Excreted,DrugBank
DB09068,Membrane Transport Modulators,DrugBank
DB09068,Nervous System,DrugBank
DB09068,Neurotransmitter Agents,DrugBank
DB09068,Neurotransmitter Uptake Inhibitors,DrugBank
DB09068,Piperazines,DrugBank
DB09068,Psychoanaleptics,DrugBank
DB09068,Psychotropic Drugs,DrugBank
DB09068,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09068,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB09068,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB09068,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB09068,Serotonin Agents,DrugBank
DB09068,Serotonin Modulators,DrugBank
DB09068,Serotonin Receptor Agonists,DrugBank
DB09068,Serotonin Receptor Antagonists,DrugBank
DB09068,Tranquilizing Agents,DrugBank
DB09069,Cardiac Therapy,DrugBank
DB09069,Cardiovascular Agents,DrugBank
DB09069,Piperazines,DrugBank
DB09069,Vasodilating Agents,DrugBank
DB09070,Anabolic Agents,DrugBank
DB09070,"Antineoplastic Agents, Hormonal",DrugBank
DB09070,Cardiovascular Agents,DrugBank
DB09070,Estrogen Receptor Modulators,DrugBank
DB09070,Estrogens,DrugBank
DB09070,"Estrogens, Antiestrogens, and Estrogen Agonist-Antagonists",DrugBank
DB09070,Fused-Ring Compounds,DrugBank
DB09070,Genito Urinary System and Sex Hormones,DrugBank
DB09070,Hormone Antagonists,DrugBank
DB09070,Hormones,DrugBank
DB09070,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09070,Norpregnanes,DrugBank
DB09070,Norsteroids,DrugBank
DB09070,Sex Hormones and Modulators of the Genital System,DrugBank
DB09070,Steroids,DrugBank
DB09071,Central Nervous System Depressants,DrugBank
DB09071,Cycloparaffins,DrugBank
DB09071,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09071,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09071,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09071,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09071,Cytochrome P-450 Substrates,DrugBank
DB09071,Drugs that are Mainly Renally Excreted,DrugBank
DB09071,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09071,Hypnotics and Sedatives,DrugBank
DB09071,Melatonin Receptor Agonists,DrugBank
DB09071,Nervous System,DrugBank
DB09071,Psycholeptics,DrugBank
DB09071,"Receptors, Melatonin, agonists",DrugBank
DB09072,"Acids, Acyclic",DrugBank
DB09072,"Adjuvants, Anesthesia",DrugBank
DB09072,Anesthetics,DrugBank
DB09072,"Anesthetics, General",DrugBank
DB09072,"Anesthetics, Intravenous",DrugBank
DB09072,Butyrates,DrugBank
DB09072,Central Nervous System Agents,DrugBank
DB09072,Central Nervous System Depressants,DrugBank
DB09072,Hydroxy Acids,DrugBank
DB09072,Hydroxybutyrates,DrugBank
DB09072,Miscellaneous Central Nervous System Agents,DrugBank
DB09072,Nervous System,DrugBank
DB09073,Antineoplastic Agents,DrugBank
DB09073,Antineoplastic and Immunomodulating Agents,DrugBank
DB09073,BCRP/ABCG2 Inhibitors,DrugBank
DB09073,BCRP/ABCG2 Substrates,DrugBank
DB09073,Cyclin-dependent kinase (CDK) inhibitors,DrugBank
DB09073,"Cyclin-Dependent Kinases, antagonists & inhibitors",DrugBank
DB09073,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09073,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09073,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09073,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09073,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09073,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09073,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09073,Cytochrome P-450 Substrates,DrugBank
DB09073,Enzyme Inhibitors,DrugBank
DB09073,Immunosuppressive Agents,DrugBank
DB09073,Kinase Inhibitor,DrugBank
DB09073,Myelosuppressive Agents,DrugBank
DB09073,Narrow Therapeutic Index Drugs,DrugBank
DB09073,OCT1 inhibitors,DrugBank
DB09073,P-glycoprotein inhibitors,DrugBank
DB09073,P-glycoprotein substrates,DrugBank
DB09073,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09073,Protein Kinase Inhibitors,DrugBank
DB09074,Antineoplastic Agents,DrugBank
DB09074,Antineoplastic and Immunomodulating Agents,DrugBank
DB09074,BCRP/ABCG2 Inhibitors,DrugBank
DB09074,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB09074,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB09074,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09074,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09074,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09074,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09074,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09074,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09074,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09074,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09074,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09074,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB09074,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB09074,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09074,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB09074,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09074,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB09074,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09074,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09074,Cytochrome P-450 Substrates,DrugBank
DB09074,Enzyme Inhibitors,DrugBank
DB09074,Immunosuppressive Agents,DrugBank
DB09074,MATE 1 Inhibitors,DrugBank
DB09074,MATE 2-K Inhibitors,DrugBank
DB09074,MATE inhibitors,DrugBank
DB09074,Myelosuppressive Agents,DrugBank
DB09074,Narrow Therapeutic Index Drugs,DrugBank
DB09074,OAT3/SLC22A8 Inhibitors,DrugBank
DB09074,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09074,OCT1 inhibitors,DrugBank
DB09074,OCT2 Inhibitors,DrugBank
DB09074,P-glycoprotein inhibitors,DrugBank
DB09074,P-glycoprotein substrates,DrugBank
DB09074,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09074,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB09074,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB09074,Pyridazines,DrugBank
DB09074,UGT1A1 Inhibitors,DrugBank
DB09075,Anticoagulants,DrugBank
DB09075,Antithrombins,DrugBank
DB09075,Blood and Blood Forming Organs,DrugBank
DB09075,Direct factor Xa inhibitors,DrugBank
DB09075,Drugs that are Mainly Renally Excreted,DrugBank
DB09075,Enzyme Inhibitors,DrugBank
DB09075,Factor Xa Inhibitors,DrugBank
DB09075,Hematologic Agents,DrugBank
DB09075,P-glycoprotein substrates,DrugBank
DB09075,Protease Inhibitors,DrugBank
DB09075,Serine Protease Inhibitors,DrugBank
DB09075,Sulfur Compounds,DrugBank
DB09076,"Adrenergics, Inhalants",DrugBank
DB09076,Agents producing tachycardia,DrugBank
DB09076,Agents to Treat Airway Disease,DrugBank
DB09076,Anticholinergic Agents,DrugBank
DB09076,Antimuscarinics Antispasmodics,DrugBank
DB09076,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09076,Cytochrome P-450 Substrates,DrugBank
DB09076,Drugs for Obstructive Airway Diseases,DrugBank
DB09076,Muscarinic Antagonists,DrugBank
DB09076,OCT1 substrates,DrugBank
DB09076,OCT2 Substrates,DrugBank
DB09076,P-glycoprotein substrates,DrugBank
DB09076,"Pulmonary Disease, Chronic Obstructive, drug therapy",DrugBank
DB09077,"Amino Acids, Peptides, and Proteins",DrugBank
DB09077,Antibodies,DrugBank
DB09077,"Antibodies, Monoclonal",DrugBank
DB09077,Antineoplastic Agents,DrugBank
DB09077,Antineoplastic and Immunomodulating Agents,DrugBank
DB09077,Blood Proteins,DrugBank
DB09077,Cancer immunotherapy,DrugBank
DB09077,Globulins,DrugBank
DB09077,Glycolipid Disialoganglioside-directed Antibody,DrugBank
DB09077,Glycolipid Disialoganglioside-directed Antibody Interactions,DrugBank
DB09077,Hypotensive Agents,DrugBank
DB09077,Immunoglobulins,DrugBank
DB09077,Immunoproteins,DrugBank
DB09077,Immunosuppressive Agents,DrugBank
DB09077,Immunotherapy,DrugBank
DB09077,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09077,Myelosuppressive Agents,DrugBank
DB09077,Narrow Therapeutic Index Drugs,DrugBank
DB09077,Proteins,DrugBank
DB09077,Serum Globulins,DrugBank
DB09078,Amides,DrugBank
DB09078,Antineoplastic Agents,DrugBank
DB09078,Antineoplastic and Immunomodulating Agents,DrugBank
DB09078,BCRP/ABCG2 Substrates,DrugBank
DB09078,Benzene Derivatives,DrugBank
DB09078,BSEP/ABCB11 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB09078,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB09078,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09078,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB09078,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09078,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09078,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09078,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09078,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09078,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB09078,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09078,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09078,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09078,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09078,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09078,Cytochrome P-450 Substrates,DrugBank
DB09078,Enzyme Inhibitors,DrugBank
DB09078,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09078,Kinase Inhibitor,DrugBank
DB09078,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09078,OAT1/SLC22A6 inhibitors,DrugBank
DB09078,OAT3/SLC22A8 Inhibitors,DrugBank
DB09078,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09078,OATP1B3 inhibitors,DrugBank
DB09078,OCT2 Inhibitors,DrugBank
DB09078,P-glycoprotein inhibitors,DrugBank
DB09078,P-glycoprotein substrates,DrugBank
DB09078,Protein Kinase Inhibitors,DrugBank
DB09078,QTc Prolonging Agents,DrugBank
DB09078,Receptor Tyrosine Kinase Inhibitors,DrugBank
DB09078,Tyrosine Kinase Inhibitors,DrugBank
DB09079,Antifibrotic Agents,DrugBank
DB09079,Antineoplastic Agents,DrugBank
DB09079,Antineoplastic and Immunomodulating Agents,DrugBank
DB09079,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09079,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09079,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09079,Cytochrome P-450 Substrates,DrugBank
DB09079,Enzyme Inhibitors,DrugBank
DB09079,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09079,Kinase Inhibitor,DrugBank
DB09079,OCT1 inhibitors,DrugBank
DB09079,OCT1 substrates,DrugBank
DB09079,P-glycoprotein inhibitors,DrugBank
DB09079,P-glycoprotein substrates,DrugBank
DB09079,Protein Kinase Inhibitors,DrugBank
DB09079,Tyrosine Kinase Inhibitors,DrugBank
DB09079,UGT1A1 Substrates,DrugBank
DB09080,Adrenergic Agonists,DrugBank
DB09080,Adrenergic beta-1 Receptor Agonists,DrugBank
DB09080,Adrenergic beta-2 Receptor Agonists,DrugBank
DB09080,Adrenergic beta-Agonists,DrugBank
DB09080,"Adrenergics, Inhalants",DrugBank
DB09080,Agents producing tachycardia,DrugBank
DB09080,Agents that produce hypertension,DrugBank
DB09080,Agents to Treat Airway Disease,DrugBank
DB09080,Anti-Asthmatic Agents,DrugBank
DB09080,Autonomic Agents,DrugBank
DB09080,Bronchodilator Agents,DrugBank
DB09080,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09080,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09080,Cytochrome P-450 Substrates,DrugBank
DB09080,Drugs for Obstructive Airway Diseases,DrugBank
DB09080,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09080,Long-acting beta-adrenoceptor agonists,DrugBank
DB09080,Oxazines,DrugBank
DB09080,Peripheral Nervous System Agents,DrugBank
DB09080,Potential QTc-Prolonging Agents,DrugBank
DB09080,QTc Prolonging Agents,DrugBank
DB09080,Respiratory System Agents,DrugBank
DB09080,Selective Beta 2-adrenergic Agonists,DrugBank
DB09081,Antioxidants,DrugBank
DB09081,Benzoquinones,DrugBank
DB09081,Biological Factors,DrugBank
DB09081,Coenzymes,DrugBank
DB09081,"Compounds used in a research, industrial, or household setting",DrugBank
DB09081,Drugs that are Mainly Renally Excreted,DrugBank
DB09081,Enzymes and Coenzymes,DrugBank
DB09081,Nervous System,DrugBank
DB09081,Protective Agents,DrugBank
DB09081,Psychoanaleptics,DrugBank
DB09081,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB09081,Quinones,DrugBank
DB09082,Adrenergic Agonists,DrugBank
DB09082,Adrenergic beta-2 Receptor Agonists,DrugBank
DB09082,Adrenergic beta-Agonists,DrugBank
DB09082,"Adrenergics, Inhalants",DrugBank
DB09082,Agents producing tachycardia,DrugBank
DB09082,Agents that produce hypertension,DrugBank
DB09082,Agents to Treat Airway Disease,DrugBank
DB09082,Alcohols,DrugBank
DB09082,Benzene Derivatives,DrugBank
DB09082,Benzyl Compounds,DrugBank
DB09082,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09082,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09082,Cytochrome P-450 Substrates,DrugBank
DB09082,Drugs for Obstructive Airway Diseases,DrugBank
DB09082,Drugs that are Mainly Renally Excreted,DrugBank
DB09082,"Hydrocarbons, Chlorinated",DrugBank
DB09082,"Hydrocarbons, Halogenated",DrugBank
DB09082,Immunosuppressive Agents,DrugBank
DB09082,Long-acting beta-adrenoceptor agonists,DrugBank
DB09082,P-glycoprotein substrates,DrugBank
DB09082,Potential QTc-Prolonging Agents,DrugBank
DB09082,QTc Prolonging Agents,DrugBank
DB09083,Benzazepines,DrugBank
DB09083,Bradycardia-Causing Agents,DrugBank
DB09083,Cardiac Therapy,DrugBank
DB09083,Cardiovascular Agents,DrugBank
DB09083,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09083,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09083,Cytochrome P-450 Substrates,DrugBank
DB09083,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09083,Highest Risk QTc-Prolonging Agents,DrugBank
DB09083,Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists,DrugBank
DB09083,Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker,DrugBank
DB09083,Miscellaneous Cardiac Drugs,DrugBank
DB09083,QTc Prolonging Agents,DrugBank
DB09084,Agents causing hyperkalemia,DrugBank
DB09084,Agents that produce hypertension,DrugBank
DB09084,Alimentary Tract and Metabolism,DrugBank
DB09084,Anti-Inflammatory Agents,DrugBank
DB09084,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09084,Antiinflammatory and Antirheumatic Products,DrugBank
DB09084,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09084,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB09084,Antiinflammatory Products for Vaginal Administration,DrugBank
DB09084,Drugs that are Mainly Renally Excreted,DrugBank
DB09084,Genito Urinary System and Sex Hormones,DrugBank
DB09084,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09084,Indazoles,DrugBank
DB09084,Mouthwashes and Gargles,DrugBank
DB09084,Musculo-Skeletal System,DrugBank
DB09084,Nephrotoxic agents,DrugBank
DB09084,Non COX-2 selective NSAIDS,DrugBank
DB09084,Pyrazoles,DrugBank
DB09084,Stomatological Preparations,DrugBank
DB09084,Throat Preparations,DrugBank
DB09084,Topical Products for Joint and Muscular Pain,DrugBank
DB09085,"Acids, Carbocyclic",DrugBank
DB09085,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB09085,Aminobenzoates,DrugBank
DB09085,Anesthetics,DrugBank
DB09085,Anesthetics for Topical Use,DrugBank
DB09085,"Anesthetics, General",DrugBank
DB09085,"Anesthetics, Local",DrugBank
DB09085,Antipruritics and Local Anesthetics,DrugBank
DB09085,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB09085,Benzene Derivatives,DrugBank
DB09085,Benzoates,DrugBank
DB09085,Central Nervous System Agents,DrugBank
DB09085,Central Nervous System Depressants,DrugBank
DB09085,Dental Agents,DrugBank
DB09085,Dermatologicals,DrugBank
DB09085,Esters of Aminobenzoic Acid,DrugBank
DB09085,Local Anesthesia,DrugBank
DB09085,Local Anesthetics (Ester),DrugBank
DB09085,Methemoglobinemia Associated Agents,DrugBank
DB09085,Nervous System,DrugBank
DB09085,Ophthalmologicals,DrugBank
DB09085,para-Aminobenzoates,DrugBank
DB09085,Peripheral Nervous System Agents,DrugBank
DB09085,Sensory Organs,DrugBank
DB09085,Sensory System Agents,DrugBank
DB09085,Vasoprotectives,DrugBank
DB09087,"Adjuvants, Immunologic",DrugBank
DB09087,Aluminium Compounds,DrugBank
DB09087,Immunologic Factors,DrugBank
DB09087,Metal cations,DrugBank
DB09087,Metal divalent cations,DrugBank
DB09087,Potassium Salt,DrugBank
DB09087,Sulfates,DrugBank
DB09087,Sulfur Acids,DrugBank
DB09087,Sulfur Compounds,DrugBank
DB09087,Sulfuric Acids,DrugBank
DB09089,"Acids, Carbocyclic",DrugBank
DB09089,Agents causing hyperkalemia,DrugBank
DB09089,Agents producing tachycardia,DrugBank
DB09089,Alimentary Tract and Metabolism,DrugBank
DB09089,Antiarrhythmic agents,DrugBank
DB09089,Anticholinergic Agents,DrugBank
DB09089,Antimuscarinics Antispasmodics,DrugBank
DB09089,Arylsulfonates,DrugBank
DB09089,Arylsulfonic Acids,DrugBank
DB09089,Autonomic Agents,DrugBank
DB09089,Benzene Derivatives,DrugBank
DB09089,Benzoates,DrugBank
DB09089,Bradycardia-Causing Agents,DrugBank
DB09089,Calcium Channel Blockers,DrugBank
DB09089,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09089,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09089,Cytochrome P-450 Substrates,DrugBank
DB09089,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB09089,Drugs that are Mainly Renally Excreted,DrugBank
DB09089,Gastrointestinal Agents,DrugBank
DB09089,Hydroxy Acids,DrugBank
DB09089,Hydroxybenzoate Ethers,DrugBank
DB09089,Hydroxybenzoates,DrugBank
DB09089,Muscarinic Antagonists,DrugBank
DB09089,Parasympatholytics,DrugBank
DB09089,Peripheral Nervous System Agents,DrugBank
DB09089,Phenols,DrugBank
DB09089,Phenyl Ethers,DrugBank
DB09089,Potential QTc-Prolonging Agents,DrugBank
DB09089,Prokinetic Agents,DrugBank
DB09089,QTc Prolonging Agents,DrugBank
DB09089,Sulfonic Acids,DrugBank
DB09089,Sulfur Acids,DrugBank
DB09089,Sulfur Compounds,DrugBank
DB09089,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB09090,Agents causing hyperkalemia,DrugBank
DB09090,Alimentary Tract and Metabolism,DrugBank
DB09090,Antiarrhythmic agents,DrugBank
DB09090,Autonomic Agents,DrugBank
DB09090,Bradycardia-Causing Agents,DrugBank
DB09090,Calcium Channel Blockers,DrugBank
DB09090,Calcium-Regulating Hormones and Agents,DrugBank
DB09090,Cardiovascular Agents,DrugBank
DB09090,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09090,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09090,Cytochrome P-450 Substrates,DrugBank
DB09090,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB09090,Membrane Transport Modulators,DrugBank
DB09090,Miscellaneous GI Drugs,DrugBank
DB09090,Oxazines,DrugBank
DB09090,Parasympatholytics,DrugBank
DB09090,Peripheral Nervous System Agents,DrugBank
DB09090,Potential QTc-Prolonging Agents,DrugBank
DB09090,QTc Prolonging Agents,DrugBank
DB09090,Vasodilating Agents,DrugBank
DB09091,11-Hydroxycorticosteroids,DrugBank
DB09091,17-Hydroxycorticosteroids,DrugBank
DB09091,Adrenal Cortex Hormones,DrugBank
DB09091,Alimentary Tract and Metabolism,DrugBank
DB09091,Anti-Allergic Agents,DrugBank
DB09091,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB09091,Cell-mediated Immunity,DrugBank
DB09091,Corticosteroids,DrugBank
DB09091,Corticosteroids Acting Locally,DrugBank
DB09091,Drugs that are Mainly Renally Excreted,DrugBank
DB09091,Fused-Ring Compounds,DrugBank
DB09091,Hormones,DrugBank
DB09091,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09091,Hydroxycorticosteroids,DrugBank
DB09091,Immunosuppressive Agents,DrugBank
DB09091,Increased Histamine Release,DrugBank
DB09091,Intestinal Antiinflammatory Agents,DrugBank
DB09091,Nasal Preparations,DrugBank
DB09091,Pregnanes,DrugBank
DB09091,Pregnenediones,DrugBank
DB09091,Pregnenes,DrugBank
DB09091,Standardized Chemical Allergen,DrugBank
DB09091,Steroids,DrugBank
DB09092,Cardiovascular Agents,DrugBank
DB09092,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09092,Nicotinic Acids,DrugBank
DB09092,Peripheral Vasodilators,DrugBank
DB09092,Purine Derivatives,DrugBank
DB09092,Purines,DrugBank
DB09092,Purinones,DrugBank
DB09092,Pyridines,DrugBank
DB09092,Vasodilating Agents,DrugBank
DB09093,Agents that produce neuromuscular block (indirect),DrugBank
DB09093,Alimentary Tract and Metabolism,DrugBank
DB09093,Anti-Bacterial Agents,DrugBank
DB09093,Anti-Infective Agents,DrugBank
DB09093,Antibacterials for Systemic Use,DrugBank
DB09093,Antibiotics for Topical Use,DrugBank
DB09093,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB09093,Antiinfectives for Systemic Use,DrugBank
DB09093,Antiparasitic Agents,DrugBank
DB09093,Antiprotozoals,DrugBank
DB09093,Dermatologicals,DrugBank
DB09093,Enzyme Inhibitors,DrugBank
DB09093,Naphthacenes,DrugBank
DB09093,Ophthalmologicals,DrugBank
DB09093,Protein Synthesis Inhibitors,DrugBank
DB09093,Sensory Organs,DrugBank
DB09093,Stomatological Preparations,DrugBank
DB09093,Tetracyclines,DrugBank
DB09095,Adrenal Cortex Hormones,DrugBank
DB09095,Anti-Inflammatory Agents,DrugBank
DB09095,Corticosteroids,DrugBank
DB09095,"Corticosteroids, Dermatological Preparations",DrugBank
DB09095,"Corticosteroids, Potent (Group III)",DrugBank
DB09095,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09095,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09095,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09095,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09095,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09095,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB09095,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB09095,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09095,Cytochrome P-450 Substrates,DrugBank
DB09095,Dermatologicals,DrugBank
DB09095,Drugs that are Mainly Renally Excreted,DrugBank
DB09095,Fused-Ring Compounds,DrugBank
DB09095,Glucocorticoids,DrugBank
DB09095,Hormones,DrugBank
DB09095,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09095,Hyperglycemia-Associated Agents,DrugBank
DB09095,Immunosuppressive Agents,DrugBank
DB09095,Pregnadienediols,DrugBank
DB09095,Pregnadienes,DrugBank
DB09095,Pregnanes,DrugBank
DB09095,Steroids,DrugBank
DB09095,"Steroids, Fluorinated",DrugBank
DB09097,Dopamine Agents,DrugBank
DB09097,Dopamine Agonists,DrugBank
DB09097,Dopamine D2 Receptor Agonists,DrugBank
DB09097,Genito Urinary System and Sex Hormones,DrugBank
DB09097,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09097,Miscellaneous Therapeutic Agents,DrugBank
DB09097,Neurotransmitter Agents,DrugBank
DB09097,Prolactine Inhibitors,DrugBank
DB09097,Quinolines,DrugBank
DB09098,"Amino Acids, Peptides, and Proteins",DrugBank
DB09098,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB09098,Growth Hormone,DrugBank
DB09098,Hormones,DrugBank
DB09098,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09098,Peptide Hormones,DrugBank
DB09098,Peptides,DrugBank
DB09098,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB09098,Pituitary Hormones,DrugBank
DB09098,"Pituitary Hormones, Anterior",DrugBank
DB09098,Somatropin and Somatropin Agonists,DrugBank
DB09098,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB09099,"Amino Acids, Peptides, and Proteins",DrugBank
DB09099,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09099,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09099,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09099,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09099,Hormones,DrugBank
DB09099,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09099,Hypothalamic Hormones,DrugBank
DB09099,Nerve Tissue Proteins,DrugBank
DB09099,Neuropeptides,DrugBank
DB09099,P-glycoprotein substrates,DrugBank
DB09099,Pancreatic Hormones,DrugBank
DB09099,Peptide Hormones,DrugBank
DB09099,Peptides,DrugBank
DB09099,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB09099,Pituitary Hormone Release Inhibiting Hormones,DrugBank
DB09099,Proteins,DrugBank
DB09099,Somatostatin and Analogues,DrugBank
DB09099,"Somatostatin, agonists",DrugBank
DB09099,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB09100,Agents used to treat hypothyroidism,DrugBank
DB09100,Thyroid Products,DrugBank
DB09101,Anti-HIV Agents,DrugBank
DB09101,Anti-Infective Agents,DrugBank
DB09101,Anti-Retroviral Agents,DrugBank
DB09101,Antiinfectives for Systemic Use,DrugBank
DB09101,Antiviral Agents,DrugBank
DB09101,Antivirals for Systemic Use,DrugBank
DB09101,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB09101,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB09101,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09101,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09101,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09101,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB09101,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09101,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09101,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09101,Cytochrome P-450 Substrates,DrugBank
DB09101,Direct Acting Antivirals,DrugBank
DB09101,Enzyme Inhibitors,DrugBank
DB09101,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09101,HIV Integrase,DrugBank
DB09101,HIV Integrase Inhibitors,DrugBank
DB09101,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,DrugBank
DB09101,Integrase Inhibitors,DrugBank
DB09101,Quinolines,DrugBank
DB09101,UGT1A1 Substrates,DrugBank
DB09102,"Acids, Acyclic",DrugBank
DB09102,Amino Acids,DrugBank
DB09102,"Amino Acids, Branched-Chain",DrugBank
DB09102,"Amino Acids, Essential",DrugBank
DB09102,"Amino Acids, Peptides, and Proteins",DrugBank
DB09102,Antiinfectives for Systemic Use,DrugBank
DB09102,Antiviral Agents,DrugBank
DB09102,Antivirals for Systemic Use,DrugBank
DB09102,Antivirals for treatment of HCV infections,DrugBank
DB09102,BCRP/ABCG2 Inhibitors,DrugBank
DB09102,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09102,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09102,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09102,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB09102,Cytochrome P-450 Substrates,DrugBank
DB09102,Direct Acting Antivirals,DrugBank
DB09102,HCV Replication Complex Inhibitors,DrugBank
DB09102,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB09102,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09102,OATP1B3 inhibitors,DrugBank
DB09102,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB09102,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB09102,P-glycoprotein inhibitors,DrugBank
DB09102,P-glycoprotein substrates,DrugBank
DB09103,"Adjuvants, Immunologic",DrugBank
DB09103,"Amino Acids, Peptides, and Proteins",DrugBank
DB09103,Antineoplastic and Immunomodulating Agents,DrugBank
DB09103,Biological Factors,DrugBank
DB09103,Colony-Stimulating Factors,DrugBank
DB09103,Cytokines,DrugBank
DB09103,Drugs that are Mainly Renally Excreted,DrugBank
DB09103,Hematopoietic Cell Growth Factors,DrugBank
DB09103,Intercellular Signaling Peptides and Proteins,DrugBank
DB09103,Peptides,DrugBank
DB09103,Proteins,DrugBank
DB09104,Agents that produce neuromuscular block (indirect),DrugBank
DB09104,Alimentary Tract and Metabolism,DrugBank
DB09104,Alkalies,DrugBank
DB09104,Aluminum and magnesium containing antacids,DrugBank
DB09104,Anions,DrugBank
DB09104,Antacids,DrugBank
DB09104,Antacids and Adsorbents,DrugBank
DB09104,Basic Ointments and Protectants,DrugBank
DB09104,Drugs for Acid Related Disorders,DrugBank
DB09104,Drugs that are Mainly Renally Excreted,DrugBank
DB09104,Electrolytes,DrugBank
DB09104,Emollients Demulcents and Protectants,DrugBank
DB09104,Gastric Acid Lowering Agents,DrugBank
DB09104,Gastrointestinal Agents,DrugBank
DB09104,Genito Urinary System and Sex Hormones,DrugBank
DB09104,Hydroxides,DrugBank
DB09104,Ions,DrugBank
DB09104,Laxatives,DrugBank
DB09104,"Laxatives, magnesium containing",DrugBank
DB09104,Magnesium Compounds,DrugBank
DB09104,Magnesium Salts,DrugBank
DB09104,Metal cations,DrugBank
DB09104,Metal divalent cations,DrugBank
DB09104,Osmotic Laxatives,DrugBank
DB09104,Urologicals,DrugBank
DB09105,Alimentary Tract and Metabolism,DrugBank
DB09105,"Amino Acids, Peptides, and Proteins",DrugBank
DB09105,Antibodies,DrugBank
DB09105,Blood Proteins,DrugBank
DB09105,Enzyme Replacement Therapy,DrugBank
DB09105,Enzymes,DrugBank
DB09105,Enzymes and Coenzymes,DrugBank
DB09105,Esterases,DrugBank
DB09105,Globulins,DrugBank
DB09105,Hydrolases,DrugBank
DB09105,"Hypophosphatasia, drug therapy",DrugBank
DB09105,Immunoglobulin Isotypes,DrugBank
DB09105,Immunoglobulins,DrugBank
DB09105,Immunoproteins,DrugBank
DB09105,Phosphoric Monoester Hydrolases,DrugBank
DB09105,Proteins,DrugBank
DB09105,Recombinant Proteins,DrugBank
DB09105,Serum Globulins,DrugBank
DB09105,Tissue-nonspecific Alkaline Phosphatase,DrugBank
DB09106,Blood and Blood Forming Organs,DrugBank
DB09106,Blood and Related Products,DrugBank
DB09106,Blood Substitutes,DrugBank
DB09106,Blood Substitutes and Perfusion Solutions,DrugBank
DB09106,Blood Substitutes and Plasma Protein Fractions,DrugBank
DB09106,Carbohydrates,DrugBank
DB09106,"Compounds used in a research, industrial, or household setting",DrugBank
DB09106,Dietary Carbohydrates,DrugBank
DB09106,Drugs that are Mainly Renally Excreted,DrugBank
DB09106,Glucans,DrugBank
DB09106,Hematologic Agents,DrugBank
DB09106,Increased Intravascular Volume,DrugBank
DB09106,Osmotic Activity,DrugBank
DB09106,Plasma Substitutes,DrugBank
DB09106,Polysaccharides,DrugBank
DB09106,Replacement Preparations,DrugBank
DB09106,Starch,DrugBank
DB09107,Alcohols,DrugBank
DB09107,"Amino Acids, Peptides, and Proteins",DrugBank
DB09107,Antianemic Preparations,DrugBank
DB09107,Biological Factors,DrugBank
DB09107,Blood and Blood Forming Organs,DrugBank
DB09107,Carbohydrates,DrugBank
DB09107,Colony-Stimulating Factors,DrugBank
DB09107,"Compounds used in a research, industrial, or household setting",DrugBank
DB09107,Cytokines,DrugBank
DB09107,Erythropoiesis-Stimulating Agents,DrugBank
DB09107,Ethylene Glycols,DrugBank
DB09107,Glycoconjugates,DrugBank
DB09107,Glycols,DrugBank
DB09107,Glycoproteins,DrugBank
DB09107,Hematinics,DrugBank
DB09107,Hematopoietic Cell Growth Factors,DrugBank
DB09107,Increased Erythroid Cell Production,DrugBank
DB09107,Intercellular Signaling Peptides and Proteins,DrugBank
DB09107,Macromolecular Substances,DrugBank
DB09107,Pegylated agents,DrugBank
DB09107,Peptides,DrugBank
DB09107,Polymers,DrugBank
DB09107,Proteins,DrugBank
DB09109,"Amino Acids, Peptides, and Proteins",DrugBank
DB09109,Biological Factors,DrugBank
DB09109,Blood Coagulation Factors,DrugBank
DB09109,Blood Proteins,DrugBank
DB09109,Hemostatics,DrugBank
DB09109,Protein Precursors,DrugBank
DB09109,Proteins,DrugBank
DB09109,Recombinant Proteins,DrugBank
DB09111,Blood Substitutes,DrugBank
DB09111,Carbohydrates,DrugBank
DB09111,"Compounds used in a research, industrial, or household setting",DrugBank
DB09111,Dietary Carbohydrates,DrugBank
DB09111,Drugs that are Mainly Renally Excreted,DrugBank
DB09111,Glucans,DrugBank
DB09111,Hematologic Agents,DrugBank
DB09111,Increased Intravascular Volume,DrugBank
DB09111,Osmotic Activity,DrugBank
DB09111,Plasma Substitutes,DrugBank
DB09111,Polysaccharides,DrugBank
DB09111,Starch,DrugBank
DB09112,Acids,DrugBank
DB09112,"Acids, Noncarboxylic",DrugBank
DB09112,Anions,DrugBank
DB09112,Antidotes,DrugBank
DB09112,"Compounds used in a research, industrial, or household setting",DrugBank
DB09112,"Diet, Food, and Nutrition",DrugBank
DB09112,Electrolytes,DrugBank
DB09112,Food,DrugBank
DB09112,Food Additives,DrugBank
DB09112,Food Ingredients,DrugBank
DB09112,Food Preservatives,DrugBank
DB09112,Hypotensive Agents,DrugBank
DB09112,Indicators and Reagents,DrugBank
DB09112,Ions,DrugBank
DB09112,Laboratory Chemicals,DrugBank
DB09112,Nitrites,DrugBank
DB09112,Nitrogen Compounds,DrugBank
DB09112,Physiological Phenomena,DrugBank
DB09112,Sodium Compounds,DrugBank
DB09113,Alveolar Surface Tension Reduction,DrugBank
DB09113,Bradycardia-Causing Agents,DrugBank
DB09113,Complex Mixtures,DrugBank
DB09113,Lipids,DrugBank
DB09113,Membrane Lipids,DrugBank
DB09113,Pulmonary Surfactants,DrugBank
DB09113,Respiratory System Agents,DrugBank
DB09113,Surface-Active Agents,DrugBank
DB09113,Surfactant Activity,DrugBank
DB09117,Acetaldehyde,DrugBank
DB09117,Anticonvulsants,DrugBank
DB09117,Central Nervous System Agents,DrugBank
DB09117,Central Nervous System Depressants,DrugBank
DB09117,Hypnotics and Sedatives,DrugBank
DB09117,Nervous System,DrugBank
DB09117,Psycholeptics,DrugBank
DB09118,Anticonvulsants,DrugBank
DB09118,BCRP/ABCG2 Inhibitors,DrugBank
DB09118,Central Nervous System Agents,DrugBank
DB09118,Central Nervous System Depressants,DrugBank
DB09118,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09118,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09118,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB09118,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP2C19 Inhibitors (strong),DrugBank
DB09118,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09118,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09118,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09118,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09118,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09118,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09118,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB09118,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09118,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09118,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09118,Cytochrome P-450 Substrates,DrugBank
DB09118,Dioxoles,DrugBank
DB09118,Drugs causing inadvertant photosensitivity,DrugBank
DB09118,Drugs that are Mainly Renally Excreted,DrugBank
DB09118,Miscellaneous Anticonvulsants,DrugBank
DB09118,Nervous System,DrugBank
DB09118,P-glycoprotein inhibitors,DrugBank
DB09118,Photosensitizing Agents,DrugBank
DB09119,Anticonvulsants,DrugBank
DB09119,Carboxamide Derivatives,DrugBank
DB09119,Cardiovascular Agents,DrugBank
DB09119,Central Nervous System Agents,DrugBank
DB09119,Central Nervous System Depressants,DrugBank
DB09119,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09119,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB09119,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09119,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09119,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB09119,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09119,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09119,Eslicarbazepine and prodrugs,DrugBank
DB09119,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09119,Membrane Transport Modulators,DrugBank
DB09119,Nervous System,DrugBank
DB09119,Sodium Channel Blockers,DrugBank
DB09119,UGT1A1 Substrates,DrugBank
DB09119,Voltage-Gated Sodium Channel Blockers,DrugBank
DB09120,Alkaloids,DrugBank
DB09120,Alkenes,DrugBank
DB09120,Alkynes,DrugBank
DB09120,Amides,DrugBank
DB09120,Analgesics,DrugBank
DB09120,Benzene Derivatives,DrugBank
DB09120,Capsaicin and Similar Agents,DrugBank
DB09120,Catechols,DrugBank
DB09120,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09120,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB09120,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09120,Cytochrome P-450 CYP2C19 Inhibitors (moderate),DrugBank
DB09120,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09120,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB09120,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB09120,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB09120,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09120,Fatty Acids,DrugBank
DB09120,"Fatty Acids, Monounsaturated",DrugBank
DB09120,"Fatty Acids, Unsaturated",DrugBank
DB09120,"Hydrocarbons, Acyclic",DrugBank
DB09120,Lipids,DrugBank
DB09120,Musculo-Skeletal System,DrugBank
DB09120,Other Nonsteroidal Anti-inflammatory Agents,DrugBank
DB09120,Phenols,DrugBank
DB09120,Polyunsaturated Alkamides,DrugBank
DB09120,Solanaceous Alkaloids,DrugBank
DB09120,Topical Products for Joint and Muscular Pain,DrugBank
DB09121,Antiinflammatory and Antirheumatic Products,DrugBank
DB09121,Antirheumatic Agents,DrugBank
DB09121,Drugs that are Mainly Renally Excreted,DrugBank
DB09121,Gold Preparations,DrugBank
DB09121,Musculo-Skeletal System,DrugBank
DB09121,Organogold Compounds,DrugBank
DB09121,Organometallic Compounds,DrugBank
DB09121,Specific Antirheumatic Agents,DrugBank
DB09122,"Adjuvants, Immunologic",DrugBank
DB09122,"Amino Acids, Peptides, and Proteins",DrugBank
DB09122,Antineoplastic and Immunomodulating Agents,DrugBank
DB09122,Biological Factors,DrugBank
DB09122,"Compounds used in a research, industrial, or household setting",DrugBank
DB09122,Immunosuppressive Agents,DrugBank
DB09122,Intercellular Signaling Peptides and Proteins,DrugBank
DB09122,Interferon Type I,DrugBank
DB09122,Interferon-beta,DrugBank
DB09122,Interferons,DrugBank
DB09122,Macromolecular Substances,DrugBank
DB09122,Myelosuppressive Agents,DrugBank
DB09122,Pegylated agents,DrugBank
DB09122,Peptides,DrugBank
DB09122,Polymers,DrugBank
DB09122,Proteins,DrugBank
DB09123,Adrenal Cortex Hormones,DrugBank
DB09123,Antineoplastic Agents,DrugBank
DB09123,"Antineoplastic Agents, Hormonal",DrugBank
DB09123,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB09123,"Contraceptive Agents, Female",DrugBank
DB09123,"Contraceptive Agents, Hormonal",DrugBank
DB09123,"Contraceptive Agents, Male",DrugBank
DB09123,"Contraceptives, Oral",DrugBank
DB09123,"Contraceptives, Oral, Hormonal",DrugBank
DB09123,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09123,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09123,Cytochrome P-450 Substrates,DrugBank
DB09123,Drugs that are Mainly Renally Excreted,DrugBank
DB09123,Estranes,DrugBank
DB09123,Estrenes,DrugBank
DB09123,Fused-Ring Compounds,DrugBank
DB09123,Genito Urinary System and Sex Hormones,DrugBank
DB09123,Gonadal Hormones,DrugBank
DB09123,Gonadal Steroid Hormones,DrugBank
DB09123,Hormonal Contraceptives for Systemic Use,DrugBank
DB09123,Hormone Antagonists,DrugBank
DB09123,Hormones,DrugBank
DB09123,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09123,Hyperglycemia-Associated Agents,DrugBank
DB09123,Pregnadien Derivatives,DrugBank
DB09123,Progestin Contraceptives,DrugBank
DB09123,Progestins,DrugBank
DB09123,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB09123,Reproductive Control Agents,DrugBank
DB09123,Sex Hormones and Modulators of the Genital System,DrugBank
DB09123,Steroids,DrugBank
DB09123,Testosterone Congeners,DrugBank
DB09124,Adrenal Cortex Hormones,DrugBank
DB09124,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09124,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09124,Cytochrome P-450 Substrates,DrugBank
DB09124,Fused-Ring Compounds,DrugBank
DB09124,Genito Urinary System and Sex Hormones,DrugBank
DB09124,Pregnadien Derivatives,DrugBank
DB09124,Pregnadienes,DrugBank
DB09124,Pregnanes,DrugBank
DB09124,Progestins,DrugBank
DB09124,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB09124,Sex Hormones and Modulators of the Genital System,DrugBank
DB09124,Steroids,DrugBank
DB09125,"Acids, Acyclic",DrugBank
DB09125,Agents causing hyperkalemia,DrugBank
DB09125,Alimentary Tract and Metabolism,DrugBank
DB09125,Alkalinizing Activity,DrugBank
DB09125,Calculi Dissolution Agent,DrugBank
DB09125,Citrates,DrugBank
DB09125,Citric Acid Derivatives,DrugBank
DB09125,Diuretics,DrugBank
DB09125,Expectorants,DrugBank
DB09125,Metabolic Alkalinizer,DrugBank
DB09125,Mineral Supplements,DrugBank
DB09125,Minerals,DrugBank
DB09125,Natriuretic Agents,DrugBank
DB09125,Potassium Salt,DrugBank
DB09125,Replacement Preparations,DrugBank
DB09125,Respiratory System Agents,DrugBank
DB09125,Tricarboxylic Acids,DrugBank
DB09125,Urinary Alkalinisers,DrugBank
DB09128,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB09128,Adrenergic alpha-Antagonists,DrugBank
DB09128,Adrenergic Antagonists,DrugBank
DB09128,Agents that produce hypertension,DrugBank
DB09128,Antidepressive Agents,DrugBank
DB09128,Antidepressive Agents Indicated for Depression,DrugBank
DB09128,Antipsychotic Agents,DrugBank
DB09128,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB09128,Central Nervous System Depressants,DrugBank
DB09128,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09128,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09128,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09128,Cytochrome P-450 Substrates,DrugBank
DB09128,Dopamine Agents,DrugBank
DB09128,Dopamine Agonists,DrugBank
DB09128,Dopamine D2 Receptor Agonists,DrugBank
DB09128,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09128,Hyperglycemia-Associated Agents,DrugBank
DB09128,MATE 2 Inhibitors,DrugBank
DB09128,MATE inhibitors,DrugBank
DB09128,Nervous System,DrugBank
DB09128,Neurotoxic agents,DrugBank
DB09128,Neurotransmitter Agents,DrugBank
DB09128,Psycholeptics,DrugBank
DB09128,Quinolines,DrugBank
DB09128,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09128,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB09128,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09128,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09128,Serotonin Agents,DrugBank
DB09128,Serotonin Receptor Agonists,DrugBank
DB09128,Serotonin Receptor Antagonists,DrugBank
DB09128,Sulfur Compounds,DrugBank
DB09129,Anions,DrugBank
DB09129,Antioxidants,DrugBank
DB09129,Biological Factors,DrugBank
DB09129,Chlorine Compounds,DrugBank
DB09129,"Compounds used in a research, industrial, or household setting",DrugBank
DB09129,Drugs that are Mainly Renally Excreted,DrugBank
DB09129,Electrolytes,DrugBank
DB09129,Ions,DrugBank
DB09129,Minerals,DrugBank
DB09129,Protective Agents,DrugBank
DB09129,Replacement Preparations,DrugBank
DB09130,Copper-containing Intrauterine Device,DrugBank
DB09130,Decreased Embryonic Implantation,DrugBank
DB09130,Decreased Sperm Motility,DrugBank
DB09130,"Diet, Food, and Nutrition",DrugBank
DB09130,Elements,DrugBank
DB09130,Food,DrugBank
DB09130,Inhibit Ovum Fertilization,DrugBank
DB09130,Metals,DrugBank
DB09130,"Metals, Heavy",DrugBank
DB09130,Micronutrients,DrugBank
DB09130,Minerals,DrugBank
DB09130,Physiological Phenomena,DrugBank
DB09130,Replacement Preparations,DrugBank
DB09130,Trace Elements,DrugBank
DB09130,Transition Elements,DrugBank
DB09132,Alcohols,DrugBank
DB09132,Amino Sugars,DrugBank
DB09132,Carbohydrates,DrugBank
DB09132,Chelating Agents,DrugBank
DB09132,"Compounds used in a research, industrial, or household setting",DrugBank
DB09132,Contrast Media,DrugBank
DB09132,Diagnostic Uses of Chemicals,DrugBank
DB09132,Drugs that are Mainly Renally Excreted,DrugBank
DB09132,Gadolinium-based Contrast Agent,DrugBank
DB09132,Hexosamines,DrugBank
DB09132,Magnetic Resonance Imaging Contrast Media,DrugBank
DB09132,Other Diagnostics,DrugBank
DB09132,Paramagnetic Contrast Media,DrugBank
DB09132,Sequestering Agents,DrugBank
DB09132,Sugar Alcohols,DrugBank
DB09133,"Acids, Carbocyclic",DrugBank
DB09133,Alcohols,DrugBank
DB09133,Amino Sugars,DrugBank
DB09133,Benzene Derivatives,DrugBank
DB09133,Benzoates,DrugBank
DB09133,Carbohydrates,DrugBank
DB09133,"Compounds used in a research, industrial, or household setting",DrugBank
DB09133,Contrast Media,DrugBank
DB09133,Diagnostic Uses of Chemicals,DrugBank
DB09133,Drugs that are Mainly Renally Excreted,DrugBank
DB09133,Hexosamines,DrugBank
DB09133,Iodobenzoates,DrugBank
DB09133,Radiographic Contrast Agent,DrugBank
DB09133,Roentgenography,DrugBank
DB09133,Sugar Alcohols,DrugBank
DB09133,Triiodobenzoic Acids,DrugBank
DB09133,"Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media",DrugBank
DB09133,X-Ray Contrast Activity,DrugBank
DB09133,"X-Ray Contrast Media, Iodinated",DrugBank
DB09134,"Acids, Carbocyclic",DrugBank
DB09134,Benzene Derivatives,DrugBank
DB09134,Benzoates,DrugBank
DB09134,"Compounds used in a research, industrial, or household setting",DrugBank
DB09134,Contrast Media,DrugBank
DB09134,Diagnostic Uses of Chemicals,DrugBank
DB09134,Drugs that are Mainly Renally Excreted,DrugBank
DB09134,Iodinated Contrast Agents,DrugBank
DB09134,Iodobenzoates,DrugBank
DB09134,Radiographic Contrast Agent,DrugBank
DB09134,Roentgenography,DrugBank
DB09134,"Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media",DrugBank
DB09134,X-Ray Contrast Activity,DrugBank
DB09134,"X-Ray Contrast Media, Iodinated",DrugBank
DB09135,"Acids, Carbocyclic",DrugBank
DB09135,Benzene Derivatives,DrugBank
DB09135,Benzoates,DrugBank
DB09135,"Compounds used in a research, industrial, or household setting",DrugBank
DB09135,Contrast Media,DrugBank
DB09135,Diagnostic Uses of Chemicals,DrugBank
DB09135,Drugs that are Mainly Renally Excreted,DrugBank
DB09135,Iodinated Contrast Agents,DrugBank
DB09135,Iodobenzoates,DrugBank
DB09135,Radiographic Contrast Agent,DrugBank
DB09135,Triiodobenzoic Acids,DrugBank
DB09135,"Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media",DrugBank
DB09135,X-Ray Contrast Activity,DrugBank
DB09135,"X-Ray Contrast Media, Iodinated",DrugBank
DB09136,Amines,DrugBank
DB09136,Aniline Compounds,DrugBank
DB09136,Coloring Agents,DrugBank
DB09136,"Compounds used in a research, industrial, or household setting",DrugBank
DB09136,Diagnostic Dye,DrugBank
DB09136,Drugs that are Mainly Renally Excreted,DrugBank
DB09137,Amines,DrugBank
DB09137,Amino Acids,DrugBank
DB09137,"Amino Acids, Peptides, and Proteins",DrugBank
DB09137,"Compounds used in a research, industrial, or household setting",DrugBank
DB09137,Diagnostic Radiopharmaceuticals,DrugBank
DB09137,Diagnostic Uses of Chemicals,DrugBank
DB09137,Drugs that are Mainly Renally Excreted,DrugBank
DB09137,Hepatic and Reticulo Endothelial System,DrugBank
DB09137,Indicators and Reagents,DrugBank
DB09137,Laboratory Chemicals,DrugBank
DB09137,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09137,OATP1B3 substrates,DrugBank
DB09137,Organometallic Compounds,DrugBank
DB09137,Radioactive Diagnostic Agent,DrugBank
DB09137,Radiopharmaceutical Activity,DrugBank
DB09137,Radiopharmaceuticals,DrugBank
DB09137,Technetium (99Mtc) Compounds,DrugBank
DB09139,Diagnostic Radiopharmaceuticals,DrugBank
DB09139,Drugs that are Mainly Renally Excreted,DrugBank
DB09139,Organometallic Compounds,DrugBank
DB09139,Organophosphonates,DrugBank
DB09139,Organophosphorus Compounds,DrugBank
DB09139,Radioactive Diagnostic Agent,DrugBank
DB09139,Radiopharmaceutical Activity,DrugBank
DB09139,Skeleton,DrugBank
DB09139,Technetium (99Mtc) Compounds,DrugBank
DB09142,"Amino Acids, Peptides, and Proteins",DrugBank
DB09142,Cholecystokinin Analog,DrugBank
DB09142,Diagnostic Agents,DrugBank
DB09142,Gallbladder Function,DrugBank
DB09142,Gastrointestinal Hormones,DrugBank
DB09142,Hormones,DrugBank
DB09142,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09142,OATP1B3 substrates,DrugBank
DB09142,Peptides,DrugBank
DB09142,Tests for Bile Duct Patency,DrugBank
DB09143,Antineoplastic Agents,DrugBank
DB09143,Antineoplastic and Immunomodulating Agents,DrugBank
DB09143,Benzene Derivatives,DrugBank
DB09143,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09143,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09143,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09143,Cytochrome P-450 Substrates,DrugBank
DB09143,Hedgehog Pathway Inhibitor,DrugBank
DB09143,Hedgehog pathway inhibitors,DrugBank
DB09143,Narrow Therapeutic Index Drugs,DrugBank
DB09143,Smoothened Receptor Antagonists,DrugBank
DB09146,"Acids, Acyclic",DrugBank
DB09146,Carbohydrates,DrugBank
DB09146,Disaccharides,DrugBank
DB09146,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB09146,Ferric Compounds,DrugBank
DB09146,Hydroxy Acids,DrugBank
DB09146,Iron Compounds,DrugBank
DB09146,Iron Preparations,DrugBank
DB09146,"Iron Trivalent, Oral Preparations",DrugBank
DB09146,Oligosaccharides,DrugBank
DB09146,Organometallic Compounds,DrugBank
DB09146,Pharmaceutical Preparations,DrugBank
DB09146,Phosphate-removing Agents,DrugBank
DB09146,Polysaccharides,DrugBank
DB09146,Sugar Acids,DrugBank
DB09147,Acids,DrugBank
DB09147,"Acids, Noncarboxylic",DrugBank
DB09147,Anions,DrugBank
DB09147,Electrolytes,DrugBank
DB09147,Elements,DrugBank
DB09147,Ions,DrugBank
DB09147,Iron Compounds,DrugBank
DB09147,Metals,DrugBank
DB09147,"Metals, Heavy",DrugBank
DB09147,Parenteral Iron Replacement,DrugBank
DB09147,Phosphate salts,DrugBank
DB09147,Phosphoric Acids,DrugBank
DB09147,Phosphorus Acids,DrugBank
DB09147,Phosphorus Compounds,DrugBank
DB09147,Polyphosphates,DrugBank
DB09147,Transition Elements,DrugBank
DB09148,Amines,DrugBank
DB09148,Benzene Derivatives,DrugBank
DB09148,Benzylidene Compounds,DrugBank
DB09148,Central Nervous System,DrugBank
DB09148,Diagnostic Radiopharmaceuticals,DrugBank
DB09148,Drugs that are Mainly Renally Excreted,DrugBank
DB09148,Fluorine Radioisotopes,DrugBank
DB09148,Positron Emitting Activity,DrugBank
DB09148,Radioactive Diagnostic Agent,DrugBank
DB09149,Alcohols,DrugBank
DB09149,Amines,DrugBank
DB09149,Central Nervous System,DrugBank
DB09149,Diagnostic Radiopharmaceuticals,DrugBank
DB09149,Drugs that are Mainly Renally Excreted,DrugBank
DB09149,Fluorine Radioisotopes,DrugBank
DB09149,Glycols,DrugBank
DB09149,Positron Emitting Activity,DrugBank
DB09149,Radioactive Diagnostic Agent,DrugBank
DB09153,Alimentary Tract and Metabolism,DrugBank
DB09153,Blood and Blood Forming Organs,DrugBank
DB09153,Blood Substitutes and Perfusion Solutions,DrugBank
DB09153,Chlorides,DrugBank
DB09153,Chlorine Compounds,DrugBank
DB09153,Diluents,DrugBank
DB09153,"EENT Drugs, Miscellaneous",DrugBank
DB09153,Electrolyte Solutions,DrugBank
DB09153,I.V. Solution Additives,DrugBank
DB09153,Irrigating Solutions,DrugBank
DB09153,Mineral Supplements,DrugBank
DB09153,Other Miscellaneous Therapeutic Agents,DrugBank
DB09153,Replacement Preparations,DrugBank
DB09153,"Respiratory Agents, Miscellaneous",DrugBank
DB09153,Salt Solutions,DrugBank
DB09153,Sodium,DrugBank
DB09153,Sodium Compounds,DrugBank
DB09154,"Acids, Acyclic",DrugBank
DB09154,Antacids and Adsorbents,DrugBank
DB09154,Anticoagulants,DrugBank
DB09154,Blood and Blood Forming Organs,DrugBank
DB09154,Blood Substitutes and Perfusion Solutions,DrugBank
DB09154,Buffers,DrugBank
DB09154,Citrates,DrugBank
DB09154,Citric Acid Derivatives,DrugBank
DB09154,"Compounds used in a research, industrial, or household setting",DrugBank
DB09154,"Diet, Food, and Nutrition",DrugBank
DB09154,Food,DrugBank
DB09154,Food Additives,DrugBank
DB09154,Food Ingredients,DrugBank
DB09154,Food Preservatives,DrugBank
DB09154,Hematologic Agents,DrugBank
DB09154,Irrigating Solutions,DrugBank
DB09154,Laboratory Chemicals,DrugBank
DB09154,Miscellaneous Anticoagulants,DrugBank
DB09154,Miscellaneous GI Drugs,DrugBank
DB09154,Neurotoxic agents,DrugBank
DB09154,Physiological Phenomena,DrugBank
DB09154,Salt Solutions,DrugBank
DB09154,Tricarboxylic Acids,DrugBank
DB09154,Urinary Alkalinisers,DrugBank
DB09156,Benzene Derivatives,DrugBank
DB09156,"Compounds used in a research, industrial, or household setting",DrugBank
DB09156,Contrast Media,DrugBank
DB09156,Diagnostic Uses of Chemicals,DrugBank
DB09156,Drugs that are Mainly Renally Excreted,DrugBank
DB09156,Iodinated Contrast Agents,DrugBank
DB09156,Radiographic Contrast Agent,DrugBank
DB09156,Roentgenography,DrugBank
DB09156,"Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media",DrugBank
DB09156,X-Ray Contrast Activity,DrugBank
DB09156,"X-Ray Contrast Media, Iodinated",DrugBank
DB09161,"Compounds used in a research, industrial, or household setting",DrugBank
DB09161,Diagnostic Radiopharmaceuticals,DrugBank
DB09161,Diagnostic Uses of Chemicals,DrugBank
DB09161,Indicators and Reagents,DrugBank
DB09161,Laboratory Chemicals,DrugBank
DB09161,Nitriles,DrugBank
DB09161,Organometallic Compounds,DrugBank
DB09161,Organotechnetium Compounds,DrugBank
DB09161,P-glycoprotein substrates,DrugBank
DB09161,Radioactive Diagnostic Agent,DrugBank
DB09161,Radiopharmaceutical Activity,DrugBank
DB09161,Radiopharmaceuticals,DrugBank
DB09161,Technetium (99Mtc) Compounds,DrugBank
DB09163,Amines,DrugBank
DB09163,Central Nervous System,DrugBank
DB09163,"Compounds used in a research, industrial, or household setting",DrugBank
DB09163,Diagnostic Radiopharmaceuticals,DrugBank
DB09163,Diagnostic Uses of Chemicals,DrugBank
DB09163,Drugs that are Mainly Renally Excreted,DrugBank
DB09163,Hydroxylamines,DrugBank
DB09163,Indicators and Reagents,DrugBank
DB09163,Laboratory Chemicals,DrugBank
DB09163,Organometallic Compounds,DrugBank
DB09163,Organotechnetium Compounds,DrugBank
DB09163,Oximes,DrugBank
DB09163,Radioactive Diagnostic Agent,DrugBank
DB09163,Radiopharmaceutical Activity,DrugBank
DB09163,Radiopharmaceuticals,DrugBank
DB09163,Technetium (99Mtc) Compounds,DrugBank
DB09165,Acids,DrugBank
DB09165,"Acids, Noncarboxylic",DrugBank
DB09165,"Compounds used in a research, industrial, or household setting",DrugBank
DB09165,Diagnostic Radiopharmaceuticals,DrugBank
DB09165,Diagnostic Uses of Chemicals,DrugBank
DB09165,Diphosphates,DrugBank
DB09165,Drugs that are Mainly Renally Excreted,DrugBank
DB09165,Indicators and Reagents,DrugBank
DB09165,Laboratory Chemicals,DrugBank
DB09165,Phosphate salts,DrugBank
DB09165,Phosphoric Acids,DrugBank
DB09165,Phosphorus Acids,DrugBank
DB09165,Phosphorus Compounds,DrugBank
DB09165,Polyphosphates,DrugBank
DB09165,Radioactive Diagnostic Agent,DrugBank
DB09165,Radiopharmaceutical Activity,DrugBank
DB09165,Radiopharmaceuticals,DrugBank
DB09165,Skeleton,DrugBank
DB09165,Technetium (99Mtc) Compounds,DrugBank
DB09165,Technetium Compounds,DrugBank
DB09166,Anti-Anxiety Agents,DrugBank
DB09166,Benzazepines,DrugBank
DB09166,Benzodiazepine hypnotics and sedatives,DrugBank
DB09166,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB09166,Benzodiazepinones,DrugBank
DB09166,Central Nervous System Agents,DrugBank
DB09166,Central Nervous System Depressants,DrugBank
DB09166,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB09166,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09166,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09166,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09166,Cytochrome P-450 Substrates,DrugBank
DB09166,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09166,Hypnotics and Sedatives,DrugBank
DB09166,Muscle Relaxants,DrugBank
DB09166,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB09166,Nervous System,DrugBank
DB09166,Psycholeptics,DrugBank
DB09166,Psychotropic Drugs,DrugBank
DB09166,Tranquilizing Agents,DrugBank
DB09167,Adrenergic Agents,DrugBank
DB09167,Adrenergic Uptake Inhibitors,DrugBank
DB09167,Agents producing tachycardia,DrugBank
DB09167,Agents that produce hypertension,DrugBank
DB09167,Agents that reduce seizure threshold,DrugBank
DB09167,Anticholinergic Agents,DrugBank
DB09167,Antidepressive Agents,DrugBank
DB09167,"Antidepressive Agents, Tricyclic",DrugBank
DB09167,Central Nervous System Agents,DrugBank
DB09167,Central Nervous System Depressants,DrugBank
DB09167,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB09167,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09167,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB09167,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09167,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09167,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09167,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09167,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09167,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB09167,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB09167,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09167,Dibenzothiepins,DrugBank
DB09167,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09167,Histamine Antagonists,DrugBank
DB09167,Histamine H1 Antagonists,DrugBank
DB09167,Membrane Transport Modulators,DrugBank
DB09167,Muscarinic Antagonists,DrugBank
DB09167,Narrow Therapeutic Index Drugs,DrugBank
DB09167,Nervous System,DrugBank
DB09167,Neurotoxic agents,DrugBank
DB09167,Neurotransmitter Agents,DrugBank
DB09167,Neurotransmitter Uptake Inhibitors,DrugBank
DB09167,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB09167,Potential QTc-Prolonging Agents,DrugBank
DB09167,Psychoanaleptics,DrugBank
DB09167,Psychotropic Drugs,DrugBank
DB09167,QTc Prolonging Agents,DrugBank
DB09167,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09167,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB09167,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB09167,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09167,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09167,Serotonin Agents,DrugBank
DB09167,Serotonin Modulators,DrugBank
DB09167,Serotonin Receptor Antagonists,DrugBank
DB09167,Sulfur Compounds,DrugBank
DB09167,Tertiary amine tricyclic antidepressants,DrugBank
DB09167,Thiepins,DrugBank
DB09173,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09173,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09173,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09173,Cytochrome P-450 Substrates,DrugBank
DB09173,Illicit Drugs,DrugBank
DB09173,Piperidines,DrugBank
DB09173,Street Drugs,DrugBank
DB09174,Analgesics,DrugBank
DB09174,Central Nervous System Agents,DrugBank
DB09174,Central Nervous System Depressants,DrugBank
DB09174,Narcotics,DrugBank
DB09174,Opioids,DrugBank
DB09174,Peripheral Nervous System Agents,DrugBank
DB09174,Piperidines,DrugBank
DB09174,Sensory System Agents,DrugBank
DB09174,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09183,Amides,DrugBank
DB09183,Amines,DrugBank
DB09183,Antiinfectives for Systemic Use,DrugBank
DB09183,Antiviral Agents,DrugBank
DB09183,Antivirals for Systemic Use,DrugBank
DB09183,Antivirals for treatment of HCV infections,DrugBank
DB09183,BCRP/ABCG2 Inhibitors,DrugBank
DB09183,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09183,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09183,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09183,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09183,Cytochrome P-450 Substrates,DrugBank
DB09183,Direct Acting Antivirals,DrugBank
DB09183,Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor,DrugBank
DB09183,Naphthalenes,DrugBank
DB09183,P-glycoprotein substrates,DrugBank
DB09183,Pyrimidines,DrugBank
DB09183,Pyrimidinones,DrugBank
DB09183,RNA Replicase Inhibitors,DrugBank
DB09183,Sulfones,DrugBank
DB09183,Sulfur Compounds,DrugBank
DB09183,Treatments for Hepatitis C,DrugBank
DB09183,UGT1A1 Inhibitors,DrugBank
DB09184,Adrenergic Uptake Inhibitors,DrugBank
DB09184,Alcohols,DrugBank
DB09184,Antidepressive Agents,DrugBank
DB09184,Central Nervous System Depressants,DrugBank
DB09184,Oxazines,DrugBank
DB09185,Adrenergic Agents,DrugBank
DB09185,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB09185,Adrenergic alpha-Antagonists,DrugBank
DB09185,Adrenergic Antagonists,DrugBank
DB09185,Adrenergic beta-Antagonists,DrugBank
DB09185,Adrenergic Uptake Inhibitors,DrugBank
DB09185,Anticholinergic Agents,DrugBank
DB09185,Antidepressive Agents,DrugBank
DB09185,"Antidepressive Agents, Second-Generation",DrugBank
DB09185,Central Nervous System Agents,DrugBank
DB09185,Central Nervous System Depressants,DrugBank
DB09185,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB09185,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB09185,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB09185,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09185,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09185,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09185,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09185,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB09185,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09185,Cytochrome P-450 Substrates,DrugBank
DB09185,Drugs that are Mainly Renally Excreted,DrugBank
DB09185,Histamine Antagonists,DrugBank
DB09185,Histamine H1 Antagonists,DrugBank
DB09185,Histamine H2 Antagonists,DrugBank
DB09185,Histamine H3 Antagonists,DrugBank
DB09185,MATE 1 Inhibitors,DrugBank
DB09185,MATE inhibitors,DrugBank
DB09185,Membrane Transport Modulators,DrugBank
DB09185,Monoamine Oxidase A Inhibitors,DrugBank
DB09185,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB09185,Monoamine Oxidase B Inhibitors,DrugBank
DB09185,Monoamine Oxidase Inhibitors,DrugBank
DB09185,Morpholines,DrugBank
DB09185,Muscarinic Antagonists,DrugBank
DB09185,Nervous System,DrugBank
DB09185,Neurotransmitter Agents,DrugBank
DB09185,Neurotransmitter Uptake Inhibitors,DrugBank
DB09185,Norepinephrine Reuptake Inhibitor,DrugBank
DB09185,Norepinephrine Uptake Inhibitors,DrugBank
DB09185,Oxazines,DrugBank
DB09185,Psychoanaleptics,DrugBank
DB09185,Psychotropic Drugs,DrugBank
DB09185,UGT1A9 Substrates,DrugBank
DB09186,Adrenergic Uptake Inhibitors,DrugBank
DB09186,Amines,DrugBank
DB09186,Antidepressive Agents,DrugBank
DB09186,Central Nervous System Depressants,DrugBank
DB09186,"Norepinephrine, antagonists & inhibitors",DrugBank
DB09186,Propylamines,DrugBank
DB09187,Adrenergic Uptake Inhibitors,DrugBank
DB09187,Antidepressive Agents,DrugBank
DB09187,Central Nervous System Depressants,DrugBank
DB09187,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09187,Pyrans,DrugBank
DB09190,Adrenergic Uptake Inhibitors,DrugBank
DB09190,Amines,DrugBank
DB09190,Antidepressive Agents,DrugBank
DB09190,Carbon Radioisotopes,DrugBank
DB09190,Central Nervous System Depressants,DrugBank
DB09190,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09194,Antidepressive Agents,DrugBank
DB09194,Central Nervous System Depressants,DrugBank
DB09194,Combined Inhibitors of Serotonin/Norepinephrine Reuptake,DrugBank
DB09194,Drugs that are Mainly Renally Excreted,DrugBank
DB09194,Nervous System,DrugBank
DB09194,Piperazines,DrugBank
DB09194,Psychoanaleptics,DrugBank
DB09194,Pyridines,DrugBank
DB09194,Pyridones,DrugBank
DB09194,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09194,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09194,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09194,Serotonin Agents,DrugBank
DB09194,Serotonin Modulators,DrugBank
DB09194,Serotonin Receptor Antagonists,DrugBank
DB09195,Antidepressive Agents,DrugBank
DB09195,Central Nervous System Depressants,DrugBank
DB09195,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09195,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09195,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09195,Cytochrome P-450 Substrates,DrugBank
DB09195,Drugs that are Mainly Renally Excreted,DrugBank
DB09195,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09195,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09195,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB09195,Serotonin Agents,DrugBank
DB09195,Serotonin Modulators,DrugBank
DB09195,Serotonin Receptor Antagonists,DrugBank
DB09198,Alimentary Tract and Metabolism,DrugBank
DB09198,Blood Glucose Lowering Agents,DrugBank
DB09198,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09198,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB09198,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09198,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09198,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09198,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09198,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09198,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09198,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09198,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09198,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09198,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09198,Cytochrome P-450 Substrates,DrugBank
DB09198,Drugs Used in Diabetes,DrugBank
DB09198,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09198,"PPAR alpha, agonists",DrugBank
DB09198,"PPAR gamma, agonists",DrugBank
DB09198,Sulfur Compounds,DrugBank
DB09198,Thiazoles,DrugBank
DB09198,Thiazolidinediones,DrugBank
DB09199,Blood Glucose Lowering Agents,DrugBank
DB09199,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09199,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09199,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09199,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09199,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09199,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09199,Cytochrome P-450 Substrates,DrugBank
DB09199,Sulfur Compounds,DrugBank
DB09199,Thiazoles,DrugBank
DB09199,Thiazolidinediones,DrugBank
DB09200,Blood Glucose Lowering Agents,DrugBank
DB09200,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09200,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09200,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09200,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09200,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09200,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09200,Cytochrome P-450 Substrates,DrugBank
DB09200,Sulfur Compounds,DrugBank
DB09200,Thiazoles,DrugBank
DB09200,Thiazolidinediones,DrugBank
DB09201,Blood Glucose Lowering Agents,DrugBank
DB09201,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09201,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09201,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09201,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09201,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09201,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09201,Cytochrome P-450 Substrates,DrugBank
DB09201,Sulfur Compounds,DrugBank
DB09201,Thiazoles,DrugBank
DB09201,Thiazolidinediones,DrugBank
DB09202,Adrenergic Agents,DrugBank
DB09202,Adrenergic Agonists,DrugBank
DB09202,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB09202,Adrenergic alpha-Agonists,DrugBank
DB09202,Agents producing tachycardia,DrugBank
DB09202,Agents that produce hypertension,DrugBank
DB09202,Cardiovascular Agents,DrugBank
DB09202,Nasal Decongestants,DrugBank
DB09202,Neurotransmitter Agents,DrugBank
DB09202,Respiratory System Agents,DrugBank
DB09202,Vasoconstrictor Agents,DrugBank
DB09203,Adrenergic Agents,DrugBank
DB09203,Adrenergic Agonists,DrugBank
DB09203,Adrenergic alpha-Agonists,DrugBank
DB09203,Adrenergic and Dopaminergic Agents,DrugBank
DB09203,Agents producing tachycardia,DrugBank
DB09203,Agents that produce hypertension,DrugBank
DB09203,Alcohols,DrugBank
DB09203,Amines,DrugBank
DB09203,Amino Alcohols,DrugBank
DB09203,Autonomic Agents,DrugBank
DB09203,Biogenic Amines,DrugBank
DB09203,Biogenic Monoamines,DrugBank
DB09203,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB09203,Cardiac Therapy,DrugBank
DB09203,Cardiovascular Agents,DrugBank
DB09203,Decongestants and Antiallergics,DrugBank
DB09203,Ethanolamines,DrugBank
DB09203,Nasal Decongestants,DrugBank
DB09203,Neurotransmitter Agents,DrugBank
DB09203,Ophthalmologicals,DrugBank
DB09203,Peripheral Nervous System Agents,DrugBank
DB09203,Respiratory System Agents,DrugBank
DB09203,Sensory Organs,DrugBank
DB09203,Sympathomimetics,DrugBank
DB09203,Sympathomimetics Used as Decongestants,DrugBank
DB09203,Vasoconstrictor Agents,DrugBank
DB09204,Adrenergic Agents,DrugBank
DB09204,Adrenergic Antagonists,DrugBank
DB09204,Adrenergic beta-Antagonists,DrugBank
DB09204,Agents causing hyperkalemia,DrugBank
DB09204,Alcohols,DrugBank
DB09204,Amines,DrugBank
DB09204,Amino Alcohols,DrugBank
DB09204,Bradycardia-Causing Agents,DrugBank
DB09204,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09204,Cytochrome P-450 Substrates,DrugBank
DB09204,Drugs that are Mainly Renally Excreted,DrugBank
DB09204,Hypotensive Agents,DrugBank
DB09204,Neurotransmitter Agents,DrugBank
DB09204,Propanols,DrugBank
DB09205,Adrenergic Agents,DrugBank
DB09205,Adrenergic alpha-Antagonists,DrugBank
DB09205,Adrenergic Antagonists,DrugBank
DB09205,Agents that produce hypertension,DrugBank
DB09205,Amines,DrugBank
DB09205,Autonomic Agents,DrugBank
DB09205,Cardiovascular Agents,DrugBank
DB09205,Cholinesterase substrates,DrugBank
DB09205,Dimethylamines,DrugBank
DB09205,Drugs that are Mainly Renally Excreted,DrugBank
DB09205,Drugs Used in Erectile Dysfunction,DrugBank
DB09205,Genito Urinary System and Sex Hormones,DrugBank
DB09205,Methylamines,DrugBank
DB09205,Miotics,DrugBank
DB09205,Neurotransmitter Agents,DrugBank
DB09205,Peripheral Nervous System Agents,DrugBank
DB09205,Peripheral Vasodilators,DrugBank
DB09205,Sympatholytics,DrugBank
DB09205,Urologicals,DrugBank
DB09205,Vasodilating Agents,DrugBank
DB09206,Adrenergic Agents,DrugBank
DB09206,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB09206,Adrenergic alpha-Antagonists,DrugBank
DB09206,Adrenergic Antagonists,DrugBank
DB09206,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB09206,Antihypertensive Agents,DrugBank
DB09206,Cardiovascular Agents,DrugBank
DB09206,Neurotransmitter Agents,DrugBank
DB09206,Peripheral alpha-1 blockers,DrugBank
DB09206,Vasodilating Agents,DrugBank
DB09207,Dopamine Agents,DrugBank
DB09207,Dopamine Antagonists,DrugBank
DB09207,Dopamine D2 Receptor Antagonists,DrugBank
DB09207,Neurotransmitter Agents,DrugBank
DB09208,Antigout Preparations,DrugBank
DB09208,"Compounds used in a research, industrial, or household setting",DrugBank
DB09208,Enzymes,DrugBank
DB09208,Enzymes and Coenzymes,DrugBank
DB09208,Musculo-Skeletal System,DrugBank
DB09208,Oxidoreductases,DrugBank
DB09208,Pegylated agents,DrugBank
DB09208,Recombinant Proteins,DrugBank
DB09208,Uric Acid-specific Enzyme,DrugBank
DB09209,Alkaloids,DrugBank
DB09209,Analgesics,DrugBank
DB09209,Antitussive Agents,DrugBank
DB09209,Central Nervous System Agents,DrugBank
DB09209,Cough and Cold Preparations,DrugBank
DB09209,Drugs that are Mainly Renally Excreted,DrugBank
DB09209,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09209,Morphinans,DrugBank
DB09209,Morphine Derivatives,DrugBank
DB09209,Opiate Alkaloids,DrugBank
DB09209,Opium Alkaloids and Derivatives,DrugBank
DB09209,Oxazines,DrugBank
DB09209,Peripheral Nervous System Agents,DrugBank
DB09209,Phenanthrenes,DrugBank
DB09209,Respiratory System Agents,DrugBank
DB09209,Sensory System Agents,DrugBank
DB09210,Acetamides,DrugBank
DB09210,Acetates,DrugBank
DB09210,"Acids, Acyclic",DrugBank
DB09210,Amides,DrugBank
DB09210,Central Nervous System Agents,DrugBank
DB09210,"Compounds used in a research, industrial, or household setting",DrugBank
DB09210,Drugs that are Mainly Renally Excreted,DrugBank
DB09210,Nervous System,DrugBank
DB09210,Neuroprotective Agents,DrugBank
DB09210,Nootropic Agents,DrugBank
DB09210,Protective Agents,DrugBank
DB09210,Psychoanaleptics,DrugBank
DB09210,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB09210,Pyrrolidines,DrugBank
DB09210,Pyrrolidinones,DrugBank
DB09211,Anticoagulants,DrugBank
DB09211,Autacoids,DrugBank
DB09211,Biological Factors,DrugBank
DB09211,Blood and Blood Forming Organs,DrugBank
DB09211,Eicosanoids,DrugBank
DB09211,Fatty Acids,DrugBank
DB09211,"Fatty Acids, Monounsaturated",DrugBank
DB09211,"Fatty Acids, Unsaturated",DrugBank
DB09211,Fibrinolytic Agents,DrugBank
DB09211,Inflammation Mediators,DrugBank
DB09211,Lipids,DrugBank
DB09211,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB09211,Prostaglandins,DrugBank
DB09211,Prostaglandins E,DrugBank
DB09212,"Acids, Carbocyclic",DrugBank
DB09212,Agents causing hyperkalemia,DrugBank
DB09212,Agents that produce hypertension,DrugBank
DB09212,Analgesics,DrugBank
DB09212,"Analgesics, Non-Narcotic",DrugBank
DB09212,Anti-Inflammatory Agents,DrugBank
DB09212,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09212,Antiinflammatory and Antirheumatic Products,DrugBank
DB09212,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09212,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB09212,Antirheumatic Agents,DrugBank
DB09212,Musculo-Skeletal System,DrugBank
DB09212,Nephrotoxic agents,DrugBank
DB09212,Non COX-2 selective NSAIDS,DrugBank
DB09212,Peripheral Nervous System Agents,DrugBank
DB09212,Propionates,DrugBank
DB09212,Sensory System Agents,DrugBank
DB09212,Topical Products for Joint and Muscular Pain,DrugBank
DB09212,UGT2B7 substrates,DrugBank
DB09213,"Acids, Carbocyclic",DrugBank
DB09213,Agents causing hyperkalemia,DrugBank
DB09213,Agents that produce hypertension,DrugBank
DB09213,Anti-Inflammatory Agents,DrugBank
DB09213,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09213,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB09213,Antiinflammatory and Antirheumatic Products,DrugBank
DB09213,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09213,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09213,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09213,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09213,Cytochrome P-450 Substrates,DrugBank
DB09213,Musculo-Skeletal System,DrugBank
DB09213,Nephrotoxic agents,DrugBank
DB09213,Non COX-2 selective NSAIDS,DrugBank
DB09213,Phenylpropionates,DrugBank
DB09213,Propionates,DrugBank
DB09213,UGT1A1 Substrates,DrugBank
DB09213,UGT1A3 substrates,DrugBank
DB09213,UGT1A9 Substrates,DrugBank
DB09213,UGT2B7 substrates,DrugBank
DB09214,"Acids, Carbocyclic",DrugBank
DB09214,Agents causing hyperkalemia,DrugBank
DB09214,Agents that produce hypertension,DrugBank
DB09214,Alcohols,DrugBank
DB09214,Analgesics,DrugBank
DB09214,"Analgesics, Non-Narcotic",DrugBank
DB09214,Anti-Inflammatory Agents,DrugBank
DB09214,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09214,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB09214,Antiinflammatory and Antirheumatic Products,DrugBank
DB09214,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09214,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB09214,Antirheumatic Agents,DrugBank
DB09214,Central Nervous System Agents,DrugBank
DB09214,Drugs that are Mainly Renally Excreted,DrugBank
DB09214,Glycols,DrugBank
DB09214,Musculo-Skeletal System,DrugBank
DB09214,Nephrotoxic agents,DrugBank
DB09214,Nervous System,DrugBank
DB09214,Non COX-2 selective NSAIDS,DrugBank
DB09214,Peripheral Nervous System Agents,DrugBank
DB09214,Phenylpropionates,DrugBank
DB09214,Propionates,DrugBank
DB09214,Propylene Glycols,DrugBank
DB09214,Sensory System Agents,DrugBank
DB09214,Topical Products for Joint and Muscular Pain,DrugBank
DB09215,Agents causing hyperkalemia,DrugBank
DB09215,Agents that produce hypertension,DrugBank
DB09215,Analgesics,DrugBank
DB09215,"Analgesics, Non-Narcotic",DrugBank
DB09215,Anti-Inflammatory Agents,DrugBank
DB09215,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09215,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB09215,Antiinflammatory and Antirheumatic Products,DrugBank
DB09215,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09215,Antirheumatic Agents,DrugBank
DB09215,Musculo-Skeletal System,DrugBank
DB09215,Nephrotoxic agents,DrugBank
DB09215,Non COX-2 selective NSAIDS,DrugBank
DB09215,Oxicams,DrugBank
DB09215,Peripheral Nervous System Agents,DrugBank
DB09215,Sensory System Agents,DrugBank
DB09216,"Acids, Carbocyclic",DrugBank
DB09216,Agents causing hyperkalemia,DrugBank
DB09216,Agents that produce hypertension,DrugBank
DB09216,Aminobenzoates,DrugBank
DB09216,Analgesics,DrugBank
DB09216,"Analgesics, Non-Narcotic",DrugBank
DB09216,Anti-Inflammatory Agents,DrugBank
DB09216,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09216,Antiinflammatory and Antirheumatic Products,DrugBank
DB09216,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09216,Antirheumatic Agents,DrugBank
DB09216,Benzene Derivatives,DrugBank
DB09216,Benzoates,DrugBank
DB09216,Bradycardia-Causing Agents,DrugBank
DB09216,Calcium-Regulating Hormones and Agents,DrugBank
DB09216,Cardiovascular Agents,DrugBank
DB09216,Central Nervous System Agents,DrugBank
DB09216,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09216,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09216,Cytochrome P-450 Substrates,DrugBank
DB09216,Fenamates,DrugBank
DB09216,Hormone Antagonists,DrugBank
DB09216,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09216,Membrane Transport Modulators,DrugBank
DB09216,"Migraine Disorders, drug therapy",DrugBank
DB09216,Musculo-Skeletal System,DrugBank
DB09216,Nephrotoxic agents,DrugBank
DB09216,Neurotransmitter Agents,DrugBank
DB09216,Non COX-2 selective NSAIDS,DrugBank
DB09216,Peripheral Nervous System Agents,DrugBank
DB09216,Prostaglandin Antagonists,DrugBank
DB09216,Sensory System Agents,DrugBank
DB09217,Agents causing hyperkalemia,DrugBank
DB09217,Agents that produce hypertension,DrugBank
DB09217,Anti-Inflammatory Agents,DrugBank
DB09217,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09217,Furans,DrugBank
DB09217,Lactones,DrugBank
DB09217,Nephrotoxic agents,DrugBank
DB09217,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB09217,Sulfur Compounds,DrugBank
DB09218,Agents causing hyperkalemia,DrugBank
DB09218,Agents that produce hypertension,DrugBank
DB09218,Amino Acids,DrugBank
DB09218,"Amino Acids, Basic",DrugBank
DB09218,"Amino Acids, Diamino",DrugBank
DB09218,"Amino Acids, Peptides, and Proteins",DrugBank
DB09218,Analgesics,DrugBank
DB09218,"Analgesics, Non-Narcotic",DrugBank
DB09218,Anti-Inflammatory Agents,DrugBank
DB09218,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09218,Antirheumatic Agents,DrugBank
DB09218,Nephrotoxic agents,DrugBank
DB09218,Nicotinic Acids,DrugBank
DB09218,Non COX-2 selective NSAIDS,DrugBank
DB09218,Peripheral Nervous System Agents,DrugBank
DB09218,Pyridines,DrugBank
DB09218,Sensory System Agents,DrugBank
DB09219,Alimentary Tract and Metabolism,DrugBank
DB09219,Contact Laxatives,DrugBank
DB09219,Drugs for Constipation,DrugBank
DB09219,Drugs that are Mainly Renally Excreted,DrugBank
DB09219,Laxatives,DrugBank
DB09220,Agents causing hyperkalemia,DrugBank
DB09220,Antiarrhythmic agents,DrugBank
DB09220,Antihypertensive Agents,DrugBank
DB09220,Cardiac Therapy,DrugBank
DB09220,Cardiovascular Agents,DrugBank
DB09220,Drugs that are Mainly Renally Excreted,DrugBank
DB09220,Micronutrients,DrugBank
DB09220,Nicotinic Acids,DrugBank
DB09220,Nitrates,DrugBank
DB09220,Potassium Channel Opener,DrugBank
DB09220,Pyridines,DrugBank
DB09220,Vasodilating Agents,DrugBank
DB09220,Vasodilators Used in Cardiac Diseases,DrugBank
DB09222,Acute-Phase Proteins,DrugBank
DB09222,"Amino Acids, Peptides, and Proteins",DrugBank
DB09222,Biological Factors,DrugBank
DB09222,Blood and Blood Forming Organs,DrugBank
DB09222,Blood Coagulation Factors,DrugBank
DB09222,Blood Proteins,DrugBank
DB09222,Fibrinogen,DrugBank
DB09222,Hemostatics,DrugBank
DB09222,Increased Coagulation Activity,DrugBank
DB09222,Protein Precursors,DrugBank
DB09222,Proteins,DrugBank
DB09223,Antidepressive Agents,DrugBank
DB09223,Antipsychotic Agents,DrugBank
DB09223,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB09223,Central Nervous System Depressants,DrugBank
DB09223,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09223,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09223,Cytochrome P-450 Substrates,DrugBank
DB09223,Dopamine Antagonists,DrugBank
DB09223,Dopamine D2 Receptor Antagonists,DrugBank
DB09223,Drugs that are Mainly Renally Excreted,DrugBank
DB09223,Neurotoxic agents,DrugBank
DB09223,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09223,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09223,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09223,Serotonin Agents,DrugBank
DB09223,Serotonin Receptor Antagonists,DrugBank
DB09224,Antiarrhythmic agents,DrugBank
DB09224,Antipsychotic Agents,DrugBank
DB09224,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB09224,Butyrophenone Derivatives,DrugBank
DB09224,Central Nervous System Agents,DrugBank
DB09224,Central Nervous System Depressants,DrugBank
DB09224,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09224,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09224,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09224,Dopamine Antagonists,DrugBank
DB09224,Dopamine D2 Receptor Antagonists,DrugBank
DB09224,Drugs that are Mainly Renally Excreted,DrugBank
DB09224,Ketones,DrugBank
DB09224,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09224,Nervous System,DrugBank
DB09224,Neurotoxic agents,DrugBank
DB09224,Psycholeptics,DrugBank
DB09224,Psychotropic Drugs,DrugBank
DB09224,QTc Prolonging Agents,DrugBank
DB09224,Tranquilizing Agents,DrugBank
DB09225,Antidepressive Agents,DrugBank
DB09225,Antipsychotic Agents,DrugBank
DB09225,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB09225,Central Nervous System Agents,DrugBank
DB09225,Central Nervous System Depressants,DrugBank
DB09225,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09225,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09225,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09225,Cytochrome P-450 Substrates,DrugBank
DB09225,Dopamine Antagonists,DrugBank
DB09225,Dopamine D2 Receptor Antagonists,DrugBank
DB09225,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09225,Nervous System,DrugBank
DB09225,Neurotoxic agents,DrugBank
DB09225,Psycholeptics,DrugBank
DB09225,Psychotropic Drugs,DrugBank
DB09225,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09225,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB09225,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB09225,Serotonin Agents,DrugBank
DB09225,Serotonin Receptor Antagonists,DrugBank
DB09225,Sulfur Compounds,DrugBank
DB09225,Thiepins,DrugBank
DB09225,Tranquilizing Agents,DrugBank
DB09226,Antidepressive Agents,DrugBank
DB09226,Antipsychotic Agents,DrugBank
DB09226,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB09226,Central Nervous System Agents,DrugBank
DB09226,Central Nervous System Depressants,DrugBank
DB09226,Neurotoxic agents,DrugBank
DB09226,Neurotransmitter Agents,DrugBank
DB09226,Psychotropic Drugs,DrugBank
DB09226,Serotonin Agents,DrugBank
DB09226,Tranquilizing Agents,DrugBank
DB09227,Agents causing hyperkalemia,DrugBank
DB09227,Antiarrhythmic agents,DrugBank
DB09227,Bradycardia-Causing Agents,DrugBank
DB09227,Calcium Channel Blockers,DrugBank
DB09227,Calcium-Regulating Hormones and Agents,DrugBank
DB09227,Cardiovascular Agents,DrugBank
DB09227,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09227,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09227,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09227,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB09227,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09227,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09227,Cytochrome P-450 Substrates,DrugBank
DB09227,Dihydropyridine Derivatives,DrugBank
DB09227,Dihydropyridines,DrugBank
DB09227,Hypotensive Agents,DrugBank
DB09227,Membrane Transport Modulators,DrugBank
DB09227,Pyridines,DrugBank
DB09227,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09227,Vasodilating Agents,DrugBank
DB09229,Agents causing hyperkalemia,DrugBank
DB09229,Antiarrhythmic agents,DrugBank
DB09229,Bradycardia-Causing Agents,DrugBank
DB09229,Calcium Channel Blockers,DrugBank
DB09229,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09229,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09229,Cytochrome P-450 Substrates,DrugBank
DB09229,Potential QTc-Prolonging Agents,DrugBank
DB09229,Pyridines,DrugBank
DB09229,QTc Prolonging Agents,DrugBank
DB09229,Vasodilating Agents,DrugBank
DB09230,"Acids, Acyclic",DrugBank
DB09230,Agents causing hyperkalemia,DrugBank
DB09230,Amino Acids,DrugBank
DB09230,"Amino Acids, Cyclic",DrugBank
DB09230,"Amino Acids, Peptides, and Proteins",DrugBank
DB09230,Antiarrhythmic agents,DrugBank
DB09230,Azetidines,DrugBank
DB09230,Azetines,DrugBank
DB09230,Bradycardia-Causing Agents,DrugBank
DB09230,Calcium Channel Blockers,DrugBank
DB09230,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09230,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09230,Cytochrome P-450 Substrates,DrugBank
DB09230,Imines,DrugBank
DB09230,Imino Acids,DrugBank
DB09230,Pyridines,DrugBank
DB09230,Vasodilating Agents,DrugBank
DB09231,Agents causing hyperkalemia,DrugBank
DB09231,Antiarrhythmic agents,DrugBank
DB09231,Bradycardia-Causing Agents,DrugBank
DB09231,Calcium Channel Blockers,DrugBank
DB09231,Calcium-Regulating Hormones and Agents,DrugBank
DB09231,Cardiovascular Agents,DrugBank
DB09231,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09231,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09231,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09231,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB09231,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09231,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09231,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09231,Cytochrome P-450 Substrates,DrugBank
DB09231,Dihydropyridine Derivatives,DrugBank
DB09231,Dihydropyridines,DrugBank
DB09231,Membrane Transport Modulators,DrugBank
DB09231,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09231,Pyridines,DrugBank
DB09231,QTc Prolonging Agents,DrugBank
DB09231,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09231,Vasodilating Agents,DrugBank
DB09232,Agents causing hyperkalemia,DrugBank
DB09232,Antiarrhythmic agents,DrugBank
DB09232,Bradycardia-Causing Agents,DrugBank
DB09232,Calcium Channel Blockers,DrugBank
DB09232,Calcium-Regulating Hormones and Agents,DrugBank
DB09232,Cardiovascular Agents,DrugBank
DB09232,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09232,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09232,Cytochrome P-450 Substrates,DrugBank
DB09232,Dihydropyridine Derivatives,DrugBank
DB09232,Hypotensive Agents,DrugBank
DB09232,Membrane Transport Modulators,DrugBank
DB09232,Pyridines,DrugBank
DB09232,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09232,Vasodilating Agents,DrugBank
DB09234,Agents causing hyperkalemia,DrugBank
DB09234,Antiarrhythmic agents,DrugBank
DB09234,Bradycardia-Causing Agents,DrugBank
DB09234,Calcium Channel Blockers,DrugBank
DB09234,Calcium-Regulating Hormones and Agents,DrugBank
DB09234,Cardiovascular Agents,DrugBank
DB09234,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09234,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09234,Cytochrome P-450 Substrates,DrugBank
DB09234,Dihydropyridines,DrugBank
DB09234,Membrane Transport Modulators,DrugBank
DB09234,Pyridines,DrugBank
DB09234,Vasodilating Agents,DrugBank
DB09235,Agents causing hyperkalemia,DrugBank
DB09235,Antiarrhythmic agents,DrugBank
DB09235,Antihypertensive Agents,DrugBank
DB09235,Benzene Derivatives,DrugBank
DB09235,Bradycardia-Causing Agents,DrugBank
DB09235,Calcium Channel Blockers,DrugBank
DB09235,Calcium-Regulating Hormones and Agents,DrugBank
DB09235,Cardiovascular Agents,DrugBank
DB09235,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09235,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09235,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09235,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09235,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09235,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09235,Cytochrome P-450 Substrates,DrugBank
DB09235,Diuretics,DrugBank
DB09235,Hypotensive Agents,DrugBank
DB09235,Membrane Transport Modulators,DrugBank
DB09235,Natriuretic Agents,DrugBank
DB09235,Nitro Compounds,DrugBank
DB09235,Phenols,DrugBank
DB09235,Potential QTc-Prolonging Agents,DrugBank
DB09235,Pyridines,DrugBank
DB09235,QTc Prolonging Agents,DrugBank
DB09235,Vasodilating Agents,DrugBank
DB09236,Agents causing hyperkalemia,DrugBank
DB09236,Antiarrhythmic agents,DrugBank
DB09236,Antihypertensive Agents,DrugBank
DB09236,Bradycardia-Causing Agents,DrugBank
DB09236,Calcium Channel Blockers,DrugBank
DB09236,Calcium-Regulating Hormones and Agents,DrugBank
DB09236,Cardiovascular Agents,DrugBank
DB09236,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09236,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09236,Cytochrome P-450 Substrates,DrugBank
DB09236,Dihydropyridine Derivatives,DrugBank
DB09236,Hypotensive Agents,DrugBank
DB09236,Membrane Transport Modulators,DrugBank
DB09236,Mutagens,DrugBank
DB09236,Potential QTc-Prolonging Agents,DrugBank
DB09236,Pyridines,DrugBank
DB09236,QTc Prolonging Agents,DrugBank
DB09236,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09236,Vasodilating Agents,DrugBank
DB09237,Antiarrhythmic agents,DrugBank
DB09237,Antihypertensive Agents,DrugBank
DB09237,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB09237,Calcium Channel Blockers,DrugBank
DB09237,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09237,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09237,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09237,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB09237,Cytochrome P-450 Substrates,DrugBank
DB09237,Dihydropyridine Derivatives,DrugBank
DB09237,Nicotinic Acids,DrugBank
DB09237,P-glycoprotein substrates,DrugBank
DB09237,Pyridines,DrugBank
DB09237,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09238,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB09238,Agents causing hyperkalemia,DrugBank
DB09238,Antiarrhythmic agents,DrugBank
DB09238,Antihypertensive Agents,DrugBank
DB09238,Benzene Derivatives,DrugBank
DB09238,Bradycardia-Causing Agents,DrugBank
DB09238,Calcium Channel Blockers,DrugBank
DB09238,Calcium-Regulating Hormones and Agents,DrugBank
DB09238,Cardiovascular Agents,DrugBank
DB09238,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB09238,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB09238,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09238,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB09238,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB09238,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09238,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09238,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09238,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09238,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09238,Cytochrome P-450 Substrates,DrugBank
DB09238,Dihydropyridine Derivatives,DrugBank
DB09238,Membrane Transport Modulators,DrugBank
DB09238,Nitro Compounds,DrugBank
DB09238,Pyridines,DrugBank
DB09238,Selective Calcium Channel Blockers With Mainly Vascular Effects,DrugBank
DB09238,Vasodilating Agents,DrugBank
DB09239,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB09239,Adrenergic alpha-Antagonists,DrugBank
DB09239,Adrenergic Antagonists,DrugBank
DB09239,Agents causing hyperkalemia,DrugBank
DB09239,Antiarrhythmic agents,DrugBank
DB09239,Antihypertensive Agents,DrugBank
DB09239,Antineoplastic Agents,DrugBank
DB09239,Bradycardia-Causing Agents,DrugBank
DB09239,Calcium Channel Blockers,DrugBank
DB09239,Calcium-Regulating Hormones and Agents,DrugBank
DB09239,Cardiovascular Agents,DrugBank
DB09239,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09239,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09239,Cytochrome P-450 Substrates,DrugBank
DB09239,Membrane Transport Modulators,DrugBank
DB09239,P-glycoprotein inhibitors,DrugBank
DB09239,Potential QTc-Prolonging Agents,DrugBank
DB09239,Pyridines,DrugBank
DB09239,QTc Prolonging Agents,DrugBank
DB09239,Vasodilating Agents,DrugBank
DB09240,Agents causing hyperkalemia,DrugBank
DB09240,Antiarrhythmic agents,DrugBank
DB09240,Bradycardia-Causing Agents,DrugBank
DB09240,Calcium Channel Blockers,DrugBank
DB09240,Calcium-Regulating Hormones and Agents,DrugBank
DB09240,Cardiovascular Agents,DrugBank
DB09240,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09240,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09240,Cytochrome P-450 Substrates,DrugBank
DB09240,Dihydropyridines,DrugBank
DB09240,Membrane Transport Modulators,DrugBank
DB09240,Pyridines,DrugBank
DB09240,Vasodilating Agents,DrugBank
DB09241,Agents that produce hypertension,DrugBank
DB09241,Agents that reduce seizure threshold,DrugBank
DB09241,Antidepressive Agents,DrugBank
DB09241,Antidotes,DrugBank
DB09241,Antipsychotic Agents,DrugBank
DB09241,Central Nervous System Depressants,DrugBank
DB09241,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09241,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09241,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09241,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09241,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB09241,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB09241,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09241,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09241,Cytochrome P-450 Substrates,DrugBank
DB09241,Diagnostic Agents,DrugBank
DB09241,Drugs causing inadvertant photosensitivity,DrugBank
DB09241,Drugs that are Mainly Renally Excreted,DrugBank
DB09241,Enzyme Inhibitors,DrugBank
DB09241,Gastric Function,DrugBank
DB09241,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09241,MATE 1 Inhibitors,DrugBank
DB09241,MATE 2 Inhibitors,DrugBank
DB09241,MATE inhibitors,DrugBank
DB09241,Miscellaneous Therapeutic Agents,DrugBank
DB09241,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB09241,Monoamine Oxidase Inhibitors,DrugBank
DB09241,Neurotoxic agents,DrugBank
DB09241,OCT2 Inhibitors,DrugBank
DB09241,Oxidation-Reduction Agent,DrugBank
DB09241,P-glycoprotein inhibitors,DrugBank
DB09241,P-glycoprotein substrates,DrugBank
DB09241,Phenothiazines,DrugBank
DB09241,Photosensitizing Agents,DrugBank
DB09241,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09241,Sulfur Compounds,DrugBank
DB09241,Tests for Gastric Secretion,DrugBank
DB09241,UGT1A4 Inhibitors,DrugBank
DB09241,UGT1A9 Inhibitors,DrugBank
DB09242,Adrenergic Agonists,DrugBank
DB09242,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB09242,Adrenergic alpha-Agonists,DrugBank
DB09242,Agents producing tachycardia,DrugBank
DB09242,Agents that produce hypertension,DrugBank
DB09242,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB09242,Antihypertensive Agents,DrugBank
DB09242,Cardiovascular Agents,DrugBank
DB09242,Hypotensive Agents,DrugBank
DB09242,Imidazoline Receptor Agonists,DrugBank
DB09242,Sympatholytics,DrugBank
DB09243,Agents that produce hypertension,DrugBank
DB09243,Agents that reduce seizure threshold,DrugBank
DB09243,Antidepressive Agents,DrugBank
DB09243,Central Nervous System Depressants,DrugBank
DB09243,Monoamine Oxidase Inhibitors,DrugBank
DB09243,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09244,Agents that produce hypertension,DrugBank
DB09244,Agents that reduce seizure threshold,DrugBank
DB09244,Antidepressive Agents,DrugBank
DB09244,Central Nervous System Agents,DrugBank
DB09244,Central Nervous System Depressants,DrugBank
DB09244,Drugs that are Mainly Renally Excreted,DrugBank
DB09244,Enzyme Inhibitors,DrugBank
DB09244,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09244,Indoles,DrugBank
DB09244,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB09244,Monoamine Oxidase Inhibitors,DrugBank
DB09244,Psychotropic Drugs,DrugBank
DB09244,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09244,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB09244,Serotonin 5-HT1A Receptor Antagonists,DrugBank
DB09244,Serotonin Agents,DrugBank
DB09244,Serotonin Receptor Antagonists,DrugBank
DB09245,Agents that produce hypertension,DrugBank
DB09245,Agents that reduce seizure threshold,DrugBank
DB09245,Antidepressive Agents,DrugBank
DB09245,Central Nervous System Agents,DrugBank
DB09245,Central Nervous System Depressants,DrugBank
DB09245,Drugs that are Mainly Renally Excreted,DrugBank
DB09245,Enzyme Inhibitors,DrugBank
DB09245,Monoamine Oxidase A Inhibitors,DrugBank
DB09245,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB09245,Monoamine Oxidase Inhibitors,DrugBank
DB09245,Nervous System,DrugBank
DB09245,Oxazoles,DrugBank
DB09245,Psychoanaleptics,DrugBank
DB09245,Psychotropic Drugs,DrugBank
DB09245,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09246,Agents that produce hypertension,DrugBank
DB09246,Agents that reduce seizure threshold,DrugBank
DB09246,Antidepressive Agents,DrugBank
DB09246,Central Nervous System Depressants,DrugBank
DB09246,Monoamine Oxidase Inhibitors,DrugBank
DB09246,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09247,Acetates,DrugBank
DB09247,"Acids, Acyclic",DrugBank
DB09247,Antidepressive Agents,DrugBank
DB09247,Central Nervous System Depressants,DrugBank
DB09247,Hydroxy Acids,DrugBank
DB09247,Nervous System,DrugBank
DB09247,Psychoanaleptics,DrugBank
DB09248,Agents that produce hypertension,DrugBank
DB09248,Agents that reduce seizure threshold,DrugBank
DB09248,Antidepressive Agents,DrugBank
DB09248,Central Nervous System Depressants,DrugBank
DB09248,Monoamine Oxidase Inhibitors,DrugBank
DB09248,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09249,Agents that produce hypertension,DrugBank
DB09249,Agents that reduce seizure threshold,DrugBank
DB09249,Antidepressive Agents,DrugBank
DB09249,Central Nervous System Depressants,DrugBank
DB09249,Monoamine Oxidase Inhibitors,DrugBank
DB09249,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09250,Agents that produce hypertension,DrugBank
DB09250,Agents that reduce seizure threshold,DrugBank
DB09250,Antidepressive Agents,DrugBank
DB09250,Central Nervous System Depressants,DrugBank
DB09250,Monoamine Oxidase Inhibitors,DrugBank
DB09250,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09251,Agents that produce hypertension,DrugBank
DB09251,Agents that reduce seizure threshold,DrugBank
DB09251,Antidepressive Agents,DrugBank
DB09251,Central Nervous System Depressants,DrugBank
DB09251,Monoamine Oxidase Inhibitors,DrugBank
DB09251,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09252,"Acids, Acyclic",DrugBank
DB09252,Agents that produce hypertension,DrugBank
DB09252,Agents that reduce seizure threshold,DrugBank
DB09252,Antidepressive Agents,DrugBank
DB09252,Central Nervous System Depressants,DrugBank
DB09252,Fatty Acids,DrugBank
DB09252,"Fatty Acids, Volatile",DrugBank
DB09252,Lipids,DrugBank
DB09252,Monoamine Oxidase Inhibitors,DrugBank
DB09252,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09253,Agents that produce hypertension,DrugBank
DB09253,Agents that reduce seizure threshold,DrugBank
DB09253,Antidepressive Agents,DrugBank
DB09253,Central Nervous System Depressants,DrugBank
DB09253,Monoamine Oxidase Inhibitors,DrugBank
DB09253,"Monoamine Oxidase Inhibitors, Non-Selective",DrugBank
DB09253,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09254,Acetamides,DrugBank
DB09254,Agents that produce hypertension,DrugBank
DB09254,Agents that reduce seizure threshold,DrugBank
DB09254,Amides,DrugBank
DB09254,Antidepressive Agents,DrugBank
DB09254,Benzene Derivatives,DrugBank
DB09254,Central Nervous System Depressants,DrugBank
DB09254,Monoamine Oxidase Inhibitors,DrugBank
DB09254,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09255,Anticoagulants,DrugBank
DB09255,Biopolymers,DrugBank
DB09255,Blood and Blood Forming Organs,DrugBank
DB09255,Blood and Related Products,DrugBank
DB09255,Blood Substitutes,DrugBank
DB09255,Blood Substitutes and Perfusion Solutions,DrugBank
DB09255,Blood Substitutes and Plasma Protein Fractions,DrugBank
DB09255,Carbohydrates,DrugBank
DB09255,"Compounds used in a research, industrial, or household setting",DrugBank
DB09255,Dextrans,DrugBank
DB09255,Drugs that are Mainly Renally Excreted,DrugBank
DB09255,Glucans,DrugBank
DB09255,Hematologic Agents,DrugBank
DB09255,Increased Intravascular Volume,DrugBank
DB09255,Macromolecular Substances,DrugBank
DB09255,Osmotic Activity,DrugBank
DB09255,Plasma Substitutes,DrugBank
DB09255,Polymers,DrugBank
DB09255,Polysaccharides,DrugBank
DB09256,Antimetabolites,DrugBank
DB09256,Antineoplastic Agents,DrugBank
DB09256,Antineoplastic and Immunomodulating Agents,DrugBank
DB09256,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09256,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB09256,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB09256,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index,DrugBank
DB09256,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09256,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB09256,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB09256,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index,DrugBank
DB09256,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09256,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09256,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB09256,Cytochrome P-450 Substrates,DrugBank
DB09256,Drugs that are Mainly Renally Excreted,DrugBank
DB09256,Fluoropyrimidines,DrugBank
DB09256,Fluorouracil and prodrugs,DrugBank
DB09256,Narrow Therapeutic Index Drugs,DrugBank
DB09256,Noxae,DrugBank
DB09256,Pyrimidine Analogues,DrugBank
DB09256,Pyrimidines,DrugBank
DB09256,Pyrimidinones,DrugBank
DB09256,Thyroxine-binding globulin inducers,DrugBank
DB09256,Toxic Actions,DrugBank
DB09257,Drugs that are Mainly Renally Excreted,DrugBank
DB09258,Agents causing hyperkalemia,DrugBank
DB09258,Anticoagulants,DrugBank
DB09258,Blood and Blood Forming Organs,DrugBank
DB09258,Carbohydrates,DrugBank
DB09258,Glycosaminoglycans,DrugBank
DB09258,Hematologic Agents,DrugBank
DB09258,Heparin (Low Molecular Weight),DrugBank
DB09258,Heparin and similars,DrugBank
DB09258,Polysaccharides,DrugBank
DB09259,Agents causing hyperkalemia,DrugBank
DB09259,Anticoagulants,DrugBank
DB09259,Blood and Blood Forming Organs,DrugBank
DB09259,Carbohydrates,DrugBank
DB09259,Cardiovascular Agents,DrugBank
DB09259,Fibrin Modulating Agents,DrugBank
DB09259,Glycosaminoglycans,DrugBank
DB09259,Hematologic Agents,DrugBank
DB09259,Heparin (Low Molecular Weight),DrugBank
DB09259,Heparin and similars,DrugBank
DB09259,Polysaccharides,DrugBank
DB09260,Agents causing hyperkalemia,DrugBank
DB09260,Anticoagulants,DrugBank
DB09260,Blood and Blood Forming Organs,DrugBank
DB09260,Carbohydrates,DrugBank
DB09260,Cardiovascular Agents,DrugBank
DB09260,Fibrin Modulating Agents,DrugBank
DB09260,Glycosaminoglycans,DrugBank
DB09260,Hematologic Agents,DrugBank
DB09260,Heparin (Low Molecular Weight),DrugBank
DB09260,Heparin and similars,DrugBank
DB09260,Polysaccharides,DrugBank
DB09261,Agents causing hyperkalemia,DrugBank
DB09261,Anticoagulants,DrugBank
DB09261,Carbohydrates,DrugBank
DB09261,Glycosaminoglycans,DrugBank
DB09261,Hematologic Agents,DrugBank
DB09261,Heparin (Low Molecular Weight),DrugBank
DB09261,Heparin and similars,DrugBank
DB09261,Polysaccharides,DrugBank
DB09262,Agents producing tachycardia,DrugBank
DB09262,Anticholinergic Agents,DrugBank
DB09262,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09262,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09262,Cytochrome P-450 Substrates,DrugBank
DB09262,Drugs for Urinary Frequency and Incontinence,DrugBank
DB09262,Drugs that are Mainly Renally Excreted,DrugBank
DB09262,Genito Urinary System and Sex Hormones,DrugBank
DB09262,Muscarinic Antagonists,DrugBank
DB09262,UGT1A4 substrates,DrugBank
DB09262,Urologicals,DrugBank
DB09263,Cation Exchange Resins,DrugBank
DB09263,"Compounds used in a research, industrial, or household setting",DrugBank
DB09263,Macromolecular Substances,DrugBank
DB09263,Potassium Binder,DrugBank
DB09263,Potassium Ion Binding Activity,DrugBank
DB09263,Potassium-removing Agents,DrugBank
DB09264,"Amino Acids, Peptides, and Proteins",DrugBank
DB09264,Antibodies,DrugBank
DB09264,"Antibodies, Monoclonal",DrugBank
DB09264,"Antibodies, Monoclonal, Humanized",DrugBank
DB09264,Antidotes,DrugBank
DB09264,Blood Proteins,DrugBank
DB09264,Drugs that are Mainly Renally Excreted,DrugBank
DB09264,Globulins,DrugBank
DB09264,Humanized Monoclonal Antibody Fragment,DrugBank
DB09264,Immunoglobulins,DrugBank
DB09264,Immunoproteins,DrugBank
DB09264,Proteins,DrugBank
DB09264,Serum Globulins,DrugBank
DB09265,Alimentary Tract and Metabolism,DrugBank
DB09265,"Amino Acids, Peptides, and Proteins",DrugBank
DB09265,Blood Glucose Lowering Agents,DrugBank
DB09265,Drugs that are Mainly Renally Excreted,DrugBank
DB09265,Drugs Used in Diabetes,DrugBank
DB09265,GLP-1 Agonists,DrugBank
DB09265,Glucagon-Like Peptide Receptors,DrugBank
DB09265,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB09265,Incretin Mimetics,DrugBank
DB09265,Membrane Proteins,DrugBank
DB09265,Proteins,DrugBank
DB09265,"Receptors, G-Protein-Coupled",DrugBank
DB09265,"Receptors, Gastrointestinal Hormone",DrugBank
DB09265,"Receptors, Peptide",DrugBank
DB09266,Diagnostic Radiopharmaceuticals,DrugBank
DB09266,Radioactive Diagnostic Agent,DrugBank
DB09266,Radiopharmaceutical Activity,DrugBank
DB09266,Technetium (99Mtc) Compounds,DrugBank
DB09266,Tumour Detection,DrugBank
DB09268,"Acids, Acyclic",DrugBank
DB09268,Alimentary Tract and Metabolism,DrugBank
DB09268,Contact Laxatives,DrugBank
DB09268,Drugs for Constipation,DrugBank
DB09268,Drugs that are Mainly Renally Excreted,DrugBank
DB09268,Gastrointestinal Agents,DrugBank
DB09268,Laxatives,DrugBank
DB09268,Pyridines,DrugBank
DB09268,Tricarboxylic Acids,DrugBank
DB09269,"Acids, Carbocyclic",DrugBank
DB09269,Alimentary Tract and Metabolism,DrugBank
DB09269,Ammonium Ion Binding Activity,DrugBank
DB09269,Nitrogen Binding Agent,DrugBank
DB09269,Noxae,DrugBank
DB09269,Toxic Actions,DrugBank
DB09269,Urea Cycle Disorder Agents,DrugBank
DB09269,Various Alimentary Tract and Metabolism Products,DrugBank
DB09270,Agents Causing Muscle Toxicity,DrugBank
DB09270,Benzoquinones,DrugBank
DB09270,Cardiac Therapy,DrugBank
DB09270,Coenzymes,DrugBank
DB09270,"Diet, Food, and Nutrition",DrugBank
DB09270,Electron Transport Chain Complex Proteins,DrugBank
DB09270,Enzymes and Coenzymes,DrugBank
DB09270,Food,DrugBank
DB09270,Hypoglycemia-Associated Agents,DrugBank
DB09270,Micronutrients,DrugBank
DB09270,Other Nutritional Agents,DrugBank
DB09270,P-glycoprotein substrates,DrugBank
DB09270,Physiological Phenomena,DrugBank
DB09270,Quinones,DrugBank
DB09270,Ubiquinone,DrugBank
DB09270,Vitamins,DrugBank
DB09271,Alimentary Tract and Metabolism,DrugBank
DB09271,Alkaloids,DrugBank
DB09271,Autonomic Agents,DrugBank
DB09271,Aza Compounds,DrugBank
DB09271,Azabicyclo Compounds,DrugBank
DB09271,"Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds",DrugBank
DB09271,"Belladonna and Derivatives, Plain",DrugBank
DB09271,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB09271,Parasympatholytics,DrugBank
DB09271,Peripheral Nervous System Agents,DrugBank
DB09271,Tropanes,DrugBank
DB09272,Alimentary Tract and Metabolism,DrugBank
DB09272,Amino Acids,DrugBank
DB09272,"Amino Acids, Aromatic",DrugBank
DB09272,"Amino Acids, Cyclic",DrugBank
DB09272,"Amino Acids, Peptides, and Proteins",DrugBank
DB09272,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB09272,Antipropulsives,DrugBank
DB09272,Gastrointestinal Agents,DrugBank
DB09272,Miscellaneous GI Drugs,DrugBank
DB09272,Mixed Agonist / Antagonist Opioids,DrugBank
DB09272,mu-Opioid Receptor Agonist,DrugBank
DB09272,OAT3/SLC22A8 Substrates,DrugBank
DB09272,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09272,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09272,Opioid Antagonists,DrugBank
DB09272,Opioids,DrugBank
DB09272,"Receptors, Opioid, delta, antagonists & inhibitors",DrugBank
DB09272,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09273,Adrenergic Agonists,DrugBank
DB09273,Adrenergic beta-2 Receptor Agonists,DrugBank
DB09273,Adrenergic beta-Agonists,DrugBank
DB09273,Agents producing tachycardia,DrugBank
DB09273,Agents that produce hypertension,DrugBank
DB09273,Alkaloids,DrugBank
DB09273,Anti-Asthmatic Agents,DrugBank
DB09273,Antitussive Agents,DrugBank
DB09273,Autonomic Agents,DrugBank
DB09273,Bronchodilator Agents,DrugBank
DB09273,Central Nervous System Agents,DrugBank
DB09273,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09273,Cytochrome P-450 Substrates,DrugBank
DB09273,Drugs for Obstructive Airway Diseases,DrugBank
DB09273,Enzyme Inhibitors,DrugBank
DB09273,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09273,Peripheral Nervous System Agents,DrugBank
DB09273,Phosphodiesterase 5 Inhibitors,DrugBank
DB09273,Phosphodiesterase Inhibitors,DrugBank
DB09273,Purines,DrugBank
DB09273,Purinones,DrugBank
DB09273,Respiratory System Agents,DrugBank
DB09273,Vasodilating Agents,DrugBank
DB09273,Xanthine derivatives,DrugBank
DB09274,"Acids, Acyclic",DrugBank
DB09274,Anions,DrugBank
DB09274,Anthelmintics,DrugBank
DB09274,Anti-Infective Agents,DrugBank
DB09274,Antimalarials,DrugBank
DB09274,Antineoplastic Agents,DrugBank
DB09274,Antiparasitic Agents,DrugBank
DB09274,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB09274,Antiplatyhelmintic Agents,DrugBank
DB09274,Antiprotozoals,DrugBank
DB09274,Antiviral Agents,DrugBank
DB09274,Artemisinin and derivatives,DrugBank
DB09274,Artemisinins,DrugBank
DB09274,BCRP/ABCG2 Substrates,DrugBank
DB09274,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB09274,Cytochrome P-450 Substrates,DrugBank
DB09274,Dicarboxylic Acids,DrugBank
DB09274,Electrolytes,DrugBank
DB09274,Free Radicals,DrugBank
DB09274,Ions,DrugBank
DB09274,OAT3/SLC22A8 Inhibitors,DrugBank
DB09274,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09274,Oxides,DrugBank
DB09274,Oxygen Compounds,DrugBank
DB09274,P-glycoprotein substrates,DrugBank
DB09274,Peroxides,DrugBank
DB09274,Reactive Oxygen Species,DrugBank
DB09274,Schistosomicides,DrugBank
DB09274,Terpenes,DrugBank
DB09274,UGT1A9 Substrates,DrugBank
DB09274,UGT2B7 substrates,DrugBank
DB09275,Alimentary Tract and Metabolism,DrugBank
DB09275,Anti-Infective Agents,DrugBank
DB09275,Anti-Ulcer Agents,DrugBank
DB09275,Bismuth containing drugs,DrugBank
DB09275,Drugs for Acid Related Disorders,DrugBank
DB09275,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB09275,Gastrointestinal Agents,DrugBank
DB09275,Neurotoxic agents,DrugBank
DB09276,"Acids, Acyclic",DrugBank
DB09276,Antiinflammatory and Antirheumatic Products,DrugBank
DB09276,Antirheumatic Agents,DrugBank
DB09276,Dicarboxylic Acids,DrugBank
DB09276,Drugs that are Mainly Renally Excreted,DrugBank
DB09276,Gold Compounds,DrugBank
DB09276,Gold Preparations,DrugBank
DB09276,Malates,DrugBank
DB09276,Musculo-Skeletal System,DrugBank
DB09276,Organogold Compounds,DrugBank
DB09276,Organometallic Compounds,DrugBank
DB09276,Specific Antirheumatic Agents,DrugBank
DB09276,Sulfhydryl Compounds,DrugBank
DB09276,Sulfur Compounds,DrugBank
DB09276,Thiomalates,DrugBank
DB09276,UGT1A1 Inhibitors,DrugBank
DB09277,Drugs that are Mainly Renally Excreted,DrugBank
DB09278,Adsorption,DrugBank
DB09278,Alimentary Tract and Metabolism,DrugBank
DB09278,Anions,DrugBank
DB09278,Antacids and Adsorbents,DrugBank
DB09278,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB09278,Antidotes,DrugBank
DB09278,Antifoaming Agents,DrugBank
DB09278,Carbon,DrugBank
DB09278,Charcoal Preparations,DrugBank
DB09278,"Compounds used in a research, industrial, or household setting",DrugBank
DB09278,Electrolytes,DrugBank
DB09278,Elements,DrugBank
DB09278,Intestinal Adsorbents,DrugBank
DB09278,Ions,DrugBank
DB09278,Microspheres,DrugBank
DB09278,Oxygen Compounds,DrugBank
DB09278,Protective Agents,DrugBank
DB09279,Agents Acting on the Renin-Angiotensin System,DrugBank
DB09279,Agents causing hyperkalemia,DrugBank
DB09279,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB09279,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB09279,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB09279,Angiotensin Receptor Antagonists,DrugBank
DB09279,BCRP/ABCG2 Substrates,DrugBank
DB09279,Benzene Derivatives,DrugBank
DB09279,Hypotensive Agents,DrugBank
DB09279,Lipid Modifying Agents,DrugBank
DB09279,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09280,Amines,DrugBank
DB09280,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB09280,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB09280,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB09280,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB09280,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB09280,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB09280,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB09280,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09280,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB09280,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09280,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB09280,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09280,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09280,Dioxoles,DrugBank
DB09280,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09280,P-glycoprotein inducers,DrugBank
DB09280,P-glycoprotein inhibitors,DrugBank
DB09280,Pyridines,DrugBank
DB09281,Agents that produce neuromuscular block (indirect),DrugBank
DB09281,Aluminum and magnesium containing antacids,DrugBank
DB09281,Antacids,DrugBank
DB09281,Drugs that are Mainly Renally Excreted,DrugBank
DB09281,Gastric Acid Lowering Agents,DrugBank
DB09281,Gastrointestinal Agents,DrugBank
DB09281,Laxatives,DrugBank
DB09281,Magnesium Compounds,DrugBank
DB09281,Metal cations,DrugBank
DB09281,Metal divalent cations,DrugBank
DB09281,Minerals,DrugBank
DB09281,Silicates,DrugBank
DB09281,Silicon Compounds,DrugBank
DB09282,Cardiac Therapy,DrugBank
DB09282,Cardiovascular Agents,DrugBank
DB09282,Morpholines,DrugBank
DB09282,Nitric Oxide Donors,DrugBank
DB09282,Oxadiazoles,DrugBank
DB09282,Oxazines,DrugBank
DB09282,Oxazoles,DrugBank
DB09282,Sydnones,DrugBank
DB09282,Vasodilating Agents,DrugBank
DB09282,Vasodilators Used in Cardiac Diseases,DrugBank
DB09283,Antiplatelet agents,DrugBank
DB09283,Cardiac Therapy,DrugBank
DB09283,Cardiovascular Agents,DrugBank
DB09283,Enzyme Inhibitors,DrugBank
DB09283,Hematologic Agents,DrugBank
DB09283,Phosphodiesterase Inhibitors,DrugBank
DB09283,Pyrimidines,DrugBank
DB09283,Triazoles,DrugBank
DB09283,Vasodilating Agents,DrugBank
DB09283,Vasodilators Used in Cardiac Diseases,DrugBank
DB09284,Cardiac Therapy,DrugBank
DB09284,Cardiovascular Agents,DrugBank
DB09284,Oxazoles,DrugBank
DB09284,Vasodilating Agents,DrugBank
DB09284,Vasodilators Used in Cardiac Diseases,DrugBank
DB09285,"Acids, Carbocyclic",DrugBank
DB09285,Agents causing hyperkalemia,DrugBank
DB09285,Agents that produce hypertension,DrugBank
DB09285,Aminobenzoates,DrugBank
DB09285,Anti-Inflammatory Agents,DrugBank
DB09285,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09285,Antiinflammatory and Antirheumatic Products,DrugBank
DB09285,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09285,Benzene Derivatives,DrugBank
DB09285,Benzoates,DrugBank
DB09285,Fenamates,DrugBank
DB09285,Musculo-Skeletal System,DrugBank
DB09285,Nephrotoxic agents,DrugBank
DB09285,Nicotinic Acids,DrugBank
DB09285,ortho-Aminobenzoates,DrugBank
DB09285,Pyridines,DrugBank
DB09285,UGT1A9 Inhibitors,DrugBank
DB09286,Antidepressive Agents,DrugBank
DB09286,Antipsychotic Agents,DrugBank
DB09286,Butyrophenone Derivatives,DrugBank
DB09286,Central Nervous System Agents,DrugBank
DB09286,Central Nervous System Depressants,DrugBank
DB09286,Dopamine Antagonists,DrugBank
DB09286,Dopamine D2 Receptor Antagonists,DrugBank
DB09286,Hypotensive Agents,DrugBank
DB09286,Ketones,DrugBank
DB09286,Nervous System,DrugBank
DB09286,Neurotoxic agents,DrugBank
DB09286,Neurotransmitter Agents,DrugBank
DB09286,Psycholeptics,DrugBank
DB09286,Psychotropic Drugs,DrugBank
DB09286,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09286,Serotonin Agents,DrugBank
DB09286,Serotonin Receptor Antagonists,DrugBank
DB09286,Tranquilizing Agents,DrugBank
DB09287,Alcohols,DrugBank
DB09287,Alimentary Tract and Metabolism,DrugBank
DB09287,"Compounds used in a research, industrial, or household setting",DrugBank
DB09287,Drug Delivery Systems,DrugBank
DB09287,Drugs for Constipation,DrugBank
DB09287,Electrolytes,DrugBank
DB09287,Ethylene Glycols,DrugBank
DB09287,Excipients,DrugBank
DB09287,Gastrointestinal Agents,DrugBank
DB09287,Glycols,DrugBank
DB09287,Laxatives,DrugBank
DB09287,Macromolecular Substances,DrugBank
DB09287,Osmotic Activity,DrugBank
DB09287,Osmotic Laxatives,DrugBank
DB09287,P-glycoprotein inhibitors,DrugBank
DB09287,Pegylated agents,DrugBank
DB09287,Pharmaceutic Aids,DrugBank
DB09287,Pharmaceutical Preparations,DrugBank
DB09287,Pharmaceutical Vehicles,DrugBank
DB09287,Polyethylene Glycols,DrugBank
DB09287,Polymers,DrugBank
DB09287,Solvents,DrugBank
DB09287,Stimulation Large Intestine Fluid/Electrolyte Secretion,DrugBank
DB09287,Surface-Active Agents,DrugBank
DB09288,Acetaminophen and Prodrugs,DrugBank
DB09288,Acetanilides,DrugBank
DB09288,Agents causing hyperkalemia,DrugBank
DB09288,Agents that produce hypertension,DrugBank
DB09288,Amides,DrugBank
DB09288,Amines,DrugBank
DB09288,Analgesics,DrugBank
DB09288,"Analgesics, Non-Narcotic",DrugBank
DB09288,Anilides,DrugBank
DB09288,Aniline Compounds,DrugBank
DB09288,Anti-Inflammatory Agents,DrugBank
DB09288,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09288,Antirheumatic Agents,DrugBank
DB09288,Central Nervous System Agents,DrugBank
DB09288,Cholinesterase substrates,DrugBank
DB09288,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB09288,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09288,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09288,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09288,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09288,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09288,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09288,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09288,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09288,Cytochrome P-450 Substrates,DrugBank
DB09288,Drugs that are Mainly Renally Excreted,DrugBank
DB09288,Nephrotoxic agents,DrugBank
DB09288,Nervous System,DrugBank
DB09288,Non COX-2 selective NSAIDS,DrugBank
DB09288,Peripheral Nervous System Agents,DrugBank
DB09288,Prodrugs,DrugBank
DB09288,Sensory System Agents,DrugBank
DB09288,UGT1A1 Substrates,DrugBank
DB09288,UGT1A6 substrate,DrugBank
DB09288,UGT1A9 Substrates,DrugBank
DB09289,Agents Causing Muscle Toxicity,DrugBank
DB09289,Agents that produce hypertension,DrugBank
DB09289,Agents that reduce seizure threshold,DrugBank
DB09289,Analgesics,DrugBank
DB09289,Antidepressive Agents,DrugBank
DB09289,"Antidepressive Agents, Tricyclic",DrugBank
DB09289,Azepines,DrugBank
DB09289,Central Nervous System Agents,DrugBank
DB09289,Central Nervous System Depressants,DrugBank
DB09289,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09289,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09289,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09289,Cytochrome P-450 Substrates,DrugBank
DB09289,Narrow Therapeutic Index Drugs,DrugBank
DB09289,Nervous System,DrugBank
DB09289,Neurotoxic agents,DrugBank
DB09289,Psychoanaleptics,DrugBank
DB09289,Psychotropic Drugs,DrugBank
DB09289,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09289,Serotonin Agents,DrugBank
DB09289,Serotonin Modulators,DrugBank
DB09289,Sulfur Compounds,DrugBank
DB09289,Thiepins,DrugBank
DB09290,Antidepressive Agents,DrugBank
DB09290,Antiemetics,DrugBank
DB09290,Autonomic Agents,DrugBank
DB09290,Central Nervous System Agents,DrugBank
DB09290,Central Nervous System Depressants,DrugBank
DB09290,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09290,Cytochrome P-450 Substrates,DrugBank
DB09290,Gastrointestinal Agents,DrugBank
DB09290,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09290,Neurotransmitter Agents,DrugBank
DB09290,Peripheral Nervous System Agents,DrugBank
DB09290,Serotonin Agents,DrugBank
DB09290,Serotonin Receptor Antagonists,DrugBank
DB09291,Alimentary Tract and Metabolism,DrugBank
DB09291,Antiemetics and Antinauseants,DrugBank
DB09291,BCRP/ABCG2 Inhibitors,DrugBank
DB09291,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09291,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB09291,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09291,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09291,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09291,Cytochrome P-450 Substrates,DrugBank
DB09291,Neurokinin 1 Antagonists,DrugBank
DB09291,Neurokinin-1 Receptor Antagonists,DrugBank
DB09291,Neurotransmitter Agents,DrugBank
DB09291,P-glycoprotein inhibitors,DrugBank
DB09291,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB09292,"Acids, Acyclic",DrugBank
DB09292,Agents causing angioedema,DrugBank
DB09292,Amino Acids,DrugBank
DB09292,"Amino Acids, Branched-Chain",DrugBank
DB09292,"Amino Acids, Essential",DrugBank
DB09292,"Amino Acids, Peptides, and Proteins",DrugBank
DB09292,Benzene Derivatives,DrugBank
DB09292,Butyrates,DrugBank
DB09292,Drugs that are Mainly Renally Excreted,DrugBank
DB09292,Hypotensive Agents,DrugBank
DB09292,Neprilysin Inhibitor,DrugBank
DB09292,"Neprilysin, antagonists & inhibitors",DrugBank
DB09292,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09292,OATP1B3 inhibitors,DrugBank
DB09292,Pharmaceutical Preparations,DrugBank
DB09292,Tetrazoles,DrugBank
DB09293,Diagnostic Radiopharmaceuticals,DrugBank
DB09293,Iodine (131I) Compounds,DrugBank
DB09293,Radioactive Therapeutic Agent,DrugBank
DB09293,Radiopharmaceutical Activity,DrugBank
DB09293,Therapeutic Radiopharmaceuticals,DrugBank
DB09293,Thyroid Diagnostic Radiopharmaceuticals,DrugBank
DB09295,Agents causing hyperkalemia,DrugBank
DB09295,Agents that produce hypertension,DrugBank
DB09295,Anti-Inflammatory Agents,DrugBank
DB09295,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB09295,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09295,Nephrotoxic agents,DrugBank
DB09295,Niflumic Acid and Prodrugs,DrugBank
DB09295,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB09296,Amides,DrugBank
DB09296,Amines,DrugBank
DB09296,Amino Acids,DrugBank
DB09296,"Amino Acids, Branched-Chain",DrugBank
DB09296,"Amino Acids, Cyclic",DrugBank
DB09296,"Amino Acids, Essential",DrugBank
DB09296,"Amino Acids, Peptides, and Proteins",DrugBank
DB09296,Aniline Compounds,DrugBank
DB09296,Antiinfectives for Systemic Use,DrugBank
DB09296,Antiviral Agents,DrugBank
DB09296,Antivirals for Systemic Use,DrugBank
DB09296,Antivirals for treatment of HCV infections,DrugBank
DB09296,BCRP/ABCG2 Substrates,DrugBank
DB09296,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09296,Cytochrome P-450 Substrates,DrugBank
DB09296,Direct Acting Antivirals,DrugBank
DB09296,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB09296,Imino Acids,DrugBank
DB09296,P-glycoprotein substrates,DrugBank
DB09296,Treatments for Hepatitis C,DrugBank
DB09296,UGT1A1 Inhibitors,DrugBank
DB09297,Amides,DrugBank
DB09297,Amino Acids,DrugBank
DB09297,"Amino Acids, Cyclic",DrugBank
DB09297,"Amino Acids, Peptides, and Proteins",DrugBank
DB09297,Antiinfectives for Systemic Use,DrugBank
DB09297,Antiviral Agents,DrugBank
DB09297,Antivirals for Systemic Use,DrugBank
DB09297,Antivirals for treatment of HCV infections,DrugBank
DB09297,BCRP/ABCG2 Inhibitors,DrugBank
DB09297,Cycloparaffins,DrugBank
DB09297,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09297,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09297,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB09297,Cytochrome P-450 Substrates,DrugBank
DB09297,Direct Acting Antivirals,DrugBank
DB09297,HCV NS3/4A Protease Inhibitors,DrugBank
DB09297,Imino Acids,DrugBank
DB09297,Lactams,DrugBank
DB09297,NS3/4A Protease Inhibitors,DrugBank
DB09297,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09297,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09297,OATP1B3 inhibitors,DrugBank
DB09297,OATP1B3 substrates,DrugBank
DB09297,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB09297,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB09297,P-glycoprotein substrates,DrugBank
DB09297,Sulfones,DrugBank
DB09297,Sulfur Compounds,DrugBank
DB09297,Treatments for Hepatitis C,DrugBank
DB09297,UGT1A1 Inhibitors,DrugBank
DB09298,Alimentary Tract and Metabolism,DrugBank
DB09298,Antineoplastic Agents,DrugBank
DB09298,"Antineoplastic Agents, Phytogenic",DrugBank
DB09298,Antioxidants,DrugBank
DB09298,Benzopyrans,DrugBank
DB09298,Bile and Liver Therapy,DrugBank
DB09298,Biological Factors,DrugBank
DB09298,Chromones,DrugBank
DB09298,"Compounds used in a research, industrial, or household setting",DrugBank
DB09298,Flavonoids,DrugBank
DB09298,Flavonolignans,DrugBank
DB09298,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09298,Liver Therapy,DrugBank
DB09298,"Liver Therapy, Lipotropics",DrugBank
DB09298,OAT1/SLC22A6 inhibitors,DrugBank
DB09298,OAT1/SLC22A6 Substrates,DrugBank
DB09298,OAT3/SLC22A8 Substrates,DrugBank
DB09298,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB09298,OATP1B3 inhibitors,DrugBank
DB09298,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB09298,Protective Agents,DrugBank
DB09298,Pyrans,DrugBank
DB09298,UGT1A1 Inhibitors,DrugBank
DB09299,Amino Acids,DrugBank
DB09299,"Amino Acids, Peptides, and Proteins",DrugBank
DB09299,Antiinfectives for Systemic Use,DrugBank
DB09299,Antiviral Agents,DrugBank
DB09299,Antivirals for Systemic Use,DrugBank
DB09299,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB09299,BCRP/ABCG2 Substrates,DrugBank
DB09299,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09299,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09299,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09299,Cytochrome P-450 Substrates,DrugBank
DB09299,Direct Acting Antivirals,DrugBank
DB09299,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB09299,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09299,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB09299,Nephrotoxic agents,DrugBank
DB09299,Nucleoside and Nucleotide Reverse Transcriptase Inhibitors,DrugBank
DB09299,OAT1/SLC22A6 Substrates,DrugBank
DB09299,OAT3/SLC22A8 Substrates,DrugBank
DB09299,OATP1B1/SLCO1B1 Substrates,DrugBank
DB09299,OATP1B3 substrates,DrugBank
DB09299,Organophosphonates,DrugBank
DB09299,Organophosphorus Compounds,DrugBank
DB09299,P-glycoprotein substrates,DrugBank
DB09299,Purines,DrugBank
DB09299,Tenofovir and prodrugs,DrugBank
DB09299,Vitamin B Complex,DrugBank
DB09299,Vitamins,DrugBank
DB09300,Agents producing tachycardia,DrugBank
DB09300,Alimentary Tract and Metabolism,DrugBank
DB09300,Alkaloids,DrugBank
DB09300,Amines,DrugBank
DB09300,Anticholinergic Agents,DrugBank
DB09300,Antimuscarinics Antispasmodics,DrugBank
DB09300,Autonomic Agents,DrugBank
DB09300,Aza Compounds,DrugBank
DB09300,Azabicyclo Compounds,DrugBank
DB09300,"Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds",DrugBank
DB09300,"Belladonna and Derivatives, Plain",DrugBank
DB09300,Cholinergic Agents,DrugBank
DB09300,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB09300,Muscarinic Antagonists,DrugBank
DB09300,Neurotransmitter Agents,DrugBank
DB09300,Parasympatholytics,DrugBank
DB09300,Peripheral Nervous System Agents,DrugBank
DB09300,Quaternary Ammonium Compounds,DrugBank
DB09300,Scopolamine Derivatives,DrugBank
DB09300,Tropanes,DrugBank
DB09301,Antiinflammatory and Antirheumatic Products,DrugBank
DB09301,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB09301,Carbohydrates,DrugBank
DB09301,Chondroitin,DrugBank
DB09301,Drugs that are Mainly Renally Excreted,DrugBank
DB09301,Glycosaminoglycans,DrugBank
DB09301,Musculo-Skeletal System,DrugBank
DB09301,Polysaccharides,DrugBank
DB09302,"Amino Acids, Peptides, and Proteins",DrugBank
DB09302,Antibodies,DrugBank
DB09302,"Antibodies, Monoclonal",DrugBank
DB09302,Anticholesteremic Agents,DrugBank
DB09302,Antimetabolites,DrugBank
DB09302,Blood Proteins,DrugBank
DB09302,Enzyme Inhibitors,DrugBank
DB09302,Globulins,DrugBank
DB09302,"Hypercholesterolemia, drug therapy",DrugBank
DB09302,Hypolipidemic Agents,DrugBank
DB09302,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB09302,Immunoglobulins,DrugBank
DB09302,Immunoproteins,DrugBank
DB09302,Lipid Modifying Agents,DrugBank
DB09302,"Lipid Modifying Agents, Plain",DrugBank
DB09302,Lipid Regulating Agents,DrugBank
DB09302,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB09302,PCSK9 Inhibitor,DrugBank
DB09302,Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors,DrugBank
DB09302,Protease Inhibitors,DrugBank
DB09302,Proteins,DrugBank
DB09302,Serine Protease Inhibitors,DrugBank
DB09302,Serum Globulins,DrugBank
DB09303,"Amino Acids, Peptides, and Proteins",DrugBank
DB09303,Antibodies,DrugBank
DB09303,"Antibodies, Monoclonal",DrugBank
DB09303,Anticholesteremic Agents,DrugBank
DB09303,Antimetabolites,DrugBank
DB09303,Blood Proteins,DrugBank
DB09303,Enzyme Inhibitors,DrugBank
DB09303,Globulins,DrugBank
DB09303,Hypolipidemic Agents,DrugBank
DB09303,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB09303,Immunoglobulins,DrugBank
DB09303,Immunoproteins,DrugBank
DB09303,Lipid Modifying Agents,DrugBank
DB09303,"Lipid Modifying Agents, Plain",DrugBank
DB09303,Lipid Regulating Agents,DrugBank
DB09303,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB09303,PCSK9 Inhibitor,DrugBank
DB09303,Protease Inhibitors,DrugBank
DB09303,Proteins,DrugBank
DB09303,Serine Protease Inhibitors,DrugBank
DB09303,Serum Globulins,DrugBank
DB09304,"Antidepressive Agents, Tetracyclic",DrugBank
DB09304,Dibenzazepines,DrugBank
DB09304,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09305,"Antidepressive Agents, Tetracyclic",DrugBank
DB09305,Benzazepines,DrugBank
DB09305,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09307,Agents that produce hypertension,DrugBank
DB09307,Agents that reduce seizure threshold,DrugBank
DB09307,Anthracenes,DrugBank
DB09307,Antidepressive Agents,DrugBank
DB09307,"Antidepressive Agents, Tetracyclic",DrugBank
DB09307,"Antidepressive Agents, Tricyclic",DrugBank
DB09307,Central Nervous System Agents,DrugBank
DB09307,Central Nervous System Depressants,DrugBank
DB09307,Neurotoxic agents,DrugBank
DB09307,Psychotropic Drugs,DrugBank
DB09307,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09308,Anti-Bacterial Agents,DrugBank
DB09308,Anti-Infective Agents,DrugBank
DB09308,Antibacterials for Systemic Use,DrugBank
DB09308,Antiinfectives for Systemic Use,DrugBank
DB09308,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09308,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09308,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09308,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09308,Ketolides,DrugBank
DB09308,Lactones,DrugBank
DB09308,Macrolides,DrugBank
DB09308,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB09308,Polyketides,DrugBank
DB09309,Anti-Bacterial Agents,DrugBank
DB09309,Anti-Infective Agents,DrugBank
DB09309,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09309,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09309,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB09309,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09309,Lactones,DrugBank
DB09309,Leucomycins,DrugBank
DB09309,Macrolides,DrugBank
DB09309,Polyketides,DrugBank
DB09310,Blood and Blood Forming Organs,DrugBank
DB09310,Blood Coagulation Factors,DrugBank
DB09310,Hemostatics,DrugBank
DB09311,Antidiarrheals,DrugBank
DB09311,Bulk-Forming Laxatives,DrugBank
DB09311,"Compounds used in a research, industrial, or household setting",DrugBank
DB09311,Gastrointestinal Agents,DrugBank
DB09311,Laxatives,DrugBank
DB09311,Macromolecular Substances,DrugBank
DB09311,Plastics,DrugBank
DB09311,Polymers,DrugBank
DB09311,"Resins, Synthetic",DrugBank
DB09312,"Amino Acids, Peptides, and Proteins",DrugBank
DB09312,Antibodies,DrugBank
DB09312,Antibody-Surface Protein Interactions,DrugBank
DB09312,Antineoplastic and Immunomodulating Agents,DrugBank
DB09312,Biological Products,DrugBank
DB09312,Blood,DrugBank
DB09312,Blood Proteins,DrugBank
DB09312,Body Fluids,DrugBank
DB09312,Complex Mixtures,DrugBank
DB09312,Fluids and Secretions,DrugBank
DB09312,Globulins,DrugBank
DB09312,Immune Sera,DrugBank
DB09312,Immunoglobulin G,DrugBank
DB09312,Immunoglobulins,DrugBank
DB09312,Immunologic Factors,DrugBank
DB09312,Immunoproteins,DrugBank
DB09312,Immunosuppressive Agents,DrugBank
DB09312,Immunotherapy,DrugBank
DB09312,Increased T Lymphocyte Destruction,DrugBank
DB09312,Lymphocyte Function Alteration,DrugBank
DB09312,Miscellaneous Therapeutic Agents,DrugBank
DB09312,Proteins,DrugBank
DB09312,Selective Immunosuppressants,DrugBank
DB09312,Serum,DrugBank
DB09312,Serum Globulins,DrugBank
DB09317,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09317,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09317,Cytochrome P-450 Substrates,DrugBank
DB09317,Drugs that are Mainly Renally Excreted,DrugBank
DB09317,Estrogens,DrugBank
DB09317,Gonadal Hormones,DrugBank
DB09317,Gonadal Steroid Hormones,DrugBank
DB09317,Hormones,DrugBank
DB09317,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09317,Thyroxine-binding globulin inducers,DrugBank
DB09318,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09318,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09318,Cytochrome P-450 Substrates,DrugBank
DB09318,Drugs that are Mainly Renally Excreted,DrugBank
DB09318,Estrogens,DrugBank
DB09318,Gonadal Hormones,DrugBank
DB09318,Gonadal Steroid Hormones,DrugBank
DB09318,Hormones,DrugBank
DB09318,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09318,Thyroxine-binding globulin inducers,DrugBank
DB09319,Amides,DrugBank
DB09319,Anti-Bacterial Agents,DrugBank
DB09319,Anti-Infective Agents,DrugBank
DB09319,Antibacterials for Systemic Use,DrugBank
DB09319,Antiinfectives for Systemic Use,DrugBank
DB09319,Beta-Lactam Antibacterials,DrugBank
DB09319,beta-Lactams,DrugBank
DB09319,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09319,Lactams,DrugBank
DB09319,Penicillin G,DrugBank
DB09319,Penicillins,DrugBank
DB09319,Penicillins With Extended Spectrum,DrugBank
DB09319,Sulfur Compounds,DrugBank
DB09320,"Acids, Carbocyclic",DrugBank
DB09320,Amides,DrugBank
DB09320,Aminobenzoates,DrugBank
DB09320,Anti-Bacterial Agents,DrugBank
DB09320,Anti-Infective Agents,DrugBank
DB09320,Antibacterials for Systemic Use,DrugBank
DB09320,Antiinfectives for Systemic Use,DrugBank
DB09320,Benzene Derivatives,DrugBank
DB09320,Benzoates,DrugBank
DB09320,Beta-Lactam Antibacterials,DrugBank
DB09320,Beta-Lactamase Sensitive Penicillins,DrugBank
DB09320,beta-Lactams,DrugBank
DB09320,Drugs that are Mainly Renally Excreted,DrugBank
DB09320,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09320,Lactams,DrugBank
DB09320,para-Aminobenzoates,DrugBank
DB09320,Penicillin G,DrugBank
DB09320,Penicillins,DrugBank
DB09320,Sulfur Compounds,DrugBank
DB09321,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB09321,Basic Ointments and Protectants,DrugBank
DB09321,Basic Powders and Demulcents,DrugBank
DB09321,"Compounds used in a research, industrial, or household setting",DrugBank
DB09321,Cosmetics,DrugBank
DB09321,Dermatologicals,DrugBank
DB09321,Metal cations,DrugBank
DB09321,Metal divalent cations,DrugBank
DB09321,Oxides,DrugBank
DB09321,Oxygen Compounds,DrugBank
DB09321,Protective Agents,DrugBank
DB09321,Radiation-Protective Agents,DrugBank
DB09321,Sunscreen Agents,DrugBank
DB09321,Vasoprotectives,DrugBank
DB09321,Zinc Compounds,DrugBank
DB09322,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB09322,Alimentary Tract and Metabolism,DrugBank
DB09322,Astringents,DrugBank
DB09322,Blood and Blood Forming Organs,DrugBank
DB09322,Blood Substitutes and Perfusion Solutions,DrugBank
DB09322,Dermatologicals,DrugBank
DB09322,Electrolyte Solutions,DrugBank
DB09322,I.V. Solution Additives,DrugBank
DB09322,Metal cations,DrugBank
DB09322,Metal divalent cations,DrugBank
DB09322,Mineral Supplements,DrugBank
DB09322,Minerals,DrugBank
DB09322,Misc. Skin and Mucous Membrane Agents,DrugBank
DB09322,Replacement Preparations,DrugBank
DB09322,Sulfates,DrugBank
DB09322,Sulfur Acids,DrugBank
DB09322,Sulfur Compounds,DrugBank
DB09322,Sulfuric Acids,DrugBank
DB09322,Vasoprotectives,DrugBank
DB09322,Zinc Compounds,DrugBank
DB09324,Amides,DrugBank
DB09324,Anti-Infective Agents,DrugBank
DB09324,Antibacterials for Systemic Use,DrugBank
DB09324,Antiinfectives for Systemic Use,DrugBank
DB09324,Beta-Lactam Antibacterials,DrugBank
DB09324,beta-Lactamase Inhibitors,DrugBank
DB09324,beta-Lactams,DrugBank
DB09324,Drugs that are Mainly Renally Excreted,DrugBank
DB09324,Enzyme Inhibitors,DrugBank
DB09324,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09324,Lactams,DrugBank
DB09324,OAT1/SLC22A6 Substrates,DrugBank
DB09324,Sulfur Compounds,DrugBank
DB09325,Alimentary Tract and Metabolism,DrugBank
DB09325,Anions,DrugBank
DB09325,Caries Prophylactic Agents,DrugBank
DB09325,Cariostatic Agents,DrugBank
DB09325,"Compounds used in a research, industrial, or household setting",DrugBank
DB09325,Dental Agents,DrugBank
DB09325,Drugs that are Mainly Renally Excreted,DrugBank
DB09325,Fluorides,DrugBank
DB09325,Fluorine Compounds,DrugBank
DB09325,Ions,DrugBank
DB09325,Mineral Supplements,DrugBank
DB09325,Miscellaneous Therapeutic Agents,DrugBank
DB09325,Mouthwashes and Gargles,DrugBank
DB09325,Protective Agents,DrugBank
DB09325,Sodium Compounds,DrugBank
DB09325,Stomatological Preparations,DrugBank
DB09327,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB09327,Cytochrome P-450 Substrates,DrugBank
DB09328,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB09328,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB09328,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09329,Alcohols,DrugBank
DB09329,"Amino Acids, Peptides, and Proteins",DrugBank
DB09329,Biological Factors,DrugBank
DB09329,Blood Coagulation Factors,DrugBank
DB09329,Blood Proteins,DrugBank
DB09329,"Compounds used in a research, industrial, or household setting",DrugBank
DB09329,Drugs that are Mainly Renally Excreted,DrugBank
DB09329,Ethylene Glycols,DrugBank
DB09329,Glycols,DrugBank
DB09329,Hemostatics,DrugBank
DB09329,Human Antihemophilic Factors,DrugBank
DB09329,Macromolecular Substances,DrugBank
DB09329,Pegylated agents,DrugBank
DB09329,Polymers,DrugBank
DB09329,Protein Precursors,DrugBank
DB09329,Proteins,DrugBank
DB09329,Recombinant Proteins,DrugBank
DB09330,"Acids, Acyclic",DrugBank
DB09330,Acrylates,DrugBank
DB09330,Amides,DrugBank
DB09330,Amines,DrugBank
DB09330,Antineoplastic Agents,DrugBank
DB09330,Antineoplastic and Immunomodulating Agents,DrugBank
DB09330,BCRP/ABCG2 Inhibitors,DrugBank
DB09330,BCRP/ABCG2 Substrates,DrugBank
DB09330,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09330,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09330,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09330,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB09330,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09330,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09330,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09330,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB09330,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB09330,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09330,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB09330,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09330,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09330,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09330,Cytochrome P-450 Substrates,DrugBank
DB09330,Enzyme Inhibitors,DrugBank
DB09330,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB09330,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09330,Kinase Inhibitor,DrugBank
DB09330,Narrow Therapeutic Index Drugs,DrugBank
DB09330,P-glycoprotein substrates,DrugBank
DB09330,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09330,Protein Kinase Inhibitors,DrugBank
DB09330,Tyrosine Kinase Inhibitors,DrugBank
DB09331,"Amino Acids, Peptides, and Proteins",DrugBank
DB09331,Antibodies,DrugBank
DB09331,"Antibodies, Monoclonal",DrugBank
DB09331,Antineoplastic Agents,DrugBank
DB09331,Antineoplastic and Immunomodulating Agents,DrugBank
DB09331,Blood Proteins,DrugBank
DB09331,Cancer immunotherapy,DrugBank
DB09331,CD38 (Clusters of Differentiation 38) inhibitors,DrugBank
DB09331,CD38-directed Antibody Interactions,DrugBank
DB09331,CD38-directed Cytolytic Antibody,DrugBank
DB09331,Globulins,DrugBank
DB09331,Immunoglobulins,DrugBank
DB09331,Immunoproteins,DrugBank
DB09331,Immunotherapy,DrugBank
DB09331,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09331,Narrow Therapeutic Index Drugs,DrugBank
DB09331,Proteins,DrugBank
DB09331,Serum Globulins,DrugBank
DB09338,Alkylmercury Compounds,DrugBank
DB09338,Diuretics,DrugBank
DB09338,Drugs that are Mainly Renally Excreted,DrugBank
DB09338,Enzyme Inhibitors,DrugBank
DB09338,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB09338,Mercurial Diuretics,DrugBank
DB09338,Organomercury Compounds,DrugBank
DB09338,Organometallic Compounds,DrugBank
DB09342,"Acids, Carbocyclic",DrugBank
DB09342,Aminobenzoates,DrugBank
DB09342,Anesthetics,DrugBank
DB09342,"Anesthetics, Local",DrugBank
DB09342,Benzene Derivatives,DrugBank
DB09342,Benzoates,DrugBank
DB09342,Central Nervous System Agents,DrugBank
DB09342,Central Nervous System Depressants,DrugBank
DB09342,Hydroxy Acids,DrugBank
DB09342,Hydroxybenzoate Ethers,DrugBank
DB09342,Hydroxybenzoates,DrugBank
DB09342,para-Aminobenzoates,DrugBank
DB09342,Peripheral Nervous System Agents,DrugBank
DB09342,Sensory System Agents,DrugBank
DB09343,MATE 1 Substrates,DrugBank
DB09343,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB09343,MATE substrates,DrugBank
DB09343,Narrow Therapeutic Index Drugs,DrugBank
DB09343,OCT2 Substrates,DrugBank
DB09343,OCT2 Substrates with a Narrow Therapeutic Index,DrugBank
DB09343,Pyrimidines,DrugBank
DB09343,Pyrimidinones,DrugBank
DB09343,Thymidine Phosphorylase Inhibitor,DrugBank
DB09344,Antivaricose Therapy,DrugBank
DB09344,Carbohydrates,DrugBank
DB09344,Cariogenic Agents,DrugBank
DB09344,"Compounds used in a research, industrial, or household setting",DrugBank
DB09344,"Diet, Food, and Nutrition",DrugBank
DB09344,Drugs that are Mainly Renally Excreted,DrugBank
DB09344,Flavoring Agents,DrugBank
DB09344,Food,DrugBank
DB09344,Food Additives,DrugBank
DB09344,Food Ingredients,DrugBank
DB09344,Hexoses,DrugBank
DB09344,Ketoses,DrugBank
DB09344,Monosaccharides,DrugBank
DB09344,Physiological Phenomena,DrugBank
DB09344,Sclerosing Agents for Local Injection,DrugBank
DB09344,Sweetening Agents,DrugBank
DB09344,Vasoprotectives,DrugBank
DB09345,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB09345,Anesthetics,DrugBank
DB09345,Anesthetics for Topical Use,DrugBank
DB09345,"Anesthetics, Local",DrugBank
DB09345,Antipruritics and Local Anesthetics,DrugBank
DB09345,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB09345,Central Nervous System Agents,DrugBank
DB09345,Central Nervous System Depressants,DrugBank
DB09345,Dermatologicals,DrugBank
DB09345,Oxazines,DrugBank
DB09345,Peripheral Nervous System Agents,DrugBank
DB09345,Sensory System Agents,DrugBank
DB09345,Vasoprotectives,DrugBank
DB09351,Adrenergic Antagonists,DrugBank
DB09351,Adrenergic beta-Antagonists,DrugBank
DB09351,Agents causing hyperkalemia,DrugBank
DB09351,Bradycardia-Causing Agents,DrugBank
DB09351,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09351,Cytochrome P-450 Substrates,DrugBank
DB09352,Adrenergic Agonists,DrugBank
DB09352,Amines,DrugBank
DB09352,Amphetamines,DrugBank
DB09352,Autonomic Agents,DrugBank
DB09352,Ethylamines,DrugBank
DB09352,Mydriatics,DrugBank
DB09352,Peripheral Nervous System Agents,DrugBank
DB09352,Phenethylamines,DrugBank
DB09352,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09352,Sympathomimetics,DrugBank
DB09357,Alanine,DrugBank
DB09357,Alimentary Tract and Metabolism,DrugBank
DB09357,Amino Acids,DrugBank
DB09357,"Amino Acids, Peptides, and Proteins",DrugBank
DB09357,Cicatrizants,DrugBank
DB09357,Dermatologicals,DrugBank
DB09357,Drugs that are Mainly Renally Excreted,DrugBank
DB09357,Imides,DrugBank
DB09357,Ophthalmologicals,DrugBank
DB09357,Preparations for Treatment of Wounds and Ulcers,DrugBank
DB09357,Sensory Organs,DrugBank
DB09357,Vitamin B Complex,DrugBank
DB09357,Vitamin D and Analogues,DrugBank
DB09357,Vitamins,DrugBank
DB09357,Vitamins (Fat Soluble),DrugBank
DB09357,Wound Healing,DrugBank
DB09363,Alkaloids,DrugBank
DB09363,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB09363,Antihypertensive Agents,DrugBank
DB09363,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09363,Indole Alkaloids,DrugBank
DB09363,Indoles,DrugBank
DB09363,Indolizidines,DrugBank
DB09363,Indolizines,DrugBank
DB09363,Secologanin Tryptamine Alkaloids,DrugBank
DB09369,Antineoplastic and Immunomodulating Agents,DrugBank
DB09369,Endocrine Therapy,DrugBank
DB09369,Estradiol Congeners,DrugBank
DB09369,Estranes,DrugBank
DB09369,Estrenes,DrugBank
DB09369,Estrogens,DrugBank
DB09369,Fused-Ring Compounds,DrugBank
DB09369,Gonadal Hormones,DrugBank
DB09369,Gonadal Steroid Hormones,DrugBank
DB09369,Hormones,DrugBank
DB09369,Hormones and Related Agents,DrugBank
DB09369,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09369,Steroids,DrugBank
DB09371,Adrenal Cortex Hormones,DrugBank
DB09371,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB09371,"Contraceptive Agents, Female",DrugBank
DB09371,"Contraceptive Agents, Hormonal",DrugBank
DB09371,"Contraceptives, Oral",DrugBank
DB09371,"Contraceptives, Oral, Hormonal",DrugBank
DB09371,"Contraceptives, Oral, Synthetic",DrugBank
DB09371,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09371,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09371,Cytochrome P-450 Substrates,DrugBank
DB09371,Fused-Ring Compounds,DrugBank
DB09371,Genito Urinary System and Sex Hormones,DrugBank
DB09371,Hormonal Contraceptives for Systemic Use,DrugBank
DB09371,Norpregnanes,DrugBank
DB09371,Norpregnenes,DrugBank
DB09371,Norsteroids,DrugBank
DB09371,Progestin Contraceptives,DrugBank
DB09371,Progestins,DrugBank
DB09371,Reproductive Control Agents,DrugBank
DB09371,Sex Hormones and Modulators of the Genital System,DrugBank
DB09371,Steroids,DrugBank
DB09374,BSEP/ABCB11 Substrates,DrugBank
DB09374,Cardiac Function,DrugBank
DB09374,Coloring Agents,DrugBank
DB09374,"Compounds used in a research, industrial, or household setting",DrugBank
DB09374,Diagnostic Dye,DrugBank
DB09374,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB09374,Indoles,DrugBank
DB09374,Liver Function,DrugBank
DB09374,Roentgenography,DrugBank
DB09378,Adrenal Cortex Hormones,DrugBank
DB09378,Anti-Inflammatory Agents,DrugBank
DB09378,Corticosteroids,DrugBank
DB09378,Corticosteroids for Systemic Use,DrugBank
DB09378,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09378,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09378,Cytochrome P-450 Substrates,DrugBank
DB09378,Fused-Ring Compounds,DrugBank
DB09378,Hormones,DrugBank
DB09378,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09378,Immunosuppressive Agents,DrugBank
DB09378,Pregnadienes,DrugBank
DB09378,Pregnadienetriols,DrugBank
DB09378,Pregnanes,DrugBank
DB09378,Steroids,DrugBank
DB09378,"Steroids, Fluorinated",DrugBank
DB09381,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09381,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09381,Cytochrome P-450 Substrates,DrugBank
DB09381,Estrogens,DrugBank
DB09381,Thyroxine-binding globulin inducers,DrugBank
DB09383,Adrenal Cortex Hormones,DrugBank
DB09383,Corticosteroids,DrugBank
DB09383,Corticosteroids for Systemic Use,DrugBank
DB09383,"Corticosteroids for Systemic Use, Plain",DrugBank
DB09383,Cytochrome P-450 CYP3A Inducers,DrugBank
DB09383,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09383,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB09383,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB09383,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09383,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB09383,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB09383,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09383,Cytochrome P-450 Substrates,DrugBank
DB09383,Fused-Ring Compounds,DrugBank
DB09383,Glucocorticoids,DrugBank
DB09383,Hyperglycemia-Associated Agents,DrugBank
DB09383,Immunosuppressive Agents,DrugBank
DB09383,Pregnadienediols,DrugBank
DB09383,Pregnadienes,DrugBank
DB09383,Pregnanes,DrugBank
DB09383,Steroids,DrugBank
DB09383,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB09383,Thyroxine-binding globulin inhibitors,DrugBank
DB09389,Adrenal Cortex Hormones,DrugBank
DB09389,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB09389,"Contraceptive Agents, Female",DrugBank
DB09389,"Contraceptive Agents, Hormonal",DrugBank
DB09389,"Contraceptives, Oral",DrugBank
DB09389,"Contraceptives, Oral, Hormonal",DrugBank
DB09389,"Contraceptives, Oral, Synthetic",DrugBank
DB09389,"Contraceptives, Postcoital",DrugBank
DB09389,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09389,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09389,Cytochrome P-450 Substrates,DrugBank
DB09389,Fused-Ring Compounds,DrugBank
DB09389,Genito Urinary System and Sex Hormones,DrugBank
DB09389,Hormonal Contraceptives for Systemic Use,DrugBank
DB09389,Norpregnanes,DrugBank
DB09389,Norpregnenes,DrugBank
DB09389,Norsteroids,DrugBank
DB09389,Progestin Contraceptives,DrugBank
DB09389,Progestins,DrugBank
DB09389,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB09389,Reproductive Control Agents,DrugBank
DB09389,Sex Hormones and Modulators of the Genital System,DrugBank
DB09389,Steroids,DrugBank
DB09394,"Acid Etching, Dental",DrugBank
DB09394,Acids,DrugBank
DB09394,"Acids, Noncarboxylic",DrugBank
DB09394,"Compounds used in a research, industrial, or household setting",DrugBank
DB09394,Dental Materials,DrugBank
DB09394,Drugs that are Mainly Renally Excreted,DrugBank
DB09394,Phosphorus Acids,DrugBank
DB09394,Phosphorus Compounds,DrugBank
DB09395,Acetates,DrugBank
DB09395,"Acids, Acyclic",DrugBank
DB09395,Blood and Blood Forming Organs,DrugBank
DB09395,Blood Substitutes and Perfusion Solutions,DrugBank
DB09395,Drugs that are Mainly Renally Excreted,DrugBank
DB09395,Electrolyte Solutions,DrugBank
DB09395,I.V. Solution Additives,DrugBank
DB09395,Replacement Preparations,DrugBank
DB09401,Alcohols,DrugBank
DB09401,Antianginal Agents,DrugBank
DB09401,Carbohydrates,DrugBank
DB09401,Cardiovascular Agents,DrugBank
DB09401,Diuretics,DrugBank
DB09401,"Diuretics, Osmotic",DrugBank
DB09401,Natriuretic Agents,DrugBank
DB09401,Noxae,DrugBank
DB09401,Organic Nitrates,DrugBank
DB09401,Terpenes,DrugBank
DB09401,Vasodilating Agents,DrugBank
DB09407,Agents that produce neuromuscular block (indirect),DrugBank
DB09407,Alimentary Tract and Metabolism,DrugBank
DB09407,Blood and Blood Forming Organs,DrugBank
DB09407,Blood Substitutes and Perfusion Solutions,DrugBank
DB09407,Chlorides,DrugBank
DB09407,Chlorine Compounds,DrugBank
DB09407,Drugs that are Mainly Renally Excreted,DrugBank
DB09407,Electrolyte Solutions,DrugBank
DB09407,Hemodialysis Solution,DrugBank
DB09407,I.V. Solution Additives,DrugBank
DB09407,Magnesium Compounds,DrugBank
DB09407,Metal cations,DrugBank
DB09407,Metal divalent cations,DrugBank
DB09407,Mineral Supplements,DrugBank
DB09407,Minerals,DrugBank
DB09409,Agents that produce neuromuscular block (indirect),DrugBank
DB09409,Laxatives,DrugBank
DB09413,Acids,DrugBank
DB09413,"Acids, Noncarboxylic",DrugBank
DB09413,Anions,DrugBank
DB09413,Buffers,DrugBank
DB09413,Cariostatic Agents,DrugBank
DB09413,"Compounds used in a research, industrial, or household setting",DrugBank
DB09413,Dental Materials,DrugBank
DB09413,Electrolytes,DrugBank
DB09413,Ions,DrugBank
DB09413,Laboratory Chemicals,DrugBank
DB09413,Laxatives,DrugBank
DB09413,Phosphate salts,DrugBank
DB09413,Phosphoric Acids,DrugBank
DB09413,Phosphorus Acids,DrugBank
DB09413,Phosphorus Compounds,DrugBank
DB09413,Potassium Salt,DrugBank
DB09413,Protective Agents,DrugBank
DB09413,Replacement Preparations,DrugBank
DB09414,Acids,DrugBank
DB09414,"Acids, Noncarboxylic",DrugBank
DB09414,Anions,DrugBank
DB09414,Buffers,DrugBank
DB09414,Cariostatic Agents,DrugBank
DB09414,"Compounds used in a research, industrial, or household setting",DrugBank
DB09414,Dental Materials,DrugBank
DB09414,Electrolytes,DrugBank
DB09414,Ions,DrugBank
DB09414,Laboratory Chemicals,DrugBank
DB09414,Laxatives,DrugBank
DB09414,Phosphate salts,DrugBank
DB09414,Phosphoric Acids,DrugBank
DB09414,Phosphorus Acids,DrugBank
DB09414,Phosphorus Compounds,DrugBank
DB09414,Potassium Salt,DrugBank
DB09414,Protective Agents,DrugBank
DB09418,Acids,DrugBank
DB09418,"Acids, Noncarboxylic",DrugBank
DB09418,Antithyroid agents,DrugBank
DB09418,Chlorine Compounds,DrugBank
DB09418,Drugs that are Mainly Renally Excreted,DrugBank
DB09418,Perchlorates,DrugBank
DB09418,Potassium Salt,DrugBank
DB09418,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB09418,Thyroid Products,DrugBank
DB09421,"Amino Acids, Peptides, and Proteins",DrugBank
DB09421,Diagnostic Agents,DrugBank
DB09421,Hormones,DrugBank
DB09421,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09421,Hypothalamic Hormones,DrugBank
DB09421,Nerve Tissue Proteins,DrugBank
DB09421,Neuropeptides,DrugBank
DB09421,Oligopeptides,DrugBank
DB09421,Peptide Hormones,DrugBank
DB09421,Peptides,DrugBank
DB09421,Pituitary Hormone-Releasing Hormones,DrugBank
DB09421,Proteins,DrugBank
DB09421,Tests for Thyreoidea Function,DrugBank
DB09421,Thyroid Products,DrugBank
DB09421,Thyrotropin-Releasing Hormone,DrugBank
DB09422,Biological Products,DrugBank
DB09422,Caloric Agents,DrugBank
DB09422,Complex Mixtures,DrugBank
DB09422,"Diet, Food, and Nutrition",DrugBank
DB09422,Dietary Fats,DrugBank
DB09422,"Dietary Fats, Unsaturated",DrugBank
DB09422,Fats,DrugBank
DB09422,"Fats, Unsaturated",DrugBank
DB09422,Food,DrugBank
DB09422,Lipid Emulsion,DrugBank
DB09422,Lipids,DrugBank
DB09422,Oils,DrugBank
DB09422,Physiological Phenomena,DrugBank
DB09422,Plant Oils,DrugBank
DB09422,Plant Preparations,DrugBank
DB09449,Acids,DrugBank
DB09449,"Acids, Noncarboxylic",DrugBank
DB09449,Agents that reduce seizure threshold,DrugBank
DB09449,Alimentary Tract and Metabolism,DrugBank
DB09449,Anions,DrugBank
DB09449,Blood and Blood Forming Organs,DrugBank
DB09449,Blood Substitutes and Perfusion Solutions,DrugBank
DB09449,Drugs for Constipation,DrugBank
DB09449,Drugs for Treatment of Hypercalcemia,DrugBank
DB09449,Electrolyte Solutions,DrugBank
DB09449,Electrolytes,DrugBank
DB09449,Enemas,DrugBank
DB09449,I.V. Solution Additives,DrugBank
DB09449,Ions,DrugBank
DB09449,Laxatives,DrugBank
DB09449,Osmotic Laxatives,DrugBank
DB09449,Phosphate salts,DrugBank
DB09449,Phosphoric Acids,DrugBank
DB09449,Phosphorus Acids,DrugBank
DB09449,Phosphorus Compounds,DrugBank
DB09449,Potassium Salt,DrugBank
DB09449,Urinary Acidifying Agents,DrugBank
DB09456,Alimentary Tract and Metabolism,DrugBank
DB09456,Blood Glucose Lowering Agents,DrugBank
DB09456,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09456,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09456,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09456,Drugs Used in Diabetes,DrugBank
DB09456,Insulin,DrugBank
DB09456,"Insulin, Short-Acting",DrugBank
DB09456,"Insulins and Analogues for Injection, Fast-Acting",DrugBank
DB09459,"Acids, Acyclic",DrugBank
DB09459,Carbohydrates,DrugBank
DB09459,Chelating Agents,DrugBank
DB09459,Dicarboxylic Acids,DrugBank
DB09459,Hydroxy Acids,DrugBank
DB09459,Sugar Acids,DrugBank
DB09459,Urinary Alkalinisers,DrugBank
DB09462,Alcohols,DrugBank
DB09462,Alimentary Tract and Metabolism,DrugBank
DB09462,Basic Ointments and Protectants,DrugBank
DB09462,Carbohydrates,DrugBank
DB09462,Cell-mediated Immunity,DrugBank
DB09462,"Compounds used in a research, industrial, or household setting",DrugBank
DB09462,Cryoprotective Agents,DrugBank
DB09462,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB09462,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB09462,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09462,Drugs for Constipation,DrugBank
DB09462,Enemas,DrugBank
DB09462,Increased Histamine Release,DrugBank
DB09462,Increased IgG Production,DrugBank
DB09462,Irrigating Solutions,DrugBank
DB09462,Laxatives,DrugBank
DB09462,Non-Standardized Chemical Allergen,DrugBank
DB09462,Osmotic Laxatives,DrugBank
DB09462,Other Cold and Cough Preparations,DrugBank
DB09462,Other Diagnostics,DrugBank
DB09462,Protective Agents,DrugBank
DB09462,Solvents,DrugBank
DB09462,Sugar Alcohols,DrugBank
DB09462,Triose Sugar Alcohols,DrugBank
DB09472,Alimentary Tract and Metabolism,DrugBank
DB09472,Anions,DrugBank
DB09472,Drugs for Constipation,DrugBank
DB09472,Drugs that are Mainly Renally Excreted,DrugBank
DB09472,Electrolytes,DrugBank
DB09472,Gastrointestinal Agents,DrugBank
DB09472,Ions,DrugBank
DB09472,Laxatives,DrugBank
DB09472,Mineral Supplements,DrugBank
DB09472,Osmotic Laxatives,DrugBank
DB09472,Sodium,DrugBank
DB09472,Sulfur Acids,DrugBank
DB09472,Sulfur Compounds,DrugBank
DB09472,Sulfuric Acids,DrugBank
DB09477,Agents Acting on the Renin-Angiotensin System,DrugBank
DB09477,Agents causing angioedema,DrugBank
DB09477,Agents causing hyperkalemia,DrugBank
DB09477,"Amino Acids, Peptides, and Proteins",DrugBank
DB09477,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB09477,Antihypertensive Agents,DrugBank
DB09477,Antihypertensive Agents Indicated for Hypertension,DrugBank
DB09477,Cardiovascular Agents,DrugBank
DB09477,Decreased Blood Pressure,DrugBank
DB09477,Dipeptides,DrugBank
DB09477,Drugs causing inadvertant photosensitivity,DrugBank
DB09477,Drugs that are Mainly Renally Excreted,DrugBank
DB09477,Enzyme Inhibitors,DrugBank
DB09477,Hypotensive Agents,DrugBank
DB09477,Oligopeptides,DrugBank
DB09477,Peptides,DrugBank
DB09477,Photosensitizing Agents,DrugBank
DB09477,Protease Inhibitors,DrugBank
DB09480,Agents producing tachycardia,DrugBank
DB09480,Agents that produce hypertension,DrugBank
DB09480,Amines,DrugBank
DB09480,Amphetamines,DrugBank
DB09480,Central Nervous System,DrugBank
DB09480,"Compounds used in a research, industrial, or household setting",DrugBank
DB09480,Diagnostic Radiopharmaceuticals,DrugBank
DB09480,Diagnostic Uses of Chemicals,DrugBank
DB09480,Ethylamines,DrugBank
DB09480,Indicators and Reagents,DrugBank
DB09480,Iodine (123I) Compounds,DrugBank
DB09480,Laboratory Chemicals,DrugBank
DB09480,Phenethylamines,DrugBank
DB09480,Radiopharmaceuticals,DrugBank
DB09480,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB09480,Sympathomimetics,DrugBank
DB09481,Agents that produce neuromuscular block (indirect),DrugBank
DB09481,Alimentary Tract and Metabolism,DrugBank
DB09481,Aluminum and magnesium containing antacids,DrugBank
DB09481,Antacids,DrugBank
DB09481,Bleaching Agents,DrugBank
DB09481,"Compounds used in a research, industrial, or household setting",DrugBank
DB09481,Drugs for Acid Related Disorders,DrugBank
DB09481,Drugs for Constipation,DrugBank
DB09481,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB09481,Drugs that are Mainly Renally Excreted,DrugBank
DB09481,Elements,DrugBank
DB09481,Gastric Acid Lowering Agents,DrugBank
DB09481,Hygroscopic Agents,DrugBank
DB09481,Laxatives,DrugBank
DB09481,"Laxatives, magnesium containing",DrugBank
DB09481,Magnesium Compounds,DrugBank
DB09481,Metal cations,DrugBank
DB09481,Metal divalent cations,DrugBank
DB09481,Metals,DrugBank
DB09481,"Metals, Alkaline Earth",DrugBank
DB09481,"Metals, Light",DrugBank
DB09481,Osmotic Laxatives,DrugBank
DB09481,Oxidants,DrugBank
DB09483,Blood and Blood Forming Organs,DrugBank
DB09483,Blood Substitutes and Perfusion Solutions,DrugBank
DB09483,Electrolyte Solutions,DrugBank
DB09483,I.V. Solution Additives,DrugBank
DB09483,Laxatives,DrugBank
DB09483,Potassium Salt,DrugBank
DB09484,Acids,DrugBank
DB09484,"Acids, Noncarboxylic",DrugBank
DB09484,Alimentary Tract and Metabolism,DrugBank
DB09484,Anions,DrugBank
DB09484,Caries Prophylactic Agents,DrugBank
DB09484,Cariostatic Agents,DrugBank
DB09484,"Compounds used in a research, industrial, or household setting",DrugBank
DB09484,Dental Agents,DrugBank
DB09484,Electrolytes,DrugBank
DB09484,Fluorides,DrugBank
DB09484,Fluorine Compounds,DrugBank
DB09484,Ions,DrugBank
DB09484,Laxatives,DrugBank
DB09484,Mineral Supplements,DrugBank
DB09484,Phosphoric Acids,DrugBank
DB09484,Phosphorus Acids,DrugBank
DB09484,Phosphorus Compounds,DrugBank
DB09484,Protective Agents,DrugBank
DB09484,Stomatological Preparations,DrugBank
DB09484,Toothpastes,DrugBank
DB09488,Antihistamines for Systemic Use,DrugBank
DB09488,Drugs that are Mainly Renally Excreted,DrugBank
DB09488,Histamine Agents,DrugBank
DB09488,Histamine Antagonists,DrugBank
DB09488,Histamine H1 Antagonists,DrugBank
DB09488,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB09488,Neurotransmitter Agents,DrugBank
DB09488,Potential QTc-Prolonging Agents,DrugBank
DB09488,Pyridines,DrugBank
DB09488,QTc Prolonging Agents,DrugBank
DB09496,"Acids, Carbocyclic",DrugBank
DB09496,"Compounds used in a research, industrial, or household setting",DrugBank
DB09496,Cosmetics,DrugBank
DB09496,Dermatologicals,DrugBank
DB09496,Drugs that are Mainly Renally Excreted,DrugBank
DB09496,Emollients and Protectives,DrugBank
DB09496,Protective Agents,DrugBank
DB09496,Protectives Against UV-Radiation,DrugBank
DB09496,Protectives Against UV-Radiation for Topical Use,DrugBank
DB09496,Radiation-Protective Agents,DrugBank
DB09496,Sunscreen Agents,DrugBank
DB09499,Acids,DrugBank
DB09499,Anti-Infective Agents,DrugBank
DB09499,Antidotes,DrugBank
DB09499,Antioxidants,DrugBank
DB09499,Biological Factors,DrugBank
DB09499,Chelating Agents,DrugBank
DB09499,"Compounds used in a research, industrial, or household setting",DrugBank
DB09499,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB09499,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB09499,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09499,Minerals,DrugBank
DB09499,Protective Agents,DrugBank
DB09499,Sequestering Agents,DrugBank
DB09499,Sulfates,DrugBank
DB09499,Sulfur Acids,DrugBank
DB09499,Sulfur Compounds,DrugBank
DB09499,Sulfuric Acids,DrugBank
DB09501,Amines,DrugBank
DB09501,Ammonium Compounds,DrugBank
DB09501,Contrast Media,DrugBank
DB09501,Iron Compounds,DrugBank
DB09501,Magnetic Resonance Imaging Contrast Media,DrugBank
DB09501,Nitrogen Compounds,DrugBank
DB09501,Onium Compounds,DrugBank
DB09501,Paramagnetic Contrast Media,DrugBank
DB09502,Carbohydrates,DrugBank
DB09502,"Compounds used in a research, industrial, or household setting",DrugBank
DB09502,Deoxy Sugars,DrugBank
DB09502,Deoxyglucose,DrugBank
DB09502,Diagnostic Radiopharmaceuticals,DrugBank
DB09502,Diagnostic Uses of Chemicals,DrugBank
DB09502,Drugs that are Mainly Renally Excreted,DrugBank
DB09502,Indicators and Reagents,DrugBank
DB09502,Laboratory Chemicals,DrugBank
DB09502,Radioactive Diagnostic Agent,DrugBank
DB09502,Radiopharmaceutical Activity,DrugBank
DB09502,Radiopharmaceuticals,DrugBank
DB09502,Tumour Detection,DrugBank
DB09507,Colloids,DrugBank
DB09507,Complex Mixtures,DrugBank
DB09507,"Compounds used in a research, industrial, or household setting",DrugBank
DB09507,Contrast Media,DrugBank
DB09507,Ferrous Compounds,DrugBank
DB09507,Iron Compounds,DrugBank
DB09507,Macromolecular Substances,DrugBank
DB09507,Magnetic Iron Oxide Nanoparticles,DrugBank
DB09507,Magnetic Resonance Imaging Contrast Media,DrugBank
DB09507,Metal Nanoparticles,DrugBank
DB09507,Nanoparticles,DrugBank
DB09507,Nanostructures,DrugBank
DB09507,Organosilicon Compounds,DrugBank
DB09507,Pharmaceutical Preparations,DrugBank
DB09507,Polymers,DrugBank
DB09507,Silicon Compounds,DrugBank
DB09507,Superparamagnetic Contrast Media,DrugBank
DB09508,Biopolymers,DrugBank
DB09508,Carbohydrates,DrugBank
DB09508,"Compounds used in a research, industrial, or household setting",DrugBank
DB09508,Contrast Media,DrugBank
DB09508,Diagnostic Uses of Chemicals,DrugBank
DB09508,Ferrous Compounds,DrugBank
DB09508,Glucans,DrugBank
DB09508,Iron Compounds,DrugBank
DB09508,Macromolecular Substances,DrugBank
DB09508,Magnetic Iron Oxide Nanoparticles,DrugBank
DB09508,Metal Nanoparticles,DrugBank
DB09508,Nanoparticles,DrugBank
DB09508,Nanostructures,DrugBank
DB09508,Polymers,DrugBank
DB09508,Polysaccharides,DrugBank
DB09508,Suspensions,DrugBank
DB09517,Iron Preparations,DrugBank
DB09517,Parenteral Iron Replacement,DrugBank
DB09527,Gastrointestinal Agents,DrugBank
DB09527,Secretin,DrugBank
DB09532,"Amino Acids, Peptides, and Proteins",DrugBank
DB09532,Diagnostic Agents,DrugBank
DB09532,Gastrointestinal Agents,DrugBank
DB09532,Gastrointestinal Hormones,DrugBank
DB09532,Hormones,DrugBank
DB09532,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09532,Nerve Tissue Proteins,DrugBank
DB09532,Neuropeptides,DrugBank
DB09532,Peptide Hormones,DrugBank
DB09532,Peptides,DrugBank
DB09532,Proteins,DrugBank
DB09532,Secretin,DrugBank
DB09532,Secretin-class Hormone,DrugBank
DB09532,Tests for Pancreatic Function,DrugBank
DB09539,Autacoids,DrugBank
DB09539,Biological Factors,DrugBank
DB09539,"Diet, Food, and Nutrition",DrugBank
DB09539,Dietary Fats,DrugBank
DB09539,"Dietary Fats, Unsaturated",DrugBank
DB09539,Eicosanoids,DrugBank
DB09539,Fats,DrugBank
DB09539,Fatty Acids,DrugBank
DB09539,"Fatty Acids, Omega-3",DrugBank
DB09539,"Fatty Acids, Unsaturated",DrugBank
DB09539,Fish Oils,DrugBank
DB09539,Food,DrugBank
DB09539,Inflammation Mediators,DrugBank
DB09539,Lipids,DrugBank
DB09539,Nootropic Agents,DrugBank
DB09539,Oils,DrugBank
DB09539,Pharmaceutical Preparations,DrugBank
DB09539,Physiological Phenomena,DrugBank
DB09543,"Acids, Carbocyclic",DrugBank
DB09543,Analgesics,DrugBank
DB09543,Antirheumatic Agents,DrugBank
DB09543,Benzene Derivatives,DrugBank
DB09543,Benzoates,DrugBank
DB09543,Betula,DrugBank
DB09543,Biological Products,DrugBank
DB09543,Complex Mixtures,DrugBank
DB09543,"Compounds used in a research, industrial, or household setting",DrugBank
DB09543,Fixatives,DrugBank
DB09543,Gaultheria,DrugBank
DB09543,Hydroxy Acids,DrugBank
DB09543,Hydroxybenzoates,DrugBank
DB09543,Lipids,DrugBank
DB09543,Oils,DrugBank
DB09543,Pharmaceutical Preparations,DrugBank
DB09543,Phenols,DrugBank
DB09543,Plant Preparations,DrugBank
DB09543,Salicylates,DrugBank
DB09546,Drugs that are Mainly Renally Excreted,DrugBank
DB09546,Radioactive Diagnostic Agent,DrugBank
DB09546,Radiopharmaceutical Activity,DrugBank
DB09555,Agents that reduce seizure threshold,DrugBank
DB09555,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB09555,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB09555,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09555,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09555,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09555,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB09555,Cytochrome P-450 Substrates,DrugBank
DB09555,Histamine Agents,DrugBank
DB09555,Histamine Antagonists,DrugBank
DB09555,Histamine H1 Antagonists,DrugBank
DB09555,Moderate Risk QTc-Prolonging Agents,DrugBank
DB09555,Neurotransmitter Agents,DrugBank
DB09555,OCT1 inhibitors,DrugBank
DB09555,OCT1 substrates,DrugBank
DB09555,OCT2 Inhibitors,DrugBank
DB09555,Pyridines,DrugBank
DB09555,QTc Prolonging Agents,DrugBank
DB09555,Stereoisomerism,DrugBank
DB09559,"Amino Acids, Peptides, and Proteins",DrugBank
DB09559,Antibodies,DrugBank
DB09559,"Antibodies, Monoclonal",DrugBank
DB09559,Antineoplastic Agents,DrugBank
DB09559,"Antineoplastic Agents, Immunological",DrugBank
DB09559,Antineoplastic and Immunomodulating Agents,DrugBank
DB09559,Blood Proteins,DrugBank
DB09559,Cancer immunotherapy,DrugBank
DB09559,EGFR (Epidermal Growth Factor Receptor) inhibitors,DrugBank
DB09559,Epidermal Growth Factor Receptor Antagonist,DrugBank
DB09559,"ErbB Receptors, antagonists & inhibitors",DrugBank
DB09559,Globulins,DrugBank
DB09559,HER1 Antagonists,DrugBank
DB09559,Immunoglobulins,DrugBank
DB09559,Immunoproteins,DrugBank
DB09559,Immunotherapy,DrugBank
DB09559,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB09559,Narrow Therapeutic Index Drugs,DrugBank
DB09559,Proteins,DrugBank
DB09559,Serum Globulins,DrugBank
DB09564,Alimentary Tract and Metabolism,DrugBank
DB09564,"Amino Acids, Peptides, and Proteins",DrugBank
DB09564,Blood Glucose Lowering Agents,DrugBank
DB09564,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB09564,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB09564,Cytochrome P-450 Enzyme Inducers,DrugBank
DB09564,Drugs Used in Diabetes,DrugBank
DB09564,Hormones,DrugBank
DB09564,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB09564,Insulin,DrugBank
DB09564,Insulin Analog,DrugBank
DB09564,"Insulin, Long-Acting",DrugBank
DB09564,Long-acting Insulins,DrugBank
DB09564,Pancreatic Hormones,DrugBank
DB09564,Peptide Hormones,DrugBank
DB09564,Peptides,DrugBank
DB09567,Biological Products,DrugBank
DB09567,"Diet, Food, and Nutrition",DrugBank
DB09567,Dietary Fats,DrugBank
DB09567,"Dietary Fats, Unsaturated",DrugBank
DB09567,Fats,DrugBank
DB09567,"Fats, Unsaturated",DrugBank
DB09567,Food,DrugBank
DB09567,Lipid Emulsion,DrugBank
DB09567,Lipids,DrugBank
DB09567,Oils,DrugBank
DB09567,Physiological Phenomena,DrugBank
DB09567,Plant Oils,DrugBank
DB09567,Plant Preparations,DrugBank
DB09568,"Fatty Acids, Omega-3",DrugBank
DB09570,Antineoplastic Agents,DrugBank
DB09570,Antineoplastic and Immunomodulating Agents,DrugBank
DB09570,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 CYP3A Substrates,DrugBank
DB09570,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB09570,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Cytochrome P-450 Substrates,DrugBank
DB09570,Drugs that are Mainly Renally Excreted,DrugBank
DB09570,Narrow Therapeutic Index Drugs,DrugBank
DB09570,P-glycoprotein substrates,DrugBank
DB09570,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB09570,Proteasome Inhibitors,DrugBank
DB10061,Diphtheria Vaccines,DrugBank
DB10061,Meningococcal Vaccines,DrugBank
DB10061,Vaccines,DrugBank
DB10062,Actively Acquired Immunity,DrugBank
DB10062,Antiinfectives for Systemic Use,DrugBank
DB10062,Immune Sera,DrugBank
DB10062,Immune Sera and Immunoglobulins,DrugBank
DB10062,Inactivated Rabies Virus Vaccine,DrugBank
DB10062,Rabies Vaccines,DrugBank
DB10062,Vaccines,DrugBank
DB10276,Actively Acquired Immunity,DrugBank
DB10276,Antiinfectives for Systemic Use,DrugBank
DB10276,Biological Products,DrugBank
DB10276,Complex Mixtures,DrugBank
DB10276,Live Attenuated Rotavirus Vaccine,DrugBank
DB10276,Live Rotavirus Vaccine,DrugBank
DB10276,Rota Virus Diarrhea Vaccines,DrugBank
DB10276,Vaccines,DrugBank
DB10276,Viral Vaccines,DrugBank
DB10283,Actively Acquired Immunity,DrugBank
DB10283,Antiinfectives for Systemic Use,DrugBank
DB10283,Biological Products,DrugBank
DB10283,Complex Mixtures,DrugBank
DB10283,Immune Sera,DrugBank
DB10283,Immune Sera and Immunoglobulins,DrugBank
DB10283,Inactivated Rabies Virus Vaccine,DrugBank
DB10283,Rabies Vaccines,DrugBank
DB10283,Vaccines,DrugBank
DB10283,Viral Vaccines,DrugBank
DB10315,Actively Acquired Immunity,DrugBank
DB10315,Live Attenuated Measles Virus Vaccine,DrugBank
DB10315,Vaccines,DrugBank
DB10316,Actively Acquired Immunity,DrugBank
DB10316,Live Mumps Virus Vaccine,DrugBank
DB10316,Vaccines,DrugBank
DB10317,Actively Acquired Immunity,DrugBank
DB10317,Antiinfectives for Systemic Use,DrugBank
DB10317,Live Attenuated Rubella Virus Vaccine,DrugBank
DB10317,Live vaccines,DrugBank
DB10317,Measles vaccines,DrugBank
DB10317,Rubella Vaccines,DrugBank
DB10317,Vaccines,DrugBank
DB10317,Viral Vaccines,DrugBank
DB10318,Actively Acquired Immunity,DrugBank
DB10318,Antiinfectives for Systemic Use,DrugBank
DB10318,Biological Products,DrugBank
DB10318,Complex Mixtures,DrugBank
DB10318,Herpesvirus Vaccines,DrugBank
DB10318,Live Attenuated Herpes Zoster Virus Vaccine,DrugBank
DB10318,Live Attenuated Varicella Zoster Virus Vaccine,DrugBank
DB10318,Live vaccines,DrugBank
DB10318,Vaccines,DrugBank
DB10318,Varicella Zoster Vaccines,DrugBank
DB10318,Viral Vaccines,DrugBank
DB10343,Actively Acquired Immunity,DrugBank
DB10343,Increased Immunologically Active Molecule Activity,DrugBank
DB10343,Increased Macrophage Proliferation,DrugBank
DB10343,Live Attenuated Bacillus Calmette-Guerin Immunotherapy,DrugBank
DB10343,Live Attenuated Bacillus Calmette-Guerin Vaccine,DrugBank
DB10343,Live vaccines,DrugBank
DB10343,Vaccines,DrugBank
DB10349,Cell-mediated Immunity,DrugBank
DB10349,Grass Pollen Allergen Extracts,DrugBank
DB10349,Increased Histamine Release,DrugBank
DB10349,Increased IgG Production,DrugBank
DB10349,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10351,Allergenic Extracts,DrugBank
DB10351,Cell-mediated Immunity,DrugBank
DB10351,Grass Pollen Allergen Extracts,DrugBank
DB10351,Increased Histamine Release,DrugBank
DB10351,Increased IgG Production,DrugBank
DB10351,Standardized Pollen Allergenic Extract,DrugBank
DB10353,Cell-mediated Immunity,DrugBank
DB10353,Grass Pollen Allergen Extracts,DrugBank
DB10353,Increased Histamine Release,DrugBank
DB10353,Increased IgG Production,DrugBank
DB10353,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10365,Cell-mediated Immunity,DrugBank
DB10365,Grass Pollen Allergen Extracts,DrugBank
DB10365,Increased Histamine Release,DrugBank
DB10365,Increased IgG Production,DrugBank
DB10365,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10366,Allergenic Extracts,DrugBank
DB10366,Cell-mediated Immunity,DrugBank
DB10366,Grass Pollen Allergen Extracts,DrugBank
DB10366,Increased Histamine Release,DrugBank
DB10366,Increased IgG Production,DrugBank
DB10366,Standardized Pollen Allergenic Extract,DrugBank
DB10370,Allergenic Extracts,DrugBank
DB10370,Cell-mediated Immunity,DrugBank
DB10370,Grass Pollen Allergen Extracts,DrugBank
DB10370,Increased Histamine Release,DrugBank
DB10370,Increased IgG Production,DrugBank
DB10370,Standardized Pollen Allergenic Extract,DrugBank
DB10379,Allergenic Extracts,DrugBank
DB10379,Cell-mediated Immunity,DrugBank
DB10379,Grass Pollen Allergen Extracts,DrugBank
DB10379,Increased Histamine Release,DrugBank
DB10379,Increased IgG Production,DrugBank
DB10379,Standardized Pollen Allergenic Extract,DrugBank
DB10389,Allergenic Extracts,DrugBank
DB10389,Cell-mediated Immunity,DrugBank
DB10389,Grass Pollen Allergen Extracts,DrugBank
DB10389,Increased Histamine Release,DrugBank
DB10389,Increased IgG Production,DrugBank
DB10389,Standardized Pollen Allergenic Extract,DrugBank
DB10394,Allergenic Extracts,DrugBank
DB10394,Biological Products,DrugBank
DB10394,Cell-mediated Immunity,DrugBank
DB10394,Complex Mixtures,DrugBank
DB10394,Grass Pollen Allergen Extracts,DrugBank
DB10394,Increased Histamine Release,DrugBank
DB10394,Increased IgG Production,DrugBank
DB10394,Standardized Pollen Allergenic Extract,DrugBank
DB10395,Cell-mediated Immunity,DrugBank
DB10395,Grass Pollen Allergen Extracts,DrugBank
DB10395,Increased Histamine Release,DrugBank
DB10395,Increased IgG Production,DrugBank
DB10395,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10403,Allergenic Extracts,DrugBank
DB10403,Cell-mediated Immunity,DrugBank
DB10403,Grass Pollen Allergen Extracts,DrugBank
DB10403,Increased Histamine Release,DrugBank
DB10403,Increased IgG Production,DrugBank
DB10403,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10403,Standardized Pollen Allergenic Extract,DrugBank
DB10404,Allergenic Extracts,DrugBank
DB10404,Cell-mediated Immunity,DrugBank
DB10404,Grass Pollen Allergen Extracts,DrugBank
DB10404,Increased Histamine Release,DrugBank
DB10404,Increased IgG Production,DrugBank
DB10404,Standardized Pollen Allergenic Extract,DrugBank
DB10489,Cell-mediated Immunity,DrugBank
DB10489,Grass Pollen Allergen Extracts,DrugBank
DB10489,Increased Histamine Release,DrugBank
DB10489,Increased IgG Production,DrugBank
DB10489,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10494,Cell-mediated Immunity,DrugBank
DB10494,Grass Pollen Allergen Extracts,DrugBank
DB10494,Increased Histamine Release,DrugBank
DB10494,Increased IgG Production,DrugBank
DB10494,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10534,Cell-mediated Immunity,DrugBank
DB10534,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB10534,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB10534,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB10534,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB10534,Increased Histamine Release,DrugBank
DB10534,Non-Standardized Food Allergenic Extract,DrugBank
DB10583,Actively Acquired Immunity,DrugBank
DB10583,Antiinfectives for Systemic Use,DrugBank
DB10583,Bacterial Vaccines,DrugBank
DB10583,Biological Products,DrugBank
DB10583,Complex Mixtures,DrugBank
DB10583,Inactivated Clostridium Tetani Vaccine,DrugBank
DB10583,Tetanus Vaccines,DrugBank
DB10583,Toxoids,DrugBank
DB10583,Vaccines,DrugBank
DB10584,Actively Acquired Immunity,DrugBank
DB10584,Antiinfectives for Systemic Use,DrugBank
DB10584,Bacterial Vaccines,DrugBank
DB10584,Biological Products,DrugBank
DB10584,Complex Mixtures,DrugBank
DB10584,Diphtheria,DrugBank
DB10584,Diphtheria Vaccines,DrugBank
DB10584,Inactivated Corynebacterium Diphtheriae Vaccine,DrugBank
DB10584,Toxoids,DrugBank
DB10584,Vaccines,DrugBank
DB10600,Inactivated Influenza A Virus Vaccine,DrugBank
DB10600,Influenza Vaccines,DrugBank
DB10600,Vaccines,DrugBank
DB10600,Viral Vaccines,DrugBank
DB10713,Cell-mediated Immunity,DrugBank
DB10713,Grass Pollen Allergen Extracts,DrugBank
DB10713,Increased Histamine Release,DrugBank
DB10713,Increased IgG Production,DrugBank
DB10713,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10714,Cell-mediated Immunity,DrugBank
DB10714,Grass Pollen Allergen Extracts,DrugBank
DB10714,Increased Histamine Release,DrugBank
DB10714,Increased IgG Production,DrugBank
DB10714,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10715,Cell-mediated Immunity,DrugBank
DB10715,Grass Pollen Allergen Extracts,DrugBank
DB10715,Increased Histamine Release,DrugBank
DB10715,Increased IgG Production,DrugBank
DB10715,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10716,Cell-mediated Immunity,DrugBank
DB10716,Grass Pollen Allergen Extracts,DrugBank
DB10716,Increased Histamine Release,DrugBank
DB10716,Increased IgG Production,DrugBank
DB10716,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10717,Cell-mediated Immunity,DrugBank
DB10717,Grass Pollen Allergen Extracts,DrugBank
DB10717,Increased Histamine Release,DrugBank
DB10717,Increased IgG Production,DrugBank
DB10717,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10719,Cell-mediated Immunity,DrugBank
DB10719,Grass Pollen Allergen Extracts,DrugBank
DB10719,Increased Histamine Release,DrugBank
DB10719,Increased IgG Production,DrugBank
DB10719,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10769,Actively Acquired Immunity,DrugBank
DB10769,Biological Products,DrugBank
DB10769,Complex Mixtures,DrugBank
DB10769,Inactivated Japanese Encephalitis Virus Vaccine,DrugBank
DB10769,Vaccines,DrugBank
DB10769,Viral Vaccines,DrugBank
DB10794,Actively Acquired Immunity,DrugBank
DB10794,Inactivated Influenza B Virus Vaccine,DrugBank
DB10794,Influenza Vaccines,DrugBank
DB10794,Vaccines,DrugBank
DB10794,Viral Vaccines,DrugBank
DB10803,Actively Acquired Immunity,DrugBank
DB10803,Antiinfectives for Systemic Use,DrugBank
DB10803,Bacterial Vaccines,DrugBank
DB10803,Inactivated Salmonella Typhi Vaccine,DrugBank
DB10803,Typhoid vaccines,DrugBank
DB10803,Vaccines,DrugBank
DB10804,Live Attenuated Bacillus Calmette-Guerin Immunotherapy,DrugBank
DB10804,Live Attenuated Bacillus Calmette-Guerin Vaccine,DrugBank
DB10804,Live vaccines,DrugBank
DB10804,Vaccines,DrugBank
DB10805,Actively Acquired Immunity,DrugBank
DB10805,Antiinfectives for Systemic Use,DrugBank
DB10805,Biological Products,DrugBank
DB10805,Complex Mixtures,DrugBank
DB10805,Live Attenuated Yellow Fever Virus Vaccine,DrugBank
DB10805,Live vaccines,DrugBank
DB10805,Vaccines,DrugBank
DB10805,Viral Vaccines,DrugBank
DB10805,Yellow Fever Vaccines,DrugBank
DB10836,Cell-mediated Immunity,DrugBank
DB10836,Grass Pollen Allergen Extracts,DrugBank
DB10836,Increased Histamine Release,DrugBank
DB10836,Increased IgG Production,DrugBank
DB10836,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10879,Cell-mediated Immunity,DrugBank
DB10879,Grass Pollen Allergen Extracts,DrugBank
DB10879,Increased Histamine Release,DrugBank
DB10879,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10949,Allergenic Extracts,DrugBank
DB10949,Cell-mediated Immunity,DrugBank
DB10949,Grass Pollen Allergen Extracts,DrugBank
DB10949,Increased Histamine Release,DrugBank
DB10949,Increased IgG Production,DrugBank
DB10949,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10962,Cell-mediated Immunity,DrugBank
DB10962,Grass Pollen Allergen Extracts,DrugBank
DB10962,Increased Histamine Release,DrugBank
DB10962,Increased IgG Production,DrugBank
DB10962,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10963,Cell-mediated Immunity,DrugBank
DB10963,Grass Pollen Allergen Extracts,DrugBank
DB10963,Increased Histamine Release,DrugBank
DB10963,Increased IgG Production,DrugBank
DB10963,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10964,Cell-mediated Immunity,DrugBank
DB10964,Grass Pollen Allergen Extracts,DrugBank
DB10964,Increased Histamine Release,DrugBank
DB10964,Increased IgG Production,DrugBank
DB10964,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10966,Cell-mediated Immunity,DrugBank
DB10966,Grass Pollen Allergen Extracts,DrugBank
DB10966,Increased Histamine Release,DrugBank
DB10966,Increased IgG Production,DrugBank
DB10966,Non-Standardized Pollen Allergenic Extract,DrugBank
DB10989,Actively Acquired Immunity,DrugBank
DB10989,Biological Products,DrugBank
DB10989,Complex Mixtures,DrugBank
DB10989,Inactivated Hepatitis A Virus Vaccine,DrugBank
DB10989,Vaccines,DrugBank
DB10989,Viral Hepatitis Vaccines,DrugBank
DB10989,Viral Vaccines,DrugBank
DB10990,Actively Acquired Immunity,DrugBank
DB10990,Haemophilus Vaccines,DrugBank
DB10990,Inactivated Haemophilus Influenzae B Vaccine,DrugBank
DB10990,Vaccines,DrugBank
DB10990,"Vaccines, Inactivated",DrugBank
DB10991,Actively Acquired Immunity,DrugBank
DB10991,Biological Products,DrugBank
DB10991,Complex Mixtures,DrugBank
DB10991,Inactivated Bordetella Pertussis Vaccine,DrugBank
DB10991,Vaccines,DrugBank
DB11003,Actively Acquired Immunity,DrugBank
DB11003,Anthrax Vaccines,DrugBank
DB11003,Bacterial Vaccines,DrugBank
DB11003,Biological Products,DrugBank
DB11003,Complex Mixtures,DrugBank
DB11003,Live Attenuated Bacillus Anthracis Vaccine,DrugBank
DB11003,Live vaccines,DrugBank
DB11003,Vaccines,DrugBank
DB11003,"Vaccines, Attenuated",DrugBank
DB11038,Actively Acquired Immunity,DrugBank
DB11038,Inactivated Influenza A Virus Vaccine,DrugBank
DB11038,Influenza Vaccines,DrugBank
DB11038,Vaccines,DrugBank
DB11038,Viral Vaccines,DrugBank
DB11040,Actively Acquired Immunity,DrugBank
DB11040,Inactivated Influenza B Virus Vaccine,DrugBank
DB11040,Influenza Vaccines,DrugBank
DB11040,Vaccines,DrugBank
DB11040,Viral Vaccines,DrugBank
DB11041,Actively Acquired Immunity,DrugBank
DB11041,Inactivated Influenza A Virus Vaccine,DrugBank
DB11041,Influenza Vaccines,DrugBank
DB11041,Vaccines,DrugBank
DB11041,Viral Vaccines,DrugBank
DB11044,Actively Acquired Immunity,DrugBank
DB11044,Inactivated Influenza B Virus Vaccine,DrugBank
DB11044,Influenza Vaccines,DrugBank
DB11044,Vaccines,DrugBank
DB11044,Viral Vaccines,DrugBank
DB11050,Actively Acquired Immunity,DrugBank
DB11050,Inactivated Salmonella Typhi Vaccine,DrugBank
DB11050,Live Attenuated Salmonella Typhi Vaccine,DrugBank
DB11050,Live vaccines,DrugBank
DB11050,Vaccines,DrugBank
DB11051,Autologous Cultured Cell,DrugBank
DB11057,Alimentary Tract and Metabolism,DrugBank
DB11057,Basic Ointments and Protectants,DrugBank
DB11057,Dermatologicals,DrugBank
DB11057,Drugs for Constipation,DrugBank
DB11057,Emollients,DrugBank
DB11057,Laxatives,DrugBank
DB11057,Softener and Emollient Laxatives,DrugBank
DB11057,"Softeners, Emollients",DrugBank
DB11059,Anorexigenic Agents & Respiratory and CNS Stimulants,DrugBank
DB11059,Artificial Tears,DrugBank
DB11059,Bulk-Forming Laxatives,DrugBank
DB11059,Carbohydrates,DrugBank
DB11059,Carboxymethylcellulose Sodium,DrugBank
DB11059,Cellulose,DrugBank
DB11059,"Compounds used in a research, industrial, or household setting",DrugBank
DB11059,"EENT Drugs, Miscellaneous",DrugBank
DB11059,Gastrointestinal Agents,DrugBank
DB11059,Glucans,DrugBank
DB11059,Laxatives,DrugBank
DB11059,Polysaccharides,DrugBank
DB11079,"Acids, Carbocyclic",DrugBank
DB11079,Agents causing hyperkalemia,DrugBank
DB11079,Anti-Inflammatory Agents,DrugBank
DB11079,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11079,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB11079,Benzene Derivatives,DrugBank
DB11079,Benzoates,DrugBank
DB11079,Hydroxy Acids,DrugBank
DB11079,Hydroxybenzoates,DrugBank
DB11079,Nephrotoxic agents,DrugBank
DB11079,Non COX-2 selective NSAIDS,DrugBank
DB11079,Phenols,DrugBank
DB11079,Salicylates,DrugBank
DB11079,Sunscreen Agents,DrugBank
DB11085,Anti-Acne Preparations,DrugBank
DB11085,Anti-Acne Preparations for Topical Use,DrugBank
DB11085,Anti-Infective Agents,DrugBank
DB11085,"Anti-Infective Agents, Local",DrugBank
DB11085,Benzene Derivatives,DrugBank
DB11085,Dermatologicals,DrugBank
DB11085,Drugs that are Mainly Renally Excreted,DrugBank
DB11085,Ophthalmologicals,DrugBank
DB11085,Phenols,DrugBank
DB11085,Root Canal Filling Materials,DrugBank
DB11085,Sensory Organs,DrugBank
DB11089,Alimentary Tract and Metabolism,DrugBank
DB11089,Drugs for Constipation,DrugBank
DB11089,Enemas,DrugBank
DB11089,Laxatives,DrugBank
DB11089,Softener and Emollient Laxatives,DrugBank
DB11089,"Softeners, Emollients",DrugBank
DB11089,Succinates,DrugBank
DB11089,Surface-Active Agents,DrugBank
DB11090,Anions,DrugBank
DB11090,"Compounds used in a research, industrial, or household setting",DrugBank
DB11090,Drugs that are Mainly Renally Excreted,DrugBank
DB11090,Electrolytes,DrugBank
DB11090,Explosive Agents,DrugBank
DB11090,Ions,DrugBank
DB11090,Nitrogen Compounds,DrugBank
DB11090,Potassium Salt,DrugBank
DB11091,Alimentary Tract and Metabolism,DrugBank
DB11091,Anions,DrugBank
DB11091,Anti-Infective Agents,DrugBank
DB11091,"Anti-Infective Agents, Local",DrugBank
DB11091,Antifibrinolytic Agents,DrugBank
DB11091,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB11091,Antiseptics and Disinfectants,DrugBank
DB11091,"Compounds used in a research, industrial, or household setting",DrugBank
DB11091,Dermatologicals,DrugBank
DB11091,Electrolytes,DrugBank
DB11091,Free Radicals,DrugBank
DB11091,Ions,DrugBank
DB11091,Noxae,DrugBank
DB11091,Otologicals,DrugBank
DB11091,Oxidants,DrugBank
DB11091,Oxides,DrugBank
DB11091,Oxygen Compounds,DrugBank
DB11091,Peroxides,DrugBank
DB11091,Reactive Oxygen Species,DrugBank
DB11091,Sensory Organs,DrugBank
DB11091,Stomatological Preparations,DrugBank
DB11091,Toxic Actions,DrugBank
DB11093,"Acids, Acyclic",DrugBank
DB11093,Alimentary Tract and Metabolism,DrugBank
DB11093,Biological Factors,DrugBank
DB11093,Calcium Compounds,DrugBank
DB11093,Calcium Salts,DrugBank
DB11093,Calcium-Regulating Hormones and Agents,DrugBank
DB11093,Citrates,DrugBank
DB11093,"Compounds used in a research, industrial, or household setting",DrugBank
DB11093,Dicarboxylic Acids,DrugBank
DB11093,"Diet, Food, and Nutrition",DrugBank
DB11093,Elements,DrugBank
DB11093,Food,DrugBank
DB11093,Food Additives,DrugBank
DB11093,Food Ingredients,DrugBank
DB11093,Hydroxy Acids,DrugBank
DB11093,Metals,DrugBank
DB11093,"Metals, Alkaline Earth",DrugBank
DB11093,Mineral Supplements,DrugBank
DB11093,Physiological Phenomena,DrugBank
DB11093,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB11093,Radioisotopes,DrugBank
DB11093,Tricarboxylic Acids,DrugBank
DB11094,Bone Density Conservation Agents,DrugBank
DB11094,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11094,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11094,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11094,Cytochrome P-450 Substrates,DrugBank
DB11094,"Diet, Food, and Nutrition",DrugBank
DB11094,Food,DrugBank
DB11094,Fused-Ring Compounds,DrugBank
DB11094,Micronutrients,DrugBank
DB11094,Physiological Phenomena,DrugBank
DB11094,Secosteroids,DrugBank
DB11094,Steroids,DrugBank
DB11094,Vitamin D and Analogues,DrugBank
DB11094,Vitamins,DrugBank
DB11094,Vitamins (Fat Soluble),DrugBank
DB11095,"Amino Acids, Peptides, and Proteins",DrugBank
DB11095,Anticoagulants,DrugBank
DB11095,Antithrombin Proteins,DrugBank
DB11095,Antithrombins,DrugBank
DB11095,Blood and Blood Forming Organs,DrugBank
DB11095,Cardiovascular Agents,DrugBank
DB11095,Enzyme Inhibitors,DrugBank
DB11095,Fibrin Modulating Agents,DrugBank
DB11095,Hematologic Agents,DrugBank
DB11095,Peptides,DrugBank
DB11095,Protease Inhibitors,DrugBank
DB11095,Proteins,DrugBank
DB11095,Serine Protease Inhibitors,DrugBank
DB11095,Serpins,DrugBank
DB11095,Thrombin Inhibitors,DrugBank
DB11097,Biological Products,DrugBank
DB11097,Bulk-Forming Laxatives,DrugBank
DB11097,Complex Mixtures,DrugBank
DB11097,Gastrointestinal Agents,DrugBank
DB11097,Herbs and Natural Products,DrugBank
DB11097,Laxatives,DrugBank
DB11097,Plant Extracts,DrugBank
DB11097,Plant Preparations,DrugBank
DB11098,Agents causing hyperkalemia,DrugBank
DB11098,Alimentary Tract and Metabolism,DrugBank
DB11098,Anions,DrugBank
DB11098,"Carbon Compounds, Inorganic",DrugBank
DB11098,Carbonates,DrugBank
DB11098,Carbonic Acid,DrugBank
DB11098,Drugs that are Mainly Renally Excreted,DrugBank
DB11098,Electrolytes,DrugBank
DB11098,Ions,DrugBank
DB11098,Mineral Supplements,DrugBank
DB11098,Potassium Salt,DrugBank
DB11100,Amides,DrugBank
DB11100,Basic Ointments and Protectants,DrugBank
DB11100,Dermatologicals,DrugBank
DB11100,Herbs and Natural Products,DrugBank
DB11100,Hydantoins,DrugBank
DB11100,Imidazoles,DrugBank
DB11100,Imidazolidines,DrugBank
DB11100,Thyroxine-binding globulin substrates,DrugBank
DB11102,Amino Acids,DrugBank
DB11102,"Amino Acids, Aromatic",DrugBank
DB11102,"Amino Acids, Cyclic",DrugBank
DB11102,"Amino Acids, Peptides, and Proteins",DrugBank
DB11102,Drugs that are Mainly Renally Excreted,DrugBank
DB11107,"Acids, Acyclic",DrugBank
DB11107,Carbohydrates,DrugBank
DB11107,Dicarboxylic Acids,DrugBank
DB11107,Hydroxy Acids,DrugBank
DB11107,Laxatives,DrugBank
DB11107,Potassium Salt,DrugBank
DB11107,Sugar Acids,DrugBank
DB11110,"Acids, Acyclic",DrugBank
DB11110,Agents that produce neuromuscular block (indirect),DrugBank
DB11110,Alimentary Tract and Metabolism,DrugBank
DB11110,Blood and Blood Forming Organs,DrugBank
DB11110,Blood Substitutes and Perfusion Solutions,DrugBank
DB11110,Citrates,DrugBank
DB11110,Drugs for Constipation,DrugBank
DB11110,Gastrointestinal Agents,DrugBank
DB11110,Irrigating Solutions,DrugBank
DB11110,Laxatives,DrugBank
DB11110,"Laxatives, magnesium containing",DrugBank
DB11110,Magnesium Compounds,DrugBank
DB11110,Metal cations,DrugBank
DB11110,Metal divalent cations,DrugBank
DB11110,Mineral Supplements,DrugBank
DB11110,Osmotic Laxatives,DrugBank
DB11110,Salt Solutions,DrugBank
DB11110,Tricarboxylic Acids,DrugBank
DB11113,Alimentary Tract and Metabolism,DrugBank
DB11113,Biological Products,DrugBank
DB11113,Complex Mixtures,DrugBank
DB11113,Contact Laxatives,DrugBank
DB11113,Drugs for Constipation,DrugBank
DB11113,Fats,DrugBank
DB11113,"Fats, Unsaturated",DrugBank
DB11113,Gastrointestinal Agents,DrugBank
DB11113,Laxatives,DrugBank
DB11113,Lipids,DrugBank
DB11113,Oils,DrugBank
DB11113,Plant Oils,DrugBank
DB11113,Plant Preparations,DrugBank
DB11114,Biological Products,DrugBank
DB11114,Complex Mixtures,DrugBank
DB11114,Drugs that are Mainly Renally Excreted,DrugBank
DB11114,Lipids,DrugBank
DB11114,Oils,DrugBank
DB11114,Other Cold and Cough Preparations,DrugBank
DB11114,Plant Oils,DrugBank
DB11114,Plant Preparations,DrugBank
DB11114,Terpenes,DrugBank
DB11124,Adrenergic Agents,DrugBank
DB11124,Adrenergic Agonists,DrugBank
DB11124,Adrenergic alpha-1 Receptor Agonists,DrugBank
DB11124,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11124,Adrenergic alpha-Agonists,DrugBank
DB11124,Adrenergic beta-1 Receptor Agonists,DrugBank
DB11124,Adrenergic beta-2 Receptor Agonists,DrugBank
DB11124,Adrenergic beta-3 Receptor Agonists,DrugBank
DB11124,Adrenergic beta-Agonists,DrugBank
DB11124,Agents producing tachycardia,DrugBank
DB11124,Agents that produce hypertension,DrugBank
DB11124,Alcohols,DrugBank
DB11124,Alpha-and Beta-adrenergic Agonists,DrugBank
DB11124,Amines,DrugBank
DB11124,Amino Alcohols,DrugBank
DB11124,Anti-Asthmatic Agents,DrugBank
DB11124,Autonomic Agents,DrugBank
DB11124,Benzene Derivatives,DrugBank
DB11124,Biogenic Amines,DrugBank
DB11124,Biogenic Monoamines,DrugBank
DB11124,Bronchodilator Agents,DrugBank
DB11124,Cardiovascular Agents,DrugBank
DB11124,Catecholamines,DrugBank
DB11124,Catechols,DrugBank
DB11124,Epinephrine and similars,DrugBank
DB11124,Ethanolamines,DrugBank
DB11124,Mydriatics,DrugBank
DB11124,Neurotransmitter Agents,DrugBank
DB11124,Peripheral Nervous System Agents,DrugBank
DB11124,Phenols,DrugBank
DB11124,Respiratory System Agents,DrugBank
DB11124,Sympathomimetics,DrugBank
DB11124,Vasoconstrictor Agents,DrugBank
DB11126,"Acids, Acyclic",DrugBank
DB11126,Alimentary Tract and Metabolism,DrugBank
DB11126,Blood and Blood Forming Organs,DrugBank
DB11126,Blood Substitutes and Perfusion Solutions,DrugBank
DB11126,Calcium Salts,DrugBank
DB11126,Carbohydrates,DrugBank
DB11126,Dermatologicals,DrugBank
DB11126,Electrolyte Solutions,DrugBank
DB11126,Gluconates,DrugBank
DB11126,Hydroxy Acids,DrugBank
DB11126,I.V. Solution Additives,DrugBank
DB11126,Mineral Supplements,DrugBank
DB11126,Minerals,DrugBank
DB11126,Replacement Preparations,DrugBank
DB11126,Sugar Acids,DrugBank
DB11127,Alimentary Tract and Metabolism,DrugBank
DB11127,Blood and Blood Forming Organs,DrugBank
DB11127,Blood Substitutes and Perfusion Solutions,DrugBank
DB11127,"Diet, Food, and Nutrition",DrugBank
DB11127,Drugs that are Mainly Renally Excreted,DrugBank
DB11127,Electrolyte Solutions,DrugBank
DB11127,Elements,DrugBank
DB11127,Food,DrugBank
DB11127,I.V. Solution Additives,DrugBank
DB11127,Micronutrients,DrugBank
DB11127,Mineral Supplements,DrugBank
DB11127,Minerals,DrugBank
DB11127,Physiological Phenomena,DrugBank
DB11127,Replacement Preparations,DrugBank
DB11127,Selenium Compounds,DrugBank
DB11127,Sodium Compounds,DrugBank
DB11127,Trace Elements,DrugBank
DB11130,Alimentary Tract and Metabolism,DrugBank
DB11130,Analgesics,DrugBank
DB11130,Antidiarrheals,DrugBank
DB11130,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB11130,Antipropulsives,DrugBank
DB11130,Antitussive Agents,DrugBank
DB11130,Biological Products,DrugBank
DB11130,Central Nervous System Agents,DrugBank
DB11130,Central Nervous System Depressants,DrugBank
DB11130,Complex Mixtures,DrugBank
DB11130,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11130,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11130,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11130,Cytochrome P-450 Substrates,DrugBank
DB11130,Drugs that are Mainly Renally Excreted,DrugBank
DB11130,Gastrointestinal Agents,DrugBank
DB11130,Narcotics,DrugBank
DB11130,Natural Opium Alkaloids,DrugBank
DB11130,Nervous System,DrugBank
DB11130,Opiate Agonists,DrugBank
DB11130,Opioid Agonist,DrugBank
DB11130,Opioids,DrugBank
DB11130,Peripheral Nervous System Agents,DrugBank
DB11130,Plant Extracts,DrugBank
DB11130,Plant Preparations,DrugBank
DB11130,Respiratory System Agents,DrugBank
DB11130,Sensory System Agents,DrugBank
DB11130,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB11133,Alimentary Tract and Metabolism,DrugBank
DB11133,Bile and Liver Therapy,DrugBank
DB11133,Dietary Fats,DrugBank
DB11133,"Dietary Fats, Unsaturated",DrugBank
DB11133,Fats,DrugBank
DB11133,Fatty Acids,DrugBank
DB11133,"Fatty Acids, Omega-3",DrugBank
DB11133,"Fatty Acids, Unsaturated",DrugBank
DB11133,Fish Oils,DrugBank
DB11133,Lipids,DrugBank
DB11133,Liver Therapy,DrugBank
DB11133,"Liver Therapy, Lipotropics",DrugBank
DB11133,Membrane Lipids,DrugBank
DB11133,Oils,DrugBank
DB11133,Phospholipids,DrugBank
DB11135,Alimentary Tract and Metabolism,DrugBank
DB11135,Antioxidants,DrugBank
DB11135,Biological Factors,DrugBank
DB11135,Chalcogens,DrugBank
DB11135,"Compounds used in a research, industrial, or household setting",DrugBank
DB11135,"Diet, Food, and Nutrition",DrugBank
DB11135,Drugs that are Mainly Renally Excreted,DrugBank
DB11135,Elements,DrugBank
DB11135,Food,DrugBank
DB11135,Micronutrients,DrugBank
DB11135,Mineral Supplements,DrugBank
DB11135,Minerals,DrugBank
DB11135,Physiological Phenomena,DrugBank
DB11135,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB11135,Protective Agents,DrugBank
DB11135,Selenium Compounds,DrugBank
DB11135,Trace Elements,DrugBank
DB11136,Cell-mediated Immunity,DrugBank
DB11136,"Diet, Food, and Nutrition",DrugBank
DB11136,Drugs that are Mainly Renally Excreted,DrugBank
DB11136,Elements,DrugBank
DB11136,Food,DrugBank
DB11136,Increased Histamine Release,DrugBank
DB11136,Metals,DrugBank
DB11136,"Metals, Heavy",DrugBank
DB11136,Micronutrients,DrugBank
DB11136,Minerals,DrugBank
DB11136,Physiological Phenomena,DrugBank
DB11136,Standardized Chemical Allergen,DrugBank
DB11136,Trace Elements,DrugBank
DB11136,Transition Elements,DrugBank
DB11145,Alimentary Tract and Metabolism,DrugBank
DB11145,"Anti-Infective Agents, Local",DrugBank
DB11145,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB11145,Antiseptics and Disinfectants,DrugBank
DB11145,Dermatologicals,DrugBank
DB11145,Drugs that are Mainly Renally Excreted,DrugBank
DB11145,Genito Urinary System and Sex Hormones,DrugBank
DB11145,Gynecological Antiinfectives and Antiseptics,DrugBank
DB11145,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11145,Hydroxyquinolines,DrugBank
DB11145,Quinoline Derivatives,DrugBank
DB11145,Quinolines,DrugBank
DB11145,Stomatological Preparations,DrugBank
DB11145,Throat Preparations,DrugBank
DB11148,"Acids, Carbocyclic",DrugBank
DB11148,Aminobenzoates,DrugBank
DB11148,Anesthetics,DrugBank
DB11148,"Anesthetics, Local",DrugBank
DB11148,Benzene Derivatives,DrugBank
DB11148,Benzoates,DrugBank
DB11148,Central Nervous System Agents,DrugBank
DB11148,Central Nervous System Depressants,DrugBank
DB11148,Cholinesterase substrates,DrugBank
DB11148,Drugs that are Mainly Renally Excreted,DrugBank
DB11148,para-Aminobenzoates,DrugBank
DB11148,Peripheral Nervous System Agents,DrugBank
DB11148,Sensory System Agents,DrugBank
DB11153,Alkalies,DrugBank
DB11153,Anions,DrugBank
DB11153,"Compounds used in a research, industrial, or household setting",DrugBank
DB11153,Electrolytes,DrugBank
DB11153,Indicators and Reagents,DrugBank
DB11153,Ions,DrugBank
DB11153,Laboratory Chemicals,DrugBank
DB11153,Potassium Salt,DrugBank
DB11154,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB11154,Metal cations,DrugBank
DB11154,Metal divalent cations,DrugBank
DB11154,Vasoprotectives,DrugBank
DB11154,Zinc Compounds,DrugBank
DB11156,Anthelmintics,DrugBank
DB11156,Anti-Infective Agents,DrugBank
DB11156,Antinematodal Agents,DrugBank
DB11156,Antiparasitic Agents,DrugBank
DB11156,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB11156,Central Nervous System Depressants,DrugBank
DB11156,Drugs that are Mainly Renally Excreted,DrugBank
DB11156,Neuromuscular Agents,DrugBank
DB11156,Neuromuscular Blocking Agents,DrugBank
DB11156,Neuromuscular Depolarizing Agents,DrugBank
DB11156,Peripheral Nervous System Agents,DrugBank
DB11156,Pyrimidines,DrugBank
DB11156,Sulfur Compounds,DrugBank
DB11156,Tetrahydropyrimidine Derivatives,DrugBank
DB11156,Thiophenes,DrugBank
DB11164,Diagnostic Agents,DrugBank
DB11164,Drugs that are Mainly Renally Excreted,DrugBank
DB11164,Radioactive Diagnostic Agent,DrugBank
DB11166,Anticoagulants,DrugBank
DB11166,Decreased Coagulation Factor Activity,DrugBank
DB11166,Factor Xa Inhibitors,DrugBank
DB11166,Recombinant Antithrombin,DrugBank
DB11166,Thrombin Inhibitors,DrugBank
DB11171,Hematinics,DrugBank
DB11171,Iron Compounds,DrugBank
DB11181,Alkaloids,DrugBank
DB11181,Anticholinergic Agents,DrugBank
DB11181,Autonomic Agents,DrugBank
DB11181,Aza Compounds,DrugBank
DB11181,Azabicyclo Compounds,DrugBank
DB11181,Muscarinic Antagonists,DrugBank
DB11181,Mydriatics and Cycloplegics,DrugBank
DB11181,Ophthalmologicals,DrugBank
DB11181,Parasympatholytics,DrugBank
DB11181,Peripheral Nervous System Agents,DrugBank
DB11181,Sensory Organs,DrugBank
DB11189,Agents that produce neuromuscular block (indirect),DrugBank
DB11189,Laxatives,DrugBank
DB11198,Alimentary Tract and Metabolism,DrugBank
DB11198,Angiosperms,DrugBank
DB11198,Antiemetics,DrugBank
DB11198,Antifoaming Agents,DrugBank
DB11198,Autonomic Agents,DrugBank
DB11198,Biological Products,DrugBank
DB11198,Central Nervous System Agents,DrugBank
DB11198,Complex Mixtures,DrugBank
DB11198,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11198,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11198,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11198,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11198,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11198,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11198,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB11198,Embryophyta,DrugBank
DB11198,Eukaryota,DrugBank
DB11198,Gastrointestinal Agents,DrugBank
DB11198,Herbs and Natural Products,DrugBank
DB11198,Lamiaceae,DrugBank
DB11198,Lamiales,DrugBank
DB11198,Lipids,DrugBank
DB11198,Mentha,DrugBank
DB11198,Non-Standardized Food Allergenic Extract,DrugBank
DB11198,Non-Standardized Plant Allergenic Extract,DrugBank
DB11198,Oils,DrugBank
DB11198,"Oils, Volatile",DrugBank
DB11198,Parasympatholytics,DrugBank
DB11198,Peripheral Nervous System Agents,DrugBank
DB11198,Plant Oils,DrugBank
DB11198,Plant Preparations,DrugBank
DB11198,Streptophyta,DrugBank
DB11198,Tracheophyta,DrugBank
DB11198,Viridiplantae,DrugBank
DB11199,Agents that reduce seizure threshold,DrugBank
DB11199,Non-Standardized Food Allergenic Extract,DrugBank
DB11199,Non-Standardized Plant Allergenic Extract,DrugBank
DB11201,Anti-Inflammatory Agents,DrugBank
DB11201,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11210,Amino Acids,DrugBank
DB11210,"Amino Acids, Peptides, and Proteins",DrugBank
DB11210,Iron Compounds,DrugBank
DB11228,Alimentary Tract and Metabolism,DrugBank
DB11228,Bulk-Forming Laxatives,DrugBank
DB11228,Carbohydrates,DrugBank
DB11228,Cellulose,DrugBank
DB11228,"Compounds used in a research, industrial, or household setting",DrugBank
DB11228,Drugs for Constipation,DrugBank
DB11228,"EENT Drugs, Miscellaneous",DrugBank
DB11228,Glucans,DrugBank
DB11228,Laxatives,DrugBank
DB11228,Polysaccharides,DrugBank
DB11230,Agents that produce neuromuscular block (indirect),DrugBank
DB11230,Minerals,DrugBank
DB11230,Pharmaceutic Aids,DrugBank
DB11230,Silicon Compounds,DrugBank
DB11235,Agents producing tachycardia,DrugBank
DB11235,"Antiallergic Agents, Excl. Corticosteroids",DrugBank
DB11235,Anticholinergic Agents,DrugBank
DB11235,Antihistamines for Systemic Use,DrugBank
DB11235,Antihistamines for Topical Use,DrugBank
DB11235,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB11235,Dermatologicals,DrugBank
DB11235,Histamine Agents,DrugBank
DB11235,Histamine Antagonists,DrugBank
DB11235,Histamine H1 Antagonists,DrugBank
DB11235,Muscarinic Antagonists,DrugBank
DB11235,Nasal Preparations,DrugBank
DB11235,Neurotransmitter Agents,DrugBank
DB11235,Substituted Ethylene Diamines,DrugBank
DB11238,Agents that reduce seizure threshold,DrugBank
DB11238,Antirheumatic Agents,DrugBank
DB11238,Biological Products,DrugBank
DB11238,Complex Mixtures,DrugBank
DB11238,"Dietary Fats, Unsaturated",DrugBank
DB11238,Fatty Acids,DrugBank
DB11238,"Fatty Acids, Essential",DrugBank
DB11238,"Fatty Acids, Omega-6",DrugBank
DB11238,"Fatty Acids, Unsaturated",DrugBank
DB11238,Linolenic Acids,DrugBank
DB11238,Lipids,DrugBank
DB11238,Oils,DrugBank
DB11238,Plant Oils,DrugBank
DB11238,Plant Preparations,DrugBank
DB11248,"Acids, Acyclic",DrugBank
DB11248,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB11248,Alimentary Tract and Metabolism,DrugBank
DB11248,Carbohydrates,DrugBank
DB11248,Hydroxy Acids,DrugBank
DB11248,Metal cations,DrugBank
DB11248,Metal divalent cations,DrugBank
DB11248,Mineral Supplements,DrugBank
DB11248,Sugar Acids,DrugBank
DB11248,Vasoprotectives,DrugBank
DB11248,Zinc Compounds,DrugBank
DB11251,Alimentary Tract and Metabolism,DrugBank
DB11251,Antioxidants,DrugBank
DB11251,Benzopyrans,DrugBank
DB11251,Biological Factors,DrugBank
DB11251,"Compounds used in a research, industrial, or household setting",DrugBank
DB11251,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11251,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11251,Cytochrome P-450 Substrates,DrugBank
DB11251,"Diet, Food, and Nutrition",DrugBank
DB11251,Drugs that are Mainly Renally Excreted,DrugBank
DB11251,Food,DrugBank
DB11251,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11251,Micronutrients,DrugBank
DB11251,Physiological Phenomena,DrugBank
DB11251,Protective Agents,DrugBank
DB11251,Pyrans,DrugBank
DB11251,Vitamin E,DrugBank
DB11251,Vitamins,DrugBank
DB11251,Vitamins (Fat Soluble),DrugBank
DB11256,Amino Acids,DrugBank
DB11256,"Amino Acids, Acidic",DrugBank
DB11256,"Amino Acids, Dicarboxylic",DrugBank
DB11256,"Amino Acids, Peptides, and Proteins",DrugBank
DB11256,Coenzymes,DrugBank
DB11256,Enzymes and Coenzymes,DrugBank
DB11256,Folate Analog,DrugBank
DB11256,Folic Acid and Derivatives,DrugBank
DB11256,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11256,Pteridines,DrugBank
DB11256,Pterins,DrugBank
DB11256,Vitamin B Complex,DrugBank
DB11256,Vitamins,DrugBank
DB11268,Aldehydes,DrugBank
DB11268,Anticoagulants,DrugBank
DB11268,Benzene Derivatives,DrugBank
DB11268,Hematologic Agents,DrugBank
DB11268,Phenols,DrugBank
DB11273,Agents that produce hypertension,DrugBank
DB11273,Alkaloids,DrugBank
DB11273,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11273,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11273,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11273,Cytochrome P-450 Substrates,DrugBank
DB11273,Dopamine Agents,DrugBank
DB11273,Dopamine Agonists,DrugBank
DB11273,Ergot Alkaloids and Derivatives,DrugBank
DB11273,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB11273,Ergotamines,DrugBank
DB11273,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11273,Neurotransmitter Agents,DrugBank
DB11274,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11274,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11274,Cytochrome P-450 Substrates,DrugBank
DB11275,Alkaloids,DrugBank
DB11275,Dopamine Agonists,DrugBank
DB11278,Adrenergic Agonists,DrugBank
DB11278,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11278,Adrenergic alpha-Agonists,DrugBank
DB11278,Agents producing tachycardia,DrugBank
DB11278,Agents that produce hypertension,DrugBank
DB11278,Alcohols,DrugBank
DB11278,Amines,DrugBank
DB11278,Amino Alcohols,DrugBank
DB11278,Drugs that are Mainly Renally Excreted,DrugBank
DB11278,Ethylamines,DrugBank
DB11278,Phenethylamines,DrugBank
DB11278,Propanolamines,DrugBank
DB11278,Propanols,DrugBank
DB11281,Alkalies,DrugBank
DB11281,Anions,DrugBank
DB11281,Bismuth containing drugs,DrugBank
DB11281,"Carbon Compounds, Inorganic",DrugBank
DB11281,Carbonic Acid,DrugBank
DB11281,Electrolytes,DrugBank
DB11281,Elements,DrugBank
DB11281,"Elements, Radioactive",DrugBank
DB11281,Ions,DrugBank
DB11281,Isotopes,DrugBank
DB11281,Metals,DrugBank
DB11281,"Metals, Heavy",DrugBank
DB11281,Neurotoxic agents,DrugBank
DB11281,Radioisotopes,DrugBank
DB11311,"Amino Acids, Peptides, and Proteins",DrugBank
DB11311,Biological Factors,DrugBank
DB11311,Blood Coagulation Factors,DrugBank
DB11311,Blood Proteins,DrugBank
DB11311,Enzyme Precursors,DrugBank
DB11311,Enzymes and Coenzymes,DrugBank
DB11311,Increased Coagulation Activity,DrugBank
DB11311,Protein Precursors,DrugBank
DB11311,Proteins,DrugBank
DB11311,"Prothrombin, agonists",DrugBank
DB11312,"Amino Acids, Peptides, and Proteins",DrugBank
DB11312,Anticoagulants,DrugBank
DB11312,Biological Factors,DrugBank
DB11312,Blood and Blood Forming Organs,DrugBank
DB11312,Blood Coagulation Factor Inhibitors,DrugBank
DB11312,Blood Proteins,DrugBank
DB11312,Cardiovascular Agents,DrugBank
DB11312,Decreased Coagulation Factor Activity,DrugBank
DB11312,Enzyme Precursors,DrugBank
DB11312,Enzymes,DrugBank
DB11312,Enzymes and Coenzymes,DrugBank
DB11312,Fibrin Modulating Agents,DrugBank
DB11312,Fibrinolytic Agents,DrugBank
DB11312,Glycoconjugates,DrugBank
DB11312,Glycoproteins,DrugBank
DB11312,Hematologic Agents,DrugBank
DB11312,Protein Precursors,DrugBank
DB11312,Proteins,DrugBank
DB11315,Agents producing tachycardia,DrugBank
DB11315,Alimentary Tract and Metabolism,DrugBank
DB11315,Alkaloids,DrugBank
DB11315,Anticholinergic Agents,DrugBank
DB11315,Autonomic Agents,DrugBank
DB11315,Aza Compounds,DrugBank
DB11315,Azabicyclo Compounds,DrugBank
DB11315,"Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds",DrugBank
DB11315,"Belladonna and Derivatives, Plain",DrugBank
DB11315,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB11315,Muscarinic Antagonists,DrugBank
DB11315,Mydriatics and Cycloplegics,DrugBank
DB11315,Ophthalmologicals,DrugBank
DB11315,Parasympatholytics,DrugBank
DB11315,Peripheral Nervous System Agents,DrugBank
DB11315,Scopolamine Derivatives,DrugBank
DB11315,Sensory Organs,DrugBank
DB11315,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB11315,Tropanes,DrugBank
DB11323,"Acids, Carbocyclic",DrugBank
DB11323,Anti-Inflammatory Agents,DrugBank
DB11323,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11323,Benzene Derivatives,DrugBank
DB11323,Benzoates,DrugBank
DB11323,Hydroxy Acids,DrugBank
DB11323,Hydroxybenzoates,DrugBank
DB11323,Phenols,DrugBank
DB11328,Drugs that are Mainly Renally Excreted,DrugBank
DB11330,"Amino Acids, Peptides, and Proteins",DrugBank
DB11330,Biological Factors,DrugBank
DB11330,Blood Coagulation Factors,DrugBank
DB11330,Blood Proteins,DrugBank
DB11330,Enzyme Precursors,DrugBank
DB11330,Enzymes and Coenzymes,DrugBank
DB11330,Factor IX,DrugBank
DB11330,Protein Precursors,DrugBank
DB11330,Proteins,DrugBank
DB11338,Biological Products,DrugBank
DB11338,Complex Mixtures,DrugBank
DB11338,Drugs that are Mainly Renally Excreted,DrugBank
DB11338,Oils,DrugBank
DB11338,Plant Oils,DrugBank
DB11338,Plant Preparations,DrugBank
DB11348,Acids,DrugBank
DB11348,"Acids, Noncarboxylic",DrugBank
DB11348,Alimentary Tract and Metabolism,DrugBank
DB11348,Apatites,DrugBank
DB11348,Biocompatible Materials,DrugBank
DB11348,Calcium Compounds,DrugBank
DB11348,Calcium Phosphates,DrugBank
DB11348,Calcium Salts,DrugBank
DB11348,Ceramics,DrugBank
DB11348,"Compounds used in a research, industrial, or household setting",DrugBank
DB11348,Hydroxyapatites,DrugBank
DB11348,Mineral Supplements,DrugBank
DB11348,Minerals,DrugBank
DB11348,Phosphate salts,DrugBank
DB11348,Phosphoric Acids,DrugBank
DB11348,Phosphorus Acids,DrugBank
DB11348,Phosphorus Compounds,DrugBank
DB11358,Agents that reduce seizure threshold,DrugBank
DB11358,Angiosperms,DrugBank
DB11358,Anti-Inflammatory Agents,DrugBank
DB11358,Antirheumatic Agents,DrugBank
DB11358,Biological Products,DrugBank
DB11358,Complex Mixtures,DrugBank
DB11358,Dermatologicals,DrugBank
DB11358,"Dietary Fats, Unsaturated",DrugBank
DB11358,Drugs that are Mainly Renally Excreted,DrugBank
DB11358,Embryophyta,DrugBank
DB11358,Eukaryota,DrugBank
DB11358,Fatty Acids,DrugBank
DB11358,"Fatty Acids, Essential",DrugBank
DB11358,"Fatty Acids, Omega-6",DrugBank
DB11358,"Fatty Acids, Unsaturated",DrugBank
DB11358,Hypolipidemic Agents,DrugBank
DB11358,Linolenic Acids,DrugBank
DB11358,Lipid Regulating Agents,DrugBank
DB11358,Lipids,DrugBank
DB11358,Oenothera,DrugBank
DB11358,Oils,DrugBank
DB11358,Onagraceae,DrugBank
DB11358,Peripheral Nervous System Agents,DrugBank
DB11358,Plant Oils,DrugBank
DB11358,Plant Preparations,DrugBank
DB11358,Sensory System Agents,DrugBank
DB11358,Streptophyta,DrugBank
DB11358,Tracheophyta,DrugBank
DB11358,Viridiplantae,DrugBank
DB11362,Acetates,DrugBank
DB11362,"Acids, Acyclic",DrugBank
DB11362,Amides,DrugBank
DB11362,Antihypertensive Agents,DrugBank
DB11362,Blood and Blood Forming Organs,DrugBank
DB11362,Cardiovascular Agents,DrugBank
DB11362,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11362,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11362,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11362,Cytochrome P-450 Substrates,DrugBank
DB11362,Fatty Acids,DrugBank
DB11362,"Fatty Acids, Volatile",DrugBank
DB11362,Lipids,DrugBank
DB11362,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11362,OATP1B3 substrates,DrugBank
DB11362,P-glycoprotein substrates,DrugBank
DB11362,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB11362,Prodrugs,DrugBank
DB11362,Prostacyclin Receptor Agonist,DrugBank
DB11362,Prostacyclin Receptor Agonists,DrugBank
DB11362,"Receptors, Prostaglandin, agonists",DrugBank
DB11362,Vasodilating Agents,DrugBank
DB11363,Anaplastic lymphoma kinase (ALK) inhibitors,DrugBank
DB11363,Antineoplastic Agents,DrugBank
DB11363,Antineoplastic and Immunomodulating Agents,DrugBank
DB11363,BCRP/ABCG2 Inhibitors,DrugBank
DB11363,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11363,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11363,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11363,Cytochrome P-450 Substrates,DrugBank
DB11363,Enzyme Inhibitors,DrugBank
DB11363,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11363,Indoles,DrugBank
DB11363,Kinase Inhibitor,DrugBank
DB11363,Narrow Therapeutic Index Drugs,DrugBank
DB11363,P-glycoprotein inhibitors,DrugBank
DB11363,P-glycoprotein substrates,DrugBank
DB11363,Protein Kinase Inhibitors,DrugBank
DB11363,Tyrosine Kinase Inhibitors,DrugBank
DB11364,"Adjuvants, Immunologic",DrugBank
DB11364,Amino Acids,DrugBank
DB11364,"Amino Acids, Acidic",DrugBank
DB11364,"Amino Acids, Cyclic",DrugBank
DB11364,"Amino Acids, Peptides, and Proteins",DrugBank
DB11364,Antineoplastic and Immunomodulating Agents,DrugBank
DB11364,Drugs that are Mainly Renally Excreted,DrugBank
DB11364,Glutamates,DrugBank
DB11364,Imino Acids,DrugBank
DB11364,Immunologic Factors,DrugBank
DB11364,Pyrrolidines,DrugBank
DB11364,Pyrrolidinones,DrugBank
DB11364,Sulfur Compounds,DrugBank
DB11364,Thiazoles,DrugBank
DB11365,Alimentary Tract and Metabolism,DrugBank
DB11365,Anthracenes,DrugBank
DB11365,Anthraquinones,DrugBank
DB11365,Biological Products,DrugBank
DB11365,Carbohydrates,DrugBank
DB11365,Complex Mixtures,DrugBank
DB11365,Contact Laxatives,DrugBank
DB11365,Drugs for Constipation,DrugBank
DB11365,Gastrointestinal Agents,DrugBank
DB11365,Glycosides,DrugBank
DB11365,Herbs and Natural Products,DrugBank
DB11365,Laxatives,DrugBank
DB11365,Pharmaceutical Preparations,DrugBank
DB11365,Plant Extracts,DrugBank
DB11365,Plant Preparations,DrugBank
DB11365,Quinones,DrugBank
DB11366,"Adjuvants, Immunologic",DrugBank
DB11366,Angiogenesis Inhibitors,DrugBank
DB11366,Angiogenesis Modulating Agents,DrugBank
DB11366,Antineoplastic Agents,DrugBank
DB11366,Antineoplastic and Immunomodulating Agents,DrugBank
DB11366,Growth Inhibitors,DrugBank
DB11366,Growth Substances,DrugBank
DB11366,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11366,Immunologic Factors,DrugBank
DB11366,Quinolines,DrugBank
DB11367,Amides,DrugBank
DB11367,Anti-Bacterial Agents,DrugBank
DB11367,Antibacterials for Systemic Use,DrugBank
DB11367,Antiinfectives for Systemic Use,DrugBank
DB11367,beta-Lactams,DrugBank
DB11367,Cephalosporins,DrugBank
DB11367,Drugs that are Mainly Renally Excreted,DrugBank
DB11367,First-Generation Cephalosporins,DrugBank
DB11367,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11367,Lactams,DrugBank
DB11367,Nephrotoxic agents,DrugBank
DB11367,Sulfur Compounds,DrugBank
DB11367,Thiazines,DrugBank
DB11371,Anesthetics,DrugBank
DB11371,"Anesthetics, General",DrugBank
DB11371,Central Nervous System Agents,DrugBank
DB11371,Central Nervous System Depressants,DrugBank
DB11371,Fused-Ring Compounds,DrugBank
DB11371,Nervous System,DrugBank
DB11371,Neurotransmitter Agents,DrugBank
DB11371,Pregnanes,DrugBank
DB11371,Steroids,DrugBank
DB11372,Adrenal Cortex Hormones,DrugBank
DB11372,Estranes,DrugBank
DB11372,Estrenes,DrugBank
DB11372,Fused-Ring Compounds,DrugBank
DB11372,Hormones,DrugBank
DB11372,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11372,Progesterone Congeners,DrugBank
DB11372,Progestins,DrugBank
DB11372,Steroids,DrugBank
DB11373,Adrenergic Agents,DrugBank
DB11373,Adrenergic Agonists,DrugBank
DB11373,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11373,Adrenergic alpha-Agonists,DrugBank
DB11373,Agents producing tachycardia,DrugBank
DB11373,Agents that produce hypertension,DrugBank
DB11373,Agrochemicals,DrugBank
DB11373,Amines,DrugBank
DB11373,Aniline Compounds,DrugBank
DB11373,Benzene Derivatives,DrugBank
DB11373,"Compounds used in a research, industrial, or household setting",DrugBank
DB11373,Insect Repellents,DrugBank
DB11373,Insecticides,DrugBank
DB11373,Neurotransmitter Agents,DrugBank
DB11373,Pesticide Synergists,DrugBank
DB11373,Pesticides,DrugBank
DB11373,Protective Agents,DrugBank
DB11373,Toxic Actions,DrugBank
DB11375,Anti-Bacterial Agents,DrugBank
DB11375,Anti-Infective Agents,DrugBank
DB11375,Carbohydrates,DrugBank
DB11375,Growth Substances,DrugBank
DB11375,Polysaccharides,DrugBank
DB11376,Antipsychotic Agents,DrugBank
DB11376,Antipsychotic Agents (First Generation [Typical]),DrugBank
DB11376,Butyrophenones,DrugBank
DB11376,Central Nervous System Agents,DrugBank
DB11376,Central Nervous System Depressants,DrugBank
DB11376,Dopamine Agents,DrugBank
DB11376,Dopamine Antagonists,DrugBank
DB11376,Dopamine D2 Receptor Antagonists,DrugBank
DB11376,Hypnotics and Sedatives,DrugBank
DB11376,Ketones,DrugBank
DB11376,Neurotoxic agents,DrugBank
DB11376,Neurotransmitter Agents,DrugBank
DB11376,Psychotropic Drugs,DrugBank
DB11376,Tranquilizing Agents,DrugBank
DB11377,Anti-Bacterial Agents,DrugBank
DB11377,Anti-Infective Agents,DrugBank
DB11377,Antigens,DrugBank
DB11377,"Antigens, Bacterial",DrugBank
DB11377,Biological Factors,DrugBank
DB11377,Carbohydrates,DrugBank
DB11377,Polysaccharides,DrugBank
DB11377,"Polysaccharides, Bacterial",DrugBank
DB11383,Anti-Bacterial Agents,DrugBank
DB11383,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11383,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11383,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11383,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11383,Lactones,DrugBank
DB11383,Macrolides,DrugBank
DB11383,Polyketides,DrugBank
DB11387,Anesthetics,DrugBank
DB11387,"Anesthetics, General",DrugBank
DB11387,"Compounds used in a research, industrial, or household setting",DrugBank
DB11387,"Hydrocarbons, Chlorinated",DrugBank
DB11387,"Hydrocarbons, Halogenated",DrugBank
DB11387,Nervous System,DrugBank
DB11387,Solvents,DrugBank
DB11387,Trihalomethanes,DrugBank
DB11389,Amides,DrugBank
DB11389,Amines,DrugBank
DB11389,Aniline Compounds,DrugBank
DB11389,Anthelmintics,DrugBank
DB11389,Anti-Infective Agents,DrugBank
DB11389,Antiparasitic Agents,DrugBank
DB11389,Antiplatyhelmintic Agents,DrugBank
DB11389,Sulfonamides,DrugBank
DB11389,Sulfones,DrugBank
DB11389,Sulfur Compounds,DrugBank
DB11390,Agrochemicals,DrugBank
DB11390,Anthelmintics,DrugBank
DB11390,Anti-Infective Agents,DrugBank
DB11390,Antinematodal Agents,DrugBank
DB11390,Antiparasitic Agents,DrugBank
DB11390,Benzopyrans,DrugBank
DB11390,Cholinergic Agents,DrugBank
DB11390,Cholinesterase Inhibitors,DrugBank
DB11390,"Compounds used in a research, industrial, or household setting",DrugBank
DB11390,Coumarins,DrugBank
DB11390,Enzyme Inhibitors,DrugBank
DB11390,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11390,Insecticides,DrugBank
DB11390,Neurotransmitter Agents,DrugBank
DB11390,Organophosphates,DrugBank
DB11390,Organophosphorus Compounds,DrugBank
DB11390,Organothiophosphates,DrugBank
DB11390,Organothiophosphorus Compounds,DrugBank
DB11390,Pesticides,DrugBank
DB11390,Potential QTc-Prolonging Agents,DrugBank
DB11390,Pyrans,DrugBank
DB11390,QTc Prolonging Agents,DrugBank
DB11390,Sulfur Compounds,DrugBank
DB11390,Toxic Actions,DrugBank
DB11390,Umbelliferones,DrugBank
DB11397,Agrochemicals,DrugBank
DB11397,Anthelmintics,DrugBank
DB11397,Anti-Infective Agents,DrugBank
DB11397,Antiparasitic Agents,DrugBank
DB11397,Cholinergic Agents,DrugBank
DB11397,Cholinesterase Inhibitors,DrugBank
DB11397,"Compounds used in a research, industrial, or household setting",DrugBank
DB11397,Enzyme Inhibitors,DrugBank
DB11397,Insecticides,DrugBank
DB11397,Neurotransmitter Agents,DrugBank
DB11397,Organophosphates,DrugBank
DB11397,Organophosphorus Compounds,DrugBank
DB11397,Pesticides,DrugBank
DB11397,Potential QTc-Prolonging Agents,DrugBank
DB11397,QTc Prolonging Agents,DrugBank
DB11397,Toxic Actions,DrugBank
DB11401,Anti-Bacterial Agents,DrugBank
DB11401,Anti-Infective Agents,DrugBank
DB11401,Pyridines,DrugBank
DB11404,4-Quinolones,DrugBank
DB11404,Anti-Bacterial Agents,DrugBank
DB11404,Anti-Infective Agents,DrugBank
DB11404,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11404,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11404,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11404,Fluoroquinolones,DrugBank
DB11404,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11404,Quinolines,DrugBank
DB11404,Quinolones,DrugBank
DB11405,Agrochemicals,DrugBank
DB11405,Anthelmintics,DrugBank
DB11405,Anti-Bacterial Agents,DrugBank
DB11405,Anti-Infective Agents,DrugBank
DB11405,Antiparasitic Agents,DrugBank
DB11405,"Compounds used in a research, industrial, or household setting",DrugBank
DB11405,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11405,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11405,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11405,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11405,Insecticides,DrugBank
DB11405,Lactones,DrugBank
DB11405,Macrolides,DrugBank
DB11405,Pesticides,DrugBank
DB11405,Polyketides,DrugBank
DB11405,Toxic Actions,DrugBank
DB11408,Agrochemicals,DrugBank
DB11408,"Compounds used in a research, industrial, or household setting",DrugBank
DB11408,Insecticides,DrugBank
DB11408,Organophosphates,DrugBank
DB11408,Organophosphorus Compounds,DrugBank
DB11408,Organothiophosphorus Compounds,DrugBank
DB11408,Pesticides,DrugBank
DB11408,Potential QTc-Prolonging Agents,DrugBank
DB11408,QTc Prolonging Agents,DrugBank
DB11408,Sulfur Compounds,DrugBank
DB11408,Toxic Actions,DrugBank
DB11411,Abortifacient Agents,DrugBank
DB11411,"Abortifacient Agents, Nonsteroidal",DrugBank
DB11411,Autacoids,DrugBank
DB11411,Biological Factors,DrugBank
DB11411,Eicosanoids,DrugBank
DB11411,Fatty Acids,DrugBank
DB11411,"Fatty Acids, Unsaturated",DrugBank
DB11411,Inflammation Mediators,DrugBank
DB11411,Lipids,DrugBank
DB11411,Prostaglandins,DrugBank
DB11411,"Prostaglandins, Synthetic",DrugBank
DB11411,Reproductive Control Agents,DrugBank
DB11412,Agrochemicals,DrugBank
DB11412,Cholinergic Agents,DrugBank
DB11412,Cholinesterase Inhibitors,DrugBank
DB11412,"Compounds used in a research, industrial, or household setting",DrugBank
DB11412,Enzyme Inhibitors,DrugBank
DB11412,Insecticides,DrugBank
DB11412,Neurotransmitter Agents,DrugBank
DB11412,Organophosphates,DrugBank
DB11412,Organophosphorus Compounds,DrugBank
DB11412,Organothiophosphates,DrugBank
DB11412,Organothiophosphorus Compounds,DrugBank
DB11412,Pesticides,DrugBank
DB11412,Potential QTc-Prolonging Agents,DrugBank
DB11412,QTc Prolonging Agents,DrugBank
DB11412,Sulfur Compounds,DrugBank
DB11412,Toxic Actions,DrugBank
DB11413,Alcohols,DrugBank
DB11413,Anti-Bacterial Agents,DrugBank
DB11413,Anti-Infective Agents,DrugBank
DB11413,Benzene Derivatives,DrugBank
DB11413,Glycols,DrugBank
DB11413,Nitro Compounds,DrugBank
DB11413,Nitrobenzenes,DrugBank
DB11413,Propylene Glycols,DrugBank
DB11416,Anti-Bacterial Agents,DrugBank
DB11416,Anti-Infective Agents,DrugBank
DB11416,Lactones,DrugBank
DB11416,Polyketides,DrugBank
DB11417,"Acids, Acyclic",DrugBank
DB11417,Carbohydrates,DrugBank
DB11417,"Compounds used in a research, industrial, or household setting",DrugBank
DB11417,Coordination Complexes,DrugBank
DB11417,Dextrans,DrugBank
DB11417,Glucans,DrugBank
DB11417,Hydroxy Acids,DrugBank
DB11417,Iron Compounds,DrugBank
DB11417,Pharmaceutical Preparations,DrugBank
DB11417,Polysaccharides,DrugBank
DB11419,Benzopyrans,DrugBank
DB11419,Coumarins,DrugBank
DB11419,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11419,Pyrans,DrugBank
DB11423,Anti-Bacterial Agents,DrugBank
DB11423,Anti-Infective Agents,DrugBank
DB11423,Antiparasitic Agents,DrugBank
DB11423,Antiprotozoals,DrugBank
DB11423,Coccidiostats,DrugBank
DB11423,"Compounds used in a research, industrial, or household setting",DrugBank
DB11423,Ethers,DrugBank
DB11423,"Ethers, Cyclic",DrugBank
DB11423,Furans,DrugBank
DB11423,Ionophores,DrugBank
DB11423,Lactones,DrugBank
DB11423,Membrane Transport Modulators,DrugBank
DB11423,Polyether Polyketides,DrugBank
DB11423,Polyketides,DrugBank
DB11425,Autacoids,DrugBank
DB11425,Biological Factors,DrugBank
DB11425,Eicosanoids,DrugBank
DB11425,Fatty Acids,DrugBank
DB11425,"Fatty Acids, Unsaturated",DrugBank
DB11425,Inflammation Mediators,DrugBank
DB11425,Lipids,DrugBank
DB11425,Prostaglandins,DrugBank
DB11425,"Prostaglandins, Synthetic",DrugBank
DB11426,4-Quinolones,DrugBank
DB11426,Anti-Bacterial Agents,DrugBank
DB11426,Anti-Infective Agents,DrugBank
DB11426,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11426,Quinolines,DrugBank
DB11426,Quinolones,DrugBank
DB11428,Adrenergic Agents,DrugBank
DB11428,Adrenergic Agonists,DrugBank
DB11428,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11428,Adrenergic alpha-Agonists,DrugBank
DB11428,Agents producing tachycardia,DrugBank
DB11428,Agents that produce hypertension,DrugBank
DB11428,Analgesics,DrugBank
DB11428,"Analgesics, Non-Narcotic",DrugBank
DB11428,Central Nervous System Agents,DrugBank
DB11428,Central Nervous System Depressants,DrugBank
DB11428,Hypnotics and Sedatives,DrugBank
DB11428,Imidazoles,DrugBank
DB11428,Neurotransmitter Agents,DrugBank
DB11428,Peripheral Nervous System Agents,DrugBank
DB11428,Sensory System Agents,DrugBank
DB11429,Estranes,DrugBank
DB11429,Estrenes,DrugBank
DB11429,Fused-Ring Compounds,DrugBank
DB11429,Gonadal Hormones,DrugBank
DB11429,Gonadal Steroid Hormones,DrugBank
DB11429,Hormones,DrugBank
DB11429,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11429,Steroids,DrugBank
DB11429,Testosterone and derivatives,DrugBank
DB11429,Testosterone Congeners,DrugBank
DB11432,Anti-Bacterial Agents,DrugBank
DB11432,Anti-Infective Agents,DrugBank
DB11432,Antiparasitic Agents,DrugBank
DB11432,Antiprotozoals,DrugBank
DB11432,Coccidiostats,DrugBank
DB11432,Ionophores,DrugBank
DB11442,Anti-Bacterial Agents,DrugBank
DB11442,Anti-Infective Agents,DrugBank
DB11442,Antibacterials for Systemic Use,DrugBank
DB11442,Antiinfectives for Systemic Use,DrugBank
DB11442,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11442,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11442,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11442,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11442,Lactones,DrugBank
DB11442,Macrolides,DrugBank
DB11442,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB11443,4-Quinolones,DrugBank
DB11443,Anti-Bacterial Agents,DrugBank
DB11443,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11443,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11443,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11443,Fluoroquinolones,DrugBank
DB11443,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11443,Potential QTc-Prolonging Agents,DrugBank
DB11443,QTc Prolonging Agents,DrugBank
DB11443,Quinolines,DrugBank
DB11443,Quinolones,DrugBank
DB11447,Agents that reduce seizure threshold,DrugBank
DB11447,Anti-Infective Agents,DrugBank
DB11447,Antiparasitic Agents,DrugBank
DB11447,Antiprotozoals,DrugBank
DB11447,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11447,Sulfur Compounds,DrugBank
DB11448,Agrochemicals,DrugBank
DB11448,"Compounds used in a research, industrial, or household setting",DrugBank
DB11448,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11448,Insecticides,DrugBank
DB11448,Isoindoles,DrugBank
DB11448,Organophosphates,DrugBank
DB11448,Organophosphorus Compounds,DrugBank
DB11448,Organothiophosphates,DrugBank
DB11448,Organothiophosphorus Compounds,DrugBank
DB11448,Pesticides,DrugBank
DB11448,Phthalimides,DrugBank
DB11448,Potential QTc-Prolonging Agents,DrugBank
DB11448,QTc Prolonging Agents,DrugBank
DB11448,Sulfur Compounds,DrugBank
DB11448,Toxic Actions,DrugBank
DB11454,Autacoids,DrugBank
DB11454,Biological Factors,DrugBank
DB11454,Eicosanoids,DrugBank
DB11454,Fatty Acids,DrugBank
DB11454,"Fatty Acids, Unsaturated",DrugBank
DB11454,Inflammation Mediators,DrugBank
DB11454,Lipids,DrugBank
DB11454,Prostaglandins,DrugBank
DB11454,"Prostaglandins F, Synthetic",DrugBank
DB11454,"Prostaglandins, Synthetic",DrugBank
DB11455,"Acids, Carbocyclic",DrugBank
DB11455,Agents causing hyperkalemia,DrugBank
DB11455,Agents that produce hypertension,DrugBank
DB11455,Amines,DrugBank
DB11455,Aniline Compounds,DrugBank
DB11455,Anti-Inflammatory Agents,DrugBank
DB11455,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11455,Nephrotoxic agents,DrugBank
DB11455,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB11458,Anti-Bacterial Agents,DrugBank
DB11458,Anti-Infective Agents,DrugBank
DB11458,Antiparasitic Agents,DrugBank
DB11458,Antiprotozoals,DrugBank
DB11458,Arsenicals,DrugBank
DB11458,Coccidiostats,DrugBank
DB11459,Anti-Bacterial Agents,DrugBank
DB11459,Anti-Infective Agents,DrugBank
DB11459,Antiparasitic Agents,DrugBank
DB11459,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11459,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11459,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11459,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11459,Lactones,DrugBank
DB11459,Macrolides,DrugBank
DB11459,Polyketides,DrugBank
DB11461,Amides,DrugBank
DB11461,Amines,DrugBank
DB11461,Aniline Compounds,DrugBank
DB11461,Anti-Infective Agents,DrugBank
DB11461,"Anti-Infective Agents, Urinary",DrugBank
DB11461,Benzene Derivatives,DrugBank
DB11461,Benzenesulfonamides,DrugBank
DB11461,Sulfanilamides,DrugBank
DB11461,Sulfonamides,DrugBank
DB11461,Sulfones,DrugBank
DB11461,Sulfur Compounds,DrugBank
DB11462,Amides,DrugBank
DB11462,Amines,DrugBank
DB11462,Aniline Compounds,DrugBank
DB11462,Benzene Derivatives,DrugBank
DB11462,Benzenesulfonamides,DrugBank
DB11462,Sulfanilamides,DrugBank
DB11462,Sulfonamides,DrugBank
DB11462,Sulfones,DrugBank
DB11462,Sulfur Compounds,DrugBank
DB11463,Amides,DrugBank
DB11463,Amines,DrugBank
DB11463,Aniline Compounds,DrugBank
DB11463,Sulfonamides,DrugBank
DB11463,Sulfones,DrugBank
DB11463,Sulfur Compounds,DrugBank
DB11464,Amides,DrugBank
DB11464,Amines,DrugBank
DB11464,Aniline Compounds,DrugBank
DB11464,Anti-Infective Agents,DrugBank
DB11464,Antiparasitic Agents,DrugBank
DB11464,Antiprotozoals,DrugBank
DB11464,Benzene Derivatives,DrugBank
DB11464,Benzenesulfonamides,DrugBank
DB11464,Sulfanilamides,DrugBank
DB11464,Sulfonamides,DrugBank
DB11464,Sulfones,DrugBank
DB11464,Sulfur Compounds,DrugBank
DB11466,Agents causing hyperkalemia,DrugBank
DB11466,Agents that produce hypertension,DrugBank
DB11466,Analgesics,DrugBank
DB11466,"Analgesics, Non-Narcotic",DrugBank
DB11466,Anti-Inflammatory Agents,DrugBank
DB11466,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11466,Antirheumatic Agents,DrugBank
DB11466,Immunologic Factors,DrugBank
DB11466,Immunosuppressive Agents,DrugBank
DB11466,Nephrotoxic agents,DrugBank
DB11466,Non COX-2 selective NSAIDS,DrugBank
DB11466,Peripheral Nervous System Agents,DrugBank
DB11466,Sensory System Agents,DrugBank
DB11467,"Amino Acids, Peptides, and Proteins",DrugBank
DB11467,Anti-Bacterial Agents,DrugBank
DB11467,Anti-Infective Agents,DrugBank
DB11467,Peptides,DrugBank
DB11467,"Peptides, Cyclic",DrugBank
DB11468,Anti-Bacterial Agents,DrugBank
DB11468,Anti-Infective Agents,DrugBank
DB11468,Terpenes,DrugBank
DB11470,Anti-Bacterial Agents,DrugBank
DB11470,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11470,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11470,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11470,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11470,Lactones,DrugBank
DB11470,Macrolides,DrugBank
DB11471,Anti-Bacterial Agents,DrugBank
DB11471,Anti-Infective Agents,DrugBank
DB11471,Lactones,DrugBank
DB11471,Macrolides,DrugBank
DB11473,Agrochemicals,DrugBank
DB11473,Anthelmintics,DrugBank
DB11473,Anti-Infective Agents,DrugBank
DB11473,Antiparasitic Agents,DrugBank
DB11473,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB11473,Antitrematodals,DrugBank
DB11473,Cholinergic Agents,DrugBank
DB11473,Cholinesterase Inhibitors,DrugBank
DB11473,"Compounds used in a research, industrial, or household setting",DrugBank
DB11473,Enzyme Inhibitors,DrugBank
DB11473,Insecticides,DrugBank
DB11473,Neurotransmitter Agents,DrugBank
DB11473,Organophosphonates,DrugBank
DB11473,Organophosphorous Compounds,DrugBank
DB11473,Organophosphorus Compounds,DrugBank
DB11473,Pesticides,DrugBank
DB11473,Toxic Actions,DrugBank
DB11474,Anti-Bacterial Agents,DrugBank
DB11474,Anti-Infective Agents,DrugBank
DB11474,Carbohydrates,DrugBank
DB11474,Lactones,DrugBank
DB11474,Oligosaccharides,DrugBank
DB11474,Polyketides,DrugBank
DB11474,Polysaccharides,DrugBank
DB11475,Anti-Bacterial Agents,DrugBank
DB11475,Anti-Infective Agents,DrugBank
DB11475,Lactones,DrugBank
DB11475,Macrolides,DrugBank
DB11477,Adrenergic Agents,DrugBank
DB11477,Adrenergic Agonists,DrugBank
DB11477,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11477,Adrenergic alpha-Agonists,DrugBank
DB11477,Agents producing tachycardia,DrugBank
DB11477,Agents that produce hypertension,DrugBank
DB11477,Analgesics,DrugBank
DB11477,Central Nervous System Agents,DrugBank
DB11477,Central Nervous System Depressants,DrugBank
DB11477,Hypnotics and Sedatives,DrugBank
DB11477,Muscle Relaxants,DrugBank
DB11477,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB11477,Neuromuscular Agents,DrugBank
DB11477,Neurotransmitter Agents,DrugBank
DB11477,Peripheral Nervous System Agents,DrugBank
DB11477,Sensory System Agents,DrugBank
DB11477,Sulfur Compounds,DrugBank
DB11477,Thiazines,DrugBank
DB11478,Benzene Derivatives,DrugBank
DB11478,Estrogens,DrugBank
DB11478,"Estrogens, Non-Steroidal",DrugBank
DB11478,Hormones,DrugBank
DB11478,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11478,Lactones,DrugBank
DB11478,Phenols,DrugBank
DB11478,Resorcinols,DrugBank
DB11478,Zearalenone,DrugBank
DB11481,Adrenergic Agents,DrugBank
DB11481,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB11481,Adrenergic alpha-Antagonists,DrugBank
DB11481,Adrenergic Antagonists,DrugBank
DB11481,Agents that produce hypertension,DrugBank
DB11481,Neurotransmitter Agents,DrugBank
DB11485,Amides,DrugBank
DB11485,Anti-Bacterial Agents,DrugBank
DB11485,Anti-Infective Agents,DrugBank
DB11485,beta-Lactams,DrugBank
DB11485,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11485,Lactams,DrugBank
DB11485,Sulfur Compounds,DrugBank
DB11485,Thiazines,DrugBank
DB11487,Adrenal Cortex Hormones,DrugBank
DB11487,Anti-Allergic Agents,DrugBank
DB11487,Anti-Inflammatory Agents,DrugBank
DB11487,Corticosteroids,DrugBank
DB11487,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11487,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11487,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11487,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11487,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11487,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11487,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11487,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11487,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11487,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB11487,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11487,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11487,Cytochrome P-450 Substrates,DrugBank
DB11487,Fused-Ring Compounds,DrugBank
DB11487,Glucocorticoids,DrugBank
DB11487,Hormones,DrugBank
DB11487,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11487,Hyperglycemia-Associated Agents,DrugBank
DB11487,Immunosuppressive Agents,DrugBank
DB11487,Pregnadienes,DrugBank
DB11487,Pregnadienetriols,DrugBank
DB11487,Pregnanes,DrugBank
DB11487,Steroids,DrugBank
DB11487,"Steroids, Fluorinated",DrugBank
DB11491,4-Quinolones,DrugBank
DB11491,Anti-Bacterial Agents,DrugBank
DB11491,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11491,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11491,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11491,Fluoroquinolones,DrugBank
DB11491,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11491,Potential QTc-Prolonging Agents,DrugBank
DB11491,QTc Prolonging Agents,DrugBank
DB11491,Quinolines,DrugBank
DB11491,Quinolones,DrugBank
DB11493,Acids,DrugBank
DB11493,"Acids, Noncarboxylic",DrugBank
DB11493,Anions,DrugBank
DB11493,Electrolytes,DrugBank
DB11493,Ions,DrugBank
DB11493,Phosphate salts,DrugBank
DB11493,Phosphoric Acids,DrugBank
DB11493,Phosphorus Acids,DrugBank
DB11493,Phosphorus Compounds,DrugBank
DB11502,"Acids, Carbocyclic",DrugBank
DB11502,Anesthetics,DrugBank
DB11502,"Anesthetics, Local",DrugBank
DB11502,Benzene Derivatives,DrugBank
DB11502,Benzoates,DrugBank
DB11502,Central Nervous System Agents,DrugBank
DB11502,Central Nervous System Depressants,DrugBank
DB11502,Peripheral Nervous System Agents,DrugBank
DB11502,Sensory System Agents,DrugBank
DB11511,4-Quinolones,DrugBank
DB11511,Anti-Bacterial Agents,DrugBank
DB11511,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB11511,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11511,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11511,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11511,Cytochrome P-450 Substrates,DrugBank
DB11511,Fluoroquinolones,DrugBank
DB11511,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11511,Potential QTc-Prolonging Agents,DrugBank
DB11511,QTc Prolonging Agents,DrugBank
DB11511,Quinolines,DrugBank
DB11511,Quinolones,DrugBank
DB11512,Agents that produce neuromuscular block (indirect),DrugBank
DB11512,Aminoglycoside Antibacterials,DrugBank
DB11512,Anti-Bacterial Agents,DrugBank
DB11512,Anti-Infective Agents,DrugBank
DB11512,Carbohydrates,DrugBank
DB11512,Glycosides,DrugBank
DB11512,Nephrotoxic agents,DrugBank
DB11512,Ophthalmologicals,DrugBank
DB11512,Sensory Organs,DrugBank
DB11518,Agents causing hyperkalemia,DrugBank
DB11518,Agents that produce hypertension,DrugBank
DB11518,Analgesics,DrugBank
DB11518,"Analgesics, Non-Narcotic",DrugBank
DB11518,Anti-Inflammatory Agents,DrugBank
DB11518,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB11518,Antipyretics,DrugBank
DB11518,Antirheumatic Agents,DrugBank
DB11518,Central Nervous System Agents,DrugBank
DB11518,Nephrotoxic agents,DrugBank
DB11518,Nicotinic Acids,DrugBank
DB11518,Non COX-2 selective NSAIDS,DrugBank
DB11518,Peripheral Nervous System Agents,DrugBank
DB11518,Pyridines,DrugBank
DB11518,Sensory System Agents,DrugBank
DB11518,Veterinary Drugs,DrugBank
DB11519,Abortifacient Agents,DrugBank
DB11519,Autacoids,DrugBank
DB11519,Biological Factors,DrugBank
DB11519,"Contraceptive Agents, Hormonal",DrugBank
DB11519,Eicosanoids,DrugBank
DB11519,Fatty Acids,DrugBank
DB11519,"Fatty Acids, Unsaturated",DrugBank
DB11519,Inflammation Mediators,DrugBank
DB11519,Lipids,DrugBank
DB11519,Luteolytic Agents,DrugBank
DB11519,Prostaglandins,DrugBank
DB11519,"Prostaglandins, Synthetic",DrugBank
DB11519,Reproductive Control Agents,DrugBank
DB11520,Agents that produce neuromuscular block (indirect),DrugBank
DB11520,Aminoglycoside Antibacterials,DrugBank
DB11520,Anthelmintics,DrugBank
DB11520,Anti-Bacterial Agents,DrugBank
DB11520,Anti-Infective Agents,DrugBank
DB11520,Antiparasitic Agents,DrugBank
DB11520,Carbohydrates,DrugBank
DB11520,Glycosides,DrugBank
DB11520,Nephrotoxic agents,DrugBank
DB11525,Anti-Bacterial Agents,DrugBank
DB11525,Anti-Infective Agents,DrugBank
DB11525,Ionophores,DrugBank
DB11526,"Acids, Carbocyclic",DrugBank
DB11526,Amides,DrugBank
DB11526,Antineoplastic Agents,DrugBank
DB11526,Antineoplastic and Immunomodulating Agents,DrugBank
DB11526,Benzene Derivatives,DrugBank
DB11526,Benzoates,DrugBank
DB11526,Protein Kinase Inhibitors,DrugBank
DB11526,Sulfur Compounds,DrugBank
DB11529,Adrenal Cortex Hormones,DrugBank
DB11529,Corticosteroids,DrugBank
DB11529,Corticosteroids for Systemic Use,DrugBank
DB11529,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11529,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11529,Cytochrome P-450 Substrates,DrugBank
DB11529,Fused-Ring Compounds,DrugBank
DB11529,Hormones,DrugBank
DB11529,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11529,Immunosuppressive Agents,DrugBank
DB11529,Pregnadienes,DrugBank
DB11529,Pregnanes,DrugBank
DB11529,Steroids,DrugBank
DB11537,Anti-Bacterial Agents,DrugBank
DB11537,Carbohydrates,DrugBank
DB11537,Glycosides,DrugBank
DB11537,Lincosamides,DrugBank
DB11537,Neurotoxic agents,DrugBank
DB11537,Pyrrolidines,DrugBank
DB11540,Antipsychotic Agents,DrugBank
DB11540,Central Nervous System Depressants,DrugBank
DB11540,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11540,Neurotoxic agents,DrugBank
DB11540,Phenothiazines,DrugBank
DB11540,Sulfur Compounds,DrugBank
DB11541,Adrenergic Agents,DrugBank
DB11541,Adrenergic Agonists,DrugBank
DB11541,Adrenergic beta-Agonists,DrugBank
DB11541,Agents producing tachycardia,DrugBank
DB11541,Agents that produce hypertension,DrugBank
DB11541,Amines,DrugBank
DB11541,Ethylamines,DrugBank
DB11541,Growth Substances,DrugBank
DB11541,Neurotransmitter Agents,DrugBank
DB11543,Adrenergic Agents,DrugBank
DB11543,Adrenergic Agonists,DrugBank
DB11543,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11543,Adrenergic alpha-Agonists,DrugBank
DB11543,Agents producing tachycardia,DrugBank
DB11543,Agents that produce hypertension,DrugBank
DB11543,Anesthetics,DrugBank
DB11543,Central Nervous System Agents,DrugBank
DB11543,Central Nervous System Depressants,DrugBank
DB11543,Hypnotics and Sedatives,DrugBank
DB11543,Neurotransmitter Agents,DrugBank
DB11544,Anti-Bacterial Agents,DrugBank
DB11544,Anti-Infective Agents,DrugBank
DB11544,Antiparasitic Agents,DrugBank
DB11544,Antiprotozoals,DrugBank
DB11544,Coccidiostats,DrugBank
DB11544,Ethers,DrugBank
DB11544,"Ethers, Cyclic",DrugBank
DB11544,Ionophores,DrugBank
DB11544,Lactones,DrugBank
DB11544,P-glycoprotein inhibitors,DrugBank
DB11544,Polyketides,DrugBank
DB11549,Anesthetics,DrugBank
DB11549,"Anesthetics, Dissociative",DrugBank
DB11549,"Anesthetics, General",DrugBank
DB11549,"Anesthetics, Intravenous",DrugBank
DB11549,Anticonvulsants,DrugBank
DB11549,Central Nervous System Agents,DrugBank
DB11549,Central Nervous System Depressants,DrugBank
DB11549,Cyclohexanes,DrugBank
DB11549,Cyclohexanones,DrugBank
DB11549,Cycloparaffins,DrugBank
DB11549,Ketones,DrugBank
DB11549,Sulfur Compounds,DrugBank
DB11549,Thiophenes,DrugBank
DB11552,"Acids, Carbocyclic",DrugBank
DB11552,Anesthetics,DrugBank
DB11552,Benzene Derivatives,DrugBank
DB11552,Benzoates,DrugBank
DB11552,Central Nervous System Agents,DrugBank
DB11552,Central Nervous System Depressants,DrugBank
DB11554,Anti-Bacterial Agents,DrugBank
DB11554,Lactones,DrugBank
DB11554,Macrolides,DrugBank
DB11555,Anti-Anxiety Agents,DrugBank
DB11555,Central Nervous System Agents,DrugBank
DB11555,Central Nervous System Depressants,DrugBank
DB11555,GABA Agents,DrugBank
DB11555,GABA Modulators,DrugBank
DB11555,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11555,Neurotransmitter Agents,DrugBank
DB11555,Psychotropic Drugs,DrugBank
DB11555,Tranquilizing Agents,DrugBank
DB11556,Adrenergic Agents,DrugBank
DB11556,Adrenergic Agonists,DrugBank
DB11556,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11556,Adrenergic alpha-Agonists,DrugBank
DB11556,Agents producing tachycardia,DrugBank
DB11556,Agents that produce hypertension,DrugBank
DB11556,Analgesics,DrugBank
DB11556,Central Nervous System Agents,DrugBank
DB11556,Central Nervous System Depressants,DrugBank
DB11556,Hypnotics and Sedatives,DrugBank
DB11556,Neurotransmitter Agents,DrugBank
DB11556,Peripheral Nervous System Agents,DrugBank
DB11556,Sensory System Agents,DrugBank
DB11560,Acetates,DrugBank
DB11560,"Acids, Acyclic",DrugBank
DB11560,Antigout Preparations,DrugBank
DB11560,Antirheumatic Agents,DrugBank
DB11560,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11560,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11560,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11560,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11560,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11560,Cytochrome P-450 Substrates,DrugBank
DB11560,Drugs that are Mainly Renally Excreted,DrugBank
DB11560,Musculo-Skeletal System,DrugBank
DB11560,Preparations Increasing Uric Acid Excretion,DrugBank
DB11560,Sulfhydryl Compounds,DrugBank
DB11560,Sulfur Compounds,DrugBank
DB11560,Urate Transporter 1 Inhibitor,DrugBank
DB11560,Urate Transporter 1 Inhibitors,DrugBank
DB11560,Uricosuric Agents,DrugBank
DB11564,Blood Glucose Lowering Agents,DrugBank
DB11564,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11564,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB11564,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11564,Insulin,DrugBank
DB11567,Alcohols,DrugBank
DB11567,"Amino Acids, Peptides, and Proteins",DrugBank
DB11567,Blood Glucose Lowering Agents,DrugBank
DB11567,"Compounds used in a research, industrial, or household setting",DrugBank
DB11567,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11567,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB11567,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11567,Ethylene Glycols,DrugBank
DB11567,Glycols,DrugBank
DB11567,Hormones,DrugBank
DB11567,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11567,Insulin,DrugBank
DB11567,"Insulin, Long-Acting",DrugBank
DB11567,Macromolecular Substances,DrugBank
DB11567,Pancreatic Hormones,DrugBank
DB11567,Pegylated agents,DrugBank
DB11567,Peptide Hormones,DrugBank
DB11567,Peptides,DrugBank
DB11567,Polymers,DrugBank
DB11568,Blood Glucose Lowering Agents,DrugBank
DB11568,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11568,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB11568,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11568,Insulin,DrugBank
DB11568,"Insulin, Short-Acting",DrugBank
DB11569,"Amino Acids, Peptides, and Proteins",DrugBank
DB11569,Antibodies,DrugBank
DB11569,"Antibodies, Monoclonal",DrugBank
DB11569,"Antibodies, Monoclonal, Humanized",DrugBank
DB11569,Antineoplastic and Immunomodulating Agents,DrugBank
DB11569,Blood Proteins,DrugBank
DB11569,Dermatologicals,DrugBank
DB11569,Globulins,DrugBank
DB11569,Immunoglobulins,DrugBank
DB11569,Immunoproteins,DrugBank
DB11569,Immunosuppressive Agents,DrugBank
DB11569,Interleukin Inhibitors,DrugBank
DB11569,Interleukin-17,DrugBank
DB11569,Interleukin-17A Antagonist,DrugBank
DB11569,Misc. Skin and Mucous Membrane Agents,DrugBank
DB11569,Proteins,DrugBank
DB11569,Serum Globulins,DrugBank
DB11574,Antiinfectives for Systemic Use,DrugBank
DB11574,Antiviral Agents,DrugBank
DB11574,Antivirals for Systemic Use,DrugBank
DB11574,Antivirals for treatment of HCV infections,DrugBank
DB11574,BCRP/ABCG2 Inhibitors,DrugBank
DB11574,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11574,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11574,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11574,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11574,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB11574,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11574,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB11574,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11574,Cytochrome P-450 Substrates,DrugBank
DB11574,Direct Acting Antivirals,DrugBank
DB11574,Experimental Unapproved Treatments for COVID-19,DrugBank
DB11574,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB11574,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11574,P-glycoprotein inhibitors,DrugBank
DB11574,P-glycoprotein substrates,DrugBank
DB11574,Treatments for Hepatitis C,DrugBank
DB11575,"Acids, Acyclic",DrugBank
DB11575,Amides,DrugBank
DB11575,Anti-Infective Agents,DrugBank
DB11575,Antiinfectives for Systemic Use,DrugBank
DB11575,Antiviral Agents,DrugBank
DB11575,Antivirals for Systemic Use,DrugBank
DB11575,Antivirals for treatment of HCV infections,DrugBank
DB11575,BCRP/ABCG2 Inhibitors,DrugBank
DB11575,Cycloparaffins,DrugBank
DB11575,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11575,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11575,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11575,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB11575,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11575,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11575,Cytochrome P-450 Substrates,DrugBank
DB11575,Direct Acting Antivirals,DrugBank
DB11575,HCV NS3/4A Protease Inhibitors,DrugBank
DB11575,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11575,Lactams,DrugBank
DB11575,NS3/4A Protease Inhibitors,DrugBank
DB11575,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11575,OATP1B3 substrates,DrugBank
DB11575,P-glycoprotein substrates,DrugBank
DB11575,Sulfones,DrugBank
DB11575,Sulfur Compounds,DrugBank
DB11575,Treatments for Hepatitis C,DrugBank
DB11576,Biopolymers,DrugBank
DB11576,Carbohydrates,DrugBank
DB11576,"Compounds used in a research, industrial, or household setting",DrugBank
DB11576,Contrast Media,DrugBank
DB11576,Diagnostic Uses of Chemicals,DrugBank
DB11576,Glucans,DrugBank
DB11576,Iron Compounds,DrugBank
DB11576,Macromolecular Substances,DrugBank
DB11576,Magnetic Iron Oxide Nanoparticles,DrugBank
DB11576,Magnetic Resonance Imaging Contrast Media,DrugBank
DB11576,Metal Nanoparticles,DrugBank
DB11576,Nanoparticles,DrugBank
DB11576,Nanostructures,DrugBank
DB11576,Polymers,DrugBank
DB11576,Polysaccharides,DrugBank
DB11576,Superparamagnetic Contrast Media,DrugBank
DB11577,Coloring Agents,DrugBank
DB11577,"Compounds used in a research, industrial, or household setting",DrugBank
DB11577,Diagnostic Agents,DrugBank
DB11577,Diagnostic Dye,DrugBank
DB11577,Drugs that are Mainly Renally Excreted,DrugBank
DB11577,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11577,Indoles,DrugBank
DB11577,Tests for Renal Function and Ureteral Injuries,DrugBank
DB11580,"Amino Acids, Peptides, and Proteins",DrugBank
DB11580,Antibodies,DrugBank
DB11580,"Antibodies, Monoclonal",DrugBank
DB11580,"Antibodies, Monoclonal, Humanized",DrugBank
DB11580,Antineoplastic and Immunomodulating Agents,DrugBank
DB11580,Blood Proteins,DrugBank
DB11580,Complement C5 inhibitors,DrugBank
DB11580,Complement Inactivating Agents,DrugBank
DB11580,Complement Inactivator Proteins,DrugBank
DB11580,Globulins,DrugBank
DB11580,Immunoglobulins,DrugBank
DB11580,Immunologic Factors,DrugBank
DB11580,Immunoproteins,DrugBank
DB11580,Immunosuppressive Agents,DrugBank
DB11580,Immunotherapy,DrugBank
DB11580,Proteins,DrugBank
DB11580,Selective Immunosuppressants,DrugBank
DB11580,Serum Globulins,DrugBank
DB11581,Amides,DrugBank
DB11581,Antineoplastic Agents,DrugBank
DB11581,Antineoplastic and Immunomodulating Agents,DrugBank
DB11581,BCL-2 Inhibitor,DrugBank
DB11581,BCRP/ABCG2 Inhibitors,DrugBank
DB11581,BCRP/ABCG2 Substrates,DrugBank
DB11581,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11581,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11581,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11581,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB11581,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11581,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11581,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11581,Cytochrome P-450 Substrates,DrugBank
DB11581,Increased Cellular Death,DrugBank
DB11581,Narrow Therapeutic Index Drugs,DrugBank
DB11581,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11581,P-glycoprotein inhibitors,DrugBank
DB11581,P-glycoprotein substrates,DrugBank
DB11581,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11581,Sulfones,DrugBank
DB11581,Sulfur Compounds,DrugBank
DB11582,Alkaloids,DrugBank
DB11582,Central Nervous System Depressants,DrugBank
DB11582,Muscle Relaxants,DrugBank
DB11582,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB11582,Musculo-Skeletal System,DrugBank
DB11586,Amides,DrugBank
DB11586,Antiinfectives for Systemic Use,DrugBank
DB11586,Antiviral Agents,DrugBank
DB11586,Antivirals for Systemic Use,DrugBank
DB11586,Antivirals for treatment of HCV infections,DrugBank
DB11586,Cytochrome P-450 CYP2A6 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11586,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB11586,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11586,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11586,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11586,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11586,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11586,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11586,Cytochrome P-450 CYP3A5 Inducers (weak),DrugBank
DB11586,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11586,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11586,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11586,Cytochrome P-450 Substrates,DrugBank
DB11586,Direct Acting Antivirals,DrugBank
DB11586,Enzyme Inhibitors,DrugBank
DB11586,HCV Protease Inhibitors,DrugBank
DB11586,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11586,HIV Protease Inhibitors,DrugBank
DB11586,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11586,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11586,OATP1B3 inhibitors,DrugBank
DB11586,OATP2B1/SLCO2B1 substrates,DrugBank
DB11586,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB11586,P-glycoprotein inhibitors,DrugBank
DB11586,P-glycoprotein substrates,DrugBank
DB11586,Protease Inhibitors,DrugBank
DB11586,Sulfones,DrugBank
DB11586,Sulfur Compounds,DrugBank
DB11587,Adrenergic Agonists,DrugBank
DB11587,Adrenergic beta-2 Receptor Agonists,DrugBank
DB11587,Adrenergic beta-Agonists,DrugBank
DB11587,Agents producing tachycardia,DrugBank
DB11587,Agents that produce hypertension,DrugBank
DB11587,Alcohols,DrugBank
DB11587,Amines,DrugBank
DB11587,Amino Alcohols,DrugBank
DB11587,Drugs that are Mainly Renally Excreted,DrugBank
DB11587,Ethylamines,DrugBank
DB11587,Phenethylamines,DrugBank
DB11587,Propanolamines,DrugBank
DB11587,Propanols,DrugBank
DB11591,Antihistamines for Systemic Use,DrugBank
DB11591,Decongestants and Antiallergics,DrugBank
DB11591,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11591,Histamine Antagonists,DrugBank
DB11591,Histamine H1 Antagonists,DrugBank
DB11591,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB11591,Ophthalmologicals,DrugBank
DB11591,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB11591,Potential QTc-Prolonging Agents,DrugBank
DB11591,QTc Prolonging Agents,DrugBank
DB11591,Sensory Organs,DrugBank
DB11593,Anti-Bacterial Agents,DrugBank
DB11593,Anti-Infective Agents,DrugBank
DB11593,beta-Lactamase Inhibitors,DrugBank
DB11593,Enzyme Inhibitors,DrugBank
DB11595,"Amino Acids, Peptides, and Proteins",DrugBank
DB11595,Antibodies,DrugBank
DB11595,"Antibodies, Monoclonal",DrugBank
DB11595,"Antibodies, Monoclonal, Humanized",DrugBank
DB11595,Antineoplastic Agents,DrugBank
DB11595,"Antineoplastic Agents, Immunological",DrugBank
DB11595,Antineoplastic and Immunomodulating Agents,DrugBank
DB11595,Blood Proteins,DrugBank
DB11595,Cancer immunotherapy,DrugBank
DB11595,Globulins,DrugBank
DB11595,Immune Checkpoint Inhibitors,DrugBank
DB11595,Immunoglobulins,DrugBank
DB11595,Immunoproteins,DrugBank
DB11595,Immunotherapy,DrugBank
DB11595,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB11595,Narrow Therapeutic Index Drugs,DrugBank
DB11595,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11595,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11595,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB11595,Programmed Death Receptor-1-directed Antibody Interactions,DrugBank
DB11595,Proteins,DrugBank
DB11595,Serum Globulins,DrugBank
DB11596,Antidotes,DrugBank
DB11596,Coenzymes,DrugBank
DB11596,"Compounds used in a research, industrial, or household setting",DrugBank
DB11596,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB11596,Enzymes and Coenzymes,DrugBank
DB11596,Folate Analog,DrugBank
DB11596,Folic Acid Analogues,DrugBank
DB11596,Folic Acid and Derivatives,DrugBank
DB11596,Formyltetrahydrofolates,DrugBank
DB11596,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11596,Micronutrients,DrugBank
DB11596,Protective Agents,DrugBank
DB11596,Pteridines,DrugBank
DB11596,Pterins,DrugBank
DB11596,Tetrahydrofolates,DrugBank
DB11596,Vitamin B Complex,DrugBank
DB11596,Vitamins,DrugBank
DB11597,"Amino Acids, Peptides, and Proteins",DrugBank
DB11597,Antiinfectives for Systemic Use,DrugBank
DB11597,Blood Proteins,DrugBank
DB11597,Endogenous Antigen Neutralization,DrugBank
DB11597,Human Immunoglobulin G,DrugBank
DB11597,Immune Sera and Immunoglobulins,DrugBank
DB11597,Immunoglobulins,DrugBank
DB11597,Passively Acquired Immunity,DrugBank
DB11597,Proteins,DrugBank
DB11597,Serum,DrugBank
DB11597,Serum Globulins,DrugBank
DB11597,Specific Immunoglobulins,DrugBank
DB11598,Alpha-Globulins,DrugBank
DB11598,"Amino Acids, Peptides, and Proteins",DrugBank
DB11598,Anticoagulants,DrugBank
DB11598,Antithrombin III,DrugBank
DB11598,"Antithrombin III, agonists",DrugBank
DB11598,Antithrombin Proteins,DrugBank
DB11598,Biological Factors,DrugBank
DB11598,Blood and Blood Forming Organs,DrugBank
DB11598,Blood Coagulation Factor Inhibitors,DrugBank
DB11598,Blood Proteins,DrugBank
DB11598,Carbohydrates,DrugBank
DB11598,Drugs that are Mainly Renally Excreted,DrugBank
DB11598,Enzyme Inhibitors,DrugBank
DB11598,Globulins,DrugBank
DB11598,Glycosaminoglycans,DrugBank
DB11598,Hematologic Agents,DrugBank
DB11598,Oligosaccharides,DrugBank
DB11598,Peptides,DrugBank
DB11598,Polysaccharides,DrugBank
DB11598,Proteins,DrugBank
DB11598,Serum Globulins,DrugBank
DB11603,Human Rabies Immune Globulins,DrugBank
DB11603,Serum,DrugBank
DB11603,Vaccines,DrugBank
DB11604,"Amino Acids, Peptides, and Proteins",DrugBank
DB11604,Antiinfectives for Systemic Use,DrugBank
DB11604,Blood Proteins,DrugBank
DB11604,Human Tetanus Immune Globulins,DrugBank
DB11604,Immune Sera and Immunoglobulins,DrugBank
DB11604,Immunoglobulins,DrugBank
DB11604,Proteins,DrugBank
DB11604,Serum,DrugBank
DB11604,Serum Globulins,DrugBank
DB11604,Specific Immunoglobulins,DrugBank
DB11606,Blood and Blood Forming Organs,DrugBank
DB11606,Blood Coagulation Factors,DrugBank
DB11606,Hemostatics,DrugBank
DB11608,"Amino Acids, Peptides, and Proteins",DrugBank
DB11608,Biological Factors,DrugBank
DB11608,Blood Coagulation Factors,DrugBank
DB11608,Blood Proteins,DrugBank
DB11608,Enzyme Precursors,DrugBank
DB11608,Enzymes and Coenzymes,DrugBank
DB11608,Globulins,DrugBank
DB11608,Hemostatics,DrugBank
DB11608,Immunoglobulin Constant Regions,DrugBank
DB11608,Immunoglobulin Fragments,DrugBank
DB11608,Immunoglobulins,DrugBank
DB11608,Immunoproteins,DrugBank
DB11608,Peptide Fragments,DrugBank
DB11608,Peptides,DrugBank
DB11608,Protein Precursors,DrugBank
DB11608,Proteins,DrugBank
DB11608,Recombinant Proteins,DrugBank
DB11608,Serum Globulins,DrugBank
DB11609,Analgesics,DrugBank
DB11609,Antitussive Agents,DrugBank
DB11609,Central Nervous System Agents,DrugBank
DB11609,Central Nervous System Depressants,DrugBank
DB11609,Cough and Cold Preparations,DrugBank
DB11609,Ketones,DrugBank
DB11609,Narcotics,DrugBank
DB11609,Opioids,DrugBank
DB11609,Opium Alkaloids and Derivatives,DrugBank
DB11609,Peripheral Nervous System Agents,DrugBank
DB11609,Respiratory System Agents,DrugBank
DB11609,Sensory System Agents,DrugBank
DB11609,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB11613,"Acids, Acyclic",DrugBank
DB11613,Anti-Infective Agents,DrugBank
DB11613,Antiinfectives for Systemic Use,DrugBank
DB11613,Antiviral Agents,DrugBank
DB11613,Antivirals for Systemic Use,DrugBank
DB11613,Antivirals for treatment of HCV infections,DrugBank
DB11613,BCRP/ABCG2 Inhibitors,DrugBank
DB11613,BCRP/ABCG2 Substrates,DrugBank
DB11613,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11613,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11613,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11613,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11613,Cytochrome P-450 Substrates,DrugBank
DB11613,Direct Acting Antivirals,DrugBank
DB11613,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB11613,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11613,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11613,OATP1B3 inhibitors,DrugBank
DB11613,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB11613,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB11613,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB11613,P-glycoprotein inhibitors,DrugBank
DB11613,P-glycoprotein substrates,DrugBank
DB11613,Pyrans,DrugBank
DB11613,Treatments for Hepatitis C,DrugBank
DB11614,Antihistamines for Systemic Use,DrugBank
DB11614,Benzocycloheptenes,DrugBank
DB11614,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11614,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11614,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11614,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11614,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11614,Cytochrome P-450 Substrates,DrugBank
DB11614,Dibenzocycloheptenes,DrugBank
DB11614,Histamine Antagonists,DrugBank
DB11614,Histamine H1 Antagonists,DrugBank
DB11614,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB11614,Piperidines,DrugBank
DB11614,"Platelet Activating Factor, antagonists & inhibitors",DrugBank
DB11614,Potential QTc-Prolonging Agents,DrugBank
DB11614,QTc Prolonging Agents,DrugBank
DB11616,Anthracyclines,DrugBank
DB11616,Anthracyclines and Related Substances,DrugBank
DB11616,Antineoplastic Agents,DrugBank
DB11616,Antineoplastic and Immunomodulating Agents,DrugBank
DB11616,Carbohydrates,DrugBank
DB11616,Cytotoxic Antibiotics and Related Substances,DrugBank
DB11616,Cytotoxins,DrugBank
DB11616,Glycosides,DrugBank
DB11616,Immunosuppressive Agents,DrugBank
DB11616,Naphthacenes,DrugBank
DB11617,Anthracyclines,DrugBank
DB11617,Anthracyclines and Related Substances,DrugBank
DB11617,"Antibiotics, Antineoplastic",DrugBank
DB11617,Antineoplastic Agents,DrugBank
DB11617,Antineoplastic and Immunomodulating Agents,DrugBank
DB11617,Carbohydrates,DrugBank
DB11617,Cytotoxic Antibiotics and Related Substances,DrugBank
DB11617,Cytotoxins,DrugBank
DB11617,Enzyme Inhibitors,DrugBank
DB11617,Glycosides,DrugBank
DB11617,Naphthacenes,DrugBank
DB11617,Topoisomerase II Inhibitors,DrugBank
DB11617,Topoisomerase Inhibitors,DrugBank
DB11618,Anthracyclines,DrugBank
DB11618,Anthracyclines and Related Substances,DrugBank
DB11618,"Antibiotics, Antineoplastic",DrugBank
DB11618,Antineoplastic Agents,DrugBank
DB11618,Antineoplastic and Immunomodulating Agents,DrugBank
DB11618,Carbohydrates,DrugBank
DB11618,Cytotoxic Antibiotics and Related Substances,DrugBank
DB11618,Cytotoxins,DrugBank
DB11618,Glycosides,DrugBank
DB11618,Naphthacenes,DrugBank
DB11619,Adrenal Cortex Hormones,DrugBank
DB11619,Antigonadotropins and Similar Agents,DrugBank
DB11619,"Contraceptive Agents, Female",DrugBank
DB11619,"Contraceptive Agents, Hormonal",DrugBank
DB11619,"Contraceptives, Oral",DrugBank
DB11619,"Contraceptives, Oral, Hormonal",DrugBank
DB11619,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11619,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11619,Cytochrome P-450 Substrates,DrugBank
DB11619,Fused-Ring Compounds,DrugBank
DB11619,Genito Urinary System and Sex Hormones,DrugBank
DB11619,Hormonal Contraceptives for Systemic Use,DrugBank
DB11619,Hormones,DrugBank
DB11619,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11619,Norpregnanes,DrugBank
DB11619,Norpregnatrienes,DrugBank
DB11619,Norsteroids,DrugBank
DB11619,Progestin Contraceptives,DrugBank
DB11619,Progestins,DrugBank
DB11619,Reproductive Control Agents,DrugBank
DB11619,Sex Hormones and Modulators of the Genital System,DrugBank
DB11619,Steroids,DrugBank
DB11621,"Amino Acids, Peptides, and Proteins",DrugBank
DB11621,Antibodies,DrugBank
DB11621,Biological Products,DrugBank
DB11621,Blood,DrugBank
DB11621,Blood Proteins,DrugBank
DB11621,Body Fluids,DrugBank
DB11621,Complex Mixtures,DrugBank
DB11621,Fluids and Secretions,DrugBank
DB11621,Globulins,DrugBank
DB11621,Human Varicella Zoster Immune Globulins,DrugBank
DB11621,"Immunization, Passive",DrugBank
DB11621,Immunoglobulins,DrugBank
DB11621,Immunoproteins,DrugBank
DB11621,Proteins,DrugBank
DB11621,Serum,DrugBank
DB11621,Serum Globulins,DrugBank
DB11622,Bile Acids and Salts,DrugBank
DB11622,Cholagogues and Choleretics,DrugBank
DB11622,Cholanes,DrugBank
DB11622,Cholic Acids,DrugBank
DB11622,Fused-Ring Compounds,DrugBank
DB11622,Gastrointestinal Agents,DrugBank
DB11622,Laxatives,DrugBank
DB11622,Steroids,DrugBank
DB11627,Actively Acquired Immunity,DrugBank
DB11627,"Amino Acids, Peptides, and Proteins",DrugBank
DB11627,Antigens,DrugBank
DB11627,"Antigens, Viral",DrugBank
DB11627,Antiinfectives for Systemic Use,DrugBank
DB11627,"Bacterial and viral vaccines, combined",DrugBank
DB11627,Biological Factors,DrugBank
DB11627,Biological Products,DrugBank
DB11627,Cancer immunotherapy,DrugBank
DB11627,Complex Mixtures,DrugBank
DB11627,Hepatitis Antigens,DrugBank
DB11627,Hepatitis B Antigens,DrugBank
DB11627,Hepatitis B Surface Antigens,DrugBank
DB11627,"Hepatitis B Surface Antigens, drug effects",DrugBank
DB11627,Hepatitis B Vaccines,DrugBank
DB11627,Immunotherapy,DrugBank
DB11627,Inactivated Hepatitis B Virus Vaccine,DrugBank
DB11627,Proteins,DrugBank
DB11627,Vaccines,DrugBank
DB11627,Viral Hepatitis Vaccines,DrugBank
DB11627,Viral Proteins,DrugBank
DB11627,Viral Vaccines,DrugBank
DB11630,Antineoplastic Agents,DrugBank
DB11630,Antineoplastic and Immunomodulating Agents,DrugBank
DB11630,Biological Factors,DrugBank
DB11630,Dermatologicals,DrugBank
DB11630,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11630,Narrow Therapeutic Index Drugs,DrugBank
DB11630,Photosensitizing Agents,DrugBank
DB11630,"Pigments, Biological",DrugBank
DB11630,Porphyrins,DrugBank
DB11630,Radiation-Sensitizing Agents,DrugBank
DB11630,Sensitizers Used in Photodynamic/radiation Therapy,DrugBank
DB11632,Anti-Dyskinesia Agents,DrugBank
DB11632,Anti-Parkinson Drugs,DrugBank
DB11632,BCRP/ABCG2 Substrates,DrugBank
DB11632,Central Nervous System Agents,DrugBank
DB11632,COMT Inhibitors,DrugBank
DB11632,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11632,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11632,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB11632,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11632,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB11632,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB11632,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB11632,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB11632,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11632,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB11632,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11632,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB11632,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11632,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11632,Dopamine Agents,DrugBank
DB11632,Enzyme Inhibitors,DrugBank
DB11632,Hypotensive Agents,DrugBank
DB11632,Nervous System,DrugBank
DB11632,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11632,OATP1B3 substrates,DrugBank
DB11632,OATP2B1/SLCO2B1 substrates,DrugBank
DB11632,Oxazoles,DrugBank
DB11632,P-glycoprotein substrates,DrugBank
DB11633,Anti-Infective Agents,DrugBank
DB11633,Antifungal Agents,DrugBank
DB11633,Antiinfectives for Systemic Use,DrugBank
DB11633,Antimycotics for Systemic Use,DrugBank
DB11633,Azole Antifungals,DrugBank
DB11633,BCRP/ABCG2 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11633,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB11633,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11633,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB11633,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB11633,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB11633,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11633,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB11633,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB11633,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11633,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11633,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11633,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11633,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11633,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB11633,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11633,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11633,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB11633,Cytochrome P-450 CYP3A5 Inhibitors (moderate),DrugBank
DB11633,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11633,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11633,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11633,Cytochrome P-450 Substrates,DrugBank
DB11633,Isavuconazole and Prodrugs,DrugBank
DB11633,OCT2 Inhibitors,DrugBank
DB11633,P-glycoprotein inhibitors,DrugBank
DB11633,Triazole and tetrazole derivatives,DrugBank
DB11633,Triazole Derivatives,DrugBank
DB11633,UGT1A9 Inhibitors,DrugBank
DB11635,Alimentary Tract and Metabolism,DrugBank
DB11635,Benzopyrans,DrugBank
DB11635,"Compounds used in a research, industrial, or household setting",DrugBank
DB11635,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11635,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11635,Cytochrome P-450 Substrates,DrugBank
DB11635,Drug Carriers,DrugBank
DB11635,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11635,Pyrans,DrugBank
DB11635,Vitamin E,DrugBank
DB11635,Vitamins,DrugBank
DB11635,Vitamins (Fat Soluble),DrugBank
DB11636,Adrenal Cortex Hormones,DrugBank
DB11636,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11636,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11636,Cytochrome P-450 Substrates,DrugBank
DB11636,Fused-Ring Compounds,DrugBank
DB11636,Genito Urinary System and Sex Hormones,DrugBank
DB11636,Hormonal Contraceptives for Systemic Use,DrugBank
DB11636,Pregnadien Derivatives,DrugBank
DB11636,Pregnadienes,DrugBank
DB11636,Pregnanes,DrugBank
DB11636,Progesterone Congeners,DrugBank
DB11636,Progestins,DrugBank
DB11636,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB11636,Sex Hormones and Modulators of the Genital System,DrugBank
DB11636,Steroids,DrugBank
DB11637,Antiinfectives for Systemic Use,DrugBank
DB11637,Antimycobacterials,DrugBank
DB11637,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11637,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11637,Cytochrome P-450 Substrates,DrugBank
DB11637,Drugs for Treatment of Tuberculosis,DrugBank
DB11637,Imidazoles,DrugBank
DB11637,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11637,Nitro Compounds,DrugBank
DB11637,QTc Prolonging Agents,DrugBank
DB11638,Anti-Infective Agents,DrugBank
DB11638,Antimalarials,DrugBank
DB11638,Antiparasitic Agents,DrugBank
DB11638,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB11638,Antiprotozoals,DrugBank
DB11638,Artemisia,DrugBank
DB11638,Artemisinin and derivatives,DrugBank
DB11638,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11638,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB11638,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11638,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11638,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11638,Free Radicals,DrugBank
DB11638,Peroxides,DrugBank
DB11638,Reactive Oxygen Species,DrugBank
DB11638,Sesquiterpenes,DrugBank
DB11638,Terpenes,DrugBank
DB11638,UGT1A9 Substrates,DrugBank
DB11638,UGT2B7 substrates,DrugBank
DB11640,Amines,DrugBank
DB11640,Aminopyridines,DrugBank
DB11640,Membrane Transport Modulators,DrugBank
DB11640,Miscellaneous Central Nervous System Agents,DrugBank
DB11640,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11640,OCT2 Inhibitors,DrugBank
DB11640,Peripheral Nervous System Agents,DrugBank
DB11640,Potassium Channel Blockers,DrugBank
DB11640,Pyridines,DrugBank
DB11640,QTc Prolonging Agents,DrugBank
DB11641,Alkaloids,DrugBank
DB11641,Antineoplastic Agents,DrugBank
DB11641,Antineoplastic and Immunomodulating Agents,DrugBank
DB11641,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11641,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11641,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11641,Cytochrome P-450 Substrates,DrugBank
DB11641,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11641,Indole Alkaloids,DrugBank
DB11641,Indoles,DrugBank
DB11641,Indolizidines,DrugBank
DB11641,Indolizines,DrugBank
DB11641,Narrow Therapeutic Index Drugs,DrugBank
DB11641,P-glycoprotein substrates,DrugBank
DB11641,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11641,Secologanin Tryptamine Alkaloids,DrugBank
DB11641,Vinca Alkaloids,DrugBank
DB11642,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11642,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB11642,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11642,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB11642,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11642,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB11642,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11642,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11642,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11642,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11642,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11642,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11642,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11642,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11642,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11642,Cytochrome P-450 Substrates,DrugBank
DB11642,Drugs causing inadvertant photosensitivity,DrugBank
DB11642,Drugs that are Mainly Renally Excreted,DrugBank
DB11642,Histamine Antagonists,DrugBank
DB11642,Histamine H3 Antagonists,DrugBank
DB11642,Histamine-3 (H3) Receptor Antagonists/Inverse Agonists,DrugBank
DB11642,Histamine-3 Receptor Antagonist/Inverse Agonist,DrugBank
DB11642,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11642,Nervous System,DrugBank
DB11642,OCT1 inhibitors,DrugBank
DB11642,Photosensitizing Agents,DrugBank
DB11642,QTc Prolonging Agents,DrugBank
DB11642,"Receptors, Histamine H3",DrugBank
DB11644,Anti-Inflammatory Agents,DrugBank
DB11644,BCRP/ABCG2 Inhibitors,DrugBank
DB11644,Fused-Ring Compounds,DrugBank
DB11644,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11644,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11644,Immunologic Factors,DrugBank
DB11644,Miscellaneous Cardiac Drugs,DrugBank
DB11644,Nervous System,DrugBank
DB11644,OAT1/SLC22A6 inhibitors,DrugBank
DB11644,OAT3/SLC22A8 Inhibitors,DrugBank
DB11644,Transthyretin Stabilizers,DrugBank
DB11646,"Amino Acids, Peptides, and Proteins",DrugBank
DB11646,Antibodies,DrugBank
DB11646,Antineoplastic Agents,DrugBank
DB11646,"Antineoplastic Agents, Immunological",DrugBank
DB11646,Blood Proteins,DrugBank
DB11646,Globulins,DrugBank
DB11646,Immunoglobulins,DrugBank
DB11646,Immunoproteins,DrugBank
DB11646,Proteins,DrugBank
DB11646,Serum Globulins,DrugBank
DB11651,Antineoplastic Agents,DrugBank
DB11651,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11652,Antineoplastic Agents,DrugBank
DB11652,Antineoplastic and Immunomodulating Agents,DrugBank
DB11652,BCRP/ABCG2 Substrates,DrugBank
DB11652,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11652,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11652,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11652,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11652,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11652,Cytochrome P-450 Substrates,DrugBank
DB11652,Enzyme Inhibitors,DrugBank
DB11652,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11652,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,DrugBank
DB11652,Kinase Inhibitor,DrugBank
DB11652,MATE 1 Inhibitors,DrugBank
DB11652,MATE 2 Inhibitors,DrugBank
DB11652,MATE inhibitors,DrugBank
DB11652,OCT2 Inhibitors,DrugBank
DB11652,P-glycoprotein inhibitors,DrugBank
DB11652,P-glycoprotein substrates,DrugBank
DB11652,Protein Kinase Inhibitors,DrugBank
DB11652,Tyrosine Kinase Inhibitors,DrugBank
DB11657,"Amino Acids, Peptides, and Proteins",DrugBank
DB11657,Antibodies,DrugBank
DB11657,"Antibodies, Monoclonal",DrugBank
DB11657,"B-Cell Activating Factor, antagonists & inhibitors",DrugBank
DB11657,Blood Proteins,DrugBank
DB11657,Globulins,DrugBank
DB11657,Immunoglobulins,DrugBank
DB11657,Immunoproteins,DrugBank
DB11657,Proteins,DrugBank
DB11657,Serum Globulins,DrugBank
DB11660,Antiglaucoma Preparations and Miotics,DrugBank
DB11660,Autacoids,DrugBank
DB11660,Biological Factors,DrugBank
DB11660,Drugs that are Mainly Renally Excreted,DrugBank
DB11660,Eicosanoids,DrugBank
DB11660,Fatty Acids,DrugBank
DB11660,"Fatty Acids, Unsaturated",DrugBank
DB11660,Inflammation Mediators,DrugBank
DB11660,Lipids,DrugBank
DB11660,OATP2B1/SLCO2B1 substrates,DrugBank
DB11660,Ophthalmologicals,DrugBank
DB11660,Prostaglandin analogs reducing intraocular pressure (IOP),DrugBank
DB11660,Prostaglandins,DrugBank
DB11660,"Prostaglandins, Synthetic",DrugBank
DB11660,Sensory Organs,DrugBank
DB11661,Pegylated agents,DrugBank
DB11662,Amides,DrugBank
DB11662,Antineoplastic Agents,DrugBank
DB11662,Benzene Derivatives,DrugBank
DB11662,Protein Kinase Inhibitors,DrugBank
DB11664,Alkaloids,DrugBank
DB11664,Central Nervous System Agents,DrugBank
DB11664,Central Nervous System Depressants,DrugBank
DB11664,Hallucinogens,DrugBank
DB11664,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11664,Indole Alkaloids,DrugBank
DB11664,Indoles,DrugBank
DB11664,Indolizidines,DrugBank
DB11664,Indolizines,DrugBank
DB11664,Psychotropic Drugs,DrugBank
DB11664,Tryptamines,DrugBank
DB11668,"Amino Acids, Peptides, and Proteins",DrugBank
DB11668,Biological Factors,DrugBank
DB11668,Blood Coagulation Factors,DrugBank
DB11668,Blood Proteins,DrugBank
DB11668,Endopeptidases,DrugBank
DB11668,Enzymes,DrugBank
DB11668,Enzymes and Coenzymes,DrugBank
DB11668,Hydrolases,DrugBank
DB11668,Peptide Hydrolases,DrugBank
DB11668,Peptides,DrugBank
DB11668,Proteins,DrugBank
DB11668,Serine Endopeptidases,DrugBank
DB11668,Serine Proteases,DrugBank
DB11668,Wound Healing,DrugBank
DB11669,Antineoplastic Agents,DrugBank
DB11669,Cyclodecanes,DrugBank
DB11669,Cycloparaffins,DrugBank
DB11669,Diterpenes,DrugBank
DB11669,Terpenes,DrugBank
DB11669,Tumor Necrosis Factor Blockers,DrugBank
DB11672,Alkanes,DrugBank
DB11672,Analgesics,DrugBank
DB11672,"Analgesics, Non-Narcotic",DrugBank
DB11672,Anti-Inflammatory Agents,DrugBank
DB11672,Antineoplastic Agents,DrugBank
DB11672,Antirheumatic Agents,DrugBank
DB11672,Benzene Derivatives,DrugBank
DB11672,Catechols,DrugBank
DB11672,Coloring Agents,DrugBank
DB11672,"Compounds used in a research, industrial, or household setting",DrugBank
DB11672,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB11672,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP2B6 Inhibitors (moderate),DrugBank
DB11672,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB11672,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB11672,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11672,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11672,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB11672,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11672,Diarylheptanoids,DrugBank
DB11672,Enzyme Inhibitors,DrugBank
DB11672,Heptanes,DrugBank
DB11672,"Hydrocarbons, Acyclic",DrugBank
DB11672,P-glycoprotein inhibitors,DrugBank
DB11672,P-glycoprotein substrates,DrugBank
DB11672,Peripheral Nervous System Agents,DrugBank
DB11672,Phenols,DrugBank
DB11672,Sensory System Agents,DrugBank
DB11674,Benzopyrans,DrugBank
DB11674,Chromones,DrugBank
DB11674,Estrogens,DrugBank
DB11674,"Estrogens, Non-Steroidal",DrugBank
DB11674,Flavonoids,DrugBank
DB11674,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11674,Hormones,DrugBank
DB11674,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11674,Isoflavones,DrugBank
DB11674,Phytoestrogens,DrugBank
DB11675,"Acids, Carbocyclic",DrugBank
DB11675,Alimentary Tract and Metabolism,DrugBank
DB11675,Amides,DrugBank
DB11675,Anti-Ulcer Agents,DrugBank
DB11675,Antidepressive Agents,DrugBank
DB11675,Benzene Derivatives,DrugBank
DB11675,Benzoates,DrugBank
DB11675,Central Nervous System Depressants,DrugBank
DB11675,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB11675,Gastrointestinal Agents,DrugBank
DB11675,Neurotransmitter Agents,DrugBank
DB11675,Oxazines,DrugBank
DB11675,Propulsives,DrugBank
DB11675,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB11675,Serotonin Agents,DrugBank
DB11675,Serotonin Receptor Agonists,DrugBank
DB11678,Alcohols,DrugBank
DB11678,Alkanes,DrugBank
DB11678,Alkanesulfonates,DrugBank
DB11678,Alkanesulfonic Acids,DrugBank
DB11678,Alkylating Drugs,DrugBank
DB11678,Antineoplastic Agents,DrugBank
DB11678,"Antineoplastic Agents, Alkylating",DrugBank
DB11678,Antineoplastic and Immunomodulating Agents,DrugBank
DB11678,Butylene Glycols,DrugBank
DB11678,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11678,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11678,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11678,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11678,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11678,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11678,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11678,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11678,Cytochrome P-450 Substrates,DrugBank
DB11678,Glycols,DrugBank
DB11678,"Hydrocarbons, Acyclic",DrugBank
DB11678,Mesylates,DrugBank
DB11678,Noxae,DrugBank
DB11678,Sulfonic Acids,DrugBank
DB11678,Sulfur Acids,DrugBank
DB11678,Sulfur Compounds,DrugBank
DB11678,Toxic Actions,DrugBank
DB11679,Antineoplastic Agents,DrugBank
DB11679,Antineoplastic and Immunomodulating Agents,DrugBank
DB11679,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11679,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11679,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11679,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11679,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11679,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11679,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB11679,Cytochrome P-450 Substrates,DrugBank
DB11679,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11679,Protein Kinase Inhibitors,DrugBank
DB11679,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,DrugBank
DB11680,"Amino Acids, Peptides, and Proteins",DrugBank
DB11680,Antibodies,DrugBank
DB11680,"Antibodies, Monoclonal",DrugBank
DB11680,"Antibodies, Monoclonal, Humanized",DrugBank
DB11680,Blood Proteins,DrugBank
DB11680,Globulins,DrugBank
DB11680,Immunoglobulins,DrugBank
DB11680,Immunoproteins,DrugBank
DB11680,Proteins,DrugBank
DB11680,Serum Globulins,DrugBank
DB11682,Amino Acids,DrugBank
DB11682,"Amino Acids, Peptides, and Proteins",DrugBank
DB11682,Antianemic Preparations,DrugBank
DB11682,BCRP/ABCG2 Substrates,DrugBank
DB11682,Blood and Blood Forming Organs,DrugBank
DB11682,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11682,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB11682,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11682,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11682,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11682,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11682,Cytochrome P-450 Substrates,DrugBank
DB11682,Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor,DrugBank
DB11682,"Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors",DrugBank
DB11682,OAT1/SLC22A6 Substrates,DrugBank
DB11682,OAT3/SLC22A8 Substrates,DrugBank
DB11682,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11682,OATP1B3 inhibitors,DrugBank
DB11682,Pyrimidines,DrugBank
DB11682,Pyrimidinones,DrugBank
DB11685,"Amino Acids, Peptides, and Proteins",DrugBank
DB11685,Antibodies,DrugBank
DB11685,Blood Proteins,DrugBank
DB11685,Globulins,DrugBank
DB11685,Immunoglobulins,DrugBank
DB11685,Immunoproteins,DrugBank
DB11685,Proteins,DrugBank
DB11685,Serum Globulins,DrugBank
DB11686,"Acids, Carbocyclic",DrugBank
DB11686,Antidepressive Agents,DrugBank
DB11686,Central Nervous System Depressants,DrugBank
DB11686,Serotonin Agents,DrugBank
DB11686,Serotonin Receptor Antagonists,DrugBank
DB11688,Amides,DrugBank
DB11688,Antineoplastic Agents,DrugBank
DB11688,Nitroso Compounds,DrugBank
DB11688,Nitrosourea Compounds,DrugBank
DB11689,Antineoplastic Agents,DrugBank
DB11689,Antineoplastic and Immunomodulating Agents,DrugBank
DB11689,BCRP/ABCG2 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11689,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11689,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11689,Cytochrome P-450 Substrates,DrugBank
DB11689,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11689,Kinase Inhibitor,DrugBank
DB11689,Mitogen-activated protein kinase (MEK) inhibitors,DrugBank
DB11689,Mitogen-Activated Protein Kinase Kinase 1 Inhibitors,DrugBank
DB11689,Mitogen-Activated Protein Kinase Kinase 2 Inhibitors,DrugBank
DB11689,P-glycoprotein substrates,DrugBank
DB11689,Protein Kinase Inhibitors,DrugBank
DB11689,Tyrosine Kinase Inhibitors,DrugBank
DB11689,UGT1A1 Substrates,DrugBank
DB11691,Alimentary Tract and Metabolism,DrugBank
DB11691,Alkaloids,DrugBank
DB11691,Drugs for Constipation,DrugBank
DB11691,Drugs that are Mainly Renally Excreted,DrugBank
DB11691,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11691,Morphinans,DrugBank
DB11691,Opiate Alkaloids,DrugBank
DB11691,Opioid Antagonists,DrugBank
DB11691,Peripheral Opioid Receptor Antagonists,DrugBank
DB11691,Phenanthrenes,DrugBank
DB11691,UGT1A3 substrates,DrugBank
DB11693,"Amino Acids, Peptides, and Proteins",DrugBank
DB11693,Antineoplastic and Immunomodulating Agents,DrugBank
DB11693,Calcineurin Inhibitor Immunosuppressant,DrugBank
DB11693,Calcineurin Inhibitors,DrugBank
DB11693,Cyclosporins,DrugBank
DB11693,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11693,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11693,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11693,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11693,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11693,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11693,Cytochrome P-450 Substrates,DrugBank
DB11693,Immunosuppressive Agents,DrugBank
DB11693,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB11693,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB11693,P-glycoprotein inhibitors,DrugBank
DB11693,P-glycoprotein substrates,DrugBank
DB11693,Peptides,DrugBank
DB11693,"Peptides, Cyclic",DrugBank
DB11694,Amides,DrugBank
DB11694,Amines,DrugBank
DB11694,Antineoplastic Agents,DrugBank
DB11694,Benzene Derivatives,DrugBank
DB11694,Enzyme Inhibitors,DrugBank
DB11694,Protein Kinase Inhibitors,DrugBank
DB11694,Pyridines,DrugBank
DB11697,Antineoplastic Agents,DrugBank
DB11697,Antineoplastic and Immunomodulating Agents,DrugBank
DB11697,BCRP/ABCG2 Inhibitors,DrugBank
DB11697,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11697,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB11697,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11697,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11697,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11697,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11697,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11697,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11697,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11697,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11697,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11697,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11697,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11697,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11697,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11697,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11697,Cytochrome P-450 Substrates,DrugBank
DB11697,"fms-Like Tyrosine Kinase 3, antagonists & inhibitors",DrugBank
DB11697,"Janus Kinase 2, antagonists & inhibitors",DrugBank
DB11697,Janus Kinase Inhibitor,DrugBank
DB11697,"Janus Kinases, antagonists & inhibitors",DrugBank
DB11697,Kinase Inhibitor,DrugBank
DB11697,OCT1 inhibitors,DrugBank
DB11697,OCT2 Inhibitors,DrugBank
DB11697,P-glycoprotein inhibitors,DrugBank
DB11697,Potential QTc-Prolonging Agents,DrugBank
DB11697,Protein Kinase Inhibitors,DrugBank
DB11697,QTc Prolonging Agents,DrugBank
DB11697,Tyrosine Kinase Inhibitors,DrugBank
DB11698,Alimentary Tract and Metabolism,DrugBank
DB11698,Blood Glucose Lowering Agents,DrugBank
DB11698,Carbohydrates,DrugBank
DB11698,Diuretics,DrugBank
DB11698,Drugs Used in Diabetes,DrugBank
DB11698,Glycosides,DrugBank
DB11698,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB11698,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB11698,Sulfur Compounds,DrugBank
DB11699,Alimentary Tract and Metabolism,DrugBank
DB11699,Antiarrhythmic agents,DrugBank
DB11699,Antidepressive Agents,DrugBank
DB11699,Antiemetics,DrugBank
DB11699,Antiemetics and Antinauseants,DrugBank
DB11699,Autonomic Agents,DrugBank
DB11699,Central Nervous System Agents,DrugBank
DB11699,Central Nervous System Depressants,DrugBank
DB11699,Drugs that are Mainly Renally Excreted,DrugBank
DB11699,Gastrointestinal Agents,DrugBank
DB11699,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11699,Indoles,DrugBank
DB11699,Neurotransmitter Agents,DrugBank
DB11699,Peripheral Nervous System Agents,DrugBank
DB11699,Serotonin 5-HT3 Receptor Antagonists,DrugBank
DB11699,Serotonin Agents,DrugBank
DB11699,Serotonin Receptor Antagonists,DrugBank
DB11703,"Acids, Carbocyclic",DrugBank
DB11703,Amides,DrugBank
DB11703,Antineoplastic Agents,DrugBank
DB11703,Antineoplastic and Immunomodulating Agents,DrugBank
DB11703,Benzene Derivatives,DrugBank
DB11703,Benzoates,DrugBank
DB11703,Bruton's tyrosine kinase (BTK) inhibitors,DrugBank
DB11703,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11703,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11703,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11703,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB11703,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11703,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11703,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB11703,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB11703,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11703,Cytochrome P-450 Substrates,DrugBank
DB11703,Enzyme Inhibitors,DrugBank
DB11703,Kinase Inhibitor,DrugBank
DB11703,Narrow Therapeutic Index Drugs,DrugBank
DB11703,Protein Kinase Inhibitors,DrugBank
DB11703,Tyrosine Kinase Inhibitors,DrugBank
DB11707,"Chemokine CXCL12, antagonists & inhibitors",DrugBank
DB11707,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB11707,Nucleotides,DrugBank
DB11707,Oligonucleotides,DrugBank
DB11707,Pegylated agents,DrugBank
DB11707,Polynucleotides,DrugBank
DB11708,Antineoplastic and Immunomodulating Agents,DrugBank
DB11708,Bridged-Ring Compounds,DrugBank
DB11708,Cycloparaffins,DrugBank
DB11708,Enzyme Inhibitors,DrugBank
DB11708,Immunologic Factors,DrugBank
DB11708,Immunosuppressive Agents,DrugBank
DB11708,Janus Kinase Inhibitor,DrugBank
DB11708,Nicotinic Acids,DrugBank
DB11708,Pyridines,DrugBank
DB11708,Selective Immunosuppressants,DrugBank
DB11712,BCRP/ABCG2 Inhibitors,DrugBank
DB11712,BCRP/ABCG2 Substrates,DrugBank
DB11712,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11712,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11712,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11712,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11712,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11712,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11712,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB11712,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11712,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11712,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11712,Cytochrome P-450 Substrates,DrugBank
DB11712,Dioxoles,DrugBank
DB11712,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11712,OAT1/SLC22A6 inhibitors,DrugBank
DB11712,OAT3/SLC22A8 Inhibitors,DrugBank
DB11712,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11712,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11712,OATP1B3 inhibitors,DrugBank
DB11712,OCT2 Inhibitors,DrugBank
DB11712,P-glycoprotein inhibitors,DrugBank
DB11712,P-glycoprotein substrates,DrugBank
DB11714,"Amino Acids, Peptides, and Proteins",DrugBank
DB11714,"Antibiotics, Antineoplastic",DrugBank
DB11714,Antibodies,DrugBank
DB11714,"Antibodies, Monoclonal",DrugBank
DB11714,Antineoplastic Agents,DrugBank
DB11714,"Antineoplastic Agents, Immunological",DrugBank
DB11714,Antineoplastic and Immunomodulating Agents,DrugBank
DB11714,Blood Proteins,DrugBank
DB11714,Cancer immunotherapy,DrugBank
DB11714,Globulins,DrugBank
DB11714,Immune Checkpoint Inhibitors,DrugBank
DB11714,Immunoglobulins,DrugBank
DB11714,Immunoproteins,DrugBank
DB11714,Immunotherapy,DrugBank
DB11714,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB11714,Narrow Therapeutic Index Drugs,DrugBank
DB11714,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11714,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11714,Programmed Death Ligand-1 Antagonists,DrugBank
DB11714,Programmed Death Ligand-1 Blocker,DrugBank
DB11714,Programmed Death Ligand-1-directed Antibody Interactions,DrugBank
DB11714,Proteins,DrugBank
DB11714,Serum Globulins,DrugBank
DB11715,"Amino Acids, Peptides, and Proteins",DrugBank
DB11715,Antibodies,DrugBank
DB11715,"Antibodies, Monoclonal",DrugBank
DB11715,"Antibodies, Monoclonal, Humanized",DrugBank
DB11715,Blood Proteins,DrugBank
DB11715,Globulins,DrugBank
DB11715,Immunoglobulins,DrugBank
DB11715,Immunoproteins,DrugBank
DB11715,Proteins,DrugBank
DB11715,Serum Globulins,DrugBank
DB11716,Anti-Infective Agents,DrugBank
DB11716,Antineoplastic Agents,DrugBank
DB11716,Antiparasitic Agents,DrugBank
DB11716,Antiprotozoals,DrugBank
DB11716,Imidazoles,DrugBank
DB11716,Nitro Compounds,DrugBank
DB11716,Nitroimidazoles,DrugBank
DB11716,Radiation-Sensitizing Agents,DrugBank
DB11717,Amides,DrugBank
DB11717,Amines,DrugBank
DB11717,Antineoplastic Agents,DrugBank
DB11717,Antineoplastic and Immunomodulating Agents,DrugBank
DB11717,Hydroxylamines,DrugBank
DB11717,Sulfones,DrugBank
DB11717,Sulfur Compounds,DrugBank
DB11718,Amides,DrugBank
DB11718,Antineoplastic Agents,DrugBank
DB11718,Antineoplastic and Immunomodulating Agents,DrugBank
DB11718,B-Raf serine-threonine kinase (BRAF) inhibitors,DrugBank
DB11718,BCRP/ABCG2 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11718,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11718,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11718,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11718,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11718,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11718,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11718,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11718,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB11718,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB11718,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11718,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11718,Cytochrome P-450 Substrates,DrugBank
DB11718,Kinase Inhibitor,DrugBank
DB11718,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11718,OAT1/SLC22A6 inhibitors,DrugBank
DB11718,OAT3/SLC22A8 Inhibitors,DrugBank
DB11718,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11718,OATP1B3 inhibitors,DrugBank
DB11718,OCT2 Inhibitors,DrugBank
DB11718,P-glycoprotein inhibitors,DrugBank
DB11718,P-glycoprotein substrates,DrugBank
DB11718,Protein Kinase Inhibitors,DrugBank
DB11718,QTc Prolonging Agents,DrugBank
DB11718,Sulfones,DrugBank
DB11718,Sulfur Compounds,DrugBank
DB11718,UGT1A1 Inhibitors,DrugBank
DB11720,"Amino Acids, Peptides, and Proteins",DrugBank
DB11720,Angiotensins,DrugBank
DB11720,Antihypertensive Agents,DrugBank
DB11720,Autacoids,DrugBank
DB11720,Biological Factors,DrugBank
DB11720,Cardiovascular Agents,DrugBank
DB11720,Hormones,DrugBank
DB11720,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11720,Inflammation Mediators,DrugBank
DB11720,Nerve Tissue Proteins,DrugBank
DB11720,Neuropeptides,DrugBank
DB11720,Oligopeptides,DrugBank
DB11720,Peptide Hormones,DrugBank
DB11720,Peptides,DrugBank
DB11720,Proteins,DrugBank
DB11720,Vasodilating Agents,DrugBank
DB11723,Acids,DrugBank
DB11723,"Acids, Noncarboxylic",DrugBank
DB11723,Agents causing angioedema,DrugBank
DB11723,Blood Glucose Lowering Agents,DrugBank
DB11723,Boron Compounds,DrugBank
DB11723,DPP-IV Inhibitors,DrugBank
DB11727,"Amino Acids, Peptides, and Proteins",DrugBank
DB11727,Angiogenesis Inhibitors,DrugBank
DB11727,Angiogenesis Modulating Agents,DrugBank
DB11727,Angiogenic Proteins,DrugBank
DB11727,Angiostatic Proteins,DrugBank
DB11727,Antineoplastic Agents,DrugBank
DB11727,Biological Factors,DrugBank
DB11727,Collagen,DrugBank
DB11727,Collagen Type XVIII,DrugBank
DB11727,Extracellular Matrix Proteins,DrugBank
DB11727,Growth Inhibitors,DrugBank
DB11727,Growth Substances,DrugBank
DB11727,Intercellular Signaling Peptides and Proteins,DrugBank
DB11727,Non-Fibrillar Collagens,DrugBank
DB11727,Peptides,DrugBank
DB11727,Proteins,DrugBank
DB11727,Recombinant Proteins,DrugBank
DB11727,Scleroproteins,DrugBank
DB11730,Amines,DrugBank
DB11730,Antineoplastic Agents,DrugBank
DB11730,Antineoplastic and Immunomodulating Agents,DrugBank
DB11730,Cyclin-dependent kinase (CDK) inhibitors,DrugBank
DB11730,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11730,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11730,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11730,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB11730,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11730,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11730,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11730,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11730,Cytochrome P-450 Substrates,DrugBank
DB11730,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11730,Highest Risk QTc-Prolonging Agents,DrugBank
DB11730,Kinase Inhibitor,DrugBank
DB11730,Narrow Therapeutic Index Drugs,DrugBank
DB11730,Protein Kinase Inhibitors,DrugBank
DB11730,Pyridines,DrugBank
DB11730,QTc Prolonging Agents,DrugBank
DB11731,"Amino Acids, Peptides, and Proteins",DrugBank
DB11731,Antibodies,DrugBank
DB11731,"Antibodies, Monoclonal",DrugBank
DB11731,"Antibodies, Monoclonal, Humanized",DrugBank
DB11731,Blood Proteins,DrugBank
DB11731,Globulins,DrugBank
DB11731,Immunoglobulins,DrugBank
DB11731,Immunologic Factors,DrugBank
DB11731,Immunoproteins,DrugBank
DB11731,Proteins,DrugBank
DB11731,Serum Globulins,DrugBank
DB11732,Amides,DrugBank
DB11732,Analgesics,DrugBank
DB11732,Antidepressive Agents,DrugBank
DB11732,Antimigraine Preparations,DrugBank
DB11732,BCRP/ABCG2 Inhibitors,DrugBank
DB11732,Central Nervous System Depressants,DrugBank
DB11732,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11732,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11732,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11732,MATE 1 Inhibitors,DrugBank
DB11732,MATE 2 Inhibitors,DrugBank
DB11732,MATE inhibitors,DrugBank
DB11732,Nervous System,DrugBank
DB11732,Neurotransmitter Agents,DrugBank
DB11732,OCT1 inhibitors,DrugBank
DB11732,P-glycoprotein inhibitors,DrugBank
DB11732,P-glycoprotein substrates,DrugBank
DB11732,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB11732,Serotonin (5-HT) 1F Receptor Agonists,DrugBank
DB11732,Serotonin Agents,DrugBank
DB11737,Antineoplastic Agents,DrugBank
DB11737,Antineoplastic and Immunomodulating Agents,DrugBank
DB11737,Crown Compounds,DrugBank
DB11737,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11737,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11737,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11737,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11737,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11737,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB11737,Cytochrome P-450 CYP3A5 Inducers (weak),DrugBank
DB11737,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11737,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11737,Cytochrome P-450 Substrates,DrugBank
DB11737,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB11737,Ethers,DrugBank
DB11737,"Ethers, Cyclic",DrugBank
DB11737,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11737,Protein Kinase Inhibitors,DrugBank
DB11737,Tyrosine Kinase Inhibitors,DrugBank
DB11738,Adrenergic Agents,DrugBank
DB11738,Adrenergic Agonists,DrugBank
DB11738,Adrenergic alpha-2 Receptor Agonists,DrugBank
DB11738,Adrenergic alpha-Agonists,DrugBank
DB11738,Agents producing tachycardia,DrugBank
DB11738,Agents that produce hypertension,DrugBank
DB11738,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB11738,Antihypertensive Agents,DrugBank
DB11738,Autonomic Agents,DrugBank
DB11738,Cardiovascular Agents,DrugBank
DB11738,Imidazoline Receptor Agonists,DrugBank
DB11738,Neurotransmitter Agents,DrugBank
DB11738,Oxazoles,DrugBank
DB11738,Peripheral Nervous System Agents,DrugBank
DB11738,Sympatholytics,DrugBank
DB11739,Alimentary Tract and Metabolism,DrugBank
DB11739,Amides,DrugBank
DB11739,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11739,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11739,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11739,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11739,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11739,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11739,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11739,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11739,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11739,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11739,Cytochrome P-450 Substrates,DrugBank
DB11739,Drugs for Acid Related Disorders,DrugBank
DB11739,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB11739,Gastric Acid Lowering Agents,DrugBank
DB11739,P-glycoprotein inhibitors,DrugBank
DB11739,Potassium-competitive Acid Blockers,DrugBank
DB11739,Sulfones,DrugBank
DB11739,Sulfur Compounds,DrugBank
DB11742,Antihistamines for Systemic Use,DrugBank
DB11742,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11742,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11742,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11742,Cytochrome P-450 Substrates,DrugBank
DB11742,Histamine Agents,DrugBank
DB11742,Histamine Antagonists,DrugBank
DB11742,Histamine H1 Antagonists,DrugBank
DB11742,Ketones,DrugBank
DB11742,Neurotransmitter Agents,DrugBank
DB11742,Potential QTc-Prolonging Agents,DrugBank
DB11742,QTc Prolonging Agents,DrugBank
DB11744,Anti-Bacterial Agents,DrugBank
DB11744,"Leucine-tRNA Ligase, antagonists & inhibitors",DrugBank
DB11746,"Amino Acids, Peptides, and Proteins",DrugBank
DB11746,Antibodies,DrugBank
DB11746,"Antibodies, Monoclonal",DrugBank
DB11746,"Antibodies, Monoclonal, Humanized",DrugBank
DB11746,Blood Proteins,DrugBank
DB11746,Globulins,DrugBank
DB11746,Immunoglobulins,DrugBank
DB11746,Immunoproteins,DrugBank
DB11746,Proteins,DrugBank
DB11746,Serum Globulins,DrugBank
DB11750,Adrenal Cortex Hormones,DrugBank
DB11750,Anti-Inflammatory Agents,DrugBank
DB11750,Corticosteroid Hormone Receptor Agonists,DrugBank
DB11750,Corticosteroids,DrugBank
DB11750,"Corticosteroids, Dermatological Preparations",DrugBank
DB11750,"Corticosteroids, Very Potent (Group IV)",DrugBank
DB11750,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11750,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11750,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11750,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11750,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11750,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11750,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB11750,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11750,Cytochrome P-450 Substrates,DrugBank
DB11750,Dermatologicals,DrugBank
DB11750,Fused-Ring Compounds,DrugBank
DB11750,Glucocorticoids,DrugBank
DB11750,Hormones,DrugBank
DB11750,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11750,Hyperglycemia-Associated Agents,DrugBank
DB11750,Immunosuppressive Agents,DrugBank
DB11750,Steroids,DrugBank
DB11750,"Steroids, Fluorinated",DrugBank
DB11750,Thyroxine-binding globulin inhibitors,DrugBank
DB11751,Anti-HIV Agents,DrugBank
DB11751,Anti-Infective Agents,DrugBank
DB11751,Anti-Retroviral Agents,DrugBank
DB11751,Antiinfectives for Systemic Use,DrugBank
DB11751,Antiviral Agents,DrugBank
DB11751,Antivirals for Systemic Use,DrugBank
DB11751,BCRP/ABCG2 Substrates,DrugBank
DB11751,Direct Acting Antivirals,DrugBank
DB11751,Enzyme Inhibitors,DrugBank
DB11751,HIV Integrase Inhibitors,DrugBank
DB11751,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,DrugBank
DB11751,Integrase Inhibitors,DrugBank
DB11751,OAT1/SLC22A6 inhibitors,DrugBank
DB11751,OAT3/SLC22A8 Inhibitors,DrugBank
DB11751,Organic Anion Transporter 1 Inhibitors,DrugBank
DB11751,P-glycoprotein substrates,DrugBank
DB11751,Piperazines,DrugBank
DB11751,Pyridines,DrugBank
DB11751,UGT1A1 Substrates,DrugBank
DB11751,UGT1A9 Substrates,DrugBank
DB11752,"Adjuvants, Immunologic",DrugBank
DB11752,Anti-Bacterial Agents,DrugBank
DB11752,Antineoplastic Agents,DrugBank
DB11752,Biological Factors,DrugBank
DB11752,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11752,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11752,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11752,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11752,Enzyme Activation,DrugBank
DB11752,Ethers,DrugBank
DB11752,"Ethers, Cyclic",DrugBank
DB11752,Immunologic Factors,DrugBank
DB11752,Lactones,DrugBank
DB11752,Macrolides,DrugBank
DB11752,Marine Toxins,DrugBank
DB11752,Polyether Polyketides,DrugBank
DB11752,Polyether Toxins,DrugBank
DB11752,"Toxins, Biological",DrugBank
DB11753,Alimentary Tract and Metabolism,DrugBank
DB11753,Anti-Bacterial Agents,DrugBank
DB11753,Anti-Infective Agents,DrugBank
DB11753,Antibiotics for Topical Use,DrugBank
DB11753,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB11753,Antiinfectives for Systemic Use,DrugBank
DB11753,Antimycobacterials,DrugBank
DB11753,Antirheumatic Agents,DrugBank
DB11753,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11753,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB11753,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB11753,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11753,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11753,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB11753,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11753,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB11753,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11753,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11753,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11753,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11753,Dermatologicals,DrugBank
DB11753,Drugs for Treatment of Tuberculosis,DrugBank
DB11753,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11753,Intestinal Antiinfectives,DrugBank
DB11753,"Lactams, Macrocyclic",DrugBank
DB11753,MATE 1 Inhibitors,DrugBank
DB11753,MATE inhibitors,DrugBank
DB11753,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11753,OATP1B3 inhibitors,DrugBank
DB11753,Ophthalmologicals,DrugBank
DB11753,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB11753,Otologicals,DrugBank
DB11753,P-glycoprotein inhibitors,DrugBank
DB11753,P-glycoprotein substrates,DrugBank
DB11753,Rifamycin Antibacterial,DrugBank
DB11753,Rifamycins,DrugBank
DB11753,Sensory Organs,DrugBank
DB11755,Agents that produce hypertension,DrugBank
DB11755,Antidepressive Agents,DrugBank
DB11755,Central Nervous System Depressants,DrugBank
DB11755,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB11755,Serotonin Agents,DrugBank
DB11755,Serotonin Receptor Agonists,DrugBank
DB11756,"Amino Acids, Peptides, and Proteins",DrugBank
DB11756,Antibodies,DrugBank
DB11756,"Antibodies, Monoclonal",DrugBank
DB11756,"Antibodies, Monoclonal, Humanized",DrugBank
DB11756,Blood Proteins,DrugBank
DB11756,Globulins,DrugBank
DB11756,Immunoglobulins,DrugBank
DB11756,Immunoproteins,DrugBank
DB11756,Proteins,DrugBank
DB11756,Serum Globulins,DrugBank
DB11757,Adenosine A2 Receptor Antagonists,DrugBank
DB11757,Anti-Parkinson Drugs,DrugBank
DB11757,BCRP/ABCG2 Inhibitors,DrugBank
DB11757,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11757,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11757,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11757,Cytochrome P-450 Substrates,DrugBank
DB11757,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11757,MATE 1 Inhibitors,DrugBank
DB11757,MATE 2 Inhibitors,DrugBank
DB11757,MATE inhibitors,DrugBank
DB11757,Nervous System,DrugBank
DB11757,Neurotransmitter Agents,DrugBank
DB11757,OAT1/SLC22A6 inhibitors,DrugBank
DB11757,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11757,OATP1B3 inhibitors,DrugBank
DB11757,P-glycoprotein inhibitors,DrugBank
DB11757,Purinergic Agents,DrugBank
DB11757,Purinergic Antagonists,DrugBank
DB11757,Purinergic P1 Receptor Antagonists,DrugBank
DB11760,Antineoplastic Agents,DrugBank
DB11760,Antineoplastic and Immunomodulating Agents,DrugBank
DB11760,BCRP/ABCG2 Substrates,DrugBank
DB11760,Enzyme Inhibitors,DrugBank
DB11760,Narrow Therapeutic Index Drugs,DrugBank
DB11760,P-glycoprotein substrates,DrugBank
DB11760,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11760,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB11760,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB11760,Pyridazines,DrugBank
DB11761,Alimentary Tract and Metabolism,DrugBank
DB11761,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11761,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11761,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11761,Cytochrome P-450 Substrates,DrugBank
DB11761,Drugs for Constipation,DrugBank
DB11761,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11761,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB11761,Sodium-Hydrogen Exchanger 3 Inhibitor,DrugBank
DB11761,Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitors,DrugBank
DB11761,Sulfur Compounds,DrugBank
DB11763,"Acids, Carbocyclic",DrugBank
DB11763,Amides,DrugBank
DB11763,Antineoplastic Agents,DrugBank
DB11763,Antineoplastic and Immunomodulating Agents,DrugBank
DB11763,BCRP/ABCG2 Inhibitors,DrugBank
DB11763,BCRP/ABCG2 Substrates,DrugBank
DB11763,Benzene Derivatives,DrugBank
DB11763,Benzoates,DrugBank
DB11763,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11763,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11763,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB11763,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11763,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11763,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11763,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11763,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11763,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11763,Cytochrome P-450 Substrates,DrugBank
DB11763,Enzyme Inhibitors,DrugBank
DB11763,Janus Kinase Inhibitor,DrugBank
DB11763,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11763,OATP1B3 substrates,DrugBank
DB11763,P-glycoprotein substrates,DrugBank
DB11763,Protein Kinase Inhibitors,DrugBank
DB11763,UGT1A1 Inducers,DrugBank
DB11763,UGT1A1 Inhibitors,DrugBank
DB11763,UGT1A9 Inhibitors,DrugBank
DB11767,"Amino Acids, Peptides, and Proteins",DrugBank
DB11767,Antibodies,DrugBank
DB11767,"Antibodies, Monoclonal",DrugBank
DB11767,Antineoplastic and Immunomodulating Agents,DrugBank
DB11767,Antirheumatic Agents,DrugBank
DB11767,Biologics for Rheumatoid Arthritis Treatment,DrugBank
DB11767,Blood Proteins,DrugBank
DB11767,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11767,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11767,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11767,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11767,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11767,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB11767,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11767,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11767,Disease-modifying Antirheumatic Agents,DrugBank
DB11767,Globulins,DrugBank
DB11767,Immunoglobulins,DrugBank
DB11767,Immunoproteins,DrugBank
DB11767,Immunosuppressive Agents,DrugBank
DB11767,Immunotherapy,DrugBank
DB11767,Interleukin Inhibitors,DrugBank
DB11767,Interleukin-6 Receptor Antagonist,DrugBank
DB11767,Proteins,DrugBank
DB11767,Serum Globulins,DrugBank
DB11770,Adrenergic Agents,DrugBank
DB11770,Adrenergic Antagonists,DrugBank
DB11770,Adrenergic beta-Antagonists,DrugBank
DB11770,Agents causing hyperkalemia,DrugBank
DB11770,Alcohols,DrugBank
DB11770,Amines,DrugBank
DB11770,Amino Alcohols,DrugBank
DB11770,Antiarrhythmic agents,DrugBank
DB11770,Antihypertensive Agents,DrugBank
DB11770,"Beta Blocking Agents, Selective",DrugBank
DB11770,Bradycardia-Causing Agents,DrugBank
DB11770,Cardiovascular Agents,DrugBank
DB11770,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11770,Cytochrome P-450 Substrates,DrugBank
DB11770,Neurotransmitter Agents,DrugBank
DB11770,P-glycoprotein substrates,DrugBank
DB11770,Potential QTc-Prolonging Agents,DrugBank
DB11770,Propanols,DrugBank
DB11770,QTc Prolonging Agents,DrugBank
DB11771,"Amino Acids, Peptides, and Proteins",DrugBank
DB11771,Antibodies,DrugBank
DB11771,"Antibodies, Monoclonal",DrugBank
DB11771,Antineoplastic Agents,DrugBank
DB11771,Antineoplastic and Immunomodulating Agents,DrugBank
DB11771,Blood Proteins,DrugBank
DB11771,CTLA-4-directed Blocking Antibody,DrugBank
DB11771,Globulins,DrugBank
DB11771,Immune Checkpoint Inhibitors,DrugBank
DB11771,Immunoglobulins,DrugBank
DB11771,Immunoproteins,DrugBank
DB11771,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB11771,Proteins,DrugBank
DB11771,Serum Globulins,DrugBank
DB11774,4-Quinolones,DrugBank
DB11774,Anti-Bacterial Agents,DrugBank
DB11774,Anti-Infective Agents,DrugBank
DB11774,Antibacterials for Systemic Use,DrugBank
DB11774,Antiinfectives for Systemic Use,DrugBank
DB11774,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11774,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB11774,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11774,Drugs for Treatment of Tuberculosis,DrugBank
DB11774,Enzyme Inhibitors,DrugBank
DB11774,Fluoroquinolones,DrugBank
DB11774,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11774,Potential QTc-Prolonging Agents,DrugBank
DB11774,QTc Prolonging Agents,DrugBank
DB11774,Quinolines,DrugBank
DB11774,Quinolones,DrugBank
DB11774,Topoisomerase II Inhibitors,DrugBank
DB11774,Topoisomerase Inhibitors,DrugBank
DB11776,"Amino Acids, Peptides, and Proteins",DrugBank
DB11776,Antibodies,DrugBank
DB11776,"Antibodies, Monoclonal",DrugBank
DB11776,Antineoplastic and Immunomodulating Agents,DrugBank
DB11776,Blood Proteins,DrugBank
DB11776,Dermatologicals,DrugBank
DB11776,Globulins,DrugBank
DB11776,Immunoglobulins,DrugBank
DB11776,Immunoproteins,DrugBank
DB11776,Immunosuppressive Agents,DrugBank
DB11776,Interleukin 17 Receptor A Antagonists,DrugBank
DB11776,Interleukin Inhibitors,DrugBank
DB11776,Interleukin-17 Receptor A Antagonist,DrugBank
DB11776,Proteins,DrugBank
DB11776,"Receptors, Interleukin-17",DrugBank
DB11776,Serum Globulins,DrugBank
DB11779,Amides,DrugBank
DB11779,Amino Acids,DrugBank
DB11779,"Amino Acids, Cyclic",DrugBank
DB11779,"Amino Acids, Peptides, and Proteins",DrugBank
DB11779,Cycloparaffins,DrugBank
DB11779,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11779,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11779,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB11779,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11779,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11779,Imino Acids,DrugBank
DB11779,Lactams,DrugBank
DB11779,Sulfones,DrugBank
DB11779,Sulfur Compounds,DrugBank
DB11780,Acids,DrugBank
DB11780,"Acids, Noncarboxylic",DrugBank
DB11780,Anions,DrugBank
DB11780,Anti-Infective Agents,DrugBank
DB11780,Antioxidants,DrugBank
DB11780,Biological Factors,DrugBank
DB11780,Blood Glucose Lowering Agents,DrugBank
DB11780,"Compounds used in a research, industrial, or household setting",DrugBank
DB11780,Electrolytes,DrugBank
DB11780,Free Radical Scavengers,DrugBank
DB11780,Hydrogen Sulfide,DrugBank
DB11780,Hypolipidemic Agents,DrugBank
DB11780,Ions,DrugBank
DB11780,Lipid Regulating Agents,DrugBank
DB11780,Protective Agents,DrugBank
DB11780,Sulfides,DrugBank
DB11780,Sulfur Acids,DrugBank
DB11780,Sulfur Compounds,DrugBank
DB11783,Agents Acting on the Renin-Angiotensin System,DrugBank
DB11783,Agents causing angioedema,DrugBank
DB11783,Agents causing hyperkalemia,DrugBank
DB11783,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB11783,Antihypertensive Agents,DrugBank
DB11783,Cardiovascular Agents,DrugBank
DB11783,Enzyme Inhibitors,DrugBank
DB11783,Hypotensive Agents,DrugBank
DB11783,Imidazoles,DrugBank
DB11783,Protease Inhibitors,DrugBank
DB11785,Adrenergic Agents,DrugBank
DB11785,Adrenergic Agonists,DrugBank
DB11785,Adrenergic Antagonists,DrugBank
DB11785,Adrenergic beta-Antagonists,DrugBank
DB11785,Agents causing hyperkalemia,DrugBank
DB11785,Agents producing tachycardia,DrugBank
DB11785,Agents that produce hypertension,DrugBank
DB11785,Alkaloids,DrugBank
DB11785,Analgesics,DrugBank
DB11785,"Analgesics, Non-Narcotic",DrugBank
DB11785,Anti-Inflammatory Agents,DrugBank
DB11785,Anti-Ulcer Agents,DrugBank
DB11785,Antiarrhythmic agents,DrugBank
DB11785,Antioxidants,DrugBank
DB11785,Antirheumatic Agents,DrugBank
DB11785,Autonomic Agents,DrugBank
DB11785,Bradycardia-Causing Agents,DrugBank
DB11785,Cardiovascular Agents,DrugBank
DB11785,"Compounds used in a research, industrial, or household setting",DrugBank
DB11785,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11785,Cytochrome P-450 Substrates,DrugBank
DB11785,"Drugs, Chinese Herbal",DrugBank
DB11785,Free Radical Scavengers,DrugBank
DB11785,Gastrointestinal Agents,DrugBank
DB11785,Neurotransmitter Agents,DrugBank
DB11785,Parasympatholytics,DrugBank
DB11785,Peripheral Nervous System Agents,DrugBank
DB11785,Plant Extracts,DrugBank
DB11785,Potential QTc-Prolonging Agents,DrugBank
DB11785,QTc Prolonging Agents,DrugBank
DB11785,Sensory System Agents,DrugBank
DB11785,Vasodilating Agents,DrugBank
DB11789,Bile Acids and Salts,DrugBank
DB11789,Cholanes,DrugBank
DB11789,Cholic Acids,DrugBank
DB11789,Fused-Ring Compounds,DrugBank
DB11789,Steroids,DrugBank
DB11791,"Acids, Carbocyclic",DrugBank
DB11791,Amides,DrugBank
DB11791,Antineoplastic Agents,DrugBank
DB11791,Antineoplastic and Immunomodulating Agents,DrugBank
DB11791,BCRP/ABCG2 Inhibitors,DrugBank
DB11791,Benzene Derivatives,DrugBank
DB11791,Benzoates,DrugBank
DB11791,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11791,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11791,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11791,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11791,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11791,Cytochrome P-450 Substrates,DrugBank
DB11791,Kinase Inhibitor,DrugBank
DB11791,MATE 1 Inhibitors,DrugBank
DB11791,MATE 2 Inhibitors,DrugBank
DB11791,MATE 2-K Inhibitors,DrugBank
DB11791,MATE inhibitors,DrugBank
DB11791,Mesenchymal Epithelial Transition Inhibitors,DrugBank
DB11791,P-glycoprotein inhibitors,DrugBank
DB11791,P-glycoprotein substrates,DrugBank
DB11791,Protein Kinase Inhibitors,DrugBank
DB11791,Tyrosine Kinase Inhibitors,DrugBank
DB11792,Amides,DrugBank
DB11792,Enzyme Inhibitors,DrugBank
DB11792,Phosphodiesterase 5 Inhibitors,DrugBank
DB11792,Phosphodiesterase Inhibitors,DrugBank
DB11792,Pyrimidines,DrugBank
DB11792,Sulfones,DrugBank
DB11792,Sulfur Compounds,DrugBank
DB11792,Vasodilating Agents,DrugBank
DB11793,Antineoplastic Agents,DrugBank
DB11793,Antineoplastic and Immunomodulating Agents,DrugBank
DB11793,BCRP/ABCG2 Inhibitors,DrugBank
DB11793,BCRP/ABCG2 Substrates,DrugBank
DB11793,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB11793,Cytochrome P-450 CYP1A2 Inducers (weak),DrugBank
DB11793,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11793,Enzyme Inhibitors,DrugBank
DB11793,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11793,MATE 1 Inhibitors,DrugBank
DB11793,MATE 1 Substrates,DrugBank
DB11793,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB11793,MATE 2 Inhibitors,DrugBank
DB11793,MATE 2 Substrates,DrugBank
DB11793,MATE 2 Substrates with a Narrow Therapeutic Index,DrugBank
DB11793,MATE inhibitors,DrugBank
DB11793,MATE substrates,DrugBank
DB11793,Narrow Therapeutic Index Drugs,DrugBank
DB11793,P-glycoprotein substrates,DrugBank
DB11793,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11793,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB11793,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB11793,Pyrazoles,DrugBank
DB11795,Antineoplastic Agents,DrugBank
DB11795,Enzyme Inhibitors,DrugBank
DB11795,Oxazines,DrugBank
DB11795,Protein Kinase Inhibitors,DrugBank
DB11796,Anti-HIV Agents,DrugBank
DB11796,Anti-Infective Agents,DrugBank
DB11796,Anti-Retroviral Agents,DrugBank
DB11796,Antiinfectives for Systemic Use,DrugBank
DB11796,Antiviral Agents,DrugBank
DB11796,Antivirals for Systemic Use,DrugBank
DB11796,BCRP/ABCG2 Inhibitors,DrugBank
DB11796,BCRP/ABCG2 Substrates,DrugBank
DB11796,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11796,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11796,Cytochrome P-450 Substrates,DrugBank
DB11796,Direct Acting Antivirals,DrugBank
DB11796,HIV Fusion Inhibitors,DrugBank
DB11796,Human Immunodeficiency Virus Type 1 (HIV-1) gp120-directed Attachment Inhibitors,DrugBank
DB11796,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11796,OATP1B3 inhibitors,DrugBank
DB11796,Organophosphorus Compounds,DrugBank
DB11796,P-glycoprotein substrates,DrugBank
DB11796,Potential QTc-Prolonging Agents,DrugBank
DB11796,QTc Prolonging Agents,DrugBank
DB11796,Viral Fusion Protein Inhibitors,DrugBank
DB11799,Antiinfectives for Systemic Use,DrugBank
DB11799,Antiviral Agents,DrugBank
DB11799,Antivirals for Systemic Use,DrugBank
DB11799,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB11799,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11799,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11799,Cytochrome P-450 Substrates,DrugBank
DB11799,Direct Acting Antivirals,DrugBank
DB11799,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11799,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,DrugBank
DB11799,MATE 1 Inhibitors,DrugBank
DB11799,MATE inhibitors,DrugBank
DB11799,Pyridines,DrugBank
DB11799,UGT1A1 Substrates,DrugBank
DB11800,Amides,DrugBank
DB11800,Antineoplastic Agents,DrugBank
DB11800,Antineoplastic and Immunomodulating Agents,DrugBank
DB11800,BCRP/ABCG2 Inhibitors,DrugBank
DB11800,Benzene Derivatives,DrugBank
DB11800,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11800,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11800,Cytochrome P-450 Substrates,DrugBank
DB11800,Enzyme Inhibitors,DrugBank
DB11800,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11800,Kinase Inhibitor,DrugBank
DB11800,P-glycoprotein substrates,DrugBank
DB11800,Protein Kinase Inhibitors,DrugBank
DB11800,"Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors",DrugBank
DB11800,Tyrosine Kinase Inhibitors,DrugBank
DB11800,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,DrugBank
DB11803,"Amino Acids, Peptides, and Proteins",DrugBank
DB11803,Antibodies,DrugBank
DB11803,"Antibodies, Monoclonal",DrugBank
DB11803,Antineoplastic and Immunomodulating Agents,DrugBank
DB11803,Blood Proteins,DrugBank
DB11803,Globulins,DrugBank
DB11803,Immunoglobulins,DrugBank
DB11803,Immunoproteins,DrugBank
DB11803,Immunosuppressive Agents,DrugBank
DB11803,Immunotherapy,DrugBank
DB11803,Interleukin Inhibitors,DrugBank
DB11803,Proteins,DrugBank
DB11803,Serum Globulins,DrugBank
DB11805,Antineoplastic Agents,DrugBank
DB11805,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11805,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11805,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11805,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11805,Dioxoles,DrugBank
DB11805,Enzyme Inhibitors,DrugBank
DB11805,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11805,Tyrosine Kinase Inhibitors,DrugBank
DB11809,Anions,DrugBank
DB11809,Anti-Infective Agents,DrugBank
DB11809,Antimalarials,DrugBank
DB11809,Antiparasitic Agents,DrugBank
DB11809,Antiprotozoals,DrugBank
DB11809,Bridged-Ring Compounds,DrugBank
DB11809,Cycloparaffins,DrugBank
DB11809,Electrolytes,DrugBank
DB11809,Free Radicals,DrugBank
DB11809,Ions,DrugBank
DB11809,Oxides,DrugBank
DB11809,Oxygen Compounds,DrugBank
DB11809,Reactive Oxygen Species,DrugBank
DB11812,Antineoplastic Agents,DrugBank
DB11812,Biological Factors,DrugBank
DB11812,Dermatologicals,DrugBank
DB11812,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11812,Photosensitizing Agents,DrugBank
DB11812,"Pigments, Biological",DrugBank
DB11812,Radiation-Sensitizing Agents,DrugBank
DB11817,Amides,DrugBank
DB11817,Antineoplastic and Immunomodulating Agents,DrugBank
DB11817,Antirheumatic Agents,DrugBank
DB11817,Azetines,DrugBank
DB11817,BCRP/ABCG2 Inhibitors,DrugBank
DB11817,BCRP/ABCG2 Substrates,DrugBank
DB11817,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11817,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11817,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11817,Cytochrome P-450 Substrates,DrugBank
DB11817,Disease-modifying Antirheumatic Agents,DrugBank
DB11817,Drugs that are Mainly Renally Excreted,DrugBank
DB11817,Experimental Unapproved Treatments for COVID-19,DrugBank
DB11817,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11817,Immunosuppressive Agents,DrugBank
DB11817,Janus Kinase Inhibitor,DrugBank
DB11817,Janus Kinase Inhibitors,DrugBank
DB11817,MATE 2 Inhibitors,DrugBank
DB11817,MATE 2 Substrates,DrugBank
DB11817,MATE 2 Substrates with a Narrow Therapeutic Index,DrugBank
DB11817,MATE inhibitors,DrugBank
DB11817,MATE substrates,DrugBank
DB11817,Narrow Therapeutic Index Drugs,DrugBank
DB11817,OAT1/SLC22A6 inhibitors,DrugBank
DB11817,OAT3/SLC22A8 Inhibitors,DrugBank
DB11817,OAT3/SLC22A8 Substrates,DrugBank
DB11817,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index,DrugBank
DB11817,OATP1B3 inhibitors,DrugBank
DB11817,OCT2 Inhibitors,DrugBank
DB11817,P-glycoprotein substrates,DrugBank
DB11817,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11817,Selective Immunosuppressants,DrugBank
DB11817,Sulfones,DrugBank
DB11817,Sulfur Compounds,DrugBank
DB11823,Agents producing tachycardia,DrugBank
DB11823,Anesthetics,DrugBank
DB11823,"Anesthetics, General",DrugBank
DB11823,Antidepressive Agents,DrugBank
DB11823,Antidepressive Agents Indicated for Depression,DrugBank
DB11823,Central Nervous System Agents,DrugBank
DB11823,Central Nervous System Depressants,DrugBank
DB11823,Cyclohexanes,DrugBank
DB11823,Cycloparaffins,DrugBank
DB11823,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11823,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB11823,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11823,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11823,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11823,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11823,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11823,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11823,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11823,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11823,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11823,Cytochrome P-450 Substrates,DrugBank
DB11823,Miscellaneous Antidepressants,DrugBank
DB11823,Nervous System,DrugBank
DB11823,NMDA Receptor Antagonists,DrugBank
DB11823,Non-Competitive N-Methyl D-Aspartate (NMDA) Receptor Antagonists,DrugBank
DB11823,Psychoanaleptics,DrugBank
DB11823,Psychotropic Drugs,DrugBank
DB11824,Benzene Derivatives,DrugBank
DB11824,Blood Glucose Lowering Agents,DrugBank
DB11824,Carbohydrates,DrugBank
DB11824,Glycosides,DrugBank
DB11824,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB11826,"Amino Acids, Peptides, and Proteins",DrugBank
DB11826,"Antibodies, Monoclonal",DrugBank
DB11826,"Antibodies, Monoclonal, Humanized",DrugBank
DB11826,Blood Proteins,DrugBank
DB11826,Globulins,DrugBank
DB11826,Immunoglobulin Fragments,DrugBank
DB11826,Immunoglobulins,DrugBank
DB11826,Immunoproteins,DrugBank
DB11826,Peptide Fragments,DrugBank
DB11826,Peptides,DrugBank
DB11826,Proteins,DrugBank
DB11826,Serum Globulins,DrugBank
DB11827,Alimentary Tract and Metabolism,DrugBank
DB11827,BCRP/ABCG2 Substrates,DrugBank
DB11827,Blood Glucose Lowering Agents,DrugBank
DB11827,Diuretics,DrugBank
DB11827,Drugs Used in Diabetes,DrugBank
DB11827,P-glycoprotein substrates,DrugBank
DB11827,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB11827,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB11827,UGT1A1 Inhibitors,DrugBank
DB11827,UGT1A4 Inhibitors,DrugBank
DB11827,UGT1A9 Substrates,DrugBank
DB11827,UGT2B7 substrates,DrugBank
DB11828,Antineoplastic Agents,DrugBank
DB11828,Antineoplastic and Immunomodulating Agents,DrugBank
DB11828,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11828,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11828,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11828,Cytochrome P-450 Substrates,DrugBank
DB11828,Enzyme Inhibitors,DrugBank
DB11828,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11828,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,DrugBank
DB11828,Kinase Inhibitor,DrugBank
DB11828,Narrow Therapeutic Index Drugs,DrugBank
DB11828,P-glycoprotein inhibitors,DrugBank
DB11828,Protein Kinase Inhibitors,DrugBank
DB11828,Tyrosine Kinase Inhibitors,DrugBank
DB11830,"Acids, Carbocyclic",DrugBank
DB11830,Amides,DrugBank
DB11830,Antineoplastic Agents,DrugBank
DB11830,Benzene Derivatives,DrugBank
DB11830,Benzoates,DrugBank
DB11830,Enzyme Inhibitors,DrugBank
DB11830,Histone Deacetylase Inhibitors,DrugBank
DB11830,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11830,QTc Prolonging Agents,DrugBank
DB11832,Antineoplastic Agents,DrugBank
DB11832,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11832,"Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors",DrugBank
DB11832,"Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors",DrugBank
DB11832,Tyrosine Kinase Inhibitors,DrugBank
DB11834,"Amino Acids, Peptides, and Proteins",DrugBank
DB11834,Antibodies,DrugBank
DB11834,"Antibodies, Monoclonal",DrugBank
DB11834,Antineoplastic and Immunomodulating Agents,DrugBank
DB11834,Blood Proteins,DrugBank
DB11834,Globulins,DrugBank
DB11834,Immunoglobulins,DrugBank
DB11834,Immunoproteins,DrugBank
DB11834,Immunosuppressive Agents,DrugBank
DB11834,Interleukin Inhibitors,DrugBank
DB11834,Interleukin-23 Antagonist,DrugBank
DB11834,Interleukin-23 Subunit p19,DrugBank
DB11834,Misc. Skin and Mucous Membrane Agents,DrugBank
DB11834,Proteins,DrugBank
DB11834,Serum Globulins,DrugBank
DB11837,Antiadrenal Preparations,DrugBank
DB11837,Anticorticosteroids,DrugBank
DB11837,Cortisol Synthesis Inhibitors,DrugBank
DB11837,"Cytochrome P-450 CYP11B2, antagonists & inhibitors",DrugBank
DB11837,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP1A2 Inhibitors (moderate),DrugBank
DB11837,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB11837,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB11837,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB11837,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11837,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB11837,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11837,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB11837,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11837,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB11837,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB11837,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11837,Cytochrome P-450 Substrates,DrugBank
DB11837,Cytochrome P450 11B1 Inhibitors,DrugBank
DB11837,MATE 1 Inhibitors,DrugBank
DB11837,MATE inhibitors,DrugBank
DB11837,OAT1/SLC22A6 inhibitors,DrugBank
DB11837,OAT3/SLC22A8 Inhibitors,DrugBank
DB11837,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11837,OCT1 inhibitors,DrugBank
DB11837,OCT2 Inhibitors,DrugBank
DB11837,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB11837,UGT1A1 Inhibitors,DrugBank
DB11837,UGT1A4 substrates,DrugBank
DB11837,UGT2B7 substrates,DrugBank
DB11840,"Amino Acids, Peptides, and Proteins",DrugBank
DB11840,Antibodies,DrugBank
DB11840,"Antibodies, Monoclonal",DrugBank
DB11840,"Antibodies, Monoclonal, Humanized",DrugBank
DB11840,Blood Proteins,DrugBank
DB11840,Globulins,DrugBank
DB11840,Immunoglobulins,DrugBank
DB11840,Immunoproteins,DrugBank
DB11840,Proteins,DrugBank
DB11840,Serum Globulins,DrugBank
DB11841,"Acids, Carbocyclic",DrugBank
DB11841,Amides,DrugBank
DB11841,Antineoplastic Agents,DrugBank
DB11841,Antineoplastic and Immunomodulating Agents,DrugBank
DB11841,Benzene Derivatives,DrugBank
DB11841,Benzoates,DrugBank
DB11841,Enzyme Inhibitors,DrugBank
DB11841,Histone deacetylase (HDAC) inhibitors,DrugBank
DB11841,Histone Deacetylase Inhibitors,DrugBank
DB11841,Moderate Risk QTc-Prolonging Agents,DrugBank
DB11841,QTc Prolonging Agents,DrugBank
DB11842,"Amino Acids, Peptides, and Proteins",DrugBank
DB11842,"Angiotensin II, antagonists & inhibitors",DrugBank
DB11842,Angiotensins,DrugBank
DB11842,Autacoids,DrugBank
DB11842,Biological Factors,DrugBank
DB11842,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB11842,Cardiac Therapy,DrugBank
DB11842,Cardiovascular Agents,DrugBank
DB11842,Hormones,DrugBank
DB11842,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11842,Inflammation Mediators,DrugBank
DB11842,Nerve Tissue Proteins,DrugBank
DB11842,Neuropeptides,DrugBank
DB11842,Oligopeptides,DrugBank
DB11842,Peptide Hormones,DrugBank
DB11842,Peptides,DrugBank
DB11842,Proteins,DrugBank
DB11842,Vasoconstriction,DrugBank
DB11842,Vasoconstrictor Agents,DrugBank
DB11849,"Amino Acids, Peptides, and Proteins",DrugBank
DB11849,Antibodies,DrugBank
DB11849,"Antibodies, Monoclonal",DrugBank
DB11849,"Antibodies, Monoclonal, Humanized",DrugBank
DB11849,Blood Proteins,DrugBank
DB11849,Globulins,DrugBank
DB11849,Immunoglobulins,DrugBank
DB11849,Immunoproteins,DrugBank
DB11849,Proteins,DrugBank
DB11849,Serum Globulins,DrugBank
DB11850,"Amino Acids, Peptides, and Proteins",DrugBank
DB11850,Antibodies,DrugBank
DB11850,"Antibodies, Monoclonal",DrugBank
DB11850,Antineoplastic and Immunomodulating Agents,DrugBank
DB11850,Blood Proteins,DrugBank
DB11850,CD20-directed Cytolytic Antibody,DrugBank
DB11850,Globulins,DrugBank
DB11850,Immunoglobulins,DrugBank
DB11850,Immunoproteins,DrugBank
DB11850,Immunosuppressive Agents,DrugBank
DB11850,"Leukemia, Lymphocytic, Chronic, B-Cell, drug therapy",DrugBank
DB11850,Proteins,DrugBank
DB11850,Selective Immunosuppressants,DrugBank
DB11850,Serum Globulins,DrugBank
DB11853,Amides,DrugBank
DB11853,Anti-Gonadotropin-Releasing Hormones,DrugBank
DB11853,Antiandrogens,DrugBank
DB11853,Antineoplastic and Immunomodulating Agents,DrugBank
DB11853,BCRP/ABCG2 Inhibitors,DrugBank
DB11853,Benzene Derivatives,DrugBank
DB11853,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11853,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB11853,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11853,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11853,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11853,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11853,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11853,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB11853,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11853,Cytochrome P-450 Substrates,DrugBank
DB11853,Decreased GnRH Secretion,DrugBank
DB11853,Endocrine Therapy,DrugBank
DB11853,Gonadotropin Releasing Hormone Receptor Antagonists,DrugBank
DB11853,Gonadotropin-releasing Hormone Antagonists,DrugBank
DB11853,Hormone Antagonists,DrugBank
DB11853,Hormone Antagonists and Related Agents,DrugBank
DB11853,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11853,Hypothalamic Hormones,DrugBank
DB11853,P-glycoprotein inhibitors,DrugBank
DB11853,P-glycoprotein substrates,DrugBank
DB11853,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB11853,Potential QTc-Prolonging Agents,DrugBank
DB11853,"Prostatic Neoplasms, drug therapy",DrugBank
DB11853,Pyrimidines,DrugBank
DB11853,QTc Prolonging Agents,DrugBank
DB11853,"Receptors, LHRH, antagonists & inhibitors",DrugBank
DB11853,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB11855,Amides,DrugBank
DB11855,Anticholinergic Agents,DrugBank
DB11855,BCRP/ABCG2 Substrates,DrugBank
DB11855,Benzene Derivatives,DrugBank
DB11855,Bronchodilator Agents,DrugBank
DB11855,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11855,Cytochrome P-450 Substrates,DrugBank
DB11855,Drugs for Obstructive Airway Diseases,DrugBank
DB11855,Muscarinic Antagonists,DrugBank
DB11855,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11855,OATP1B3 substrates,DrugBank
DB11855,P-glycoprotein substrates,DrugBank
DB11856,"Amino Acids, Peptides, and Proteins",DrugBank
DB11856,Antibodies,DrugBank
DB11856,"Antibodies, Monoclonal",DrugBank
DB11856,"Antibodies, Monoclonal, Humanized",DrugBank
DB11856,Blood Proteins,DrugBank
DB11856,Immunoglobulins,DrugBank
DB11856,Immunoproteins,DrugBank
DB11856,Proteins,DrugBank
DB11856,Serum Globulins,DrugBank
DB11857,"Amino Acids, Peptides, and Proteins",DrugBank
DB11857,Antibodies,DrugBank
DB11857,"Antibodies, Monoclonal",DrugBank
DB11857,Blood Proteins,DrugBank
DB11857,Globulins,DrugBank
DB11857,Immunoglobulins,DrugBank
DB11857,Immunoproteins,DrugBank
DB11857,Proteins,DrugBank
DB11857,Serum Globulins,DrugBank
DB11859,Anesthetics,DrugBank
DB11859,Anticonvulsants,DrugBank
DB11859,Antidepressive Agents,DrugBank
DB11859,Carbohydrates,DrugBank
DB11859,Central Nervous System Agents,DrugBank
DB11859,Central Nervous System Depressants,DrugBank
DB11859,Corpus Luteum Hormones,DrugBank
DB11859,Cyclodextrins,DrugBank
DB11859,Dextrins,DrugBank
DB11859,Dietary Carbohydrates,DrugBank
DB11859,Fused-Ring Compounds,DrugBank
DB11859,GABA Agents,DrugBank
DB11859,GABA Modulators,DrugBank
DB11859,Glucans,DrugBank
DB11859,Gonadal Hormones,DrugBank
DB11859,Gonadal Steroid Hormones,DrugBank
DB11859,Hormones,DrugBank
DB11859,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB11859,Nervous System,DrugBank
DB11859,Neuroactive Steroid Gamma-Aminobutyric Acid (GABA) A Receptor Positive Modulators,DrugBank
DB11859,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,DrugBank
DB11859,Neurotransmitter Agents,DrugBank
DB11859,Pharmaceutical Preparations,DrugBank
DB11859,Polysaccharides,DrugBank
DB11859,Pregnanes,DrugBank
DB11859,Pregnenediones,DrugBank
DB11859,Pregnenes,DrugBank
DB11859,Progesterone Congeners,DrugBank
DB11859,Psychoanaleptics,DrugBank
DB11859,Starch,DrugBank
DB11859,Steroids,DrugBank
DB11862,"Amino Acids, Peptides, and Proteins",DrugBank
DB11862,Antibodies,DrugBank
DB11862,"Antibodies, Monoclonal",DrugBank
DB11862,"Antibodies, Monoclonal, Humanized",DrugBank
DB11862,Blood Proteins,DrugBank
DB11862,Globulins,DrugBank
DB11862,Immunoglobulins,DrugBank
DB11862,Immunoproteins,DrugBank
DB11862,Proteins,DrugBank
DB11862,Serum Globulins,DrugBank
DB11866,"Amino Acids, Peptides, and Proteins",DrugBank
DB11866,Antibodies,DrugBank
DB11866,"Antibodies, Monoclonal",DrugBank
DB11866,"Antibodies, Monoclonal, Humanized",DrugBank
DB11866,Blood Proteins,DrugBank
DB11866,Bone Anabolic Agents,DrugBank
DB11866,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB11866,Drugs for Treatment of Bone Diseases,DrugBank
DB11866,Globulins,DrugBank
DB11866,Immunoglobulins,DrugBank
DB11866,Immunoproteins,DrugBank
DB11866,Musculo-Skeletal System,DrugBank
DB11866,Proteins,DrugBank
DB11866,Sclerostin Inhibitors,DrugBank
DB11866,Serum Globulins,DrugBank
DB11868,Acetamides,DrugBank
DB11868,Acetates,DrugBank
DB11868,"Acids, Acyclic",DrugBank
DB11868,Amides,DrugBank
DB11868,Anticonvulsants,DrugBank
DB11868,Central Nervous System Agents,DrugBank
DB11868,Central Nervous System Depressants,DrugBank
DB11868,Nootropic Agents,DrugBank
DB11868,Pyrrolidines,DrugBank
DB11868,Pyrrolidinones,DrugBank
DB11869,"Amino Acids, Peptides, and Proteins",DrugBank
DB11869,"ATP Binding Cassette Transporter, Subfamily B, Member 1",DrugBank
DB11869,"Drug Resistance, Multiple",DrugBank
DB11869,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11869,OATP1B3 inhibitors,DrugBank
DB11869,P-glycoprotein inhibitors,DrugBank
DB11869,P-glycoprotein substrates,DrugBank
DB11869,Peptides,DrugBank
DB11869,"Peptides, Cyclic",DrugBank
DB11871,Acetamides,DrugBank
DB11871,Adrenergic Agonists,DrugBank
DB11871,Adrenergic beta-2 Receptor Agonists,DrugBank
DB11871,Adrenergic beta-Agonists,DrugBank
DB11871,Agents producing tachycardia,DrugBank
DB11871,Agents that produce hypertension,DrugBank
DB11871,Amides,DrugBank
DB11871,Benzene Derivatives,DrugBank
DB11871,Sulfones,DrugBank
DB11871,Sulfur Compounds,DrugBank
DB11873,"Acids, Acyclic",DrugBank
DB11873,Antigout Preparations,DrugBank
DB11873,Antirheumatic Agents,DrugBank
DB11873,Fatty Acids,DrugBank
DB11873,"Fatty Acids, Volatile",DrugBank
DB11873,Lipids,DrugBank
DB11880,Antineoplastic Agents,DrugBank
DB11880,Enzyme Inhibitors,DrugBank
DB11880,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11880,Topoisomerase II Inhibitors,DrugBank
DB11880,Topoisomerase Inhibitors,DrugBank
DB11884,"Amino Acids, Peptides, and Proteins",DrugBank
DB11884,Antibodies,DrugBank
DB11884,"Antibodies, Monoclonal",DrugBank
DB11884,Benzazepines,DrugBank
DB11884,Blood Proteins,DrugBank
DB11884,Globulins,DrugBank
DB11884,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11884,Immunoglobulins,DrugBank
DB11884,Immunoproteins,DrugBank
DB11884,Proteins,DrugBank
DB11884,Serum Globulins,DrugBank
DB11886,Amides,DrugBank
DB11886,Antineoplastic Agents,DrugBank
DB11886,Antineoplastic and Immunomodulating Agents,DrugBank
DB11886,BCRP/ABCG2 Inhibitors,DrugBank
DB11886,BCRP/ABCG2 Substrates,DrugBank
DB11886,Benzene Derivatives,DrugBank
DB11886,BSEP/ABCB11 Inhibitors,DrugBank
DB11886,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11886,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11886,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11886,Cytochrome P-450 Substrates,DrugBank
DB11886,"Fibroblast Growth Factor 2, antagonists & inhibitors",DrugBank
DB11886,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,DrugBank
DB11886,Kinase Inhibitor,DrugBank
DB11886,MATE 1 Inhibitors,DrugBank
DB11886,MATE 2 Inhibitors,DrugBank
DB11886,MATE inhibitors,DrugBank
DB11886,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11886,OATP1B3 inhibitors,DrugBank
DB11886,OCT1 inhibitors,DrugBank
DB11886,OCT2 Inhibitors,DrugBank
DB11886,P-glycoprotein inhibitors,DrugBank
DB11886,P-glycoprotein substrates,DrugBank
DB11886,Protein Kinase Inhibitors,DrugBank
DB11886,"Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors",DrugBank
DB11886,"Receptors, Fibroblast Growth Factor, antagonists & inhibitors",DrugBank
DB11886,Tyrosine Kinase Inhibitors,DrugBank
DB11889,Amines,DrugBank
DB11889,Antidepressive Agents,DrugBank
DB11889,Central Nervous System Depressants,DrugBank
DB11889,Ethylamines,DrugBank
DB11889,"Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors",DrugBank
DB11891,Antineoplastic Agents,DrugBank
DB11891,Histone Deacetylase Inhibitors,DrugBank
DB11891,Oxazines,DrugBank
DB11891,"Phosphatidylinositol 3-Kinases, antagonists & inhibitors",DrugBank
DB11891,Potential QTc-Prolonging Agents,DrugBank
DB11891,QTc Prolonging Agents,DrugBank
DB11892,4-Quinolones,DrugBank
DB11892,Anti-Bacterial Agents,DrugBank
DB11892,Anti-Infective Agents,DrugBank
DB11892,Antibacterials for Systemic Use,DrugBank
DB11892,Antiinfectives for Systemic Use,DrugBank
DB11892,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11892,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11892,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11892,Dioxoles,DrugBank
DB11892,Enzyme Inhibitors,DrugBank
DB11892,Fluoroquinolones,DrugBank
DB11892,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11892,Potential QTc-Prolonging Agents,DrugBank
DB11892,QTc Prolonging Agents,DrugBank
DB11892,Quinolines,DrugBank
DB11892,Quinolones,DrugBank
DB11892,Topoisomerase II Inhibitors,DrugBank
DB11892,Topoisomerase Inhibitors,DrugBank
DB11894,Antineoplastic Agents,DrugBank
DB11894,"PPAR gamma, antagonists & inhibitors",DrugBank
DB11894,Sulfur Compounds,DrugBank
DB11894,Thiazoles,DrugBank
DB11898,Blood Glucose Lowering Agents,DrugBank
DB11898,Ligands,DrugBank
DB11898,Sulfur Compounds,DrugBank
DB11898,Thiazoles,DrugBank
DB11901,Androgen Receptor Inhibitors,DrugBank
DB11901,Antiandrogens,DrugBank
DB11901,Antineoplastic Agents,DrugBank
DB11901,Antineoplastic and Immunomodulating Agents,DrugBank
DB11901,BCRP/ABCG2 Inducers,DrugBank
DB11901,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB11901,Cytochrome P-450 CYP2C19 Inducers (strong),DrugBank
DB11901,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11901,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11901,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB11901,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11901,Cytochrome P-450 CYP3A Inducers (strong),DrugBank
DB11901,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11901,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11901,Cytochrome P-450 CYP3A4 Inducers (strong),DrugBank
DB11901,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11901,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11901,Cytochrome P-450 Substrates,DrugBank
DB11901,Drugs that are Mainly Renally Excreted,DrugBank
DB11901,Endocrine Therapy,DrugBank
DB11901,Hormone Antagonists and Related Agents,DrugBank
DB11901,Imidazoles,DrugBank
DB11901,Imidazolidines,DrugBank
DB11901,MATE 1 Inhibitors,DrugBank
DB11901,MATE 2 Inhibitors,DrugBank
DB11901,MATE inhibitors,DrugBank
DB11901,OAT3/SLC22A8 Inhibitors,DrugBank
DB11901,OATP1B1/SLCO1B1 Inducers,DrugBank
DB11901,OCT2 Inhibitors,DrugBank
DB11901,P-glycoprotein inducers,DrugBank
DB11901,"Prostatic Neoplasms, drug therapy",DrugBank
DB11903,Agents producing tachycardia,DrugBank
DB11903,Cannabinoid Receptor Agonists,DrugBank
DB11903,Cannabinoids and similars,DrugBank
DB11903,"Receptor, Cannabinoid, CB2, agonists",DrugBank
DB11907,"Acids, Acyclic",DrugBank
DB11907,Acrylates,DrugBank
DB11907,Amides,DrugBank
DB11907,Antineoplastic Agents,DrugBank
DB11907,Antineoplastic and Immunomodulating Agents,DrugBank
DB11907,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB11907,Protein Kinase Inhibitors,DrugBank
DB11912,Amines,DrugBank
DB11912,Anti-Bacterial Agents,DrugBank
DB11912,Enzyme Inhibitors,DrugBank
DB11912,Hydroxy Acids,DrugBank
DB11912,Hydroxylamines,DrugBank
DB11914,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB11914,"Amino Acids, Peptides, and Proteins",DrugBank
DB11914,Antibodies,DrugBank
DB11914,"Antibodies, Monoclonal",DrugBank
DB11914,"Antibodies, Monoclonal, Humanized",DrugBank
DB11914,Blood Proteins,DrugBank
DB11914,Dermatologicals,DrugBank
DB11914,Globulins,DrugBank
DB11914,Immunoglobulins,DrugBank
DB11914,Immunoproteins,DrugBank
DB11914,Interleukin-13 Antagonist,DrugBank
DB11914,Proteins,DrugBank
DB11914,Serum Globulins,DrugBank
DB11915,Amino Acids,DrugBank
DB11915,"Amino Acids, Branched-Chain",DrugBank
DB11915,"Amino Acids, Peptides, and Proteins",DrugBank
DB11915,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11915,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11915,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11915,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11915,Cytochrome P-450 Substrates,DrugBank
DB11915,Drugs that are Mainly Renally Excreted,DrugBank
DB11915,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11915,Nervous System,DrugBank
DB11915,Quinolizines,DrugBank
DB11915,Vesicular Monoamine Transporter 2 Inhibitor,DrugBank
DB11915,Vesicular Monoamine Transporter 2 Inhibitors,DrugBank
DB11918,Antineoplastic Agents,DrugBank
DB11918,Aza Compounds,DrugBank
DB11918,Immunologic Factors,DrugBank
DB11918,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB11918,Nucleosides,DrugBank
DB11918,Pyrimidine Nucleosides,DrugBank
DB11918,Pyrimidines,DrugBank
DB11918,Ribonucleosides,DrugBank
DB11919,Antineoplastic Agents,DrugBank
DB11919,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11919,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11919,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11919,Cytochrome P-450 Substrates,DrugBank
DB11919,Enzyme Inhibitors,DrugBank
DB11919,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11919,Purines,DrugBank
DB11919,Purinones,DrugBank
DB11919,Xanthine derivatives,DrugBank
DB11921,Adrenal Cortex Hormones,DrugBank
DB11921,Anti-Inflammatory Agents,DrugBank
DB11921,Corticosteroid Hormone Receptor Agonists,DrugBank
DB11921,Corticosteroids,DrugBank
DB11921,Corticosteroids for Systemic Use,DrugBank
DB11921,"Corticosteroids for Systemic Use, Plain",DrugBank
DB11921,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11921,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11921,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11921,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB11921,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11921,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB11921,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB11921,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11921,Cytochrome P-450 Substrates,DrugBank
DB11921,Fused-Ring Compounds,DrugBank
DB11921,Glucocorticoids,DrugBank
DB11921,Hyperglycemia-Associated Agents,DrugBank
DB11921,Immunosuppressive Agents,DrugBank
DB11921,Steroids,DrugBank
DB11921,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB11925,"Acids, Carbocyclic",DrugBank
DB11925,Amides,DrugBank
DB11925,Benzene Derivatives,DrugBank
DB11925,Benzoates,DrugBank
DB11925,mTOR Inhibitors,DrugBank
DB11925,Oxazines,DrugBank
DB11925,Protein Kinase Inhibitors,DrugBank
DB11930,"Amino Acids, Peptides, and Proteins",DrugBank
DB11930,Antibodies,DrugBank
DB11930,"Antibodies, Monoclonal",DrugBank
DB11930,Blood Proteins,DrugBank
DB11930,Globulins,DrugBank
DB11930,Immunoglobulins,DrugBank
DB11930,Immunoproteins,DrugBank
DB11930,Proteins,DrugBank
DB11930,Serum Globulins,DrugBank
DB11932,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB11932,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11932,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11932,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11932,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB11932,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB11932,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11932,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB11932,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB11932,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11932,Cytochrome P-450 Substrates,DrugBank
DB11932,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB11932,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB11932,Matrix Metalloproteinase Inhibitors,DrugBank
DB11932,Pediculicides,DrugBank
DB11932,Pyridines,DrugBank
DB11935,Amides,DrugBank
DB11935,Anti-Bacterial Agents,DrugBank
DB11935,Antibacterials for Systemic Use,DrugBank
DB11935,Antiinfectives for Systemic Use,DrugBank
DB11935,beta-Lactams,DrugBank
DB11935,Cephalosporins,DrugBank
DB11935,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11935,Lactams,DrugBank
DB11935,Nephrotoxic agents,DrugBank
DB11935,Second-Generation Cephalosporins,DrugBank
DB11935,Sulfur Compounds,DrugBank
DB11935,Thiazines,DrugBank
DB11936,"Acids, Acyclic",DrugBank
DB11936,Adenosine Triphosphate-Citrate Lyase Inhibitor,DrugBank
DB11936,Adenosine Triphosphate-Citrate Lyase Inhibitors,DrugBank
DB11936,Enzyme Inhibitors,DrugBank
DB11936,Hypolipidemic Agents,DrugBank
DB11936,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB11936,Lipid Modifying Agents,DrugBank
DB11936,"Lipid Modifying Agents, Plain",DrugBank
DB11936,Lipid Regulating Agents,DrugBank
DB11936,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB11936,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB11936,OATP1B3 inhibitors,DrugBank
DB11936,OATP1B3 substrates,DrugBank
DB11936,UGT2B7 substrates,DrugBank
DB11942,Antineoplastic Agents,DrugBank
DB11942,Antineoplastic and Immunomodulating Agents,DrugBank
DB11942,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11942,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11942,Cytochrome P-450 Substrates,DrugBank
DB11942,Nuclear Export Inhibitors,DrugBank
DB11942,OATP1B3 inhibitors,DrugBank
DB11943,4-Quinolones,DrugBank
DB11943,Anti-Bacterial Agents,DrugBank
DB11943,Anti-Infective Agents,DrugBank
DB11943,Antibacterials for Systemic Use,DrugBank
DB11943,Antiinfectives for Systemic Use,DrugBank
DB11943,BCRP/ABCG2 Substrates,DrugBank
DB11943,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11943,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB11943,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB11943,Cytochrome P-450 CYP2E1 Inducers (weak),DrugBank
DB11943,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11943,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB11943,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB11943,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11943,Drugs that are Mainly Renally Excreted,DrugBank
DB11943,Fluoroquinolone Antibacterial,DrugBank
DB11943,Fluoroquinolones,DrugBank
DB11943,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11943,Potential QTc-Prolonging Agents,DrugBank
DB11943,QTc Prolonging Agents,DrugBank
DB11943,Quinolines,DrugBank
DB11943,Quinolones,DrugBank
DB11943,UGT1A1 Substrates,DrugBank
DB11943,UGT1A3 substrates,DrugBank
DB11945,"Amino Acids, Peptides, and Proteins",DrugBank
DB11945,Antibodies,DrugBank
DB11945,"Antibodies, Monoclonal",DrugBank
DB11945,Antineoplastic Agents,DrugBank
DB11945,"Antineoplastic Agents, Immunological",DrugBank
DB11945,Antineoplastic and Immunomodulating Agents,DrugBank
DB11945,Blood Proteins,DrugBank
DB11945,Cancer immunotherapy,DrugBank
DB11945,Globulins,DrugBank
DB11945,Immune Checkpoint Inhibitors,DrugBank
DB11945,Immunoglobulins,DrugBank
DB11945,Immunoproteins,DrugBank
DB11945,Immunotherapy,DrugBank
DB11945,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB11945,Narrow Therapeutic Index Drugs,DrugBank
DB11945,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11945,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB11945,Programmed Death Ligand-1 Antagonists,DrugBank
DB11945,Programmed Death Ligand-1 Blocker,DrugBank
DB11945,Programmed Death Ligand-1-directed Antibody Interactions,DrugBank
DB11945,Proteins,DrugBank
DB11945,Serum Globulins,DrugBank
DB11950,Agents causing angioedema,DrugBank
DB11950,Alimentary Tract and Metabolism,DrugBank
DB11950,Blood Glucose Lowering Agents,DrugBank
DB11950,DPP-IV Inhibitors,DrugBank
DB11950,Drugs Used in Diabetes,DrugBank
DB11950,Sulfur Compounds,DrugBank
DB11950,Thiazoles,DrugBank
DB11951,Central Nervous System Agents,DrugBank
DB11951,Central Nervous System Depressants,DrugBank
DB11951,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB11951,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB11951,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11951,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB11951,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11951,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11951,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB11951,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11951,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11951,Cytochrome P-450 Substrates,DrugBank
DB11951,Hypnotics and Sedatives,DrugBank
DB11951,Nervous System,DrugBank
DB11951,Neurotransmitter Agents,DrugBank
DB11951,Orexin Receptor Antagonists,DrugBank
DB11951,P-glycoprotein substrates,DrugBank
DB11951,Psycholeptics,DrugBank
DB11951,"Sleep Aids, Pharmaceutical",DrugBank
DB11951,Sleep Initiation and Maintenance Disorders,DrugBank
DB11952,Antineoplastic Agents,DrugBank
DB11952,Antineoplastic and Immunomodulating Agents,DrugBank
DB11952,BCRP/ABCG2 Substrates,DrugBank
DB11952,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11952,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11952,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11952,Cytochrome P-450 Substrates,DrugBank
DB11952,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11952,Kinase Inhibitor,DrugBank
DB11952,P-glycoprotein substrates,DrugBank
DB11952,"Phosphatidylinositol 3-Kinases, antagonists & inhibitors",DrugBank
DB11952,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,DrugBank
DB11952,Protein Kinase Inhibitors,DrugBank
DB11957,Amines,DrugBank
DB11957,Antidepressive Agents,DrugBank
DB11957,Benzene Derivatives,DrugBank
DB11957,Benzyl Compounds,DrugBank
DB11957,Central Nervous System Depressants,DrugBank
DB11957,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11957,"Hydrocarbons, Fluorinated",DrugBank
DB11957,"Hydrocarbons, Halogenated",DrugBank
DB11957,Neurotransmitter Agents,DrugBank
DB11957,Serotonin Agents,DrugBank
DB11957,Serotonin Receptor Antagonists,DrugBank
DB11959,"Alzheimer Disease, drug therapy",DrugBank
DB11959,"Amino Acids, Peptides, and Proteins",DrugBank
DB11959,Antibodies,DrugBank
DB11959,"Antibodies, Monoclonal",DrugBank
DB11959,"Antibodies, Monoclonal, Humanized",DrugBank
DB11959,Blood Proteins,DrugBank
DB11959,Globulins,DrugBank
DB11959,Immunoglobulins,DrugBank
DB11959,Immunoproteins,DrugBank
DB11959,Proteins,DrugBank
DB11959,Serum Globulins,DrugBank
DB11960,Agents causing hyperkalemia,DrugBank
DB11960,Antiarrhythmic agents,DrugBank
DB11960,Antineoplastic Agents,DrugBank
DB11960,Bradycardia-Causing Agents,DrugBank
DB11960,Calcium Channel Blockers,DrugBank
DB11960,Calcium-Regulating Hormones and Agents,DrugBank
DB11960,Cardiovascular Agents,DrugBank
DB11960,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11960,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11960,Cytochrome P-450 Substrates,DrugBank
DB11960,Membrane Transport Modulators,DrugBank
DB11962,mTOR Inhibitors,DrugBank
DB11963,Antineoplastic Agents,DrugBank
DB11963,Antineoplastic and Immunomodulating Agents,DrugBank
DB11963,BCRP/ABCG2 Inhibitors,DrugBank
DB11963,BCRP/ABCG2 Substrates,DrugBank
DB11963,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11963,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB11963,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11963,Cytochrome P-450 CYP2D6 Inhibitors (strong),DrugBank
DB11963,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11963,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB11963,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11963,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11963,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB11963,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11963,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11963,Cytochrome P-450 Substrates,DrugBank
DB11963,Enzyme Inhibitors,DrugBank
DB11963,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB11963,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11963,Kinase Inhibitor,DrugBank
DB11963,Narrow Therapeutic Index Drugs,DrugBank
DB11963,OCT1 inhibitors,DrugBank
DB11963,P-glycoprotein inhibitors,DrugBank
DB11963,P-glycoprotein substrates,DrugBank
DB11963,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11963,Protein Kinase Inhibitors,DrugBank
DB11963,Quinazolines,DrugBank
DB11963,Tyrosine Kinase Inhibitors,DrugBank
DB11963,UGT1A1 Inhibitors,DrugBank
DB11964,Alimentary Tract and Metabolism,DrugBank
DB11964,Anti-Ulcer Agents,DrugBank
DB11964,Benzimidazoles,DrugBank
DB11964,Drugs for Acid Related Disorders,DrugBank
DB11964,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB11964,Gastric Acid Lowering Agents,DrugBank
DB11964,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11964,Proton Pump Inhibitors,DrugBank
DB11964,Pyridines,DrugBank
DB11964,Sulfoxides,DrugBank
DB11964,Sulfur Compounds,DrugBank
DB11967,Antineoplastic Agents,DrugBank
DB11967,Antineoplastic and Immunomodulating Agents,DrugBank
DB11967,BCRP/ABCG2 Substrates,DrugBank
DB11967,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB11967,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB11967,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB11967,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB11967,Cytochrome P-450 Substrates,DrugBank
DB11967,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11967,Kinase Inhibitor,DrugBank
DB11967,"MAP Kinase Kinase 1, antagonists & inhibitors",DrugBank
DB11967,"MAP Kinase Kinase 2, antagonists & inhibitors",DrugBank
DB11967,Mitogen-activated protein kinase (MEK) inhibitors,DrugBank
DB11967,Narrow Therapeutic Index Drugs,DrugBank
DB11967,P-glycoprotein substrates,DrugBank
DB11967,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11967,Protein Kinase Inhibitors,DrugBank
DB11967,UGT1A1 Substrates,DrugBank
DB11967,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB11972,"Amino Acids, Peptides, and Proteins",DrugBank
DB11972,Antibodies,DrugBank
DB11972,"Antibodies, Monoclonal",DrugBank
DB11972,Antineoplastic Agents,DrugBank
DB11972,"Antineoplastic Agents, Immunological",DrugBank
DB11972,Blood Proteins,DrugBank
DB11972,Globulins,DrugBank
DB11972,Immunoglobulins,DrugBank
DB11972,Immunoproteins,DrugBank
DB11972,Proteins,DrugBank
DB11972,Serum Globulins,DrugBank
DB11973,Antineoplastic Agents,DrugBank
DB11973,Aza Compounds,DrugBank
DB11973,Enzyme Inhibitors,DrugBank
DB11973,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11973,Protein Kinase Inhibitors,DrugBank
DB11973,"Receptor, EphB4, antagonists & inhibitors",DrugBank
DB11973,"Receptor, ErbB-2, antagonists & inhibitors",DrugBank
DB11973,Tyrosine Kinase Inhibitors,DrugBank
DB11973,"Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors",DrugBank
DB11976,"Amino Acids, Peptides, and Proteins",DrugBank
DB11976,Antibodies,DrugBank
DB11976,"Antibodies, Monoclonal",DrugBank
DB11976,Antineoplastic and Immunomodulating Agents,DrugBank
DB11976,Blood Proteins,DrugBank
DB11976,Globulins,DrugBank
DB11976,Immunoglobulins,DrugBank
DB11976,Immunoproteins,DrugBank
DB11976,Immunosuppressive Agents,DrugBank
DB11976,Proteins,DrugBank
DB11976,Selective Immunosuppressants,DrugBank
DB11976,Serum Globulins,DrugBank
DB11976,Type I Interferon Receptor Antagonist,DrugBank
DB11978,Amides,DrugBank
DB11978,Antineoplastic Agents,DrugBank
DB11978,Antineoplastic and Immunomodulating Agents,DrugBank
DB11978,BCRP/ABCG2 Inhibitors,DrugBank
DB11978,BCRP/ABCG2 Substrates,DrugBank
DB11978,Benzene Derivatives,DrugBank
DB11978,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11978,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11978,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11978,Cytochrome P-450 Substrates,DrugBank
DB11978,Hedgehog Pathway Inhibitor,DrugBank
DB11978,Hedgehog pathway inhibitors,DrugBank
DB11978,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11978,Highest Risk QTc-Prolonging Agents,DrugBank
DB11978,MATE 1 Inhibitors,DrugBank
DB11978,MATE 2 Inhibitors,DrugBank
DB11978,MATE inhibitors,DrugBank
DB11978,P-glycoprotein inhibitors,DrugBank
DB11978,P-glycoprotein substrates,DrugBank
DB11978,QTc Prolonging Agents,DrugBank
DB11978,Smoothened Receptor Antagonists,DrugBank
DB11978,UGT1A9 Substrates,DrugBank
DB11979,Anti-Gonadotropin-Releasing Hormones,DrugBank
DB11979,Antigonadotropins and Similar Agents,DrugBank
DB11979,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB11979,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB11979,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB11979,Cytochrome P-450 CYP3A Inducers,DrugBank
DB11979,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11979,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11979,Cytochrome P-450 Substrates,DrugBank
DB11979,Decreased GnRH Secretion,DrugBank
DB11979,Gonadotropin Releasing Hormone Receptor Antagonists,DrugBank
DB11979,Gonadotropin-releasing Hormone Antagonists,DrugBank
DB11979,"Hydrocarbons, Halogenated",DrugBank
DB11979,Hypothalamic Hormones,DrugBank
DB11979,OATP1B1/SLCO1B1 Substrates,DrugBank
DB11979,P-glycoprotein inhibitors,DrugBank
DB11979,P-glycoprotein substrates,DrugBank
DB11979,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB11979,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB11984,Anticoagulants,DrugBank
DB11984,Antithrombins,DrugBank
DB11984,Enzyme Inhibitors,DrugBank
DB11984,Factor Xa Inhibitors,DrugBank
DB11984,Hematologic Agents,DrugBank
DB11984,Protease Inhibitors,DrugBank
DB11984,Pyrimidines,DrugBank
DB11984,Serine Protease Inhibitors,DrugBank
DB11984,Sulfur Compounds,DrugBank
DB11986,Amides,DrugBank
DB11986,Antineoplastic Agents,DrugBank
DB11986,Antineoplastic and Immunomodulating Agents,DrugBank
DB11986,Benzene Derivatives,DrugBank
DB11986,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11986,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11986,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB11986,Cytochrome P-450 Substrates,DrugBank
DB11986,Enzyme Inhibitors,DrugBank
DB11986,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11986,Kinase Inhibitor,DrugBank
DB11986,Narrow Therapeutic Index Drugs,DrugBank
DB11986,P-glycoprotein inhibitors,DrugBank
DB11986,P-glycoprotein substrates,DrugBank
DB11986,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB11986,Protein Kinase Inhibitors,DrugBank
DB11986,Pyrazoles,DrugBank
DB11986,QTc Prolonging Agents,DrugBank
DB11986,ROS1 tyrosine kinase inhibitors,DrugBank
DB11986,Tyrosine Kinase Inhibitors,DrugBank
DB11988,"Amino Acids, Peptides, and Proteins",DrugBank
DB11988,Antibodies,DrugBank
DB11988,"Antibodies, Monoclonal",DrugBank
DB11988,"Antibodies, Monoclonal, Humanized",DrugBank
DB11988,Antineoplastic and Immunomodulating Agents,DrugBank
DB11988,Blood Proteins,DrugBank
DB11988,CD20-directed Antibody Interactions,DrugBank
DB11988,CD20-directed Cytolytic Antibody,DrugBank
DB11988,Globulins,DrugBank
DB11988,Immunoglobulins,DrugBank
DB11988,Immunologic Factors,DrugBank
DB11988,Immunomodulatory Agents,DrugBank
DB11988,Immunoproteins,DrugBank
DB11988,Immunosuppressive Agents,DrugBank
DB11988,Proteins,DrugBank
DB11988,Selective Immunosuppressants,DrugBank
DB11988,Serum Globulins,DrugBank
DB11989,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB11989,Anti-Infective Agents,DrugBank
DB11989,Antiparasitic Agents,DrugBank
DB11989,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB11989,Antiprotozoals,DrugBank
DB11989,Drugs that are Mainly Renally Excreted,DrugBank
DB11989,Imidazoles,DrugBank
DB11989,Immunologic Factors,DrugBank
DB11989,Mutagens,DrugBank
DB11989,Nitro Compounds,DrugBank
DB11989,Nitroimidazole Antimicrobial,DrugBank
DB11989,Nitroimidazole Derivatives,DrugBank
DB11989,Noxae,DrugBank
DB11989,Toxic Actions,DrugBank
DB11989,Trypanocidal Agents,DrugBank
DB11992,Agents causing angioedema,DrugBank
DB11992,Blood Glucose Lowering Agents,DrugBank
DB11992,DPP-IV Inhibitors,DrugBank
DB11992,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11994,Anthracenes,DrugBank
DB11994,Anti-Inflammatory Agents,DrugBank
DB11994,Antiinflammatory and Antirheumatic Products,DrugBank
DB11994,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB11994,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB11994,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB11994,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB11994,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB11994,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB11994,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB11994,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB11994,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB11994,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB11994,Musculo-Skeletal System,DrugBank
DB11994,Quinones,DrugBank
DB11995,BCRP/ABCG2 Inhibitors,DrugBank
DB11995,Blood and Blood Forming Organs,DrugBank
DB11995,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB11995,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB11995,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB11995,Cytochrome P-450 CYP2C9 Inducers (weak),DrugBank
DB11995,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB11995,Cytochrome P-450 CYP3A Substrates,DrugBank
DB11995,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB11995,Cytochrome P-450 Enzyme Inducers,DrugBank
DB11995,Cytochrome P-450 Substrates,DrugBank
DB11995,Hemostatics,DrugBank
DB11995,OAT3/SLC22A8 Inhibitors,DrugBank
DB11995,P-glycoprotein substrates,DrugBank
DB11995,"Receptors, Thrombopoietin, agonists",DrugBank
DB11995,Sulfur Compounds,DrugBank
DB11995,Thrombopoietin Receptor Agonist,DrugBank
DB11999,Antineoplastic Agents,DrugBank
DB11999,Antineoplastic and Immunomodulating Agents,DrugBank
DB11999,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB11999,Sulfur Compounds,DrugBank
DB12001,Amines,DrugBank
DB12001,Antineoplastic Agents,DrugBank
DB12001,Antineoplastic and Immunomodulating Agents,DrugBank
DB12001,BCRP/ABCG2 Inhibitors,DrugBank
DB12001,BCRP/ABCG2 Substrates,DrugBank
DB12001,Cyclin-dependent kinase (CDK) inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12001,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12001,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12001,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12001,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12001,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12001,Cytochrome P-450 Substrates,DrugBank
DB12001,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12001,Kinase Inhibitor,DrugBank
DB12001,MATE 1 Inhibitors,DrugBank
DB12001,MATE 1 Substrates,DrugBank
DB12001,MATE 1 Substrates with a Narrow Therapeutic Index,DrugBank
DB12001,MATE 2 Inhibitors,DrugBank
DB12001,MATE inhibitors,DrugBank
DB12001,MATE substrates,DrugBank
DB12001,Narrow Therapeutic Index Drugs,DrugBank
DB12001,OCT2 Inhibitors,DrugBank
DB12001,P-glycoprotein inhibitors,DrugBank
DB12001,P-glycoprotein substrates,DrugBank
DB12001,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB12001,Protein Kinase Inhibitors,DrugBank
DB12001,Pyridines,DrugBank
DB12005,Amino Acids,DrugBank
DB12005,"Amino Acids, Branched-Chain",DrugBank
DB12005,"Amino Acids, Peptides, and Proteins",DrugBank
DB12005,"Amyloid Precursor Protein Secretases, antagonists & inhibitors",DrugBank
DB12005,Antineoplastic Agents,DrugBank
DB12005,Antineoplastic and Immunomodulating Agents,DrugBank
DB12005,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12005,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12005,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB12005,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB12005,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12005,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB12005,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB12005,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB12005,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB12005,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12005,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12005,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12005,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12005,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12005,Cytochrome P-450 Substrates,DrugBank
DB12005,Enzyme Inhibitors,DrugBank
DB12005,Gamma Secretase Inhibitor,DrugBank
DB12005,Gamma Secretase Inhibitors and Modulators,DrugBank
DB12005,P-glycoprotein inhibitors,DrugBank
DB12005,P-glycoprotein substrates,DrugBank
DB12007,Benzopyrans,DrugBank
DB12007,Chromones,DrugBank
DB12007,Drugs that are Mainly Renally Excreted,DrugBank
DB12007,Flavonoids,DrugBank
DB12007,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12007,Isoflavones,DrugBank
DB12007,Pyrans,DrugBank
DB12010,Amines,DrugBank
DB12010,BCRP/ABCG2 Inhibitors,DrugBank
DB12010,Blood and Blood Forming Organs,DrugBank
DB12010,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12010,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12010,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12010,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12010,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12010,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12010,Cytochrome P-450 Substrates,DrugBank
DB12010,Experimental Unapproved Treatments for COVID-19,DrugBank
DB12010,Hemostatics,DrugBank
DB12010,Kinase Inhibitor,DrugBank
DB12010,Oxazines,DrugBank
DB12010,Phosphodiesterase 5 Inhibitors,DrugBank
DB12010,Pyridines,DrugBank
DB12010,Tyrosine Kinase Inhibitors,DrugBank
DB12010,UGT1A1 Inhibitors,DrugBank
DB12010,UGT1A9 Substrates,DrugBank
DB12010,Vasodilating Agents,DrugBank
DB12015,Antineoplastic Agents,DrugBank
DB12015,Antineoplastic and Immunomodulating Agents,DrugBank
DB12015,BCRP/ABCG2 Inhibitors,DrugBank
DB12015,BCRP/ABCG2 Substrates,DrugBank
DB12015,Breast Neoplasms,DrugBank
DB12015,"Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors",DrugBank
DB12015,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12015,Cytochrome P-450 CYP2B6 Inducers (moderate),DrugBank
DB12015,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12015,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12015,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12015,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12015,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB12015,Cytochrome P-450 CYP2C9 Inducers (moderate),DrugBank
DB12015,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB12015,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12015,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12015,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12015,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12015,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB12015,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12015,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB12015,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12015,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12015,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12015,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12015,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12015,Cytochrome P-450 Substrates,DrugBank
DB12015,Kinase Inhibitor,DrugBank
DB12015,Narrow Therapeutic Index Drugs,DrugBank
DB12015,P-glycoprotein inhibitors,DrugBank
DB12015,"Phosphatidylinositol 3-Kinases, antagonists & inhibitors",DrugBank
DB12015,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,DrugBank
DB12015,Protein Kinase Inhibitors,DrugBank
DB12015,Sulfur Compounds,DrugBank
DB12016,Antineoplastic and Immunomodulating Agents,DrugBank
DB12016,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12016,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12016,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12016,Cytochrome P-450 Substrates,DrugBank
DB12016,Immunologic Factors,DrugBank
DB12016,Immunomodulatory Agents,DrugBank
DB12016,Immunosuppressive Agents,DrugBank
DB12016,"Receptors, Lysosphingolipid, antagonists & inhibitors",DrugBank
DB12016,Selective Immunosuppressants,DrugBank
DB12016,Sphingosine 1 Phosphate Receptor Modulators,DrugBank
DB12016,Sphingosine 1-phosphate Receptor Modulator,DrugBank
DB12016,Sphingosine-1-phosphate (S1P) receptor modulators,DrugBank
DB12016,Sulfur Compounds,DrugBank
DB12016,UGT1A1 Substrates,DrugBank
DB12016,UGT2B7 substrates,DrugBank
DB12020,"Acids, Carbocyclic",DrugBank
DB12020,Amides,DrugBank
DB12020,Anti-Infective Agents,DrugBank
DB12020,Antiinfectives for Systemic Use,DrugBank
DB12020,Antiviral Agents,DrugBank
DB12020,Antivirals for Systemic Use,DrugBank
DB12020,BCRP/ABCG2 Inhibitors,DrugBank
DB12020,Benzene Derivatives,DrugBank
DB12020,Benzoates,DrugBank
DB12020,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12020,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12020,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12020,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB12020,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB12020,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB12020,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12020,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12020,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12020,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB12020,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12020,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12020,Direct Acting Antivirals,DrugBank
DB12020,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12020,Imides,DrugBank
DB12020,Isoindoles,DrugBank
DB12020,Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor,DrugBank
DB12020,Phthalic Acids,DrugBank
DB12020,UGT1A1 Substrates,DrugBank
DB12020,UGT1A3 substrates,DrugBank
DB12020,UGT1A4 substrates,DrugBank
DB12023,"Amino Acids, Peptides, and Proteins",DrugBank
DB12023,Anti-Asthmatic Agents,DrugBank
DB12023,Antibodies,DrugBank
DB12023,"Antibodies, Monoclonal",DrugBank
DB12023,"Antibodies, Monoclonal, Humanized",DrugBank
DB12023,Blood Proteins,DrugBank
DB12023,Drugs for Obstructive Airway Diseases,DrugBank
DB12023,Globulins,DrugBank
DB12023,Immunoglobulins,DrugBank
DB12023,Immunoproteins,DrugBank
DB12023,Interleukin 5 Receptor alpha-directed Antibody Interactions,DrugBank
DB12023,Interleukin Antagonists,DrugBank
DB12023,Interleukin-5 Receptor alpha-directed Cytolytic Antibody,DrugBank
DB12023,Proteins,DrugBank
DB12023,Respiratory System Agents,DrugBank
DB12023,Serum Globulins,DrugBank
DB12025,Adrenal Cortex Hormones,DrugBank
DB12025,Alkylating Drugs,DrugBank
DB12025,Antineoplastic Agents,DrugBank
DB12025,"Antineoplastic Agents, Alkylating",DrugBank
DB12025,Antispermatogenic Agents,DrugBank
DB12025,Ethers,DrugBank
DB12025,"Ethers, Cyclic",DrugBank
DB12025,Immunologic Factors,DrugBank
DB12025,Immunosuppressive Agents,DrugBank
DB12025,Noxae,DrugBank
DB12025,Reproductive Control Agents,DrugBank
DB12025,Terpenes,DrugBank
DB12025,Toxic Actions,DrugBank
DB12026,"Acids, Acyclic",DrugBank
DB12026,Amides,DrugBank
DB12026,Amino Acids,DrugBank
DB12026,"Amino Acids, Branched-Chain",DrugBank
DB12026,"Amino Acids, Cyclic",DrugBank
DB12026,"Amino Acids, Essential",DrugBank
DB12026,"Amino Acids, Peptides, and Proteins",DrugBank
DB12026,Aminobutyrates,DrugBank
DB12026,Antiinfectives for Systemic Use,DrugBank
DB12026,Antiviral Agents,DrugBank
DB12026,Antivirals for Systemic Use,DrugBank
DB12026,Antivirals for treatment of HCV infections,DrugBank
DB12026,BCRP/ABCG2 Inhibitors,DrugBank
DB12026,BCRP/ABCG2 Substrates,DrugBank
DB12026,Butyrates,DrugBank
DB12026,Cycloparaffins,DrugBank
DB12026,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12026,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12026,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12026,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12026,Cytochrome P-450 Substrates,DrugBank
DB12026,Direct Acting Antivirals,DrugBank
DB12026,HCV NS3/4A Protease Inhibitors,DrugBank
DB12026,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12026,Imino Acids,DrugBank
DB12026,Isobutyrates,DrugBank
DB12026,Lactams,DrugBank
DB12026,NS3/4A Protease Inhibitors,DrugBank
DB12026,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12026,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12026,OATP1B3 inhibitors,DrugBank
DB12026,OATP1B3 substrates,DrugBank
DB12026,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB12026,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB12026,P-glycoprotein inhibitors,DrugBank
DB12026,P-glycoprotein substrates,DrugBank
DB12026,Sulfones,DrugBank
DB12026,Sulfur Compounds,DrugBank
DB12026,Treatments for Hepatitis C,DrugBank
DB12028,Anti-Infective Agents,DrugBank
DB12028,Antimetabolites,DrugBank
DB12028,Antineoplastic Agents,DrugBank
DB12028,Deoxyribonucleosides,DrugBank
DB12028,Deoxyuridine,DrugBank
DB12028,Noxae,DrugBank
DB12028,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12028,Nucleosides,DrugBank
DB12028,Pyrimidine Nucleosides,DrugBank
DB12028,Pyrimidines,DrugBank
DB12028,Radiation-Sensitizing Agents,DrugBank
DB12028,Toxic Actions,DrugBank
DB12034,"Amino Acids, Peptides, and Proteins",DrugBank
DB12034,Antibodies,DrugBank
DB12034,"Antibodies, Monoclonal",DrugBank
DB12034,Blood Proteins,DrugBank
DB12034,Globulins,DrugBank
DB12034,Immunoglobulins,DrugBank
DB12034,Immunoproteins,DrugBank
DB12034,Proteins,DrugBank
DB12034,Serum Globulins,DrugBank
DB12035,Anti-Acne Preparations,DrugBank
DB12035,Anti-Acne Preparations for Systemic Use,DrugBank
DB12035,Anti-Bacterial Agents,DrugBank
DB12035,Anti-Infective Agents,DrugBank
DB12035,Antibacterials for Systemic Use,DrugBank
DB12035,Antiinfectives for Systemic Use,DrugBank
DB12035,Dermatologicals,DrugBank
DB12035,Naphthacenes,DrugBank
DB12035,P-glycoprotein inhibitors,DrugBank
DB12035,Tetracyclines,DrugBank
DB12036,Antineoplastic Agents,DrugBank
DB12036,Enzyme Inhibitors,DrugBank
DB12036,Protein Kinase Inhibitors,DrugBank
DB12051,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12051,Quinolines,DrugBank
DB12051,Sulfonamides,DrugBank
DB12051,Sulfones,DrugBank
DB12051,Sulfur Compounds,DrugBank
DB12053,"Amino Acids, Peptides, and Proteins",DrugBank
DB12053,Antibodies,DrugBank
DB12053,"Antibodies, Monoclonal",DrugBank
DB12053,"Antibodies, Monoclonal, Humanized",DrugBank
DB12053,Blood Proteins,DrugBank
DB12053,Globulins,DrugBank
DB12053,Immunoglobulins,DrugBank
DB12053,Immunologic Factors,DrugBank
DB12053,Immunoproteins,DrugBank
DB12053,Proteins,DrugBank
DB12053,Serum Globulins,DrugBank
DB12054,"Amino Acids, Peptides, and Proteins",DrugBank
DB12054,Antihypertensive Agents,DrugBank
DB12054,Cardiovascular Agents,DrugBank
DB12054,Endothelin Receptor Antagonists,DrugBank
DB12054,Peptides,DrugBank
DB12056,"Amino Acids, Peptides, and Proteins",DrugBank
DB12056,Angiogenesis Inhibitors,DrugBank
DB12056,Angiogenesis Modulating Agents,DrugBank
DB12056,Antineoplastic Agents,DrugBank
DB12056,Growth Inhibitors,DrugBank
DB12056,Growth Substances,DrugBank
DB12056,Proteins,DrugBank
DB12056,Recombinant Proteins,DrugBank
DB12057,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB12057,Adrenergic alpha-Antagonists,DrugBank
DB12057,Adrenergic Antagonists,DrugBank
DB12057,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12057,Quinolizines,DrugBank
DB12062,Antineoplastic Agents,DrugBank
DB12062,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12070,"Acids, Acyclic",DrugBank
DB12070,Anti-Infective Agents,DrugBank
DB12070,Antiinfectives for Systemic Use,DrugBank
DB12070,Antiviral Agents,DrugBank
DB12070,Antivirals for Systemic Use,DrugBank
DB12070,BCRP/ABCG2 Inhibitors,DrugBank
DB12070,BSEP/ABCB11 Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12070,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB12070,Cytochrome P-450 CYP2C19 Inducers (moderate),DrugBank
DB12070,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB12070,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12070,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB12070,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB12070,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB12070,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12070,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12070,Cytochrome P-450 Substrates,DrugBank
DB12070,Cytomegalovirus DNA Terminase Complex Inhibitor,DrugBank
DB12070,Direct Acting Antivirals,DrugBank
DB12070,DNA Terminase Complex Inhibitors,DrugBank
DB12070,Enzyme Inhibitors,DrugBank
DB12070,Fatty Acids,DrugBank
DB12070,"Fatty Acids, Volatile",DrugBank
DB12070,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12070,Lipids,DrugBank
DB12070,OAT3/SLC22A8 Inhibitors,DrugBank
DB12070,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12070,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12070,OATP1B3 inhibitors,DrugBank
DB12070,OATP1B3 substrates,DrugBank
DB12070,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB12070,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB12070,P-glycoprotein inhibitors,DrugBank
DB12070,P-glycoprotein substrates,DrugBank
DB12070,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB12070,UGT1A1 Substrates,DrugBank
DB12070,UGT1A3 substrates,DrugBank
DB12071,Antidepressive Agents,DrugBank
DB12071,Central Nervous System Depressants,DrugBank
DB12071,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12071,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12071,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB12071,Serotonin 5-HT2C Receptor Agonists,DrugBank
DB12071,Serotonin Agents,DrugBank
DB12071,Serotonin Receptor Agonists,DrugBank
DB12073,Anti-Infective Agents,DrugBank
DB12073,Antifungal Agents,DrugBank
DB12073,Azole Antifungals,DrugBank
DB12073,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12073,Stereoisomerism,DrugBank
DB12073,Triazoles,DrugBank
DB12077,"Amino Acids, Peptides, and Proteins",DrugBank
DB12077,Antibodies,DrugBank
DB12077,Blood Proteins,DrugBank
DB12077,Globulins,DrugBank
DB12077,Immunoglobulins,DrugBank
DB12077,Immunoproteins,DrugBank
DB12077,Proteins,DrugBank
DB12077,Serum Globulins,DrugBank
DB12080,"Acids, Acyclic",DrugBank
DB12080,Adrenergic Agents,DrugBank
DB12080,Adrenergic Agonists,DrugBank
DB12080,Adrenergic beta-3 Receptor Agonists,DrugBank
DB12080,Adrenergic beta-Agonists,DrugBank
DB12080,Agents producing tachycardia,DrugBank
DB12080,Agents that produce hypertension,DrugBank
DB12080,Amines,DrugBank
DB12080,Amphetamines,DrugBank
DB12080,Drugs for Urinary Frequency and Incontinence,DrugBank
DB12080,Ethylamines,DrugBank
DB12080,Fatty Acids,DrugBank
DB12080,"Fatty Acids, Volatile",DrugBank
DB12080,Lipids,DrugBank
DB12080,Neurotransmitter Agents,DrugBank
DB12080,Phenethylamines,DrugBank
DB12080,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12080,Sympathomimetics,DrugBank
DB12081,11-Hydroxycorticosteroids,DrugBank
DB12081,17-Hydroxycorticosteroids,DrugBank
DB12081,Adrenal Cortex Hormones,DrugBank
DB12081,Angiogenesis Inhibitors,DrugBank
DB12081,Angiogenesis Modulating Agents,DrugBank
DB12081,Antineoplastic Agents,DrugBank
DB12081,Antineovascularisation Agents,DrugBank
DB12081,Fused-Ring Compounds,DrugBank
DB12081,Growth Inhibitors,DrugBank
DB12081,Growth Substances,DrugBank
DB12081,Hormones,DrugBank
DB12081,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12081,Hydroxycorticosteroids,DrugBank
DB12081,Ocular Vascular Disorder Agents,DrugBank
DB12081,Ophthalmologicals,DrugBank
DB12081,Pregnanes,DrugBank
DB12081,Pregnenediones,DrugBank
DB12081,Pregnenes,DrugBank
DB12081,Sensory Organs,DrugBank
DB12081,Steroids,DrugBank
DB12082,"Adjuvants, Immunologic",DrugBank
DB12082,Anti-Infective Agents,DrugBank
DB12082,Antineoplastic Agents,DrugBank
DB12082,Cardiotonic Agents,DrugBank
DB12082,Cardiovascular Agents,DrugBank
DB12082,"Compounds used in a research, industrial, or household setting",DrugBank
DB12082,Enzyme Inhibitors,DrugBank
DB12082,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12082,Immunologic Factors,DrugBank
DB12082,Phosphodiesterase Inhibitors,DrugBank
DB12082,Protective Agents,DrugBank
DB12083,"Adjuvants, Immunologic",DrugBank
DB12083,Antineoplastic Agents,DrugBank
DB12083,"Hydrocarbons, Halogenated",DrugBank
DB12083,Immunologic Factors,DrugBank
DB12083,Mustard Compounds,DrugBank
DB12083,Nitrogen Mustard Compounds,DrugBank
DB12083,Organophosphorus Compounds,DrugBank
DB12083,Phosphoramide Mustards,DrugBank
DB12083,Phosphoramides,DrugBank
DB12085,Antineoplastic Agents,DrugBank
DB12085,"Proto-Oncogene Proteins c-bcl-2, antagonists & inhibitors",DrugBank
DB12085,Sulfur Compounds,DrugBank
DB12086,Agents producing tachycardia,DrugBank
DB12086,Alkaloids,DrugBank
DB12086,Anticholinergic Agents,DrugBank
DB12086,Autonomic Agents,DrugBank
DB12086,Aza Compounds,DrugBank
DB12086,Azabicyclo Compounds,DrugBank
DB12086,Drugs for Obstructive Airway Diseases,DrugBank
DB12086,Muscarinic Antagonists,DrugBank
DB12086,Parasympatholytics,DrugBank
DB12086,Peripheral Nervous System Agents,DrugBank
DB12086,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB12086,Tropanes,DrugBank
DB12089,"Amino Acids, Peptides, and Proteins",DrugBank
DB12089,Anti-Bacterial Agents,DrugBank
DB12089,Antibodies,DrugBank
DB12089,"Antibodies, Monoclonal",DrugBank
DB12089,"Antibodies, Monoclonal, Humanized",DrugBank
DB12089,Antibody-drug Conjugates,DrugBank
DB12089,Antimitotic Agents,DrugBank
DB12089,Antineoplastic Agents,DrugBank
DB12089,"Antineoplastic Agents, Immunological",DrugBank
DB12089,"Antineoplastic Agents, Phytogenic",DrugBank
DB12089,Blood Proteins,DrugBank
DB12089,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12089,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12089,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12089,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12089,Globulins,DrugBank
DB12089,Immunoconjugates,DrugBank
DB12089,Immunoglobulins,DrugBank
DB12089,Immunologic Factors,DrugBank
DB12089,Immunoproteins,DrugBank
DB12089,Immunotoxins,DrugBank
DB12089,"Lactams, Macrocyclic",DrugBank
DB12089,Lactones,DrugBank
DB12089,Macrolides,DrugBank
DB12089,Maytansine,DrugBank
DB12089,Mitosis Modulators,DrugBank
DB12089,Noxae,DrugBank
DB12089,Proteins,DrugBank
DB12089,Serum Globulins,DrugBank
DB12089,Toxic Actions,DrugBank
DB12089,Trastuzumab,DrugBank
DB12089,Tubulin Modulators,DrugBank
DB12090,"Amino Acids, Peptides, and Proteins",DrugBank
DB12090,Antibodies,DrugBank
DB12090,"Antibodies, Monoclonal",DrugBank
DB12090,"Antibodies, Neutralizing",DrugBank
DB12090,Blood Proteins,DrugBank
DB12090,Globulins,DrugBank
DB12090,Immunoglobulins,DrugBank
DB12090,Immunoproteins,DrugBank
DB12090,Proteins,DrugBank
DB12090,Serum Globulins,DrugBank
DB12092,Adrenergic Agents,DrugBank
DB12092,Adrenergic alpha-Antagonists,DrugBank
DB12092,Adrenergic Antagonists,DrugBank
DB12092,Agents causing hyperkalemia,DrugBank
DB12092,Agents that produce hypertension,DrugBank
DB12092,Antiarrhythmic agents,DrugBank
DB12092,Antihypertensive Agents,DrugBank
DB12092,Antiplatelet agents,DrugBank
DB12092,Bradycardia-Causing Agents,DrugBank
DB12092,Calcium Channel Blockers,DrugBank
DB12092,Calcium-Regulating Hormones and Agents,DrugBank
DB12092,Cardiovascular Agents,DrugBank
DB12092,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12092,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12092,Cytochrome P-450 Substrates,DrugBank
DB12092,Hematologic Agents,DrugBank
DB12092,Membrane Transport Modulators,DrugBank
DB12092,Neurotransmitter Agents,DrugBank
DB12092,Vasodilating Agents,DrugBank
DB12093,Adrenergic Agents,DrugBank
DB12093,Agents causing hyperkalemia,DrugBank
DB12093,Alkaloids,DrugBank
DB12093,Analgesics,DrugBank
DB12093,"Analgesics, Non-Narcotic",DrugBank
DB12093,Antiarrhythmic agents,DrugBank
DB12093,Antihypertensive Agents,DrugBank
DB12093,Antipsychotic Agents,DrugBank
DB12093,Benzylisoquinolines,DrugBank
DB12093,Bradycardia-Causing Agents,DrugBank
DB12093,Calcium Channel Blockers,DrugBank
DB12093,Calcium-Regulating Hormones and Agents,DrugBank
DB12093,Cardiovascular Agents,DrugBank
DB12093,Central Nervous System Agents,DrugBank
DB12093,Central Nervous System Depressants,DrugBank
DB12093,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12093,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12093,Cytochrome P-450 Substrates,DrugBank
DB12093,Dopamine Agents,DrugBank
DB12093,Dopamine Antagonists,DrugBank
DB12093,Dopamine D2 Receptor Antagonists,DrugBank
DB12093,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12093,Membrane Transport Modulators,DrugBank
DB12093,Neurotoxic agents,DrugBank
DB12093,Neurotransmitter Agents,DrugBank
DB12093,Peripheral Nervous System Agents,DrugBank
DB12093,Potential QTc-Prolonging Agents,DrugBank
DB12093,Psychotropic Drugs,DrugBank
DB12093,QTc Prolonging Agents,DrugBank
DB12093,Sensory System Agents,DrugBank
DB12093,Tranquilizing Agents,DrugBank
DB12093,Vasodilating Agents,DrugBank
DB12095,Antidiarrheals,DrugBank
DB12095,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12095,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12095,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12095,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12095,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12095,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12095,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12095,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12095,P-glycoprotein inhibitors,DrugBank
DB12095,P-glycoprotein substrates,DrugBank
DB12095,Tryptophan Hydroxylase Inhibitor,DrugBank
DB12095,UGT2B7 inducers,DrugBank
DB12097,Agents causing hyperkalemia,DrugBank
DB12100,Adrenergic Agonists,DrugBank
DB12100,Adrenergic beta-2 Receptor Agonists,DrugBank
DB12100,Adrenergic beta-Agonists,DrugBank
DB12100,Agents producing tachycardia,DrugBank
DB12100,Agents that produce hypertension,DrugBank
DB12100,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12100,Quinolines,DrugBank
DB12102,"Amino Acids, Peptides, and Proteins",DrugBank
DB12102,Antibodies,DrugBank
DB12102,"Antibodies, Monoclonal",DrugBank
DB12102,Blood Proteins,DrugBank
DB12102,Globulins,DrugBank
DB12102,Immunoglobulins,DrugBank
DB12102,Immunoproteins,DrugBank
DB12102,Proteins,DrugBank
DB12102,Serum Globulins,DrugBank
DB12104,"Amino Acids, Peptides, and Proteins",DrugBank
DB12104,Antibodies,DrugBank
DB12104,Blood Proteins,DrugBank
DB12104,Globulins,DrugBank
DB12104,Immunoglobulins,DrugBank
DB12104,Immunoproteins,DrugBank
DB12104,Proteins,DrugBank
DB12104,Serum Globulins,DrugBank
DB12105,"Amino Acids, Peptides, and Proteins",DrugBank
DB12105,Anti-Anxiety Agents,DrugBank
DB12105,Central Nervous System Depressants,DrugBank
DB12107,Acids,DrugBank
DB12107,"Acids, Noncarboxylic",DrugBank
DB12107,Anti-Infective Agents,DrugBank
DB12107,Antibacterials for Systemic Use,DrugBank
DB12107,Antiinfectives for Systemic Use,DrugBank
DB12107,beta-Lactamase Inhibitors,DrugBank
DB12107,Boron Compounds,DrugBank
DB12107,Drugs that are Mainly Renally Excreted,DrugBank
DB12107,Enzyme Inhibitors,DrugBank
DB12108,Antineoplastic Agents,DrugBank
DB12108,Azepines,DrugBank
DB12108,"Phosphatidylinositol 3-Kinases, antagonists & inhibitors",DrugBank
DB12110,Antidepressive Agents,DrugBank
DB12110,Central Nervous System Depressants,DrugBank
DB12110,Neurotransmitter Agents,DrugBank
DB12110,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12110,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB12110,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB12110,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB12110,Serotonin Agents,DrugBank
DB12110,Serotonin Receptor Agonists,DrugBank
DB12110,Serotonin Receptor Antagonists,DrugBank
DB12111,Antidepressive Agents,DrugBank
DB12111,Central Nervous System Depressants,DrugBank
DB12111,Neurotransmitter Agents,DrugBank
DB12111,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12111,Serotonin Agents,DrugBank
DB12111,Serotonin Receptor Agonists,DrugBank
DB12118,Activin Signaling Inhibitor,DrugBank
DB12118,"Amino Acids, Peptides, and Proteins",DrugBank
DB12118,Antihypertensive Agents,DrugBank
DB12118,Antihypertensives for Pulmonary Arterial Hypertension,DrugBank
DB12118,Blood Proteins,DrugBank
DB12118,Immunoglobulin G,DrugBank
DB12118,Immunoglobulins,DrugBank
DB12118,Proteins,DrugBank
DB12118,Recombinant Fusion Proteins,DrugBank
DB12118,Recombinant Proteins,DrugBank
DB12118,Serum Globulins,DrugBank
DB12119,"Amino Acids, Peptides, and Proteins",DrugBank
DB12119,Antibodies,DrugBank
DB12119,"Antibodies, Monoclonal",DrugBank
DB12119,"Antibodies, Monoclonal, Humanized",DrugBank
DB12119,Blood Proteins,DrugBank
DB12119,Globulins,DrugBank
DB12119,Immunoglobulins,DrugBank
DB12119,Immunoproteins,DrugBank
DB12119,Proteins,DrugBank
DB12119,Serum Globulins,DrugBank
DB12123,Cardiovascular Agents,DrugBank
DB12123,Peripheral Vasodilators,DrugBank
DB12123,Vasodilating Agents,DrugBank
DB12124,Alkaloids,DrugBank
DB12124,Antineoplastic Agents,DrugBank
DB12124,"Antineoplastic Agents, Phytogenic",DrugBank
DB12126,"Amino Acids, Peptides, and Proteins",DrugBank
DB12126,Autacoids,DrugBank
DB12126,Biological Factors,DrugBank
DB12126,"Bradykinin, agonists",DrugBank
DB12126,Cardiovascular Agents,DrugBank
DB12126,Inflammation Mediators,DrugBank
DB12126,Intercellular Signaling Peptides and Proteins,DrugBank
DB12126,Kinins,DrugBank
DB12126,Nerve Tissue Proteins,DrugBank
DB12126,Neuropeptides,DrugBank
DB12126,Oligopeptides,DrugBank
DB12126,Peptides,DrugBank
DB12126,Proteins,DrugBank
DB12126,Vasodilating Agents,DrugBank
DB12127,Amides,DrugBank
DB12127,Anti-Bacterial Agents,DrugBank
DB12127,Anti-Infective Agents,DrugBank
DB12127,Antibacterials for Systemic Use,DrugBank
DB12127,Antiinfectives for Systemic Use,DrugBank
DB12127,Beta-Lactam Antibacterials,DrugBank
DB12127,beta-Lactams,DrugBank
DB12127,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12127,Lactams,DrugBank
DB12127,Penicillin G,DrugBank
DB12127,Penicillins,DrugBank
DB12127,Sulfur Compounds,DrugBank
DB12130,Amides,DrugBank
DB12130,Amines,DrugBank
DB12130,Anaplastic lymphoma kinase (ALK) inhibitors,DrugBank
DB12130,Antineoplastic Agents,DrugBank
DB12130,Antineoplastic and Immunomodulating Agents,DrugBank
DB12130,BCRP/ABCG2 Inhibitors,DrugBank
DB12130,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12130,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12130,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12130,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12130,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12130,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12130,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12130,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12130,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12130,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12130,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12130,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12130,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12130,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12130,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12130,Cytochrome P-450 Substrates,DrugBank
DB12130,Kinase Inhibitor,DrugBank
DB12130,Lactams,DrugBank
DB12130,MATE 1 Inhibitors,DrugBank
DB12130,MATE inhibitors,DrugBank
DB12130,OAT3/SLC22A8 Inhibitors,DrugBank
DB12130,Organic Cation Transporter 1 Inhibitors,DrugBank
DB12130,P-glycoprotein inducers,DrugBank
DB12130,Protein Kinase Inhibitors,DrugBank
DB12130,Pyridines,DrugBank
DB12130,ROS1 tyrosine kinase inhibitors,DrugBank
DB12130,Tyrosine Kinase Inhibitors,DrugBank
DB12130,UGT1A3 substrates,DrugBank
DB12131,Agents causing hyperkalemia,DrugBank
DB12131,Alkaloids,DrugBank
DB12131,Antiarrhythmic agents,DrugBank
DB12131,Anticonvulsants,DrugBank
DB12131,Bradycardia-Causing Agents,DrugBank
DB12131,Calcium Channel Blockers,DrugBank
DB12131,Cardiovascular Agents,DrugBank
DB12131,Central Nervous System Agents,DrugBank
DB12131,Central Nervous System Depressants,DrugBank
DB12131,"Compounds used in a research, industrial, or household setting",DrugBank
DB12131,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12131,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12131,Cytochrome P-450 Substrates,DrugBank
DB12131,Enzyme Inhibitors,DrugBank
DB12131,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12131,Indole Alkaloids,DrugBank
DB12131,Indoles,DrugBank
DB12131,Indolizidines,DrugBank
DB12131,Indolizines,DrugBank
DB12131,Nervous System,DrugBank
DB12131,Neuroprotective Agents,DrugBank
DB12131,Nootropic Agents,DrugBank
DB12131,Phosphodiesterase Inhibitors,DrugBank
DB12131,Protective Agents,DrugBank
DB12131,Psychoanaleptics,DrugBank
DB12131,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB12131,Secologanin Tryptamine Alkaloids,DrugBank
DB12131,Vasodilating Agents,DrugBank
DB12134,Antibacterials for Systemic Use,DrugBank
DB12134,Antiinfectives for Systemic Use,DrugBank
DB12134,BCRP/ABCG2 Substrates,DrugBank
DB12134,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12134,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12134,Cytochrome P-450 Substrates,DrugBank
DB12134,Enzyme Inhibitors,DrugBank
DB12134,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12134,MATE 1 Inhibitors,DrugBank
DB12134,MATE 2 Inhibitors,DrugBank
DB12134,MATE inhibitors,DrugBank
DB12134,Naphthalenes,DrugBank
DB12134,Topoisomerase Inhibitors,DrugBank
DB12134,Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor,DrugBank
DB12137,Enzyme Inhibitors,DrugBank
DB12137,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12137,Phosphodiesterase 4 Inhibitors,DrugBank
DB12137,Phosphodiesterase Inhibitors,DrugBank
DB12137,Quinolines,DrugBank
DB12137,Sulfur Compounds,DrugBank
DB12141,Amines,DrugBank
DB12141,Antineoplastic Agents,DrugBank
DB12141,Antineoplastic and Immunomodulating Agents,DrugBank
DB12141,BCRP/ABCG2 Inhibitors,DrugBank
DB12141,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12141,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12141,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12141,Cytochrome P-450 Substrates,DrugBank
DB12141,Enzyme Inhibitors,DrugBank
DB12141,"fms-Like Tyrosine Kinase 3, antagonists & inhibitors",DrugBank
DB12141,Kinase Inhibitor,DrugBank
DB12141,MATE 1 Inhibitors,DrugBank
DB12141,MATE inhibitors,DrugBank
DB12141,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12141,OCT1 inhibitors,DrugBank
DB12141,P-glycoprotein substrates,DrugBank
DB12141,Protein Kinase Inhibitors,DrugBank
DB12141,QTc Prolonging Agents,DrugBank
DB12141,Tyrosine Kinase Inhibitors,DrugBank
DB12142,"Amino Acids, Peptides, and Proteins",DrugBank
DB12142,Antibodies,DrugBank
DB12142,"Antibodies, Monoclonal",DrugBank
DB12142,"Antibodies, Monoclonal, Humanized",DrugBank
DB12142,Antineoplastic Agents,DrugBank
DB12142,Blood Proteins,DrugBank
DB12142,Globulins,DrugBank
DB12142,Immunoglobulin Isotypes,DrugBank
DB12142,Immunoglobulins,DrugBank
DB12142,Immunoproteins,DrugBank
DB12142,Proteins,DrugBank
DB12142,Serum Globulins,DrugBank
DB12146,Amino Acids,DrugBank
DB12146,"Amino Acids, Peptides, and Proteins",DrugBank
DB12146,Antineoplastic Agents,DrugBank
DB12146,Enzyme Inhibitors,DrugBank
DB12146,Protein Kinase Inhibitors,DrugBank
DB12146,Sulfur Compounds,DrugBank
DB12147,Antineoplastic Agents,DrugBank
DB12147,Antineoplastic and Immunomodulating Agents,DrugBank
DB12147,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12147,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB12147,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12147,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12147,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12147,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12147,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12147,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12147,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12147,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12147,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12147,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12147,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12147,Cytochrome P-450 Substrates,DrugBank
DB12147,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,DrugBank
DB12147,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12147,Kinase Inhibitor,DrugBank
DB12147,Narrow Therapeutic Index Drugs,DrugBank
DB12147,OCT2 Inhibitors,DrugBank
DB12147,P-glycoprotein inhibitors,DrugBank
DB12147,P-glycoprotein substrates,DrugBank
DB12147,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB12147,Protein Kinase Inhibitors,DrugBank
DB12147,"Receptors, Fibroblast Growth Factor, antagonists & inhibitors",DrugBank
DB12147,Tumor Suppressor Proteins,DrugBank
DB12147,Tyrosine Kinase Inhibitors,DrugBank
DB12151,Anti-Infective Agents,DrugBank
DB12151,Antiinfectives for Systemic Use,DrugBank
DB12151,Antiviral Agents,DrugBank
DB12151,Antivirals for Systemic Use,DrugBank
DB12151,BCRP/ABCG2 Inhibitors,DrugBank
DB12151,BSEP/ABCB11 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12151,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12151,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12151,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor,DrugBank
DB12151,Direct Acting Antivirals,DrugBank
DB12151,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB12151,OAT1/SLC22A6 inhibitors,DrugBank
DB12151,OAT3/SLC22A8 Inhibitors,DrugBank
DB12151,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12151,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12151,OATP1B3 substrates,DrugBank
DB12151,Organophosphorus Compounds,DrugBank
DB12151,Pyrimidines,DrugBank
DB12151,Pyrimidinones,DrugBank
DB12152,"Amino Acids, Peptides, and Proteins",DrugBank
DB12152,Antibodies,DrugBank
DB12152,"Antibodies, Monoclonal",DrugBank
DB12152,"Antibodies, Monoclonal, Humanized",DrugBank
DB12152,Blood Proteins,DrugBank
DB12152,Globulins,DrugBank
DB12152,Immunoglobulins,DrugBank
DB12152,Immunoproteins,DrugBank
DB12152,Proteins,DrugBank
DB12152,Serum Globulins,DrugBank
DB12156,Anti-Infective Agents,DrugBank
DB12156,Antifungal Agents,DrugBank
DB12156,Antineoplastic Agents,DrugBank
DB12156,Deoxyribonucleosides,DrugBank
DB12156,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12156,Mutagens,DrugBank
DB12156,Noxae,DrugBank
DB12156,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12156,Nucleosides,DrugBank
DB12156,Purine Nucleosides,DrugBank
DB12156,Purines,DrugBank
DB12156,Toxic Actions,DrugBank
DB12157,"Amino Acids, Peptides, and Proteins",DrugBank
DB12157,Analgesics,DrugBank
DB12157,"Analgesics, Non-Narcotic",DrugBank
DB12157,Antibodies,DrugBank
DB12157,"Antibodies, Monoclonal",DrugBank
DB12157,Blood Proteins,DrugBank
DB12157,Central Nervous System Agents,DrugBank
DB12157,Globulins,DrugBank
DB12157,Immunoglobulins,DrugBank
DB12157,Immunoproteins,DrugBank
DB12157,Peripheral Nervous System Agents,DrugBank
DB12157,Proteins,DrugBank
DB12157,Sensory System Agents,DrugBank
DB12157,Serum Globulins,DrugBank
DB12159,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB12159,"Amino Acids, Peptides, and Proteins",DrugBank
DB12159,Anti-Asthmatic Agents,DrugBank
DB12159,Antibodies,DrugBank
DB12159,"Antibodies, Monoclonal",DrugBank
DB12159,Blood Proteins,DrugBank
DB12159,Dermatologicals,DrugBank
DB12159,Globulins,DrugBank
DB12159,Immunoglobulins,DrugBank
DB12159,Immunoproteins,DrugBank
DB12159,Interleukin 4 Receptor alpha Antagonists,DrugBank
DB12159,Interleukin-4 Receptor alpha Antagonist,DrugBank
DB12159,"Interleukin-4 Receptor alpha Subunit, antagonists & inhibitors",DrugBank
DB12159,Misc. Skin and Mucous Membrane Agents,DrugBank
DB12159,Proteins,DrugBank
DB12159,Serum Globulins,DrugBank
DB12161,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12161,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12161,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12161,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12161,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12161,Cytochrome P-450 Substrates,DrugBank
DB12161,Drugs that are Mainly Renally Excreted,DrugBank
DB12161,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12161,Highest Risk QTc-Prolonging Agents,DrugBank
DB12161,Nervous System,DrugBank
DB12161,QTc Prolonging Agents,DrugBank
DB12161,Quinolizines,DrugBank
DB12161,Vesicular Monoamine Transporter 2 Inhibitor,DrugBank
DB12161,Vesicular Monoamine Transporter 2 Inhibitors,DrugBank
DB12163,"Acids, Acyclic",DrugBank
DB12163,Antidepressive Agents,DrugBank
DB12163,Antiplatelet agents,DrugBank
DB12163,Cardiovascular Agents,DrugBank
DB12163,Central Nervous System Depressants,DrugBank
DB12163,Dicarboxylic Acids,DrugBank
DB12163,Fibrin Modulating Agents,DrugBank
DB12163,Hematologic Agents,DrugBank
DB12163,Neurotransmitter Agents,DrugBank
DB12163,Serotonin Agents,DrugBank
DB12163,Serotonin Receptor Antagonists,DrugBank
DB12169,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB12169,"Amino Acids, Peptides, and Proteins",DrugBank
DB12169,Antibodies,DrugBank
DB12169,"Asthma, drug therapy",DrugBank
DB12169,Blood Proteins,DrugBank
DB12169,Dermatologicals,DrugBank
DB12169,Globulins,DrugBank
DB12169,Immunoglobulins,DrugBank
DB12169,Immunoproteins,DrugBank
DB12169,Interleukin-13 Antagonist,DrugBank
DB12169,Proteins,DrugBank
DB12169,Serum Globulins,DrugBank
DB12174,Amines,DrugBank
DB12174,Antineoplastic Agents,DrugBank
DB12174,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12174,Histone Deacetylase Inhibitors,DrugBank
DB12174,Hydroxy Acids,DrugBank
DB12174,Hydroxylamines,DrugBank
DB12174,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12174,QTc Prolonging Agents,DrugBank
DB12177,Antidepressive Agents,DrugBank
DB12177,Benzene Derivatives,DrugBank
DB12177,Cardiovascular Agents,DrugBank
DB12177,Central Nervous System Depressants,DrugBank
DB12177,Fibrin Modulating Agents,DrugBank
DB12177,Hematologic Agents,DrugBank
DB12177,"Hydrocarbons, Fluorinated",DrugBank
DB12177,"Hydrocarbons, Halogenated",DrugBank
DB12177,Neurotransmitter Agents,DrugBank
DB12177,Serotonin Agents,DrugBank
DB12177,Serotonin Receptor Antagonists,DrugBank
DB12182,"Adjuvants, Immunologic",DrugBank
DB12182,"Amino Acids, Peptides, and Proteins",DrugBank
DB12182,Antineoplastic Agents,DrugBank
DB12182,Antirheumatic Agents,DrugBank
DB12182,Biological Factors,DrugBank
DB12182,Cytokines,DrugBank
DB12182,Immunologic Factors,DrugBank
DB12182,Intercellular Signaling Peptides and Proteins,DrugBank
DB12182,"Interleukin-4, antagonists & inhibitors",DrugBank
DB12182,Interleukins,DrugBank
DB12182,Peptides,DrugBank
DB12182,Proteins,DrugBank
DB12184,Anti-Anxiety Agents,DrugBank
DB12184,Antidepressive Agents,DrugBank
DB12184,Central Nervous System Agents,DrugBank
DB12184,Central Nervous System Depressants,DrugBank
DB12184,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12184,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12184,Cytochrome P-450 Substrates,DrugBank
DB12184,Nervous System,DrugBank
DB12184,Neurotransmitter Agents,DrugBank
DB12184,Psychoanaleptics,DrugBank
DB12184,Psychotropic Drugs,DrugBank
DB12184,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12184,Serotonin Agents,DrugBank
DB12184,Serotonin Receptor Agonists,DrugBank
DB12184,Tranquilizing Agents,DrugBank
DB12185,Alkaloids,DrugBank
DB12185,Antineoplastic Agents,DrugBank
DB12185,Enzyme Inhibitors,DrugBank
DB12185,Topoisomerase I Inhibitors,DrugBank
DB12185,Topoisomerase Inhibitors,DrugBank
DB12189,"Amino Acids, Peptides, and Proteins",DrugBank
DB12189,Antibodies,DrugBank
DB12189,"Antibodies, Monoclonal",DrugBank
DB12189,"Antibodies, Monoclonal, Humanized",DrugBank
DB12189,Blood Proteins,DrugBank
DB12189,Gastrointestinal Agents,DrugBank
DB12189,Globulins,DrugBank
DB12189,Immunoglobulins,DrugBank
DB12189,Immunologic Factors,DrugBank
DB12189,Immunoproteins,DrugBank
DB12189,Integrin Receptor Antagonist,DrugBank
DB12189,Proteins,DrugBank
DB12189,Serum Globulins,DrugBank
DB12193,Agents producing tachycardia,DrugBank
DB12193,Cannabinoid Receptor Agonists,DrugBank
DB12193,Cannabinoids and similars,DrugBank
DB12193,Hormones,DrugBank
DB12193,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12193,Neurotransmitter Agents,DrugBank
DB12193,Terpenes,DrugBank
DB12193,Tumor Necrosis Factor Blockers,DrugBank
DB12194,17-Ketosteroids,DrugBank
DB12194,Adrenal Cortex Hormones,DrugBank
DB12194,Androstanes,DrugBank
DB12194,Androstenes,DrugBank
DB12194,Enzyme Inhibitors,DrugBank
DB12194,Fused-Ring Compounds,DrugBank
DB12194,Gonadal Hormones,DrugBank
DB12194,Gonadal Steroid Hormones,DrugBank
DB12194,Hormones,DrugBank
DB12194,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12194,Ketosteroids,DrugBank
DB12194,Steroids,DrugBank
DB12194,Testosterone Congeners,DrugBank
DB12202,"Amino Acids, Peptides, and Proteins",DrugBank
DB12202,Antibodies,DrugBank
DB12202,"Antibodies, Monoclonal",DrugBank
DB12202,Antineoplastic Agents,DrugBank
DB12202,"Antineoplastic Agents, Immunological",DrugBank
DB12202,Blood Proteins,DrugBank
DB12202,Globulins,DrugBank
DB12202,Immunoglobulins,DrugBank
DB12202,Immunoproteins,DrugBank
DB12202,Proteins,DrugBank
DB12202,Serum Globulins,DrugBank
DB12205,"Amino Acids, Peptides, and Proteins",DrugBank
DB12205,Antibodies,DrugBank
DB12205,"Antibodies, Monoclonal",DrugBank
DB12205,Blood Proteins,DrugBank
DB12205,Globulins,DrugBank
DB12205,Immunoglobulins,DrugBank
DB12205,Immunoproteins,DrugBank
DB12205,Proteins,DrugBank
DB12205,Serum Globulins,DrugBank
DB12208,Carbohydrates,DrugBank
DB12208,Hematinics,DrugBank
DB12208,Hematologic Agents,DrugBank
DB12208,Iron Compounds,DrugBank
DB12208,Oligosaccharides,DrugBank
DB12208,Polysaccharides,DrugBank
DB12212,Adrenergic Agents,DrugBank
DB12212,Adrenergic Antagonists,DrugBank
DB12212,Adrenergic beta-Antagonists,DrugBank
DB12212,Agents causing hyperkalemia,DrugBank
DB12212,Amides,DrugBank
DB12212,Antiarrhythmic agents,DrugBank
DB12212,Antihypertensive Agents,DrugBank
DB12212,"Beta Blocking Agents, Selective",DrugBank
DB12212,Bradycardia-Causing Agents,DrugBank
DB12212,Cardiovascular Agents,DrugBank
DB12212,Cholinesterase substrates,DrugBank
DB12212,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12212,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12212,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12212,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12212,Cytochrome P-450 Substrates,DrugBank
DB12212,Negative Inotrope,DrugBank
DB12212,Neurotransmitter Agents,DrugBank
DB12212,Oxazines,DrugBank
DB12213,"Amino Acids, Peptides, and Proteins",DrugBank
DB12213,Antibodies,DrugBank
DB12213,"Antibodies, Monoclonal",DrugBank
DB12213,"Antibodies, Monoclonal, Humanized",DrugBank
DB12213,Blood Proteins,DrugBank
DB12213,Globulins,DrugBank
DB12213,Immunoglobulins,DrugBank
DB12213,Immunoproteins,DrugBank
DB12213,Proteins,DrugBank
DB12213,Serum Globulins,DrugBank
DB12214,Alcohols,DrugBank
DB12214,Alimentary Tract and Metabolism,DrugBank
DB12214,Blood Glucose Lowering Agents,DrugBank
DB12214,Carbohydrates,DrugBank
DB12214,Diuretics,DrugBank
DB12214,Drugs Used in Diabetes,DrugBank
DB12214,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB12214,Sugar Alcohols,DrugBank
DB12216,Anti-Inflammatory Agents,DrugBank
DB12216,Antipsoriatics,DrugBank
DB12216,Antipsoriatics for Systemic Use,DrugBank
DB12216,Benzopyrans,DrugBank
DB12216,Coumarins,DrugBank
DB12216,Dermatologicals,DrugBank
DB12216,Furocoumarins,DrugBank
DB12216,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12216,Photosensitizing Agents,DrugBank
DB12216,Photosensitizing Agents for Phototherapy,DrugBank
DB12216,Psoralens for Systemic Use,DrugBank
DB12216,Pyrans,DrugBank
DB12216,Radiation-Sensitizing Agents,DrugBank
DB12218,Antineoplastic Agents,DrugBank
DB12218,Antineoplastic and Immunomodulating Agents,DrugBank
DB12218,BCRP/ABCG2 Inhibitors,DrugBank
DB12218,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12218,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12218,Cytochrome P-450 Substrates,DrugBank
DB12218,MATE 1 Inhibitors,DrugBank
DB12218,MATE 2 Inhibitors,DrugBank
DB12218,MATE inhibitors,DrugBank
DB12218,OAT3/SLC22A8 Inhibitors,DrugBank
DB12218,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12218,OATP1B3 inhibitors,DrugBank
DB12218,OCT2 Inhibitors,DrugBank
DB12218,Protein Kinase Inhibitors,DrugBank
DB12218,"Proto-Oncogene Proteins c-akt, antagonists & inhibitors",DrugBank
DB12218,UGT2B7 substrates,DrugBank
DB12221,Agents causing hyperkalemia,DrugBank
DB12221,Diuretics,DrugBank
DB12221,Fused-Ring Compounds,DrugBank
DB12221,Hormone Antagonists,DrugBank
DB12221,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12221,Mineralocorticoid Receptor Antagonists,DrugBank
DB12221,Natriuretic Agents,DrugBank
DB12221,Potassium-Sparing Diuretics,DrugBank
DB12221,Pregnadienes,DrugBank
DB12221,Pregnanes,DrugBank
DB12221,Steroids,DrugBank
DB12222,Alkaloids,DrugBank
DB12222,Antineoplastic Agents,DrugBank
DB12229,Antidepressive Agents,DrugBank
DB12229,Central Nervous System Depressants,DrugBank
DB12229,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12229,Pyrazoles,DrugBank
DB12229,Serotonin Agents,DrugBank
DB12229,Serotonin Receptor Antagonists,DrugBank
DB12229,Sulfur Compounds,DrugBank
DB12230,Adrenergic Agents,DrugBank
DB12230,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB12230,Adrenergic alpha-Antagonists,DrugBank
DB12230,Adrenergic Antagonists,DrugBank
DB12230,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12230,Neurotransmitter Agents,DrugBank
DB12230,Peripheral alpha-1 blockers,DrugBank
DB12231,Agrochemicals,DrugBank
DB12231,"Compounds used in a research, industrial, or household setting",DrugBank
DB12231,Insecticides,DrugBank
DB12231,Organophosphates,DrugBank
DB12231,Organophosphorus Compounds,DrugBank
DB12231,Organothiophosphates,DrugBank
DB12231,Organothiophosphorus Compounds,DrugBank
DB12231,Pesticides,DrugBank
DB12231,Potential QTc-Prolonging Agents,DrugBank
DB12231,QTc Prolonging Agents,DrugBank
DB12231,Sulfur Compounds,DrugBank
DB12231,Toxic Actions,DrugBank
DB12232,"Adjuvants, Immunologic",DrugBank
DB12232,Amides,DrugBank
DB12232,Antineoplastic Agents,DrugBank
DB12232,Carbohydrates,DrugBank
DB12232,Ceramides,DrugBank
DB12232,Cerebrosides,DrugBank
DB12232,Glycoconjugates,DrugBank
DB12232,Glycolipids,DrugBank
DB12232,Glycosphingolipids,DrugBank
DB12232,Immunologic Factors,DrugBank
DB12232,Lipids,DrugBank
DB12232,Membrane Lipids,DrugBank
DB12232,Neutral Glycosphingolipids,DrugBank
DB12232,Sphingolipids,DrugBank
DB12235,Adrenal Cortex Hormones,DrugBank
DB12235,"Contraceptives, Oral",DrugBank
DB12235,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12235,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12235,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12235,Cytochrome P-450 Substrates,DrugBank
DB12235,Estradiol Congeners,DrugBank
DB12235,Estranes,DrugBank
DB12235,Estrenes,DrugBank
DB12235,Estrogen Contraceptives,DrugBank
DB12235,Estrogens,DrugBank
DB12235,"Estrogens, agonists",DrugBank
DB12235,Fused-Ring Compounds,DrugBank
DB12235,Genito Urinary System and Sex Hormones,DrugBank
DB12235,Gonadal Hormones,DrugBank
DB12235,Gonadal Steroid Hormones,DrugBank
DB12235,Hormonal Contraceptives for Systemic Use,DrugBank
DB12235,Hormones,DrugBank
DB12235,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12235,Sex Hormones and Modulators of the Genital System,DrugBank
DB12235,Steroids,DrugBank
DB12235,UGT2B7 substrates,DrugBank
DB12236,Alimentary Tract and Metabolism,DrugBank
DB12236,Benzene Derivatives,DrugBank
DB12236,Blood Glucose Lowering Agents,DrugBank
DB12236,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12236,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12236,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12236,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12236,Cytochrome P-450 Substrates,DrugBank
DB12236,"Diabetes Mellitus, Type 2, drug therapy",DrugBank
DB12236,Diuretics,DrugBank
DB12236,Drugs Used in Diabetes,DrugBank
DB12236,Glycosides,DrugBank
DB12236,Oral Hypoglycemics,DrugBank
DB12236,P-glycoprotein substrates,DrugBank
DB12236,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB12236,"Sodium-Glucose Transport Proteins, antagonists & inhibitors",DrugBank
DB12236,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB12236,UGT1A1 Substrates,DrugBank
DB12236,UGT1A9 Substrates,DrugBank
DB12240,"Amino Acids, Peptides, and Proteins",DrugBank
DB12240,Antibodies,DrugBank
DB12240,"Antibodies, Monoclonal",DrugBank
DB12240,"Antibodies, Monoclonal, Humanized",DrugBank
DB12240,Antibody-drug Conjugates,DrugBank
DB12240,Antineoplastic Agents,DrugBank
DB12240,Antineoplastic and Immunomodulating Agents,DrugBank
DB12240,Blood Proteins,DrugBank
DB12240,Cancer immunotherapy,DrugBank
DB12240,CD79b-directed AntibodyDrug Conjugates,DrugBank
DB12240,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12240,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12240,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12240,Cytochrome P-450 Substrates,DrugBank
DB12240,Globulins,DrugBank
DB12240,Immunoglobulins,DrugBank
DB12240,Immunologic Factors,DrugBank
DB12240,Immunoproteins,DrugBank
DB12240,Immunotherapy,DrugBank
DB12240,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB12240,Noxae,DrugBank
DB12240,P-glycoprotein substrates,DrugBank
DB12240,Proteins,DrugBank
DB12240,Serum Globulins,DrugBank
DB12240,Toxic Actions,DrugBank
DB12245,Anthelmintics,DrugBank
DB12245,Anti-Infective Agents,DrugBank
DB12245,Antihelminthic,DrugBank
DB12245,Antiparasitic Agents,DrugBank
DB12245,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB12245,Antiplatyhelmintic Agents,DrugBank
DB12245,Antitrematodals,DrugBank
DB12245,Benzimidazoles,DrugBank
DB12245,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB12245,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12245,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12245,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12245,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12245,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12245,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12245,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12245,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12245,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12245,Cytochrome P-450 Substrates,DrugBank
DB12245,Cytochrome P450 2A6 Inhibitors,DrugBank
DB12245,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12245,Potential QTc-Prolonging Agents,DrugBank
DB12245,QTc Prolonging Agents,DrugBank
DB12246,"Amino Acids, Peptides, and Proteins",DrugBank
DB12246,Antibodies,DrugBank
DB12246,Blood Proteins,DrugBank
DB12246,Globulins,DrugBank
DB12246,Immunoglobulins,DrugBank
DB12246,Immunoproteins,DrugBank
DB12246,Proteins,DrugBank
DB12246,Serum Globulins,DrugBank
DB12248,Adrenergic Agents,DrugBank
DB12248,Adrenergic Agonists,DrugBank
DB12248,Adrenergic beta-Agonists,DrugBank
DB12248,Adrenergics for Systemic Use,DrugBank
DB12248,"Adrenergics, Inhalants",DrugBank
DB12248,Agents producing tachycardia,DrugBank
DB12248,Agents that produce hypertension,DrugBank
DB12248,Agents to Treat Airway Disease,DrugBank
DB12248,Alcohols,DrugBank
DB12248,Amines,DrugBank
DB12248,Amino Alcohols,DrugBank
DB12248,Anti-Asthmatic Agents,DrugBank
DB12248,Autonomic Agents,DrugBank
DB12248,Bronchodilator Agents,DrugBank
DB12248,Drugs for Obstructive Airway Diseases,DrugBank
DB12248,Ethanolamines,DrugBank
DB12248,Neurotransmitter Agents,DrugBank
DB12248,Peripheral Nervous System Agents,DrugBank
DB12248,Respiratory System Agents,DrugBank
DB12248,Selective Beta 2-adrenergic Agonists,DrugBank
DB12250,"Amino Acids, Peptides, and Proteins",DrugBank
DB12250,Antibodies,DrugBank
DB12250,"Antibodies, Monoclonal",DrugBank
DB12250,Blood Proteins,DrugBank
DB12250,Globulins,DrugBank
DB12250,Immunoglobulins,DrugBank
DB12250,Immunoproteins,DrugBank
DB12250,Proteins,DrugBank
DB12250,Radiation-Sensitizing Agents,DrugBank
DB12250,"Receptor, IGF Type 1",DrugBank
DB12250,Serum Globulins,DrugBank
DB12255,Amino Acids,DrugBank
DB12255,"Amino Acids, Peptides, and Proteins",DrugBank
DB12255,Antianemic Preparations,DrugBank
DB12255,BCRP/ABCG2 Inhibitors,DrugBank
DB12255,Blood and Blood Forming Organs,DrugBank
DB12255,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12255,Cytochrome P-450 CYP2B6 Inducers (weak),DrugBank
DB12255,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12255,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12255,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12255,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12255,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12255,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12255,Erythropoiesis-Stimulating Agents,DrugBank
DB12255,Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor,DrugBank
DB12255,"Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors",DrugBank
DB12255,OAT3/SLC22A8 Inhibitors,DrugBank
DB12255,OAT3/SLC22A8 Substrates,DrugBank
DB12255,Pyridines,DrugBank
DB12255,UGT1A1 Inducers,DrugBank
DB12255,UGT1A1 Substrates,DrugBank
DB12255,UGT1A9 Substrates,DrugBank
DB12255,UGT2B7 substrates,DrugBank
DB12257,Antineoplastic Agents,DrugBank
DB12257,Chlorine Compounds,DrugBank
DB12257,"Compounds used in a research, industrial, or household setting",DrugBank
DB12257,Cross-Linking Reagents,DrugBank
DB12257,Elements,DrugBank
DB12257,Indicators and Reagents,DrugBank
DB12257,Laboratory Chemicals,DrugBank
DB12257,Metals,DrugBank
DB12257,"Metals, Heavy",DrugBank
DB12257,Nitrogen Compounds,DrugBank
DB12257,Radiation-Sensitizing Agents,DrugBank
DB12257,Transition Elements,DrugBank
DB12258,"Amino Acids, Peptides, and Proteins",DrugBank
DB12258,Antineovascularisation Agents,DrugBank
DB12258,Ocular Vascular Disorder Agents,DrugBank
DB12258,Ophthalmologicals,DrugBank
DB12258,Pegylated agents,DrugBank
DB12258,Proteins,DrugBank
DB12258,Recombinant Proteins,DrugBank
DB12258,Sensory Organs,DrugBank
DB12261,"Amino Acids, Peptides, and Proteins",DrugBank
DB12261,Antibodies,DrugBank
DB12261,"Antibodies, Monoclonal",DrugBank
DB12261,Blood Proteins,DrugBank
DB12261,Globulins,DrugBank
DB12261,Immunoglobulins,DrugBank
DB12261,Immunoproteins,DrugBank
DB12261,Proteins,DrugBank
DB12261,Serum Globulins,DrugBank
DB12265,Agents Against Leishmaniasis and Trypanosomiasis,DrugBank
DB12265,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB12265,Antiprotozoals,DrugBank
DB12265,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB12265,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12265,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12265,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB12265,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12265,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12265,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12265,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12265,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB12265,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB12265,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12265,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12265,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12265,Cytochrome P-450 Substrates,DrugBank
DB12265,Imidazoles,DrugBank
DB12265,MATE 1 Inhibitors,DrugBank
DB12265,MATE 2 Inhibitors,DrugBank
DB12265,MATE 2-K Inhibitors,DrugBank
DB12265,MATE inhibitors,DrugBank
DB12265,Nitro Compounds,DrugBank
DB12265,Nitroimidazole Antimicrobial,DrugBank
DB12265,Nitroimidazole Derivatives,DrugBank
DB12265,OAT1/SLC22A6 inhibitors,DrugBank
DB12265,OAT3/SLC22A8 Inhibitors,DrugBank
DB12265,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12265,OATP1B3 inhibitors,DrugBank
DB12265,OCT2 Inhibitors,DrugBank
DB12265,Organic Anion Transporter 1 Inhibitors,DrugBank
DB12265,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB12265,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB12266,Anti-Bacterial Agents,DrugBank
DB12266,Antineoplastic Agents,DrugBank
DB12266,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12266,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12266,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12266,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12266,Lactones,DrugBank
DB12266,Macrolides,DrugBank
DB12266,Polyketides,DrugBank
DB12266,Pteridines,DrugBank
DB12266,Pterins,DrugBank
DB12267,Anaplastic lymphoma kinase (ALK) inhibitors,DrugBank
DB12267,Antineoplastic Agents,DrugBank
DB12267,Antineoplastic and Immunomodulating Agents,DrugBank
DB12267,BCRP/ABCG2 Inhibitors,DrugBank
DB12267,BCRP/ABCG2 Substrates,DrugBank
DB12267,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12267,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB12267,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12267,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12267,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12267,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12267,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12267,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12267,Cytochrome P-450 Substrates,DrugBank
DB12267,Kinase Inhibitor,DrugBank
DB12267,MATE 1 Inhibitors,DrugBank
DB12267,MATE 2 Inhibitors,DrugBank
DB12267,MATE inhibitors,DrugBank
DB12267,Narrow Therapeutic Index Drugs,DrugBank
DB12267,Protein Kinase Inhibitors,DrugBank
DB12267,Tyrosine Kinase Inhibitors,DrugBank
DB12268,Agents causing angioedema,DrugBank
DB12268,Blood Glucose Lowering Agents,DrugBank
DB12268,Dipeptidyl Peptidase 4,DrugBank
DB12268,DPP-IV Inhibitors,DrugBank
DB12268,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12273,Antipsychotic Agents,DrugBank
DB12273,Central Nervous System Agents,DrugBank
DB12273,Central Nervous System Depressants,DrugBank
DB12273,Dopamine Agents,DrugBank
DB12273,Dopamine Antagonists,DrugBank
DB12273,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12273,Neurotoxic agents,DrugBank
DB12273,Neurotransmitter Agents,DrugBank
DB12273,Psychotropic Drugs,DrugBank
DB12273,Tranquilizing Agents,DrugBank
DB12274,"Alzheimer Disease, drug therapy",DrugBank
DB12274,"Amino Acids, Peptides, and Proteins",DrugBank
DB12274,Amyloid Beta-directed Antibodies,DrugBank
DB12274,Anti-Dementia Drugs,DrugBank
DB12274,Antibodies,DrugBank
DB12274,"Antibodies, Monoclonal",DrugBank
DB12274,Blood Proteins,DrugBank
DB12274,Globulins,DrugBank
DB12274,Immunoglobulins,DrugBank
DB12274,Immunoproteins,DrugBank
DB12274,Nervous System,DrugBank
DB12274,Proteins,DrugBank
DB12274,Psychoanaleptics,DrugBank
DB12274,Serum Globulins,DrugBank
DB12278,"Acids, Carbocyclic",DrugBank
DB12278,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB12278,Adrenergic alpha-Antagonists,DrugBank
DB12278,Adrenergic Antagonists,DrugBank
DB12278,Agents producing tachycardia,DrugBank
DB12278,Agents that produce hypertension,DrugBank
DB12278,Anticholinergic Agents,DrugBank
DB12278,Autonomic Agents,DrugBank
DB12278,Cholinergic Agents,DrugBank
DB12278,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12278,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12278,Cytochrome P-450 Substrates,DrugBank
DB12278,Diphenylacetic Acids,DrugBank
DB12278,Drugs for Urinary Frequency and Incontinence,DrugBank
DB12278,Drugs that are Mainly Renally Excreted,DrugBank
DB12278,Genito Urinary System and Sex Hormones,DrugBank
DB12278,Genitourinary Agents,DrugBank
DB12278,Hydroxy Acids,DrugBank
DB12278,Muscarinic Antagonists,DrugBank
DB12278,Neurotransmitter Agents,DrugBank
DB12278,Parasympatholytics,DrugBank
DB12278,Peripheral Nervous System Agents,DrugBank
DB12278,Phenylacetates,DrugBank
DB12278,Urological Agents,DrugBank
DB12278,Urologicals,DrugBank
DB12279,"Amino Acids, Peptides, and Proteins",DrugBank
DB12279,Antineoplastic Agents,DrugBank
DB12279,Histone Deacetylase Inhibitors,DrugBank
DB12279,Peptides,DrugBank
DB12279,"Peptides, Cyclic",DrugBank
DB12282,"Acids, Carbocyclic",DrugBank
DB12282,Amides,DrugBank
DB12282,BCRP/ABCG2 Inhibitors,DrugBank
DB12282,BCRP/ABCG2 Substrates,DrugBank
DB12282,Benzene Derivatives,DrugBank
DB12282,Benzoates,DrugBank
DB12282,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB12282,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB12282,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12282,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12282,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12282,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12282,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12282,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12282,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12282,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12282,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12282,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12282,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12282,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12282,Cytochrome P-450 Substrates,DrugBank
DB12282,"Focal Adhesion Kinase 1, antagonists & inhibitors",DrugBank
DB12282,MATE 2 Inhibitors,DrugBank
DB12282,MATE inhibitors,DrugBank
DB12282,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12282,OATP1B3 inhibitors,DrugBank
DB12282,Sulfones,DrugBank
DB12282,Sulfur Compounds,DrugBank
DB12282,UGT1A1 Inhibitors,DrugBank
DB12286,Antiarrhythmic agents,DrugBank
DB12286,Cardiotonic Agents,DrugBank
DB12286,Cardiovascular Agents,DrugBank
DB12286,"Compounds used in a research, industrial, or household setting",DrugBank
DB12286,Enzyme Inhibitors,DrugBank
DB12286,Hydrazines,DrugBank
DB12286,Hydrazones,DrugBank
DB12286,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12286,Phosphodiesterase 3 Inhibitors,DrugBank
DB12286,Phosphodiesterase Inhibitors,DrugBank
DB12286,Protective Agents,DrugBank
DB12286,Pyridazines,DrugBank
DB12286,QTc Prolonging Agents,DrugBank
DB12286,Vasodilating Agents,DrugBank
DB12289,"Acids, Carbocyclic",DrugBank
DB12289,Amides,DrugBank
DB12289,Anticoagulants,DrugBank
DB12289,Antithrombins,DrugBank
DB12289,Benzene Derivatives,DrugBank
DB12289,Benzoates,DrugBank
DB12289,Enzyme Inhibitors,DrugBank
DB12289,Factor Xa Inhibitors,DrugBank
DB12289,Hematologic Agents,DrugBank
DB12289,Protease Inhibitors,DrugBank
DB12289,Serine Protease Inhibitors,DrugBank
DB12290,Benzopyrans,DrugBank
DB12290,Cardiovascular Agents,DrugBank
DB12290,Chromones,DrugBank
DB12290,Flavonoids,DrugBank
DB12290,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12290,Pyrans,DrugBank
DB12290,Vasodilating Agents,DrugBank
DB12296,"Amino Acids, Peptides, and Proteins",DrugBank
DB12296,Antibodies,DrugBank
DB12296,"Antibodies, Monoclonal",DrugBank
DB12296,Blood Proteins,DrugBank
DB12296,Globulins,DrugBank
DB12296,Immunoglobulins,DrugBank
DB12296,Immunoproteins,DrugBank
DB12296,Proteins,DrugBank
DB12296,Serum Globulins,DrugBank
DB12301,Antiinfectives for Systemic Use,DrugBank
DB12301,Antiviral Agents,DrugBank
DB12301,Antivirals for Systemic Use,DrugBank
DB12301,Antivirals used in combination for the treatment of HIV infections,DrugBank
DB12301,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12301,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12301,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12301,Cytochrome P-450 Substrates,DrugBank
DB12301,Direct Acting Antivirals,DrugBank
DB12301,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB12301,Non-Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB12301,Nonnucleoside Reverse Transcriptase Inhibitors,DrugBank
DB12301,Pyridines,DrugBank
DB12308,Anesthetics,DrugBank
DB12308,Central Nervous System Agents,DrugBank
DB12308,Central Nervous System Depressants,DrugBank
DB12308,Fused-Ring Compounds,DrugBank
DB12308,Pregnanes,DrugBank
DB12308,Steroids,DrugBank
DB12313,Adrenergic Agents,DrugBank
DB12313,Adrenergic Agonists,DrugBank
DB12313,Adrenergic and Dopaminergic Agents,DrugBank
DB12313,Adrenergic beta-Agonists,DrugBank
DB12313,Agents producing tachycardia,DrugBank
DB12313,Agents that produce hypertension,DrugBank
DB12313,Amines,DrugBank
DB12313,Benzene Derivatives,DrugBank
DB12313,Biogenic Amines,DrugBank
DB12313,Biogenic Monoamines,DrugBank
DB12313,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB12313,Cardiac Therapy,DrugBank
DB12313,Cardiovascular Agents,DrugBank
DB12313,Catecholamines,DrugBank
DB12313,Catechols,DrugBank
DB12313,Dopamine Agents,DrugBank
DB12313,Dopamine Agonists,DrugBank
DB12313,Neurotransmitter Agents,DrugBank
DB12313,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB12313,Phenols,DrugBank
DB12313,Vasodilating Agents,DrugBank
DB12314,Amidines,DrugBank
DB12314,Anti-Infective Agents,DrugBank
DB12314,Antimalarials,DrugBank
DB12314,Antiparasitic Agents,DrugBank
DB12314,Antiprotozoals,DrugBank
DB12314,Biguanides,DrugBank
DB12314,Guanidines,DrugBank
DB12317,"Amino Acids, Peptides, and Proteins",DrugBank
DB12317,Antibodies,DrugBank
DB12317,"Antibodies, Monoclonal",DrugBank
DB12317,"Antibodies, Monoclonal, Humanized",DrugBank
DB12317,Blood Proteins,DrugBank
DB12317,Globulins,DrugBank
DB12317,Immunoglobulins,DrugBank
DB12317,Immunoproteins,DrugBank
DB12317,Proteins,DrugBank
DB12317,Serum Globulins,DrugBank
DB12319,Antigout Preparations,DrugBank
DB12319,Antirheumatic Agents,DrugBank
DB12319,Benzofurans,DrugBank
DB12319,BSEP/ABCB11 Substrates,DrugBank
DB12319,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12319,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12319,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12319,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12319,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12319,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12319,Musculo-Skeletal System,DrugBank
DB12319,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12319,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB12319,Preparations Increasing Uric Acid Excretion,DrugBank
DB12319,Uricosuric Agents,DrugBank
DB12321,Antiplatelet agents,DrugBank
DB12321,Hematologic Agents,DrugBank
DB12327,Alkaloids,DrugBank
DB12327,Central Nervous System Agents,DrugBank
DB12327,Central Nervous System Depressants,DrugBank
DB12327,Diterpene Alkaloids,DrugBank
DB12327,Diterpenes,DrugBank
DB12327,Hallucinogens,DrugBank
DB12327,Psychotropic Drugs,DrugBank
DB12327,Salvia,DrugBank
DB12327,Terpenes,DrugBank
DB12329,Anti-Bacterial Agents,DrugBank
DB12329,Antibacterials for Systemic Use,DrugBank
DB12329,Antiinfectives for Systemic Use,DrugBank
DB12329,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12329,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12329,Cytochrome P-450 Substrates,DrugBank
DB12329,Monoamine Oxidase A Substrates,DrugBank
DB12329,Naphthacenes,DrugBank
DB12329,Tetracyclines,DrugBank
DB12331,"Amino Acids, Peptides, and Proteins",DrugBank
DB12331,Antibodies,DrugBank
DB12331,"Antibodies, Monoclonal",DrugBank
DB12331,Blood Proteins,DrugBank
DB12331,Globulins,DrugBank
DB12331,Immunoglobulins,DrugBank
DB12331,Immunoproteins,DrugBank
DB12331,Proteins,DrugBank
DB12331,Serum Globulins,DrugBank
DB12332,Antineoplastic Agents,DrugBank
DB12332,Antineoplastic and Immunomodulating Agents,DrugBank
DB12332,BCRP/ABCG2 Inhibitors,DrugBank
DB12332,BCRP/ABCG2 Substrates,DrugBank
DB12332,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB12332,Cytochrome P-450 CYP1A2 Inducers (moderate),DrugBank
DB12332,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB12332,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12332,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB12332,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB12332,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB12332,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12332,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB12332,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12332,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB12332,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12332,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB12332,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12332,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12332,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB12332,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB12332,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB12332,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12332,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12332,Cytochrome P-450 Substrates,DrugBank
DB12332,Enzyme Inhibitors,DrugBank
DB12332,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12332,MATE 1 Inhibitors,DrugBank
DB12332,MATE 2 Inhibitors,DrugBank
DB12332,MATE inhibitors,DrugBank
DB12332,Narrow Therapeutic Index Drugs,DrugBank
DB12332,OAT1/SLC22A6 inhibitors,DrugBank
DB12332,OAT3/SLC22A8 Inhibitors,DrugBank
DB12332,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12332,OATP1B3 inhibitors,DrugBank
DB12332,OCT1 inhibitors,DrugBank
DB12332,P-glycoprotein inhibitors,DrugBank
DB12332,P-glycoprotein substrates,DrugBank
DB12332,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB12332,Poly (ADP-ribose) polymerase (PARP) inhibitors,DrugBank
DB12332,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB12332,UGT1A1 Inhibitors,DrugBank
DB12335,"Amino Acids, Peptides, and Proteins",DrugBank
DB12335,Analgesics,DrugBank
DB12335,Antibodies,DrugBank
DB12335,"Antibodies, Monoclonal",DrugBank
DB12335,"Antibodies, Monoclonal, Humanized",DrugBank
DB12335,Blood Proteins,DrugBank
DB12335,Central Nervous System Agents,DrugBank
DB12335,Globulins,DrugBank
DB12335,Immunoglobulins,DrugBank
DB12335,Immunoproteins,DrugBank
DB12335,Nervous System,DrugBank
DB12335,Peripheral Nervous System Agents,DrugBank
DB12335,Proteins,DrugBank
DB12335,"Receptor, Nerve Growth Factor, antagonists & inhibitors",DrugBank
DB12335,Sensory System Agents,DrugBank
DB12335,Serum Globulins,DrugBank
DB12338,"Acids, Acyclic",DrugBank
DB12338,Anticonvulsants,DrugBank
DB12338,Central Nervous System Depressants,DrugBank
DB12338,Nervous System,DrugBank
DB12339,Anti-Bacterial Agents,DrugBank
DB12339,Anti-Infective Agents,DrugBank
DB12339,Oxazoles,DrugBank
DB12340,Amides,DrugBank
DB12340,Amines,DrugBank
DB12340,Antineoplastic Agents,DrugBank
DB12340,Antineoplastic and Immunomodulating Agents,DrugBank
DB12340,Sulfones,DrugBank
DB12340,Sulfur Compounds,DrugBank
DB12342,"Amino Acids, Peptides, and Proteins",DrugBank
DB12342,Antibodies,DrugBank
DB12342,Blood Proteins,DrugBank
DB12342,Globulins,DrugBank
DB12342,Immunoglobulins,DrugBank
DB12342,Immunoproteins,DrugBank
DB12342,Proteins,DrugBank
DB12342,Serum Globulins,DrugBank
DB12343,Amides,DrugBank
DB12343,Anti-Bacterial Agents,DrugBank
DB12343,Anti-Infective Agents,DrugBank
DB12343,Antibacterials for Systemic Use,DrugBank
DB12343,Antiinfectives for Systemic Use,DrugBank
DB12343,Beta-Lactam Antibacterials,DrugBank
DB12343,beta-Lactams,DrugBank
DB12343,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12343,Lactams,DrugBank
DB12343,Penicillins,DrugBank
DB12343,Penicillins With Extended Spectrum,DrugBank
DB12343,Sulfur Compounds,DrugBank
DB12344,"Amino Acids, Peptides, and Proteins",DrugBank
DB12344,Antibodies,DrugBank
DB12344,"Antibodies, Monoclonal",DrugBank
DB12344,Blood Proteins,DrugBank
DB12344,Dermatologicals,DrugBank
DB12344,Globulins,DrugBank
DB12344,Immunoglobulins,DrugBank
DB12344,Immunoproteins,DrugBank
DB12344,Proteins,DrugBank
DB12344,Serum Globulins,DrugBank
DB12352,Alkylating Drugs,DrugBank
DB12352,Amides,DrugBank
DB12352,"Antibiotics, Antineoplastic",DrugBank
DB12352,Antineoplastic Agents,DrugBank
DB12352,"Antineoplastic Agents, Alkylating",DrugBank
DB12352,"Compounds used in a research, industrial, or household setting",DrugBank
DB12352,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12352,Indoles,DrugBank
DB12352,Noxae,DrugBank
DB12352,Toxic Actions,DrugBank
DB12361,Agents that produce hypertension,DrugBank
DB12361,Antidepressive Agents,DrugBank
DB12361,Azepines,DrugBank
DB12361,Central Nervous System Depressants,DrugBank
DB12361,Neurotransmitter Agents,DrugBank
DB12361,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB12361,Serotonin Agents,DrugBank
DB12361,Serotonin Receptor Agonists,DrugBank
DB12363,"Amino Acids, Peptides, and Proteins",DrugBank
DB12363,Antibodies,DrugBank
DB12363,"Antibodies, Monoclonal",DrugBank
DB12363,"Antibodies, Neutralizing",DrugBank
DB12363,Blood Proteins,DrugBank
DB12363,Globulins,DrugBank
DB12363,Immunoglobulins,DrugBank
DB12363,Immunoproteins,DrugBank
DB12363,Proteins,DrugBank
DB12363,Serum Globulins,DrugBank
DB12364,"Acids, Carbocyclic",DrugBank
DB12364,Amides,DrugBank
DB12364,Anticoagulants,DrugBank
DB12364,Antithrombins,DrugBank
DB12364,Benzene Derivatives,DrugBank
DB12364,Benzoates,DrugBank
DB12364,Blood and Blood Forming Organs,DrugBank
DB12364,Direct factor Xa inhibitors,DrugBank
DB12364,Enzyme Inhibitors,DrugBank
DB12364,Factor Xa Inhibitors,DrugBank
DB12364,Hematologic Agents,DrugBank
DB12364,P-glycoprotein substrates,DrugBank
DB12364,Protease Inhibitors,DrugBank
DB12364,Serine Protease Inhibitors,DrugBank
DB12371,Agents that produce hypertension,DrugBank
DB12371,Antineoplastic and Immunomodulating Agents,DrugBank
DB12371,Azetines,DrugBank
DB12371,Benzene Derivatives,DrugBank
DB12371,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12371,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB12371,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12371,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12371,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12371,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12371,Cytochrome P-450 Substrates,DrugBank
DB12371,Immunologic Factors,DrugBank
DB12371,Immunomodulatory Agents,DrugBank
DB12371,Immunosuppressive Agents,DrugBank
DB12371,Immunotherapy,DrugBank
DB12371,Narrow Therapeutic Index Drugs,DrugBank
DB12371,"Receptors, Lysosphingolipid, antagonists & inhibitors",DrugBank
DB12371,Selective Immunosuppressants,DrugBank
DB12371,Sphingosine 1 Phosphate Receptor Modulators,DrugBank
DB12371,Sphingosine 1-phosphate Receptor Modulator,DrugBank
DB12371,Sphingosine-1-phosphate (S1P) receptor modulators,DrugBank
DB12376,Amines,DrugBank
DB12376,Antineoplastic Agents,DrugBank
DB12376,Enzyme Inhibitors,DrugBank
DB12376,Histone Deacetylase Inhibitors,DrugBank
DB12376,Hydroxy Acids,DrugBank
DB12376,Hydroxylamines,DrugBank
DB12376,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12376,QTc Prolonging Agents,DrugBank
DB12377,Antibacterials for Systemic Use,DrugBank
DB12377,Antiinfectives for Systemic Use,DrugBank
DB12377,Aza Compounds,DrugBank
DB12377,beta-Lactamase Inhibitors,DrugBank
DB12377,Enzyme Inhibitors,DrugBank
DB12377,MATE 1 Substrates,DrugBank
DB12377,MATE 2 Substrates,DrugBank
DB12377,MATE substrates,DrugBank
DB12377,OAT3/SLC22A8 Substrates,DrugBank
DB12379,"Antibiotics, Antineoplastic",DrugBank
DB12379,Antineoplastic Agents,DrugBank
DB12379,Coloring Agents,DrugBank
DB12379,"Compounds used in a research, industrial, or household setting",DrugBank
DB12379,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB12379,Cytochrome P-450 Substrates,DrugBank
DB12379,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12379,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",DrugBank
DB12379,Protein Kinase Inhibitors,DrugBank
DB12381,Antineoplastic Agents,DrugBank
DB12381,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12381,Nicotinic Acids,DrugBank
DB12381,Protein Kinase Inhibitors,DrugBank
DB12381,Pyrazoles,DrugBank
DB12381,Pyridines,DrugBank
DB12382,Amines,DrugBank
DB12382,Antineoplastic Agents,DrugBank
DB12382,Enzyme Inhibitors,DrugBank
DB12382,Histone Deacetylase Inhibitors,DrugBank
DB12382,Hydroxy Acids,DrugBank
DB12382,Hydroxylamines,DrugBank
DB12382,Sulfur Compounds,DrugBank
DB12385,Alkaloids,DrugBank
DB12385,Antineoplastic Agents,DrugBank
DB12385,"Antineoplastic Agents, Phytogenic",DrugBank
DB12386,Live Attenuated Bacillus Calmette-Guerin Vaccine,DrugBank
DB12386,Live vaccines,DrugBank
DB12386,Vaccines,DrugBank
DB12387,mTOR Inhibitors,DrugBank
DB12390,"Acids, Acyclic",DrugBank
DB12390,Alimentary Tract and Metabolism,DrugBank
DB12390,Antimetabolites,DrugBank
DB12390,BCRP/ABCG2 Substrates,DrugBank
DB12390,Bile and Liver Therapy,DrugBank
DB12390,Bile Therapy,DrugBank
DB12390,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12390,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12390,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12390,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12390,Cytochrome P-450 Substrates,DrugBank
DB12390,Fatty Acids,DrugBank
DB12390,"Fatty Acids, Volatile",DrugBank
DB12390,Hypolipidemic Agents,DrugBank
DB12390,Lipid Regulating Agents,DrugBank
DB12390,Lipids,DrugBank
DB12390,OAT3/SLC22A8 Substrates,DrugBank
DB12390,P-glycoprotein substrates,DrugBank
DB12390,"PPAR delta, agonists",DrugBank
DB12391,Anti-Bacterial Agents,DrugBank
DB12391,Antineoplastic Agents,DrugBank
DB12391,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12391,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12391,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12391,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12391,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12391,Lactones,DrugBank
DB12391,Macrolides,DrugBank
DB12391,Polyketides,DrugBank
DB12391,Thiazoles,DrugBank
DB12395,Adrenergic Uptake Inhibitors,DrugBank
DB12395,Antidepressive Agents,DrugBank
DB12395,Central Nervous System Depressants,DrugBank
DB12395,Oxazines,DrugBank
DB12396,"Amino Acids, Peptides, and Proteins",DrugBank
DB12396,Antibodies,DrugBank
DB12396,"Antibodies, Monoclonal",DrugBank
DB12396,Blood Proteins,DrugBank
DB12396,Globulins,DrugBank
DB12396,Immunoglobulins,DrugBank
DB12396,Immunoproteins,DrugBank
DB12396,Proteins,DrugBank
DB12396,Serum Globulins,DrugBank
DB12399,Amides,DrugBank
DB12399,Anti-Inflammatory Agents,DrugBank
DB12399,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB12399,Antiinflammatory and Antirheumatic Products,DrugBank
DB12399,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB12399,COX-2 Inhibitors,DrugBank
DB12399,Cyclooxygenase Inhibitors,DrugBank
DB12399,Musculo-Skeletal System,DrugBank
DB12399,Selective Cyclooxygenase 2 Inhibitors (NSAIDs),DrugBank
DB12399,Sulfones,DrugBank
DB12399,Sulfur Compounds,DrugBank
DB12401,Antipsychotic Agents,DrugBank
DB12401,Butyrophenone Derivatives,DrugBank
DB12401,Butyrophenones,DrugBank
DB12401,Central Nervous System Agents,DrugBank
DB12401,Central Nervous System Depressants,DrugBank
DB12401,Ketones,DrugBank
DB12401,Nervous System,DrugBank
DB12401,Neurotoxic agents,DrugBank
DB12401,Psycholeptics,DrugBank
DB12401,Psychotropic Drugs,DrugBank
DB12401,Tranquilizing Agents,DrugBank
DB12404,Benzazepines,DrugBank
DB12404,Benzodiazepine hypnotics and sedatives,DrugBank
DB12404,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB12404,Central Nervous System Depressants,DrugBank
DB12404,GABA Agents,DrugBank
DB12404,GABA Modulators,DrugBank
DB12404,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12404,Hypnotics and Sedatives,DrugBank
DB12404,Nervous System,DrugBank
DB12404,Psycholeptics,DrugBank
DB12404,Tranquilizing Agents,DrugBank
DB12406,"Adjuvants, Immunologic",DrugBank
DB12406,Analgesics,DrugBank
DB12406,"Analgesics, Non-Narcotic",DrugBank
DB12406,Anti-Inflammatory Agents,DrugBank
DB12406,Antirheumatic Agents,DrugBank
DB12406,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12406,Cytochrome P-450 Substrates,DrugBank
DB12406,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12406,Immunologic Factors,DrugBank
DB12406,Peripheral Nervous System Agents,DrugBank
DB12406,Purines,DrugBank
DB12406,Purinones,DrugBank
DB12406,Radiation-Sensitizing Agents,DrugBank
DB12406,Sensory System Agents,DrugBank
DB12406,Xanthine derivatives,DrugBank
DB12409,"Amino Acids, Peptides, and Proteins",DrugBank
DB12409,Biological Factors,DrugBank
DB12409,Blood Coagulation Factors,DrugBank
DB12409,Blood Proteins,DrugBank
DB12409,Endopeptidases,DrugBank
DB12409,Enzymes,DrugBank
DB12409,Enzymes and Coenzymes,DrugBank
DB12409,Factor VII,DrugBank
DB12409,Hydrolases,DrugBank
DB12409,Peptide Hydrolases,DrugBank
DB12409,Proteins,DrugBank
DB12409,Serine Endopeptidases,DrugBank
DB12409,Serine Proteases,DrugBank
DB12412,Agents causing angioedema,DrugBank
DB12412,Alimentary Tract and Metabolism,DrugBank
DB12412,Blood Glucose Lowering Agents,DrugBank
DB12412,"Diabetes Mellitus, Type 2, drug therapy",DrugBank
DB12412,DPP-IV Inhibitors,DrugBank
DB12412,Drugs Used in Diabetes,DrugBank
DB12412,Oral Hypoglycemics,DrugBank
DB12412,Piperidines,DrugBank
DB12413,"Amino Acids, Peptides, and Proteins",DrugBank
DB12413,Antibodies,DrugBank
DB12413,"Antibodies, Monoclonal",DrugBank
DB12413,Antibody-drug Conjugates,DrugBank
DB12413,Blood Proteins,DrugBank
DB12413,Globulins,DrugBank
DB12413,Immunoglobulins,DrugBank
DB12413,Immunoproteins,DrugBank
DB12413,Proteins,DrugBank
DB12413,Serum Globulins,DrugBank
DB12416,"Acids, Acyclic",DrugBank
DB12416,Agents Acting on the Renin-Angiotensin System,DrugBank
DB12416,Renin Inhibitors,DrugBank
DB12417,Agents causing angioedema,DrugBank
DB12417,Blood Glucose Lowering Agents,DrugBank
DB12417,DPP-IV Inhibitors,DrugBank
DB12417,Enzyme Inhibitors,DrugBank
DB12417,Protease Inhibitors,DrugBank
DB12422,Anticarcinogenic Agents,DrugBank
DB12422,Antineoplastic Agents,DrugBank
DB12422,"Compounds used in a research, industrial, or household setting",DrugBank
DB12422,Isocyanates,DrugBank
DB12422,Protective Agents,DrugBank
DB12422,Sulfur Compounds,DrugBank
DB12425,Thyroxine-binding globulin substrates,DrugBank
DB12427,Antidepressive Agents,DrugBank
DB12427,Central Nervous System Depressants,DrugBank
DB12431,"Amino Acids, Peptides, and Proteins",DrugBank
DB12431,Biological Factors,DrugBank
DB12431,Carbohydrates,DrugBank
DB12431,Colony-Stimulating Factors,DrugBank
DB12431,Cytokines,DrugBank
DB12431,Glycoconjugates,DrugBank
DB12431,Glycoproteins,DrugBank
DB12431,Hematopoietic Cell Growth Factors,DrugBank
DB12431,Intercellular Signaling Peptides and Proteins,DrugBank
DB12431,Interleukin-3,DrugBank
DB12431,Interleukins,DrugBank
DB12431,Peptides,DrugBank
DB12431,Proteins,DrugBank
DB12445,Agents causing hyperkalemia,DrugBank
DB12445,Agents that produce hypertension,DrugBank
DB12445,Analgesics,DrugBank
DB12445,"Analgesics, Non-Narcotic",DrugBank
DB12445,Anti-Inflammatory Agents,DrugBank
DB12445,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB12445,Antiplatelet agents,DrugBank
DB12445,Antirheumatic Agents,DrugBank
DB12445,Benzene Derivatives,DrugBank
DB12445,Cardiovascular Agents,DrugBank
DB12445,Cysteine Proteinase Inhibitors,DrugBank
DB12445,Enzyme Inhibitors,DrugBank
DB12445,Fibrin Modulating Agents,DrugBank
DB12445,Hematologic Agents,DrugBank
DB12445,Hydroxybenzoates,DrugBank
DB12445,Nephrotoxic agents,DrugBank
DB12445,Non COX-2 selective NSAIDS,DrugBank
DB12445,Peripheral Nervous System Agents,DrugBank
DB12445,Phenols,DrugBank
DB12445,Protease Inhibitors,DrugBank
DB12445,Salicylates,DrugBank
DB12445,Sensory System Agents,DrugBank
DB12455,Anti-Bacterial Agents,DrugBank
DB12455,Antibacterials for Systemic Use,DrugBank
DB12455,Antiinfectives for Systemic Use,DrugBank
DB12455,Naphthacenes,DrugBank
DB12455,P-glycoprotein substrates,DrugBank
DB12455,Tetracyclines,DrugBank
DB12456,"Amino Acids, Peptides, and Proteins",DrugBank
DB12456,Antibodies,DrugBank
DB12456,"Antibodies, Monoclonal",DrugBank
DB12456,"Antibodies, Monoclonal, Humanized",DrugBank
DB12456,Anticholesteremic Agents,DrugBank
DB12456,Antimetabolites,DrugBank
DB12456,Blood Proteins,DrugBank
DB12456,Globulins,DrugBank
DB12456,Hypolipidemic Agents,DrugBank
DB12456,Immunoglobulins,DrugBank
DB12456,Immunoproteins,DrugBank
DB12456,Lipid Regulating Agents,DrugBank
DB12456,Proteins,DrugBank
DB12456,Serum Globulins,DrugBank
DB12457,Analgesics,DrugBank
DB12457,Antimigraine Preparations,DrugBank
DB12457,BCRP/ABCG2 Substrates,DrugBank
DB12457,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB12457,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB12457,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12457,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12457,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12457,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12457,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB12457,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12457,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12457,Cytochrome P-450 Substrates,DrugBank
DB12457,MATE 1 Inhibitors,DrugBank
DB12457,MATE inhibitors,DrugBank
DB12457,Migraine Disorders,DrugBank
DB12457,Nervous System,DrugBank
DB12457,OAT3/SLC22A8 Inhibitors,DrugBank
DB12457,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12457,OATP1B3 inhibitors,DrugBank
DB12457,OCT2 Inhibitors,DrugBank
DB12457,P-glycoprotein substrates,DrugBank
DB12459,Alkaloids,DrugBank
DB12459,Antineoplastic Agents,DrugBank
DB12459,Antineoplastic and Immunomodulating Agents,DrugBank
DB12459,Enzyme Inhibitors,DrugBank
DB12459,Topoisomerase 1 (TOP1) inhibitors,DrugBank
DB12459,Topoisomerase I Inhibitors,DrugBank
DB12459,Topoisomerase Inhibitors,DrugBank
DB12461,Androgens,DrugBank
DB12461,Imidazoles,DrugBank
DB12461,Imidazolidines,DrugBank
DB12465,Antidepressive Agents,DrugBank
DB12465,Antihypertensive Agents,DrugBank
DB12465,Antiplatelet agents,DrugBank
DB12465,Cardiovascular Agents,DrugBank
DB12465,Central Nervous System Depressants,DrugBank
DB12465,Hematologic Agents,DrugBank
DB12465,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12465,Neurotransmitter Agents,DrugBank
DB12465,Piperidines,DrugBank
DB12465,Quinazolines,DrugBank
DB12465,Quinazolinones,DrugBank
DB12465,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12465,Serotonin Agents,DrugBank
DB12465,Serotonin Receptor Antagonists,DrugBank
DB12466,Anti-Infective Agents,DrugBank
DB12466,Antiinfectives for Systemic Use,DrugBank
DB12466,Antiviral Agents,DrugBank
DB12466,Antivirals for Systemic Use,DrugBank
DB12466,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12466,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12466,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB12466,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB12466,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12466,Direct Acting Antivirals,DrugBank
DB12466,Experimental Unapproved Treatments for COVID-19,DrugBank
DB12466,OAT1/SLC22A6 inhibitors,DrugBank
DB12466,OAT3/SLC22A8 Inhibitors,DrugBank
DB12466,P-glycoprotein inhibitors,DrugBank
DB12471,Anti-Infective Agents,DrugBank
DB12471,Antifungal Agents,DrugBank
DB12471,Antiinfectives for Systemic Use,DrugBank
DB12471,Antimycotics for Systemic Use,DrugBank
DB12471,Carbohydrates,DrugBank
DB12471,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12471,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12471,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12471,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12471,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12471,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12471,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12471,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12471,Cytochrome P-450 Substrates,DrugBank
DB12471,OATP1B3 inhibitors,DrugBank
DB12471,P-glycoprotein substrates,DrugBank
DB12471,Terpenes,DrugBank
DB12471,Triterpenes,DrugBank
DB12471,Triterpenoid Antifungal,DrugBank
DB12471,Triterpenoid Antifungals,DrugBank
DB12473,Alkanes,DrugBank
DB12473,Alkanesulfonic Acids,DrugBank
DB12473,Anti-Infective Agents,DrugBank
DB12473,"Anti-Infective Agents, Local",DrugBank
DB12473,Antineoplastic Agents,DrugBank
DB12473,Blood Substitutes and Perfusion Solutions,DrugBank
DB12473,"Hydrocarbons, Acyclic",DrugBank
DB12473,Irrigating Solutions,DrugBank
DB12473,Sulfonic Acids,DrugBank
DB12473,Sulfur Acids,DrugBank
DB12473,Sulfur Compounds,DrugBank
DB12473,Thiazines,DrugBank
DB12474,Adrenal Cortex Hormones,DrugBank
DB12474,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB12474,"Contraceptive Agents, Female",DrugBank
DB12474,"Contraceptive Agents, Hormonal",DrugBank
DB12474,"Contraceptives, Oral",DrugBank
DB12474,"Contraceptives, Oral, Hormonal",DrugBank
DB12474,"Contraceptives, Oral, Synthetic",DrugBank
DB12474,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12474,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12474,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12474,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12474,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12474,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12474,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12474,Cytochrome P-450 Substrates,DrugBank
DB12474,Estren Derivatives,DrugBank
DB12474,Fused-Ring Compounds,DrugBank
DB12474,Genito Urinary System and Sex Hormones,DrugBank
DB12474,Hormonal Contraceptives for Systemic Use,DrugBank
DB12474,Norpregnanes,DrugBank
DB12474,Norpregnenes,DrugBank
DB12474,Norsteroids,DrugBank
DB12474,Progestin Contraceptives,DrugBank
DB12474,Progestins,DrugBank
DB12474,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB12474,Reproductive Control Agents,DrugBank
DB12474,Sex Hormones and Modulators of the Genital System,DrugBank
DB12474,Steroids,DrugBank
DB12478,Anti-Dyskinesia Agents,DrugBank
DB12478,Anti-Parkinson Agents (Dopamine Agonist),DrugBank
DB12478,Anti-Parkinson Drugs,DrugBank
DB12478,Central Nervous System Agents,DrugBank
DB12478,Dopamine Agents,DrugBank
DB12478,Dopamine Agonists,DrugBank
DB12478,Nervous System,DrugBank
DB12478,Neurotransmitter Agents,DrugBank
DB12478,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB12478,Piperazines,DrugBank
DB12480,Agents that produce hypertension,DrugBank
DB12480,Analgesics,DrugBank
DB12480,"Analgesics, Non-Narcotic",DrugBank
DB12480,Anti-HIV Agents,DrugBank
DB12480,Anti-Infective Agents,DrugBank
DB12480,Anti-Inflammatory Agents,DrugBank
DB12480,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB12480,Anti-Retroviral Agents,DrugBank
DB12480,Antimalarials,DrugBank
DB12480,Antineoplastic Agents,DrugBank
DB12480,"Antineoplastic Agents, Phytogenic",DrugBank
DB12480,Antiparasitic Agents,DrugBank
DB12480,Antiprotozoals,DrugBank
DB12480,Antirheumatic Agents,DrugBank
DB12480,Antiviral Agents,DrugBank
DB12480,Hormone Antagonists,DrugBank
DB12480,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12480,Lupanes,DrugBank
DB12480,Non COX-2 selective NSAIDS,DrugBank
DB12480,Pentacyclic Triterpenes,DrugBank
DB12480,Peripheral Nervous System Agents,DrugBank
DB12480,Prostaglandin Antagonists,DrugBank
DB12480,Sensory System Agents,DrugBank
DB12480,Terpenes,DrugBank
DB12480,Triterpenes,DrugBank
DB12482,"Acids, Carbocyclic",DrugBank
DB12482,Alimentary Tract and Metabolism,DrugBank
DB12482,Amides,DrugBank
DB12482,Benzene Derivatives,DrugBank
DB12482,Benzoates,DrugBank
DB12482,Cholinergic Agents,DrugBank
DB12482,Cholinesterase Inhibitors,DrugBank
DB12482,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB12482,Enzyme Inhibitors,DrugBank
DB12482,Gastrointestinal Agents,DrugBank
DB12482,Neurotransmitter Agents,DrugBank
DB12482,Propulsives,DrugBank
DB12482,Sulfur Compounds,DrugBank
DB12483,Antineoplastic Agents,DrugBank
DB12483,Antineoplastic and Immunomodulating Agents,DrugBank
DB12483,BCRP/ABCG2 Substrates,DrugBank
DB12483,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB12483,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12483,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12483,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12483,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12483,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index,DrugBank
DB12483,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB12483,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index,DrugBank
DB12483,Cytochrome P-450 Substrates,DrugBank
DB12483,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12483,Kinase Inhibitor,DrugBank
DB12483,MATE 2 Inhibitors,DrugBank
DB12483,MATE inhibitors,DrugBank
DB12483,Narrow Therapeutic Index Drugs,DrugBank
DB12483,P-glycoprotein substrates,DrugBank
DB12483,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB12483,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,DrugBank
DB12483,Protein Kinase Inhibitors,DrugBank
DB12487,Estradiol Congeners,DrugBank
DB12487,Estranes,DrugBank
DB12487,Estrenes,DrugBank
DB12487,Estrogens,DrugBank
DB12487,Fused-Ring Compounds,DrugBank
DB12487,Genito Urinary System and Sex Hormones,DrugBank
DB12487,Gonadal Hormones,DrugBank
DB12487,Gonadal Steroid Hormones,DrugBank
DB12487,Hormones,DrugBank
DB12487,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12487,"Natural and Semisynthetic Estrogens, Plain",DrugBank
DB12487,Sex Hormones and Modulators of the Genital System,DrugBank
DB12487,Steroids,DrugBank
DB12489,"Amino Acids, Peptides, and Proteins",DrugBank
DB12489,Antibodies,DrugBank
DB12489,"Antibodies, Monoclonal",DrugBank
DB12489,Antibody-drug Conjugates,DrugBank
DB12489,Antineoplastic Agents,DrugBank
DB12489,Antineoplastic and Immunomodulating Agents,DrugBank
DB12489,Blood Proteins,DrugBank
DB12489,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12489,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12489,Cytochrome P-450 Substrates,DrugBank
DB12489,Globulins,DrugBank
DB12489,Immunoconjugates,DrugBank
DB12489,Immunoglobulins,DrugBank
DB12489,Immunologic Factors,DrugBank
DB12489,Immunoproteins,DrugBank
DB12489,"Lactams, Macrocyclic",DrugBank
DB12489,Lactones,DrugBank
DB12489,Microtubule Inhibition,DrugBank
DB12489,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB12489,P-glycoprotein substrates,DrugBank
DB12489,Proteins,DrugBank
DB12489,Serum Globulins,DrugBank
DB12492,Analgesics,DrugBank
DB12492,Central Nervous System Agents,DrugBank
DB12492,Central Nervous System Depressants,DrugBank
DB12492,Diphenylpropylamine Derivatives,DrugBank
DB12492,Isonipecotic Acids,DrugBank
DB12492,Narcotics,DrugBank
DB12492,Nervous System,DrugBank
DB12492,Opioids,DrugBank
DB12492,Peripheral Nervous System Agents,DrugBank
DB12492,Piperidines,DrugBank
DB12492,Sensory System Agents,DrugBank
DB12492,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12498,"Amino Acids, Peptides, and Proteins",DrugBank
DB12498,Antibodies,DrugBank
DB12498,"Antibodies, Monoclonal",DrugBank
DB12498,"Antibodies, Monoclonal, Humanized",DrugBank
DB12498,Antineoplastic Agents,DrugBank
DB12498,Antineoplastic and Immunomodulating Agents,DrugBank
DB12498,Blood Proteins,DrugBank
DB12498,Cancer immunotherapy,DrugBank
DB12498,Chemokine Receptor Type 4 Interaction,DrugBank
DB12498,Chemokine Receptor Type 4 Interactions,DrugBank
DB12498,Globulins,DrugBank
DB12498,Immunoglobulins,DrugBank
DB12498,Immunoproteins,DrugBank
DB12498,Immunotherapy,DrugBank
DB12498,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB12498,Narrow Therapeutic Index Drugs,DrugBank
DB12498,Proteins,DrugBank
DB12498,Serum Globulins,DrugBank
DB12500,Amides,DrugBank
DB12500,Antineoplastic Agents,DrugBank
DB12500,Antineoplastic and Immunomodulating Agents,DrugBank
DB12500,BCRP/ABCG2 Inhibitors,DrugBank
DB12500,Benzene Derivatives,DrugBank
DB12500,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12500,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12500,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12500,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12500,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12500,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12500,Cytochrome P-450 Substrates,DrugBank
DB12500,Genito Urinary System and Sex Hormones,DrugBank
DB12500,Gynecological Antiinfectives and Antiseptics,DrugBank
DB12500,Janus Kinase Inhibitor,DrugBank
DB12500,Kinase Inhibitor,DrugBank
DB12500,MATE 1 Inhibitors,DrugBank
DB12500,MATE 2 Inhibitors,DrugBank
DB12500,MATE inhibitors,DrugBank
DB12500,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12500,OATP1B3 inhibitors,DrugBank
DB12500,P-glycoprotein inhibitors,DrugBank
DB12500,P-glycoprotein substrates,DrugBank
DB12500,Protein Kinase Inhibitors,DrugBank
DB12500,Sulfonamides,DrugBank
DB12500,Sulfones,DrugBank
DB12500,Sulfur Compounds,DrugBank
DB12500,Tyrosine Kinase Inhibitors,DrugBank
DB12513,Anti-Inflammatory Agents,DrugBank
DB12513,Antioxidants,DrugBank
DB12513,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB12513,Cytochrome P-450 CYP2C8 Inducers (weak),DrugBank
DB12513,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12513,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12513,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12513,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12513,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB12513,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12513,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12513,Cytochrome P-450 Substrates,DrugBank
DB12513,Nervous System,DrugBank
DB12513,OAT1/SLC22A6 inhibitors,DrugBank
DB12513,Oxidation-Reduction Agent,DrugBank
DB12513,Terpenes,DrugBank
DB12513,Triterpenes,DrugBank
DB12515,Alkaloids,DrugBank
DB12515,Antineoplastic Agents,DrugBank
DB12515,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12515,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12515,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12515,Cytochrome P-450 Substrates,DrugBank
DB12518,"Acids, Carbocyclic",DrugBank
DB12518,Amides,DrugBank
DB12518,Antipsychotic Agents,DrugBank
DB12518,Benzamides and benzamide derivatives,DrugBank
DB12518,Benzene Derivatives,DrugBank
DB12518,Benzoates,DrugBank
DB12518,Central Nervous System Agents,DrugBank
DB12518,Central Nervous System Depressants,DrugBank
DB12518,Chlorobenzoates,DrugBank
DB12518,Dopamine Agents,DrugBank
DB12518,Dopamine Antagonists,DrugBank
DB12518,Dopamine D2 Receptor Antagonists,DrugBank
DB12518,Neurotoxic agents,DrugBank
DB12518,Neurotransmitter Agents,DrugBank
DB12518,Psychotropic Drugs,DrugBank
DB12518,Tranquilizing Agents,DrugBank
DB12520,"Amino Acids, Peptides, and Proteins",DrugBank
DB12520,Antibodies,DrugBank
DB12520,"Antibodies, Monoclonal",DrugBank
DB12520,"Antibodies, Monoclonal, Humanized",DrugBank
DB12520,Blood Proteins,DrugBank
DB12520,Globulins,DrugBank
DB12520,Immunoglobulins,DrugBank
DB12520,Immunoproteins,DrugBank
DB12520,Proteins,DrugBank
DB12520,Serum Globulins,DrugBank
DB12523,Antihistamines for Systemic Use,DrugBank
DB12523,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12523,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12523,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12523,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12523,Histamine Agents,DrugBank
DB12523,Histamine Antagonists,DrugBank
DB12523,Histamine H1 Antagonists,DrugBank
DB12523,"Histamine H1 Antagonists, Non-Sedating",DrugBank
DB12523,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12523,Neurotransmitter Agents,DrugBank
DB12523,QTc Prolonging Agents,DrugBank
DB12525,"Adjuvants, Immunologic",DrugBank
DB12525,"Amino Acids, Peptides, and Proteins",DrugBank
DB12525,Antineoplastic Agents,DrugBank
DB12525,Antineoplastic and Immunomodulating Agents,DrugBank
DB12525,Biological Factors,DrugBank
DB12525,Carbohydrates,DrugBank
DB12525,Colony-Stimulating Factors,DrugBank
DB12525,Cytokines,DrugBank
DB12525,Glycoconjugates,DrugBank
DB12525,Glycoproteins,DrugBank
DB12525,Granulocyte-Macrophage Colony-Stimulating Factor,DrugBank
DB12525,Hematopoietic Cell Growth Factors,DrugBank
DB12525,Intercellular Signaling Peptides and Proteins,DrugBank
DB12525,Peptides,DrugBank
DB12525,Proteins,DrugBank
DB12526,"Acids, Acyclic",DrugBank
DB12526,Adrenergic Agonists,DrugBank
DB12526,Adrenergic beta-2 Receptor Agonists,DrugBank
DB12526,Adrenergic beta-Agonists,DrugBank
DB12526,Anticholinergic Agents,DrugBank
DB12526,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12526,Muscarinic Antagonists,DrugBank
DB12526,Quinolines,DrugBank
DB12530,"Amino Acids, Peptides, and Proteins",DrugBank
DB12530,Antibodies,DrugBank
DB12530,"Antibodies, Monoclonal",DrugBank
DB12530,"Antibodies, Monoclonal, Humanized",DrugBank
DB12530,Antineoplastic and Immunomodulating Agents,DrugBank
DB12530,Blood Proteins,DrugBank
DB12530,CD19 Directed Cytolytic Antibodies,DrugBank
DB12530,CD19-directed Cytolytic Antibody,DrugBank
DB12530,Globulins,DrugBank
DB12530,Immunoglobulins,DrugBank
DB12530,Immunoproteins,DrugBank
DB12530,Immunosuppressive Agents,DrugBank
DB12530,Proteins,DrugBank
DB12530,Selective Immunosuppressants,DrugBank
DB12530,Serum Globulins,DrugBank
DB12531,Anti-HIV Agents,DrugBank
DB12531,Anti-Infective Agents,DrugBank
DB12531,Anti-Retroviral Agents,DrugBank
DB12531,Antiviral Agents,DrugBank
DB12531,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12531,Cytochrome P-450 Substrates,DrugBank
DB12531,Enzyme Inhibitors,DrugBank
DB12531,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12531,Nucleic Acid Synthesis Inhibitors,DrugBank
DB12531,Purines,DrugBank
DB12531,Purinones,DrugBank
DB12531,Reverse Transcriptase Inhibitors,DrugBank
DB12531,Xanthine derivatives,DrugBank
DB12532,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB12532,Alcohols,DrugBank
DB12532,Amines,DrugBank
DB12532,Amino Alcohols,DrugBank
DB12532,Anesthetics,DrugBank
DB12532,"Anesthetics, Local",DrugBank
DB12532,Central Nervous System Agents,DrugBank
DB12532,Central Nervous System Depressants,DrugBank
DB12532,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12532,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12532,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12532,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12532,Peripheral Nervous System Agents,DrugBank
DB12532,Sensory System Agents,DrugBank
DB12532,Vasoprotectives,DrugBank
DB12534,"Amino Acids, Peptides, and Proteins",DrugBank
DB12534,Antibodies,DrugBank
DB12534,"Antibodies, Monoclonal",DrugBank
DB12534,Antirheumatic Agents,DrugBank
DB12534,Blood Proteins,DrugBank
DB12534,Globulins,DrugBank
DB12534,Immunoglobulins,DrugBank
DB12534,Immunoproteins,DrugBank
DB12534,Proteins,DrugBank
DB12534,Serum Globulins,DrugBank
DB12537,Benzazepines,DrugBank
DB12537,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB12537,"Benzodiazepines, antagonists & inhibitors",DrugBank
DB12537,Central Nervous System Depressants,DrugBank
DB12537,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12537,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12537,Cytochrome P-450 Substrates,DrugBank
DB12537,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12539,Anthelmintics,DrugBank
DB12539,Anti-Infective Agents,DrugBank
DB12539,Anticarcinogenic Agents,DrugBank
DB12539,Antineoplastic Agents,DrugBank
DB12539,Antiparasitic Agents,DrugBank
DB12539,Antiplatyhelmintic Agents,DrugBank
DB12539,"Compounds used in a research, industrial, or household setting",DrugBank
DB12539,Enzyme Inhibitors,DrugBank
DB12539,Nucleic Acid Synthesis Inhibitors,DrugBank
DB12539,Protective Agents,DrugBank
DB12539,Reverse Transcriptase Inhibitors,DrugBank
DB12539,Schistosomicides,DrugBank
DB12539,Sulfur Compounds,DrugBank
DB12543,Alkaloids,DrugBank
DB12543,Antipsychotic Agents,DrugBank
DB12543,Central Nervous System Agents,DrugBank
DB12543,Central Nervous System Depressants,DrugBank
DB12543,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12543,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12543,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12543,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12543,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12543,Cytochrome P-450 Substrates,DrugBank
DB12543,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB12543,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12543,Morphinans,DrugBank
DB12543,Nervous System,DrugBank
DB12543,Opiate Alkaloids,DrugBank
DB12543,Opioid Antagonists,DrugBank
DB12543,Peripheral Nervous System Agents,DrugBank
DB12543,Phenanthrenes,DrugBank
DB12543,Psycholeptics,DrugBank
DB12543,Sensory System Agents,DrugBank
DB12545,"Acids, Carbocyclic",DrugBank
DB12545,Agents causing hyperkalemia,DrugBank
DB12545,Agents that produce hypertension,DrugBank
DB12545,Analgesics,DrugBank
DB12545,"Analgesics, Non-Narcotic",DrugBank
DB12545,Anti-Inflammatory Agents,DrugBank
DB12545,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB12545,Antiplatelet agents,DrugBank
DB12545,Antirheumatic Agents,DrugBank
DB12545,Blood and Blood Forming Organs,DrugBank
DB12545,Cyclooxygenase Inhibitors,DrugBank
DB12545,Enzyme Inhibitors,DrugBank
DB12545,Hematologic Agents,DrugBank
DB12545,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12545,Nephrotoxic agents,DrugBank
DB12545,Non COX-2 selective NSAIDS,DrugBank
DB12545,Peripheral Nervous System Agents,DrugBank
DB12545,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB12545,Sensory System Agents,DrugBank
DB12548,Agents Acting on the Renin-Angiotensin System,DrugBank
DB12548,Amides,DrugBank
DB12548,Angiotensin 2 Receptor Blocker,DrugBank
DB12548,Angiotensin II receptor antagonists,DrugBank
DB12548,Angiotensin II Type 1 Receptor Blockers,DrugBank
DB12548,Angiotensin Receptor Antagonists,DrugBank
DB12548,BCRP/ABCG2 Inhibitors,DrugBank
DB12548,BCRP/ABCG2 Substrates,DrugBank
DB12548,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12548,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12548,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB12548,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB12548,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB12548,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB12548,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12548,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12548,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12548,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12548,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12548,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12548,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12548,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12548,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12548,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12548,Cytochrome P-450 Substrates,DrugBank
DB12548,Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA),DrugBank
DB12548,Endothelin Receptor Antagonists,DrugBank
DB12548,OAT3/SLC22A8 Inhibitors,DrugBank
DB12548,OATP1B3 inhibitors,DrugBank
DB12548,P-glycoprotein inhibitors,DrugBank
DB12548,P-glycoprotein substrates,DrugBank
DB12548,Sulfones,DrugBank
DB12548,Sulfur Compounds,DrugBank
DB12549,Antineoplastic Agents,DrugBank
DB12549,"Compounds used in a research, industrial, or household setting",DrugBank
DB12549,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12549,Indicators and Reagents,DrugBank
DB12549,Intercalating Agents,DrugBank
DB12549,Laboratory Chemicals,DrugBank
DB12551,Adrenergic Agents,DrugBank
DB12551,Adrenergic alpha-2 Receptor Antagonists,DrugBank
DB12551,Adrenergic alpha-Antagonists,DrugBank
DB12551,Adrenergic Antagonists,DrugBank
DB12551,Agents that produce hypertension,DrugBank
DB12551,Dioxanes,DrugBank
DB12551,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12551,Imidazoles,DrugBank
DB12551,Neurotransmitter Agents,DrugBank
DB12554,Agents Causing Muscle Toxicity,DrugBank
DB12554,Agents producing tachycardia,DrugBank
DB12554,Alimentary Tract and Metabolism,DrugBank
DB12554,Amines,DrugBank
DB12554,Anticholinergic Agents,DrugBank
DB12554,Autonomic Agents,DrugBank
DB12554,Central Nervous System Agents,DrugBank
DB12554,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB12554,Ethylamines,DrugBank
DB12554,Muscarinic Antagonists,DrugBank
DB12554,Parasympatholytics,DrugBank
DB12554,Peripheral Nervous System Agents,DrugBank
DB12554,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB12560,"Amino Acids, Peptides, and Proteins",DrugBank
DB12560,Antibodies,DrugBank
DB12560,"Antibodies, Monoclonal",DrugBank
DB12560,"Antibodies, Monoclonal, Humanized",DrugBank
DB12560,Blood Proteins,DrugBank
DB12560,Globulins,DrugBank
DB12560,Immunoglobulins,DrugBank
DB12560,Immunoproteins,DrugBank
DB12560,Proteins,DrugBank
DB12560,Serum Globulins,DrugBank
DB12565,Amines,DrugBank
DB12565,Antineoplastic Agents,DrugBank
DB12565,Enzyme Inhibitors,DrugBank
DB12565,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12565,Histone Deacetylase Inhibitors,DrugBank
DB12565,Hydroxy Acids,DrugBank
DB12565,Hydroxylamines,DrugBank
DB12565,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12565,QTc Prolonging Agents,DrugBank
DB12568,"Amino Acids, Peptides, and Proteins",DrugBank
DB12568,Biological Products,DrugBank
DB12568,Carbohydrates,DrugBank
DB12568,Complex Mixtures,DrugBank
DB12568,Glycoconjugates,DrugBank
DB12568,Glycoproteins,DrugBank
DB12568,Membrane Proteins,DrugBank
DB12568,Proteins,DrugBank
DB12568,Vaccines,DrugBank
DB12576,"Acids, Carbocyclic",DrugBank
DB12576,Central Nervous System Depressants,DrugBank
DB12576,Hypnotics and Sedatives,DrugBank
DB12577,Antineoplastic Agents,DrugBank
DB12577,"Antineoplastic Agents, Phytogenic",DrugBank
DB12577,Benzene Derivatives,DrugBank
DB12577,Benzylidene Compounds,DrugBank
DB12578,Anti-Inflammatory Agents,DrugBank
DB12578,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12578,Nucleotides,DrugBank
DB12578,Oligonucleotides,DrugBank
DB12578,Pegylated agents,DrugBank
DB12578,Polynucleotides,DrugBank
DB12579,Dopamine Agents,DrugBank
DB12579,Dopamine Antagonists,DrugBank
DB12579,Dopamine D2 Receptor Antagonists,DrugBank
DB12579,Neurotransmitter Agents,DrugBank
DB12582,Alkenes,DrugBank
DB12582,Alkynes,DrugBank
DB12582,Amides,DrugBank
DB12582,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12582,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12582,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12582,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12582,Dioxoles,DrugBank
DB12582,Enzyme Inhibitors,DrugBank
DB12582,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12582,"Hydrocarbons, Acyclic",DrugBank
DB12582,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB12582,P-glycoprotein inhibitors,DrugBank
DB12582,Piper nigrum,DrugBank
DB12584,"Amino Acids, Peptides, and Proteins",DrugBank
DB12584,Antibodies,DrugBank
DB12584,"Antibodies, Monoclonal",DrugBank
DB12584,Blood Proteins,DrugBank
DB12584,Globulins,DrugBank
DB12584,Immunoglobulins,DrugBank
DB12584,Immunoproteins,DrugBank
DB12584,Proteins,DrugBank
DB12584,Serum Globulins,DrugBank
DB12589,"Amino Acids, Peptides, and Proteins",DrugBank
DB12589,Antibodies,DrugBank
DB12589,"Antibodies, Monoclonal",DrugBank
DB12589,"Antibodies, Monoclonal, Humanized",DrugBank
DB12589,Antineoplastic Agents,DrugBank
DB12589,"Antineoplastic Agents, Immunological",DrugBank
DB12589,Blood Proteins,DrugBank
DB12589,Globulins,DrugBank
DB12589,Immunoglobulins,DrugBank
DB12589,Immunoproteins,DrugBank
DB12589,Proteins,DrugBank
DB12589,Serum Globulins,DrugBank
DB12590,Benzazepines,DrugBank
DB12590,Central Nervous System Agents,DrugBank
DB12590,Central Nervous System Depressants,DrugBank
DB12590,GABA Agents,DrugBank
DB12590,GABA Modulators,DrugBank
DB12590,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12590,Hypnotics (Nonbenzodiazepine),DrugBank
DB12590,Hypnotics and Sedatives,DrugBank
DB12590,Neurotransmitter Agents,DrugBank
DB12590,Sulfur Compounds,DrugBank
DB12593,Antineoplastic Agents,DrugBank
DB12593,Azirines,DrugBank
DB12593,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12593,Indoles,DrugBank
DB12593,Quinones,DrugBank
DB12596,Antimitotic Agents,DrugBank
DB12596,Antineoplastic Agents,DrugBank
DB12596,"Antineoplastic Agents, Phytogenic",DrugBank
DB12596,Benzene Derivatives,DrugBank
DB12596,Benzyl Compounds,DrugBank
DB12596,Combretum,DrugBank
DB12596,Mitosis Modulators,DrugBank
DB12596,Tubulin Modulators,DrugBank
DB12597,Antineoplastic Agents,DrugBank
DB12597,Antineoplastic and Immunomodulating Agents,DrugBank
DB12597,Bcr-Abl Tyrosine Kinase Inhibitors,DrugBank
DB12597,BCRP/ABCG2 Inhibitors,DrugBank
DB12597,BCRP/ABCG2 Substrates,DrugBank
DB12597,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB12597,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB12597,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12597,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12597,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12597,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12597,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12597,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12597,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12597,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12597,Cytochrome P-450 Substrates,DrugBank
DB12597,Enzyme Inhibitors,DrugBank
DB12597,Nicotinic Acids,DrugBank
DB12597,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12597,OATP1B3 inhibitors,DrugBank
DB12597,OCT1 inhibitors,DrugBank
DB12597,P-glycoprotein inhibitors,DrugBank
DB12597,P-glycoprotein substrates,DrugBank
DB12597,Protein Kinase Inhibitors,DrugBank
DB12597,Pyridines,DrugBank
DB12597,Tyrosine Kinase Inhibitors,DrugBank
DB12597,UGT1A1 Inhibitors,DrugBank
DB12597,UGT2B17 substrates,DrugBank
DB12597,UGT2B7 substrates,DrugBank
DB12598,Amidines,DrugBank
DB12598,Analgesics,DrugBank
DB12598,"Analgesics, Non-Narcotic",DrugBank
DB12598,Anti-Inflammatory Agents,DrugBank
DB12598,Anticoagulants,DrugBank
DB12598,Antirheumatic Agents,DrugBank
DB12598,Complement Inactivating Agents,DrugBank
DB12598,Enzyme Inhibitors,DrugBank
DB12598,"Fibrinolysin, antagonists & inhibitors",DrugBank
DB12598,Hematologic Agents,DrugBank
DB12598,Immunologic Factors,DrugBank
DB12598,"Kallikreins, antagonists & inhibitors",DrugBank
DB12598,OCT1 substrates,DrugBank
DB12598,OCT2 Substrates,DrugBank
DB12598,Peripheral Nervous System Agents,DrugBank
DB12598,Protease Inhibitors,DrugBank
DB12598,Sensory System Agents,DrugBank
DB12598,Serine Protease Inhibitors,DrugBank
DB12598,Trypsin Inhibitors,DrugBank
DB12604,Agents that produce neuromuscular block (indirect),DrugBank
DB12604,Aminoglycoside Antibacterials,DrugBank
DB12604,Anti-Bacterial Agents,DrugBank
DB12604,Anti-Infective Agents,DrugBank
DB12604,Antibacterials for Systemic Use,DrugBank
DB12604,Antiinfectives for Systemic Use,DrugBank
DB12604,Carbohydrates,DrugBank
DB12604,Drugs that are Mainly Renally Excreted,DrugBank
DB12604,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB12604,Enzyme Inhibitors,DrugBank
DB12604,Gentamicins,DrugBank
DB12604,Glycosides,DrugBank
DB12604,Narrow Therapeutic Index Drugs,DrugBank
DB12604,Nephrotoxic agents,DrugBank
DB12604,Protein Synthesis Inhibitors,DrugBank
DB12605,"Acids, Carbocyclic",DrugBank
DB12605,Antiarrhythmic agents,DrugBank
DB12605,Benzene Derivatives,DrugBank
DB12605,Calcium Channel Blockers,DrugBank
DB12605,Calcium Channel Blockers (Nondihydropyridine),DrugBank
DB12605,Calcium-Regulating Hormones and Agents,DrugBank
DB12605,Cardiovascular Agents,DrugBank
DB12605,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12605,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12605,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12605,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12605,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12605,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12605,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12605,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12605,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12605,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12605,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12605,Cytochrome P-450 Substrates,DrugBank
DB12605,MATE 1 Inhibitors,DrugBank
DB12605,MATE inhibitors,DrugBank
DB12605,Membrane Transport Modulators,DrugBank
DB12605,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12605,P-glycoprotein inhibitors,DrugBank
DB12605,P-glycoprotein substrates,DrugBank
DB12605,Phenylalkylamine Derivatives,DrugBank
DB12605,Selective Calcium Channel Blockers With Direct Cardiac Effects,DrugBank
DB12609,"Amino Acids, Peptides, and Proteins",DrugBank
DB12609,Antibodies,DrugBank
DB12609,"Antibodies, Monoclonal",DrugBank
DB12609,Blood Proteins,DrugBank
DB12609,Globulins,DrugBank
DB12609,Immunoglobulins,DrugBank
DB12609,Immunoproteins,DrugBank
DB12609,Proteins,DrugBank
DB12609,Serum Globulins,DrugBank
DB12610,Agents that produce hypertension,DrugBank
DB12610,Analgesics,DrugBank
DB12610,"Analgesics, Non-Narcotic",DrugBank
DB12610,Anti-Inflammatory Agents,DrugBank
DB12610,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB12610,Anti-Ulcer Agents,DrugBank
DB12610,Antioxidants,DrugBank
DB12610,Antirheumatic Agents,DrugBank
DB12610,Biological Factors,DrugBank
DB12610,Central Nervous System Agents,DrugBank
DB12610,"Compounds used in a research, industrial, or household setting",DrugBank
DB12610,Cyclooxygenase Inhibitors,DrugBank
DB12610,Enzyme Inhibitors,DrugBank
DB12610,Gastrointestinal Agents,DrugBank
DB12610,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12610,Neuroprotective Agents,DrugBank
DB12610,Peripheral Nervous System Agents,DrugBank
DB12610,Protective Agents,DrugBank
DB12610,Selenium Compounds,DrugBank
DB12610,Sensory System Agents,DrugBank
DB12612,Antineoplastic and Immunomodulating Agents,DrugBank
DB12612,BCRP/ABCG2 Substrates,DrugBank
DB12612,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12612,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12612,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12612,Cytochrome P-450 Substrates,DrugBank
DB12612,Immunologic Factors,DrugBank
DB12612,Immunomodulatory Agents,DrugBank
DB12612,Immunosuppressive Agents,DrugBank
DB12612,Indenes,DrugBank
DB12612,Oxazoles,DrugBank
DB12612,P-glycoprotein substrates,DrugBank
DB12612,Selective Immunosuppressants,DrugBank
DB12612,Sphingosine 1 Phosphate Receptor Modulators,DrugBank
DB12612,Sphingosine 1-phosphate Receptor Modulator,DrugBank
DB12612,Sphingosine-1-phosphate (S1P) receptor modulators,DrugBank
DB12615,Agents that produce neuromuscular block (indirect),DrugBank
DB12615,Aminoglycoside Antibacterials,DrugBank
DB12615,Anti-Bacterial Agents,DrugBank
DB12615,Antibacterials for Systemic Use,DrugBank
DB12615,Antiinfectives for Systemic Use,DrugBank
DB12615,Carbohydrates,DrugBank
DB12615,Drugs that are Mainly Renally Excreted,DrugBank
DB12615,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB12615,Gentamicins,DrugBank
DB12615,Glycosides,DrugBank
DB12615,MATE 1 Inhibitors,DrugBank
DB12615,MATE 2 Inhibitors,DrugBank
DB12615,MATE inhibitors,DrugBank
DB12615,Narrow Therapeutic Index Drugs,DrugBank
DB12615,Nephrotoxic agents,DrugBank
DB12617,Analgesics,DrugBank
DB12617,"Analgesics, Non-Narcotic",DrugBank
DB12617,Anti-Infective Agents,DrugBank
DB12617,Anti-Inflammatory Agents,DrugBank
DB12617,"Antibiotics, Antineoplastic",DrugBank
DB12617,Antimalarials,DrugBank
DB12617,Antineoplastic Agents,DrugBank
DB12617,Antiparasitic Agents,DrugBank
DB12617,Antiprotozoals,DrugBank
DB12617,Antirheumatic Agents,DrugBank
DB12617,Enzyme Inhibitors,DrugBank
DB12617,Immunologic Factors,DrugBank
DB12617,Immunosuppressive Agents,DrugBank
DB12617,"IMP Dehydrogenase, antagonists & inhibitors",DrugBank
DB12617,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12617,Nucleosides,DrugBank
DB12617,Peripheral Nervous System Agents,DrugBank
DB12617,Sensory System Agents,DrugBank
DB12625,Agents causing angioedema,DrugBank
DB12625,Alimentary Tract and Metabolism,DrugBank
DB12625,Blood Glucose Lowering Agents,DrugBank
DB12625,Dipeptidyl Peptidase 4,DrugBank
DB12625,DPP-IV Inhibitors,DrugBank
DB12625,Drugs Used in Diabetes,DrugBank
DB12625,Oral Hypoglycemics,DrugBank
DB12629,"Acids, Acyclic",DrugBank
DB12629,Amino Acids,DrugBank
DB12629,"Amino Acids, Aromatic",DrugBank
DB12629,"Amino Acids, Cyclic",DrugBank
DB12629,"Amino Acids, Peptides, and Proteins",DrugBank
DB12629,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12629,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12629,Cytochrome P-450 Substrates,DrugBank
DB12629,Fatty Acids,DrugBank
DB12629,"Fatty Acids, Volatile",DrugBank
DB12629,Hormones,DrugBank
DB12629,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12629,Lipids,DrugBank
DB12629,Thyroid Products,DrugBank
DB12629,Thyronines,DrugBank
DB12637,Antineoplastic Agents,DrugBank
DB12637,Fertility Agents,DrugBank
DB12637,"Fertility Agents, Female",DrugBank
DB12637,Fused-Ring Compounds,DrugBank
DB12637,Hormone Antagonists,DrugBank
DB12637,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12637,Reproductive Control Agents,DrugBank
DB12637,Steroids,DrugBank
DB12638,Antineoplastic Agents,DrugBank
DB12638,Dioxoles,DrugBank
DB12638,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12645,"Acids, Acyclic",DrugBank
DB12645,Amines,DrugBank
DB12645,Antineoplastic Agents,DrugBank
DB12645,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB12645,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB12645,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12645,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12645,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12645,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12645,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12645,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12645,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12645,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12645,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12645,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12645,Enzyme Inhibitors,DrugBank
DB12645,Histone Deacetylase Inhibitors,DrugBank
DB12645,Hydroxy Acids,DrugBank
DB12645,Hydroxylamines,DrugBank
DB12645,Musculo-Skeletal System,DrugBank
DB12645,OCT2 Inhibitors,DrugBank
DB12645,Potential QTc-Prolonging Agents,DrugBank
DB12645,QTc Prolonging Agents,DrugBank
DB12649,Agents producing tachycardia,DrugBank
DB12649,Amides,DrugBank
DB12649,Cannabinoid Receptor Antagonists,DrugBank
DB12649,Cannabinoids and similars,DrugBank
DB12649,Hormones,DrugBank
DB12649,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12649,Neurotransmitter Agents,DrugBank
DB12649,"Receptor, Cannabinoid, CB1, antagonists & inhibitors",DrugBank
DB12649,Sulfones,DrugBank
DB12649,Sulfur Compounds,DrugBank
DB12661,Adrenergic Agents,DrugBank
DB12661,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB12661,Adrenergic alpha-Antagonists,DrugBank
DB12661,Adrenergic Antagonists,DrugBank
DB12661,Agents that produce hypertension,DrugBank
DB12661,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB12661,Antidepressive Agents,DrugBank
DB12661,Antihypertensive Agents,DrugBank
DB12661,Cardiovascular Agents,DrugBank
DB12661,Central Nervous System Depressants,DrugBank
DB12661,Neurotransmitter Agents,DrugBank
DB12661,Peripheral alpha-1 blockers,DrugBank
DB12661,Serotonin Agents,DrugBank
DB12661,Serotonin Receptor Agonists,DrugBank
DB12661,Vasodilating Agents,DrugBank
DB12667,Anti-Bacterial Agents,DrugBank
DB12667,Anti-Infective Agents,DrugBank
DB12667,Antiinfectives for Systemic Use,DrugBank
DB12667,Antimycobacterials,DrugBank
DB12667,Drugs for Treatment of Tuberculosis,DrugBank
DB12667,Isonicotinic Acids,DrugBank
DB12667,Pyridines,DrugBank
DB12667,Thiocarbamide Derivatives,DrugBank
DB12670,Alkaloids,DrugBank
DB12670,Diuretics,DrugBank
DB12670,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12670,Natriuretic Agents,DrugBank
DB12670,Purines,DrugBank
DB12670,Purinones,DrugBank
DB12671,"Acids, Carbocyclic",DrugBank
DB12671,Angiogenesis Inhibitors,DrugBank
DB12671,Angiogenesis Modulating Agents,DrugBank
DB12671,Antineoplastic Agents,DrugBank
DB12671,Cycloparaffins,DrugBank
DB12671,Ethers,DrugBank
DB12671,"Ethers, Cyclic",DrugBank
DB12671,Growth Inhibitors,DrugBank
DB12671,Growth Substances,DrugBank
DB12671,Terpenes,DrugBank
DB12674,Alkylating Drugs,DrugBank
DB12674,Antineoplastic Agents,DrugBank
DB12674,Antineoplastic and Immunomodulating Agents,DrugBank
DB12674,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12674,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12674,Cytochrome P-450 Substrates,DrugBank
DB12674,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12674,Indole Alkaloids,DrugBank
DB12674,Indoles,DrugBank
DB12674,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12674,OATP1B3 inhibitors,DrugBank
DB12674,OCT1 inhibitors,DrugBank
DB12674,P-glycoprotein inhibitors,DrugBank
DB12674,P-glycoprotein substrates,DrugBank
DB12674,Pyridines,DrugBank
DB12677,"Amino Acids, Peptides, and Proteins",DrugBank
DB12677,Antineoplastic Agents,DrugBank
DB12677,Peptides,DrugBank
DB12681,"Acids, Carbocyclic",DrugBank
DB12681,Alcohols,DrugBank
DB12681,Antineoplastic Agents,DrugBank
DB12681,Benzene Derivatives,DrugBank
DB12681,Benzoates,DrugBank
DB12681,"Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors",DrugBank
DB12681,Enzyme Inhibitors,DrugBank
DB12681,Fatty Alcohols,DrugBank
DB12681,Hydroxy Acids,DrugBank
DB12681,Hydroxybenzoates,DrugBank
DB12681,Lipids,DrugBank
DB12681,Phenols,DrugBank
DB12681,Sesquiterpenes,DrugBank
DB12681,Terpenes,DrugBank
DB12683,"Amino Acids, Peptides, and Proteins",DrugBank
DB12683,Antibodies,DrugBank
DB12683,"Antibodies, Monoclonal",DrugBank
DB12683,"Antibodies, Monoclonal, Humanized",DrugBank
DB12683,Blood Proteins,DrugBank
DB12683,Globulins,DrugBank
DB12683,Immunoglobulins,DrugBank
DB12683,Immunoproteins,DrugBank
DB12683,Proteins,DrugBank
DB12683,Serum Globulins,DrugBank
DB12688,"Amino Acids, Peptides, and Proteins",DrugBank
DB12688,Antibodies,DrugBank
DB12688,"Antibodies, Monoclonal",DrugBank
DB12688,Antineoplastic Agents,DrugBank
DB12688,Antineoplastic and Immunomodulating Agents,DrugBank
DB12688,Blood Proteins,DrugBank
DB12688,Cancer immunotherapy,DrugBank
DB12688,CD22 (Clusters of Differentiation 22) inhibitors,DrugBank
DB12688,CD22-Directed Cytotoxins,DrugBank
DB12688,Cytotoxins,DrugBank
DB12688,Globulins,DrugBank
DB12688,Immunoconjugates,DrugBank
DB12688,Immunoglobulins,DrugBank
DB12688,Immunologic Factors,DrugBank
DB12688,Immunotherapy,DrugBank
DB12688,Immunotoxins,DrugBank
DB12688,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB12688,Narrow Therapeutic Index Drugs,DrugBank
DB12688,Noxae,DrugBank
DB12688,Proteins,DrugBank
DB12688,Serum Globulins,DrugBank
DB12688,Toxic Actions,DrugBank
DB12692,Amidines,DrugBank
DB12692,"Antibiotics, Antineoplastic",DrugBank
DB12692,Antineoplastic Agents,DrugBank
DB12692,Antineoplastic and Immunomodulating Agents,DrugBank
DB12692,"Compounds used in a research, industrial, or household setting",DrugBank
DB12692,Immunologic Factors,DrugBank
DB12692,Immunosuppressive Agents,DrugBank
DB12692,Protective Agents,DrugBank
DB12692,Radiation-Protective Agents,DrugBank
DB12692,Selective Immunosuppressants,DrugBank
DB12693,Anti-Anxiety Agents,DrugBank
DB12693,Antidepressive Agents,DrugBank
DB12693,"Antidepressive Agents, Second-Generation",DrugBank
DB12693,Antipsychotic Agents,DrugBank
DB12693,Central Nervous System Agents,DrugBank
DB12693,Central Nervous System Depressants,DrugBank
DB12693,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12693,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB12693,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12693,Hypoglycemia-Associated Agents,DrugBank
DB12693,Neurotoxic agents,DrugBank
DB12693,Neurotransmitter Agents,DrugBank
DB12693,Piperidines,DrugBank
DB12693,Psychotropic Drugs,DrugBank
DB12693,Pyrimidines,DrugBank
DB12693,Pyrimidinones,DrugBank
DB12693,Selective Serotonin Reuptake Inhibitors,DrugBank
DB12693,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12693,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB12693,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB12693,Serotonin Agents,DrugBank
DB12693,Serotonin Modulators,DrugBank
DB12693,Serotonin Receptor Antagonists,DrugBank
DB12693,Tranquilizing Agents,DrugBank
DB12695,"Aldehyde Dehydrogenase, antagonists & inhibitors",DrugBank
DB12695,Anticarcinogenic Agents,DrugBank
DB12695,Antineoplastic Agents,DrugBank
DB12695,Carcinogens,DrugBank
DB12695,"Compounds used in a research, industrial, or household setting",DrugBank
DB12695,Enzyme Inhibitors,DrugBank
DB12695,Isocyanates,DrugBank
DB12695,Noxae,DrugBank
DB12695,Protective Agents,DrugBank
DB12695,Sulfur Compounds,DrugBank
DB12695,Toxic Actions,DrugBank
DB12697,Amino Acids,DrugBank
DB12697,"Amino Acids, Peptides, and Proteins",DrugBank
DB12697,"Amino Acids, Sulfur",DrugBank
DB12697,Anticarcinogenic Agents,DrugBank
DB12697,Antineoplastic Agents,DrugBank
DB12697,"Compounds used in a research, industrial, or household setting",DrugBank
DB12697,Cysteine,DrugBank
DB12697,Organoselenium Compounds,DrugBank
DB12697,Protective Agents,DrugBank
DB12697,Selenium Compounds,DrugBank
DB12697,Sulfur Compounds,DrugBank
DB12698,"Amino Acids, Peptides, and Proteins",DrugBank
DB12698,Anti-HIV Agents,DrugBank
DB12698,Anti-Infective Agents,DrugBank
DB12698,Anti-Retroviral Agents,DrugBank
DB12698,Antibodies,DrugBank
DB12698,"Antibodies, Monoclonal",DrugBank
DB12698,"Antibodies, Monoclonal, Humanized",DrugBank
DB12698,Antiinfectives for Systemic Use,DrugBank
DB12698,Antiviral Agents,DrugBank
DB12698,Antivirals for Systemic Use,DrugBank
DB12698,Blood Proteins,DrugBank
DB12698,CD4-directed Antibody Interactions,DrugBank
DB12698,CD4-directed Blocking Antibody,DrugBank
DB12698,Direct Acting Antivirals,DrugBank
DB12698,Globulins,DrugBank
DB12698,HIV 1 Post-attachment Fusion Inhibitors,DrugBank
DB12698,HIV Fusion Inhibitors,DrugBank
DB12698,Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor,DrugBank
DB12698,Immunoglobulins,DrugBank
DB12698,Immunoproteins,DrugBank
DB12698,Proteins,DrugBank
DB12698,Serum Globulins,DrugBank
DB12699,"Adjuvants, Immunologic",DrugBank
DB12699,Albumins,DrugBank
DB12699,"Amino Acids, Peptides, and Proteins",DrugBank
DB12699,Antineoplastic and Immunomodulating Agents,DrugBank
DB12699,Biological Factors,DrugBank
DB12699,Blood Proteins,DrugBank
DB12699,Carbohydrates,DrugBank
DB12699,Colony-Stimulating Factors,DrugBank
DB12699,Cytokines,DrugBank
DB12699,Glycoconjugates,DrugBank
DB12699,Glycoproteins,DrugBank
DB12699,Hematopoietic Cell Growth Factors,DrugBank
DB12699,Intercellular Signaling Peptides and Proteins,DrugBank
DB12699,Peptides,DrugBank
DB12699,Proteins,DrugBank
DB12699,Recombinant Proteins,DrugBank
DB12699,Serum Albumin,DrugBank
DB12701,"Amino Acids, Peptides, and Proteins",DrugBank
DB12701,Antibodies,DrugBank
DB12701,"Antibodies, Monoclonal",DrugBank
DB12701,Antineoplastic Agents,DrugBank
DB12701,"Antineoplastic Agents, Immunological",DrugBank
DB12701,Blood Proteins,DrugBank
DB12701,Globulins,DrugBank
DB12701,Immunoglobulins,DrugBank
DB12701,Immunoproteins,DrugBank
DB12701,Proteins,DrugBank
DB12701,Serum Globulins,DrugBank
DB12704,Analgesics,DrugBank
DB12704,Antiarrhythmic agents,DrugBank
DB12704,Cardiovascular Agents,DrugBank
DB12704,Central Nervous System Agents,DrugBank
DB12704,Diuretics,DrugBank
DB12704,Natriuretic Agents,DrugBank
DB12704,Peripheral Nervous System Agents,DrugBank
DB12704,"Receptors, Opioid, kappa, agonists",DrugBank
DB12704,Sensory System Agents,DrugBank
DB12710,Antipsychotic Agents,DrugBank
DB12710,Central Nervous System Agents,DrugBank
DB12710,Central Nervous System Depressants,DrugBank
DB12710,Dopamine Agents,DrugBank
DB12710,Dopamine Antagonists,DrugBank
DB12710,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12710,Nervous System,DrugBank
DB12710,Neurotoxic agents,DrugBank
DB12710,Neurotransmitter Agents,DrugBank
DB12710,Phenothiazines,DrugBank
DB12710,Phenothiazines With Piperazine Structure,DrugBank
DB12710,Psycholeptics,DrugBank
DB12710,Psychotropic Drugs,DrugBank
DB12710,Sulfur Compounds,DrugBank
DB12710,Tranquilizing Agents,DrugBank
DB12712,Acetanilides,DrugBank
DB12712,Amides,DrugBank
DB12712,Amines,DrugBank
DB12712,Anilides,DrugBank
DB12712,Aniline Compounds,DrugBank
DB12712,Antiarrhythmic agents,DrugBank
DB12712,BSEP/ABCB11 Substrates,DrugBank
DB12712,Cardiovascular Agents,DrugBank
DB12712,Membrane Transport Modulators,DrugBank
DB12712,Potential QTc-Prolonging Agents,DrugBank
DB12712,QTc Prolonging Agents,DrugBank
DB12712,Sodium Channel Blockers,DrugBank
DB12713,Alimentary Tract and Metabolism,DrugBank
DB12713,BCRP/ABCG2 Inhibitors,DrugBank
DB12713,Blood Glucose Lowering Agents,DrugBank
DB12713,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB12713,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB12713,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12713,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12713,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12713,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12713,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB12713,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12713,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB12713,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12713,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12713,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12713,Cytochrome P-450 Substrates,DrugBank
DB12713,Diuretics,DrugBank
DB12713,Drugs Used in Diabetes,DrugBank
DB12713,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12713,OATP1B3 inhibitors,DrugBank
DB12713,P-glycoprotein inhibitors,DrugBank
DB12713,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors,DrugBank
DB12713,"Sodium-Glucose Transporter 1, antagonists & inhibitors",DrugBank
DB12713,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB12713,UGT1A1 Substrates,DrugBank
DB12713,UGT1A9 Substrates,DrugBank
DB12713,UGT2B7 substrates,DrugBank
DB12718,"Amino Acids, Peptides, and Proteins",DrugBank
DB12718,Antibodies,DrugBank
DB12718,"Antibodies, Monoclonal",DrugBank
DB12718,"Antibodies, Neutralizing",DrugBank
DB12718,Blood Proteins,DrugBank
DB12718,Globulins,DrugBank
DB12718,Immunoglobulins,DrugBank
DB12718,Immunoproteins,DrugBank
DB12718,Proteins,DrugBank
DB12718,Serum Globulins,DrugBank
DB12725,Antidepressive Agents,DrugBank
DB12725,Central Nervous System Depressants,DrugBank
DB12725,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12725,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12725,Serotonin 5-HT4 Receptor Agonists,DrugBank
DB12725,Serotonin Agents,DrugBank
DB12725,Serotonin Receptor Agonists,DrugBank
DB12726,"Amino Acids, Peptides, and Proteins",DrugBank
DB12726,Anticoagulants,DrugBank
DB12726,Blood Proteins,DrugBank
DB12726,Cardiovascular Agents,DrugBank
DB12726,Endopeptidases,DrugBank
DB12726,Enzymes,DrugBank
DB12726,Enzymes and Coenzymes,DrugBank
DB12726,Fibrin Modulating Agents,DrugBank
DB12726,Fibrinolytic Agents,DrugBank
DB12726,Hematologic Agents,DrugBank
DB12726,Hydrolases,DrugBank
DB12726,Peptide Hydrolases,DrugBank
DB12726,Proteins,DrugBank
DB12726,Serine Endopeptidases,DrugBank
DB12726,Serine Proteases,DrugBank
DB12730,"Amino Acids, Peptides, and Proteins",DrugBank
DB12730,Antimitotic Agents,DrugBank
DB12730,Antineoplastic Agents,DrugBank
DB12730,Mitosis Modulators,DrugBank
DB12730,Peptides,DrugBank
DB12730,"Peptides, Cyclic",DrugBank
DB12730,Tubulin Modulators,DrugBank
DB12734,"Amino Acids, Peptides, and Proteins",DrugBank
DB12734,Antibodies,DrugBank
DB12734,"Antibodies, Monoclonal",DrugBank
DB12734,"Antibodies, Monoclonal, Humanized",DrugBank
DB12734,Blood Proteins,DrugBank
DB12734,Globulins,DrugBank
DB12734,Immunoglobulins,DrugBank
DB12734,Immunoproteins,DrugBank
DB12734,Proteins,DrugBank
DB12734,Serum Globulins,DrugBank
DB12736,Antineoplastic Agents,DrugBank
DB12736,Imidazoles,DrugBank
DB12736,Nitro Compounds,DrugBank
DB12736,Nitroimidazoles,DrugBank
DB12736,Radiation-Sensitizing Agents,DrugBank
DB12749,Antiplatelet agents,DrugBank
DB12749,Central Nervous System Agents,DrugBank
DB12749,"Compounds used in a research, industrial, or household setting",DrugBank
DB12749,"Drugs, Chinese Herbal",DrugBank
DB12749,Hematologic Agents,DrugBank
DB12749,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12749,Neuroprotective Agents,DrugBank
DB12749,Plant Extracts,DrugBank
DB12749,Protective Agents,DrugBank
DB12752,Adrenergic Agents,DrugBank
DB12752,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB12752,Adrenergic alpha-Antagonists,DrugBank
DB12752,Adrenergic Antagonists,DrugBank
DB12752,Adrenergic beta-Antagonists,DrugBank
DB12752,Agents causing hyperkalemia,DrugBank
DB12752,Alcohols,DrugBank
DB12752,Amines,DrugBank
DB12752,Amino Alcohols,DrugBank
DB12752,Autonomic Agents,DrugBank
DB12752,Bradycardia-Causing Agents,DrugBank
DB12752,Cardiovascular Agents,DrugBank
DB12752,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB12752,Cytochrome P-450 Substrates,DrugBank
DB12752,Negative Inotrope,DrugBank
DB12752,Neurotransmitter Agents,DrugBank
DB12752,Peripheral Nervous System Agents,DrugBank
DB12752,Propanols,DrugBank
DB12752,Sympathomimetics,DrugBank
DB12752,Vasodilating Agents,DrugBank
DB12766,Antiarrhythmic agents,DrugBank
DB12766,Antihypertensive Agents,DrugBank
DB12766,Cardiovascular Agents,DrugBank
DB12766,Diuretics,DrugBank
DB12766,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB12766,Natriuretic Agents,DrugBank
DB12766,Potential QTc-Prolonging Agents,DrugBank
DB12766,QTc Prolonging Agents,DrugBank
DB12768,"Adjuvants, Immunologic",DrugBank
DB12768,Antineoplastic and Immunomodulating Agents,DrugBank
DB12768,Bacterial Vaccines,DrugBank
DB12768,Biological Products,DrugBank
DB12768,Cancer immunotherapy,DrugBank
DB12768,Complex Mixtures,DrugBank
DB12768,Immunologic Factors,DrugBank
DB12768,Immunotherapy,DrugBank
DB12768,Live Attenuated Bacillus Calmette-Guerin Vaccine,DrugBank
DB12768,Live vaccines,DrugBank
DB12768,Tuberculosis Vaccines,DrugBank
DB12768,Vaccines,DrugBank
DB12769,Antimetabolites,DrugBank
DB12769,Antineoplastic Agents,DrugBank
DB12769,Coenzymes,DrugBank
DB12769,Enzyme Inhibitors,DrugBank
DB12769,Enzymes and Coenzymes,DrugBank
DB12769,Folic Acid Analogues,DrugBank
DB12769,Folic Acid Antagonists,DrugBank
DB12769,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12769,Noxae,DrugBank
DB12769,Pteridines,DrugBank
DB12769,Pterins,DrugBank
DB12769,Toxic Actions,DrugBank
DB12770,Acetates,DrugBank
DB12770,"Acids, Acyclic",DrugBank
DB12770,Alimentary Tract and Metabolism,DrugBank
DB12770,Amides,DrugBank
DB12770,Anti-Ulcer Agents,DrugBank
DB12770,Drugs for Acid Related Disorders,DrugBank
DB12770,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB12770,Gastric Acid Lowering Agents,DrugBank
DB12770,Gastrointestinal Agents,DrugBank
DB12770,Histamine Agents,DrugBank
DB12770,Histamine Antagonists,DrugBank
DB12770,Histamine H2 Antagonists,DrugBank
DB12770,Neurotransmitter Agents,DrugBank
DB12771,Alcohols,DrugBank
DB12771,Anti-Infective Agents,DrugBank
DB12771,Antioxidants,DrugBank
DB12771,Antiplatelet agents,DrugBank
DB12771,Biological Factors,DrugBank
DB12771,"Compounds used in a research, industrial, or household setting",DrugBank
DB12771,Hematologic Agents,DrugBank
DB12771,Protective Agents,DrugBank
DB12773,"Amino Acids, Peptides, and Proteins",DrugBank
DB12773,Antibodies,DrugBank
DB12773,"Antibodies, Monoclonal",DrugBank
DB12773,Blood Proteins,DrugBank
DB12773,Globulins,DrugBank
DB12773,Immunoglobulins,DrugBank
DB12773,Immunologic Factors,DrugBank
DB12773,Immunoproteins,DrugBank
DB12773,Proteins,DrugBank
DB12773,Serum Globulins,DrugBank
DB12774,mTOR Inhibitors,DrugBank
DB12774,Oxazines,DrugBank
DB12775,"Amino Acids, Peptides, and Proteins",DrugBank
DB12775,Antibodies,DrugBank
DB12775,"Antibodies, Monoclonal",DrugBank
DB12775,"Antibodies, Monoclonal, Humanized",DrugBank
DB12775,Blood Proteins,DrugBank
DB12775,Globulins,DrugBank
DB12775,Immunoglobulins,DrugBank
DB12775,Immunoproteins,DrugBank
DB12775,Proteins,DrugBank
DB12775,Serum Globulins,DrugBank
DB12776,"Acids, Carbocyclic",DrugBank
DB12776,Antipruritics,DrugBank
DB12776,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12776,Phosphodiesterase 4 Inhibitors,DrugBank
DB12776,Phosphodiesterase Inhibitors,DrugBank
DB12779,Adrenergic Agents,DrugBank
DB12779,Adrenergic Agonists,DrugBank
DB12779,Adrenergic beta-Agonists,DrugBank
DB12779,Agents producing tachycardia,DrugBank
DB12779,Agents that produce hypertension,DrugBank
DB12779,Analgesics,DrugBank
DB12779,"Analgesics, Non-Narcotic",DrugBank
DB12779,Anti-Inflammatory Agents,DrugBank
DB12779,Antirheumatic Agents,DrugBank
DB12779,Cardiotonic Agents,DrugBank
DB12779,Cardiovascular Agents,DrugBank
DB12779,"Compounds used in a research, industrial, or household setting",DrugBank
DB12779,Fibrin Modulating Agents,DrugBank
DB12779,Hematologic Agents,DrugBank
DB12779,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12779,Isoquinolines,DrugBank
DB12779,Neurotransmitter Agents,DrugBank
DB12779,Peripheral Nervous System Agents,DrugBank
DB12779,Protective Agents,DrugBank
DB12779,Sensory System Agents,DrugBank
DB12781,Blood Glucose Lowering Agents,DrugBank
DB12781,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12781,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB12781,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12781,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12781,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12781,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12781,Cytochrome P-450 Substrates,DrugBank
DB12781,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12781,Sulfur Compounds,DrugBank
DB12781,Thiazoles,DrugBank
DB12781,Thiazolidinediones,DrugBank
DB12783,Anti-Dyskinesia Agents,DrugBank
DB12783,Anti-Parkinson Drugs,DrugBank
DB12783,Aromatic L-amino Acid Decarboxylase Inhibitors,DrugBank
DB12783,Central Nervous System Agents,DrugBank
DB12783,Dopamine Agents,DrugBank
DB12783,Drugs that are Mainly Renally Excreted,DrugBank
DB12783,Enzyme Inhibitors,DrugBank
DB12783,Hydrazines,DrugBank
DB12783,Neurotransmitter Agents,DrugBank
DB12789,Abortifacient Agents,DrugBank
DB12789,"Abortifacient Agents, Nonsteroidal",DrugBank
DB12789,Autacoids,DrugBank
DB12789,Biological Factors,DrugBank
DB12789,Eicosanoids,DrugBank
DB12789,Fatty Acids,DrugBank
DB12789,"Fatty Acids, Unsaturated",DrugBank
DB12789,Genito Urinary System and Sex Hormones,DrugBank
DB12789,Inflammation Mediators,DrugBank
DB12789,Lipids,DrugBank
DB12789,Prostaglandins,DrugBank
DB12789,Prostaglandins F,DrugBank
DB12789,Reproductive Control Agents,DrugBank
DB12789,Uterotonic agents,DrugBank
DB12797,"Amino Acids, Peptides, and Proteins",DrugBank
DB12797,Antibodies,DrugBank
DB12797,"Antibodies, Monoclonal",DrugBank
DB12797,Antineoplastic Agents,DrugBank
DB12797,"Antineoplastic Agents, Immunological",DrugBank
DB12797,Blood Proteins,DrugBank
DB12797,Globulins,DrugBank
DB12797,Immunoglobulins,DrugBank
DB12797,Immunoproteins,DrugBank
DB12797,Proteins,DrugBank
DB12797,Serum Globulins,DrugBank
DB12799,Carbon Radioisotopes,DrugBank
DB12799,"Drug Resistance, Multiple",DrugBank
DB12799,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12799,P-glycoprotein inhibitors,DrugBank
DB12806,Histamine Antagonists,DrugBank
DB12806,Histamine H1 Antagonists,DrugBank
DB12806,Pyridazines,DrugBank
DB12807,"Amino Acids, Peptides, and Proteins",DrugBank
DB12807,Antibodies,DrugBank
DB12807,Biological Factors,DrugBank
DB12807,Blood Proteins,DrugBank
DB12807,Globulins,DrugBank
DB12807,Immunoglobulins,DrugBank
DB12807,Immunologic Factors,DrugBank
DB12807,Immunoproteins,DrugBank
DB12807,Proteins,DrugBank
DB12807,Serum Globulins,DrugBank
DB12807,"Toxins, Biological",DrugBank
DB12814,"Adjuvants, Immunologic",DrugBank
DB12814,Antineoplastic and Immunomodulating Agents,DrugBank
DB12814,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12814,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12814,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12814,Immunosuppressive Agents,DrugBank
DB12814,Interferons,DrugBank
DB12814,Myelosuppressive Agents,DrugBank
DB12814,Pegylated agents,DrugBank
DB12815,"Amino Acids, Peptides, and Proteins",DrugBank
DB12815,Antibodies,DrugBank
DB12815,"Antibodies, Monoclonal",DrugBank
DB12815,Blood Proteins,DrugBank
DB12815,Globulins,DrugBank
DB12815,Immunoglobulins,DrugBank
DB12815,Immunoproteins,DrugBank
DB12815,Proteins,DrugBank
DB12815,Serum Globulins,DrugBank
DB12817,BCRP/ABCG2 Inhibitors,DrugBank
DB12817,BCRP/ABCG2 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12817,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12817,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12817,Cytochrome P-450 Substrates,DrugBank
DB12817,Enzyme Inhibitors,DrugBank
DB12817,OAT1/SLC22A6 inhibitors,DrugBank
DB12817,OAT3/SLC22A8 Inhibitors,DrugBank
DB12817,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12817,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12817,OATP1B3 inhibitors,DrugBank
DB12817,OATP1B3 substrates,DrugBank
DB12817,Oxazines,DrugBank
DB12817,Oxazoles,DrugBank
DB12817,P-glycoprotein inhibitors,DrugBank
DB12817,P-glycoprotein substrates,DrugBank
DB12817,Pyrimidines,DrugBank
DB12817,Pyrimidinones,DrugBank
DB12817,Topoisomerase II Inhibitors,DrugBank
DB12817,Topoisomerase Inhibitors,DrugBank
DB12821,Anions,DrugBank
DB12821,"Compounds used in a research, industrial, or household setting",DrugBank
DB12821,Contrast Media,DrugBank
DB12821,Diagnostic Uses of Chemicals,DrugBank
DB12821,Electrolytes,DrugBank
DB12821,Elements,DrugBank
DB12821,"Hydrocarbons, Fluorinated",DrugBank
DB12821,"Hydrocarbons, Halogenated",DrugBank
DB12821,Ions,DrugBank
DB12821,Iron Compounds,DrugBank
DB12821,Metals,DrugBank
DB12821,"Metals, Heavy",DrugBank
DB12821,Oxygen Compounds,DrugBank
DB12821,Transition Elements,DrugBank
DB12823,"Acids, Carbocyclic",DrugBank
DB12823,Benzene Derivatives,DrugBank
DB12823,Benzopyrans,DrugBank
DB12823,Coumarins,DrugBank
DB12823,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12823,"Hydrocarbons, Fluorinated",DrugBank
DB12823,"Hydrocarbons, Halogenated",DrugBank
DB12823,Pyrans,DrugBank
DB12825,Acetates,DrugBank
DB12825,Anti-Bacterial Agents,DrugBank
DB12825,Anti-Infective Agents,DrugBank
DB12825,Antibacterials for Systemic Use,DrugBank
DB12825,Antiinfectives for Systemic Use,DrugBank
DB12825,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12825,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12825,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12825,Cytochrome P-450 Substrates,DrugBank
DB12825,P-glycoprotein substrates,DrugBank
DB12825,Pleuromutilin Antibacterial,DrugBank
DB12825,QTc Prolonging Agents,DrugBank
DB12825,Sulfur Compounds,DrugBank
DB12826,"Amino Acids, Peptides, and Proteins",DrugBank
DB12826,Antibodies,DrugBank
DB12826,"Antibodies, Monoclonal",DrugBank
DB12826,Blood Proteins,DrugBank
DB12826,Globulins,DrugBank
DB12826,Immunoglobulins,DrugBank
DB12826,Immunoproteins,DrugBank
DB12826,Proteins,DrugBank
DB12826,Serum Globulins,DrugBank
DB12829,Anti-Bacterial Agents,DrugBank
DB12829,Anti-Infective Agents,DrugBank
DB12829,Antiinfectives for Systemic Use,DrugBank
DB12829,Antimycobacterials,DrugBank
DB12829,Drugs for Treatment of Tuberculosis,DrugBank
DB12829,Semicarbazides,DrugBank
DB12829,Semicarbazones,DrugBank
DB12829,Sulfur Compounds,DrugBank
DB12829,Thiosemicarbazones,DrugBank
DB12831,Amidines,DrugBank
DB12831,Anticoagulants,DrugBank
DB12831,Enzyme Inhibitors,DrugBank
DB12831,Guanidines,DrugBank
DB12831,Hematologic Agents,DrugBank
DB12831,Protease Inhibitors,DrugBank
DB12831,Serine Protease Inhibitors,DrugBank
DB12832,Alkylating Drugs,DrugBank
DB12832,Antineoplastic Agents,DrugBank
DB12832,"Antineoplastic Agents, Alkylating",DrugBank
DB12832,Antineoplastic and Immunomodulating Agents,DrugBank
DB12832,Fused-Ring Compounds,DrugBank
DB12832,"Hydrocarbons, Halogenated",DrugBank
DB12832,Mustard Compounds,DrugBank
DB12832,Nitrogen Mustard Analogues,DrugBank
DB12832,Nitrogen Mustard Compounds,DrugBank
DB12832,Noxae,DrugBank
DB12832,Pregnadienes,DrugBank
DB12832,Pregnadienetriols,DrugBank
DB12832,Pregnanes,DrugBank
DB12832,Steroids,DrugBank
DB12832,Toxic Actions,DrugBank
DB12833,Anti-Anxiety Agents,DrugBank
DB12833,Antidepressive Agents,DrugBank
DB12833,Central Nervous System Agents,DrugBank
DB12833,Central Nervous System Depressants,DrugBank
DB12833,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12833,Neurotransmitter Agents,DrugBank
DB12833,Psychotropic Drugs,DrugBank
DB12833,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12833,Serotonin Agents,DrugBank
DB12833,Serotonin Receptor Agonists,DrugBank
DB12833,Tranquilizing Agents,DrugBank
DB12836,Amides,DrugBank
DB12836,Benzene Derivatives,DrugBank
DB12836,P-glycoprotein substrates,DrugBank
DB12836,Sulfonamides,DrugBank
DB12836,Sulfones,DrugBank
DB12836,Sulfur Compounds,DrugBank
DB12839,Alimentary Tract and Metabolism,DrugBank
DB12839,"Amino Acids, Peptides, and Proteins",DrugBank
DB12839,Ammonia-Lyases,DrugBank
DB12839,Carbon-Nitrogen Lyases,DrugBank
DB12839,Enzymes,DrugBank
DB12839,Enzymes and Coenzymes,DrugBank
DB12839,Lyases,DrugBank
DB12839,Pegylated agents,DrugBank
DB12839,Phenylalanine Metabolizing Enzyme,DrugBank
DB12839,Proteins,DrugBank
DB12842,Alcohols,DrugBank
DB12842,Alkaloids,DrugBank
DB12842,"Compounds used in a research, industrial, or household setting",DrugBank
DB12842,Ethylene Glycols,DrugBank
DB12842,Glycols,DrugBank
DB12842,Macromolecular Substances,DrugBank
DB12842,Pegylated agents,DrugBank
DB12842,Polymers,DrugBank
DB12843,Cardanolides,DrugBank
DB12843,Cardiac Glycosides,DrugBank
DB12843,Fused-Ring Compounds,DrugBank
DB12843,Glycosides,DrugBank
DB12843,Steroids,DrugBank
DB12844,"Amino Acids, Peptides, and Proteins",DrugBank
DB12844,Antibodies,DrugBank
DB12844,"Antibodies, Monoclonal",DrugBank
DB12844,"Antibodies, Monoclonal, Humanized",DrugBank
DB12844,Blood Proteins,DrugBank
DB12844,Globulins,DrugBank
DB12844,Immunoglobulins,DrugBank
DB12844,Immunoproteins,DrugBank
DB12844,Proteins,DrugBank
DB12844,Serum Globulins,DrugBank
DB12845,"Amino Acids, Peptides, and Proteins",DrugBank
DB12845,Antibodies,DrugBank
DB12845,Blood Proteins,DrugBank
DB12845,Globulins,DrugBank
DB12845,Immunoglobulins,DrugBank
DB12845,Immunoproteins,DrugBank
DB12845,Proteins,DrugBank
DB12845,Serum Globulins,DrugBank
DB12846,Adrenergic Agents,DrugBank
DB12846,Adrenergic Agonists,DrugBank
DB12846,Adrenergic beta-Agonists,DrugBank
DB12846,Adrenergics for Systemic Use,DrugBank
DB12846,"Adrenergics, Inhalants",DrugBank
DB12846,Agents producing tachycardia,DrugBank
DB12846,Agents that produce hypertension,DrugBank
DB12846,Alcohols,DrugBank
DB12846,Alkaloids,DrugBank
DB12846,Amines,DrugBank
DB12846,Amino Alcohols,DrugBank
DB12846,Anti-Asthmatic Agents,DrugBank
DB12846,Autonomic Agents,DrugBank
DB12846,Benzene Derivatives,DrugBank
DB12846,Bronchodilator Agents,DrugBank
DB12846,Catecholamines,DrugBank
DB12846,Catechols,DrugBank
DB12846,Drugs for Obstructive Airway Diseases,DrugBank
DB12846,Ethanolamines,DrugBank
DB12846,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12846,Neurotransmitter Agents,DrugBank
DB12846,Peripheral Nervous System Agents,DrugBank
DB12846,Pharmaceutical Preparations,DrugBank
DB12846,Phenols,DrugBank
DB12846,Purines,DrugBank
DB12846,Purinones,DrugBank
DB12846,Respiratory System Agents,DrugBank
DB12846,Selective Beta 2-adrenergic Agonists,DrugBank
DB12849,"Amino Acids, Peptides, and Proteins",DrugBank
DB12849,Antibodies,DrugBank
DB12849,"Antibodies, Monoclonal",DrugBank
DB12849,"Antibodies, Monoclonal, Humanized",DrugBank
DB12849,Blood Proteins,DrugBank
DB12849,Globulins,DrugBank
DB12849,Immunoglobulins,DrugBank
DB12849,Immunoproteins,DrugBank
DB12849,Proteins,DrugBank
DB12849,Serum Globulins,DrugBank
DB12866,"Acids, Acyclic",DrugBank
DB12866,Amines,DrugBank
DB12866,Fatty Acids,DrugBank
DB12866,"Fatty Acids, Volatile",DrugBank
DB12866,Lipids,DrugBank
DB12866,OAT3/SLC22A8 Inhibitors,DrugBank
DB12866,Pyridines,DrugBank
DB12867,Antipsychotic Agents,DrugBank
DB12867,Butyrophenone Derivatives,DrugBank
DB12867,Butyrophenones,DrugBank
DB12867,Central Nervous System Agents,DrugBank
DB12867,Central Nervous System Depressants,DrugBank
DB12867,Dopamine Agents,DrugBank
DB12867,Dopamine Antagonists,DrugBank
DB12867,Ketones,DrugBank
DB12867,Nervous System,DrugBank
DB12867,Neurotoxic agents,DrugBank
DB12867,Neurotransmitter Agents,DrugBank
DB12867,Psycholeptics,DrugBank
DB12867,Psychotropic Drugs,DrugBank
DB12867,Tranquilizing Agents,DrugBank
DB12870,Amino Acids,DrugBank
DB12870,"Amino Acids, Peptides, and Proteins",DrugBank
DB12870,"Amino Acids, Sulfur",DrugBank
DB12870,Antimetabolites,DrugBank
DB12870,Antineoplastic Agents,DrugBank
DB12870,"Compounds used in a research, industrial, or household setting",DrugBank
DB12870,Enzyme Inhibitors,DrugBank
DB12870,Noxae,DrugBank
DB12870,Protective Agents,DrugBank
DB12870,Radiation-Protective Agents,DrugBank
DB12870,Radiation-Sensitizing Agents,DrugBank
DB12870,Sulfur Compounds,DrugBank
DB12870,Toxic Actions,DrugBank
DB12873,Alcohols,DrugBank
DB12873,Alkylating Drugs,DrugBank
DB12873,Antineoplastic Agents,DrugBank
DB12873,"Antineoplastic Agents, Alkylating",DrugBank
DB12873,Carbohydrates,DrugBank
DB12873,Galactitol,DrugBank
DB12873,Noxae,DrugBank
DB12873,Sugar Alcohols,DrugBank
DB12873,Toxic Actions,DrugBank
DB12874,Amides,DrugBank
DB12874,Antineoplastic Agents,DrugBank
DB12874,Antineoplastic and Immunomodulating Agents,DrugBank
DB12874,BCRP/ABCG2 Inhibitors,DrugBank
DB12874,Benzene Derivatives,DrugBank
DB12874,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12874,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12874,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB12874,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB12874,Cytochrome P-450 Substrates,DrugBank
DB12874,Enzyme Inhibitors,DrugBank
DB12874,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12874,Kinase Inhibitor,DrugBank
DB12874,P-glycoprotein inhibitors,DrugBank
DB12874,P-glycoprotein substrates,DrugBank
DB12874,Protein Kinase Inhibitors,DrugBank
DB12874,Sulfur Compounds,DrugBank
DB12874,Thiazoles,DrugBank
DB12874,Tyrosine Kinase Inhibitors,DrugBank
DB12874,UGT1A1 Inhibitors,DrugBank
DB12877,Anti-Allergic Agents,DrugBank
DB12877,Anti-Asthmatic Agents,DrugBank
DB12877,Antihistamines for Systemic Use,DrugBank
DB12877,Histamine Agents,DrugBank
DB12877,Histamine Antagonists,DrugBank
DB12877,Histamine H1 Antagonists,DrugBank
DB12877,Moderate Risk QTc-Prolonging Agents,DrugBank
DB12877,Neurotransmitter Agents,DrugBank
DB12877,Piperazine Derivatives,DrugBank
DB12877,QTc Prolonging Agents,DrugBank
DB12877,Respiratory System Agents,DrugBank
DB12881,Anticarcinogenic Agents,DrugBank
DB12881,Antineoplastic Agents,DrugBank
DB12881,"Compounds used in a research, industrial, or household setting",DrugBank
DB12881,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12881,Protective Agents,DrugBank
DB12883,Antidepressive Agents,DrugBank
DB12883,Central Nervous System Depressants,DrugBank
DB12883,Neurotransmitter Agents,DrugBank
DB12883,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12883,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB12883,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB12883,Serotonin Agents,DrugBank
DB12883,Serotonin Receptor Agonists,DrugBank
DB12883,Serotonin Receptor Antagonists,DrugBank
DB12884,Gastric Acid Lowering Agents,DrugBank
DB12884,Histamine Agents,DrugBank
DB12884,Histamine Antagonists,DrugBank
DB12884,Histamine H2 Antagonists,DrugBank
DB12884,Neurotransmitter Agents,DrugBank
DB12887,Amides,DrugBank
DB12887,Antineoplastic Agents,DrugBank
DB12887,Antineoplastic and Immunomodulating Agents,DrugBank
DB12887,BCRP/ABCG2 Substrates,DrugBank
DB12887,Benzene Derivatives,DrugBank
DB12887,Benzoates,DrugBank
DB12887,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12887,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12887,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12887,Cytochrome P-450 Substrates,DrugBank
DB12887,MATE 1 Inhibitors,DrugBank
DB12887,MATE 2 Inhibitors,DrugBank
DB12887,MATE 2-K Inhibitors,DrugBank
DB12887,MATE inhibitors,DrugBank
DB12887,Methyltransferase Inhibitor,DrugBank
DB12887,Methyltransferase Inhibitors,DrugBank
DB12887,Oxazines,DrugBank
DB12887,P-glycoprotein substrates,DrugBank
DB12887,Pyridines,DrugBank
DB12890,Dopamine Agents,DrugBank
DB12890,Dopamine Agonists,DrugBank
DB12890,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12890,Neurotransmitter Agents,DrugBank
DB12890,Nonergot-derivative Dopamine Receptor Agonists,DrugBank
DB12891,"Amino Acids, Peptides, and Proteins",DrugBank
DB12891,Antibodies,DrugBank
DB12891,"Antibodies, Monoclonal",DrugBank
DB12891,"Antibodies, Monoclonal, Humanized",DrugBank
DB12891,Blood Proteins,DrugBank
DB12891,Globulins,DrugBank
DB12891,Immunoglobulins,DrugBank
DB12891,Immunoproteins,DrugBank
DB12891,Proteins,DrugBank
DB12891,Serum Globulins,DrugBank
DB12893,Alkaloids,DrugBank
DB12893,"Amino Acids, Peptides, and Proteins",DrugBank
DB12893,Antibodies,DrugBank
DB12893,"Antibodies, Monoclonal",DrugBank
DB12893,"Antibodies, Monoclonal, Humanized",DrugBank
DB12893,Antibody-drug Conjugates,DrugBank
DB12893,Antineoplastic Agents,DrugBank
DB12893,Antineoplastic and Immunomodulating Agents,DrugBank
DB12893,Blood Proteins,DrugBank
DB12893,Cancer immunotherapy,DrugBank
DB12893,Globulins,DrugBank
DB12893,Immunoglobulins,DrugBank
DB12893,Immunologic Factors,DrugBank
DB12893,Immunoproteins,DrugBank
DB12893,Immunotherapy,DrugBank
DB12893,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB12893,Noxae,DrugBank
DB12893,Proteins,DrugBank
DB12893,Serum Globulins,DrugBank
DB12893,Topoisomerase Inhibitors,DrugBank
DB12893,Toxic Actions,DrugBank
DB12893,Trop-2-Directed Monoclonal Antibodies,DrugBank
DB12893,UGT1A1 Substrates,DrugBank
DB12901,Anti-Infective Agents,DrugBank
DB12901,Antineoplastic Agents,DrugBank
DB12901,Antiviral Agents,DrugBank
DB12901,Arabinonucleosides,DrugBank
DB12901,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12901,Nucleosides,DrugBank
DB12901,Pyrimidine Nucleosides,DrugBank
DB12901,Pyrimidines,DrugBank
DB12902,Alkylating Drugs,DrugBank
DB12902,Antineoplastic Agents,DrugBank
DB12902,"Antineoplastic Agents, Alkylating",DrugBank
DB12902,Antineoplastic and Immunomodulating Agents,DrugBank
DB12902,"Hydrocarbons, Halogenated",DrugBank
DB12902,Immunologic Factors,DrugBank
DB12902,Immunosuppressive Agents,DrugBank
DB12902,Mustard Compounds,DrugBank
DB12902,Mutagens,DrugBank
DB12902,Nitrogen Mustard Analogues,DrugBank
DB12902,Nitrogen Mustard Compounds,DrugBank
DB12902,Noxae,DrugBank
DB12902,Organophosphorus Compounds,DrugBank
DB12902,Phosphoramide Mustards,DrugBank
DB12902,Phosphoramides,DrugBank
DB12902,Toxic Actions,DrugBank
DB12909,Acyltransferases,DrugBank
DB12909,"Amino Acids, Peptides, and Proteins",DrugBank
DB12909,Aminoacyltransferases,DrugBank
DB12909,Biological Factors,DrugBank
DB12909,Blood Coagulation Factors,DrugBank
DB12909,Blood Proteins,DrugBank
DB12909,Enzyme Precursors,DrugBank
DB12909,Enzymes,DrugBank
DB12909,Enzymes and Coenzymes,DrugBank
DB12909,"Factor XIIIa, antagonists & inhibitors",DrugBank
DB12909,Hemostatics,DrugBank
DB12909,Increased Coagulation Activity,DrugBank
DB12909,Increased Fibrin Polymerization Activity,DrugBank
DB12909,Protein Precursors,DrugBank
DB12909,Proteins,DrugBank
DB12909,Transferases,DrugBank
DB12909,Transglutaminases,DrugBank
DB12912,Antimetabolites,DrugBank
DB12912,Antineoplastic Agents,DrugBank
DB12912,Enzyme Inhibitors,DrugBank
DB12912,Folic Acid Antagonists,DrugBank
DB12912,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12912,Noxae,DrugBank
DB12912,"Thymidylate Synthase, antagonists & inhibitors",DrugBank
DB12912,Toxic Actions,DrugBank
DB12914,BCRP/ABCG2 Inhibitors,DrugBank
DB12914,BCRP/ABCG2 Substrates,DrugBank
DB12914,BSEP/ABCB11 Inhibitors,DrugBank
DB12914,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB12914,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB12914,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB12914,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12914,Cytochrome P-450 Substrates,DrugBank
DB12914,OAT3/SLC22A8 Inhibitors,DrugBank
DB12914,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12914,OATP1B1/SLCO1B1 Substrates,DrugBank
DB12914,OATP1B3 inhibitors,DrugBank
DB12914,OATP1B3 substrates,DrugBank
DB12914,Pyrimidines,DrugBank
DB12914,Pyrimidinones,DrugBank
DB12914,Thyroid Hormone Receptor beta Agonist,DrugBank
DB12914,Thyroid hormone receptor-beta (THR-beta) agonist,DrugBank
DB12914,UGT1A4 Inhibitors,DrugBank
DB12914,UGT1A9 Inhibitors,DrugBank
DB12916,Alcohols,DrugBank
DB12916,Alkylating Drugs,DrugBank
DB12916,Antineoplastic Agents,DrugBank
DB12916,"Antineoplastic Agents, Alkylating",DrugBank
DB12916,Carbohydrates,DrugBank
DB12916,Galactitol,DrugBank
DB12916,Noxae,DrugBank
DB12916,Sugar Alcohols,DrugBank
DB12916,Toxic Actions,DrugBank
DB12917,Agents reducing cytokine levels,DrugBank
DB12917,"Amino Acids, Peptides, and Proteins",DrugBank
DB12917,Antibodies,DrugBank
DB12917,"Antibodies, Monoclonal",DrugBank
DB12917,"Antibodies, Monoclonal, Humanized",DrugBank
DB12917,Antineoplastic and Immunomodulating Agents,DrugBank
DB12917,Blood Proteins,DrugBank
DB12917,Globulins,DrugBank
DB12917,Immunoglobulins,DrugBank
DB12917,Immunoproteins,DrugBank
DB12917,Immunosuppressive Agents,DrugBank
DB12917,Interleukin Inhibitors,DrugBank
DB12917,Proteins,DrugBank
DB12917,Serum Globulins,DrugBank
DB12920,Antineoplastic Agents,DrugBank
DB12920,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12921,Amides,DrugBank
DB12921,Amines,DrugBank
DB12921,Aniline Compounds,DrugBank
DB12921,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12921,Sulfonamides,DrugBank
DB12921,Sulfones,DrugBank
DB12921,Sulfur Compounds,DrugBank
DB12923,Agents causing hyperkalemia,DrugBank
DB12923,Amines,DrugBank
DB12923,Antiarrhythmic agents,DrugBank
DB12923,Bradycardia-Causing Agents,DrugBank
DB12923,Calcium Channel Blockers,DrugBank
DB12923,Calcium-Regulating Hormones and Agents,DrugBank
DB12923,Cardiovascular Agents,DrugBank
DB12923,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12923,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12923,Cytochrome P-450 Substrates,DrugBank
DB12923,Ethylamines,DrugBank
DB12923,Membrane Transport Modulators,DrugBank
DB12923,P-glycoprotein inhibitors,DrugBank
DB12923,Phenethylamines,DrugBank
DB12923,Phenylalkylamine Derivatives,DrugBank
DB12923,Potential QTc-Prolonging Agents,DrugBank
DB12923,QTc Prolonging Agents,DrugBank
DB12923,Selective Calcium Channel Blockers With Direct Cardiac Effects,DrugBank
DB12923,Vasodilating Agents,DrugBank
DB12923,Verapamil and analogues,DrugBank
DB12926,Adrenergic and Dopaminergic Agents,DrugBank
DB12926,Alcohols,DrugBank
DB12926,Alkaloids,DrugBank
DB12926,Amines,DrugBank
DB12926,Amino Alcohols,DrugBank
DB12926,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB12926,Cardiac Therapy,DrugBank
DB12926,Cardiovascular Agents,DrugBank
DB12926,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12926,Cytochrome P-450 Substrates,DrugBank
DB12926,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12926,Propanolamines,DrugBank
DB12926,Propanols,DrugBank
DB12926,Purines,DrugBank
DB12926,Purinones,DrugBank
DB12926,Vasodilating Agents,DrugBank
DB12926,Xanthine derivatives,DrugBank
DB12927,Adrenergic and Dopaminergic Agents,DrugBank
DB12927,Agents that produce hypertension,DrugBank
DB12927,Alcohols,DrugBank
DB12927,Alkaloids,DrugBank
DB12927,Amines,DrugBank
DB12927,Amino Alcohols,DrugBank
DB12927,Benzene Derivatives,DrugBank
DB12927,Biogenic Amines,DrugBank
DB12927,Biogenic Monoamines,DrugBank
DB12927,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB12927,Cardiac Therapy,DrugBank
DB12927,Cardiovascular Agents,DrugBank
DB12927,Catecholamines,DrugBank
DB12927,Catechols,DrugBank
DB12927,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12927,Cytochrome P-450 Substrates,DrugBank
DB12927,Epinephrine and similars,DrugBank
DB12927,Ethanolamines,DrugBank
DB12927,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12927,Phenols,DrugBank
DB12927,Purines,DrugBank
DB12927,Purinones,DrugBank
DB12927,Xanthine derivatives,DrugBank
DB12930,Adrenergic Agents,DrugBank
DB12930,Agents that produce hypertension,DrugBank
DB12930,Agents that reduce seizure threshold,DrugBank
DB12930,Antidepressive Agents,DrugBank
DB12930,"Antidepressive Agents, Tricyclic",DrugBank
DB12930,Central Nervous System Agents,DrugBank
DB12930,Central Nervous System Depressants,DrugBank
DB12930,Dibenzazepines,DrugBank
DB12930,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12930,Membrane Transport Modulators,DrugBank
DB12930,Narrow Therapeutic Index Drugs,DrugBank
DB12930,Nervous System,DrugBank
DB12930,Neurotoxic agents,DrugBank
DB12930,Neurotransmitter Agents,DrugBank
DB12930,Neurotransmitter Uptake Inhibitors,DrugBank
DB12930,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB12930,Psychoanaleptics,DrugBank
DB12930,Psychotropic Drugs,DrugBank
DB12930,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB12935,Blood Glucose Lowering Agents,DrugBank
DB12935,Carbohydrates,DrugBank
DB12935,Glycosides,DrugBank
DB12935,Sodium-Glucose Transporter 2 Inhibitors,DrugBank
DB12939,Anti-Infective Agents,DrugBank
DB12939,Antifungal Agents,DrugBank
DB12939,Carbohydrates,DrugBank
DB12939,Enzyme Inhibitors,DrugBank
DB12939,Glycosides,DrugBank
DB12941,Androgen Receptor Inhibitors,DrugBank
DB12941,Antiandrogens,DrugBank
DB12941,"Antiandrogens, non-steroidal",DrugBank
DB12941,Antineoplastic Agents,DrugBank
DB12941,Antineoplastic and Immunomodulating Agents,DrugBank
DB12941,BCRP/ABCG2 Inhibitors,DrugBank
DB12941,BCRP/ABCG2 Substrates,DrugBank
DB12941,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12941,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12941,Cytochrome P-450 Substrates,DrugBank
DB12941,Endocrine Therapy,DrugBank
DB12941,Hormone Antagonists and Related Agents,DrugBank
DB12941,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12941,OATP1B3 inhibitors,DrugBank
DB12941,P-glycoprotein substrates,DrugBank
DB12941,UGT1A1 Substrates,DrugBank
DB12941,UGT1A9 Substrates,DrugBank
DB12942,Alcohols,DrugBank
DB12942,Alimentary Tract and Metabolism,DrugBank
DB12942,Carbohydrates,DrugBank
DB12942,"Compounds used in a research, industrial, or household setting",DrugBank
DB12942,"Diet, Food, and Nutrition",DrugBank
DB12942,Drugs for Constipation,DrugBank
DB12942,Flavoring Agents,DrugBank
DB12942,Food,DrugBank
DB12942,Food Additives,DrugBank
DB12942,Food Ingredients,DrugBank
DB12942,Gastrointestinal Agents,DrugBank
DB12942,Laxatives,DrugBank
DB12942,Osmotic Activity,DrugBank
DB12942,Osmotic Laxatives,DrugBank
DB12942,Pharmaceutic Aids,DrugBank
DB12942,Pharmaceutical Preparations,DrugBank
DB12942,Stimulation Small Intestine Fluid/Electrolyte Secretion,DrugBank
DB12942,Sweetening Agents,DrugBank
DB12943,"Amino Acids, Peptides, and Proteins",DrugBank
DB12943,Antibodies,DrugBank
DB12943,"Antibodies, Monoclonal",DrugBank
DB12943,"Antibodies, Monoclonal, Humanized",DrugBank
DB12943,Blood Proteins,DrugBank
DB12943,Globulins,DrugBank
DB12943,Immunoglobulins,DrugBank
DB12943,Immunoproteins,DrugBank
DB12943,Proteins,DrugBank
DB12943,Serum Globulins,DrugBank
DB12945,Antihypertensive Agents,DrugBank
DB12945,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB12945,Cardiovascular Agents,DrugBank
DB12945,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB12945,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB12945,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB12945,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12945,Cytochrome P-450 Substrates,DrugBank
DB12945,Hydrazinophthalazine Derivatives,DrugBank
DB12945,Hydrazinophthalazine Derivatives and Diuretics,DrugBank
DB12945,Phthalazines,DrugBank
DB12945,Pyridazines,DrugBank
DB12947,Antimetabolites,DrugBank
DB12947,Antineoplastic Agents,DrugBank
DB12947,Appetite Stimulants,DrugBank
DB12947,Central Nervous System Agents,DrugBank
DB12947,Central Nervous System Stimulants,DrugBank
DB12947,Deoxyribonucleosides,DrugBank
DB12947,Deoxyuridine,DrugBank
DB12947,Fluoropyrimidines,DrugBank
DB12947,Fluorouracil and prodrugs,DrugBank
DB12947,Immunologic Factors,DrugBank
DB12947,Immunosuppressive Agents,DrugBank
DB12947,Isomerism,DrugBank
DB12947,Noxae,DrugBank
DB12947,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB12947,Nucleosides,DrugBank
DB12947,Pyrimidine Nucleosides,DrugBank
DB12947,Pyrimidines,DrugBank
DB12947,Toxic Actions,DrugBank
DB12948,Amines,DrugBank
DB12948,Antineoplastic Agents,DrugBank
DB12948,Enzyme Inhibitors,DrugBank
DB12948,Hydroxy Acids,DrugBank
DB12948,Hydroxylamines,DrugBank
DB12948,"Ribonucleotide Reductases, antagonists & inhibitors",DrugBank
DB12950,Albumins,DrugBank
DB12950,"Amino Acids, Peptides, and Proteins",DrugBank
DB12950,Blood Proteins,DrugBank
DB12950,Growth Hormone,DrugBank
DB12950,Hormones,DrugBank
DB12950,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB12950,Peptide Hormones,DrugBank
DB12950,Peptides,DrugBank
DB12950,Pituitary Hormones,DrugBank
DB12950,"Pituitary Hormones, Anterior",DrugBank
DB12950,Proteins,DrugBank
DB12950,Recombinant Proteins,DrugBank
DB12950,Serum Albumin,DrugBank
DB12951,"Acids, Acyclic",DrugBank
DB12951,Amino Acids,DrugBank
DB12951,"Amino Acids, Peptides, and Proteins",DrugBank
DB12951,Aminobutyrates,DrugBank
DB12951,Antidepressive Agents,DrugBank
DB12951,Butyrates,DrugBank
DB12951,Central Nervous System Depressants,DrugBank
DB12951,Nervous System,DrugBank
DB12951,Psychoanaleptics,DrugBank
DB12952,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12952,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12952,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB12952,Cytochrome P-450 Substrates,DrugBank
DB12958,Antipsychotic Agents,DrugBank
DB12958,Central Nervous System Depressants,DrugBank
DB12958,Nervous System,DrugBank
DB12958,Neurotoxic agents,DrugBank
DB12958,Psycholeptics,DrugBank
DB12958,Sulfur Compounds,DrugBank
DB12967,Amidines,DrugBank
DB12967,Antineoplastic Agents,DrugBank
DB12967,Antineoplastic and Immunomodulating Agents,DrugBank
DB12967,Enzyme Inhibitors,DrugBank
DB12967,Guanidines,DrugBank
DB12975,Anti-Infective Agents,DrugBank
DB12975,Antimalarials,DrugBank
DB12975,Antiparasitic Agents,DrugBank
DB12975,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB12975,Antiprotozoals,DrugBank
DB12975,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12976,"Amino Acids, Peptides, and Proteins",DrugBank
DB12976,Antibodies,DrugBank
DB12976,"Antibodies, Monoclonal",DrugBank
DB12976,Blood Proteins,DrugBank
DB12976,Globulins,DrugBank
DB12976,Immunoglobulins,DrugBank
DB12976,Immunoproteins,DrugBank
DB12976,Proteins,DrugBank
DB12976,Serum Globulins,DrugBank
DB12978,Amines,DrugBank
DB12978,Antineoplastic Agents,DrugBank
DB12978,Antineoplastic and Immunomodulating Agents,DrugBank
DB12978,Cancer immunotherapy,DrugBank
DB12978,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB12978,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB12978,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB12978,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB12978,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB12978,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB12978,Cytochrome P-450 CYP3A Inducers,DrugBank
DB12978,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB12978,Cytochrome P-450 CYP3A Substrates,DrugBank
DB12978,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB12978,Cytochrome P-450 CYP3A4 Inducers (weak),DrugBank
DB12978,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB12978,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB12978,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB12978,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB12978,Cytochrome P-450 Enzyme Inducers,DrugBank
DB12978,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB12978,Cytochrome P-450 Substrates,DrugBank
DB12978,Hepatotoxic Agents,DrugBank
DB12978,Immunotherapy,DrugBank
DB12978,Kinase Inhibitor,DrugBank
DB12978,MATE 1 Inhibitors,DrugBank
DB12978,MATE 2 Inhibitors,DrugBank
DB12978,MATE inhibitors,DrugBank
DB12978,Narrow Therapeutic Index Drugs,DrugBank
DB12978,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB12978,OATP1B3 inhibitors,DrugBank
DB12978,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB12978,Protein Kinase Inhibitors,DrugBank
DB12978,Pyridines,DrugBank
DB12978,Tyrosine Kinase Inhibitors,DrugBank
DB12978,UGT1A1 Inhibitors,DrugBank
DB12978,UGT1A4 substrates,DrugBank
DB12987,Antineoplastic Agents,DrugBank
DB12987,Pyridines,DrugBank
DB12989,Agrochemicals,DrugBank
DB12989,Bacterial Toxins,DrugBank
DB12989,Biological Factors,DrugBank
DB12989,Central Nervous System Depressants,DrugBank
DB12989,Complex Mixtures,DrugBank
DB12989,"Compounds used in a research, industrial, or household setting",DrugBank
DB12989,Cyanobacteria Toxins,DrugBank
DB12989,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB12989,Insecticides,DrugBank
DB12989,Marine Toxins,DrugBank
DB12989,Mollusk Venoms,DrugBank
DB12989,Neuromuscular Agents,DrugBank
DB12989,Neuromuscular Blocking Agents,DrugBank
DB12989,Peripheral Nervous System Agents,DrugBank
DB12989,Pesticides,DrugBank
DB12989,Purines,DrugBank
DB12989,Toxic Actions,DrugBank
DB12989,"Toxins, Biological",DrugBank
DB12989,Venoms,DrugBank
DB12991,Amidines,DrugBank
DB12991,"Antibiotics, Antineoplastic",DrugBank
DB12991,Antineoplastic Agents,DrugBank
DB12991,"Compounds used in a research, industrial, or household setting",DrugBank
DB12991,Immunologic Factors,DrugBank
DB12991,Immunosuppressive Agents,DrugBank
DB12991,Protective Agents,DrugBank
DB12991,Radiation-Protective Agents,DrugBank
DB12996,Anti-Infective Agents,DrugBank
DB12996,Antineoplastic Agents,DrugBank
DB12996,"Antineoplastic Agents, Phytogenic",DrugBank
DB12996,Antioxidants,DrugBank
DB12996,Benzene Derivatives,DrugBank
DB12996,Biological Factors,DrugBank
DB12996,Carbohydrates,DrugBank
DB12996,Chelating Agents,DrugBank
DB12996,"Compounds used in a research, industrial, or household setting",DrugBank
DB12996,Glycosides,DrugBank
DB12996,Immunologic Factors,DrugBank
DB12996,Immunosuppressive Agents,DrugBank
DB12996,Phenols,DrugBank
DB12996,Protective Agents,DrugBank
DB12996,Sequestering Agents,DrugBank
DB12996,Verbenaceae,DrugBank
DB13001,Agents causing hyperkalemia,DrugBank
DB13001,Agents that produce hypertension,DrugBank
DB13001,Analgesics,DrugBank
DB13001,"Analgesics, Non-Narcotic",DrugBank
DB13001,Anti-Inflammatory Agents,DrugBank
DB13001,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13001,Antirheumatic Agents,DrugBank
DB13001,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13001,Nephrotoxic agents,DrugBank
DB13001,Peripheral Nervous System Agents,DrugBank
DB13001,Pyridines,DrugBank
DB13001,Sensory System Agents,DrugBank
DB13001,Sulfur Compounds,DrugBank
DB13001,Thiophenes,DrugBank
DB13003,Adrenal Cortex Hormones,DrugBank
DB13003,Anti-Inflammatory Agents,DrugBank
DB13003,Corticosteroids,DrugBank
DB13003,Corticosteroids for Systemic Use,DrugBank
DB13003,"Corticosteroids for Systemic Use, Plain",DrugBank
DB13003,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13003,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13003,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13003,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB13003,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB13003,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13003,Fused-Ring Compounds,DrugBank
DB13003,Glucocorticoids,DrugBank
DB13003,Hyperglycemia-Associated Agents,DrugBank
DB13003,Immunosuppressive Agents,DrugBank
DB13003,Pregnanes,DrugBank
DB13003,Steroids,DrugBank
DB13003,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13005,Antineoplastic Agents,DrugBank
DB13005,Enzyme Inhibitors,DrugBank
DB13005,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13005,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy",DrugBank
DB13005,Protein Kinase Inhibitors,DrugBank
DB13007,"Amino Acids, Peptides, and Proteins",DrugBank
DB13007,Antibodies,DrugBank
DB13007,"Antibodies, Monoclonal",DrugBank
DB13007,"Antibodies, Monoclonal, Humanized",DrugBank
DB13007,Antibody-drug Conjugates,DrugBank
DB13007,Antineoplastic Agents,DrugBank
DB13007,Antineoplastic and Immunomodulating Agents,DrugBank
DB13007,Blood Proteins,DrugBank
DB13007,Cancer immunotherapy,DrugBank
DB13007,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13007,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13007,Cytochrome P-450 Substrates,DrugBank
DB13007,Globulins,DrugBank
DB13007,Immunoglobulins,DrugBank
DB13007,Immunoproteins,DrugBank
DB13007,Immunotherapy,DrugBank
DB13007,Microtubule Inhibitors,DrugBank
DB13007,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB13007,Nectin-4-directed Antibodies,DrugBank
DB13007,P-glycoprotein substrates,DrugBank
DB13007,Proteins,DrugBank
DB13007,Serum Globulins,DrugBank
DB13014,Anthracenes,DrugBank
DB13014,Anti-Infective Agents,DrugBank
DB13014,Antidepressive Agents,DrugBank
DB13014,Antineoplastic Agents,DrugBank
DB13014,Benz(a)Anthracenes,DrugBank
DB13014,Central Nervous System Agents,DrugBank
DB13014,Central Nervous System Depressants,DrugBank
DB13014,Enzyme Inhibitors,DrugBank
DB13014,Immunologic Factors,DrugBank
DB13014,Immunosuppressive Agents,DrugBank
DB13014,Phenalenes,DrugBank
DB13014,Psychotropic Drugs,DrugBank
DB13014,Radiation-Sensitizing Agents,DrugBank
DB13017,"Amino Acids, Peptides, and Proteins",DrugBank
DB13017,Antibodies,DrugBank
DB13017,"Antibodies, Monoclonal",DrugBank
DB13017,"Antibodies, Monoclonal, Humanized",DrugBank
DB13017,Benzazepines,DrugBank
DB13017,Blood Proteins,DrugBank
DB13017,Globulins,DrugBank
DB13017,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13017,Immunoglobulins,DrugBank
DB13017,Immunologic Factors,DrugBank
DB13017,Immunoproteins,DrugBank
DB13017,Proteins,DrugBank
DB13017,Serum Globulins,DrugBank
DB13025,"Acids, Carbocyclic",DrugBank
DB13025,Amines,DrugBank
DB13025,Antipsychotic Agents,DrugBank
DB13025,Benzamides and benzamide derivatives,DrugBank
DB13025,Benzene Derivatives,DrugBank
DB13025,Benzoates,DrugBank
DB13025,Central Nervous System Agents,DrugBank
DB13025,Central Nervous System Depressants,DrugBank
DB13025,Dopamine Agents,DrugBank
DB13025,Dopamine Antagonists,DrugBank
DB13025,Dopamine D2 Receptor Antagonists,DrugBank
DB13025,Drugs that are Mainly Renally Excreted,DrugBank
DB13025,Ethylamines,DrugBank
DB13025,Nervous System,DrugBank
DB13025,Neurotoxic agents,DrugBank
DB13025,Neurotransmitter Agents,DrugBank
DB13025,Psycholeptics,DrugBank
DB13025,Psychotropic Drugs,DrugBank
DB13025,Tranquilizing Agents,DrugBank
DB13028,Amides,DrugBank
DB13028,Anti-Bacterial Agents,DrugBank
DB13028,Anti-Infective Agents,DrugBank
DB13028,Antibacterials for Systemic Use,DrugBank
DB13028,Antiinfectives for Systemic Use,DrugBank
DB13028,beta-Lactams,DrugBank
DB13028,Carbapenems,DrugBank
DB13028,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13028,Lactams,DrugBank
DB13029,Enzyme Inhibitors,DrugBank
DB13029,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13029,Phosphodiesterase 4 Inhibitors,DrugBank
DB13029,Phosphodiesterase Inhibitors,DrugBank
DB13036,Amides,DrugBank
DB13036,Antiplatelet agents,DrugBank
DB13036,Hematologic Agents,DrugBank
DB13036,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13036,Indoles,DrugBank
DB13036,"Receptors, Thromboxane, antagonists & inhibitors",DrugBank
DB13036,Sulfones,DrugBank
DB13036,Sulfur Compounds,DrugBank
DB13037,"Amino Acids, Peptides, and Proteins",DrugBank
DB13037,Antibodies,DrugBank
DB13037,"Antibodies, Monoclonal",DrugBank
DB13037,Blood Proteins,DrugBank
DB13037,Globulins,DrugBank
DB13037,Immunoglobulins,DrugBank
DB13037,Immunoproteins,DrugBank
DB13037,Proteins,DrugBank
DB13037,Serum Globulins,DrugBank
DB13044,Adrenal Cortex Hormones,DrugBank
DB13044,"Contraceptive Agents, Male",DrugBank
DB13044,Hormonal Contraceptives for Systemic Use,DrugBank
DB13044,Reproductive Control Agents,DrugBank
DB13044,Sesquiterpenes,DrugBank
DB13044,Terpenes,DrugBank
DB13045,"Amino Acids, Peptides, and Proteins",DrugBank
DB13045,Antibodies,DrugBank
DB13045,"Antibodies, Monoclonal",DrugBank
DB13045,Blood Proteins,DrugBank
DB13045,Globulins,DrugBank
DB13045,Immunoglobulins,DrugBank
DB13045,Immunoproteins,DrugBank
DB13045,Proteins,DrugBank
DB13045,Serum Globulins,DrugBank
DB13046,Adenine Nucleotides,DrugBank
DB13046,Antineoplastic Agents,DrugBank
DB13046,Cyclic AMP,DrugBank
DB13046,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13046,Immunologic Factors,DrugBank
DB13046,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13046,Nucleotides,DrugBank
DB13046,"Nucleotides, Cyclic",DrugBank
DB13046,Purine Nucleotides,DrugBank
DB13046,Purines,DrugBank
DB13046,Ribonucleotides,DrugBank
DB13055,14-alpha Demethylase Inhibitors,DrugBank
DB13055,Antifungal Agents,DrugBank
DB13055,Antiinfectives for Systemic Use,DrugBank
DB13055,Antimycotics for Systemic Use,DrugBank
DB13055,Azole Antifungals,DrugBank
DB13055,BCRP/ABCG2 Inhibitors,DrugBank
DB13055,Tetrazoles,DrugBank
DB13055,Triazole and tetrazole derivatives,DrugBank
DB13058,Cholinergic Agents,DrugBank
DB13058,Cholinesterase Inhibitors,DrugBank
DB13058,Enzyme Inhibitors,DrugBank
DB13058,Neurotransmitter Agents,DrugBank
DB13058,Sulfur Compounds,DrugBank
DB13064,Agents producing tachycardia,DrugBank
DB13064,Agents that produce hypertension,DrugBank
DB13064,Autonomic Agents,DrugBank
DB13064,Nasal Preparations,DrugBank
DB13064,Peripheral Nervous System Agents,DrugBank
DB13064,Sympathomimetics,DrugBank
DB13064,"Sympathomimetics, Plain",DrugBank
DB13066,Antineoplastic Agents,DrugBank
DB13066,"Antineoplastic Agents, Hormonal",DrugBank
DB13066,Dermatologicals,DrugBank
DB13066,Enzyme Inhibitors,DrugBank
DB13066,Hormone Antagonists,DrugBank
DB13066,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13068,"Amino Acids, Peptides, and Proteins",DrugBank
DB13068,Cyclosporins,DrugBank
DB13068,Immunosuppressive Agents,DrugBank
DB13068,Peptides,DrugBank
DB13068,"Peptides, Cyclic",DrugBank
DB13069,Alkylating Drugs,DrugBank
DB13069,Amides,DrugBank
DB13069,Antineoplastic Agents,DrugBank
DB13069,Antineoplastic and Immunomodulating Agents,DrugBank
DB13069,Nitroso Compounds,DrugBank
DB13069,Nitrosourea Compounds,DrugBank
DB13069,Nitrosoureas,DrugBank
DB13070,Agents producing tachycardia,DrugBank
DB13070,Cannabinoid Receptor Antagonists,DrugBank
DB13070,Cannabinoids and similars,DrugBank
DB13070,Hormones,DrugBank
DB13070,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13070,Neurotransmitter Agents,DrugBank
DB13070,"Receptor, Cannabinoid, CB1, antagonists & inhibitors",DrugBank
DB13073,"Amino Acids, Peptides, and Proteins",DrugBank
DB13073,Antibodies,DrugBank
DB13073,"Antibodies, Monoclonal",DrugBank
DB13073,"Antibodies, Monoclonal, Humanized",DrugBank
DB13073,Blood Proteins,DrugBank
DB13073,Globulins,DrugBank
DB13073,Immunoglobulins,DrugBank
DB13073,Immunoproteins,DrugBank
DB13073,Proteins,DrugBank
DB13073,Serum Globulins,DrugBank
DB13074,Amino Acids,DrugBank
DB13074,"Amino Acids, Aromatic",DrugBank
DB13074,"Amino Acids, Cyclic",DrugBank
DB13074,"Amino Acids, Peptides, and Proteins",DrugBank
DB13074,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13074,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13074,Cytochrome P-450 Substrates,DrugBank
DB13074,Diagnostic Agents,DrugBank
DB13074,Growth Hormone Secretagogue Receptor Agonist,DrugBank
DB13074,Growth Hormone Secretagogue Receptor Agonists,DrugBank
DB13074,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13074,Highest Risk QTc-Prolonging Agents,DrugBank
DB13074,QTc Prolonging Agents,DrugBank
DB13074,Tests for Pituitary Function,DrugBank
DB13077,Anti-Bacterial Agents,DrugBank
DB13077,Anti-Infective Agents,DrugBank
DB13077,Enzyme Inhibitors,DrugBank
DB13077,Oxazoles,DrugBank
DB13077,Protein Synthesis Inhibitors,DrugBank
DB13082,Central Nervous System Agents,DrugBank
DB13082,Central Nervous System Depressants,DrugBank
DB13082,"Compounds used in a research, industrial, or household setting",DrugBank
DB13082,Neuroprotective Agents,DrugBank
DB13082,Nootropic Agents,DrugBank
DB13082,Protective Agents,DrugBank
DB13082,Psychotropic Drugs,DrugBank
DB13082,Pyrrolidines,DrugBank
DB13092,Anti-Acne Preparations,DrugBank
DB13092,Anti-Acne Preparations for Topical Use,DrugBank
DB13092,Anti-Bacterial Agents,DrugBank
DB13092,Anti-Infective Agents,DrugBank
DB13092,Antiinfectives for Treatment of Acne,DrugBank
DB13092,Dermatologicals,DrugBank
DB13092,Naphthacenes,DrugBank
DB13092,Tetracyclines,DrugBank
DB13097,Cholestanes,DrugBank
DB13097,Cholestenes,DrugBank
DB13097,Fused-Ring Compounds,DrugBank
DB13097,Lipids,DrugBank
DB13097,Membrane Lipids,DrugBank
DB13097,Secosteroids,DrugBank
DB13097,Steroids,DrugBank
DB13097,Sterols,DrugBank
DB13097,Vitamin D and Analogues,DrugBank
DB13097,Vitamins,DrugBank
DB13097,Vitamins (Fat Soluble),DrugBank
DB13099,Central Nervous System Depressants,DrugBank
DB13099,Hypnotics and Sedatives,DrugBank
DB13099,Nervous System,DrugBank
DB13099,Psycholeptics,DrugBank
DB13104,Antineoplastic Agents,DrugBank
DB13104,Enzyme Inhibitors,DrugBank
DB13104,Protein Kinase Inhibitors,DrugBank
DB13108,Agents producing tachycardia,DrugBank
DB13108,Agents that produce hypertension,DrugBank
DB13108,Amines,DrugBank
DB13108,Amphetamines,DrugBank
DB13108,Ethylamines,DrugBank
DB13108,Illicit Drugs,DrugBank
DB13108,Phenethylamines,DrugBank
DB13108,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13108,Street Drugs,DrugBank
DB13108,Sympathomimetics,DrugBank
DB13114,Agents that produce hypertension,DrugBank
DB13114,Agents that reduce seizure threshold,DrugBank
DB13114,Antidepressive Agents,DrugBank
DB13114,"Antidepressive Agents, Tricyclic",DrugBank
DB13114,Benzocycloheptenes,DrugBank
DB13114,Central Nervous System Depressants,DrugBank
DB13114,Dibenzocycloheptenes,DrugBank
DB13114,Narrow Therapeutic Index Drugs,DrugBank
DB13114,Neurotoxic agents,DrugBank
DB13114,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13124,Anticoagulants,DrugBank
DB13124,Benzopyrans,DrugBank
DB13124,Capillary Stabilizing Agents,DrugBank
DB13124,Chromones,DrugBank
DB13124,Flavonoids,DrugBank
DB13124,Flavonols,DrugBank
DB13124,Hematologic Agents,DrugBank
DB13124,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13124,Pyrans,DrugBank
DB13124,Vasoprotectives,DrugBank
DB13125,"Acids, Carbocyclic",DrugBank
DB13125,BCRP/ABCG2 Substrates,DrugBank
DB13125,Blood and Blood Forming Organs,DrugBank
DB13125,Hemostatics,DrugBank
DB13125,P-glycoprotein substrates,DrugBank
DB13125,Sulfur Compounds,DrugBank
DB13125,Thrombopoietin Receptor Agonist,DrugBank
DB13127,"Amino Acids, Peptides, and Proteins",DrugBank
DB13127,Antibodies,DrugBank
DB13127,"Antibodies, Monoclonal",DrugBank
DB13127,"Antibodies, Monoclonal, Humanized",DrugBank
DB13127,Antineoplastic and Immunomodulating Agents,DrugBank
DB13127,Blood Proteins,DrugBank
DB13127,Globulins,DrugBank
DB13127,Immunoglobulins,DrugBank
DB13127,Immunoproteins,DrugBank
DB13127,Immunosuppressive Agents,DrugBank
DB13127,Interleukin Inhibitors,DrugBank
DB13127,Proteins,DrugBank
DB13127,Serum Globulins,DrugBank
DB13128,"Adjuvants, Immunologic",DrugBank
DB13128,Antineoplastic Agents,DrugBank
DB13128,"Antineoplastic Agents, Phytogenic",DrugBank
DB13128,beta-Glucans,DrugBank
DB13128,Carbohydrates,DrugBank
DB13128,"Compounds used in a research, industrial, or household setting",DrugBank
DB13128,Glucans,DrugBank
DB13128,Immunologic Factors,DrugBank
DB13128,Polysaccharides,DrugBank
DB13132,Anti-Infective Agents,DrugBank
DB13132,Antimalarials,DrugBank
DB13132,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB13132,Antiprotozoals,DrugBank
DB13132,Artemisia,DrugBank
DB13132,Artemisinin and derivatives,DrugBank
DB13132,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB13132,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB13132,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB13132,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13132,Cytochrome P-450 Substrates,DrugBank
DB13132,Free Radicals,DrugBank
DB13132,Peroxides,DrugBank
DB13132,Reactive Oxygen Species,DrugBank
DB13132,Sesquiterpenes,DrugBank
DB13132,Terpenes,DrugBank
DB13133,"Amino Acids, Peptides, and Proteins",DrugBank
DB13133,Biological Factors,DrugBank
DB13133,Blood and Blood Forming Organs,DrugBank
DB13133,Blood Coagulation Factors,DrugBank
DB13133,Blood Proteins,DrugBank
DB13133,Hemostatics,DrugBank
DB13133,Increased Coagulation Activity,DrugBank
DB13133,Increased Platelet Aggregation,DrugBank
DB13133,Proteins,DrugBank
DB13133,von Willebrand Factor,DrugBank
DB13133,"von Willebrand Factor, antagonists & inhibitors",DrugBank
DB13136,Anticoagulants,DrugBank
DB13136,Blood and Blood Forming Organs,DrugBank
DB13136,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13136,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB13136,Cytochrome P-450 Substrates,DrugBank
DB13136,Hematologic Agents,DrugBank
DB13136,Indans,DrugBank
DB13136,Indenes,DrugBank
DB13136,Narrow Therapeutic Index Drugs,DrugBank
DB13136,Vitamin K Antagonists,DrugBank
DB13139,Adrenergic Agonists,DrugBank
DB13139,Adrenergic beta-2 Receptor Agonists,DrugBank
DB13139,Adrenergic beta-Agonists,DrugBank
DB13139,Agents producing tachycardia,DrugBank
DB13139,Agents that produce hypertension,DrugBank
DB13139,Agents to Treat Airway Disease,DrugBank
DB13139,Alcohols,DrugBank
DB13139,Amines,DrugBank
DB13139,Amino Alcohols,DrugBank
DB13139,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13139,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13139,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13139,Drugs that are Mainly Renally Excreted,DrugBank
DB13139,Ethanolamines,DrugBank
DB13139,Ethylamines,DrugBank
DB13139,OATP1B1/SLCO1B1 Substrates,DrugBank
DB13139,OATP1B3 substrates,DrugBank
DB13139,Phenethylamines,DrugBank
DB13140,"Amino Acids, Peptides, and Proteins",DrugBank
DB13140,Antibacterial monoclonal antibodies,DrugBank
DB13140,Antibodies,DrugBank
DB13140,"Antibodies, Monoclonal",DrugBank
DB13140,"Antibodies, Neutralizing",DrugBank
DB13140,Antiinfectives for Systemic Use,DrugBank
DB13140,Blood Proteins,DrugBank
DB13140,Globulins,DrugBank
DB13140,Immune Sera and Immunoglobulins,DrugBank
DB13140,Immunoglobulins,DrugBank
DB13140,Immunoproteins,DrugBank
DB13140,Proteins,DrugBank
DB13140,Serum Globulins,DrugBank
DB13140,Specific Immunoglobulins,DrugBank
DB13142,Alimentary Tract and Metabolism,DrugBank
DB13142,Calcium Salts,DrugBank
DB13142,Carbohydrates,DrugBank
DB13142,Mineral Supplements,DrugBank
DB13142,Oligosaccharides,DrugBank
DB13142,Polysaccharides,DrugBank
DB13143,Estrogens,DrugBank
DB13143,Genito Urinary System and Sex Hormones,DrugBank
DB13143,Sex Hormones and Modulators of the Genital System,DrugBank
DB13143,"Synthetic Estrogens, Plain",DrugBank
DB13144,"Adjuvants, Immunologic",DrugBank
DB13144,"Amino Acids, Peptides, and Proteins",DrugBank
DB13144,Antineoplastic and Immunomodulating Agents,DrugBank
DB13144,Biological Factors,DrugBank
DB13144,Carbohydrates,DrugBank
DB13144,Colony-Stimulating Factors,DrugBank
DB13144,Cytokines,DrugBank
DB13144,Glycoconjugates,DrugBank
DB13144,Glycoproteins,DrugBank
DB13144,Granulocyte Colony-Stimulating Factors,DrugBank
DB13144,Hematologic Agents,DrugBank
DB13144,Hematopoietic Cell Growth Factors,DrugBank
DB13144,Immunologic Factors,DrugBank
DB13144,Intercellular Signaling Peptides and Proteins,DrugBank
DB13144,Peptides,DrugBank
DB13144,Proteins,DrugBank
DB13145,Antineoplastic Agents,DrugBank
DB13145,Drugs that are Mainly Renally Excreted,DrugBank
DB13145,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB13145,Narrow Therapeutic Index Drugs,DrugBank
DB13145,Organometallic Compounds,DrugBank
DB13145,Platinum Compounds,DrugBank
DB13148,"Amino Acids, Peptides, and Proteins",DrugBank
DB13148,Biological Factors,DrugBank
DB13148,Blood and Blood Forming Organs,DrugBank
DB13148,Blood Coagulation Factors,DrugBank
DB13148,Blood Proteins,DrugBank
DB13148,Enzyme Precursors,DrugBank
DB13148,Enzymes and Coenzymes,DrugBank
DB13148,Factor X,DrugBank
DB13148,"Factor X, agonists",DrugBank
DB13148,"Factor X, antagonists & inhibitors",DrugBank
DB13148,Hemostatics,DrugBank
DB13148,Increased Coagulation Activity,DrugBank
DB13148,Protein Precursors,DrugBank
DB13148,Proteins,DrugBank
DB13149,"Amino Acids, Peptides, and Proteins",DrugBank
DB13149,Anticoagulants,DrugBank
DB13149,Biological Factors,DrugBank
DB13149,Blood Coagulation Factor Inhibitors,DrugBank
DB13149,Blood Coagulation Factors,DrugBank
DB13149,Blood Proteins,DrugBank
DB13149,Carbohydrates,DrugBank
DB13149,Glycoconjugates,DrugBank
DB13149,Glycoproteins,DrugBank
DB13149,Hematologic Agents,DrugBank
DB13149,Proteins,DrugBank
DB13150,"Amino Acids, Peptides, and Proteins",DrugBank
DB13150,Biological Factors,DrugBank
DB13150,Blood and Blood Forming Organs,DrugBank
DB13150,Blood Coagulation Factors,DrugBank
DB13150,Blood Proteins,DrugBank
DB13150,Enzyme Precursors,DrugBank
DB13150,Enzymes and Coenzymes,DrugBank
DB13150,Hemostatics,DrugBank
DB13150,Increased Coagulation Activity,DrugBank
DB13150,Protein Precursors,DrugBank
DB13150,Proteins,DrugBank
DB13151,"Amino Acids, Peptides, and Proteins",DrugBank
DB13151,Biological Factors,DrugBank
DB13151,Blood and Blood Forming Organs,DrugBank
DB13151,Blood Coagulation Factors,DrugBank
DB13151,Blood Proteins,DrugBank
DB13151,Coagulants,DrugBank
DB13151,Hematologic Agents,DrugBank
DB13151,Hemostatics,DrugBank
DB13151,Proteins,DrugBank
DB13151,Reversed Anticoagulation Activity,DrugBank
DB13152,"Amino Acids, Peptides, and Proteins",DrugBank
DB13152,Biological Factors,DrugBank
DB13152,Blood and Blood Forming Organs,DrugBank
DB13152,Blood Coagulation Factors,DrugBank
DB13152,Blood Proteins,DrugBank
DB13152,Enzyme Precursors,DrugBank
DB13152,Enzymes and Coenzymes,DrugBank
DB13152,Factor IX,DrugBank
DB13152,Hemostatics,DrugBank
DB13152,Increased Coagulation Activity,DrugBank
DB13152,Protein Precursors,DrugBank
DB13152,Proteins,DrugBank
DB13155,Benzopyrans,DrugBank
DB13155,Carbohydrates,DrugBank
DB13155,Coumarins,DrugBank
DB13155,Glucosides,DrugBank
DB13155,Glycosides,DrugBank
DB13155,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13155,Pyrans,DrugBank
DB13156,Acetanilides,DrugBank
DB13156,"Adjuvants, Immunologic",DrugBank
DB13156,Amides,DrugBank
DB13156,Amines,DrugBank
DB13156,Anilides,DrugBank
DB13156,Aniline Compounds,DrugBank
DB13156,Anti-Infective Agents,DrugBank
DB13156,Antiinfectives for Systemic Use,DrugBank
DB13156,Antiviral Agents,DrugBank
DB13156,Drugs that are Mainly Renally Excreted,DrugBank
DB13156,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13156,Immunologic Factors,DrugBank
DB13156,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13156,Nucleosides,DrugBank
DB13156,Purine Nucleosides,DrugBank
DB13156,Purines,DrugBank
DB13156,Ribonucleosides,DrugBank
DB13158,Adrenal Cortex Hormones,DrugBank
DB13158,Anti-Inflammatory Agents,DrugBank
DB13158,Corticosteroids,DrugBank
DB13158,"Corticosteroids, Dermatological Preparations",DrugBank
DB13158,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB13158,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13158,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13158,Cytochrome P-450 Substrates,DrugBank
DB13158,Dermatologicals,DrugBank
DB13158,Drugs that are Mainly Renally Excreted,DrugBank
DB13158,Fused-Ring Compounds,DrugBank
DB13158,Hormones,DrugBank
DB13158,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13158,Immunosuppressive Agents,DrugBank
DB13158,Ointments,DrugBank
DB13158,Ophthalmologicals,DrugBank
DB13158,Pregnadienes,DrugBank
DB13158,Pregnadienetriols,DrugBank
DB13158,Pregnanes,DrugBank
DB13158,Sensory Organs,DrugBank
DB13158,Steroids,DrugBank
DB13158,"Steroids, Fluorinated",DrugBank
DB13160,Analgesics,DrugBank
DB13160,Central Nervous System Agents,DrugBank
DB13160,Central Nervous System Depressants,DrugBank
DB13160,Narcotics,DrugBank
DB13160,Opioids,DrugBank
DB13160,Peripheral Nervous System Agents,DrugBank
DB13160,Piperidines,DrugBank
DB13160,Sensory System Agents,DrugBank
DB13160,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13164,Antineoplastic Agents,DrugBank
DB13164,Antineoplastic and Immunomodulating Agents,DrugBank
DB13164,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB13164,Protein Kinase Inhibitors,DrugBank
DB13166,ACE Inhibitors and Diuretics,DrugBank
DB13166,Agents Acting on the Renin-Angiotensin System,DrugBank
DB13166,Agents causing angioedema,DrugBank
DB13166,Agents causing hyperkalemia,DrugBank
DB13166,Amino Acids,DrugBank
DB13166,"Amino Acids, Cyclic",DrugBank
DB13166,"Amino Acids, Peptides, and Proteins",DrugBank
DB13166,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB13166,Antihypertensive Agents,DrugBank
DB13166,Cardiovascular Agents,DrugBank
DB13166,Enzyme Inhibitors,DrugBank
DB13166,Imino Acids,DrugBank
DB13166,Protease Inhibitors,DrugBank
DB13167,Acetic Acid Derivatives and Related Substances,DrugBank
DB13167,"Acids, Carbocyclic",DrugBank
DB13167,Agents causing hyperkalemia,DrugBank
DB13167,Agents that produce hypertension,DrugBank
DB13167,Analgesics,DrugBank
DB13167,"Analgesics, Non-Narcotic",DrugBank
DB13167,Anti-Inflammatory Agents,DrugBank
DB13167,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13167,Antiinflammatory and Antirheumatic Products,DrugBank
DB13167,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13167,Antirheumatic Agents,DrugBank
DB13167,Drugs that are Mainly Renally Excreted,DrugBank
DB13167,Musculo-Skeletal System,DrugBank
DB13167,Nephrotoxic agents,DrugBank
DB13167,Non COX-2 selective NSAIDS,DrugBank
DB13167,Peripheral Nervous System Agents,DrugBank
DB13167,Sensory System Agents,DrugBank
DB13169,Alimentary Tract and Metabolism,DrugBank
DB13169,Anabolic Agents,DrugBank
DB13169,Anabolic Agents for Systemic Use,DrugBank
DB13169,Anabolic Steroids,DrugBank
DB13169,Androgens,DrugBank
DB13169,Estranes,DrugBank
DB13169,Estren Derivatives,DrugBank
DB13169,Estrenes,DrugBank
DB13169,Fused-Ring Compounds,DrugBank
DB13169,Gonadal Hormones,DrugBank
DB13169,Gonadal Steroid Hormones,DrugBank
DB13169,Hormones,DrugBank
DB13169,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13169,Nandrolone and esters,DrugBank
DB13169,Ophthalmologicals,DrugBank
DB13169,Sensory Organs,DrugBank
DB13169,Steroids,DrugBank
DB13169,Testosterone Congeners,DrugBank
DB13169,Thyroxine-binding globulin inhibitors,DrugBank
DB13170,Alimentary Tract and Metabolism,DrugBank
DB13170,"Amino Acids, Peptides, and Proteins",DrugBank
DB13170,Drugs for Constipation,DrugBank
DB13170,Enzyme Activators,DrugBank
DB13170,Gastrointestinal Agents,DrugBank
DB13170,Guanylate Cyclase Activators,DrugBank
DB13170,Guanylate Cyclase-C Agonist,DrugBank
DB13170,Guanylyl Cyclase C Agonists,DrugBank
DB13170,Hormones,DrugBank
DB13170,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13170,Laxatives,DrugBank
DB13170,Miscellaneous GI Drugs,DrugBank
DB13170,Peptide Hormones,DrugBank
DB13170,Peptides,DrugBank
DB13170,"Receptors, Guanylate Cyclase-Coupled, agonists",DrugBank
DB13172,Anti-Bacterial Agents,DrugBank
DB13172,Anti-Infective Agents,DrugBank
DB13172,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13172,Nucleosides,DrugBank
DB13172,Pyrimidine Nucleosides,DrugBank
DB13172,Pyrimidines,DrugBank
DB13174,Anthracenes,DrugBank
DB13174,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13174,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13174,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB13174,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB13174,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB13174,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB13174,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB13174,Cytochrome P-450 CYP2E1 Inhibitors (weak),DrugBank
DB13174,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13174,Enzyme Inhibitors,DrugBank
DB13174,"NADH, NADPH Oxidoreductases, antagonists & inhibitors",DrugBank
DB13174,Quinones,DrugBank
DB13177,Benzopyrans,DrugBank
DB13177,Carbohydrates,DrugBank
DB13177,Coumarins,DrugBank
DB13177,Glycosides,DrugBank
DB13177,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13177,Pyrans,DrugBank
DB13177,Umbelliferones,DrugBank
DB13178,Alcohols,DrugBank
DB13178,Alimentary Tract and Metabolism,DrugBank
DB13178,Carbohydrates,DrugBank
DB13178,Drugs that are Mainly Renally Excreted,DrugBank
DB13178,Micronutrients,DrugBank
DB13178,Other Nutritional Agents,DrugBank
DB13178,Sugar Alcohols,DrugBank
DB13178,Vitamin B Complex,DrugBank
DB13178,Vitamins,DrugBank
DB13179,Anti-Bacterial Agents,DrugBank
DB13179,Anti-Infective Agents,DrugBank
DB13179,Antibacterials for Systemic Use,DrugBank
DB13179,Antiinfectives for Systemic Use,DrugBank
DB13179,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB13179,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB13179,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13179,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13179,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13179,Cytochrome P-450 CYP3A4 Inhibitors (strong),DrugBank
DB13179,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13179,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB13179,Cytochrome P-450 CYP3A5 Inhibitors (strong),DrugBank
DB13179,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB13179,Cytochrome P-450 CYP3A7 Inhibitors (strong),DrugBank
DB13179,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13179,Cytochrome P-450 Substrates,DrugBank
DB13179,Lactones,DrugBank
DB13179,Macrolides,DrugBank
DB13179,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13179,P-glycoprotein inhibitors,DrugBank
DB13180,"Acids, Acyclic",DrugBank
DB13180,Carbohydrates,DrugBank
DB13180,Chelating Agents,DrugBank
DB13180,Hydroxy Acids,DrugBank
DB13180,Laxatives,DrugBank
DB13180,Sugar Acids,DrugBank
DB13182,Antineoplastic Agents,DrugBank
DB13182,Benzopyrans,DrugBank
DB13182,Chromones,DrugBank
DB13182,Enzyme Inhibitors,DrugBank
DB13182,"Estrogens, Non-Steroidal",DrugBank
DB13182,Flavonoids,DrugBank
DB13182,Growth Inhibitors,DrugBank
DB13182,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13182,Hormones,DrugBank
DB13182,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13182,Phytoestrogens,DrugBank
DB13182,Pyrans,DrugBank
DB13182,Topoisomerase II Inhibitors,DrugBank
DB13182,Topoisomerase Inhibitors,DrugBank
DB13185,Alimentary Tract and Metabolism,DrugBank
DB13185,Anabolic Agents for Systemic Use,DrugBank
DB13185,Anabolic Steroids,DrugBank
DB13185,Drugs that are Mainly Renally Excreted,DrugBank
DB13185,Estradiol Congeners,DrugBank
DB13185,Estranes,DrugBank
DB13185,Estren Derivatives,DrugBank
DB13185,Estrenes,DrugBank
DB13185,Fused-Ring Compounds,DrugBank
DB13185,Gonadal Hormones,DrugBank
DB13185,Gonadal Steroid Hormones,DrugBank
DB13185,Hormones,DrugBank
DB13185,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13185,Steroids,DrugBank
DB13191,Amino Acids,DrugBank
DB13191,"Amino Acids, Peptides, and Proteins",DrugBank
DB13191,Cardiac Therapy,DrugBank
DB13191,Cardiotonic Agents,DrugBank
DB13191,Cardiovascular Agents,DrugBank
DB13191,"Compounds used in a research, industrial, or household setting",DrugBank
DB13191,Drugs that are Mainly Renally Excreted,DrugBank
DB13191,Phosphoamino Acids,DrugBank
DB13191,Protective Agents,DrugBank
DB13192,"Amino Acids, Peptides, and Proteins",DrugBank
DB13192,Biological Factors,DrugBank
DB13192,Blood and Blood Forming Organs,DrugBank
DB13192,Blood Coagulation Factors,DrugBank
DB13192,Blood Proteins,DrugBank
DB13192,Coagulants,DrugBank
DB13192,Factor VIII,DrugBank
DB13192,Hematologic Agents,DrugBank
DB13192,Hemophilia A,DrugBank
DB13192,Hemostatics,DrugBank
DB13192,Human Antihemophilic Factors,DrugBank
DB13192,Increased Coagulation Activity,DrugBank
DB13192,Protein Precursors,DrugBank
DB13192,Proteins,DrugBank
DB13197,"Amino Acids, Peptides, and Proteins",DrugBank
DB13197,Biological Factors,DrugBank
DB13197,Blood Coagulation Factors,DrugBank
DB13197,Blood Proteins,DrugBank
DB13197,Coagulants,DrugBank
DB13197,Endopeptidases,DrugBank
DB13197,Enzymes,DrugBank
DB13197,Enzymes and Coenzymes,DrugBank
DB13197,Fertility Agents,DrugBank
DB13197,"Fertility Agents, Male",DrugBank
DB13197,Hematologic Agents,DrugBank
DB13197,Hydrolases,DrugBank
DB13197,Kallikreins,DrugBank
DB13197,"Kallikreins, antagonists & inhibitors",DrugBank
DB13197,Peptide Hydrolases,DrugBank
DB13197,Peripheral Vasodilators,DrugBank
DB13197,Proteins,DrugBank
DB13197,Reproductive Control Agents,DrugBank
DB13197,Serine Endopeptidases,DrugBank
DB13197,Serine Proteases,DrugBank
DB13199,Anticoagulants,DrugBank
DB13199,Blood and Blood Forming Organs,DrugBank
DB13199,Cardiovascular Agents,DrugBank
DB13199,Cell-mediated Immunity,DrugBank
DB13199,Endopeptidases,DrugBank
DB13199,Enzymes,DrugBank
DB13199,Enzymes and Coenzymes,DrugBank
DB13199,Fibrin Modulating Agents,DrugBank
DB13199,Fibrinolytic Agents,DrugBank
DB13199,Hematologic Agents,DrugBank
DB13199,Hydrolases,DrugBank
DB13199,Increased Histamine Release,DrugBank
DB13199,Increased IgG Production,DrugBank
DB13199,Non-Standardized Fungal Allergenic Extract,DrugBank
DB13199,Peptide Hydrolases,DrugBank
DB13200,"Adjuvants, Immunologic",DrugBank
DB13200,Alcohols,DrugBank
DB13200,"Amino Acids, Peptides, and Proteins",DrugBank
DB13200,Antineoplastic and Immunomodulating Agents,DrugBank
DB13200,Biological Factors,DrugBank
DB13200,Carbohydrates,DrugBank
DB13200,Colony-Stimulating Factors,DrugBank
DB13200,Cytokines,DrugBank
DB13200,Ethylene Glycols,DrugBank
DB13200,Glycoconjugates,DrugBank
DB13200,Glycols,DrugBank
DB13200,Glycoproteins,DrugBank
DB13200,Granulocyte Colony-Stimulating Factors,DrugBank
DB13200,Hematopoietic Cell Growth Factors,DrugBank
DB13200,Intercellular Signaling Peptides and Proteins,DrugBank
DB13200,Macromolecular Substances,DrugBank
DB13200,Pegylated agents,DrugBank
DB13200,Peptides,DrugBank
DB13200,Polymers,DrugBank
DB13200,Proteins,DrugBank
DB13201,"Amino Acids, Peptides, and Proteins",DrugBank
DB13201,Biological Factors,DrugBank
DB13201,Blood Coagulation Factors,DrugBank
DB13201,Blood Proteins,DrugBank
DB13201,Enzyme Precursors,DrugBank
DB13201,Enzymes and Coenzymes,DrugBank
DB13201,Protein Precursors,DrugBank
DB13201,Proteins,DrugBank
DB13203,Alkaloids,DrugBank
DB13203,Analgesics,DrugBank
DB13203,Anti-Asthmatic Agents,DrugBank
DB13203,Autonomic Agents,DrugBank
DB13203,Bronchodilator Agents,DrugBank
DB13203,Cardiovascular Agents,DrugBank
DB13203,Central Nervous System Agents,DrugBank
DB13203,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13203,Cytochrome P-450 Substrates,DrugBank
DB13203,Drugs for Obstructive Airway Diseases,DrugBank
DB13203,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13203,Peripheral Nervous System Agents,DrugBank
DB13203,Purines,DrugBank
DB13203,Purinones,DrugBank
DB13203,Respiratory System Agents,DrugBank
DB13203,Sensory System Agents,DrugBank
DB13203,Vasodilating Agents,DrugBank
DB13203,Xanthine derivatives,DrugBank
DB13206,2-Amino-1-Phenylethanol Derivatives,DrugBank
DB13206,Alcohols,DrugBank
DB13206,Amines,DrugBank
DB13206,Amino Alcohols,DrugBank
DB13206,Cardiovascular Agents,DrugBank
DB13206,Ethylamines,DrugBank
DB13206,Peripheral Vasodilators,DrugBank
DB13206,Vasodilating Agents,DrugBank
DB13208,Adrenal Cortex Hormones,DrugBank
DB13208,Corticosteroids,DrugBank
DB13208,Corticosteroids for Systemic Use,DrugBank
DB13208,"Corticosteroids for Systemic Use, Plain",DrugBank
DB13208,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13208,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13208,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13208,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13208,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13208,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB13208,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB13208,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13208,Cytochrome P-450 Substrates,DrugBank
DB13208,Fused-Ring Compounds,DrugBank
DB13208,Glucocorticoids,DrugBank
DB13208,Hyperglycemia-Associated Agents,DrugBank
DB13208,Immunosuppressive Agents,DrugBank
DB13208,Pregnadienes,DrugBank
DB13208,Pregnadienetriols,DrugBank
DB13208,Pregnanes,DrugBank
DB13208,Steroids,DrugBank
DB13208,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13209,Alimentary Tract and Metabolism,DrugBank
DB13209,Antacids,DrugBank
DB13209,Bismuth containing drugs,DrugBank
DB13209,Drugs for Acid Related Disorders,DrugBank
DB13209,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB13209,Elements,DrugBank
DB13209,"Elements, Radioactive",DrugBank
DB13209,Gastric Acid Lowering Agents,DrugBank
DB13209,Gastrointestinal Agents,DrugBank
DB13209,Isotopes,DrugBank
DB13209,Metals,DrugBank
DB13209,"Metals, Heavy",DrugBank
DB13209,Neurotoxic agents,DrugBank
DB13209,Radioisotopes,DrugBank
DB13211,Amidines,DrugBank
DB13211,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB13211,Antihypertensive Agents,DrugBank
DB13211,Guanidine Derivatives,DrugBank
DB13213,Antipsychotic Agents,DrugBank
DB13213,Central Nervous System Depressants,DrugBank
DB13213,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13213,Nervous System,DrugBank
DB13213,Neurotoxic agents,DrugBank
DB13213,Phenothiazines,DrugBank
DB13213,Phenothiazines With Piperazine Structure,DrugBank
DB13213,Psycholeptics,DrugBank
DB13213,Sulfur Compounds,DrugBank
DB13214,Anti-Infective Agents,DrugBank
DB13214,Ophthalmologicals,DrugBank
DB13214,Sensory Organs,DrugBank
DB13214,Sulfonamides,DrugBank
DB13217,Acetic Acid Derivatives and Related Substances,DrugBank
DB13217,"Acids, Acyclic",DrugBank
DB13217,Agents causing hyperkalemia,DrugBank
DB13217,Agents that produce hypertension,DrugBank
DB13217,Analgesics,DrugBank
DB13217,"Analgesics, Non-Narcotic",DrugBank
DB13217,Anti-Inflammatory Agents,DrugBank
DB13217,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13217,Antiinflammatory and Antirheumatic Products,DrugBank
DB13217,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13217,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13217,Antirheumatic Agents,DrugBank
DB13217,Fatty Acids,DrugBank
DB13217,"Fatty Acids, Volatile",DrugBank
DB13217,Lipids,DrugBank
DB13217,Musculo-Skeletal System,DrugBank
DB13217,Nephrotoxic agents,DrugBank
DB13217,Non COX-2 selective NSAIDS,DrugBank
DB13217,Peripheral Nervous System Agents,DrugBank
DB13217,Sensory System Agents,DrugBank
DB13217,Sulfur Compounds,DrugBank
DB13217,Topical Products for Joint and Muscular Pain,DrugBank
DB13219,Amines,DrugBank
DB13219,Antidepressive Agents,DrugBank
DB13219,Central Nervous System Depressants,DrugBank
DB13219,Nervous System,DrugBank
DB13219,Psychoanaleptics,DrugBank
DB13221,Amides,DrugBank
DB13221,Central Nervous System Depressants,DrugBank
DB13221,Hypnotics and Sedatives,DrugBank
DB13221,Nervous System,DrugBank
DB13221,Psycholeptics,DrugBank
DB13223,Adrenal Cortex Hormones,DrugBank
DB13223,Corticosteroids,DrugBank
DB13223,"Corticosteroids, Dermatological Preparations",DrugBank
DB13223,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB13223,Dermatologicals,DrugBank
DB13223,Fused-Ring Compounds,DrugBank
DB13223,Immunosuppressive Agents,DrugBank
DB13223,Steroids,DrugBank
DB13225,Agents that produce hypertension,DrugBank
DB13225,Agents that reduce seizure threshold,DrugBank
DB13225,Antidepressive Agents,DrugBank
DB13225,"Antidepressive Agents, Tricyclic",DrugBank
DB13225,Central Nervous System Agents,DrugBank
DB13225,Central Nervous System Depressants,DrugBank
DB13225,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13225,Narrow Therapeutic Index Drugs,DrugBank
DB13225,Nervous System,DrugBank
DB13225,Neurotoxic agents,DrugBank
DB13225,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13225,Psychoanaleptics,DrugBank
DB13225,Psychotropic Drugs,DrugBank
DB13225,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13228,Cardiac Therapy,DrugBank
DB13228,Cardiovascular Agents,DrugBank
DB13228,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13228,Quinolone Vasodilators,DrugBank
DB13228,Vasodilating Agents,DrugBank
DB13228,Vasodilators Used in Cardiac Diseases,DrugBank
DB13229,Anesthetics,DrugBank
DB13229,"Anesthetics, General",DrugBank
DB13229,Nervous System,DrugBank
DB13229,Pyrimidines,DrugBank
DB13229,Pyrimidinones,DrugBank
DB13230,Adrenal Cortex Hormones,DrugBank
DB13230,Antineoplastic and Immunomodulating Agents,DrugBank
DB13230,Endocrine Therapy,DrugBank
DB13230,Genito Urinary System and Sex Hormones,DrugBank
DB13230,Hormones and Related Agents,DrugBank
DB13230,Pregnen (4) Derivatives,DrugBank
DB13230,Progestins,DrugBank
DB13230,Sex Hormones and Modulators of the Genital System,DrugBank
DB13231,Alimentary Tract and Metabolism,DrugBank
DB13231,Calcium Salts,DrugBank
DB13231,Hydroxy Acids,DrugBank
DB13231,Mineral Supplements,DrugBank
DB13232,Agents causing hyperkalemia,DrugBank
DB13232,Agents that produce hypertension,DrugBank
DB13232,Analgesics,DrugBank
DB13232,"Analgesics, Non-Narcotic",DrugBank
DB13232,Anti-Inflammatory Agents,DrugBank
DB13232,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13232,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13232,Antirheumatic Agents,DrugBank
DB13232,Musculo-Skeletal System,DrugBank
DB13232,Nephrotoxic agents,DrugBank
DB13232,Non COX-2 selective NSAIDS,DrugBank
DB13232,Peripheral Nervous System Agents,DrugBank
DB13232,Pyrazoles,DrugBank
DB13232,Pyrazolones,DrugBank
DB13232,Sensory System Agents,DrugBank
DB13232,Topical Products for Joint and Muscular Pain,DrugBank
DB13233,Amino Acids,DrugBank
DB13233,"Amino Acids, Peptides, and Proteins",DrugBank
DB13233,Antidepressive Agents,DrugBank
DB13233,Central Nervous System Agents,DrugBank
DB13233,Central Nervous System Depressants,DrugBank
DB13233,Hypoglycemia-Associated Agents,DrugBank
DB13233,Membrane Transport Modulators,DrugBank
DB13233,Nervous System,DrugBank
DB13233,Neurotransmitter Agents,DrugBank
DB13233,Neurotransmitter Uptake Inhibitors,DrugBank
DB13233,Psychoanaleptics,DrugBank
DB13233,Psychotropic Drugs,DrugBank
DB13233,Selective Serotonin Reuptake Inhibitors,DrugBank
DB13233,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13233,Serotonin Agents,DrugBank
DB13233,Serotonin Modulators,DrugBank
DB13234,"Acids, Carbocyclic",DrugBank
DB13234,Amines,DrugBank
DB13234,Anesthetics,DrugBank
DB13234,"Anesthetics, General",DrugBank
DB13234,"Anesthetics, Intravenous",DrugBank
DB13234,Central Nervous System Agents,DrugBank
DB13234,Central Nervous System Depressants,DrugBank
DB13234,Diethylamines,DrugBank
DB13234,Ethylamines,DrugBank
DB13234,Nervous System,DrugBank
DB13234,Phenylacetates,DrugBank
DB13240,Antiarrhythmic agents,DrugBank
DB13240,Carbohydrates,DrugBank
DB13240,Cardanolides,DrugBank
DB13240,Cardenolides,DrugBank
DB13240,Cardiac Glycosides,DrugBank
DB13240,Cardiac Therapy,DrugBank
DB13240,Cardiotonic Agents,DrugBank
DB13240,Cardiovascular Agents,DrugBank
DB13240,"Compounds used in a research, industrial, or household setting",DrugBank
DB13240,Fused-Ring Compounds,DrugBank
DB13240,Glycosides,DrugBank
DB13240,Protective Agents,DrugBank
DB13240,Steroids,DrugBank
DB13240,Strophanthins,DrugBank
DB13240,Strophanthus Glycosides,DrugBank
DB13241,"Amino Acids, Peptides, and Proteins",DrugBank
DB13241,"Antibodies, Monoclonal",DrugBank
DB13241,Antineoplastic and Immunomodulating Agents,DrugBank
DB13241,Blood Proteins,DrugBank
DB13241,Immunoglobulins,DrugBank
DB13241,Immunosuppressive Agents,DrugBank
DB13241,Proteins,DrugBank
DB13241,Selective Immunosuppressants,DrugBank
DB13241,Serum Globulins,DrugBank
DB13243,Antimetabolites,DrugBank
DB13243,Antineoplastic Agents,DrugBank
DB13243,Antineoplastic and Immunomodulating Agents,DrugBank
DB13243,Noxae,DrugBank
DB13243,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13243,Nucleosides,DrugBank
DB13243,Ribonucleosides,DrugBank
DB13243,Toxic Actions,DrugBank
DB13244,Amino Acids,DrugBank
DB13244,"Amino Acids, Peptides, and Proteins",DrugBank
DB13244,Antifibrinolytic Agents,DrugBank
DB13244,Blood and Blood Forming Organs,DrugBank
DB13244,Hemostatics,DrugBank
DB13246,Agents that produce hypertension,DrugBank
DB13246,Agents that reduce seizure threshold,DrugBank
DB13246,Antidepressive Agents,DrugBank
DB13246,"Antidepressive Agents, Tricyclic",DrugBank
DB13246,Central Nervous System Depressants,DrugBank
DB13246,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13246,Nervous System,DrugBank
DB13246,Neurotoxic agents,DrugBank
DB13246,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13246,Psychoanaleptics,DrugBank
DB13246,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13248,Alimentary Tract and Metabolism,DrugBank
DB13248,Amides,DrugBank
DB13248,Amines,DrugBank
DB13248,Aniline Compounds,DrugBank
DB13248,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB13248,Genito Urinary System and Sex Hormones,DrugBank
DB13248,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13248,Intestinal Antiinfectives,DrugBank
DB13248,Sulfanilamides,DrugBank
DB13248,Sulfonamides,DrugBank
DB13248,Sulfones,DrugBank
DB13248,Sulfur Compounds,DrugBank
DB13248,Thiazoles,DrugBank
DB13249,Agents that produce neuromuscular block (indirect),DrugBank
DB13249,Alimentary Tract and Metabolism,DrugBank
DB13249,Aluminum and magnesium containing antacids,DrugBank
DB13249,Antacids,DrugBank
DB13249,Drugs for Acid Related Disorders,DrugBank
DB13249,Gastric Acid Lowering Agents,DrugBank
DB13249,Magnesium Compounds,DrugBank
DB13249,Metal cations,DrugBank
DB13249,Metal divalent cations,DrugBank
DB13249,Minerals,DrugBank
DB13249,Silicates,DrugBank
DB13249,Silicon Compounds,DrugBank
DB13251,Adrenergic Agents,DrugBank
DB13251,Adrenergic Agonists,DrugBank
DB13251,Adrenergic alpha-Agonists,DrugBank
DB13251,Adrenergic and Dopaminergic Agents,DrugBank
DB13251,Agents producing tachycardia,DrugBank
DB13251,Agents that produce hypertension,DrugBank
DB13251,Alcohols,DrugBank
DB13251,Amines,DrugBank
DB13251,Amino Alcohols,DrugBank
DB13251,Biogenic Amines,DrugBank
DB13251,Biogenic Monoamines,DrugBank
DB13251,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13251,Cardiac Therapy,DrugBank
DB13251,Cardiovascular Agents,DrugBank
DB13251,Ethanolamines,DrugBank
DB13251,Ethylamines,DrugBank
DB13251,Neurotransmitter Agents,DrugBank
DB13251,Phenethylamines,DrugBank
DB13251,Vasoconstrictor Agents,DrugBank
DB13252,Agents producing tachycardia,DrugBank
DB13252,Anti-Parkinson Drugs,DrugBank
DB13252,Anticholinergic Agents,DrugBank
DB13252,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13252,Muscarinic Antagonists,DrugBank
DB13252,Nervous System,DrugBank
DB13252,Sulfur Compounds,DrugBank
DB13252,Tertiary Amines,DrugBank
DB13252,Thiepins,DrugBank
DB13253,"Barbiturates, Plain",DrugBank
DB13253,Central Nervous System Agents,DrugBank
DB13253,Central Nervous System Depressants,DrugBank
DB13253,Hypnotics and Sedatives,DrugBank
DB13253,Nervous System,DrugBank
DB13253,Psycholeptics,DrugBank
DB13253,Pyrimidines,DrugBank
DB13253,Pyrimidinones,DrugBank
DB13254,Agents producing tachycardia,DrugBank
DB13254,Alimentary Tract and Metabolism,DrugBank
DB13254,Anticholinergic Agents,DrugBank
DB13254,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13254,Muscarinic Antagonists,DrugBank
DB13254,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13255,Alcohols,DrugBank
DB13255,Antianginal Agents,DrugBank
DB13255,Cardiac Therapy,DrugBank
DB13255,Glycols,DrugBank
DB13255,Organic Nitrates,DrugBank
DB13255,Vasodilating Agents,DrugBank
DB13255,Vasodilators Used in Cardiac Diseases,DrugBank
DB13256,Antipsychotic Agents,DrugBank
DB13256,Central Nervous System Agents,DrugBank
DB13256,Central Nervous System Depressants,DrugBank
DB13256,"Diazepines, Oxazepines, Thiazepines and Oxepines",DrugBank
DB13256,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13256,Nervous System,DrugBank
DB13256,Neurotoxic agents,DrugBank
DB13256,Psycholeptics,DrugBank
DB13256,Psychotropic Drugs,DrugBank
DB13256,Sulfur Compounds,DrugBank
DB13256,Thiazepines,DrugBank
DB13256,Thiepins,DrugBank
DB13256,Tranquilizing Agents,DrugBank
DB13257,"Anemia, Iron-Deficiency",DrugBank
DB13257,Delayed-Action Preparations,DrugBank
DB13257,Hematinics,DrugBank
DB13257,Iron Compounds,DrugBank
DB13257,Iron Preparations,DrugBank
DB13257,Minerals,DrugBank
DB13257,Organometallic Compounds,DrugBank
DB13257,Pharmaceutical Preparations,DrugBank
DB13257,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB13259,Anesthetics,DrugBank
DB13259,"Anesthetics, Local",DrugBank
DB13259,Central Nervous System Agents,DrugBank
DB13259,Central Nervous System Depressants,DrugBank
DB13259,"Hydrocarbons, Chlorinated",DrugBank
DB13259,"Hydrocarbons, Halogenated",DrugBank
DB13259,Nervous System,DrugBank
DB13259,Peripheral Nervous System Agents,DrugBank
DB13259,Sensory System Agents,DrugBank
DB13261,4-Quinolones,DrugBank
DB13261,Anti-Bacterial Agents,DrugBank
DB13261,Anti-Infective Agents,DrugBank
DB13261,Antibacterials for Systemic Use,DrugBank
DB13261,Antiinfectives for Systemic Use,DrugBank
DB13261,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13261,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13261,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13261,Enzyme Inhibitors,DrugBank
DB13261,Fluoroquinolones,DrugBank
DB13261,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13261,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13261,QTc Prolonging Agents,DrugBank
DB13261,Quinolines,DrugBank
DB13261,Quinolones,DrugBank
DB13261,Topoisomerase II Inhibitors,DrugBank
DB13261,Topoisomerase Inhibitors,DrugBank
DB13264,Agents that produce neuromuscular block (indirect),DrugBank
DB13264,Amides,DrugBank
DB13264,Anti-Bacterial Agents,DrugBank
DB13264,Anti-Infective Agents,DrugBank
DB13264,Antibacterials for Systemic Use,DrugBank
DB13264,Antiinfectives for Systemic Use,DrugBank
DB13264,beta-Lactams,DrugBank
DB13264,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13264,Lactams,DrugBank
DB13264,Naphthacenes,DrugBank
DB13264,Sulfur Compounds,DrugBank
DB13264,Tetracyclines,DrugBank
DB13265,"Acids, Carbocyclic",DrugBank
DB13265,Benzene Derivatives,DrugBank
DB13265,Benzoates,DrugBank
DB13265,Cardiac Therapy,DrugBank
DB13265,Cardiovascular Agents,DrugBank
DB13265,Hydroxy Acids,DrugBank
DB13265,Hydroxybenzoate Ethers,DrugBank
DB13265,Hydroxybenzoates,DrugBank
DB13265,Phenols,DrugBank
DB13265,Phenyl Ethers,DrugBank
DB13265,Vasodilating Agents,DrugBank
DB13265,Vasodilators Used in Cardiac Diseases,DrugBank
DB13266,Amides,DrugBank
DB13266,Anti-Bacterial Agents,DrugBank
DB13266,Anti-Infective Agents,DrugBank
DB13266,Antibacterials for Systemic Use,DrugBank
DB13266,Antiinfectives for Systemic Use,DrugBank
DB13266,beta-Lactams,DrugBank
DB13266,Cephalosporins,DrugBank
DB13266,First-Generation Cephalosporins,DrugBank
DB13266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13266,Lactams,DrugBank
DB13266,Nephrotoxic agents,DrugBank
DB13266,Sulfur Compounds,DrugBank
DB13266,Thiazines,DrugBank
DB13269,Alcohols,DrugBank
DB13269,"Anti-Infective Agents, Local",DrugBank
DB13269,Benzene Derivatives,DrugBank
DB13269,Benzyl Compounds,DrugBank
DB13269,Drugs that are Mainly Renally Excreted,DrugBank
DB13269,Throat Preparations,DrugBank
DB13270,Agents that produce neuromuscular block (indirect),DrugBank
DB13270,Aminoglycoside Antibacterials,DrugBank
DB13270,Anti-Bacterial Agents,DrugBank
DB13270,Anti-Infective Agents,DrugBank
DB13270,Antibacterials for Systemic Use,DrugBank
DB13270,Antiinfectives for Systemic Use,DrugBank
DB13270,Carbohydrates,DrugBank
DB13270,Drugs that are Mainly Renally Excreted,DrugBank
DB13270,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB13270,Glycosides,DrugBank
DB13270,Narrow Therapeutic Index Drugs,DrugBank
DB13270,Nephrotoxic agents,DrugBank
DB13270,Ophthalmologicals,DrugBank
DB13270,Sensory Organs,DrugBank
DB13273,"Acids, Carbocyclic",DrugBank
DB13273,Amides,DrugBank
DB13273,Antidepressive Agents,DrugBank
DB13273,"Antidepressive Agents, Second-Generation",DrugBank
DB13273,Antipsychotic Agents,DrugBank
DB13273,Benzamides and benzamide derivatives,DrugBank
DB13273,Benzene Derivatives,DrugBank
DB13273,Benzoates,DrugBank
DB13273,Central Nervous System Agents,DrugBank
DB13273,Central Nervous System Depressants,DrugBank
DB13273,Dopamine Agents,DrugBank
DB13273,Dopamine Antagonists,DrugBank
DB13273,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13273,Nervous System,DrugBank
DB13273,Neurotoxic agents,DrugBank
DB13273,Neurotransmitter Agents,DrugBank
DB13273,Psycholeptics,DrugBank
DB13273,Psychotropic Drugs,DrugBank
DB13273,QTc Prolonging Agents,DrugBank
DB13273,Tranquilizing Agents,DrugBank
DB13274,Agents that produce neuromuscular block (indirect),DrugBank
DB13274,Aminoglycoside Antibacterials,DrugBank
DB13274,Anti-Bacterial Agents,DrugBank
DB13274,Anti-Infective Agents,DrugBank
DB13274,Carbohydrates,DrugBank
DB13274,Drugs that are Mainly Renally Excreted,DrugBank
DB13274,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB13274,Glycosides,DrugBank
DB13274,Irritants,DrugBank
DB13274,Narrow Therapeutic Index Drugs,DrugBank
DB13274,Nephrotoxic agents,DrugBank
DB13274,Ophthalmic Solutions,DrugBank
DB13274,Ophthalmologicals,DrugBank
DB13274,Sensory Organs,DrugBank
DB13275,Anticoagulants,DrugBank
DB13275,Blood and Blood Forming Organs,DrugBank
DB13275,Indenes,DrugBank
DB13275,Vitamin K Antagonists,DrugBank
DB13277,Antigout Preparations,DrugBank
DB13277,Antirheumatic Agents,DrugBank
DB13277,Cardiac Therapy,DrugBank
DB13277,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13277,Uricosuric Agents,DrugBank
DB13277,Vasodilators Used in Cardiac Diseases,DrugBank
DB13279,Benzopyrans,DrugBank
DB13279,Cardiac Therapy,DrugBank
DB13279,Cardiovascular Agents,DrugBank
DB13279,Coumarins,DrugBank
DB13279,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13279,Pyrans,DrugBank
DB13279,Vasodilating Agents,DrugBank
DB13279,Vasodilators Used in Cardiac Diseases,DrugBank
DB13280,Alimentary Tract and Metabolism,DrugBank
DB13280,Aluminium Compounds,DrugBank
DB13280,Aluminum and magnesium containing antacids,DrugBank
DB13280,Antacids,DrugBank
DB13280,Drugs for Acid Related Disorders,DrugBank
DB13280,Gastric Acid Lowering Agents,DrugBank
DB13280,Metal cations,DrugBank
DB13280,Metal divalent cations,DrugBank
DB13283,Amides,DrugBank
DB13283,Amines,DrugBank
DB13283,Aniline Compounds,DrugBank
DB13283,Anti-Infective Agents,DrugBank
DB13283,Antibacterials for Systemic Use,DrugBank
DB13283,Antiinfectives for Systemic Use,DrugBank
DB13283,Benzene Derivatives,DrugBank
DB13283,Benzenesulfonamides,DrugBank
DB13283,Short-Acting Antibacterial Sulfonamides,DrugBank
DB13283,Sulfanilamides,DrugBank
DB13283,Sulfonamides,DrugBank
DB13283,Sulfonamides and trimethoprim,DrugBank
DB13283,Sulfones,DrugBank
DB13283,Sulfur Compounds,DrugBank
DB13284,Diuretics,DrugBank
DB13284,Genito Urinary System and Sex Hormones,DrugBank
DB13284,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13284,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13284,Sulfonamides,DrugBank
DB13286,Acetic Acid Derivatives and Related Substances,DrugBank
DB13286,"Acids, Acyclic",DrugBank
DB13286,Agents causing hyperkalemia,DrugBank
DB13286,Agents that produce hypertension,DrugBank
DB13286,Analgesics,DrugBank
DB13286,"Analgesics, Non-Narcotic",DrugBank
DB13286,Anti-Inflammatory Agents,DrugBank
DB13286,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13286,Antiinflammatory and Antirheumatic Products,DrugBank
DB13286,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13286,Antirheumatic Agents,DrugBank
DB13286,Dicarboxylic Acids,DrugBank
DB13286,Musculo-Skeletal System,DrugBank
DB13286,Nephrotoxic agents,DrugBank
DB13286,Non COX-2 selective NSAIDS,DrugBank
DB13286,Peripheral Nervous System Agents,DrugBank
DB13286,Sensory System Agents,DrugBank
DB13287,Anti-Bacterial Agents,DrugBank
DB13287,Anti-Infective Agents,DrugBank
DB13287,Antibacterials for Systemic Use,DrugBank
DB13287,Antiinfectives for Systemic Use,DrugBank
DB13287,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13287,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13287,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13287,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13287,Lactones,DrugBank
DB13287,Macrolides,DrugBank
DB13287,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13287,Polyketides,DrugBank
DB13292,Antihistamines for Systemic Use,DrugBank
DB13292,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13292,Sulfur Compounds,DrugBank
DB13292,Xanthenes,DrugBank
DB13293,Agents Causing Muscle Toxicity,DrugBank
DB13293,Antidotes,DrugBank
DB13293,Autonomic Agents,DrugBank
DB13293,Biological Products,DrugBank
DB13293,Central Nervous System Agents,DrugBank
DB13293,Complex Mixtures,DrugBank
DB13293,Cough and Cold Preparations,DrugBank
DB13293,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13293,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13293,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13293,Cytochrome P-450 Substrates,DrugBank
DB13293,Drugs that are Mainly Renally Excreted,DrugBank
DB13293,Emetics,DrugBank
DB13293,Expectorants,DrugBank
DB13293,Gastrointestinal Agents,DrugBank
DB13293,Peripheral Nervous System Agents,DrugBank
DB13293,Plant Extracts,DrugBank
DB13293,Plant Preparations,DrugBank
DB13294,Alcohols,DrugBank
DB13294,Anti-Bacterial Agents,DrugBank
DB13294,Anti-Infective Agents,DrugBank
DB13294,Benzene Derivatives,DrugBank
DB13294,Glycols,DrugBank
DB13294,Nitro Compounds,DrugBank
DB13294,Nitrobenzenes,DrugBank
DB13294,Ophthalmologicals,DrugBank
DB13294,Propylene Glycols,DrugBank
DB13294,Sensory Organs,DrugBank
DB13295,Anticholinergic Agents,DrugBank
DB13295,Benzylisoquinolines,DrugBank
DB13295,Central Nervous System Depressants,DrugBank
DB13295,Cholinergic Agents,DrugBank
DB13295,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13295,Isoquinolines,DrugBank
DB13295,Muscle Relaxants,DrugBank
DB13295,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB13295,Musculo-Skeletal System,DrugBank
DB13295,Neuromuscular Agents,DrugBank
DB13295,Neuromuscular Blocking Agents,DrugBank
DB13295,Neuromuscular Nondepolarizing Blockade,DrugBank
DB13295,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB13295,Neurotransmitter Agents,DrugBank
DB13295,Nicotinic Antagonists,DrugBank
DB13295,Peripheral Nervous System Agents,DrugBank
DB13300,Amides,DrugBank
DB13300,Anti-Bacterial Agents,DrugBank
DB13300,Anti-Infective Agents,DrugBank
DB13300,Antibacterials for Systemic Use,DrugBank
DB13300,Antiinfectives for Systemic Use,DrugBank
DB13300,Beta-Lactam Antibacterials,DrugBank
DB13300,beta-Lactams,DrugBank
DB13300,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13300,Lactams,DrugBank
DB13300,Penicillin G,DrugBank
DB13300,Penicillins,DrugBank
DB13300,Penicillins With Extended Spectrum,DrugBank
DB13300,Sulfur Compounds,DrugBank
DB13303,Carbamic Acid Esters,DrugBank
DB13303,Central Nervous System Depressants,DrugBank
DB13303,Muscle Relaxants,DrugBank
DB13303,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13303,Musculo-Skeletal System,DrugBank
DB13303,Pyrimidines,DrugBank
DB13303,Pyrimidinones,DrugBank
DB13304,Alkylating Drugs,DrugBank
DB13304,Antineoplastic Agents,DrugBank
DB13304,"Antineoplastic Agents, Alkylating",DrugBank
DB13304,Antineoplastic and Immunomodulating Agents,DrugBank
DB13304,Aziridines,DrugBank
DB13304,Azirines,DrugBank
DB13304,Ethylene Imines,DrugBank
DB13304,Noxae,DrugBank
DB13304,Toxic Actions,DrugBank
DB13307,Bufanolides,DrugBank
DB13307,Carbohydrates,DrugBank
DB13307,Cardanolides,DrugBank
DB13307,Cardiac Glycosides,DrugBank
DB13307,Cardiac Therapy,DrugBank
DB13307,Cardiotonic Agents,DrugBank
DB13307,Cardiovascular Agents,DrugBank
DB13307,"Compounds used in a research, industrial, or household setting",DrugBank
DB13307,Enzyme Inhibitors,DrugBank
DB13307,Fused-Ring Compounds,DrugBank
DB13307,Glycosides,DrugBank
DB13307,Protective Agents,DrugBank
DB13307,Scilla Glycosides,DrugBank
DB13307,Steroids,DrugBank
DB13310,Adrenal Cortex Hormones,DrugBank
DB13310,Benzopyrans,DrugBank
DB13310,Chromans,DrugBank
DB13310,"Contraceptive Agents, Female",DrugBank
DB13310,"Contraceptives, Oral",DrugBank
DB13310,"Contraceptives, Postcoital",DrugBank
DB13310,Estrogen Antagonists,DrugBank
DB13310,Genito Urinary System and Sex Hormones,DrugBank
DB13310,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13310,Hormonal Contraceptives for Systemic Use,DrugBank
DB13310,Hormone Antagonists,DrugBank
DB13310,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13310,Pyrans,DrugBank
DB13310,Reproductive Control Agents,DrugBank
DB13310,Selective Estrogen Receptor Modulators,DrugBank
DB13310,Sex Hormones and Modulators of the Genital System,DrugBank
DB13312,ACE Inhibitors and Calcium Channel Blockers,DrugBank
DB13312,ACE Inhibitors and Diuretics,DrugBank
DB13312,Agents Acting on the Renin-Angiotensin System,DrugBank
DB13312,Agents causing angioedema,DrugBank
DB13312,Agents causing hyperkalemia,DrugBank
DB13312,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB13312,Antihypertensive Agents,DrugBank
DB13312,Cardiovascular Agents,DrugBank
DB13312,Enzyme Inhibitors,DrugBank
DB13312,Indenes,DrugBank
DB13312,Protease Inhibitors,DrugBank
DB13314,"Acids, Acyclic",DrugBank
DB13314,Agents causing hyperkalemia,DrugBank
DB13314,Agents that produce hypertension,DrugBank
DB13314,Analgesics,DrugBank
DB13314,"Analgesics, Non-Narcotic",DrugBank
DB13314,Anti-Inflammatory Agents,DrugBank
DB13314,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13314,Antiinflammatory and Antirheumatic Products,DrugBank
DB13314,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13314,Antirheumatic Agents,DrugBank
DB13314,Fatty Acids,DrugBank
DB13314,"Fatty Acids, Volatile",DrugBank
DB13314,Lipids,DrugBank
DB13314,Musculo-Skeletal System,DrugBank
DB13314,Nephrotoxic agents,DrugBank
DB13314,Non COX-2 selective NSAIDS,DrugBank
DB13314,Peripheral Nervous System Agents,DrugBank
DB13314,Propionates,DrugBank
DB13314,Sensory System Agents,DrugBank
DB13316,Adrenergic and Dopaminergic Agents,DrugBank
DB13316,Agents that produce hypertension,DrugBank
DB13316,Amines,DrugBank
DB13316,Autonomic Agents,DrugBank
DB13316,Benzene Derivatives,DrugBank
DB13316,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13316,Cardiac Therapy,DrugBank
DB13316,Cardiotonic Agents,DrugBank
DB13316,Cardiovascular Agents,DrugBank
DB13316,Catecholamines,DrugBank
DB13316,Catechols,DrugBank
DB13316,"Compounds used in a research, industrial, or household setting",DrugBank
DB13316,Diuretics,DrugBank
DB13316,Dopamine Agents,DrugBank
DB13316,Dopamine Agonists,DrugBank
DB13316,Dopamine D1 Receptor Agonists,DrugBank
DB13316,Epinephrine and similars,DrugBank
DB13316,Mydriatics,DrugBank
DB13316,Mydriatics and Cycloplegics,DrugBank
DB13316,Natriuretic Agents,DrugBank
DB13316,Neurotransmitter Agents,DrugBank
DB13316,Ophthalmologicals,DrugBank
DB13316,Peripheral Nervous System Agents,DrugBank
DB13316,Phenols,DrugBank
DB13316,Protective Agents,DrugBank
DB13316,Sensory Organs,DrugBank
DB13316,Sympathomimetics Excl. Antiglaucoma Preparations,DrugBank
DB13316,Vasodilating Agents,DrugBank
DB13317,Agents causing hyperkalemia,DrugBank
DB13317,Agents that produce hypertension,DrugBank
DB13317,Analgesics,DrugBank
DB13317,"Analgesics, Non-Narcotic",DrugBank
DB13317,Anti-Inflammatory Agents,DrugBank
DB13317,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13317,Antiinflammatory and Antirheumatic Products,DrugBank
DB13317,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13317,Antiinflammatory Products for Vaginal Administration,DrugBank
DB13317,Antirheumatic Agents,DrugBank
DB13317,Genito Urinary System and Sex Hormones,DrugBank
DB13317,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13317,Musculo-Skeletal System,DrugBank
DB13317,Nephrotoxic agents,DrugBank
DB13317,Non COX-2 selective NSAIDS,DrugBank
DB13317,Peripheral Nervous System Agents,DrugBank
DB13317,Propionates,DrugBank
DB13317,Sensory System Agents,DrugBank
DB13318,Alkaloids,DrugBank
DB13318,Antimitotic Agents,DrugBank
DB13318,Antineoplastic Agents,DrugBank
DB13318,"Antineoplastic Agents, Phytogenic",DrugBank
DB13318,Antineoplastic and Immunomodulating Agents,DrugBank
DB13318,Colchicine Derivatives,DrugBank
DB13318,Mitosis Modulators,DrugBank
DB13318,Tubulin Modulators,DrugBank
DB13320,Antibacterials for Systemic Use,DrugBank
DB13320,Antiinfectives for Systemic Use,DrugBank
DB13320,Long-Acting Antibacterial Sulfonamides,DrugBank
DB13320,Sulfonamides,DrugBank
DB13320,Sulfonamides and trimethoprim,DrugBank
DB13322,Alimentary Tract and Metabolism,DrugBank
DB13322,Alkalies,DrugBank
DB13322,Aluminium Compounds,DrugBank
DB13322,Aluminum and magnesium containing antacids,DrugBank
DB13322,Anions,DrugBank
DB13322,Antacids,DrugBank
DB13322,Drugs for Acid Related Disorders,DrugBank
DB13322,Electrolytes,DrugBank
DB13322,Gastric Acid Lowering Agents,DrugBank
DB13322,Gastrointestinal Agents,DrugBank
DB13322,Hydroxides,DrugBank
DB13322,Ions,DrugBank
DB13322,Magnesium Compounds,DrugBank
DB13322,Metal cations,DrugBank
DB13322,Metal divalent cations,DrugBank
DB13323,Agents that produce hypertension,DrugBank
DB13323,Anesthetics,DrugBank
DB13323,"Anesthetics, General",DrugBank
DB13323,"Anesthetics, Inhalation",DrugBank
DB13323,Central Nervous System Agents,DrugBank
DB13323,Central Nervous System Depressants,DrugBank
DB13323,"Compounds used in a research, industrial, or household setting",DrugBank
DB13323,"Hydrocarbons, Chlorinated",DrugBank
DB13323,"Hydrocarbons, Halogenated",DrugBank
DB13323,Nervous System,DrugBank
DB13323,Solvents,DrugBank
DB13324,Benzazepines,DrugBank
DB13324,Central Nervous System Agents,DrugBank
DB13324,Central Nervous System Depressants,DrugBank
DB13324,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13324,Muscle Relaxants,DrugBank
DB13324,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13324,Musculo-Skeletal System,DrugBank
DB13324,Neuromuscular Agents,DrugBank
DB13324,Peripheral Nervous System Agents,DrugBank
DB13327,"Acids, Carbocyclic",DrugBank
DB13327,Antiplatelet agents,DrugBank
DB13327,Blood and Blood Forming Organs,DrugBank
DB13327,Hematologic Agents,DrugBank
DB13327,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB13328,Amides,DrugBank
DB13328,Amines,DrugBank
DB13328,Anesthetics,DrugBank
DB13328,"Anesthetics, Local",DrugBank
DB13328,Anilides,DrugBank
DB13328,Aniline Compounds,DrugBank
DB13328,Nervous System,DrugBank
DB13331,Central Nervous System Depressants,DrugBank
DB13331,Hypnotics and Sedatives,DrugBank
DB13331,Nervous System,DrugBank
DB13331,Piperidinedione Derivatives,DrugBank
DB13331,Psycholeptics,DrugBank
DB13331,Pyridines,DrugBank
DB13334,Alkanes,DrugBank
DB13334,Alkanesulfonates,DrugBank
DB13334,Alkanesulfonic Acids,DrugBank
DB13334,Alkylating Drugs,DrugBank
DB13334,Antineoplastic Agents,DrugBank
DB13334,Antineoplastic and Immunomodulating Agents,DrugBank
DB13334,"Hydrocarbons, Acyclic",DrugBank
DB13334,Sulfonic Acids,DrugBank
DB13334,Sulfur Acids,DrugBank
DB13334,Sulfur Compounds,DrugBank
DB13335,Anti-Anxiety Agents,DrugBank
DB13335,Benzazepines,DrugBank
DB13335,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB13335,Central Nervous System Agents,DrugBank
DB13335,Central Nervous System Depressants,DrugBank
DB13335,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13335,Nervous System,DrugBank
DB13335,Psycholeptics,DrugBank
DB13335,Psychotropic Drugs,DrugBank
DB13335,Tranquilizing Agents,DrugBank
DB13337,Anti-Bacterial Agents,DrugBank
DB13337,Antibacterials for Systemic Use,DrugBank
DB13337,Antiinfectives for Systemic Use,DrugBank
DB13337,Beta-Lactam Antibacterials,DrugBank
DB13337,Beta-Lactamase Sensitive Penicillins,DrugBank
DB13337,beta-Lactams,DrugBank
DB13337,Penicillins,DrugBank
DB13338,Anti-Bacterial Agents,DrugBank
DB13338,Antibacterials for Systemic Use,DrugBank
DB13338,Antiinfectives for Systemic Use,DrugBank
DB13338,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13338,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13338,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13338,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13338,Enzyme Inhibitors,DrugBank
DB13338,Lactones,DrugBank
DB13338,"Leukocyte Elastase, antagonists & inhibitors",DrugBank
DB13338,Macrolides,DrugBank
DB13338,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13338,Polyketides,DrugBank
DB13339,Alkylating Drugs,DrugBank
DB13339,Antineoplastic Agents,DrugBank
DB13339,"Antineoplastic Agents, Alkylating",DrugBank
DB13339,Antineoplastic and Immunomodulating Agents,DrugBank
DB13339,Epoxy Compounds,DrugBank
DB13339,Ethers,DrugBank
DB13339,"Ethers, Cyclic",DrugBank
DB13339,Noxae,DrugBank
DB13339,Toxic Actions,DrugBank
DB13340,Alcohols,DrugBank
DB13340,Amines,DrugBank
DB13340,Amino Alcohols,DrugBank
DB13340,Cardiovascular Agents,DrugBank
DB13340,Ethylamines,DrugBank
DB13340,Peripheral Vasodilators,DrugBank
DB13340,Phenethylamines,DrugBank
DB13340,Propanolamines,DrugBank
DB13340,Propanols,DrugBank
DB13340,Vasodilating Agents,DrugBank
DB13341,Agents producing tachycardia,DrugBank
DB13341,Agents that produce hypertension,DrugBank
DB13341,Autonomic Agents,DrugBank
DB13341,Centrally Acting Sympathomimetics,DrugBank
DB13341,Nervous System,DrugBank
DB13341,Oxazoles,DrugBank
DB13341,Peripheral Nervous System Agents,DrugBank
DB13341,Psychoanaleptics,DrugBank
DB13341,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB13341,Sympathomimetics,DrugBank
DB13345,Adrenergic Agents,DrugBank
DB13345,Adrenergic Antagonists,DrugBank
DB13345,Agents that produce hypertension,DrugBank
DB13345,Alkaloids,DrugBank
DB13345,BSEP/ABCB11 Substrates,DrugBank
DB13345,Cardiovascular Agents,DrugBank
DB13345,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13345,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13345,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB13345,Cytochrome P-450 Substrates,DrugBank
DB13345,Ergot Alkaloids and Derivatives,DrugBank
DB13345,Ergotamines,DrugBank
DB13345,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13345,Neurotransmitter Agents,DrugBank
DB13345,Peripheral Vasodilators,DrugBank
DB13345,Vasodilating Agents,DrugBank
DB13346,Acetamides,DrugBank
DB13346,Acetic Acid Derivatives and Related Substances,DrugBank
DB13346,Agents causing hyperkalemia,DrugBank
DB13346,Amides,DrugBank
DB13346,Amines,DrugBank
DB13346,Analgesics,DrugBank
DB13346,"Analgesics, Non-Narcotic",DrugBank
DB13346,Anti-Inflammatory Agents,DrugBank
DB13346,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13346,"Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)",DrugBank
DB13346,Antiinflammatory and Antirheumatic Products,DrugBank
DB13346,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13346,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13346,Antineoplastic Agents,DrugBank
DB13346,Antirheumatic Agents,DrugBank
DB13346,Benzene Derivatives,DrugBank
DB13346,Benzeneacetamides,DrugBank
DB13346,Histone Deacetylase Inhibitors,DrugBank
DB13346,Hydroxamic Acids,DrugBank
DB13346,Hydroxy Acids,DrugBank
DB13346,Hydroxylamines,DrugBank
DB13346,Musculo-Skeletal System,DrugBank
DB13346,Nephrotoxic agents,DrugBank
DB13346,Non COX-2 selective NSAIDS,DrugBank
DB13346,Peripheral Nervous System Agents,DrugBank
DB13346,Sensory System Agents,DrugBank
DB13346,Topical Products for Joint and Muscular Pain,DrugBank
DB13347,Anticoagulants,DrugBank
DB13347,Blood and Blood Forming Organs,DrugBank
DB13347,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13347,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13347,Cytochrome P-450 Substrates,DrugBank
DB13347,Indans,DrugBank
DB13347,Indenes,DrugBank
DB13347,Vitamin K Antagonists,DrugBank
DB13349,Antihistamines for Systemic Use,DrugBank
DB13349,Pyridazines,DrugBank
DB13349,Substituted Alkylamines,DrugBank
DB13351,"Acids, Carbocyclic",DrugBank
DB13351,Agents producing tachycardia,DrugBank
DB13351,Alimentary Tract and Metabolism,DrugBank
DB13351,Anticholinergic Agents,DrugBank
DB13351,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13351,Muscarinic Antagonists,DrugBank
DB13351,Phenylacetates,DrugBank
DB13351,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13352,Alcohols,DrugBank
DB13352,Amines,DrugBank
DB13352,Amino Alcohols,DrugBank
DB13352,Anti-Dyskinesia Agents,DrugBank
DB13352,Antidepressive Agents,DrugBank
DB13352,Central Nervous System Agents,DrugBank
DB13352,Central Nervous System Depressants,DrugBank
DB13352,Ethanolamines,DrugBank
DB13352,Methylamines,DrugBank
DB13352,Nervous System,DrugBank
DB13352,Psychoanaleptics,DrugBank
DB13352,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB13352,Psychotropic Drugs,DrugBank
DB13354,"Acids, Acyclic",DrugBank
DB13354,Carbamic Acid Esters,DrugBank
DB13354,Central Nervous System Depressants,DrugBank
DB13354,Muscle Relaxants,DrugBank
DB13354,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13354,Musculo-Skeletal System,DrugBank
DB13357,Carbamic Acid Esters,DrugBank
DB13357,Central Nervous System Depressants,DrugBank
DB13357,Muscle Relaxants,DrugBank
DB13357,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13357,Musculo-Skeletal System,DrugBank
DB13358,Antiarrhythmic agents,DrugBank
DB13358,"Antiarrhythmics, Class I",DrugBank
DB13358,"Antiarrhythmics, Class Ia",DrugBank
DB13358,Cardiac Therapy,DrugBank
DB13358,Cardiovascular Agents,DrugBank
DB13358,Hypoglycemia-Associated Agents,DrugBank
DB13358,Potential QTc-Prolonging Agents,DrugBank
DB13358,QTc Prolonging Agents,DrugBank
DB13359,Agents that produce neuromuscular block (indirect),DrugBank
DB13359,Alimentary Tract and Metabolism,DrugBank
DB13359,Amino Acids,DrugBank
DB13359,"Amino Acids, Acidic",DrugBank
DB13359,"Amino Acids, Dicarboxylic",DrugBank
DB13359,"Amino Acids, Peptides, and Proteins",DrugBank
DB13359,Excitatory Amino Acids,DrugBank
DB13359,Magnesium Compounds,DrugBank
DB13359,Metal cations,DrugBank
DB13359,Metal divalent cations,DrugBank
DB13359,Mineral Supplements,DrugBank
DB13362,Amides,DrugBank
DB13362,Anticonvulsants,DrugBank
DB13362,Central Nervous System Agents,DrugBank
DB13362,Central Nervous System Depressants,DrugBank
DB13362,Nervous System,DrugBank
DB13364,Agents causing hyperkalemia,DrugBank
DB13364,Agents that produce hypertension,DrugBank
DB13364,Analgesics,DrugBank
DB13364,"Analgesics, Non-Narcotic",DrugBank
DB13364,Anti-Inflammatory Agents,DrugBank
DB13364,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13364,Antiinflammatory and Antirheumatic Products,DrugBank
DB13364,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13364,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13364,Antirheumatic Agents,DrugBank
DB13364,Musculo-Skeletal System,DrugBank
DB13364,Nephrotoxic agents,DrugBank
DB13364,Non COX-2 selective NSAIDS,DrugBank
DB13364,Peripheral Nervous System Agents,DrugBank
DB13364,Pyrazoles,DrugBank
DB13364,Pyrazolones,DrugBank
DB13364,Sensory System Agents,DrugBank
DB13364,Topical Products for Joint and Muscular Pain,DrugBank
DB13365,Alimentary Tract and Metabolism,DrugBank
DB13365,Calcium Salts,DrugBank
DB13365,Mineral Supplements,DrugBank
DB13367,Antiplatelet agents,DrugBank
DB13367,Benzopyrans,DrugBank
DB13367,Blood and Blood Forming Organs,DrugBank
DB13367,Coumarins,DrugBank
DB13367,Hematologic Agents,DrugBank
DB13367,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13367,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB13367,Pyrans,DrugBank
DB13369,Agents producing tachycardia,DrugBank
DB13369,Alimentary Tract and Metabolism,DrugBank
DB13369,Anticholinergic Agents,DrugBank
DB13369,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13369,Muscarinic Antagonists,DrugBank
DB13369,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13370,Amides,DrugBank
DB13370,Central Nervous System Agents,DrugBank
DB13370,Central Nervous System Depressants,DrugBank
DB13370,Hypnotics and Sedatives,DrugBank
DB13370,Nervous System,DrugBank
DB13370,Psycholeptics,DrugBank
DB13371,Acetates,DrugBank
DB13371,Acetic Acid Derivatives and Related Substances,DrugBank
DB13371,"Acids, Acyclic",DrugBank
DB13371,Agents causing hyperkalemia,DrugBank
DB13371,Agents that produce hypertension,DrugBank
DB13371,Amides,DrugBank
DB13371,Analgesics,DrugBank
DB13371,"Analgesics, Non-Narcotic",DrugBank
DB13371,Anti-Inflammatory Agents,DrugBank
DB13371,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13371,Antiinflammatory and Antirheumatic Products,DrugBank
DB13371,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13371,Antirheumatic Agents,DrugBank
DB13371,Musculo-Skeletal System,DrugBank
DB13371,Nephrotoxic agents,DrugBank
DB13371,Non COX-2 selective NSAIDS,DrugBank
DB13371,Peripheral Nervous System Agents,DrugBank
DB13371,Sensory System Agents,DrugBank
DB13374,Alkaloids,DrugBank
DB13374,Antihypertensive Agents,DrugBank
DB13374,Antineoplastic Agents,DrugBank
DB13374,Cardiovascular Agents,DrugBank
DB13374,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13374,Indole Alkaloids,DrugBank
DB13374,Indoles,DrugBank
DB13374,Indolizidines,DrugBank
DB13374,Indolizines,DrugBank
DB13374,Peripheral Vasodilators,DrugBank
DB13374,Secologanin Tryptamine Alkaloids,DrugBank
DB13374,Vasodilating Agents,DrugBank
DB13374,Vinca Alkaloids,DrugBank
DB13375,"Adjuvants, Immunologic",DrugBank
DB13375,"Amino Acids, Peptides, and Proteins",DrugBank
DB13375,Antibodies,DrugBank
DB13375,"Antibodies, Monoclonal",DrugBank
DB13375,Antineoplastic Agents,DrugBank
DB13375,Antineoplastic and Immunomodulating Agents,DrugBank
DB13375,Blood Proteins,DrugBank
DB13375,Cancer immunotherapy,DrugBank
DB13375,Globulins,DrugBank
DB13375,Immunoglobulins,DrugBank
DB13375,Immunologic Factors,DrugBank
DB13375,Immunoproteins,DrugBank
DB13375,Immunotherapy,DrugBank
DB13375,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB13375,Proteins,DrugBank
DB13375,Serum Globulins,DrugBank
DB13377,"Barbiturates, Plain",DrugBank
DB13377,Central Nervous System Depressants,DrugBank
DB13377,Hypnotics and Sedatives,DrugBank
DB13377,Nervous System,DrugBank
DB13377,Psycholeptics,DrugBank
DB13378,Adrenergic Agents,DrugBank
DB13378,Adrenergic Agonists,DrugBank
DB13378,Adrenergic alpha-Agonists,DrugBank
DB13378,Adrenergic and Dopaminergic Agents,DrugBank
DB13378,Agents producing tachycardia,DrugBank
DB13378,Agents that produce hypertension,DrugBank
DB13378,Alcohols,DrugBank
DB13378,Amines,DrugBank
DB13378,Amino Alcohols,DrugBank
DB13378,Biogenic Amines,DrugBank
DB13378,Biogenic Monoamines,DrugBank
DB13378,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13378,Cardiac Therapy,DrugBank
DB13378,Ethanolamines,DrugBank
DB13378,Ethylamines,DrugBank
DB13378,Neurotransmitter Agents,DrugBank
DB13378,Phenethylamines,DrugBank
DB13380,"Acids, Carbocyclic",DrugBank
DB13380,Agents producing tachycardia,DrugBank
DB13380,Alimentary Tract and Metabolism,DrugBank
DB13380,Anticholinergic Agents,DrugBank
DB13380,Diphenylacetic Acids,DrugBank
DB13380,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13380,Hydroxy Acids,DrugBank
DB13380,Muscarinic Antagonists,DrugBank
DB13380,Phenylacetates,DrugBank
DB13380,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13381,Acetates,DrugBank
DB13381,"Acids, Acyclic",DrugBank
DB13381,Amines,DrugBank
DB13381,Antianemic Preparations,DrugBank
DB13381,Blood and Blood Forming Organs,DrugBank
DB13381,"Compounds used in a research, industrial, or household setting",DrugBank
DB13381,Diamines,DrugBank
DB13381,Ethylenediamines,DrugBank
DB13381,Iron Chelating Agents,DrugBank
DB13381,Iron Compounds,DrugBank
DB13381,Iron Preparations,DrugBank
DB13381,"Iron Trivalent, Oral Preparations",DrugBank
DB13381,Parenteral Iron Replacement,DrugBank
DB13381,Polyamines,DrugBank
DB13381,Sequestering Agents,DrugBank
DB13382,Antipsychotic Agents,DrugBank
DB13382,Central Nervous System Agents,DrugBank
DB13382,Central Nervous System Depressants,DrugBank
DB13382,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13382,Muscle Relaxants,DrugBank
DB13382,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13382,Nervous System,DrugBank
DB13382,Neuromuscular Agents,DrugBank
DB13382,Neurotoxic agents,DrugBank
DB13382,Peripheral Nervous System Agents,DrugBank
DB13382,Phenothiazines,DrugBank
DB13382,Phenothiazines With Aliphatic Side-Chain,DrugBank
DB13382,Psycholeptics,DrugBank
DB13382,Sulfur Compounds,DrugBank
DB13384,Agents that produce hypertension,DrugBank
DB13384,Agents that reduce seizure threshold,DrugBank
DB13384,Antidepressive Agents,DrugBank
DB13384,"Antidepressive Agents, Tricyclic",DrugBank
DB13384,Central Nervous System Agents,DrugBank
DB13384,Central Nervous System Depressants,DrugBank
DB13384,Narrow Therapeutic Index Drugs,DrugBank
DB13384,Nervous System,DrugBank
DB13384,Neurotoxic agents,DrugBank
DB13384,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13384,Psychoanaleptics,DrugBank
DB13384,Psychotropic Drugs,DrugBank
DB13384,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13385,Agents that produce hypertension,DrugBank
DB13385,Alkaloids,DrugBank
DB13385,Anti-Parkinson Drugs,DrugBank
DB13385,Cardiovascular Agents,DrugBank
DB13385,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13385,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13385,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB13385,Cytochrome P-450 Substrates,DrugBank
DB13385,Dopamine Agents,DrugBank
DB13385,Dopamine Agonists,DrugBank
DB13385,Ergot Alkaloids and Derivatives,DrugBank
DB13385,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB13385,Ergotamines,DrugBank
DB13385,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13385,Nervous System,DrugBank
DB13385,Neurotransmitter Agents,DrugBank
DB13385,Vasodilating Agents,DrugBank
DB13386,Estranes,DrugBank
DB13386,Estrenes,DrugBank
DB13386,Estrogens,DrugBank
DB13386,Fused-Ring Compounds,DrugBank
DB13386,Genito Urinary System and Sex Hormones,DrugBank
DB13386,Hormones,DrugBank
DB13386,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13386,"Ovulation Stimulants, Synthetic",DrugBank
DB13386,Sex Hormones and Modulators of the Genital System,DrugBank
DB13386,Steroids,DrugBank
DB13393,Agents Causing Muscle Toxicity,DrugBank
DB13393,Alkaloids,DrugBank
DB13393,Amebicides,DrugBank
DB13393,Anti-Infective Agents,DrugBank
DB13393,Antinematodal Agents,DrugBank
DB13393,Antiparasitic Agents,DrugBank
DB13393,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB13393,Antiprotozoals,DrugBank
DB13393,Autonomic Agents,DrugBank
DB13393,Central Nervous System Agents,DrugBank
DB13393,Emetics,DrugBank
DB13393,Enzyme Inhibitors,DrugBank
DB13393,Gastrointestinal Agents,DrugBank
DB13393,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13393,Isoquinolines,DrugBank
DB13393,Peripheral Nervous System Agents,DrugBank
DB13393,Protein Synthesis Inhibitors,DrugBank
DB13394,Alcohols,DrugBank
DB13394,Alimentary Tract and Metabolism,DrugBank
DB13394,Amines,DrugBank
DB13394,Amino Alcohols,DrugBank
DB13394,Benzene Derivatives,DrugBank
DB13394,Biogenic Amines,DrugBank
DB13394,Biogenic Monoamines,DrugBank
DB13394,Blood and Blood Forming Organs,DrugBank
DB13394,Cardiovascular Agents,DrugBank
DB13394,Catecholamines,DrugBank
DB13394,Catechols,DrugBank
DB13394,Coagulants,DrugBank
DB13394,Ethanolamines,DrugBank
DB13394,Hematologic Agents,DrugBank
DB13394,Hemostatics,DrugBank
DB13394,Local Hemostatics,DrugBank
DB13394,Phenols,DrugBank
DB13394,Stomatological Preparations,DrugBank
DB13394,Vasoconstrictor Agents,DrugBank
DB13396,Anticonvulsants,DrugBank
DB13396,Central Nervous System Depressants,DrugBank
DB13396,Hydantoins,DrugBank
DB13396,Nervous System,DrugBank
DB13396,Thyroxine-binding globulin substrates,DrugBank
DB13398,Adrenergic Agents,DrugBank
DB13398,Adrenergic Agonists,DrugBank
DB13398,Adrenergic beta-Agonists,DrugBank
DB13398,Agents producing tachycardia,DrugBank
DB13398,Agents that produce hypertension,DrugBank
DB13398,Alcohols,DrugBank
DB13398,Amines,DrugBank
DB13398,Amino Alcohols,DrugBank
DB13398,Cardiac Therapy,DrugBank
DB13398,Cardiotonic Agents,DrugBank
DB13398,Cardiovascular Agents,DrugBank
DB13398,"Compounds used in a research, industrial, or household setting",DrugBank
DB13398,Ethylamines,DrugBank
DB13398,Ketones,DrugBank
DB13398,Neurotransmitter Agents,DrugBank
DB13398,Phenethylamines,DrugBank
DB13398,Propanolamines,DrugBank
DB13398,Propanols,DrugBank
DB13398,Propiophenones,DrugBank
DB13398,Protective Agents,DrugBank
DB13398,Vasodilating Agents,DrugBank
DB13398,Vasodilators Used in Cardiac Diseases,DrugBank
DB13399,Agents that produce hypertension,DrugBank
DB13399,Alkaloids,DrugBank
DB13399,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13399,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13399,Cytochrome P-450 Substrates,DrugBank
DB13399,Dopamine Agents,DrugBank
DB13399,Ergolines,DrugBank
DB13399,Ergot Alkaloids and Derivatives,DrugBank
DB13399,Genito Urinary System and Sex Hormones,DrugBank
DB13399,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13399,Neurotransmitter Agents,DrugBank
DB13399,Prolactine Inhibitors,DrugBank
DB13400,Antihypertensive Agents,DrugBank
DB13400,Antiplatelet agents,DrugBank
DB13400,Cardiac Therapy,DrugBank
DB13400,Cardiovascular Agents,DrugBank
DB13400,Enzyme Inhibitors,DrugBank
DB13400,Hematologic Agents,DrugBank
DB13400,Morpholines,DrugBank
DB13400,Nitric Oxide Donors,DrugBank
DB13400,Oxadiazoles,DrugBank
DB13400,Oxazines,DrugBank
DB13400,Oxazoles,DrugBank
DB13400,"Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors",DrugBank
DB13400,Sydnones,DrugBank
DB13400,Vasodilating Agents,DrugBank
DB13400,Vasodilators Used in Cardiac Diseases,DrugBank
DB13401,Antiarrhythmic agents,DrugBank
DB13401,Carbohydrates,DrugBank
DB13401,Cardanolides,DrugBank
DB13401,Cardenolides,DrugBank
DB13401,Cardiac Glycosides,DrugBank
DB13401,Cardiac Therapy,DrugBank
DB13401,Cardiotonic Agents,DrugBank
DB13401,Cardiovascular Agents,DrugBank
DB13401,"Compounds used in a research, industrial, or household setting",DrugBank
DB13401,Digitalis Glycosides,DrugBank
DB13401,Digoxin and derivatives,DrugBank
DB13401,Enzyme Inhibitors,DrugBank
DB13401,Fused-Ring Compounds,DrugBank
DB13401,Glycosides,DrugBank
DB13401,Protective Agents,DrugBank
DB13401,Steroids,DrugBank
DB13402,Central Nervous System Depressants,DrugBank
DB13402,Hypnotics and Sedatives,DrugBank
DB13402,Nervous System,DrugBank
DB13402,Psycholeptics,DrugBank
DB13403,Antipsychotic Agents,DrugBank
DB13403,Central Nervous System Depressants,DrugBank
DB13403,Indole Derivatives,DrugBank
DB13403,Nervous System,DrugBank
DB13403,Neurotoxic agents,DrugBank
DB13403,Psycholeptics,DrugBank
DB13405,Amides,DrugBank
DB13405,Diuretics,DrugBank
DB13405,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13405,Natriuretic Agents,DrugBank
DB13405,Sulfonamides,DrugBank
DB13405,Sulfones,DrugBank
DB13405,Sulfur Compounds,DrugBank
DB13406,Alimentary Tract and Metabolism,DrugBank
DB13406,Amides,DrugBank
DB13406,Benzene Derivatives,DrugBank
DB13406,Benzenesulfonamides,DrugBank
DB13406,Blood Glucose Lowering Agents,DrugBank
DB13406,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13406,Cytochrome P-450 Substrates,DrugBank
DB13406,Drugs Used in Diabetes,DrugBank
DB13406,Insulin Secretagogues,DrugBank
DB13406,Oral Hypoglycemics,DrugBank
DB13406,Sulfonamides,DrugBank
DB13406,Sulfones,DrugBank
DB13406,Sulfonylureas,DrugBank
DB13406,Sulfur Compounds,DrugBank
DB13407,Agents causing hyperkalemia,DrugBank
DB13407,Agents that produce hypertension,DrugBank
DB13407,Analgesics,DrugBank
DB13407,"Analgesics, Non-Narcotic",DrugBank
DB13407,Anti-Inflammatory Agents,DrugBank
DB13407,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13407,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13407,Antirheumatic Agents,DrugBank
DB13407,Musculo-Skeletal System,DrugBank
DB13407,Nephrotoxic agents,DrugBank
DB13407,Nervous System,DrugBank
DB13407,Nicotinic Acids,DrugBank
DB13407,Non COX-2 selective NSAIDS,DrugBank
DB13407,Peripheral Nervous System Agents,DrugBank
DB13407,Pyrazoles,DrugBank
DB13407,Pyrazolones,DrugBank
DB13407,Pyridines,DrugBank
DB13407,Sensory System Agents,DrugBank
DB13407,Topical Products for Joint and Muscular Pain,DrugBank
DB13408,Antianginal Agents,DrugBank
DB13408,Cardiac Therapy,DrugBank
DB13408,Organic Nitrates,DrugBank
DB13408,Vasodilating Agents,DrugBank
DB13408,Vasodilators Used in Cardiac Diseases,DrugBank
DB13409,Anti-Bacterial Agents,DrugBank
DB13409,Antibacterials for Systemic Use,DrugBank
DB13409,Antiinfectives for Systemic Use,DrugBank
DB13409,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13409,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13409,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13409,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13409,Lactones,DrugBank
DB13409,Macrolides,DrugBank
DB13409,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13410,Amidines,DrugBank
DB13410,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB13410,Antihypertensive Agents,DrugBank
DB13410,Guanidine Derivatives,DrugBank
DB13410,Guanidines,DrugBank
DB13411,Agents that produce hypertension,DrugBank
DB13411,Agents that reduce seizure threshold,DrugBank
DB13411,Antidepressive Agents,DrugBank
DB13411,"Antidepressive Agents, Tricyclic",DrugBank
DB13411,Central Nervous System Agents,DrugBank
DB13411,Central Nervous System Depressants,DrugBank
DB13411,Dibenzazepines,DrugBank
DB13411,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13411,Nervous System,DrugBank
DB13411,Neurotoxic agents,DrugBank
DB13411,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13411,Psychoanaleptics,DrugBank
DB13411,Psychotropic Drugs,DrugBank
DB13411,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13413,Agents producing tachycardia,DrugBank
DB13413,Anti-Parkinson Drugs,DrugBank
DB13413,Anticholinergic Agents,DrugBank
DB13413,Cholinergic Agents,DrugBank
DB13413,Muscarinic Antagonists,DrugBank
DB13413,Nervous System,DrugBank
DB13413,Neurotransmitter Agents,DrugBank
DB13413,Piperidines,DrugBank
DB13413,Piperidones,DrugBank
DB13413,Tertiary Amines,DrugBank
DB13414,Central Nervous System Depressants,DrugBank
DB13414,Muscle Relaxants,DrugBank
DB13414,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13414,Musculo-Skeletal System,DrugBank
DB13418,Estradiol Congeners,DrugBank
DB13418,Estrogen Antagonists,DrugBank
DB13418,"Estrogenic Steroids, Alkylated",DrugBank
DB13418,Estrogens,DrugBank
DB13418,Fused-Ring Compounds,DrugBank
DB13418,Genito Urinary System and Sex Hormones,DrugBank
DB13418,Gonadal Hormones,DrugBank
DB13418,Gonadal Steroid Hormones,DrugBank
DB13418,Hormone Antagonists,DrugBank
DB13418,Hormones,DrugBank
DB13418,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13418,Norpregnanes,DrugBank
DB13418,Norpregnatrienes,DrugBank
DB13418,Norsteroids,DrugBank
DB13418,Sex Hormones and Modulators of the Genital System,DrugBank
DB13418,Steroids,DrugBank
DB13418,"Synthetic Estrogens, Plain",DrugBank
DB13420,Amines,DrugBank
DB13420,Antihistamines for Systemic Use,DrugBank
DB13420,Antipsychotic Agents,DrugBank
DB13420,Central Nervous System Depressants,DrugBank
DB13420,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13420,Neurotoxic agents,DrugBank
DB13420,Phenothiazine Derivatives,DrugBank
DB13420,Phenothiazines,DrugBank
DB13420,Propylamines,DrugBank
DB13420,Sulfur Compounds,DrugBank
DB13422,Cardiovascular Agents,DrugBank
DB13422,Lipid Modifying Agents,DrugBank
DB13422,"Lipid Modifying Agents, Plain",DrugBank
DB13422,Nicotinic Acid and Derivatives,DrugBank
DB13422,Nicotinic Acids,DrugBank
DB13422,Pyridines,DrugBank
DB13422,Vasodilating Agents,DrugBank
DB13423,Antianemic Preparations,DrugBank
DB13423,Blood and Blood Forming Organs,DrugBank
DB13423,Iron Compounds,DrugBank
DB13423,Iron Preparations,DrugBank
DB13423,"Iron Trivalent, Oral Preparations",DrugBank
DB13429,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB13429,Antihypertensive Agents,DrugBank
DB13429,Imidazoles,DrugBank
DB13429,Imidazoline Receptor Agonists,DrugBank
DB13429,Imidazolines,DrugBank
DB13430,Diuretics,DrugBank
DB13430,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13430,Hyperglycemia-Associated Agents,DrugBank
DB13430,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB13430,Sulfonamides,DrugBank
DB13430,Sulfones,DrugBank
DB13430,Sulfur Compounds,DrugBank
DB13430,Thiazides,DrugBank
DB13432,Acetic Acid Derivatives and Related Substances,DrugBank
DB13432,Agents causing hyperkalemia,DrugBank
DB13432,Agents that produce hypertension,DrugBank
DB13432,Analgesics,DrugBank
DB13432,"Analgesics, Non-Narcotic",DrugBank
DB13432,Anti-Inflammatory Agents,DrugBank
DB13432,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13432,Antiinflammatory and Antirheumatic Products,DrugBank
DB13432,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13432,Antirheumatic Agents,DrugBank
DB13432,Musculo-Skeletal System,DrugBank
DB13432,Nephrotoxic agents,DrugBank
DB13432,Non COX-2 selective NSAIDS,DrugBank
DB13432,Peripheral Nervous System Agents,DrugBank
DB13432,Prostaglandin Antagonists,DrugBank
DB13432,Sensory System Agents,DrugBank
DB13433,"Acids, Acyclic",DrugBank
DB13433,Agents Causing Muscle Toxicity,DrugBank
DB13433,Benzene Derivatives,DrugBank
DB13433,Butyrates,DrugBank
DB13433,Clofibric Acid,DrugBank
DB13433,Ethers,DrugBank
DB13433,Fibric Acids,DrugBank
DB13433,Isobutyrates,DrugBank
DB13433,Lipid Modifying Agents,DrugBank
DB13433,"Lipid Modifying Agents, Plain",DrugBank
DB13433,Lipid Regulating Agents,DrugBank
DB13433,Phenols,DrugBank
DB13433,Phenyl Ethers,DrugBank
DB13435,Antihypertensive Agents,DrugBank
DB13435,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB13435,Cardiovascular Agents,DrugBank
DB13435,Hydrazinophthalazine Derivatives,DrugBank
DB13435,Vasodilating Agents,DrugBank
DB13437,Anti-Anxiety Agents,DrugBank
DB13437,Anticonvulsants,DrugBank
DB13437,Benzazepines,DrugBank
DB13437,Benzodiazepine hypnotics and sedatives,DrugBank
DB13437,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB13437,Central Nervous System Agents,DrugBank
DB13437,Central Nervous System Depressants,DrugBank
DB13437,GABA Agents,DrugBank
DB13437,GABA Modulators,DrugBank
DB13437,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13437,Hypnotics and Sedatives,DrugBank
DB13437,Muscle Relaxants,DrugBank
DB13437,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13437,Nervous System,DrugBank
DB13437,Neuromuscular Agents,DrugBank
DB13437,Neurotransmitter Agents,DrugBank
DB13437,Peripheral Nervous System Agents,DrugBank
DB13437,Psycholeptics,DrugBank
DB13437,Psychotropic Drugs,DrugBank
DB13437,Tranquilizing Agents,DrugBank
DB13443,Adrenergic Antagonists,DrugBank
DB13443,Adrenergic beta-Antagonists,DrugBank
DB13443,Agents causing hyperkalemia,DrugBank
DB13443,Antihypertensive Agents,DrugBank
DB13443,"Beta Blocking Agents, Selective",DrugBank
DB13443,Bradycardia-Causing Agents,DrugBank
DB13443,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13443,Cytochrome P-450 Substrates,DrugBank
DB13446,Alimentary Tract and Metabolism,DrugBank
DB13446,Biological Products,DrugBank
DB13446,Biopolymers,DrugBank
DB13446,Blood Glucose Lowering Agents,DrugBank
DB13446,Carbohydrates,DrugBank
DB13446,Complex Mixtures,DrugBank
DB13446,"Compounds used in a research, industrial, or household setting",DrugBank
DB13446,Dietary Fiber,DrugBank
DB13446,Drugs Used in Diabetes,DrugBank
DB13446,Macromolecular Substances,DrugBank
DB13446,Plant Exudates,DrugBank
DB13446,Polymers,DrugBank
DB13446,Polysaccharides,DrugBank
DB13448,Acetates,DrugBank
DB13448,"Acids, Acyclic",DrugBank
DB13448,Agents producing tachycardia,DrugBank
DB13448,Anti-Parkinson Drugs,DrugBank
DB13448,Anticholinergic Agents,DrugBank
DB13448,Hydroxy Acids,DrugBank
DB13448,Muscarinic Antagonists,DrugBank
DB13448,Nervous System,DrugBank
DB13448,Sulfur Compounds,DrugBank
DB13448,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13448,Tertiary Amines,DrugBank
DB13449,Alkaloids,DrugBank
DB13449,Anti-Asthmatic Agents,DrugBank
DB13449,Autonomic Agents,DrugBank
DB13449,Bronchodilator Agents,DrugBank
DB13449,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13449,Cytochrome P-450 Substrates,DrugBank
DB13449,Drugs for Obstructive Airway Diseases,DrugBank
DB13449,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13449,Peripheral Nervous System Agents,DrugBank
DB13449,Purines,DrugBank
DB13449,Purinones,DrugBank
DB13449,Respiratory System Agents,DrugBank
DB13449,Xanthine derivatives,DrugBank
DB13449,Xanthines and Adrenergics,DrugBank
DB13451,Anticoagulants,DrugBank
DB13451,Benzopyrans,DrugBank
DB13451,Blood and Blood Forming Organs,DrugBank
DB13451,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13451,Pyrans,DrugBank
DB13451,Vitamin K Antagonists,DrugBank
DB13452,Antihypertensive Agents,DrugBank
DB13452,"Arteriolar Smooth Muscle, Agents Acting On",DrugBank
DB13452,Cardiovascular Agents,DrugBank
DB13452,Hydrazinophthalazine Derivatives,DrugBank
DB13452,Vasodilating Agents,DrugBank
DB13453,Agents that produce hypertension,DrugBank
DB13453,Anesthetics,DrugBank
DB13453,"Anesthetics, General",DrugBank
DB13453,"Anesthetics, Inhalation",DrugBank
DB13453,Central Nervous System Agents,DrugBank
DB13453,Central Nervous System Depressants,DrugBank
DB13453,Diagnostic Agents,DrugBank
DB13453,Elements,DrugBank
DB13453,Gases,DrugBank
DB13453,Nervous System,DrugBank
DB13453,Noble Gases,DrugBank
DB13454,Alkaloids,DrugBank
DB13454,Analgesics,DrugBank
DB13454,Central Nervous System Agents,DrugBank
DB13454,Central Nervous System Depressants,DrugBank
DB13454,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13454,Morphinans,DrugBank
DB13454,Narcotics,DrugBank
DB13454,Natural Opium Alkaloids,DrugBank
DB13454,Nervous System,DrugBank
DB13454,Opiate Alkaloids,DrugBank
DB13454,Opioids,DrugBank
DB13454,Peripheral Nervous System Agents,DrugBank
DB13454,Phenanthrenes,DrugBank
DB13454,Pyridines,DrugBank
DB13454,Sensory System Agents,DrugBank
DB13454,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13455,"Acids, Acyclic",DrugBank
DB13455,Amino Acids,DrugBank
DB13455,"Amino Acids, Peptides, and Proteins",DrugBank
DB13455,Aminobutyrates,DrugBank
DB13455,Anticonvulsants,DrugBank
DB13455,Butyrates,DrugBank
DB13455,Central Nervous System Agents,DrugBank
DB13455,Central Nervous System Depressants,DrugBank
DB13455,Central Nervous System Stimulants,DrugBank
DB13455,Convulsants,DrugBank
DB13455,GABA Agents,DrugBank
DB13455,GABA Agonists,DrugBank
DB13455,Hypnotics and Sedatives,DrugBank
DB13455,Nervous System,DrugBank
DB13455,Neurotransmitter Agents,DrugBank
DB13455,Psychoanaleptics,DrugBank
DB13455,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB13455,Psychotropic Drugs,DrugBank
DB13455,Tranquilizing Agents,DrugBank
DB13456,Anti-Bacterial Agents,DrugBank
DB13456,Anti-Infective Agents,DrugBank
DB13456,Antibacterials for Systemic Use,DrugBank
DB13456,Antiinfectives for Systemic Use,DrugBank
DB13456,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13456,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13456,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13456,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13456,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13456,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13456,Cytochrome P-450 Substrates,DrugBank
DB13456,Lactones,DrugBank
DB13456,Macrolides,DrugBank
DB13456,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13456,Polyketides,DrugBank
DB13457,Antidepressive Agents,DrugBank
DB13457,Central Nervous System Depressants,DrugBank
DB13457,Nervous System,DrugBank
DB13457,Oxazines,DrugBank
DB13457,Psychoanaleptics,DrugBank
DB13459,Antifungal Agents,DrugBank
DB13459,Antifungals for Dermatological Use,DrugBank
DB13459,Antifungals for Topical Use,DrugBank
DB13459,Dermatologicals,DrugBank
DB13459,Pyrrolidines,DrugBank
DB13460,Agents Causing Muscle Toxicity,DrugBank
DB13460,Fibric Acids,DrugBank
DB13460,Lipid Modifying Agents,DrugBank
DB13460,"Lipid Modifying Agents, Plain",DrugBank
DB13460,Lipid Regulating Agents,DrugBank
DB13461,Anti-Bacterial Agents,DrugBank
DB13461,Antibacterials for Systemic Use,DrugBank
DB13461,Antiinfectives for Systemic Use,DrugBank
DB13461,Cephalosporins,DrugBank
DB13461,Nephrotoxic agents,DrugBank
DB13461,Third-Generation Cephalosporins,DrugBank
DB13464,"Amino Acids, Peptides, and Proteins",DrugBank
DB13464,Cardiovascular Agents,DrugBank
DB13464,Coagulants,DrugBank
DB13464,Hematologic Agents,DrugBank
DB13464,Hemostatics,DrugBank
DB13464,Hormones,DrugBank
DB13464,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13464,Nerve Tissue Proteins,DrugBank
DB13464,Neuropeptides,DrugBank
DB13464,Oligopeptides,DrugBank
DB13464,Peptide Hormones,DrugBank
DB13464,Peptides,DrugBank
DB13464,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB13464,Pituitary Hormones,DrugBank
DB13464,"Pituitary Hormones, Posterior",DrugBank
DB13464,Posterior Pituitary Lobe Hormones,DrugBank
DB13464,Proteins,DrugBank
DB13464,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13464,Vasoconstrictor Agents,DrugBank
DB13464,Vasopressin and Analogues,DrugBank
DB13464,Vasopressins,DrugBank
DB13466,Alkaloids,DrugBank
DB13466,Antihistamines for Systemic Use,DrugBank
DB13466,Aza Compounds,DrugBank
DB13466,Azabicyclo Compounds,DrugBank
DB13466,Histamine Agents,DrugBank
DB13466,Histamine Antagonists,DrugBank
DB13466,Histamine H1 Antagonists,DrugBank
DB13466,Neurotransmitter Agents,DrugBank
DB13467,Carbohydrates,DrugBank
DB13467,Cardanolides,DrugBank
DB13467,Cardenolides,DrugBank
DB13467,Cardiac Glycosides,DrugBank
DB13467,Cardiac Therapy,DrugBank
DB13467,Digitalis Glycosides,DrugBank
DB13467,Fused-Ring Compounds,DrugBank
DB13467,Glycosides,DrugBank
DB13467,Steroids,DrugBank
DB13468,Agents producing tachycardia,DrugBank
DB13468,Alkaloids,DrugBank
DB13468,Anti-Parkinson Drugs,DrugBank
DB13468,Anticholinergic Agents,DrugBank
DB13468,Aza Compounds,DrugBank
DB13468,Azabicyclo Compounds,DrugBank
DB13468,Ethers of Tropine or Tropine Derivatives,DrugBank
DB13468,Muscarinic Antagonists,DrugBank
DB13468,Nervous System,DrugBank
DB13470,Amides,DrugBank
DB13470,Anti-Bacterial Agents,DrugBank
DB13470,Anti-Infective Agents,DrugBank
DB13470,Antibacterials for Systemic Use,DrugBank
DB13470,Antiinfectives for Systemic Use,DrugBank
DB13470,beta-Lactams,DrugBank
DB13470,Cephalosporins,DrugBank
DB13470,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13470,Lactams,DrugBank
DB13470,Nephrotoxic agents,DrugBank
DB13470,Sulfur Compounds,DrugBank
DB13470,Thiazines,DrugBank
DB13470,Third-Generation Cephalosporins,DrugBank
DB13478,Analgesics,DrugBank
DB13478,Azepines,DrugBank
DB13478,Central Nervous System Agents,DrugBank
DB13478,Central Nervous System Depressants,DrugBank
DB13478,Cholinesterase Inhibitors,DrugBank
DB13478,Mixed Agonist / Antagonist Opioids,DrugBank
DB13478,Narcotics,DrugBank
DB13478,Nervous System,DrugBank
DB13478,Opioid Antagonists,DrugBank
DB13478,Opioids,DrugBank
DB13478,Peripheral Nervous System Agents,DrugBank
DB13478,Sensory System Agents,DrugBank
DB13478,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13479,Antihistamines for Systemic Use,DrugBank
DB13479,Substituted Ethylene Diamines,DrugBank
DB13480,"Adjuvants, Immunologic",DrugBank
DB13480,Antineoplastic Agents,DrugBank
DB13480,Antineoplastic and Immunomodulating Agents,DrugBank
DB13480,beta-Glucans,DrugBank
DB13480,Carbohydrates,DrugBank
DB13480,"Compounds used in a research, industrial, or household setting",DrugBank
DB13480,Glucans,DrugBank
DB13480,Immunologic Factors,DrugBank
DB13480,Polysaccharides,DrugBank
DB13481,Agents causing hyperkalemia,DrugBank
DB13481,Agents that produce hypertension,DrugBank
DB13481,Alkaloids,DrugBank
DB13481,Analgesics,DrugBank
DB13481,"Analgesics, Non-Narcotic",DrugBank
DB13481,Anti-Inflammatory Agents,DrugBank
DB13481,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13481,Antiinflammatory and Antirheumatic Products,DrugBank
DB13481,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13481,Antirheumatic Agents,DrugBank
DB13481,Cyclooxygenase Inhibitors,DrugBank
DB13481,Enzyme Inhibitors,DrugBank
DB13481,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13481,Indole Alkaloids,DrugBank
DB13481,Indoles,DrugBank
DB13481,Indolizidines,DrugBank
DB13481,Indolizines,DrugBank
DB13481,Musculo-Skeletal System,DrugBank
DB13481,Nephrotoxic agents,DrugBank
DB13481,Non COX-2 selective NSAIDS,DrugBank
DB13481,Peripheral Nervous System Agents,DrugBank
DB13481,Sensory System Agents,DrugBank
DB13485,Antibacterials for Systemic Use,DrugBank
DB13485,Antiinfectives for Systemic Use,DrugBank
DB13485,Long-Acting Antibacterial Sulfonamides,DrugBank
DB13485,Sulfonamides,DrugBank
DB13485,Sulfonamides and trimethoprim,DrugBank
DB13486,Alimentary Tract and Metabolism,DrugBank
DB13486,Aluminum and magnesium containing antacids,DrugBank
DB13486,Anions,DrugBank
DB13486,Antacids,DrugBank
DB13486,Drugs for Acid Related Disorders,DrugBank
DB13486,Drugs for Constipation,DrugBank
DB13486,Electrolytes,DrugBank
DB13486,Free Radicals,DrugBank
DB13486,Gastric Acid Lowering Agents,DrugBank
DB13486,Ions,DrugBank
DB13486,Laxatives,DrugBank
DB13486,Magnesium Compounds,DrugBank
DB13486,Metal cations,DrugBank
DB13486,Metal divalent cations,DrugBank
DB13486,Osmotic Laxatives,DrugBank
DB13486,Oxides,DrugBank
DB13486,Oxygen Compounds,DrugBank
DB13486,Reactive Oxygen Species,DrugBank
DB13488,Agents causing hyperkalemia,DrugBank
DB13488,Antiarrhythmic agents,DrugBank
DB13488,Bradycardia-Causing Agents,DrugBank
DB13488,Calcium Channel Blockers,DrugBank
DB13488,Calcium-Regulating Hormones and Agents,DrugBank
DB13488,Cardiovascular Agents,DrugBank
DB13488,Cycloheptanes,DrugBank
DB13488,Cycloparaffins,DrugBank
DB13488,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13488,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13488,Cytochrome P-450 Substrates,DrugBank
DB13488,Membrane Transport Modulators,DrugBank
DB13488,Peripheral Vasodilators,DrugBank
DB13488,Potential QTc-Prolonging Agents,DrugBank
DB13488,QTc Prolonging Agents,DrugBank
DB13488,Vasodilating Agents,DrugBank
DB13491,Adrenal Cortex Hormones,DrugBank
DB13491,Corticosteroids,DrugBank
DB13491,"Corticosteroids, Dermatological Preparations",DrugBank
DB13491,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB13491,Dermatologicals,DrugBank
DB13491,Fused-Ring Compounds,DrugBank
DB13491,Immunosuppressive Agents,DrugBank
DB13491,Steroids,DrugBank
DB13495,Agrochemicals,DrugBank
DB13495,Antiglaucoma Preparations and Miotics,DrugBank
DB13495,Cholinergic Agents,DrugBank
DB13495,Cholinesterase Inhibitors,DrugBank
DB13495,"Compounds used in a research, industrial, or household setting",DrugBank
DB13495,Enzyme Inhibitors,DrugBank
DB13495,Insecticides,DrugBank
DB13495,Neurotransmitter Agents,DrugBank
DB13495,Ophthalmologicals,DrugBank
DB13495,Organophosphates,DrugBank
DB13495,Organophosphorus Compounds,DrugBank
DB13495,Parasympathomimetics,DrugBank
DB13495,Pesticides,DrugBank
DB13495,Sensory Organs,DrugBank
DB13495,Toxic Actions,DrugBank
DB13496,Agents that produce hypertension,DrugBank
DB13496,Agents that reduce seizure threshold,DrugBank
DB13496,Antidepressive Agents,DrugBank
DB13496,"Antidepressive Agents, Tricyclic",DrugBank
DB13496,Central Nervous System Agents,DrugBank
DB13496,Central Nervous System Depressants,DrugBank
DB13496,Cyclooctanes,DrugBank
DB13496,Cycloparaffins,DrugBank
DB13496,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13496,Indoles,DrugBank
DB13496,Narrow Therapeutic Index Drugs,DrugBank
DB13496,Nervous System,DrugBank
DB13496,Neurotoxic agents,DrugBank
DB13496,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13496,Psychoanaleptics,DrugBank
DB13496,Psychotropic Drugs,DrugBank
DB13496,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13499,Amides,DrugBank
DB13499,Anti-Bacterial Agents,DrugBank
DB13499,Anti-Infective Agents,DrugBank
DB13499,Antibacterials for Systemic Use,DrugBank
DB13499,Antiinfectives for Systemic Use,DrugBank
DB13499,beta-Lactams,DrugBank
DB13499,Cephalosporins,DrugBank
DB13499,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13499,Lactams,DrugBank
DB13499,Nephrotoxic agents,DrugBank
DB13499,Sulfur Compounds,DrugBank
DB13499,Thiazines,DrugBank
DB13499,Third-Generation Cephalosporins,DrugBank
DB13500,Agents causing hyperkalemia,DrugBank
DB13500,Agents producing tachycardia,DrugBank
DB13500,Alimentary Tract and Metabolism,DrugBank
DB13500,Amines,DrugBank
DB13500,Ammonium Compounds,DrugBank
DB13500,Antiarrhythmic agents,DrugBank
DB13500,Anticholinergic Agents,DrugBank
DB13500,Autonomic Agents,DrugBank
DB13500,Bradycardia-Causing Agents,DrugBank
DB13500,Calcium Channel Blockers,DrugBank
DB13500,Calcium-Regulating Hormones and Agents,DrugBank
DB13500,Cardiovascular Agents,DrugBank
DB13500,Cholinergic Agents,DrugBank
DB13500,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13500,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13500,Cytochrome P-450 Substrates,DrugBank
DB13500,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13500,Gastrointestinal Agents,DrugBank
DB13500,Membrane Transport Modulators,DrugBank
DB13500,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13500,Muscarinic Antagonists,DrugBank
DB13500,Neurotransmitter Agents,DrugBank
DB13500,Nitrogen Compounds,DrugBank
DB13500,Onium Compounds,DrugBank
DB13500,Parasympatholytics,DrugBank
DB13500,Peripheral Nervous System Agents,DrugBank
DB13500,QTc Prolonging Agents,DrugBank
DB13500,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13500,Vasodilating Agents,DrugBank
DB13501,Agents causing hyperkalemia,DrugBank
DB13501,Agents that produce hypertension,DrugBank
DB13501,Analgesics,DrugBank
DB13501,"Analgesics, Non-Narcotic",DrugBank
DB13501,Anti-Inflammatory Agents,DrugBank
DB13501,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13501,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13501,Antimetabolites,DrugBank
DB13501,Antirheumatic Agents,DrugBank
DB13501,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13501,Hypolipidemic Agents,DrugBank
DB13501,Lipid Regulating Agents,DrugBank
DB13501,Musculo-Skeletal System,DrugBank
DB13501,Nephrotoxic agents,DrugBank
DB13501,Non COX-2 selective NSAIDS,DrugBank
DB13501,Ophthalmologicals,DrugBank
DB13501,Peripheral Nervous System Agents,DrugBank
DB13501,Pyrazoles,DrugBank
DB13501,Sensory Organs,DrugBank
DB13501,Sensory System Agents,DrugBank
DB13501,Topical Products for Joint and Muscular Pain,DrugBank
DB13503,"Amino Acids, Peptides, and Proteins",DrugBank
DB13503,Anti-Bacterial Agents,DrugBank
DB13503,Anti-Infective Agents,DrugBank
DB13503,"Anti-Infective Agents, Local",DrugBank
DB13503,Antibiotics for Topical Use,DrugBank
DB13503,Cholinesterase Inhibitors,DrugBank
DB13503,Dermatologicals,DrugBank
DB13503,Ophthalmologicals,DrugBank
DB13503,Peptides,DrugBank
DB13503,"Peptides, Cyclic",DrugBank
DB13503,Sensory Organs,DrugBank
DB13503,Throat Preparations,DrugBank
DB13504,Amides,DrugBank
DB13504,Anti-Bacterial Agents,DrugBank
DB13504,Anti-Infective Agents,DrugBank
DB13504,Antibacterials for Systemic Use,DrugBank
DB13504,Antiinfectives for Systemic Use,DrugBank
DB13504,beta-Lactams,DrugBank
DB13504,Cephalosporins,DrugBank
DB13504,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13504,Lactams,DrugBank
DB13504,Nephrotoxic agents,DrugBank
DB13504,Sulfur Compounds,DrugBank
DB13504,Thiazines,DrugBank
DB13504,Third-Generation Cephalosporins,DrugBank
DB13505,Agents producing tachycardia,DrugBank
DB13505,Alimentary Tract and Metabolism,DrugBank
DB13505,Amines,DrugBank
DB13505,Anticholinergic Agents,DrugBank
DB13505,Autonomic Agents,DrugBank
DB13505,Central Nervous System Depressants,DrugBank
DB13505,Cholinergic Agents,DrugBank
DB13505,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13505,Drugs for Urinary Frequency and Incontinence,DrugBank
DB13505,Genito Urinary System and Sex Hormones,DrugBank
DB13505,Genitourinary Agents,DrugBank
DB13505,Hypnotics and Sedatives,DrugBank
DB13505,Muscarinic Antagonists,DrugBank
DB13505,Nervous System,DrugBank
DB13505,Neurotransmitter Agents,DrugBank
DB13505,Onium Compounds,DrugBank
DB13505,Parasympatholytics,DrugBank
DB13505,Peripheral Nervous System Agents,DrugBank
DB13505,Psycholeptics,DrugBank
DB13505,Quaternary Ammonium Compounds,DrugBank
DB13505,Urological Agents,DrugBank
DB13505,Urologicals,DrugBank
DB13506,Amides,DrugBank
DB13506,Anti-Bacterial Agents,DrugBank
DB13506,Anti-Infective Agents,DrugBank
DB13506,"Anti-Infective Agents, Urinary",DrugBank
DB13506,beta-Lactams,DrugBank
DB13506,Genito Urinary System and Sex Hormones,DrugBank
DB13506,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13506,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13506,Lactams,DrugBank
DB13506,Penicillin G,DrugBank
DB13506,Penicillins,DrugBank
DB13506,Sulfur Compounds,DrugBank
DB13507,"Acids, Carbocyclic",DrugBank
DB13507,Agents producing tachycardia,DrugBank
DB13507,Alimentary Tract and Metabolism,DrugBank
DB13507,Anticholinergic Agents,DrugBank
DB13507,Diphenylacetic Acids,DrugBank
DB13507,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13507,Hydroxy Acids,DrugBank
DB13507,Muscarinic Antagonists,DrugBank
DB13507,Phenylacetates,DrugBank
DB13507,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13508,Adrenergic Agents,DrugBank
DB13508,Adrenergic Antagonists,DrugBank
DB13508,Adrenergic beta-Antagonists,DrugBank
DB13508,Agents causing hyperkalemia,DrugBank
DB13508,Alcohols,DrugBank
DB13508,Amines,DrugBank
DB13508,Amino Alcohols,DrugBank
DB13508,Antihypertensive Agents,DrugBank
DB13508,"Beta Blocking Agents, Non-Selective",DrugBank
DB13508,Bradycardia-Causing Agents,DrugBank
DB13508,Cardiovascular Agents,DrugBank
DB13508,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13508,Cytochrome P-450 Substrates,DrugBank
DB13508,Neurotransmitter Agents,DrugBank
DB13508,Propanols,DrugBank
DB13509,Analgesics,DrugBank
DB13509,Benzene Derivatives,DrugBank
DB13509,Blood and Blood Forming Organs,DrugBank
DB13509,Hydroxybenzoates,DrugBank
DB13509,Nervous System,DrugBank
DB13509,Phenols,DrugBank
DB13509,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB13509,Salicylates,DrugBank
DB13509,Salicylic Acid and Derivatives,DrugBank
DB13510,Adrenergic alpha-Antagonists,DrugBank
DB13510,Adrenergic Antagonists,DrugBank
DB13510,Agents that produce hypertension,DrugBank
DB13510,Antiplatelet agents,DrugBank
DB13510,Cardiovascular Agents,DrugBank
DB13510,Peripheral Vasodilators,DrugBank
DB13510,Vasodilating Agents,DrugBank
DB13511,"Acids, Carbocyclic",DrugBank
DB13511,Alimentary Tract and Metabolism,DrugBank
DB13511,Amides,DrugBank
DB13511,Antiemetics,DrugBank
DB13511,Autonomic Agents,DrugBank
DB13511,Benzene Derivatives,DrugBank
DB13511,Benzoates,DrugBank
DB13511,Central Nervous System Agents,DrugBank
DB13511,Dopamine Antagonists,DrugBank
DB13511,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13511,Gastrointestinal Agents,DrugBank
DB13511,Peripheral Nervous System Agents,DrugBank
DB13511,Propulsives,DrugBank
DB13514,"Acids, Acyclic",DrugBank
DB13514,Agents causing hyperkalemia,DrugBank
DB13514,Agents that produce hypertension,DrugBank
DB13514,Analgesics,DrugBank
DB13514,"Analgesics, Non-Narcotic",DrugBank
DB13514,Anti-Inflammatory Agents,DrugBank
DB13514,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13514,Antigout Preparations,DrugBank
DB13514,Antirheumatic Agents,DrugBank
DB13514,Fatty Acids,DrugBank
DB13514,"Fatty Acids, Volatile",DrugBank
DB13514,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13514,Lipids,DrugBank
DB13514,Nephrotoxic agents,DrugBank
DB13514,Non COX-2 selective NSAIDS,DrugBank
DB13514,Ophthalmologicals,DrugBank
DB13514,Peripheral Nervous System Agents,DrugBank
DB13514,Pyrans,DrugBank
DB13514,Sensory Organs,DrugBank
DB13514,Sensory System Agents,DrugBank
DB13517,"Amino Acids, Peptides, and Proteins",DrugBank
DB13517,Angiotensins,DrugBank
DB13517,Autacoids,DrugBank
DB13517,Biological Factors,DrugBank
DB13517,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13517,Cardiac Therapy,DrugBank
DB13517,Cardiovascular Agents,DrugBank
DB13517,Inflammation Mediators,DrugBank
DB13517,Oligopeptides,DrugBank
DB13517,Peptides,DrugBank
DB13517,Vasoconstrictor Agents,DrugBank
DB13520,Agents that produce hypertension,DrugBank
DB13520,Alkaloids,DrugBank
DB13520,Antidepressive Agents,DrugBank
DB13520,Central Nervous System Depressants,DrugBank
DB13520,Dopamine Agents,DrugBank
DB13520,Dopamine Agonists,DrugBank
DB13520,Ergolines,DrugBank
DB13520,Ergot Alkaloids and Derivatives,DrugBank
DB13520,Ergot-derivative Dopamine Receptor Agonists,DrugBank
DB13520,Genito Urinary System and Sex Hormones,DrugBank
DB13520,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13520,Neurotransmitter Agents,DrugBank
DB13520,Prolactine Inhibitors,DrugBank
DB13520,Serotonin 5-HT1 Receptor Antagonists,DrugBank
DB13520,Serotonin 5-HT1D Receptor Antagonists,DrugBank
DB13520,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB13520,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB13520,Serotonin 5-HT2C Receptor Antagonists,DrugBank
DB13520,Serotonin Agents,DrugBank
DB13520,Serotonin Receptor Agonists,DrugBank
DB13520,Serotonin Receptor Antagonists,DrugBank
DB13522,Amides,DrugBank
DB13522,Analgesics,DrugBank
DB13522,Anti-Anxiety Agents,DrugBank
DB13522,Central Nervous System Agents,DrugBank
DB13522,Central Nervous System Depressants,DrugBank
DB13522,Nervous System,DrugBank
DB13522,Peripheral Nervous System Agents,DrugBank
DB13522,Psychoanaleptics,DrugBank
DB13522,Psychotropic Drugs,DrugBank
DB13522,Sensory System Agents,DrugBank
DB13522,Tranquilizing Agents,DrugBank
DB13523,"Acids, Carbocyclic",DrugBank
DB13523,Amides,DrugBank
DB13523,Antipsychotic Agents,DrugBank
DB13523,Benzamides and benzamide derivatives,DrugBank
DB13523,Benzene Derivatives,DrugBank
DB13523,Benzoates,DrugBank
DB13523,Central Nervous System Agents,DrugBank
DB13523,Central Nervous System Depressants,DrugBank
DB13523,"Menopause, drug effects",DrugBank
DB13523,Nervous System,DrugBank
DB13523,Neurotoxic agents,DrugBank
DB13523,Psycholeptics,DrugBank
DB13523,"Psychophysiologic Disorders, drug therapy",DrugBank
DB13523,Psychotropic Drugs,DrugBank
DB13523,Tranquilizing Agents,DrugBank
DB13524,Agents causing hyperkalemia,DrugBank
DB13524,Agents that produce hypertension,DrugBank
DB13524,Analgesics,DrugBank
DB13524,"Analgesics, Non-Narcotic",DrugBank
DB13524,Anti-Inflammatory Agents,DrugBank
DB13524,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13524,Antirheumatic Agents,DrugBank
DB13524,Nephrotoxic agents,DrugBank
DB13524,Nervous System,DrugBank
DB13524,Non COX-2 selective NSAIDS,DrugBank
DB13524,Peripheral Nervous System Agents,DrugBank
DB13524,Pyrazoles,DrugBank
DB13524,Pyrazolones,DrugBank
DB13524,Sensory System Agents,DrugBank
DB13526,Alcohols,DrugBank
DB13526,Alimentary Tract and Metabolism,DrugBank
DB13526,Drugs for Constipation,DrugBank
DB13526,Glycols,DrugBank
DB13526,Laxatives,DrugBank
DB13526,Osmotic Laxatives,DrugBank
DB13527,Acetic Acid Derivatives and Related Substances,DrugBank
DB13527,Agents causing hyperkalemia,DrugBank
DB13527,Agents that produce hypertension,DrugBank
DB13527,Analgesics,DrugBank
DB13527,"Analgesics, Non-Narcotic",DrugBank
DB13527,Anti-Inflammatory Agents,DrugBank
DB13527,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13527,Antiinflammatory and Antirheumatic Products,DrugBank
DB13527,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13527,Antirheumatic Agents,DrugBank
DB13527,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13527,Indoles,DrugBank
DB13527,Musculo-Skeletal System,DrugBank
DB13527,Nephrotoxic agents,DrugBank
DB13527,Non COX-2 selective NSAIDS,DrugBank
DB13527,Peripheral Nervous System Agents,DrugBank
DB13527,Sensory System Agents,DrugBank
DB13528,Adrenal Cortex Hormones,DrugBank
DB13528,Antiandrogens,DrugBank
DB13528,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB13528,"Contraceptive Agents, Female",DrugBank
DB13528,"Contraceptive Agents, Hormonal",DrugBank
DB13528,"Contraceptives, Oral",DrugBank
DB13528,"Contraceptives, Oral, Hormonal",DrugBank
DB13528,"Contraceptives, Oral, Synthetic",DrugBank
DB13528,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13528,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13528,Cytochrome P-450 Substrates,DrugBank
DB13528,Fused-Ring Compounds,DrugBank
DB13528,Genito Urinary System and Sex Hormones,DrugBank
DB13528,Hormonal Contraceptives for Systemic Use,DrugBank
DB13528,Hormone Antagonists,DrugBank
DB13528,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13528,Pregnadien Derivatives,DrugBank
DB13528,Pregnadienes,DrugBank
DB13528,Pregnanes,DrugBank
DB13528,Progestin Contraceptives,DrugBank
DB13528,Progestins,DrugBank
DB13528,"Progestogens and Estrogens, Sequential Preparations",DrugBank
DB13528,Reproductive Control Agents,DrugBank
DB13528,Sex Hormones and Modulators of the Genital System,DrugBank
DB13528,Steroids,DrugBank
DB13528,"Steroids, Chlorinated",DrugBank
DB13530,Adrenergic Agents,DrugBank
DB13530,Adrenergic Antagonists,DrugBank
DB13530,Adrenergic beta-Antagonists,DrugBank
DB13530,Agents causing hyperkalemia,DrugBank
DB13530,Alcohols,DrugBank
DB13530,Amines,DrugBank
DB13530,Amino Alcohols,DrugBank
DB13530,"Beta Blocking Agents, Non-Selective",DrugBank
DB13530,Bradycardia-Causing Agents,DrugBank
DB13530,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13530,Cytochrome P-450 Substrates,DrugBank
DB13530,Neurotransmitter Agents,DrugBank
DB13530,Phenoxypropanolamines,DrugBank
DB13530,Propanolamines,DrugBank
DB13530,Propanols,DrugBank
DB13532,Antihypertensive Agents,DrugBank
DB13532,Benzothiadiazines,DrugBank
DB13532,Cardiovascular Agents,DrugBank
DB13532,Diuretics,DrugBank
DB13532,Genito Urinary System and Sex Hormones,DrugBank
DB13532,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13532,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13532,Hyperglycemia-Associated Agents,DrugBank
DB13532,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB13532,Membrane Transport Modulators,DrugBank
DB13532,Natriuretic Agents,DrugBank
DB13532,Sodium Chloride Symporter Inhibitors,DrugBank
DB13532,Sulfonamides,DrugBank
DB13532,Sulfones,DrugBank
DB13532,Sulfur Compounds,DrugBank
DB13532,Thiazides,DrugBank
DB13533,Adrenal Cortex Hormones,DrugBank
DB13533,Estranes,DrugBank
DB13533,Estren Derivatives,DrugBank
DB13533,Fused-Ring Compounds,DrugBank
DB13533,Genito Urinary System and Sex Hormones,DrugBank
DB13533,Progesterone Congeners,DrugBank
DB13533,Progestins,DrugBank
DB13533,Sex Hormones and Modulators of the Genital System,DrugBank
DB13533,Steroids,DrugBank
DB13534,Anti-Anxiety Agents,DrugBank
DB13534,Central Nervous System Depressants,DrugBank
DB13534,Hypnotics (Nonbenzodiazepine),DrugBank
DB13534,Hypnotics and Sedatives,DrugBank
DB13534,Nervous System,DrugBank
DB13534,Psycholeptics,DrugBank
DB13535,"Amino Acids, Peptides, and Proteins",DrugBank
DB13535,Antibacterial monoclonal antibodies,DrugBank
DB13535,Antibodies,DrugBank
DB13535,"Antibodies, Monoclonal",DrugBank
DB13535,Antiinfectives for Systemic Use,DrugBank
DB13535,Blood Proteins,DrugBank
DB13535,Globulins,DrugBank
DB13535,Immune Sera and Immunoglobulins,DrugBank
DB13535,Immunoglobulin M,DrugBank
DB13535,Immunoglobulins,DrugBank
DB13535,Immunoproteins,DrugBank
DB13535,Proteins,DrugBank
DB13535,Serum Globulins,DrugBank
DB13537,Carbohydrates,DrugBank
DB13537,Cardanolides,DrugBank
DB13537,Cardenolides,DrugBank
DB13537,Cardiac Glycosides,DrugBank
DB13537,Cardiac Therapy,DrugBank
DB13537,Digitalis Glycosides,DrugBank
DB13537,Fused-Ring Compounds,DrugBank
DB13537,Glycosides,DrugBank
DB13537,Isomerism,DrugBank
DB13537,Steroids,DrugBank
DB13538,Agents causing hyperkalemia,DrugBank
DB13538,Agents that produce hypertension,DrugBank
DB13538,Analgesics,DrugBank
DB13538,"Analgesics, Non-Narcotic",DrugBank
DB13538,Anti-Inflammatory Agents,DrugBank
DB13538,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13538,Antirheumatic Agents,DrugBank
DB13538,Antitussive Agents,DrugBank
DB13538,Benzene Derivatives,DrugBank
DB13538,Central Nervous System Agents,DrugBank
DB13538,Expectorants,DrugBank
DB13538,Hydroxybenzoates,DrugBank
DB13538,Nephrotoxic agents,DrugBank
DB13538,Nervous System,DrugBank
DB13538,Non COX-2 selective NSAIDS,DrugBank
DB13538,Peripheral Nervous System Agents,DrugBank
DB13538,Phenols,DrugBank
DB13538,Respiratory System Agents,DrugBank
DB13538,Salicylates,DrugBank
DB13538,Salicylic Acid and Derivatives,DrugBank
DB13538,Sensory System Agents,DrugBank
DB13540,Agents that produce neuromuscular block (indirect),DrugBank
DB13540,Aminoglycoside Antibacterials,DrugBank
DB13540,Anti-Bacterial Agents,DrugBank
DB13540,Anti-Infective Agents,DrugBank
DB13540,Antibacterials for Systemic Use,DrugBank
DB13540,Antiinfectives for Systemic Use,DrugBank
DB13540,Carbohydrates,DrugBank
DB13540,Drugs that are Mainly Renally Excreted,DrugBank
DB13540,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB13540,Glycosides,DrugBank
DB13540,Narrow Therapeutic Index Drugs,DrugBank
DB13540,Nephrotoxic agents,DrugBank
DB13541,Analgesics,DrugBank
DB13541,Antidepressive Agents,DrugBank
DB13541,Antimigraine Preparations,DrugBank
DB13541,Biological Factors,DrugBank
DB13541,Central Nervous System Depressants,DrugBank
DB13541,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13541,Indoles,DrugBank
DB13541,Nervous System,DrugBank
DB13541,Neurotransmitter Agents,DrugBank
DB13541,"Pigments, Biological",DrugBank
DB13541,Quinones,DrugBank
DB13541,Serotonin Agents,DrugBank
DB13541,Serotonin Receptor Antagonists,DrugBank
DB13542,"Acids, Carbocyclic",DrugBank
DB13542,Agents producing tachycardia,DrugBank
DB13542,Alimentary Tract and Metabolism,DrugBank
DB13542,Analgesics,DrugBank
DB13542,"Analgesics, Non-Narcotic",DrugBank
DB13542,Anti-Inflammatory Agents,DrugBank
DB13542,Anticholinergic Agents,DrugBank
DB13542,Antirheumatic Agents,DrugBank
DB13542,Diphenylacetic Acids,DrugBank
DB13542,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13542,Hydroxy Acids,DrugBank
DB13542,Muscarinic Antagonists,DrugBank
DB13542,Peripheral Nervous System Agents,DrugBank
DB13542,Phenylacetates,DrugBank
DB13542,Sensory System Agents,DrugBank
DB13542,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13543,Alcohols,DrugBank
DB13543,Alkylating Drugs,DrugBank
DB13543,Antineoplastic Agents,DrugBank
DB13543,"Antineoplastic Agents, Alkylating",DrugBank
DB13543,Antineoplastic and Immunomodulating Agents,DrugBank
DB13543,Carbohydrates,DrugBank
DB13543,Noxae,DrugBank
DB13543,Sugar Alcohols,DrugBank
DB13543,Toxic Actions,DrugBank
DB13544,Agents causing hyperkalemia,DrugBank
DB13544,Agents that produce hypertension,DrugBank
DB13544,Amides,DrugBank
DB13544,Analgesics,DrugBank
DB13544,"Analgesics, Non-Narcotic",DrugBank
DB13544,Anti-Inflammatory Agents,DrugBank
DB13544,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13544,Antirheumatic Agents,DrugBank
DB13544,Nephrotoxic agents,DrugBank
DB13544,Nervous System,DrugBank
DB13544,Non COX-2 selective NSAIDS,DrugBank
DB13544,Peripheral Nervous System Agents,DrugBank
DB13544,Salicylic Acid and Derivatives,DrugBank
DB13544,Sensory System Agents,DrugBank
DB13545,Antigout Preparations,DrugBank
DB13545,Musculo-Skeletal System,DrugBank
DB13545,Preparations Increasing Uric Acid Excretion,DrugBank
DB13546,Antiarrhythmic agents,DrugBank
DB13546,Cardiovascular Agents,DrugBank
DB13546,Central Nervous System Agents,DrugBank
DB13546,"Compounds used in a research, industrial, or household setting",DrugBank
DB13546,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13546,Nervous System,DrugBank
DB13546,Neuroprotective Agents,DrugBank
DB13546,Protective Agents,DrugBank
DB13546,Psychoanaleptics,DrugBank
DB13546,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB13546,QTc Prolonging Agents,DrugBank
DB13547,Amides,DrugBank
DB13547,Amines,DrugBank
DB13547,Aniline Compounds,DrugBank
DB13547,Benzene Derivatives,DrugBank
DB13547,Benzenesulfonamides,DrugBank
DB13547,Genito Urinary System and Sex Hormones,DrugBank
DB13547,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13547,Sulfonamides,DrugBank
DB13547,Sulfones,DrugBank
DB13547,Sulfur Compounds,DrugBank
DB13550,Antidepressive Agents,DrugBank
DB13550,Benzene Derivatives,DrugBank
DB13550,Central Nervous System Agents,DrugBank
DB13550,Central Nervous System Depressants,DrugBank
DB13550,Nervous System,DrugBank
DB13550,Psychoanaleptics,DrugBank
DB13550,Psychotropic Drugs,DrugBank
DB13550,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13551,Antigout Preparations,DrugBank
DB13551,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13551,Musculo-Skeletal System,DrugBank
DB13551,Preparations With No Effect on Uric Acid Metabolism,DrugBank
DB13552,Antipsychotic Agents,DrugBank
DB13552,Butyrophenone Derivatives,DrugBank
DB13552,Butyrophenones,DrugBank
DB13552,Central Nervous System Agents,DrugBank
DB13552,Central Nervous System Depressants,DrugBank
DB13552,Dopamine Agents,DrugBank
DB13552,Dopamine Antagonists,DrugBank
DB13552,Ketones,DrugBank
DB13552,Nervous System,DrugBank
DB13552,Neurotoxic agents,DrugBank
DB13552,Neurotransmitter Agents,DrugBank
DB13552,Psycholeptics,DrugBank
DB13552,Psychotropic Drugs,DrugBank
DB13552,Tranquilizing Agents,DrugBank
DB13554,Antipsychotic Agents,DrugBank
DB13554,Butyrophenone Derivatives,DrugBank
DB13554,Central Nervous System Depressants,DrugBank
DB13554,Ketones,DrugBank
DB13554,Nervous System,DrugBank
DB13554,Neurotoxic agents,DrugBank
DB13554,Psycholeptics,DrugBank
DB13555,Alkaloids,DrugBank
DB13555,Antiarrhythmic agents,DrugBank
DB13555,"Antiarrhythmics, Class I",DrugBank
DB13555,"Antiarrhythmics, Class Ia",DrugBank
DB13555,"Antiarrhythmics, Class Ic",DrugBank
DB13555,Cardiac Therapy,DrugBank
DB13555,Cardiovascular Agents,DrugBank
DB13555,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13555,Indole Alkaloids,DrugBank
DB13555,Indoles,DrugBank
DB13555,Indolizidines,DrugBank
DB13555,Indolizines,DrugBank
DB13555,Potential QTc-Prolonging Agents,DrugBank
DB13555,QTc Prolonging Agents,DrugBank
DB13555,Secologanin Tryptamine Alkaloids,DrugBank
DB13556,Antibacterials for Systemic Use,DrugBank
DB13556,Antiinfectives for Systemic Use,DrugBank
DB13556,Long-Acting Antibacterial Sulfonamides,DrugBank
DB13556,Sulfonamides,DrugBank
DB13556,Sulfonamides and trimethoprim,DrugBank
DB13557,Antipsychotic Agents,DrugBank
DB13557,Central Nervous System Depressants,DrugBank
DB13557,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13557,Nervous System,DrugBank
DB13557,Neurotoxic agents,DrugBank
DB13557,Phenothiazines With Piperazine Structure,DrugBank
DB13557,Psycholeptics,DrugBank
DB13557,Sulfur Compounds,DrugBank
DB13559,Adrenergic Agents,DrugBank
DB13559,Adrenergic Agonists,DrugBank
DB13559,Adrenergic beta-Agonists,DrugBank
DB13559,"Adrenergics, Inhalants",DrugBank
DB13559,Agents producing tachycardia,DrugBank
DB13559,Agents that produce hypertension,DrugBank
DB13559,Benzene Derivatives,DrugBank
DB13559,Drugs for Obstructive Airway Diseases,DrugBank
DB13559,Neurotransmitter Agents,DrugBank
DB13559,Phenols,DrugBank
DB13559,Selective Beta 2-adrenergic Agonists,DrugBank
DB13563,Adrenal Cortex Hormones,DrugBank
DB13563,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB13563,"Contraceptive Agents, Female",DrugBank
DB13563,"Contraceptives, Oral",DrugBank
DB13563,"Contraceptives, Oral, Synthetic",DrugBank
DB13563,Fused-Ring Compounds,DrugBank
DB13563,Genito Urinary System and Sex Hormones,DrugBank
DB13563,Hormonal Contraceptives for Systemic Use,DrugBank
DB13563,Norpregnanes,DrugBank
DB13563,Norpregnatrienes,DrugBank
DB13563,Norsteroids,DrugBank
DB13563,Progestin Contraceptives,DrugBank
DB13563,Progestins,DrugBank
DB13563,Reproductive Control Agents,DrugBank
DB13563,Sex Hormones and Modulators of the Genital System,DrugBank
DB13563,Steroids,DrugBank
DB13566,Antihistamines for Systemic Use,DrugBank
DB13569,Antianemic Preparations,DrugBank
DB13569,Blood and Blood Forming Organs,DrugBank
DB13569,"Iron Bivalent, Oral Preparations",DrugBank
DB13569,Iron Compounds,DrugBank
DB13569,Iron Preparations,DrugBank
DB13571,Alkenes,DrugBank
DB13571,Antifungal Agents,DrugBank
DB13571,Genito Urinary System and Sex Hormones,DrugBank
DB13571,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13571,"Hydrocarbons, Acyclic",DrugBank
DB13571,Lactones,DrugBank
DB13571,Polyketides,DrugBank
DB13572,"Acids, Acyclic",DrugBank
DB13572,Anti-Anxiety Agents,DrugBank
DB13572,Carbamates,DrugBank
DB13572,Central Nervous System Depressants,DrugBank
DB13572,Nervous System,DrugBank
DB13572,Psycholeptics,DrugBank
DB13573,Alkaloids,DrugBank
DB13573,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13573,Cytochrome P-450 Substrates,DrugBank
DB13573,Drugs for Obstructive Airway Diseases,DrugBank
DB13573,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13573,Purines,DrugBank
DB13573,Purinones,DrugBank
DB13573,Xanthine derivatives,DrugBank
DB13575,Alkaloids,DrugBank
DB13575,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB13575,Antihypertensive Agents,DrugBank
DB13575,Cardiovascular Agents,DrugBank
DB13575,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13575,Indole Alkaloids,DrugBank
DB13575,Indoles,DrugBank
DB13575,Indolizidines,DrugBank
DB13575,Indolizines,DrugBank
DB13575,Secologanin Tryptamine Alkaloids,DrugBank
DB13577,"Barbiturates, Plain",DrugBank
DB13577,Central Nervous System Depressants,DrugBank
DB13577,Hypnotics and Sedatives,DrugBank
DB13577,Nervous System,DrugBank
DB13577,Psycholeptics,DrugBank
DB13577,Pyrimidines,DrugBank
DB13577,Pyrimidinones,DrugBank
DB13578,Anesthetics,DrugBank
DB13578,"Anesthetics, Local",DrugBank
DB13578,Esters of Aminobenzoic Acid,DrugBank
DB13578,Nervous System,DrugBank
DB13580,Alimentary Tract and Metabolism,DrugBank
DB13580,Amides,DrugBank
DB13580,Amines,DrugBank
DB13580,Aniline Compounds,DrugBank
DB13580,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB13580,Intestinal Antiinfectives,DrugBank
DB13580,Sulfanilamides,DrugBank
DB13580,Sulfonamides,DrugBank
DB13580,Sulfones,DrugBank
DB13580,Sulfur Compounds,DrugBank
DB13580,Thiazoles,DrugBank
DB13581,"Acids, Carbocyclic",DrugBank
DB13581,Agents producing tachycardia,DrugBank
DB13581,Alimentary Tract and Metabolism,DrugBank
DB13581,Anticholinergic Agents,DrugBank
DB13581,Autonomic Agents,DrugBank
DB13581,Cyclohexanes,DrugBank
DB13581,Cycloparaffins,DrugBank
DB13581,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13581,Muscarinic Antagonists,DrugBank
DB13581,Parasympatholytics,DrugBank
DB13581,Peripheral Nervous System Agents,DrugBank
DB13581,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13584,Amines,DrugBank
DB13584,Anticholinergic Agents,DrugBank
DB13584,Central Nervous System Depressants,DrugBank
DB13584,Cholinergic Agents,DrugBank
DB13584,Muscle Relaxants,DrugBank
DB13584,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB13584,Musculo-Skeletal System,DrugBank
DB13584,Neuromuscular Agents,DrugBank
DB13584,Neuromuscular Blocking Agents,DrugBank
DB13584,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB13584,Neurotoxic agents,DrugBank
DB13584,Neurotransmitter Agents,DrugBank
DB13584,Nicotinic Antagonists,DrugBank
DB13584,Onium Compounds,DrugBank
DB13584,Peripheral Nervous System Agents,DrugBank
DB13584,Quaternary Ammonium Compounds,DrugBank
DB13587,5-Androstanon (3) Derivatives,DrugBank
DB13587,Anabolic Agents,DrugBank
DB13587,Androgens,DrugBank
DB13587,Androstanes,DrugBank
DB13587,Androstanols,DrugBank
DB13587,Fused-Ring Compounds,DrugBank
DB13587,Genito Urinary System and Sex Hormones,DrugBank
DB13587,Hormones,DrugBank
DB13587,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13587,Sex Hormones and Modulators of the Genital System,DrugBank
DB13587,Steroids,DrugBank
DB13587,Testosterone Congeners,DrugBank
DB13588,Antidepressive Agents,DrugBank
DB13588,Cardiovascular Agents,DrugBank
DB13588,Central Nervous System Depressants,DrugBank
DB13588,Furans,DrugBank
DB13588,Neurotransmitter Agents,DrugBank
DB13588,Peripheral Vasodilators,DrugBank
DB13588,Serotonin Agents,DrugBank
DB13588,Serotonin Receptor Antagonists,DrugBank
DB13588,Vasodilating Agents,DrugBank
DB13590,"Acids, Acyclic",DrugBank
DB13590,Alimentary Tract and Metabolism,DrugBank
DB13590,Amines,DrugBank
DB13590,Amino Acids,DrugBank
DB13590,"Amino Acids, Peptides, and Proteins",DrugBank
DB13590,Calcium Salts,DrugBank
DB13590,Carbohydrates,DrugBank
DB13590,Gluconates,DrugBank
DB13590,Hydroxy Acids,DrugBank
DB13590,Mineral Supplements,DrugBank
DB13590,Peptides,DrugBank
DB13590,Peptoids,DrugBank
DB13590,Sugar Acids,DrugBank
DB13592,Alkaloids,DrugBank
DB13592,Anti-Asthmatic Agents,DrugBank
DB13592,Autonomic Agents,DrugBank
DB13592,Bronchodilator Agents,DrugBank
DB13592,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13592,Cytochrome P-450 Substrates,DrugBank
DB13592,Drugs for Obstructive Airway Diseases,DrugBank
DB13592,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13592,Peripheral Nervous System Agents,DrugBank
DB13592,Purines,DrugBank
DB13592,Purinones,DrugBank
DB13592,Respiratory System Agents,DrugBank
DB13592,Xanthine derivatives,DrugBank
DB13592,Xanthines and Adrenergics,DrugBank
DB13595,Alimentary Tract and Metabolism,DrugBank
DB13595,Aluminum and magnesium containing antacids,DrugBank
DB13595,Antacids,DrugBank
DB13595,Drugs for Acid Related Disorders,DrugBank
DB13595,Drugs that are Mainly Renally Excreted,DrugBank
DB13595,Gastric Acid Lowering Agents,DrugBank
DB13595,Minerals,DrugBank
DB13595,Pharmaceutic Aids,DrugBank
DB13595,Silicon Compounds,DrugBank
DB13598,Agents that produce hypertension,DrugBank
DB13598,Anesthetics,DrugBank
DB13598,"Anesthetics, General",DrugBank
DB13598,"Anesthetics, Inhalation",DrugBank
DB13598,Central Nervous System Agents,DrugBank
DB13598,Central Nervous System Depressants,DrugBank
DB13598,"Compounds used in a research, industrial, or household setting",DrugBank
DB13598,Ethers,DrugBank
DB13598,Ethyl Ethers,DrugBank
DB13598,Nervous System,DrugBank
DB13598,Neurotoxic agents,DrugBank
DB13598,Solvents,DrugBank
DB13601,Central Nervous System Agents,DrugBank
DB13601,Central Nervous System Depressants,DrugBank
DB13601,Nervous System,DrugBank
DB13601,Nootropic Agents,DrugBank
DB13601,Psychoanaleptics,DrugBank
DB13601,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB13601,Psychotropic Drugs,DrugBank
DB13602,Adrenal Cortex Hormones,DrugBank
DB13602,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13602,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13602,Cytochrome P-450 Substrates,DrugBank
DB13602,Fused-Ring Compounds,DrugBank
DB13602,Genito Urinary System and Sex Hormones,DrugBank
DB13602,Norpregnadienes,DrugBank
DB13602,Norpregnanes,DrugBank
DB13602,Norsteroids,DrugBank
DB13602,Pregnadien Derivatives,DrugBank
DB13602,Progestins,DrugBank
DB13602,Sex Hormones and Modulators of the Genital System,DrugBank
DB13602,Steroids,DrugBank
DB13603,Anti-Infective Agents,DrugBank
DB13603,Antifungal Agents,DrugBank
DB13603,Antifungals for Dermatological Use,DrugBank
DB13603,Antifungals for Topical Use,DrugBank
DB13603,Dermatologicals,DrugBank
DB13604,Amidines,DrugBank
DB13604,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB13604,Antihypertensive Agents,DrugBank
DB13604,Guanidine Derivatives,DrugBank
DB13604,Guanidines,DrugBank
DB13605,Analgesics,DrugBank
DB13605,Anesthetics,DrugBank
DB13605,"Anesthetics, General",DrugBank
DB13605,Central Nervous System Agents,DrugBank
DB13605,Central Nervous System Depressants,DrugBank
DB13605,Isonipecotic Acids,DrugBank
DB13605,Narcotics,DrugBank
DB13605,Nervous System,DrugBank
DB13605,Opioid Anesthetics,DrugBank
DB13605,Opioids,DrugBank
DB13605,Peripheral Nervous System Agents,DrugBank
DB13605,Piperidines,DrugBank
DB13605,Sensory System Agents,DrugBank
DB13605,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13606,Alkaloids,DrugBank
DB13606,Analgesics,DrugBank
DB13606,Benzomorphan Derivatives,DrugBank
DB13606,Benzomorphans,DrugBank
DB13606,Central Nervous System Agents,DrugBank
DB13606,Central Nervous System Depressants,DrugBank
DB13606,Morphinans,DrugBank
DB13606,Narcotics,DrugBank
DB13606,Nervous System,DrugBank
DB13606,Opiate Alkaloids,DrugBank
DB13606,Opioids,DrugBank
DB13606,Peripheral Nervous System Agents,DrugBank
DB13606,Phenanthrenes,DrugBank
DB13606,Sensory System Agents,DrugBank
DB13606,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13609,Anions,DrugBank
DB13609,Antiinfectives for Systemic Use,DrugBank
DB13609,Antiviral Agents,DrugBank
DB13609,Antivirals for Systemic Use,DrugBank
DB13609,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13609,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13609,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13609,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB13609,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13609,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13609,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13609,Cytochrome P-450 Substrates,DrugBank
DB13609,Direct Acting Antivirals,DrugBank
DB13609,Electrolytes,DrugBank
DB13609,Experimental Unapproved Treatments for COVID-19,DrugBank
DB13609,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13609,Hydrogen Sulfide,DrugBank
DB13609,Ions,DrugBank
DB13609,Sulfur Compounds,DrugBank
DB13609,UGT1A9 Inhibitors,DrugBank
DB13609,UGT1A9 Substrates,DrugBank
DB13609,UGT2B7 Inhibitors,DrugBank
DB13612,Agents causing hyperkalemia,DrugBank
DB13612,Agents that produce hypertension,DrugBank
DB13612,Amides,DrugBank
DB13612,Analgesics,DrugBank
DB13612,"Analgesics, Non-Narcotic",DrugBank
DB13612,Anti-Inflammatory Agents,DrugBank
DB13612,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13612,Antirheumatic Agents,DrugBank
DB13612,Benzene Derivatives,DrugBank
DB13612,Blood and Blood Forming Organs,DrugBank
DB13612,Hydroxybenzoates,DrugBank
DB13612,Nephrotoxic agents,DrugBank
DB13612,Nervous System,DrugBank
DB13612,Non COX-2 selective NSAIDS,DrugBank
DB13612,Peripheral Nervous System Agents,DrugBank
DB13612,Phenols,DrugBank
DB13612,Platelet Aggregation Inhibitors Excl. Heparin,DrugBank
DB13612,Salicylates,DrugBank
DB13612,Salicylic Acid and Derivatives,DrugBank
DB13612,Sensory System Agents,DrugBank
DB13615,"Adjuvants, Immunologic",DrugBank
DB13615,"Amino Acids, Peptides, and Proteins",DrugBank
DB13615,Amino Sugars,DrugBank
DB13615,Antineoplastic and Immunomodulating Agents,DrugBank
DB13615,Cancer immunotherapy,DrugBank
DB13615,Carbohydrates,DrugBank
DB13615,Glycerophosphates,DrugBank
DB13615,Glycerophospholipids,DrugBank
DB13615,Glycopeptides,DrugBank
DB13615,Immunologic Factors,DrugBank
DB13615,Immunotherapy,DrugBank
DB13615,Lipids,DrugBank
DB13615,Membrane Lipids,DrugBank
DB13615,Muramic Acids,DrugBank
DB13615,Peptides,DrugBank
DB13615,Phosphatidic Acids,DrugBank
DB13615,Phospholipids,DrugBank
DB13615,Sugar Acids,DrugBank
DB13616,Amines,DrugBank
DB13616,Anticoagulants,DrugBank
DB13616,Antithrombins,DrugBank
DB13616,Azetines,DrugBank
DB13616,Benzene Derivatives,DrugBank
DB13616,Benzyl Compounds,DrugBank
DB13616,Blood and Blood Forming Organs,DrugBank
DB13616,Enzyme Inhibitors,DrugBank
DB13616,Hematologic Agents,DrugBank
DB13616,Protease Inhibitors,DrugBank
DB13616,Serine Protease Inhibitors,DrugBank
DB13617,Amides,DrugBank
DB13617,Diuretics,DrugBank
DB13617,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13617,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13617,Sulfonamides,DrugBank
DB13617,Sulfones,DrugBank
DB13617,Sulfur Compounds,DrugBank
DB13619,Agents producing tachycardia,DrugBank
DB13619,Anti-Parkinson Drugs,DrugBank
DB13619,Anticholinergic Agents,DrugBank
DB13619,Cholinergic Agents,DrugBank
DB13619,Muscarinic Antagonists,DrugBank
DB13619,Nervous System,DrugBank
DB13619,Neurotransmitter Agents,DrugBank
DB13619,Tertiary Amines,DrugBank
DB13620,Alimentary Tract and Metabolism,DrugBank
DB13620,Mineral Supplements,DrugBank
DB13620,Potassium Salt,DrugBank
DB13623,Anti-Anxiety Agents,DrugBank
DB13623,Central Nervous System Depressants,DrugBank
DB13623,Nervous System,DrugBank
DB13623,Psycholeptics,DrugBank
DB13624,Adrenergic Agents,DrugBank
DB13624,Adrenergic Agonists,DrugBank
DB13624,Adrenergic beta-Agonists,DrugBank
DB13624,Adrenergics for Systemic Use,DrugBank
DB13624,Agents producing tachycardia,DrugBank
DB13624,Agents that produce hypertension,DrugBank
DB13624,Amines,DrugBank
DB13624,Amphetamines,DrugBank
DB13624,Drugs for Obstructive Airway Diseases,DrugBank
DB13624,Ethylamines,DrugBank
DB13624,Neurotransmitter Agents,DrugBank
DB13624,Non-selective Beta-adrenergic Agonists,DrugBank
DB13624,Phenethylamines,DrugBank
DB13624,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13624,Sympathomimetics,DrugBank
DB13626,Alimentary Tract and Metabolism,DrugBank
DB13626,Alkalies,DrugBank
DB13626,Aluminium Compounds,DrugBank
DB13626,Aluminum and magnesium containing antacids,DrugBank
DB13626,Amino Acids,DrugBank
DB13626,"Amino Acids, Peptides, and Proteins",DrugBank
DB13626,Anions,DrugBank
DB13626,Antacids,DrugBank
DB13626,Drugs for Acid Related Disorders,DrugBank
DB13626,Electrolytes,DrugBank
DB13626,Gastric Acid Lowering Agents,DrugBank
DB13626,Hydroxides,DrugBank
DB13626,Ions,DrugBank
DB13626,Metal cations,DrugBank
DB13626,Metal divalent cations,DrugBank
DB13627,4-Quinolones,DrugBank
DB13627,Anti-Bacterial Agents,DrugBank
DB13627,Anti-Infective Agents,DrugBank
DB13627,"Anti-Infective Agents, Urinary",DrugBank
DB13627,Antibacterials for Systemic Use,DrugBank
DB13627,Antiinfectives for Systemic Use,DrugBank
DB13627,Antineoplastic Agents,DrugBank
DB13627,Enzyme Inhibitors,DrugBank
DB13627,Fluoroquinolones,DrugBank
DB13627,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13627,Potential QTc-Prolonging Agents,DrugBank
DB13627,QTc Prolonging Agents,DrugBank
DB13627,Quinolines,DrugBank
DB13627,Quinolones,DrugBank
DB13627,Topoisomerase II Inhibitors,DrugBank
DB13627,Topoisomerase Inhibitors,DrugBank
DB13629,Agents causing hyperkalemia,DrugBank
DB13629,Agents that produce hypertension,DrugBank
DB13629,Analgesics,DrugBank
DB13629,"Analgesics, Non-Narcotic",DrugBank
DB13629,Anti-Inflammatory Agents,DrugBank
DB13629,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13629,Antiinflammatory and Antirheumatic Products,DrugBank
DB13629,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13629,"Antiinflammatory Preparations, Non-Steroids for Topical Use",DrugBank
DB13629,Antirheumatic Agents,DrugBank
DB13629,Butylpyrazolidines,DrugBank
DB13629,Musculo-Skeletal System,DrugBank
DB13629,Nephrotoxic agents,DrugBank
DB13629,Peripheral Nervous System Agents,DrugBank
DB13629,Pyrazoles,DrugBank
DB13629,Pyrazolones,DrugBank
DB13629,Sensory System Agents,DrugBank
DB13629,Topical Products for Joint and Muscular Pain,DrugBank
DB13631,"Antiadrenergic Agents, Centrally Acting",DrugBank
DB13631,Antihypertensive Agents,DrugBank
DB13631,Secologanin Tryptamine Alkaloids,DrugBank
DB13633,Alimentary Tract and Metabolism,DrugBank
DB13633,Alkenes,DrugBank
DB13633,Anti-Bacterial Agents,DrugBank
DB13633,Anti-Infective Agents,DrugBank
DB13633,Antifungal Agents,DrugBank
DB13633,Antifungals for Dermatological Use,DrugBank
DB13633,Antifungals for Topical Use,DrugBank
DB13633,Antiinfectives and Antiseptics for Local Oral Treatment,DrugBank
DB13633,Antiparasitic Agents,DrugBank
DB13633,Antiprotozoals,DrugBank
DB13633,Dermatologicals,DrugBank
DB13633,Drugs Used in Benign Prostatic Hypertrophy,DrugBank
DB13633,Genito Urinary System and Sex Hormones,DrugBank
DB13633,Genitourinary Agents,DrugBank
DB13633,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13633,"Hydrocarbons, Acyclic",DrugBank
DB13633,Lactones,DrugBank
DB13633,Macrolides,DrugBank
DB13633,Polyenes,DrugBank
DB13633,Stomatological Preparations,DrugBank
DB13633,Urological Agents,DrugBank
DB13633,Urologicals,DrugBank
DB13634,Alkaloids,DrugBank
DB13634,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13634,Cytochrome P-450 Substrates,DrugBank
DB13634,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13634,Peripheral Vasodilators,DrugBank
DB13634,Purine Derivatives,DrugBank
DB13634,Purines,DrugBank
DB13634,Purinones,DrugBank
DB13634,Xanthine derivatives,DrugBank
DB13635,Antiarrhythmic agents,DrugBank
DB13635,Cardiac Therapy,DrugBank
DB13635,Cardiovascular Agents,DrugBank
DB13635,Central Nervous System Agents,DrugBank
DB13635,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13636,Agents producing tachycardia,DrugBank
DB13636,Anti-Parkinson Drugs,DrugBank
DB13636,Anticholinergic Agents,DrugBank
DB13636,"Ethers, Chemically Close to Antihistamines",DrugBank
DB13636,Muscarinic Antagonists,DrugBank
DB13636,Nervous System,DrugBank
DB13637,Amines,DrugBank
DB13637,Antianginal Agents,DrugBank
DB13637,Cardiac Therapy,DrugBank
DB13637,Diamines,DrugBank
DB13637,Organic Nitrates,DrugBank
DB13637,Polyamines,DrugBank
DB13637,Vasodilating Agents,DrugBank
DB13637,Vasodilators Used in Cardiac Diseases,DrugBank
DB13638,Amides,DrugBank
DB13638,Anti-Bacterial Agents,DrugBank
DB13638,Antibacterials for Systemic Use,DrugBank
DB13638,Antiinfectives for Systemic Use,DrugBank
DB13638,beta-Lactams,DrugBank
DB13638,Cephalosporins,DrugBank
DB13638,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13638,Lactams,DrugBank
DB13638,Nephrotoxic agents,DrugBank
DB13638,Second-Generation Cephalosporins,DrugBank
DB13638,Sulfur Compounds,DrugBank
DB13638,Thiazines,DrugBank
DB13642,Central Nervous System Depressants,DrugBank
DB13642,Muscle Relaxants,DrugBank
DB13642,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13642,Musculo-Skeletal System,DrugBank
DB13643,Anti-Anxiety Agents,DrugBank
DB13643,Benzazepines,DrugBank
DB13643,Benzodiazepine hypnotics and sedatives,DrugBank
DB13643,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB13643,Central Nervous System Agents,DrugBank
DB13643,Central Nervous System Depressants,DrugBank
DB13643,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13643,Hypnotics and Sedatives,DrugBank
DB13643,Nervous System,DrugBank
DB13643,Psycholeptics,DrugBank
DB13643,Psychotropic Drugs,DrugBank
DB13643,Tranquilizing Agents,DrugBank
DB13644,Antithyroid agents,DrugBank
DB13644,Hormone Antagonists,DrugBank
DB13644,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13644,Pyrimidines,DrugBank
DB13644,Pyrimidinones,DrugBank
DB13644,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13644,Thiouracil,DrugBank
DB13644,Thiouracils,DrugBank
DB13644,Thyroid Products,DrugBank
DB13645,Antiarrhythmic agents,DrugBank
DB13645,"Antiarrhythmics, Class I",DrugBank
DB13645,"Antiarrhythmics, Class Ic",DrugBank
DB13645,Cardiac Therapy,DrugBank
DB13645,Cardiovascular Agents,DrugBank
DB13645,Central Nervous System Agents,DrugBank
DB13645,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13645,Sulfur Compounds,DrugBank
DB13646,Agents causing angioedema,DrugBank
DB13646,"Amino Acids, Peptides, and Proteins",DrugBank
DB13646,Anticoagulants,DrugBank
DB13646,Blood and Blood Forming Organs,DrugBank
DB13646,Blood Proteins,DrugBank
DB13646,Cardiovascular Agents,DrugBank
DB13646,Endopeptidases,DrugBank
DB13646,Enzyme Precursors,DrugBank
DB13646,Enzymes,DrugBank
DB13646,Enzymes and Coenzymes,DrugBank
DB13646,Fibrin Modulating Agents,DrugBank
DB13646,Fibrinolytic Agents,DrugBank
DB13646,Hematologic Agents,DrugBank
DB13646,Hydrolases,DrugBank
DB13646,Peptide Hydrolases,DrugBank
DB13646,Plasminogen Activators,DrugBank
DB13646,Proteins,DrugBank
DB13646,Serine Endopeptidases,DrugBank
DB13646,Serine Proteases,DrugBank
DB13647,Alkylating Drugs,DrugBank
DB13647,Amides,DrugBank
DB13647,Antineoplastic Agents,DrugBank
DB13647,"Antineoplastic Agents, Alkylating",DrugBank
DB13647,Antineoplastic and Immunomodulating Agents,DrugBank
DB13647,Nitroso Compounds,DrugBank
DB13647,Nitrosourea Compounds,DrugBank
DB13647,Nitrosoureas,DrugBank
DB13647,Noxae,DrugBank
DB13647,Toxic Actions,DrugBank
DB13648,"Adjuvants, Anesthesia",DrugBank
DB13648,Alkaloids,DrugBank
DB13648,Amines,DrugBank
DB13648,Anticholinergic Agents,DrugBank
DB13648,Benzylisoquinolines,DrugBank
DB13648,Central Nervous System Agents,DrugBank
DB13648,Central Nervous System Depressants,DrugBank
DB13648,Cholinergic Agents,DrugBank
DB13648,Curare Alkaloids,DrugBank
DB13648,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13648,Isoquinolines,DrugBank
DB13648,Muscle Relaxants,DrugBank
DB13648,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB13648,Musculo-Skeletal System,DrugBank
DB13648,Neuromuscular Agents,DrugBank
DB13648,Neuromuscular Blocking Agents,DrugBank
DB13648,Neuromuscular-Blocking Agents (Nondepolarizing),DrugBank
DB13648,Neurotransmitter Agents,DrugBank
DB13648,Nicotinic Antagonists,DrugBank
DB13648,Onium Compounds,DrugBank
DB13648,Peripheral Nervous System Agents,DrugBank
DB13648,Quaternary Ammonium Compounds,DrugBank
DB13648,Tetrahydroisoquinolines,DrugBank
DB13648,Toxiferine,DrugBank
DB13649,Agents causing hyperkalemia,DrugBank
DB13649,Agents that produce hypertension,DrugBank
DB13649,Analgesics,DrugBank
DB13649,"Analgesics, Non-Narcotic",DrugBank
DB13649,Anti-Inflammatory Agents,DrugBank
DB13649,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13649,Antiinflammatory and Antirheumatic Products,DrugBank
DB13649,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13649,Antirheumatic Agents,DrugBank
DB13649,Central Nervous System Agents,DrugBank
DB13649,Cyclooxygenase Inhibitors,DrugBank
DB13649,Enzyme Inhibitors,DrugBank
DB13649,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13649,Musculo-Skeletal System,DrugBank
DB13649,Nephrotoxic agents,DrugBank
DB13649,Peripheral Nervous System Agents,DrugBank
DB13649,Sensory System Agents,DrugBank
DB13650,Alcohols,DrugBank
DB13650,Alimentary Tract and Metabolism,DrugBank
DB13650,Alkalies,DrugBank
DB13650,Aluminium Compounds,DrugBank
DB13650,Aluminum and magnesium containing antacids,DrugBank
DB13650,Anions,DrugBank
DB13650,Antacids,DrugBank
DB13650,Drugs for Acid Related Disorders,DrugBank
DB13650,Electrolytes,DrugBank
DB13650,Gastric Acid Lowering Agents,DrugBank
DB13650,Glycols,DrugBank
DB13650,Hydroxides,DrugBank
DB13650,Ions,DrugBank
DB13650,Metal cations,DrugBank
DB13650,Metal divalent cations,DrugBank
DB13650,Propylene Glycols,DrugBank
DB13651,Alkaloids,DrugBank
DB13651,Antiarrhythmic agents,DrugBank
DB13651,"Antiarrhythmics, Class I",DrugBank
DB13651,"Antiarrhythmics, Class Ia",DrugBank
DB13651,Cardiac Therapy,DrugBank
DB13651,Cardiovascular Agents,DrugBank
DB13651,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13651,Indole Alkaloids,DrugBank
DB13651,Indoles,DrugBank
DB13651,Indolizidines,DrugBank
DB13651,Indolizines,DrugBank
DB13651,Potential QTc-Prolonging Agents,DrugBank
DB13651,QTc Prolonging Agents,DrugBank
DB13651,Secologanin Tryptamine Alkaloids,DrugBank
DB13652,Antiarrhythmic agents,DrugBank
DB13652,"Antiarrhythmics, Class III",DrugBank
DB13652,Cardiac Therapy,DrugBank
DB13652,Cardiovascular Agents,DrugBank
DB13652,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13652,Naphthalenes,DrugBank
DB13652,QTc Prolonging Agents,DrugBank
DB13653,Acetamides,DrugBank
DB13653,Amides,DrugBank
DB13653,Antiarrhythmic agents,DrugBank
DB13653,"Antiarrhythmics, Class I",DrugBank
DB13653,"Antiarrhythmics, Class Ic",DrugBank
DB13653,Benzene Derivatives,DrugBank
DB13653,Cardiac Therapy,DrugBank
DB13653,Cardiovascular Agents,DrugBank
DB13653,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13653,QTc Prolonging Agents,DrugBank
DB13657,"Acids, Carbocyclic",DrugBank
DB13657,Agents causing hyperkalemia,DrugBank
DB13657,Agents that produce hypertension,DrugBank
DB13657,Amides,DrugBank
DB13657,Amines,DrugBank
DB13657,Analgesics,DrugBank
DB13657,"Analgesics, Non-Narcotic",DrugBank
DB13657,Anilides,DrugBank
DB13657,Aniline Compounds,DrugBank
DB13657,Anti-Inflammatory Agents,DrugBank
DB13657,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13657,Antirheumatic Agents,DrugBank
DB13657,Benzene Derivatives,DrugBank
DB13657,Benzoates,DrugBank
DB13657,Hydroxy Acids,DrugBank
DB13657,Hydroxybenzoates,DrugBank
DB13657,Nephrotoxic agents,DrugBank
DB13657,Nervous System,DrugBank
DB13657,Non COX-2 selective NSAIDS,DrugBank
DB13657,Peripheral Nervous System Agents,DrugBank
DB13657,Phenols,DrugBank
DB13657,Salicylic Acid and Derivatives,DrugBank
DB13657,Sensory System Agents,DrugBank
DB13660,Amides,DrugBank
DB13660,Anti-Bacterial Agents,DrugBank
DB13660,Anti-Infective Agents,DrugBank
DB13660,Antibacterials for Systemic Use,DrugBank
DB13660,Antiinfectives for Systemic Use,DrugBank
DB13660,Beta-Lactam Antibacterials,DrugBank
DB13660,Beta-Lactamase Sensitive Penicillins,DrugBank
DB13660,beta-Lactams,DrugBank
DB13660,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13660,Lactams,DrugBank
DB13660,Penicillins,DrugBank
DB13660,Sulfur Compounds,DrugBank
DB13662,"Acids, Acyclic",DrugBank
DB13662,Central Nervous System Depressants,DrugBank
DB13662,Hypnotics and Sedatives,DrugBank
DB13662,Nervous System,DrugBank
DB13662,Psycholeptics,DrugBank
DB13663,Diuretics,DrugBank
DB13663,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13663,Sulfonamides,DrugBank
DB13664,Adrenal Cortex Hormones,DrugBank
DB13664,Anti-Inflammatory Agents,DrugBank
DB13664,Corticosteroids,DrugBank
DB13664,Fused-Ring Compounds,DrugBank
DB13664,Immunosuppressive Agents,DrugBank
DB13664,Ophthalmologicals,DrugBank
DB13664,Sensory Organs,DrugBank
DB13664,Steroids,DrugBank
DB13665,Antipsychotic Agents,DrugBank
DB13665,Butyrophenone Derivatives,DrugBank
DB13665,Central Nervous System Agents,DrugBank
DB13665,Central Nervous System Depressants,DrugBank
DB13665,Hypnotics and Sedatives,DrugBank
DB13665,Ketones,DrugBank
DB13665,Nervous System,DrugBank
DB13665,Neurotoxic agents,DrugBank
DB13665,Psycholeptics,DrugBank
DB13665,Psychotropic Drugs,DrugBank
DB13665,Tranquilizing Agents,DrugBank
DB13666,Agents producing tachycardia,DrugBank
DB13666,Alimentary Tract and Metabolism,DrugBank
DB13666,Anticholinergic Agents,DrugBank
DB13666,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13666,Muscarinic Antagonists,DrugBank
DB13666,Oxazines,DrugBank
DB13666,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13667,Amides,DrugBank
DB13667,Anti-Bacterial Agents,DrugBank
DB13667,Anti-Infective Agents,DrugBank
DB13667,Antibacterials for Systemic Use,DrugBank
DB13667,Antiinfectives for Systemic Use,DrugBank
DB13667,beta Lactam Antibiotics,DrugBank
DB13667,beta-Lactams,DrugBank
DB13667,Cephalosporins,DrugBank
DB13667,Fourth-Generation Cephalosporins,DrugBank
DB13667,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13667,Lactams,DrugBank
DB13667,Nephrotoxic agents,DrugBank
DB13667,Sulfur Compounds,DrugBank
DB13667,Tetrazoles,DrugBank
DB13667,Thiazines,DrugBank
DB13668,Anti-Dementia Drugs,DrugBank
DB13668,Cholinesterase Inhibitors,DrugBank
DB13668,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13668,Nervous System,DrugBank
DB13668,Psychoanaleptics,DrugBank
DB13668,Quinolines,DrugBank
DB13673,Agents that produce neuromuscular block (indirect),DrugBank
DB13673,Aminoglycoside Antibacterials,DrugBank
DB13673,Anti-Bacterial Agents,DrugBank
DB13673,Anti-Infective Agents,DrugBank
DB13673,Antibacterials for Systemic Use,DrugBank
DB13673,Antiinfectives for Systemic Use,DrugBank
DB13673,Carbohydrates,DrugBank
DB13673,Drugs that are Mainly Renally Excreted,DrugBank
DB13673,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB13673,Glycosides,DrugBank
DB13673,Narrow Therapeutic Index Drugs,DrugBank
DB13673,Nephrotoxic agents,DrugBank
DB13675,Alimentary Tract and Metabolism,DrugBank
DB13675,Amides,DrugBank
DB13675,Blood Glucose Lowering Agents,DrugBank
DB13675,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13675,Cytochrome P-450 Substrates,DrugBank
DB13675,Drugs Used in Diabetes,DrugBank
DB13675,Insulin Secretagogues,DrugBank
DB13675,Oral Hypoglycemics,DrugBank
DB13675,Sulfones,DrugBank
DB13675,Sulfonylureas,DrugBank
DB13675,Sulfur Compounds,DrugBank
DB13676,Antipsychotic Agents,DrugBank
DB13676,Central Nervous System Depressants,DrugBank
DB13676,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13676,Nervous System,DrugBank
DB13676,Neurotoxic agents,DrugBank
DB13676,Psycholeptics,DrugBank
DB13677,Alkylating Drugs,DrugBank
DB13677,Antineoplastic Agents,DrugBank
DB13677,"Antineoplastic Agents, Alkylating",DrugBank
DB13677,Antineoplastic and Immunomodulating Agents,DrugBank
DB13677,Aziridines,DrugBank
DB13677,Azirines,DrugBank
DB13677,Benzoquinones,DrugBank
DB13677,Ethylene Imines,DrugBank
DB13677,Noxae,DrugBank
DB13677,Quinones,DrugBank
DB13677,Toxic Actions,DrugBank
DB13678,Agents producing tachycardia,DrugBank
DB13678,Alimentary Tract and Metabolism,DrugBank
DB13678,Anticholinergic Agents,DrugBank
DB13678,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13678,Muscarinic Antagonists,DrugBank
DB13678,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13679,Agents that reduce seizure threshold,DrugBank
DB13679,Antihistamines for Systemic Use,DrugBank
DB13679,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB13679,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB13679,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13679,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13679,Cytochrome P-450 Substrates,DrugBank
DB13679,Histamine Agents,DrugBank
DB13679,Histamine Antagonists,DrugBank
DB13679,Histamine H1 Antagonists,DrugBank
DB13679,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13679,Neurotransmitter Agents,DrugBank
DB13679,Pyridines,DrugBank
DB13679,QTc Prolonging Agents,DrugBank
DB13679,Stereoisomerism,DrugBank
DB13679,Substituted Alkylamines,DrugBank
DB13681,Cardiovascular Agents,DrugBank
DB13681,Oxazoles,DrugBank
DB13681,Peripheral Vasodilators,DrugBank
DB13681,Vasodilating Agents,DrugBank
DB13682,Amides,DrugBank
DB13682,Anti-Bacterial Agents,DrugBank
DB13682,Anti-Infective Agents,DrugBank
DB13682,Antibacterials for Systemic Use,DrugBank
DB13682,Antiinfectives for Systemic Use,DrugBank
DB13682,beta Lactam Antibiotics,DrugBank
DB13682,beta-Lactams,DrugBank
DB13682,Cephalosporins,DrugBank
DB13682,Fourth-Generation Cephalosporins,DrugBank
DB13682,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13682,Lactams,DrugBank
DB13682,Nephrotoxic agents,DrugBank
DB13682,Sulfur Compounds,DrugBank
DB13682,Thiazines,DrugBank
DB13683,Anesthetics,DrugBank
DB13683,Anesthetics for Topical Use,DrugBank
DB13683,"Anesthetics, Local",DrugBank
DB13683,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",DrugBank
DB13683,Central Nervous System Agents,DrugBank
DB13683,Central Nervous System Depressants,DrugBank
DB13683,Dermatologicals,DrugBank
DB13683,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13683,Peripheral Nervous System Agents,DrugBank
DB13683,Sensory System Agents,DrugBank
DB13685,Adrenal Cortex Hormones,DrugBank
DB13685,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB13685,"Contraceptive Agents, Female",DrugBank
DB13685,"Contraceptives, Oral",DrugBank
DB13685,"Contraceptives, Postcoital",DrugBank
DB13685,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13685,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13685,Cytochrome P-450 Substrates,DrugBank
DB13685,Fused-Ring Compounds,DrugBank
DB13685,Genito Urinary System and Sex Hormones,DrugBank
DB13685,Hormonal Contraceptives for Systemic Use,DrugBank
DB13685,Norpregnanes,DrugBank
DB13685,Norsteroids,DrugBank
DB13685,Progestin Contraceptives,DrugBank
DB13685,Progestins,DrugBank
DB13685,Sex Hormones and Modulators of the Genital System,DrugBank
DB13685,Steroids,DrugBank
DB13686,Anti-Bacterial Agents,DrugBank
DB13686,Antibacterials for Systemic Use,DrugBank
DB13686,Antiinfectives for Systemic Use,DrugBank
DB13686,Beta-Lactam Antibacterials,DrugBank
DB13686,Beta-Lactamase Sensitive Penicillins,DrugBank
DB13686,beta-Lactams,DrugBank
DB13686,Penicillins,DrugBank
DB13687,Central Nervous System Depressants,DrugBank
DB13687,Hypnotics and Sedatives,DrugBank
DB13687,Nervous System,DrugBank
DB13687,Nicotinic Acids,DrugBank
DB13687,Psycholeptics,DrugBank
DB13687,Pyridines,DrugBank
DB13690,Alkenes,DrugBank
DB13690,Anesthetics,DrugBank
DB13690,"Anesthetics, General",DrugBank
DB13690,Central Nervous System Agents,DrugBank
DB13690,Central Nervous System Depressants,DrugBank
DB13690,Ethers,DrugBank
DB13690,"Hydrocarbons, Acyclic",DrugBank
DB13690,Nervous System,DrugBank
DB13691,Antiarrhythmic agents,DrugBank
DB13691,Carbohydrates,DrugBank
DB13691,Cardanolides,DrugBank
DB13691,Cardenolides,DrugBank
DB13691,Cardiac Glycosides,DrugBank
DB13691,Cardiac Therapy,DrugBank
DB13691,Cardiotonic Agents,DrugBank
DB13691,Cardiovascular Agents,DrugBank
DB13691,"Compounds used in a research, industrial, or household setting",DrugBank
DB13691,Digitalis Glycosides,DrugBank
DB13691,Digoxin and derivatives,DrugBank
DB13691,Enzyme Inhibitors,DrugBank
DB13691,Fused-Ring Compounds,DrugBank
DB13691,Glycosides,DrugBank
DB13691,Potential QTc-Prolonging Agents,DrugBank
DB13691,Protective Agents,DrugBank
DB13691,QTc Prolonging Agents,DrugBank
DB13691,Steroids,DrugBank
DB13692,Adrenergic Agents,DrugBank
DB13692,Adrenergic Agonists,DrugBank
DB13692,Adrenergic beta-Agonists,DrugBank
DB13692,Adrenergics for Systemic Use,DrugBank
DB13692,"Adrenergics, Inhalants",DrugBank
DB13692,Agents producing tachycardia,DrugBank
DB13692,Agents that produce hypertension,DrugBank
DB13692,Anti-Asthmatic Agents,DrugBank
DB13692,Autonomic Agents,DrugBank
DB13692,Benzylisoquinolines,DrugBank
DB13692,Bronchodilator Agents,DrugBank
DB13692,Drugs for Obstructive Airway Diseases,DrugBank
DB13692,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13692,Isoquinolines,DrugBank
DB13692,Neurotransmitter Agents,DrugBank
DB13692,Peripheral Nervous System Agents,DrugBank
DB13692,Respiratory System Agents,DrugBank
DB13692,Selective Beta 2-adrenergic Agonists,DrugBank
DB13692,Sympathomimetics,DrugBank
DB13693,Amides,DrugBank
DB13693,Anti-Bacterial Agents,DrugBank
DB13693,Anti-Infective Agents,DrugBank
DB13693,Antibacterials for Systemic Use,DrugBank
DB13693,Antiinfectives for Systemic Use,DrugBank
DB13693,Beta-Lactam Antibacterials,DrugBank
DB13693,beta-Lactams,DrugBank
DB13693,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13693,Lactams,DrugBank
DB13693,Penicillin G,DrugBank
DB13693,Penicillins,DrugBank
DB13693,Penicillins With Extended Spectrum,DrugBank
DB13693,Sulfur Compounds,DrugBank
DB13694,Cholinergic Agents,DrugBank
DB13694,Cholinesterase Inhibitors,DrugBank
DB13694,Enzyme Inhibitors,DrugBank
DB13694,Nervous System,DrugBank
DB13694,Neurotransmitter Agents,DrugBank
DB13694,Parasympathomimetics,DrugBank
DB13694,Pyridines,DrugBank
DB13695,Agents producing tachycardia,DrugBank
DB13695,Alimentary Tract and Metabolism,DrugBank
DB13695,Amines,DrugBank
DB13695,Ammonium Compounds,DrugBank
DB13695,Anticholinergic Agents,DrugBank
DB13695,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13695,Muscarinic Antagonists,DrugBank
DB13695,Nitrogen Compounds,DrugBank
DB13695,Onium Compounds,DrugBank
DB13695,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13699,Amides,DrugBank
DB13699,Amines,DrugBank
DB13699,Aniline Compounds,DrugBank
DB13699,Antibacterials for Systemic Use,DrugBank
DB13699,Antiinfectives for Systemic Use,DrugBank
DB13699,Short-Acting Antibacterial Sulfonamides,DrugBank
DB13699,Sulfonamides,DrugBank
DB13699,Sulfonamides and trimethoprim,DrugBank
DB13699,Sulfones,DrugBank
DB13699,Sulfur Compounds,DrugBank
DB13703,Adrenergic and Dopaminergic Agents,DrugBank
DB13703,Agents producing tachycardia,DrugBank
DB13703,Agents that produce hypertension,DrugBank
DB13703,Amines,DrugBank
DB13703,Amphetamines,DrugBank
DB13703,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13703,Cardiac Therapy,DrugBank
DB13703,Ethylamines,DrugBank
DB13703,Phenethylamines,DrugBank
DB13703,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13703,Sympathomimetics,DrugBank
DB13704,"Amino Acids, Peptides, and Proteins",DrugBank
DB13704,Anti-Bacterial Agents,DrugBank
DB13704,Anti-Infective Agents,DrugBank
DB13704,Antibacterials for Systemic Use,DrugBank
DB13704,Antiinfectives for Systemic Use,DrugBank
DB13704,"Macrolides, Lincosamides and Streptogramins",DrugBank
DB13704,Peptides,DrugBank
DB13704,"Peptides, Cyclic",DrugBank
DB13704,Streptogramins,DrugBank
DB13705,Amines,DrugBank
DB13705,Anti-Bacterial Agents,DrugBank
DB13705,Anti-Infective Agents,DrugBank
DB13705,"Anti-Infective Agents, Local",DrugBank
DB13705,Antiseptics and Disinfectants,DrugBank
DB13705,Bis-Trimethylammonium Compounds,DrugBank
DB13705,Dermatologicals,DrugBank
DB13705,Onium Compounds,DrugBank
DB13705,Quaternary Ammonium Compounds,DrugBank
DB13707,"Acids, Acyclic",DrugBank
DB13707,Alimentary Tract and Metabolism,DrugBank
DB13707,Carbohydrates,DrugBank
DB13707,Dicarboxylic Acids,DrugBank
DB13707,Drugs for Constipation,DrugBank
DB13707,Hydroxy Acids,DrugBank
DB13707,Laxatives,DrugBank
DB13707,Osmotic Laxatives,DrugBank
DB13707,Sugar Acids,DrugBank
DB13708,Diuretics,DrugBank
DB13708,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13708,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13708,Natriuretic Agents,DrugBank
DB13708,Sulfonamides,DrugBank
DB13710,Alimentary Tract and Metabolism,DrugBank
DB13710,Anabolic Agents,DrugBank
DB13710,Anabolic Agents for Systemic Use,DrugBank
DB13710,Anabolic Steroids,DrugBank
DB13710,Androstan Derivatives,DrugBank
DB13710,Androstanes,DrugBank
DB13710,Androstenes,DrugBank
DB13710,Androstenols,DrugBank
DB13710,Fused-Ring Compounds,DrugBank
DB13710,Hormones,DrugBank
DB13710,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13710,Steroids,DrugBank
DB13710,Testosterone Congeners,DrugBank
DB13711,Antihistamines for Systemic Use,DrugBank
DB13711,Cholagogues and Choleretics,DrugBank
DB13711,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13711,Histamine Agents,DrugBank
DB13711,Histamine Antagonists,DrugBank
DB13711,Neurotransmitter Agents,DrugBank
DB13713,Antihistamines for Systemic Use,DrugBank
DB13713,Benzene Derivatives,DrugBank
DB13713,Histamine Agents,DrugBank
DB13713,Histamine Antagonists,DrugBank
DB13713,Neurotransmitter Agents,DrugBank
DB13715,Azepines,DrugBank
DB13715,Cardiac Therapy,DrugBank
DB13715,Cardiovascular Agents,DrugBank
DB13715,Vasodilating Agents,DrugBank
DB13715,Vasodilators Used in Cardiac Diseases,DrugBank
DB13718,Alkaloids,DrugBank
DB13718,Antiarrhythmic agents,DrugBank
DB13718,Autonomic Agents,DrugBank
DB13718,Cardiovascular Agents,DrugBank
DB13718,Cinchona Alkaloids,DrugBank
DB13718,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13718,Musculo-Skeletal System,DrugBank
DB13718,Parasympatholytics,DrugBank
DB13718,Peripheral Nervous System Agents,DrugBank
DB13718,Quinolines,DrugBank
DB13718,Quinuclidines,DrugBank
DB13719,Alcohols,DrugBank
DB13719,Amines,DrugBank
DB13719,Amino Alcohols,DrugBank
DB13719,Anions,DrugBank
DB13719,Antianginal Agents,DrugBank
DB13719,Cardiac Therapy,DrugBank
DB13719,Electrolytes,DrugBank
DB13719,Ions,DrugBank
DB13719,Nitrogen Compounds,DrugBank
DB13719,Organic Nitrates,DrugBank
DB13719,Vasodilating Agents,DrugBank
DB13719,Vasodilators Used in Cardiac Diseases,DrugBank
DB13720,Agents producing tachycardia,DrugBank
DB13720,Alimentary Tract and Metabolism,DrugBank
DB13720,Anti-Asthmatic Agents,DrugBank
DB13720,Anticholinergic Agents,DrugBank
DB13720,Autonomic Agents,DrugBank
DB13720,Bronchodilator Agents,DrugBank
DB13720,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13720,Muscarinic Antagonists,DrugBank
DB13720,Parasympatholytics,DrugBank
DB13720,Peripheral Nervous System Agents,DrugBank
DB13720,Respiratory System Agents,DrugBank
DB13720,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13722,"Acids, Carbocyclic",DrugBank
DB13722,Agents causing hyperkalemia,DrugBank
DB13722,Agents that produce hypertension,DrugBank
DB13722,Analgesics,DrugBank
DB13722,"Analgesics, Non-Narcotic",DrugBank
DB13722,Anti-Inflammatory Agents,DrugBank
DB13722,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13722,Antiinflammatory and Antirheumatic Products,DrugBank
DB13722,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13722,Antirheumatic Agents,DrugBank
DB13722,Musculo-Skeletal System,DrugBank
DB13722,Nephrotoxic agents,DrugBank
DB13722,Non COX-2 selective NSAIDS,DrugBank
DB13722,Peripheral Nervous System Agents,DrugBank
DB13722,Propionates,DrugBank
DB13722,Sensory System Agents,DrugBank
DB13724,Anti-Infective Agents,DrugBank
DB13724,Antifungal Agents,DrugBank
DB13724,Antiparasitic Agents,DrugBank
DB13724,Antiprotozoals,DrugBank
DB13724,Antitrichomonal Agents,DrugBank
DB13724,Furans,DrugBank
DB13724,Genito Urinary System and Sex Hormones,DrugBank
DB13724,Gynecological Antiinfectives and Antiseptics,DrugBank
DB13724,Nitro Compounds,DrugBank
DB13724,Nitrofurans,DrugBank
DB13724,Oxazoles,DrugBank
DB13724,Oxazolidinones,DrugBank
DB13725,Agents causing hyperkalemia,DrugBank
DB13725,Alkanes,DrugBank
DB13725,Amines,DrugBank
DB13725,Antiarrhythmic agents,DrugBank
DB13725,Autonomic Agents,DrugBank
DB13725,Bradycardia-Causing Agents,DrugBank
DB13725,Butanes,DrugBank
DB13725,Calcium Channel Blockers,DrugBank
DB13725,Calcium-Regulating Hormones and Agents,DrugBank
DB13725,Cardiovascular Agents,DrugBank
DB13725,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13725,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13725,Cytochrome P-450 Substrates,DrugBank
DB13725,Drugs for Urinary Frequency and Incontinence,DrugBank
DB13725,Genito Urinary System and Sex Hormones,DrugBank
DB13725,Highest Risk QTc-Prolonging Agents,DrugBank
DB13725,"Hydrocarbons, Acyclic",DrugBank
DB13725,Membrane Transport Modulators,DrugBank
DB13725,Parasympatholytics,DrugBank
DB13725,Peripheral Nervous System Agents,DrugBank
DB13725,QTc Prolonging Agents,DrugBank
DB13725,Urologicals,DrugBank
DB13725,Vasodilating Agents,DrugBank
DB13726,Alimentary Tract and Metabolism,DrugBank
DB13726,Amides,DrugBank
DB13726,Amidines,DrugBank
DB13726,Amines,DrugBank
DB13726,Aniline Compounds,DrugBank
DB13726,Anti-Infective Agents,DrugBank
DB13726,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB13726,Benzene Derivatives,DrugBank
DB13726,Benzenesulfonamides,DrugBank
DB13726,Guanidines,DrugBank
DB13726,Intestinal Antiinfectives,DrugBank
DB13726,Sulfanilamides,DrugBank
DB13726,Sulfonamides,DrugBank
DB13726,Sulfones,DrugBank
DB13726,Sulfur Compounds,DrugBank
DB13728,Adrenal Cortex Hormones,DrugBank
DB13728,Anti-Inflammatory Agents,DrugBank
DB13728,Corticosteroids,DrugBank
DB13728,"Corticosteroids, Dermatological Preparations",DrugBank
DB13728,"Corticosteroids, Potent (Group III)",DrugBank
DB13728,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13728,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13728,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13728,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB13728,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB13728,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13728,Dermatologicals,DrugBank
DB13728,Fused-Ring Compounds,DrugBank
DB13728,Glucocorticoids,DrugBank
DB13728,Hormones,DrugBank
DB13728,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13728,Immunosuppressive Agents,DrugBank
DB13728,Pregnadienes,DrugBank
DB13728,Pregnadienetriols,DrugBank
DB13728,Pregnanes,DrugBank
DB13728,Steroids,DrugBank
DB13728,"Steroids, Fluorinated",DrugBank
DB13729,Amidines,DrugBank
DB13729,Antifibrinolytic Agents,DrugBank
DB13729,Blood and Blood Forming Organs,DrugBank
DB13729,Enzyme Inhibitors,DrugBank
DB13729,Guanidines,DrugBank
DB13729,Hemostatics,DrugBank
DB13729,Protease Inhibitors,DrugBank
DB13729,Proteinase Inhibitors,DrugBank
DB13729,Serine Protease Inhibitors,DrugBank
DB13729,Trypsin Inhibitors,DrugBank
DB13733,Alcohols,DrugBank
DB13733,Central Nervous System Depressants,DrugBank
DB13733,Fatty Alcohols,DrugBank
DB13733,Hypnotics and Sedatives,DrugBank
DB13733,Lipids,DrugBank
DB13733,Nervous System,DrugBank
DB13733,Psycholeptics,DrugBank
DB13735,Benzene Derivatives,DrugBank
DB13735,Catechols,DrugBank
DB13735,Ethers,DrugBank
DB13735,Methyl Ethers,DrugBank
DB13735,Phenols,DrugBank
DB13735,Phenyl Ethers,DrugBank
DB13735,Potassium Salt,DrugBank
DB13737,"Barbiturates, Plain",DrugBank
DB13737,Central Nervous System Depressants,DrugBank
DB13737,Hypnotics and Sedatives,DrugBank
DB13737,Nervous System,DrugBank
DB13737,Psycholeptics,DrugBank
DB13737,Pyrimidines,DrugBank
DB13737,Pyrimidinones,DrugBank
DB13738,Agents producing tachycardia,DrugBank
DB13738,Alimentary Tract and Metabolism,DrugBank
DB13738,Amino Acids,DrugBank
DB13738,"Amino Acids, Peptides, and Proteins",DrugBank
DB13738,Anticholinergic Agents,DrugBank
DB13738,Autonomic Agents,DrugBank
DB13738,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13738,Muscarinic Antagonists,DrugBank
DB13738,Parasympatholytics,DrugBank
DB13738,Peripheral Nervous System Agents,DrugBank
DB13738,"Synthetic Anticholinergics, Esters With Tertiary Amino Group",DrugBank
DB13739,Amides,DrugBank
DB13739,Anti-Bacterial Agents,DrugBank
DB13739,Antibacterials for Systemic Use,DrugBank
DB13739,Antiinfectives for Systemic Use,DrugBank
DB13739,Beta-Lactam Antibacterials,DrugBank
DB13739,Beta-Lactamase Sensitive Penicillins,DrugBank
DB13739,beta-Lactams,DrugBank
DB13739,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13739,Lactams,DrugBank
DB13739,Penicillins,DrugBank
DB13739,Sulfur Compounds,DrugBank
DB13742,"Amino Acids, Peptides, and Proteins",DrugBank
DB13742,Anti-Parathyroid Agents,DrugBank
DB13742,Bone Density Conservation Agents,DrugBank
DB13742,Calcitonin Preparations,DrugBank
DB13742,Calcium Homeostasis,DrugBank
DB13742,Calcium-Regulating Hormones and Agents,DrugBank
DB13742,Hormones,DrugBank
DB13742,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13742,Nerve Tissue Proteins,DrugBank
DB13742,Neuropeptides,DrugBank
DB13742,Peptide Hormones,DrugBank
DB13742,Peptides,DrugBank
DB13742,Proteins,DrugBank
DB13742,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13742,Thyroid Products,DrugBank
DB13744,Anti-Infective Agents,DrugBank
DB13744,"Anti-Infective Agents, Urinary",DrugBank
DB13744,Antibacterials for Systemic Use,DrugBank
DB13744,Antiinfectives for Systemic Use,DrugBank
DB13744,Nicotinic Acids,DrugBank
DB13744,Potential QTc-Prolonging Agents,DrugBank
DB13744,Pyridines,DrugBank
DB13744,QTc Prolonging Agents,DrugBank
DB13744,Quinolones,DrugBank
DB13745,Central Nervous System Depressants,DrugBank
DB13745,Muscle Relaxants,DrugBank
DB13745,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB13745,Musculo-Skeletal System,DrugBank
DB13745,Pyridines,DrugBank
DB13746,Agents causing hyperkalemia,DrugBank
DB13746,Agrochemicals,DrugBank
DB13746,Antiarrhythmic agents,DrugBank
DB13746,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB13746,Bradycardia-Causing Agents,DrugBank
DB13746,Calcium Channel Blockers,DrugBank
DB13746,"Compounds used in a research, industrial, or household setting",DrugBank
DB13746,Cyclopentane Monoterpenes,DrugBank
DB13746,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13746,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13746,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13746,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13746,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13746,Cytochrome P-450 Substrates,DrugBank
DB13746,"Ectoparasiticides, Incl. Scabicides",DrugBank
DB13746,"Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents",DrugBank
DB13746,Insecticides,DrugBank
DB13746,Monoterpenes,DrugBank
DB13746,Pesticides,DrugBank
DB13746,"Pyrethrines, Incl. Synthetic Compounds",DrugBank
DB13746,Pyrethrins,DrugBank
DB13746,Stereoisomerism,DrugBank
DB13746,Terpenes,DrugBank
DB13746,Toxic Actions,DrugBank
DB13749,"Acids, Acyclic",DrugBank
DB13749,Agents that produce neuromuscular block (indirect),DrugBank
DB13749,Alimentary Tract and Metabolism,DrugBank
DB13749,Carbohydrates,DrugBank
DB13749,Hydroxy Acids,DrugBank
DB13749,Magnesium Compounds,DrugBank
DB13749,Metal cations,DrugBank
DB13749,Metal divalent cations,DrugBank
DB13749,Mineral Supplements,DrugBank
DB13749,Sugar Acids,DrugBank
DB13751,Alimentary Tract and Metabolism,DrugBank
DB13751,Anti-Inflammatory Agents,DrugBank
DB13751,Bile and Liver Therapy,DrugBank
DB13751,BSEP/ABCB11 Substrates,DrugBank
DB13751,Liver Therapy,DrugBank
DB13751,"Liver Therapy, Lipotropics",DrugBank
DB13751,Pentacyclic Triterpenes,DrugBank
DB13751,Terpenes,DrugBank
DB13751,Triterpenes,DrugBank
DB13753,Antisickling Agents,DrugBank
DB13753,Cardiovascular Agents,DrugBank
DB13753,Hematologic Agents,DrugBank
DB13753,Peripheral Vasodilators,DrugBank
DB13753,Vasodilating Agents,DrugBank
DB13754,Anti-Anxiety Agents,DrugBank
DB13754,Central Nervous System Depressants,DrugBank
DB13754,Muscle Relaxants,DrugBank
DB13754,"Muscle Relaxants, Centrally Acting Agents",DrugBank
DB13754,Nervous System,DrugBank
DB13754,Psycholeptics,DrugBank
DB13756,Cardanolides,DrugBank
DB13756,Cardiac Glycosides,DrugBank
DB13756,Cardiac Therapy,DrugBank
DB13756,Cardiotonic Agents,DrugBank
DB13756,Cardiovascular Agents,DrugBank
DB13756,"Compounds used in a research, industrial, or household setting",DrugBank
DB13756,Fused-Ring Compounds,DrugBank
DB13756,Glycosides,DrugBank
DB13756,Protective Agents,DrugBank
DB13756,Steroids,DrugBank
DB13757,Acetamides,DrugBank
DB13757,Adrenergic Agents,DrugBank
DB13757,Adrenergic Antagonists,DrugBank
DB13757,Adrenergic beta-Antagonists,DrugBank
DB13757,Agents causing hyperkalemia,DrugBank
DB13757,Alcohols,DrugBank
DB13757,Amides,DrugBank
DB13757,Amines,DrugBank
DB13757,Amino Alcohols,DrugBank
DB13757,Antihypertensive Agents,DrugBank
DB13757,Autonomic Agents,DrugBank
DB13757,Benzene Derivatives,DrugBank
DB13757,"Beta Blocking Agents, Selective",DrugBank
DB13757,Bradycardia-Causing Agents,DrugBank
DB13757,Cardiovascular Agents,DrugBank
DB13757,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13757,Cytochrome P-450 Substrates,DrugBank
DB13757,Neurotransmitter Agents,DrugBank
DB13757,Peripheral Nervous System Agents,DrugBank
DB13757,Propanols,DrugBank
DB13757,Sympathomimetics,DrugBank
DB13759,Agents producing tachycardia,DrugBank
DB13759,Alimentary Tract and Metabolism,DrugBank
DB13759,Anticholinergic Agents,DrugBank
DB13759,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13759,Muscarinic Antagonists,DrugBank
DB13759,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13760,Alimentary Tract and Metabolism,DrugBank
DB13760,Drugs for Acid Related Disorders,DrugBank
DB13760,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB13760,Gastric Acid Lowering Agents,DrugBank
DB13760,Histamine Antagonists,DrugBank
DB13760,Histamine H2 Antagonists,DrugBank
DB13762,2-Pyridinylmethylsulfinylbenzimidazoles,DrugBank
DB13762,Acid Reducers,DrugBank
DB13762,Alimentary Tract and Metabolism,DrugBank
DB13762,Anti-Ulcer Agents,DrugBank
DB13762,Benzimidazoles,DrugBank
DB13762,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13762,Cytochrome P-450 Substrates,DrugBank
DB13762,Drugs for Acid Related Disorders,DrugBank
DB13762,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB13762,Enzyme Inhibitors,DrugBank
DB13762,Gastric Acid Lowering Agents,DrugBank
DB13762,Gastrointestinal Agents,DrugBank
DB13762,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13762,Proton Pump Inhibitors,DrugBank
DB13762,Pyridines,DrugBank
DB13762,Sulfoxides,DrugBank
DB13762,Sulfur Compounds,DrugBank
DB13766,Agents causing hyperkalemia,DrugBank
DB13766,Antiarrhythmic agents,DrugBank
DB13766,Bradycardia-Causing Agents,DrugBank
DB13766,Calcium Channel Blockers,DrugBank
DB13766,Calcium-Regulating Hormones and Agents,DrugBank
DB13766,Cardiovascular Agents,DrugBank
DB13766,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13766,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13766,Cytochrome P-450 Substrates,DrugBank
DB13766,Membrane Transport Modulators,DrugBank
DB13766,Negative Inotrope,DrugBank
DB13766,Non-Selective Calcium Channel Blockers,DrugBank
DB13766,Piperazines,DrugBank
DB13766,Potential QTc-Prolonging Agents,DrugBank
DB13766,QTc Prolonging Agents,DrugBank
DB13766,Vasodilating Agents,DrugBank
DB13767,Antineoplastic Agents,DrugBank
DB13767,Antineoplastic and Immunomodulating Agents,DrugBank
DB13767,Aromatase Inhibitors,DrugBank
DB13767,Carbon Radioisotopes,DrugBank
DB13767,Endocrine Therapy,DrugBank
DB13767,Enzyme Inhibitors,DrugBank
DB13767,Estrogen Antagonists,DrugBank
DB13767,Hormone Antagonists,DrugBank
DB13767,Hormone Antagonists and Related Agents,DrugBank
DB13767,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13767,Steroid Synthesis Inhibitors,DrugBank
DB13769,Agents producing tachycardia,DrugBank
DB13769,Alimentary Tract and Metabolism,DrugBank
DB13769,Anticholinergic Agents,DrugBank
DB13769,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13769,Muscarinic Antagonists,DrugBank
DB13769,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13770,"Barbiturates, Plain",DrugBank
DB13770,Central Nervous System Depressants,DrugBank
DB13770,Hypnotics and Sedatives,DrugBank
DB13770,Nervous System,DrugBank
DB13770,Psycholeptics,DrugBank
DB13770,Pyrimidines,DrugBank
DB13770,Pyrimidinones,DrugBank
DB13772,4-Quinolones,DrugBank
DB13772,Anti-Bacterial Agents,DrugBank
DB13772,Antibacterials for Systemic Use,DrugBank
DB13772,Antiinfectives for Systemic Use,DrugBank
DB13772,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13772,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13772,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13772,Enzyme Inhibitors,DrugBank
DB13772,Fluoroquinolones,DrugBank
DB13772,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13772,Potential QTc-Prolonging Agents,DrugBank
DB13772,QTc Prolonging Agents,DrugBank
DB13772,Quinolines,DrugBank
DB13772,Quinolones,DrugBank
DB13772,Topoisomerase II Inhibitors,DrugBank
DB13772,Topoisomerase Inhibitors,DrugBank
DB13773,Amides,DrugBank
DB13773,Amines,DrugBank
DB13773,Aniline Compounds,DrugBank
DB13773,Anti-Bacterial Agents,DrugBank
DB13773,Anti-Infective Agents,DrugBank
DB13773,Antibacterials for Systemic Use,DrugBank
DB13773,Antiinfectives for Systemic Use,DrugBank
DB13773,Benzene Derivatives,DrugBank
DB13773,Benzenesulfonamides,DrugBank
DB13773,Long-Acting Antibacterial Sulfonamides,DrugBank
DB13773,Sulfanilamides,DrugBank
DB13773,Sulfonamide Antibacterial,DrugBank
DB13773,Sulfonamides,DrugBank
DB13773,Sulfonamides and trimethoprim,DrugBank
DB13773,Sulfones,DrugBank
DB13773,Sulfur Compounds,DrugBank
DB13775,Adrenergic Agents,DrugBank
DB13775,Adrenergic Antagonists,DrugBank
DB13775,Adrenergic beta-Antagonists,DrugBank
DB13775,Agents causing hyperkalemia,DrugBank
DB13775,Alcohols,DrugBank
DB13775,Amines,DrugBank
DB13775,Amino Alcohols,DrugBank
DB13775,Antiarrhythmic agents,DrugBank
DB13775,"Beta Blocking Agents, Non-Selective",DrugBank
DB13775,Bradycardia-Causing Agents,DrugBank
DB13775,Cardiovascular Agents,DrugBank
DB13775,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13775,Cytochrome P-450 Substrates,DrugBank
DB13775,Neurotransmitter Agents,DrugBank
DB13775,Propanols,DrugBank
DB13775,Sulfur Compounds,DrugBank
DB13777,Adrenergic Agents,DrugBank
DB13777,Adrenergic Agonists,DrugBank
DB13777,Adrenergic and Dopaminergic Agents,DrugBank
DB13777,Adrenergic beta-1 Receptor Agonists,DrugBank
DB13777,Adrenergic beta-Agonists,DrugBank
DB13777,Agents producing tachycardia,DrugBank
DB13777,Agents that produce hypertension,DrugBank
DB13777,Alcohols,DrugBank
DB13777,Amines,DrugBank
DB13777,Amino Alcohols,DrugBank
DB13777,Autonomic Agents,DrugBank
DB13777,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13777,Cardiac Therapy,DrugBank
DB13777,Cardiotonic Agents,DrugBank
DB13777,Cardiovascular Agents,DrugBank
DB13777,"Compounds used in a research, industrial, or household setting",DrugBank
DB13777,Neurotransmitter Agents,DrugBank
DB13777,Peripheral Nervous System Agents,DrugBank
DB13777,Phenoxypropanolamines,DrugBank
DB13777,Propanolamines,DrugBank
DB13777,Propanols,DrugBank
DB13777,Protective Agents,DrugBank
DB13777,Sympathomimetics,DrugBank
DB13778,Amides,DrugBank
DB13778,Anti-Bacterial Agents,DrugBank
DB13778,Anti-Infective Agents,DrugBank
DB13778,Antibacterials for Systemic Use,DrugBank
DB13778,Antiinfectives for Systemic Use,DrugBank
DB13778,beta-Lactams,DrugBank
DB13778,Cephalosporins,DrugBank
DB13778,First-Generation Cephalosporins,DrugBank
DB13778,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13778,Lactams,DrugBank
DB13778,Nephrotoxic agents,DrugBank
DB13778,Sulfur Compounds,DrugBank
DB13778,Thiazines,DrugBank
DB13779,Amidines,DrugBank
DB13779,"Antiadrenergic Agents, Peripherally Acting",DrugBank
DB13779,Antihypertensive Agents,DrugBank
DB13779,Guanidine Derivatives,DrugBank
DB13780,Agents Causing Muscle Toxicity,DrugBank
DB13780,Fibric Acids,DrugBank
DB13780,Lipid Modifying Agents,DrugBank
DB13780,"Lipid Modifying Agents, Plain",DrugBank
DB13780,Lipid Regulating Agents,DrugBank
DB13781,Adrenergic Agents,DrugBank
DB13781,Adrenergic Agonists,DrugBank
DB13781,Adrenergic beta-1 Receptor Agonists,DrugBank
DB13781,Adrenergic beta-Agonists,DrugBank
DB13781,Agents producing tachycardia,DrugBank
DB13781,Agents that produce hypertension,DrugBank
DB13781,Alcohols,DrugBank
DB13781,Amines,DrugBank
DB13781,Amino Alcohols,DrugBank
DB13781,Cardiac Stimulants Excl. Cardiac Glycosides,DrugBank
DB13781,Cardiac Therapy,DrugBank
DB13781,Morpholines,DrugBank
DB13781,Neurotransmitter Agents,DrugBank
DB13781,Oxazines,DrugBank
DB13781,Phenoxypropanolamines,DrugBank
DB13781,Propanolamines,DrugBank
DB13781,Propanols,DrugBank
DB13782,Agents that produce hypertension,DrugBank
DB13782,Agents that reduce seizure threshold,DrugBank
DB13782,Antidepressive Agents,DrugBank
DB13782,"Antidepressive Agents, Tricyclic",DrugBank
DB13782,Central Nervous System Depressants,DrugBank
DB13782,Dibenzazepines,DrugBank
DB13782,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13782,Narrow Therapeutic Index Drugs,DrugBank
DB13782,Nervous System,DrugBank
DB13782,Neurotoxic agents,DrugBank
DB13782,Non-Selective Monoamine Reuptake Inhibitors,DrugBank
DB13782,Psychoanaleptics,DrugBank
DB13782,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13783,Acetic Acid Derivatives and Related Substances,DrugBank
DB13783,Agents causing hyperkalemia,DrugBank
DB13783,Agents that produce hypertension,DrugBank
DB13783,Analgesics,DrugBank
DB13783,"Analgesics, Non-Narcotic",DrugBank
DB13783,Anti-Inflammatory Agents,DrugBank
DB13783,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13783,Antigout Preparations,DrugBank
DB13783,Antiinflammatory and Antirheumatic Products,DrugBank
DB13783,"Antiinflammatory and Antirheumatic Products, Non-Steroids",DrugBank
DB13783,Antirheumatic Agents,DrugBank
DB13783,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13783,Indoles,DrugBank
DB13783,Musculo-Skeletal System,DrugBank
DB13783,Nephrotoxic agents,DrugBank
DB13783,Non COX-2 selective NSAIDS,DrugBank
DB13783,Peripheral Nervous System Agents,DrugBank
DB13783,Sensory System Agents,DrugBank
DB13783,UGT2B7 substrates,DrugBank
DB13784,Analgesics,DrugBank
DB13784,"Analgesics, Non-Narcotic",DrugBank
DB13784,Antiemetics,DrugBank
DB13784,Antipsychotic Agents,DrugBank
DB13784,Autonomic Agents,DrugBank
DB13784,Central Nervous System Agents,DrugBank
DB13784,Central Nervous System Depressants,DrugBank
DB13784,Gastrointestinal Agents,DrugBank
DB13784,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13784,Nervous System,DrugBank
DB13784,Neurotoxic agents,DrugBank
DB13784,Peripheral Nervous System Agents,DrugBank
DB13784,Phenothiazines,DrugBank
DB13784,Phenothiazines With Piperazine Structure,DrugBank
DB13784,Psycholeptics,DrugBank
DB13784,Psychotropic Drugs,DrugBank
DB13784,Sensory System Agents,DrugBank
DB13784,Sulfur Compounds,DrugBank
DB13784,Tranquilizing Agents,DrugBank
DB13786,Agents that produce neuromuscular block (indirect),DrugBank
DB13786,Alimentary Tract and Metabolism,DrugBank
DB13786,Magnesium Compounds,DrugBank
DB13786,Metal cations,DrugBank
DB13786,Metal divalent cations,DrugBank
DB13786,Mineral Supplements,DrugBank
DB13786,Pyrimidines,DrugBank
DB13786,Pyrimidinones,DrugBank
DB13787,"Acids, Carbocyclic",DrugBank
DB13787,Analgesics,DrugBank
DB13787,Central Nervous System Agents,DrugBank
DB13787,Central Nervous System Depressants,DrugBank
DB13787,Cyclohexanecarboxylic Acids,DrugBank
DB13787,Narcotics,DrugBank
DB13787,Nervous System,DrugBank
DB13787,Opioids,DrugBank
DB13787,Peripheral Nervous System Agents,DrugBank
DB13787,Sensory System Agents,DrugBank
DB13787,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13791,Agents causing hyperkalemia,DrugBank
DB13791,Antiarrhythmic agents,DrugBank
DB13791,Antipsychotic Agents,DrugBank
DB13791,Bradycardia-Causing Agents,DrugBank
DB13791,Calcium Channel Blockers,DrugBank
DB13791,Central Nervous System Agents,DrugBank
DB13791,Central Nervous System Depressants,DrugBank
DB13791,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13791,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13791,Cytochrome P-450 Substrates,DrugBank
DB13791,Diphenylbutylpiperidine Derivatives,DrugBank
DB13791,Dopamine Agents,DrugBank
DB13791,Dopamine Antagonists,DrugBank
DB13791,Dopamine D2 Receptor Antagonists,DrugBank
DB13791,Moderate Risk QTc-Prolonging Agents,DrugBank
DB13791,Nervous System,DrugBank
DB13791,Neurotoxic agents,DrugBank
DB13791,Neurotransmitter Agents,DrugBank
DB13791,Piperidines,DrugBank
DB13791,Psycholeptics,DrugBank
DB13791,Psychotropic Drugs,DrugBank
DB13791,QTc Prolonging Agents,DrugBank
DB13791,Tranquilizing Agents,DrugBank
DB13792,Amides,DrugBank
DB13792,Diuretics,DrugBank
DB13792,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13792,Natriuretic Agents,DrugBank
DB13792,Piperidines,DrugBank
DB13792,Sulfonamides,DrugBank
DB13792,Sulfones,DrugBank
DB13792,Sulfur Compounds,DrugBank
DB13793,Alkaloids,DrugBank
DB13793,Cardiovascular Agents,DrugBank
DB13793,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13793,Indole Alkaloids,DrugBank
DB13793,Indoles,DrugBank
DB13793,Indolizidines,DrugBank
DB13793,Indolizines,DrugBank
DB13793,Peripheral Vasodilators,DrugBank
DB13793,Secologanin Tryptamine Alkaloids,DrugBank
DB13793,Vasodilating Agents,DrugBank
DB13799,Anticonvulsants,DrugBank
DB13799,Central Nervous System Depressants,DrugBank
DB13799,Nervous System,DrugBank
DB13799,Oxazolidine Derivatives,DrugBank
DB13800,Alimentary Tract and Metabolism,DrugBank
DB13800,Calcium Salts,DrugBank
DB13800,Enzyme Inhibitors,DrugBank
DB13800,Keto Acids,DrugBank
DB13800,Mineral Supplements,DrugBank
DB13801,Antihypertensive Agents,DrugBank
DB13801,Cardiovascular Agents,DrugBank
DB13801,Diuretics,DrugBank
DB13801,High-Ceiling Diuretics,DrugBank
DB13801,Natriuretic Agents,DrugBank
DB13801,Pyrazoles,DrugBank
DB13801,Pyrazolone Derivatives,DrugBank
DB13803,Amides,DrugBank
DB13803,Antihypertensive Agents,DrugBank
DB13803,Cardiovascular Agents,DrugBank
DB13803,Diuretics,DrugBank
DB13803,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB13803,Natriuretic Agents,DrugBank
DB13803,Sulfonamides,DrugBank
DB13803,Sulfones,DrugBank
DB13803,Sulfur Compounds,DrugBank
DB13804,Antithyroid agents,DrugBank
DB13804,Pyrimidines,DrugBank
DB13804,Pyrimidinones,DrugBank
DB13804,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13804,Thiouracils,DrugBank
DB13804,Thyroid Products,DrugBank
DB13804,"Uridine Phosphorylase, antagonists & inhibitors",DrugBank
DB13805,Amines,DrugBank
DB13805,"Barbiturates, Plain",DrugBank
DB13805,Benzene Derivatives,DrugBank
DB13805,Central Nervous System Depressants,DrugBank
DB13805,Enzyme Inhibitors,DrugBank
DB13805,Hydroxy Acids,DrugBank
DB13805,Hydroxylamines,DrugBank
DB13805,Hypnotics and Sedatives,DrugBank
DB13805,Nervous System,DrugBank
DB13805,Psycholeptics,DrugBank
DB13807,Antigout Preparations,DrugBank
DB13807,Antirheumatic Agents,DrugBank
DB13807,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13807,Musculo-Skeletal System,DrugBank
DB13807,Preparations Inhibiting Uric Acid Production,DrugBank
DB13807,Purines,DrugBank
DB13808,Antihistamines for Systemic Use,DrugBank
DB13808,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13808,Indole Alkaloids,DrugBank
DB13808,Indoles,DrugBank
DB13808,Pyridines,DrugBank
DB13809,Amino Acids,DrugBank
DB13809,"Amino Acids, Acidic",DrugBank
DB13809,"Amino Acids, Dicarboxylic",DrugBank
DB13809,"Amino Acids, Peptides, and Proteins",DrugBank
DB13809,Antineoplastic Agents,DrugBank
DB13809,Antineoplastic and Immunomodulating Agents,DrugBank
DB13809,Cardiotoxic antineoplastic agents,DrugBank
DB13809,Cyclodecanes,DrugBank
DB13809,Cycloparaffins,DrugBank
DB13809,Diterpenes,DrugBank
DB13809,Glutamates,DrugBank
DB13809,Peptides,DrugBank
DB13809,Taxoids,DrugBank
DB13809,Terpenes,DrugBank
DB13811,Antineoplastic Agents,DrugBank
DB13811,Antineoplastic and Immunomodulating Agents,DrugBank
DB13811,Antisense Elements (Genetics),DrugBank
DB13811,Antisense Oligonucleotides,DrugBank
DB13811,"Compounds used in a research, industrial, or household setting",DrugBank
DB13811,"DNA, Antisense",DrugBank
DB13811,Laboratory Chemicals,DrugBank
DB13811,Molecular Probes,DrugBank
DB13811,Nucleic Acid Probes,DrugBank
DB13811,Nucleic Acids,DrugBank
DB13811,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13811,Nucleotides,DrugBank
DB13811,"Oligodeoxyribonucleotides, Antisense",DrugBank
DB13811,Oligonucleotides,DrugBank
DB13811,Polynucleotides,DrugBank
DB13811,Sulfur Compounds,DrugBank
DB13812,Alkaloids,DrugBank
DB13812,Anti-Asthmatic Agents,DrugBank
DB13812,Autonomic Agents,DrugBank
DB13812,Bronchodilator Agents,DrugBank
DB13812,Cardiovascular Agents,DrugBank
DB13812,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13812,Cytochrome P-450 Substrates,DrugBank
DB13812,Drugs for Obstructive Airway Diseases,DrugBank
DB13812,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13812,Peripheral Nervous System Agents,DrugBank
DB13812,Purines,DrugBank
DB13812,Purinones,DrugBank
DB13812,Respiratory System Agents,DrugBank
DB13812,Vasodilating Agents,DrugBank
DB13812,Xanthine derivatives,DrugBank
DB13814,Amides,DrugBank
DB13814,Anti-Bacterial Agents,DrugBank
DB13814,Anti-Infective Agents,DrugBank
DB13814,Antibacterials for Systemic Use,DrugBank
DB13814,Antiinfectives for Systemic Use,DrugBank
DB13814,Beta-Lactam Antibacterials,DrugBank
DB13814,beta-Lactams,DrugBank
DB13814,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13814,Lactams,DrugBank
DB13814,Penicillin G,DrugBank
DB13814,Penicillins,DrugBank
DB13814,Penicillins With Extended Spectrum,DrugBank
DB13814,Sulfur Compounds,DrugBank
DB13816,Amides,DrugBank
DB13816,Anti-Bacterial Agents,DrugBank
DB13816,Antibacterials for Systemic Use,DrugBank
DB13816,Antiinfectives for Systemic Use,DrugBank
DB13816,Beta-Lactam Antibacterials,DrugBank
DB13816,beta-Lactams,DrugBank
DB13816,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13816,Lactams,DrugBank
DB13816,Penicillin G,DrugBank
DB13816,Penicillins,DrugBank
DB13816,Penicillins With Extended Spectrum,DrugBank
DB13816,Sulfur Compounds,DrugBank
DB13817,Amides,DrugBank
DB13817,Central Nervous System Depressants,DrugBank
DB13817,Hypnotics and Sedatives,DrugBank
DB13817,Nervous System,DrugBank
DB13817,Psycholeptics,DrugBank
DB13820,Antihistamines for Systemic Use,DrugBank
DB13820,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13820,Phenothiazine Derivatives,DrugBank
DB13820,Sulfur Compounds,DrugBank
DB13821,Amides,DrugBank
DB13821,Anti-Bacterial Agents,DrugBank
DB13821,Anti-Infective Agents,DrugBank
DB13821,Antibacterials for Systemic Use,DrugBank
DB13821,Antiinfectives for Systemic Use,DrugBank
DB13821,beta-Lactams,DrugBank
DB13821,Cephalosporins,DrugBank
DB13821,First-Generation Cephalosporins,DrugBank
DB13821,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13821,Lactams,DrugBank
DB13821,Nephrotoxic agents,DrugBank
DB13821,Sulfur Compounds,DrugBank
DB13821,Thiazines,DrugBank
DB13823,Anti-Bacterial Agents,DrugBank
DB13823,Anti-Infective Agents,DrugBank
DB13823,"Anti-Infective Agents, Urinary",DrugBank
DB13823,Antibacterials for Systemic Use,DrugBank
DB13823,Antiinfectives for Systemic Use,DrugBank
DB13823,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13823,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB13823,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13823,Fluoroquinolones,DrugBank
DB13823,Nicotinic Acids,DrugBank
DB13823,Piperazines,DrugBank
DB13823,Potential QTc-Prolonging Agents,DrugBank
DB13823,Pyridines,DrugBank
DB13823,QTc Prolonging Agents,DrugBank
DB13824,Alimentary Tract and Metabolism,DrugBank
DB13824,Anti-Ulcer Agents,DrugBank
DB13824,Autacoids,DrugBank
DB13824,Biological Factors,DrugBank
DB13824,Drugs for Acid Related Disorders,DrugBank
DB13824,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB13824,Eicosanoids,DrugBank
DB13824,Fatty Acids,DrugBank
DB13824,"Fatty Acids, Unsaturated",DrugBank
DB13824,Gastrointestinal Agents,DrugBank
DB13824,Inflammation Mediators,DrugBank
DB13824,Lipids,DrugBank
DB13824,Prostaglandins,DrugBank
DB13824,"Prostaglandins E, Synthetic",DrugBank
DB13824,"Prostaglandins, Synthetic",DrugBank
DB13829,Alimentary Tract and Metabolism,DrugBank
DB13829,Antacids,DrugBank
DB13829,Bone Substitutes,DrugBank
DB13829,Calcium Compounds,DrugBank
DB13829,Drugs for Acid Related Disorders,DrugBank
DB13829,Gastric Acid Lowering Agents,DrugBank
DB13829,Minerals,DrugBank
DB13829,Silicon Compounds,DrugBank
DB13831,Antidotes,DrugBank
DB13831,Antiseptics and Disinfectants,DrugBank
DB13831,"Compounds used in a research, industrial, or household setting",DrugBank
DB13831,Dermatologicals,DrugBank
DB13831,Indicators and Reagents,DrugBank
DB13831,Laboratory Chemicals,DrugBank
DB13831,Manganese Compounds,DrugBank
DB13831,Potassium Compounds,DrugBank
DB13831,Potassium Salt,DrugBank
DB13832,Alkylating Drugs,DrugBank
DB13832,Amides,DrugBank
DB13832,Antineoplastic Agents,DrugBank
DB13832,Antineoplastic and Immunomodulating Agents,DrugBank
DB13832,Nitroso Compounds,DrugBank
DB13832,Nitrosoureas,DrugBank
DB13835,Agents causing hyperkalemia,DrugBank
DB13835,Alimentary Tract and Metabolism,DrugBank
DB13835,Antiarrhythmic agents,DrugBank
DB13835,Bradycardia-Causing Agents,DrugBank
DB13835,Calcium Channel Blockers,DrugBank
DB13835,Calcium-Regulating Hormones and Agents,DrugBank
DB13835,Cardiovascular Agents,DrugBank
DB13835,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13835,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13835,Cytochrome P-450 Substrates,DrugBank
DB13835,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13835,Excitatory Amino Acid Agents,DrugBank
DB13835,Excitatory Amino Acid Antagonists,DrugBank
DB13835,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13835,Membrane Transport Modulators,DrugBank
DB13835,Neurotransmitter Agents,DrugBank
DB13835,Vasodilating Agents,DrugBank
DB13836,Amides,DrugBank
DB13836,Anti-Bacterial Agents,DrugBank
DB13836,Anti-Infective Agents,DrugBank
DB13836,Antibacterials for Systemic Use,DrugBank
DB13836,Antiinfectives for Systemic Use,DrugBank
DB13836,Beta-Lactam Antibacterials,DrugBank
DB13836,beta-Lactams,DrugBank
DB13836,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13836,Lactams,DrugBank
DB13836,Penicillin G,DrugBank
DB13836,Penicillins,DrugBank
DB13836,Penicillins With Extended Spectrum,DrugBank
DB13836,Sulfur Compounds,DrugBank
DB13837,Benzazepines,DrugBank
DB13837,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB13837,Benzodiazepinones,DrugBank
DB13837,Central Nervous System Depressants,DrugBank
DB13837,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13837,Hypnotics and Sedatives,DrugBank
DB13837,Nervous System,DrugBank
DB13837,Psycholeptics,DrugBank
DB13840,Antihistamines for Systemic Use,DrugBank
DB13840,Phenothiazine Derivatives,DrugBank
DB13841,Antipsychotic Agents,DrugBank
DB13841,Central Nervous System Agents,DrugBank
DB13841,Central Nervous System Depressants,DrugBank
DB13841,Dopamine Agents,DrugBank
DB13841,Dopamine Antagonists,DrugBank
DB13841,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13841,Nervous System,DrugBank
DB13841,Neurotoxic agents,DrugBank
DB13841,Neurotransmitter Agents,DrugBank
DB13841,Psycholeptics,DrugBank
DB13841,Psychotropic Drugs,DrugBank
DB13841,Sulfur Compounds,DrugBank
DB13841,Thioxanthene Derivatives,DrugBank
DB13841,Thioxanthenes,DrugBank
DB13841,Tranquilizing Agents,DrugBank
DB13841,Xanthenes,DrugBank
DB13843,Adrenal Cortex Hormones,DrugBank
DB13843,Corticosteroids,DrugBank
DB13843,Corticosteroids for Systemic Use,DrugBank
DB13843,"Corticosteroids for Systemic Use, Plain",DrugBank
DB13843,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13843,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13843,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13843,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB13843,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB13843,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13843,Fused-Ring Compounds,DrugBank
DB13843,Glucocorticoids,DrugBank
DB13843,Hyperglycemia-Associated Agents,DrugBank
DB13843,Immunosuppressive Agents,DrugBank
DB13843,Pregnanes,DrugBank
DB13843,Pregnenes,DrugBank
DB13843,Steroids,DrugBank
DB13843,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB13844,Agents producing tachycardia,DrugBank
DB13844,Alimentary Tract and Metabolism,DrugBank
DB13844,Anticholinergic Agents,DrugBank
DB13844,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13844,Muscarinic Antagonists,DrugBank
DB13844,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13845,Cardiac Therapy,DrugBank
DB13845,Cardiovascular Agents,DrugBank
DB13845,Ketones,DrugBank
DB13845,Propiophenones,DrugBank
DB13845,Vasodilating Agents,DrugBank
DB13845,Vasodilators Used in Cardiac Diseases,DrugBank
DB13846,Antihistamines for Systemic Use,DrugBank
DB13848,Amines,DrugBank
DB13848,Amino Acids,DrugBank
DB13848,"Amino Acids, Aromatic",DrugBank
DB13848,"Amino Acids, Cyclic",DrugBank
DB13848,"Amino Acids, Peptides, and Proteins",DrugBank
DB13848,Benzene Derivatives,DrugBank
DB13848,Catecholamines,DrugBank
DB13848,Catechols,DrugBank
DB13848,Diagnostic Radiopharmaceuticals,DrugBank
DB13848,Fluorine Radioisotopes,DrugBank
DB13848,Phenols,DrugBank
DB13849,"Acids, Acyclic",DrugBank
DB13849,Agents Causing Muscle Toxicity,DrugBank
DB13849,Benzene Derivatives,DrugBank
DB13849,Butyrates,DrugBank
DB13849,Clofibric Acid,DrugBank
DB13849,Ethers,DrugBank
DB13849,Fibric Acids,DrugBank
DB13849,Isobutyrates,DrugBank
DB13849,Lipid Modifying Agents,DrugBank
DB13849,"Lipid Modifying Agents, Plain",DrugBank
DB13849,Lipid Regulating Agents,DrugBank
DB13849,Phenols,DrugBank
DB13849,Phenyl Ethers,DrugBank
DB13850,Agents producing tachycardia,DrugBank
DB13850,Alimentary Tract and Metabolism,DrugBank
DB13850,Anticholinergic Agents,DrugBank
DB13850,Drugs for Functional Gastrointestinal Disorders,DrugBank
DB13850,Muscarinic Antagonists,DrugBank
DB13850,"Synthetic Anticholinergics, Quaternary Ammonium Compounds",DrugBank
DB13851,Amebicides,DrugBank
DB13851,Anti-Infective Agents,DrugBank
DB13851,Antimalarials,DrugBank
DB13851,Antiparasitic Agents,DrugBank
DB13851,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB13851,Antiplatyhelmintic Agents,DrugBank
DB13851,Antiprotozoals,DrugBank
DB13851,Artemisinin and derivatives,DrugBank
DB13851,Free Radicals,DrugBank
DB13851,Peroxides,DrugBank
DB13851,Reactive Oxygen Species,DrugBank
DB13851,Schistosomicides,DrugBank
DB13851,Sesquiterpenes,DrugBank
DB13851,Terpenes,DrugBank
DB13852,Agents producing tachycardia,DrugBank
DB13852,Agents that produce hypertension,DrugBank
DB13852,Alimentary Tract and Metabolism,DrugBank
DB13852,Amines,DrugBank
DB13852,"Antiobesity Preparations, Excl. Diet Products",DrugBank
DB13852,Autonomic Agents,DrugBank
DB13852,Centrally Acting Antiobesity Products,DrugBank
DB13852,Ethylamines,DrugBank
DB13852,Peripheral Nervous System Agents,DrugBank
DB13852,Phenethylamines,DrugBank
DB13852,Sympathomimetics,DrugBank
DB13854,Agents that reduce seizure threshold,DrugBank
DB13854,Dermatologicals,DrugBank
DB13854,Fatty Acids,DrugBank
DB13854,"Fatty Acids, Essential",DrugBank
DB13854,"Fatty Acids, Omega-6",DrugBank
DB13854,"Fatty Acids, Unsaturated",DrugBank
DB13854,Linolenic Acids,DrugBank
DB13854,Lipids,DrugBank
DB13856,Adrenal Cortex Hormones,DrugBank
DB13856,Corticosteroids,DrugBank
DB13856,"Corticosteroids, Dermatological Preparations",DrugBank
DB13856,"Corticosteroids, Potent (Group III)",DrugBank
DB13856,Dermatologicals,DrugBank
DB13856,Fused-Ring Compounds,DrugBank
DB13856,Immunosuppressive Agents,DrugBank
DB13856,Steroids,DrugBank
DB13857,Adrenal Cortex Hormones,DrugBank
DB13857,"Contraceptive Agents, Female",DrugBank
DB13857,"Contraceptives, Oral",DrugBank
DB13857,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13857,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13857,Cytochrome P-450 Substrates,DrugBank
DB13857,Fused-Ring Compounds,DrugBank
DB13857,Genito Urinary System and Sex Hormones,DrugBank
DB13857,Hormonal Contraceptives for Systemic Use,DrugBank
DB13857,Norpregnanes,DrugBank
DB13857,Norpregnenes,DrugBank
DB13857,Norsteroids,DrugBank
DB13857,Pregnadien Derivatives,DrugBank
DB13857,Progesterone Congeners,DrugBank
DB13857,Progestin Contraceptives,DrugBank
DB13857,Progestins,DrugBank
DB13857,Sex Hormones and Modulators of the Genital System,DrugBank
DB13857,Steroids,DrugBank
DB13860,"Acids, Carbocyclic",DrugBank
DB13860,Agents causing hyperkalemia,DrugBank
DB13860,Agents that produce hypertension,DrugBank
DB13860,Analgesics,DrugBank
DB13860,"Analgesics, Non-Narcotic",DrugBank
DB13860,Anti-Inflammatory Agents,DrugBank
DB13860,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB13860,Antirheumatic Agents,DrugBank
DB13860,Benzene Derivatives,DrugBank
DB13860,Benzoates,DrugBank
DB13860,Hydroxy Acids,DrugBank
DB13860,Hydroxybenzoates,DrugBank
DB13860,Nephrotoxic agents,DrugBank
DB13860,Nervous System,DrugBank
DB13860,Non COX-2 selective NSAIDS,DrugBank
DB13860,Peripheral Nervous System Agents,DrugBank
DB13860,Phenols,DrugBank
DB13860,Salicylic Acid and Derivatives,DrugBank
DB13860,Sensory System Agents,DrugBank
DB13862,Acids,DrugBank
DB13862,"Acids, Noncarboxylic",DrugBank
DB13862,Agents that produce neuromuscular block (indirect),DrugBank
DB13862,Anions,DrugBank
DB13862,Blood and Blood Forming Organs,DrugBank
DB13862,Blood Substitutes and Perfusion Solutions,DrugBank
DB13862,Electrolyte Solutions,DrugBank
DB13862,Electrolytes,DrugBank
DB13862,I.V. Solution Additives,DrugBank
DB13862,Ions,DrugBank
DB13862,Phosphoric Acids,DrugBank
DB13862,Phosphorus Acids,DrugBank
DB13862,Phosphorus Compounds,DrugBank
DB13863,Antiarrhythmic agents,DrugBank
DB13863,Carbohydrates,DrugBank
DB13863,Cardiac Therapy,DrugBank
DB13863,Cardiovascular Agents,DrugBank
DB13863,Central Nervous System Agents,DrugBank
DB13863,"Compounds used in a research, industrial, or household setting",DrugBank
DB13863,Fructosephosphates,DrugBank
DB13863,Hexosediphosphates,DrugBank
DB13863,Hexosephosphates,DrugBank
DB13863,Immunologic Factors,DrugBank
DB13863,Neuroprotective Agents,DrugBank
DB13863,Protective Agents,DrugBank
DB13863,Sugar Phosphates,DrugBank
DB13866,Adrenal Cortex Hormones,DrugBank
DB13866,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13866,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13866,Cytochrome P-450 Substrates,DrugBank
DB13866,Estren Derivatives,DrugBank
DB13866,Fused-Ring Compounds,DrugBank
DB13866,Genito Urinary System and Sex Hormones,DrugBank
DB13866,Hormonal Contraceptives for Systemic Use,DrugBank
DB13866,Norpregnanes,DrugBank
DB13866,Norpregnenes,DrugBank
DB13866,Norsteroids,DrugBank
DB13866,Progestins,DrugBank
DB13866,Sex Hormones and Modulators of the Genital System,DrugBank
DB13866,Steroids,DrugBank
DB13867,Adrenal Cortex Hormones,DrugBank
DB13867,Androstadienes,DrugBank
DB13867,Androstanes,DrugBank
DB13867,Androstenes,DrugBank
DB13867,Anti-Allergic Agents,DrugBank
DB13867,Anti-Asthmatic Agents,DrugBank
DB13867,Anti-Inflammatory Agents,DrugBank
DB13867,Autonomic Agents,DrugBank
DB13867,Bronchodilator Agents,DrugBank
DB13867,Corticosteroid Hormone Receptor Agonists,DrugBank
DB13867,Corticosteroids,DrugBank
DB13867,"Corticosteroids, Dermatological Preparations",DrugBank
DB13867,"Corticosteroids, Potent (Group III)",DrugBank
DB13867,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB13867,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB13867,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13867,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13867,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13867,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13867,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13867,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13867,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13867,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13867,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB13867,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB13867,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB13867,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB13867,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13867,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13867,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13867,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13867,Cytochrome P-450 Substrates,DrugBank
DB13867,Dermatologicals,DrugBank
DB13867,Drugs for Obstructive Airway Diseases,DrugBank
DB13867,Fused-Ring Compounds,DrugBank
DB13867,Glucocorticoids,DrugBank
DB13867,Hyperglycemia-Associated Agents,DrugBank
DB13867,Immunosuppressive Agents,DrugBank
DB13867,Nasal Preparations,DrugBank
DB13867,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13867,P-glycoprotein substrates,DrugBank
DB13867,Peripheral Nervous System Agents,DrugBank
DB13867,Respiratory System Agents,DrugBank
DB13867,Steroids,DrugBank
DB13867,Thyroxine-binding globulin inhibitors,DrugBank
DB13868,Anti-Infective Agents,DrugBank
DB13868,Antiviral Agents,DrugBank
DB13868,Enzyme Inhibitors,DrugBank
DB13868,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB13868,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13868,Nephrotoxic agents,DrugBank
DB13868,Nucleic Acid Synthesis Inhibitors,DrugBank
DB13868,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB13868,Organophosphorus Compounds,DrugBank
DB13868,Purines,DrugBank
DB13868,Reverse Transcriptase Inhibitors,DrugBank
DB13872,Benzazepines,DrugBank
DB13872,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB13872,Benzodiazepinones,DrugBank
DB13872,Central Nervous System Agents,DrugBank
DB13872,Central Nervous System Depressants,DrugBank
DB13872,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13872,Hypnotics and Sedatives,DrugBank
DB13872,Nervous System,DrugBank
DB13872,Psycholeptics,DrugBank
DB13873,"Acids, Acyclic",DrugBank
DB13873,Agents Causing Muscle Toxicity,DrugBank
DB13873,Anticholesteremic Agents,DrugBank
DB13873,Benzene Derivatives,DrugBank
DB13873,Benzophenones,DrugBank
DB13873,Butyrates,DrugBank
DB13873,Drugs that are Mainly Renally Excreted,DrugBank
DB13873,Ethers,DrugBank
DB13873,Fibric Acids,DrugBank
DB13873,Hypolipidemic Agents,DrugBank
DB13873,Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB13873,Isobutyrates,DrugBank
DB13873,Ketones,DrugBank
DB13873,Lipid Modifying Agents,DrugBank
DB13873,"Lipid Modifying Agents, Plain",DrugBank
DB13873,Lipid Regulating Agents,DrugBank
DB13873,Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia,DrugBank
DB13873,Peroxisome Proliferator Receptor alpha Agonist,DrugBank
DB13873,Phenols,DrugBank
DB13873,Phenyl Ethers,DrugBank
DB13874,Amines,DrugBank
DB13874,Antineoplastic Agents,DrugBank
DB13874,Antineoplastic and Immunomodulating Agents,DrugBank
DB13874,BCRP/ABCG2 Inhibitors,DrugBank
DB13874,BCRP/ABCG2 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB13874,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13874,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13874,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13874,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13874,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13874,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13874,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13874,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13874,Cytochrome P-450 Substrates,DrugBank
DB13874,Isocitrate dehydrogenase (IDH) inhibitors,DrugBank
DB13874,Isocitrate Dehydrogenase 2 Inhibitor,DrugBank
DB13874,Isocitrate dehydrogenase-2 (IDH2) Inhibitors,DrugBank
DB13874,Narrow Therapeutic Index Drugs,DrugBank
DB13874,OAT1/SLC22A6 inhibitors,DrugBank
DB13874,OAT3/SLC22A8 Inhibitors,DrugBank
DB13874,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13874,OATP1B3 inhibitors,DrugBank
DB13874,OCT2 Inhibitors,DrugBank
DB13874,P-glycoprotein inhibitors,DrugBank
DB13874,P-glycoprotein substrates,DrugBank
DB13874,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB13874,Pyridines,DrugBank
DB13874,UGT1A1 Inhibitors,DrugBank
DB13874,UGT1A1 Substrates,DrugBank
DB13874,UGT1A1 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,UGT1A3 substrates,DrugBank
DB13874,UGT1A3 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,UGT1A4 substrates,DrugBank
DB13874,UGT1A9 Substrates,DrugBank
DB13874,UGT1A9 Substrates with a Narrow Therapeutic Index,DrugBank
DB13874,UGT2B7 substrates,DrugBank
DB13874,UGT2B7 Substrates with a Narrow Therapeutic Index,DrugBank
DB13875,Agents that produce hypertension,DrugBank
DB13875,Agents that reduce seizure threshold,DrugBank
DB13875,Alkaloids,DrugBank
DB13875,Antidepressive Agents,DrugBank
DB13875,Carbolines,DrugBank
DB13875,Central Nervous System Agents,DrugBank
DB13875,Central Nervous System Depressants,DrugBank
DB13875,Central Nervous System Stimulants,DrugBank
DB13875,Enzyme Inhibitors,DrugBank
DB13875,Harmala Alkaloids,DrugBank
DB13875,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13875,Indole Alkaloids,DrugBank
DB13875,Indoles,DrugBank
DB13875,Indolizidines,DrugBank
DB13875,Indolizines,DrugBank
DB13875,Monoamine Oxidase Inhibitors,DrugBank
DB13875,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13876,Antidepressive Agents,DrugBank
DB13876,Central Nervous System Depressants,DrugBank
DB13876,Enzyme Inhibitors,DrugBank
DB13876,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB13876,Monoamine Oxidase Inhibitors,DrugBank
DB13876,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13877,"Acids, Carbocyclic",DrugBank
DB13877,Amides,DrugBank
DB13877,Antineoplastic Agents,DrugBank
DB13877,Benzene Derivatives,DrugBank
DB13877,Benzoates,DrugBank
DB13877,Enzyme Inhibitors,DrugBank
DB13877,Poly(ADP-ribose) Polymerase Inhibitors,DrugBank
DB13878,Antiinfectives for Systemic Use,DrugBank
DB13878,Antiviral Agents,DrugBank
DB13878,Antivirals for Systemic Use,DrugBank
DB13878,Antivirals for treatment of HCV infections,DrugBank
DB13878,BCRP/ABCG2 Inhibitors,DrugBank
DB13878,BCRP/ABCG2 Substrates,DrugBank
DB13878,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13878,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13878,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13878,Direct Acting Antivirals,DrugBank
DB13878,Hepatitis C Virus NS5A Inhibitor,DrugBank
DB13878,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13878,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13878,OATP1B3 inhibitors,DrugBank
DB13878,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB13878,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB13878,P-glycoprotein inhibitors,DrugBank
DB13878,P-glycoprotein substrates,DrugBank
DB13878,Treatments for Hepatitis C,DrugBank
DB13878,UGT1A1 Inhibitors,DrugBank
DB13879,"Acids, Acyclic",DrugBank
DB13879,Amides,DrugBank
DB13879,Amino Acids,DrugBank
DB13879,"Amino Acids, Branched-Chain",DrugBank
DB13879,"Amino Acids, Cyclic",DrugBank
DB13879,"Amino Acids, Essential",DrugBank
DB13879,"Amino Acids, Peptides, and Proteins",DrugBank
DB13879,Aminobutyrates,DrugBank
DB13879,Antiinfectives for Systemic Use,DrugBank
DB13879,Antiviral Agents,DrugBank
DB13879,Antivirals for Systemic Use,DrugBank
DB13879,Antivirals for treatment of HCV infections,DrugBank
DB13879,BCRP/ABCG2 Inhibitors,DrugBank
DB13879,BCRP/ABCG2 Substrates,DrugBank
DB13879,Butyrates,DrugBank
DB13879,Cycloparaffins,DrugBank
DB13879,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13879,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13879,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13879,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB13879,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13879,Direct Acting Antivirals,DrugBank
DB13879,HCV NS3/4A Protease Inhibitors,DrugBank
DB13879,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13879,Imino Acids,DrugBank
DB13879,Isobutyrates,DrugBank
DB13879,Lactams,DrugBank
DB13879,NS3/4A Protease Inhibitors,DrugBank
DB13879,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13879,OATP1B1/SLCO1B1 Substrates,DrugBank
DB13879,OATP1B3 inhibitors,DrugBank
DB13879,OATP1B3 substrates,DrugBank
DB13879,Organic Anion Transporting Polypeptide 1B1 Inhibitors,DrugBank
DB13879,Organic Anion Transporting Polypeptide 1B3 Inhibitors,DrugBank
DB13879,P-glycoprotein inhibitors,DrugBank
DB13879,P-glycoprotein substrates,DrugBank
DB13879,Sulfones,DrugBank
DB13879,Sulfur Compounds,DrugBank
DB13879,Treatments for Hepatitis C,DrugBank
DB13879,UGT1A1 Inhibitors,DrugBank
DB13881,"Amino Acids, Peptides, and Proteins",DrugBank
DB13881,Antineoplastic Agents,DrugBank
DB13881,"Antineoplastic Agents, Immunological",DrugBank
DB13881,Antineoplastic and Immunomodulating Agents,DrugBank
DB13881,Antineoplastic cell and gene therapy,DrugBank
DB13881,Cancer immunotherapy,DrugBank
DB13881,CD19 Receptor Interactions,DrugBank
DB13881,CD19-directed Chimeric Antigen Receptor,DrugBank
DB13881,Genetically-modified Autologous T Cells,DrugBank
DB13881,Immunotherapy,DrugBank
DB13881,Membrane Proteins,DrugBank
DB13881,Proteins,DrugBank
DB13881,"Receptors, Antigen",DrugBank
DB13884,Albumins,DrugBank
DB13884,"Amino Acids, Peptides, and Proteins",DrugBank
DB13884,Biological Factors,DrugBank
DB13884,Blood Coagulation Factors,DrugBank
DB13884,Blood Proteins,DrugBank
DB13884,Drugs that are Mainly Renally Excreted,DrugBank
DB13884,Enzyme Precursors,DrugBank
DB13884,Enzymes and Coenzymes,DrugBank
DB13884,Hemostatics,DrugBank
DB13884,Protein Precursors,DrugBank
DB13884,Proteins,DrugBank
DB13884,Recombinant Proteins,DrugBank
DB13886,"Amino Acids, Peptides, and Proteins",DrugBank
DB13886,Antibodies,DrugBank
DB13886,Antiinfectives for Systemic Use,DrugBank
DB13886,Blood Proteins,DrugBank
DB13886,Globulins,DrugBank
DB13886,Human Immunoglobulin G,DrugBank
DB13886,Immune Sera and Immunoglobulins,DrugBank
DB13886,"Immunization, Passive",DrugBank
DB13886,Immunoglobulin G,DrugBank
DB13886,Immunoglobulin Isotypes,DrugBank
DB13886,Immunoglobulins,DrugBank
DB13886,Immunoproteins,DrugBank
DB13886,Passively Acquired Immunity,DrugBank
DB13886,Proteins,DrugBank
DB13886,Serum,DrugBank
DB13886,Serum Globulins,DrugBank
DB13886,Specific Immunoglobulins,DrugBank
DB13886,Virus Neutralization,DrugBank
DB13896,Alphaherpesvirinae,DrugBank
DB13896,Antineoplastic Agents,DrugBank
DB13896,"Antineoplastic Agents, Immunological",DrugBank
DB13896,Antineoplastic and Immunomodulating Agents,DrugBank
DB13896,Antineoplastic cell and gene therapy,DrugBank
DB13896,Cancer immunotherapy,DrugBank
DB13896,Complex Mixtures,DrugBank
DB13896,DNA Viruses,DrugBank
DB13896,Herpesviridae,DrugBank
DB13896,Immunotherapy,DrugBank
DB13896,Simplexvirus,DrugBank
DB13896,Viruses,DrugBank
DB13909,"Acids, Carbocyclic",DrugBank
DB13909,Antacids and Adsorbents,DrugBank
DB13909,Anti-Infective Agents,DrugBank
DB13909,Antidiarrheals,DrugBank
DB13909,Benzene Derivatives,DrugBank
DB13909,Benzoates,DrugBank
DB13909,Bismuth containing drugs,DrugBank
DB13909,Coagulants,DrugBank
DB13909,Drugs that are Mainly Renally Excreted,DrugBank
DB13909,Hematologic Agents,DrugBank
DB13909,Hemostatics,DrugBank
DB13909,Hydroxy Acids,DrugBank
DB13909,Hydroxybenzoates,DrugBank
DB13909,Neurotoxic agents,DrugBank
DB13909,Phenols,DrugBank
DB13910,Bismuth containing drugs,DrugBank
DB13910,"EENT Drugs, Miscellaneous",DrugBank
DB13910,Neurotoxic agents,DrugBank
DB13910,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13912,Antineoplastic Agents,DrugBank
DB13912,Benzopyrans,DrugBank
DB13912,Coumarins,DrugBank
DB13912,Enzyme Inhibitors,DrugBank
DB13912,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13912,Pyrans,DrugBank
DB13912,Topoisomerase II Inhibitors,DrugBank
DB13912,Topoisomerase Inhibitors,DrugBank
DB13913,Anticholinergic Agents,DrugBank
DB13913,Antimuscarinics Antispasmodics,DrugBank
DB13913,Muscarinic Antagonists,DrugBank
DB13915,Antigens,DrugBank
DB13915,"Antigens, CD",DrugBank
DB13915,"Antigens, Differentiation",DrugBank
DB13915,"Antigens, Differentiation, B-Lymphocyte",DrugBank
DB13915,"Antigens, Surface",DrugBank
DB13915,Antineoplastic Agents,DrugBank
DB13915,"Antineoplastic Agents, Immunological",DrugBank
DB13915,Antineoplastic and Immunomodulating Agents,DrugBank
DB13915,Antineoplastic cell and gene therapy,DrugBank
DB13915,Biological Factors,DrugBank
DB13915,Cancer immunotherapy,DrugBank
DB13915,CD19 Receptor Interactions,DrugBank
DB13915,CD19-directed Chimeric Antigen Receptor,DrugBank
DB13915,Complex Mixtures,DrugBank
DB13915,Genetically-modified Autologous T Cells,DrugBank
DB13915,Immunization,DrugBank
DB13915,"Immunization, Passive",DrugBank
DB13915,Immunomodulation,DrugBank
DB13915,Immunotherapy,DrugBank
DB13916,"Antibiotics, Antineoplastic",DrugBank
DB13916,Antimetabolites,DrugBank
DB13916,Antineoplastic Agents,DrugBank
DB13916,Noxae,DrugBank
DB13916,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB13916,Nucleosides,DrugBank
DB13916,Ribonucleosides,DrugBank
DB13916,Toxic Actions,DrugBank
DB13917,Agents that produce hypertension,DrugBank
DB13917,Amines,DrugBank
DB13917,Benzene Derivatives,DrugBank
DB13917,Catecholamines,DrugBank
DB13917,Catechols,DrugBank
DB13917,Epinephrine and similars,DrugBank
DB13917,Phenols,DrugBank
DB13919,Agents Acting on the Renin-Angiotensin System,DrugBank
DB13919,Agents causing hyperkalemia,DrugBank
DB13919,Angiotensin 2 Receptor Blocker,DrugBank
DB13919,Angiotensin II receptor antagonists,DrugBank
DB13919,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,DrugBank
DB13919,Angiotensin II receptor blockers (ARBs) and diuretics,DrugBank
DB13919,"Angiotensin II receptor blockers (ARBs), plain",DrugBank
DB13919,Angiotensin II Type 2 Receptor Blockers,DrugBank
DB13919,Angiotensin Receptor Antagonists,DrugBank
DB13919,Antihypertensive Agents,DrugBank
DB13919,Benzene Derivatives,DrugBank
DB13919,Cardiovascular Agents,DrugBank
DB13919,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB13919,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB13919,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB13919,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB13919,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB13919,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13919,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13919,Cytochrome P-450 Substrates,DrugBank
DB13919,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13919,Lipid Modifying Agents,DrugBank
DB13919,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13919,P-glycoprotein inhibitors,DrugBank
DB13919,UGT1A3 substrates,DrugBank
DB13923,"Amino Acids, Peptides, and Proteins",DrugBank
DB13923,Antibodies,DrugBank
DB13923,"Antibodies, Monoclonal",DrugBank
DB13923,"Antibodies, Monoclonal, Humanized",DrugBank
DB13923,"Antihemorrhagic Agents, Miscellaneous",DrugBank
DB13923,Blood and Blood Forming Organs,DrugBank
DB13923,Blood Coagulation Factors,DrugBank
DB13923,Blood Proteins,DrugBank
DB13923,Globulins,DrugBank
DB13923,Hemostatics,DrugBank
DB13923,Immunoglobulins,DrugBank
DB13923,Immunoproteins,DrugBank
DB13923,Proteins,DrugBank
DB13923,Serum Globulins,DrugBank
DB13924,Vaccines,DrugBank
DB13924,Varicella Zoster Vaccines,DrugBank
DB13928,Alimentary Tract and Metabolism,DrugBank
DB13928,"Amino Acids, Peptides, and Proteins",DrugBank
DB13928,Blood Glucose Lowering Agents,DrugBank
DB13928,Drugs Used in Diabetes,DrugBank
DB13928,Gastrointestinal Hormones,DrugBank
DB13928,GLP-1 Agonists,DrugBank
DB13928,Glucagon-like peptide-1 (GLP-1) analogues,DrugBank
DB13928,Glucagon-Like Peptides,DrugBank
DB13928,Hormones,DrugBank
DB13928,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13928,Incretin Mimetics,DrugBank
DB13928,Pancreatic Hormones,DrugBank
DB13928,Peptide Hormones,DrugBank
DB13928,Peptides,DrugBank
DB13928,Proteins,DrugBank
DB13929,Antiplatelet agents,DrugBank
DB13929,Hematologic Agents,DrugBank
DB13929,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13929,Hormone Antagonists,DrugBank
DB13929,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13933,"Amino Acids, Peptides, and Proteins",DrugBank
DB13933,Biological Factors,DrugBank
DB13933,Blood Coagulation Factors,DrugBank
DB13933,Blood Proteins,DrugBank
DB13933,"Compounds used in a research, industrial, or household setting",DrugBank
DB13933,Enzyme Precursors,DrugBank
DB13933,Enzymes and Coenzymes,DrugBank
DB13933,Hemostatics,DrugBank
DB13933,Macromolecular Substances,DrugBank
DB13933,Pegylated agents,DrugBank
DB13933,Polymers,DrugBank
DB13933,Protein Precursors,DrugBank
DB13933,Proteins,DrugBank
DB13940,Agents producing tachycardia,DrugBank
DB13940,Agents that produce hypertension,DrugBank
DB13940,Amines,DrugBank
DB13940,Amphetamines,DrugBank
DB13940,Antidepressive Agents,DrugBank
DB13940,Central Nervous System Depressants,DrugBank
DB13940,Ethylamines,DrugBank
DB13940,Phenethylamines,DrugBank
DB13940,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13940,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB13940,Serotonin Agents,DrugBank
DB13940,Serotonin Receptor Agonists,DrugBank
DB13940,Sympathomimetics,DrugBank
DB13941,Anti-Infective Agents,DrugBank
DB13941,Antimalarials,DrugBank
DB13941,Antiparasitic Agents,DrugBank
DB13941,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB13941,Antiprotozoals,DrugBank
DB13941,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB13941,Cytochrome P-450 CYP2B6 Inhibitors (weak),DrugBank
DB13941,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB13941,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB13941,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13941,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13941,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB13941,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB13941,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13941,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13941,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13941,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB13941,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13941,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13941,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13941,Cytochrome P-450 Substrates,DrugBank
DB13941,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13943,Anabolic Agents,DrugBank
DB13943,Androgens,DrugBank
DB13943,Androstanes,DrugBank
DB13943,Androstenes,DrugBank
DB13943,Androstenols,DrugBank
DB13943,BCRP/ABCG2 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13943,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13943,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13943,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13943,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13943,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13943,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13943,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13943,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13943,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13943,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13943,Cytochrome P-450 Substrates,DrugBank
DB13943,Delayed-Action Preparations,DrugBank
DB13943,Drugs that are Mainly Renally Excreted,DrugBank
DB13943,Fused-Ring Compounds,DrugBank
DB13943,Gonadal Hormones,DrugBank
DB13943,Gonadal Steroid Hormones,DrugBank
DB13943,Hormones,DrugBank
DB13943,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13943,OAT3/SLC22A8 Inducers,DrugBank
DB13943,P-glycoprotein inhibitors,DrugBank
DB13943,Steroids,DrugBank
DB13943,Testosterone and derivatives,DrugBank
DB13943,Testosterone Congeners,DrugBank
DB13943,Thyroxine-binding globulin inhibitors,DrugBank
DB13944,Adrenal Cortex Hormones,DrugBank
DB13944,Androgens,DrugBank
DB13944,Androstanes,DrugBank
DB13944,Androstenes,DrugBank
DB13944,Androstenols,DrugBank
DB13944,BCRP/ABCG2 Substrates,DrugBank
DB13944,"Contraceptive Agents, Male",DrugBank
DB13944,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13944,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13944,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13944,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13944,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13944,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13944,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13944,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13944,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13944,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13944,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13944,Cytochrome P-450 Substrates,DrugBank
DB13944,Drugs that are Mainly Renally Excreted,DrugBank
DB13944,Fused-Ring Compounds,DrugBank
DB13944,Gonadal Hormones,DrugBank
DB13944,Gonadal Steroid Hormones,DrugBank
DB13944,Hormonal Contraceptives for Systemic Use,DrugBank
DB13944,Hormones,DrugBank
DB13944,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13944,OAT3/SLC22A8 Inducers,DrugBank
DB13944,P-glycoprotein inhibitors,DrugBank
DB13944,Steroids,DrugBank
DB13944,Testosterone and derivatives,DrugBank
DB13944,Testosterone Congeners,DrugBank
DB13944,Thyroxine-binding globulin inhibitors,DrugBank
DB13946,Androgens,DrugBank
DB13946,Androstanes,DrugBank
DB13946,Androstenes,DrugBank
DB13946,Androstenols,DrugBank
DB13946,BCRP/ABCG2 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13946,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13946,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13946,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13946,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13946,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13946,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13946,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13946,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13946,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13946,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13946,Cytochrome P-450 Substrates,DrugBank
DB13946,Drugs that are Mainly Renally Excreted,DrugBank
DB13946,Fused-Ring Compounds,DrugBank
DB13946,Gonadal Hormones,DrugBank
DB13946,Gonadal Steroid Hormones,DrugBank
DB13946,Hormones,DrugBank
DB13946,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13946,OAT3/SLC22A8 Inducers,DrugBank
DB13946,OATP1B3 substrates,DrugBank
DB13946,P-glycoprotein inhibitors,DrugBank
DB13946,Steroids,DrugBank
DB13946,Testosterone and derivatives,DrugBank
DB13946,Testosterone Congeners,DrugBank
DB13946,Thyroxine-binding globulin inhibitors,DrugBank
DB13947,Androstanes,DrugBank
DB13947,Androstenes,DrugBank
DB13947,Androstenols,DrugBank
DB13947,Fused-Ring Compounds,DrugBank
DB13947,Gonadal Hormones,DrugBank
DB13947,Gonadal Steroid Hormones,DrugBank
DB13947,Hormones,DrugBank
DB13947,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13947,Steroids,DrugBank
DB13947,Testosterone and derivatives,DrugBank
DB13947,Testosterone Congeners,DrugBank
DB13948,Antidepressive Agents,DrugBank
DB13948,Central Nervous System Depressants,DrugBank
DB13948,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB13948,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB13948,Serotonin Agents,DrugBank
DB13948,Serotonin Receptor Agonists,DrugBank
DB13949,Iron Compounds,DrugBank
DB13949,Parenteral Iron Replacement,DrugBank
DB13949,Phosphate Binder,DrugBank
DB13949,Phosphate Chelating Activity,DrugBank
DB13949,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB13950,Agents causing hyperkalemia,DrugBank
DB13950,Agents producing tachycardia,DrugBank
DB13950,Analgesics,DrugBank
DB13950,Antiarrhythmic agents,DrugBank
DB13950,Bradycardia-Causing Agents,DrugBank
DB13950,Calcium Channel Blockers,DrugBank
DB13950,Calcium-Regulating Hormones and Agents,DrugBank
DB13950,Cannabinoid Receptor Antagonists,DrugBank
DB13950,Cannabinoids and similars,DrugBank
DB13950,Cardiovascular Agents,DrugBank
DB13950,Central Nervous System Agents,DrugBank
DB13950,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13950,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13950,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13950,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13950,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13950,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13950,Cytochrome P-450 Substrates,DrugBank
DB13950,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13950,Membrane Transport Modulators,DrugBank
DB13950,Oxazines,DrugBank
DB13950,Peripheral Nervous System Agents,DrugBank
DB13950,"Receptor, Cannabinoid, CB1, antagonists & inhibitors",DrugBank
DB13950,Sensory System Agents,DrugBank
DB13951,P-glycoprotein substrates,DrugBank
DB13951,Testosterone and derivatives,DrugBank
DB13952,BCRP/ABCG2 Inhibitors,DrugBank
DB13952,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13952,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13952,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB13952,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13952,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13952,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13952,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13952,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13952,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13952,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13952,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13952,Cytochrome P-450 Substrates,DrugBank
DB13952,Drugs that are Mainly Renally Excreted,DrugBank
DB13952,Estrogens,DrugBank
DB13952,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13952,OCT1 inhibitors,DrugBank
DB13952,OCT2 Inhibitors,DrugBank
DB13952,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB13952,P-glycoprotein substrates,DrugBank
DB13952,Thyroxine-binding globulin inducers,DrugBank
DB13952,UGT1A1 Substrates,DrugBank
DB13953,Adrenal Cortex Hormones,DrugBank
DB13953,BCRP/ABCG2 Inhibitors,DrugBank
DB13953,"Contraceptive Agents, Hormonal",DrugBank
DB13953,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13953,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13953,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB13953,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13953,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13953,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13953,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13953,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13953,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13953,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13953,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13953,Cytochrome P-450 Substrates,DrugBank
DB13953,Estradiol Congeners,DrugBank
DB13953,Estranes,DrugBank
DB13953,Estrenes,DrugBank
DB13953,Estrogens,DrugBank
DB13953,Fused-Ring Compounds,DrugBank
DB13953,Gonadal Hormones,DrugBank
DB13953,Gonadal Steroid Hormones,DrugBank
DB13953,Hormonal Contraceptives for Systemic Use,DrugBank
DB13953,Hormones,DrugBank
DB13953,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13953,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13953,OCT1 inhibitors,DrugBank
DB13953,OCT2 Inhibitors,DrugBank
DB13953,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB13953,P-glycoprotein substrates,DrugBank
DB13953,Reproductive Control Agents,DrugBank
DB13953,Steroids,DrugBank
DB13953,UGT1A1 Substrates,DrugBank
DB13954,Adrenal Cortex Hormones,DrugBank
DB13954,BCRP/ABCG2 Inhibitors,DrugBank
DB13954,"Contraceptive Agents, Female",DrugBank
DB13954,"Contraceptive Agents, Hormonal",DrugBank
DB13954,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13954,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13954,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13954,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13954,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13954,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13954,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13954,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13954,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13954,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13954,Cytochrome P-450 Substrates,DrugBank
DB13954,Drugs that are Mainly Renally Excreted,DrugBank
DB13954,Estradiol Congeners,DrugBank
DB13954,Estranes,DrugBank
DB13954,Estrenes,DrugBank
DB13954,Estrogen Contraceptives,DrugBank
DB13954,Estrogens,DrugBank
DB13954,Fused-Ring Compounds,DrugBank
DB13954,Gonadal Hormones,DrugBank
DB13954,Gonadal Steroid Hormones,DrugBank
DB13954,Hormonal Contraceptives for Systemic Use,DrugBank
DB13954,Hormones,DrugBank
DB13954,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13954,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13954,OCT1 inhibitors,DrugBank
DB13954,OCT2 Inhibitors,DrugBank
DB13954,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB13954,P-glycoprotein substrates,DrugBank
DB13954,Reproductive Control Agents,DrugBank
DB13954,Steroids,DrugBank
DB13954,Thyroxine-binding globulin inducers,DrugBank
DB13954,UGT1A1 Substrates,DrugBank
DB13955,BCRP/ABCG2 Inhibitors,DrugBank
DB13955,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13955,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13955,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB13955,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13955,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13955,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13955,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13955,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13955,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13955,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13955,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13955,Cytochrome P-450 Substrates,DrugBank
DB13955,Drugs that are Mainly Renally Excreted,DrugBank
DB13955,Estradiol Congeners,DrugBank
DB13955,Estranes,DrugBank
DB13955,Estrenes,DrugBank
DB13955,Fused-Ring Compounds,DrugBank
DB13955,Gonadal Hormones,DrugBank
DB13955,Gonadal Steroid Hormones,DrugBank
DB13955,Hormones,DrugBank
DB13955,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13955,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13955,OCT1 inhibitors,DrugBank
DB13955,OCT2 Inhibitors,DrugBank
DB13955,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB13955,P-glycoprotein substrates,DrugBank
DB13955,Steroids,DrugBank
DB13955,UGT1A1 Substrates,DrugBank
DB13956,Adrenal Cortex Hormones,DrugBank
DB13956,BCRP/ABCG2 Inhibitors,DrugBank
DB13956,"Contraceptive Agents, Female",DrugBank
DB13956,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13956,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13956,Cytochrome P-450 CYP1A2 Inhibitors (weak),DrugBank
DB13956,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP3A Inducers,DrugBank
DB13956,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13956,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB13956,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB13956,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB13956,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB13956,Cytochrome P-450 Enzyme Inducers,DrugBank
DB13956,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13956,Cytochrome P-450 Substrates,DrugBank
DB13956,Drugs that are Mainly Renally Excreted,DrugBank
DB13956,Estradiol Congeners,DrugBank
DB13956,"Estradiol, agonists",DrugBank
DB13956,Estranes,DrugBank
DB13956,Estrenes,DrugBank
DB13956,Estrogen Contraceptives,DrugBank
DB13956,Estrogens,DrugBank
DB13956,Fused-Ring Compounds,DrugBank
DB13956,Gonadal Hormones,DrugBank
DB13956,Gonadal Steroid Hormones,DrugBank
DB13956,Hormonal Contraceptives for Systemic Use,DrugBank
DB13956,Hormones,DrugBank
DB13956,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13956,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB13956,OCT1 inhibitors,DrugBank
DB13956,OCT2 Inhibitors,DrugBank
DB13956,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB13956,P-glycoprotein substrates,DrugBank
DB13956,Steroids,DrugBank
DB13956,Thyroxine-binding globulin inducers,DrugBank
DB13956,UGT1A1 Substrates,DrugBank
DB13958,Estranes,DrugBank
DB13958,Estrenes,DrugBank
DB13958,Fused-Ring Compounds,DrugBank
DB13958,Gonadal Hormones,DrugBank
DB13958,Gonadal Steroid Hormones,DrugBank
DB13958,Hormones,DrugBank
DB13958,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB13958,Steroids,DrugBank
DB13958,Testosterone and derivatives,DrugBank
DB13958,Testosterone Congeners,DrugBank
DB13961,Agents causing hyperkalemia,DrugBank
DB13961,Antiarrhythmic agents,DrugBank
DB13961,Bradycardia-Causing Agents,DrugBank
DB13961,Calcium Channel Blockers,DrugBank
DB13961,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13961,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13961,Cytochrome P-450 Substrates,DrugBank
DB13961,Fish Oils,DrugBank
DB13961,Lipids,DrugBank
DB13961,Oils,DrugBank
DB13961,Vasodilating Agents,DrugBank
DB13967,Amines,DrugBank
DB13967,Aniline Compounds,DrugBank
DB13967,Coloring Agents,DrugBank
DB13967,"Compounds used in a research, industrial, or household setting",DrugBank
DB13967,Diagnostic Agents,DrugBank
DB13967,Drugs that are Mainly Renally Excreted,DrugBank
DB13967,Other Diagnostics,DrugBank
DB13975,Angiosperms,DrugBank
DB13975,Biological Products,DrugBank
DB13975,Complex Mixtures,DrugBank
DB13975,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB13975,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB13975,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB13975,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB13975,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB13975,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB13975,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB13975,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB13975,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB13975,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB13975,Embryophyta,DrugBank
DB13975,Eukaryota,DrugBank
DB13975,Genito Urinary System and Sex Hormones,DrugBank
DB13975,Herbs and Natural Products,DrugBank
DB13975,Pharmaceutical Preparations,DrugBank
DB13975,Plant Preparations,DrugBank
DB13975,Ranunculaceae,DrugBank
DB13975,Ranunculales,DrugBank
DB13975,Streptophyta,DrugBank
DB13975,Tracheophyta,DrugBank
DB13975,Viridiplantae,DrugBank
DB13976,"Amino Acids, Peptides, and Proteins",DrugBank
DB13976,Antibodies,DrugBank
DB13976,"Antibodies, Monoclonal",DrugBank
DB13976,Blood Proteins,DrugBank
DB13976,Diagnostic Radiopharmaceuticals,DrugBank
DB13976,Globulins,DrugBank
DB13976,Immunoglobulins,DrugBank
DB13976,Immunoproteins,DrugBank
DB13976,Inflammation and Infection Detection,DrugBank
DB13976,Proteins,DrugBank
DB13976,Serum Globulins,DrugBank
DB13976,Technetium (99Mtc) Compounds,DrugBank
DB13977,Alkalies,DrugBank
DB13977,Anions,DrugBank
DB13977,"Carbon Compounds, Inorganic",DrugBank
DB13977,Carbonic Acid,DrugBank
DB13977,Electrolytes,DrugBank
DB13977,Elements,DrugBank
DB13977,Ions,DrugBank
DB13977,Metals,DrugBank
DB13977,"Metals, Alkali",DrugBank
DB13977,"Metals, Light",DrugBank
DB13977,Potassium Salt,DrugBank
DB13979,"Amino Acids, Peptides, and Proteins",DrugBank
DB13979,Antibodies,DrugBank
DB13979,"Antibodies, Monoclonal",DrugBank
DB13979,Blood Proteins,DrugBank
DB13979,Globulins,DrugBank
DB13979,Immunoglobulins,DrugBank
DB13979,Immunoproteins,DrugBank
DB13979,Proteins,DrugBank
DB13979,Radiopharmaceuticals,DrugBank
DB13979,Serum Globulins,DrugBank
DB13981,Adrenal Cortex Hormones,DrugBank
DB13981,Combination Contraceptives (with Estrogen and derivatives),DrugBank
DB13981,"Contraceptive Agents, Female",DrugBank
DB13981,"Contraceptives, Oral",DrugBank
DB13981,Cytochrome P-450 CYP3A Substrates,DrugBank
DB13981,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB13981,Cytochrome P-450 Substrates,DrugBank
DB13981,Fused-Ring Compounds,DrugBank
DB13981,Hormonal Contraceptives for Systemic Use,DrugBank
DB13981,Norpregnanes,DrugBank
DB13981,Norsteroids,DrugBank
DB13981,Pregnadienes,DrugBank
DB13981,Pregnanes,DrugBank
DB13981,Progesterone Congeners,DrugBank
DB13981,Progestin Contraceptives,DrugBank
DB13981,Progestins,DrugBank
DB13981,Steroids,DrugBank
DB13984,Anesthetics,DrugBank
DB13984,Central Nervous System Agents,DrugBank
DB13984,Central Nervous System Depressants,DrugBank
DB13984,Cycloparaffins,DrugBank
DB13987,Drugs that are Mainly Renally Excreted,DrugBank
DB13987,Elements,DrugBank
DB13987,Metals,DrugBank
DB13987,"Metals, Alkaline Earth",DrugBank
DB13987,"Metals, Heavy",DrugBank
DB13987,Strontium Radioisotopes,DrugBank
DB13989,Diuretics,DrugBank
DB13989,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB13989,Sodium Chloride Symporter Inhibitors,DrugBank
DB13993,Anti-Anxiety Agents,DrugBank
DB13993,Central Nervous System Depressants,DrugBank
DB13993,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB13993,"Hydrocarbons, Halogenated",DrugBank
DB13995,Enzymes,DrugBank
DB13995,Enzymes and Coenzymes,DrugBank
DB13995,Hydrolases,DrugBank
DB13995,Parenteral Iron Replacement,DrugBank
DB13995,Peptide Hydrolases,DrugBank
DB13995,Phosphate salts,DrugBank
DB13996,"Acids, Acyclic",DrugBank
DB13996,Agents that produce neuromuscular block (indirect),DrugBank
DB13996,Fatty Acids,DrugBank
DB13996,"Fatty Acids, Volatile",DrugBank
DB13996,Laxatives,DrugBank
DB13996,Lipids,DrugBank
DB13999,"Amino Acids, Peptides, and Proteins",DrugBank
DB13999,Biological Factors,DrugBank
DB13999,Blood Coagulation Factors,DrugBank
DB13999,Blood Proteins,DrugBank
DB13999,Hemostatics,DrugBank
DB13999,Protein Precursors,DrugBank
DB13999,Proteins,DrugBank
DB13999,Recombinant Proteins,DrugBank
DB14004,"Amino Acids, Peptides, and Proteins",DrugBank
DB14004,Antibodies,DrugBank
DB14004,"Antibodies, Monoclonal",DrugBank
DB14004,"Antibodies, Monoclonal, Humanized",DrugBank
DB14004,Antineoplastic and Immunomodulating Agents,DrugBank
DB14004,Blood Proteins,DrugBank
DB14004,Globulins,DrugBank
DB14004,Immunoglobulins,DrugBank
DB14004,Immunoproteins,DrugBank
DB14004,Interleukin Inhibitors,DrugBank
DB14004,Interleukin-23 Antagonist,DrugBank
DB14004,Interleukin-23 Subunit p19,DrugBank
DB14004,Proteins,DrugBank
DB14004,Serum Globulins,DrugBank
DB14006,"Acids, Carbocyclic",DrugBank
DB14006,Alcohols,DrugBank
DB14006,Amines,DrugBank
DB14006,Amino Alcohols,DrugBank
DB14006,Analgesics,DrugBank
DB14006,Benzene Derivatives,DrugBank
DB14006,Benzoates,DrugBank
DB14006,Drugs that are Mainly Renally Excreted,DrugBank
DB14006,Ethanolamines,DrugBank
DB14006,Hydroxy Acids,DrugBank
DB14006,Hydroxybenzoates,DrugBank
DB14006,Nervous System,DrugBank
DB14006,OCT1 inhibitors,DrugBank
DB14006,OCT1 substrates,DrugBank
DB14006,OCT2 Inhibitors,DrugBank
DB14006,OCT2 Substrates,DrugBank
DB14006,Onium Compounds,DrugBank
DB14006,Pharmaceutical Preparations,DrugBank
DB14006,Phenols,DrugBank
DB14006,Quaternary Ammonium Compounds,DrugBank
DB14006,Salicylates,DrugBank
DB14006,Salicylic Acid and Derivatives,DrugBank
DB14006,Trimethyl Ammonium Compounds,DrugBank
DB14007,Acetates,DrugBank
DB14007,"Acids, Acyclic",DrugBank
DB14007,Amines,DrugBank
DB14007,Antidotes,DrugBank
DB14007,Chelating Agents,DrugBank
DB14007,"Compounds used in a research, industrial, or household setting",DrugBank
DB14007,Drugs that are Mainly Renally Excreted,DrugBank
DB14007,Iron Chelating Agents,DrugBank
DB14007,Lead Chelating Activity,DrugBank
DB14007,Lead Chelator,DrugBank
DB14007,Polyamines,DrugBank
DB14007,Protective Agents,DrugBank
DB14007,Sequestering Agents,DrugBank
DB14009,Agents producing tachycardia,DrugBank
DB14009,BCRP/ABCG2 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB14009,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14009,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB14009,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2C9 Inhibitors (moderate),DrugBank
DB14009,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14009,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14009,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB14009,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB14009,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14009,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14009,Cytochrome P-450 Substrates,DrugBank
DB14009,P-glycoprotein inhibitors,DrugBank
DB14009,Pharmaceutical Preparations,DrugBank
DB14009,UGT1A9 Inhibitors,DrugBank
DB14009,UGT1A9 Substrates,DrugBank
DB14009,UGT2B17 substrates,DrugBank
DB14009,UGT2B7 inducers,DrugBank
DB14009,UGT2B7 Inhibitors,DrugBank
DB14009,UGT2B7 substrates,DrugBank
DB14010,Agents that produce hypertension,DrugBank
DB14010,Amines,DrugBank
DB14010,Antidepressive Agents,DrugBank
DB14010,Biogenic Amines,DrugBank
DB14010,Biogenic Monoamines,DrugBank
DB14010,Central Nervous System Depressants,DrugBank
DB14010,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14010,Cytochrome P-450 Substrates,DrugBank
DB14010,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14010,Indoles,DrugBank
DB14010,"N,N-Dimethyltryptamine",DrugBank
DB14010,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB14010,Serotonin 5-HT1 Receptor Agonists,DrugBank
DB14010,Serotonin 5-HT2 Receptor Agonists,DrugBank
DB14010,Serotonin Agents,DrugBank
DB14010,Serotonin Receptor Agonists,DrugBank
DB14010,Tryptamines,DrugBank
DB14011,Agents producing tachycardia,DrugBank
DB14011,Analgesics,DrugBank
DB14011,BCRP/ABCG2 Inhibitors,DrugBank
DB14011,Cannabinoid Receptor Agonists,DrugBank
DB14011,Cannabinoids and similars,DrugBank
DB14011,Central Nervous System Agents,DrugBank
DB14011,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14011,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14011,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14011,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14011,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB14011,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB14011,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14011,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14011,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14011,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14011,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB14011,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB14011,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14011,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB14011,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown),DrugBank
DB14011,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14011,Cytochrome P-450 Substrates,DrugBank
DB14011,Peripheral Nervous System Agents,DrugBank
DB14011,Pharmaceutical Preparations,DrugBank
DB14011,Sensory System Agents,DrugBank
DB14011,Terpenes,DrugBank
DB14012,"Amino Acids, Peptides, and Proteins",DrugBank
DB14012,Antibodies,DrugBank
DB14012,"Antibodies, Monoclonal",DrugBank
DB14012,Blood Proteins,DrugBank
DB14012,Drugs Affecting Bone Structure and Mineralization,DrugBank
DB14012,Drugs for Treatment of Bone Diseases,DrugBank
DB14012,Fibroblast Growth Factor-23 Blocking Antibodies,DrugBank
DB14012,Globulins,DrugBank
DB14012,Immunoglobulins,DrugBank
DB14012,Immunoproteins,DrugBank
DB14012,Musculo-Skeletal System,DrugBank
DB14012,Proteins,DrugBank
DB14012,Serum Globulins,DrugBank
DB14018,Alcohols,DrugBank
DB14018,Alkaloids,DrugBank
DB14018,Amines,DrugBank
DB14018,Amino Alcohols,DrugBank
DB14018,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB14018,Cytochrome P-450 Substrates,DrugBank
DB14018,Diuretics,DrugBank
DB14018,Drugs for Obstructive Airway Diseases,DrugBank
DB14018,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14018,Pharmaceutical Preparations,DrugBank
DB14018,Propanols,DrugBank
DB14018,Purines,DrugBank
DB14018,Purinones,DrugBank
DB14018,Xanthine derivatives,DrugBank
DB14019,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14019,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14019,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14019,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB14019,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14019,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14019,Cytochrome P-450 Substrates,DrugBank
DB14019,Netupitant and prodrug,DrugBank
DB14019,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB14022,Bacterial Vaccines,DrugBank
DB14022,Biological Products,DrugBank
DB14022,Complex Mixtures,DrugBank
DB14022,Salmonella Vaccines,DrugBank
DB14022,Vaccines,DrugBank
DB14022,"Vaccines, Typhoid",DrugBank
DB14025,4-Quinolones,DrugBank
DB14025,Anti-Bacterial Agents,DrugBank
DB14025,Anti-Infective Agents,DrugBank
DB14025,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14025,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB14025,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB14025,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB14025,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB14025,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB14025,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB14025,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB14025,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14025,Enzyme Inhibitors,DrugBank
DB14025,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14025,Hypoglycemia-Associated Agents,DrugBank
DB14025,Quinolines,DrugBank
DB14025,Quinolones,DrugBank
DB14025,Topoisomerase II Inhibitors,DrugBank
DB14025,Topoisomerase Inhibitors,DrugBank
DB14026,"Acids, Carbocyclic",DrugBank
DB14026,Alkylmercury Compounds,DrugBank
DB14026,Analgesics,DrugBank
DB14026,"Analgesics, Non-Narcotic",DrugBank
DB14026,Benzene Derivatives,DrugBank
DB14026,Benzoates,DrugBank
DB14026,Central Nervous System Agents,DrugBank
DB14026,Ethylmercury Compounds,DrugBank
DB14026,Hydroxy Acids,DrugBank
DB14026,Hydroxybenzoates,DrugBank
DB14026,Organomercury Compounds,DrugBank
DB14026,Organometallic Compounds,DrugBank
DB14026,Peripheral Nervous System Agents,DrugBank
DB14026,Phenols,DrugBank
DB14026,Salicylates,DrugBank
DB14026,Sensory System Agents,DrugBank
DB14026,Sulfur Compounds,DrugBank
DB14027,"Amino Acids, Peptides, and Proteins",DrugBank
DB14027,Blood Glucose Lowering Agents,DrugBank
DB14027,Gastrointestinal Hormones,DrugBank
DB14027,GLP-1 Agonists,DrugBank
DB14027,Glucagon-Like Peptides,DrugBank
DB14027,Hormones,DrugBank
DB14027,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14027,Proglucagon,DrugBank
DB14028,Amino Acids,DrugBank
DB14028,"Amino Acids, Aromatic",DrugBank
DB14028,"Amino Acids, Cyclic",DrugBank
DB14028,"Amino Acids, Peptides, and Proteins",DrugBank
DB14028,Anti-Anxiety Agents,DrugBank
DB14028,Benzazepines,DrugBank
DB14028,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB14028,Benzodiazepinones,DrugBank
DB14028,Central Nervous System Agents,DrugBank
DB14028,Central Nervous System Depressants,DrugBank
DB14028,GABA Agents,DrugBank
DB14028,GABA Modulators,DrugBank
DB14028,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14028,Nervous System,DrugBank
DB14028,Neurotransmitter Agents,DrugBank
DB14028,Psycholeptics,DrugBank
DB14028,Psychotropic Drugs,DrugBank
DB14028,Tranquilizing Agents,DrugBank
DB14029,Alkaloids,DrugBank
DB14029,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14029,Cytochrome P-450 CYP1A2 Inhibitors (strong),DrugBank
DB14029,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14029,Enzyme Inhibitors,DrugBank
DB14029,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14029,Purines,DrugBank
DB14029,Purinones,DrugBank
DB14029,Xanthine derivatives,DrugBank
DB14031,Alkylating Drugs,DrugBank
DB14031,Antineoplastic Agents,DrugBank
DB14031,"Antineoplastic Agents, Alkylating",DrugBank
DB14031,Aziridines,DrugBank
DB14031,Azirines,DrugBank
DB14031,Cholinesterase Inhibitors,DrugBank
DB14031,Noxae,DrugBank
DB14031,Toxic Actions,DrugBank
DB14031,Triazines,DrugBank
DB14033,Amides,DrugBank
DB14033,Amines,DrugBank
DB14033,Aniline Compounds,DrugBank
DB14033,Anti-Bacterial Agents,DrugBank
DB14033,Benzene Derivatives,DrugBank
DB14033,Benzenesulfonamides,DrugBank
DB14033,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB14033,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB14033,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14033,Genito Urinary System and Sex Hormones,DrugBank
DB14033,Gynecological Antiinfectives and Antiseptics,DrugBank
DB14033,Sulfanilamides,DrugBank
DB14033,Sulfonamide Antibacterial,DrugBank
DB14033,Sulfonamides,DrugBank
DB14033,Sulfones,DrugBank
DB14033,Sulfur Compounds,DrugBank
DB14035,Blood Glucose Lowering Agents,DrugBank
DB14035,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14035,Pyrans,DrugBank
DB14035,Sulfur Compounds,DrugBank
DB14035,Thiazoles,DrugBank
DB14039,"Amino Acids, Peptides, and Proteins",DrugBank
DB14039,Analgesics,DrugBank
DB14039,Antibodies,DrugBank
DB14039,"Antibodies, Monoclonal",DrugBank
DB14039,Antimigraine Preparations,DrugBank
DB14039,Blood Proteins,DrugBank
DB14039,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB14039,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB14039,Central Nervous System Agents,DrugBank
DB14039,Globulins,DrugBank
DB14039,Immunoglobulins,DrugBank
DB14039,Immunoproteins,DrugBank
DB14039,Nervous System,DrugBank
DB14039,Peripheral Nervous System Agents,DrugBank
DB14039,Proteins,DrugBank
DB14039,Sensory System Agents,DrugBank
DB14039,Serum Globulins,DrugBank
DB14040,"Amino Acids, Peptides, and Proteins",DrugBank
DB14040,Analgesics,DrugBank
DB14040,Antibodies,DrugBank
DB14040,"Antibodies, Monoclonal",DrugBank
DB14040,"Antibodies, Monoclonal, Humanized",DrugBank
DB14040,Antimigraine Preparations,DrugBank
DB14040,Blood Proteins,DrugBank
DB14040,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB14040,Calcitonin Gene-related Peptide Antagonist,DrugBank
DB14040,Globulins,DrugBank
DB14040,Immunoglobulins,DrugBank
DB14040,Immunoproteins,DrugBank
DB14040,Nervous System,DrugBank
DB14040,Proteins,DrugBank
DB14040,Serum Globulins,DrugBank
DB14041,"Amino Acids, Peptides, and Proteins",DrugBank
DB14041,Analgesics,DrugBank
DB14041,Antibodies,DrugBank
DB14041,"Antibodies, Monoclonal",DrugBank
DB14041,"Antibodies, Monoclonal, Humanized",DrugBank
DB14041,Antimigraine Preparations,DrugBank
DB14041,Blood Proteins,DrugBank
DB14041,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB14041,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB14041,Central Nervous System Agents,DrugBank
DB14041,Globulins,DrugBank
DB14041,Immunoglobulins,DrugBank
DB14041,Immunoproteins,DrugBank
DB14041,Nervous System,DrugBank
DB14041,Peripheral Nervous System Agents,DrugBank
DB14041,Proteins,DrugBank
DB14041,Sensory System Agents,DrugBank
DB14041,Serum Globulins,DrugBank
DB14042,"Amino Acids, Peptides, and Proteins",DrugBank
DB14042,Analgesics,DrugBank
DB14042,Antibodies,DrugBank
DB14042,"Antibodies, Monoclonal",DrugBank
DB14042,"Antibodies, Monoclonal, Humanized",DrugBank
DB14042,Antimigraine Preparations,DrugBank
DB14042,Blood Proteins,DrugBank
DB14042,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB14042,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB14042,Central Nervous System Agents,DrugBank
DB14042,Globulins,DrugBank
DB14042,Immunoglobulins,DrugBank
DB14042,Immunoproteins,DrugBank
DB14042,Nervous System,DrugBank
DB14042,Peripheral Nervous System Agents,DrugBank
DB14042,Proteins,DrugBank
DB14042,Sensory System Agents,DrugBank
DB14042,Serum Globulins,DrugBank
DB14043,Agents producing tachycardia,DrugBank
DB14043,Alcohols,DrugBank
DB14043,Amines,DrugBank
DB14043,Amino Alcohols,DrugBank
DB14043,Analgesics,DrugBank
DB14043,"Analgesics, Non-Narcotic",DrugBank
DB14043,Anti-Infective Agents,DrugBank
DB14043,Anti-Inflammatory Agents,DrugBank
DB14043,Antirheumatic Agents,DrugBank
DB14043,Cannabinoids and similars,DrugBank
DB14043,Central Nervous System Agents,DrugBank
DB14043,Fatty Acids,DrugBank
DB14043,Hormones,DrugBank
DB14043,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14043,Lipids,DrugBank
DB14043,Neurotransmitter Agents,DrugBank
DB14043,Peripheral Nervous System Agents,DrugBank
DB14043,Sensory System Agents,DrugBank
DB14048,Acids,DrugBank
DB14048,"Acids, Noncarboxylic",DrugBank
DB14048,Anions,DrugBank
DB14048,"Compounds used in a research, industrial, or household setting",DrugBank
DB14048,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB14048,Electrolytes,DrugBank
DB14048,Gastric Acid Lowering Agents,DrugBank
DB14048,Ion Exchange Resins,DrugBank
DB14048,Ions,DrugBank
DB14048,Laboratory Chemicals,DrugBank
DB14048,Minerals,DrugBank
DB14048,Oxides,DrugBank
DB14048,Oxygen Compounds,DrugBank
DB14048,Potassium Binder,DrugBank
DB14048,Potassium-removing Agents,DrugBank
DB14048,Silicon Compounds,DrugBank
DB14049,Anions,DrugBank
DB14049,Antianginal Agents,DrugBank
DB14049,Electrolytes,DrugBank
DB14049,Ions,DrugBank
DB14049,Nitrates,DrugBank
DB14049,Nitrogen Compounds,DrugBank
DB14049,Organic Nitrates,DrugBank
DB14049,Vasodilating Agents,DrugBank
DB14050,Anticonvulsants,DrugBank
DB14050,Central Nervous System Depressants,DrugBank
DB14050,Terpenes,DrugBank
DB14051,"Amino Acids, Peptides, and Proteins",DrugBank
DB14051,Anti-Bacterial Agents,DrugBank
DB14051,Anti-Infective Agents,DrugBank
DB14051,Lipids,DrugBank
DB14051,Malacidins,DrugBank
DB14051,Peptides,DrugBank
DB14052,"Amino Acids, Peptides, and Proteins",DrugBank
DB14052,Anti-Bacterial Agents,DrugBank
DB14052,Anti-Infective Agents,DrugBank
DB14052,Lipids,DrugBank
DB14052,Malacidins,DrugBank
DB14052,Peptides,DrugBank
DB14055,Anticoagulants,DrugBank
DB14055,Cytochrome P-450 CYP2C18 Substrates,DrugBank
DB14055,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14055,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14055,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14055,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14055,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14055,Cytochrome P-450 Substrates,DrugBank
DB14055,Vitamin K Antagonists,DrugBank
DB14056,Anti-Bacterial Agents,DrugBank
DB14056,Anti-Infective Agents,DrugBank
DB14056,"Compounds used in a research, industrial, or household setting",DrugBank
DB14056,Ethers,DrugBank
DB14056,"Ethers, Cyclic",DrugBank
DB14056,Furans,DrugBank
DB14056,Ionophores,DrugBank
DB14056,Lactones,DrugBank
DB14056,Membrane Transport Modulators,DrugBank
DB14056,Polyether Polyketides,DrugBank
DB14056,Polyketides,DrugBank
DB14056,Pyrans,DrugBank
DB14057,"Amino Acids, Peptides, and Proteins",DrugBank
DB14057,Anti-Bacterial Agents,DrugBank
DB14057,Anti-Infective Agents,DrugBank
DB14057,BSEP/ABCB11 Inhibitors,DrugBank
DB14057,"Compounds used in a research, industrial, or household setting",DrugBank
DB14057,Depsipeptides,DrugBank
DB14057,Ionophores,DrugBank
DB14057,Membrane Transport Modulators,DrugBank
DB14057,P-glycoprotein inhibitors,DrugBank
DB14057,P-glycoprotein substrates,DrugBank
DB14057,Peptides,DrugBank
DB14057,"Peptides, Cyclic",DrugBank
DB14058,"Amino Acids, Peptides, and Proteins",DrugBank
DB14058,Anti-Infective Agents,DrugBank
DB14058,Antifungal Agents,DrugBank
DB14058,Enzyme Inhibitors,DrugBank
DB14058,Peptides,DrugBank
DB14058,"Peptides, Cyclic",DrugBank
DB14059,Agents causing hyperkalemia,DrugBank
DB14059,Agents that produce hypertension,DrugBank
DB14059,Amides,DrugBank
DB14059,Analgesics,DrugBank
DB14059,"Analgesics, Non-Narcotic",DrugBank
DB14059,Anti-Inflammatory Agents,DrugBank
DB14059,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB14059,Antirheumatic Agents,DrugBank
DB14059,Benzene Derivatives,DrugBank
DB14059,Cyclooxygenase Inhibitors,DrugBank
DB14059,Enzyme Inhibitors,DrugBank
DB14059,Nephrotoxic agents,DrugBank
DB14059,Peripheral Nervous System Agents,DrugBank
DB14059,Sensory System Agents,DrugBank
DB14059,Sulfonamides,DrugBank
DB14059,Sulfones,DrugBank
DB14059,Sulfur Compounds,DrugBank
DB14060,Agents causing hyperkalemia,DrugBank
DB14060,Agents that produce hypertension,DrugBank
DB14060,Amides,DrugBank
DB14060,Analgesics,DrugBank
DB14060,"Analgesics, Non-Narcotic",DrugBank
DB14060,Anti-Inflammatory Agents,DrugBank
DB14060,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB14060,Antirheumatic Agents,DrugBank
DB14060,Benzene Derivatives,DrugBank
DB14060,Cyclooxygenase Inhibitors,DrugBank
DB14060,Enzyme Inhibitors,DrugBank
DB14060,Nephrotoxic agents,DrugBank
DB14060,Nitro Compounds,DrugBank
DB14060,Peripheral Nervous System Agents,DrugBank
DB14060,Sensory System Agents,DrugBank
DB14060,Sulfones,DrugBank
DB14060,Sulfur Compounds,DrugBank
DB14063,Agents causing hyperkalemia,DrugBank
DB14063,Amines,DrugBank
DB14063,Antiarrhythmic agents,DrugBank
DB14063,Bradycardia-Causing Agents,DrugBank
DB14063,Calcium Channel Blockers,DrugBank
DB14063,Calcium-Regulating Hormones and Agents,DrugBank
DB14063,Cardiovascular Agents,DrugBank
DB14063,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14063,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14063,Cytochrome P-450 Substrates,DrugBank
DB14063,Ethylamines,DrugBank
DB14063,Membrane Transport Modulators,DrugBank
DB14063,Moderate Risk QTc-Prolonging Agents,DrugBank
DB14063,P-glycoprotein inhibitors,DrugBank
DB14063,Phenethylamines,DrugBank
DB14063,QTc Prolonging Agents,DrugBank
DB14063,Vasodilating Agents,DrugBank
DB14064,Agents causing hyperkalemia,DrugBank
DB14064,Amines,DrugBank
DB14064,Antiarrhythmic agents,DrugBank
DB14064,Bradycardia-Causing Agents,DrugBank
DB14064,Calcium Channel Blockers,DrugBank
DB14064,Calcium-Regulating Hormones and Agents,DrugBank
DB14064,Cardiovascular Agents,DrugBank
DB14064,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14064,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14064,Cytochrome P-450 Substrates,DrugBank
DB14064,Ethylamines,DrugBank
DB14064,Membrane Transport Modulators,DrugBank
DB14064,P-glycoprotein inhibitors,DrugBank
DB14064,Phenethylamines,DrugBank
DB14065,Agents causing hyperkalemia,DrugBank
DB14065,Antiarrhythmic agents,DrugBank
DB14065,Bradycardia-Causing Agents,DrugBank
DB14065,Calcium Channel Blockers,DrugBank
DB14065,Calcium-Regulating Hormones and Agents,DrugBank
DB14065,Cardiovascular Agents,DrugBank
DB14065,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14065,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14065,Cytochrome P-450 Substrates,DrugBank
DB14065,Membrane Transport Modulators,DrugBank
DB14065,P-glycoprotein inhibitors,DrugBank
DB14066,Agents causing hyperkalemia,DrugBank
DB14066,Alkaloids,DrugBank
DB14066,Anti-Infective Agents,DrugBank
DB14066,Antiarrhythmic agents,DrugBank
DB14066,Antimalarials,DrugBank
DB14066,Antineoplastic Agents,DrugBank
DB14066,"Antineoplastic Agents, Phytogenic",DrugBank
DB14066,Antiparasitic Agents,DrugBank
DB14066,Antiprotozoals,DrugBank
DB14066,Bradycardia-Causing Agents,DrugBank
DB14066,Calcium Channel Blockers,DrugBank
DB14066,Calcium-Regulating Hormones and Agents,DrugBank
DB14066,Cardiovascular Agents,DrugBank
DB14066,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14066,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14066,Cytochrome P-450 Substrates,DrugBank
DB14066,"Drugs, Chinese Herbal",DrugBank
DB14066,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14066,Immunologic Factors,DrugBank
DB14066,Immunosuppressive Agents,DrugBank
DB14066,Isoquinolines,DrugBank
DB14066,Membrane Transport Modulators,DrugBank
DB14066,P-glycoprotein inhibitors,DrugBank
DB14066,Plant Extracts,DrugBank
DB14067,Antineoplastic Agents,DrugBank
DB14067,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14067,P-glycoprotein inhibitors,DrugBank
DB14068,Agents causing hyperkalemia,DrugBank
DB14068,Antiarrhythmic agents,DrugBank
DB14068,Antihypertensive Agents,DrugBank
DB14068,Antineoplastic Agents,DrugBank
DB14068,Bradycardia-Causing Agents,DrugBank
DB14068,Calcium Channel Blockers,DrugBank
DB14068,Calcium-Regulating Hormones and Agents,DrugBank
DB14068,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14068,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14068,Cytochrome P-450 Substrates,DrugBank
DB14068,Membrane Transport Modulators,DrugBank
DB14068,P-glycoprotein inhibitors,DrugBank
DB14068,Pyridines,DrugBank
DB14069,"Drug Resistance, Multiple",DrugBank
DB14069,P-glycoprotein inhibitors,DrugBank
DB14071,Agents that reduce seizure threshold,DrugBank
DB14071,Amines,DrugBank
DB14071,Naphthalenes,DrugBank
DB14071,P-glycoprotein inhibitors,DrugBank
DB14077,Agents that produce neuromuscular block (indirect),DrugBank
DB14077,Fatty Acids,DrugBank
DB14077,Lipids,DrugBank
DB14093,Testosterone and derivatives,DrugBank
DB14094,Anticoagulants,DrugBank
DB14094,Antihypertensive Agents,DrugBank
DB14094,Antioxidants,DrugBank
DB14094,Benzopyrans,DrugBank
DB14094,Biological Factors,DrugBank
DB14094,Cardiovascular Agents,DrugBank
DB14094,"Compounds used in a research, industrial, or household setting",DrugBank
DB14094,Hematologic Agents,DrugBank
DB14094,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14094,Protective Agents,DrugBank
DB14094,Pyrans,DrugBank
DB14125,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14125,Agents causing angioedema,DrugBank
DB14125,Agents causing hyperkalemia,DrugBank
DB14125,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14125,Antihypertensive Agents,DrugBank
DB14125,Cardiovascular Agents,DrugBank
DB14125,Decreased Blood Pressure,DrugBank
DB14125,Enzyme Inhibitors,DrugBank
DB14125,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14125,Protease Inhibitors,DrugBank
DB14126,Anti-HIV Agents,DrugBank
DB14126,Anti-Infective Agents,DrugBank
DB14126,Anti-Retroviral Agents,DrugBank
DB14126,Antiviral Agents,DrugBank
DB14126,Drugs that are Mainly Renally Excreted,DrugBank
DB14126,Enzyme Inhibitors,DrugBank
DB14126,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB14126,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14126,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,DrugBank
DB14126,Nephrotoxic agents,DrugBank
DB14126,Nucleic Acid Synthesis Inhibitors,DrugBank
DB14126,Nucleoside Reverse Transcriptase Inhibitors,DrugBank
DB14126,OAT3/SLC22A8 Substrates,DrugBank
DB14126,Organophosphonates,DrugBank
DB14126,Organophosphorus Compounds,DrugBank
DB14126,P-glycoprotein substrates,DrugBank
DB14126,Purines,DrugBank
DB14126,Reverse Transcriptase Inhibitors,DrugBank
DB14126,Tenofovir and prodrugs,DrugBank
DB14132,Alkaloids,DrugBank
DB14132,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB14132,Cytochrome P-450 Substrates,DrugBank
DB14132,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14132,Purines,DrugBank
DB14132,Purinones,DrugBank
DB14132,Xanthine derivatives,DrugBank
DB14184,Aldehydes,DrugBank
DB14184,Antimutagenic Agents,DrugBank
DB14184,Antineoplastic Agents,DrugBank
DB14184,"Antineoplastic Agents, Phytogenic",DrugBank
DB14184,Cell-mediated Immunity,DrugBank
DB14184,"Compounds used in a research, industrial, or household setting",DrugBank
DB14184,"Diet, Food, and Nutrition",DrugBank
DB14184,Drugs that are Mainly Renally Excreted,DrugBank
DB14184,Flavoring Agents,DrugBank
DB14184,Food,DrugBank
DB14184,Food Additives,DrugBank
DB14184,Food Ingredients,DrugBank
DB14184,Increased Histamine Release,DrugBank
DB14184,Pharmaceutic Aids,DrugBank
DB14184,Pharmaceutical Preparations,DrugBank
DB14184,Physiological Phenomena,DrugBank
DB14184,Protective Agents,DrugBank
DB14184,Standardized Chemical Allergen,DrugBank
DB14185,Adrenergic alpha-1 Receptor Antagonists,DrugBank
DB14185,Adrenergic alpha-Antagonists,DrugBank
DB14185,Adrenergic Antagonists,DrugBank
DB14185,Agents that produce hypertension,DrugBank
DB14185,Antidepressive Agents,DrugBank
DB14185,Antipsychotic Agents,DrugBank
DB14185,Antipsychotic Agents (Second Generation [Atypical]),DrugBank
DB14185,Aripiprazole and prodrugs,DrugBank
DB14185,Central Nervous System Agents,DrugBank
DB14185,Central Nervous System Depressants,DrugBank
DB14185,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14185,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14185,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14185,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14185,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14185,Cytochrome P-450 Substrates,DrugBank
DB14185,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14185,Histamine Antagonists,DrugBank
DB14185,Histamine H1 Antagonists,DrugBank
DB14185,Neurotoxic agents,DrugBank
DB14185,Piperazines,DrugBank
DB14185,Potential QTc-Prolonging Agents,DrugBank
DB14185,Psychotropic Drugs,DrugBank
DB14185,QTc Prolonging Agents,DrugBank
DB14185,Quinolines,DrugBank
DB14185,Quinolones,DrugBank
DB14185,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB14185,Serotonin 5-HT2 Receptor Antagonists,DrugBank
DB14185,Serotonin 5-HT2A Receptor Antagonists,DrugBank
DB14185,Serotonin Agents,DrugBank
DB14185,Serotonin Receptor Antagonists,DrugBank
DB14185,Tranquilizing Agents,DrugBank
DB14193,"Acids, Acyclic",DrugBank
DB14193,"Adjuvants, Immunologic",DrugBank
DB14193,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14193,Allergens,DrugBank
DB14193,Anti-Infective Agents,DrugBank
DB14193,Antigens,DrugBank
DB14193,Biological Factors,DrugBank
DB14193,Carbamates,DrugBank
DB14193,Cell-mediated Immunity,DrugBank
DB14193,Chelating Agents,DrugBank
DB14193,"Compounds used in a research, industrial, or household setting",DrugBank
DB14193,Immunologic Factors,DrugBank
DB14193,Increased Histamine Release,DrugBank
DB14193,Metal cations,DrugBank
DB14193,Metal divalent cations,DrugBank
DB14193,Sequestering Agents,DrugBank
DB14193,Standardized Chemical Allergen,DrugBank
DB14193,Sulfur Compounds,DrugBank
DB14193,Thiocarbamates,DrugBank
DB14193,Vasoprotectives,DrugBank
DB14193,Zinc Compounds,DrugBank
DB14194,"Acids, Acyclic",DrugBank
DB14194,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14194,Carbamates,DrugBank
DB14194,Cell-mediated Immunity,DrugBank
DB14194,Increased Histamine Release,DrugBank
DB14194,Metal cations,DrugBank
DB14194,Metal divalent cations,DrugBank
DB14194,Standardized Chemical Allergen,DrugBank
DB14194,Sulfur Compounds,DrugBank
DB14194,Vasoprotectives,DrugBank
DB14194,Zinc Compounds,DrugBank
DB14207,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14207,Agents causing angioedema,DrugBank
DB14207,Agents causing hyperkalemia,DrugBank
DB14207,Amino Acids,DrugBank
DB14207,"Amino Acids, Cyclic",DrugBank
DB14207,"Amino Acids, Peptides, and Proteins",DrugBank
DB14207,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14207,Antiarrhythmic agents,DrugBank
DB14207,Antihypertensive Agents,DrugBank
DB14207,Cardiovascular Agents,DrugBank
DB14207,Enzyme Inhibitors,DrugBank
DB14207,Imino Acids,DrugBank
DB14207,Organophosphorus Compounds,DrugBank
DB14207,Phosphinic Acids,DrugBank
DB14207,Prodrugs,DrugBank
DB14207,Protease Inhibitors,DrugBank
DB14208,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14208,Agents causing angioedema,DrugBank
DB14208,Agents causing hyperkalemia,DrugBank
DB14208,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14208,Antihypertensive Agents,DrugBank
DB14208,Cardiovascular Agents,DrugBank
DB14208,Enzyme Inhibitors,DrugBank
DB14208,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14208,Protease Inhibitors,DrugBank
DB14209,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14209,Agents causing angioedema,DrugBank
DB14209,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14209,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14210,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14210,Agents causing angioedema,DrugBank
DB14210,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14210,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14210,Isoquinolines,DrugBank
DB14211,"Amino Acids, Peptides, and Proteins",DrugBank
DB14211,Antibodies,DrugBank
DB14211,Blood Proteins,DrugBank
DB14211,Globulins,DrugBank
DB14211,Immunoglobulins,DrugBank
DB14211,Immunoproteins,DrugBank
DB14211,Lewis X Antigen,DrugBank
DB14211,Proteins,DrugBank
DB14211,Radioactive Diagnostic Agent,DrugBank
DB14211,Serum Globulins,DrugBank
DB14213,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14213,Agents causing angioedema,DrugBank
DB14213,Agents causing hyperkalemia,DrugBank
DB14213,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14213,Antihypertensive Agents,DrugBank
DB14213,Cardiovascular Agents,DrugBank
DB14213,Enzyme Inhibitors,DrugBank
DB14213,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14213,Protease Inhibitors,DrugBank
DB14217,Agents Acting on the Renin-Angiotensin System,DrugBank
DB14217,Agents causing angioedema,DrugBank
DB14217,Agents causing hyperkalemia,DrugBank
DB14217,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB14217,Antihypertensive Agents,DrugBank
DB14217,Cardiovascular Agents,DrugBank
DB14217,Enzyme Inhibitors,DrugBank
DB14217,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14217,Isoquinolines,DrugBank
DB14217,Protease Inhibitors,DrugBank
DB14219,"Acids, Acyclic",DrugBank
DB14219,Dicarboxylic Acids,DrugBank
DB14219,Immunosuppressive Agents,DrugBank
DB14231,Agents causing angioedema,DrugBank
DB14231,Agents that produce hypertension,DrugBank
DB14231,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14232,Benzene Derivatives,DrugBank
DB14232,Contact Laxatives,DrugBank
DB14232,Cresols,DrugBank
DB14232,Increased Large Intestinal Motility,DrugBank
DB14232,Laxatives,DrugBank
DB14232,Phenols,DrugBank
DB14232,Stimulation Large Intestine Fluid/Electrolyte Secretion,DrugBank
DB14240,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14240,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14240,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB14240,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14240,Herbs and Natural Products,DrugBank
DB14256,Agents that reduce seizure threshold,DrugBank
DB14256,Angiosperms,DrugBank
DB14256,Apiaceae,DrugBank
DB14256,Biological Products,DrugBank
DB14256,Complex Mixtures,DrugBank
DB14256,Embryophyta,DrugBank
DB14256,Eukaryota,DrugBank
DB14256,Pharmaceutical Preparations,DrugBank
DB14256,Plant Extracts,DrugBank
DB14256,Plant Preparations,DrugBank
DB14256,Streptophyta,DrugBank
DB14256,Terpenes,DrugBank
DB14256,Tracheophyta,DrugBank
DB14256,Viridiplantae,DrugBank
DB14337,Angiosperms,DrugBank
DB14337,Biological Products,DrugBank
DB14337,Complex Mixtures,DrugBank
DB14337,"Drugs, Chinese Herbal",DrugBank
DB14337,Embryophyta,DrugBank
DB14337,Eukaryota,DrugBank
DB14337,Herbs (Hypotensive Properties),DrugBank
DB14337,Herbs and Natural Products,DrugBank
DB14337,Lamiaceae,DrugBank
DB14337,Lamiales,DrugBank
DB14337,Pharmaceutical Preparations,DrugBank
DB14337,Plant Extracts,DrugBank
DB14337,Plant Preparations,DrugBank
DB14337,Salvia,DrugBank
DB14337,Salvia miltiorrhiza,DrugBank
DB14337,Streptophyta,DrugBank
DB14337,Tracheophyta,DrugBank
DB14337,Viridiplantae,DrugBank
DB14384,Inactivated Influenza A Virus Vaccine,DrugBank
DB14384,Influenza Vaccines,DrugBank
DB14384,Vaccines,DrugBank
DB14384,Viral Vaccines,DrugBank
DB14385,Inactivated Influenza B Virus Vaccine,DrugBank
DB14385,Influenza Vaccines,DrugBank
DB14385,Vaccines,DrugBank
DB14385,Viral Vaccines,DrugBank
DB14394,Actively Acquired Immunity,DrugBank
DB14394,Influenza Vaccines,DrugBank
DB14394,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB14394,Vaccines,DrugBank
DB14394,Viral Vaccines,DrugBank
DB14409,Actively Acquired Immunity,DrugBank
DB14409,Adenovirus Vaccines,DrugBank
DB14409,Live Human Adenovirus Type 4 Vaccine,DrugBank
DB14409,Live vaccines,DrugBank
DB14409,Vaccines,DrugBank
DB14409,Viral Vaccines,DrugBank
DB14443,Bacterial Vaccines,DrugBank
DB14443,Biological Products,DrugBank
DB14443,Complex Mixtures,DrugBank
DB14443,Live Attenuated Cholera Vaccine,DrugBank
DB14443,Live vaccines,DrugBank
DB14443,Vaccines,DrugBank
DB14445,Actively Acquired Immunity,DrugBank
DB14445,Inactivated Influenza A Virus Vaccine,DrugBank
DB14445,Influenza Vaccines,DrugBank
DB14445,Vaccines,DrugBank
DB14445,Viral Vaccines,DrugBank
DB14449,Actively Acquired Immunity,DrugBank
DB14449,Influenza Vaccines,DrugBank
DB14449,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB14449,Vaccines,DrugBank
DB14449,Viral Vaccines,DrugBank
DB14473,"Amino Acids, Peptides, and Proteins",DrugBank
DB14473,Biological Factors,DrugBank
DB14473,Blood Coagulation Factors,DrugBank
DB14473,Blood Proteins,DrugBank
DB14473,Coagulants,DrugBank
DB14473,Factor VIII,DrugBank
DB14473,Hematologic Agents,DrugBank
DB14473,Human Antihemophilic Factors,DrugBank
DB14473,Protein Precursors,DrugBank
DB14473,Proteins,DrugBank
DB14481,Acids,DrugBank
DB14481,"Acids, Noncarboxylic",DrugBank
DB14481,Calcium Compounds,DrugBank
DB14481,Phosphate salts,DrugBank
DB14481,Phosphoric Acids,DrugBank
DB14481,Phosphorus Acids,DrugBank
DB14481,Phosphorus Compounds,DrugBank
DB14482,"Acids, Acyclic",DrugBank
DB14482,Antioxidants,DrugBank
DB14482,Biological Factors,DrugBank
DB14482,Carbohydrates,DrugBank
DB14482,"Compounds used in a research, industrial, or household setting",DrugBank
DB14482,"Diet, Food, and Nutrition",DrugBank
DB14482,Food,DrugBank
DB14482,Hydroxy Acids,DrugBank
DB14482,Laxatives,DrugBank
DB14482,Micronutrients,DrugBank
DB14482,Physiological Phenomena,DrugBank
DB14482,Protective Agents,DrugBank
DB14482,Sugar Acids,DrugBank
DB14482,Urinary Acidifying Agents,DrugBank
DB14482,Vitamin C and analogues,DrugBank
DB14482,Vitamins,DrugBank
DB14483,"Acids, Acyclic",DrugBank
DB14483,Antioxidants,DrugBank
DB14483,Biological Factors,DrugBank
DB14483,Carbohydrates,DrugBank
DB14483,"Compounds used in a research, industrial, or household setting",DrugBank
DB14483,"Diet, Food, and Nutrition",DrugBank
DB14483,Food,DrugBank
DB14483,Hydroxy Acids,DrugBank
DB14483,Micronutrients,DrugBank
DB14483,Physiological Phenomena,DrugBank
DB14483,Protective Agents,DrugBank
DB14483,Sugar Acids,DrugBank
DB14483,Urinary Acidifying Agents,DrugBank
DB14483,Vitamin C and analogues,DrugBank
DB14483,Vitamins,DrugBank
DB14484,"Acids, Acyclic",DrugBank
DB14484,Antioxidants,DrugBank
DB14484,Biological Factors,DrugBank
DB14484,Carbohydrates,DrugBank
DB14484,"Compounds used in a research, industrial, or household setting",DrugBank
DB14484,"Diet, Food, and Nutrition",DrugBank
DB14484,Food,DrugBank
DB14484,Hydroxy Acids,DrugBank
DB14484,Micronutrients,DrugBank
DB14484,Physiological Phenomena,DrugBank
DB14484,Protective Agents,DrugBank
DB14484,Sugar Acids,DrugBank
DB14484,Urinary Acidifying Agents,DrugBank
DB14485,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14485,Metal cations,DrugBank
DB14485,Metal divalent cations,DrugBank
DB14485,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB14485,Urinary Acidifying Agents,DrugBank
DB14485,Vasoprotectives,DrugBank
DB14485,Vitamin C and analogues,DrugBank
DB14485,Vitamins,DrugBank
DB14485,Zinc Compounds,DrugBank
DB14486,Urinary Acidifying Agents,DrugBank
DB14486,Vitamin B Complex,DrugBank
DB14486,Vitamin C and analogues,DrugBank
DB14486,Vitamins,DrugBank
DB14487,Acetates,DrugBank
DB14487,"Acids, Acyclic",DrugBank
DB14487,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14487,Alimentary Tract and Metabolism,DrugBank
DB14487,Metal cations,DrugBank
DB14487,Metal divalent cations,DrugBank
DB14487,Minerals,DrugBank
DB14487,Various Alimentary Tract and Metabolism Products,DrugBank
DB14487,Vasoprotectives,DrugBank
DB14487,Zinc Compounds,DrugBank
DB14488,"Anemia, Iron-Deficiency",DrugBank
DB14488,Antianemia Drugs,DrugBank
DB14488,Antianemic Preparations,DrugBank
DB14488,Blood and Blood Forming Organs,DrugBank
DB14488,Hematinics,DrugBank
DB14488,Hematologic Agents,DrugBank
DB14488,"Iron Bivalent, Oral Preparations",DrugBank
DB14488,Iron Compounds,DrugBank
DB14488,Iron Preparations,DrugBank
DB14488,Minerals,DrugBank
DB14488,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB14489,Antianemic Preparations,DrugBank
DB14489,Blood and Blood Forming Organs,DrugBank
DB14489,Hematinics,DrugBank
DB14489,Hematologic Agents,DrugBank
DB14489,"Iron Bivalent, Oral Preparations",DrugBank
DB14489,Iron Compounds,DrugBank
DB14489,Iron Preparations,DrugBank
DB14490,"Acids, Acyclic",DrugBank
DB14490,Antianemic Preparations,DrugBank
DB14490,Antioxidants,DrugBank
DB14490,Biological Factors,DrugBank
DB14490,Blood and Blood Forming Organs,DrugBank
DB14490,Carbohydrates,DrugBank
DB14490,"Compounds used in a research, industrial, or household setting",DrugBank
DB14490,"Diet, Food, and Nutrition",DrugBank
DB14490,Food,DrugBank
DB14490,Hydroxy Acids,DrugBank
DB14490,"Iron Bivalent, Oral Preparations",DrugBank
DB14490,Iron Preparations,DrugBank
DB14490,Micronutrients,DrugBank
DB14490,Physiological Phenomena,DrugBank
DB14490,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB14490,Protective Agents,DrugBank
DB14490,Sugar Acids,DrugBank
DB14490,Urinary Acidifying Agents,DrugBank
DB14491,Antianemic Preparations,DrugBank
DB14491,Blood and Blood Forming Organs,DrugBank
DB14491,"Diet, Food, and Nutrition",DrugBank
DB14491,Elements,DrugBank
DB14491,Food,DrugBank
DB14491,"Iron Bivalent, Oral Preparations",DrugBank
DB14491,Iron Compounds,DrugBank
DB14491,Iron Preparations,DrugBank
DB14491,Micronutrients,DrugBank
DB14491,Minerals,DrugBank
DB14491,Physiological Phenomena,DrugBank
DB14491,Trace Elements,DrugBank
DB14492,Anions,DrugBank
DB14492,Coagulants,DrugBank
DB14492,Coloring Agents,DrugBank
DB14492,"Compounds used in a research, industrial, or household setting",DrugBank
DB14492,Disinfectants,DrugBank
DB14492,Electrolytes,DrugBank
DB14492,Hematologic Agents,DrugBank
DB14492,Hemostatics,DrugBank
DB14492,Iodine Compounds,DrugBank
DB14492,Ions,DrugBank
DB14492,Irritants,DrugBank
DB14492,Noxae,DrugBank
DB14492,Potassium Salt,DrugBank
DB14492,Toxic Actions,DrugBank
DB14498,Acetates,DrugBank
DB14498,"Acids, Acyclic",DrugBank
DB14498,Agents causing hyperkalemia,DrugBank
DB14498,Blood and Blood Forming Organs,DrugBank
DB14498,Blood Substitutes and Perfusion Solutions,DrugBank
DB14498,Drugs that are Mainly Renally Excreted,DrugBank
DB14498,Electrolyte Solutions,DrugBank
DB14498,I.V. Solution Additives,DrugBank
DB14498,Potassium Compounds,DrugBank
DB14498,Potassium Salt,DrugBank
DB14498,Replacement Preparations,DrugBank
DB14499,Anions,DrugBank
DB14499,Drugs that are Mainly Renally Excreted,DrugBank
DB14499,Electrolytes,DrugBank
DB14499,Ions,DrugBank
DB14499,Laxatives,DrugBank
DB14499,Osmotic Laxatives,DrugBank
DB14499,Potassium Salt,DrugBank
DB14499,Sulfur Acids,DrugBank
DB14499,Sulfur Compounds,DrugBank
DB14499,Sulfuric Acids,DrugBank
DB14500,Agents causing hyperkalemia,DrugBank
DB14500,Alimentary Tract and Metabolism,DrugBank
DB14500,Diuretics,DrugBank
DB14500,Elements,DrugBank
DB14500,High-Ceiling Diuretics,DrugBank
DB14500,"Low-Ceiling Diuretics, Excl. Thiazides",DrugBank
DB14500,Metals,DrugBank
DB14500,"Metals, Alkali",DrugBank
DB14500,"Metals, Light",DrugBank
DB14500,Mineral Supplements,DrugBank
DB14500,Minerals,DrugBank
DB14500,Potassium Salt,DrugBank
DB14500,Replacement Preparations,DrugBank
DB14502,Acids,DrugBank
DB14502,"Acids, Noncarboxylic",DrugBank
DB14502,Anions,DrugBank
DB14502,Electrolytes,DrugBank
DB14502,Ions,DrugBank
DB14502,Laxatives,DrugBank
DB14502,Osmotic Laxatives,DrugBank
DB14502,Phosphoric Acids,DrugBank
DB14502,Phosphorus Acids,DrugBank
DB14502,Phosphorus Compounds,DrugBank
DB14502,Urinary Acidifying Agents,DrugBank
DB14503,Laxatives,DrugBank
DB14503,Osmotic Laxatives,DrugBank
DB14504,Laxatives,DrugBank
DB14504,Osmotic Laxatives,DrugBank
DB14506,Lithium Compounds,DrugBank
DB14506,Narrow Therapeutic Index Drugs,DrugBank
DB14507,"Acids, Acyclic",DrugBank
DB14507,Antidepressive Agents,DrugBank
DB14507,Antimanic Agents,DrugBank
DB14507,Central Nervous System Depressants,DrugBank
DB14507,Lithium Compounds,DrugBank
DB14507,Mood Stabilizer,DrugBank
DB14507,Narrow Therapeutic Index Drugs,DrugBank
DB14507,Nephrotoxic agents,DrugBank
DB14507,Neurotoxic agents,DrugBank
DB14507,Psychotropic Drugs,DrugBank
DB14507,QTc Prolonging Agents,DrugBank
DB14507,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB14507,Serotonin Agents,DrugBank
DB14507,Serotonin Modulators,DrugBank
DB14507,Tricarboxylic Acids,DrugBank
DB14508,"Acids, Acyclic",DrugBank
DB14508,Dermatologicals,DrugBank
DB14508,Dicarboxylic Acids,DrugBank
DB14508,Lithium Compounds,DrugBank
DB14508,Ointments,DrugBank
DB14509,Acids,DrugBank
DB14509,"Acids, Noncarboxylic",DrugBank
DB14509,Alkalies,DrugBank
DB14509,Anions,DrugBank
DB14509,Antidepressive Agents,DrugBank
DB14509,Antimanic Agents,DrugBank
DB14509,"Carbon Compounds, Inorganic",DrugBank
DB14509,Carbonates,DrugBank
DB14509,Carbonic Acid,DrugBank
DB14509,Central Nervous System Agents,DrugBank
DB14509,Central Nervous System Depressants,DrugBank
DB14509,Drugs that are Mainly Renally Excreted,DrugBank
DB14509,Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index,DrugBank
DB14509,Electrolytes,DrugBank
DB14509,Enzyme Inhibitors,DrugBank
DB14509,Ions,DrugBank
DB14509,Lithium Compounds,DrugBank
DB14509,Mood Stabilizer,DrugBank
DB14509,Narrow Therapeutic Index Drugs,DrugBank
DB14509,Nephrotoxic agents,DrugBank
DB14509,Nervous System,DrugBank
DB14509,Neurotoxic agents,DrugBank
DB14509,Psycholeptics,DrugBank
DB14509,Psychotropic Drugs,DrugBank
DB14509,QTc Prolonging Agents,DrugBank
DB14509,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB14509,Serotonin Agents,DrugBank
DB14509,Serotonin Modulators,DrugBank
DB14509,Tranquilizing Agents,DrugBank
DB14512,Adrenal Cortex Hormones,DrugBank
DB14512,Adrenals,DrugBank
DB14512,"Adrenergics, Inhalants",DrugBank
DB14512,Anti-Allergic Agents,DrugBank
DB14512,Anti-Inflammatory Agents,DrugBank
DB14512,Corticosteroids,DrugBank
DB14512,"Corticosteroids, Dermatological Preparations",DrugBank
DB14512,"Corticosteroids, Potent (Group III)",DrugBank
DB14512,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB14512,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB14512,Cytochrome P-450 CYP2C8 Inhibitors (strong),DrugBank
DB14512,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14512,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14512,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14512,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14512,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14512,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14512,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14512,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14512,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14512,Cytochrome P-450 Substrates,DrugBank
DB14512,Dermatologicals,DrugBank
DB14512,Drugs for Obstructive Airway Diseases,DrugBank
DB14512,Fused-Ring Compounds,DrugBank
DB14512,Glucocorticoids,DrugBank
DB14512,Hyperglycemia-Associated Agents,DrugBank
DB14512,Immunosuppressive Agents,DrugBank
DB14512,Nasal Preparations,DrugBank
DB14512,Pregnadienes,DrugBank
DB14512,Steroids,DrugBank
DB14512,Thyroxine-binding globulin inhibitors,DrugBank
DB14513,Elements,DrugBank
DB14513,Laxatives,DrugBank
DB14513,Magnesium Compounds,DrugBank
DB14513,Metal cations,DrugBank
DB14513,Metal divalent cations,DrugBank
DB14513,Metals,DrugBank
DB14513,"Metals, Alkaline Earth",DrugBank
DB14513,"Metals, Light",DrugBank
DB14513,Minerals,DrugBank
DB14514,Alimentary Tract and Metabolism,DrugBank
DB14514,Enzyme Inhibitors,DrugBank
DB14514,Keto Acids,DrugBank
DB14514,Magnesium Compounds,DrugBank
DB14514,Metal cations,DrugBank
DB14514,Metal divalent cations,DrugBank
DB14514,Mineral Supplements,DrugBank
DB14515,Alimentary Tract and Metabolism,DrugBank
DB14515,Magnesium Compounds,DrugBank
DB14515,Metal cations,DrugBank
DB14515,Metal divalent cations,DrugBank
DB14515,Mineral Supplements,DrugBank
DB14516,Increased Large Intestinal Motility,DrugBank
DB14516,Inhibition Large Intestine Fluid/Electrolyte Absorption,DrugBank
DB14516,Laxatives,DrugBank
DB14516,Osmotic Activity,DrugBank
DB14516,Osmotic Laxatives,DrugBank
DB14517,Acids,DrugBank
DB14517,"Acids, Noncarboxylic",DrugBank
DB14517,"Adjuvants, Immunologic",DrugBank
DB14517,Alimentary Tract and Metabolism,DrugBank
DB14517,Aluminium Compounds,DrugBank
DB14517,Aluminum and magnesium containing antacids,DrugBank
DB14517,Anions,DrugBank
DB14517,Antacids,DrugBank
DB14517,Drugs for Acid Related Disorders,DrugBank
DB14517,Electrolytes,DrugBank
DB14517,Gastric Acid Lowering Agents,DrugBank
DB14517,Gastrointestinal Agents,DrugBank
DB14517,Immunologic Factors,DrugBank
DB14517,Ions,DrugBank
DB14517,Metal cations,DrugBank
DB14517,Metal divalent cations,DrugBank
DB14517,Phosphoric Acids,DrugBank
DB14517,Phosphorus Acids,DrugBank
DB14517,Phosphorus Compounds,DrugBank
DB14520,"Anemia, Iron-Deficiency",DrugBank
DB14520,Drugs for Treatment of Hyperkalemia and Hyperphosphatemia,DrugBank
DB14520,Iron Compounds,DrugBank
DB14520,Organometallic Compounds,DrugBank
DB14520,Phosphate Binder,DrugBank
DB14523,Acids,DrugBank
DB14523,"Acids, Noncarboxylic",DrugBank
DB14523,Anions,DrugBank
DB14523,Electrolytes,DrugBank
DB14523,Ions,DrugBank
DB14523,Phosphate salts,DrugBank
DB14523,Phosphoric Acids,DrugBank
DB14523,Phosphorus Acids,DrugBank
DB14523,Phosphorus Compounds,DrugBank
DB14526,Drugs that are Mainly Renally Excreted,DrugBank
DB14527,Anions,DrugBank
DB14527,Drugs that are Mainly Renally Excreted,DrugBank
DB14527,Electrolytes,DrugBank
DB14527,Ions,DrugBank
DB14527,Nitrogen Compounds,DrugBank
DB14528,Drugs that are Mainly Renally Excreted,DrugBank
DB14529,Drugs that are Mainly Renally Excreted,DrugBank
DB14529,Nicotinic Acids,DrugBank
DB14530,Drugs that are Mainly Renally Excreted,DrugBank
DB14533,Acids,DrugBank
DB14533,"Acids, Noncarboxylic",DrugBank
DB14533,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14533,Anions,DrugBank
DB14533,Basic Ointments and Protectants,DrugBank
DB14533,Blood and Blood Forming Organs,DrugBank
DB14533,Blood Substitutes and Perfusion Solutions,DrugBank
DB14533,Chlorine Compounds,DrugBank
DB14533,"Compounds used in a research, industrial, or household setting",DrugBank
DB14533,Cosmetics,DrugBank
DB14533,Dental Agents,DrugBank
DB14533,"EENT Drugs, Miscellaneous",DrugBank
DB14533,Electrolyte Solutions,DrugBank
DB14533,Electrolytes,DrugBank
DB14533,Household Products,DrugBank
DB14533,I.V. Solution Additives,DrugBank
DB14533,Ions,DrugBank
DB14533,Metal cations,DrugBank
DB14533,Metal divalent cations,DrugBank
DB14533,Mouthwashes,DrugBank
DB14533,"Skin Ulcer, drug therapy",DrugBank
DB14533,Vasoprotectives,DrugBank
DB14533,Zinc Compounds,DrugBank
DB14538,11-Hydroxycorticosteroids,DrugBank
DB14538,17-Hydroxycorticosteroids,DrugBank
DB14538,Adrenal Cortex Hormones,DrugBank
DB14538,Corticosteroids,DrugBank
DB14538,"Corticosteroids, Dermatological Preparations",DrugBank
DB14538,"Corticosteroids, Potent (Group III)",DrugBank
DB14538,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14538,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14538,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14538,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14538,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14538,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14538,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14538,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14538,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14538,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14538,Cytochrome P-450 Substrates,DrugBank
DB14538,Dermatologicals,DrugBank
DB14538,Fused-Ring Compounds,DrugBank
DB14538,Hormones,DrugBank
DB14538,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14538,Hydrocortisone and derivatives,DrugBank
DB14538,Hydroxycorticosteroids,DrugBank
DB14538,Immunosuppressive Agents,DrugBank
DB14538,Pregnanes,DrugBank
DB14538,Pregnenediones,DrugBank
DB14538,Pregnenes,DrugBank
DB14538,Steroids,DrugBank
DB14539,11-Hydroxycorticosteroids,DrugBank
DB14539,17-Hydroxycorticosteroids,DrugBank
DB14539,Adrenal Cortex Hormones,DrugBank
DB14539,Aerosols,DrugBank
DB14539,Anti-Inflammatory Agents,DrugBank
DB14539,Corticosteroids,DrugBank
DB14539,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14539,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14539,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14539,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14539,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14539,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14539,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14539,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14539,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14539,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14539,Cytochrome P-450 Substrates,DrugBank
DB14539,Fused-Ring Compounds,DrugBank
DB14539,Hormones,DrugBank
DB14539,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14539,Hydrocortisone and derivatives,DrugBank
DB14539,Hydroxycorticosteroids,DrugBank
DB14539,Immunosuppressive Agents,DrugBank
DB14539,Pregnanes,DrugBank
DB14539,Pregnenediones,DrugBank
DB14539,Pregnenes,DrugBank
DB14539,Steroids,DrugBank
DB14540,11-Hydroxycorticosteroids,DrugBank
DB14540,17-Hydroxycorticosteroids,DrugBank
DB14540,"Administration, Topical",DrugBank
DB14540,Adrenal Cortex Hormones,DrugBank
DB14540,Corticosteroids,DrugBank
DB14540,"Corticosteroids, Dermatological Preparations",DrugBank
DB14540,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB14540,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14540,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14540,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14540,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14540,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14540,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14540,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14540,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14540,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14540,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14540,Cytochrome P-450 Substrates,DrugBank
DB14540,Dermatologicals,DrugBank
DB14540,Fused-Ring Compounds,DrugBank
DB14540,Hormones,DrugBank
DB14540,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14540,Hydrocortisone and derivatives,DrugBank
DB14540,Hydroxycorticosteroids,DrugBank
DB14540,Immunosuppressive Agents,DrugBank
DB14540,Pregnanes,DrugBank
DB14540,Pregnenediones,DrugBank
DB14540,Pregnenes,DrugBank
DB14540,Steroids,DrugBank
DB14541,11-Hydroxycorticosteroids,DrugBank
DB14541,17-Hydroxycorticosteroids,DrugBank
DB14541,Adrenal Cortex Hormones,DrugBank
DB14541,Corticosteroids,DrugBank
DB14541,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14541,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14541,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14541,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14541,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14541,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14541,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14541,Cytochrome P-450 Substrates,DrugBank
DB14541,Fused-Ring Compounds,DrugBank
DB14541,Hormones,DrugBank
DB14541,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14541,Hydrocortisone and derivatives,DrugBank
DB14541,Hydroxycorticosteroids,DrugBank
DB14541,Pregnanes,DrugBank
DB14541,Pregnenediones,DrugBank
DB14541,Pregnenes,DrugBank
DB14541,Steroids,DrugBank
DB14542,11-Hydroxycorticosteroids,DrugBank
DB14542,17-Hydroxycorticosteroids,DrugBank
DB14542,Adrenal Cortex Hormones,DrugBank
DB14542,Corticosteroids,DrugBank
DB14542,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14542,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14542,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14542,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14542,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14542,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14542,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14542,Cytochrome P-450 Substrates,DrugBank
DB14542,Fused-Ring Compounds,DrugBank
DB14542,Hormones,DrugBank
DB14542,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14542,Hydrocortisone and derivatives,DrugBank
DB14542,Hydroxycorticosteroids,DrugBank
DB14542,Pregnanes,DrugBank
DB14542,Pregnenediones,DrugBank
DB14542,Pregnenes,DrugBank
DB14542,Steroids,DrugBank
DB14543,11-Hydroxycorticosteroids,DrugBank
DB14543,17-Hydroxycorticosteroids,DrugBank
DB14543,Adrenal Cortex Hormones,DrugBank
DB14543,Anti-Inflammatory Agents,DrugBank
DB14543,Corticosteroids,DrugBank
DB14543,"Corticosteroids, Dermatological Preparations",DrugBank
DB14543,"Corticosteroids, Moderately Potent (Group II)",DrugBank
DB14543,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14543,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14543,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14543,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14543,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14543,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14543,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14543,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14543,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14543,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14543,Cytochrome P-450 Substrates,DrugBank
DB14543,Dermatologicals,DrugBank
DB14543,Fused-Ring Compounds,DrugBank
DB14543,Hormones,DrugBank
DB14543,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14543,Hydrocortisone and derivatives,DrugBank
DB14543,Hydroxycorticosteroids,DrugBank
DB14543,Immunosuppressive Agents,DrugBank
DB14543,Pregnanes,DrugBank
DB14543,Pregnenediones,DrugBank
DB14543,Pregnenes,DrugBank
DB14543,Steroids,DrugBank
DB14544,11-Hydroxycorticosteroids,DrugBank
DB14544,17-Hydroxycorticosteroids,DrugBank
DB14544,Adrenal Cortex Hormones,DrugBank
DB14544,Anti-Inflammatory Agents,DrugBank
DB14544,Corticosteroids,DrugBank
DB14544,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14544,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14544,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14544,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14544,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14544,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14544,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14544,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14544,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14544,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14544,Cytochrome P-450 Substrates,DrugBank
DB14544,Fused-Ring Compounds,DrugBank
DB14544,Hormones,DrugBank
DB14544,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14544,Hydrocortisone and derivatives,DrugBank
DB14544,Hydroxycorticosteroids,DrugBank
DB14544,Immunosuppressive Agents,DrugBank
DB14544,Pregnanes,DrugBank
DB14544,Pregnenediones,DrugBank
DB14544,Pregnenes,DrugBank
DB14544,Steroids,DrugBank
DB14545,11-Hydroxycorticosteroids,DrugBank
DB14545,17-Hydroxycorticosteroids,DrugBank
DB14545,Adrenal Cortex Hormones,DrugBank
DB14545,Adrenals,DrugBank
DB14545,Anti-Inflammatory Agents,DrugBank
DB14545,Corticosteroids,DrugBank
DB14545,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14545,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14545,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14545,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14545,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14545,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14545,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14545,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14545,Cytochrome P-450 Substrates,DrugBank
DB14545,Fused-Ring Compounds,DrugBank
DB14545,Hormones,DrugBank
DB14545,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14545,Hydrocortisone and derivatives,DrugBank
DB14545,Hydroxycorticosteroids,DrugBank
DB14545,Immunosuppressive Agents,DrugBank
DB14545,Pregnanes,DrugBank
DB14545,Pregnenediones,DrugBank
DB14545,Pregnenes,DrugBank
DB14545,Steroids,DrugBank
DB14546,Anions,DrugBank
DB14546,Electrolytes,DrugBank
DB14546,Increased Large Intestinal Motility,DrugBank
DB14546,Inhibition Large Intestine Fluid/Electrolyte Absorption,DrugBank
DB14546,Ions,DrugBank
DB14546,Laxatives,DrugBank
DB14546,Osmotic Activity,DrugBank
DB14546,Osmotic Laxatives,DrugBank
DB14546,Sulfates,DrugBank
DB14546,Sulfur Acids,DrugBank
DB14546,Sulfur Compounds,DrugBank
DB14546,Sulfuric Acids,DrugBank
DB14548,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use,DrugBank
DB14548,Metal cations,DrugBank
DB14548,Metal divalent cations,DrugBank
DB14548,Vasoprotectives,DrugBank
DB14548,Zinc Compounds,DrugBank
DB14562,"Amino Acids, Peptides, and Proteins",DrugBank
DB14562,Antidotes,DrugBank
DB14562,Biological Factors,DrugBank
DB14562,Blood Coagulation Factors,DrugBank
DB14562,Blood Proteins,DrugBank
DB14562,Coagulants,DrugBank
DB14562,Endopeptidases,DrugBank
DB14562,Enzymes,DrugBank
DB14562,Enzymes and Coenzymes,DrugBank
DB14562,Factor X,DrugBank
DB14562,Hydrolases,DrugBank
DB14562,Peptide Hydrolases,DrugBank
DB14562,Proteins,DrugBank
DB14562,Serine Endopeptidases,DrugBank
DB14562,Serine Proteases,DrugBank
DB14568,Amino Acids,DrugBank
DB14568,"Amino Acids, Peptides, and Proteins",DrugBank
DB14568,Antineoplastic Agents,DrugBank
DB14568,Antineoplastic and Immunomodulating Agents,DrugBank
DB14568,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14568,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14568,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14568,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14568,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB14568,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB14568,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14568,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14568,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14568,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14568,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14568,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB14568,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14568,Cytochrome P-450 Substrates,DrugBank
DB14568,Enzyme Inhibitors,DrugBank
DB14568,Isocitrate dehydrogenase (IDH) inhibitors,DrugBank
DB14568,Isocitrate Dehydrogenase 1 Inhibitor,DrugBank
DB14568,Isocitrate dehydrogenase-1 (IDH1) inhibitors,DrugBank
DB14568,Isocitrate Dehydrogenase-1 Inhibitors,DrugBank
DB14568,Moderate Risk QTc-Prolonging Agents,DrugBank
DB14568,Narrow Therapeutic Index Drugs,DrugBank
DB14568,OAT3/SLC22A8 Inhibitors,DrugBank
DB14568,P-glycoprotein inhibitors,DrugBank
DB14568,P-glycoprotein substrates,DrugBank
DB14568,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB14568,QTc Prolonging Agents,DrugBank
DB14569,Anti-Bacterial Agents,DrugBank
DB14569,Anti-Infective Agents,DrugBank
DB14569,Antibacterials for Systemic Use,DrugBank
DB14569,Antiinfectives for Systemic Use,DrugBank
DB14569,BCRP/ABCG2 Inhibitors,DrugBank
DB14569,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB14569,Oxazoles,DrugBank
DB14569,Oxazolidinone Antibacterial,DrugBank
DB14570,Adrenal Cortex Hormones,DrugBank
DB14570,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14570,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14570,Cytochrome P-450 Substrates,DrugBank
DB14570,Fused-Ring Compounds,DrugBank
DB14570,Genito Urinary System and Sex Hormones,DrugBank
DB14570,Gonadal Hormones,DrugBank
DB14570,Gonadal Steroid Hormones,DrugBank
DB14570,Hormones,DrugBank
DB14570,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14570,Hydroxyprogesterones,DrugBank
DB14570,Pregnanes,DrugBank
DB14570,Pregnen (4) Derivatives,DrugBank
DB14570,Pregnenediones,DrugBank
DB14570,Pregnenes,DrugBank
DB14570,Progesterone and Derivatives,DrugBank
DB14570,Progesterone Congeners,DrugBank
DB14570,Progestins,DrugBank
DB14570,Sex Hormones and Modulators of the Genital System,DrugBank
DB14570,Steroids,DrugBank
DB14572,Antacids,DrugBank
DB14572,Anti-Infective Agents,DrugBank
DB14572,Anti-Ulcer Agents,DrugBank
DB14572,Gastric Acid Lowering Agents,DrugBank
DB14572,Gastrointestinal Agents,DrugBank
DB14575,Anticonvulsants,DrugBank
DB14575,Carboxamide Derivatives,DrugBank
DB14575,Cardiovascular Agents,DrugBank
DB14575,Central Nervous System Depressants,DrugBank
DB14575,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB14575,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB14575,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14575,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14575,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14575,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14575,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14575,Eslicarbazepine and prodrugs,DrugBank
DB14575,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14575,Membrane Transport Modulators,DrugBank
DB14575,Nervous System,DrugBank
DB14575,Sodium Channel Blockers,DrugBank
DB14575,UGT1A1 Substrates,DrugBank
DB14575,Voltage-Gated Sodium Channel Blockers,DrugBank
DB14577,Blood Coagulation Factors,DrugBank
DB14577,Calcium Salts,DrugBank
DB14577,Increased Coagulation Factor Activity,DrugBank
DB14577,Phosphate Binder,DrugBank
DB14577,"Polyvalent cation containing laxatives, antacids, oral supplements",DrugBank
DB14580,Alzheimer Disease,DrugBank
DB14580,"Alzheimer Disease, drug therapy",DrugBank
DB14580,"Amino Acids, Peptides, and Proteins",DrugBank
DB14580,Amyloid Beta-directed Antibodies,DrugBank
DB14580,Anti-Dementia Drugs,DrugBank
DB14580,Antibodies,DrugBank
DB14580,"Antibodies, Monoclonal",DrugBank
DB14580,Blood Proteins,DrugBank
DB14580,Globulins,DrugBank
DB14580,Immunoglobulins,DrugBank
DB14580,Immunoproteins,DrugBank
DB14580,Nervous System,DrugBank
DB14580,Proteins,DrugBank
DB14580,Psychoanaleptics,DrugBank
DB14580,Serum Globulins,DrugBank
DB14583,Adrenal Cortex Hormones,DrugBank
DB14583,"Contraceptive Agents, Female",DrugBank
DB14583,"Contraceptive Agents, Hormonal",DrugBank
DB14583,"Contraceptive Devices, Female",DrugBank
DB14583,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14583,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14583,Cytochrome P-450 Substrates,DrugBank
DB14583,Drug Implants,DrugBank
DB14583,Estradiol Congeners,DrugBank
DB14583,"Estrogenic Steroids, Alkylated",DrugBank
DB14583,Fused-Ring Compounds,DrugBank
DB14583,Gonadal Hormones,DrugBank
DB14583,Gonadal Steroid Hormones,DrugBank
DB14583,Hormonal Contraceptives for Systemic Use,DrugBank
DB14583,Hormones,DrugBank
DB14583,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14583,Intravaginal Contraceptives,DrugBank
DB14583,Norpregnanes,DrugBank
DB14583,Norpregnatrienes,DrugBank
DB14583,Norpregnenes,DrugBank
DB14583,Norsteroids,DrugBank
DB14583,Pharmaceutical Preparations,DrugBank
DB14583,Pregnanes,DrugBank
DB14583,Pregnenes,DrugBank
DB14583,Progestins,DrugBank
DB14583,Reproductive Control Agents,DrugBank
DB14583,Steroids,DrugBank
DB14585,Alimentary Tract and Metabolism,DrugBank
DB14585,Angiosperms,DrugBank
DB14585,Biological Products,DrugBank
DB14585,Bulk-Forming Laxatives,DrugBank
DB14585,Complex Mixtures,DrugBank
DB14585,Drugs for Constipation,DrugBank
DB14585,Embryophyta,DrugBank
DB14585,Eukaryota,DrugBank
DB14585,Gastrointestinal Agents,DrugBank
DB14585,Lamiales,DrugBank
DB14585,Laxatives,DrugBank
DB14585,Pharmaceutical Preparations,DrugBank
DB14585,Plant Extracts,DrugBank
DB14585,Plant Preparations,DrugBank
DB14585,Plantaginaceae,DrugBank
DB14585,Streptophyta,DrugBank
DB14585,Tracheophyta,DrugBank
DB14585,Viridiplantae,DrugBank
DB00873,Adrenal Cortex Hormones,DrugBank
DB00873,Androstadienes,DrugBank
DB00873,Androstanes,DrugBank
DB00873,Androstenes,DrugBank
DB00873,Anti-Allergic Agents,DrugBank
DB00873,Anti-Inflammatory Agents,DrugBank
DB00873,Corticosteroid Hormone Receptor Agonists,DrugBank
DB00873,Corticosteroids,DrugBank
DB00873,Fused-Ring Compounds,DrugBank
DB00873,Ophthalmologicals,DrugBank
DB00873,Sensory Organs,DrugBank
DB00873,Steroids,DrugBank
DB14597,"Amino Acids, Peptides, and Proteins",DrugBank
DB14597,Antibodies,DrugBank
DB14597,"Antibodies, Monoclonal",DrugBank
DB14597,"Antibodies, Monoclonal, Humanized",DrugBank
DB14597,Blood and Blood Forming Organs,DrugBank
DB14597,Blood Proteins,DrugBank
DB14597,Drugs Used in Hereditary Angioedema,DrugBank
DB14597,Globulins,DrugBank
DB14597,Immunoglobulins,DrugBank
DB14597,Immunoproteins,DrugBank
DB14597,Kallikrein Inhibitors,DrugBank
DB14597,Plasma Kallikrein Inhibitor,DrugBank
DB14597,Proteins,DrugBank
DB14597,Serum Globulins,DrugBank
DB14619,Actively Acquired Immunity,DrugBank
DB14619,Inactivated Influenza A Virus Vaccine,DrugBank
DB14619,Influenza Vaccines,DrugBank
DB14619,Vaccines,DrugBank
DB14619,Viral Vaccines,DrugBank
DB14620,Actively Acquired Immunity,DrugBank
DB14620,Inactivated Influenza A Virus Vaccine,DrugBank
DB14620,Influenza Vaccines,DrugBank
DB14620,Vaccines,DrugBank
DB14620,"Vaccines, Inactivated",DrugBank
DB14620,Viral Vaccines,DrugBank
DB14627,Gastrointestinal Agents,DrugBank
DB14627,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14627,Indoles,DrugBank
DB14627,Laxatives,DrugBank
DB14631,Adrenal Cortex Hormones,DrugBank
DB14631,Adrenals,DrugBank
DB14631,Anti-Inflammatory Agents,DrugBank
DB14631,Corticosteroids,DrugBank
DB14631,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14631,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14631,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14631,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14631,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14631,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14631,Cytochrome P-450 Substrates,DrugBank
DB14631,Fused-Ring Compounds,DrugBank
DB14631,Glucocorticoids,DrugBank
DB14631,Hormones,DrugBank
DB14631,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14631,OAT3/SLC22A8 Substrates,DrugBank
DB14631,P-glycoprotein inducers,DrugBank
DB14631,P-glycoprotein substrates,DrugBank
DB14631,Pregnadienes,DrugBank
DB14631,Pregnadienetriols,DrugBank
DB14631,Pregnanes,DrugBank
DB14631,Steroids,DrugBank
DB14633,Adrenal Cortex Hormones,DrugBank
DB14633,Corticosteroids,DrugBank
DB14633,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14633,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14633,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14633,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14633,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14633,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14633,Fused-Ring Compounds,DrugBank
DB14633,Glucocorticoids,DrugBank
DB14633,Hormones,DrugBank
DB14633,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14633,Pregnadienes,DrugBank
DB14633,Pregnadienetriols,DrugBank
DB14633,Pregnanes,DrugBank
DB14633,Steroids,DrugBank
DB14634,Adrenal Cortex Hormones,DrugBank
DB14634,Corticosteroids,DrugBank
DB14634,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14634,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14634,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14634,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14634,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14634,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14634,Fused-Ring Compounds,DrugBank
DB14634,Glucocorticoids,DrugBank
DB14634,Hormones,DrugBank
DB14634,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14634,Pregnadienes,DrugBank
DB14634,Pregnanes,DrugBank
DB14634,Steroids,DrugBank
DB14635,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB14635,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB14635,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14642,"Amino Acids, Peptides, and Proteins",DrugBank
DB14642,Antidiuretic Agents,DrugBank
DB14642,Cardiovascular Agents,DrugBank
DB14642,Coagulants,DrugBank
DB14642,Hematologic Agents,DrugBank
DB14642,Hemostatics,DrugBank
DB14642,Hormones,DrugBank
DB14642,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14642,Natriuretic Agents,DrugBank
DB14642,Nerve Tissue Proteins,DrugBank
DB14642,Neuropeptides,DrugBank
DB14642,Oligopeptides,DrugBank
DB14642,Peptide Hormones,DrugBank
DB14642,Peptides,DrugBank
DB14642,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB14642,Pituitary Hormones,DrugBank
DB14642,"Pituitary Hormones, Posterior",DrugBank
DB14642,Posterior Pituitary Lobe Hormones,DrugBank
DB14642,Proteins,DrugBank
DB14642,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB14642,Vasoconstrictor Agents,DrugBank
DB14642,Vasopressin and Analogues,DrugBank
DB14642,Vasopressins,DrugBank
DB14643,Adrenal Cortex Hormones,DrugBank
DB14643,Anti-Inflammatory Agents,DrugBank
DB14643,Corticosteroids,DrugBank
DB14643,"Corticosteroids, Dermatological Preparations",DrugBank
DB14643,"Corticosteroids, Potent (Group III)",DrugBank
DB14643,Dermatologicals,DrugBank
DB14643,Fused-Ring Compounds,DrugBank
DB14643,Pregnadienes,DrugBank
DB14643,Pregnadienetriols,DrugBank
DB14643,Pregnanes,DrugBank
DB14643,Steroids,DrugBank
DB14644,Adrenal Cortex Hormones,DrugBank
DB14644,Adrenals,DrugBank
DB14644,Anti-Inflammatory Agents,DrugBank
DB14644,Antineoplastic Agents,DrugBank
DB14644,"Antineoplastic Agents, Hormonal",DrugBank
DB14644,Central Nervous System Agents,DrugBank
DB14644,"Compounds used in a research, industrial, or household setting",DrugBank
DB14644,Corticosteroids,DrugBank
DB14644,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14644,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14644,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14644,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14644,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14644,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14644,Fused-Ring Compounds,DrugBank
DB14644,Glucocorticoids,DrugBank
DB14644,Hormones,DrugBank
DB14644,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14644,Neuroprotective Agents,DrugBank
DB14644,Pregnadienes,DrugBank
DB14644,Pregnadienetriols,DrugBank
DB14644,Pregnanes,DrugBank
DB14644,Protective Agents,DrugBank
DB14644,Steroids,DrugBank
DB14646,Adrenal Cortex Hormones,DrugBank
DB14646,Anti-Inflammatory Agents,DrugBank
DB14646,Antineoplastic Agents,DrugBank
DB14646,"Antineoplastic Agents, Hormonal",DrugBank
DB14646,Corticosteroids,DrugBank
DB14646,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14646,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14646,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14646,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14646,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14646,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14646,Fused-Ring Compounds,DrugBank
DB14646,Glucocorticoids,DrugBank
DB14646,Hormones,DrugBank
DB14646,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14646,Pregnadienediols,DrugBank
DB14646,Pregnadienes,DrugBank
DB14646,Pregnanes,DrugBank
DB14646,Steroids,DrugBank
DB14646,Thyroxine-binding globulin inhibitors,DrugBank
DB14649,Adrenal Cortex Hormones,DrugBank
DB14649,Anti-Inflammatory Agents,DrugBank
DB14649,BCRP/ABCG2 Inhibitors,DrugBank
DB14649,BSEP/ABCB11 inducers,DrugBank
DB14649,Corticosteroids,DrugBank
DB14649,Cytochrome P-450 CYP2A6 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14649,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB14649,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB14649,Cytochrome P-450 CYP2E1 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP2E1 Inducers (strength unknown),DrugBank
DB14649,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14649,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14649,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14649,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP3A4 Inducers (moderate),DrugBank
DB14649,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14649,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB14649,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14649,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP3A5 Inducers (moderate),DrugBank
DB14649,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14649,Cytochrome P-450 CYP3A7 Inducers,DrugBank
DB14649,Cytochrome P-450 CYP3A7 Inducers (strength unknown),DrugBank
DB14649,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB14649,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14649,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14649,Cytochrome P-450 Substrates,DrugBank
DB14649,Fused-Ring Compounds,DrugBank
DB14649,OAT3/SLC22A8 Substrates,DrugBank
DB14649,P-glycoprotein inducers,DrugBank
DB14649,P-glycoprotein inhibitors,DrugBank
DB14649,P-glycoprotein substrates,DrugBank
DB14649,Pregnadienes,DrugBank
DB14649,Pregnadienetriols,DrugBank
DB14649,Pregnanes,DrugBank
DB14649,Steroids,DrugBank
DB14649,"Steroids, Fluorinated",DrugBank
DB14651,Antipsychotic Agents,DrugBank
DB14651,Central Nervous System Depressants,DrugBank
DB14651,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14651,Neurotoxic agents,DrugBank
DB14651,Phenothiazines,DrugBank
DB14651,Sulfur Compounds,DrugBank
DB14652,Adrenal Cortex Hormones,DrugBank
DB14652,Anti-Inflammatory Agents,DrugBank
DB14652,Corticosteroids,DrugBank
DB14652,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14652,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14652,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14652,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14652,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14652,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14652,Fused-Ring Compounds,DrugBank
DB14652,Glucocorticoids,DrugBank
DB14652,Hormones,DrugBank
DB14652,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14652,Pregnadienediols,DrugBank
DB14652,Pregnadienes,DrugBank
DB14652,Pregnanes,DrugBank
DB14652,Steroids,DrugBank
DB14652,"Steroids, Fluorinated",DrugBank
DB14655,Androstanes,DrugBank
DB14655,Fused-Ring Compounds,DrugBank
DB14655,Steroids,DrugBank
DB14655,Testosterone and derivatives,DrugBank
DB14659,Adrenal Cortex Hormones,DrugBank
DB14659,Corticosteroids,DrugBank
DB14659,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14659,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14659,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14659,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14659,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14659,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14659,Fused-Ring Compounds,DrugBank
DB14659,Glucocorticoids,DrugBank
DB14659,Hormones,DrugBank
DB14659,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14659,Pregnadienes,DrugBank
DB14659,Pregnanes,DrugBank
DB14659,Steroids,DrugBank
DB14669,Adrenal Cortex Hormones,DrugBank
DB14669,Corticosteroids,DrugBank
DB14669,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14669,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14669,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14669,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14669,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14669,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14669,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14669,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14669,Cytochrome P-450 Substrates,DrugBank
DB14669,Fused-Ring Compounds,DrugBank
DB14669,Glucocorticoids,DrugBank
DB14669,Hormones,DrugBank
DB14669,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14669,OAT3/SLC22A8 Substrates,DrugBank
DB14669,P-glycoprotein inducers,DrugBank
DB14669,P-glycoprotein substrates,DrugBank
DB14669,Pregnadienes,DrugBank
DB14669,Pregnadienetriols,DrugBank
DB14669,Pregnanes,DrugBank
DB14669,Steroids,DrugBank
DB14669,"Steroids, Fluorinated",DrugBank
DB14672,Benzazepines,DrugBank
DB14672,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB14672,Benzodiazepinones,DrugBank
DB14672,Central Nervous System Depressants,DrugBank
DB14672,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14674,Alkylating Drugs,DrugBank
DB14674,Antineoplastic Agents,DrugBank
DB14674,"Antineoplastic Agents, Alkylating",DrugBank
DB14674,"Antineoplastic Agents, Hormonal",DrugBank
DB14674,Estranes,DrugBank
DB14674,Estrenes,DrugBank
DB14674,Fused-Ring Compounds,DrugBank
DB14674,"Hydrocarbons, Halogenated",DrugBank
DB14674,Mustard Compounds,DrugBank
DB14674,Nitrogen Mustard Compounds,DrugBank
DB14674,Noxae,DrugBank
DB14674,Steroids,DrugBank
DB14674,Toxic Actions,DrugBank
DB14678,Adrenal Cortex Hormones,DrugBank
DB14678,"Contraceptive Agents, Female",DrugBank
DB14678,"Contraceptive Agents, Hormonal",DrugBank
DB14678,"Contraceptives, Oral",DrugBank
DB14678,"Contraceptives, Oral, Synthetic",DrugBank
DB14678,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14678,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14678,Cytochrome P-450 Substrates,DrugBank
DB14678,Fused-Ring Compounds,DrugBank
DB14678,Hormonal Contraceptives for Systemic Use,DrugBank
DB14678,Norpregnanes,DrugBank
DB14678,Norpregnenes,DrugBank
DB14678,Norsteroids,DrugBank
DB14678,Progesterone Congeners,DrugBank
DB14678,Progestins,DrugBank
DB14678,Reproductive Control Agents,DrugBank
DB14678,Steroids,DrugBank
DB14679,Adrenal Cortex Hormones,DrugBank
DB14679,Fused-Ring Compounds,DrugBank
DB14679,Norpregnanes,DrugBank
DB14679,Norsteroids,DrugBank
DB14679,Progestins,DrugBank
DB14679,Steroids,DrugBank
DB14680,Antineoplastic Agents,DrugBank
DB14680,"Antineoplastic Agents, Phytogenic",DrugBank
DB14680,Benzene Derivatives,DrugBank
DB14680,Benzylidene Compounds,DrugBank
DB14681,17-Hydroxycorticosteroids,DrugBank
DB14681,Adrenal Cortex Hormones,DrugBank
DB14681,Anti-Inflammatory Agents,DrugBank
DB14681,Corticosteroid Hormone Receptor Agonists,DrugBank
DB14681,Corticosteroids,DrugBank
DB14681,Corticosteroids for Systemic Use,DrugBank
DB14681,"Corticosteroids for Systemic Use, Plain",DrugBank
DB14681,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14681,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14681,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14681,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB14681,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB14681,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14681,Fused-Ring Compounds,DrugBank
DB14681,Glucocorticoids,DrugBank
DB14681,Hormones,DrugBank
DB14681,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14681,Hydroxycorticosteroids,DrugBank
DB14681,Ophthalmologicals,DrugBank
DB14681,Pregnanes,DrugBank
DB14681,Pregnenes,DrugBank
DB14681,Sensory Organs,DrugBank
DB14681,Steroids,DrugBank
DB14681,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB14684,Alimentary Tract and Metabolism,DrugBank
DB14684,Antidiarrheals,DrugBank
DB14684,Bulk-Forming Laxatives,DrugBank
DB14684,Calcium Salts,DrugBank
DB14684,"Compounds used in a research, industrial, or household setting",DrugBank
DB14684,Drugs for Constipation,DrugBank
DB14684,Gastrointestinal Agents,DrugBank
DB14684,Laxatives,DrugBank
DB14684,Macromolecular Substances,DrugBank
DB14684,Plastics,DrugBank
DB14684,Polymers,DrugBank
DB14684,"Resins, Synthetic",DrugBank
DB14685,Actively Acquired Immunity,DrugBank
DB14685,Adenovirus Vaccines,DrugBank
DB14685,Live Human Adenovirus Type 7 Vaccine,DrugBank
DB14685,Live vaccines,DrugBank
DB14685,Vaccines,DrugBank
DB14685,Viral Vaccines,DrugBank
DB14695,Iron Compounds,DrugBank
DB14695,Organometallic Compounds,DrugBank
DB14695,Phosphate Binder,DrugBank
DB14695,Phosphate Chelating Activity,DrugBank
DB14700,Blood Coagulation Factors,DrugBank
DB14700,Pegylated agents,DrugBank
DB14707,"Amino Acids, Peptides, and Proteins",DrugBank
DB14707,Antibodies,DrugBank
DB14707,"Antibodies, Monoclonal",DrugBank
DB14707,Antineoplastic Agents,DrugBank
DB14707,"Antineoplastic Agents, Immunological",DrugBank
DB14707,Antineoplastic and Immunomodulating Agents,DrugBank
DB14707,Blood Proteins,DrugBank
DB14707,Cancer immunotherapy,DrugBank
DB14707,Globulins,DrugBank
DB14707,Immune Checkpoint Inhibitors,DrugBank
DB14707,Immunoglobulins,DrugBank
DB14707,Immunoproteins,DrugBank
DB14707,Immunotherapy,DrugBank
DB14707,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14707,Narrow Therapeutic Index Drugs,DrugBank
DB14707,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB14707,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB14707,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB14707,Proteins,DrugBank
DB14707,Serum Globulins,DrugBank
DB14711,Actively Acquired Immunity,DrugBank
DB14711,Biological Products,DrugBank
DB14711,Complex Mixtures,DrugBank
DB14711,Live vaccines,DrugBank
DB14711,Live Vaccinia Virus Vaccine,DrugBank
DB14711,Vaccines,DrugBank
DB14711,Viral Vaccines,DrugBank
DB14712,Adenosine Deaminase Inhibitors,DrugBank
DB14712,"Adjuvants, Immunologic",DrugBank
DB14712,"Amino Acids, Peptides, and Proteins",DrugBank
DB14712,Aminohydrolases,DrugBank
DB14712,Antineoplastic and Immunomodulating Agents,DrugBank
DB14712,Enzyme Inhibitors,DrugBank
DB14712,Enzyme Replacement Therapy,DrugBank
DB14712,Enzymes,DrugBank
DB14712,Enzymes and Coenzymes,DrugBank
DB14712,Hydrolases,DrugBank
DB14712,Nucleoside Deaminases,DrugBank
DB14712,Pegylated agents,DrugBank
DB14712,Proteins,DrugBank
DB14712,Recombinant Adenosine Deaminases,DrugBank
DB14712,Recombinant Proteins,DrugBank
DB14713,Antisense Elements (Genetics),DrugBank
DB14713,Antisense Oligonucleotides,DrugBank
DB14713,Decreased RNA Integrity,DrugBank
DB14713,"DNA, Antisense",DrugBank
DB14713,Increased Protein Breakdown,DrugBank
DB14713,Molecular Probes,DrugBank
DB14713,Nephrotoxic agents,DrugBank
DB14713,Nervous System,DrugBank
DB14713,Nucleic Acid Probes,DrugBank
DB14713,Nucleic Acids,DrugBank
DB14713,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB14713,Nucleotides,DrugBank
DB14713,"Oligodeoxyribonucleotides, Antisense",DrugBank
DB14713,Oligonucleotides,DrugBank
DB14713,Polynucleotides,DrugBank
DB14713,Potential QTc-Prolonging Agents,DrugBank
DB14713,QTc Prolonging Agents,DrugBank
DB14713,Transthyretin-directed RNA Interaction,DrugBank
DB14715,Benzazepines,DrugBank
DB14715,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB14715,Central Nervous System Depressants,DrugBank
DB14715,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14718,Benzazepines,DrugBank
DB14718,Central Nervous System Agents,DrugBank
DB14718,Central Nervous System Depressants,DrugBank
DB14718,GABA Agents,DrugBank
DB14718,GABA Modulators,DrugBank
DB14718,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14718,Hypnotics and Sedatives,DrugBank
DB14718,Illicit Drugs,DrugBank
DB14718,Neurotransmitter Agents,DrugBank
DB14719,Anti-Anxiety Agents,DrugBank
DB14719,Benzodiazepines and benzodiazepine derivatives,DrugBank
DB14719,Central Nervous System Agents,DrugBank
DB14719,Central Nervous System Depressants,DrugBank
DB14719,Hypnotics and Sedatives,DrugBank
DB14719,Nervous System,DrugBank
DB14719,Psycholeptics,DrugBank
DB14723,Antineoplastic Agents,DrugBank
DB14723,Antineoplastic and Immunomodulating Agents,DrugBank
DB14723,BCRP/ABCG2 Substrates,DrugBank
DB14723,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14723,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14723,Cytochrome P-450 Substrates,DrugBank
DB14723,Kinase Inhibitor,DrugBank
DB14723,P-glycoprotein substrates,DrugBank
DB14723,Protein Kinase Inhibitors,DrugBank
DB14723,Tropomyosin Receptor Kinases Inhibitors,DrugBank
DB14723,Tyrosine Kinase Inhibitors,DrugBank
DB14724,Agents reducing cytokine levels,DrugBank
DB14724,"Amino Acids, Peptides, and Proteins",DrugBank
DB14724,Antibodies,DrugBank
DB14724,"Antibodies, Monoclonal",DrugBank
DB14724,Antineoplastic and Immunomodulating Agents,DrugBank
DB14724,Blood Proteins,DrugBank
DB14724,Globulins,DrugBank
DB14724,Immunoglobulins,DrugBank
DB14724,Immunoproteins,DrugBank
DB14724,Immunosuppressive Agents,DrugBank
DB14724,Interferon gamma Antagonists,DrugBank
DB14724,Interferon gamma Blocker,DrugBank
DB14724,Interferon-gamma,DrugBank
DB14724,"Lymphohistiocytosis, Hemophagocytic",DrugBank
DB14724,Proteins,DrugBank
DB14724,Selective Immunosuppressants,DrugBank
DB14724,Serum Globulins,DrugBank
DB14725,Amides,DrugBank
DB14725,Anti-Bacterial Agents,DrugBank
DB14725,Anti-Infective Agents,DrugBank
DB14725,beta-Lactams,DrugBank
DB14725,Cephalosporins,DrugBank
DB14725,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14725,Lactams,DrugBank
DB14725,Sulfur Compounds,DrugBank
DB14725,Thiazines,DrugBank
DB14726,Anticoagulants,DrugBank
DB14726,Antithrombins,DrugBank
DB14726,Benzimidazoles,DrugBank
DB14726,Direct factor Xa inhibitors,DrugBank
DB14726,Enzyme Inhibitors,DrugBank
DB14726,Factor Xa Inhibitors,DrugBank
DB14726,Hematologic Agents,DrugBank
DB14726,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14726,Protease Inhibitors,DrugBank
DB14726,Pyridines,DrugBank
DB14726,Serine Protease Inhibitors,DrugBank
DB14726,Thrombin Inhibitors,DrugBank
DB14730,Alcohols,DrugBank
DB14730,Amidohydrolases,DrugBank
DB14730,Antineoplastic Agents,DrugBank
DB14730,Antineoplastic and Immunomodulating Agents,DrugBank
DB14730,Asparagine-specific Enzyme,DrugBank
DB14730,"Compounds used in a research, industrial, or household setting",DrugBank
DB14730,Enzymes,DrugBank
DB14730,Enzymes and Coenzymes,DrugBank
DB14730,Ethylene Glycols,DrugBank
DB14730,Glycols,DrugBank
DB14730,Hydrolases,DrugBank
DB14730,Macromolecular Substances,DrugBank
DB14730,Polymers,DrugBank
DB14731,"Amino Acids, Peptides, and Proteins",DrugBank
DB14731,Antineoplastic Agents,DrugBank
DB14731,Antineoplastic and Immunomodulating Agents,DrugBank
DB14731,CD123 Interaction,DrugBank
DB14731,CD123 Interactions,DrugBank
DB14731,Cytotoxins,DrugBank
DB14731,Narrow Therapeutic Index Drugs,DrugBank
DB14731,Proteins,DrugBank
DB14731,Recombinant Fusion Proteins,DrugBank
DB14731,Recombinant Proteins,DrugBank
DB14733,Amides,DrugBank
DB14733,Anti-Bacterial Agents,DrugBank
DB14733,Anti-Infective Agents,DrugBank
DB14733,Antibacterials for Systemic Use,DrugBank
DB14733,Antiinfectives for Systemic Use,DrugBank
DB14733,beta-Lactams,DrugBank
DB14733,BSEP/ABCB11 Inhibitors,DrugBank
DB14733,Cephalosporins,DrugBank
DB14733,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14733,Lactams,DrugBank
DB14733,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB14733,OATP1B3 inhibitors,DrugBank
DB14733,Sulfur Compounds,DrugBank
DB14733,Thiazines,DrugBank
DB14737,BCRP/ABCG2 Inhibitors,DrugBank
DB14737,Cannabinoids and similars,DrugBank
DB14737,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14737,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14737,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB14737,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14737,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB14737,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14737,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP3A5 Inhibitors (weak),DrugBank
DB14737,Cytochrome P-450 CYP3A7 Inhibitors,DrugBank
DB14737,Cytochrome P-450 CYP3A7 Inhibitors (weak),DrugBank
DB14737,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14737,Cytochrome P-450 Substrates,DrugBank
DB14737,P-glycoprotein inhibitors,DrugBank
DB14737,Terpenes,DrugBank
DB14737,UGT1A9 Inhibitors,DrugBank
DB14737,UGT1A9 Substrates,DrugBank
DB14737,UGT2B7 inducers,DrugBank
DB14737,UGT2B7 substrates,DrugBank
DB14738,"Amino Acids, Peptides, and Proteins",DrugBank
DB14738,Biological Factors,DrugBank
DB14738,Blood Coagulation Factors,DrugBank
DB14738,Blood Proteins,DrugBank
DB14738,Factor VIII,DrugBank
DB14738,Hemostatics,DrugBank
DB14738,Proteins,DrugBank
DB14738,Recombinant Proteins,DrugBank
DB14740,Blood and Blood Forming Organs,DrugBank
DB14740,Carbon-Oxygen Lyases,DrugBank
DB14740,Enzymes,DrugBank
DB14740,Enzymes and Coenzymes,DrugBank
DB14740,Glycoside Hydrolases,DrugBank
DB14740,"Hyaluronoglucosaminidase, antagonists & inhibitors",DrugBank
DB14740,Hydrolases,DrugBank
DB14740,Lyases,DrugBank
DB14740,Polysaccharide-Lyases,DrugBank
DB00781,Alimentary Tract and Metabolism,DrugBank
DB00781,"Amino Acids, Peptides, and Proteins",DrugBank
DB00781,Anti-Bacterial Agents,DrugBank
DB00781,Anti-Infective Agents,DrugBank
DB00781,Antibacterials for Systemic Use,DrugBank
DB00781,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents",DrugBank
DB00781,Antiinfectives for Systemic Use,DrugBank
DB00781,Antimicrobial Cationic Peptides,DrugBank
DB00781,Antimicrobial Peptides,DrugBank
DB00781,Intestinal Antiinfectives,DrugBank
DB00781,Lipopeptides,DrugBank
DB00781,Neurotoxic agents,DrugBank
DB00781,Ophthalmological and Otological Preparations,DrugBank
DB00781,Ophthalmologicals,DrugBank
DB00781,Otologicals,DrugBank
DB00781,Peptides,DrugBank
DB00781,"Peptides, Cyclic",DrugBank
DB00781,Polymyxin-class Antibacterial,DrugBank
DB00781,Polymyxins,DrugBank
DB00781,Pore Forming Cytotoxic Proteins,DrugBank
DB00781,Proteins,DrugBank
DB00781,Sensory Organs,DrugBank
DB14752,Adrenergic Agonists,DrugBank
DB14752,Adrenergic alpha-Agonists,DrugBank
DB14752,Adrenergic beta-Agonists,DrugBank
DB14752,Alpha-and Beta-adrenergic Agonists,DrugBank
DB14752,Herbs and Natural Products,DrugBank
DB14752,Norepinephrine Releasing Agents,DrugBank
DB14752,Sympathomimetic (Adrenergic) Agents,DrugBank
DB14754,"Acids, Acyclic",DrugBank
DB14754,Adrenergic Agents,DrugBank
DB14754,Adrenergic Uptake Inhibitors,DrugBank
DB14754,Agents producing tachycardia,DrugBank
DB14754,Agents that produce hypertension,DrugBank
DB14754,Amino Acids,DrugBank
DB14754,"Amino Acids, Aromatic",DrugBank
DB14754,"Amino Acids, Cyclic",DrugBank
DB14754,"Amino Acids, Peptides, and Proteins",DrugBank
DB14754,Antidepressive Agents,DrugBank
DB14754,Central Nervous System Agents,DrugBank
DB14754,Central Nervous System Depressants,DrugBank
DB14754,Centrally Acting Sympathomimetics,DrugBank
DB14754,Dopamine Agents,DrugBank
DB14754,Dopamine And Norepinephrine Reuptake Inhibitors,DrugBank
DB14754,Dopamine Uptake Inhibitors,DrugBank
DB14754,Drugs that are Mainly Renally Excreted,DrugBank
DB14754,MATE 1 Substrates,DrugBank
DB14754,MATE substrates,DrugBank
DB14754,Nervous System,DrugBank
DB14754,Norepinephrine Reuptake Inhibitor,DrugBank
DB14754,OCT2 Substrates,DrugBank
DB14754,Psychoanaleptics,DrugBank
DB14754,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB14754,Wakefulness-Promoting Agents,DrugBank
DB14761,Adenine Nucleotides,DrugBank
DB14761,Amino Acids,DrugBank
DB14761,"Amino Acids, Peptides, and Proteins",DrugBank
DB14761,Anti-Infective Agents,DrugBank
DB14761,Antiinfectives for Systemic Use,DrugBank
DB14761,Antimetabolites,DrugBank
DB14761,Antiviral Agents,DrugBank
DB14761,Antivirals for Systemic Use,DrugBank
DB14761,Approved Treatments for COVID-19,DrugBank
DB14761,BSEP/ABCB11 Inhibitors,DrugBank
DB14761,Carbohydrates,DrugBank
DB14761,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14761,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14761,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14761,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14761,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14761,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB14761,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14761,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14761,Cytochrome P-450 Substrates,DrugBank
DB14761,Direct Acting Antivirals,DrugBank
DB14761,Glycosides,DrugBank
DB14761,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14761,MATE 1 Inhibitors,DrugBank
DB14761,MATE inhibitors,DrugBank
DB14761,Noxae,DrugBank
DB14761,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB14761,Nucleosides and Nucleotides,DrugBank
DB14761,Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors,DrugBank
DB14761,Nucleotides,DrugBank
DB14761,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB14761,OATP1B1/SLCO1B1 Substrates,DrugBank
DB14761,OATP1B3 inhibitors,DrugBank
DB14761,P-glycoprotein substrates,DrugBank
DB14761,Prodrugs,DrugBank
DB14761,Purine Nucleotides,DrugBank
DB14761,Purines,DrugBank
DB14761,Ribonucleotides,DrugBank
DB14761,SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor,DrugBank
DB14761,Toxic Actions,DrugBank
DB14762,"Amino Acids, Peptides, and Proteins",DrugBank
DB14762,Antibodies,DrugBank
DB14762,"Antibodies, Monoclonal",DrugBank
DB14762,"Antibodies, Monoclonal, Humanized",DrugBank
DB14762,Antineoplastic and Immunomodulating Agents,DrugBank
DB14762,Blood Proteins,DrugBank
DB14762,Globulins,DrugBank
DB14762,Immunoglobulins,DrugBank
DB14762,Immunoproteins,DrugBank
DB14762,Immunosuppressive Agents,DrugBank
DB14762,Immunotherapy,DrugBank
DB14762,Interleukin Inhibitors,DrugBank
DB14762,Interleukin-23 Antagonist,DrugBank
DB14762,Interleukin-23 Subunit p19,DrugBank
DB14762,Misc. Skin and Mucous Membrane Agents,DrugBank
DB14762,Proteins,DrugBank
DB14762,Selective Immunosuppressants,DrugBank
DB14762,Serum Globulins,DrugBank
DB14763,Amidines,DrugBank
DB14763,Anti-Infective Agents,DrugBank
DB14763,Antimalarials,DrugBank
DB14763,Antiparasitic Agents,DrugBank
DB14763,"Antiparasitic Products, Insecticides and Repellents",DrugBank
DB14763,Antiprotozoals,DrugBank
DB14763,Biguanides,DrugBank
DB14763,Enzyme Inhibitors,DrugBank
DB14763,Folic Acid Antagonists,DrugBank
DB14763,Guanidines,DrugBank
DB14764,Biological Products,DrugBank
DB14764,Complex Mixtures,DrugBank
DB14764,Vaccines,DrugBank
DB14764,Viral Vaccines,DrugBank
DB14765,Antineoplastic Agents,DrugBank
DB14765,Enzyme Inhibitors,DrugBank
DB14765,Protein Kinase Inhibitors,DrugBank
DB14766,"Acids, Acyclic",DrugBank
DB14766,Antineoplastic and Immunomodulating Agents,DrugBank
DB14766,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14766,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14766,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14766,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14766,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14766,Cytochrome P-450 Substrates,DrugBank
DB14766,Fatty Acids,DrugBank
DB14766,"Fatty Acids, Volatile",DrugBank
DB14766,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14766,Immunosuppressive Agents,DrugBank
DB14766,Lipids,DrugBank
DB14766,Sphingosine-1-phosphate (S1P) receptor modulators,DrugBank
DB14776,"Amino Acids, Peptides, and Proteins",DrugBank
DB14776,Antibodies,DrugBank
DB14776,"Antibodies, Monoclonal",DrugBank
DB14776,"Antibodies, Monoclonal, Humanized",DrugBank
DB14776,Blood Proteins,DrugBank
DB14776,Globulins,DrugBank
DB14776,Immune Checkpoint Inhibitors,DrugBank
DB14776,Immunoglobulins,DrugBank
DB14776,Immunoproteins,DrugBank
DB14776,Proteins,DrugBank
DB14776,Serum Globulins,DrugBank
DB14777,"Amino Acids, Peptides, and Proteins",DrugBank
DB14777,Anti-Bacterial Agents,DrugBank
DB14777,Anti-Infective Agents,DrugBank
DB14777,Peptides,DrugBank
DB14778,"Amino Acids, Peptides, and Proteins",DrugBank
DB14778,Antibodies,DrugBank
DB14778,Blood Proteins,DrugBank
DB14778,Globulins,DrugBank
DB14778,Immunoglobulins,DrugBank
DB14778,Immunoproteins,DrugBank
DB14778,Proteins,DrugBank
DB14778,Serum Globulins,DrugBank
DB14783,"Acids, Acyclic",DrugBank
DB14783,Antineoplastic and Immunomodulating Agents,DrugBank
DB14783,Dicarboxylic Acids,DrugBank
DB14783,Fumarates,DrugBank
DB14783,Hepatotoxic Agents,DrugBank
DB14783,Immunosuppressive Agents,DrugBank
DB14784,"Amino Acids, Peptides, and Proteins",DrugBank
DB14784,Anthracyclines,DrugBank
DB14784,Antibodies,DrugBank
DB14784,"Antibodies, Monoclonal",DrugBank
DB14784,Blood Proteins,DrugBank
DB14784,Carbohydrates,DrugBank
DB14784,Globulins,DrugBank
DB14784,Glycosides,DrugBank
DB14784,Immunoglobulin Fab Fragments,DrugBank
DB14784,Immunoglobulin Fragments,DrugBank
DB14784,Immunoglobulin Variable Region,DrugBank
DB14784,Immunoglobulins,DrugBank
DB14784,Immunologic Factors,DrugBank
DB14784,Immunoproteins,DrugBank
DB14784,Naphthacenes,DrugBank
DB14784,Peptide Fragments,DrugBank
DB14784,Peptides,DrugBank
DB14784,Proteins,DrugBank
DB14784,Serum Globulins,DrugBank
DB14792,Antineoplastic Agents,DrugBank
DB14809,"Amino Acids, Peptides, and Proteins",DrugBank
DB14809,Antibodies,DrugBank
DB14809,Antibody-drug Conjugates,DrugBank
DB14809,Blood Proteins,DrugBank
DB14809,Globulins,DrugBank
DB14809,Immunoglobulins,DrugBank
DB14809,Immunologic Factors,DrugBank
DB14809,"Lactams, Macrocyclic",DrugBank
DB14809,Lactones,DrugBank
DB14809,Proteins,DrugBank
DB14809,Serum Globulins,DrugBank
DB14811,"Amino Acids, Peptides, and Proteins",DrugBank
DB14811,Antibodies,DrugBank
DB14811,"Antibodies, Monoclonal",DrugBank
DB14811,Antineoplastic Agents,DrugBank
DB14811,Antineoplastic and Immunomodulating Agents,DrugBank
DB14811,Blood Proteins,DrugBank
DB14811,Cancer immunotherapy,DrugBank
DB14811,CD38 (Clusters of Differentiation 38) inhibitors,DrugBank
DB14811,CD38-directed Antibody Interactions,DrugBank
DB14811,CD38-directed Cytolytic Antibody,DrugBank
DB14811,Globulins,DrugBank
DB14811,Immunoglobulins,DrugBank
DB14811,Immunoproteins,DrugBank
DB14811,Immunotherapy,DrugBank
DB14811,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14811,"Multiple Myeloma, drug therapy",DrugBank
DB14811,Narrow Therapeutic Index Drugs,DrugBank
DB14811,Proteins,DrugBank
DB14811,Serum Globulins,DrugBank
DB14824,"Amino Acids, Peptides, and Proteins",DrugBank
DB14824,Antibodies,DrugBank
DB14824,"Antibodies, Monoclonal",DrugBank
DB14824,Blood Proteins,DrugBank
DB14824,Globulins,DrugBank
DB14824,Immunoglobulins,DrugBank
DB14824,Immunoproteins,DrugBank
DB14824,Proteins,DrugBank
DB14824,Serum Globulins,DrugBank
DB14840,Amides,DrugBank
DB14840,Antineoplastic Agents,DrugBank
DB14840,Antineoplastic and Immunomodulating Agents,DrugBank
DB14840,BCRP/ABCG2 Inhibitors,DrugBank
DB14840,BCRP/ABCG2 Substrates,DrugBank
DB14840,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB14840,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB14840,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14840,Cytochrome P-450 CYP2E1 Substrates,DrugBank
DB14840,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14840,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14840,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14840,Cytochrome P-450 Substrates,DrugBank
DB14840,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14840,Kinase Inhibitor,DrugBank
DB14840,MATE 1 Inhibitors,DrugBank
DB14840,MATE inhibitors,DrugBank
DB14840,P-glycoprotein inhibitors,DrugBank
DB14840,P-glycoprotein substrates,DrugBank
DB14840,Platelet-derived Growth Factor alpha Receptor Inhibitors,DrugBank
DB14840,Protein Kinase Inhibitors,DrugBank
DB14840,Stem Cell Factor (KIT) Receptor Inhibitors,DrugBank
DB14843,"Amino Acids, Peptides, and Proteins",DrugBank
DB14843,Antibodies,DrugBank
DB14843,"Antibodies, Monoclonal",DrugBank
DB14843,"Antibodies, Monoclonal, Humanized",DrugBank
DB14843,Blood Proteins,DrugBank
DB14843,Globulins,DrugBank
DB14843,Immunoglobulins,DrugBank
DB14843,Immunoproteins,DrugBank
DB14843,Proteins,DrugBank
DB14843,Serum Globulins,DrugBank
DB14844,Antineoplastic Agents,DrugBank
DB14844,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14844,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14844,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14844,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14844,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB14844,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB14844,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB14844,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB14844,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB14844,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14844,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14844,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14844,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14844,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14844,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14844,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14844,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14844,Cytochrome P-450 Substrates,DrugBank
DB14844,Highest Risk QTc-Prolonging Agents,DrugBank
DB14844,MATE 1 Inhibitors,DrugBank
DB14844,MATE 2 Inhibitors,DrugBank
DB14844,MATE inhibitors,DrugBank
DB14844,OAT1/SLC22A6 inhibitors,DrugBank
DB14844,OAT3/SLC22A8 Inhibitors,DrugBank
DB14844,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB14844,OATP1B3 inhibitors,DrugBank
DB14844,OCT1 inhibitors,DrugBank
DB14844,QTc Prolonging Agents,DrugBank
DB14845,Antineoplastic and Immunomodulating Agents,DrugBank
DB14845,"Arthritis, Rheumatoid, drug therapy",DrugBank
DB14845,Immunosuppressive Agents,DrugBank
DB14845,"Janus Kinase 1, antagonists & inhibitors",DrugBank
DB14845,Janus Kinase Inhibitor,DrugBank
DB14845,"Janus Kinases, antagonists & inhibitors",DrugBank
DB14845,P-glycoprotein substrates,DrugBank
DB14845,Selective Immunosuppressants,DrugBank
DB14851,"Amino Acids, Peptides, and Proteins",DrugBank
DB14851,Antibodies,DrugBank
DB14851,"Antibodies, Monoclonal",DrugBank
DB14851,Antineoplastic Agents,DrugBank
DB14851,"Antineoplastic Agents, Immunological",DrugBank
DB14851,Antineoplastic and Immunomodulating Agents,DrugBank
DB14851,Blood Proteins,DrugBank
DB14851,Globulins,DrugBank
DB14851,Immune Checkpoint Inhibitors,DrugBank
DB14851,Immunoglobulins,DrugBank
DB14851,Immunoproteins,DrugBank
DB14851,Lymphocyte Activation Gene-3 Blocker,DrugBank
DB14851,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14851,Proteins,DrugBank
DB14851,Serum Globulins,DrugBank
DB14860,Antineoplastic Agents,DrugBank
DB14860,Enzyme Inhibitors,DrugBank
DB14860,P-glycoprotein substrates,DrugBank
DB14860,Protein Kinase Inhibitors,DrugBank
DB14864,"Amino Acids, Peptides, and Proteins",DrugBank
DB14864,Angiogenesis Inhibitors,DrugBank
DB14864,Antibodies,DrugBank
DB14864,"Antibodies, Monoclonal",DrugBank
DB14864,"Antibodies, Monoclonal, Humanized",DrugBank
DB14864,Antineovascularisation Agents,DrugBank
DB14864,Blood Proteins,DrugBank
DB14864,"EENT Drugs, Miscellaneous",DrugBank
DB14864,Globulins,DrugBank
DB14864,Immunoglobulins,DrugBank
DB14864,Immunoproteins,DrugBank
DB14864,Ocular Vascular Disorder Agents,DrugBank
DB14864,Ophthalmologicals,DrugBank
DB14864,Proteins,DrugBank
DB14864,Sensory Organs,DrugBank
DB14864,Serum Globulins,DrugBank
DB14864,Vascular Endothelial Growth Factor Inhibitor,DrugBank
DB14865,"Amino Acids, Peptides, and Proteins",DrugBank
DB14865,Analgesics,DrugBank
DB14865,"Analgesics, Non-Narcotic",DrugBank
DB14865,Antineoplastic Agents,DrugBank
DB14865,Biological Factors,DrugBank
DB14865,Central Nervous System Agents,DrugBank
DB14865,Cytokines,DrugBank
DB14865,Intercellular Signaling Peptides and Proteins,DrugBank
DB14865,Interleukin-2,DrugBank
DB14865,Interleukins,DrugBank
DB14865,Lymphokines,DrugBank
DB14865,Peptides,DrugBank
DB14865,Peripheral Nervous System Agents,DrugBank
DB14865,Proteins,DrugBank
DB14865,Sensory System Agents,DrugBank
DB14871,"Amino Acids, Peptides, and Proteins",DrugBank
DB14871,Antibodies,DrugBank
DB14871,"Antibodies, Monoclonal",DrugBank
DB14871,"Antibodies, Monoclonal, Humanized",DrugBank
DB14871,Blood Proteins,DrugBank
DB14871,Globulins,DrugBank
DB14871,Immunoglobulins,DrugBank
DB14871,Immunoproteins,DrugBank
DB14871,Proteins,DrugBank
DB14871,Serum Globulins,DrugBank
DB14877,"Amino Acids, Peptides, and Proteins",DrugBank
DB14877,Antibodies,DrugBank
DB14877,"Antibodies, Monoclonal",DrugBank
DB14877,"Antibodies, Monoclonal, Humanized",DrugBank
DB14877,Antineoplastic Agents,DrugBank
DB14877,"Antineoplastic Agents, Immunological",DrugBank
DB14877,Blood Proteins,DrugBank
DB14877,Globulins,DrugBank
DB14877,Immunoglobulins,DrugBank
DB14877,Immunoproteins,DrugBank
DB14877,Proteins,DrugBank
DB14877,Serum Globulins,DrugBank
DB14881,Analgesics,DrugBank
DB14881,Anesthetics,DrugBank
DB14881,Central Nervous System Agents,DrugBank
DB14881,Central Nervous System Depressants,DrugBank
DB14881,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14881,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14881,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB14881,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14881,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14881,Cytochrome P-450 Substrates,DrugBank
DB14881,Ligands,DrugBank
DB14881,Narcotics,DrugBank
DB14881,Nervous System,DrugBank
DB14881,Neuraxial Anesthetics,DrugBank
DB14881,Opiate Agonists,DrugBank
DB14881,Opioid Agonist,DrugBank
DB14881,Opioids,DrugBank
DB14881,Peripheral Nervous System Agents,DrugBank
DB14881,Sensory System Agents,DrugBank
DB14881,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome,DrugBank
DB14881,Sulfur Compounds,DrugBank
DB14891,"Amino Acids, Peptides, and Proteins",DrugBank
DB14891,"Antibodies, Monoclonal",DrugBank
DB14891,"Antibodies, Monoclonal, Humanized",DrugBank
DB14891,Blood Proteins,DrugBank
DB14891,Globulins,DrugBank
DB14891,Immunoglobulin Fab Fragments,DrugBank
DB14891,Immunoglobulin Fragments,DrugBank
DB14891,Immunoglobulin Variable Region,DrugBank
DB14891,Immunoglobulins,DrugBank
DB14891,Immunoproteins,DrugBank
DB14891,Peptide Fragments,DrugBank
DB14891,Peptides,DrugBank
DB14891,Proteins,DrugBank
DB14891,Serum Globulins,DrugBank
DB14895,Adrenergic Agonists,DrugBank
DB14895,Adrenergic beta-3 Receptor Agonists,DrugBank
DB14895,Adrenergic beta-Agonists,DrugBank
DB14895,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14895,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14895,Cytochrome P-450 Substrates,DrugBank
DB14895,Drugs for Urinary Frequency and Incontinence,DrugBank
DB14895,Genito Urinary System and Sex Hormones,DrugBank
DB14895,Genitourinary Smooth Muscle Relaxants,DrugBank
DB14895,P-glycoprotein substrates,DrugBank
DB14895,Pyrimidines,DrugBank
DB14895,Selective Beta 3-adrenergic Agonists,DrugBank
DB14895,Urologicals,DrugBank
DB14897,"Amino Acids, Peptides, and Proteins",DrugBank
DB14897,Antibodies,DrugBank
DB14897,"Antibodies, Monoclonal",DrugBank
DB14897,"Antibodies, Monoclonal, Humanized",DrugBank
DB14897,Blood Proteins,DrugBank
DB14897,Globulins,DrugBank
DB14897,Immunoglobulins,DrugBank
DB14897,Immunoproteins,DrugBank
DB14897,Proteins,DrugBank
DB14897,Serum Globulins,DrugBank
DB14905,"Amino Acids, Peptides, and Proteins",DrugBank
DB14905,Antibodies,DrugBank
DB14905,"Antibodies, Monoclonal",DrugBank
DB14905,"Antibodies, Monoclonal, Humanized",DrugBank
DB14905,Blood Proteins,DrugBank
DB14905,Globulins,DrugBank
DB14905,Immunoglobulins,DrugBank
DB14905,Immunoproteins,DrugBank
DB14905,Proteins,DrugBank
DB14905,Serum Globulins,DrugBank
DB14907,"Amino Acids, Peptides, and Proteins",DrugBank
DB14907,Antibodies,DrugBank
DB14907,"Antibodies, Monoclonal",DrugBank
DB14907,"Antibodies, Monoclonal, Humanized",DrugBank
DB14907,Blood Proteins,DrugBank
DB14907,"Compounds used in a research, industrial, or household setting",DrugBank
DB14907,Diagnostic Uses of Chemicals,DrugBank
DB14907,Elements,DrugBank
DB14907,Globulins,DrugBank
DB14907,Immunoglobulins,DrugBank
DB14907,Immunoproteins,DrugBank
DB14907,Indicators and Reagents,DrugBank
DB14907,Isotopes,DrugBank
DB14907,Laboratory Chemicals,DrugBank
DB14907,Metals,DrugBank
DB14907,"Metals, Heavy",DrugBank
DB14907,Proteins,DrugBank
DB14907,Radiopharmaceuticals,DrugBank
DB14907,Serum Globulins,DrugBank
DB14907,Transition Elements,DrugBank
DB14908,"Amino Acids, Peptides, and Proteins",DrugBank
DB14908,Antibodies,DrugBank
DB14908,"Antibodies, Monoclonal",DrugBank
DB14908,"Antibodies, Monoclonal, Humanized",DrugBank
DB14908,Blood Proteins,DrugBank
DB14908,Globulins,DrugBank
DB14908,Immunoglobulins,DrugBank
DB14908,Immunoproteins,DrugBank
DB14908,"Myelin-Associated Glycoprotein, antagonists & inhibitors",DrugBank
DB14908,Proteins,DrugBank
DB14908,Serum Globulins,DrugBank
DB14909,Antineoplastic Agents,DrugBank
DB14909,Antineoplastic and Immunomodulating Agents,DrugBank
DB14909,Enzyme Inhibitors,DrugBank
DB14909,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB14909,Nucleotides,DrugBank
DB14909,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB14909,OATP1B3 inhibitors,DrugBank
DB14909,Oligonucleotide Telomerase Inhibitor,DrugBank
DB14909,Polynucleotides,DrugBank
DB14909,"Telomerase, antagonists & inhibitors",DrugBank
DB14910,"Amino Acids, Peptides, and Proteins",DrugBank
DB14910,Analgesics,DrugBank
DB14910,Anti-Inflammatory Agents,DrugBank
DB14910,Anti-Ulcer Agents,DrugBank
DB14910,Antibodies,DrugBank
DB14910,"Antibodies, Monoclonal",DrugBank
DB14910,"Antibodies, Monoclonal, Humanized",DrugBank
DB14910,Antineoplastic and Immunomodulating Agents,DrugBank
DB14910,Antirheumatic Agents,DrugBank
DB14910,Blood Proteins,DrugBank
DB14910,Gastrointestinal Agents,DrugBank
DB14910,Globulins,DrugBank
DB14910,Immunoglobulins,DrugBank
DB14910,Immunoproteins,DrugBank
DB14910,Immunosuppressive Agents,DrugBank
DB14910,Interleukin Inhibitors,DrugBank
DB14910,Interleukin-23 Antagonist,DrugBank
DB14910,Proteins,DrugBank
DB14910,Serum Globulins,DrugBank
DB14919,"Amino Acids, Peptides, and Proteins",DrugBank
DB14919,Antibodies,DrugBank
DB14919,"Antibodies, Monoclonal",DrugBank
DB14919,Antineoplastic and Immunomodulating Agents,DrugBank
DB14919,Blood Proteins,DrugBank
DB14919,Globulins,DrugBank
DB14919,Immunoglobulins,DrugBank
DB14919,Immunologic Factors,DrugBank
DB14919,Immunoproteins,DrugBank
DB14919,Immunosuppressive Agents,DrugBank
DB14919,Neonatal Fc Receptor Blocker,DrugBank
DB14919,Proteins,DrugBank
DB14919,Serum Globulins,DrugBank
DB14921,Amines,DrugBank
DB14921,Benzene Derivatives,DrugBank
DB14921,Benzyl Compounds,DrugBank
DB14921,Cardiac Myosin Inhibitor,DrugBank
DB14921,Cardiac Therapy,DrugBank
DB14921,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB14921,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB14921,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB14921,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB14921,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14921,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14921,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB14921,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB14921,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14921,Cytochrome P-450 CYP3A Inducers,DrugBank
DB14921,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14921,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB14921,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB14921,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14921,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB14921,Cytochrome P-450 Enzyme Inducers,DrugBank
DB14921,Cytochrome P-450 Substrates,DrugBank
DB14921,Pyrimidines,DrugBank
DB14921,Pyrimidinones,DrugBank
DB14922,"Amino Acids, Peptides, and Proteins",DrugBank
DB14922,Antibodies,DrugBank
DB14922,"Antibodies, Monoclonal",DrugBank
DB14922,"Antibodies, Monoclonal, Humanized",DrugBank
DB14922,Antineoplastic Agents,DrugBank
DB14922,"Antineoplastic Agents, Immunological",DrugBank
DB14922,Antineoplastic and Immunomodulating Agents,DrugBank
DB14922,Blood Proteins,DrugBank
DB14922,Globulins,DrugBank
DB14922,Immune Checkpoint Inhibitors,DrugBank
DB14922,Immunoglobulins,DrugBank
DB14922,Immunoproteins,DrugBank
DB14922,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14922,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB14922,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB14922,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB14922,Proteins,DrugBank
DB14922,Serum Globulins,DrugBank
DB14924,Antineoplastic and Immunomodulating Agents,DrugBank
DB14924,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB14924,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB14924,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB14924,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB14924,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14924,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB14924,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14924,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB14924,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB14924,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14924,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB14924,Cytochrome P-450 Substrates,DrugBank
DB14924,Immunomodulatory Agents,DrugBank
DB14924,Immunosuppressive Agents,DrugBank
DB14924,"Janus Kinase 3, antagonists & inhibitors",DrugBank
DB14924,Janus Kinase Inhibitor,DrugBank
DB14924,Janus Kinase Inhibitors,DrugBank
DB14924,"Janus Kinases, antagonists & inhibitors",DrugBank
DB14938,"Acids, Acyclic",DrugBank
DB14938,Analgesics,DrugBank
DB14938,"Analgesics, Non-Narcotic",DrugBank
DB14938,Anti-Inflammatory Agents,DrugBank
DB14938,"Anti-Inflammatory Agents, Non-Steroidal",DrugBank
DB14938,Antirheumatic Agents,DrugBank
DB14938,Benzene Derivatives,DrugBank
DB14938,Biphenyl Compounds,DrugBank
DB14938,Peripheral Nervous System Agents,DrugBank
DB14938,Propionates,DrugBank
DB14938,Sensory System Agents,DrugBank
DB14947,"Amino Acids, Peptides, and Proteins",DrugBank
DB14947,Antibodies,DrugBank
DB14947,"Antibodies, Monoclonal",DrugBank
DB14947,Antineoplastic Agents,DrugBank
DB14947,Antineoplastic and Immunomodulating Agents,DrugBank
DB14947,Blood Proteins,DrugBank
DB14947,Globulins,DrugBank
DB14947,Immunoglobulins,DrugBank
DB14947,Immunoproteins,DrugBank
DB14947,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14947,Proteins,DrugBank
DB14947,Serum Globulins,DrugBank
DB14951,Alcohols,DrugBank
DB14951,Antineoplastic Agents,DrugBank
DB14951,Antineoplastic and Immunomodulating Agents,DrugBank
DB14951,Enzyme Inhibitors,DrugBank
DB14951,Ethylene Glycols,DrugBank
DB14951,Glycols,DrugBank
DB14951,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14951,Macromolecular Substances,DrugBank
DB14951,Polymers,DrugBank
DB14951,Topoisomerase 1 (TOP1) inhibitors,DrugBank
DB14951,Topoisomerase II Inhibitors,DrugBank
DB14951,Topoisomerase Inhibitors,DrugBank
DB14952,"Amino Acids, Peptides, and Proteins",DrugBank
DB14952,Antibodies,DrugBank
DB14952,"Antibodies, Monoclonal",DrugBank
DB14952,Blood Proteins,DrugBank
DB14952,Globulins,DrugBank
DB14952,Immunoglobulins,DrugBank
DB14952,Immunoproteins,DrugBank
DB14952,Proteins,DrugBank
DB14952,Serum Globulins,DrugBank
DB14959,"Amino Acids, Peptides, and Proteins",DrugBank
DB14959,Antibodies,DrugBank
DB14959,Blood Proteins,DrugBank
DB14959,Globulins,DrugBank
DB14959,Immunoglobulins,DrugBank
DB14959,Immunoproteins,DrugBank
DB14959,Proteins,DrugBank
DB14959,Serum Globulins,DrugBank
DB14960,"Amino Acids, Peptides, and Proteins",DrugBank
DB14960,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB14960,Growth Hormone,DrugBank
DB14960,Hormones,DrugBank
DB14960,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB14960,Peptide Hormones,DrugBank
DB14960,Peptides,DrugBank
DB14960,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB14960,Pituitary Hormones,DrugBank
DB14960,"Pituitary Hormones, Anterior",DrugBank
DB14960,Recombinant Human Growth Hormone,DrugBank
DB14960,Somatropin and Somatropin Agonists,DrugBank
DB14960,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB14962,"Amino Acids, Peptides, and Proteins",DrugBank
DB14962,Antibodies,DrugBank
DB14962,"Antibodies, Monoclonal",DrugBank
DB14962,"Antibodies, Monoclonal, Humanized",DrugBank
DB14962,Antibody-drug Conjugates,DrugBank
DB14962,Antineoplastic Agents,DrugBank
DB14962,Antineoplastic and Immunomodulating Agents,DrugBank
DB14962,BCRP/ABCG2 Substrates,DrugBank
DB14962,Blood Proteins,DrugBank
DB14962,Cancer immunotherapy,DrugBank
DB14962,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14962,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14962,Cytochrome P-450 Substrates,DrugBank
DB14962,Globulins,DrugBank
DB14962,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB14962,HER2 Receptor Antagonists,DrugBank
DB14962,Immunoglobulins,DrugBank
DB14962,Immunologic Factors,DrugBank
DB14962,Immunoproteins,DrugBank
DB14962,Immunotherapy,DrugBank
DB14962,MATE 2 Substrates,DrugBank
DB14962,MATE substrates,DrugBank
DB14962,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14962,Noxae,DrugBank
DB14962,OATP1B3 substrates,DrugBank
DB14962,P-glycoprotein substrates,DrugBank
DB14962,Proteins,DrugBank
DB14962,Serum Globulins,DrugBank
DB14962,Topoisomerase Inhibitors,DrugBank
DB14962,Toxic Actions,DrugBank
DB14963,Carbohydrates,DrugBank
DB14963,Gastrointestinal Agents,DrugBank
DB14963,Laxatives,DrugBank
DB14963,Plants,DrugBank
DB14963,Polysaccharides,DrugBank
DB14967,"Amino Acids, Peptides, and Proteins",DrugBank
DB14967,Antibodies,DrugBank
DB14967,"Antibodies, Monoclonal",DrugBank
DB14967,"Antibodies, Monoclonal, Humanized",DrugBank
DB14967,Antineoplastic Agents,DrugBank
DB14967,Antineoplastic and Immunomodulating Agents,DrugBank
DB14967,Blood Proteins,DrugBank
DB14967,Globulins,DrugBank
DB14967,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB14967,HER2 Receptor Antagonists,DrugBank
DB14967,Immunoglobulins,DrugBank
DB14967,Immunoproteins,DrugBank
DB14967,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB14967,Proteins,DrugBank
DB14967,Serum Globulins,DrugBank
DB14973,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB14973,Amides,DrugBank
DB14973,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB14973,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14973,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14973,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14973,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14973,Cytochrome P-450 Substrates,DrugBank
DB14973,Dermatologicals,DrugBank
DB14973,Enzyme Inhibitors,DrugBank
DB14973,"Janus Kinase 1, antagonists & inhibitors",DrugBank
DB14973,Janus Kinase Inhibitor,DrugBank
DB14973,Janus Kinase Inhibitors,DrugBank
DB14973,"Janus Kinases, antagonists & inhibitors",DrugBank
DB14973,OAT3/SLC22A8 Substrates,DrugBank
DB14973,OCT1 inhibitors,DrugBank
DB14973,P-glycoprotein inhibitors,DrugBank
DB14973,Protein Kinase Inhibitors,DrugBank
DB14973,Sulfones,DrugBank
DB14973,Sulfur Compounds,DrugBank
DB14975,Aldehydes,DrugBank
DB14975,Blood and Blood Forming Organs,DrugBank
DB14975,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB14975,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB14975,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14975,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14975,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14975,Cytochrome P-450 Substrates,DrugBank
DB14975,Hematologic Agents,DrugBank
DB14975,Hemoglobin S Polymerization Inhibitors,DrugBank
DB14988,Activin Receptors,DrugBank
DB14988,"Amino Acids, Peptides, and Proteins",DrugBank
DB14988,Blood Proteins,DrugBank
DB14988,Enzymes,DrugBank
DB14988,Enzymes and Coenzymes,DrugBank
DB14988,Globulins,DrugBank
DB14988,Immunoglobulin Constant Regions,DrugBank
DB14988,Immunoglobulin Fragments,DrugBank
DB14988,Immunoglobulins,DrugBank
DB14988,Immunoproteins,DrugBank
DB14988,Intracellular Signaling Peptides and Proteins,DrugBank
DB14988,Membrane Proteins,DrugBank
DB14988,Peptide Fragments,DrugBank
DB14988,Peptides,DrugBank
DB14988,Phosphotransferases,DrugBank
DB14988,Phosphotransferases (Alcohol Group Acceptor),DrugBank
DB14988,Protein Kinases,DrugBank
DB14988,Protein-Serine-Threonine Kinases,DrugBank
DB14988,Proteins,DrugBank
DB14988,"Receptors, Growth Factor",DrugBank
DB14988,"Receptors, Peptide",DrugBank
DB14988,"Receptors, Transforming Growth Factor beta",DrugBank
DB14988,Recombinant Proteins,DrugBank
DB14988,Serum Globulins,DrugBank
DB14988,Transferases,DrugBank
DB14989,Antineoplastic Agents,DrugBank
DB14989,Antineoplastic and Immunomodulating Agents,DrugBank
DB14989,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB14989,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB14989,Cytochrome P-450 CYP3A Substrates,DrugBank
DB14989,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB14989,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB14989,Cytochrome P-450 Substrates,DrugBank
DB14989,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB14989,Kinase Inhibitor,DrugBank
DB14989,P-glycoprotein inhibitors,DrugBank
DB14989,Protein Kinase Inhibitors,DrugBank
DB14996,"Amino Acids, Peptides, and Proteins",DrugBank
DB14996,Antibodies,DrugBank
DB14996,"Antibodies, Monoclonal",DrugBank
DB14996,Antineoplastic and Immunomodulating Agents,DrugBank
DB14996,Blood Proteins,DrugBank
DB14996,Classical Complement Pathway Inhibitor,DrugBank
DB14996,Complement Inactivating Agents,DrugBank
DB14996,Globulins,DrugBank
DB14996,Immunoglobulins,DrugBank
DB14996,Immunoproteins,DrugBank
DB14996,Immunosuppressive Agents,DrugBank
DB14996,Proteins,DrugBank
DB14996,Selective Immunosuppressants,DrugBank
DB14996,Serum Globulins,DrugBank
DB14997,"Amino Acids, Peptides, and Proteins",DrugBank
DB14997,Antibodies,DrugBank
DB14997,"Antibodies, Monoclonal",DrugBank
DB14997,"Antibodies, Monoclonal, Humanized",DrugBank
DB14997,"Arthritis, Rheumatoid, drug therapy",DrugBank
DB14997,Blood Proteins,DrugBank
DB14997,Globulins,DrugBank
DB14997,Immunoglobulins,DrugBank
DB14997,Immunoproteins,DrugBank
DB14997,Proteins,DrugBank
DB14997,Serum Globulins,DrugBank
DB14999,"Amino Acids, Peptides, and Proteins",DrugBank
DB14999,Anti-Infective Agents,DrugBank
DB14999,Biological Factors,DrugBank
DB14999,Experimental Unapproved Treatments for COVID-19,DrugBank
DB14999,Immunologic Factors,DrugBank
DB14999,Intercellular Signaling Peptides and Proteins,DrugBank
DB14999,Interferon Type I,DrugBank
DB14999,Interferons,DrugBank
DB14999,Peptides,DrugBank
DB14999,Proteins,DrugBank
DB15001,"Adjuvants, Immunologic",DrugBank
DB15001,"Amino Acids, Peptides, and Proteins",DrugBank
DB15001,Antineoplastic and Immunomodulating Agents,DrugBank
DB15001,Biological Factors,DrugBank
DB15001,Blood Proteins,DrugBank
DB15001,Carbohydrates,DrugBank
DB15001,Colony-Stimulating Factors,DrugBank
DB15001,Cytokines,DrugBank
DB15001,Globulins,DrugBank
DB15001,Glycoconjugates,DrugBank
DB15001,Glycoproteins,DrugBank
DB15001,Granulocyte Colony-Stimulating Factors,DrugBank
DB15001,Hematopoietic Cell Growth Factors,DrugBank
DB15001,Immunoglobulin Constant Regions,DrugBank
DB15001,Immunoglobulin Fragments,DrugBank
DB15001,Immunoglobulins,DrugBank
DB15001,Immunoproteins,DrugBank
DB15001,Intercellular Signaling Peptides and Proteins,DrugBank
DB15001,Leukocyte Growth Factor,DrugBank
DB15001,Peptide Fragments,DrugBank
DB15001,Peptides,DrugBank
DB15001,Proteins,DrugBank
DB15001,Serum Globulins,DrugBank
DB15002,Antisense Elements (Genetics),DrugBank
DB15002,Antithrombin-directed RNA Interaction,DrugBank
DB15002,Nucleic Acids,DrugBank
DB15002,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB15002,"RNA, Antisense",DrugBank
DB15002,"RNA, Small Untranslated",DrugBank
DB15002,"RNA, Untranslated",DrugBank
DB15002,Small Interfering RNA,DrugBank
DB15011,Amines,DrugBank
DB15011,Antineoplastic and Immunomodulating Agents,DrugBank
DB15011,Complement 5a Receptor Antagonist,DrugBank
DB15011,Complement Inactivating Agents,DrugBank
DB15011,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB15011,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB15011,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB15011,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB15011,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15011,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15011,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15011,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15011,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15011,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15011,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15011,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15011,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15011,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15011,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15011,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15011,Cytochrome P-450 Substrates,DrugBank
DB15011,Immunosuppressive Agents,DrugBank
DB15011,P-glycoprotein substrates,DrugBank
DB15011,Piperidines,DrugBank
DB15011,Selective Immunosuppressants,DrugBank
DB15014,"Amino Acids, Peptides, and Proteins",DrugBank
DB15014,Antibodies,DrugBank
DB15014,Blood Proteins,DrugBank
DB15014,Globulins,DrugBank
DB15014,Immunoglobulins,DrugBank
DB15014,Immunoproteins,DrugBank
DB15014,Proteins,DrugBank
DB15014,Serum Globulins,DrugBank
DB15022,"Amino Acids, Peptides, and Proteins",DrugBank
DB15022,Antibodies,DrugBank
DB15022,"Antibodies, Monoclonal",DrugBank
DB15022,Blood Proteins,DrugBank
DB15022,Globulins,DrugBank
DB15022,Immunoglobulins,DrugBank
DB15022,Immunoproteins,DrugBank
DB15022,Proteins,DrugBank
DB15022,Serum Globulins,DrugBank
DB15031,Central Nervous System Depressants,DrugBank
DB15031,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15031,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15031,Cytochrome P-450 Substrates,DrugBank
DB15031,Hypnotics and Sedatives,DrugBank
DB15031,Nervous System,DrugBank
DB15031,Orexin Receptor Antagonists,DrugBank
DB15031,Psycholeptics,DrugBank
DB15031,Wakefulness-Promoting Agents,DrugBank
DB15035,Antineoplastic Agents,DrugBank
DB15035,Antineoplastic and Immunomodulating Agents,DrugBank
DB15035,Bruton's tyrosine kinase (BTK) inhibitors,DrugBank
DB15035,Bruton's Tyrosine Kinase Inhibitors,DrugBank
DB15035,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB15035,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB15035,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB15035,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index,DrugBank
DB15035,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15035,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15035,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index,DrugBank
DB15035,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15035,Cytochrome P-450 Substrates,DrugBank
DB15035,Enzyme Inhibitors,DrugBank
DB15035,Hematologic Agents,DrugBank
DB15035,Kinase Inhibitor,DrugBank
DB15035,Narrow Therapeutic Index Drugs,DrugBank
DB15035,P-glycoprotein substrates,DrugBank
DB15035,P-glycoprotein substrates with a Narrow Therapeutic Index,DrugBank
DB15035,Protein Kinase Inhibitors,DrugBank
DB15035,Teratogens,DrugBank
DB15035,Tyrosine Kinase Inhibitors,DrugBank
DB15043,"Amino Acids, Peptides, and Proteins",DrugBank
DB15043,Antibodies,DrugBank
DB15043,"Antibodies, Monoclonal",DrugBank
DB15043,Antineoplastic Agents,DrugBank
DB15043,"Antineoplastic Agents, Immunological",DrugBank
DB15043,Antineoplastic and Immunomodulating Agents,DrugBank
DB15043,Blood Proteins,DrugBank
DB15043,Globulins,DrugBank
DB15043,Immune Checkpoint Inhibitors,DrugBank
DB15043,Immunoglobulins,DrugBank
DB15043,Immunoproteins,DrugBank
DB15043,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15043,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB15043,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB15043,Proteins,DrugBank
DB15043,Serum Globulins,DrugBank
DB15044,"Amino Acids, Peptides, and Proteins",DrugBank
DB15044,Antibodies,DrugBank
DB15044,"Antibodies, Monoclonal",DrugBank
DB15044,"Antibodies, Monoclonal, Humanized",DrugBank
DB15044,Antineoplastic Agents,DrugBank
DB15044,Antineoplastic and Immunomodulating Agents,DrugBank
DB15044,Blood Proteins,DrugBank
DB15044,Cancer immunotherapy,DrugBank
DB15044,Globulins,DrugBank
DB15044,Immunoglobulins,DrugBank
DB15044,Immunoproteins,DrugBank
DB15044,Immunotherapy,DrugBank
DB15044,"Lymphoma, B-Cell",DrugBank
DB15044,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15044,Proteins,DrugBank
DB15044,Serum Globulins,DrugBank
DB15045,"Amino Acids, Peptides, and Proteins",DrugBank
DB15045,Blood Proteins,DrugBank
DB15045,Globulins,DrugBank
DB15045,Immunoglobulin Constant Regions,DrugBank
DB15045,Immunoglobulin Fragments,DrugBank
DB15045,Immunoglobulins,DrugBank
DB15045,Immunoproteins,DrugBank
DB15045,Membrane Proteins,DrugBank
DB15045,Peptide Fragments,DrugBank
DB15045,Peptides,DrugBank
DB15045,Proteins,DrugBank
DB15045,Recombinant Proteins,DrugBank
DB15045,Serum Globulins,DrugBank
DB15057,Antineoplastic Agents,DrugBank
DB15057,Cytosine Nucleotides,DrugBank
DB15057,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB15057,Nucleotides,DrugBank
DB15057,Pyrimidine Nucleotides,DrugBank
DB15057,Pyrimidines,DrugBank
DB15057,Ribonucleotides,DrugBank
DB15059,Amides,DrugBank
DB15059,Antihypertensive Agents,DrugBank
DB15059,BCRP/ABCG2 Inhibitors,DrugBank
DB15059,BCRP/ABCG2 Substrates,DrugBank
DB15059,BSEP/ABCB11 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP2C18 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP2C18 Inhibitors (strength unknown),DrugBank
DB15059,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB15059,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15059,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15059,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15059,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15059,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15059,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15059,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15059,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15059,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15059,Endothelin Receptor Antagonists,DrugBank
DB15059,P-glycoprotein substrates,DrugBank
DB15059,Sulfones,DrugBank
DB15059,Sulfur Compounds,DrugBank
DB15059,UGT1A1 Inhibitors,DrugBank
DB15059,UGT1A1 Substrates,DrugBank
DB15059,UGT2B7 Inhibitors,DrugBank
DB15059,UGT2B7 substrates,DrugBank
DB15066,Alimentary Tract and Metabolism,DrugBank
DB15066,Amino Sugars,DrugBank
DB15066,Aminolevulinate Synthase 1-directed RNA Interaction,DrugBank
DB15066,Aminolevulinate Synthase 1-Directed Small Interfering RNAs,DrugBank
DB15066,Antisense Oligonucleotides,DrugBank
DB15066,Carbohydrates,DrugBank
DB15066,Galactosamine,DrugBank
DB15066,Hepatotoxic Agents,DrugBank
DB15066,Hexosamines,DrugBank
DB15066,Nephrotoxic agents,DrugBank
DB15066,Oligonucleotides,DrugBank
DB15066,Other Miscellaneous Therapeutic Agents,DrugBank
DB15066,"Porphyrias, Hepatic",DrugBank
DB15066,"RNA, Antisense",DrugBank
DB15066,Small Interfering RNA,DrugBank
DB15066,Various Alimentary Tract and Metabolism Products,DrugBank
DB15076,"Amino Acids, Peptides, and Proteins",DrugBank
DB15076,Antibodies,DrugBank
DB15076,"Antibodies, Monoclonal",DrugBank
DB15076,Blood Proteins,DrugBank
DB15076,Globulins,DrugBank
DB15076,Immunoglobulins,DrugBank
DB15076,Immunoproteins,DrugBank
DB15076,Proteins,DrugBank
DB15076,Serum Globulins,DrugBank
DB15089,"Amino Acids, Peptides, and Proteins",DrugBank
DB15089,Antibodies,DrugBank
DB15089,"Antibodies, Monoclonal",DrugBank
DB15089,"Antibodies, Monoclonal, Humanized",DrugBank
DB15089,Blood Proteins,DrugBank
DB15089,Globulins,DrugBank
DB15089,Immunoglobulins,DrugBank
DB15089,Immunoproteins,DrugBank
DB15089,Proteins,DrugBank
DB15089,Serum Globulins,DrugBank
DB15090,"Amino Acids, Peptides, and Proteins",DrugBank
DB15090,Antibodies,DrugBank
DB15090,"Antibodies, Monoclonal",DrugBank
DB15090,Blood Proteins,DrugBank
DB15090,Drugs for Obstructive Airway Diseases,DrugBank
DB15090,Globulins,DrugBank
DB15090,Immunoglobulins,DrugBank
DB15090,Immunoproteins,DrugBank
DB15090,Proteins,DrugBank
DB15090,Serum Globulins,DrugBank
DB15090,Thymic Stromal Lymphopoietin Blocker,DrugBank
DB15091,Antineoplastic and Immunomodulating Agents,DrugBank
DB15091,Antirheumatic Agents,DrugBank
DB15091,BCRP/ABCG2 Inhibitors,DrugBank
DB15091,BCRP/ABCG2 Substrates,DrugBank
DB15091,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15091,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15091,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15091,Cytochrome P-450 Substrates,DrugBank
DB15091,Disease-modifying Antirheumatic Agents,DrugBank
DB15091,Enzyme Inhibitors,DrugBank
DB15091,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15091,Immunosuppressive Agents,DrugBank
DB15091,Janus Kinase Inhibitor,DrugBank
DB15091,Janus Kinase Inhibitors,DrugBank
DB15091,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB15091,P-glycoprotein inhibitors,DrugBank
DB15091,P-glycoprotein substrates,DrugBank
DB15091,Protein Kinase Inhibitors,DrugBank
DB15091,Selective Immunosuppressants,DrugBank
DB15093,Alcohols,DrugBank
DB15093,Amino Acids,DrugBank
DB15093,"Amino Acids, Cyclic",DrugBank
DB15093,"Amino Acids, Essential",DrugBank
DB15093,"Amino Acids, Peptides, and Proteins",DrugBank
DB15093,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB15093,Benzene Derivatives,DrugBank
DB15093,Carbohydrates,DrugBank
DB15093,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB15093,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB15093,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB15093,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB15093,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15093,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15093,Growth Hormone,DrugBank
DB15093,Hormones,DrugBank
DB15093,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15093,Human Growth Hormone Analogs,DrugBank
DB15093,Lipids,DrugBank
DB15093,Peptide Hormones,DrugBank
DB15093,Peptides,DrugBank
DB15093,Phenols,DrugBank
DB15093,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB15093,Pituitary Hormones,DrugBank
DB15093,"Pituitary Hormones, Anterior",DrugBank
DB15093,Somatropin and Somatropin Agonists,DrugBank
DB15093,Sugar Alcohols,DrugBank
DB15093,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB15095,"Amino Acids, Peptides, and Proteins",DrugBank
DB15095,Biological Factors,DrugBank
DB15095,Carbohydrates,DrugBank
DB15095,Colony-Stimulating Factors,DrugBank
DB15095,Cytokines,DrugBank
DB15095,Glycoconjugates,DrugBank
DB15095,Glycoproteins,DrugBank
DB15095,Hematopoietic Cell Growth Factors,DrugBank
DB15095,Intercellular Signaling Peptides and Proteins,DrugBank
DB15095,Interleukins,DrugBank
DB15095,Peptides,DrugBank
DB15095,Proteins,DrugBank
DB15095,Recombinant Proteins,DrugBank
DB15097,Amides,DrugBank
DB15097,BCRP/ABCG2 Substrates,DrugBank
DB15097,Benzene Derivatives,DrugBank
DB15097,Cough and Cold Preparations,DrugBank
DB15097,MATE 1 Substrates,DrugBank
DB15097,MATE 2 Substrates,DrugBank
DB15097,MATE substrates,DrugBank
DB15097,P-glycoprotein substrates,DrugBank
DB15097,Sulfonamides,DrugBank
DB15097,Sulfones,DrugBank
DB15097,Sulfur Compounds,DrugBank
DB15101,"Amino Acids, Peptides, and Proteins",DrugBank
DB15101,Antibodies,DrugBank
DB15101,"Antibodies, Monoclonal",DrugBank
DB15101,"Antibodies, Monoclonal, Humanized",DrugBank
DB15101,Blood Proteins,DrugBank
DB15101,Globulins,DrugBank
DB15101,Immunoglobulins,DrugBank
DB15101,Immunoproteins,DrugBank
DB15101,Proteins,DrugBank
DB15101,Serum Globulins,DrugBank
DB15102,Antineoplastic Agents,DrugBank
DB15102,Antineoplastic and Immunomodulating Agents,DrugBank
DB15102,BCRP/ABCG2 Substrates,DrugBank
DB15102,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15102,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15102,Cytochrome P-450 Substrates,DrugBank
DB15102,"Fibroblast Growth Factor 2, antagonists & inhibitors",DrugBank
DB15102,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,DrugBank
DB15102,Kinase Inhibitor,DrugBank
DB15102,MATE 1 Inhibitors,DrugBank
DB15102,MATE inhibitors,DrugBank
DB15102,OCT2 Inhibitors,DrugBank
DB15102,Oxazines,DrugBank
DB15102,P-glycoprotein inhibitors,DrugBank
DB15102,P-glycoprotein substrates,DrugBank
DB15102,Protein Kinase Inhibitors,DrugBank
DB15102,"Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors",DrugBank
DB15102,"Receptor, Fibroblast Growth Factor, Type 2, antagonists & inhibitors",DrugBank
DB15102,"Receptors, Fibroblast Growth Factor, antagonists & inhibitors",DrugBank
DB15104,"Amino Acids, Peptides, and Proteins",DrugBank
DB15104,Antibodies,DrugBank
DB15104,"Antibodies, Monoclonal",DrugBank
DB15104,"Antibodies, Monoclonal, Humanized",DrugBank
DB15104,Blood Proteins,DrugBank
DB15104,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15104,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15104,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15104,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15104,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15104,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB15104,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB15104,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB15104,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15104,Cytochrome P-450 Substrates,DrugBank
DB15104,Globulins,DrugBank
DB15104,Immunoglobulins,DrugBank
DB15104,Immunoproteins,DrugBank
DB15104,Microtubule Inhibitors,DrugBank
DB15104,Proteins,DrugBank
DB15104,Serum Globulins,DrugBank
DB15112,Alcohols,DrugBank
DB15112,"Amino Acids, Peptides, and Proteins",DrugBank
DB15112,Ethylene Glycols,DrugBank
DB15112,Glycols,DrugBank
DB15112,Growth Hormone,DrugBank
DB15112,Hormones,DrugBank
DB15112,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15112,Macromolecular Substances,DrugBank
DB15112,Peptide Hormones,DrugBank
DB15112,Peptides,DrugBank
DB15112,Pituitary Hormones,DrugBank
DB15112,"Pituitary Hormones, Anterior",DrugBank
DB15112,Polymers,DrugBank
DB15113,"Amino Acids, Peptides, and Proteins",DrugBank
DB15113,Antibodies,DrugBank
DB15113,"Antibodies, Monoclonal",DrugBank
DB15113,Blood Proteins,DrugBank
DB15113,Globulins,DrugBank
DB15113,Immunoglobulin Isotypes,DrugBank
DB15113,Immunoglobulins,DrugBank
DB15113,Immunoproteins,DrugBank
DB15113,Proteins,DrugBank
DB15113,Serum Globulins,DrugBank
DB15114,Adrenal Cortex Hormones,DrugBank
DB15114,Anti-Inflammatory Agents,DrugBank
DB15114,Corticosteroids,DrugBank
DB15114,Corticosteroids for Systemic Use,DrugBank
DB15114,"Corticosteroids for Systemic Use, Plain",DrugBank
DB15114,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB15114,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15114,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15114,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15114,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15114,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15114,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB15114,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15114,Cytochrome P-450 Substrates,DrugBank
DB15114,Fused-Ring Compounds,DrugBank
DB15114,Glucocorticoids,DrugBank
DB15114,Pregnadienes,DrugBank
DB15114,Pregnanes,DrugBank
DB15114,Steroids,DrugBank
DB15114,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB15114,UGT1A3 substrates,DrugBank
DB15114,UGT2B17 substrates,DrugBank
DB15114,UGT2B7 substrates,DrugBank
DB15118,"Amino Acids, Peptides, and Proteins",DrugBank
DB15118,Antibodies,DrugBank
DB15118,Antineoplastic Agents,DrugBank
DB15118,Antineoplastic and Immunomodulating Agents,DrugBank
DB15118,Blood Proteins,DrugBank
DB15118,Claudin 18.2-directed Cytolytic Antibody,DrugBank
DB15118,Globulins,DrugBank
DB15118,Immunoglobulins,DrugBank
DB15118,Immunoproteins,DrugBank
DB15118,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15118,Proteins,DrugBank
DB15118,Serum Globulins,DrugBank
DB15119,"Adjuvants, Immunologic",DrugBank
DB15119,Alfa Interferons,DrugBank
DB15119,Antineoplastic and Immunomodulating Agents,DrugBank
DB15119,Cancer immunotherapy,DrugBank
DB15119,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB15119,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB15119,Cytochrome P-450 CYP2A6 Inhibitors,DrugBank
DB15119,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown),DrugBank
DB15119,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB15119,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB15119,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15119,Immunosuppressive Agents,DrugBank
DB15119,Immunotherapy,DrugBank
DB15119,Interferons,DrugBank
DB15119,Myelosuppressive Agents,DrugBank
DB15120,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15120,Histamine Antagonists,DrugBank
DB15122,Deuterium,DrugBank
DB15122,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15122,Purines,DrugBank
DB15122,Purinones,DrugBank
DB15122,Xanthine derivatives,DrugBank
DB15131,"Amino Acids, Peptides, and Proteins",DrugBank
DB15131,Biological Factors,DrugBank
DB15131,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB15131,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB15131,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15131,Cytokines,DrugBank
DB15131,Intercellular Signaling Peptides and Proteins,DrugBank
DB15131,Interferon Type I,DrugBank
DB15131,Interferons,DrugBank
DB15131,Peptides,DrugBank
DB15131,Proteins,DrugBank
DB15133,Antineoplastic Agents,DrugBank
DB15133,Antineoplastic and Immunomodulating Agents,DrugBank
DB15133,BCRP/ABCG2 Inhibitors,DrugBank
DB15133,BSEP/ABCB11 Inhibitors,DrugBank
DB15133,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB15133,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15133,Cytochrome P-450 CYP2C9 Inhibitors (strong),DrugBank
DB15133,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15133,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15133,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15133,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB15133,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15133,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15133,Cytochrome P-450 Substrates,DrugBank
DB15133,Kinase Inhibitor,DrugBank
DB15133,MATE 1 Inhibitors,DrugBank
DB15133,MATE 2 Inhibitors,DrugBank
DB15133,MATE inhibitors,DrugBank
DB15133,Mesenchymal Epithelial Transition Inhibitors,DrugBank
DB15133,OCT1 inhibitors,DrugBank
DB15133,OCT2 Inhibitors,DrugBank
DB15133,P-glycoprotein inhibitors,DrugBank
DB15133,P-glycoprotein substrates,DrugBank
DB15133,Protein Kinase Inhibitors,DrugBank
DB15133,"Proto-Oncogene Proteins c-met, antagonists & inhibitors",DrugBank
DB15133,Tyrosine Kinase Inhibitors,DrugBank
DB15135,"Amino Acids, Peptides, and Proteins",DrugBank
DB15135,Antibodies,DrugBank
DB15135,"Antibodies, Monoclonal",DrugBank
DB15135,"Antibodies, Monoclonal, Humanized",DrugBank
DB15135,Blood Proteins,DrugBank
DB15135,Globulins,DrugBank
DB15135,Immunoglobulins,DrugBank
DB15135,Immunoproteins,DrugBank
DB15135,Proteins,DrugBank
DB15135,Serum Globulins,DrugBank
DB15141,BCRP/ABCG2 Inhibitors,DrugBank
DB15141,Cystic Fibrosis Transmembrane Conductance Regulator Potentiators,DrugBank
DB15141,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15141,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15141,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15141,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15141,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15141,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15141,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15141,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15149,Antineoplastic Agents,DrugBank
DB15149,Antineoplastic and Immunomodulating Agents,DrugBank
DB15149,BCRP/ABCG2 Substrates,DrugBank
DB15149,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15149,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15149,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15149,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15149,Cytochrome P-450 Substrates,DrugBank
DB15149,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,DrugBank
DB15149,Kinase Inhibitor,DrugBank
DB15149,P-glycoprotein inhibitors,DrugBank
DB15149,P-glycoprotein substrates,DrugBank
DB15149,Protein Kinase Inhibitors,DrugBank
DB15157,Antineoplastic Agents,DrugBank
DB15157,Carbohydrates,DrugBank
DB15157,Enzyme Inhibitors,DrugBank
DB15157,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15157,Imines,DrugBank
DB15157,Imino Sugars,DrugBank
DB15157,Protein Kinase Inhibitors,DrugBank
DB15157,Pyrans,DrugBank
DB15157,Pyrrolidines,DrugBank
DB15160,"Amino Acids, Peptides, and Proteins",DrugBank
DB15160,Antibodies,DrugBank
DB15160,Blood Proteins,DrugBank
DB15160,"Glioma, drug therapy",DrugBank
DB15160,Globulins,DrugBank
DB15160,Immunoglobulin Isotypes,DrugBank
DB15160,Immunoglobulins,DrugBank
DB15160,Immunoproteins,DrugBank
DB15160,Membrane Proteins,DrugBank
DB15160,Proteins,DrugBank
DB15160,"Receptors, Death Domain",DrugBank
DB15160,Recombinant Proteins,DrugBank
DB15160,Serum Globulins,DrugBank
DB15165,"Aptamers, Nucleotide",DrugBank
DB15165,Complement Inactivating Agents,DrugBank
DB15165,Complement Inactivator Proteins,DrugBank
DB15165,Immunologic Factors,DrugBank
DB15165,Immunosuppressive Agents,DrugBank
DB15165,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB15165,Nucleotides,DrugBank
DB15165,Oligonucleotides,DrugBank
DB15165,Ophthalmologicals,DrugBank
DB15165,Polynucleotides,DrugBank
DB15165,Sensory Organs,DrugBank
DB15167,"Acids, Carbocyclic",DrugBank
DB15167,Amides,DrugBank
DB15167,Benzene Derivatives,DrugBank
DB15167,Benzoates,DrugBank
DB15167,Dopamine Agents,DrugBank
DB15167,Dopamine Antagonists,DrugBank
DB15167,Dopamine D2 Receptor Antagonists,DrugBank
DB15167,Neurotransmitter Agents,DrugBank
DB15171,Alimentary Tract and Metabolism,DrugBank
DB15171,"Amino Acids, Peptides, and Proteins",DrugBank
DB15171,Blood Glucose Lowering Agents,DrugBank
DB15171,Drugs Used in Diabetes,DrugBank
DB15171,Gastrointestinal Hormones,DrugBank
DB15171,GLP-1 Agonists,DrugBank
DB15171,Glucagon-Like Peptide Receptors,DrugBank
DB15171,Glucose-dependent Insulinotropic Polypeptide Receptor Agonist,DrugBank
DB15171,Hormones,DrugBank
DB15171,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15171,Incretins,DrugBank
DB15171,Membrane Proteins,DrugBank
DB15171,Nerve Tissue Proteins,DrugBank
DB15171,Neuropeptides,DrugBank
DB15171,Peptide Hormones,DrugBank
DB15171,Peptides,DrugBank
DB15171,Proteins,DrugBank
DB15171,"Receptors, G-Protein-Coupled",DrugBank
DB15171,"Receptors, Gastrointestinal Hormone",DrugBank
DB15171,"Receptors, Peptide",DrugBank
DB15172,"Amino Acids, Peptides, and Proteins",DrugBank
DB15172,Antibodies,DrugBank
DB15172,"Antibodies, Monoclonal",DrugBank
DB15172,"Antibodies, Neutralizing",DrugBank
DB15172,Blood Proteins,DrugBank
DB15172,Globulins,DrugBank
DB15172,Immunoglobulins,DrugBank
DB15172,Immunoproteins,DrugBank
DB15172,Proteins,DrugBank
DB15172,Serum Globulins,DrugBank
DB15192,Histamine Antagonists,DrugBank
DB15203,Amides,DrugBank
DB15203,Anticonvulsants,DrugBank
DB15203,Central Nervous System Depressants,DrugBank
DB15203,Sulfones,DrugBank
DB15203,Sulfur Compounds,DrugBank
DB15212,"Acids, Acyclic",DrugBank
DB15212,Fatty Acids,DrugBank
DB15212,"Fatty Acids, Volatile",DrugBank
DB15212,Fibric Acids,DrugBank
DB15212,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15212,Lipid Modifying Agents,DrugBank
DB15212,"Lipid Modifying Agents, Plain",DrugBank
DB15212,Lipid Regulating Agents,DrugBank
DB15212,Lipids,DrugBank
DB15213,Anti-Bacterial Agents,DrugBank
DB15213,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15213,"Lactams, Macrocyclic",DrugBank
DB15213,Rifamycins,DrugBank
DB15215,Antineoplastic Agents,DrugBank
DB15215,Enzyme Inhibitors,DrugBank
DB15215,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15215,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB15215,Nucleosides,DrugBank
DB15215,Protein Synthesis Inhibitors,DrugBank
DB15215,Purines,DrugBank
DB15217,"Amino Acids, Peptides, and Proteins",DrugBank
DB15217,Blood Glucose Lowering Agents,DrugBank
DB15217,Gastrointestinal Agents,DrugBank
DB15217,Gastrointestinal Hormones,DrugBank
DB15217,Hormones,DrugBank
DB15217,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15217,Incretins,DrugBank
DB15217,Nerve Tissue Proteins,DrugBank
DB15217,Neuropeptides,DrugBank
DB15217,Peptide Hormones,DrugBank
DB15217,Peptides,DrugBank
DB15217,Proteins,DrugBank
DB15218,"Amino Acids, Peptides, and Proteins",DrugBank
DB15218,Antibodies,DrugBank
DB15218,"Antibodies, Monoclonal",DrugBank
DB15218,Antineoplastic and Immunomodulating Agents,DrugBank
DB15218,Blood Proteins,DrugBank
DB15218,Complement Inactivating Agents,DrugBank
DB15218,Globulins,DrugBank
DB15218,Immunoglobulins,DrugBank
DB15218,Immunoproteins,DrugBank
DB15218,Immunosuppressive Agents,DrugBank
DB15218,Proteins,DrugBank
DB15218,Serum Globulins,DrugBank
DB15225,"Amino Acids, Peptides, and Proteins",DrugBank
DB15225,Antibodies,DrugBank
DB15225,"Antibodies, Monoclonal",DrugBank
DB15225,Blood Proteins,DrugBank
DB15225,Globulins,DrugBank
DB15225,Immunoglobulins,DrugBank
DB15225,Immunoproteins,DrugBank
DB15225,Proteins,DrugBank
DB15225,Serum Globulins,DrugBank
DB15226,"Amino Acids, Peptides, and Proteins",DrugBank
DB15226,Antihypertensive Agents,DrugBank
DB15226,Antihypoglycemic Agent,DrugBank
DB15226,Glucagon Receptor Agonists,DrugBank
DB15226,Glycogenolytic Hormones,DrugBank
DB15226,Hormones,DrugBank
DB15226,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15226,Increased Glycogenolysis,DrugBank
DB15226,Pancreatic Hormones,DrugBank
DB15226,Peptide Hormones,DrugBank
DB15226,Peptides,DrugBank
DB15226,Proglucagon,DrugBank
DB15226,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB15233,Antineoplastic Agents,DrugBank
DB15233,Antineoplastic and Immunomodulating Agents,DrugBank
DB15233,BCRP/ABCG2 Inhibitors,DrugBank
DB15233,Bile Salt Export Pump Inhibitors,DrugBank
DB15233,BSEP/ABCB11 Inhibitors,DrugBank
DB15233,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15233,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15233,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15233,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15233,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15233,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15233,Cytochrome P-450 Substrates,DrugBank
DB15233,Kinase Inhibitor,DrugBank
DB15233,MATE 1 Inhibitors,DrugBank
DB15233,MATE 2 Inhibitors,DrugBank
DB15233,MATE 2-K Inhibitors,DrugBank
DB15233,MATE inhibitors,DrugBank
DB15233,P-glycoprotein inhibitors,DrugBank
DB15233,Protein Kinase Inhibitors,DrugBank
DB15233,Tyrosine Kinase Inhibitors,DrugBank
DB15245,Acetates,DrugBank
DB15245,"Acids, Acyclic",DrugBank
DB15245,Amides,DrugBank
DB15245,Anti-Infective Agents,DrugBank
DB15245,Antifungal Agents,DrugBank
DB15252,"Agents for Dermatitis, Excluding Corticosteroids",DrugBank
DB15252,"Amino Acids, Peptides, and Proteins",DrugBank
DB15252,Antibodies,DrugBank
DB15252,"Antibodies, Monoclonal",DrugBank
DB15252,"Antibodies, Monoclonal, Humanized",DrugBank
DB15252,Blood Proteins,DrugBank
DB15252,Dermatologicals,DrugBank
DB15252,Globulins,DrugBank
DB15252,Immunoglobulins,DrugBank
DB15252,Immunoproteins,DrugBank
DB15252,Interleukin Inhibitors,DrugBank
DB15252,Interleukin-31 Receptor alpha Antagonist,DrugBank
DB15252,Proteins,DrugBank
DB15252,Serum Globulins,DrugBank
DB15253,"Amino Acids, Peptides, and Proteins",DrugBank
DB15253,Antibodies,DrugBank
DB15253,"Antibodies, Monoclonal",DrugBank
DB15253,Blood Proteins,DrugBank
DB15253,Globulins,DrugBank
DB15253,Immunoglobulins,DrugBank
DB15253,Immunoproteins,DrugBank
DB15253,Immunosuppressive Agents,DrugBank
DB15253,Proteins,DrugBank
DB15253,Serum Globulins,DrugBank
DB15254,BCRP/ABCG2 Substrates,DrugBank
DB15254,Benzopyrans,DrugBank
DB15254,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15254,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15254,Cytochrome P-450 Substrates,DrugBank
DB15254,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15254,Kinase Inhibitor,DrugBank
DB15254,Protein Kinase Inhibitors,DrugBank
DB15254,Pyrans,DrugBank
DB15258,Antineoplastic and Immunomodulating Agents,DrugBank
DB15258,Endopeptidases,DrugBank
DB15258,Immunosuppressive Agents,DrugBank
DB15258,Immunotherapy,DrugBank
DB15258,Selective Immunosuppressants,DrugBank
DB15263,"Amino Acids, Peptides, and Proteins",DrugBank
DB15263,Diagnostic Agents,DrugBank
DB15263,Hormones,DrugBank
DB15263,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15263,Peptide Hormones,DrugBank
DB15263,Peptides,DrugBank
DB15263,Pituitary Hormones,DrugBank
DB15263,"Pituitary Hormones, Anterior",DrugBank
DB15263,Tests for Thyreoidea Function,DrugBank
DB15263,Thyroid Products,DrugBank
DB15266,B-Raf serine-threonine kinase (BRAF) inhibitors,DrugBank
DB15266,BCRP/ABCG2 Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB15266,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB15266,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15266,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15266,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15266,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15266,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15266,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15266,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15266,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15266,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15266,Cytochrome P-450 Substrates,DrugBank
DB15266,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15266,Kinase Inhibitor,DrugBank
DB15266,Sulfur Compounds,DrugBank
DB15270,Antibodies,DrugBank
DB15270,Antineoplastic and Immunomodulating Agents,DrugBank
DB15270,Globulins,DrugBank
DB15270,Human Immunoglobulin G,DrugBank
DB15270,Immunoglobulin Fc Fragments,DrugBank
DB15270,Immunoproteins,DrugBank
DB15270,Immunosuppressive Agents,DrugBank
DB15270,Neonatal Fc Receptor Blocker,DrugBank
DB15270,Selective Immunosuppressants,DrugBank
DB15274,Bacterial Vaccines,DrugBank
DB15274,Biological Products,DrugBank
DB15274,Complex Mixtures,DrugBank
DB15274,Vaccines,DrugBank
DB15277,"Amino Acids, Peptides, and Proteins",DrugBank
DB15277,Antibodies,DrugBank
DB15277,"Antibodies, Monoclonal",DrugBank
DB15277,Blood Proteins,DrugBank
DB15277,Globulins,DrugBank
DB15277,Immunoglobulins,DrugBank
DB15277,Immunoproteins,DrugBank
DB15277,Proteins,DrugBank
DB15277,Serum Globulins,DrugBank
DB15283,"Amino Acids, Peptides, and Proteins",DrugBank
DB15283,Antineoplastic Agents,DrugBank
DB15283,Antineoplastic and Immunomodulating Agents,DrugBank
DB15283,Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager,DrugBank
DB15283,Cancer immunotherapy,DrugBank
DB15283,Immunotherapy,DrugBank
DB15283,"Melanoma, therapy",DrugBank
DB15283,Proteins,DrugBank
DB15283,Recombinant Proteins,DrugBank
DB15289,Antineoplastic Agents,DrugBank
DB15289,Enzyme Inhibitors,DrugBank
DB15289,Perilla,DrugBank
DB15289,Terpenes,DrugBank
DB15290,"Adjuvants, Immunologic",DrugBank
DB15290,Antineoplastic and Immunomodulating Agents,DrugBank
DB15290,Colony-Stimulating Factors,DrugBank
DB15300,Alkaloids,DrugBank
DB15300,Antiarrhythmic agents,DrugBank
DB15300,"Antiarrhythmics, Class I",DrugBank
DB15300,"Antiarrhythmics, Class Ia",DrugBank
DB15300,Autonomic Agents,DrugBank
DB15300,Cardiac Therapy,DrugBank
DB15300,Cardiovascular Agents,DrugBank
DB15300,Cinchona Alkaloids,DrugBank
DB15300,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15300,Parasympatholytics,DrugBank
DB15300,Peripheral Nervous System Agents,DrugBank
DB15300,Quinolines,DrugBank
DB15300,Quinuclidines,DrugBank
DB15305,BCRP/ABCG2 Substrates,DrugBank
DB15305,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB15305,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15305,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15305,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB15305,Cytochrome P-450 Substrates,DrugBank
DB15305,MATE 1 Inhibitors,DrugBank
DB15305,MATE 2 Inhibitors,DrugBank
DB15305,MATE inhibitors,DrugBank
DB15305,Musculo-Skeletal System,DrugBank
DB15305,Other Miscellaneous Therapeutic Agents,DrugBank
DB15305,P-glycoprotein substrates,DrugBank
DB15305,Peripheral Nervous System Agents,DrugBank
DB15305,Survival Motor Neuron-2-directed RNA Interaction,DrugBank
DB15305,Survival of Motor Neuron 2 Splicing Modifier,DrugBank
DB15317,"Acids, Acyclic",DrugBank
DB15317,Alkaloids,DrugBank
DB15317,Carbamates,DrugBank
DB15317,Cholinergic Agents,DrugBank
DB15317,Cholinesterase Inhibitors,DrugBank
DB15317,Enzyme Inhibitors,DrugBank
DB15317,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15317,Indole Alkaloids,DrugBank
DB15317,Indoles,DrugBank
DB15317,Indolizidines,DrugBank
DB15317,Indolizines,DrugBank
DB15317,Neurotransmitter Agents,DrugBank
DB15317,Phenylcarbamates,DrugBank
DB15317,Stereoisomerism,DrugBank
DB15321,Amides,DrugBank
DB15321,Amines,DrugBank
DB15321,Aniline Compounds,DrugBank
DB15321,Antineoplastic Agents,DrugBank
DB15321,Histone Deacetylase Inhibitors,DrugBank
DB15321,Hydroxy Acids,DrugBank
DB15321,Hydroxylamines,DrugBank
DB15328,Analgesics,DrugBank
DB15328,Antimigraine Preparations,DrugBank
DB15328,BCRP/ABCG2 Substrates,DrugBank
DB15328,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB15328,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB15328,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB15328,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB15328,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15328,Cytochrome P-450 CYP2C8 Inhibitors (weak),DrugBank
DB15328,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15328,Cytochrome P-450 CYP2C9 Inhibitors (weak),DrugBank
DB15328,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB15328,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB15328,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15328,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15328,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15328,Cytochrome P-450 Substrates,DrugBank
DB15328,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates,DrugBank
DB15328,Nervous System,DrugBank
DB15328,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB15328,OATP1B1/SLCO1B1 Substrates,DrugBank
DB15328,OATP1B3 inhibitors,DrugBank
DB15328,OATP1B3 substrates,DrugBank
DB15328,OCT2 Inhibitors,DrugBank
DB15328,P-glycoprotein substrates,DrugBank
DB15328,UGT1A1 Inhibitors,DrugBank
DB15334,Anticarcinogenic Agents,DrugBank
DB15334,Antineoplastic Agents,DrugBank
DB15334,Benzopyrans,DrugBank
DB15334,Chromones,DrugBank
DB15334,"Compounds used in a research, industrial, or household setting",DrugBank
DB15334,Estrogens,DrugBank
DB15334,"Estrogens, Non-Steroidal",DrugBank
DB15334,Flavonoids,DrugBank
DB15334,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15334,Hormones,DrugBank
DB15334,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15334,Isoflavones,DrugBank
DB15334,Phytoestrogens,DrugBank
DB15334,Protective Agents,DrugBank
DB15334,Pyrans,DrugBank
DB15335,Benzopyrans,DrugBank
DB15335,Chromones,DrugBank
DB15335,Estrogens,DrugBank
DB15335,"Estrogens, Non-Steroidal",DrugBank
DB15335,Flavonoids,DrugBank
DB15335,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15335,Hormones,DrugBank
DB15335,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15335,Phytoestrogens,DrugBank
DB15335,Pyrans,DrugBank
DB15336,"Amino Acids, Peptides, and Proteins",DrugBank
DB15336,Antibodies,DrugBank
DB15336,Blood Proteins,DrugBank
DB15336,Enzymes,DrugBank
DB15336,Enzymes and Coenzymes,DrugBank
DB15336,Globulins,DrugBank
DB15336,Glycoside Hydrolases,DrugBank
DB15336,Hydrolases,DrugBank
DB15336,Immunoglobulins,DrugBank
DB15336,Immunoproteins,DrugBank
DB15336,Proteins,DrugBank
DB15336,Recombinant Proteins,DrugBank
DB15336,Serum Globulins,DrugBank
DB15349,"Amino Acids, Peptides, and Proteins",DrugBank
DB15349,Antibodies,DrugBank
DB15349,"Antibodies, Monoclonal",DrugBank
DB15349,"Antibodies, Monoclonal, Humanized",DrugBank
DB15349,Blood Proteins,DrugBank
DB15349,Globulins,DrugBank
DB15349,Immunoglobulins,DrugBank
DB15349,Immunologic Factors,DrugBank
DB15349,Proteins,DrugBank
DB15349,Serum Globulins,DrugBank
DB15351,Antineoplastic Agents,DrugBank
DB15351,Biological Factors,DrugBank
DB15351,Dermatologicals,DrugBank
DB15351,Hematoporphyrin Derivative,DrugBank
DB15351,Hematoporphyrins,DrugBank
DB15351,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15351,Photosensitizing Agents,DrugBank
DB15351,"Pigments, Biological",DrugBank
DB15351,Porphyrins,DrugBank
DB15351,Radiation-Sensitizing Agents,DrugBank
DB15357,Autonomic Agents,DrugBank
DB15357,Central Nervous System Agents,DrugBank
DB15357,Cholinergic Agents,DrugBank
DB15357,Cholinergic Agonists,DrugBank
DB15357,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB15357,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB15357,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB15357,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15357,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15357,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15357,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15357,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15357,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15357,Cytochrome P-450 Substrates,DrugBank
DB15357,Muscarinic Agonists,DrugBank
DB15357,Neurotransmitter Agents,DrugBank
DB15357,P-glycoprotein inhibitors,DrugBank
DB15357,Parasympathomimetics,DrugBank
DB15357,Peripheral Nervous System Agents,DrugBank
DB15357,Sulfur Compounds,DrugBank
DB15357,Thiazoles,DrugBank
DB15360,Analgesics,DrugBank
DB15360,Carbon Radioisotopes,DrugBank
DB15360,Central Nervous System Agents,DrugBank
DB15360,Central Nervous System Depressants,DrugBank
DB15360,Narcotics,DrugBank
DB15360,Opioids,DrugBank
DB15360,Peripheral Nervous System Agents,DrugBank
DB15360,Piperidines,DrugBank
DB15360,Sensory System Agents,DrugBank
DB15363,"Amino Acids, Peptides, and Proteins",DrugBank
DB15363,Antibodies,DrugBank
DB15363,"Antibodies, Monoclonal",DrugBank
DB15363,Blood Proteins,DrugBank
DB15363,Globulins,DrugBank
DB15363,Immunoglobulins,DrugBank
DB15363,Immunoproteins,DrugBank
DB15363,Proteins,DrugBank
DB15363,Serum Globulins,DrugBank
DB15366,"Amino Acids, Peptides, and Proteins",DrugBank
DB15366,Antiarrhythmic agents,DrugBank
DB15366,Antineoplastic Agents,DrugBank
DB15366,Calcium Channel Blockers,DrugBank
DB15366,Calcium-Regulating Hormones and Agents,DrugBank
DB15366,Cardiovascular Agents,DrugBank
DB15366,Carrier Proteins,DrugBank
DB15366,Ion Channels,DrugBank
DB15366,Membrane Transport Modulators,DrugBank
DB15366,Membrane Transport Proteins,DrugBank
DB15366,Proteins,DrugBank
DB15366,Transient Receptor Potential Channels,DrugBank
DB15383,"Amino Acids, Peptides, and Proteins",DrugBank
DB15383,Antibodies,DrugBank
DB15383,"Antibodies, Monoclonal",DrugBank
DB15383,"Antibodies, Monoclonal, Humanized",DrugBank
DB15383,Antineoplastic Agents,DrugBank
DB15383,"Antineoplastic Agents, Immunological",DrugBank
DB15383,Blood Proteins,DrugBank
DB15383,Globulins,DrugBank
DB15383,Immunoglobulins,DrugBank
DB15383,Immunoproteins,DrugBank
DB15383,Proteins,DrugBank
DB15383,Serum Globulins,DrugBank
DB15395,"Amino Acids, Peptides, and Proteins",DrugBank
DB15395,"Antibodies, Monoclonal",DrugBank
DB15395,Antineoplastic Agents,DrugBank
DB15395,Antineoplastic and Immunomodulating Agents,DrugBank
DB15395,Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager,DrugBank
DB15395,Bispecific Monoclonal Antibodies,DrugBank
DB15395,Blood Proteins,DrugBank
DB15395,Immunoglobulins,DrugBank
DB15395,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15395,Proteins,DrugBank
DB15395,Serum Globulins,DrugBank
DB15397,"Amino Acids, Peptides, and Proteins",DrugBank
DB15397,Antibodies,DrugBank
DB15397,"Antibodies, Monoclonal",DrugBank
DB15397,Blood Proteins,DrugBank
DB15397,Globulins,DrugBank
DB15397,Immunoglobulins,DrugBank
DB15397,Immunoproteins,DrugBank
DB15397,Proteins,DrugBank
DB15397,Serum Globulins,DrugBank
DB15401,Amines,DrugBank
DB15401,Amino Acids,DrugBank
DB15401,"Amino Acids, Cyclic",DrugBank
DB15401,"Amino Acids, Peptides, and Proteins",DrugBank
DB15401,Antineoplastic and Immunomodulating Agents,DrugBank
DB15401,BCRP/ABCG2 Inhibitors,DrugBank
DB15401,Complement Factor D Inhibitor,DrugBank
DB15401,Complement Inactivating Agents,DrugBank
DB15401,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15401,Imino Acids,DrugBank
DB15401,Immunosuppressive Agents,DrugBank
DB15401,P-glycoprotein inhibitors,DrugBank
DB15401,Pyrazoles,DrugBank
DB15401,Pyridines,DrugBank
DB15409,"Amino Acids, Peptides, and Proteins",DrugBank
DB15409,Antibodies,DrugBank
DB15409,"Antibodies, Monoclonal",DrugBank
DB15409,"Antibodies, Monoclonal, Humanized",DrugBank
DB15409,Blood Proteins,DrugBank
DB15409,Globulins,DrugBank
DB15409,Immunoglobulins,DrugBank
DB15409,Immunologic Factors,DrugBank
DB15409,Proteins,DrugBank
DB15409,Serum Globulins,DrugBank
DB15415,"Amino Acids, Peptides, and Proteins",DrugBank
DB15415,Antibodies,DrugBank
DB15415,"Antibodies, Monoclonal",DrugBank
DB15415,Blood Proteins,DrugBank
DB15415,Globulins,DrugBank
DB15415,Immunoglobulin G,DrugBank
DB15415,Immunoglobulins,DrugBank
DB15415,Immunoproteins,DrugBank
DB15415,Proteins,DrugBank
DB15415,Serum Globulins,DrugBank
DB15419,Antineoplastic Agents,DrugBank
DB15419,Aza Compounds,DrugBank
DB15419,Histone Deacetylase Inhibitors,DrugBank
DB15428,"Amino Acids, Peptides, and Proteins",DrugBank
DB15428,Antibodies,DrugBank
DB15428,Blood Proteins,DrugBank
DB15428,Globulins,DrugBank
DB15428,Immunoglobulins,DrugBank
DB15428,Immunoproteins,DrugBank
DB15428,Neuropilin-1,DrugBank
DB15428,Proteins,DrugBank
DB15428,Serum Globulins,DrugBank
DB15432,"Amino Acids, Peptides, and Proteins",DrugBank
DB15432,Antibodies,DrugBank
DB15432,"Antibodies, Monoclonal",DrugBank
DB15432,"Antibodies, Monoclonal, Humanized",DrugBank
DB15432,Blood Proteins,DrugBank
DB15432,Globulins,DrugBank
DB15432,Immunoglobulins,DrugBank
DB15432,Immunologic Factors,DrugBank
DB15432,Immunoproteins,DrugBank
DB15432,Proteins,DrugBank
DB15432,Serum Globulins,DrugBank
DB15434,"Amino Acids, Peptides, and Proteins",DrugBank
DB15434,"Antibodies, Monoclonal",DrugBank
DB15434,"Antibodies, Monoclonal, Humanized",DrugBank
DB15434,Antineoplastic Agents,DrugBank
DB15434,Antineoplastic and Immunomodulating Agents,DrugBank
DB15434,Blood Proteins,DrugBank
DB15434,Cancer immunotherapy,DrugBank
DB15434,CD20-directed Antibody Interactions,DrugBank
DB15434,CD3-directed Antibody Interactions,DrugBank
DB15434,Immunoglobulins,DrugBank
DB15434,Immunosuppressive Agents,DrugBank
DB15434,Immunotherapy,DrugBank
DB15434,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15434,Myelosuppressive Agents,DrugBank
DB15434,Proteins,DrugBank
DB15434,Serum Globulins,DrugBank
DB15441,Alcohols,DrugBank
DB15441,"Amino Acids, Peptides, and Proteins",DrugBank
DB15441,"Antibodies, Monoclonal",DrugBank
DB15441,"Antibodies, Monoclonal, Humanized",DrugBank
DB15441,Blood Proteins,DrugBank
DB15441,Ethylene Glycols,DrugBank
DB15441,Globulins,DrugBank
DB15441,Glycols,DrugBank
DB15441,Immunoglobulins,DrugBank
DB15441,Immunoproteins,DrugBank
DB15441,Macromolecular Substances,DrugBank
DB15441,Polymers,DrugBank
DB15441,Proteins,DrugBank
DB15441,Serum Globulins,DrugBank
DB15442,BCRP/ABCG2 Substrates,DrugBank
DB15442,Cyclin-dependent Kinase 4 Inhibitors,DrugBank
DB15442,Cyclin-dependent Kinase 6 Inhibitors,DrugBank
DB15442,"Cyclin-Dependent Kinases, antagonists & inhibitors",DrugBank
DB15442,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB15442,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB15442,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB15442,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB15442,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15442,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15442,Detoxifying Agents for Antineoplastic Treatment,DrugBank
DB15442,Kinase Inhibitor,DrugBank
DB15442,MATE 1 Inhibitors,DrugBank
DB15442,MATE 2 Inhibitors,DrugBank
DB15442,MATE 2-K Inhibitors,DrugBank
DB15442,MATE inhibitors,DrugBank
DB15442,OCT2 Inhibitors,DrugBank
DB15442,P-glycoprotein substrates,DrugBank
DB15442,Protein Kinase Inhibitors,DrugBank
DB15443,"Amino Acids, Peptides, and Proteins",DrugBank
DB15443,Antibodies,DrugBank
DB15443,Biological Factors,DrugBank
DB15443,Blood Proteins,DrugBank
DB15443,Cytokines,DrugBank
DB15443,Globulins,DrugBank
DB15443,Immunoglobulins,DrugBank
DB15443,Immunoproteins,DrugBank
DB15443,Intercellular Signaling Peptides and Proteins,DrugBank
DB15443,Interleukins,DrugBank
DB15443,Lymphokines,DrugBank
DB15443,Peptides,DrugBank
DB15443,Proteins,DrugBank
DB15443,Serum Globulins,DrugBank
DB15444,Cystic Fibrosis Transmembrane Conductance Regulator Correctors,DrugBank
DB15444,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15444,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15444,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15444,Cytochrome P-450 CYP3A4 Substrates (strength unknown),DrugBank
DB15444,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB15444,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15444,Cytochrome P-450 Substrates,DrugBank
DB15444,Membrane Transport Modulators,DrugBank
DB15444,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB15444,OATP1B3 inhibitors,DrugBank
DB15444,P-glycoprotein inhibitors,DrugBank
DB15444,P-glycoprotein substrates,DrugBank
DB15453,"Amino Acids, Peptides, and Proteins",DrugBank
DB15453,Antibodies,DrugBank
DB15453,"Antibodies, Monoclonal",DrugBank
DB15453,Blood Proteins,DrugBank
DB15453,Globulins,DrugBank
DB15453,Immunoglobulins,DrugBank
DB15453,Immunoproteins,DrugBank
DB15453,Immunotoxins,DrugBank
DB15453,Proteins,DrugBank
DB15453,Serum Globulins,DrugBank
DB15456,BCRP/ABCG2 Substrates,DrugBank
DB15456,Cardiac Therapy,DrugBank
DB15456,Guanylate Cyclase Stimulators,DrugBank
DB15456,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15456,Hypotensive Agents,DrugBank
DB15456,P-glycoprotein substrates,DrugBank
DB15456,Soluble Guanylate Cyclase Stimulator,DrugBank
DB15456,Teratogens,DrugBank
DB15456,UGT1A1 Substrates,DrugBank
DB15456,UGT1A9 Substrates,DrugBank
DB15456,Vasodilators Used in Cardiac Diseases,DrugBank
DB15461,Actively Acquired Immunity,DrugBank
DB15461,Bacterial Vaccines,DrugBank
DB15461,Biological Products,DrugBank
DB15461,Complex Mixtures,DrugBank
DB15461,Inactivated Yersinia Pestis Vaccine,DrugBank
DB15461,Vaccines,DrugBank
DB15463,Antineoplastic Agents,DrugBank
DB15463,Antineoplastic and Immunomodulating Agents,DrugBank
DB15463,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB15463,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15463,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15463,Cytochrome P-450 Substrates,DrugBank
DB15463,Hypoxia-inducible Factor Inhibitor,DrugBank
DB15463,MATE 2 Inhibitors,DrugBank
DB15463,MATE inhibitors,DrugBank
DB15463,OATP1B1/SLCO1B1 Substrates,DrugBank
DB15463,OATP1B3 substrates,DrugBank
DB15463,P-glycoprotein substrates,DrugBank
DB15463,UGT2B17 substrates,DrugBank
DB15465,Opioids,DrugBank
DB15466,Alkylating Drugs,DrugBank
DB15466,"Amino Acids, Peptides, and Proteins",DrugBank
DB15466,Antineoplastic Agents,DrugBank
DB15466,"Antineoplastic Agents, Alkylating",DrugBank
DB15466,"Hydrocarbons, Halogenated",DrugBank
DB15466,Mustard Compounds,DrugBank
DB15466,Noxae,DrugBank
DB15466,Peptides,DrugBank
DB15466,Toxic Actions,DrugBank
DB15471,"Amino Acids, Peptides, and Proteins",DrugBank
DB15471,Antibodies,DrugBank
DB15471,"Antibodies, Monoclonal",DrugBank
DB15471,Antineoplastic Agents,DrugBank
DB15471,Antineoplastic and Immunomodulating Agents,DrugBank
DB15471,Bispecific HER2-directed Antibody,DrugBank
DB15471,Bispecific Monoclonal Antibodies,DrugBank
DB15471,Blood Proteins,DrugBank
DB15471,Globulins,DrugBank
DB15471,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,DrugBank
DB15471,HER2-targeted Antibodies,DrugBank
DB15471,Immunoglobulins,DrugBank
DB15471,Immunoproteins,DrugBank
DB15471,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15471,Proteins,DrugBank
DB15471,Serum Globulins,DrugBank
DB15477,Anthracenes,DrugBank
DB15477,Anthraquinones,DrugBank
DB15477,Biological Products,DrugBank
DB15477,Gastrointestinal Agents,DrugBank
DB15477,Laxatives,DrugBank
DB15477,Plant Extracts,DrugBank
DB15477,Plant Preparations,DrugBank
DB15477,Quinones,DrugBank
DB15478,Biological Products,DrugBank
DB15478,Cascara,DrugBank
DB15478,Laxatives,DrugBank
DB15478,Plant Extracts,DrugBank
DB15478,Plant Preparations,DrugBank
DB15483,Anti-Infective Agents,DrugBank
DB15483,Antiviral Agents,DrugBank
DB15483,Biological Products,DrugBank
DB15483,Complex Mixtures,DrugBank
DB15483,Monkeypox Vaccines,DrugBank
DB15483,Smallpox Vaccines,DrugBank
DB15483,Vaccines,DrugBank
DB15483,Viral Vaccines,DrugBank
DB15490,Antidepressive Agents,DrugBank
DB15490,Central Nervous System Agents,DrugBank
DB15490,Central Nervous System Depressants,DrugBank
DB15490,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15490,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15490,Cytochrome P-450 Substrates,DrugBank
DB15490,"Depression, Postpartum",DrugBank
DB15490,Fused-Ring Compounds,DrugBank
DB15490,Nervous System,DrugBank
DB15490,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,DrugBank
DB15490,Pregnanes,DrugBank
DB15490,Psychoanaleptics,DrugBank
DB15490,Psychotropic Drugs,DrugBank
DB15490,Steroids,DrugBank
DB15492,Amides,DrugBank
DB15492,Dopamine Agents,DrugBank
DB15492,Dopamine Antagonists,DrugBank
DB15492,Neurotransmitter Agents,DrugBank
DB15559,"Amino Acids, Peptides, and Proteins",DrugBank
DB15559,Antibodies,DrugBank
DB15559,"Antibodies, Bispecific",DrugBank
DB15559,"Antibodies, Monoclonal",DrugBank
DB15559,"Antibodies, Monoclonal, Humanized",DrugBank
DB15559,Bispecific Monoclonal Antibodies,DrugBank
DB15559,Blood Proteins,DrugBank
DB15559,Globulins,DrugBank
DB15559,Immunoglobulin Isotypes,DrugBank
DB15559,Immunoglobulins,DrugBank
DB15559,Immunoproteins,DrugBank
DB15559,Proteins,DrugBank
DB15559,Serum Globulins,DrugBank
DB15561,Adeno-associated Viral Vector Therapies,DrugBank
DB15561,"Amino Acids, Peptides, and Proteins",DrugBank
DB15561,Biological Factors,DrugBank
DB15561,Biological Products,DrugBank
DB15561,Blood and Blood Forming Organs,DrugBank
DB15561,Blood Coagulation Factors,DrugBank
DB15561,Blood Proteins,DrugBank
DB15561,Cellular and Gene Therapy,DrugBank
DB15561,Complex Mixtures,DrugBank
DB15561,Genetic Therapy,DrugBank
DB15561,Hemostatics,DrugBank
DB15561,Protein Precursors,DrugBank
DB15561,Proteins,DrugBank
DB15561,Recombinant Proteins,DrugBank
DB15565,Agents Acting on the Renin-Angiotensin System,DrugBank
DB15565,Angiotensin-Converting Enzyme Inhibitors,DrugBank
DB15565,Antihypertensive Agents,DrugBank
DB15565,Cardiovascular Agents,DrugBank
DB15565,Enzyme Inhibitors,DrugBank
DB15565,Protease Inhibitors,DrugBank
DB15565,Pyridazines,DrugBank
DB15566,Adrenal Cortex Hormones,DrugBank
DB15566,Anti-Inflammatory Agents,DrugBank
DB15566,Corticosteroids,DrugBank
DB15566,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15566,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15566,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15566,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15566,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15566,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15566,Cytochrome P-450 Substrates,DrugBank
DB15566,Fused-Ring Compounds,DrugBank
DB15566,P-glycoprotein substrates,DrugBank
DB15566,Pregnadienes,DrugBank
DB15566,Pregnadienetriols,DrugBank
DB15566,Pregnanes,DrugBank
DB15566,Prodrugs,DrugBank
DB15566,Steroids,DrugBank
DB15568,Antineoplastic Agents,DrugBank
DB15568,"Antineoplastic Agents, Immunological",DrugBank
DB15568,Antineoplastic and Immunomodulating Agents,DrugBank
DB15568,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB15568,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB15568,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB15568,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15568,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15568,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15568,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB15568,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB15568,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15568,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15568,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15568,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15568,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15568,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15568,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15568,Cytochrome P-450 Substrates,DrugBank
DB15568,Immune Checkpoint Inhibitors,DrugBank
DB15568,Nitriles,DrugBank
DB15568,P-glycoprotein inhibitors,DrugBank
DB15568,QTc Prolonging Agents,DrugBank
DB15568,RAS GTPase Inhibitors,DrugBank
DB15569,Antineoplastic Agents,DrugBank
DB15569,"Antineoplastic Agents, Immunological",DrugBank
DB15569,Antineoplastic and Immunomodulating Agents,DrugBank
DB15569,BCRP/ABCG2 Inhibitors,DrugBank
DB15569,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB15569,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB15569,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB15569,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB15569,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB15569,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB15569,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15569,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15569,Cytochrome P-450 Substrates,DrugBank
DB15569,Immune Checkpoint Inhibitors,DrugBank
DB15569,P-glycoprotein inhibitors,DrugBank
DB15569,RAS GTPase Inhibitors,DrugBank
DB15575,"Amino Acids, Peptides, and Proteins",DrugBank
DB15575,Antineoplastic Agents,DrugBank
DB15575,Antineoplastic and Immunomodulating Agents,DrugBank
DB15575,Chlorophyll,DrugBank
DB15575,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15575,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB15575,OATP1B3 inhibitors,DrugBank
DB15575,Palladium,DrugBank
DB15575,"Photoreceptors, Microbial",DrugBank
DB15575,Photosensitizing Agents,DrugBank
DB15575,Proteins,DrugBank
DB15575,Sensitizers Used in Photodynamic/radiation Therapy,DrugBank
DB15593,Antisense Elements (Genetics),DrugBank
DB15593,Antisense Oligonucleotides,DrugBank
DB15593,"Compounds used in a research, industrial, or household setting",DrugBank
DB15593,Drugs that are Mainly Renally Excreted,DrugBank
DB15593,Laboratory Chemicals,DrugBank
DB15593,Molecular Probes,DrugBank
DB15593,Musculo-Skeletal System,DrugBank
DB15593,Nucleic Acid Probes,DrugBank
DB15593,Nucleic Acids,DrugBank
DB15593,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB15593,Nucleotides,DrugBank
DB15593,Oligonucleotides,DrugBank
DB15593,Polynucleotides,DrugBank
DB15595,Immunization,DrugBank
DB15595,Immunologic Factors,DrugBank
DB15595,Vaccines,DrugBank
DB15595,Viral Vaccines,DrugBank
DB15598,Antianemic Preparations,DrugBank
DB15598,Blood and Blood Forming Organs,DrugBank
DB15598,Hematinics,DrugBank
DB15598,Hematologic Agents,DrugBank
DB15598,Iron Compounds,DrugBank
DB15598,Iron Preparations,DrugBank
DB15598,"Iron Trivalent, Oral Preparations",DrugBank
DB15598,Organometallic Compounds,DrugBank
DB15598,Parenteral Iron Replacement,DrugBank
DB15598,Pyrans,DrugBank
DB15598,UGT1A6 substrate,DrugBank
DB15614,Cholestanes,DrugBank
DB15614,Cholestenes,DrugBank
DB15614,Fused-Ring Compounds,DrugBank
DB15614,Lipids,DrugBank
DB15614,Membrane Lipids,DrugBank
DB15614,Secosteroids,DrugBank
DB15614,Steroids,DrugBank
DB15614,Sterols,DrugBank
DB15614,Vitamin D and Analogues,DrugBank
DB15614,Vitamins,DrugBank
DB15614,Vitamins (Fat Soluble),DrugBank
DB15623,"Acids, Acyclic",DrugBank
DB15623,Amides,DrugBank
DB15623,Anti-HIV Agents,DrugBank
DB15623,Antiviral Agents,DrugBank
DB15623,Antivirals for Systemic Use,DrugBank
DB15623,Enzyme Inhibitors,DrugBank
DB15623,Experimental Unapproved Treatments for COVID-19,DrugBank
DB15623,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15623,HIV Protease Inhibitors,DrugBank
DB15623,Protease Inhibitors,DrugBank
DB15623,Sulfones,DrugBank
DB15623,Sulfur Compounds,DrugBank
DB15623,Thiazoles,DrugBank
DB15626,"Amino Acids, Peptides, and Proteins",DrugBank
DB15626,Antibodies,DrugBank
DB15626,"Antibodies, Monoclonal",DrugBank
DB15626,"Antibodies, Monoclonal, Humanized",DrugBank
DB15626,Antineoplastic and Immunomodulating Agents,DrugBank
DB15626,Blood Proteins,DrugBank
DB15626,Globulins,DrugBank
DB15626,Immunoglobulins,DrugBank
DB15626,Immunoproteins,DrugBank
DB15626,Immunosuppressive Agents,DrugBank
DB15626,Interleukin Inhibitors,DrugBank
DB15626,Interleukin-36 Receptor Antagonist,DrugBank
DB15626,Proteins,DrugBank
DB15626,Serum Globulins,DrugBank
DB15627,"Amino Acids, Peptides, and Proteins",DrugBank
DB15627,Anions,DrugBank
DB15627,Antibodies,DrugBank
DB15627,"Antibodies, Monoclonal",DrugBank
DB15627,"Antibodies, Monoclonal, Humanized",DrugBank
DB15627,Antineoplastic Agents,DrugBank
DB15627,Antineoplastic and Immunomodulating Agents,DrugBank
DB15627,Blood Proteins,DrugBank
DB15627,Electrolytes,DrugBank
DB15627,Globulins,DrugBank
DB15627,Hydrogen Sulfide,DrugBank
DB15627,Immune Checkpoint Inhibitors,DrugBank
DB15627,Immunoglobulins,DrugBank
DB15627,Immunoproteins,DrugBank
DB15627,Ions,DrugBank
DB15627,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15627,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB15627,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB15627,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB15627,Programmed Death Receptor-1-directed Antibody Interactions,DrugBank
DB15627,Proteins,DrugBank
DB15627,Serum Globulins,DrugBank
DB15627,Sulfides,DrugBank
DB15627,Sulfur Compounds,DrugBank
DB15628,"Amino Acids, Peptides, and Proteins",DrugBank
DB15628,Antibodies,DrugBank
DB15628,Blood Proteins,DrugBank
DB15628,Globulins,DrugBank
DB15628,Immunoglobulins,DrugBank
DB15628,Immunologic Factors,DrugBank
DB15628,Immunoproteins,DrugBank
DB15628,Immunosuppression,DrugBank
DB15628,Immunosuppressive Agents,DrugBank
DB15628,Proteins,DrugBank
DB15628,"Receptors, Interleukin-2",DrugBank
DB15628,Serum Globulins,DrugBank
DB15631,"Adjuvants, Immunologic",DrugBank
DB15631,"Amino Acids, Peptides, and Proteins",DrugBank
DB15631,Angiogenesis Inhibitors,DrugBank
DB15631,Angiogenesis Modulating Agents,DrugBank
DB15631,Antineoplastic Agents,DrugBank
DB15631,Biological Factors,DrugBank
DB15631,Cytokines,DrugBank
DB15631,Growth Inhibitors,DrugBank
DB15631,Growth Substances,DrugBank
DB15631,Immunologic Factors,DrugBank
DB15631,Intercellular Signaling Peptides and Proteins,DrugBank
DB15631,"Interleukin-12, antagonists & inhibitors",DrugBank
DB15631,Interleukins,DrugBank
DB15631,Peptides,DrugBank
DB15631,Proteins,DrugBank
DB15636,"Amino Acids, Peptides, and Proteins",DrugBank
DB15636,Antineoplastic and Immunomodulating Agents,DrugBank
DB15636,Blood Proteins,DrugBank
DB15636,Complement Inactivating Agents,DrugBank
DB15636,Immunoproteins,DrugBank
DB15636,Immunosuppressive Agents,DrugBank
DB15636,Peptides,DrugBank
DB15636,Proteins,DrugBank
DB15641,Antineoplastic Agents,DrugBank
DB15641,Antioxidants,DrugBank
DB15641,Benzene Derivatives,DrugBank
DB15641,Benzylidene Compounds,DrugBank
DB15641,Biological Factors,DrugBank
DB15641,"Compounds used in a research, industrial, or household setting",DrugBank
DB15641,Estrogen Antagonists,DrugBank
DB15641,Hormone Antagonists,DrugBank
DB15641,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15641,Protective Agents,DrugBank
DB15641,Stilbenes,DrugBank
DB15646,Amides,DrugBank
DB15646,Amino Acids,DrugBank
DB15646,"Amino Acids, Basic",DrugBank
DB15646,"Amino Acids, Diamino",DrugBank
DB15646,"Amino Acids, Peptides, and Proteins",DrugBank
DB15646,Bradykinin B2 Receptor Antagonists,DrugBank
DB15646,Bradykinin Receptor Antagonists,DrugBank
DB15646,Complement Inactivating Agents,DrugBank
DB15646,Immunologic Factors,DrugBank
DB15646,Immunosuppressive Agents,DrugBank
DB15646,Sulfones,DrugBank
DB15646,Sulfur Compounds,DrugBank
DB15654,Biological Products,DrugBank
DB15654,COVID-19 Vaccines,DrugBank
DB15654,Experimental Unapproved Treatments for COVID-19,DrugBank
DB15654,mRNA Vaccines,DrugBank
DB15654,Nucleic Acid-Based Vaccines,DrugBank
DB15654,Vaccines,DrugBank
DB15654,"Vaccines, Synthetic",DrugBank
DB15654,Viral Vaccines,DrugBank
DB15656,Biological Products,DrugBank
DB15656,Complex Mixtures,DrugBank
DB15656,COVID-19 Vaccines,DrugBank
DB15656,Experimental Unapproved Treatments for COVID-19,DrugBank
DB15656,Nucleic Acid-Based Vaccines,DrugBank
DB15656,Vaccines,DrugBank
DB15656,"Vaccines, DNA",DrugBank
DB15656,"Vaccines, Synthetic",DrugBank
DB15656,Viral Vaccines,DrugBank
DB15657,Anti-Bacterial Agents,DrugBank
DB15669,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB15669,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB15669,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB15669,Cytochrome P-450 Substrates,DrugBank
DB15669,Genito Urinary System and Sex Hormones,DrugBank
DB15669,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15669,Neurokinin 3 Receptor Antagonist,DrugBank
DB15669,Sulfur Compounds,DrugBank
DB15669,Thiazoles,DrugBank
DB15673,Acetates,DrugBank
DB15673,"Acids, Acyclic",DrugBank
DB15673,Amides,DrugBank
DB15673,Anti-HIV Agents,DrugBank
DB15673,Antiinfectives for Systemic Use,DrugBank
DB15673,Antiviral Agents,DrugBank
DB15673,Antivirals for Systemic Use,DrugBank
DB15673,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15673,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15673,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15673,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB15673,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15673,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15673,Cytochrome P-450 Substrates,DrugBank
DB15673,Direct Acting Antivirals,DrugBank
DB15673,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15673,Human Immunodeficiency Virus 1 Capsid Inhibitor,DrugBank
DB15673,P-glycoprotein substrates,DrugBank
DB15673,Pyrazoles,DrugBank
DB15673,UGT1A1 Substrates,DrugBank
DB15685,Agents that produce hypertension,DrugBank
DB15685,Antineoplastic Agents,DrugBank
DB15685,Antineoplastic and Immunomodulating Agents,DrugBank
DB15685,BCRP/ABCG2 Inhibitors,DrugBank
DB15685,BCRP/ABCG2 Substrates,DrugBank
DB15685,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15685,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15685,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15685,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15685,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15685,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15685,Cytochrome P-450 Substrates,DrugBank
DB15685,Hepatotoxic Agents,DrugBank
DB15685,Kinase Inhibitor,DrugBank
DB15685,MATE 1 Inhibitors,DrugBank
DB15685,MATE inhibitors,DrugBank
DB15685,P-glycoprotein inhibitors,DrugBank
DB15685,P-glycoprotein substrates,DrugBank
DB15685,Protein Kinase Inhibitors,DrugBank
DB15685,QTc Prolonging Agents,DrugBank
DB15685,Rearranged during Transfection (RET) Inhibitors,DrugBank
DB15685,Tyrosine Kinase Inhibitors,DrugBank
DB15688,Analgesics,DrugBank
DB15688,Antimigraine Preparations,DrugBank
DB15688,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB15688,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB15688,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15688,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15688,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15688,Cytochrome P-450 Substrates,DrugBank
DB15688,Experimental Unapproved Treatments for COVID-19,DrugBank
DB15688,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15688,MATE 1 Substrates,DrugBank
DB15688,MATE substrates,DrugBank
DB15688,Nasal Preparations,DrugBank
DB15688,Nervous System,DrugBank
DB15688,OATP1B3 substrates,DrugBank
DB15688,P-glycoprotein substrates,DrugBank
DB15688,Pyrazoles,DrugBank
DB15688,Quinolines,DrugBank
DB15688,"Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors",DrugBank
DB15699,"Amino Acids, Peptides, and Proteins",DrugBank
DB15699,Antineoplastic Agents,DrugBank
DB15699,"Antineoplastic Agents, Immunological",DrugBank
DB15699,Antineoplastic and Immunomodulating Agents,DrugBank
DB15699,Antineoplastic cell and gene therapy,DrugBank
DB15699,Cancer immunotherapy,DrugBank
DB15699,CD19-Directed Genetically Modified Autologous T-cell Immunotherapies,DrugBank
DB15699,Immunization,DrugBank
DB15699,"Immunization, Passive",DrugBank
DB15699,Immunologic Techniques,DrugBank
DB15699,Immunomodulation,DrugBank
DB15699,Immunotherapy,DrugBank
DB15699,Investigative Techniques,DrugBank
DB15699,Membrane Proteins,DrugBank
DB15699,Proteins,DrugBank
DB15699,"Receptors, Antigen",DrugBank
DB15699,"Receptors, Antigen, T-Cell",DrugBank
DB15699,"Receptors, Artificial",DrugBank
DB15699,"Receptors, Cytoplasmic and Nuclear",DrugBank
DB15718,"Amino Acids, Peptides, and Proteins",DrugBank
DB15718,Anti-Infective Agents,DrugBank
DB15718,Antibodies,DrugBank
DB15718,"Antibodies, Monoclonal",DrugBank
DB15718,"Antibodies, Monoclonal, Humanized",DrugBank
DB15718,Antiviral Agents,DrugBank
DB15718,Blood Proteins,DrugBank
DB15718,Experimental Unapproved Treatments for COVID-19,DrugBank
DB15718,Globulins,DrugBank
DB15718,Immunoglobulins,DrugBank
DB15718,Immunoproteins,DrugBank
DB15718,Proteins,DrugBank
DB15718,Serum Globulins,DrugBank
DB15719,"Amino Acids, Peptides, and Proteins",DrugBank
DB15719,Antibodies,DrugBank
DB15719,"Antibodies, Monoclonal",DrugBank
DB15719,"Antibodies, Monoclonal, Humanized",DrugBank
DB15719,Antibody-drug Conjugates,DrugBank
DB15719,Antineoplastic Agents,DrugBank
DB15719,Antineoplastic and Immunomodulating Agents,DrugBank
DB15719,Blood Proteins,DrugBank
DB15719,BSEP/ABCB11 Substrates,DrugBank
DB15719,Cancer immunotherapy,DrugBank
DB15719,Globulins,DrugBank
DB15719,Immunoglobulins,DrugBank
DB15719,Immunoproteins,DrugBank
DB15719,Immunotherapy,DrugBank
DB15719,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15719,OATP1B1/SLCO1B1 Substrates,DrugBank
DB15719,OATP1B3 substrates,DrugBank
DB15719,P-glycoprotein substrates,DrugBank
DB15719,Proteins,DrugBank
DB15719,Serum Globulins,DrugBank
DB15719,Tubulin Inhibiting Agent,DrugBank
DB15749,"Amino Acids, Peptides, and Proteins",DrugBank
DB15749,Biological Factors,DrugBank
DB15749,Cytokines,DrugBank
DB15749,Intercellular Signaling Peptides and Proteins,DrugBank
DB15749,Interferons,DrugBank
DB15749,Peptides,DrugBank
DB15749,Proteins,DrugBank
DB15753,"Adjuvants, Immunologic",DrugBank
DB15753,Antineoplastic and Immunomodulating Agents,DrugBank
DB15753,Interferons,DrugBank
DB15762,"Amino Acids, Peptides, and Proteins",DrugBank
DB15762,Antibodies,DrugBank
DB15762,"Antibodies, Monoclonal",DrugBank
DB15762,"Antibodies, Monoclonal, Humanized",DrugBank
DB15762,Antineoplastic and Immunomodulating Agents,DrugBank
DB15762,Blood Proteins,DrugBank
DB15762,Globulins,DrugBank
DB15762,Immunoglobulins,DrugBank
DB15762,Immunoproteins,DrugBank
DB15762,Immunosuppressive Agents,DrugBank
DB15762,Interleukin Inhibitors,DrugBank
DB15762,Interleukin-6 Receptor Antagonist,DrugBank
DB15762,Proteins,DrugBank
DB15762,Serum Globulins,DrugBank
DB15763,Hematinics,DrugBank
DB15763,Hematologic Agents,DrugBank
DB15763,Iron Compounds,DrugBank
DB15763,Polysaccharides,DrugBank
DB15766,"Amino Acids, Peptides, and Proteins",DrugBank
DB15766,"Antibodies, Monoclonal",DrugBank
DB15766,"Antibodies, Monoclonal, Humanized",DrugBank
DB15766,Antineoplastic Agents,DrugBank
DB15766,Antineoplastic and Immunomodulating Agents,DrugBank
DB15766,Blood Proteins,DrugBank
DB15766,Immune Checkpoint Inhibitors,DrugBank
DB15766,Immunoglobulins,DrugBank
DB15766,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15766,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB15766,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB15766,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB15766,Proteins,DrugBank
DB15766,Serum Globulins,DrugBank
DB15770,"Amino Acids, Peptides, and Proteins",DrugBank
DB15770,Antibodies,DrugBank
DB15770,Blood Proteins,DrugBank
DB15770,Globulins,DrugBank
DB15770,Immune Checkpoint Inhibitors,DrugBank
DB15770,Immunoglobulins,DrugBank
DB15770,Immunoproteins,DrugBank
DB15770,Programmed Death Ligand-1 Blocker,DrugBank
DB15770,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB15770,Proteins,DrugBank
DB15770,Serum Globulins,DrugBank
DB15775,Adrenal Cortex Hormones,DrugBank
DB15775,Algestone,DrugBank
DB15775,Anti-Inflammatory Agents,DrugBank
DB15775,"Contraceptive Agents, Female",DrugBank
DB15775,"Contraceptive Agents, Hormonal",DrugBank
DB15775,Fused-Ring Compounds,DrugBank
DB15775,Hormonal Contraceptives for Systemic Use,DrugBank
DB15775,Hormones,DrugBank
DB15775,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15775,Pregnanes,DrugBank
DB15775,Pregnenediones,DrugBank
DB15775,Pregnenes,DrugBank
DB15775,Progesterone and Derivatives,DrugBank
DB15775,Progestins,DrugBank
DB15775,Reproductive Control Agents,DrugBank
DB15775,Steroids,DrugBank
DB15777,Adrenal Cortex Hormones,DrugBank
DB15777,Anti-Inflammatory Agents,DrugBank
DB15777,Corticosteroids,DrugBank
DB15777,Fused-Ring Compounds,DrugBank
DB15777,Glucocorticoids,DrugBank
DB15777,Hormones,DrugBank
DB15777,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15777,Pregnadienediols,DrugBank
DB15777,Pregnadienes,DrugBank
DB15777,Pregnanes,DrugBank
DB15777,Steroids,DrugBank
DB15777,"Steroids, Fluorinated",DrugBank
DB15786,"Adjuvants, Immunologic",DrugBank
DB15786,Antioxidants,DrugBank
DB15786,Antiplatelet agents,DrugBank
DB15786,Benzopyrans,DrugBank
DB15786,Biological Factors,DrugBank
DB15786,Biological Products,DrugBank
DB15786,Chromones,DrugBank
DB15786,Complex Mixtures,DrugBank
DB15786,"Compounds used in a research, industrial, or household setting",DrugBank
DB15786,Hematologic Agents,DrugBank
DB15786,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15786,Immunologic Factors,DrugBank
DB15786,Pharmaceutical Preparations,DrugBank
DB15786,Pinus,DrugBank
DB15786,Plant Preparations,DrugBank
DB15786,Protective Agents,DrugBank
DB15786,Pyrans,DrugBank
DB15810,Biological Products,DrugBank
DB15810,Complex Mixtures,DrugBank
DB15810,COVID-19 Vaccines,DrugBank
DB15810,Vaccines,DrugBank
DB15810,Viral Vaccines,DrugBank
DB15821,Adrenal Cortex Hormones,DrugBank
DB15821,Anti-Inflammatory Agents,DrugBank
DB15821,Corticosteroids,DrugBank
DB15821,Fused-Ring Compounds,DrugBank
DB15821,Glucocorticoids,DrugBank
DB15821,Hormones,DrugBank
DB15821,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15821,Pregnadienediols,DrugBank
DB15821,Pregnadienes,DrugBank
DB15821,Pregnanes,DrugBank
DB15821,Steroids,DrugBank
DB15821,"Steroids, Fluorinated",DrugBank
DB15822,Antineoplastic Agents,DrugBank
DB15822,Antineoplastic and Immunomodulating Agents,DrugBank
DB15822,BCRP/ABCG2 Inhibitors,DrugBank
DB15822,BCRP/ABCG2 Substrates,DrugBank
DB15822,BSEP/ABCB11 Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB15822,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB15822,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB15822,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB15822,Cytochrome P-450 CYP3A Inducers,DrugBank
DB15822,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP3A Substrates,DrugBank
DB15822,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB15822,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB15822,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB15822,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB15822,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB15822,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB15822,Cytochrome P-450 Enzyme Inducers,DrugBank
DB15822,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15822,Cytochrome P-450 Substrates,DrugBank
DB15822,Kinase Inhibitor,DrugBank
DB15822,MATE 1 Inhibitors,DrugBank
DB15822,MATE 2 Inhibitors,DrugBank
DB15822,MATE inhibitors,DrugBank
DB15822,OAT1/SLC22A6 inhibitors,DrugBank
DB15822,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB15822,OATP1B3 inhibitors,DrugBank
DB15822,P-glycoprotein inhibitors,DrugBank
DB15822,P-glycoprotein substrates,DrugBank
DB15822,Protein Kinase Inhibitors,DrugBank
DB15822,Rearranged during Transfection (RET) Inhibitors,DrugBank
DB15857,Biological Products,DrugBank
DB15857,Complex Mixtures,DrugBank
DB15857,COVID-19 Vaccines,DrugBank
DB15857,Vaccines,DrugBank
DB15857,Viral Vaccines,DrugBank
DB15861,Antihypertensive Agents,DrugBank
DB15861,Benzothiadiazines,DrugBank
DB15861,Cardiovascular Agents,DrugBank
DB15861,Diuretics,DrugBank
DB15861,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15861,Low-Ceiling Diuretics and Potassium-Sparing Agents,DrugBank
DB15861,Natriuretic Agents,DrugBank
DB15861,Sulfonamides,DrugBank
DB15861,Sulfones,DrugBank
DB15861,Sulfur Compounds,DrugBank
DB15861,Thiazides,DrugBank
DB15865,"Amino Acids, Peptides, and Proteins",DrugBank
DB15865,Antibodies,DrugBank
DB15865,Blood Proteins,DrugBank
DB15865,Globulins,DrugBank
DB15865,Immunoglobulin Isotypes,DrugBank
DB15865,Immunoglobulins,DrugBank
DB15865,"Immunoglobulins, Intravenous",DrugBank
DB15865,Immunoproteins,DrugBank
DB15865,Proteins,DrugBank
DB15865,Serum Globulins,DrugBank
DB15874,Alimentary Tract and Metabolism,DrugBank
DB15874,"alpha-Galactosidase, antagonists & inhibitors",DrugBank
DB15874,"Amino Acids, Peptides, and Proteins",DrugBank
DB15874,Enzyme Replacement Therapy,DrugBank
DB15874,Enzymes,DrugBank
DB15874,Enzymes and Coenzymes,DrugBank
DB15874,Galactosidases,DrugBank
DB15874,Glycoside Hydrolases,DrugBank
DB15874,Hydrolases,DrugBank
DB15874,Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme,DrugBank
DB15874,Protein Isoforms,DrugBank
DB15874,Proteins,DrugBank
DB15880,Anticoagulants,DrugBank
DB15880,Blood and Blood Forming Organs,DrugBank
DB15880,Carbohydrates,DrugBank
DB15880,Chondroitin,DrugBank
DB15880,Fibrinolytic Agents,DrugBank
DB15880,Glycosaminoglycans,DrugBank
DB15880,Hematologic Agents,DrugBank
DB15880,Polysaccharides,DrugBank
DB15889,Anthracenes,DrugBank
DB15889,Anthraquinones,DrugBank
DB15889,Biological Products,DrugBank
DB15889,Complex Mixtures,DrugBank
DB15889,Gastrointestinal Agents,DrugBank
DB15889,Laxatives,DrugBank
DB15889,Plant Extracts,DrugBank
DB15889,Plant Preparations,DrugBank
DB15889,Quinones,DrugBank
DB15898,"Amino Acids, Peptides, and Proteins",DrugBank
DB15898,Anti-Infective Agents,DrugBank
DB15898,Antibodies,DrugBank
DB15898,"Antibodies, Monoclonal",DrugBank
DB15898,"Antibodies, Monoclonal, Humanized",DrugBank
DB15898,Antiviral Agents,DrugBank
DB15898,Blood Proteins,DrugBank
DB15898,Globulins,DrugBank
DB15898,Immunoglobulins,DrugBank
DB15898,Immunoproteins,DrugBank
DB15898,Proteins,DrugBank
DB15898,Serum Globulins,DrugBank
DB15898,Treatments for Ebola Virus Disease,DrugBank
DB15899,"Amino Acids, Peptides, and Proteins",DrugBank
DB15899,Anti-Infective Agents,DrugBank
DB15899,Antibodies,DrugBank
DB15899,"Antibodies, Monoclonal",DrugBank
DB15899,"Antibodies, Monoclonal, Humanized",DrugBank
DB15899,Antiviral Agents,DrugBank
DB15899,Blood Proteins,DrugBank
DB15899,Globulins,DrugBank
DB15899,Immunoglobulins,DrugBank
DB15899,Immunoproteins,DrugBank
DB15899,Proteins,DrugBank
DB15899,Serum Globulins,DrugBank
DB15899,Treatments for Ebola Virus Disease,DrugBank
DB15900,"Amino Acids, Peptides, and Proteins",DrugBank
DB15900,Anti-Infective Agents,DrugBank
DB15900,Antibodies,DrugBank
DB15900,"Antibodies, Monoclonal",DrugBank
DB15900,"Antibodies, Monoclonal, Humanized",DrugBank
DB15900,Antiviral Agents,DrugBank
DB15900,Blood Proteins,DrugBank
DB15900,Globulins,DrugBank
DB15900,Immunoglobulins,DrugBank
DB15900,Immunoproteins,DrugBank
DB15900,Proteins,DrugBank
DB15900,Serum Globulins,DrugBank
DB15900,Treatments for Ebola Virus Disease,DrugBank
DB15903,Adrenal Cortex Hormones,DrugBank
DB15903,Antiandrogens,DrugBank
DB15903,"Contraceptive Agents, Female",DrugBank
DB15903,"Contraceptive Agents, Hormonal",DrugBank
DB15903,"Contraceptives, Oral",DrugBank
DB15903,"Contraceptives, Oral, Hormonal",DrugBank
DB15903,"Contraceptives, Oral, Synthetic",DrugBank
DB15903,Fused-Ring Compounds,DrugBank
DB15903,Hormonal Contraceptives for Systemic Use,DrugBank
DB15903,Hormone Antagonists,DrugBank
DB15903,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15903,Pregnadienes,DrugBank
DB15903,Pregnanes,DrugBank
DB15903,Reproductive Control Agents,DrugBank
DB15903,Steroids,DrugBank
DB15903,"Steroids, Chlorinated",DrugBank
DB15930,"Acids, Acyclic",DrugBank
DB15930,Agrochemicals,DrugBank
DB15930,Carbamates,DrugBank
DB15930,Cholinergic Agents,DrugBank
DB15930,Cholinesterase Inhibitors,DrugBank
DB15930,"Compounds used in a research, industrial, or household setting",DrugBank
DB15930,Enzyme Inhibitors,DrugBank
DB15930,Insecticides,DrugBank
DB15930,Naphthalenes,DrugBank
DB15930,Neurotransmitter Agents,DrugBank
DB15930,Pesticides,DrugBank
DB15930,Toxic Actions,DrugBank
DB15940,"Amino Acids, Peptides, and Proteins",DrugBank
DB15940,Antibodies,DrugBank
DB15940,"Antibodies, Monoclonal",DrugBank
DB15940,Antiinfectives for Systemic Use,DrugBank
DB15940,Antiviral monoclonal antibodies,DrugBank
DB15940,Approved Treatments for COVID-19,DrugBank
DB15940,Blood Proteins,DrugBank
DB15940,Globulins,DrugBank
DB15940,Immune Sera and Immunoglobulins,DrugBank
DB15940,Immunoglobulins,DrugBank
DB15940,Immunoproteins,DrugBank
DB15940,Proteins,DrugBank
DB15940,Serum Globulins,DrugBank
DB15941,"Amino Acids, Peptides, and Proteins",DrugBank
DB15941,Antibodies,DrugBank
DB15941,"Antibodies, Monoclonal",DrugBank
DB15941,Antiinfectives for Systemic Use,DrugBank
DB15941,Antiviral monoclonal antibodies,DrugBank
DB15941,Approved Treatments for COVID-19,DrugBank
DB15941,Blood Proteins,DrugBank
DB15941,Globulins,DrugBank
DB15941,Immune Sera and Immunoglobulins,DrugBank
DB15941,Immunoglobulins,DrugBank
DB15941,Immunoproteins,DrugBank
DB15941,Proteins,DrugBank
DB15941,Serum Globulins,DrugBank
DB15944,Antifibrinolytic Agents,DrugBank
DB15944,Coagulants,DrugBank
DB15944,"Diet, Food, and Nutrition",DrugBank
DB15944,Diterpenes,DrugBank
DB15944,Fibrin Modulating Agents,DrugBank
DB15944,Food,DrugBank
DB15944,Hematologic Agents,DrugBank
DB15944,Hemostatics,DrugBank
DB15944,Micronutrients,DrugBank
DB15944,Naphthalenes,DrugBank
DB15944,Naphthoquinones,DrugBank
DB15944,Physiological Phenomena,DrugBank
DB15944,Phytol,DrugBank
DB15944,Quinones,DrugBank
DB15944,Terpenes,DrugBank
DB15944,Vitamin K,DrugBank
DB15944,Vitamins,DrugBank
DB15944,Vitamins (Fat Soluble),DrugBank
DB15959,Diuretics,DrugBank
DB15959,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB15959,Membrane Transport Modulators,DrugBank
DB15959,Natriuretic Agents,DrugBank
DB15959,Sodium Potassium Chloride Symporter Inhibitors,DrugBank
DB15965,Agents that produce hypertension,DrugBank
DB15965,"Amino Acids, Peptides, and Proteins",DrugBank
DB15965,Antibodies,DrugBank
DB15965,"Antibodies, Monoclonal",DrugBank
DB15965,"Antibodies, Monoclonal, Humanized",DrugBank
DB15965,Antineoplastic Agents,DrugBank
DB15965,Antineoplastic and Immunomodulating Agents,DrugBank
DB15965,Blood Proteins,DrugBank
DB15965,Carbohydrates,DrugBank
DB15965,Globulins,DrugBank
DB15965,Glycoconjugates,DrugBank
DB15965,Glycolipid Disialoganglioside-directed Antibody,DrugBank
DB15965,Glycolipid Disialoganglioside-directed Antibody Interactions,DrugBank
DB15965,Immunoglobulins,DrugBank
DB15965,Immunoproteins,DrugBank
DB15965,Immunotherapy,DrugBank
DB15965,Lipids,DrugBank
DB15965,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB15965,Neurotoxic agents,DrugBank
DB15965,Proteins,DrugBank
DB15965,Serum Globulins,DrugBank
DB15972,Adrenal Cortex Hormones,DrugBank
DB15972,Corticosteroids,DrugBank
DB15972,Corticosteroids for Systemic Use,DrugBank
DB15972,"Corticosteroids for Systemic Use, Plain",DrugBank
DB15972,Fused-Ring Compounds,DrugBank
DB15972,Hormones,DrugBank
DB15972,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB15972,Hydroxycorticosteroids,DrugBank
DB15972,Mineralocorticoids,DrugBank
DB15972,Pregnanes,DrugBank
DB15972,Pregnenediones,DrugBank
DB15972,Pregnenes,DrugBank
DB15972,Steroids,DrugBank
DB15972,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB15975,Amides,DrugBank
DB15975,Amines,DrugBank
DB15975,Aniline Compounds,DrugBank
DB15975,Antibacterials for Systemic Use,DrugBank
DB15975,Antiinfectives for Systemic Use,DrugBank
DB15975,Sulfonamides,DrugBank
DB15975,Sulfonamides and trimethoprim,DrugBank
DB15975,Sulfones,DrugBank
DB15975,Sulfur Compounds,DrugBank
DB15982,BCRP/ABCG2 Substrates,DrugBank
DB15982,Blood and Blood Forming Organs,DrugBank
DB15982,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB15982,Cytochrome P-450 CYP2D6 Inhibitors (moderate),DrugBank
DB15982,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB15982,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB15982,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB15982,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB15982,Drugs Used in Hereditary Angioedema,DrugBank
DB15982,Enzyme Inhibitors,DrugBank
DB15982,Kallikrein Inhibitors,DrugBank
DB15982,"Kallikreins, antagonists & inhibitors",DrugBank
DB15982,Moderate Risk QTc-Prolonging Agents,DrugBank
DB15982,P-glycoprotein inhibitors,DrugBank
DB15982,P-glycoprotein substrates,DrugBank
DB15982,Plasma Kallikrein Inhibitor,DrugBank
DB15982,Protease Inhibitors,DrugBank
DB15982,QTc Prolonging Agents,DrugBank
DB15982,Serine Protease Inhibitors,DrugBank
DB16001,Androstanes,DrugBank
DB16001,Androstenes,DrugBank
DB16001,Androstenols,DrugBank
DB16001,Fused-Ring Compounds,DrugBank
DB16001,Gonadal Hormones,DrugBank
DB16001,Gonadal Steroid Hormones,DrugBank
DB16001,Hormones,DrugBank
DB16001,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16001,Steroids,DrugBank
DB16001,Testosterone Congeners,DrugBank
DB16002,Androstanes,DrugBank
DB16002,Androstenes,DrugBank
DB16002,Androstenols,DrugBank
DB16002,Fused-Ring Compounds,DrugBank
DB16002,Gonadal Hormones,DrugBank
DB16002,Gonadal Steroid Hormones,DrugBank
DB16002,Hormones,DrugBank
DB16002,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16002,Steroids,DrugBank
DB16002,Testosterone Congeners,DrugBank
DB16003,Androstanes,DrugBank
DB16003,Androstenes,DrugBank
DB16003,Androstenols,DrugBank
DB16003,Fused-Ring Compounds,DrugBank
DB16003,Gonadal Hormones,DrugBank
DB16003,Gonadal Steroid Hormones,DrugBank
DB16003,Hormones,DrugBank
DB16003,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16003,Steroids,DrugBank
DB16003,Testosterone Congeners,DrugBank
DB16007,"Amino Acids, Peptides, and Proteins",DrugBank
DB16007,Biological Factors,DrugBank
DB16007,Blood Coagulation Factors,DrugBank
DB16007,Blood Proteins,DrugBank
DB16007,Coagulants,DrugBank
DB16007,Factor VIII,DrugBank
DB16007,Hematologic Agents,DrugBank
DB16007,Hemostatics,DrugBank
DB16007,Pegylated agents,DrugBank
DB16007,Protein Precursors,DrugBank
DB16007,Proteins,DrugBank
DB16007,Recombinant Proteins,DrugBank
DB16021,"Acids, Carbocyclic",DrugBank
DB16021,Amides,DrugBank
DB16021,Antipsychotic Agents,DrugBank
DB16021,Benzamides and benzamide derivatives,DrugBank
DB16021,Benzene Derivatives,DrugBank
DB16021,Benzoates,DrugBank
DB16021,Central Nervous System Depressants,DrugBank
DB16021,Nervous System,DrugBank
DB16021,Psycholeptics,DrugBank
DB16077,"Amino Acids, Peptides, and Proteins",DrugBank
DB16077,Antibodies,DrugBank
DB16077,"Antibodies, Monoclonal",DrugBank
DB16077,Antineoplastic Agents,DrugBank
DB16077,"Antineoplastic Agents, Immunological",DrugBank
DB16077,Blood Proteins,DrugBank
DB16077,Globulins,DrugBank
DB16077,Immunoglobulins,DrugBank
DB16077,Immunoproteins,DrugBank
DB16077,Proteins,DrugBank
DB16077,Serum Globulins,DrugBank
DB16098,Analgesics,DrugBank
DB16098,Antimigraine Preparations,DrugBank
DB16098,BCRP/ABCG2 Substrates,DrugBank
DB16098,Calcitonin Gene-Related Peptide (CGRP) Antagonists,DrugBank
DB16098,Calcitonin Gene-Related Peptide Receptor Antagonists,DrugBank
DB16098,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16098,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16098,Cytochrome P-450 Substrates,DrugBank
DB16098,MATE 1 Inhibitors,DrugBank
DB16098,MATE inhibitors,DrugBank
DB16098,Nervous System,DrugBank
DB16098,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16098,OATP1B1/SLCO1B1 Substrates,DrugBank
DB16098,OATP1B3 inhibitors,DrugBank
DB16098,OATP1B3 substrates,DrugBank
DB16098,OCT1 inhibitors,DrugBank
DB16098,P-glycoprotein substrates,DrugBank
DB16128,"Amino Acids, Peptides, and Proteins",DrugBank
DB16128,Antibodies,DrugBank
DB16128,"Antibodies, Monoclonal",DrugBank
DB16128,Antineoplastic and Immunomodulating Agents,DrugBank
DB16128,Blood Proteins,DrugBank
DB16128,Complement C5 inhibitors,DrugBank
DB16128,Complement Inactivating Agents,DrugBank
DB16128,Globulins,DrugBank
DB16128,Immunoglobulins,DrugBank
DB16128,Immunoproteins,DrugBank
DB16128,Immunosuppressive Agents,DrugBank
DB16128,Proteins,DrugBank
DB16128,Serum Globulins,DrugBank
DB16151,"Amino Acids, Peptides, and Proteins",DrugBank
DB16151,Anti-Infective Agents,DrugBank
DB16151,Antibodies,DrugBank
DB16151,"Antibodies, Monoclonal",DrugBank
DB16151,Antifungal Agents,DrugBank
DB16151,Blood Proteins,DrugBank
DB16151,Globulins,DrugBank
DB16151,HSP90 Heat-Shock Proteins,DrugBank
DB16151,Immunoglobulins,DrugBank
DB16151,Immunoproteins,DrugBank
DB16151,Proteins,DrugBank
DB16151,Serum Globulins,DrugBank
DB16157,BCRP/ABCG2 Substrates,DrugBank
DB16157,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB16157,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16157,Cytochrome P-450 Substrates,DrugBank
DB16157,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16157,Phosphodiesterase 3 Inhibitors,DrugBank
DB16157,Phosphodiesterase 4 Inhibitors,DrugBank
DB16157,Phosphodiesterase Inhibitors,DrugBank
DB16157,Pyrimidines,DrugBank
DB16165,Agents causing hyperkalemia,DrugBank
DB16165,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB16165,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB16165,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16165,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16165,Cytochrome P-450 Substrates,DrugBank
DB16165,Diuretics,DrugBank
DB16165,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16165,Mineralocorticoid Receptor Antagonists,DrugBank
DB16165,Nonsteroidal Mineralocorticoid-Receptor Antagonist,DrugBank
DB16170,"Amino Acids, Peptides, and Proteins",DrugBank
DB16170,Antibodies,DrugBank
DB16170,Blood Proteins,DrugBank
DB16170,Globulins,DrugBank
DB16170,Immunoglobulins,DrugBank
DB16170,Immunoproteins,DrugBank
DB16170,Proteins,DrugBank
DB16170,Serum Globulins,DrugBank
DB16195,"Amino Acids, Peptides, and Proteins",DrugBank
DB16195,Anti-Bacterial Agents,DrugBank
DB16195,Antibodies,DrugBank
DB16195,Antibody-drug Conjugates,DrugBank
DB16195,Blood Proteins,DrugBank
DB16195,Globulins,DrugBank
DB16195,Immunoglobulins,DrugBank
DB16195,Immunologic Factors,DrugBank
DB16195,"Lactams, Macrocyclic",DrugBank
DB16195,Lactones,DrugBank
DB16195,Macrolides,DrugBank
DB16195,Proteins,DrugBank
DB16195,Serum Globulins,DrugBank
DB16200,"Acids, Carbocyclic",DrugBank
DB16200,Antineoplastic and Immunomodulating Agents,DrugBank
DB16200,Benzene Derivatives,DrugBank
DB16200,Complement Factor B Inhibitor,DrugBank
DB16200,Complement Inactivating Agents,DrugBank
DB16200,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB16200,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16200,Cytochrome P-450 Substrates,DrugBank
DB16200,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16200,Immunosuppressive Agents,DrugBank
DB16200,UGT1A1 Substrates,DrugBank
DB16200,UGT1A3 substrates,DrugBank
DB16216,Antineoplastic Agents,DrugBank
DB16216,Antineoplastic and Immunomodulating Agents,DrugBank
DB16216,BCRP/ABCG2 Inhibitors,DrugBank
DB16216,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16216,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16216,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16216,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB16216,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16216,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16216,Cytochrome P-450 Substrates,DrugBank
DB16216,Enzyme Inhibitors,DrugBank
DB16216,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB16216,Kinase Inhibitor,DrugBank
DB16216,OCT1 inhibitors,DrugBank
DB16216,Oxazines,DrugBank
DB16216,Protein Kinase Inhibitors,DrugBank
DB16216,UGT1A1 Inhibitors,DrugBank
DB16217,"Adjuvants, Immunologic",DrugBank
DB16217,Antineoplastic and Immunomodulating Agents,DrugBank
DB16217,BCRP/ABCG2 Inhibitors,DrugBank
DB16217,BCRP/ABCG2 Substrates,DrugBank
DB16217,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB16217,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB16217,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB16217,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB16217,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16217,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16217,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16217,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB16217,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16217,Cytochrome P-450 Substrates,DrugBank
DB16217,Kinase Inhibitor,DrugBank
DB16217,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16217,OATP1B3 inhibitors,DrugBank
DB16217,P-glycoprotein substrates,DrugBank
DB16220,"Amino Acids, Peptides, and Proteins",DrugBank
DB16220,Anterior Pituitary Lobe Hormones and Analogues,DrugBank
DB16220,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB16220,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB16220,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB16220,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB16220,Cytochrome P-450 Enzyme Inducers,DrugBank
DB16220,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16220,Growth Hormone,DrugBank
DB16220,Hormones,DrugBank
DB16220,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16220,P-glycoprotein substrates,DrugBank
DB16220,Peptide Hormones,DrugBank
DB16220,Peptides,DrugBank
DB16220,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB16220,Pituitary Hormones,DrugBank
DB16220,"Pituitary Hormones, Anterior",DrugBank
DB16220,Prodrugs,DrugBank
DB16220,Recombinant Human Growth Hormone,DrugBank
DB16220,Somatropin and Somatropin Agonists,DrugBank
DB16220,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB16222,"Amino Acids, Peptides, and Proteins",DrugBank
DB16222,Antibodies,DrugBank
DB16222,"Antibodies, Monoclonal",DrugBank
DB16222,Antibody-drug Conjugates,DrugBank
DB16222,Antineoplastic Agents,DrugBank
DB16222,"Antineoplastic Agents, Immunological",DrugBank
DB16222,Antineoplastic and Immunomodulating Agents,DrugBank
DB16222,Benzazepines,DrugBank
DB16222,Blood Proteins,DrugBank
DB16222,CD19-Directed Monoclonal Antibodies,DrugBank
DB16222,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16222,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16222,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB16222,Cytochrome P-450 Substrates,DrugBank
DB16222,Globulins,DrugBank
DB16222,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16222,Immunoglobulins,DrugBank
DB16222,Immunoproteins,DrugBank
DB16222,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16222,P-glycoprotein substrates,DrugBank
DB16222,Proteins,DrugBank
DB16222,Serum Globulins,DrugBank
DB16225,"Amino Acids, Peptides, and Proteins",DrugBank
DB16225,Antibodies,DrugBank
DB16225,"Antibodies, Monoclonal",DrugBank
DB16225,Antineoplastic Agents,DrugBank
DB16225,"Antineoplastic Agents, Immunological",DrugBank
DB16225,Blood Proteins,DrugBank
DB16225,Globulins,DrugBank
DB16225,Immunoglobulins,DrugBank
DB16225,Immunoproteins,DrugBank
DB16225,Proteins,DrugBank
DB16225,Serum Globulins,DrugBank
DB16226,Alimentary Tract and Metabolism,DrugBank
DB16226,Bile and Liver Therapy,DrugBank
DB16226,Bile Therapy,DrugBank
DB16226,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16226,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16226,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB16226,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16226,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16226,Ileal bile acid transport inhibitor,DrugBank
DB16226,Ileal Bile Acid Transporter Inhibitor,DrugBank
DB16226,Organic Anion Transporting Polypeptide 2B1 Inhibitors,DrugBank
DB16226,Sulfur Compounds,DrugBank
DB16236,"Anemia, Hemolytic, Congenital, drug therapy",DrugBank
DB16236,Blood and Blood Forming Organs,DrugBank
DB16236,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB16236,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB16236,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB16236,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB16236,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB16236,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB16236,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB16236,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB16236,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB16236,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB16236,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB16236,Cytochrome P-450 CYP3A Inducers,DrugBank
DB16236,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16236,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB16236,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB16236,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16236,Cytochrome P-450 Enzyme Inducers,DrugBank
DB16236,Cytochrome P-450 Substrates,DrugBank
DB16236,Enzyme Activators,DrugBank
DB16236,Genito Urinary System and Sex Hormones,DrugBank
DB16236,Gynecological Antiinfectives and Antiseptics,DrugBank
DB16236,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16236,P-glycoprotein inhibitors,DrugBank
DB16236,P-glycoprotein substrates,DrugBank
DB16236,Pyruvate Kinase Activator,DrugBank
DB16236,Sulfonamides,DrugBank
DB16236,Sulfones,DrugBank
DB16236,UGT1A1 Inducers,DrugBank
DB16250,Alkaloids,DrugBank
DB16250,Antineoplastic Agents,DrugBank
DB16250,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16250,Pyridines,DrugBank
DB16250,Solanaceous Alkaloids,DrugBank
DB16257,"Amino Acids, Peptides, and Proteins",DrugBank
DB16257,"Antibodies, Monoclonal",DrugBank
DB16257,Blood Proteins,DrugBank
DB16257,Immunoglobulins,DrugBank
DB16257,Neonatal Fc Receptor Blocker,DrugBank
DB16257,Proteins,DrugBank
DB16257,Serum Globulins,DrugBank
DB16261,"Acids, Acyclic",DrugBank
DB16261,Alimentary Tract and Metabolism,DrugBank
DB16261,Benzazepines,DrugBank
DB16261,Bile and Liver Therapy,DrugBank
DB16261,Bile Therapy,DrugBank
DB16261,Fatty Acids,DrugBank
DB16261,"Fatty Acids, Volatile",DrugBank
DB16261,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16261,Ileal bile acid transport inhibitor,DrugBank
DB16261,Ileal Bile Acid Transporter Inhibitor,DrugBank
DB16261,Lipids,DrugBank
DB16261,P-glycoprotein substrates,DrugBank
DB16265,"Amino Acids, Peptides, and Proteins",DrugBank
DB16265,Antibodies,DrugBank
DB16265,"Antibodies, Monoclonal",DrugBank
DB16265,Blood Proteins,DrugBank
DB16265,Globulins,DrugBank
DB16265,Immunoglobulins,DrugBank
DB16265,Immunoproteins,DrugBank
DB16265,Proteins,DrugBank
DB16265,Serum Globulins,DrugBank
DB16267,Antineoplastic Agents,DrugBank
DB16267,Antineoplastic and Immunomodulating Agents,DrugBank
DB16267,BCRP/ABCG2 Inhibitors,DrugBank
DB16267,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB16267,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB16267,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB16267,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB16267,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB16267,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB16267,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB16267,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB16267,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB16267,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB16267,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB16267,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB16267,Cytochrome P-450 CYP3A Inducers,DrugBank
DB16267,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16267,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB16267,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB16267,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16267,Cytochrome P-450 Enzyme Inducers,DrugBank
DB16267,Cytochrome P-450 Substrates,DrugBank
DB16267,Enzyme Inhibitors,DrugBank
DB16267,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16267,Isocitrate dehydrogenase (IDH) inhibitors,DrugBank
DB16267,Isocitrate dehydrogenase-1 (IDH1) inhibitors,DrugBank
DB16267,Isocitrate Dehydrogenase-1 Inhibitors,DrugBank
DB16267,MATE 1 Inhibitors,DrugBank
DB16267,MATE 2 Inhibitors,DrugBank
DB16267,MATE inhibitors,DrugBank
DB16267,OAT3/SLC22A8 Inhibitors,DrugBank
DB16267,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16267,OATP1B3 inhibitors,DrugBank
DB16267,OCT2 Inhibitors,DrugBank
DB16267,P-glycoprotein inhibitors,DrugBank
DB16267,Potential QTc-Prolonging Agents,DrugBank
DB16267,QTc Prolonging Agents,DrugBank
DB16277,BCRP/ABCG2 Substrates,DrugBank
DB16277,BSEP/ABCB11 Inhibitors,DrugBank
DB16277,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB16277,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB16277,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB16277,Cytochrome P-450 CYP2D6 Inhibitors (weak),DrugBank
DB16277,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16277,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16277,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16277,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16277,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB16277,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16277,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB16277,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16277,Cytochrome P-450 Substrates,DrugBank
DB16277,MATE 1 Inhibitors,DrugBank
DB16277,MATE 2 Inhibitors,DrugBank
DB16277,MATE inhibitors,DrugBank
DB16277,P-glycoprotein inhibitors,DrugBank
DB16277,P-glycoprotein substrates,DrugBank
DB16277,Somatostatin Receptor Agonists,DrugBank
DB16277,UGT1A1 Inhibitors,DrugBank
DB16277,UGT1A1 Substrates,DrugBank
DB16277,UGT1A3 Inhibitors,DrugBank
DB16277,UGT1A9 Inhibitors,DrugBank
DB16277,UGT1A9 Substrates,DrugBank
DB16282,"Amino Acids, Peptides, and Proteins",DrugBank
DB16282,Antineoplastic Agents,DrugBank
DB16282,Enzymes,DrugBank
DB16282,Enzymes and Coenzymes,DrugBank
DB16282,Hydrolases,DrugBank
DB16282,Proteins,DrugBank
DB16282,Ureohydrolases,DrugBank
DB16326,BCRP/ABCG2 Substrates,DrugBank
DB16326,Biological Factors,DrugBank
DB16326,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16326,"Pigments, Biological",DrugBank
DB16326,Pteridines,DrugBank
DB16335,OAT3/SLC22A8 Substrates,DrugBank
DB16335,Penem Antibacterial,DrugBank
DB16355,"Amino Acids, Peptides, and Proteins",DrugBank
DB16355,Anti-Infective Agents,DrugBank
DB16355,Antibodies,DrugBank
DB16355,"Antibodies, Monoclonal",DrugBank
DB16355,Antiinfectives for Systemic Use,DrugBank
DB16355,Antiviral Agents,DrugBank
DB16355,Antiviral monoclonal antibodies,DrugBank
DB16355,Approved Treatments for COVID-19,DrugBank
DB16355,Blood Proteins,DrugBank
DB16355,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16355,Globulins,DrugBank
DB16355,Immune Sera and Immunoglobulins,DrugBank
DB16355,Immunoglobulins,DrugBank
DB16355,Immunoproteins,DrugBank
DB16355,Proteins,DrugBank
DB16355,Serum Globulins,DrugBank
DB16371,"Amino Acids, Peptides, and Proteins",DrugBank
DB16371,Antibodies,DrugBank
DB16371,"Antibodies, Monoclonal",DrugBank
DB16371,Antineoplastic Agents,DrugBank
DB16371,Antineoplastic and Immunomodulating Agents,DrugBank
DB16371,Bispecific CD20-directed CD3 T Cell Engager,DrugBank
DB16371,Bispecific Monoclonal Antibodies,DrugBank
DB16371,Blood Proteins,DrugBank
DB16371,Globulins,DrugBank
DB16371,Immunoglobulins,DrugBank
DB16371,Immunoproteins,DrugBank
DB16371,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16371,Proteins,DrugBank
DB16371,Serum Globulins,DrugBank
DB16376,"Amino Acids, Peptides, and Proteins",DrugBank
DB16376,Antibodies,DrugBank
DB16376,"Antibodies, Neutralizing",DrugBank
DB16376,Blood Proteins,DrugBank
DB16376,Globulins,DrugBank
DB16376,Immunoglobulins,DrugBank
DB16376,Immunoproteins,DrugBank
DB16376,Proteins,DrugBank
DB16376,Serum Globulins,DrugBank
DB16385,"Amino Acids, Peptides, and Proteins",DrugBank
DB16385,Anti-Infective Agents,DrugBank
DB16385,Antibodies,DrugBank
DB16385,"Antibodies, Monoclonal",DrugBank
DB16385,Antiinfectives for Systemic Use,DrugBank
DB16385,Antiviral Agents,DrugBank
DB16385,Antiviral monoclonal antibodies,DrugBank
DB16385,Blood Proteins,DrugBank
DB16385,Globulins,DrugBank
DB16385,Immune Sera and Immunoglobulins,DrugBank
DB16385,Immunoglobulins,DrugBank
DB16385,Immunoproteins,DrugBank
DB16385,Proteins,DrugBank
DB16385,Serum Globulins,DrugBank
DB16385,Treatments for Ebola Virus Disease,DrugBank
DB16385,Zaire Ebolavirus Glycoprotein-directed Antibody,DrugBank
DB16388,"Amino Acids, Peptides, and Proteins",DrugBank
DB16388,Antibodies,DrugBank
DB16388,"Antibodies, Monoclonal",DrugBank
DB16388,Blood Proteins,DrugBank
DB16388,Colony Stimulating Factor-1 Receptor Blocker,DrugBank
DB16388,Globulins,DrugBank
DB16388,Immunoglobulins,DrugBank
DB16388,Immunoproteins,DrugBank
DB16388,Proteins,DrugBank
DB16388,Serum Globulins,DrugBank
DB16390,Amines,DrugBank
DB16390,Antineoplastic Agents,DrugBank
DB16390,Antineoplastic and Immunomodulating Agents,DrugBank
DB16390,BCRP/ABCG2 Inhibitors,DrugBank
DB16390,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16390,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16390,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB16390,Cytochrome P-450 CYP3A7 Substrates,DrugBank
DB16390,Cytochrome P-450 Substrates,DrugBank
DB16390,Enzyme Inhibitors,DrugBank
DB16390,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB16390,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16390,Kinase Inhibitor,DrugBank
DB16390,P-glycoprotein inhibitors,DrugBank
DB16390,P-glycoprotein substrates,DrugBank
DB16390,Protein Kinase Inhibitors,DrugBank
DB16390,QTc Prolonging Agents,DrugBank
DB16390,Tyrosine Kinase Inhibitors,DrugBank
DB16393,"Amino Acids, Peptides, and Proteins",DrugBank
DB16393,Antibodies,DrugBank
DB16393,"Antibodies, Monoclonal",DrugBank
DB16393,Antiinfectives for Systemic Use,DrugBank
DB16393,Antiviral Agents,DrugBank
DB16393,Antiviral monoclonal antibodies,DrugBank
DB16393,Antivirals for Systemic Use,DrugBank
DB16393,Blood Proteins,DrugBank
DB16393,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16393,Globulins,DrugBank
DB16393,Immune Sera and Immunoglobulins,DrugBank
DB16393,Immunoglobulins,DrugBank
DB16393,Immunoproteins,DrugBank
DB16393,Proteins,DrugBank
DB16393,Serum Globulins,DrugBank
DB16394,"Amino Acids, Peptides, and Proteins",DrugBank
DB16394,Antibodies,DrugBank
DB16394,"Antibodies, Monoclonal",DrugBank
DB16394,Antiinfectives for Systemic Use,DrugBank
DB16394,Antiviral Agents,DrugBank
DB16394,Antiviral monoclonal antibodies,DrugBank
DB16394,Antivirals for Systemic Use,DrugBank
DB16394,Blood Proteins,DrugBank
DB16394,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16394,Globulins,DrugBank
DB16394,Immune Sera and Immunoglobulins,DrugBank
DB16394,Immunoglobulins,DrugBank
DB16394,Immunoproteins,DrugBank
DB16394,Proteins,DrugBank
DB16394,Serum Globulins,DrugBank
DB16410,"Amino Acids, Peptides, and Proteins",DrugBank
DB16410,"Antibodies, Monoclonal",DrugBank
DB16410,Antibody-drug Conjugates,DrugBank
DB16410,Antineoplastic Agents,DrugBank
DB16410,Antineoplastic and Immunomodulating Agents,DrugBank
DB16410,BCRP/ABCG2 Substrates,DrugBank
DB16410,Blood Proteins,DrugBank
DB16410,Immunoglobulins,DrugBank
DB16410,MATE 2 Substrates,DrugBank
DB16410,MATE substrates,DrugBank
DB16410,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16410,OATP1B1/SLCO1B1 Substrates,DrugBank
DB16410,OATP1B3 substrates,DrugBank
DB16410,P-glycoprotein substrates,DrugBank
DB16410,Proteins,DrugBank
DB16410,Serum Globulins,DrugBank
DB16410,Topoisomerase I Inhibitors,DrugBank
DB16410,Trop-2-Directed Monoclonal Antibodies,DrugBank
DB16416,"Amino Acids, Peptides, and Proteins",DrugBank
DB16416,Antibodies,DrugBank
DB16416,"Antibodies, Monoclonal",DrugBank
DB16416,Antineoplastic and Immunomodulating Agents,DrugBank
DB16416,Blood Proteins,DrugBank
DB16416,Complement Inactivating Agents,DrugBank
DB16416,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16416,Globulins,DrugBank
DB16416,Immunoglobulins,DrugBank
DB16416,Immunologic Factors,DrugBank
DB16416,Immunoproteins,DrugBank
DB16416,Immunosuppressive Agents,DrugBank
DB16416,Proteins,DrugBank
DB16416,Serum Globulins,DrugBank
DB16421,"Amino Acids, Peptides, and Proteins",DrugBank
DB16421,Antibodies,DrugBank
DB16421,"Antibodies, Monoclonal",DrugBank
DB16421,Blood Glucose Lowering Agents,DrugBank
DB16421,Blood Proteins,DrugBank
DB16421,Globulins,DrugBank
DB16421,Immunoglobulins,DrugBank
DB16421,Immunoproteins,DrugBank
DB16421,Proteins,DrugBank
DB16421,"Receptors, Glucagon, antagonists & inhibitors",DrugBank
DB16421,Serum Globulins,DrugBank
DB16479,"Amino Acids, Peptides, and Proteins",DrugBank
DB16479,Antineoplastic Agents,DrugBank
DB16479,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16479,Interleukin-15,DrugBank
DB16479,Proteins,DrugBank
DB16479,"Receptors, Interleukin-15",DrugBank
DB16479,Recombinant Proteins,DrugBank
DB16582,Antineoplastic Agents,DrugBank
DB16582,Antineoplastic and Immunomodulating Agents,DrugBank
DB16582,Antineoplastic cell and gene therapy,DrugBank
DB16582,Cancer immunotherapy,DrugBank
DB16582,CD19-Directed Genetically Modified Autologous T-cell Immunotherapies,DrugBank
DB16582,Immunotherapy,DrugBank
DB16607,"Adjuvants, Immunologic",DrugBank
DB16607,Antimanic Agents,DrugBank
DB16607,Central Nervous System Agents,DrugBank
DB16607,Central Nervous System Depressants,DrugBank
DB16607,Chlorides,DrugBank
DB16607,Chlorine Compounds,DrugBank
DB16607,Diagnostic Agents,DrugBank
DB16607,Immunologic Factors,DrugBank
DB16607,Lithium Compounds,DrugBank
DB16607,Psychotropic Drugs,DrugBank
DB16607,Tranquilizing Agents,DrugBank
DB16611,Vaccines,DrugBank
DB16611,Viral Vaccines,DrugBank
DB16623,Adrenergic Agents,DrugBank
DB16623,Adrenergic Agonists,DrugBank
DB16623,Adrenergic alpha-Agonists,DrugBank
DB16623,Alcohols,DrugBank
DB16623,Amines,DrugBank
DB16623,Amino Alcohols,DrugBank
DB16623,Neurotransmitter Agents,DrugBank
DB16625,17-Ketosteroids,DrugBank
DB16625,Adrenal Cortex Hormones,DrugBank
DB16625,Androstanes,DrugBank
DB16625,Androstenes,DrugBank
DB16625,Androstenols,DrugBank
DB16625,Fused-Ring Compounds,DrugBank
DB16625,Gonadal Hormones,DrugBank
DB16625,Gonadal Steroid Hormones,DrugBank
DB16625,Hormones,DrugBank
DB16625,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16625,Ketosteroids,DrugBank
DB16625,Steroids,DrugBank
DB16625,Testosterone Congeners,DrugBank
DB16629,Agents that produce hypertension,DrugBank
DB16629,Central Nervous System Agents,DrugBank
DB16629,Central Nervous System Stimulants,DrugBank
DB16629,Central Nervous System Stimulation,DrugBank
DB16629,Centrally Acting Sympathomimetics,DrugBank
DB16629,Dopamine Agents,DrugBank
DB16629,Dopamine Uptake Inhibitors,DrugBank
DB16629,Membrane Transport Modulators,DrugBank
DB16629,Nervous System,DrugBank
DB16629,Neurotransmitter Agents,DrugBank
DB16629,Neurotransmitter Uptake Inhibitors,DrugBank
DB16629,Phenylacetates,DrugBank
DB16629,Piperidines,DrugBank
DB16629,Psychoanaleptics,DrugBank
DB16629,"Psychostimulants, Agents Used for ADHD and Nootropics",DrugBank
DB16641,"Amino Acids, Peptides, and Proteins",DrugBank
DB16641,Antibodies,DrugBank
DB16641,"Antibodies, Monoclonal",DrugBank
DB16641,Antineoplastic Agents,DrugBank
DB16641,Antineoplastic and Immunomodulating Agents,DrugBank
DB16641,Blood Proteins,DrugBank
DB16641,Globulins,DrugBank
DB16641,Immunoglobulins,DrugBank
DB16641,Immunoproteins,DrugBank
DB16641,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16641,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB16641,Proteins,DrugBank
DB16641,Serum Globulins,DrugBank
DB16647,"Alzheimer Disease, drug therapy",DrugBank
DB16647,"Amino Acids, Peptides, and Proteins",DrugBank
DB16647,Amyloid Beta-directed Antibodies,DrugBank
DB16647,Anti-Dementia Drugs,DrugBank
DB16647,Antibodies,DrugBank
DB16647,"Antibodies, Monoclonal",DrugBank
DB16647,Blood Proteins,DrugBank
DB16647,Globulins,DrugBank
DB16647,Immunoglobulins,DrugBank
DB16647,Immunoproteins,DrugBank
DB16647,Nervous System,DrugBank
DB16647,Proteins,DrugBank
DB16647,Psychoanaleptics,DrugBank
DB16647,Serum Globulins,DrugBank
DB16648,Antineoplastic Agents,DrugBank
DB16648,Live vaccines,DrugBank
DB16648,Vaccines,DrugBank
DB16650,Antineoplastic and Immunomodulating Agents,DrugBank
DB16650,BCRP/ABCG2 Inhibitors,DrugBank
DB16650,BCRP/ABCG2 Substrates,DrugBank
DB16650,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB16650,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB16650,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16650,Cytochrome P-450 Substrates,DrugBank
DB16650,Dermatologicals,DrugBank
DB16650,Enzyme Inhibitors,DrugBank
DB16650,Immunosuppressive Agents,DrugBank
DB16650,Janus Kinase Inhibitor,DrugBank
DB16650,Janus Kinase Inhibitors,DrugBank
DB16650,OATP1B3 inhibitors,DrugBank
DB16650,OCT1 substrates,DrugBank
DB16650,P-glycoprotein substrates,DrugBank
DB16650,Protein Kinase Inhibitors,DrugBank
DB16650,Selective Immunosuppressants,DrugBank
DB16650,Tyrosine Kinase 2 Inhibitor,DrugBank
DB16650,Tyrosine Kinase Inhibitors,DrugBank
DB16650,UGT1A9 Substrates,DrugBank
DB16655,"Amino Acids, Peptides, and Proteins",DrugBank
DB16655,"Antibodies, Monoclonal",DrugBank
DB16655,Antineoplastic Agents,DrugBank
DB16655,Antineoplastic and Immunomodulating Agents,DrugBank
DB16655,Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager,DrugBank
DB16655,Bispecific Monoclonal Antibodies,DrugBank
DB16655,Blood Proteins,DrugBank
DB16655,Immunoglobulins,DrugBank
DB16655,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16655,Proteins,DrugBank
DB16655,Serum Globulins,DrugBank
DB16659,"Amino Acids, Peptides, and Proteins",DrugBank
DB16659,Antibodies,DrugBank
DB16659,"Antibodies, Neutralizing",DrugBank
DB16659,Blood Proteins,DrugBank
DB16659,Globulins,DrugBank
DB16659,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16659,Immunoglobulins,DrugBank
DB16659,Immunoproteins,DrugBank
DB16659,"Nucleic Acids, Nucleotides, and Nucleosides",DrugBank
DB16659,Nucleosides,DrugBank
DB16659,Proteins,DrugBank
DB16659,Purine Nucleosides,DrugBank
DB16659,Purines,DrugBank
DB16659,Ribonucleosides,DrugBank
DB16659,Serum Globulins,DrugBank
DB16665,"Amino Acids, Peptides, and Proteins",DrugBank
DB16665,Antineoplastic Agents,DrugBank
DB16665,"Antineoplastic Agents, Immunological",DrugBank
DB16665,Antineoplastic and Immunomodulating Agents,DrugBank
DB16665,Antineoplastic cell and gene therapy,DrugBank
DB16665,Autologous Cellular Immunotherapy,DrugBank
DB16665,Cancer immunotherapy,DrugBank
DB16665,Immunotherapy,DrugBank
DB16665,Membrane Proteins,DrugBank
DB16665,Proteins,DrugBank
DB16665,"Receptors, Antigen",DrugBank
DB16665,"Receptors, Antigen, T-Cell",DrugBank
DB16665,"Receptors, Artificial",DrugBank
DB16665,"Receptors, Cytoplasmic and Nuclear",DrugBank
DB16672,"Amino Acids, Peptides, and Proteins",DrugBank
DB16672,"Antibodies, Monoclonal",DrugBank
DB16672,"Antibodies, Monoclonal, Humanized",DrugBank
DB16672,Antineoplastic Agents,DrugBank
DB16672,Antineoplastic and Immunomodulating Agents,DrugBank
DB16672,Bispecific CD20-directed CD3 T Cell Engager,DrugBank
DB16672,Bispecific Monoclonal Antibodies,DrugBank
DB16672,Blood Proteins,DrugBank
DB16672,Cancer immunotherapy,DrugBank
DB16672,CD20-directed Antibody Interactions,DrugBank
DB16672,CD3-directed Antibody Interactions,DrugBank
DB16672,Immunoglobulins,DrugBank
DB16672,Immunotherapy,DrugBank
DB16672,Increased Cytokine Production,DrugBank
DB16672,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16672,Proteins,DrugBank
DB16672,Serum Globulins,DrugBank
DB16678,"Amino Acids, Peptides, and Proteins",DrugBank
DB16678,Antibodies,DrugBank
DB16678,"Antibodies, Monoclonal",DrugBank
DB16678,Antineoplastic Agents,DrugBank
DB16678,Antineoplastic and Immunomodulating Agents,DrugBank
DB16678,Bispecific Monoclonal Antibodies,DrugBank
DB16678,Blood Proteins,DrugBank
DB16678,Globulins,DrugBank
DB16678,Immunoglobulins,DrugBank
DB16678,Immunoproteins,DrugBank
DB16678,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16678,Proteins,DrugBank
DB16678,Serum Globulins,DrugBank
DB16684,Antineoplastic Agents,DrugBank
DB16684,Antineoplastic and Immunomodulating Agents,DrugBank
DB16684,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16690,Alimentary Tract and Metabolism,DrugBank
DB16690,Drugs for Acid Related Disorders,DrugBank
DB16690,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord),DrugBank
DB16690,Gastric Acid Lowering Agents,DrugBank
DB16690,Proton Pump Inhibitors,DrugBank
DB16691,Amides,DrugBank
DB16691,Amino Acids,DrugBank
DB16691,"Amino Acids, Branched-Chain",DrugBank
DB16691,"Amino Acids, Cyclic",DrugBank
DB16691,"Amino Acids, Essential",DrugBank
DB16691,"Amino Acids, Peptides, and Proteins",DrugBank
DB16691,Anti-Infective Agents,DrugBank
DB16691,Antiinfectives for Systemic Use,DrugBank
DB16691,Antiviral Agents,DrugBank
DB16691,Antivirals for Systemic Use,DrugBank
DB16691,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16691,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16691,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16691,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB16691,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16691,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16691,Cytochrome P-450 Substrates,DrugBank
DB16691,Direct Acting Antivirals,DrugBank
DB16691,Enzyme Inhibitors,DrugBank
DB16691,Experimental Unapproved Treatments for COVID-19,DrugBank
DB16691,Imino Acids,DrugBank
DB16691,P-glycoprotein inhibitors,DrugBank
DB16691,P-glycoprotein substrates,DrugBank
DB16691,Protease Inhibitors,DrugBank
DB16691,Viral Protease Inhibitors,DrugBank
DB16693,Alimentary Tract and Metabolism,DrugBank
DB16693,"Amino Acids, Peptides, and Proteins",DrugBank
DB16693,Blood Glucose Lowering Agents,DrugBank
DB16693,Drugs Used in Diabetes,DrugBank
DB16693,Hormones,DrugBank
DB16693,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB16693,Hypoglycemia-Associated Agents,DrugBank
DB16693,Insulin,DrugBank
DB16693,"Insulin, Long-Acting",DrugBank
DB16693,Long-acting Insulins,DrugBank
DB16693,Pancreatic Hormones,DrugBank
DB16693,Peptide Hormones,DrugBank
DB16693,Peptides,DrugBank
DB16694,"Amino Acids, Peptides, and Proteins",DrugBank
DB16694,Antineoplastic and Immunomodulating Agents,DrugBank
DB16694,Complement Inactivating Agents,DrugBank
DB16694,Complement Inactivator Proteins,DrugBank
DB16694,Immunosuppressive Agents,DrugBank
DB16694,Ophthalmologicals,DrugBank
DB16694,Peptides,DrugBank
DB16694,Selective Immunosuppressants,DrugBank
DB16694,Sensory Organs,DrugBank
DB16695,"Amino Acids, Peptides, and Proteins",DrugBank
DB16695,Antibodies,DrugBank
DB16695,"Antibodies, Monoclonal",DrugBank
DB16695,Antineoplastic Agents,DrugBank
DB16695,"Antineoplastic Agents, Immunological",DrugBank
DB16695,Antineoplastic and Immunomodulating Agents,DrugBank
DB16695,Bispecific Monoclonal Antibodies,DrugBank
DB16695,Blood Proteins,DrugBank
DB16695,Globulins,DrugBank
DB16695,Immunoglobulins,DrugBank
DB16695,Immunoproteins,DrugBank
DB16695,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16695,Proteins,DrugBank
DB16695,Serum Globulins,DrugBank
DB16703,Acetates,DrugBank
DB16703,"Acids, Acyclic",DrugBank
DB16703,Amides,DrugBank
DB16703,Antineoplastic and Immunomodulating Agents,DrugBank
DB16703,BCRP/ABCG2 Inhibitors,DrugBank
DB16703,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB16703,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB16703,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB16703,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB16703,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB16703,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB16703,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB16703,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB16703,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16703,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16703,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16703,Cytochrome P-450 Substrates,DrugBank
DB16703,Enzyme Inhibitors,DrugBank
DB16703,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB16703,Immunosuppressive Agents,DrugBank
DB16703,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16703,P-glycoprotein inhibitors,DrugBank
DB16703,P-glycoprotein substrates,DrugBank
DB16703,Protein Kinase Inhibitors,DrugBank
DB16703,Selective Immunosuppressants,DrugBank
DB16703,UGT1A1 Inhibitors,DrugBank
DB16703,UGT1A9 Inhibitors,DrugBank
DB16703,UGT1A9 Substrates,DrugBank
DB16704,Anti-Bacterial Agents,DrugBank
DB16704,Anti-Infective Agents,DrugBank
DB16704,Aza Compounds,DrugBank
DB16704,beta-Lactamase Inhibitors,DrugBank
DB16704,Enzyme Inhibitors,DrugBank
DB16704,OAT1/SLC22A6 Substrates,DrugBank
DB16732,"Amino Acids, Peptides, and Proteins",DrugBank
DB16732,Antibodies,DrugBank
DB16732,"Antibodies, Monoclonal",DrugBank
DB16732,Antineoplastic Agents,DrugBank
DB16732,"Antineoplastic Agents, Immunological",DrugBank
DB16732,Antineoplastic and Immunomodulating Agents,DrugBank
DB16732,Blood Proteins,DrugBank
DB16732,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16732,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16732,Cytochrome P-450 Substrates,DrugBank
DB16732,Globulins,DrugBank
DB16732,Immunoglobulins,DrugBank
DB16732,Immunoproteins,DrugBank
DB16732,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB16732,P-glycoprotein substrates,DrugBank
DB16732,Peptides,DrugBank
DB16732,Proteins,DrugBank
DB16732,Serum Globulins,DrugBank
DB16738,Antineoplastic Agents,DrugBank
DB16738,Antineoplastic and Immunomodulating Agents,DrugBank
DB16738,Antineoplastic cell and gene therapy,DrugBank
DB16741,Antineoplastic Agents,DrugBank
DB16741,Proteasome Inhibitors,DrugBank
DB16747,"Amino Acids, Peptides, and Proteins",DrugBank
DB16747,Antibodies,DrugBank
DB16747,"Antibodies, Monoclonal",DrugBank
DB16747,Blood Proteins,DrugBank
DB16747,Globulins,DrugBank
DB16747,Immune Checkpoint Inhibitors,DrugBank
DB16747,Immunoglobulins,DrugBank
DB16747,Immunoproteins,DrugBank
DB16747,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB16747,Programmed Death Receptor-1 Blocking Antibody,DrugBank
DB16747,Proteins,DrugBank
DB16747,Serum Globulins,DrugBank
DB16755,"Amino Acids, Peptides, and Proteins",DrugBank
DB16755,Antibodies,DrugBank
DB16755,Approved Treatments for COVID-19,DrugBank
DB16755,Blood Proteins,DrugBank
DB16755,Globulins,DrugBank
DB16755,Immunoglobulins,DrugBank
DB16755,Immunoproteins,DrugBank
DB16755,Proteins,DrugBank
DB16755,Serum Globulins,DrugBank
DB16783,Adeno-associated Viral Vector Therapies,DrugBank
DB16783,Blood and Blood Forming Organs,DrugBank
DB16783,Blood Coagulation Factors,DrugBank
DB16783,Hemostatics,DrugBank
DB16783,Hepatotoxic Agents,DrugBank
DB16791,Adeno-associated Viral Vector Therapies,DrugBank
DB16791,Blood and Blood Forming Organs,DrugBank
DB16791,Blood Coagulation Factors,DrugBank
DB16791,Cellular and Gene Therapy,DrugBank
DB16791,Hemostatics,DrugBank
DB16820,Acetylcholine Release Inhibitors,DrugBank
DB16820,"Amino Acids, Peptides, and Proteins",DrugBank
DB16820,Bacterial Proteins,DrugBank
DB16820,Bacterial Toxins,DrugBank
DB16820,Biological Factors,DrugBank
DB16820,"Botulinum Toxins, Type A",DrugBank
DB16820,Central Nervous System Depressants,DrugBank
DB16820,Cholinergic Agents,DrugBank
DB16820,Endopeptidases,DrugBank
DB16820,Enzymes,DrugBank
DB16820,Enzymes and Coenzymes,DrugBank
DB16820,Hydrolases,DrugBank
DB16820,Membrane Transport Modulators,DrugBank
DB16820,Metalloendopeptidases,DrugBank
DB16820,Metalloproteases,DrugBank
DB16820,Neuromuscular Agents,DrugBank
DB16820,Neuromuscular Blocking Agents,DrugBank
DB16820,Neurotransmitter Agents,DrugBank
DB16820,Peptide Hydrolases,DrugBank
DB16820,Proteins,DrugBank
DB16820,"Toxins, Biological",DrugBank
DB16826,Antineoplastic Agents,DrugBank
DB16826,Antineoplastic and Immunomodulating Agents,DrugBank
DB16826,BCRP/ABCG2 Inhibitors,DrugBank
DB16826,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB16826,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB16826,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB16826,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB16826,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP3A Inducers,DrugBank
DB16826,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16826,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16826,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB16826,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16826,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB16826,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16826,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB16826,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB16826,Cytochrome P-450 Enzyme Inducers,DrugBank
DB16826,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16826,Cytochrome P-450 Substrates,DrugBank
DB16826,Kinase Inhibitor,DrugBank
DB16826,MATE 2 Inhibitors,DrugBank
DB16826,MATE inhibitors,DrugBank
DB16826,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16826,P-glycoprotein inhibitors,DrugBank
DB16826,P-glycoprotein substrates,DrugBank
DB16826,Protein Kinase Inhibitors,DrugBank
DB16826,ROS1 tyrosine kinase inhibitors,DrugBank
DB16826,Tyrosine Kinase Inhibitors,DrugBank
DB16826,UGT1A1 Inhibitors,DrugBank
DB16852,Antineoplastic and Immunomodulating Agents,DrugBank
DB16852,BCRP/ABCG2 Inhibitors,DrugBank
DB16852,Bruton's tyrosine kinase (BTK) inhibitors,DrugBank
DB16852,Bruton's Tyrosine Kinase Inhibitors,DrugBank
DB16852,BSEP/ABCB11 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB16852,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB16852,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP2C19 inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB16852,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP3A Inducers,DrugBank
DB16852,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP3A Substrates,DrugBank
DB16852,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB16852,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB16852,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB16852,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB16852,Cytochrome P-450 CYP3A5 Inhibitors,DrugBank
DB16852,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown),DrugBank
DB16852,Cytochrome P-450 Enzyme Inducers,DrugBank
DB16852,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB16852,Cytochrome P-450 Substrates,DrugBank
DB16852,Enzyme Inhibitors,DrugBank
DB16852,Immunosuppressive Agents,DrugBank
DB16852,Kinase Inhibitor,DrugBank
DB16852,MATE 1 Inhibitors,DrugBank
DB16852,MATE inhibitors,DrugBank
DB16852,OAT1/SLC22A6 inhibitors,DrugBank
DB16852,OAT3/SLC22A8 Inhibitors,DrugBank
DB16852,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB16852,OATP1B3 inhibitors,DrugBank
DB16852,OCT1 inhibitors,DrugBank
DB16852,OCT2 Inhibitors,DrugBank
DB16852,P-glycoprotein inhibitors,DrugBank
DB16852,P-glycoprotein substrates,DrugBank
DB16852,Protein Kinase Inhibitors,DrugBank
DB16852,Selective Immunosuppressants,DrugBank
DB16901,Influenza Vaccines,DrugBank
DB16901,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB16901,Vaccines,DrugBank
DB16901,Viral Vaccines,DrugBank
DB16956,"Acids, Acyclic",DrugBank
DB16956,Amino Acids,DrugBank
DB16956,"Amino Acids, Branched-Chain",DrugBank
DB16956,"Amino Acids, Essential",DrugBank
DB16956,"Amino Acids, Peptides, and Proteins",DrugBank
DB16956,BCRP/ABCG2 Inhibitors,DrugBank
DB16956,BSEP/ABCB11 Inhibitors,DrugBank
DB16956,Fatty Acids,DrugBank
DB16956,"Fatty Acids, Volatile",DrugBank
DB16956,Lipids,DrugBank
DB16956,OAT1/SLC22A6 inhibitors,DrugBank
DB16956,OAT3/SLC22A8 Inhibitors,DrugBank
DB16956,OAT3/SLC22A8 Substrates,DrugBank
DB16956,P-glycoprotein inhibitors,DrugBank
DB16956,Valerates,DrugBank
DB17048,"Adjuvants, Immunologic",DrugBank
DB17048,Adrenal Cortex Hormones,DrugBank
DB17048,Anthelmintics,DrugBank
DB17048,Anti-Infective Agents,DrugBank
DB17048,Anticoagulants,DrugBank
DB17048,Antinematodal Agents,DrugBank
DB17048,Antineoplastic Agents,DrugBank
DB17048,"Antineoplastic Agents, Phytogenic",DrugBank
DB17048,Antiparasitic Agents,DrugBank
DB17048,Cardiotonic Agents,DrugBank
DB17048,Cardiovascular Agents,DrugBank
DB17048,"Compounds used in a research, industrial, or household setting",DrugBank
DB17048,Hematologic Agents,DrugBank
DB17048,Hormonal Contraceptives for Systemic Use,DrugBank
DB17048,Immunologic Factors,DrugBank
DB17048,Naphthalenes,DrugBank
DB17048,Protective Agents,DrugBank
DB17048,Quinones,DrugBank
DB17048,Reproductive Control Agents,DrugBank
DB17048,Superoxides,DrugBank
DB17083,Anti-Gonadotropin-Releasing Hormones,DrugBank
DB17083,BCRP/ABCG2 Substrates,DrugBank
DB17083,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB17083,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB17083,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB17083,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB17083,Cytochrome P-450 CYP3A Substrates,DrugBank
DB17083,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB17083,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB17083,Cytochrome P-450 Substrates,DrugBank
DB17083,Gonadotropin Releasing Hormone Receptor Antagonists,DrugBank
DB17083,Hypothalamic Hormones,DrugBank
DB17083,OAT1/SLC22A6 inhibitors,DrugBank
DB17083,OAT3/SLC22A8 Inhibitors,DrugBank
DB17083,OAT3/SLC22A8 Substrates,DrugBank
DB17083,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB17083,OATP1B1/SLCO1B1 Substrates,DrugBank
DB17083,OATP1B3 inhibitors,DrugBank
DB17083,OATP1B3 substrates,DrugBank
DB17083,Pituitary and Hypothalamic Hormones and Analogues,DrugBank
DB17083,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB17088,"Amino Acids, Peptides, and Proteins",DrugBank
DB17088,Antigens,DrugBank
DB17088,Biological Factors,DrugBank
DB17088,Biological Products,DrugBank
DB17088,Complex Mixtures,DrugBank
DB17088,COVID-19 Vaccines,DrugBank
DB17088,mRNA Vaccines,DrugBank
DB17088,Nucleic Acid-Based Vaccines,DrugBank
DB17088,Proteins,DrugBank
DB17088,Recombinant Proteins,DrugBank
DB17088,Vaccines,DrugBank
DB17088,"Vaccines, Acellular",DrugBank
DB17088,"Vaccines, Subunit",DrugBank
DB17088,"Vaccines, Synthetic",DrugBank
DB17088,Viral Vaccines,DrugBank
DB17097,Amines,DrugBank
DB17097,Antineoplastic Agents,DrugBank
DB17097,Antineoplastic and Immunomodulating Agents,DrugBank
DB17097,BCRP/ABCG2 Inhibitors,DrugBank
DB17097,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB17097,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB17097,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB17097,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB17097,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB17097,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB17097,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB17097,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB17097,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB17097,Cytochrome P-450 CYP3A Inducers,DrugBank
DB17097,Cytochrome P-450 CYP3A Substrates,DrugBank
DB17097,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB17097,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB17097,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB17097,Cytochrome P-450 Enzyme Inducers,DrugBank
DB17097,Cytochrome P-450 Substrates,DrugBank
DB17097,Enzyme Inhibitors,DrugBank
DB17097,Isocitrate dehydrogenase (IDH) inhibitors,DrugBank
DB17097,Isocitrate Dehydrogenase 1 Inhibitor,DrugBank
DB17097,Isocitrate Dehydrogenase 2 Inhibitor,DrugBank
DB17097,Isocitrate dehydrogenase-1 (IDH1) inhibitors,DrugBank
DB17097,Isocitrate dehydrogenase-2 (IDH2) Inhibitors,DrugBank
DB17097,Polyamines,DrugBank
DB17107,Antineoplastic Agents,DrugBank
DB17107,Antineoplastic and Immunomodulating Agents,DrugBank
DB17107,Antineoplastic cell and gene therapy,DrugBank
DB17107,Autologous Cellular Immunotherapy,DrugBank
DB17107,Cancer immunotherapy,DrugBank
DB17107,Immunotherapy,DrugBank
DB17171,BCRP/ABCG2 Substrates,DrugBank
DB17171,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB17171,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB17171,Cytochrome P-450 CYP3A Substrates,DrugBank
DB17171,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB17171,Cytochrome P-450 Enzyme Inducers,DrugBank
DB17171,Cytochrome P-450 Substrates,DrugBank
DB17171,Menin Inhibitor,DrugBank
DB17171,P-glycoprotein substrates,DrugBank
DB17171,QTc Prolonging Agents,DrugBank
DB17171,UDP Glucuronosyltransferases Inhibitors,DrugBank
DB17171,UGT1A9 Inhibitors,DrugBank
DB17171,UGT2B17 Inhibitors,DrugBank
DB17256,"Amino Acids, Peptides, and Proteins",DrugBank
DB17256,Antibodies,DrugBank
DB17256,"Antibodies, Monoclonal",DrugBank
DB17256,Antineoplastic Agents,DrugBank
DB17256,Antineoplastic and Immunomodulating Agents,DrugBank
DB17256,Bispecific Monoclonal Antibodies,DrugBank
DB17256,Blood Proteins,DrugBank
DB17256,CD3-directed Antibody,DrugBank
DB17256,Globulins,DrugBank
DB17256,Immunoglobulins,DrugBank
DB17256,Immunoproteins,DrugBank
DB17256,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB17256,Proteins,DrugBank
DB17256,Serum Globulins,DrugBank
DB17362,Antineoplastic Agents,DrugBank
DB17362,Antineoplastic and Immunomodulating Agents,DrugBank
DB17362,Antineoplastic cell and gene therapy,DrugBank
DB17362,Autologous Cellular Immunotherapy,DrugBank
DB17362,CD19-Directed Genetically Modified Autologous T-cell Immunotherapies,DrugBank
DB17362,Genetically-modified Autologous T Cells,DrugBank
DB17447,"Amino Acids, Peptides, and Proteins",DrugBank
DB17447,"Antibodies, Monoclonal",DrugBank
DB17447,Bispecific Monoclonal Antibodies,DrugBank
DB17447,Blood Proteins,DrugBank
DB17447,Immunoglobulins,DrugBank
DB17447,Proteins,DrugBank
DB17447,Serum Globulins,DrugBank
DB17451,Antineoplastic Agents,DrugBank
DB17451,Antineoplastic and Immunomodulating Agents,DrugBank
DB17451,Immune Checkpoint Inhibitors,DrugBank
DB17451,Monoclonal antibodies and antibody drug conjugates,DrugBank
DB17451,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,DrugBank
DB17472,Antineoplastic Agents,DrugBank
DB17472,Antineoplastic and Immunomodulating Agents,DrugBank
DB17472,BCRP/ABCG2 Inhibitors,DrugBank
DB17472,BCRP/ABCG2 Substrates,DrugBank
DB17472,Bruton's tyrosine kinase (BTK) inhibitors,DrugBank
DB17472,Cancer immunotherapy,DrugBank
DB17472,Cytochrome P-450 CYP1A2 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB17472,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB17472,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP2C19 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP2C19 Inhibitors (weak),DrugBank
DB17472,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP2C8 Inhibitors (moderate),DrugBank
DB17472,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP3A Inducers,DrugBank
DB17472,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP3A Substrates,DrugBank
DB17472,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB17472,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB17472,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB17472,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB17472,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB17472,Cytochrome P-450 CYP3A5 Inducers,DrugBank
DB17472,Cytochrome P-450 CYP3A5 Inducers (strength unknown),DrugBank
DB17472,Cytochrome P-450 Enzyme Inducers,DrugBank
DB17472,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB17472,Cytochrome P-450 Substrates,DrugBank
DB17472,Enzyme Inhibitors,DrugBank
DB17472,Immunosuppressive Agents,DrugBank
DB17472,Immunotherapy,DrugBank
DB17472,Kinase Inhibitor,DrugBank
DB17472,Myelosuppressive Agents,DrugBank
DB17472,P-glycoprotein inhibitors,DrugBank
DB17472,P-glycoprotein substrates,DrugBank
DB17472,Protein Kinase Inhibitors,DrugBank
DB17472,Tyrosine Kinase Inhibitors,DrugBank
DB17472,UGT1A9 Substrates,DrugBank
DB17520,BCRP/ABCG2 Inhibitors,DrugBank
DB17520,BSEP/ABCB11 Inhibitors,DrugBank
DB17520,Kinase Inhibitor,DrugBank
DB17520,MATE 1 Inhibitors,DrugBank
DB17520,MATE 2 Inhibitors,DrugBank
DB17520,MATE inhibitors,DrugBank
DB17520,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB17520,OATP1B3 inhibitors,DrugBank
DB17520,OCT2 Inhibitors,DrugBank
DB17520,P-glycoprotein inhibitors,DrugBank
DB17520,P-glycoprotein substrates,DrugBank
DB17709,BCRP/ABCG2 Inhibitors,DrugBank
DB17709,BCRP/ABCG2 Substrates,DrugBank
DB17709,BSEP/ABCB11 Inhibitors,DrugBank
DB17709,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB17709,Cytochrome P-450 CYP3A Substrates,DrugBank
DB17709,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB17709,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB17709,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB17709,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB17709,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB17709,Cytochrome P-450 Substrates,DrugBank
DB17709,Kinase Inhibitor,DrugBank
DB17709,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB17709,OATP1B3 inhibitors,DrugBank
DB17709,P-glycoprotein inhibitors,DrugBank
DB17709,P-glycoprotein substrates,DrugBank
DB17725,"Amino Acids, Peptides, and Proteins",DrugBank
DB17725,Antibodies,DrugBank
DB17725,"Antibodies, Monoclonal",DrugBank
DB17725,Blood and Blood Forming Organs,DrugBank
DB17725,Blood Proteins,DrugBank
DB17725,Globulins,DrugBank
DB17725,Hemostatics,DrugBank
DB17725,Immunoglobulins,DrugBank
DB17725,Immunoproteins,DrugBank
DB17725,Proteins,DrugBank
DB17725,Serum Globulins,DrugBank
DB17762,Respiratory syncytial virus (RSV) vaccines,DrugBank
DB17762,Vaccines,DrugBank
DB17762,Viral Vaccines,DrugBank
DB17929,Acetylcholine Release Inhibitors,DrugBank
DB17929,Botulinum Toxins,DrugBank
DB17929,"Botulinum Toxins, Type A",DrugBank
DB17929,Central Nervous System Depressants,DrugBank
DB17929,Muscle Relaxants,DrugBank
DB17929,"Muscle Relaxants, Peripherally Acting Agents",DrugBank
DB17929,Musculo-Skeletal System,DrugBank
DB17929,Neuromuscular Agents,DrugBank
DB17929,Neuromuscular Blocking Agents,DrugBank
DB17999,"Acids, Carbocyclic",DrugBank
DB17999,"Amyloidosis, prevention & control",DrugBank
DB17999,BCRP/ABCG2 Substrates,DrugBank
DB17999,Benzene Derivatives,DrugBank
DB17999,Benzoates,DrugBank
DB17999,Cardiac Therapy,DrugBank
DB17999,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB17999,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB17999,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB17999,OAT1/SLC22A6 inhibitors,DrugBank
DB17999,OAT3/SLC22A8 Inhibitors,DrugBank
DB17999,Transthyretin Stabilizers,DrugBank
DB17999,UGT1A1 Substrates,DrugBank
DB17999,UGT1A9 Substrates,DrugBank
DB17999,UGT2B7 substrates,DrugBank
DB18000,Adrenal Cortex Hormones,DrugBank
DB18000,"Contraceptive Agents, Female",DrugBank
DB18000,"Contraceptive Agents, Hormonal",DrugBank
DB18000,"Contraceptives, Oral",DrugBank
DB18000,"Contraceptives, Oral, Hormonal",DrugBank
DB18000,"Contraceptives, Oral, Synthetic",DrugBank
DB18000,Fused-Ring Compounds,DrugBank
DB18000,Hormonal Contraceptives for Systemic Use,DrugBank
DB18000,Hormones,DrugBank
DB18000,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB18000,Pregnanes,DrugBank
DB18000,Pregnenediones,DrugBank
DB18000,Pregnenes,DrugBank
DB18000,Progesterone and Derivatives,DrugBank
DB18000,Progestins,DrugBank
DB18000,Reproductive Control Agents,DrugBank
DB18000,Steroids,DrugBank
DB18002,Alkaloids,DrugBank
DB18002,Drugs for Obstructive Airway Diseases,DrugBank
DB18002,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB18002,Purines,DrugBank
DB18002,Purinones,DrugBank
DB18002,Xanthine derivatives,DrugBank
DB18228,COVID-19 Vaccines,DrugBank
DB18228,mRNA Vaccines,DrugBank
DB18228,Vaccines,DrugBank
DB18228,Viral Vaccines,DrugBank
DB18237,Cycloparaffins,DrugBank
DB18237,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18237,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18237,Cytochrome P-450 Substrates,DrugBank
DB18237,MATE 1 Inhibitors,DrugBank
DB18237,MATE 2 Inhibitors,DrugBank
DB18237,MATE inhibitors,DrugBank
DB18237,P-glycoprotein inhibitors,DrugBank
DB18237,P-glycoprotein substrates,DrugBank
DB18237,Phosphodiesterase 4 Inhibitors,DrugBank
DB18237,Phosphodiesterase Inhibitors,DrugBank
DB18305,BCRP/ABCG2 Inhibitors,DrugBank
DB18305,BCRP/ABCG2 Substrates,DrugBank
DB18305,Blood and Blood Forming Organs,DrugBank
DB18305,BSEP/ABCB11 Inhibitors,DrugBank
DB18305,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB18305,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB18305,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB18305,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB18305,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18305,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB18305,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB18305,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18305,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18305,Cytochrome P-450 Substrates,DrugBank
DB18305,Drugs Used in Hereditary Angioedema,DrugBank
DB18305,MATE 1 Inhibitors,DrugBank
DB18305,MATE 2 Inhibitors,DrugBank
DB18305,MATE inhibitors,DrugBank
DB18305,OAT3/SLC22A8 Inhibitors,DrugBank
DB18305,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB18305,OATP1B3 inhibitors,DrugBank
DB18305,OCT2 Inhibitors,DrugBank
DB18305,P-glycoprotein substrates,DrugBank
DB18305,Plasma Kallikrein Inhibitor,DrugBank
DB18373,BCRP/ABCG2 Inhibitors,DrugBank
DB18373,Cystic Fibrosis Transmembrane Conductance Regulator Correctors,DrugBank
DB18490,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB18490,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB18490,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB18490,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18490,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18490,Cytochrome P-450 Substrates,DrugBank
DB18515,"Acids, Carbocyclic",DrugBank
DB18515,Amides,DrugBank
DB18515,Benzene Derivatives,DrugBank
DB18515,Benzoates,DrugBank
DB18515,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB18515,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB18515,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18515,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB18515,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB18515,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18515,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18515,Cytochrome P-450 Substrates,DrugBank
DB18515,MATE 1 Inhibitors,DrugBank
DB18515,MATE 1 Substrates,DrugBank
DB18515,MATE inhibitors,DrugBank
DB18515,MATE substrates,DrugBank
DB18515,Menin Inhibitor,DrugBank
DB18515,OAT3/SLC22A8 Substrates,DrugBank
DB18515,OCT1 substrates,DrugBank
DB18515,OCT2 Substrates,DrugBank
DB18515,QTc Prolonging Agents,DrugBank
DB18518,Corticotropin-releasing Factor Type 1 Receptor Antagonist,DrugBank
DB18518,Cytochrome P-450 CYP2B6 Substrates,DrugBank
DB18518,Cytochrome P-450 CYP2C19 Substrates,DrugBank
DB18518,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB18518,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18518,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18518,Cytochrome P-450 Substrates,DrugBank
DB18518,"Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors",DrugBank
DB18518,Sulfur Compounds,DrugBank
DB18661,Influenza Vaccines,DrugBank
DB18661,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB18661,Vaccines,DrugBank
DB18661,Viral Vaccines,DrugBank
DB18676,"Amino Acids, Peptides, and Proteins",DrugBank
DB18676,Calcium Homeostasis,DrugBank
DB18676,Hormones,DrugBank
DB18676,"Hormones, Hormone Substitutes, and Hormone Antagonists",DrugBank
DB18676,Parathyroid Hormones and Analogues,DrugBank
DB18676,Peptide Hormones,DrugBank
DB18676,Peptides,DrugBank
DB18676,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins",DrugBank
DB18676,Thyroid Products,DrugBank
DB18701,Biological Products,DrugBank
DB18701,Chikungunya Fever,DrugBank
DB18701,Complex Mixtures,DrugBank
DB18701,Live vaccines,DrugBank
DB18701,Vaccines,DrugBank
DB18701,Viral Vaccines,DrugBank
DB18704,"Adjuvants, Immunologic",DrugBank
DB18704,"Amino Acids, Peptides, and Proteins",DrugBank
DB18704,Antineoplastic and Immunomodulating Agents,DrugBank
DB18704,Biological Factors,DrugBank
DB18704,Carbohydrates,DrugBank
DB18704,Colony-Stimulating Factors,DrugBank
DB18704,Cytokines,DrugBank
DB18704,Glycoconjugates,DrugBank
DB18704,Glycoproteins,DrugBank
DB18704,Granulocyte Colony-Stimulating Factors,DrugBank
DB18704,Hematopoietic Cell Growth Factors,DrugBank
DB18704,Intercellular Signaling Peptides and Proteins,DrugBank
DB18704,Leukocyte Growth Factor,DrugBank
DB18704,Peptides,DrugBank
DB18704,Proteins,DrugBank
DB18704,Recombinant Proteins,DrugBank
DB18705,COVID-19 Vaccines,DrugBank
DB18705,Vaccines,DrugBank
DB18705,Viral Vaccines,DrugBank
DB18711,BCRP/ABCG2 Inhibitors,DrugBank
DB18711,Cytochrome P-450 CYP1A2 Inducers,DrugBank
DB18711,Cytochrome P-450 CYP1A2 Inducers (strength unknown),DrugBank
DB18711,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB18711,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB18711,Cytochrome P-450 CYP2C8 Substrates,DrugBank
DB18711,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB18711,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB18711,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB18711,Cytochrome P-450 CYP3A Inducers,DrugBank
DB18711,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18711,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB18711,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB18711,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18711,Cytochrome P-450 Enzyme Inducers,DrugBank
DB18711,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18711,Cytochrome P-450 Substrates,DrugBank
DB18711,Kinase Inhibitor,DrugBank
DB18711,MATE 1 Substrates,DrugBank
DB18711,MATE 2 Inhibitors,DrugBank
DB18711,MATE inhibitors,DrugBank
DB18711,MATE substrates,DrugBank
DB18711,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB18711,P-glycoprotein inhibitors,DrugBank
DB18711,P-glycoprotein substrates,DrugBank
DB18711,QTc Prolonging Agents,DrugBank
DB18711,ROS1 tyrosine kinase inhibitors,DrugBank
DB18711,Tyrosine Kinase Inhibitors,DrugBank
DB18716,Anti-Bacterial Agents,DrugBank
DB18716,Anti-Infective Agents,DrugBank
DB18716,Aza Compounds,DrugBank
DB18716,Beta-Lactam Antibacterials,DrugBank
DB18716,beta-Lactamase Inhibitors,DrugBank
DB18716,Cytochrome P-450 CYP2E1 Inhibitors,DrugBank
DB18716,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown),DrugBank
DB18716,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18716,Enzyme Inhibitors,DrugBank
DB18716,Extended-spectrum beta-lactamase inhibitors,DrugBank
DB18739,"Amino Acids, Peptides, and Proteins",DrugBank
DB18739,Antigens,DrugBank
DB18739,Biological Factors,DrugBank
DB18739,Biological Products,DrugBank
DB18739,Complex Mixtures,DrugBank
DB18739,mRNA Vaccines,DrugBank
DB18739,Nucleic Acid-Based Vaccines,DrugBank
DB18739,Proteins,DrugBank
DB18739,Recombinant Proteins,DrugBank
DB18739,Respiratory syncytial virus (RSV) vaccines,DrugBank
DB18739,Vaccines,DrugBank
DB18739,"Vaccines, Acellular",DrugBank
DB18739,"Vaccines, Subunit",DrugBank
DB18739,"Vaccines, Synthetic",DrugBank
DB18739,Viral Vaccines,DrugBank
DB18762,BCRP/ABCG2 Inhibitors,DrugBank
DB18762,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18762,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18762,Cytochrome P-450 CYP3A5 Substrates,DrugBank
DB18762,Cytochrome P-450 Substrates,DrugBank
DB18762,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,DrugBank
DB18762,Kinase Inhibitor,DrugBank
DB18762,UGT1A4 substrates,DrugBank
DB18847,BCRP/ABCG2 Inhibitors,DrugBank
DB18847,BCRP/ABCG2 Substrates,DrugBank
DB18847,Bile Salt Export Pump Inhibitors,DrugBank
DB18847,BSEP/ABCB11 Inhibitors,DrugBank
DB18847,Cytochrome P-450 CYP1A2 Substrates,DrugBank
DB18847,Cytochrome P-450 CYP2C9 Substrates,DrugBank
DB18847,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18847,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18847,Cytochrome P-450 Substrates,DrugBank
DB18847,Janus Kinase Inhibitor,DrugBank
DB18847,Janus Kinase Inhibitors,DrugBank
DB18847,MATE 2 Inhibitors,DrugBank
DB18847,MATE inhibitors,DrugBank
DB18847,OAT3/SLC22A8 Inhibitors,DrugBank
DB18847,P-glycoprotein substrates,DrugBank
DB18877,"Amino Acids, Peptides, and Proteins",DrugBank
DB18877,Antibodies,DrugBank
DB18877,Blood Proteins,DrugBank
DB18877,Globulins,DrugBank
DB18877,Immunoglobulins,DrugBank
DB18877,Immunoproteins,DrugBank
DB18877,Proteins,DrugBank
DB18877,Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody,DrugBank
DB18877,Serum Globulins,DrugBank
DB18925,"Acids, Acyclic",DrugBank
DB18925,Acrylates,DrugBank
DB18925,Amides,DrugBank
DB18925,BCRP/ABCG2 Inhibitors,DrugBank
DB18925,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB18925,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB18925,Cytochrome P-450 CYP3A Inducers,DrugBank
DB18925,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18925,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB18925,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB18925,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18925,Cytochrome P-450 Enzyme Inducers,DrugBank
DB18925,Cytochrome P-450 Substrates,DrugBank
DB18925,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,DrugBank
DB18925,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB18925,P-glycoprotein inhibitors,DrugBank
DB18925,Tyrosine Kinase Inhibitors,DrugBank
DB18927,Amines,DrugBank
DB18927,Analgesics,DrugBank
DB18927,"Analgesics, Non-Narcotic",DrugBank
DB18927,Cardiovascular Agents,DrugBank
DB18927,Central Nervous System Agents,DrugBank
DB18927,Cytochrome P-450 CYP2B6 Inducers,DrugBank
DB18927,Cytochrome P-450 CYP2B6 Inducers (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP2C19 Inducers,DrugBank
DB18927,Cytochrome P-450 CYP2C19 Inducers (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP2C8 Inducers,DrugBank
DB18927,Cytochrome P-450 CYP2C8 Inducers (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB18927,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP2C9 Inducers,DrugBank
DB18927,Cytochrome P-450 CYP2C9 Inducers (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB18927,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP3A Inducers,DrugBank
DB18927,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18927,Cytochrome P-450 CYP3A4 Inducers,DrugBank
DB18927,Cytochrome P-450 CYP3A4 Inducers (strength unknown),DrugBank
DB18927,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18927,Cytochrome P-450 Enzyme Inducers,DrugBank
DB18927,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18927,Cytochrome P-450 Substrates,DrugBank
DB18927,Membrane Transport Modulators,DrugBank
DB18927,OAT3/SLC22A8 Inhibitors,DrugBank
DB18927,OATP1B1/SLCO1B1 Inhibitors,DrugBank
DB18927,OATP1B3 inhibitors,DrugBank
DB18927,P-glycoprotein substrates,DrugBank
DB18927,Peripheral Nervous System Agents,DrugBank
DB18927,Pyridines,DrugBank
DB18927,Sensory System Agents,DrugBank
DB18927,Sodium Channel Blockers,DrugBank
DB18927,Voltage-Gated Sodium Channel Blockers,DrugBank
DB18968,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB18968,Cytochrome P-450 CYP3A Substrates,DrugBank
DB18968,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB18968,Cytochrome P-450 CYP3A4 Inhibitors (weak),DrugBank
DB18968,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB18968,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB18968,Cytochrome P-450 Substrates,DrugBank
DB18968,Neurokinin 1 Antagonists,DrugBank
DB18968,Neurokinin 3 Receptor Antagonist,DrugBank
DB18968,P-glycoprotein substrates,DrugBank
DB18968,"Receptors, Neurokinin-3, antagonists & inhibitors",DrugBank
DB18968,Substance P/Neurokinin-1 Receptor Antagonist,DrugBank
DB19043,BCRP/ABCG2 Inhibitors,DrugBank
DB19043,Cytochrome P-450 CYP2B6 Inhibitors,DrugBank
DB19043,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown),DrugBank
DB19043,Cytochrome P-450 CYP2C9 Inhibitors,DrugBank
DB19043,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown),DrugBank
DB19043,Cytochrome P-450 CYP3A Substrates,DrugBank
DB19043,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB19043,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB19043,Cytochrome P-450 Substrates,DrugBank
DB19043,Estrogen Receptor Antagonists,DrugBank
DB19043,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB19043,P-glycoprotein inhibitors,DrugBank
DB19043,Pyrans,DrugBank
DB19043,Selective Estrogen Receptor Degraders,DrugBank
DB19043,UGT1A1 Substrates,DrugBank
DB19043,UGT1A3 substrates,DrugBank
DB19043,UGT1A9 Substrates,DrugBank
DB19325,Anticholinergic Agents,DrugBank
DB19325,Cytochrome P-450 CYP2D6 Inhibitors,DrugBank
DB19325,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown),DrugBank
DB19325,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB19325,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB19325,Cytochrome P-450 CYP3A Substrates,DrugBank
DB19325,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB19325,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown),DrugBank
DB19325,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB19325,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB19325,Cytochrome P-450 Substrates,DrugBank
DB19325,MATE 1 Inhibitors,DrugBank
DB19325,MATE inhibitors,DrugBank
DB19325,Muscarinic Antagonists,DrugBank
DB19325,OCT1 inhibitors,DrugBank
DB19325,OCT2 Inhibitors,DrugBank
DB19353,Alkaloids,DrugBank
DB19353,"Alzheimer Disease, drug therapy",DrugBank
DB19353,Amaryllidaceae Alkaloids,DrugBank
DB19353,Anti-Dementia Drugs,DrugBank
DB19353,Benzazepines,DrugBank
DB19353,Bradycardia-Causing Agents,DrugBank
DB19353,Cholinergic Agents,DrugBank
DB19353,Cholinesterase Inhibitors,DrugBank
DB19353,Cytochrome P-450 CYP2D6 Substrates,DrugBank
DB19353,Cytochrome P-450 CYP3A Substrates,DrugBank
DB19353,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB19353,Cytochrome P-450 Substrates,DrugBank
DB19353,"Heterocyclic Compounds, Fused-Ring",DrugBank
DB19353,P-glycoprotein inhibitors,DrugBank
DB19413,Influenza Vaccines,DrugBank
DB19413,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB19413,Vaccines,DrugBank
DB19413,Viral Vaccines,DrugBank
DB21667,BCRP/ABCG2 Substrates,DrugBank
DB21667,Cytochrome P-450 CYP1A1 Substrates,DrugBank
DB21667,Cytochrome P-450 CYP2C8 Inhibitors,DrugBank
DB21667,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown),DrugBank
DB21667,Cytochrome P-450 CYP3A Inhibitors,DrugBank
DB21667,Cytochrome P-450 CYP3A Substrates,DrugBank
DB21667,Cytochrome P-450 CYP3A4 Inhibitors,DrugBank
DB21667,Cytochrome P-450 CYP3A4 Inhibitors (moderate),DrugBank
DB21667,Cytochrome P-450 CYP3A4 Substrates,DrugBank
DB21667,Cytochrome P-450 Enzyme Inhibitors,DrugBank
DB21667,Cytochrome P-450 Substrates,DrugBank
DB21667,MATE 1 Inhibitors,DrugBank
DB21667,MATE 2 Inhibitors,DrugBank
DB21667,MATE 2-K Inhibitors,DrugBank
DB21667,MATE inhibitors,DrugBank
DB21667,P-glycoprotein inhibitors,DrugBank
DB21667,P-glycoprotein substrates,DrugBank
DB21908,"Amino Acids, Peptides, and Proteins",DrugBank
DB21908,Antiinfectives for Systemic Use,DrugBank
DB21908,Antiviral monoclonal antibodies,DrugBank
DB21908,Blood Proteins,DrugBank
DB21908,Immune Sera and Immunoglobulins,DrugBank
DB21908,Immunoglobulins,DrugBank
DB21908,Proteins,DrugBank
DB21908,Serum Globulins,DrugBank
DB22668,COVID-19 Vaccines,DrugBank
DB22668,mRNA Vaccines,DrugBank
DB22668,Vaccines,DrugBank
DB22668,Viral Vaccines,DrugBank
DB22790,Enzymes,DrugBank
DB22790,Enzymes and Coenzymes,DrugBank
DB22790,Glycoside Hydrolases,DrugBank
DB22790,Recombinant Proteins,DrugBank
DB31654,Influenza Vaccines,DrugBank
DB31654,Live Attenuated Influenza A Virus Vaccine,DrugBank
DB31654,Vaccines,DrugBank
DB31654,Viral Vaccines,DrugBank
